identification	O	1
of	O	1
apc2	O	1
,	O	1
a	O	1
homologue	O	1
of	O	1
the	O	1
adenomatous	B-Disease	1
polyposis	I-Disease	1
coli	I-Disease	1
tumour	I-Disease	1
suppressor	O	1
.	O	1
the	O	2
adenomatous	B-Disease	2
polyposis	I-Disease	2
coli	I-Disease	2
(	I-Disease	2
apc	I-Disease	2
)	I-Disease	2
tumour	I-Disease	2
-	O	2
suppressor	O	2
protein	O	2
controls	O	2
the	O	2
wnt	O	2
signalling	O	2
pathway	O	2
by	O	2
forming	O	2
a	O	2
complex	O	2
with	O	2
glycogen	O	2
synthase	O	2
kinase	O	2
3beta	O	2
(	O	2
gsk	O	2
-	O	2
3beta	O	2
)	O	2
,	O	2
axin	O	2
/	O	2
conductin	O	2
and	O	2
betacatenin	O	2
.	O	2
in	O	4
colon	B-Disease	4
carcinoma	I-Disease	4
cells	O	4
,	O	4
loss	O	4
of	O	4
apc	O	4
leads	O	4
to	O	4
the	O	4
accumulation	O	4
of	O	4
betacatenin	O	4
in	O	4
the	O	4
nucleus	O	4
,	O	4
where	O	4
it	O	4
binds	O	4
to	O	4
and	O	4
activates	O	4
the	O	4
tcf	O	4
-	O	4
4	O	4
transcription	O	4
factor	O	4
(	O	4
reviewed	O	4
in	O	4
[	O	4
1	O	4
]	O	4
[	O	4
2	O	4
]	O	4
)	O	4
.	O	4
like	O	7
apc	O	7
,	O	7
apc2	O	7
regulates	O	7
the	O	7
formation	O	7
of	O	7
active	O	7
betacatenin	O	7
-	O	7
tcf	O	7
complexes	O	7
,	O	7
as	O	7
demonstrated	O	7
using	O	7
transient	O	7
transcriptional	O	7
activation	O	7
assays	O	7
in	O	7
apc	O	7
-	O	7
/	O	7
-	O	7
colon	B-Disease	7
carcinoma	I-Disease	7
cells	O	7
.	O	7
apc	O	10
and	O	10
apc2	O	10
may	O	10
therefore	O	10
have	O	10
comparable	O	10
functions	O	10
in	O	10
development	O	10
and	O	10
cancer	B-Disease	10
.	O	10
a	O	11
common	O	11
msh2	O	11
mutation	O	11
in	O	11
english	O	11
and	O	11
north	O	11
american	O	11
hnpcc	B-Disease	11
families	O	11
:	O	11
origin	O	11
,	O	11
phenotypic	O	11
expression	O	11
,	O	11
and	O	11
sex	O	11
specific	O	11
differences	O	11
in	O	11
colorectal	B-Disease	11
cancer	I-Disease	11
.	O	11
the	O	12
frequency	O	12
,	O	12
origin	O	12
,	O	12
and	O	12
phenotypic	O	12
expression	O	12
of	O	12
a	O	12
germline	O	12
msh2	O	12
gene	O	12
mutation	O	12
previously	O	12
identified	O	12
in	O	12
seven	O	12
kindreds	O	12
with	O	12
hereditary	B-Disease	12
non	I-Disease	12
-	I-Disease	12
polyposis	I-Disease	12
cancer	I-Disease	12
syndrome	I-Disease	12
(	O	12
hnpcc	B-Disease	12
)	O	12
was	O	12
investigated	O	12
.	O	12
although	O	14
this	O	14
mutation	O	14
was	O	14
initially	O	14
detected	O	14
in	O	14
four	O	14
of	O	14
33	O	14
colorectal	B-Disease	14
cancer	I-Disease	14
families	O	14
analysed	O	14
from	O	14
eastern	O	14
england	O	14
,	O	14
more	O	14
extensive	O	14
analysis	O	14
has	O	14
reduced	O	14
the	O	14
frequency	O	14
to	O	14
four	O	14
of	O	14
52	O	14
(	O	14
8	O	14
%	O	14
)	O	14
english	O	14
hnpcc	B-Disease	14
kindreds	O	14
analysed	O	14
.	O	14
in	O	15
contrast	O	15
,	O	15
the	O	15
msh2	O	15
mutation	O	15
was	O	15
identified	O	15
in	O	15
10	O	15
of	O	15
20	O	15
(	O	15
50	O	15
%	O	15
)	O	15
separately	O	15
identified	O	15
colorectal	B-Disease	15
families	O	15
from	O	15
newfoundland	O	15
.	O	15
to	O	16
investigate	O	16
the	O	16
origin	O	16
of	O	16
this	O	16
mutation	O	16
in	O	16
colorectal	B-Disease	16
cancer	I-Disease	16
families	O	16
from	O	16
england	O	16
(	O	16
n	O	16
=	O	16
4	O	16
)	O	16
,	O	16
newfoundland	O	16
(	O	16
n	O	16
=	O	16
10	O	16
)	O	16
,	O	16
and	O	16
the	O	16
united	O	16
states	O	16
(	O	16
n	O	16
=	O	16
3	O	16
)	O	16
,	O	16
haplotype	O	16
analysis	O	16
using	O	16
microsatellite	O	16
markers	O	16
linked	O	16
to	O	16
msh2	O	16
was	O	16
performed	O	16
.	O	16
these	O	19
findings	O	19
suggested	O	19
a	O	19
founder	O	19
effect	O	19
within	O	19
newfoundland	O	19
similar	O	19
to	O	19
that	O	19
reported	O	19
by	O	19
others	O	19
for	O	19
two	O	19
mlh1	O	19
mutations	O	19
in	O	19
finnish	O	19
hnpcc	B-Disease	19
families	O	19
.	O	19
we	O	20
calculated	O	20
age	O	20
related	O	20
risks	O	20
of	O	20
all	O	20
,	O	20
colorectal	B-Disease	20
,	I-Disease	20
endometrial	I-Disease	20
,	I-Disease	20
and	I-Disease	20
ovarian	I-Disease	20
cancers	I-Disease	20
in	O	20
nt943	O	20
+	O	20
3	O	20
a	O	20
-	O	20
-	O	20
>	O	20
t	O	20
msh2	O	20
mutation	O	20
carriers	O	20
(	O	20
n	O	20
=	O	20
76	O	20
)	O	20
for	O	20
all	O	20
patients	O	20
and	O	20
for	O	20
men	O	20
and	O	20
women	O	20
separately	O	20
.	O	20
for	O	21
both	O	21
sexes	O	21
combined	O	21
,	O	21
the	O	21
penetrances	O	21
at	O	21
age	O	21
60	O	21
years	O	21
for	O	21
all	O	21
cancers	B-Disease	21
and	O	21
for	O	21
colorectal	B-Disease	21
cancer	I-Disease	21
were	O	21
0	O	21
.	O	21
the	O	24
risk	O	24
of	O	24
colorectal	B-Disease	24
cancer	I-Disease	24
was	O	24
significantly	O	24
higher	O	24
(	O	24
p	O	24
<	O	24
0	O	24
.	O	24
01	O	24
)	O	24
in	O	24
males	O	24
than	O	24
females	O	24
(	O	24
0	O	24
.	O	24
63	O	24
v	O	24
0	O	24
.	O	24
30	O	24
and	O	24
0	O	24
.	O	24
84	O	24
v	O	24
0	O	24
.	O	24
44	O	24
at	O	24
ages	O	24
50	O	24
and	O	24
60	O	24
years	O	24
,	O	24
respectively	O	24
)	O	24
.	O	24
for	O	25
females	O	25
there	O	25
was	O	25
a	O	25
high	O	25
risk	O	25
of	O	25
endometrial	B-Disease	25
cancer	I-Disease	25
(	O	25
0	O	25
.	O	25
5	O	25
at	O	25
age	O	25
60	O	25
years	O	25
)	O	25
and	O	25
premenopausal	B-Disease	25
ovarian	I-Disease	25
cancer	I-Disease	25
(	O	25
0	O	25
.	O	25
2	O	25
at	O	25
50	O	25
years	O	25
)	O	25
.	O	25
these	O	26
intersex	O	26
differences	O	26
in	O	26
colorectal	B-Disease	26
cancer	I-Disease	26
risks	O	26
have	O	26
implications	O	26
for	O	26
screening	O	26
programmes	O	26
and	O	26
for	O	26
attempts	O	26
to	O	26
identify	O	26
colorectal	B-Disease	26
cancer	I-Disease	26
susceptibility	O	26
modifiers	O	26
.	O	26
age	O	27
of	O	27
onset	O	27
in	O	27
huntington	B-Disease	27
disease	I-Disease	27
:	O	27
sex	O	27
specific	O	27
influence	O	27
of	O	27
apolipoprotein	O	27
e	O	27
genotype	O	27
and	O	27
normal	O	27
cag	O	27
repeat	O	27
length	O	27
.	O	27
age	O	28
of	O	28
onset	O	28
(	O	28
ao	O	28
)	O	28
of	O	28
huntington	B-Disease	28
disease	I-Disease	28
(	O	28
hd	B-Disease	28
)	O	28
is	O	28
known	O	28
to	O	28
be	O	28
correlated	O	28
with	O	28
the	O	28
length	O	28
of	O	28
an	O	28
expanded	O	28
cag	O	28
repeat	O	28
in	O	28
the	O	28
hd	B-Disease	28
gene	O	28
.	O	28
apolipoprotein	O	29
e	O	29
(	O	29
apoe	O	29
)	O	29
genotype	O	29
,	O	29
in	O	29
turn	O	29
,	O	29
is	O	29
known	O	29
to	O	29
influence	O	29
ao	O	29
in	O	29
alzheimer	B-Disease	29
disease	I-Disease	29
,	O	29
rendering	O	29
the	O	29
apoe	O	29
gene	O	29
a	O	29
likely	O	29
candidate	O	29
to	O	29
affect	O	29
ao	O	29
in	O	29
other	O	29
neurological	B-Disease	29
diseases	I-Disease	29
too	O	29
.	O	29
we	O	30
therefore	O	30
determined	O	30
apoe	O	30
genotype	O	30
and	O	30
normal	O	30
cag	O	30
repeat	O	30
length	O	30
in	O	30
the	O	30
hd	B-Disease	30
gene	O	30
for	O	30
138	O	30
hd	B-Disease	30
patients	O	30
who	O	30
were	O	30
previously	O	30
analysed	O	30
with	O	30
respect	O	30
to	O	30
cag	O	30
repeat	O	30
length	O	30
.	O	30
in	O	32
addition	O	32
to	O	32
highlighting	O	32
the	O	32
effect	O	32
of	O	32
the	O	32
normal	O	32
repeat	O	32
length	O	32
upon	O	32
ao	O	32
in	O	32
maternally	O	32
inherited	O	32
hd	B-Disease	32
and	O	32
in	O	32
male	O	32
patients	O	32
,	O	32
we	O	32
show	O	32
that	O	32
the	O	32
apoe	O	32
epsilon2epsilon3	O	32
genotype	O	32
is	O	32
associated	O	32
with	O	32
significantly	O	32
earlier	O	32
ao	O	32
in	O	32
males	O	32
than	O	32
in	O	32
females	O	32
.	O	32
our	O	34
findings	O	34
suggest	O	34
that	O	34
subtle	O	34
differences	O	34
in	O	34
the	O	34
course	O	34
of	O	34
the	O	34
neurodegeneration	B-Disease	34
in	O	34
hd	B-Disease	34
may	O	34
allow	O	34
interacting	O	34
genes	O	34
to	O	34
exert	O	34
gender	O	34
specific	O	34
effects	O	34
upon	O	34
ao	O	34
.	O	34
familial	B-Disease	35
deficiency	I-Disease	35
of	I-Disease	35
the	I-Disease	35
seventh	I-Disease	35
component	I-Disease	35
of	I-Disease	35
complement	I-Disease	35
associated	O	35
with	O	35
recurrent	O	35
bacteremic	B-Disease	35
infections	I-Disease	35
due	I-Disease	35
to	I-Disease	35
neisseria	I-Disease	35
.	O	35
the	O	36
serum	O	36
of	O	36
a	O	36
29	O	36
-	O	36
year	O	36
old	O	36
woman	O	36
with	O	36
a	O	36
recent	O	36
episode	O	36
of	O	36
disseminated	B-Disease	36
gonococcal	I-Disease	36
infection	I-Disease	36
and	O	36
a	O	36
history	O	36
of	O	36
meningococcal	B-Disease	36
meningitis	I-Disease	36
and	O	36
arthritis	B-Disease	36
as	O	36
a	O	36
child	O	36
was	O	36
found	O	36
to	O	36
lack	O	36
serum	O	36
hemolytic	O	36
complement	O	36
activity	O	36
.	O	36
the	O	39
absence	B-Disease	39
of	I-Disease	39
functional	I-Disease	39
c7	I-Disease	39
activity	O	39
could	O	39
not	O	39
be	O	39
accounted	O	39
for	O	39
on	O	39
the	O	39
basis	O	39
of	O	39
an	O	39
inhibitor	O	39
.	O	39
complete	B-Disease	41
absence	I-Disease	41
of	I-Disease	41
c7	I-Disease	41
was	O	41
also	O	41
found	O	41
in	O	41
one	O	41
sibling	O	41
who	O	41
had	O	41
the	O	41
clinical	O	41
syndrome	O	41
of	O	41
meningococcal	B-Disease	41
meningitis	I-Disease	41
and	O	41
arthritis	B-Disease	41
as	O	41
a	O	41
child	O	41
and	O	41
in	O	41
this	O	41
siblings	O	41
clinically	O	41
well	O	41
eight	O	41
-	O	41
year	O	41
-	O	41
old	O	41
son	O	41
.	O	41
hla	O	42
histocompatibility	O	42
typing	O	42
of	O	42
the	O	42
family	O	42
members	O	42
did	O	42
not	O	42
demonstrate	O	42
evidence	O	42
for	O	42
genetic	O	42
linkage	O	42
of	O	42
c7	B-Disease	42
deficiency	I-Disease	42
with	O	42
the	O	42
major	O	42
histocompatibility	O	42
loci	O	42
.	O	42
this	O	43
report	O	43
represents	O	43
the	O	43
first	O	43
cases	O	43
of	O	43
c7	B-Disease	43
deficiency	I-Disease	43
associated	O	43
with	O	43
infectious	O	43
complications	O	43
and	O	43
suggests	O	43
that	O	43
bactericidal	O	43
activity	O	43
may	O	43
be	O	43
important	O	43
in	O	43
host	O	43
defense	O	43
against	O	43
bacteremic	B-Disease	43
neisseria	I-Disease	43
infections	I-Disease	43
.	O	43
increased	O	44
incidence	O	44
of	O	44
cancer	B-Disease	44
in	O	44
patients	O	44
with	O	44
cartilage	B-Disease	44
-	I-Disease	44
hair	I-Disease	44
hypoplasia	I-Disease	44
.	O	44
objective	O	45
previous	O	45
reports	O	45
have	O	45
suggested	O	45
an	O	45
increased	O	45
risk	O	45
of	O	45
cancer	B-Disease	45
among	O	45
patients	O	45
with	O	45
cartilage	B-Disease	45
-	I-Disease	45
hair	I-Disease	45
hypoplasia	I-Disease	45
(	O	45
chh	B-Disease	45
)	O	45
.	O	45
this	O	46
study	O	46
was	O	46
carried	O	46
out	O	46
to	O	46
further	O	46
evaluate	O	46
this	O	46
risk	O	46
among	O	46
patients	O	46
with	O	46
chh	B-Disease	46
and	O	46
their	O	46
first	O	46
-	O	46
degree	O	46
relatives	O	46
.	O	46
study	O	47
design	O	47
one	O	47
hundred	O	47
twenty	O	47
-	O	47
two	O	47
patients	O	47
with	O	47
chh	B-Disease	47
were	O	47
identified	O	47
through	O	47
2	O	47
countrywide	O	47
epidemiologic	O	47
surveys	O	47
in	O	47
1974	O	47
and	O	47
in	O	47
1986	O	47
.	O	47
this	O	49
cohort	O	49
underwent	O	49
follow	O	49
-	O	49
up	O	49
for	O	49
cancer	B-Disease	49
incidence	O	49
through	O	49
the	O	49
finnish	O	49
cancer	O	49
registry	O	49
to	O	49
the	O	49
end	O	49
of	O	49
1995	O	49
.	O	49
results	O	50
a	O	50
statistically	O	50
significant	O	50
excess	O	50
risk	O	50
of	O	50
cancer	B-Disease	50
was	O	50
seen	O	50
among	O	50
the	O	50
patients	O	50
with	O	50
chh	B-Disease	50
(	O	50
standardized	O	50
incidence	O	50
ratio	O	50
6	O	50
.	O	50
9	O	50
,	O	50
95	O	50
%	O	50
confidence	O	50
interval	O	50
2	O	50
.	O	50
3	O	50
to	O	50
16	O	50
)	O	50
,	O	50
which	O	50
was	O	50
mainly	O	50
attributable	O	50
to	O	50
non	B-Disease	50
-	I-Disease	50
hodgkins	I-Disease	50
lymphoma	I-Disease	50
(	O	50
standardized	O	50
incidence	O	50
ratio	O	50
90	O	50
,	O	50
95	O	50
%	O	50
confidence	O	50
interval	O	50
18	O	50
to	O	50
264	O	50
)	O	50
.	O	50
in	O	51
addition	O	51
,	O	51
a	O	51
significant	O	51
excess	O	51
risk	O	51
of	O	51
basal	B-Disease	51
cell	I-Disease	51
carcinoma	I-Disease	51
was	O	51
seen	O	51
(	O	51
standardized	O	51
incidence	O	51
ratio	O	51
35	O	51
,	O	51
95	O	51
%	O	51
confidence	O	51
interval	O	51
7	O	51
.	O	51
2	O	51
to	O	51
102	O	51
)	O	51
.	O	51
the	O	52
cancer	B-Disease	52
incidence	O	52
among	O	52
the	O	52
siblings	O	52
or	O	52
the	O	52
parents	O	52
did	O	52
not	O	52
differ	O	52
from	O	52
the	O	52
average	O	52
cancer	B-Disease	52
incidence	O	52
in	O	52
the	O	52
finnish	O	52
population	O	52
.	O	52
conclusions	O	53
this	O	53
study	O	53
confirms	O	53
an	O	53
increased	O	53
risk	O	53
of	O	53
cancer	B-Disease	53
,	O	53
especially	O	53
non	B-Disease	53
-	I-Disease	53
hodgkins	I-Disease	53
lymphoma	I-Disease	53
,	O	53
probably	O	53
attributable	O	53
to	O	53
defective	O	53
immunity	O	53
,	O	53
among	O	53
patients	O	53
with	O	53
chh	B-Disease	53
.	O	53
genotype	O	54
and	O	54
phenotype	O	54
in	O	54
patients	O	54
with	O	54
dihydropyrimidine	B-Disease	54
dehydrogenase	I-Disease	54
deficiency	I-Disease	54
.	O	54
dihydropyrimidine	B-Disease	55
dehydrogenase	I-Disease	55
(	I-Disease	55
dpd	I-Disease	55
)	I-Disease	55
deficiency	I-Disease	55
is	O	55
an	O	55
autosomal	B-Disease	55
recessive	I-Disease	55
disease	I-Disease	55
characterised	O	55
by	O	55
thymine	O	55
-	O	55
uraciluria	O	55
in	O	55
homozygous	O	55
deficient	O	55
patients	O	55
and	O	55
has	O	55
been	O	55
associated	O	55
with	O	55
a	O	55
variable	O	55
clinical	O	55
phenotype	O	55
.	O	55
in	O	56
order	O	56
to	O	56
understand	O	56
the	O	56
genetic	O	56
and	O	56
phenotypic	O	56
basis	O	56
for	O	56
dpd	B-Disease	56
deficiency	I-Disease	56
,	O	56
we	O	56
have	O	56
reviewed	O	56
17	O	56
families	O	56
presenting	O	56
22	O	56
patients	O	56
with	O	56
complete	O	56
deficiency	B-Disease	56
of	I-Disease	56
dpd	I-Disease	56
.	O	56
analysis	O	58
of	O	58
the	O	58
prevalence	O	58
of	O	58
the	O	58
various	O	58
mutations	O	58
among	O	58
dpd	B-Disease	58
patients	O	58
has	O	58
shown	O	58
that	O	58
the	O	58
g	O	58
-	O	58
-	O	58
>	O	58
a	O	58
point	O	58
mutation	O	58
in	O	58
the	O	58
invariant	O	58
splice	O	58
donor	O	58
site	O	58
is	O	58
by	O	58
far	O	58
the	O	58
most	O	58
common	O	58
(	O	58
52	O	58
%	O	58
)	O	58
,	O	58
whereas	O	58
the	O	58
other	O	58
six	O	58
mutations	O	58
are	O	58
less	O	58
frequently	O	58
observed	O	58
.	O	58
a	O	59
large	O	59
phenotypic	O	59
variability	O	59
has	O	59
been	O	59
observed	O	59
,	O	59
with	O	59
convulsive	B-Disease	59
disorders	I-Disease	59
,	O	59
motor	B-Disease	59
retardation	I-Disease	59
and	O	59
mental	B-Disease	59
retardation	I-Disease	59
being	O	59
the	O	59
most	O	59
abundant	O	59
manifestations	O	59
.	O	59
an	O	61
altered	O	61
beta	O	61
-	O	61
alanine	O	61
,	O	61
uracil	O	61
and	O	61
thymine	O	61
homeostasis	O	61
might	O	61
underlie	O	61
the	O	61
various	O	61
clinical	B-Disease	61
abnormalities	I-Disease	61
encountered	O	61
in	O	61
patients	O	61
with	O	61
dpd	B-Disease	61
deficiency	I-Disease	61
.	O	61
fibroblast	O	62
growth	O	62
factor	O	62
homologous	O	62
factor	O	62
2	O	62
(	O	62
fhf2	O	62
)	O	62
:	O	62
gene	O	62
structure	O	62
,	O	62
expression	O	62
and	O	62
mapping	O	62
to	O	62
the	O	62
borjeson	B-Disease	62
-	I-Disease	62
forssman	I-Disease	62
-	I-Disease	62
lehmann	I-Disease	62
syndrome	I-Disease	62
region	O	62
in	O	62
xq26	O	62
delineated	O	62
by	O	62
a	O	62
duplication	O	62
breakpoint	O	62
in	O	62
a	O	62
bfls	B-Disease	62
-	O	62
like	O	62
patient	O	62
.	O	62
borjeson	B-Disease	63
-	I-Disease	63
forssman	I-Disease	63
-	I-Disease	63
lehmann	I-Disease	63
syndrome	I-Disease	63
(	O	63
bfls	B-Disease	63
)	O	63
is	O	63
a	O	63
syndromal	O	63
x	B-Disease	63
-	I-Disease	63
linked	I-Disease	63
mental	I-Disease	63
retardation	I-Disease	63
,	O	63
which	O	63
maps	O	63
by	O	63
linkage	O	63
to	O	63
the	O	63
q26	O	63
region	O	63
of	O	63
the	O	63
human	O	63
x	O	63
chromosome	O	63
.	O	63
we	O	64
have	O	64
identified	O	64
a	O	64
male	O	64
patient	O	64
with	O	64
bfls	B-Disease	64
-	O	64
like	O	64
features	O	64
and	O	64
a	O	64
duplication	O	64
,	O	64
46	O	64
,	O	64
y	O	64
,	O	64
dup	O	64
(	O	64
x	O	64
)	O	64
(	O	64
q26q28	O	64
)	O	64
,	O	64
inherited	O	64
from	O	64
his	O	64
phenotypically	O	64
normal	O	64
mother	O	64
.	O	64
the	O	73
fhf2	O	73
gene	O	73
localisation	O	73
and	O	73
tissue	O	73
-	O	73
specific	O	73
expression	O	73
pattern	O	73
suggest	O	73
it	O	73
to	O	73
be	O	73
a	O	73
candidate	O	73
gene	O	73
for	O	73
familial	O	73
cases	O	73
of	O	73
the	O	73
bfls	B-Disease	73
syndrome	I-Disease	73
and	O	73
other	O	73
syndromal	O	73
and	O	73
non	O	73
-	O	73
specific	O	73
forms	O	73
of	O	73
x	B-Disease	73
-	I-Disease	73
linked	I-Disease	73
mental	I-Disease	73
retardation	I-Disease	73
mapping	O	73
to	O	73
the	O	73
region	O	73
.	O	73
germline	O	74
e	O	74
-	O	74
cadherin	O	74
gene	O	74
(	O	74
cdh1	O	74
)	O	74
mutations	O	74
predispose	O	74
to	O	74
familial	B-Disease	74
gastric	I-Disease	74
cancer	I-Disease	74
and	O	74
colorectal	B-Disease	74
cancer	I-Disease	74
.	O	74
inherited	O	75
mutations	O	75
in	O	75
the	O	75
e	O	75
-	O	75
cadherin	O	75
gene	O	75
(	O	75
cdh1	O	75
)	O	75
were	O	75
described	O	75
recently	O	75
in	O	75
three	O	75
maori	O	75
kindreds	O	75
with	O	75
familial	B-Disease	75
gastric	I-Disease	75
cancer	I-Disease	75
.	O	75
familial	B-Disease	76
gastric	I-Disease	76
cancer	I-Disease	76
is	O	76
genetically	O	76
heterogeneous	O	76
and	O	76
it	O	76
is	O	76
not	O	76
clear	O	76
what	O	76
proportion	O	76
of	O	76
gastric	B-Disease	76
cancer	I-Disease	76
susceptibility	O	76
in	O	76
non	O	76
-	O	76
maori	O	76
populations	O	76
is	O	76
due	O	76
to	O	76
germline	O	76
cdh1	O	76
mutations	O	76
.	O	76
therefore	O	77
,	O	77
we	O	77
screened	O	77
eight	O	77
familial	B-Disease	77
gastric	I-Disease	77
cancer	I-Disease	77
kindreds	O	77
of	O	77
british	O	77
and	O	77
irish	O	77
origin	O	77
for	O	77
germline	O	77
cdh1	O	77
mutations	O	77
,	O	77
by	O	77
sscp	O	77
analysis	O	77
of	O	77
all	O	77
16	O	77
exons	O	77
and	O	77
flanking	O	77
sequences	O	77
.	O	77
each	O	78
family	O	78
contained	O	78
(	O	78
i	O	78
)	O	78
two	O	78
cases	O	78
of	O	78
gastric	B-Disease	78
cancer	I-Disease	78
in	O	78
first	O	78
degree	O	78
relatives	O	78
with	O	78
one	O	78
affected	O	78
before	O	78
age	O	78
50	O	78
years	O	78
;	O	78
or	O	78
(	O	78
ii	O	78
)	O	78
three	O	78
or	O	78
more	O	78
cases	O	78
of	O	78
gastric	B-Disease	78
cancer	I-Disease	78
.	O	78
in	O	81
one	O	81
family	O	81
there	O	81
was	O	81
evidence	O	81
of	O	81
non	O	81
-	O	81
penetrance	O	81
and	O	81
susceptibility	O	81
to	O	81
both	O	81
gastric	B-Disease	81
and	I-Disease	81
colorectal	I-Disease	81
cancer	I-Disease	81
;	O	81
thus	O	81
,	O	81
in	O	81
addition	O	81
to	O	81
six	O	81
cases	O	81
of	O	81
gastric	B-Disease	81
cancer	I-Disease	81
,	O	81
a	O	81
cdh1	O	81
mutation	O	81
carrier	O	81
developed	O	81
colorectal	B-Disease	81
cancer	I-Disease	81
at	O	81
age	O	81
30	O	81
years	O	81
.	O	81
we	O	82
have	O	82
confirmed	O	82
that	O	82
germline	O	82
mutations	O	82
in	O	82
the	O	82
cdh1	O	82
gene	O	82
cause	O	82
familial	B-Disease	82
gastric	I-Disease	82
cancer	I-Disease	82
in	O	82
non	O	82
-	O	82
maori	O	82
populations	O	82
.	O	82
however	O	83
,	O	83
only	O	83
a	O	83
minority	O	83
of	O	83
familial	O	83
gastric	B-Disease	83
cancers	I-Disease	83
can	O	83
be	O	83
accounted	O	83
for	O	83
by	O	83
cdh1	O	83
mutations	O	83
.	O	83
loss	O	84
of	O	84
e	O	84
-	O	84
cadherin	O	84
function	O	84
has	O	84
been	O	84
implicated	O	84
in	O	84
the	O	84
pathogenesis	O	84
of	O	84
sporadic	O	84
colorectal	B-Disease	84
and	I-Disease	84
other	I-Disease	84
cancers	I-Disease	84
,	O	84
and	O	84
our	O	84
findings	O	84
provide	O	84
evidence	O	84
that	O	84
germline	O	84
cdh1	O	84
mutations	O	84
predispose	O	84
to	O	84
early	O	84
onset	O	84
colorectal	B-Disease	84
cancer	I-Disease	84
.	O	84
thus	O	85
,	O	85
cdh1	O	85
should	O	85
be	O	85
investigated	O	85
as	O	85
a	O	85
cause	O	85
of	O	85
inherited	O	85
susceptibility	O	85
to	O	85
both	O	85
gastric	B-Disease	85
and	I-Disease	85
colorectal	I-Disease	85
cancers	I-Disease	85
.	O	85
a	O	86
zinc	O	86
finger	O	86
truncation	O	86
of	O	86
murine	O	86
wt1	O	86
results	O	86
in	O	86
the	O	86
characteristic	O	86
urogenital	B-Disease	86
abnormalities	I-Disease	86
of	O	86
denys	B-Disease	86
-	I-Disease	86
drash	I-Disease	86
syndrome	I-Disease	86
.	O	86
the	O	87
wilms	B-Disease	87
tumor	I-Disease	87
-	O	87
suppressor	O	87
gene	O	87
,	O	87
wt1	O	87
,	O	87
plays	O	87
a	O	87
key	O	87
role	O	87
in	O	87
urogenital	O	87
development	O	87
,	O	87
and	O	87
wt1	B-Disease	87
dysfunction	I-Disease	87
is	O	87
implicated	O	87
in	O	87
both	O	87
neoplastic	B-Disease	87
(	O	87
wilms	B-Disease	87
tumor	I-Disease	87
,	O	87
mesothelioma	B-Disease	87
,	O	87
leukemias	B-Disease	87
,	O	87
and	O	87
breast	B-Disease	87
cancer	I-Disease	87
)	O	87
and	O	87
nonneoplastic	B-Disease	87
(	O	87
glomerulosclerosis	B-Disease	87
)	O	87
disease	O	87
.	O	87
the	O	88
analysis	O	88
of	O	88
diseases	O	88
linked	O	88
specifically	O	88
with	O	88
wt1	O	88
mutations	O	88
,	O	88
such	O	88
as	O	88
denys	B-Disease	88
-	I-Disease	88
drash	I-Disease	88
syndrome	I-Disease	88
(	O	88
dds	B-Disease	88
)	O	88
,	O	88
can	O	88
provide	O	88
valuable	O	88
insight	O	88
concerning	O	88
the	O	88
role	O	88
of	O	88
wt1	O	88
in	O	88
development	O	88
and	O	88
disease	O	88
.	O	88
dds	B-Disease	89
is	O	89
a	O	89
rare	O	89
childhood	O	89
disease	O	89
characterized	O	89
by	O	89
a	O	89
nephropathy	B-Disease	89
involving	O	89
mesangial	B-Disease	89
sclerosis	I-Disease	89
,	O	89
xy	O	89
pseudohermaphroditism	B-Disease	89
,	O	89
and	O	89
/	O	89
or	O	89
wilms	B-Disease	89
tumor	I-Disease	89
(	O	89
wt	B-Disease	89
)	O	89
.	O	89
dds	B-Disease	90
patients	O	90
are	O	90
constitutionally	O	90
heterozygous	O	90
for	O	90
exonic	O	90
point	O	90
mutations	O	90
in	O	90
wt1	O	90
,	O	90
which	O	90
include	O	90
mutations	O	90
predicted	O	90
to	O	90
truncate	O	90
the	O	90
protein	O	90
within	O	90
the	O	90
c	O	90
-	O	90
terminal	O	90
zinc	O	90
finger	O	90
(	O	90
zf	O	90
)	O	90
region	O	90
.	O	90
we	O	91
report	O	91
that	O	91
heterozygosity	O	91
for	O	91
a	O	91
targeted	O	91
murine	O	91
wt1	O	91
allele	O	91
,	O	91
wt1	O	91
(	O	91
tmt396	O	91
)	O	91
,	O	91
which	O	91
truncates	O	91
zf3	O	91
at	O	91
codon	O	91
396	O	91
,	O	91
induces	O	91
mesangial	B-Disease	91
sclerosis	I-Disease	91
characteristic	O	91
of	O	91
dds	B-Disease	91
in	O	91
adult	O	91
heterozygous	O	91
and	O	91
chimeric	O	91
mice	O	91
.	O	91
male	B-Disease	92
genital	I-Disease	92
defects	I-Disease	92
also	O	92
were	O	92
evident	O	92
and	O	92
there	O	92
was	O	92
a	O	92
single	O	92
case	O	92
of	O	92
wilms	B-Disease	92
tumor	I-Disease	92
in	O	92
which	O	92
the	O	92
transcript	O	92
of	O	92
the	O	92
nontargeted	O	92
allele	O	92
showed	O	92
an	O	92
exon	O	92
9	O	92
skipping	O	92
event	O	92
,	O	92
implying	O	92
a	O	92
causal	O	92
link	O	92
between	O	92
wt1	B-Disease	92
dysfunction	I-Disease	92
and	O	92
wilms	B-Disease	92
tumorigenesis	I-Disease	92
in	O	92
mice	O	92
.	O	92
however	O	93
,	O	93
the	O	93
mutant	O	93
wt1	O	93
(	O	93
tmt396	O	93
)	O	93
protein	O	93
accounted	O	93
for	O	93
only	O	93
5	O	93
%	O	93
of	O	93
wt1	O	93
in	O	93
both	O	93
heterozygous	O	93
embryonic	O	93
stem	O	93
cells	O	93
and	O	93
the	O	93
wt	B-Disease	93
.	O	93
mechanism	O	95
of	O	95
increased	O	95
iron	O	95
absorption	O	95
in	O	95
murine	O	95
model	O	95
of	O	95
hereditary	B-Disease	95
hemochromatosis	I-Disease	95
:	O	95
increased	O	95
duodenal	O	95
expression	O	95
of	O	95
the	O	95
iron	O	95
transporter	O	95
dmt1	O	95
.	O	95
hereditary	B-Disease	96
hemochromatosis	I-Disease	96
(	O	96
hh	B-Disease	96
)	O	96
is	O	96
a	O	96
common	O	96
autosomal	B-Disease	96
recessive	I-Disease	96
disorder	I-Disease	96
characterized	O	96
by	O	96
tissue	O	96
iron	O	96
deposition	O	96
secondary	O	96
to	O	96
excessive	O	96
dietary	O	96
iron	O	96
absorption	O	96
.	O	96
we	O	97
recently	O	97
reported	O	97
that	O	97
hfe	O	97
,	O	97
the	O	97
protein	O	97
defective	O	97
in	O	97
hh	B-Disease	97
,	O	97
was	O	97
physically	O	97
associated	O	97
with	O	97
the	O	97
transferrin	O	97
receptor	O	97
(	O	97
tfr	O	97
)	O	97
in	O	97
duodenal	O	97
crypt	O	97
cells	O	97
and	O	97
proposed	O	97
that	O	97
mutations	O	97
in	O	97
hfe	O	97
attenuate	O	97
the	O	97
uptake	O	97
of	O	97
transferrin	O	97
-	O	97
bound	O	97
iron	O	97
from	O	97
plasma	O	97
by	O	97
duodenal	O	97
crypt	O	97
cells	O	97
,	O	97
leading	O	97
to	O	97
up	O	97
-	O	97
regulation	O	97
of	O	97
transporters	O	97
for	O	97
dietary	O	97
iron	O	97
.	O	97
the	O	101
positive	O	101
control	O	101
for	O	101
dmt1	O	101
up	O	101
-	O	101
regulation	O	101
was	O	101
a	O	101
murine	O	101
model	O	101
of	O	101
dietary	B-Disease	101
iron	I-Disease	101
deficiency	I-Disease	101
that	O	101
demonstrated	O	101
greatly	O	101
increased	O	101
levels	O	101
of	O	101
duodenal	O	101
dmt1	O	101
(	O	101
ire	O	101
)	O	101
mrna	O	101
.	O	101
neurophysiologic	O	105
follow	O	105
-	O	105
up	O	105
of	O	105
long	O	105
-	O	105
term	O	105
dietary	O	105
treatment	O	105
in	O	105
adult	O	105
-	O	105
onset	O	105
adrenoleukodystrophy	B-Disease	105
.	O	105
objective	O	106
to	O	106
monitor	O	106
the	O	106
effects	O	106
of	O	106
dietary	O	106
treatment	O	106
in	O	106
adult	O	106
-	O	106
onset	O	106
adrenoleukodystrophy	B-Disease	106
(	O	106
ald	B-Disease	106
)	O	106
by	O	106
means	O	106
of	O	106
somatosensory	O	106
evoked	O	106
potentials	O	106
(	O	106
seps	O	106
)	O	106
and	O	106
motor	O	106
evoked	O	106
potentials	O	106
(	O	106
meps	O	106
)	O	106
.	O	106
background	O	107
seps	O	107
and	O	107
meps	O	107
have	O	107
proved	O	107
useful	O	107
in	O	107
revealing	O	107
signs	O	107
of	O	107
progressively	O	107
severe	O	107
,	O	107
central	O	107
dying	B-Disease	107
-	I-Disease	107
back	I-Disease	107
axonopathy	I-Disease	107
in	O	107
early	O	107
stages	O	107
of	O	107
adult	O	107
-	O	107
onset	O	107
ald	B-Disease	107
.	O	107
methods	O	108
eight	O	108
patients	O	108
with	O	108
adult	O	108
-	O	108
onset	O	108
ald	B-Disease	108
underwent	O	108
clinical	O	108
examination	O	108
,	O	108
brain	O	108
and	O	108
spine	O	108
mri	O	108
,	O	108
and	O	108
sep	O	108
and	O	108
mep	O	108
studies	O	108
before	O	108
and	O	108
after	O	108
3	O	108
years	O	108
of	O	108
lorenzos	O	108
oil	O	108
dietary	O	108
therapy	O	108
.	O	108
three	O	110
of	O	110
these	O	110
patients	O	110
had	O	110
pure	O	110
spinal	B-Disease	110
sep	I-Disease	110
abnormalities	I-Disease	110
and	O	110
in	O	110
the	O	110
remaining	O	110
two	O	110
patients	O	110
seps	O	110
showed	O	110
signs	O	110
of	O	110
involvement	O	110
of	O	110
both	O	110
the	O	110
spinal	O	110
and	O	110
cerebral	O	110
somatosensory	O	110
tracts	O	110
.	O	110
after	O	111
treatment	O	111
,	O	111
the	O	111
three	O	111
patients	O	111
with	O	111
pure	O	111
spinal	B-Disease	111
abnormalities	I-Disease	111
showed	O	111
clinical	O	111
and	O	111
neurophysiologic	O	111
worsening	O	111
,	O	111
whereas	O	111
the	O	111
two	O	111
patients	O	111
with	O	111
a	O	111
more	O	111
advanced	O	111
stage	O	111
of	O	111
disease	O	111
(	O	111
exhibited	O	111
by	O	111
seps	O	111
)	O	111
showed	O	111
substantially	O	111
unchanged	O	111
clinical	O	111
and	O	111
neurophysiologic	O	111
features	O	111
.	O	111
conclusions	O	113
lorenzos	O	113
oil	O	113
therapy	O	113
had	O	113
no	O	113
effect	O	113
on	O	113
patients	O	113
with	O	113
evidence	O	113
of	O	113
inflammatory	B-Disease	113
brain	I-Disease	113
lesions	I-Disease	113
.	O	113
gch1	O	116
mutation	O	116
in	O	116
a	O	116
patient	O	116
with	O	116
adult	O	116
-	O	116
onset	O	116
oromandibular	B-Disease	116
dystonia	I-Disease	116
.	O	116
the	O	117
authors	O	117
report	O	117
a	O	117
mutation	O	117
in	O	117
exon	O	117
5	O	117
of	O	117
gch1	O	117
in	O	117
a	O	117
patient	O	117
with	O	117
adult	O	117
-	O	117
onset	O	117
oromandibular	B-Disease	117
dystonia	I-Disease	117
and	O	117
no	O	117
obvious	O	117
family	O	117
history	O	117
of	O	117
dystonia	B-Disease	117
.	O	117
these	O	119
findings	O	119
demonstrate	O	119
that	O	119
gch1	O	119
mutations	O	119
must	O	119
be	O	119
considered	O	119
even	O	119
in	O	119
patients	O	119
with	O	119
dystonic	B-Disease	119
symptoms	O	119
not	O	119
typical	O	119
of	O	119
dopa	B-Disease	119
-	I-Disease	119
responsive	I-Disease	119
dystonia	I-Disease	119
.	O	119
germline	O	120
mutations	O	120
of	O	120
the	O	120
apc	B-Disease	120
gene	O	120
in	O	120
korean	O	120
familial	B-Disease	120
adenomatous	I-Disease	120
polyposis	I-Disease	120
patients	O	120
.	O	120
we	O	121
extensively	O	121
analyzed	O	121
genomic	O	121
dna	O	121
and	O	121
messenger	O	121
rna	O	121
(	O	121
mrna	O	121
)	O	121
from	O	121
62	O	121
unrelated	O	121
korean	O	121
patients	O	121
with	O	121
familial	B-Disease	121
adenomatous	I-Disease	121
polyposis	I-Disease	121
(	O	121
fap	B-Disease	121
)	O	121
for	O	121
identification	O	121
of	O	121
germline	O	121
adenomatous	B-Disease	121
polyposis	I-Disease	121
coli	I-Disease	121
(	O	121
apc	B-Disease	121
)	O	121
gene	O	121
mutations	O	121
.	O	121
nineteen	O	125
of	O	125
the	O	125
detected	O	125
mutations	O	125
were	O	125
presumed	O	125
to	O	125
be	O	125
novel	O	125
,	O	125
thus	O	125
emphasizing	O	125
the	O	125
heterogeneity	O	125
of	O	125
the	O	125
mutational	O	125
spectrum	O	125
in	O	125
korean	O	125
fap	B-Disease	125
patients	O	125
.	O	125
using	O	127
this	O	127
combined	O	127
approach	O	127
,	O	127
we	O	127
identified	O	127
germline	O	127
apc	B-Disease	127
gene	O	127
mutations	O	127
in	O	127
29	O	127
of	O	127
the	O	127
48	O	127
fap	B-Disease	127
patients	O	127
(	O	127
60	O	127
%	O	127
)	O	127
,	O	127
including	O	127
6	O	127
patients	O	127
in	O	127
whom	O	127
sscp	O	127
analysis	O	127
failed	O	127
to	O	127
distinguish	O	127
the	O	127
mutant	O	127
allele	O	127
.	O	127
our	O	129
results	O	129
confirm	O	129
that	O	129
the	O	129
mutation	O	129
detection	O	129
rate	O	129
with	O	129
ptt	O	129
was	O	129
superior	O	129
to	O	129
that	O	129
with	O	129
sscp	O	129
,	O	129
and	O	129
suggest	O	129
that	O	129
ptt	O	129
would	O	129
be	O	129
a	O	129
more	O	129
practical	O	129
screening	O	129
method	O	129
to	O	129
detect	O	129
germline	O	129
mutations	O	129
of	O	129
the	O	129
apc	B-Disease	129
gene	O	129
in	O	129
fap	B-Disease	129
patients	O	129
.	O	129
molecular	O	130
epidemiology	O	130
of	O	130
c9	B-Disease	130
deficiency	I-Disease	130
heterozygotes	O	130
with	O	130
an	O	130
arg95stop	O	130
mutation	O	130
of	O	130
the	O	130
c9	O	130
gene	O	130
in	O	130
japan	O	130
.	O	130
deficiency	B-Disease	131
of	I-Disease	131
the	I-Disease	131
ninth	I-Disease	131
component	I-Disease	131
of	I-Disease	131
human	I-Disease	131
complement	I-Disease	131
(	O	131
c9	O	131
)	O	131
is	O	131
the	O	131
most	O	131
common	O	131
complement	B-Disease	131
deficiency	I-Disease	131
in	O	131
japan	O	131
,	O	131
with	O	131
an	O	131
incidence	O	131
of	O	131
approximately	O	131
one	O	131
homozygote	O	131
in	O	131
1000	O	131
,	O	131
but	O	131
is	O	131
very	O	131
rare	O	131
in	O	131
other	O	131
countries	O	131
.	O	131
genetic	O	132
analyses	O	132
of	O	132
japanese	O	132
c9	B-Disease	132
deficiency	I-Disease	132
have	O	132
shown	O	132
that	O	132
a	O	132
c	O	132
-	O	132
to	O	132
-	O	132
t	O	132
transition	O	132
leading	O	132
to	O	132
tga	O	132
stop	O	132
codon	O	132
for	O	132
arg95	O	132
in	O	132
exon	O	132
4	O	132
of	O	132
the	O	132
c9	O	132
gene	O	132
(	O	132
arg95stop	O	132
)	O	132
is	O	132
common	O	132
in	O	132
japanese	O	132
c9	B-Disease	132
deficiency	I-Disease	132
.	O	132
an	O	139
estimated	O	139
frequency	O	139
(	O	139
0	O	139
.	O	139
12	O	139
%	O	139
)	O	139
of	O	139
complete	O	139
c9	B-Disease	139
deficiency	I-Disease	139
due	O	139
to	O	139
homozygous	O	139
arg95stop	O	139
mutation	O	139
was	O	139
consistent	O	139
with	O	139
frequencies	O	139
determined	O	139
by	O	139
serological	O	139
studies	O	139
the	O	140
hereditary	B-Disease	140
hemochromatosis	I-Disease	140
protein	O	140
,	O	140
hfe	O	140
,	O	140
specifically	O	140
regulates	O	140
transferrin	O	140
-	O	140
mediated	O	140
iron	O	140
uptake	O	140
in	O	140
hela	O	140
cells	O	140
.	O	140
hfe	O	141
is	O	141
the	O	141
protein	O	141
product	O	141
of	O	141
the	O	141
gene	O	141
mutated	O	141
in	O	141
the	O	141
autosomal	B-Disease	141
recessive	I-Disease	141
disease	I-Disease	141
hereditary	B-Disease	141
hemochromatosis	I-Disease	141
(	O	141
feder	O	141
,	O	141
j	O	141
.	O	141
these	O	176
results	O	176
also	O	176
have	O	176
implications	O	176
for	O	176
the	O	176
understanding	O	176
of	O	176
cellular	O	176
iron	O	176
homeostasis	O	176
in	O	176
organs	O	176
such	O	176
as	O	176
the	O	176
liver	O	176
,	O	176
pancreas	O	176
,	O	176
heart	O	176
,	O	176
and	O	176
spleen	O	176
that	O	176
are	O	176
iron	O	176
loaded	O	176
in	O	176
hereditary	B-Disease	176
hemochromatotic	I-Disease	176
individuals	O	176
lacking	O	176
functional	O	176
hfe	O	176
.	O	176
mutation	O	177
and	O	177
haplotype	O	177
studies	O	177
of	O	177
familial	B-Disease	177
mediterranean	I-Disease	177
fever	I-Disease	177
reveal	O	177
new	O	177
ancestral	O	177
relationships	O	177
and	O	177
evidence	O	177
for	O	177
a	O	177
high	O	177
carrier	O	177
frequency	O	177
with	O	177
reduced	O	177
penetrance	O	177
in	O	177
the	O	177
ashkenazi	O	177
jewish	O	177
population	O	177
.	O	177
familial	B-Disease	178
mediterranean	I-Disease	178
fever	I-Disease	178
(	O	178
fmf	B-Disease	178
)	O	178
is	O	178
a	O	178
recessive	B-Disease	178
disorder	I-Disease	178
characterized	O	178
by	O	178
episodes	O	178
of	O	178
fever	O	178
with	O	178
serositis	B-Disease	178
or	O	178
synovitis	B-Disease	178
.	O	178
the	O	179
fmf	B-Disease	179
gene	O	179
(	O	179
mefv	O	179
)	O	179
was	O	179
cloned	O	179
recently	O	179
,	O	179
and	O	179
four	O	179
missense	O	179
mutations	O	179
were	O	179
identified	O	179
.	O	179
consistent	O	183
with	O	183
another	O	183
recent	O	183
report	O	183
,	O	183
the	O	183
e148q	O	183
mutation	O	183
was	O	183
observed	O	183
in	O	183
patients	O	183
of	O	183
several	O	183
ethnicities	O	183
and	O	183
on	O	183
multiple	O	183
microsatellite	O	183
haplotypes	O	183
,	O	183
but	O	183
haplotype	O	183
data	O	183
indicate	O	183
an	O	183
ancestral	O	183
relationships	O	183
between	O	183
non	O	183
-	O	183
jewish	O	183
italian	O	183
and	O	183
ashkenazi	O	183
jewish	O	183
patients	O	183
with	O	183
fmf	B-Disease	183
and	O	183
other	O	183
affected	O	183
populations	O	183
.	O	183
nevertheless	O	186
,	O	186
e148q	O	186
helps	O	186
account	O	186
for	O	186
recessive	O	186
inheritance	O	186
in	O	186
an	O	186
ashkenazi	O	186
family	O	186
previously	O	186
reported	O	186
as	O	186
an	O	186
unusual	O	186
case	O	186
of	O	186
dominantly	O	186
inherited	O	186
fmf	B-Disease	186
.	O	186
autoimmune	B-Disease	188
lymphoproliferative	I-Disease	188
syndrome	I-Disease	188
with	O	188
defective	O	188
fas	O	188
:	O	188
genotype	O	188
influences	O	188
penetrance	O	188
.	O	188
autoimmune	B-Disease	189
lymphoproliferative	I-Disease	189
syndrome	I-Disease	189
(	O	189
alps	B-Disease	189
)	O	189
is	O	189
a	O	189
disorder	B-Disease	189
of	I-Disease	189
lymphocyte	I-Disease	189
homeostasis	I-Disease	189
and	I-Disease	189
immunological	I-Disease	189
tolerance	I-Disease	189
.	O	189
of	O	191
17	O	191
unique	O	191
apt1	O	191
mutations	O	191
in	O	191
unrelated	O	191
alps	B-Disease	191
probands	O	191
,	O	191
12	O	191
(	O	191
71	O	191
%	O	191
)	O	191
occurred	O	191
in	O	191
exons	O	191
7	O	191
-	O	191
9	O	191
,	O	191
which	O	191
encode	O	191
the	O	191
intracellular	O	191
portion	O	191
of	O	191
fas	O	191
.	O	191
two	O	195
missense	O	195
fas	O	195
variants	O	195
,	O	195
not	O	195
restricted	O	195
to	O	195
patients	O	195
with	O	195
alps	B-Disease	195
,	O	195
were	O	195
identified	O	195
.	O	195
among	O	197
the	O	197
alps	B-Disease	197
-	O	197
associated	O	197
fas	O	197
mutants	O	197
,	O	197
dominant	O	197
inhibition	O	197
of	O	197
apoptosis	O	197
was	O	197
much	O	197
more	O	197
pronounced	O	197
in	O	197
mutants	O	197
affecting	O	197
the	O	197
intracellular	O	197
,	O	197
versus	O	197
extracellular	O	197
,	O	197
portion	O	197
of	O	197
the	O	197
fas	O	197
receptor	O	197
.	O	197
mutations	O	198
causing	O	198
disruption	O	198
of	O	198
the	O	198
intracellular	O	198
fas	O	198
death	O	198
domain	O	198
also	O	198
showed	O	198
a	O	198
higher	O	198
penetrance	O	198
of	O	198
alps	B-Disease	198
phenotype	O	198
features	O	198
in	O	198
mutation	O	198
-	O	198
bearing	O	198
relatives	O	198
.	O	198
significant	O	199
alps	B-Disease	199
-	O	199
related	O	199
morbidity	O	199
occurred	O	199
in	O	199
44	O	199
%	O	199
of	O	199
relatives	O	199
with	O	199
intracellular	O	199
mutations	O	199
,	O	199
versus	O	199
0	O	199
%	O	199
of	O	199
relatives	O	199
with	O	199
extracellular	O	199
mutations	O	199
.	O	199
thus	O	200
,	O	200
the	O	200
location	O	200
of	O	200
mutations	O	200
within	O	200
apt1	O	200
strongly	O	200
influences	O	200
the	O	200
development	O	200
and	O	200
the	O	200
severity	O	200
of	O	200
alps	B-Disease	200
.	O	200
multicentric	O	201
origin	O	201
of	O	201
hemochromatosis	B-Disease	201
gene	O	201
(	O	201
hfe	O	201
)	O	201
mutations	O	201
.	O	201
genetic	B-Disease	202
hemochromatosis	I-Disease	202
(	O	202
gh	B-Disease	202
)	O	202
is	O	202
believed	O	202
to	O	202
be	O	202
a	O	202
disease	O	202
restricted	O	202
to	O	202
those	O	202
of	O	202
european	O	202
ancestry	O	202
.	O	202
in	O	203
northwestern	O	203
europe	O	203
,	O	203
>	O	203
80	O	203
%	O	203
of	O	203
gh	B-Disease	203
patients	O	203
are	O	203
homozygous	O	203
for	O	203
one	O	203
mutation	O	203
,	O	203
the	O	203
substitution	O	203
of	O	203
tyrosine	O	203
for	O	203
cysteine	O	203
at	O	203
position	O	203
282	O	203
(	O	203
c282y	O	203
)	O	203
in	O	203
the	O	203
unprocessed	O	203
protein	O	203
.	O	203
in	O	204
a	O	204
proportion	O	204
of	O	204
gh	B-Disease	204
patients	O	204
,	O	204
two	O	204
mutations	O	204
are	O	204
present	O	204
,	O	204
c282y	O	204
and	O	204
h63d	O	204
.	O	204
these	O	212
selection	O	212
pressures	O	212
could	O	212
be	O	212
due	O	212
to	O	212
infectious	B-Disease	212
diseases	I-Disease	212
,	O	212
environmental	O	212
conditions	O	212
,	O	212
or	O	212
other	O	212
genetic	B-Disease	212
disorders	I-Disease	212
such	O	212
as	O	212
anemia	B-Disease	212
.	O	212
we	O	214
have	O	214
retrospectively	O	214
analyzed	O	214
837	O	214
random	O	214
anonymized	O	214
dried	O	214
blood	O	214
spot	O	214
(	O	214
dbs	O	214
)	O	214
samples	O	214
from	O	214
neonatal	O	214
screening	O	214
programs	O	214
in	O	214
scandinavia	O	214
for	O	214
mutations	O	214
in	O	214
hfe	O	214
,	O	214
the	O	214
candidate	O	214
gene	O	214
for	O	214
hemochromatosis	B-Disease	214
.	O	214
identification	O	225
of	O	225
the	O	225
mutation	O	225
in	O	225
the	O	225
alkaptonuria	B-Disease	225
mouse	O	225
model	O	225
.	O	225
alkaptonuria	B-Disease	226
(	O	226
aku	B-Disease	226
)	O	226
,	O	226
an	O	226
inborn	B-Disease	226
error	I-Disease	226
of	I-Disease	226
metabolism	I-Disease	226
caused	O	226
by	O	226
the	O	226
loss	O	226
of	O	226
homogentisate	O	226
1	O	226
,	O	226
2	O	226
-	O	226
dioxygenase	O	226
(	O	226
hgd	O	226
)	O	226
,	O	226
has	O	226
been	O	226
described	O	226
in	O	226
a	O	226
mouse	O	226
model	O	226
created	O	226
by	O	226
ethylnitrosourea	O	226
mutagenesis	O	226
but	O	226
the	O	226
mutation	O	226
in	O	226
these	O	226
mice	O	226
has	O	226
not	O	226
previously	O	226
been	O	226
identified	O	226
.	O	226
non	B-Disease	231
-	I-Disease	231
syndromic	I-Disease	231
hearing	I-Disease	231
loss	I-Disease	231
associated	O	231
with	O	231
enlarged	B-Disease	231
vestibular	I-Disease	231
aqueduct	I-Disease	231
is	O	231
caused	O	231
by	O	231
pds	B-Disease	231
mutations	O	231
.	O	231
enlarged	B-Disease	232
vestibular	I-Disease	232
aqueduct	I-Disease	232
(	O	232
eva	B-Disease	232
)	O	232
,	O	232
known	O	232
as	O	232
the	O	232
most	O	232
common	O	232
form	O	232
of	O	232
inner	B-Disease	232
ear	I-Disease	232
abnormality	I-Disease	232
,	O	232
has	O	232
recently	O	232
been	O	232
of	O	232
particular	O	232
genetic	O	232
interest	O	232
because	O	232
this	O	232
anomaly	O	232
is	O	232
inherited	O	232
in	O	232
a	O	232
recessive	O	232
manner	O	232
.	O	232
the	O	233
locus	O	233
for	O	233
non	B-Disease	233
-	I-Disease	233
syndromic	I-Disease	233
sensorineural	I-Disease	233
hearing	I-Disease	233
loss	I-Disease	233
with	O	233
eva	B-Disease	233
has	O	233
been	O	233
mapped	O	233
to	O	233
the	O	233
same	O	233
chromosomal	O	233
region	O	233
,	O	233
7q31	O	233
,	O	233
as	O	233
the	O	233
pendred	B-Disease	233
syndrome	I-Disease	233
locus	O	233
.	O	233
in	O	234
the	O	234
present	O	234
study	O	234
,	O	234
seven	O	234
mutations	O	234
in	O	234
the	O	234
pds	B-Disease	234
gene	O	234
(	O	234
pds	O	234
)	O	234
,	O	234
the	O	234
gene	O	234
responsible	O	234
for	O	234
pendred	B-Disease	234
syndrome	I-Disease	234
,	O	234
have	O	234
been	O	234
found	O	234
in	O	234
families	O	234
of	O	234
non	B-Disease	234
-	I-Disease	234
syndromic	I-Disease	234
sensorineural	I-Disease	234
hearing	I-Disease	234
loss	I-Disease	234
with	O	234
eva	B-Disease	234
.	O	234
the	O	236
present	O	236
results	O	236
provide	O	236
evidence	O	236
that	O	236
mutations	O	236
in	O	236
pds	O	236
cause	O	236
both	O	236
syndromic	B-Disease	236
and	I-Disease	236
non	I-Disease	236
-	I-Disease	236
syndromic	I-Disease	236
hearing	I-Disease	236
loss	I-Disease	236
.	O	236
.	O	236
mutational	O	237
analysis	O	237
and	O	237
genotype	O	237
-	O	237
phenotype	O	237
correlation	O	237
of	O	237
29	O	237
unrelated	O	237
japanese	O	237
patients	O	237
with	O	237
x	B-Disease	237
-	I-Disease	237
linked	I-Disease	237
adrenoleukodystrophy	I-Disease	237
.	O	237
background	O	238
x	B-Disease	238
-	I-Disease	238
linked	I-Disease	238
adrenoleukodystrophy	I-Disease	238
(	O	238
ald	B-Disease	238
)	O	238
is	O	238
an	O	238
inherited	B-Disease	238
disease	I-Disease	238
characterized	O	238
by	O	238
progressive	O	238
neurologic	B-Disease	238
dysfunction	I-Disease	238
,	O	238
occasionally	O	238
associated	O	238
with	O	238
adrenal	B-Disease	238
insufficiency	I-Disease	238
.	O	238
the	O	239
classic	O	239
form	O	239
of	O	239
ald	B-Disease	239
usually	O	239
has	O	239
onset	O	239
in	O	239
childhood	O	239
(	O	239
childhood	B-Disease	239
cerebral	I-Disease	239
ald	I-Disease	239
)	O	239
,	O	239
with	O	239
rapid	O	239
neurologic	B-Disease	239
deterioration	I-Disease	239
leading	O	239
to	O	239
a	O	239
vegetative	O	239
state	O	239
.	O	239
adult	O	240
-	O	240
onset	O	240
cerebral	B-Disease	240
ald	I-Disease	240
also	O	240
presents	O	240
with	O	240
rapidly	O	240
progressive	O	240
neurologic	B-Disease	240
dysfunction	I-Disease	240
.	O	240
milder	O	241
phenotypes	O	241
such	O	241
as	O	241
adrenomyeloneuropathy	B-Disease	241
and	O	241
addison	B-Disease	241
disease	I-Disease	241
only	O	241
also	O	241
have	O	241
been	O	241
recognized	O	241
.	O	241
objectives	O	243
to	O	243
conduct	O	243
mutational	O	243
analyses	O	243
in	O	243
29	O	243
japanese	O	243
patients	O	243
with	O	243
ald	B-Disease	243
from	O	243
29	O	243
unrelated	O	243
families	O	243
,	O	243
to	O	243
obtain	O	243
knowledge	O	243
of	O	243
the	O	243
spectrum	O	243
of	O	243
mutations	O	243
in	O	243
this	O	243
gene	O	243
,	O	243
and	O	243
to	O	243
study	O	243
genotype	O	243
-	O	243
phenotype	O	243
correlations	O	243
in	O	243
japanese	O	243
patients	O	243
.	O	243
methods	O	244
the	O	244
29	O	244
patients	O	244
comprised	O	244
13	O	244
patients	O	244
with	O	244
childhood	B-Disease	244
cerebral	I-Disease	244
ald	I-Disease	244
,	O	244
11	O	244
patients	O	244
with	O	244
adult	O	244
-	O	244
onset	O	244
cerebral	B-Disease	244
ald	I-Disease	244
,	O	244
and	O	244
5	O	244
patients	O	244
with	O	244
adrenomyeloneuropathy	B-Disease	244
.	O	244
we	O	245
conducted	O	245
detailed	O	245
mutational	O	245
analyses	O	245
of	O	245
29	O	245
unrelated	O	245
japanese	O	245
patients	O	245
with	O	245
ald	B-Disease	245
by	O	245
genomic	O	245
southern	O	245
blot	O	245
analysis	O	245
and	O	245
direct	O	245
nucleotide	O	245
sequence	O	245
analysis	O	245
of	O	245
reverse	O	245
transcriptase	O	245
-	O	245
polymerase	O	245
chain	O	245
reaction	O	245
products	O	245
derived	O	245
from	O	245
total	O	245
rna	O	245
that	O	245
was	O	245
extracted	O	245
from	O	245
cultured	O	245
skin	O	245
fibroblasts	O	245
,	O	245
lymphoblastoid	O	245
cells	O	245
,	O	245
or	O	245
peripheral	O	245
blood	O	245
leukocytes	O	245
.	O	245
results	O	246
three	O	246
patients	O	246
with	O	246
adult	O	246
-	O	246
onset	O	246
cerebral	B-Disease	246
ald	I-Disease	246
were	O	246
identified	O	246
as	O	246
having	O	246
large	O	246
genomic	O	246
rearrangements	O	246
.	O	246
the	O	247
remaining	O	247
26	O	247
patients	O	247
were	O	247
identified	O	247
as	O	247
having	O	247
21	O	247
independent	O	247
mutations	O	247
,	O	247
including	O	247
12	O	247
novel	O	247
mutations	O	247
resulting	O	247
in	O	247
small	O	247
nucleotide	O	247
alterations	O	247
in	O	247
the	O	247
ald	B-Disease	247
gene	O	247
.	O	247
conclusions	O	253
there	O	253
are	O	253
no	O	253
obvious	O	253
correlations	O	253
between	O	253
the	O	253
phenotypes	O	253
of	O	253
patients	O	253
with	O	253
ald	B-Disease	253
and	O	253
their	O	253
genotypes	O	253
,	O	253
suggesting	O	253
that	O	253
other	O	253
genetic	O	253
or	O	253
environmental	O	253
factors	O	253
modify	O	253
the	O	253
phenotypic	O	253
expressions	O	253
of	O	253
ald	B-Disease	253
.	O	253
.	O	253
a	O	254
common	O	254
human	O	254
skin	B-Disease	254
tumour	I-Disease	254
is	O	254
caused	O	254
by	O	254
activating	O	254
mutations	O	254
in	O	254
beta	O	254
-	O	254
catenin	O	254
.	O	254
one	O	257
of	O	257
the	O	257
target	O	257
genes	O	257
for	O	257
beta	O	257
-	O	257
catenin	O	257
/	O	257
tcf	O	257
encodes	O	257
c	O	257
-	O	257
myc	O	257
,	O	257
explaining	O	257
why	O	257
constitutive	O	257
activation	O	257
of	O	257
the	O	257
wnt	O	257
pathway	O	257
can	O	257
lead	O	257
to	O	257
cancer	B-Disease	257
,	O	257
particularly	O	257
in	O	257
the	O	257
colon	O	257
.	O	257
most	O	258
colon	B-Disease	258
cancers	I-Disease	258
arise	O	258
from	O	258
mutations	O	258
in	O	258
the	O	258
gene	O	258
encoding	O	258
adenomatous	B-Disease	258
polyposis	I-Disease	258
coli	I-Disease	258
(	O	258
apc	B-Disease	258
)	O	258
,	O	258
a	O	258
protein	O	258
required	O	258
for	O	258
ubiquitin	O	258
-	O	258
mediated	O	258
degradation	O	258
of	O	258
beta	O	258
-	O	258
catenin	O	258
,	O	258
but	O	258
a	O	258
small	O	258
percentage	O	258
of	O	258
colon	B-Disease	258
and	I-Disease	258
some	I-Disease	258
other	I-Disease	258
cancers	I-Disease	258
harbour	O	258
beta	O	258
-	O	258
catenin	O	258
-	O	258
stabilizing	O	258
mutations	O	258
.	O	258
recently	O	259
,	O	259
we	O	259
discovered	O	259
that	O	259
transgenic	O	259
mice	O	259
expressing	O	259
an	O	259
activated	O	259
beta	O	259
-	O	259
catenin	O	259
are	O	259
predisposed	O	259
to	O	259
developing	O	259
skin	B-Disease	259
tumours	I-Disease	259
resembling	O	259
pilomatricomas	B-Disease	259
.	O	259
given	O	260
that	O	260
the	O	260
skin	O	260
of	O	260
these	O	260
adult	O	260
mice	O	260
also	O	260
exhibits	O	260
signs	O	260
of	O	260
de	O	260
novo	O	260
hair	O	260
-	O	260
follicle	O	260
morphogenesis	O	260
,	O	260
we	O	260
wondered	O	260
whether	O	260
human	O	260
pilomatricomas	B-Disease	260
might	O	260
originate	O	260
from	O	260
hair	O	260
matrix	O	260
cells	O	260
and	O	260
whether	O	260
they	O	260
might	O	260
possess	O	260
beta	O	260
-	O	260
catenin	O	260
-	O	260
stabilizing	O	260
mutations	O	260
.	O	260
here	O	261
,	O	261
we	O	261
explore	O	261
the	O	261
cell	O	261
origin	O	261
and	O	261
aetiology	O	261
of	O	261
this	O	261
common	O	261
human	O	261
skin	B-Disease	261
tumour	I-Disease	261
.	O	261
we	O	262
found	O	262
nuclear	O	262
lef	O	262
-	O	262
1	O	262
in	O	262
the	O	262
dividing	O	262
tumour	B-Disease	262
cells	O	262
,	O	262
providing	O	262
biochemical	O	262
evidence	O	262
that	O	262
pilomatricomas	B-Disease	262
are	O	262
derived	O	262
from	O	262
hair	O	262
matrix	O	262
cells	O	262
.	O	262
at	O	263
least	O	263
75	O	263
%	O	263
of	O	263
these	O	263
tumours	B-Disease	263
possess	O	263
mutations	O	263
affecting	O	263
the	O	263
amino	O	263
-	O	263
terminal	O	263
segment	O	263
,	O	263
normally	O	263
involved	O	263
in	O	263
phosphorylation	O	263
-	O	263
dependent	O	263
,	O	263
ubiquitin	O	263
-	O	263
mediated	O	263
degradation	O	263
of	O	263
the	O	263
protein	O	263
.	O	263
this	O	264
percentage	O	264
of	O	264
ctnnb1	O	264
mutations	O	264
is	O	264
greater	O	264
than	O	264
in	O	264
all	O	264
other	O	264
human	O	264
tumours	B-Disease	264
examined	O	264
thus	O	264
far	O	264
,	O	264
and	O	264
directly	O	264
implicates	O	264
beta	O	264
-	O	264
catenin	O	264
/	O	264
lef	O	264
misregulation	O	264
as	O	264
the	O	264
major	O	264
cause	O	264
of	O	264
hair	O	264
matrix	O	264
cell	O	264
tumorigenesis	O	264
in	O	264
humans	O	264
.	O	264
.	O	264
the	O	265
pendred	B-Disease	265
syndrome	I-Disease	265
gene	O	265
encodes	O	265
a	O	265
chloride	O	265
-	O	265
iodide	O	265
transport	O	265
protein	O	265
.	O	265
pendred	B-Disease	266
syndrome	I-Disease	266
is	O	266
the	O	266
most	O	266
common	O	266
form	O	266
of	O	266
syndromic	B-Disease	266
deafness	I-Disease	266
and	O	266
characterized	O	266
by	O	266
congenital	O	266
sensorineural	B-Disease	266
hearing	I-Disease	266
loss	I-Disease	266
and	O	266
goitre	B-Disease	266
.	O	266
this	O	267
disorder	O	267
was	O	267
mapped	O	267
to	O	267
chromosome	O	267
7	O	267
and	O	267
the	O	267
gene	O	267
causing	O	267
pendred	B-Disease	267
syndrome	I-Disease	267
(	O	267
pds	B-Disease	267
)	O	267
was	O	267
subsequently	O	267
identified	O	267
by	O	267
positional	O	267
cloning	O	267
.	O	267
pendrin	O	269
is	O	269
closely	O	269
related	O	269
to	O	269
a	O	269
family	O	269
of	O	269
sulfate	O	269
transport	O	269
proteins	O	269
that	O	269
includes	O	269
the	O	269
rat	O	269
sulfate	O	269
-	O	269
anion	O	269
transporter	O	269
(	O	269
encoded	O	269
by	O	269
sat	O	269
-	O	269
1	O	269
;	O	269
29	O	269
%	O	269
amino	O	269
acid	O	269
sequence	O	269
identity	O	269
)	O	269
,	O	269
the	O	269
human	O	269
diastrophic	B-Disease	269
dysplasia	I-Disease	269
sulfate	O	269
transporter	O	269
(	O	269
encoded	O	269
by	O	269
dtd	O	269
;	O	269
32	O	269
%	O	269
)	O	269
and	O	269
the	O	269
human	O	269
sulfate	O	269
transporter	O	269
downregulated	O	269
in	O	269
adenoma	B-Disease	269
(	O	269
encoded	O	269
by	O	269
dra	O	269
;	O	269
45	O	269
%	O	269
)	O	269
.	O	269
our	O	273
results	O	273
demonstrate	O	273
that	O	273
pendrin	O	273
functions	O	273
as	O	273
a	O	273
transporter	O	273
of	O	273
chloride	O	273
and	O	273
iodide	O	273
,	O	273
but	O	273
not	O	273
sulfate	O	273
,	O	273
and	O	273
may	O	273
provide	O	273
insight	O	273
into	O	273
thyroid	O	273
physiology	O	273
and	O	273
the	O	273
pathophysiology	O	273
of	O	273
pendred	B-Disease	273
syndrome	I-Disease	273
.	O	273
.	O	273
hfe	O	274
mutations	O	274
analysis	O	274
in	O	274
711	O	274
hemochromatosis	B-Disease	274
probands	O	274
:	O	274
evidence	O	274
for	O	274
s65c	O	274
implication	O	274
in	O	274
mild	O	274
form	O	274
of	O	274
hemochromatosis	B-Disease	274
.	O	274
hereditary	B-Disease	275
hemochromatosis	I-Disease	275
(	O	275
hh	B-Disease	275
)	O	275
is	O	275
a	O	275
common	O	275
autosomal	B-Disease	275
recessive	I-Disease	275
genetic	I-Disease	275
disorder	I-Disease	275
of	O	275
iron	O	275
metabolism	O	275
.	O	275
the	O	276
hfe	O	276
candidate	O	276
gene	O	276
encoding	O	276
an	O	276
hla	O	276
class	O	276
i	O	276
-	O	276
like	O	276
protein	O	276
involved	O	276
in	O	276
hh	B-Disease	276
was	O	276
identified	O	276
in	O	276
1996	O	276
.	O	276
two	O	277
missense	O	277
mutations	O	277
have	O	277
been	O	277
described	O	277
c282y	O	277
,	O	277
accounting	O	277
for	O	277
80	O	277
%	O	277
to	O	277
90	O	277
%	O	277
of	O	277
hh	B-Disease	277
chromosomes	O	277
,	O	277
and	O	277
h63d	O	277
,	O	277
which	O	277
is	O	277
associated	O	277
with	O	277
a	O	277
milder	O	277
form	O	277
of	O	277
the	O	277
disease	O	277
representing	O	277
40	O	277
%	O	277
to	O	277
70	O	277
%	O	277
of	O	277
non	O	277
-	O	277
c282y	O	277
hh	B-Disease	277
chromosomes	O	277
.	O	277
the	O	279
results	O	279
confirm	O	279
that	O	279
the	O	279
c282y	O	279
substitution	O	279
was	O	279
the	O	279
main	O	279
mutation	O	279
involved	O	279
in	O	279
hemochromatosis	B-Disease	279
,	O	279
accounting	O	279
for	O	279
85	O	279
%	O	279
of	O	279
carrier	O	279
chromosomes	O	279
,	O	279
whereas	O	279
the	O	279
h63d	O	279
substitution	O	279
represented	O	279
39	O	279
%	O	279
of	O	279
the	O	279
hh	B-Disease	279
chromosomes	O	279
that	O	279
did	O	279
not	O	279
carry	O	279
the	O	279
c282y	O	279
mutation	O	279
.	O	279
8	O	282
%	O	282
of	O	282
hh	B-Disease	282
chromosomes	O	282
that	O	282
were	O	282
neither	O	282
c282y	O	282
nor	O	282
h63d	O	282
.	O	282
this	O	283
enrichment	O	283
of	O	283
s65c	O	283
among	O	283
hh	B-Disease	283
chromosomes	O	283
suggests	O	283
that	O	283
the	O	283
s65c	O	283
substitution	O	283
is	O	283
associated	O	283
with	O	283
the	O	283
mild	O	283
form	O	283
of	O	283
hemochromatosis	B-Disease	283
.	O	283
germline	O	284
brca1	O	284
alterations	O	284
in	O	284
a	O	284
population	O	284
-	O	284
based	O	284
series	O	284
of	O	284
ovarian	B-Disease	284
cancer	I-Disease	284
cases	O	284
.	O	284
the	O	285
objective	O	285
of	O	285
this	O	285
study	O	285
was	O	285
to	O	285
provide	O	285
more	O	285
accurate	O	285
frequency	O	285
estimates	O	285
of	O	285
breast	B-Disease	285
cancer	I-Disease	285
susceptibility	O	285
gene	O	285
1	O	285
(	O	285
brca1	O	285
)	O	285
germline	O	285
alterations	O	285
in	O	285
the	O	285
ovarian	B-Disease	285
cancer	I-Disease	285
population	O	285
.	O	285
to	O	286
achieve	O	286
this	O	286
,	O	286
we	O	286
determined	O	286
the	O	286
prevalence	O	286
of	O	286
brca1	O	286
alterations	O	286
in	O	286
a	O	286
population	O	286
-	O	286
based	O	286
series	O	286
of	O	286
consecutive	O	286
ovarian	B-Disease	286
cancer	I-Disease	286
cases	O	286
.	O	286
this	O	287
is	O	287
the	O	287
first	O	287
population	O	287
-	O	287
based	O	287
ovarian	B-Disease	287
cancer	I-Disease	287
study	O	287
reporting	O	287
brca1	O	287
alterations	O	287
derived	O	287
from	O	287
a	O	287
comprehensive	O	287
screen	O	287
of	O	287
the	O	287
entire	O	287
coding	O	287
region	O	287
.	O	287
one	O	288
hundred	O	288
and	O	288
seven	O	288
ovarian	B-Disease	288
cancer	I-Disease	288
cases	O	288
were	O	288
analyzed	O	288
for	O	288
brca1	O	288
alterations	O	288
using	O	288
the	O	288
rnase	O	288
mismatch	O	288
cleavage	O	288
assay	O	288
followed	O	288
by	O	288
direct	O	288
sequencing	O	288
.	O	288
both	O	290
patients	O	290
had	O	290
a	O	290
family	O	290
history	O	290
of	O	290
breast	B-Disease	290
or	I-Disease	290
ovarian	I-Disease	290
cancer	I-Disease	290
.	O	290
several	O	291
novel	O	291
as	O	291
well	O	291
as	O	291
previously	O	291
reported	O	291
uncharacterized	O	291
variants	O	291
were	O	291
also	O	291
identified	O	291
,	O	291
some	O	291
of	O	291
which	O	291
were	O	291
associated	O	291
with	O	291
a	O	291
family	O	291
history	O	291
of	O	291
cancer	B-Disease	291
.	O	291
the	O	292
frequency	O	292
distribution	O	292
of	O	292
common	O	292
polymorphisms	O	292
was	O	292
determined	O	292
in	O	292
the	O	292
91	O	292
caucasian	O	292
cancer	B-Disease	292
cases	O	292
in	O	292
this	O	292
series	O	292
and	O	292
24	O	292
sister	O	292
controls	O	292
using	O	292
allele	O	292
-	O	292
specific	O	292
amplification	O	292
.	O	292
the	O	293
rare	O	293
form	O	293
of	O	293
the	O	293
q356r	O	293
polymorphism	O	293
was	O	293
significantly	O	293
(	O	293
p	O	293
=	O	293
0	O	293
.	O	293
03	O	293
)	O	293
associated	O	293
with	O	293
a	O	293
family	O	293
history	O	293
of	O	293
ovarian	B-Disease	293
cancer	I-Disease	293
,	O	293
suggesting	O	293
that	O	293
this	O	293
polymorphism	O	293
may	O	293
influence	O	293
ovarian	B-Disease	293
cancer	I-Disease	293
risk	O	293
.	O	293
in	O	294
summary	O	294
,	O	294
our	O	294
data	O	294
suggest	O	294
a	O	294
role	O	294
for	O	294
some	O	294
uncharacterized	O	294
variants	O	294
and	O	294
rare	O	294
forms	O	294
of	O	294
polymorphisms	O	294
in	O	294
determining	O	294
ovarian	B-Disease	294
cancer	I-Disease	294
risk	O	294
,	O	294
and	O	294
highlight	O	294
the	O	294
necessity	O	294
to	O	294
screen	O	294
for	O	294
missense	O	294
alterations	O	294
as	O	294
well	O	294
as	O	294
truncating	O	294
mutations	O	294
in	O	294
this	O	294
population	O	294
.	O	294
adrenoleukodystrophy	O	295
-	O	295
related	O	295
protein	O	295
can	O	295
compensate	O	295
functionally	O	295
for	O	295
adrenoleukodystrophy	B-Disease	295
protein	I-Disease	295
deficiency	I-Disease	295
(	O	295
x	B-Disease	295
-	I-Disease	295
ald	I-Disease	295
)	O	295
:	O	295
implications	O	295
for	O	295
therapy	O	295
.	O	295
inherited	B-Disease	296
defects	I-Disease	296
in	O	296
the	O	296
peroxisomal	O	296
atp	O	296
-	O	296
binding	O	296
cassette	O	296
(	O	296
abc	O	296
)	O	296
transporter	O	296
adrenoleukodystrophy	B-Disease	296
protein	O	296
(	O	296
aldp	O	296
)	O	296
lead	O	296
to	O	296
the	O	296
lethal	O	296
peroxisomal	B-Disease	296
disorder	I-Disease	296
x	B-Disease	296
-	I-Disease	296
linked	I-Disease	296
adrenoleukodystrophy	I-Disease	296
(	O	296
x	B-Disease	296
-	I-Disease	296
ald	I-Disease	296
)	O	296
,	O	296
for	O	296
which	O	296
no	O	296
efficient	O	296
treatment	O	296
has	O	296
been	O	296
established	O	296
so	O	296
far	O	296
.	O	296
by	O	298
using	O	298
transient	O	298
and	O	298
stable	O	298
overexpression	O	298
of	O	298
human	O	298
cdnas	O	298
encoding	O	298
aldp	O	298
and	O	298
its	O	298
closest	O	298
relative	O	298
aldrp	O	298
,	O	298
we	O	298
could	O	298
restore	O	298
the	O	298
impaired	O	298
peroxisomal	O	298
beta	O	298
-	O	298
oxidation	O	298
in	O	298
fibroblasts	O	298
of	O	298
x	B-Disease	298
-	I-Disease	298
ald	I-Disease	298
patients	O	298
.	O	298
these	O	302
results	O	302
suggest	O	302
that	O	302
a	O	302
correction	O	302
of	O	302
the	O	302
biochemical	O	302
defect	O	302
in	O	302
x	B-Disease	302
-	I-Disease	302
ald	I-Disease	302
could	O	302
be	O	302
possible	O	302
by	O	302
drug	O	302
-	O	302
induced	O	302
overexpression	O	302
or	O	302
ectopic	O	302
expression	O	302
of	O	302
aldrp	O	302
.	O	302
.	O	302
germline	O	304
mutations	O	304
of	O	304
the	O	304
brca1	O	304
tumor	B-Disease	304
suppressor	O	304
gene	O	304
predispose	O	304
women	O	304
to	O	304
breast	B-Disease	304
and	I-Disease	304
ovarian	I-Disease	304
cancers	I-Disease	304
.	O	304
however	O	307
,	O	307
a	O	307
defective	O	307
g2	O	307
-	O	307
m	O	307
checkpoint	O	307
in	O	307
these	O	307
cells	O	307
is	O	307
accompanied	O	307
by	O	307
extensive	O	307
chromosomal	B-Disease	307
abnormalities	I-Disease	307
.	O	307
mutant	O	308
fibroblasts	O	308
contain	O	308
multiple	O	308
,	O	308
functional	O	308
centrosomes	O	308
,	O	308
which	O	308
lead	O	308
to	O	308
unequal	O	308
chromosome	O	308
segregation	O	308
,	O	308
abnormal	O	308
nuclear	O	308
division	O	308
,	O	308
and	O	308
aneuploidy	B-Disease	308
.	O	308
defective	O	310
cd95	O	310
/	O	310
apo	O	310
-	O	310
1	O	310
/	O	310
fas	O	310
signal	O	310
complex	O	310
formation	O	310
in	O	310
the	O	310
human	O	310
autoimmune	B-Disease	310
lymphoproliferative	I-Disease	310
syndrome	I-Disease	310
,	I-Disease	310
type	I-Disease	310
ia	I-Disease	310
.	O	310
heterozygous	O	311
mutations	O	311
in	O	311
the	O	311
cd95	O	311
(	O	311
apo	O	311
-	O	311
1	O	311
/	O	311
fas	O	311
)	O	311
receptor	O	311
occur	O	311
in	O	311
most	O	311
individuals	O	311
with	O	311
autoimmune	B-Disease	311
lymphoproliferative	I-Disease	311
syndrome	I-Disease	311
(	O	311
alps	B-Disease	311
)	O	311
and	O	311
dominantly	O	311
interfere	O	311
with	O	311
apoptosis	O	311
by	O	311
an	O	311
unknown	O	311
mechanism	O	311
.	O	311
we	O	312
show	O	312
that	O	312
local	O	312
or	O	312
global	O	312
alterations	O	312
in	O	312
the	O	312
structure	O	312
of	O	312
the	O	312
cytoplasmic	O	312
death	O	312
domain	O	312
from	O	312
nine	O	312
independent	O	312
alps	B-Disease	312
cd95	O	312
death	O	312
-	O	312
domain	O	312
mutations	O	312
result	O	312
in	O	312
a	O	312
failure	O	312
to	O	312
bind	O	312
the	O	312
fadd	O	312
/	O	312
mort1	O	312
signaling	O	312
protein	O	312
.	O	312
despite	O	313
heterozygosity	O	313
for	O	313
the	O	313
abnormal	O	313
allele	O	313
,	O	313
lymphocytes	O	313
from	O	313
alps	B-Disease	313
patients	O	313
showed	O	313
markedly	O	313
decreased	O	313
fadd	O	313
association	O	313
and	O	313
a	O	313
loss	O	313
of	O	313
caspase	O	313
recruitment	O	313
and	O	313
activation	O	313
after	O	313
cd95	O	313
crosslinking	O	313
.	O	313
these	O	314
data	O	314
suggest	O	314
that	O	314
intracytoplasmic	O	314
cd95	O	314
mutations	O	314
in	O	314
alps	B-Disease	314
impair	O	314
apoptosis	O	314
chiefly	O	314
by	O	314
disrupting	O	314
death	O	314
-	O	314
domain	O	314
interactions	O	314
with	O	314
the	O	314
signaling	O	314
protein	O	314
fadd	O	314
/	O	314
mort1	O	314
.	O	314
.	O	314
analysis	O	315
of	O	315
alkaptonuria	B-Disease	315
(	O	315
aku	B-Disease	315
)	O	315
mutations	O	315
and	O	315
polymorphisms	O	315
reveals	O	315
that	O	315
the	O	315
ccc	O	315
sequence	O	315
motif	O	315
is	O	315
a	O	315
mutational	O	315
hot	O	315
spot	O	315
in	O	315
the	O	315
homogentisate	O	315
1	O	315
,	O	315
2	O	315
dioxygenase	O	315
gene	O	315
(	O	315
hgo	O	315
)	O	315
.	O	315
we	O	316
recently	O	316
showed	O	316
that	O	316
alkaptonuria	B-Disease	316
(	O	316
aku	B-Disease	316
)	O	316
is	O	316
caused	O	316
by	O	316
loss	O	316
-	O	316
of	O	316
-	O	316
function	O	316
mutations	O	316
in	O	316
the	O	316
homogentisate	O	316
1	O	316
,	O	316
2	O	316
dioxygenase	O	316
gene	O	316
(	O	316
hgo	O	316
)	O	316
.	O	316
herein	O	317
we	O	317
describe	O	317
haplotype	O	317
and	O	317
mutational	O	317
analyses	O	317
of	O	317
hgo	O	317
in	O	317
seven	O	317
new	O	317
aku	B-Disease	317
pedigrees	O	317
.	O	317
these	O	318
analyses	O	318
identified	O	318
two	O	318
novel	O	318
single	O	318
-	O	318
nucleotide	O	318
polymorphisms	O	318
(	O	318
inv4	O	318
+	O	318
31a	O	318
-	O	318
-	O	318
>	O	318
g	O	318
and	O	318
inv11	O	318
+	O	318
18a	O	318
-	O	318
-	O	318
>	O	318
g	O	318
)	O	318
and	O	318
six	O	318
novel	O	318
aku	B-Disease	318
mutations	O	318
(	O	318
inv1	O	318
-	O	318
1g	O	318
-	O	318
-	O	318
>	O	318
a	O	318
,	O	318
w60g	O	318
,	O	318
y62c	O	318
,	O	318
a122d	O	318
,	O	318
p230t	O	318
,	O	318
and	O	318
d291e	O	318
)	O	318
,	O	318
which	O	318
further	O	318
illustrates	O	318
the	O	318
remarkable	O	318
allelic	O	318
heterogeneity	O	318
found	O	318
in	O	318
aku	B-Disease	318
.	O	318
fabry	B-Disease	322
disease	I-Disease	322
:	O	322
identification	O	322
of	O	322
novel	O	322
alpha	O	322
-	O	322
galactosidase	O	322
a	O	322
mutations	O	322
and	O	322
molecular	O	322
carrier	O	322
detection	O	322
by	O	322
use	O	322
of	O	322
fluorescent	O	322
chemical	O	322
cleavage	O	322
of	O	322
mismatches	O	322
.	O	322
fabry	B-Disease	323
disease	I-Disease	323
(	O	323
fd	B-Disease	323
)	O	323
(	O	323
angiokeratoma	B-Disease	323
corporis	I-Disease	323
diffusum	I-Disease	323
)	O	323
is	O	323
an	O	323
x	B-Disease	323
-	I-Disease	323
linked	I-Disease	323
inborn	I-Disease	323
error	I-Disease	323
of	I-Disease	323
glycosphingolipid	I-Disease	323
metabolism	I-Disease	323
caused	O	323
by	O	323
defects	O	323
in	O	323
the	O	323
lysosomal	O	323
alpha	O	323
-	O	323
galactosidase	O	323
a	O	323
gene	O	323
(	O	323
gla	O	323
)	O	323
.	O	323
clinically	O	325
,	O	325
affected	O	325
hemizygous	O	325
males	O	325
have	O	325
angiokeratoma	B-Disease	325
,	O	325
severe	B-Disease	325
acroparesthesia	I-Disease	325
,	O	325
renal	B-Disease	325
failure	I-Disease	325
,	O	325
and	O	325
vasculopathy	B-Disease	325
of	I-Disease	325
the	I-Disease	325
heart	I-Disease	325
and	I-Disease	325
brain	I-Disease	325
.	O	325
while	O	326
demonstration	O	326
of	O	326
alpha	B-Disease	326
-	I-Disease	326
galactosidase	I-Disease	326
deficiency	I-Disease	326
in	O	326
leukocytes	O	326
is	O	326
diagnostic	O	326
in	O	326
affected	O	326
males	O	326
,	O	326
enzymatic	O	326
detection	O	326
of	O	326
female	O	326
carriers	O	326
is	O	326
often	O	326
inconclusive	O	326
,	O	326
due	O	326
to	O	326
random	O	326
x	O	326
-	O	326
chromosomal	O	326
inactivation	O	326
,	O	326
underlining	O	326
the	O	326
need	O	326
of	O	326
molecular	O	326
investigations	O	326
for	O	326
accurate	O	326
genetic	O	326
counseling	O	326
.	O	326
by	O	327
use	O	327
of	O	327
chemical	O	327
cleavage	O	327
of	O	327
mismatches	O	327
adapted	O	327
to	O	327
fluorescence	O	327
-	O	327
based	O	327
detection	O	327
systems	O	327
,	O	327
we	O	327
have	O	327
characterized	O	327
the	O	327
mutations	O	327
underlying	O	327
alpha	B-Disease	327
-	I-Disease	327
gal	I-Disease	327
a	I-Disease	327
deficiency	I-Disease	327
in	O	327
16	O	327
individuals	O	327
from	O	327
six	O	327
unrelated	O	327
families	O	327
with	O	327
fd	B-Disease	327
.	O	327
prenatal	O	331
diagnosis	O	331
by	O	331
fish	O	331
in	O	331
a	O	331
family	O	331
with	O	331
pelizaeus	B-Disease	331
-	I-Disease	331
merzbacher	I-Disease	331
disease	I-Disease	331
caused	O	331
by	O	331
duplication	O	331
of	O	331
plp	O	331
gene	O	331
.	O	331
a	O	332
diagnosis	O	332
of	O	332
pelizaeus	B-Disease	332
-	I-Disease	332
merzbacher	I-Disease	332
disease	I-Disease	332
(	O	332
mim	O	332
312080	O	332
)	O	332
was	O	332
made	O	332
in	O	332
a	O	332
young	O	332
boy	O	332
.	O	332
the	O	336
proband	O	336
was	O	336
found	O	336
to	O	336
carry	O	336
the	O	336
duplication	O	336
,	O	336
thus	O	336
confirming	O	336
the	O	336
diagnosis	O	336
of	O	336
pelizaeus	B-Disease	336
merzbacher	I-Disease	336
disease	I-Disease	336
,	O	336
but	O	336
neither	O	336
the	O	336
aunt	O	336
nor	O	336
the	O	336
fetus	O	336
carried	O	336
a	O	336
duplication	O	336
.	O	336
.	O	336
dominant	O	337
negative	O	337
effect	O	337
of	O	337
the	O	337
apc1309	O	337
mutation	O	337
:	O	337
a	O	337
possible	O	337
explanation	O	337
for	O	337
genotype	O	337
-	O	337
phenotype	O	337
correlations	O	337
in	O	337
familial	B-Disease	337
adenomatous	I-Disease	337
polyposis	I-Disease	337
.	O	337
inactivation	O	338
of	O	338
the	O	338
adenomatous	B-Disease	338
polyposis	I-Disease	338
coli	I-Disease	338
(	O	338
apc	B-Disease	338
)	O	338
gene	O	338
product	O	338
initiates	O	338
colorectal	O	338
tumorigenesis	O	338
.	O	338
patients	O	339
with	O	339
familial	B-Disease	339
apc	I-Disease	339
(	O	339
fap	B-Disease	339
)	O	339
carry	O	339
germ	O	339
-	O	339
line	O	339
mutations	O	339
in	O	339
the	O	339
apc	B-Disease	339
gene	O	339
and	O	339
develop	O	339
multiple	O	339
colorectal	B-Disease	339
adenomas	I-Disease	339
and	O	339
subsequent	O	339
carcinomas	B-Disease	339
early	O	339
in	O	339
life	O	339
.	O	339
the	O	340
severity	O	340
of	O	340
the	O	340
disease	O	340
correlates	O	340
with	O	340
the	O	340
position	O	340
of	O	340
the	O	340
inherited	O	340
apc	B-Disease	340
mutation	O	340
(	O	340
genotype	O	340
-	O	340
phenotype	O	340
correlation	O	340
)	O	340
.	O	340
together	O	341
with	O	341
the	O	341
fact	O	341
that	O	341
both	O	341
germ	O	341
-	O	341
line	O	341
and	O	341
sporadic	O	341
apc	B-Disease	341
mutations	O	341
cluster	O	341
in	O	341
the	O	341
central	O	341
region	O	341
of	O	341
the	O	341
apc	B-Disease	341
gene	O	341
,	O	341
this	O	341
points	O	341
to	O	341
a	O	341
dominant	O	341
negative	O	341
effect	O	341
of	O	341
certain	O	341
apc	B-Disease	341
mutants	O	341
.	O	341
loss	O	342
of	O	342
apc	B-Disease	342
function	O	342
was	O	342
recently	O	342
shown	O	342
to	O	342
result	O	342
in	O	342
enhanced	O	342
beta	O	342
-	O	342
catenin	O	342
-	O	342
/	O	342
tcf	O	342
-	O	342
mediated	O	342
transcription	O	342
in	O	342
colon	O	342
epithelial	O	342
cells	O	342
.	O	342
here	O	343
,	O	343
we	O	343
provide	O	343
experimental	O	343
evidence	O	343
for	O	343
a	O	343
dominant	O	343
negative	O	343
effect	O	343
of	O	343
apc	B-Disease	343
gene	O	343
products	O	343
associated	O	343
with	O	343
severe	O	343
polyposis	B-Disease	343
.	O	343
wild	O	344
-	O	344
type	O	344
apc	B-Disease	344
activity	O	344
in	O	344
beta	O	344
-	O	344
catenin	O	344
-	O	344
/	O	344
tcf	O	344
-	O	344
mediated	O	344
transcription	O	344
was	O	344
strongly	O	344
inhibited	O	344
by	O	344
a	O	344
mutant	O	344
apc	B-Disease	344
that	O	344
is	O	344
truncated	O	344
at	O	344
codon	O	344
1309	O	344
.	O	344
in	O	345
contrast	O	345
,	O	345
mutant	O	345
apc	B-Disease	345
gene	O	345
products	O	345
that	O	345
are	O	345
associated	O	345
with	O	345
attenuated	B-Disease	345
polyposis	I-Disease	345
(	O	345
codon	O	345
386	O	345
or	O	345
1465	O	345
)	O	345
interfered	O	345
only	O	345
weakly	O	345
with	O	345
wild	O	345
-	O	345
type	O	345
apc	B-Disease	345
activity	O	345
.	O	345
these	O	346
results	O	346
suggest	O	346
a	O	346
molecular	O	346
explanation	O	346
for	O	346
the	O	346
genotype	O	346
-	O	346
phenotype	O	346
correlation	O	346
in	O	346
fap	B-Disease	346
patients	O	346
and	O	346
support	O	346
the	O	346
idea	O	346
that	O	346
colorectal	B-Disease	346
tumor	I-Disease	346
growth	O	346
might	O	346
be	O	346
,	O	346
in	O	346
part	O	346
,	O	346
driven	O	346
by	O	346
selection	O	346
for	O	346
a	O	346
mutation	O	346
in	O	346
the	O	346
mutation	O	346
cluster	O	346
region	O	346
.	O	346
.	O	346
germ	O	348
-	O	348
line	O	348
mutations	O	348
in	O	348
the	O	348
brca1	O	348
tumor	O	348
-	O	348
suppressor	O	348
gene	O	348
are	O	348
associated	O	348
with	O	348
an	O	348
increased	O	348
susceptibility	O	348
to	O	348
breast	B-Disease	348
and	I-Disease	348
ovarian	I-Disease	348
cancer	I-Disease	348
.	O	348
combined	B-Disease	355
genetic	I-Disease	355
deficiency	I-Disease	355
of	I-Disease	355
c6	I-Disease	355
and	I-Disease	355
c7	I-Disease	355
in	O	355
man	O	355
.	O	355
by	O	356
routine	O	356
screening	O	356
of	O	356
sera	O	356
,	O	356
a	O	356
subject	O	356
was	O	356
discovered	O	356
who	O	356
showed	O	356
a	O	356
sub	B-Disease	356
-	I-Disease	356
total	I-Disease	356
deficiency	I-Disease	356
of	I-Disease	356
c6	I-Disease	356
and	I-Disease	356
c7	I-Disease	356
.	O	356
no	O	357
clinical	O	357
disease	O	357
was	O	357
associated	O	357
with	O	357
this	O	357
deficiency	O	357
which	O	357
was	O	357
transmitted	O	357
through	O	357
the	O	357
subjects	O	357
family	O	357
as	O	357
a	O	357
single	O	357
genetic	O	357
characteristic	O	357
,	O	357
the	O	357
c6	B-Disease	357
deficiency	I-Disease	357
being	O	357
associated	O	357
with	O	357
a	O	357
silent	O	357
allele	O	357
at	O	357
the	O	357
structural	O	357
locus	O	357
.	O	357
changes	O	361
at	O	361
p183	O	361
of	O	361
emerin	O	361
weaken	O	361
its	O	361
protein	O	361
-	O	361
protein	O	361
interactions	O	361
resulting	O	361
in	O	361
x	B-Disease	361
-	I-Disease	361
linked	I-Disease	361
emery	I-Disease	361
-	I-Disease	361
dreifuss	I-Disease	361
muscular	I-Disease	361
dystrophy	I-Disease	361
.	O	361
emery	B-Disease	362
-	I-Disease	362
dreifuss	I-Disease	362
muscular	I-Disease	362
dystrophy	I-Disease	362
(	O	362
edmd	B-Disease	362
)	O	362
is	O	362
an	O	362
x	B-Disease	362
-	I-Disease	362
linked	I-Disease	362
recessive	I-Disease	362
muscular	I-Disease	362
dystrophy	I-Disease	362
characterized	O	362
by	O	362
early	O	362
contractures	B-Disease	362
of	I-Disease	362
the	I-Disease	362
elbows	I-Disease	362
,	I-Disease	362
achilles	I-Disease	362
tendons	I-Disease	362
and	I-Disease	362
spine	I-Disease	362
,	O	362
slowly	O	362
progressive	O	362
muscle	B-Disease	362
wasting	I-Disease	362
and	O	362
weakness	B-Disease	362
,	O	362
and	O	362
cardiomyopathy	B-Disease	362
associated	O	362
with	O	362
cardiac	B-Disease	362
conduction	I-Disease	362
defects	I-Disease	362
.	O	362
mutations	O	364
spanning	O	364
the	O	364
emerin	O	364
gene	O	364
have	O	364
been	O	364
identified	O	364
in	O	364
patients	O	364
with	O	364
edmd	B-Disease	364
.	O	364
we	O	365
present	O	365
here	O	365
the	O	365
effect	O	365
,	O	365
on	O	365
emerin	O	365
protein	O	365
expression	O	365
,	O	365
of	O	365
two	O	365
missense	O	365
mutations	O	365
identified	O	365
in	O	365
unrelated	O	365
edmd	B-Disease	365
patients	O	365
.	O	365
in	O	368
comparison	O	368
with	O	368
the	O	368
usual	O	368
edmd	B-Disease	368
phenotype	O	368
,	O	368
patients	O	368
with	O	368
p183	O	368
missense	O	368
mutations	O	368
have	O	368
a	O	368
later	O	368
age	O	368
at	O	368
onset	O	368
of	O	368
first	O	368
symptoms	O	368
,	O	368
elbow	B-Disease	368
contractures	I-Disease	368
,	O	368
ankle	B-Disease	368
contractures	I-Disease	368
,	O	368
upper	B-Disease	368
limb	I-Disease	368
weakness	I-Disease	368
and	O	368
lower	B-Disease	368
limb	I-Disease	368
weakness	I-Disease	368
,	O	368
but	O	368
there	O	368
is	O	368
no	O	368
difference	O	368
for	O	368
the	O	368
age	O	368
at	O	368
onset	O	368
of	O	368
cardiac	B-Disease	368
involvement	I-Disease	368
.	O	368
this	O	369
is	O	369
the	O	369
first	O	369
report	O	369
of	O	369
protein	O	369
studies	O	369
on	O	369
patients	O	369
with	O	369
missense	O	369
mutations	O	369
resulting	O	369
in	O	369
the	O	369
clinical	O	369
features	O	369
of	O	369
edmd	B-Disease	369
.	O	369
microdeletions	O	371
at	O	371
chromosome	O	371
bands	O	371
1q32	O	371
-	O	371
q41	O	371
as	O	371
a	O	371
cause	O	371
of	O	371
van	B-Disease	371
der	I-Disease	371
woude	I-Disease	371
syndrome	I-Disease	371
.	O	371
van	B-Disease	372
der	I-Disease	372
woude	I-Disease	372
syndrome	I-Disease	372
(	O	372
vws	B-Disease	372
)	O	372
is	O	372
an	O	372
autosomal	B-Disease	372
dominant	I-Disease	372
disorder	I-Disease	372
comprising	O	372
cleft	B-Disease	372
lip	I-Disease	372
and	O	372
/	O	372
or	O	372
cleft	B-Disease	372
palate	I-Disease	372
and	O	372
lip	B-Disease	372
pits	I-Disease	372
.	O	372
along	O	374
with	O	374
cleft	B-Disease	374
lip	I-Disease	374
/	I-Disease	374
palate	I-Disease	374
and	O	374
lip	B-Disease	374
pits	I-Disease	374
,	O	374
affected	O	374
relatives	O	374
exhibit	O	374
developmental	B-Disease	374
delays	I-Disease	374
,	O	374
suggesting	O	374
that	O	374
the	O	374
function	O	374
of	O	374
a	O	374
gene	O	374
nearby	O	374
may	O	374
also	O	374
be	O	374
disrupted	O	374
.	O	374
to	O	375
further	O	375
localize	O	375
the	O	375
vws	B-Disease	375
gene	O	375
we	O	375
searched	O	375
for	O	375
other	O	375
deletions	O	375
that	O	375
cause	O	375
vws	B-Disease	375
.	O	375
in	O	378
this	O	378
family	O	378
,	O	378
the	O	378
phenotype	O	378
in	O	378
three	O	378
generations	O	378
of	O	378
affected	O	378
individuals	O	378
was	O	378
confined	O	378
to	O	378
the	O	378
cardinal	O	378
signs	O	378
of	O	378
vws	B-Disease	378
.	O	378
no	O	381
deletions	O	381
were	O	381
detected	O	381
in	O	381
seven	O	381
cases	O	381
of	O	381
popliteal	B-Disease	381
pterygia	I-Disease	381
syndrome	I-Disease	381
,	O	381
76	O	381
cases	O	381
of	O	381
mixed	O	381
syndromic	B-Disease	381
forms	I-Disease	381
of	I-Disease	381
cleft	I-Disease	381
lip	I-Disease	381
and	I-Disease	381
palate	I-Disease	381
,	O	381
and	O	381
178	O	381
cases	O	381
of	O	381
nonsyndromic	B-Disease	381
cleft	I-Disease	381
lip	I-Disease	381
and	I-Disease	381
palate	I-Disease	381
.	O	381
splicing	O	382
defects	O	382
in	O	382
the	O	382
ataxia	B-Disease	382
-	I-Disease	382
telangiectasia	I-Disease	382
gene	O	382
,	O	382
atm	O	382
:	O	382
underlying	O	382
mutations	O	382
and	O	382
consequences	O	382
.	O	382
mutations	O	383
resulting	O	383
in	O	383
defective	O	383
splicing	O	383
constitute	O	383
a	O	383
significant	O	383
proportion	O	383
(	O	383
30	O	383
/	O	383
62	O	383
[	O	383
48	O	383
%	O	383
]	O	383
)	O	383
of	O	383
a	O	383
new	O	383
series	O	383
of	O	383
mutations	O	383
in	O	383
the	O	383
atm	O	383
gene	O	383
in	O	383
patients	O	383
with	O	383
ataxia	B-Disease	383
-	I-Disease	383
telangiectasia	I-Disease	383
(	O	383
at	B-Disease	383
)	O	383
that	O	383
were	O	383
detected	O	383
by	O	383
the	O	383
protein	O	383
-	O	383
truncation	O	383
assay	O	383
followed	O	383
by	O	383
sequence	O	383
analysis	O	383
of	O	383
genomic	O	383
dna	O	383
.	O	383
no	O	388
atm	O	388
protein	O	388
was	O	388
detected	O	388
by	O	388
western	O	388
blotting	O	388
in	O	388
any	O	388
at	B-Disease	388
cell	O	388
line	O	388
in	O	388
which	O	388
splicing	O	388
mutations	O	388
were	O	388
identified	O	388
.	O	388
alpha	O	390
-	O	390
cardiac	O	390
actin	O	390
is	O	390
a	O	390
novel	O	390
disease	O	390
gene	O	390
in	O	390
familial	B-Disease	390
hypertrophic	I-Disease	390
cardiomyopathy	I-Disease	390
.	O	390
we	O	391
identified	O	391
the	O	391
alpha	O	391
-	O	391
cardiac	O	391
actin	O	391
gene	O	391
(	O	391
actc	O	391
)	O	391
as	O	391
a	O	391
novel	O	391
disease	O	391
gene	O	391
in	O	391
a	O	391
pedigree	O	391
suffering	O	391
from	O	391
familial	B-Disease	391
hypertrophic	I-Disease	391
cardiomyopathy	I-Disease	391
(	O	391
fhc	B-Disease	391
)	O	391
.	O	391
linkage	O	392
analyses	O	392
excluded	O	392
all	O	392
the	O	392
previously	O	392
reported	O	392
fhc	B-Disease	392
loci	O	392
as	O	392
possible	O	392
disease	O	392
loci	O	392
in	O	392
the	O	392
family	O	392
studied	O	392
,	O	392
with	O	392
lod	O	392
scores	O	392
varying	O	392
between	O	392
-	O	392
2	O	392
.	O	392
mutation	O	397
analysis	O	397
of	O	397
actc	O	397
revealed	O	397
an	O	397
ala295ser	O	397
mutation	O	397
in	O	397
exon	O	397
5	O	397
close	O	397
to	O	397
2	O	397
missense	O	397
mutations	O	397
recently	O	397
described	O	397
to	O	397
cause	O	397
the	O	397
inherited	O	397
form	O	397
of	O	397
idiopathic	B-Disease	397
dilated	I-Disease	397
cardiomyopathy	I-Disease	397
(	O	397
idc	B-Disease	397
)	O	397
.	O	397
overgrowth	B-Disease	398
of	I-Disease	398
oral	I-Disease	398
mucosa	I-Disease	398
and	I-Disease	398
facial	I-Disease	398
skin	I-Disease	398
,	O	398
a	O	398
novel	O	398
feature	O	398
of	O	398
aspartylglucosaminuria	B-Disease	398
.	O	398
aspartylglucosaminuria	B-Disease	399
(	O	399
agu	B-Disease	399
)	O	399
is	O	399
a	O	399
lysosomal	B-Disease	399
storage	I-Disease	399
disorder	I-Disease	399
caused	O	399
by	O	399
deficiency	B-Disease	399
of	I-Disease	399
aspartylglucosaminidase	I-Disease	399
(	O	399
aga	O	399
)	O	399
.	O	399
the	O	400
main	O	400
symptom	O	400
is	O	400
progressive	O	400
mental	B-Disease	400
retardation	I-Disease	400
.	O	400
we	O	402
were	O	402
able	O	402
to	O	402
examine	O	402
66	O	402
finnish	O	402
agu	B-Disease	402
patients	O	402
for	O	402
changes	O	402
in	O	402
the	O	402
oral	O	402
mucosa	O	402
and	O	402
44	O	402
of	O	402
these	O	402
for	O	402
changes	O	402
in	O	402
facial	O	402
skin	O	402
.	O	402
biopsy	O	403
specimens	O	403
of	O	403
16	O	403
oral	O	403
lesions	O	403
,	O	403
12	O	403
of	O	403
them	O	403
associated	O	403
with	O	403
the	O	403
teeth	O	403
,	O	403
plus	O	403
two	O	403
facial	B-Disease	403
lesions	I-Disease	403
were	O	403
studied	O	403
histologically	O	403
.	O	403
skin	O	405
was	O	405
seborrhoeic	O	405
in	O	405
adolescent	O	405
and	O	405
adult	O	405
patients	O	405
,	O	405
with	O	405
erythema	B-Disease	405
of	I-Disease	405
the	I-Disease	405
facial	I-Disease	405
skin	I-Disease	405
already	O	405
common	O	405
in	O	405
childhood	O	405
.	O	405
of	O	406
44	O	406
patients	O	406
,	O	406
nine	O	406
(	O	406
20	O	406
%	O	406
)	O	406
had	O	406
facial	B-Disease	406
angiofibromas	I-Disease	406
,	O	406
tumours	B-Disease	406
primarily	O	406
occurring	O	406
in	O	406
association	O	406
with	O	406
tuberous	B-Disease	406
sclerosis	I-Disease	406
.	O	406
oedemic	B-Disease	407
buccal	I-Disease	407
mucosa	I-Disease	407
(	O	407
leucoedema	B-Disease	407
)	O	407
and	O	407
gingival	B-Disease	407
overgrowths	I-Disease	407
were	O	407
more	O	407
frequent	O	407
in	O	407
agu	B-Disease	407
patients	O	407
than	O	407
in	O	407
controls	O	407
(	O	407
p	O	407
<	O	407
0	O	407
.	O	407
001	O	407
)	O	407
.	O	407
of	O	408
16	O	408
oral	B-Disease	408
mucosal	I-Disease	408
lesions	I-Disease	408
studied	O	408
histologically	O	408
,	O	408
15	O	408
represented	O	408
fibroepithelial	B-Disease	408
or	I-Disease	408
epithelial	I-Disease	408
hyperplasias	I-Disease	408
and	O	408
were	O	408
reactive	O	408
in	O	408
nature	O	408
.	O	408
immunohistochemically	O	410
,	O	410
expression	O	410
of	O	410
aga	O	410
in	O	410
agu	B-Disease	410
patients	O	410
mucosal	B-Disease	410
lesions	I-Disease	410
did	O	410
not	O	410
differ	O	410
from	O	410
that	O	410
seen	O	410
in	O	410
corresponding	O	410
lesions	O	410
of	O	410
normal	O	410
subjects	O	410
.	O	410
thus	O	411
,	O	411
the	O	411
high	O	411
frequency	O	411
of	O	411
mucosal	B-Disease	411
overgrowth	I-Disease	411
in	O	411
agu	B-Disease	411
patients	O	411
does	O	411
not	O	411
appear	O	411
to	O	411
be	O	411
directly	O	411
associated	O	411
with	O	411
lysosomal	O	411
storage	O	411
or	O	411
with	O	411
alterations	O	411
in	O	411
the	O	411
level	O	411
of	O	411
aga	O	411
expression	O	411
.	O	411
characterization	O	412
of	O	412
a	O	412
germline	O	412
mosaicism	O	412
in	O	412
families	O	412
with	O	412
lowe	B-Disease	412
syndrome	I-Disease	412
,	O	412
and	O	412
identification	O	412
of	O	412
seven	O	412
novel	O	412
mutations	O	412
in	O	412
the	O	412
ocrl1	O	412
gene	O	412
.	O	412
the	O	413
oculocerebrorenal	B-Disease	413
syndrome	I-Disease	413
of	I-Disease	413
lowe	I-Disease	413
(	O	413
ocrl	B-Disease	413
)	O	413
is	O	413
an	O	413
x	B-Disease	413
-	I-Disease	413
linked	I-Disease	413
disorder	I-Disease	413
characterized	O	413
by	O	413
major	O	413
abnormalities	B-Disease	413
of	I-Disease	413
eyes	I-Disease	413
,	I-Disease	413
nervous	I-Disease	413
system	I-Disease	413
,	I-Disease	413
and	I-Disease	413
kidneys	I-Disease	413
.	O	413
we	O	416
have	O	416
examined	O	416
the	O	416
ocrl1	O	416
gene	O	416
in	O	416
eight	O	416
unrelated	O	416
patients	O	416
with	O	416
ocrl	B-Disease	416
and	O	416
have	O	416
found	O	416
seven	O	416
new	O	416
mutations	O	416
and	O	416
one	O	416
recurrent	O	416
in	O	416
-	O	416
frame	O	416
deletion	O	416
.	O	416
this	O	422
observation	O	422
has	O	422
direct	O	422
implications	O	422
for	O	422
genetic	O	422
counseling	O	422
of	O	422
lowe	B-Disease	422
syndrome	I-Disease	422
families	O	422
.	O	422
.	O	422
mefv	O	423
-	O	423
gene	O	423
analysis	O	423
in	O	423
armenian	O	423
patients	O	423
with	O	423
familial	B-Disease	423
mediterranean	I-Disease	423
fever	I-Disease	423
:	O	423
diagnostic	O	423
value	O	423
and	O	423
unfavorable	O	423
renal	O	423
prognosis	O	423
of	O	423
the	O	423
m694v	O	423
homozygous	O	423
genotype	O	423
-	O	423
genetic	O	423
and	O	423
therapeutic	O	423
implications	O	423
.	O	423
familial	B-Disease	424
mediterranean	I-Disease	424
fever	I-Disease	424
(	O	424
fmf	B-Disease	424
)	O	424
is	O	424
a	O	424
recessively	B-Disease	424
inherited	I-Disease	424
disorder	I-Disease	424
that	O	424
is	O	424
common	O	424
in	O	424
patients	O	424
of	O	424
armenian	O	424
ancestry	O	424
.	O	424
to	O	425
date	O	425
,	O	425
its	O	425
diagnosis	O	425
,	O	425
which	O	425
can	O	425
be	O	425
made	O	425
only	O	425
retrospectively	O	425
,	O	425
is	O	425
one	O	425
of	O	425
exclusion	O	425
,	O	425
based	O	425
entirely	O	425
on	O	425
nonspecific	O	425
clinical	O	425
signs	O	425
that	O	425
result	O	425
from	O	425
serosal	B-Disease	425
inflammation	I-Disease	425
and	O	425
that	O	425
may	O	425
lead	O	425
to	O	425
unnecessary	O	425
surgery	O	425
.	O	425
renal	B-Disease	426
amyloidosis	I-Disease	426
,	O	426
prevented	O	426
by	O	426
colchicine	O	426
,	O	426
is	O	426
the	O	426
most	O	426
severe	O	426
complication	O	426
of	O	426
fmf	B-Disease	426
,	O	426
a	O	426
disorder	O	426
associated	O	426
with	O	426
mutations	O	426
in	O	426
the	O	426
mefv	O	426
gene	O	426
.	O	426
to	O	427
evaluate	O	427
the	O	427
diagnostic	O	427
and	O	427
prognostic	O	427
value	O	427
of	O	427
mefv	O	427
-	O	427
gene	O	427
analysis	O	427
,	O	427
we	O	427
investigated	O	427
90	O	427
armenian	O	427
fmf	B-Disease	427
patients	O	427
from	O	427
77	O	427
unrelated	O	427
families	O	427
that	O	427
were	O	427
not	O	427
selected	O	427
through	O	427
genetic	O	427
-	O	427
linkage	O	427
analysis	O	427
.	O	427
eight	O	428
mutations	O	428
,	O	428
one	O	428
of	O	428
which	O	428
(	O	428
r408q	O	428
)	O	428
is	O	428
new	O	428
,	O	428
were	O	428
found	O	428
to	O	428
account	O	428
for	O	428
93	O	428
%	O	428
of	O	428
the	O	428
163	O	428
independent	O	428
fmf	B-Disease	428
alleles	O	428
,	O	428
with	O	428
both	O	428
fmf	B-Disease	428
alleles	O	428
identified	O	428
in	O	428
89	O	428
%	O	428
of	O	428
the	O	428
patients	O	428
.	O	428
the	O	430
m694v	O	430
homozygous	O	430
genotype	O	430
was	O	430
found	O	430
to	O	430
be	O	430
associated	O	430
with	O	430
a	O	430
higher	O	430
prevalence	O	430
of	O	430
renal	B-Disease	430
amyloidosis	I-Disease	430
and	O	430
arthritis	B-Disease	430
,	O	430
compared	O	430
with	O	430
other	O	430
genotypes	O	430
(	O	430
p	O	430
=	O	430
.	O	430
0002	O	430
and	O	430
p	O	430
=	O	430
.	O	430
006	O	430
,	O	430
respectively	O	430
)	O	430
.	O	430
noninvasive	O	432
test	O	432
for	O	432
fragile	B-Disease	432
x	I-Disease	432
syndrome	I-Disease	432
,	O	432
using	O	432
hair	O	432
root	O	432
analysis	O	432
.	O	432
identification	O	433
of	O	433
the	O	433
fmr1	O	433
gene	O	433
and	O	433
the	O	433
repeat	O	433
-	O	433
amplification	O	433
mechanism	O	433
causing	O	433
fragile	B-Disease	433
x	I-Disease	433
syndrome	I-Disease	433
led	O	433
to	O	433
development	O	433
of	O	433
reliable	O	433
dna	O	433
-	O	433
based	O	433
diagnostic	O	433
methods	O	433
,	O	433
including	O	433
southern	O	433
blot	O	433
hybridization	O	433
and	O	433
pcr	O	433
.	O	433
using	O	435
an	O	435
immunocytochemical	O	435
technique	O	435
on	O	435
blood	O	435
smears	O	435
,	O	435
we	O	435
recently	O	435
developed	O	435
a	O	435
novel	O	435
test	O	435
for	O	435
identification	O	435
of	O	435
patients	O	435
with	O	435
fragile	B-Disease	435
x	I-Disease	435
syndrome	I-Disease	435
.	O	435
here	O	437
we	O	437
describe	O	437
a	O	437
new	O	437
diagnostic	O	437
test	O	437
to	O	437
identify	O	437
male	O	437
patients	O	437
with	O	437
fragile	B-Disease	437
x	I-Disease	437
syndrome	I-Disease	437
,	O	437
on	O	437
the	O	437
basis	O	437
of	O	437
lack	O	437
of	O	437
fmrp	O	437
in	O	437
their	O	437
hair	O	437
roots	O	437
.	O	437
expression	O	438
of	O	438
fmrp	O	438
in	O	438
hair	O	438
roots	O	438
was	O	438
studied	O	438
by	O	438
use	O	438
of	O	438
an	O	438
fmrp	O	438
-	O	438
specific	O	438
antibody	O	438
test	O	438
,	O	438
and	O	438
the	O	438
percentage	O	438
of	O	438
fmrp	O	438
-	O	438
expressing	O	438
hair	O	438
roots	O	438
in	O	438
controls	O	438
and	O	438
in	O	438
male	O	438
fragile	B-Disease	438
x	I-Disease	438
patients	O	438
was	O	438
determined	O	438
.	O	438
control	O	439
individuals	O	439
showed	O	439
clear	O	439
expression	O	439
of	O	439
fmrp	O	439
in	O	439
nearly	O	439
every	O	439
hair	O	439
root	O	439
,	O	439
whereas	O	439
male	O	439
fragile	B-Disease	439
x	I-Disease	439
patients	O	439
lacked	O	439
expression	O	439
of	O	439
fmrp	O	439
in	O	439
almost	O	439
all	O	439
their	O	439
hair	O	439
roots	O	439
.	O	439
mentally	B-Disease	440
retarded	I-Disease	440
female	O	440
patients	O	440
with	O	440
a	O	440
full	O	440
mutation	O	440
showed	O	440
fmrp	O	440
expression	O	440
in	O	440
only	O	440
some	O	440
of	O	440
their	O	440
hair	O	440
roots	O	440
(	O	440
<	O	440
55	O	440
%	O	440
)	O	440
,	O	440
and	O	440
no	O	440
overlap	O	440
with	O	440
normal	O	440
female	O	440
controls	O	440
was	O	440
observed	O	440
.	O	440
the	O	441
advantages	O	441
of	O	441
this	O	441
test	O	441
are	O	441
(	O	441
1	O	441
)	O	441
plucking	O	441
of	O	441
hair	O	441
follicles	O	441
does	O	441
no	O	441
appreciable	O	441
harm	O	441
to	O	441
the	O	441
mentally	B-Disease	441
retarded	I-Disease	441
patient	O	441
,	O	441
(	O	441
2	O	441
)	O	441
hairs	O	441
can	O	441
be	O	441
sent	O	441
in	O	441
a	O	441
simple	O	441
envelope	O	441
to	O	441
a	O	441
diagnostic	O	441
center	O	441
,	O	441
and	O	441
(	O	441
3	O	441
)	O	441
the	O	441
result	O	441
of	O	441
the	O	441
test	O	441
is	O	441
available	O	441
within	O	441
5	O	441
h	O	441
of	O	441
plucking	O	441
.	O	441
in	O	442
addition	O	442
,	O	442
this	O	442
test	O	442
enabled	O	442
us	O	442
to	O	442
identify	O	442
two	O	442
fragile	B-Disease	442
x	I-Disease	442
patients	O	442
who	O	442
did	O	442
not	O	442
show	O	442
the	O	442
full	O	442
mutation	O	442
by	O	442
analysis	O	442
of	O	442
dna	O	442
isolated	O	442
from	O	442
blood	O	442
cells	O	442
.	O	442
.	O	442
in	O	443
swedish	O	443
families	O	443
with	O	443
hereditary	B-Disease	443
prostate	I-Disease	443
cancer	I-Disease	443
,	O	443
linkage	O	443
to	O	443
the	O	443
hpc1	O	443
locus	O	443
on	O	443
chromosome	O	443
1q24	O	443
-	O	443
25	O	443
is	O	443
restricted	O	443
to	O	443
families	O	443
with	O	443
early	O	443
-	O	443
onset	O	443
prostate	B-Disease	443
cancer	I-Disease	443
.	O	443
prostate	B-Disease	444
cancer	I-Disease	444
clusters	O	444
in	O	444
some	O	444
families	O	444
,	O	444
and	O	444
an	O	444
estimated	O	444
5	O	444
%	O	444
-	O	444
10	O	444
%	O	444
of	O	444
all	O	444
cases	O	444
are	O	444
estimated	O	444
to	O	444
result	O	444
from	O	444
inheritance	O	444
of	O	444
prostate	O	444
cancer	O	444
-	O	444
susceptibility	O	444
genes	O	444
.	O	444
we	O	445
previously	O	445
reported	O	445
evidence	O	445
of	O	445
linkage	O	445
to	O	445
the	O	445
1q24	O	445
-	O	445
25	O	445
region	O	445
(	O	445
hpc1	O	445
)	O	445
in	O	445
91	O	445
north	O	445
american	O	445
and	O	445
swedish	O	445
families	O	445
each	O	445
with	O	445
multiple	O	445
cases	O	445
of	O	445
prostate	B-Disease	445
cancer	I-Disease	445
(	O	445
smith	O	445
et	O	445
al	O	445
.	O	445
1996	O	445
)	O	445
.	O	445
in	O	446
the	O	446
present	O	446
report	O	446
we	O	446
analyze	O	446
40	O	446
(	O	446
12	O	446
original	O	446
and	O	446
28	O	446
newly	O	446
identified	O	446
)	O	446
swedish	O	446
families	O	446
with	O	446
hereditary	B-Disease	446
prostate	I-Disease	446
cancer	I-Disease	446
(	O	446
hpc	B-Disease	446
)	O	446
that	O	446
,	O	446
on	O	446
the	O	446
basis	O	446
of	O	446
40	O	446
markers	O	446
spanning	O	446
a	O	446
25	O	446
-	O	446
cm	O	446
interval	O	446
within	O	446
1q24	O	446
-	O	446
25	O	446
,	O	446
have	O	446
evidence	O	446
of	O	446
linkage	O	446
.	O	446
these	O	454
results	O	454
are	O	454
consistent	O	454
with	O	454
the	O	454
hypothesis	O	454
of	O	454
linkage	O	454
to	O	454
hpc1	O	454
in	O	454
a	O	454
subset	O	454
of	O	454
families	O	454
with	O	454
prostate	B-Disease	454
cancer	I-Disease	454
,	O	454
particularly	O	454
those	O	454
with	O	454
an	O	454
early	O	454
age	O	454
at	O	454
diagnosis	O	454
.	O	454
molecular	O	455
basis	O	455
of	O	455
feline	O	455
beta	B-Disease	455
-	I-Disease	455
glucuronidase	I-Disease	455
deficiency	I-Disease	455
:	O	455
an	O	455
animal	O	455
model	O	455
of	O	455
mucopolysaccharidosis	B-Disease	455
vii	I-Disease	455
.	O	455
a	O	456
family	O	456
of	O	456
domestic	O	456
cats	O	456
was	O	456
found	O	456
that	O	456
exhibited	O	456
clinical	O	456
and	O	456
biochemical	O	456
abnormalities	O	456
consistent	O	456
with	O	456
mucopolysaccharidosis	B-Disease	456
vii	I-Disease	456
,	O	456
an	O	456
autosomal	B-Disease	456
recessive	I-Disease	456
lysosomal	I-Disease	456
storage	I-Disease	456
disorder	I-Disease	456
caused	O	456
by	O	456
beta	B-Disease	456
-	I-Disease	456
glucuronidase	I-Disease	456
deficiency	I-Disease	456
.	O	456
carriers	O	463
identified	O	463
in	O	463
this	O	463
manner	O	463
produced	O	463
affected	O	463
kittens	O	463
in	O	463
prospective	O	463
breedings	O	463
,	O	463
and	O	463
a	O	463
feline	O	463
mps	B-Disease	463
vii	I-Disease	463
breeding	O	463
colony	O	463
has	O	463
been	O	463
established	O	463
.	O	463
.	O	463
a	O	464
common	O	464
molecular	O	464
basis	O	464
for	O	464
rearrangement	B-Disease	464
disorders	I-Disease	464
on	O	464
chromosome	O	464
22q11	O	464
.	O	464
the	O	465
chromosome	O	465
22q11	O	465
region	O	465
is	O	465
susceptible	O	465
to	O	465
rearrangements	O	465
that	O	465
are	O	465
associated	O	465
with	O	465
congenital	B-Disease	465
anomaly	I-Disease	465
disorders	I-Disease	465
and	O	465
malignant	B-Disease	465
tumors	I-Disease	465
.	O	465
three	O	466
congenital	B-Disease	466
anomaly	I-Disease	466
disorders	I-Disease	466
,	O	466
cat	B-Disease	466
-	I-Disease	466
eye	I-Disease	466
syndrome	I-Disease	466
,	O	466
der	B-Disease	466
(	I-Disease	466
)	I-Disease	466
syndrome	I-Disease	466
and	O	466
velo	B-Disease	466
-	I-Disease	466
cardio	I-Disease	466
-	I-Disease	466
facial	I-Disease	466
syndrome	I-Disease	466
/	O	466
digeorge	B-Disease	466
syndrome	I-Disease	466
(	O	466
vcfs	B-Disease	466
/	O	466
dgs	B-Disease	466
)	O	466
are	O	466
associated	O	466
with	O	466
tetrasomy	O	466
,	O	466
trisomy	O	466
or	O	466
monosomy	O	466
,	O	466
respectively	O	466
,	O	466
for	O	466
part	O	466
of	O	466
chromosome	O	466
22q11	O	466
.	O	466
vcfs	B-Disease	467
/	O	467
dgs	B-Disease	467
is	O	467
the	O	467
most	O	467
common	O	467
syndrome	O	467
associated	O	467
with	O	467
22q11	O	467
rearrangements	O	467
.	O	467
in	O	468
order	O	468
to	O	468
determine	O	468
whether	O	468
there	O	468
are	O	468
particular	O	468
regions	O	468
on	O	468
22q11	O	468
that	O	468
are	O	468
prone	O	468
to	O	468
rearrangements	O	468
,	O	468
the	O	468
deletion	O	468
end	O	468
-	O	468
points	O	468
in	O	468
a	O	468
large	O	468
number	O	468
of	O	468
vcfs	B-Disease	468
/	O	468
dgs	B-Disease	468
patients	O	468
were	O	468
defined	O	468
by	O	468
haplotype	O	468
analysis	O	468
.	O	468
most	O	469
vcfs	B-Disease	469
/	O	469
dgs	B-Disease	469
patients	O	469
have	O	469
a	O	469
similar	O	469
3	O	469
mb	O	469
deletion	O	469
,	O	469
some	O	469
have	O	469
a	O	469
nested	O	469
distal	O	469
deletion	O	469
breakpoint	O	469
resulting	O	469
in	O	469
a	O	469
1	O	469
.	O	469
to	O	472
investigate	O	472
this	O	472
hypothesis	O	472
,	O	472
we	O	472
developed	O	472
hamster	O	472
-	O	472
human	O	472
somatic	O	472
hybrid	O	472
cell	O	472
lines	O	472
from	O	472
vcfs	B-Disease	472
/	O	472
dgs	B-Disease	472
patients	O	472
with	O	472
all	O	472
three	O	472
classes	O	472
of	O	472
deletions	O	472
and	O	472
we	O	472
now	O	472
show	O	472
that	O	472
the	O	472
breakpoints	O	472
occur	O	472
within	O	472
similar	O	472
low	O	472
copy	O	472
repeats	O	472
,	O	472
termed	O	472
lcr22s	O	472
.	O	472
to	O	473
support	O	473
this	O	473
idea	O	473
further	O	473
,	O	473
we	O	473
identified	O	473
a	O	473
family	O	473
that	O	473
carries	O	473
an	O	473
interstitial	O	473
duplication	O	473
of	O	473
the	O	473
same	O	473
3	O	473
mb	O	473
region	O	473
that	O	473
is	O	473
deleted	O	473
in	O	473
vcfs	B-Disease	473
/	O	473
dgs	B-Disease	473
patients	O	473
.	O	473
we	O	474
present	O	474
models	O	474
to	O	474
explain	O	474
how	O	474
the	O	474
lcr22s	O	474
can	O	474
mediate	O	474
different	O	474
homologous	O	474
recombination	O	474
events	O	474
,	O	474
thereby	O	474
generating	O	474
a	O	474
number	O	474
of	O	474
rearrangements	O	474
that	O	474
are	O	474
associated	O	474
with	O	474
congenital	B-Disease	474
anomaly	I-Disease	474
disorders	I-Disease	474
.	O	474
functional	O	476
consequences	O	476
of	O	476
mutations	O	476
in	O	476
the	O	476
early	O	476
growth	O	476
response	O	476
2	O	476
gene	O	476
(	O	476
egr2	O	476
)	O	476
correlate	O	476
with	O	476
severity	O	476
of	O	476
human	O	476
myelinopathies	B-Disease	476
.	O	476
this	O	478
idea	O	478
is	O	478
based	O	478
partly	O	478
on	O	478
the	O	478
phenotype	O	478
of	O	478
homozygous	O	478
krox20	O	478
(	O	478
egr2	O	478
)	O	478
knockout	O	478
mice	O	478
,	O	478
which	O	478
display	O	478
hypomyelination	B-Disease	478
of	I-Disease	478
the	I-Disease	478
pns	I-Disease	478
and	O	478
a	O	478
block	O	478
of	O	478
schwann	O	478
cells	O	478
at	O	478
an	O	478
early	O	478
stage	O	478
of	O	478
differentiation	O	478
.	O	478
mutations	O	479
in	O	479
the	O	479
human	O	479
egr2	O	479
gene	O	479
have	O	479
recently	O	479
been	O	479
associated	O	479
with	O	479
the	O	479
inherited	B-Disease	479
peripheral	I-Disease	479
neuropathies	I-Disease	479
charcot	B-Disease	479
-	I-Disease	479
marie	I-Disease	479
-	I-Disease	479
tooth	I-Disease	479
type	I-Disease	479
1	I-Disease	479
,	O	479
dejerine	B-Disease	479
-	I-Disease	479
sottas	I-Disease	479
syndrome	I-Disease	479
and	O	479
congenital	B-Disease	479
hypomyelinating	I-Disease	479
neuropathy	I-Disease	479
.	O	479
autosomal	B-Disease	486
recessive	I-Disease	486
familial	I-Disease	486
neurohypophyseal	I-Disease	486
diabetes	I-Disease	486
insipidus	I-Disease	486
with	O	486
continued	O	486
secretion	O	486
of	O	486
mutant	O	486
weakly	O	486
active	O	486
vasopressin	O	486
.	O	486
familial	B-Disease	487
neurohypophyseal	I-Disease	487
diabetes	I-Disease	487
insipidus	I-Disease	487
is	O	487
an	O	487
autosomal	B-Disease	487
dominant	I-Disease	487
disorder	I-Disease	487
characterized	O	487
by	O	487
post	O	487
-	O	487
natal	O	487
development	O	487
of	O	487
arginine	B-Disease	487
vasopressin	I-Disease	487
(	I-Disease	487
avp	I-Disease	487
)	I-Disease	487
deficiency	I-Disease	487
due	O	487
to	O	487
mutations	O	487
in	O	487
the	O	487
avp	O	487
gene	O	487
.	O	487
all	O	488
published	O	488
mutations	O	488
affect	O	488
the	O	488
signal	O	488
peptide	O	488
or	O	488
the	O	488
neurophysin	O	488
-	O	488
ii	O	488
carrier	O	488
protein	O	488
and	O	488
are	O	488
presumed	O	488
to	O	488
interfere	O	488
with	O	488
processing	O	488
of	O	488
the	O	488
preprohormone	O	488
,	O	488
leading	O	488
to	O	488
neuronal	B-Disease	488
damage	I-Disease	488
.	O	488
we	O	489
studied	O	489
an	O	489
unusual	O	489
palestinian	O	489
family	O	489
consisting	O	489
of	O	489
asymptomatic	O	489
first	O	489
cousin	O	489
parents	O	489
and	O	489
three	O	489
children	O	489
affected	O	489
with	O	489
neurohypophyseal	B-Disease	489
diabetes	I-Disease	489
insipidus	I-Disease	489
,	O	489
suggesting	O	489
autosomal	O	489
recessive	O	489
inheritance	O	489
.	O	489
the	O	493
youngest	O	493
child	O	493
(	O	493
2	O	493
years	O	493
old	O	493
)	O	493
was	O	493
only	O	493
mildly	O	493
affected	O	493
but	O	493
had	O	493
leu	O	493
-	O	493
avp	O	493
levels	O	493
similar	O	493
to	O	493
her	O	493
severely	O	493
affected	O	493
8	O	493
-	O	493
year	O	493
-	O	493
old	O	493
brother	O	493
,	O	493
suggesting	O	493
that	O	493
unknown	O	493
mechanisms	O	493
may	O	493
partially	O	493
compensate	O	493
for	O	493
a	O	493
deficiency	B-Disease	493
of	I-Disease	493
active	I-Disease	493
avp	I-Disease	493
in	O	493
very	O	493
young	O	493
children	O	493
.	O	493
.	O	493
a	O	495
somatic	O	495
mutation	O	495
in	O	495
the	O	495
x	O	495
linked	O	495
piga	O	495
gene	O	495
is	O	495
responsible	O	495
for	O	495
the	O	495
deficiency	B-Disease	495
of	I-Disease	495
glycosyl	I-Disease	495
phosphatidylinositol	I-Disease	495
(	I-Disease	495
gpi	I-Disease	495
)	I-Disease	495
-	I-Disease	495
anchored	I-Disease	495
proteins	I-Disease	495
on	O	495
blood	O	495
cells	O	495
from	O	495
patients	O	495
with	O	495
paroxysmal	B-Disease	495
nocturnal	I-Disease	495
hemoglobinuria	I-Disease	495
.	O	495
no	O	496
inherited	O	496
form	O	496
of	O	496
gpi	B-Disease	496
-	I-Disease	496
anchor	I-Disease	496
deficiency	I-Disease	496
has	O	496
been	O	496
described	O	496
.	O	496
because	O	497
conventional	O	497
piga	O	497
gene	O	497
knockout	O	497
is	O	497
associated	O	497
with	O	497
high	O	497
embryonic	B-Disease	497
lethality	I-Disease	497
in	O	497
chimeric	O	497
mice	O	497
,	O	497
we	O	497
used	O	497
the	O	497
cre	O	497
/	O	497
loxp	O	497
system	O	497
.	O	497
piga	O	503
(	O	503
-	O	503
)	O	503
cells	O	503
had	O	503
no	O	503
growth	O	503
advantage	O	503
,	O	503
suggesting	O	503
that	O	503
other	O	503
factors	O	503
are	O	503
needed	O	503
for	O	503
their	O	503
clonal	O	503
dominance	O	503
in	O	503
patients	O	503
with	O	503
paroxysmal	B-Disease	503
nocturnal	I-Disease	503
hemoglobinuria	I-Disease	503
.	O	503
.	O	503
the	O	504
c282y	O	504
mutation	O	504
causing	O	504
hereditary	B-Disease	504
hemochromatosis	I-Disease	504
does	O	504
not	O	504
produce	O	504
a	O	504
null	O	504
allele	O	504
.	O	504
targeted	O	505
mutagenesis	O	505
was	O	505
used	O	505
to	O	505
produce	O	505
two	O	505
mutations	O	505
in	O	505
the	O	505
murine	O	505
hemochromatosis	B-Disease	505
gene	O	505
(	O	505
hfe	O	505
)	O	505
locus	O	505
.	O	505
this	O	508
mutation	O	508
is	O	508
identical	O	508
to	O	508
the	O	508
disease	O	508
-	O	508
causing	O	508
mutation	O	508
in	O	508
patients	O	508
with	O	508
hereditary	B-Disease	508
hemochromatosis	I-Disease	508
.	O	508
genotype	O	515
-	O	515
phenotype	O	515
analysis	O	515
in	O	515
x	B-Disease	515
-	I-Disease	515
linked	I-Disease	515
emery	I-Disease	515
-	I-Disease	515
dreifuss	I-Disease	515
muscular	I-Disease	515
dystrophy	I-Disease	515
and	O	515
identification	O	515
of	O	515
a	O	515
missense	O	515
mutation	O	515
associated	O	515
with	O	515
a	O	515
milder	O	515
phenotype	O	515
.	O	515
direct	O	516
sequencing	O	516
of	O	516
the	O	516
emerin	O	516
gene	O	516
in	O	516
22	O	516
families	O	516
with	O	516
emery	B-Disease	516
-	I-Disease	516
dreifuss	I-Disease	516
muscular	I-Disease	516
dystrophy	I-Disease	516
(	O	516
emd	B-Disease	516
)	O	516
revealed	O	516
mutations	O	516
in	O	516
21	O	516
(	O	516
95	O	516
%	O	516
)	O	516
,	O	516
confirming	O	516
that	O	516
emerin	O	516
mutations	O	516
can	O	516
be	O	516
identified	O	516
in	O	516
the	O	516
majority	O	516
of	O	516
families	O	516
with	O	516
x	B-Disease	516
-	I-Disease	516
linked	I-Disease	516
emd	I-Disease	516
.	O	516
age	O	522
at	O	522
onset	O	522
was	O	522
later	O	522
for	O	522
first	O	522
symptoms	O	522
and	O	522
for	O	522
development	O	522
of	O	522
ankle	B-Disease	522
contractures	I-Disease	522
and	O	522
muscle	B-Disease	522
weakness	I-Disease	522
.	O	522
severe	O	524
clinical	O	524
expression	O	524
in	O	524
x	B-Disease	524
-	I-Disease	524
linked	I-Disease	524
emery	I-Disease	524
-	I-Disease	524
dreifuss	I-Disease	524
muscular	I-Disease	524
dystrophy	I-Disease	524
.	O	524
x	B-Disease	525
-	I-Disease	525
linked	I-Disease	525
emery	I-Disease	525
-	I-Disease	525
dreifuss	I-Disease	525
muscular	I-Disease	525
dystrophy	I-Disease	525
(	O	525
edmd	B-Disease	525
)	O	525
is	O	525
a	O	525
relatively	O	525
rare	O	525
benign	B-Disease	525
neuromuscular	I-Disease	525
disorder	I-Disease	525
which	O	525
can	O	525
vary	O	525
remarkably	O	525
in	O	525
onset	O	525
,	O	525
course	O	525
and	O	525
severity	O	525
.	O	525
in	O	526
the	O	526
present	O	526
study	O	526
,	O	526
a	O	526
tctac	O	526
deletion	O	526
spanning	O	526
the	O	526
nucleotides	O	526
631	O	526
-	O	526
635	O	526
of	O	526
the	O	526
emerin	O	526
gene	O	526
caused	O	526
an	O	526
unusually	O	526
severe	O	526
disease	O	526
phenotype	O	526
including	O	526
loss	B-Disease	526
of	I-Disease	526
ambulation	I-Disease	526
and	O	526
severe	O	526
muscle	B-Disease	526
wasting	I-Disease	526
in	O	526
two	O	526
affected	O	526
brothers	O	526
.	O	526
the	O	528
interfamilial	O	528
heterogeneity	O	528
in	O	528
distribution	O	528
and	O	528
in	O	528
severity	O	528
of	O	528
the	O	528
features	O	528
in	O	528
the	O	528
two	O	528
families	O	528
point	O	528
to	O	528
environmental	O	528
or	O	528
genetic	O	528
modification	O	528
as	O	528
the	O	528
cause	O	528
of	O	528
clinical	O	528
variability	O	528
in	O	528
emery	B-Disease	528
-	I-Disease	528
dreifuss	I-Disease	528
muscular	I-Disease	528
dystrophy	I-Disease	528
.	O	528
.	O	528
common	O	529
mutations	O	529
in	O	529
brca1	O	529
and	O	529
brca2	O	529
do	O	529
not	O	529
contribute	O	529
to	O	529
early	O	529
prostate	B-Disease	529
cancer	I-Disease	529
in	O	529
jewish	O	529
men	O	529
.	O	529
background	O	530
families	O	530
with	O	530
a	O	530
high	O	530
incidence	O	530
of	O	530
hereditary	B-Disease	530
breast	I-Disease	530
cancer	I-Disease	530
,	O	530
and	O	530
subsequently	O	530
shown	O	530
to	O	530
have	O	530
terminating	O	530
mutations	O	530
in	O	530
brca1	O	530
or	O	530
brca2	O	530
,	O	530
appear	O	530
to	O	530
have	O	530
a	O	530
higher	O	530
incidence	O	530
of	O	530
prostate	B-Disease	530
cancer	I-Disease	530
among	O	530
male	O	530
relatives	O	530
.	O	530
we	O	531
aimed	O	531
to	O	531
determine	O	531
whether	O	531
the	O	531
common	O	531
germline	O	531
mutations	O	531
of	O	531
brca1	O	531
or	O	531
brca2	O	531
in	O	531
ashkenazi	O	531
jewish	O	531
men	O	531
predisposed	O	531
them	O	531
to	O	531
prostate	B-Disease	531
cancer	I-Disease	531
.	O	531
methods	O	532
we	O	532
examined	O	532
genomic	O	532
dna	O	532
from	O	532
83	O	532
(	O	532
for	O	532
brca1	O	532
185delag	O	532
)	O	532
or	O	532
82	O	532
(	O	532
for	O	532
brca2	O	532
6174delt	O	532
)	O	532
ashkenazi	O	532
jewish	O	532
prostate	B-Disease	532
cancer	I-Disease	532
patients	O	532
,	O	532
most	O	532
of	O	532
whom	O	532
were	O	532
treated	O	532
at	O	532
a	O	532
relatively	O	532
young	O	532
age	O	532
,	O	532
for	O	532
the	O	532
most	O	532
common	O	532
germline	O	532
mutation	O	532
in	O	532
each	O	532
gene	O	532
seen	O	532
in	O	532
the	O	532
ashkenazi	O	532
population	O	532
.	O	532
results	O	533
our	O	533
study	O	533
should	O	533
have	O	533
been	O	533
able	O	533
to	O	533
detect	O	533
a	O	533
4	O	533
-	O	533
5	O	533
-	O	533
fold	O	533
increase	O	533
in	O	533
the	O	533
risk	O	533
of	O	533
prostate	B-Disease	533
cancer	I-Disease	533
due	O	533
to	O	533
mutation	O	533
of	O	533
brca1	O	533
or	O	533
brca2	O	533
.	O	533
conclusions	O	535
the	O	535
incidence	O	535
of	O	535
each	O	535
of	O	535
the	O	535
germline	O	535
mutations	O	535
in	O	535
these	O	535
prostate	B-Disease	535
cancer	I-Disease	535
patients	O	535
closely	O	535
matched	O	535
their	O	535
incidence	O	535
(	O	535
about	O	535
1	O	535
%	O	535
)	O	535
in	O	535
the	O	535
general	O	535
ashkenazi	O	535
jewish	O	535
population	O	535
.	O	535
this	O	536
suggests	O	536
that	O	536
unlike	O	536
cases	O	536
of	O	536
breast	B-Disease	536
and	I-Disease	536
ovarian	I-Disease	536
cancers	I-Disease	536
,	O	536
mutations	O	536
in	O	536
brca1	O	536
or	O	536
brca2	O	536
do	O	536
not	O	536
significantly	O	536
predispose	O	536
men	O	536
to	O	536
prostate	B-Disease	536
cancer	I-Disease	536
beta	O	537
-	O	537
catenin	O	537
accumulation	O	537
and	O	537
mutation	O	537
of	O	537
the	O	537
ctnnb1	O	537
gene	O	537
in	O	537
hepatoblastoma	B-Disease	537
.	O	537
hepatoblastoma	B-Disease	538
is	O	538
a	O	538
rare	O	538
malignant	B-Disease	538
tumor	I-Disease	538
of	I-Disease	538
the	I-Disease	538
liver	I-Disease	538
that	O	538
occurs	O	538
in	O	538
children	O	538
at	O	538
an	O	538
average	O	538
age	O	538
of	O	538
2	O	538
to	O	538
3	O	538
years	O	538
.	O	538
epidemiologic	O	539
studies	O	539
have	O	539
shown	O	539
an	O	539
increased	O	539
frequency	O	539
of	O	539
this	O	539
tumor	B-Disease	539
type	O	539
in	O	539
families	O	539
affected	O	539
by	O	539
adenomatous	B-Disease	539
polyposis	I-Disease	539
coli	I-Disease	539
.	O	539
in	O	540
addition	O	540
to	O	540
the	O	540
epidemiologic	O	540
data	O	540
,	O	540
molecular	O	540
genetic	O	540
studies	O	540
suggest	O	540
that	O	540
inactivation	O	540
of	O	540
the	O	540
apc	B-Disease	540
tumor	I-Disease	540
suppressor	O	540
may	O	540
be	O	540
involved	O	540
in	O	540
hepatoblastoma	B-Disease	540
tumorigenesis	O	540
.	O	540
in	O	542
an	O	542
ongoing	O	542
immunohistochemical	O	542
study	O	542
of	O	542
beta	O	542
-	O	542
catenin	O	542
expression	O	542
in	O	542
sporadic	O	542
cases	O	542
of	O	542
tumor	B-Disease	542
types	O	542
that	O	542
are	O	542
associated	O	542
with	O	542
adenomatous	B-Disease	542
polyposis	I-Disease	542
coli	I-Disease	542
,	O	542
we	O	542
observed	O	542
increased	O	542
beta	O	542
-	O	542
catenin	O	542
levels	O	542
in	O	542
the	O	542
cytoplasm	O	542
and	O	542
in	O	542
the	O	542
nuclei	O	542
of	O	542
three	O	542
investigated	O	542
hepatoblastomas	B-Disease	542
.	O	542
sequencing	O	543
of	O	543
exon	O	543
3	O	543
of	O	543
the	O	543
beta	O	543
-	O	543
catenin	O	543
gene	O	543
(	O	543
ctnnb1	O	543
)	O	543
revealed	O	543
an	O	543
activating	O	543
mutation	O	543
in	O	543
one	O	543
of	O	543
the	O	543
tumor	B-Disease	543
samples	O	543
.	O	543
our	O	544
data	O	544
indicate	O	544
for	O	544
the	O	544
first	O	544
time	O	544
that	O	544
beta	O	544
-	O	544
catenin	O	544
accumulation	O	544
may	O	544
play	O	544
a	O	544
role	O	544
in	O	544
the	O	544
development	O	544
of	O	544
hepatoblastoma	B-Disease	544
and	O	544
that	O	544
activating	O	544
mutations	O	544
of	O	544
the	O	544
beta	O	544
-	O	544
catenin	O	544
gene	O	544
may	O	544
substitute	O	544
biallelic	O	544
apc	O	544
inactivation	O	544
in	O	544
this	O	544
tumor	B-Disease	544
type	O	544
.	O	544
decrease	O	546
in	O	546
gtp	O	546
cyclohydrolase	O	546
i	O	546
gene	O	546
expression	O	546
caused	O	546
by	O	546
inactivation	O	546
of	O	546
one	O	546
allele	O	546
in	O	546
hereditary	B-Disease	546
progressive	I-Disease	546
dystonia	I-Disease	546
with	O	546
marked	O	546
diurnal	O	546
fluctuation	O	546
.	O	546
hereditary	B-Disease	547
progressive	I-Disease	547
dystonia	I-Disease	547
with	O	547
marked	O	547
diurnal	O	547
fluctuation	O	547
(	O	547
hpd	B-Disease	547
;	O	547
dopa	B-Disease	547
-	I-Disease	547
responsive	I-Disease	547
dystonia	I-Disease	547
,	O	547
drd	B-Disease	547
)	O	547
have	O	547
been	O	547
recently	O	547
found	O	547
to	O	547
be	O	547
caused	O	547
by	O	547
a	O	547
genetic	B-Disease	547
defect	I-Disease	547
in	O	547
the	O	547
gtp	O	547
cyclohydrolase	O	547
i	O	547
(	O	547
gch1	O	547
)	O	547
gene	O	547
.	O	547
these	O	551
results	O	551
suggest	O	551
that	O	551
some	O	551
novel	O	551
mutations	O	551
should	O	551
exist	O	551
on	O	551
one	O	551
of	O	551
the	O	551
alleles	O	551
in	O	551
some	O	551
unknown	O	551
region	O	551
of	O	551
the	O	551
gch1	O	551
gene	O	551
,	O	551
and	O	551
may	O	551
decrease	O	551
the	O	551
gch1	O	551
mrna	O	551
causing	O	551
the	O	551
hpd	B-Disease	551
/	O	551
drd	B-Disease	551
symptoms	O	551
.	O	551
.	O	551
sulfate	O	552
transport	O	552
is	O	552
not	O	552
impaired	O	552
in	O	552
pendred	B-Disease	552
syndrome	I-Disease	552
thyrocytes	O	552
.	O	552
pendred	B-Disease	553
syndrome	I-Disease	553
is	O	553
the	O	553
most	O	553
common	O	553
form	O	553
of	O	553
syndromic	B-Disease	553
deafness	I-Disease	553
,	O	553
characterized	O	553
by	O	553
dyshormonogenic	B-Disease	553
goiter	I-Disease	553
associated	O	553
with	O	553
sensory	B-Disease	553
-	I-Disease	553
neural	I-Disease	553
deafness	I-Disease	553
.	O	553
the	O	554
gene	O	554
responsible	O	554
for	O	554
the	O	554
disease	O	554
(	O	554
pds	B-Disease	554
)	O	554
has	O	554
been	O	554
cloned	O	554
,	O	554
but	O	554
its	O	554
function	O	554
is	O	554
as	O	554
yet	O	554
unknown	O	554
and	O	554
the	O	554
connection	O	554
between	O	554
thyroid	B-Disease	554
goiter	I-Disease	554
and	O	554
sensory	B-Disease	554
-	I-Disease	554
neural	I-Disease	554
deafness	I-Disease	554
remains	O	554
an	O	554
enigma	O	554
.	O	554
we	O	557
tested	O	557
sulfate	O	557
transport	O	557
in	O	557
thyrocytes	O	557
obtained	O	557
from	O	557
pendred	B-Disease	557
syndrome	I-Disease	557
patients	O	557
and	O	557
found	O	557
that	O	557
it	O	557
was	O	557
not	O	557
defective	O	557
.	O	557
small	O	559
deletions	O	559
in	O	559
the	O	559
type	O	559
ii	O	559
collagen	O	559
triple	O	559
helix	O	559
produce	O	559
kniest	B-Disease	559
dysplasia	I-Disease	559
.	O	559
kniest	B-Disease	560
dysplasia	I-Disease	560
is	O	560
a	O	560
moderately	O	560
severe	O	560
type	B-Disease	560
ii	I-Disease	560
collagenopathy	I-Disease	560
,	O	560
characterized	O	560
by	O	560
short	O	560
trunk	O	560
and	O	560
limbs	O	560
,	O	560
kyphoscoliosis	B-Disease	560
,	O	560
midface	B-Disease	560
hypoplasia	I-Disease	560
,	O	560
severe	O	560
myopia	B-Disease	560
,	O	560
and	O	560
hearing	B-Disease	560
loss	I-Disease	560
.	O	560
mutations	O	561
in	O	561
the	O	561
gene	O	561
that	O	561
encodes	O	561
type	O	561
ii	O	561
collagen	O	561
(	O	561
col2a1	O	561
)	O	561
,	O	561
the	O	561
predominant	O	561
protein	O	561
of	O	561
cartilage	O	561
,	O	561
have	O	561
been	O	561
identified	O	561
in	O	561
a	O	561
number	O	561
of	O	561
individuals	O	561
with	O	561
kniest	B-Disease	561
dysplasia	I-Disease	561
.	O	561
we	O	564
used	O	564
heteroduplex	O	564
analysis	O	564
to	O	564
identify	O	564
sequence	O	564
anomalies	O	564
in	O	564
five	O	564
individuals	O	564
with	O	564
kniest	B-Disease	564
dysplasia	I-Disease	564
.	O	564
sequencing	O	565
of	O	565
the	O	565
index	O	565
patients	O	565
genomic	O	565
dna	O	565
identified	O	565
four	O	565
new	O	565
dominant	O	565
mutations	O	565
in	O	565
col2a1	O	565
that	O	565
result	O	565
in	O	565
kniest	B-Disease	565
dysplasia	I-Disease	565
a	O	565
21	O	565
-	O	565
bp	O	565
deletion	O	565
in	O	565
exon	O	565
16	O	565
,	O	565
an	O	565
18	O	565
-	O	565
bp	O	565
deletion	O	565
in	O	565
exon	O	565
19	O	565
,	O	565
and	O	565
4	O	565
-	O	565
bp	O	565
deletions	O	565
in	O	565
the	O	565
splice	O	565
donor	O	565
sites	O	565
of	O	565
introns	O	565
14	O	565
and	O	565
20	O	565
.	O	565
these	O	568
data	O	568
suggest	O	568
that	O	568
kniest	B-Disease	568
dysplasia	I-Disease	568
results	O	568
from	O	568
shorter	O	568
type	O	568
ii	O	568
collagen	O	568
monomers	O	568
,	O	568
and	O	568
support	O	568
the	O	568
hypothesis	O	568
that	O	568
alteration	O	568
of	O	568
a	O	568
specific	O	568
col2a1	O	568
domain	O	568
,	O	568
which	O	568
may	O	568
span	O	568
from	O	568
exons	O	568
12	O	568
to	O	568
24	O	568
,	O	568
leads	O	568
to	O	568
the	O	568
kniest	B-Disease	568
dysplasia	I-Disease	568
phenotype	O	568
.	O	568
.	O	568
classical	B-Disease	569
galactosemia	I-Disease	569
and	O	569
mutations	O	569
at	O	569
the	O	569
galactose	O	569
-	O	569
1	O	569
-	O	569
phosphate	O	569
uridyl	O	569
transferase	O	569
(	O	569
galt	O	569
)	O	569
gene	O	569
.	O	569
classical	B-Disease	570
galactosemia	I-Disease	570
is	O	570
caused	O	570
by	O	570
a	O	570
deficiency	O	570
in	O	570
activity	O	570
of	O	570
the	O	570
enzyme	O	570
galactose	O	570
-	O	570
1	O	570
-	O	570
phosphate	O	570
uridyl	O	570
transferase	O	570
(	O	570
galt	O	570
)	O	570
,	O	570
which	O	570
,	O	570
in	O	570
turn	O	570
,	O	570
is	O	570
caused	O	570
by	O	570
mutations	O	570
at	O	570
the	O	570
galt	O	570
gene	O	570
.	O	570
the	O	585
considerable	O	585
genetic	O	585
heterogeneity	O	585
documented	O	585
to	O	585
date	O	585
undoubtedly	O	585
contributes	O	585
to	O	585
the	O	585
phenotypic	O	585
heterogeneity	O	585
that	O	585
is	O	585
observed	O	585
in	O	585
galactosemia	B-Disease	585
.	O	585
mutations	O	587
of	O	587
the	O	587
vhl	B-Disease	587
gene	O	587
in	O	587
sporadic	B-Disease	587
renal	I-Disease	587
cell	I-Disease	587
carcinoma	I-Disease	587
:	O	587
definition	O	587
of	O	587
a	O	587
risk	O	587
factor	O	587
for	O	587
vhl	B-Disease	587
patients	O	587
to	O	587
develop	O	587
an	O	587
rcc	B-Disease	587
.	O	587
to	O	588
investigate	O	588
the	O	588
nature	O	588
of	O	588
somatic	O	588
von	B-Disease	588
hippel	I-Disease	588
-	I-Disease	588
lindau	I-Disease	588
(	O	588
vhl	B-Disease	588
)	O	588
mutations	O	588
,	O	588
we	O	588
analyzed	O	588
173	O	588
primary	O	588
sporadic	O	588
human	O	588
renal	B-Disease	588
cell	I-Disease	588
carcinomas	I-Disease	588
for	O	588
mutations	O	588
of	O	588
the	O	588
vhl	B-Disease	588
tumor	I-Disease	588
suppressor	O	588
gene	O	588
,	O	588
using	O	588
polymerase	O	588
chain	O	588
reaction	O	588
(	O	588
pcr	O	588
)	O	588
and	O	588
single	O	588
-	O	588
strand	O	588
conformational	O	588
polymorphism	O	588
analysis	O	588
(	O	588
sscp	O	588
)	O	588
of	O	588
dna	O	588
.	O	588
vhl	B-Disease	592
mutations	O	592
were	O	592
found	O	592
only	O	592
in	O	592
the	O	592
nonpapillary	B-Disease	592
renal	I-Disease	592
cell	I-Disease	592
carcinoma	I-Disease	592
(	O	592
rcc	B-Disease	592
)	O	592
subtype	O	592
,	O	592
as	O	592
previously	O	592
reported	O	592
.	O	592
to	O	593
compare	O	593
somatic	O	593
and	O	593
germline	O	593
mutations	O	593
,	O	593
we	O	593
used	O	593
the	O	593
vhl	B-Disease	593
database	O	593
,	O	593
which	O	593
includes	O	593
507	O	593
mutations	O	593
.	O	593
we	O	595
postulated	O	595
that	O	595
a	O	595
specific	O	595
pattern	O	595
of	O	595
vhl	B-Disease	595
mutations	O	595
is	O	595
associated	O	595
with	O	595
sporadic	B-Disease	595
rcc	I-Disease	595
.	O	595
we	O	597
then	O	597
analyzed	O	597
the	O	597
occurrence	O	597
of	O	597
rcc	B-Disease	597
in	O	597
vhl	B-Disease	597
families	O	597
,	O	597
based	O	597
on	O	597
the	O	597
nature	O	597
of	O	597
mutations	O	597
.	O	597
we	O	598
observed	O	598
rcc	B-Disease	598
in	O	598
at	O	598
least	O	598
one	O	598
member	O	598
of	O	598
the	O	598
vhl	B-Disease	598
families	O	598
in	O	598
77	O	598
%	O	598
of	O	598
cases	O	598
with	O	598
mutations	O	598
leading	O	598
to	O	598
truncated	O	598
proteins	O	598
versus	O	598
55	O	598
%	O	598
in	O	598
cases	O	598
with	O	598
missense	O	598
mutations	O	598
(	O	598
p	O	598
<	O	598
0	O	598
.	O	598
05	O	598
)	O	598
.	O	598
thus	O	599
,	O	599
mutations	O	599
resulting	O	599
in	O	599
truncated	O	599
proteins	O	599
may	O	599
lead	O	599
to	O	599
a	O	599
higher	O	599
risk	O	599
of	O	599
rcc	B-Disease	599
in	O	599
vhl	B-Disease	599
patients	O	599
defective	O	600
ctla	O	600
-	O	600
4	O	600
cycling	O	600
pathway	O	600
in	O	600
chediak	B-Disease	600
-	I-Disease	600
higashi	I-Disease	600
syndrome	I-Disease	600
:	O	600
a	O	600
possible	O	600
mechanism	O	600
for	O	600
deregulation	O	600
of	O	600
t	O	600
lymphocyte	O	600
activation	O	600
.	O	600
chediak	B-Disease	603
-	I-Disease	603
higashi	I-Disease	603
syndrome	I-Disease	603
(	O	603
chs	B-Disease	603
)	O	603
is	O	603
an	O	603
inherited	B-Disease	603
disorder	I-Disease	603
caused	O	603
by	O	603
mutations	O	603
in	O	603
the	O	603
lysosomal	O	603
trafficking	O	603
regulator	O	603
gene	O	603
,	O	603
lyst	O	603
.	O	603
it	O	604
results	O	604
in	O	604
defective	O	604
membrane	O	604
targeting	O	604
of	O	604
the	O	604
proteins	O	604
present	O	604
in	O	604
secretory	O	604
lysosomes	O	604
,	O	604
and	O	604
it	O	604
is	O	604
associated	O	604
with	O	604
a	O	604
variety	O	604
of	O	604
features	O	604
,	O	604
including	O	604
a	O	604
lymphoproliferative	B-Disease	604
syndrome	I-Disease	604
with	O	604
hemophagocytosis	B-Disease	604
.	O	604
the	O	605
murine	O	605
equivalent	O	605
of	O	605
chs	B-Disease	605
,	O	605
beige	O	605
mice	O	605
,	O	605
present	O	605
similar	O	605
characteristics	O	605
but	O	605
do	O	605
not	O	605
develop	O	605
the	O	605
lymphoproliferative	B-Disease	605
syndrome	I-Disease	605
.	O	605
we	O	606
show	O	606
herein	O	606
that	O	606
ctla	O	606
-	O	606
4	O	606
is	O	606
present	O	606
in	O	606
enlarged	O	606
,	O	606
abnormal	O	606
vesicles	O	606
in	O	606
chs	B-Disease	606
t	O	606
cells	O	606
and	O	606
is	O	606
not	O	606
properly	O	606
expressed	O	606
at	O	606
the	O	606
cell	O	606
surface	O	606
after	O	606
t	O	606
cell	O	606
activation	O	606
,	O	606
whereas	O	606
its	O	606
surface	O	606
expression	O	606
is	O	606
not	O	606
impaired	O	606
.	O	606
it	O	607
is	O	607
therefore	O	607
proposed	O	607
that	O	607
the	O	607
defective	O	607
surface	O	607
expression	O	607
of	O	607
ctla	O	607
-	O	607
4	O	607
by	O	607
chs	B-Disease	607
t	O	607
cells	O	607
is	O	607
involved	O	607
in	O	607
the	O	607
generation	O	607
of	O	607
lymphoproliferative	B-Disease	607
disease	I-Disease	607
.	O	607
proteolipoprotein	O	609
gene	O	609
analysis	O	609
in	O	609
82	O	609
patients	O	609
with	O	609
sporadic	O	609
pelizaeus	B-Disease	609
-	I-Disease	609
merzbacher	I-Disease	609
disease	I-Disease	609
:	O	609
duplications	O	609
,	O	609
the	O	609
major	O	609
cause	O	609
of	O	609
the	O	609
disease	O	609
,	O	609
originate	O	609
more	O	609
frequently	O	609
in	O	609
male	O	609
germ	O	609
cells	O	609
,	O	609
but	O	609
point	O	609
mutations	O	609
do	O	609
not	O	609
.	O	609
the	O	610
clinical	O	610
european	O	610
network	O	610
on	O	610
brain	B-Disease	610
dysmyelinating	I-Disease	610
disease	I-Disease	610
.	O	610
pelizaeus	B-Disease	611
-	I-Disease	611
merzbacher	I-Disease	611
disease	I-Disease	611
(	O	611
pmd	B-Disease	611
)	O	611
is	O	611
an	O	611
x	B-Disease	611
-	I-Disease	611
linked	I-Disease	611
developmental	I-Disease	611
defect	I-Disease	611
of	I-Disease	611
myelination	I-Disease	611
affecting	O	611
the	O	611
central	O	611
nervous	O	611
system	O	611
and	O	611
segregating	O	611
with	O	611
the	O	611
proteolipoprotein	O	611
(	O	611
plp	O	611
)	O	611
locus	O	611
.	O	611
investigating	O	612
82	O	612
strictly	O	612
selected	O	612
sporadic	O	612
cases	O	612
of	O	612
pmd	B-Disease	612
,	O	612
we	O	612
found	O	612
plp	O	612
mutations	O	612
in	O	612
77	O	612
%	O	612
;	O	612
complete	O	612
plp	O	612
-	O	612
gene	O	612
duplications	O	612
were	O	612
the	O	612
most	O	612
frequent	O	612
abnormality	O	612
(	O	612
62	O	612
%	O	612
)	O	612
,	O	612
whereas	O	612
point	O	612
mutations	O	612
in	O	612
coding	O	612
or	O	612
splice	O	612
-	O	612
site	O	612
regions	O	612
of	O	612
the	O	612
gene	O	612
were	O	612
involved	O	612
less	O	612
frequently	O	612
(	O	612
38	O	612
%	O	612
)	O	612
.	O	612
chromosome	O	619
breakage	O	619
in	O	619
the	O	619
prader	B-Disease	619
-	I-Disease	619
willi	I-Disease	619
and	I-Disease	619
angelman	I-Disease	619
syndromes	I-Disease	619
involves	O	619
recombination	O	619
between	O	619
large	O	619
,	O	619
transcribed	O	619
repeats	O	619
at	O	619
proximal	O	619
and	O	619
distal	O	619
breakpoints	O	619
.	O	619
prader	B-Disease	620
-	I-Disease	620
willi	I-Disease	620
syndrome	I-Disease	620
(	O	620
pws	B-Disease	620
)	O	620
and	O	620
angelman	B-Disease	620
syndrome	I-Disease	620
(	O	620
as	B-Disease	620
)	O	620
are	O	620
distinct	O	620
neurobehavioral	B-Disease	620
disorders	I-Disease	620
that	O	620
most	O	620
often	O	620
arise	O	620
from	O	620
a	O	620
4	O	620
-	O	620
mb	O	620
deletion	O	620
of	O	620
chromosome	O	620
15q11	O	620
-	O	620
q13	O	620
during	O	620
paternal	O	620
or	O	620
maternal	O	620
gametogenesis	O	620
,	O	620
respectively	O	620
.	O	620
one	O	627
of	O	627
five	O	627
pws	B-Disease	627
/	O	627
as	B-Disease	627
patients	O	627
analyzed	O	627
to	O	627
date	O	627
has	O	627
an	O	627
identifiable	O	627
,	O	627
rearranged	O	627
herc2	O	627
transcript	O	627
derived	O	627
from	O	627
the	O	627
deletion	O	627
event	O	627
.	O	627
linkage	O	630
analysis	O	630
in	O	630
a	O	630
large	O	630
brazilian	O	630
family	O	630
with	O	630
van	B-Disease	630
der	I-Disease	630
woude	I-Disease	630
syndrome	I-Disease	630
suggests	O	630
the	O	630
existence	O	630
of	O	630
a	O	630
susceptibility	O	630
locus	O	630
for	O	630
cleft	B-Disease	630
palate	I-Disease	630
at	O	630
17p11	O	630
.	O	630
2	O	630
-	O	630
11	O	630
.	O	630
1	O	630
.	O	630
van	B-Disease	631
der	I-Disease	631
woude	I-Disease	631
syndrome	I-Disease	631
(	O	631
vws	B-Disease	631
)	O	631
,	O	631
which	O	631
has	O	631
been	O	631
mapped	O	631
to	O	631
1q32	O	631
-	O	631
41	O	631
,	O	631
is	O	631
characterized	O	631
by	O	631
pits	B-Disease	631
and	I-Disease	631
/	I-Disease	631
or	I-Disease	631
sinuses	I-Disease	631
of	I-Disease	631
the	I-Disease	631
lower	I-Disease	631
lip	I-Disease	631
,	O	631
cleft	B-Disease	631
lip	I-Disease	631
/	I-Disease	631
palate	I-Disease	631
(	O	631
cl	B-Disease	631
/	I-Disease	631
p	I-Disease	631
)	O	631
,	O	631
cleft	B-Disease	631
palate	I-Disease	631
(	O	631
cp	B-Disease	631
)	O	631
,	O	631
bifid	B-Disease	631
uvula	I-Disease	631
,	O	631
and	O	631
hypodontia	B-Disease	631
(	O	631
h	B-Disease	631
)	O	631
.	O	631
the	O	632
expression	O	632
of	O	632
vws	B-Disease	632
,	O	632
which	O	632
has	O	632
incomplete	O	632
penetrance	O	632
,	O	632
is	O	632
highly	O	632
variable	O	632
.	O	632
both	O	633
the	O	633
occurrence	O	633
of	O	633
cl	B-Disease	633
/	I-Disease	633
p	I-Disease	633
and	O	633
cp	B-Disease	633
within	O	633
the	O	633
same	O	633
genealogy	O	633
and	O	633
a	O	633
recurrence	O	633
risk	O	633
<	O	633
40	O	633
%	O	633
for	O	633
cp	B-Disease	633
among	O	633
descendants	O	633
with	O	633
vws	B-Disease	633
have	O	633
suggested	O	633
that	O	633
the	O	633
development	O	633
of	O	633
clefts	B-Disease	633
in	O	633
this	O	633
syndrome	O	633
is	O	633
influenced	O	633
by	O	633
modifying	O	633
genes	O	633
at	O	633
other	O	633
loci	O	633
.	O	633
to	O	634
test	O	634
this	O	634
hypothesis	O	634
,	O	634
we	O	634
have	O	634
conducted	O	634
linkage	O	634
analysis	O	634
in	O	634
a	O	634
large	O	634
brazilian	O	634
kindred	O	634
with	O	634
vws	B-Disease	634
,	O	634
considering	O	634
as	O	634
affected	O	634
the	O	634
individuals	O	634
with	O	634
cp	B-Disease	634
,	O	634
regardless	O	634
of	O	634
whether	O	634
it	O	634
is	O	634
associated	O	634
with	O	634
other	O	634
clinical	O	634
signs	O	634
of	O	634
vws	B-Disease	634
.	O	634
1	O	637
,	O	637
together	O	637
with	O	637
the	O	637
vws	B-Disease	637
gene	O	637
at	O	637
1p32	O	637
-	O	637
41	O	637
,	O	637
enhances	O	637
the	O	637
probability	O	637
of	O	637
cp	B-Disease	637
in	O	637
an	O	637
individual	O	637
carrying	O	637
the	O	637
two	O	637
at	O	637
-	O	637
risk	O	637
genes	O	637
.	O	637
if	O	638
this	O	638
hypothesis	O	638
is	O	638
confirmed	O	638
in	O	638
other	O	638
vws	B-Disease	638
pedigrees	O	638
,	O	638
it	O	638
will	O	638
represent	O	638
one	O	638
of	O	638
the	O	638
first	O	638
examples	O	638
of	O	638
a	O	638
gene	O	638
,	O	638
mapped	O	638
through	O	638
linkage	O	638
analysis	O	638
,	O	638
which	O	638
modifies	O	638
the	O	638
expression	O	638
of	O	638
a	O	638
major	O	638
gene	O	638
.	O	638
the	O	640
gene	O	640
for	O	640
ataxia	B-Disease	640
-	I-Disease	640
telangiectasia	I-Disease	640
,	O	640
atm	O	640
,	O	640
spans	O	640
about	O	640
150	O	640
kb	O	640
of	O	640
genomic	O	640
dna	O	640
.	O	640
using	O	642
dna	O	642
as	O	642
the	O	642
starting	O	642
material	O	642
,	O	642
we	O	642
screened	O	642
the	O	642
atm	O	642
gene	O	642
in	O	642
92	O	642
a	B-Disease	642
-	I-Disease	642
t	I-Disease	642
patients	O	642
,	O	642
using	O	642
an	O	642
optimized	O	642
single	O	642
-	O	642
strand	O	642
conformation	O	642
polymorphism	O	642
(	O	642
sscp	O	642
)	O	642
technique	O	642
that	O	642
detected	O	642
all	O	642
previously	O	642
known	O	642
mutations	O	642
in	O	642
the	O	642
polymerase	O	642
chain	O	642
reaction	O	642
(	O	642
pcr	O	642
)	O	642
segments	O	642
being	O	642
analyzed	O	642
.	O	642
a	O	650
novel	O	650
frameshift	O	650
mutation	O	650
in	O	650
the	O	650
mcleod	B-Disease	650
syndrome	I-Disease	650
gene	O	650
in	O	650
a	O	650
japanese	O	650
family	O	650
.	O	650
we	O	651
report	O	651
a	O	651
novel	O	651
mutation	O	651
in	O	651
the	O	651
xk	O	651
gene	O	651
(	O	651
xk	O	651
)	O	651
in	O	651
a	O	651
japanese	O	651
patient	O	651
with	O	651
mcleod	B-Disease	651
syndrome	I-Disease	651
.	O	651
a	O	652
50	O	652
-	O	652
year	O	652
-	O	652
old	O	652
man	O	652
showed	O	652
progressive	O	652
muscular	B-Disease	652
atrophy	I-Disease	652
,	O	652
choreic	B-Disease	652
movement	I-Disease	652
,	O	652
elevated	O	652
level	O	652
of	O	652
serum	O	652
creatinine	O	652
kinase	O	652
,	O	652
and	O	652
acanthocytosis	B-Disease	652
.	O	652
we	O	655
conclude	O	655
this	O	655
single	O	655
-	O	655
base	O	655
deletion	O	655
causes	O	655
defective	O	655
kx	O	655
protein	O	655
,	O	655
which	O	655
is	O	655
responsible	O	655
for	O	655
the	O	655
mcleod	B-Disease	655
phenotype	O	655
in	O	655
this	O	655
patient	O	655
.	O	655
.	O	655
brca1	O	657
encodes	O	657
a	O	657
tumor	B-Disease	657
suppressor	O	657
that	O	657
is	O	657
mutated	O	657
in	O	657
familial	B-Disease	657
breast	I-Disease	657
and	I-Disease	657
ovarian	I-Disease	657
cancers	I-Disease	657
.	O	657
formation	O	660
of	O	660
irradiation	O	660
-	O	660
induced	O	660
foci	O	660
positive	O	660
for	O	660
brca1	O	660
,	O	660
hrad50	O	660
,	O	660
hmre11	O	660
,	O	660
or	O	660
p95	O	660
was	O	660
dramatically	O	660
reduced	O	660
in	O	660
hcc	O	660
/	O	660
1937	O	660
breast	B-Disease	660
cancer	I-Disease	660
cells	O	660
carrying	O	660
a	O	660
homozygous	O	660
mutation	O	660
in	O	660
brca1	O	660
but	O	660
was	O	660
restored	O	660
by	O	660
transfection	O	660
of	O	660
wild	O	660
-	O	660
type	O	660
brca1	O	660
.	O	660
relationship	O	663
among	O	663
genotype	O	663
,	O	663
biochemical	O	663
phenotype	O	663
,	O	663
and	O	663
cognitive	O	663
performance	O	663
in	O	663
females	O	663
with	O	663
phenylalanine	B-Disease	663
hydroxylase	I-Disease	663
deficiency	I-Disease	663
:	O	663
report	O	663
from	O	663
the	O	663
maternal	B-Disease	663
phenylketonuria	I-Disease	663
collaborative	O	663
study	O	663
.	O	663
objective	O	664
to	O	664
examine	O	664
the	O	664
relationship	O	664
of	O	664
phenylalanine	O	664
hydroxylase	O	664
(	O	664
pah	O	664
)	O	664
genotypes	O	664
to	O	664
biochemical	O	664
phenotype	O	664
and	O	664
cognitive	O	664
development	O	664
in	O	664
maternal	B-Disease	664
phenylketonuria	I-Disease	664
(	O	664
pku	B-Disease	664
)	O	664
.	O	664
methodology	O	665
pah	O	665
gene	O	665
mutations	O	665
were	O	665
examined	O	665
in	O	665
222	O	665
hyperphenylalaninemic	B-Disease	665
females	O	665
enrolled	O	665
in	O	665
the	O	665
maternal	B-Disease	665
pku	I-Disease	665
collaborative	O	665
study	O	665
(	O	665
mpkucs	O	665
)	O	665
.	O	665
based	O	667
on	O	667
previous	O	667
knowledge	O	667
about	O	667
mutation	O	667
-	O	667
phenotype	O	667
associations	O	667
,	O	667
78	O	667
of	O	667
the	O	667
mutations	O	667
could	O	667
be	O	667
assigned	O	667
to	O	667
one	O	667
of	O	667
four	O	667
classes	O	667
of	O	667
severity	O	667
(	O	667
severe	O	667
pku	B-Disease	667
,	O	667
moderate	O	667
pku	B-Disease	667
,	O	667
mild	O	667
pku	B-Disease	667
,	O	667
and	O	667
mild	B-Disease	667
hyperphenylalaninemia	I-Disease	667
[	O	667
mhp	B-Disease	667
]	O	667
)	O	667
.	O	667
the	O	673
iq	O	673
of	O	673
pah	B-Disease	673
-	I-Disease	673
deficient	I-Disease	673
mothers	O	673
with	O	673
a	O	673
severe	O	673
pku	B-Disease	673
mutation	O	673
in	O	673
combination	O	673
with	O	673
a	O	673
mhp	B-Disease	673
mutation	O	673
or	O	673
a	O	673
mild	O	673
pku	B-Disease	673
mutation	O	673
was	O	673
99	O	673
and	O	673
96	O	673
,	O	673
respectively	O	673
,	O	673
whereas	O	673
the	O	673
iq	O	673
of	O	673
pku	B-Disease	673
mothers	O	673
with	O	673
two	O	673
severe	O	673
pku	B-Disease	673
mutations	O	673
or	O	673
with	O	673
one	O	673
severe	O	673
and	O	673
one	O	673
moderate	O	673
pku	B-Disease	673
mutation	O	673
was	O	673
83	O	673
and	O	673
84	O	673
,	O	673
respectively	O	673
.	O	673
of	O	674
the	O	674
patients	O	674
with	O	674
pku	B-Disease	674
,	O	674
92	O	674
%	O	674
had	O	674
been	O	674
treated	O	674
during	O	674
childhood	O	674
.	O	674
females	O	676
with	O	676
moderate	O	676
or	O	676
mild	O	676
pku	B-Disease	676
who	O	676
were	O	676
treated	O	676
early	O	676
and	O	676
treated	O	676
for	O	676
>	O	676
6	O	676
years	O	676
showed	O	676
iq	O	676
scores	O	676
10	O	676
points	O	676
above	O	676
average	O	676
for	O	676
their	O	676
group	O	676
.	O	676
conclusions	O	677
the	O	677
reproductive	O	677
outcome	O	677
in	O	677
maternal	B-Disease	677
phenylketonuria	I-Disease	677
is	O	677
dependent	O	677
on	O	677
prenatal	O	677
metabolic	O	677
control	O	677
and	O	677
postnatal	O	677
environmental	O	677
circumstances	O	677
.	O	677
both	O	678
factors	O	678
depend	O	678
on	O	678
the	O	678
intellectual	O	678
resources	O	678
of	O	678
the	O	678
mother	O	678
with	O	678
pku	B-Disease	678
.	O	678
the	O	679
significant	O	679
relationship	O	679
among	O	679
genotype	O	679
,	O	679
biochemical	O	679
phenotype	O	679
,	O	679
and	O	679
cognitive	O	679
performance	O	679
observed	O	679
in	O	679
the	O	679
present	O	679
study	O	679
is	O	679
of	O	679
importance	O	679
for	O	679
the	O	679
development	O	679
of	O	679
an	O	679
optimal	O	679
strategy	O	679
for	O	679
future	O	679
treatment	O	679
of	O	679
females	O	679
with	O	679
pku	B-Disease	679
who	O	679
plan	O	679
pregnancy	O	679
.	O	679
.	O	679
spinal	B-Disease	680
xanthomatosis	I-Disease	680
:	O	680
a	O	680
variant	O	680
of	O	680
cerebrotendinous	B-Disease	680
xanthomatosis	I-Disease	680
.	O	680
we	O	681
describe	O	681
seven	O	681
dutch	O	681
patients	O	681
from	O	681
six	O	681
families	O	681
with	O	681
a	O	681
slowly	O	681
progressive	O	681
,	O	681
mainly	O	681
spinal	B-Disease	681
cord	I-Disease	681
syndrome	I-Disease	681
that	O	681
remained	O	681
for	O	681
many	O	681
years	O	681
the	O	681
sole	O	681
expression	O	681
of	O	681
cerebrotendinous	B-Disease	681
xanthomatosis	I-Disease	681
(	O	681
ctx	B-Disease	681
)	O	681
.	O	681
mri	O	682
demonstrated	O	682
white	B-Disease	682
matter	I-Disease	682
abnormalities	I-Disease	682
in	O	682
the	O	682
lateral	O	682
and	O	682
dorsal	O	682
columns	O	682
of	O	682
the	O	682
spinal	O	682
cord	O	682
.	O	682
we	O	685
conclude	O	685
that	O	685
spinal	B-Disease	685
xanthomatosis	I-Disease	685
is	O	685
a	O	685
clinical	O	685
and	O	685
radiological	O	685
separate	O	685
entity	O	685
of	O	685
ctx	B-Disease	685
that	O	685
should	O	685
be	O	685
included	O	685
in	O	685
the	O	685
differential	O	685
diagnosis	O	685
of	O	685
chronic	B-Disease	685
myelopathy	I-Disease	685
.	O	685
.	O	685
a	O	686
transgene	O	686
insertion	O	686
creating	O	686
a	O	686
heritable	O	686
chromosome	O	686
deletion	O	686
mouse	O	686
model	O	686
of	O	686
prader	B-Disease	686
-	I-Disease	686
willi	I-Disease	686
and	I-Disease	686
angelman	I-Disease	686
syndromes	I-Disease	686
.	O	686
prader	B-Disease	687
-	I-Disease	687
willi	I-Disease	687
syndrome	I-Disease	687
(	O	687
pws	B-Disease	687
)	O	687
and	O	687
angelman	B-Disease	687
syndrome	I-Disease	687
(	O	687
as	B-Disease	687
)	O	687
result	O	687
from	O	687
the	O	687
loss	O	687
of	O	687
function	O	687
of	O	687
imprinted	O	687
genes	O	687
in	O	687
human	O	687
chromosome	O	687
15q11	O	687
-	O	687
q13	O	687
.	O	687
we	O	689
report	O	689
here	O	689
the	O	689
characterization	O	689
of	O	689
a	O	689
transgene	O	689
insertion	O	689
(	O	689
epstein	O	689
-	O	689
barr	O	689
virus	O	689
latent	O	689
membrane	O	689
protein	O	689
2a	O	689
,	O	689
lmp2a	O	689
)	O	689
into	O	689
mouse	O	689
chromosome	O	689
7c	O	689
,	O	689
which	O	689
has	O	689
resulted	O	689
in	O	689
mouse	O	689
models	O	689
for	O	689
pws	B-Disease	689
and	O	689
as	B-Disease	689
dependent	O	689
on	O	689
the	O	689
sex	O	689
of	O	689
the	O	689
transmitting	O	689
parent	O	689
.	O	689
epigenotype	O	690
(	O	690
allelic	O	690
expression	O	690
and	O	690
dna	O	690
methylation	O	690
)	O	690
and	O	690
fluorescence	O	690
in	O	690
situ	O	690
hybridization	O	690
analyses	O	690
indicate	O	690
that	O	690
the	O	690
transgene	O	690
-	O	690
induced	O	690
mutation	O	690
has	O	690
generated	O	690
a	O	690
complete	O	690
deletion	O	690
of	O	690
the	O	690
pws	B-Disease	690
/	O	690
as	B-Disease	690
-	O	690
homologous	O	690
region	O	690
but	O	690
has	O	690
not	O	690
deleted	O	690
flanking	O	690
loci	O	690
.	O	690
because	O	691
the	O	691
intact	O	691
chromosome	O	691
7	O	691
,	O	691
opposite	O	691
the	O	691
deleted	O	691
homolog	O	691
,	O	691
maintains	O	691
the	O	691
correct	O	691
imprint	O	691
in	O	691
somatic	O	691
cells	O	691
of	O	691
pws	B-Disease	691
and	O	691
as	B-Disease	691
mice	O	691
and	O	691
establishes	O	691
the	O	691
correct	O	691
imprint	O	691
in	O	691
male	O	691
and	O	691
female	O	691
germ	O	691
cells	O	691
of	O	691
as	B-Disease	691
mice	O	691
,	O	691
homologous	O	691
association	O	691
and	O	691
replication	O	691
asynchrony	O	691
are	O	691
not	O	691
part	O	691
of	O	691
the	O	691
imprinting	O	691
mechanism	O	691
.	O	691
this	O	692
heritable	O	692
-	O	692
deletion	O	692
mouse	O	692
model	O	692
will	O	692
be	O	692
particularly	O	692
useful	O	692
for	O	692
the	O	692
identification	O	692
of	O	692
the	O	692
etiological	O	692
genes	O	692
and	O	692
mechanisms	O	692
,	O	692
phenotypic	O	692
basis	O	692
,	O	692
and	O	692
investigation	O	692
of	O	692
therapeutic	O	692
approaches	O	692
for	O	692
pws	B-Disease	692
.	O	692
.	O	692
linkage	O	693
analysis	O	693
of	O	693
5	O	693
novel	O	693
van	B-Disease	693
der	I-Disease	693
woude	I-Disease	693
syndrome	I-Disease	693
kindreds	O	693
to	O	693
1q32	O	693
-	O	693
q41	O	693
markers	O	693
further	O	693
supports	O	693
locus	O	693
homogeneity	O	693
of	O	693
the	O	693
disease	O	693
trait	O	693
.	O	693
van	B-Disease	694
der	I-Disease	694
woude	I-Disease	694
syndrome	I-Disease	694
(	O	694
vws	B-Disease	694
,	O	694
mim	O	694
119300	O	694
)	O	694
is	O	694
a	O	694
rare	O	694
autosomal	B-Disease	694
dominant	I-Disease	694
clefting	I-Disease	694
condition	I-Disease	694
with	O	694
cardinal	O	694
features	O	694
of	O	694
mucous	B-Disease	694
cysts	I-Disease	694
(	O	694
lower	B-Disease	694
-	I-Disease	694
lip	I-Disease	694
pits	I-Disease	694
)	O	694
and	O	694
clefts	B-Disease	694
to	I-Disease	694
the	I-Disease	694
lip	I-Disease	694
and	I-Disease	694
/	I-Disease	694
or	I-Disease	694
palate	I-Disease	694
.	O	694
the	O	695
vws	B-Disease	695
gene	O	695
has	O	695
been	O	695
assigned	O	695
to	O	695
a	O	695
locus	O	695
in	O	695
1q32	O	695
-	O	695
q41	O	695
by	O	695
linkage	O	695
analysis	O	695
and	O	695
physical	O	695
mapping	O	695
.	O	695
we	O	696
have	O	696
investigated	O	696
5	O	696
novel	O	696
vws	B-Disease	696
families	O	696
through	O	696
probands	O	696
attended	O	696
for	O	696
cleft	B-Disease	696
lip	I-Disease	696
and	I-Disease	696
/	I-Disease	696
or	I-Disease	696
palate	I-Disease	696
repair	O	696
at	O	696
the	O	696
department	O	696
of	O	696
maxillofacial	O	696
surgery	O	696
of	O	696
hopital	O	696
trousseau	O	696
,	O	696
paris	O	696
,	O	696
in	O	696
order	O	696
to	O	696
tentatively	O	696
refine	O	696
the	O	696
genetic	O	696
map	O	696
of	O	696
the	O	696
vws	B-Disease	696
region	O	696
in	O	696
1q32	O	696
-	O	696
q41	O	696
and	O	696
possibly	O	696
identify	O	696
unlinked	O	696
pedigrees	O	696
.	O	696
our	O	701
results	O	701
support	O	701
linkage	O	701
of	O	701
vws	B-Disease	701
within	O	701
a	O	701
region	O	701
of	O	701
tightly	O	701
linked	O	701
markers	O	701
and	O	701
do	O	701
not	O	701
favour	O	701
locus	O	701
heterogeneity	O	701
of	O	701
the	O	701
disease	O	701
trait	O	701
.	O	701
null	O	702
mutation	O	702
of	O	702
the	O	702
murine	O	702
atp7b	O	702
(	O	702
wilson	B-Disease	702
disease	I-Disease	702
)	O	702
gene	O	702
results	O	702
in	O	702
intracellular	B-Disease	702
copper	I-Disease	702
accumulation	I-Disease	702
and	O	702
late	B-Disease	702
-	I-Disease	702
onset	I-Disease	702
hepatic	I-Disease	702
nodular	I-Disease	702
transformation	I-Disease	702
.	O	702
mutations	O	704
in	O	704
the	O	704
atp7b	O	704
gene	O	704
lead	O	704
to	O	704
wilson	B-Disease	704
disease	I-Disease	704
,	O	704
a	O	704
copper	B-Disease	704
toxicity	I-Disease	704
disorder	I-Disease	704
characterized	O	704
by	O	704
dramatic	O	704
build	O	704
-	O	704
up	O	704
of	O	704
intracellular	O	704
hepatic	O	704
copper	O	704
with	O	704
subsequent	O	704
hepatic	B-Disease	704
and	I-Disease	704
neuro	I-Disease	704
-	I-Disease	704
logical	I-Disease	704
abnormalities	I-Disease	704
.	O	704
using	O	705
homologous	O	705
recombination	O	705
to	O	705
disrupt	O	705
the	O	705
normal	O	705
translation	O	705
of	O	705
atp7b	O	705
,	O	705
we	O	705
have	O	705
generated	O	705
a	O	705
strain	O	705
of	O	705
mice	O	705
that	O	705
are	O	705
homozygous	O	705
mutants	O	705
(	O	705
null	O	705
)	O	705
for	O	705
the	O	705
wilson	B-Disease	705
disease	I-Disease	705
gene	O	705
.	O	705
an	O	707
increase	O	707
in	O	707
copper	O	707
concentration	O	707
was	O	707
also	O	707
observed	O	707
in	O	707
the	O	707
kidney	O	707
,	O	707
brain	O	707
,	O	707
placenta	O	707
and	O	707
lactating	O	707
mammary	O	707
glands	O	707
of	O	707
homo	O	707
-	O	707
zygous	O	707
mutants	O	707
,	O	707
although	O	707
milk	O	707
from	O	707
the	O	707
mutant	O	707
glands	O	707
was	O	707
copper	B-Disease	707
deficient	I-Disease	707
.	O	707
morphological	B-Disease	708
abnormalities	I-Disease	708
resembling	O	708
cirrhosis	B-Disease	708
developed	O	708
in	O	708
the	O	708
majority	O	708
of	O	708
the	O	708
livers	O	708
from	O	708
homozygous	O	708
mutants	O	708
older	O	708
than	O	708
7	O	708
months	O	708
of	O	708
age	O	708
.	O	708
progeny	O	709
of	O	709
the	O	709
homozygous	O	709
mutant	O	709
females	O	709
demonstrated	O	709
neurological	B-Disease	709
abnormalities	I-Disease	709
and	O	709
growth	B-Disease	709
retardation	I-Disease	709
characteristic	O	709
of	O	709
copper	B-Disease	709
deficiency	I-Disease	709
.	O	709
in	O	711
summary	O	711
,	O	711
inactivation	O	711
of	O	711
the	O	711
murine	O	711
atp7b	O	711
gene	O	711
produces	O	711
a	O	711
form	O	711
of	O	711
cirrhotic	B-Disease	711
liver	I-Disease	711
disease	I-Disease	711
that	O	711
resembles	O	711
wilson	B-Disease	711
disease	I-Disease	711
in	O	711
humans	O	711
and	O	711
the	O	711
toxic	O	711
milk	O	711
phenotype	O	711
in	O	711
the	O	711
mouse	O	711
.	O	711
.	O	711
french	O	712
machado	B-Disease	712
-	I-Disease	712
joseph	I-Disease	712
disease	I-Disease	712
patients	O	712
do	O	712
not	O	712
exhibit	O	712
gametic	O	712
segregation	O	712
distortion	O	712
:	O	712
a	O	712
sperm	O	712
typing	O	712
analysis	O	712
.	O	712
segregation	O	713
distortion	O	713
has	O	713
been	O	713
reported	O	713
to	O	713
occur	O	713
in	O	713
a	O	713
number	O	713
of	O	713
the	O	713
trinucleotide	B-Disease	713
repeat	I-Disease	713
disorders	I-Disease	713
.	O	713
on	O	714
the	O	714
basis	O	714
of	O	714
a	O	714
sperm	O	714
typing	O	714
study	O	714
performed	O	714
in	O	714
patients	O	714
of	O	714
japanese	O	714
descent	O	714
with	O	714
machado	B-Disease	714
-	I-Disease	714
joseph	I-Disease	714
disease	I-Disease	714
(	O	714
mjd	B-Disease	714
)	O	714
,	O	714
it	O	714
was	O	714
reported	O	714
that	O	714
disease	O	714
alleles	O	714
are	O	714
preferentially	O	714
transmitted	O	714
during	O	714
meiosis	O	714
.	O	714
we	O	715
performed	O	715
a	O	715
sperm	O	715
typing	O	715
study	O	715
of	O	715
five	O	715
mjd	B-Disease	715
patients	O	715
of	O	715
french	O	715
descent	O	715
and	O	715
analysis	O	715
of	O	715
the	O	715
pooled	O	715
data	O	715
shows	O	715
a	O	715
ratio	O	715
of	O	715
mutant	O	715
to	O	715
normal	O	715
alleles	O	715
of	O	715
379	O	715
436	O	715
(	O	715
46	O	715
.	O	715
5	O	715
53	O	715
.	O	715
5	O	715
%	O	715
)	O	715
,	O	715
which	O	715
does	O	715
not	O	715
support	O	715
meiotic	O	715
segregation	O	715
distortion	O	715
.	O	715
however	O	724
,	O	724
analysis	O	724
of	O	724
the	O	724
variance	O	724
in	O	724
repeat	O	724
number	O	724
in	O	724
sperm	O	724
from	O	724
the	O	724
french	O	724
mjd	B-Disease	724
patients	O	724
overlapped	O	724
significantly	O	724
with	O	724
the	O	724
variance	O	724
in	O	724
repeat	O	724
number	O	724
observed	O	724
in	O	724
the	O	724
c	O	724
/	O	724
c	O	724
homozygous	O	724
japanese	O	724
patients	O	724
.	O	724
missense	O	725
mutation	O	725
in	O	725
the	O	725
alternative	O	725
splice	O	725
region	O	725
of	O	725
the	O	725
pax6	O	725
gene	O	725
in	O	725
eye	B-Disease	725
anomalies	I-Disease	725
.	O	725
the	O	726
pax6	O	726
gene	O	726
is	O	726
involved	O	726
in	O	726
ocular	O	726
morphogenesis	O	726
,	O	726
and	O	726
pax6	O	726
mutations	O	726
have	O	726
been	O	726
detected	O	726
in	O	726
various	O	726
types	O	726
of	O	726
ocular	B-Disease	726
anomalies	I-Disease	726
,	O	726
including	O	726
aniridia	B-Disease	726
,	O	726
peters	B-Disease	726
anomaly	I-Disease	726
,	O	726
corneal	B-Disease	726
dystrophy	I-Disease	726
,	O	726
congenital	B-Disease	726
cataract	I-Disease	726
,	O	726
and	O	726
foveal	B-Disease	726
hypoplasia	I-Disease	726
.	O	726
we	O	732
ascertained	O	732
a	O	732
novel	O	732
missense	O	732
mutation	O	732
in	O	732
four	O	732
pedigrees	O	732
with	O	732
peters	B-Disease	732
anomaly	I-Disease	732
,	O	732
congenital	B-Disease	732
cataract	I-Disease	732
,	O	732
axenfeldt	B-Disease	732
anomaly	I-Disease	732
,	O	732
and	O	732
/	O	732
or	O	732
foveal	B-Disease	732
hypoplasia	I-Disease	732
,	O	732
which	O	732
,	O	732
to	O	732
our	O	732
knowledge	O	732
,	O	732
is	O	732
the	O	732
first	O	732
mutation	O	732
identified	O	732
in	O	732
the	O	732
splice	O	732
-	O	732
variant	O	732
region	O	732
.	O	732
penetrances	O	735
of	O	735
brca1	O	735
1675dela	O	735
and	O	735
1135insa	O	735
with	O	735
respect	O	735
to	O	735
breast	B-Disease	735
cancer	I-Disease	735
and	O	735
ovarian	B-Disease	735
cancer	I-Disease	735
.	O	735
for	O	736
genetic	O	736
counseling	O	736
and	O	736
predictive	O	736
testing	O	736
in	O	736
families	O	736
with	O	736
inherited	B-Disease	736
breast	I-Disease	736
-	I-Disease	736
ovarian	I-Disease	736
cancer	I-Disease	736
,	O	736
penetrances	O	736
and	O	736
expressions	O	736
of	O	736
the	O	736
underlying	O	736
mutations	O	736
should	O	736
be	O	736
known	O	736
.	O	736
index	O	738
cases	O	738
for	O	738
the	O	738
present	O	738
study	O	738
were	O	738
found	O	738
two	O	738
different	O	738
ways	O	738
through	O	738
a	O	738
series	O	738
of	O	738
consecutive	O	738
ovarian	B-Disease	738
cancers	I-Disease	738
(	O	738
n	O	738
=	O	738
16	O	738
)	O	738
and	O	738
through	O	738
our	O	738
family	O	738
cancer	B-Disease	738
clinic	O	738
(	O	738
n	O	738
=	O	738
14	O	738
)	O	738
.	O	738
their	O	740
relatives	O	740
were	O	740
described	O	740
with	O	740
respect	O	740
to	O	740
absence	O	740
/	O	740
presence	O	740
of	O	740
breast	B-Disease	740
and	I-Disease	740
/	I-Disease	740
or	I-Disease	740
ovarian	I-Disease	740
cancer	I-Disease	740
.	O	740
the	O	743
overall	O	743
findings	O	743
were	O	743
that	O	743
disease	O	743
started	O	743
to	O	743
occur	O	743
at	O	743
age	O	743
30	O	743
years	O	743
and	O	743
that	O	743
by	O	743
age	O	743
50	O	743
years	O	743
48	O	743
%	O	743
of	O	743
the	O	743
mutation	O	743
-	O	743
carrying	O	743
women	O	743
had	O	743
experienced	O	743
breast	B-Disease	743
and	I-Disease	743
/	I-Disease	743
or	I-Disease	743
ovarian	I-Disease	743
cancer	I-Disease	743
.	O	743
more	O	744
ovarian	B-Disease	744
cancers	I-Disease	744
than	O	744
breast	B-Disease	744
cancers	I-Disease	744
were	O	744
recorded	O	744
.	O	744
both	O	745
penetrance	O	745
and	O	745
expression	O	745
(	O	745
breast	B-Disease	745
cancer	I-Disease	745
vs	O	745
.	O	745
ovarian	B-Disease	745
cancer	I-Disease	745
)	O	745
were	O	745
different	O	745
from	O	745
those	O	745
in	O	745
reports	O	745
of	O	745
the	O	745
ashkenazi	O	745
founder	O	745
mutations	O	745
.	O	745
the	O	748
dermatofibrosarcoma	B-Disease	748
protuberans	I-Disease	748
-	O	748
associated	O	748
collagen	O	748
type	O	748
ialpha1	O	748
/	O	748
platelet	O	748
-	O	748
derived	O	748
growth	O	748
factor	O	748
(	O	748
pdgf	O	748
)	O	748
b	O	748
-	O	748
chain	O	748
fusion	O	748
gene	O	748
generates	O	748
a	O	748
transforming	O	748
protein	O	748
that	O	748
is	O	748
processed	O	748
to	O	748
functional	O	748
pdgf	O	748
-	O	748
bb	O	748
.	O	748
dermatofibrosarcoma	B-Disease	749
protuberans	I-Disease	749
(	O	749
dfsp	B-Disease	749
)	O	749
displays	O	749
chromosomal	O	749
rearrangements	O	749
involving	O	749
chromosome	O	749
17	O	749
and	O	749
22	O	749
,	O	749
which	O	749
fuse	O	749
the	O	749
collagen	O	749
type	O	749
ialpha1	O	749
(	O	749
colia1	O	749
)	O	749
gene	O	749
to	O	749
the	O	749
platelet	O	749
-	O	749
derived	O	749
growth	O	749
factor	O	749
(	O	749
pdgf	O	749
)	O	749
b	O	749
-	O	749
chain	O	749
(	O	749
pdgfb	O	749
)	O	749
gene	O	749
.	O	749
finally	O	755
,	O	755
colia1	O	755
/	O	755
pdgfb	O	755
-	O	755
expressing	O	755
cells	O	755
generated	O	755
tumors	B-Disease	755
after	O	755
s	O	755
.	O	755
c	O	756
c	O	756
.	O	756
injection	O	756
into	O	756
nude	O	756
mice	O	756
,	O	756
and	O	756
tumor	B-Disease	756
growth	O	756
was	O	756
reduced	O	756
by	O	756
treatment	O	756
with	O	756
cgp57148b	O	756
.	O	756
we	O	757
conclude	O	757
that	O	757
the	O	757
colia1	O	757
/	O	757
pdgfb	O	757
fusion	O	757
associated	O	757
with	O	757
dfsp	B-Disease	757
contributes	O	757
to	O	757
tumor	B-Disease	757
development	O	757
through	O	757
ectopic	O	757
production	O	757
of	O	757
pdgf	O	757
-	O	757
bb	O	757
and	O	757
the	O	757
formation	O	757
of	O	757
an	O	757
autocrine	O	757
loop	O	757
.	O	757
our	O	758
findings	O	758
,	O	758
thus	O	758
,	O	758
suggest	O	758
that	O	758
pdgf	O	758
receptors	O	758
could	O	758
be	O	758
a	O	758
target	O	758
for	O	758
pharmacological	O	758
treatment	O	758
of	O	758
dfsp	B-Disease	758
and	O	758
giant	B-Disease	758
cell	I-Disease	758
fibroblastoma	I-Disease	758
,	O	758
e	O	758
.	O	758
g	O	758
.	O	758
,	O	758
through	O	758
the	O	758
use	O	758
of	O	758
pdgf	O	758
receptor	O	758
kinase	O	758
inhibitors	O	758
such	O	758
as	O	758
cgp57148b	O	758
.	O	758
identification	O	759
of	O	759
a	O	759
common	O	759
pex1	O	759
mutation	O	759
in	O	759
zellweger	B-Disease	759
syndrome	I-Disease	759
.	O	759
the	O	760
zellweger	B-Disease	760
spectrum	I-Disease	760
of	I-Disease	760
disease	I-Disease	760
,	O	760
encompassing	O	760
zellweger	B-Disease	760
syndrome	I-Disease	760
and	O	760
the	O	760
progressively	O	760
milder	O	760
phenotypes	O	760
of	O	760
neonatal	B-Disease	760
adrenoleukodystrophy	I-Disease	760
and	O	760
infantile	B-Disease	760
refsum	I-Disease	760
disease	I-Disease	760
,	O	760
is	O	760
due	O	760
to	O	760
a	O	760
failure	O	760
to	O	760
form	O	760
functional	O	760
peroxisomes	O	760
.	O	760
however	O	763
,	O	763
previous	O	763
studies	O	763
have	O	763
focused	O	763
on	O	763
mildly	O	763
affected	O	763
patients	O	763
and	O	763
there	O	763
is	O	763
still	O	763
no	O	763
report	O	763
of	O	763
two	O	763
mutant	O	763
pex1	O	763
alleles	O	763
in	O	763
any	O	763
zellweger	B-Disease	763
syndrome	I-Disease	763
patient	O	763
.	O	763
furthermore	O	764
,	O	764
mutations	O	764
in	O	764
the	O	764
pmp70	O	764
gene	O	764
have	O	764
also	O	764
been	O	764
identified	O	764
in	O	764
two	O	764
zellweger	B-Disease	764
syndrome	I-Disease	764
patients	O	764
from	O	764
cg1	O	764
,	O	764
raising	O	764
the	O	764
possibility	O	764
that	O	764
cg1	O	764
patients	O	764
may	O	764
represent	O	764
a	O	764
mixture	O	764
of	O	764
pex1	O	764
-	O	764
deficient	O	764
and	O	764
pmp70	O	764
-	O	764
deficient	O	764
individuals	O	764
.	O	764
to	O	765
address	O	765
the	O	765
molecular	O	765
basis	O	765
of	O	765
disease	O	765
in	O	765
zellweger	B-Disease	765
syndrome	I-Disease	765
patients	O	765
from	O	765
cg1	O	765
,	O	765
we	O	765
examined	O	765
all	O	765
24	O	765
pex1	O	765
exons	O	765
in	O	765
four	O	765
patients	O	765
,	O	765
including	O	765
both	O	765
patients	O	765
that	O	765
have	O	765
mutations	O	765
in	O	765
pmp70	O	765
.	O	765
subsequent	O	767
studies	O	767
demonstrated	O	767
that	O	767
this	O	767
mutation	O	767
is	O	767
present	O	767
in	O	767
one	O	767
-	O	767
half	O	767
of	O	767
all	O	767
cg1	O	767
patients	O	767
and	O	767
correlates	O	767
with	O	767
the	O	767
zellweger	B-Disease	767
syndrome	I-Disease	767
phenotype	O	767
.	O	767
as	O	768
this	O	768
mutation	O	768
leads	O	768
to	O	768
a	O	768
loss	O	768
of	O	768
protein	O	768
function	O	768
its	O	768
frequency	O	768
makes	O	768
it	O	768
the	O	768
most	O	768
common	O	768
cause	O	768
of	O	768
zellweger	B-Disease	768
syndrome	I-Disease	768
,	O	768
helping	O	768
to	O	768
explain	O	768
the	O	768
high	O	768
percentage	O	768
of	O	768
patients	O	768
that	O	768
belong	O	768
to	O	768
cg1	O	768
.	O	768
novel	O	769
mutations	O	769
in	O	769
the	O	769
wiskott	B-Disease	769
-	I-Disease	769
aldrich	I-Disease	769
syndrome	I-Disease	769
protein	O	769
gene	O	769
and	O	769
their	O	769
effects	O	769
on	O	769
transcriptional	O	769
,	O	769
translational	O	769
,	O	769
and	O	769
clinical	O	769
phenotypes	O	769
.	O	769
wiskott	B-Disease	770
-	I-Disease	770
aldrich	I-Disease	770
syndrome	I-Disease	770
(	O	770
was	B-Disease	770
)	O	770
is	O	770
an	O	770
x	B-Disease	770
-	I-Disease	770
linked	I-Disease	770
recessive	I-Disease	770
immunodeficiency	I-Disease	770
characterized	O	770
by	O	770
thrombocytopenia	B-Disease	770
,	O	770
eczema	B-Disease	770
,	O	770
and	O	770
recurrent	O	770
infections	O	770
,	O	770
and	O	770
caused	O	770
by	O	770
mutations	O	770
in	O	770
the	O	770
was	B-Disease	770
protein	O	770
(	O	770
wasp	O	770
)	O	770
gene	O	770
.	O	770
no	O	781
protein	O	781
was	O	781
detected	O	781
in	O	781
two	O	781
individuals	O	781
with	O	781
severe	O	781
was	B-Disease	781
.	O	781
reduced	O	782
levels	O	782
of	O	782
a	O	782
normal	O	782
-	O	782
size	O	782
wasp	O	782
with	O	782
a	O	782
missense	O	782
mutation	O	782
were	O	782
seen	O	782
in	O	782
two	O	782
individuals	O	782
with	O	782
xlt	B-Disease	782
.	O	782
duchenne	B-Disease	786
muscular	I-Disease	786
dystrophy	I-Disease	786
(	O	786
dmd	B-Disease	786
)	O	786
is	O	786
caused	O	786
by	O	786
mutations	O	786
in	O	786
the	O	786
dystrophin	O	786
gene	O	786
,	O	786
leading	O	786
to	O	786
the	O	786
absence	O	786
of	O	786
the	O	786
dystrophin	O	786
protein	O	786
in	O	786
striated	O	786
muscle	O	786
.	O	786
on	O	788
the	O	788
basis	O	788
of	O	788
the	O	788
observation	O	788
that	O	788
aminoglycoside	O	788
treatment	O	788
can	O	788
suppress	O	788
stop	O	788
codons	O	788
in	O	788
cultured	O	788
cells	O	788
,	O	788
we	O	788
tested	O	788
the	O	788
effect	O	788
of	O	788
gentamicin	O	788
on	O	788
cultured	O	788
muscle	O	788
cells	O	788
from	O	788
the	O	788
mdx	O	788
mouse	O	788
-	O	788
an	O	788
animal	O	788
model	O	788
for	O	788
dmd	B-Disease	788
that	O	788
possesses	O	788
a	O	788
premature	O	788
stop	O	788
codon	O	788
in	O	788
the	O	788
dystrophin	O	788
gene	O	788
.	O	788
we	O	791
identified	O	791
a	O	791
treatment	O	791
regimen	O	791
that	O	791
resulted	O	791
in	O	791
the	O	791
presence	O	791
of	O	791
dystrophin	O	791
in	O	791
the	O	791
cell	O	791
membrane	O	791
in	O	791
all	O	791
striated	O	791
muscles	O	791
examined	O	791
and	O	791
that	O	791
provided	O	791
functional	O	791
protection	O	791
against	O	791
muscular	B-Disease	791
injury	I-Disease	791
.	O	791
furthermore	O	793
,	O	793
these	O	793
results	O	793
raise	O	793
the	O	793
possibility	O	793
of	O	793
a	O	793
novel	O	793
treatment	O	793
regimen	O	793
for	O	793
muscular	B-Disease	793
dystrophy	I-Disease	793
and	O	793
other	O	793
diseases	O	793
caused	O	793
by	O	793
premature	O	793
stop	O	793
codon	O	793
mutations	O	793
.	O	793
this	O	794
treatment	O	794
could	O	794
prove	O	794
effective	O	794
in	O	794
up	O	794
to	O	794
15	O	794
%	O	794
of	O	794
patients	O	794
with	O	794
dmd	B-Disease	794
.	O	794
.	O	794
loss	O	795
of	O	795
the	O	795
ataxia	B-Disease	795
-	I-Disease	795
telangiectasia	I-Disease	795
gene	O	795
product	O	795
causes	O	795
oxidative	O	795
damage	O	795
in	O	795
target	O	795
organs	O	795
.	O	795
ataxia	B-Disease	796
-	I-Disease	796
telangiectasia	I-Disease	796
(	O	796
a	B-Disease	796
-	I-Disease	796
t	I-Disease	796
)	O	796
is	O	796
characterized	O	796
by	O	796
a	O	796
markedly	O	796
increased	O	796
sensitivity	O	796
to	O	796
ionizing	O	796
radiation	O	796
,	O	796
increased	O	796
incidence	O	796
of	O	796
cancer	B-Disease	796
,	O	796
and	O	796
neurodegeneration	B-Disease	796
,	O	796
especially	O	796
of	O	796
the	O	796
cerebellar	O	796
purkinje	O	796
cells	O	796
.	O	796
we	O	798
therefore	O	798
hypothesized	O	798
that	O	798
a	B-Disease	798
-	I-Disease	798
t	I-Disease	798
is	O	798
due	O	798
to	O	798
oxidative	O	798
damage	O	798
resulting	O	798
from	O	798
loss	O	798
of	O	798
function	O	798
of	O	798
the	O	798
a	B-Disease	798
-	I-Disease	798
t	I-Disease	798
gene	O	798
product	O	798
.	O	798
to	O	799
assess	O	799
this	O	799
hypothesis	O	799
,	O	799
we	O	799
employed	O	799
an	O	799
animal	O	799
model	O	799
of	O	799
a	B-Disease	799
-	I-Disease	799
t	I-Disease	799
,	O	799
the	O	799
mouse	O	799
with	O	799
a	O	799
disrupted	O	799
atm	O	799
gene	O	799
.	O	799
these	O	801
observations	O	801
provide	O	801
a	O	801
mechanistic	O	801
basis	O	801
for	O	801
the	O	801
a	B-Disease	801
-	I-Disease	801
t	I-Disease	801
phenotype	O	801
and	O	801
lay	O	801
a	O	801
rational	O	801
foundation	O	801
for	O	801
therapeutic	O	801
intervention	O	801
.	O	801
.	O	801
recessively	O	802
inherited	O	802
multiple	B-Disease	802
epiphyseal	I-Disease	802
dysplasia	I-Disease	802
with	O	802
normal	O	802
stature	O	802
,	O	802
club	B-Disease	802
foot	I-Disease	802
,	O	802
and	O	802
double	B-Disease	802
layered	I-Disease	802
patella	I-Disease	802
caused	O	802
by	O	802
a	O	802
dtdst	O	802
mutation	O	802
.	O	802
we	O	803
have	O	803
observed	O	803
over	O	803
25	O	803
different	O	803
mutations	O	803
in	O	803
the	O	803
diastrophic	B-Disease	803
dysplasia	I-Disease	803
sulphate	O	803
transporter	O	803
gene	O	803
(	O	803
dtdst	O	803
)	O	803
in	O	803
association	O	803
with	O	803
the	O	803
recessive	B-Disease	803
disorders	I-Disease	803
achondrogenesis	B-Disease	803
1b	I-Disease	803
,	O	803
atelosteogenesis	B-Disease	803
2	I-Disease	803
,	O	803
and	O	803
diastrophic	B-Disease	803
dysplasia	I-Disease	803
.	O	803
we	O	805
had	O	805
not	O	805
seen	O	805
a	O	805
case	O	805
of	O	805
homozygosity	O	805
for	O	805
c862t	O	805
(	O	805
r279w	O	805
)	O	805
until	O	805
we	O	805
analysed	O	805
dna	O	805
from	O	805
a	O	805
36	O	805
year	O	805
old	O	805
male	O	805
with	O	805
tall	O	805
-	O	805
normal	O	805
stature	O	805
(	O	805
180	O	805
cm	O	805
)	O	805
who	O	805
asked	O	805
for	O	805
genetic	O	805
counselling	O	805
for	O	805
suspected	O	805
multiple	B-Disease	805
epiphyseal	I-Disease	805
dysplasia	I-Disease	805
.	O	805
he	O	806
was	O	806
treated	O	806
for	O	806
club	B-Disease	806
foot	I-Disease	806
and	O	806
hip	B-Disease	806
dysplasia	I-Disease	806
at	O	806
birth	O	806
.	O	806
skeletal	O	807
changes	O	807
consistent	O	807
with	O	807
multiple	B-Disease	807
epiphyseal	I-Disease	807
dysplasia	I-Disease	807
,	O	807
with	O	807
the	O	807
peculiar	O	807
finding	O	807
of	O	807
a	O	807
double	B-Disease	807
layered	I-Disease	807
patella	I-Disease	807
,	O	807
were	O	807
recognised	O	807
during	O	807
childhood	O	807
.	O	807
cleft	B-Disease	808
palate	I-Disease	808
,	O	808
swelling	B-Disease	808
of	I-Disease	808
the	I-Disease	808
ear	I-Disease	808
pinna	I-Disease	808
,	O	808
and	O	808
hitch	B-Disease	808
hiker	I-Disease	808
thumb	I-Disease	808
were	O	808
absent	O	808
.	O	808
he	O	809
was	O	809
found	O	809
to	O	809
be	O	809
homozygous	O	809
,	O	809
and	O	809
both	O	809
healthy	O	809
parents	O	809
heterozygous	O	809
,	O	809
for	O	809
the	O	809
r279w	O	809
mutation	O	809
in	O	809
dtdst	O	809
,	O	809
and	O	809
his	O	809
fibroblasts	O	809
showed	O	809
a	O	809
sulphate	O	809
incorporation	O	809
defect	O	809
typical	O	809
of	O	809
dtdst	B-Disease	809
disorders	I-Disease	809
.	O	809
counselling	O	810
was	O	810
given	O	810
for	O	810
a	O	810
recessive	B-Disease	810
disorder	I-Disease	810
,	O	810
thereby	O	810
considerably	O	810
reducing	O	810
the	O	810
probability	O	810
of	O	810
affected	O	810
offspring	O	810
.	O	810
multiple	B-Disease	811
epiphyseal	I-Disease	811
dysplasia	I-Disease	811
is	O	811
more	O	811
frequently	O	811
caused	O	811
by	O	811
dominant	O	811
mutations	O	811
in	O	811
the	O	811
comp	O	811
(	O	811
edm1	B-Disease	811
,	O	811
mckusick	O	811
132400	O	811
)	O	811
and	O	811
col9a2	O	811
genes	O	811
(	O	811
edm2	B-Disease	811
,	O	811
mckusick	O	811
600204	O	811
)	O	811
.	O	811
a	O	812
few	O	812
other	O	812
patients	O	812
and	O	812
families	O	812
with	O	812
features	O	812
similar	O	812
to	O	812
our	O	812
proband	O	812
have	O	812
been	O	812
described	O	812
previously	O	812
and	O	812
considered	O	812
to	O	812
have	O	812
autosomal	O	812
recessive	O	812
med	B-Disease	812
(	O	812
edm4	B-Disease	812
,	O	812
mckusick	O	812
226900	O	812
)	O	812
.	O	812
homozygosity	O	814
for	O	814
a	O	814
novel	O	814
dtdst	O	814
mutation	O	814
in	O	814
a	O	814
child	O	814
with	O	814
a	O	814
'	O	814
broad	O	814
bone	O	814
-	O	814
platyspondylic	O	814
'	O	814
variant	O	814
of	O	814
diastrophic	B-Disease	814
dysplasia	I-Disease	814
.	O	814
atypical	O	815
or	O	815
variant	O	815
forms	O	815
of	O	815
well	O	815
-	O	815
known	O	815
chondrodysplasias	B-Disease	815
may	O	815
pose	O	815
diagnostic	O	815
problems	O	815
.	O	815
we	O	816
report	O	816
on	O	816
a	O	816
girl	O	816
with	O	816
clinical	O	816
features	O	816
suggesting	O	816
diastrophic	B-Disease	816
dysplasia	I-Disease	816
but	O	816
with	O	816
unusual	O	816
radiographic	O	816
features	O	816
including	O	816
severe	O	816
platyspondyly	B-Disease	816
,	O	816
wide	O	816
metaphyses	O	816
,	O	816
and	O	816
fibular	O	816
overgrowth	O	816
,	O	816
which	O	816
are	O	816
partially	O	816
reminiscent	O	816
of	O	816
metatropic	B-Disease	816
dysplasia	I-Disease	816
.	O	816
the	O	819
type	O	819
of	O	819
somatic	O	819
mutation	O	819
at	O	819
apc	O	819
in	O	819
familial	B-Disease	819
adenomatous	I-Disease	819
polyposis	I-Disease	819
is	O	819
determined	O	819
by	O	819
the	O	819
site	O	819
of	O	819
the	O	819
germline	O	819
mutation	O	819
:	O	819
a	O	819
new	O	819
facet	O	819
to	O	819
knudson	O	819
'	O	819
s	O	819
'	O	819
two	O	819
-	O	819
hit	O	819
'	O	819
hypothesis	O	819
.	O	819
apc	O	820
is	O	820
often	O	820
cited	O	820
as	O	820
a	O	820
prime	O	820
example	O	820
of	O	820
a	O	820
tumor	B-Disease	820
suppressor	O	820
gene	O	820
.	O	820
truncating	O	821
germline	O	821
and	O	821
somatic	O	821
mutations	O	821
(	O	821
or	O	821
,	O	821
infrequently	O	821
,	O	821
allelic	O	821
loss	O	821
)	O	821
occur	O	821
in	O	821
tumors	B-Disease	821
in	O	821
fap	B-Disease	821
(	O	821
familial	B-Disease	821
adenomatous	I-Disease	821
polyposis	I-Disease	821
)	O	821
.	O	821
most	O	822
sporadic	B-Disease	822
colorectal	I-Disease	822
cancers	I-Disease	822
also	O	822
have	O	822
two	O	822
apc	B-Disease	822
mutations	O	822
.	O	822
clues	O	823
from	O	823
attenuated	B-Disease	823
polyposis	I-Disease	823
,	O	823
missense	O	823
germline	O	823
variants	O	823
with	O	823
mild	O	823
disease	O	823
and	O	823
the	O	823
somatic	O	823
mutation	O	823
cluster	O	823
region	O	823
(	O	823
codons	O	823
1	O	823
,	O	823
250	O	823
-	O	823
1	O	823
,	O	823
450	O	823
)	O	823
indicate	O	823
,	O	823
however	O	823
,	O	823
that	O	823
apc	B-Disease	823
mutations	O	823
might	O	823
not	O	823
result	O	823
in	O	823
simple	O	823
loss	O	823
of	O	823
protein	O	823
function	O	823
.	O	823
we	O	824
have	O	824
found	O	824
that	O	824
fap	B-Disease	824
patients	O	824
with	O	824
germline	O	824
apc	B-Disease	824
mutations	O	824
within	O	824
a	O	824
small	O	824
region	O	824
(	O	824
codons	O	824
1	O	824
,	O	824
194	O	824
-	O	824
1	O	824
,	O	824
392	O	824
at	O	824
most	O	824
)	O	824
mainly	O	824
show	O	824
allelic	O	824
loss	O	824
in	O	824
their	O	824
colorectal	B-Disease	824
adenomas	I-Disease	824
,	O	824
in	O	824
contrast	O	824
to	O	824
other	O	824
fap	B-Disease	824
patients	O	824
,	O	824
whose	O	824
second	O	824
hits	O	824
tend	O	824
to	O	824
occur	O	824
by	O	824
truncating	O	824
mutations	O	824
in	O	824
the	O	824
mutation	O	824
cluster	O	824
region	O	824
.	O	824
our	O	825
results	O	825
indicate	O	825
that	O	825
different	O	825
apc	B-Disease	825
mutations	O	825
provide	O	825
cells	O	825
with	O	825
different	O	825
selective	O	825
advantages	O	825
,	O	825
with	O	825
mutations	O	825
close	O	825
to	O	825
codon	O	825
1	O	825
,	O	825
300	O	825
providing	O	825
the	O	825
greatest	O	825
advantage	O	825
.	O	825
a	O	827
different	O	827
germline	O	827
-	O	827
somatic	O	827
apc	B-Disease	827
mutation	O	827
association	O	827
exists	O	827
in	O	827
fap	B-Disease	827
desmoids	I-Disease	827
.	O	827
apc	O	828
is	O	828
not	O	828
,	O	828
therefore	O	828
,	O	828
a	O	828
classical	O	828
tumor	B-Disease	828
suppressor	O	828
.	O	828
our	O	829
findings	O	829
also	O	829
indicate	O	829
a	O	829
new	O	829
mechanism	O	829
for	O	829
disease	O	829
severity	O	829
if	O	829
a	O	829
broader	O	829
spectrum	O	829
of	O	829
mutations	O	829
is	O	829
selected	O	829
in	O	829
tumors	B-Disease	829
,	O	829
the	O	829
somatic	O	829
mutation	O	829
rate	O	829
is	O	829
effectively	O	829
higher	O	829
and	O	829
more	O	829
tumors	B-Disease	829
grow	O	829
.	O	829
.	O	829
mxi1	O	830
mutations	O	830
in	O	830
human	O	830
neurofibrosarcomas	B-Disease	830
.	O	830
mxi1	O	831
is	O	831
thought	O	831
to	O	831
negatively	O	831
regulate	O	831
myc	O	831
function	O	831
and	O	831
may	O	831
therefore	O	831
be	O	831
a	O	831
potential	O	831
tumor	B-Disease	831
suppressor	O	831
gene	O	831
.	O	831
little	O	832
effort	O	832
has	O	832
yet	O	832
been	O	832
made	O	832
to	O	832
find	O	832
alterations	O	832
involving	O	832
this	O	832
gene	O	832
in	O	832
human	O	832
solid	B-Disease	832
tumors	I-Disease	832
.	O	832
we	O	833
screened	O	833
31	O	833
human	O	833
gastric	B-Disease	833
cancers	I-Disease	833
,	O	833
7	O	833
esophageal	B-Disease	833
cancers	I-Disease	833
,	O	833
85	O	833
bone	B-Disease	833
and	I-Disease	833
soft	I-Disease	833
tissue	I-Disease	833
tumors	I-Disease	833
of	O	833
various	O	833
types	O	833
,	O	833
including	O	833
4	O	833
neurofibrosarcomas	B-Disease	833
.	O	833
we	O	834
also	O	834
examined	O	834
29	O	834
human	O	834
tumor	B-Disease	834
cell	O	834
lines	O	834
consisting	O	834
of	O	834
12	O	834
esophageal	B-Disease	834
cancers	I-Disease	834
,	O	834
7	O	834
glioma	B-Disease	834
/	O	834
glioblastomas	B-Disease	834
and	O	834
10	O	834
others	O	834
for	O	834
mxi1	O	834
mutations	O	834
in	O	834
exons	O	834
1	O	834
,	O	834
2	O	834
,	O	834
4	O	834
(	O	834
hlh	O	834
domain	O	834
)	O	834
,	O	834
5	O	834
and	O	834
6	O	834
.	O	834
we	O	836
discovered	O	836
a	O	836
missense	O	836
mutation	O	836
,	O	836
gca	O	836
to	O	836
gta	O	836
(	O	836
ala	O	836
54	O	836
val	O	836
)	O	836
,	O	836
in	O	836
exon	O	836
2	O	836
in	O	836
a	O	836
neurofibrosarcoma	B-Disease	836
patient	O	836
(	O	836
case	O	836
1	O	836
)	O	836
,	O	836
two	O	836
missense	O	836
mutations	O	836
,	O	836
aaa	O	836
to	O	836
caa	O	836
(	O	836
lys	O	836
118	O	836
gln	O	836
)	O	836
and	O	836
gaa	O	836
to	O	836
gga	O	836
(	O	836
glu	O	836
154	O	836
gly	O	836
)	O	836
in	O	836
exon	O	836
5	O	836
of	O	836
another	O	836
neurofibrosarcoma	B-Disease	836
patient	O	836
(	O	836
case	O	836
2	O	836
)	O	836
,	O	836
and	O	836
3	O	836
amino	O	836
acid	O	836
substitutions	O	836
,	O	836
gtg	O	836
to	O	836
gcg	O	836
(	O	836
val	O	836
179	O	836
ala	O	836
)	O	836
,	O	836
gtt	O	836
to	O	836
gct	O	836
(	O	836
val	O	836
181	O	836
ala	O	836
)	O	836
and	O	836
ttc	O	836
to	O	836
ctc	O	836
(	O	836
phe	O	836
186	O	836
leu	O	836
)	O	836
,	O	836
in	O	836
a	O	836
third	O	836
neurofibrosarcoma	B-Disease	836
patient	O	836
(	O	836
case	O	836
3	O	836
)	O	836
.	O	836
our	O	838
data	O	838
demonstrate	O	838
that	O	838
mutations	O	838
occur	O	838
in	O	838
the	O	838
mxi1	O	838
gene	O	838
in	O	838
neurofibrosarcoma	B-Disease	838
.	O	838
missense	O	839
mutations	O	839
in	O	839
the	O	839
functional	O	839
domain	O	839
of	O	839
mxi1	O	839
in	O	839
these	O	839
cases	O	839
may	O	839
be	O	839
involved	O	839
in	O	839
the	O	839
pathogenesis	O	839
of	O	839
neurofibrosarcoma	B-Disease	839
.	O	839
.	O	839
a	O	840
population	O	840
-	O	840
based	O	840
study	O	840
of	O	840
the	O	840
clinical	O	840
expression	O	840
of	O	840
the	O	840
hemochromatosis	B-Disease	840
gene	O	840
.	O	840
background	O	841
and	O	841
methods	O	841
hereditary	B-Disease	841
hemochromatosis	I-Disease	841
is	O	841
associated	O	841
with	O	841
homozygosity	O	841
for	O	841
the	O	841
c282y	O	841
mutation	O	841
in	O	841
the	O	841
hemochromatosis	B-Disease	841
(	O	841
hfe	O	841
)	O	841
gene	O	841
on	O	841
chromosome	O	841
6	O	841
,	O	841
elevated	O	841
serum	O	841
transferrin	O	841
saturation	O	841
,	O	841
and	O	841
excess	B-Disease	841
iron	I-Disease	841
deposits	I-Disease	841
throughout	O	841
the	O	841
body	O	841
.	O	841
four	O	849
of	O	849
the	O	849
homozygous	O	849
subjects	O	849
had	O	849
previously	O	849
been	O	849
given	O	849
a	O	849
diagnosis	O	849
of	O	849
hemochromatosis	B-Disease	849
,	O	849
and	O	849
12	O	849
had	O	849
not	O	849
.	O	849
eleven	O	852
of	O	852
the	O	852
16	O	852
homozygous	O	852
subjects	O	852
underwent	O	852
liver	O	852
biopsy	O	852
;	O	852
3	O	852
had	O	852
hepatic	B-Disease	852
fibrosis	I-Disease	852
,	O	852
and	O	852
1	O	852
,	O	852
who	O	852
had	O	852
a	O	852
history	O	852
of	O	852
excessive	B-Disease	852
alcohol	I-Disease	852
consumption	I-Disease	852
,	O	852
had	O	852
cirrhosis	B-Disease	852
and	O	852
mild	O	852
microvesicular	B-Disease	852
steatosis	I-Disease	852
.	O	852
eight	O	853
of	O	853
the	O	853
16	O	853
homozygous	O	853
subjects	O	853
had	O	853
clinical	O	853
findings	O	853
that	O	853
were	O	853
consistent	O	853
with	O	853
the	O	853
presence	O	853
of	O	853
hereditary	B-Disease	853
hemochromatosis	I-Disease	853
,	O	853
such	O	853
as	O	853
hepatomegaly	B-Disease	853
,	O	853
skin	B-Disease	853
pigmentation	I-Disease	853
,	O	853
and	O	853
arthritis	B-Disease	853
.	O	853
however	O	856
,	O	856
only	O	856
half	O	856
of	O	856
those	O	856
who	O	856
were	O	856
homozygous	O	856
had	O	856
clinical	O	856
features	O	856
of	O	856
hemochromatosis	B-Disease	856
,	O	856
and	O	856
one	O	856
quarter	O	856
had	O	856
serum	O	856
ferritin	O	856
levels	O	856
that	O	856
remained	O	856
normal	O	856
over	O	856
a	O	856
four	O	856
-	O	856
year	O	856
period	O	856
.	O	856
the	O	858
clinical	O	858
use	O	858
of	O	858
molecular	O	858
analyses	O	858
in	O	858
recessive	B-Disease	858
disorders	I-Disease	858
relies	O	858
on	O	858
the	O	858
exact	O	858
characterization	O	858
of	O	858
both	O	858
mutant	O	858
alleles	O	858
in	O	858
the	O	858
affected	O	858
patient	O	858
.	O	858
we	O	860
present	O	860
a	O	860
child	O	860
in	O	860
whom	O	860
phenylketonuria	B-Disease	860
was	O	860
apparently	O	860
caused	O	860
by	O	860
homozygosity	O	860
for	O	860
the	O	860
mutation	O	860
e390g	O	860
in	O	860
exon	O	860
11	O	860
of	O	860
the	O	860
phenylalanine	O	860
hydroxylase	O	860
(	O	860
pah	O	860
)	O	860
gene	O	860
.	O	860
early	O	864
onset	O	864
of	O	864
x	B-Disease	864
-	I-Disease	864
linked	I-Disease	864
emery	I-Disease	864
-	I-Disease	864
dreifuss	I-Disease	864
muscular	I-Disease	864
dystrophy	I-Disease	864
in	O	864
a	O	864
boy	O	864
with	O	864
emerin	O	864
gene	O	864
deletion	O	864
.	O	864
a	O	865
boy	O	865
developed	O	865
contractures	B-Disease	865
of	I-Disease	865
the	I-Disease	865
achilles	I-Disease	865
tendons	I-Disease	865
at	O	865
3	O	865
years	O	865
and	O	865
of	O	865
the	O	865
postcervical	O	865
muscles	O	865
at	O	865
7	O	865
years	O	865
,	O	865
although	O	865
neither	O	865
contractures	B-Disease	865
of	I-Disease	865
the	I-Disease	865
elbows	I-Disease	865
nor	O	865
cardiac	B-Disease	865
abnormality	I-Disease	865
were	O	865
recognized	O	865
by	O	865
the	O	865
age	O	865
of	O	865
9	O	865
years	O	865
.	O	865
these	O	868
results	O	868
confirmed	O	868
the	O	868
diagnosis	O	868
of	O	868
x	B-Disease	868
-	I-Disease	868
linked	I-Disease	868
emery	I-Disease	868
-	I-Disease	868
dreifuss	I-Disease	868
muscular	I-Disease	868
dystrophy	I-Disease	868
(	O	868
edmd	B-Disease	868
)	O	868
,	O	868
and	O	868
reinforce	O	868
the	O	868
necessity	O	868
of	O	868
molecular	O	868
genetic	O	868
diagnosis	O	868
of	O	868
the	O	868
membrane	O	868
protein	O	868
emerin	O	868
in	O	868
younger	O	868
patients	O	868
with	O	868
possible	O	868
edmd	B-Disease	868
before	O	868
appearance	O	868
of	O	868
the	O	868
typical	O	868
symptoms	O	868
,	O	868
to	O	868
avoid	O	868
sudden	B-Disease	868
cardiac	I-Disease	868
death	I-Disease	868
.	O	868
.	O	868
duchenne	B-Disease	869
/	I-Disease	869
becker	I-Disease	869
muscular	I-Disease	869
dystrophy	I-Disease	869
:	O	869
correlation	O	869
of	O	869
phenotype	O	869
by	O	869
electroretinography	O	869
with	O	869
sites	O	869
of	O	869
dystrophin	O	869
mutations	O	869
.	O	869
the	O	870
dark	O	870
-	O	870
adapted	O	870
electroretinogram	O	870
(	O	870
erg	O	870
)	O	870
of	O	870
patients	O	870
with	O	870
duchenne	B-Disease	870
and	I-Disease	870
becker	I-Disease	870
muscular	I-Disease	870
dystrophy	I-Disease	870
(	O	870
dmd	B-Disease	870
/	O	870
bmd	B-Disease	870
)	O	870
shows	O	870
a	O	870
marked	O	870
reduction	O	870
in	O	870
b	O	870
-	O	870
wave	O	870
amplitude	O	870
.	O	870
genotype	O	871
-	O	871
phenotype	O	871
studies	O	871
of	O	871
mouse	O	871
models	O	871
for	O	871
dmd	B-Disease	871
show	O	871
position	O	871
-	O	871
specific	O	871
effects	O	871
of	O	871
the	O	871
mutations	O	871
upon	O	871
the	O	871
phenotype	O	871
mice	O	871
with	O	871
5	O	871
defects	O	871
of	O	871
dystrophin	O	871
have	O	871
normal	O	871
ergs	O	871
,	O	871
those	O	871
with	O	871
defects	O	871
in	O	871
the	O	871
central	O	871
region	O	871
have	O	871
a	O	871
normal	O	871
b	O	871
-	O	871
wave	O	871
amplitude	O	871
associated	O	871
with	O	871
prolonged	O	871
implicit	O	871
times	O	871
for	O	871
both	O	871
the	O	871
b	O	871
-	O	871
wave	O	871
and	O	871
oscillatory	O	871
potentials	O	871
,	O	871
and	O	871
mice	O	871
with	O	871
3	O	871
defects	O	871
have	O	871
a	O	871
phenotype	O	871
similar	O	871
to	O	871
that	O	871
seen	O	871
in	O	871
dmd	B-Disease	871
/	O	871
bmd	B-Disease	871
patients	O	871
.	O	871
we	O	873
have	O	873
undertaken	O	873
a	O	873
systematic	O	873
evaluation	O	873
of	O	873
dmd	B-Disease	873
/	O	873
bmd	B-Disease	873
patients	O	873
through	O	873
clinical	O	873
examination	O	873
and	O	873
review	O	873
of	O	873
the	O	873
literature	O	873
in	O	873
order	O	873
to	O	873
determine	O	873
whether	O	873
the	O	873
position	O	873
-	O	873
specific	O	873
effects	O	873
of	O	873
mutations	O	873
noted	O	873
in	O	873
the	O	873
mouse	O	873
are	O	873
present	O	873
in	O	873
man	O	873
.	O	873
we	O	874
have	O	874
found	O	874
that	O	874
,	O	874
in	O	874
man	O	874
,	O	874
a	O	874
wider	O	874
variation	O	874
of	O	874
dmd	B-Disease	874
defects	I-Disease	874
correlate	O	874
with	O	874
reductions	O	874
in	O	874
the	O	874
b	O	874
-	O	874
wave	O	874
amplitude	O	874
.	O	874
our	O	876
results	O	876
suggest	O	876
that	O	876
the	O	876
most	O	876
important	O	876
determinant	O	876
in	O	876
the	O	876
erg	O	876
b	O	876
-	O	876
wave	O	876
phenotype	O	876
is	O	876
the	O	876
mutation	O	876
position	O	876
,	O	876
rather	O	876
than	O	876
muscle	B-Disease	876
disease	I-Disease	876
severity	O	876
.	O	876
cis	O	879
and	O	879
trans	O	879
effects	O	879
of	O	879
the	O	879
myotonic	B-Disease	879
dystrophy	I-Disease	879
(	O	879
dm	B-Disease	879
)	O	879
mutation	O	879
in	O	879
a	O	879
cell	O	879
culture	O	879
model	O	879
.	O	879
the	O	880
mutation	O	880
causing	O	880
myotonic	B-Disease	880
dystrophy	I-Disease	880
(	O	880
dm	B-Disease	880
)	O	880
has	O	880
been	O	880
identified	O	880
as	O	880
a	O	880
ctg	O	880
expansion	O	880
in	O	880
the	O	880
3	O	880
-	O	880
untranslated	O	880
region	O	880
(	O	880
3	O	880
-	O	880
utr	O	880
)	O	880
of	O	880
the	O	880
dm	B-Disease	880
protein	O	880
kinase	O	880
gene	O	880
(	O	880
dmpk	O	880
)	O	880
,	O	880
but	O	880
the	O	880
mechanism	O	880
(	O	880
s	O	880
)	O	880
of	O	880
pathogenesis	O	880
remain	O	880
unknown	O	880
.	O	880
studies	O	881
using	O	881
dm	B-Disease	881
patient	O	881
materials	O	881
have	O	881
often	O	881
produced	O	881
confusing	O	881
results	O	881
.	O	881
therefore	O	882
,	O	882
to	O	882
study	O	882
the	O	882
effects	O	882
of	O	882
the	O	882
dm	B-Disease	882
mutation	O	882
in	O	882
a	O	882
controlled	O	882
environment	O	882
,	O	882
we	O	882
have	O	882
established	O	882
a	O	882
cell	O	882
culture	O	882
model	O	882
system	O	882
using	O	882
c2c12	O	882
mouse	O	882
myoblasts	O	882
.	O	882
by	O	883
expressing	O	883
chimeric	O	883
reporter	O	883
constructs	O	883
containing	O	883
a	O	883
reporter	O	883
gene	O	883
fused	O	883
to	O	883
a	O	883
human	O	883
dmpk	O	883
3	O	883
-	O	883
utr	O	883
,	O	883
we	O	883
identified	O	883
both	O	883
cis	O	883
and	O	883
trans	O	883
effects	O	883
that	O	883
are	O	883
mediated	O	883
by	O	883
the	O	883
dm	B-Disease	883
mutation	O	883
.	O	883
these	O	889
results	O	889
provide	O	889
evidence	O	889
that	O	889
the	O	889
dm	B-Disease	889
mutation	O	889
acts	O	889
in	O	889
cis	O	889
to	O	889
reduce	O	889
protein	O	889
production	O	889
(	O	889
consistent	O	889
with	O	889
dmpk	B-Disease	889
haploinsufficiency	I-Disease	889
)	O	889
and	O	889
in	O	889
trans	O	889
as	O	889
a	O	889
riboregulator	O	889
to	O	889
inhibit	O	889
myogenesis	O	889
.	O	889
.	O	889
coats	B-Disease	890
'	I-Disease	890
disease	I-Disease	890
of	O	890
the	O	890
retina	O	890
(	O	890
unilateral	B-Disease	890
retinal	I-Disease	890
telangiectasis	I-Disease	890
)	O	890
caused	O	890
by	O	890
somatic	O	890
mutation	O	890
in	O	890
the	O	890
ndp	O	890
gene	O	890
:	O	890
a	O	890
role	O	890
for	O	890
norrin	O	890
in	O	890
retinal	O	890
angiogenesis	O	890
.	O	890
coats	B-Disease	891
disease	I-Disease	891
is	O	891
characterized	O	891
by	O	891
abnormal	B-Disease	891
retinal	I-Disease	891
vascular	I-Disease	891
development	I-Disease	891
(	O	891
so	O	891
-	O	891
called	O	891
retinal	B-Disease	891
telangiectasis	I-Disease	891
)	O	891
which	O	891
results	O	891
in	O	891
massive	O	891
intraretinal	B-Disease	891
and	I-Disease	891
subretinal	I-Disease	891
lipid	I-Disease	891
accumulation	I-Disease	891
(	O	891
exudative	B-Disease	891
retinal	I-Disease	891
detachment	I-Disease	891
)	O	891
.	O	891
the	O	892
classical	O	892
form	O	892
of	O	892
coats	B-Disease	892
disease	I-Disease	892
is	O	892
almost	O	892
invariably	O	892
isolated	O	892
,	O	892
unilateral	O	892
and	O	892
seen	O	892
in	O	892
males	O	892
.	O	892
a	O	893
female	O	893
with	O	893
a	O	893
unilateral	O	893
variant	O	893
of	O	893
coats	B-Disease	893
disease	I-Disease	893
gave	O	893
birth	O	893
to	O	893
a	O	893
son	O	893
affected	O	893
by	O	893
norrie	B-Disease	893
disease	I-Disease	893
.	O	893
subsequently	O	896
analysis	O	896
of	O	896
the	O	896
retinas	O	896
of	O	896
nine	O	896
enucleated	O	896
eyes	O	896
from	O	896
males	O	896
with	O	896
coats	B-Disease	896
disease	I-Disease	896
demonstrated	O	896
in	O	896
one	O	896
a	O	896
somatic	O	896
mutation	O	896
in	O	896
the	O	896
ndp	O	896
gene	O	896
which	O	896
was	O	896
not	O	896
present	O	896
within	O	896
non	O	896
-	O	896
retinal	O	896
tissue	O	896
.	O	896
we	O	897
suggest	O	897
that	O	897
coats	B-Disease	897
telangiectasis	I-Disease	897
is	O	897
secondary	O	897
to	O	897
somatic	O	897
mutation	O	897
in	O	897
the	O	897
ndp	O	897
gene	O	897
which	O	897
results	O	897
in	O	897
a	O	897
deficiency	B-Disease	897
of	I-Disease	897
norrin	I-Disease	897
(	O	897
the	O	897
protein	O	897
product	O	897
of	O	897
the	O	897
ndp	O	897
gene	O	897
)	O	897
within	O	897
the	O	897
developing	O	897
retina	O	897
.	O	897
hereditary	O	899
tp53	O	899
codon	O	899
292	O	899
and	O	899
somatic	O	899
p16ink4a	O	899
codon	O	899
94	O	899
mutations	O	899
in	O	899
a	O	899
li	B-Disease	899
-	I-Disease	899
fraumeni	I-Disease	899
syndrome	I-Disease	899
family	O	899
.	O	899
li	B-Disease	900
-	I-Disease	900
fraumeni	I-Disease	900
syndrome	I-Disease	900
is	O	900
an	O	900
autosomal	B-Disease	900
dominant	I-Disease	900
disorder	I-Disease	900
that	O	900
is	O	900
characterized	O	900
by	O	900
various	O	900
types	O	900
of	O	900
cancer	B-Disease	900
in	O	900
childhood	O	900
and	O	900
adult	O	900
cases	O	900
.	O	900
although	O	901
hereditary	O	901
tp53	O	901
mutation	O	901
is	O	901
very	O	901
rare	O	901
in	O	901
different	O	901
human	O	901
cancers	B-Disease	901
,	O	901
it	O	901
has	O	901
been	O	901
frequently	O	901
reported	O	901
in	O	901
li	B-Disease	901
-	I-Disease	901
fraumeni	I-Disease	901
syndrome	I-Disease	901
.	O	901
on	O	902
the	O	902
other	O	902
hand	O	902
,	O	902
hereditary	O	902
mutations	O	902
of	O	902
tp57kip2	O	902
,	O	902
p15ink4b	O	902
,	O	902
and	O	902
p16ink4a	O	902
,	O	902
which	O	902
affect	O	902
the	O	902
cell	O	902
cycle	O	902
similar	O	902
to	O	902
tp53	O	902
,	O	902
were	O	902
observed	O	902
in	O	902
some	O	902
types	O	902
of	O	902
cancer	B-Disease	902
.	O	902
in	O	903
a	O	903
turkish	O	903
family	O	903
with	O	903
the	O	903
diagnosis	O	903
of	O	903
li	B-Disease	903
-	I-Disease	903
fraumeni	I-Disease	903
syndrome	I-Disease	903
,	O	903
we	O	903
analyzed	O	903
the	O	903
mutation	O	903
pattern	O	903
of	O	903
tp53	O	903
,	O	903
p57kip2	O	903
,	O	903
p15ink4b	O	903
,	O	903
and	O	903
p16ink4a	O	903
in	O	903
the	O	903
peripheral	O	903
blood	O	903
,	O	903
and	O	903
loss	O	903
of	O	903
heterozygosity	O	903
(	O	903
homo	O	903
/	O	903
hemizygous	O	903
deletion	O	903
)	O	903
pattern	O	903
of	O	903
tp53	O	903
and	O	903
p15ink4b	O	903
/	O	903
p16ink4a	O	903
in	O	903
two	O	903
tumor	B-Disease	903
tissues	O	903
.	O	903
the	O	904
propositus	O	904
had	O	904
a	O	904
seminoma	B-Disease	904
,	O	904
his	O	904
daughter	O	904
a	O	904
medulloblastoma	B-Disease	904
,	O	904
and	O	904
one	O	904
of	O	904
his	O	904
healthy	O	904
cousins	O	904
,	O	904
a	O	904
tp53	O	904
codon	O	904
292	O	904
missense	O	904
point	O	904
mutation	O	904
(	O	904
aaa	O	904
-	O	904
-	O	904
>	O	904
ata	O	904
;	O	904
lys	O	904
-	O	904
-	O	904
>	O	904
ile	O	904
)	O	904
in	O	904
the	O	904
peripheral	O	904
blood	O	904
cells	O	904
.	O	904
tumor	O	905
tissue	O	905
obtained	O	905
from	O	905
the	O	905
propositus	O	905
with	O	905
the	O	905
seminoma	B-Disease	905
revealed	O	905
loss	O	905
of	O	905
heterozygosity	O	905
in	O	905
the	O	905
tp53	O	905
gene	O	905
.	O	905
in	O	906
the	O	906
analyses	O	906
of	O	906
tumor	B-Disease	906
tissues	O	906
from	O	906
the	O	906
propositus	O	906
and	O	906
his	O	906
daughter	O	906
,	O	906
a	O	906
p16ink4a	O	906
codon	O	906
94	O	906
missense	O	906
point	O	906
mutation	O	906
(	O	906
gcg	O	906
-	O	906
-	O	906
>	O	906
gag	O	906
;	O	906
ala	O	906
-	O	906
-	O	906
>	O	906
glu	O	906
)	O	906
was	O	906
observed	O	906
with	O	906
the	O	906
hereditary	O	906
tp53	O	906
mutation	O	906
.	O	906
p16ink4a	O	907
codon	O	907
94	O	907
mutation	O	907
observed	O	907
in	O	907
our	O	907
family	O	907
is	O	907
a	O	907
novel	O	907
mutation	O	907
in	O	907
li	B-Disease	907
-	I-Disease	907
fraumeni	I-Disease	907
syndrome	I-Disease	907
.	O	907
existence	O	909
of	O	909
the	O	909
p16ink4a	O	909
mutation	O	909
and	O	909
the	O	909
hereditary	O	909
tp53	O	909
mutation	O	909
with	O	909
or	O	909
without	O	909
loss	O	909
of	O	909
heterozygosity	O	909
in	O	909
the	O	909
tp53	O	909
gene	O	909
(	O	909
seminoma	B-Disease	909
/	O	909
medulloblastoma	B-Disease	909
)	O	909
may	O	909
be	O	909
evidence	O	909
for	O	909
a	O	909
common	O	909
mechanism	O	909
involved	O	909
in	O	909
tumorogenesis	B-Disease	909
.	O	909
the	O	910
gene	O	910
alterations	O	910
in	O	910
tp53	O	910
and	O	910
p16ink4a	O	910
genes	O	910
may	O	910
be	O	910
used	O	910
as	O	910
tumor	B-Disease	910
markers	O	910
in	O	910
our	O	910
family	O	910
.	O	910
.	O	910
a	O	911
novel	O	911
mutation	O	911
in	O	911
the	O	911
sodium	O	911
/	O	911
iodide	O	911
symporter	O	911
gene	O	911
in	O	911
the	O	911
largest	O	911
family	O	911
with	O	911
iodide	B-Disease	911
transport	I-Disease	911
defect	I-Disease	911
.	O	911
we	O	912
previously	O	912
reported	O	912
nine	O	912
children	O	912
with	O	912
an	O	912
autosomally	O	912
recessive	O	912
form	O	912
of	O	912
congenital	B-Disease	912
hypothyroidism	I-Disease	912
due	O	912
to	O	912
an	O	912
iodide	B-Disease	912
transport	I-Disease	912
defect	I-Disease	912
in	O	912
a	O	912
large	O	912
hutterite	O	912
family	O	912
with	O	912
extensive	O	912
consanguinity	O	912
living	O	912
in	O	912
central	O	912
canada	O	912
.	O	912
since	O	913
the	O	913
original	O	913
report	O	913
,	O	913
we	O	913
have	O	913
diagnosed	O	913
congenital	B-Disease	913
hypothyroidism	I-Disease	913
by	O	913
newborn	O	913
tsh	O	913
screening	O	913
in	O	913
9	O	913
additional	O	913
children	O	913
from	O	913
the	O	913
family	O	913
.	O	913
expression	O	918
experiments	O	918
by	O	918
transfection	O	918
of	O	918
the	O	918
mutant	O	918
nis	O	918
complimentary	O	918
dna	O	918
into	O	918
cos	O	918
-	O	918
7	O	918
cells	O	918
showed	O	918
no	O	918
perchlorate	O	918
-	O	918
sensitive	O	918
iodide	O	918
uptake	O	918
,	O	918
confirming	O	918
that	O	918
the	O	918
mutation	O	918
is	O	918
the	O	918
direct	O	918
cause	O	918
of	O	918
the	O	918
iodide	B-Disease	918
transport	I-Disease	918
defect	I-Disease	918
in	O	918
these	O	918
patients	O	918
.	O	918
it	O	920
is	O	920
now	O	920
possible	O	920
to	O	920
use	O	920
gene	O	920
diagnostics	O	920
of	O	920
this	O	920
unique	O	920
nis	O	920
mutation	O	920
to	O	920
identify	O	920
patients	O	920
with	O	920
congenital	B-Disease	920
hypothyroidism	I-Disease	920
due	O	920
to	O	920
an	O	920
iodide	B-Disease	920
transport	I-Disease	920
defect	I-Disease	920
in	O	920
this	O	920
family	O	920
and	O	920
to	O	920
determine	O	920
the	O	920
carrier	O	920
state	O	920
of	O	920
potential	O	920
parents	O	920
for	O	920
genetic	O	920
counseling	O	920
and	O	920
arranging	O	920
rapid	O	920
and	O	920
early	O	920
diagnosis	O	920
of	O	920
their	O	920
infants	O	920
.	O	920
molecular	O	921
analysis	O	921
in	O	921
familial	B-Disease	921
neurohypophyseal	I-Disease	921
diabetes	I-Disease	921
insipidus	I-Disease	921
:	O	921
early	O	921
diagnosis	O	921
of	O	921
an	O	921
asymptomatic	O	921
carrier	O	921
.	O	921
familial	B-Disease	922
neurohypophyseal	I-Disease	922
diabetes	I-Disease	922
insipidus	I-Disease	922
(	O	922
fndi	B-Disease	922
)	O	922
is	O	922
an	O	922
inherited	O	922
deficiency	B-Disease	922
of	I-Disease	922
the	I-Disease	922
hormone	I-Disease	922
arginine	I-Disease	922
vasopressin	I-Disease	922
(	O	922
avp	O	922
)	O	922
and	O	922
is	O	922
transmitted	O	922
as	O	922
an	O	922
autosomal	O	922
dominant	O	922
trait	O	922
.	O	922
the	O	930
alteration	O	930
found	O	930
in	O	930
the	O	930
second	O	930
exon	O	930
of	O	930
the	O	930
gene	O	930
in	O	930
this	O	930
family	O	930
seems	O	930
to	O	930
be	O	930
responsible	O	930
for	O	930
the	O	930
disease	O	930
,	O	930
as	O	930
all	O	930
individuals	O	930
harboring	O	930
the	O	930
mutation	O	930
had	O	930
been	O	930
previously	O	930
diagnosed	O	930
or	O	930
have	O	930
eventually	O	930
developed	O	930
fndi	B-Disease	930
.	O	930
identification	O	931
of	O	931
the	O	931
molecular	O	931
defect	O	931
underlying	O	931
fndi	B-Disease	931
in	O	931
affected	O	931
families	O	931
is	O	931
a	O	931
powerful	O	931
tool	O	931
for	O	931
early	O	931
asymptomatic	O	931
diagnosis	O	931
in	O	931
infants	O	931
.	O	931
.	O	931
deficit	O	932
of	O	932
in	O	932
vivo	O	932
mitochondrial	O	932
atp	O	932
production	O	932
in	O	932
patients	O	932
with	O	932
friedreich	B-Disease	932
ataxia	I-Disease	932
.	O	932
friedreich	B-Disease	933
ataxia	I-Disease	933
(	O	933
frda	B-Disease	933
)	O	933
,	O	933
the	O	933
most	O	933
common	O	933
of	O	933
the	O	933
inherited	B-Disease	933
ataxias	I-Disease	933
,	O	933
is	O	933
an	O	933
autosomal	B-Disease	933
recessive	I-Disease	933
degenerative	I-Disease	933
disorder	I-Disease	933
,	O	933
characterized	O	933
clinically	O	933
by	O	933
onset	O	933
before	O	933
the	O	933
age	O	933
of	O	933
25	O	933
of	O	933
progressive	B-Disease	933
gait	I-Disease	933
and	I-Disease	933
limb	I-Disease	933
ataxia	I-Disease	933
,	O	933
absence	B-Disease	933
of	I-Disease	933
deep	I-Disease	933
tendon	I-Disease	933
reflexes	I-Disease	933
,	O	933
extensor	B-Disease	933
plantar	I-Disease	933
responses	I-Disease	933
,	O	933
and	O	933
loss	B-Disease	933
of	I-Disease	933
position	I-Disease	933
and	I-Disease	933
vibration	I-Disease	933
sense	I-Disease	933
in	O	933
the	O	933
lower	O	933
limbs	O	933
.	O	933
frda	B-Disease	934
is	O	934
caused	O	934
by	O	934
a	O	934
gaa	O	934
triplet	O	934
expansion	O	934
in	O	934
the	O	934
first	O	934
intron	O	934
of	O	934
the	O	934
frda	B-Disease	934
gene	O	934
on	O	934
chromosome	O	934
9q13	O	934
in	O	934
97	O	934
%	O	934
of	O	934
patients	O	934
.	O	934
the	O	935
frda	B-Disease	935
gene	O	935
encodes	O	935
a	O	935
widely	O	935
expressed	O	935
210	O	935
-	O	935
aa	O	935
protein	O	935
,	O	935
frataxin	O	935
,	O	935
which	O	935
is	O	935
located	O	935
in	O	935
mitochondria	O	935
and	O	935
is	O	935
severely	O	935
reduced	O	935
in	O	935
frda	B-Disease	935
patients	O	935
.	O	935
here	O	937
we	O	937
report	O	937
in	O	937
vivo	O	937
evidence	O	937
of	O	937
impaired	O	937
mitochondrial	O	937
respiration	O	937
in	O	937
skeletal	O	937
muscle	O	937
of	O	937
frda	B-Disease	937
patients	O	937
.	O	937
using	O	938
phosphorus	O	938
magnetic	O	938
resonance	O	938
spectroscopy	O	938
we	O	938
demonstrated	O	938
a	O	938
maximum	O	938
rate	O	938
of	O	938
muscle	O	938
mitochondrial	O	938
atp	O	938
production	O	938
(	O	938
v	O	938
(	O	938
max	O	938
)	O	938
)	O	938
below	O	938
the	O	938
normal	O	938
range	O	938
in	O	938
all	O	938
12	O	938
frda	B-Disease	938
patients	O	938
and	O	938
a	O	938
strong	O	938
negative	O	938
correlation	O	938
between	O	938
mitochondrial	O	938
v	O	938
(	O	938
max	O	938
)	O	938
and	O	938
the	O	938
number	O	938
of	O	938
gaa	O	938
repeats	O	938
in	O	938
the	O	938
smaller	O	938
allele	O	938
.	O	938
our	O	939
results	O	939
show	O	939
that	O	939
frda	B-Disease	939
is	O	939
a	O	939
nuclear	O	939
-	O	939
encoded	O	939
mitochondrial	B-Disease	939
disorder	I-Disease	939
affecting	O	939
oxidative	O	939
phosphorylation	O	939
and	O	939
give	O	939
a	O	939
rationale	O	939
for	O	939
treatments	O	939
aimed	O	939
to	O	939
improve	O	939
mitochondrial	O	939
function	O	939
in	O	939
this	O	939
condition	O	939
.	O	939
.	O	939
identification	O	940
of	O	940
a	O	940
novel	O	940
r21x	O	940
mutation	O	940
in	O	940
the	O	940
liver	O	940
-	O	940
type	O	940
arginase	O	940
gene	O	940
(	O	940
arg1	O	940
)	O	940
in	O	940
four	O	940
portuguese	O	940
patients	O	940
with	O	940
argininemia	B-Disease	940
.	O	940
argininemia	B-Disease	941
is	O	941
a	O	941
rare	O	941
autossomal	B-Disease	941
recessive	I-Disease	941
disorder	I-Disease	941
caused	O	941
by	O	941
deficiency	B-Disease	941
in	I-Disease	941
the	I-Disease	941
cytosolic	I-Disease	941
liver	I-Disease	941
-	I-Disease	941
type	I-Disease	941
arginase	I-Disease	941
enzyme	I-Disease	941
(	O	941
l	O	941
-	O	941
arginine	O	941
urea	O	941
-	O	941
hydrolase	O	941
;	O	941
e	O	941
.	O	941
c	O	941
.	O	941
3	O	941
.	O	941
5	O	941
.	O	941
3	O	941
.	O	941
1	O	941
)	O	941
.	O	941
in	O	942
order	O	942
to	O	942
investigate	O	942
the	O	942
molecular	O	942
basis	O	942
for	O	942
argininemia	B-Disease	942
in	O	942
four	O	942
unrelated	O	942
portuguese	O	942
patients	O	942
(	O	942
two	O	942
from	O	942
northern	O	942
portugal	O	942
and	O	942
two	O	942
from	O	942
madeira	O	942
island	O	942
)	O	942
we	O	942
performed	O	942
a	O	942
dna	O	942
sequence	O	942
analysis	O	942
of	O	942
all	O	942
the	O	942
exons	O	942
and	O	942
exon	O	942
/	O	942
intron	O	942
boundaries	O	942
of	O	942
the	O	942
liver	O	942
-	O	942
type	O	942
arginase	O	942
gene	O	942
(	O	942
arg1	O	942
)	O	942
.	O	942
mutation	O	945
of	O	945
the	O	945
sterol	O	945
27	O	945
-	O	945
hydroxylase	O	945
gene	O	945
(	O	945
cyp27	O	945
)	O	945
results	O	945
in	O	945
truncation	O	945
of	O	945
mrna	O	945
expressed	O	945
in	O	945
leucocytes	O	945
in	O	945
a	O	945
japanese	O	945
family	O	945
with	O	945
cerebrotendinous	B-Disease	945
xanthomatosis	I-Disease	945
.	O	945
objectives	O	946
a	O	946
japanese	O	946
family	O	946
with	O	946
cerebrotendinous	B-Disease	946
xanthomatosis	I-Disease	946
(	O	946
ctx	B-Disease	946
)	O	946
was	O	946
investigated	O	946
for	O	946
a	O	946
sequence	O	946
alteration	O	946
in	O	946
the	O	946
sterol	O	946
27	O	946
-	O	946
hydroxylase	O	946
gene	O	946
(	O	946
cyp27	O	946
)	O	946
.	O	946
the	O	954
application	O	954
of	O	954
blood	O	954
leucocytes	O	954
can	O	954
be	O	954
a	O	954
simple	O	954
technique	O	954
on	O	954
analysing	O	954
a	O	954
constructive	O	954
abnormality	B-Disease	954
of	I-Disease	954
cyp27	I-Disease	954
mrna	O	954
.	O	954
.	O	954
clinical	O	955
and	O	955
molecular	O	955
genetic	O	955
analysis	O	955
of	O	955
19	O	955
wolfram	B-Disease	955
syndrome	I-Disease	955
kindreds	O	955
demonstrating	O	955
a	O	955
wide	O	955
spectrum	O	955
of	O	955
mutations	O	955
in	O	955
wfs1	O	955
.	O	955
wolfram	B-Disease	956
syndrome	I-Disease	956
is	O	956
an	O	956
autosomal	B-Disease	956
recessive	I-Disease	956
neurodegenerative	I-Disease	956
disorder	I-Disease	956
characterized	O	956
by	O	956
juvenile	B-Disease	956
-	I-Disease	956
onset	I-Disease	956
diabetes	I-Disease	956
mellitus	I-Disease	956
and	O	956
progressive	O	956
optic	B-Disease	956
atrophy	I-Disease	956
.	O	956
direct	O	958
dna	O	958
sequencing	O	958
was	O	958
done	O	958
to	O	958
screen	O	958
the	O	958
entire	O	958
coding	O	958
region	O	958
of	O	958
the	O	958
wfs1	O	958
gene	O	958
in	O	958
30	O	958
patients	O	958
from	O	958
19	O	958
british	O	958
kindreds	O	958
with	O	958
wolfram	B-Disease	958
syndrome	I-Disease	958
.	O	958
hence	O	967
,	O	967
molecular	O	967
screening	O	967
for	O	967
wolfram	B-Disease	967
syndrome	I-Disease	967
in	O	967
affected	O	967
families	O	967
and	O	967
for	O	967
wolfram	B-Disease	967
syndrome	I-Disease	967
-	O	967
carrier	O	967
status	O	967
in	O	967
subjects	O	967
with	O	967
psychiatric	B-Disease	967
disorders	I-Disease	967
or	O	967
diabetes	B-Disease	967
mellitus	I-Disease	967
will	O	967
require	O	967
complete	O	967
analysis	O	967
of	O	967
exon	O	967
8	O	967
and	O	967
upstream	O	967
exons	O	967
.	O	967
.	O	967
late	O	968
-	O	968
onset	O	968
familial	B-Disease	968
mediterranean	I-Disease	968
fever	I-Disease	968
(	O	968
fmf	B-Disease	968
)	O	968
:	O	968
a	O	968
subset	O	968
with	O	968
distinct	O	968
clinical	O	968
,	O	968
demographic	O	968
,	O	968
and	O	968
molecular	O	968
genetic	O	968
characteristics	O	968
.	O	968
to	O	969
determine	O	969
the	O	969
prevalence	O	969
and	O	969
characterize	O	969
demographic	O	969
,	O	969
clinical	O	969
,	O	969
and	O	969
genetic	O	969
features	O	969
of	O	969
familial	B-Disease	969
mediterranean	I-Disease	969
fever	I-Disease	969
(	O	969
fmf	B-Disease	969
)	O	969
of	O	969
late	O	969
onset	O	969
,	O	969
all	O	969
patients	O	969
experiencing	O	969
their	O	969
first	O	969
fmf	B-Disease	969
attack	O	969
at	O	969
age	O	969
40	O	969
years	O	969
or	O	969
more	O	969
were	O	969
identified	O	969
using	O	969
the	O	969
computerized	O	969
registry	O	969
of	O	969
our	O	969
fmf	B-Disease	969
clinic	O	969
,	O	969
and	O	969
then	O	969
thoroughly	O	969
interviewed	O	969
and	O	969
examined	O	969
.	O	969
the	O	970
control	O	970
group	O	970
consisted	O	970
of	O	970
40	O	970
consecutive	O	970
fmf	B-Disease	970
patients	O	970
,	O	970
who	O	970
arrived	O	970
at	O	970
the	O	970
fmf	B-Disease	970
clinic	O	970
for	O	970
their	O	970
regular	O	970
follow	O	970
-	O	970
up	O	970
visit	O	970
and	O	970
were	O	970
40	O	970
years	O	970
of	O	970
age	O	970
or	O	970
older	O	970
at	O	970
the	O	970
time	O	970
of	O	970
the	O	970
examination	O	970
.	O	970
mutational	O	972
analysis	O	972
in	O	972
the	O	972
fmf	B-Disease	972
gene	O	972
was	O	972
performed	O	972
using	O	972
a	O	972
commercial	O	972
kit	O	972
.	O	972
only	O	973
20	O	973
of	O	973
4000	O	973
(	O	973
0	O	973
.	O	973
5	O	973
%	O	973
)	O	973
patients	O	973
had	O	973
late	O	973
-	O	973
onset	O	973
fmf	B-Disease	973
.	O	973
none	O	978
had	O	978
chronic	O	978
or	O	978
prolonged	O	978
manifestations	O	978
of	O	978
fmf	B-Disease	978
,	O	978
for	O	978
example	O	978
,	O	978
amyloidosis	B-Disease	978
,	O	978
chronic	B-Disease	978
arthritis	I-Disease	978
,	O	978
or	O	978
protracted	O	978
myalgia	B-Disease	978
,	O	978
p	O	978
<	O	978
0	O	978
.	O	978
01	O	985
,	O	985
compared	O	985
to	O	985
our	O	985
regular	O	985
fmf	B-Disease	985
population	O	985
.	O	985
we	O	986
conclude	O	986
that	O	986
the	O	986
onset	O	986
of	O	986
fmf	B-Disease	986
in	O	986
a	O	986
late	O	986
age	O	986
defines	O	986
a	O	986
milder	O	986
form	O	986
of	O	986
disease	O	986
with	O	986
typical	O	986
clinical	O	986
,	O	986
demographic	O	986
,	O	986
and	O	986
molecular	O	986
genetic	O	986
characteristics	O	986
the	O	988
hereditary	B-Disease	988
breast	I-Disease	988
and	I-Disease	988
ovarian	I-Disease	988
cancer	I-Disease	988
syndrome	I-Disease	988
is	O	988
associated	O	988
with	O	988
a	O	988
high	O	988
frequency	O	988
of	O	988
brca1	O	988
mutations	O	988
.	O	988
maternal	B-Disease	997
uniparental	I-Disease	997
disomy	I-Disease	997
for	I-Disease	997
chromosome	I-Disease	997
14	I-Disease	997
in	O	997
a	O	997
boy	O	997
with	O	997
a	O	997
normal	O	997
karyotype	O	997
.	O	997
we	O	998
report	O	998
on	O	998
a	O	998
boy	O	998
with	O	998
a	O	998
maternal	B-Disease	998
uniparental	I-Disease	998
disomy	I-Disease	998
for	I-Disease	998
chromosome	I-Disease	998
14	I-Disease	998
(	O	998
upd	B-Disease	998
(	O	998
14	O	998
)	O	998
)	O	998
.	O	998
at	O	999
7	O	999
years	O	999
of	O	999
age	O	999
he	O	999
was	O	999
referred	O	999
to	O	999
us	O	999
by	O	999
the	O	999
paediatrician	O	999
because	O	999
of	O	999
symptoms	O	999
of	O	999
prader	B-Disease	999
-	I-Disease	999
willi	I-Disease	999
syndrome	I-Disease	999
(	O	999
pws	B-Disease	999
)	O	999
.	O	999
he	O	1000
showed	O	1000
short	B-Disease	1000
stature	I-Disease	1000
,	O	1000
obesity	B-Disease	1000
,	O	1000
mild	O	1000
developmental	B-Disease	1000
delay	I-Disease	1000
,	O	1000
cryptorchidism	B-Disease	1000
,	O	1000
and	O	1000
some	O	1000
mild	O	1000
dysmorphic	B-Disease	1000
features	I-Disease	1000
.	O	1000
the	O	1001
history	O	1001
further	O	1001
indicated	O	1001
intrauterine	B-Disease	1001
growth	I-Disease	1001
retardation	I-Disease	1001
at	O	1001
the	O	1001
end	O	1001
of	O	1001
the	O	1001
pregnancy	O	1001
.	O	1001
after	O	1003
birth	O	1003
he	O	1003
showed	O	1003
hypotonia	B-Disease	1003
with	O	1003
poor	O	1003
sucking	O	1003
,	O	1003
for	O	1003
which	O	1003
gavage	O	1003
feeding	O	1003
was	O	1003
needed	O	1003
.	O	1003
after	O	1005
1	O	1005
year	O	1005
he	O	1005
became	O	1005
obese	B-Disease	1005
despite	O	1005
a	O	1005
normal	O	1005
appetite	O	1005
.	O	1005
recurrent	O	1006
middle	B-Disease	1006
ear	I-Disease	1006
infections	I-Disease	1006
,	O	1006
a	O	1006
high	O	1006
pain	O	1006
threshold	O	1006
,	O	1006
and	O	1006
a	O	1006
great	O	1006
skill	O	1006
with	O	1006
jigsaw	O	1006
puzzles	O	1006
were	O	1006
reported	O	1006
.	O	1006
dna	O	1009
analysis	O	1009
for	O	1009
prader	B-Disease	1009
-	I-Disease	1009
willi	I-Disease	1009
syndrome	I-Disease	1009
showed	O	1009
no	O	1009
abnormalities	O	1009
.	O	1009
two	O	1010
years	O	1010
later	O	1010
he	O	1010
was	O	1010
re	O	1010
-	O	1010
examined	O	1010
because	O	1010
we	O	1010
thought	O	1010
his	O	1010
features	O	1010
fitted	O	1010
the	O	1010
pws	B-Disease	1010
-	O	1010
like	O	1010
phenotype	O	1010
associated	O	1010
with	O	1010
maternal	O	1010
upd	B-Disease	1010
(	O	1010
14	O	1010
)	O	1010
.	O	1010
dna	O	1012
analysis	O	1012
showed	O	1012
maternal	B-Disease	1012
heterodisomy	I-Disease	1012
for	O	1012
chromosome	O	1012
14	O	1012
.	O	1012
in	O	1013
all	O	1013
the	O	1013
previously	O	1013
described	O	1013
11	O	1013
cases	O	1013
with	O	1013
maternal	O	1013
upd	B-Disease	1013
(	O	1013
14	O	1013
)	O	1013
,	O	1013
a	O	1013
robertsonian	O	1013
translocation	O	1013
involving	O	1013
chromosome	O	1013
14	O	1013
was	O	1013
detected	O	1013
cytogenetically	O	1013
before	O	1013
dna	O	1013
analysis	O	1013
.	O	1013
this	O	1014
is	O	1014
the	O	1014
first	O	1014
report	O	1014
of	O	1014
diagnosis	O	1014
of	O	1014
maternal	O	1014
upd	B-Disease	1014
(	O	1014
14	O	1014
)	O	1014
based	O	1014
on	O	1014
clinical	O	1014
features	O	1014
.	O	1014
this	O	1015
finding	O	1015
underlines	O	1015
the	O	1015
importance	O	1015
of	O	1015
dna	O	1015
analysis	O	1015
for	O	1015
maternal	O	1015
upd	O	1015
(	O	1015
14	O	1015
)	O	1015
in	O	1015
patients	O	1015
with	O	1015
a	O	1015
similar	O	1015
pws	B-Disease	1015
-	O	1015
like	O	1015
phenotype	O	1015
even	O	1015
without	O	1015
previous	O	1015
identification	O	1015
of	O	1015
a	O	1015
robertsonian	O	1015
translocation	O	1015
involving	O	1015
chromosome	O	1015
14	O	1015
.	O	1015
.	O	1015
clinical	O	1016
and	O	1016
genetic	O	1016
study	O	1016
of	O	1016
friedreich	B-Disease	1016
ataxia	I-Disease	1016
in	O	1016
an	O	1016
australian	O	1016
population	O	1016
.	O	1016
friedreich	B-Disease	1017
ataxia	I-Disease	1017
is	O	1017
an	O	1017
autosomal	B-Disease	1017
recessive	I-Disease	1017
disorder	I-Disease	1017
caused	O	1017
by	O	1017
mutations	O	1017
in	O	1017
the	O	1017
frda	B-Disease	1017
gene	O	1017
that	O	1017
encodes	O	1017
a	O	1017
210	O	1017
-	O	1017
amino	O	1017
acid	O	1017
protein	O	1017
called	O	1017
frataxin	O	1017
.	O	1017
we	O	1021
found	O	1021
a	O	1021
correlation	O	1021
between	O	1021
the	O	1021
size	O	1021
of	O	1021
the	O	1021
smaller	O	1021
of	O	1021
the	O	1021
two	O	1021
expanded	O	1021
alleles	O	1021
and	O	1021
age	O	1021
at	O	1021
onset	O	1021
,	O	1021
age	O	1021
into	O	1021
wheelchair	O	1021
,	O	1021
scoliosis	B-Disease	1021
,	O	1021
impaired	O	1021
vibration	O	1021
sense	O	1021
,	O	1021
and	O	1021
the	O	1021
presence	O	1021
of	O	1021
foot	B-Disease	1021
deformity	I-Disease	1021
.	O	1021
there	O	1022
was	O	1022
no	O	1022
significant	O	1022
correlation	O	1022
between	O	1022
the	O	1022
size	O	1022
of	O	1022
the	O	1022
smaller	O	1022
allele	O	1022
and	O	1022
cardiomyopathy	B-Disease	1022
,	O	1022
diabetes	B-Disease	1022
mellitus	I-Disease	1022
,	O	1022
loss	B-Disease	1022
of	I-Disease	1022
proprioception	I-Disease	1022
,	O	1022
or	O	1022
bladder	B-Disease	1022
symptoms	I-Disease	1022
.	O	1022
the	O	1023
larger	O	1023
allele	O	1023
size	O	1023
correlated	O	1023
with	O	1023
bladder	B-Disease	1023
symptoms	I-Disease	1023
and	O	1023
the	O	1023
presence	O	1023
of	O	1023
foot	B-Disease	1023
deformity	I-Disease	1023
.	O	1023
the	O	1024
duration	O	1024
of	O	1024
disease	O	1024
is	O	1024
correlated	O	1024
with	O	1024
wheelchair	O	1024
use	O	1024
and	O	1024
the	O	1024
presence	O	1024
of	O	1024
diabetes	B-Disease	1024
,	O	1024
scoliosis	B-Disease	1024
,	O	1024
bladder	B-Disease	1024
symptoms	I-Disease	1024
and	O	1024
impaired	B-Disease	1024
proprioception	I-Disease	1024
,	O	1024
and	O	1024
vibration	O	1024
sense	O	1024
but	O	1024
no	O	1024
other	O	1024
complications	O	1024
studied	O	1024
.	O	1024
.	O	1024
novel	O	1025
mutations	O	1025
in	O	1025
xlrs1	O	1025
causing	O	1025
retinoschisis	B-Disease	1025
,	O	1025
including	O	1025
first	O	1025
evidence	O	1025
of	O	1025
putative	O	1025
leader	O	1025
sequence	O	1025
change	O	1025
.	O	1025
juvenile	B-Disease	1026
retinoschisis	I-Disease	1026
is	O	1026
an	O	1026
x	B-Disease	1026
-	I-Disease	1026
linked	I-Disease	1026
recessive	I-Disease	1026
disease	I-Disease	1026
caused	O	1026
by	O	1026
mutations	O	1026
in	O	1026
the	O	1026
xlrs1	O	1026
gene	O	1026
.	O	1026
we	O	1027
screened	O	1027
31	O	1027
new	O	1027
unrelated	O	1027
patients	O	1027
and	O	1027
families	O	1027
for	O	1027
xlrs1	O	1027
mutations	O	1027
in	O	1027
addition	O	1027
to	O	1027
previously	O	1027
reported	O	1027
mutations	O	1027
for	O	1027
60	O	1027
of	O	1027
our	O	1027
families	O	1027
(	O	1027
retinoschisis	B-Disease	1027
consortium	O	1027
,	O	1027
hum	O	1027
mol	O	1027
genet	O	1027
1998	O	1027
;	O	1027
7	O	1027
1185	O	1027
-	O	1027
1192	O	1027
)	O	1027
.	O	1027
growth	O	1034
hormone	O	1034
treatment	O	1034
increases	O	1034
co	O	1034
(	O	1034
2	O	1034
)	O	1034
response	O	1034
,	O	1034
ventilation	O	1034
and	O	1034
central	O	1034
inspiratory	O	1034
drive	O	1034
in	O	1034
children	O	1034
with	O	1034
prader	B-Disease	1034
-	I-Disease	1034
willi	I-Disease	1034
syndrome	I-Disease	1034
.	O	1034
we	O	1035
studied	O	1035
whether	O	1035
the	O	1035
beneficial	O	1035
effects	O	1035
of	O	1035
growth	O	1035
hormone	O	1035
(	O	1035
gh	O	1035
)	O	1035
treatment	O	1035
on	O	1035
growth	O	1035
and	O	1035
body	O	1035
composition	O	1035
in	O	1035
pws	B-Disease	1035
are	O	1035
accompanied	O	1035
by	O	1035
an	O	1035
improvement	O	1035
in	O	1035
respiratory	O	1035
function	O	1035
.	O	1035
conclusion	O	1039
treatment	O	1039
of	O	1039
children	O	1039
with	O	1039
prader	B-Disease	1039
-	I-Disease	1039
willi	I-Disease	1039
syndrome	I-Disease	1039
(	O	1039
pws	B-Disease	1039
)	O	1039
seems	O	1039
to	O	1039
have	O	1039
a	O	1039
stimulatory	O	1039
effect	O	1039
on	O	1039
central	O	1039
respiratory	O	1039
structures	O	1039
.	O	1039
the	O	1040
observed	O	1040
increase	O	1040
in	O	1040
ventilation	O	1040
and	O	1040
inspiratory	O	1040
drive	O	1040
may	O	1040
contribute	O	1040
to	O	1040
the	O	1040
improved	O	1040
activity	O	1040
level	O	1040
reported	O	1040
by	O	1040
parents	O	1040
of	O	1040
pws	B-Disease	1040
children	O	1040
during	O	1040
growth	O	1040
hormone	O	1040
therapy	O	1040
g130v	O	1041
,	O	1041
a	O	1041
common	O	1041
frda	B-Disease	1041
point	O	1041
mutation	O	1041
,	O	1041
appears	O	1041
to	O	1041
have	O	1041
arisen	O	1041
from	O	1041
a	O	1041
common	O	1041
founder	O	1041
.	O	1041
friedreich	B-Disease	1042
ataxia	I-Disease	1042
(	O	1042
frda	B-Disease	1042
)	O	1042
is	O	1042
the	O	1042
most	O	1042
common	O	1042
inherited	B-Disease	1042
ataxia	I-Disease	1042
.	O	1042
g130v	O	1047
,	O	1047
when	O	1047
present	O	1047
with	O	1047
an	O	1047
expanded	O	1047
gaa	O	1047
repeat	O	1047
on	O	1047
the	O	1047
other	O	1047
allele	O	1047
,	O	1047
is	O	1047
associated	O	1047
with	O	1047
an	O	1047
atypical	O	1047
frda	B-Disease	1047
phenotype	O	1047
.	O	1047
most	O	1052
fragile	B-Disease	1052
x	I-Disease	1052
syndrome	I-Disease	1052
patients	O	1052
have	O	1052
expansion	O	1052
of	O	1052
a	O	1052
(	O	1052
cgg	O	1052
)	O	1052
(	O	1052
n	O	1052
)	O	1052
sequence	O	1052
with	O	1052
>	O	1052
200	O	1052
repeats	O	1052
(	O	1052
full	O	1052
mutation	O	1052
)	O	1052
in	O	1052
the	O	1052
fmr1	O	1052
gene	O	1052
responsible	O	1052
for	O	1052
this	O	1052
condition	O	1052
.	O	1052
constitutional	O	1058
von	B-Disease	1058
hippel	I-Disease	1058
-	I-Disease	1058
lindau	I-Disease	1058
(	O	1058
vhl	B-Disease	1058
)	O	1058
gene	O	1058
deletions	O	1058
detected	O	1058
in	O	1058
vhl	B-Disease	1058
families	O	1058
by	O	1058
fluorescence	O	1058
in	O	1058
situ	O	1058
hybridization	O	1058
.	O	1058
von	B-Disease	1059
hippel	I-Disease	1059
-	I-Disease	1059
lindau	I-Disease	1059
(	I-Disease	1059
vhl	I-Disease	1059
)	I-Disease	1059
disease	I-Disease	1059
is	O	1059
an	O	1059
autosomal	B-Disease	1059
dominantly	I-Disease	1059
inherited	I-Disease	1059
cancer	I-Disease	1059
syndrome	I-Disease	1059
predisposing	O	1059
to	O	1059
a	O	1059
variety	O	1059
of	O	1059
tumor	B-Disease	1059
types	O	1059
that	O	1059
include	O	1059
retinal	O	1059
hemangioblastomas	B-Disease	1059
,	O	1059
hemangioblastomas	B-Disease	1059
of	O	1059
the	O	1059
central	O	1059
nervous	O	1059
system	O	1059
,	O	1059
renal	B-Disease	1059
cell	I-Disease	1059
carcinomas	I-Disease	1059
,	O	1059
pancreatic	B-Disease	1059
cysts	I-Disease	1059
and	I-Disease	1059
tumors	I-Disease	1059
,	O	1059
pheochromocytomas	B-Disease	1059
,	O	1059
endolymphatic	B-Disease	1059
sac	I-Disease	1059
tumors	I-Disease	1059
,	O	1059
and	O	1059
epididymal	B-Disease	1059
cystadenomas	I-Disease	1059
[	O	1059
w	O	1059
.	O	1059
the	O	1064
vhl	B-Disease	1064
gene	O	1064
was	O	1064
localized	O	1064
to	O	1064
chromosome	O	1064
3p25	O	1064
-	O	1064
26	O	1064
and	O	1064
cloned	O	1064
[	O	1064
f	O	1064
.	O	1064
latif	O	1064
et	O	1064
al	O	1064
.	O	1064
,	O	1064
science	O	1064
(	O	1064
washington	O	1064
dc	O	1064
)	O	1064
,	O	1064
260	O	1064
1317	O	1064
-	O	1064
1320	O	1064
,	O	1064
1993	O	1064
]	O	1064
.	O	1064
germline	O	1065
mutations	O	1065
in	O	1065
the	O	1065
vhl	B-Disease	1065
gene	O	1065
have	O	1065
been	O	1065
detected	O	1065
in	O	1065
the	O	1065
majority	O	1065
of	O	1065
vhl	B-Disease	1065
kindreds	O	1065
.	O	1065
the	O	1066
reported	O	1066
frequency	O	1066
of	O	1066
detection	O	1066
of	O	1066
vhl	B-Disease	1066
germline	O	1066
mutations	O	1066
has	O	1066
varied	O	1066
from	O	1066
39	O	1066
to	O	1066
80	O	1066
%	O	1066
(	O	1066
j	O	1066
.	O	1066
m	O	1066
.	O	1066
whaley	O	1066
et	O	1066
al	O	1066
.	O	1066
,	O	1066
am	O	1066
.	O	1066
j	O	1066
.	O	1066
hum	O	1066
.	O	1066
genet	O	1066
.	O	1066
,	O	1066
55	O	1066
1092	O	1066
-	O	1066
1102	O	1066
,	O	1066
1994	O	1066
;	O	1066
clinical	O	1066
research	O	1066
group	O	1066
for	O	1066
japan	O	1066
,	O	1066
hum	O	1066
.	O	1066
mol	O	1066
.	O	1066
genet	O	1066
.	O	1066
,	O	1066
4	O	1066
2233	O	1066
-	O	1066
2237	O	1066
,	O	1066
1995	O	1066
;	O	1066
f	O	1066
.	O	1066
chen	O	1066
et	O	1066
al	O	1066
.	O	1066
,	O	1066
hum	O	1066
.	O	1066
mutat	O	1066
.	O	1066
,	O	1066
5	O	1066
66	O	1066
-	O	1066
75	O	1066
,	O	1066
1995	O	1066
;	O	1066
e	O	1066
.	O	1066
r	O	1066
.	O	1066
maher	O	1066
et	O	1066
al	O	1066
.	O	1066
,	O	1066
j	O	1066
.	O	1066
med	O	1066
.	O	1066
genet	O	1066
.	O	1066
,	O	1066
33	O	1066
328	O	1066
-	O	1066
332	O	1066
,	O	1066
1996	O	1066
;	O	1066
b	O	1066
.	O	1066
zbar	O	1066
,	O	1066
cancer	O	1066
surv	O	1066
.	O	1066
,	O	1066
25	O	1066
219	O	1066
-	O	1066
232	O	1066
,	O	1066
1995	O	1066
)	O	1066
.	O	1066
in	O	1068
the	O	1068
present	O	1068
study	O	1068
,	O	1068
we	O	1068
report	O	1068
the	O	1068
use	O	1068
of	O	1068
fluorescence	O	1068
in	O	1068
situ	O	1068
hybridization	O	1068
(	O	1068
fish	O	1068
)	O	1068
as	O	1068
a	O	1068
method	O	1068
to	O	1068
detect	O	1068
and	O	1068
characterize	O	1068
vhl	B-Disease	1068
germline	O	1068
deletions	O	1068
.	O	1068
we	O	1069
reexamined	O	1069
a	O	1069
group	O	1069
of	O	1069
vhl	B-Disease	1069
patients	O	1069
shown	O	1069
previously	O	1069
by	O	1069
single	O	1069
-	O	1069
strand	O	1069
conformation	O	1069
and	O	1069
sequencing	O	1069
analysis	O	1069
not	O	1069
to	O	1069
harbor	O	1069
point	O	1069
mutations	O	1069
in	O	1069
the	O	1069
vhl	B-Disease	1069
locus	O	1069
.	O	1069
we	O	1070
found	O	1070
constitutional	O	1070
deletions	O	1070
in	O	1070
29	O	1070
of	O	1070
30	O	1070
vhl	B-Disease	1070
patients	O	1070
in	O	1070
this	O	1070
group	O	1070
using	O	1070
cosmid	O	1070
and	O	1070
p1	O	1070
probes	O	1070
that	O	1070
cover	O	1070
the	O	1070
vhl	B-Disease	1070
locus	O	1070
.	O	1070
we	O	1071
then	O	1071
tested	O	1071
six	O	1071
phenotypically	O	1071
normal	O	1071
offspring	O	1071
from	O	1071
four	O	1071
of	O	1071
these	O	1071
vhl	B-Disease	1071
families	O	1071
two	O	1071
were	O	1071
found	O	1071
to	O	1071
carry	O	1071
the	O	1071
deletion	O	1071
and	O	1071
the	O	1071
other	O	1071
four	O	1071
were	O	1071
deletion	O	1071
-	O	1071
free	O	1071
.	O	1071
in	O	1072
addition	O	1072
,	O	1072
germline	O	1072
mosaicism	O	1072
of	O	1072
the	O	1072
vhl	B-Disease	1072
gene	O	1072
was	O	1072
identified	O	1072
in	O	1072
one	O	1072
family	O	1072
.	O	1072
in	O	1073
sum	O	1073
,	O	1073
fish	O	1073
was	O	1073
found	O	1073
to	O	1073
be	O	1073
a	O	1073
simple	O	1073
and	O	1073
reliable	O	1073
method	O	1073
to	O	1073
detect	O	1073
vhl	B-Disease	1073
germline	O	1073
deletions	O	1073
and	O	1073
practically	O	1073
useful	O	1073
in	O	1073
cases	O	1073
where	O	1073
other	O	1073
methods	O	1073
of	O	1073
screening	O	1073
have	O	1073
failed	O	1073
to	O	1073
detect	O	1073
a	O	1073
vhl	B-Disease	1073
gene	I-Disease	1073
abnormality	I-Disease	1073
spectrum	O	1074
of	O	1074
hsnf5	O	1074
/	O	1074
ini1	O	1074
somatic	O	1074
mutations	O	1074
in	O	1074
human	O	1074
cancer	B-Disease	1074
and	O	1074
genotype	O	1074
-	O	1074
phenotype	O	1074
correlations	O	1074
.	O	1074
the	O	1075
hsnf5	O	1075
/	O	1075
ini1	O	1075
gene	O	1075
which	O	1075
encodes	O	1075
a	O	1075
member	O	1075
of	O	1075
the	O	1075
swi	O	1075
/	O	1075
snf	O	1075
chromatin	O	1075
atp	O	1075
-	O	1075
dependent	O	1075
remodeling	O	1075
complex	O	1075
,	O	1075
is	O	1075
a	O	1075
new	O	1075
tumor	B-Disease	1075
suppressor	O	1075
gene	O	1075
localized	O	1075
on	O	1075
chromosome	O	1075
22q11	O	1075
.	O	1075
2	O	1076
and	O	1076
recently	O	1076
shown	O	1076
to	O	1076
be	O	1076
mutated	O	1076
in	O	1076
malignant	B-Disease	1076
rhabdoid	I-Disease	1076
tumors	I-Disease	1076
.	O	1076
we	O	1077
have	O	1077
searched	O	1077
for	O	1077
hsnf5	O	1077
/	O	1077
ini1	O	1077
mutations	O	1077
in	O	1077
229	O	1077
tumors	B-Disease	1077
of	O	1077
various	O	1077
origins	O	1077
using	O	1077
a	O	1077
screening	O	1077
method	O	1077
based	O	1077
on	O	1077
denaturing	O	1077
high	O	1077
-	O	1077
performance	O	1077
liquid	O	1077
chromatography	O	1077
.	O	1077
mutations	O	1080
were	O	1080
retrieved	O	1080
in	O	1080
most	O	1080
rhabdoid	B-Disease	1080
tumors	I-Disease	1080
,	O	1080
whatever	O	1080
their	O	1080
sites	O	1080
of	O	1080
occurrence	O	1080
,	O	1080
indicating	O	1080
the	O	1080
common	O	1080
pathogenetic	O	1080
origin	O	1080
of	O	1080
these	O	1080
tumors	B-Disease	1080
.	O	1080
recurrent	O	1081
hsnf5	O	1081
/	O	1081
ini1	O	1081
alterations	O	1081
were	O	1081
also	O	1081
observed	O	1081
in	O	1081
choroid	B-Disease	1081
plexus	I-Disease	1081
carcinomas	I-Disease	1081
and	O	1081
in	O	1081
a	O	1081
subset	O	1081
of	O	1081
central	O	1081
primitive	O	1081
neuroectodermal	B-Disease	1081
tumors	I-Disease	1081
(	O	1081
cpnets	O	1081
)	O	1081
and	O	1081
medulloblastomas	B-Disease	1081
.	O	1081
in	O	1082
contrast	O	1082
,	O	1082
hsnf5	O	1082
/	O	1082
ini1	O	1082
point	O	1082
mutations	O	1082
were	O	1082
not	O	1082
detected	O	1082
in	O	1082
breast	B-Disease	1082
cancers	I-Disease	1082
,	O	1082
wilms	B-Disease	1082
tumors	I-Disease	1082
,	O	1082
gliomas	B-Disease	1082
,	O	1082
ependymomas	B-Disease	1082
,	O	1082
sarcomas	B-Disease	1082
and	O	1082
other	O	1082
tumor	B-Disease	1082
types	O	1082
,	O	1082
even	O	1082
though	O	1082
most	O	1082
analyzed	O	1082
cases	O	1082
harbored	O	1082
loss	O	1082
of	O	1082
heterozygosity	O	1082
at	O	1082
22q11	O	1082
.	O	1082
these	O	1084
results	O	1084
suggest	O	1084
that	O	1084
rhabdoid	B-Disease	1084
tumors	I-Disease	1084
,	O	1084
choroid	B-Disease	1084
plexus	I-Disease	1084
carcinomas	I-Disease	1084
and	O	1084
a	O	1084
subset	O	1084
of	O	1084
medulloblastomas	B-Disease	1084
and	O	1084
cpnets	O	1084
share	O	1084
common	O	1084
pathways	O	1084
of	O	1084
oncogenesis	O	1084
related	O	1084
to	O	1084
hsnf5	O	1084
/	O	1084
ini1	O	1084
alteration	O	1084
and	O	1084
that	O	1084
hsnf5	O	1084
/	O	1084
ini1	O	1084
mutations	O	1084
define	O	1084
a	O	1084
genetically	O	1084
homogeneous	O	1084
family	O	1084
of	O	1084
highly	O	1084
aggressive	O	1084
cancers	B-Disease	1084
mainly	O	1084
occurring	O	1084
in	O	1084
young	O	1084
children	O	1084
and	O	1084
frequently	O	1084
,	O	1084
but	O	1084
not	O	1084
always	O	1084
,	O	1084
exhibiting	O	1084
a	O	1084
rhabdoid	B-Disease	1084
phenotype	O	1084
spinocerebellar	B-Disease	1086
ataxia	I-Disease	1086
type	I-Disease	1086
-	I-Disease	1086
3	I-Disease	1086
or	O	1086
machado	B-Disease	1086
-	I-Disease	1086
joseph	I-Disease	1086
disease	I-Disease	1086
(	O	1086
sca3	B-Disease	1086
/	O	1086
mjd	B-Disease	1086
)	O	1086
is	O	1086
a	O	1086
member	O	1086
of	O	1086
the	O	1086
cag	B-Disease	1086
/	I-Disease	1086
polyglutamine	I-Disease	1086
repeat	I-Disease	1086
disease	I-Disease	1086
family	O	1086
.	O	1086
experimental	O	1088
models	O	1088
of	O	1088
polyglutamine	B-Disease	1088
disease	I-Disease	1088
implicate	O	1088
the	O	1088
nucleus	O	1088
in	O	1088
pathogenesis	O	1088
;	O	1088
however	O	1088
,	O	1088
the	O	1088
link	O	1088
between	O	1088
intranuclear	O	1088
expression	O	1088
of	O	1088
expanded	O	1088
polyglutamine	O	1088
and	O	1088
neuronal	B-Disease	1088
dysfunction	I-Disease	1088
remains	O	1088
unclear	O	1088
.	O	1088
here	O	1089
we	O	1089
demonstrate	O	1089
that	O	1089
ataxin	O	1089
-	O	1089
3	O	1089
,	O	1089
the	O	1089
disease	O	1089
protein	O	1089
in	O	1089
sca3	B-Disease	1089
/	O	1089
mjd	B-Disease	1089
,	O	1089
adopts	O	1089
a	O	1089
unique	O	1089
conformation	O	1089
when	O	1089
expressed	O	1089
within	O	1089
the	O	1089
nucleus	O	1089
of	O	1089
transfected	O	1089
cells	O	1089
.	O	1089
these	O	1095
data	O	1095
suggest	O	1095
that	O	1095
an	O	1095
early	O	1095
event	O	1095
in	O	1095
the	O	1095
pathogenesis	O	1095
of	O	1095
sca3	B-Disease	1095
/	O	1095
mjd	B-Disease	1095
may	O	1095
be	O	1095
an	O	1095
altered	O	1095
conformation	O	1095
of	O	1095
ataxin	O	1095
-	O	1095
3	O	1095
within	O	1095
the	O	1095
nucleus	O	1095
that	O	1095
exposes	O	1095
the	O	1095
polyglutamine	O	1095
domain	O	1095
.	O	1095
.	O	1095
the	O	1096
human	O	1096
magel2	O	1096
gene	O	1096
and	O	1096
its	O	1096
mouse	O	1096
homologue	O	1096
are	O	1096
paternally	O	1096
expressed	O	1096
and	O	1096
mapped	O	1096
to	O	1096
the	O	1096
prader	B-Disease	1096
-	I-Disease	1096
willi	I-Disease	1096
region	O	1096
.	O	1096
prader	B-Disease	1097
-	I-Disease	1097
willi	I-Disease	1097
syndrome	I-Disease	1097
(	O	1097
pws	B-Disease	1097
)	O	1097
is	O	1097
a	O	1097
complex	O	1097
neurogenetic	B-Disease	1097
disorder	I-Disease	1097
.	O	1097
the	O	1098
phenotype	O	1098
is	O	1098
likely	O	1098
to	O	1098
be	O	1098
a	O	1098
contiguous	B-Disease	1098
gene	I-Disease	1098
syndrome	I-Disease	1098
involving	O	1098
genes	O	1098
which	O	1098
are	O	1098
paternally	O	1098
expressed	O	1098
only	O	1098
,	O	1098
located	O	1098
in	O	1098
the	O	1098
human	O	1098
15q11	O	1098
-	O	1098
q13	O	1098
region	O	1098
.	O	1098
four	O	1099
mouse	O	1099
models	O	1099
of	O	1099
pws	B-Disease	1099
have	O	1099
been	O	1099
reported	O	1099
but	O	1099
these	O	1099
do	O	1099
not	O	1099
definitively	O	1099
allow	O	1099
the	O	1099
delineation	O	1099
of	O	1099
the	O	1099
critical	O	1099
region	O	1099
and	O	1099
the	O	1099
associated	O	1099
genes	O	1099
involved	O	1099
in	O	1099
the	O	1099
aetiology	O	1099
of	O	1099
pws	B-Disease	1099
.	O	1099
moreover	O	1100
,	O	1100
targeted	O	1100
mutagenesis	O	1100
of	O	1100
mouse	O	1100
homologues	O	1100
of	O	1100
the	O	1100
human	O	1100
candidate	O	1100
pws	B-Disease	1100
genes	O	1100
does	O	1100
not	O	1100
appear	O	1100
to	O	1100
result	O	1100
in	O	1100
any	O	1100
of	O	1100
the	O	1100
features	O	1100
of	O	1100
pws	B-Disease	1100
.	O	1100
therefore	O	1101
,	O	1101
the	O	1101
isolation	O	1101
of	O	1101
new	O	1101
genes	O	1101
in	O	1101
this	O	1101
region	O	1101
remains	O	1101
crucial	O	1101
for	O	1101
a	O	1101
better	O	1101
understanding	O	1101
of	O	1101
the	O	1101
molecular	O	1101
basis	O	1101
of	O	1101
pws	B-Disease	1101
.	O	1101
moreover	O	1107
,	O	1107
magel2	O	1107
/	O	1107
magel2	O	1107
are	O	1107
expressed	O	1107
only	O	1107
from	O	1107
the	O	1107
paternal	O	1107
allele	O	1107
in	O	1107
brain	O	1107
,	O	1107
suggesting	O	1107
a	O	1107
potential	O	1107
role	O	1107
in	O	1107
the	O	1107
aetiology	O	1107
of	O	1107
pws	B-Disease	1107
and	O	1107
its	O	1107
mouse	O	1107
model	O	1107
,	O	1107
respectively	O	1107
.	O	1107
.	O	1107
alveolar	B-Disease	1109
rhabdomyosarcoma	I-Disease	1109
is	O	1109
an	O	1109
aggressive	O	1109
pediatric	B-Disease	1109
cancer	I-Disease	1109
of	I-Disease	1109
striated	I-Disease	1109
muscle	I-Disease	1109
characterized	O	1109
in	O	1109
60	O	1109
%	O	1109
of	O	1109
cases	O	1109
by	O	1109
a	O	1109
t	O	1109
(	O	1109
2	O	1109
;	O	1109
13	O	1109
)	O	1109
(	O	1109
q35	O	1109
;	O	1109
q14	O	1109
)	O	1109
.	O	1109
relevance	O	1115
of	O	1115
this	O	1115
model	O	1115
was	O	1115
suggested	O	1115
by	O	1115
verification	O	1115
that	O	1115
three	O	1115
of	O	1115
these	O	1115
genes	O	1115
(	O	1115
igfbp5	O	1115
,	O	1115
hsix1	O	1115
,	O	1115
and	O	1115
slug	O	1115
)	O	1115
were	O	1115
also	O	1115
expressed	O	1115
in	O	1115
alveolar	B-Disease	1115
rhabdomyosarcoma	I-Disease	1115
cell	O	1115
lines	O	1115
.	O	1115
experimental	O	1117
hemochromatosis	B-Disease	1117
due	O	1117
to	O	1117
mhc	O	1117
class	O	1117
i	O	1117
hfe	B-Disease	1117
deficiency	I-Disease	1117
:	O	1117
immune	O	1117
status	O	1117
and	O	1117
iron	O	1117
metabolism	O	1117
.	O	1117
the	O	1118
puzzling	O	1118
linkage	O	1118
between	O	1118
genetic	O	1118
hemochromatosis	B-Disease	1118
and	O	1118
histocompatibility	O	1118
loci	O	1118
became	O	1118
even	O	1118
more	O	1118
so	O	1118
when	O	1118
the	O	1118
gene	O	1118
involved	O	1118
,	O	1118
hfe	O	1118
,	O	1118
was	O	1118
identified	O	1118
.	O	1118
hfe	B-Disease	1122
-	I-Disease	1122
deficient	I-Disease	1122
animals	O	1122
were	O	1122
analyzed	O	1122
for	O	1122
a	O	1122
comprehensive	O	1122
set	O	1122
of	O	1122
metabolic	O	1122
and	O	1122
immune	O	1122
parameters	O	1122
.	O	1122
faithfully	O	1123
mimicking	O	1123
human	O	1123
hemochromatosis	B-Disease	1123
,	O	1123
mice	O	1123
homozygous	O	1123
for	O	1123
this	O	1123
deletion	O	1123
develop	O	1123
iron	O	1123
overload	O	1123
,	O	1123
characterized	O	1123
by	O	1123
a	O	1123
higher	O	1123
plasma	O	1123
iron	O	1123
content	O	1123
and	O	1123
a	O	1123
raised	O	1123
transferrin	O	1123
saturation	O	1123
as	O	1123
well	O	1123
as	O	1123
an	O	1123
elevated	O	1123
hepatic	O	1123
iron	O	1123
load	O	1123
.	O	1123
ataxia	B-Disease	1128
-	I-Disease	1128
telangiectasia	I-Disease	1128
is	O	1128
a	O	1128
rare	O	1128
genetic	B-Disease	1128
disorder	I-Disease	1128
associated	O	1128
with	O	1128
immune	B-Disease	1128
deficiency	I-Disease	1128
,	O	1128
chromosome	B-Disease	1128
instability	I-Disease	1128
,	O	1128
and	O	1128
a	O	1128
predisposition	O	1128
to	O	1128
lymphoid	B-Disease	1128
malignancy	I-Disease	1128
.	O	1128
these	O	1132
findings	O	1132
as	O	1132
well	O	1132
as	O	1132
data	O	1132
obtained	O	1132
by	O	1132
others	O	1132
for	O	1132
patients	O	1132
with	O	1132
ataxia	B-Disease	1132
-	I-Disease	1132
telangiectasia	I-Disease	1132
suggest	O	1132
that	O	1132
structural	O	1132
rearrangement	O	1132
of	O	1132
14q	O	1132
is	O	1132
the	O	1132
initial	O	1132
chromosomal	O	1132
change	O	1132
in	O	1132
lymphocyte	O	1132
clones	O	1132
of	O	1132
patients	O	1132
with	O	1132
this	O	1132
disorder	O	1132
.	O	1132
chromosomes	O	1133
of	O	1133
lymphocytes	O	1133
from	O	1133
one	O	1133
of	O	1133
the	O	1133
patients	O	1133
were	O	1133
studied	O	1133
before	O	1133
and	O	1133
after	O	1133
the	O	1133
onset	O	1133
of	O	1133
chronic	B-Disease	1133
lymphocytic	I-Disease	1133
leukemia	I-Disease	1133
.	O	1133
before	O	1134
leukemia	B-Disease	1134
was	O	1134
diagnosed	O	1134
,	O	1134
the	O	1134
patient	O	1134
had	O	1134
a	O	1134
lymphocyte	O	1134
clone	O	1134
with	O	1134
a	O	1134
14q	O	1134
translocation	O	1134
.	O	1134
this	O	1135
clone	O	1135
appears	O	1135
to	O	1135
have	O	1135
given	O	1135
rise	O	1135
to	O	1135
the	O	1135
leukemic	B-Disease	1135
cells	O	1135
.	O	1135
we	O	1136
hypothesize	O	1136
that	O	1136
structural	O	1136
rearrangement	O	1136
of	O	1136
14q	O	1136
is	O	1136
directly	O	1136
related	O	1136
to	O	1136
abnormal	O	1136
growth	O	1136
of	O	1136
lymphocytes	O	1136
and	O	1136
that	O	1136
it	O	1136
may	O	1136
be	O	1136
a	O	1136
step	O	1136
toward	O	1136
the	O	1136
development	O	1136
of	O	1136
lymphoid	B-Disease	1136
malignancies	I-Disease	1136
.	O	1136
increasing	O	1137
evidence	O	1137
,	O	1137
provided	O	1137
by	O	1137
others	O	1137
,	O	1137
for	O	1137
the	O	1137
nonrandom	O	1137
involvement	O	1137
of	O	1137
14q	O	1137
in	O	1137
african	O	1137
-	O	1137
type	O	1137
burkitts	B-Disease	1137
lymphoma	I-Disease	1137
and	O	1137
other	O	1137
lymphoid	B-Disease	1137
neoplasms	I-Disease	1137
further	O	1137
strengthens	O	1137
this	O	1137
hypothesis	O	1137
.	O	1137
.	O	1137
exon	O	1138
9	O	1138
mutations	O	1138
in	O	1138
the	O	1138
wt1	O	1138
gene	O	1138
,	O	1138
without	O	1138
influencing	O	1138
kts	O	1138
splice	O	1138
isoforms	O	1138
,	O	1138
are	O	1138
also	O	1138
responsible	O	1138
for	O	1138
frasier	B-Disease	1138
syndrome	I-Disease	1138
.	O	1138
we	O	1139
report	O	1139
new	O	1139
mutations	O	1139
in	O	1139
exon	O	1139
9	O	1139
of	O	1139
the	O	1139
wt1	O	1139
gene	O	1139
that	O	1139
did	O	1139
not	O	1139
alter	O	1139
the	O	1139
ratio	O	1139
of	O	1139
+	O	1139
/	O	1139
-	O	1139
kts	O	1139
splice	O	1139
isoforms	O	1139
in	O	1139
two	O	1139
unrelated	O	1139
patients	O	1139
with	O	1139
frasier	B-Disease	1139
syndrome	I-Disease	1139
(	O	1139
fs	B-Disease	1139
)	O	1139
.	O	1139
the	O	1141
mutations	O	1141
found	O	1141
in	O	1141
our	O	1141
cases	O	1141
occurred	O	1141
in	O	1141
the	O	1141
same	O	1141
exon	O	1141
of	O	1141
the	O	1141
wt1	O	1141
gene	O	1141
as	O	1141
detected	O	1141
in	O	1141
denys	B-Disease	1141
-	I-Disease	1141
drash	I-Disease	1141
syndrome	I-Disease	1141
(	O	1141
dds	B-Disease	1141
)	O	1141
and	O	1141
could	O	1141
not	O	1141
be	O	1141
explained	O	1141
by	O	1141
the	O	1141
previously	O	1141
proposed	O	1141
mechanism	O	1141
.	O	1141
the	O	1142
results	O	1142
suggest	O	1142
that	O	1142
the	O	1142
two	O	1142
syndromes	O	1142
originate	O	1142
from	O	1142
the	O	1142
same	O	1142
wt1	B-Disease	1142
gene	I-Disease	1142
abnormality	I-Disease	1142
.	O	1142
from	O	1143
a	O	1143
molecular	O	1143
biological	O	1143
point	O	1143
of	O	1143
view	O	1143
,	O	1143
we	O	1143
concluded	O	1143
that	O	1143
the	O	1143
two	O	1143
diseases	O	1143
were	O	1143
not	O	1143
separable	O	1143
,	O	1143
and	O	1143
that	O	1143
fs	B-Disease	1143
should	O	1143
be	O	1143
included	O	1143
as	O	1143
an	O	1143
atypical	O	1143
form	O	1143
of	O	1143
dds	B-Disease	1143
.	O	1143
.	O	1143
splice	O	1144
-	O	1144
site	O	1144
mutation	O	1144
in	O	1144
the	O	1144
pds	B-Disease	1144
gene	O	1144
may	O	1144
result	O	1144
in	O	1144
intrafamilial	O	1144
variability	O	1144
for	O	1144
deafness	B-Disease	1144
in	O	1144
pendred	B-Disease	1144
syndrome	I-Disease	1144
.	O	1144
pendred	B-Disease	1145
syndrome	I-Disease	1145
is	O	1145
a	O	1145
recessive	B-Disease	1145
inherited	I-Disease	1145
disorder	I-Disease	1145
that	O	1145
consists	O	1145
of	O	1145
developmental	B-Disease	1145
abnormalities	I-Disease	1145
of	I-Disease	1145
the	I-Disease	1145
cochlea	I-Disease	1145
,	O	1145
sensorineural	B-Disease	1145
hearing	I-Disease	1145
loss	I-Disease	1145
,	O	1145
and	O	1145
diffuse	B-Disease	1145
thyroid	I-Disease	1145
enlargement	I-Disease	1145
(	O	1145
goiter	B-Disease	1145
)	O	1145
.	O	1145
this	O	1146
disorder	O	1146
may	O	1146
account	O	1146
for	O	1146
up	O	1146
to	O	1146
10	O	1146
%	O	1146
of	O	1146
cases	O	1146
of	O	1146
hereditary	B-Disease	1146
deafness	I-Disease	1146
.	O	1146
the	O	1147
disease	O	1147
gene	O	1147
(	O	1147
pds	B-Disease	1147
)	O	1147
has	O	1147
been	O	1147
mapped	O	1147
to	O	1147
chromosome	O	1147
7q22	O	1147
-	O	1147
q31	O	1147
,	O	1147
and	O	1147
encodes	O	1147
a	O	1147
chloride	O	1147
-	O	1147
iodide	O	1147
transport	O	1147
protein	O	1147
.	O	1147
we	O	1148
performed	O	1148
mutation	O	1148
analysis	O	1148
of	O	1148
individual	O	1148
exons	O	1148
of	O	1148
the	O	1148
pds	B-Disease	1148
gene	O	1148
in	O	1148
one	O	1148
spanish	O	1148
family	O	1148
that	O	1148
shows	O	1148
intrafamilial	O	1148
variability	O	1148
of	O	1148
the	O	1148
deafness	B-Disease	1148
phenotype	O	1148
(	O	1148
two	O	1148
patients	O	1148
with	O	1148
profound	O	1148
and	O	1148
one	O	1148
with	O	1148
moderate	O	1148
-	O	1148
severe	O	1148
deafness	B-Disease	1148
)	O	1148
.	O	1148
we	O	1149
identified	O	1149
a	O	1149
new	O	1149
splice	O	1149
-	O	1149
site	O	1149
mutation	O	1149
affecting	O	1149
intron	O	1149
4	O	1149
of	O	1149
the	O	1149
pds	B-Disease	1149
gene	O	1149
,	O	1149
at	O	1149
nucleotide	O	1149
position	O	1149
639	O	1149
+	O	1149
7	O	1149
.	O	1149
since	O	1151
the	O	1151
newly	O	1151
created	O	1151
donor	O	1151
splice	O	1151
site	O	1151
is	O	1151
likely	O	1151
to	O	1151
compete	O	1151
with	O	1151
the	O	1151
normal	O	1151
one	O	1151
,	O	1151
variations	O	1151
of	O	1151
the	O	1151
levels	O	1151
of	O	1151
normal	O	1151
and	O	1151
aberrant	O	1151
transcripts	O	1151
of	O	1151
the	O	1151
pds	B-Disease	1151
gene	O	1151
in	O	1151
the	O	1151
cochlea	O	1151
may	O	1151
explain	O	1151
the	O	1151
variability	O	1151
in	O	1151
the	O	1151
deafness	B-Disease	1151
presentation	O	1151
.	O	1151
.	O	1151
the	O	1152
molecular	O	1152
basis	O	1152
of	O	1152
sjogren	B-Disease	1152
-	I-Disease	1152
larsson	I-Disease	1152
syndrome	I-Disease	1152
:	O	1152
mutation	O	1152
analysis	O	1152
of	O	1152
the	O	1152
fatty	O	1152
aldehyde	O	1152
dehydrogenase	O	1152
gene	O	1152
.	O	1152
sjogren	B-Disease	1153
-	I-Disease	1153
larsson	I-Disease	1153
syndrome	I-Disease	1153
(	O	1153
sls	B-Disease	1153
)	O	1153
is	O	1153
an	O	1153
autosomal	B-Disease	1153
recessive	I-Disease	1153
disorder	I-Disease	1153
characterized	O	1153
by	O	1153
ichthyosis	B-Disease	1153
,	O	1153
mental	B-Disease	1153
retardation	I-Disease	1153
,	O	1153
spasticity	B-Disease	1153
,	O	1153
and	O	1153
deficient	B-Disease	1153
activity	I-Disease	1153
of	I-Disease	1153
fatty	I-Disease	1153
aldehyde	I-Disease	1153
dehydrogenase	I-Disease	1153
(	O	1153
faldh	O	1153
)	O	1153
.	O	1153
to	O	1154
define	O	1154
the	O	1154
molecular	O	1154
defects	O	1154
causing	O	1154
sls	B-Disease	1154
,	O	1154
we	O	1154
performed	O	1154
mutation	O	1154
analysis	O	1154
of	O	1154
the	O	1154
faldh	O	1154
gene	O	1154
in	O	1154
probands	O	1154
from	O	1154
63	O	1154
kindreds	O	1154
with	O	1154
sls	B-Disease	1154
.	O	1154
all	O	1156
of	O	1156
the	O	1156
patients	O	1156
with	O	1156
sls	B-Disease	1156
were	O	1156
found	O	1156
to	O	1156
carry	O	1156
mutations	O	1156
.	O	1156
at	O	1161
least	O	1161
four	O	1161
of	O	1161
the	O	1161
common	O	1161
mutations	O	1161
(	O	1161
551c	O	1161
-	O	1161
-	O	1161
>	O	1161
t	O	1161
,	O	1161
682c	O	1161
-	O	1161
-	O	1161
>	O	1161
t	O	1161
,	O	1161
733g	O	1161
-	O	1161
-	O	1161
>	O	1161
a	O	1161
,	O	1161
and	O	1161
798	O	1161
+	O	1161
1delg	O	1161
)	O	1161
were	O	1161
associated	O	1161
with	O	1161
multiple	O	1161
snp	O	1161
haplotypes	O	1161
,	O	1161
suggesting	O	1161
that	O	1161
these	O	1161
mutations	O	1161
originated	O	1161
independently	O	1161
on	O	1161
more	O	1161
than	O	1161
one	O	1161
occasion	O	1161
or	O	1161
were	O	1161
ancient	O	1161
sls	B-Disease	1161
genes	O	1161
that	O	1161
had	O	1161
undergone	O	1161
intragenic	O	1161
recombination	O	1161
.	O	1161
our	O	1162
results	O	1162
demonstrate	O	1162
that	O	1162
sls	B-Disease	1162
is	O	1162
caused	O	1162
by	O	1162
a	O	1162
strikingly	O	1162
heterogeneous	O	1162
group	O	1162
of	O	1162
mutations	O	1162
in	O	1162
the	O	1162
faldh	O	1162
gene	O	1162
and	O	1162
provide	O	1162
a	O	1162
framework	O	1162
for	O	1162
understanding	O	1162
the	O	1162
genetic	O	1162
basis	O	1162
of	O	1162
sls	B-Disease	1162
and	O	1162
the	O	1162
development	O	1162
of	O	1162
dna	O	1162
-	O	1162
based	O	1162
diagnostic	O	1162
tests	O	1162
.	O	1162
.	O	1162
loss	O	1163
-	O	1163
of	O	1163
-	O	1163
function	O	1163
mutations	O	1163
in	O	1163
the	O	1163
cathepsin	O	1163
c	O	1163
gene	O	1163
result	O	1163
in	O	1163
periodontal	B-Disease	1163
disease	I-Disease	1163
and	O	1163
palmoplantar	B-Disease	1163
keratosis	I-Disease	1163
.	O	1163
papillon	B-Disease	1164
-	I-Disease	1164
lefevre	I-Disease	1164
syndrome	I-Disease	1164
,	O	1164
or	O	1164
keratosis	B-Disease	1164
palmoplantaris	I-Disease	1164
with	O	1164
periodontopathia	B-Disease	1164
(	O	1164
pls	B-Disease	1164
,	O	1164
mim	O	1164
245000	O	1164
)	O	1164
,	O	1164
is	O	1164
an	O	1164
autosomal	B-Disease	1164
recessive	I-Disease	1164
disorder	I-Disease	1164
that	O	1164
is	O	1164
mainly	O	1164
ascertained	O	1164
by	O	1164
dentists	O	1164
because	O	1164
of	O	1164
the	O	1164
severe	O	1164
periodontitis	B-Disease	1164
that	O	1164
afflicts	O	1164
patients	O	1164
.	O	1164
both	O	1165
the	O	1165
deciduous	O	1165
and	O	1165
permanent	O	1165
dentitions	O	1165
are	O	1165
affected	O	1165
,	O	1165
resulting	O	1165
in	O	1165
premature	O	1165
tooth	B-Disease	1165
loss	I-Disease	1165
.	O	1165
palmoplantar	B-Disease	1166
keratosis	I-Disease	1166
,	O	1166
varying	O	1166
from	O	1166
mild	O	1166
psoriasiform	O	1166
scaly	O	1166
skin	O	1166
to	O	1166
overt	O	1166
hyperkeratosis	B-Disease	1166
,	O	1166
typically	O	1166
develops	O	1166
within	O	1166
the	O	1166
first	O	1166
three	O	1166
years	O	1166
of	O	1166
life	O	1166
.	O	1166
keratosis	B-Disease	1167
also	O	1167
affects	O	1167
other	O	1167
sites	O	1167
such	O	1167
as	O	1167
elbows	O	1167
and	O	1167
knees	O	1167
.	O	1167
most	O	1168
pls	B-Disease	1168
patients	O	1168
display	O	1168
both	O	1168
periodontitis	B-Disease	1168
and	O	1168
hyperkeratosis	B-Disease	1168
.	O	1168
some	O	1169
patients	O	1169
have	O	1169
only	O	1169
palmoplantar	B-Disease	1169
keratosis	I-Disease	1169
or	O	1169
periodontitis	B-Disease	1169
,	O	1169
and	O	1169
in	O	1169
rare	O	1169
individuals	O	1169
the	O	1169
periodontitis	B-Disease	1169
is	O	1169
mild	O	1169
and	O	1169
of	O	1169
late	O	1169
onset	O	1169
.	O	1169
in	O	1175
two	O	1175
of	O	1175
these	O	1175
families	O	1175
we	O	1175
used	O	1175
a	O	1175
functional	O	1175
assay	O	1175
to	O	1175
demonstrate	O	1175
an	O	1175
almost	O	1175
total	O	1175
loss	O	1175
of	O	1175
cathepsin	O	1175
c	O	1175
activity	O	1175
in	O	1175
pls	B-Disease	1175
patients	O	1175
and	O	1175
reduced	O	1175
activity	O	1175
in	O	1175
obligate	O	1175
carriers	O	1175
.	O	1175
confirmation	O	1176
of	O	1176
linkage	O	1176
of	O	1176
van	B-Disease	1176
der	I-Disease	1176
woude	I-Disease	1176
syndrome	I-Disease	1176
to	O	1176
chromosome	O	1176
1q32	O	1176
:	O	1176
evidence	O	1176
of	O	1176
association	O	1176
with	O	1176
str	O	1176
alleles	O	1176
suggests	O	1176
possible	O	1176
unique	O	1176
origin	O	1176
of	O	1176
the	O	1176
disease	O	1176
mutation	O	1176
.	O	1176
van	B-Disease	1177
der	I-Disease	1177
woude	I-Disease	1177
syndrome	I-Disease	1177
(	O	1177
vws	B-Disease	1177
)	O	1177
is	O	1177
an	O	1177
autosomal	B-Disease	1177
dominant	I-Disease	1177
craniofacial	I-Disease	1177
disorder	I-Disease	1177
with	O	1177
high	O	1177
penetrance	O	1177
and	O	1177
variable	O	1177
expression	O	1177
.	O	1177
its	O	1178
clinical	O	1178
features	O	1178
are	O	1178
variably	O	1178
expressed	O	1178
,	O	1178
but	O	1178
include	O	1178
cleft	B-Disease	1178
lip	I-Disease	1178
and	O	1178
/	O	1178
or	O	1178
cleft	B-Disease	1178
palate	I-Disease	1178
,	O	1178
lip	B-Disease	1178
pits	I-Disease	1178
and	O	1178
hypodontia	B-Disease	1178
.	O	1178
all	O	1179
vws	B-Disease	1179
families	O	1179
studied	O	1179
to	O	1179
date	O	1179
map	O	1179
the	O	1179
disease	O	1179
gene	O	1179
to	O	1179
a	O	1179
<	O	1179
2	O	1179
cm	O	1179
region	O	1179
of	O	1179
chromosome	O	1179
1q32	O	1179
,	O	1179
with	O	1179
no	O	1179
evidence	O	1179
of	O	1179
locus	O	1179
heterogeneity	O	1179
.	O	1179
the	O	1180
aim	O	1180
of	O	1180
this	O	1180
study	O	1180
is	O	1180
to	O	1180
refine	O	1180
the	O	1180
localization	O	1180
of	O	1180
the	O	1180
vws	B-Disease	1180
gene	O	1180
and	O	1180
to	O	1180
further	O	1180
assess	O	1180
possible	O	1180
heterogeneity	O	1180
.	O	1180
we	O	1181
analyzed	O	1181
four	O	1181
multiplex	O	1181
vws	B-Disease	1181
families	O	1181
.	O	1181
all	O	1182
available	O	1182
members	O	1182
were	O	1182
clinically	O	1182
assessed	O	1182
and	O	1182
genotyped	O	1182
for	O	1182
19	O	1182
short	O	1182
tandem	O	1182
repeat	O	1182
markers	O	1182
on	O	1182
chromosome	O	1182
1	O	1182
in	O	1182
the	O	1182
vws	B-Disease	1182
candidate	O	1182
gene	O	1182
region	O	1182
.	O	1182
our	O	1187
assay	O	1187
method	O	1187
for	O	1187
short	O	1187
tandem	O	1187
repeat	O	1187
(	O	1187
str	O	1187
)	O	1187
markers	O	1187
provided	O	1187
highly	O	1187
accurate	O	1187
size	O	1187
estimation	O	1187
of	O	1187
marker	O	1187
allele	O	1187
fragment	O	1187
sizes	O	1187
,	O	1187
and	O	1187
therefore	O	1187
enabled	O	1187
us	O	1187
to	O	1187
determine	O	1187
the	O	1187
specific	O	1187
alleles	O	1187
segregating	O	1187
with	O	1187
the	O	1187
vws	B-Disease	1187
gene	O	1187
in	O	1187
each	O	1187
of	O	1187
our	O	1187
four	O	1187
families	O	1187
.	O	1187
we	O	1188
observed	O	1188
a	O	1188
striking	O	1188
pattern	O	1188
of	O	1188
str	O	1188
allele	O	1188
sharing	O	1188
at	O	1188
several	O	1188
closely	O	1188
linked	O	1188
loci	O	1188
among	O	1188
our	O	1188
four	O	1188
caucasian	O	1188
vws	B-Disease	1188
families	O	1188
recruited	O	1188
at	O	1188
three	O	1188
different	O	1188
locations	O	1188
in	O	1188
the	O	1188
us	O	1188
.	O	1188
these	O	1189
results	O	1189
suggest	O	1189
the	O	1189
possibility	O	1189
of	O	1189
a	O	1189
unique	O	1189
origin	O	1189
for	O	1189
a	O	1189
mutation	O	1189
responsible	O	1189
for	O	1189
many	O	1189
or	O	1189
most	O	1189
cases	O	1189
of	O	1189
vws	B-Disease	1189
.	O	1189
a	O	1191
new	O	1191
platelet	O	1191
-	O	1191
specific	O	1191
alloantigen	O	1191
,	O	1191
termed	O	1191
sit	O	1191
(	O	1191
a	O	1191
)	O	1191
,	O	1191
was	O	1191
identified	O	1191
in	O	1191
a	O	1191
severe	O	1191
case	O	1191
of	O	1191
neonatal	B-Disease	1191
alloimmune	I-Disease	1191
thrombocytopenia	I-Disease	1191
.	O	1191
mutations	O	1203
of	O	1203
the	O	1203
cathepsin	O	1203
c	O	1203
gene	O	1203
are	O	1203
responsible	O	1203
for	O	1203
papillon	B-Disease	1203
-	I-Disease	1203
lefevre	I-Disease	1203
syndrome	I-Disease	1203
.	O	1203
papillon	B-Disease	1204
-	I-Disease	1204
lefevre	I-Disease	1204
syndrome	I-Disease	1204
(	O	1204
pls	B-Disease	1204
)	O	1204
is	O	1204
an	O	1204
autosomal	B-Disease	1204
recessive	I-Disease	1204
disorder	I-Disease	1204
characterised	O	1204
by	O	1204
palmoplantar	B-Disease	1204
hyperkeratosis	I-Disease	1204
and	O	1204
severe	O	1204
early	O	1204
onset	O	1204
periodontitis	B-Disease	1204
that	O	1204
results	O	1204
in	O	1204
the	O	1204
premature	O	1204
loss	O	1204
of	O	1204
the	O	1204
primary	O	1204
and	O	1204
secondary	O	1204
dentitions	O	1204
.	O	1204
a	O	1205
major	O	1205
gene	O	1205
locus	O	1205
for	O	1205
pls	B-Disease	1205
has	O	1205
been	O	1205
mapped	O	1205
to	O	1205
a	O	1205
2	O	1205
.	O	1205
by	O	1209
rt	O	1209
-	O	1209
pcr	O	1209
,	O	1209
we	O	1209
found	O	1209
ctsc	O	1209
is	O	1209
also	O	1209
expressed	O	1209
in	O	1209
epithelial	O	1209
regions	O	1209
commonly	O	1209
affected	O	1209
by	O	1209
pls	B-Disease	1209
,	O	1209
including	O	1209
the	O	1209
palms	O	1209
,	O	1209
soles	O	1209
,	O	1209
knees	O	1209
,	O	1209
and	O	1209
oral	O	1209
keratinised	O	1209
gingiva	O	1209
.	O	1209
sequence	O	1212
analysis	O	1212
of	O	1212
ctsc	O	1212
from	O	1212
subjects	O	1212
affected	O	1212
with	O	1212
pls	B-Disease	1212
from	O	1212
five	O	1212
consanguineous	O	1212
turkish	O	1212
families	O	1212
identified	O	1212
four	O	1212
different	O	1212
mutations	O	1212
.	O	1212
all	O	1215
pls	B-Disease	1215
patients	O	1215
were	O	1215
homozygous	O	1215
for	O	1215
cathepsin	O	1215
c	O	1215
mutations	O	1215
inherited	O	1215
from	O	1215
a	O	1215
common	O	1215
ancestor	O	1215
.	O	1215
parents	O	1216
and	O	1216
sibs	O	1216
heterozygous	O	1216
for	O	1216
cathepsin	O	1216
c	O	1216
mutations	O	1216
do	O	1216
not	O	1216
show	O	1216
either	O	1216
the	O	1216
palmoplantar	B-Disease	1216
hyperkeratosis	I-Disease	1216
or	O	1216
severe	O	1216
early	O	1216
onset	O	1216
periodontitis	B-Disease	1216
characteristic	O	1216
of	O	1216
pls	B-Disease	1216
.	O	1216
a	O	1217
more	O	1217
complete	O	1217
understanding	O	1217
of	O	1217
the	O	1217
functional	O	1217
physiology	O	1217
of	O	1217
cathepsin	O	1217
c	O	1217
carries	O	1217
significant	O	1217
implications	O	1217
for	O	1217
understanding	O	1217
normal	O	1217
and	O	1217
abnormal	O	1217
skin	O	1217
development	O	1217
and	O	1217
periodontal	B-Disease	1217
disease	I-Disease	1217
susceptibility	O	1217
mutational	O	1218
analysis	O	1218
of	O	1218
the	O	1218
hgo	O	1218
gene	O	1218
in	O	1218
finnish	O	1218
alkaptonuria	B-Disease	1218
patients	O	1218
.	O	1218
alkaptonuria	B-Disease	1219
(	O	1219
aku	B-Disease	1219
)	O	1219
,	O	1219
the	O	1219
prototypic	O	1219
inborn	B-Disease	1219
error	I-Disease	1219
of	I-Disease	1219
metabolism	I-Disease	1219
,	O	1219
has	O	1219
recently	O	1219
been	O	1219
shown	O	1219
to	O	1219
be	O	1219
caused	O	1219
by	O	1219
loss	O	1219
of	O	1219
function	O	1219
mutations	O	1219
in	O	1219
the	O	1219
homogentisate	O	1219
-	O	1219
1	O	1219
,	O	1219
2	O	1219
-	O	1219
dioxygenase	O	1219
gene	O	1219
(	O	1219
hgo	O	1219
)	O	1219
.	O	1219
so	O	1220
far	O	1220
17	O	1220
mutations	O	1220
have	O	1220
been	O	1220
characterised	O	1220
in	O	1220
aku	B-Disease	1220
patients	O	1220
of	O	1220
different	O	1220
ethnic	O	1220
origin	O	1220
.	O	1220
we	O	1221
describe	O	1221
three	O	1221
novel	O	1221
mutations	O	1221
(	O	1221
r58fs	O	1221
,	O	1221
r330s	O	1221
,	O	1221
and	O	1221
h371r	O	1221
)	O	1221
and	O	1221
one	O	1221
common	O	1221
aku	B-Disease	1221
mutation	O	1221
(	O	1221
m368v	O	1221
)	O	1221
,	O	1221
detected	O	1221
by	O	1221
mutational	O	1221
and	O	1221
polymorphism	O	1221
analysis	O	1221
of	O	1221
the	O	1221
hgo	O	1221
gene	O	1221
in	O	1221
five	O	1221
finnish	O	1221
aku	B-Disease	1221
pedigrees	O	1221
.	O	1221
the	O	1222
three	O	1222
novel	O	1222
aku	B-Disease	1222
mutations	O	1222
are	O	1222
most	O	1222
likely	O	1222
specific	O	1222
for	O	1222
the	O	1222
finnish	O	1222
population	O	1222
and	O	1222
have	O	1222
originated	O	1222
recently	O	1222
.	O	1222
.	O	1222
the	O	1223
identical	O	1223
5	O	1223
'	O	1223
splice	O	1223
-	O	1223
site	O	1223
acceptor	O	1223
mutation	O	1223
in	O	1223
five	O	1223
attenuated	B-Disease	1223
apc	I-Disease	1223
families	O	1223
from	O	1223
newfoundland	O	1223
demonstrates	O	1223
a	O	1223
founder	O	1223
effect	O	1223
.	O	1223
inherited	O	1224
mutations	O	1224
of	O	1224
the	O	1224
apc	B-Disease	1224
gene	O	1224
predispose	O	1224
carriers	O	1224
to	O	1224
multiple	O	1224
adenomatous	B-Disease	1224
polyps	I-Disease	1224
of	I-Disease	1224
the	I-Disease	1224
colon	I-Disease	1224
and	I-Disease	1224
rectum	I-Disease	1224
and	O	1224
to	O	1224
colorectal	B-Disease	1224
cancer	I-Disease	1224
.	O	1224
mutations	O	1225
located	O	1225
at	O	1225
the	O	1225
extreme	O	1225
5	O	1225
end	O	1225
of	O	1225
the	O	1225
apc	B-Disease	1225
gene	O	1225
,	O	1225
however	O	1225
,	O	1225
are	O	1225
associated	O	1225
with	O	1225
a	O	1225
less	O	1225
severe	O	1225
disease	O	1225
known	O	1225
as	O	1225
attenuated	B-Disease	1225
adenomatous	I-Disease	1225
polyposis	I-Disease	1225
coli	I-Disease	1225
(	O	1225
aapc	B-Disease	1225
)	O	1225
.	O	1225
many	O	1226
individuals	O	1226
with	O	1226
aapc	B-Disease	1226
develop	O	1226
relatively	O	1226
few	O	1226
colorectal	B-Disease	1226
polyps	I-Disease	1226
but	O	1226
are	O	1226
still	O	1226
at	O	1226
high	O	1226
risk	O	1226
for	O	1226
colorectal	B-Disease	1226
cancer	I-Disease	1226
.	O	1226
we	O	1227
report	O	1227
here	O	1227
the	O	1227
identification	O	1227
of	O	1227
a	O	1227
5	O	1227
apc	B-Disease	1227
germline	O	1227
mutation	O	1227
in	O	1227
five	O	1227
separately	O	1227
ascertained	O	1227
aapc	B-Disease	1227
families	O	1227
from	O	1227
newfoundland	O	1227
,	O	1227
canada	O	1227
.	O	1227
this	O	1228
disease	O	1228
-	O	1228
causing	O	1228
mutation	O	1228
is	O	1228
a	O	1228
single	O	1228
basepair	O	1228
change	O	1228
(	O	1228
g	O	1228
to	O	1228
a	O	1228
)	O	1228
in	O	1228
the	O	1228
splice	O	1228
-	O	1228
acceptor	O	1228
region	O	1228
of	O	1228
apc	B-Disease	1228
intron	O	1228
3	O	1228
that	O	1228
creates	O	1228
a	O	1228
mutant	O	1228
rna	O	1228
without	O	1228
exon	O	1228
4	O	1228
of	O	1228
apc	O	1228
.	O	1228
the	O	1229
observation	O	1229
of	O	1229
the	O	1229
same	O	1229
apc	B-Disease	1229
mutation	O	1229
in	O	1229
five	O	1229
families	O	1229
from	O	1229
the	O	1229
same	O	1229
geographic	O	1229
area	O	1229
demonstrates	O	1229
a	O	1229
founder	O	1229
effect	O	1229
.	O	1229
furthermore	O	1230
,	O	1230
the	O	1230
identification	O	1230
of	O	1230
this	O	1230
germline	O	1230
mutation	O	1230
strengthens	O	1230
the	O	1230
correlation	O	1230
between	O	1230
the	O	1230
5	O	1230
location	O	1230
of	O	1230
an	O	1230
apc	B-Disease	1230
disease	O	1230
-	O	1230
causing	O	1230
mutation	O	1230
and	O	1230
the	O	1230
attenuated	B-Disease	1230
polyposis	I-Disease	1230
phenotype	O	1230
.	O	1230
.	O	1230
alstrom	B-Disease	1231
syndrome	I-Disease	1231
:	O	1231
further	O	1231
evidence	O	1231
for	O	1231
linkage	O	1231
to	O	1231
human	O	1231
chromosome	O	1231
2p13	O	1231
.	O	1231
alstrom	B-Disease	1232
syndrome	I-Disease	1232
is	O	1232
a	O	1232
rare	O	1232
autosomal	B-Disease	1232
recessive	I-Disease	1232
disorder	I-Disease	1232
characterized	O	1232
by	O	1232
retinal	B-Disease	1232
degeneration	I-Disease	1232
,	O	1232
sensorineural	B-Disease	1232
hearing	I-Disease	1232
loss	I-Disease	1232
,	O	1232
early	O	1232
-	O	1232
onset	O	1232
obesity	B-Disease	1232
,	O	1232
and	O	1232
non	B-Disease	1232
-	I-Disease	1232
insulin	I-Disease	1232
-	I-Disease	1232
dependent	I-Disease	1232
diabetes	I-Disease	1232
mellitus	I-Disease	1232
.	O	1232
the	O	1233
gene	O	1233
for	O	1233
alstrom	B-Disease	1233
syndrome	I-Disease	1233
(	O	1233
alms1	O	1233
)	O	1233
has	O	1233
been	O	1233
previously	O	1233
localized	O	1233
to	O	1233
human	O	1233
chromosome	O	1233
2p13	O	1233
by	O	1233
homozygosity	O	1233
mapping	O	1233
in	O	1233
two	O	1233
distinct	O	1233
isolated	O	1233
populations	O	1233
-	O	1233
french	O	1233
acadian	O	1233
and	O	1233
north	O	1233
african	O	1233
.	O	1233
to	O	1237
confirm	O	1237
these	O	1237
findings	O	1237
,	O	1237
a	O	1237
large	O	1237
linkage	O	1237
study	O	1237
was	O	1237
performed	O	1237
in	O	1237
twelve	O	1237
additional	O	1237
families	O	1237
segregating	O	1237
for	O	1237
alstrom	B-Disease	1237
syndrome	I-Disease	1237
.	O	1237
pendred	B-Disease	1245
syndrome	I-Disease	1245
:	O	1245
phenotypic	O	1245
variability	O	1245
in	O	1245
two	O	1245
families	O	1245
carrying	O	1245
the	O	1245
same	O	1245
pds	B-Disease	1245
missense	O	1245
mutation	O	1245
.	O	1245
pendred	B-Disease	1246
syndrome	I-Disease	1246
comprises	O	1246
congenital	B-Disease	1246
sensorineural	I-Disease	1246
hearing	I-Disease	1246
loss	I-Disease	1246
,	O	1246
thyroid	B-Disease	1246
goiter	I-Disease	1246
,	O	1246
and	O	1246
positive	O	1246
perchlorate	O	1246
discharge	O	1246
test	O	1246
.	O	1246
recently	O	1247
,	O	1247
this	O	1247
autosomal	B-Disease	1247
recessive	I-Disease	1247
disorder	I-Disease	1247
was	O	1247
shown	O	1247
to	O	1247
be	O	1247
caused	O	1247
by	O	1247
mutations	O	1247
in	O	1247
the	O	1247
pds	B-Disease	1247
gene	O	1247
,	O	1247
which	O	1247
encodes	O	1247
an	O	1247
anion	O	1247
transporter	O	1247
called	O	1247
pendrin	O	1247
.	O	1247
molecular	O	1248
analysis	O	1248
of	O	1248
the	O	1248
pds	B-Disease	1248
gene	O	1248
was	O	1248
performed	O	1248
in	O	1248
two	O	1248
consanguineous	O	1248
large	O	1248
families	O	1248
from	O	1248
southern	O	1248
tunisia	O	1248
comprising	O	1248
a	O	1248
total	O	1248
of	O	1248
23	O	1248
individuals	O	1248
affected	O	1248
with	O	1248
profound	O	1248
congenital	B-Disease	1248
deafness	I-Disease	1248
;	O	1248
the	O	1248
same	O	1248
missense	O	1248
mutation	O	1248
,	O	1248
l445w	O	1248
,	O	1248
was	O	1248
identified	O	1248
in	O	1248
all	O	1248
affected	O	1248
individuals	O	1248
.	O	1248
a	O	1249
widened	B-Disease	1249
vestibular	I-Disease	1249
aqueduct	I-Disease	1249
was	O	1249
found	O	1249
in	O	1249
all	O	1249
patients	O	1249
who	O	1249
underwent	O	1249
computed	O	1249
tomography	O	1249
(	O	1249
ct	O	1249
)	O	1249
scan	O	1249
exploration	O	1249
of	O	1249
the	O	1249
inner	O	1249
ear	O	1249
.	O	1249
in	O	1250
contrast	O	1250
,	O	1250
goiter	B-Disease	1250
was	O	1250
present	O	1250
in	O	1250
only	O	1250
11	O	1250
affected	O	1250
individuals	O	1250
,	O	1250
who	O	1250
interestingly	O	1250
had	O	1250
a	O	1250
normal	O	1250
result	O	1250
of	O	1250
the	O	1250
perchlorate	O	1250
discharge	O	1250
test	O	1250
whenever	O	1250
performed	O	1250
.	O	1250
the	O	1251
present	O	1251
results	O	1251
question	O	1251
the	O	1251
sensitivity	O	1251
of	O	1251
the	O	1251
perchlorate	O	1251
test	O	1251
for	O	1251
the	O	1251
diagnosis	O	1251
of	O	1251
pendred	B-Disease	1251
syndrome	I-Disease	1251
and	O	1251
support	O	1251
the	O	1251
use	O	1251
of	O	1251
a	O	1251
molecular	O	1251
analysis	O	1251
of	O	1251
the	O	1251
pds	B-Disease	1251
gene	O	1251
in	O	1251
the	O	1251
assessment	O	1251
of	O	1251
individuals	O	1251
with	O	1251
severe	O	1251
to	O	1251
profound	O	1251
congenital	B-Disease	1251
hearing	I-Disease	1251
loss	I-Disease	1251
associated	O	1251
with	O	1251
inner	B-Disease	1251
ear	I-Disease	1251
morphological	I-Disease	1251
anomaly	I-Disease	1251
even	O	1251
in	O	1251
the	O	1251
absence	O	1251
of	O	1251
a	O	1251
thyroid	B-Disease	1251
goiter	I-Disease	1251
.	O	1251
.	O	1251
knobloch	B-Disease	1252
syndrome	I-Disease	1252
involving	O	1252
midline	B-Disease	1252
scalp	I-Disease	1252
defect	I-Disease	1252
of	I-Disease	1252
the	I-Disease	1252
frontal	I-Disease	1252
region	I-Disease	1252
.	O	1252
we	O	1253
report	O	1253
on	O	1253
a	O	1253
4	O	1253
-	O	1253
year	O	1253
-	O	1253
old	O	1253
boy	O	1253
with	O	1253
knobloch	B-Disease	1253
syndrome	I-Disease	1253
.	O	1253
he	O	1254
has	O	1254
vitreoretinal	B-Disease	1254
degeneration	I-Disease	1254
,	O	1254
high	B-Disease	1254
myopia	I-Disease	1254
,	O	1254
cataract	B-Disease	1254
,	O	1254
telecanthus	B-Disease	1254
,	O	1254
hypertelorism	B-Disease	1254
,	O	1254
and	O	1254
a	O	1254
high	B-Disease	1254
-	I-Disease	1254
arched	I-Disease	1254
palate	I-Disease	1254
.	O	1254
he	O	1255
also	O	1255
has	O	1255
a	O	1255
defect	B-Disease	1255
of	I-Disease	1255
the	I-Disease	1255
anterior	I-Disease	1255
midline	I-Disease	1255
scalp	I-Disease	1255
with	O	1255
involvement	O	1255
of	O	1255
the	O	1255
frontal	O	1255
bone	O	1255
as	O	1255
documented	O	1255
by	O	1255
a	O	1255
computed	O	1255
tomography	O	1255
(	O	1255
ct	O	1255
)	O	1255
scan	O	1255
.	O	1255
our	O	1258
patient	O	1258
illustrates	O	1258
the	O	1258
importance	O	1258
of	O	1258
investigating	O	1258
for	O	1258
underlying	O	1258
ocular	O	1258
and	O	1258
central	O	1258
nervous	O	1258
system	O	1258
pathology	O	1258
whenever	O	1258
midline	B-Disease	1258
scalp	I-Disease	1258
defects	I-Disease	1258
are	O	1258
present	O	1258
.	O	1258
.	O	1258
the	O	1259
dna	O	1259
double	O	1259
-	O	1259
strand	O	1259
break	O	1259
repair	O	1259
gene	O	1259
hmre11	O	1259
is	O	1259
mutated	O	1259
in	O	1259
individuals	O	1259
with	O	1259
an	O	1259
ataxia	B-Disease	1259
-	I-Disease	1259
telangiectasia	I-Disease	1259
-	I-Disease	1259
like	I-Disease	1259
disorder	I-Disease	1259
.	O	1259
we	O	1260
show	O	1260
that	O	1260
hypomorphic	O	1260
mutations	O	1260
in	O	1260
hmre11	O	1260
,	O	1260
but	O	1260
not	O	1260
in	O	1260
atm	O	1260
,	O	1260
are	O	1260
present	O	1260
in	O	1260
certain	O	1260
individuals	O	1260
with	O	1260
an	O	1260
ataxia	B-Disease	1260
-	I-Disease	1260
telangiectasia	I-Disease	1260
-	I-Disease	1260
like	I-Disease	1260
disorder	I-Disease	1260
(	O	1260
atld	B-Disease	1260
)	O	1260
.	O	1260
the	O	1261
cellular	O	1261
features	O	1261
resulting	O	1261
from	O	1261
these	O	1261
hmre11	O	1261
mutations	O	1261
are	O	1261
similar	O	1261
to	O	1261
those	O	1261
seen	O	1261
in	O	1261
a	B-Disease	1261
-	I-Disease	1261
t	I-Disease	1261
as	O	1261
well	O	1261
as	O	1261
nbs	B-Disease	1261
and	O	1261
include	O	1261
hypersensitivity	B-Disease	1261
to	I-Disease	1261
ionizing	I-Disease	1261
radiation	I-Disease	1261
,	O	1261
radioresistant	O	1261
dna	O	1261
synthesis	O	1261
,	O	1261
and	O	1261
abrogation	O	1261
of	O	1261
atm	O	1261
-	O	1261
dependent	O	1261
events	O	1261
,	O	1261
such	O	1261
as	O	1261
the	O	1261
activation	O	1261
of	O	1261
jun	O	1261
kinase	O	1261
following	O	1261
exposure	O	1261
to	O	1261
gamma	O	1261
irradiation	O	1261
.	O	1261
these	O	1263
data	O	1263
demonstrate	O	1263
that	O	1263
atm	O	1263
and	O	1263
the	O	1263
hmre11	O	1263
/	O	1263
hrad50	O	1263
/	O	1263
nbs1	O	1263
protein	O	1263
complex	O	1263
act	O	1263
in	O	1263
the	O	1263
same	O	1263
dna	O	1263
damage	O	1263
response	O	1263
pathway	O	1263
and	O	1263
link	O	1263
hmre11	O	1263
to	O	1263
the	O	1263
complex	O	1263
pathology	O	1263
of	O	1263
a	B-Disease	1263
-	I-Disease	1263
t	I-Disease	1263
.	O	1263
.	O	1263
mutations	O	1264
in	O	1264
tnfrsf11a	O	1264
,	O	1264
affecting	O	1264
the	O	1264
signal	O	1264
peptide	O	1264
of	O	1264
rank	O	1264
,	O	1264
cause	O	1264
familial	B-Disease	1264
expansile	I-Disease	1264
osteolysis	I-Disease	1264
.	O	1264
familial	B-Disease	1265
expansile	I-Disease	1265
osteolysis	I-Disease	1265
(	O	1265
feo	B-Disease	1265
,	O	1265
mim	O	1265
174810	O	1265
)	O	1265
is	O	1265
a	O	1265
rare	O	1265
,	O	1265
autosomal	B-Disease	1265
dominant	I-Disease	1265
bone	I-Disease	1265
disorder	I-Disease	1265
characterized	O	1265
by	O	1265
focal	O	1265
areas	O	1265
of	O	1265
increased	B-Disease	1265
bone	I-Disease	1265
remodelling	I-Disease	1265
.	O	1265
the	O	1266
osteolytic	B-Disease	1266
lesions	I-Disease	1266
,	O	1266
which	O	1266
develop	O	1266
usually	O	1266
in	O	1266
the	O	1266
long	O	1266
bones	O	1266
during	O	1266
early	O	1266
adulthood	O	1266
,	O	1266
show	O	1266
increased	O	1266
osteoblast	O	1266
and	O	1266
osteoclast	O	1266
activity	O	1266
.	O	1266
our	O	1267
previous	O	1267
linkage	O	1267
studies	O	1267
mapped	O	1267
the	O	1267
gene	O	1267
responsible	O	1267
for	O	1267
feo	B-Disease	1267
to	O	1267
an	O	1267
interval	O	1267
of	O	1267
less	O	1267
than	O	1267
5	O	1267
cm	O	1267
between	O	1267
d18s64	O	1267
and	O	1267
d18s51	O	1267
on	O	1267
chromosome	O	1267
18q21	O	1267
.	O	1267
we	O	1272
identified	O	1272
two	O	1272
heterozygous	O	1272
insertion	O	1272
mutations	O	1272
in	O	1272
exon	O	1272
1	O	1272
of	O	1272
tnfrsf11a	O	1272
in	O	1272
affected	O	1272
members	O	1272
of	O	1272
four	O	1272
families	O	1272
with	O	1272
feo	B-Disease	1272
or	O	1272
familial	B-Disease	1272
paget	I-Disease	1272
disease	I-Disease	1272
of	I-Disease	1272
bone	I-Disease	1272
(	O	1272
pdb	B-Disease	1272
)	O	1272
.	O	1272
cardiac	O	1276
na	O	1276
(	O	1276
+	O	1276
)	O	1276
channel	O	1276
dysfunction	O	1276
in	O	1276
brugada	B-Disease	1276
syndrome	I-Disease	1276
is	O	1276
aggravated	O	1276
by	O	1276
beta	O	1276
(	O	1276
1	O	1276
)	O	1276
-	O	1276
subunit	O	1276
.	O	1276
background	O	1277
mutations	O	1277
in	O	1277
the	O	1277
gene	O	1277
encoding	O	1277
the	O	1277
human	O	1277
cardiac	O	1277
na	O	1277
(	O	1277
+	O	1277
)	O	1277
channel	O	1277
alpha	O	1277
-	O	1277
subunit	O	1277
(	O	1277
hh1	O	1277
)	O	1277
are	O	1277
responsible	O	1277
for	O	1277
chromosome	O	1277
3	O	1277
-	O	1277
linked	O	1277
congenital	B-Disease	1277
long	I-Disease	1277
-	I-Disease	1277
qt	I-Disease	1277
syndrome	I-Disease	1277
(	O	1277
lqt3	B-Disease	1277
)	O	1277
and	O	1277
idiopathic	B-Disease	1277
ventricular	I-Disease	1277
fibrillation	I-Disease	1277
(	O	1277
ivf	B-Disease	1277
)	O	1277
.	O	1277
here	O	1279
,	O	1279
we	O	1279
characterize	O	1279
the	O	1279
altered	O	1279
effects	O	1279
of	O	1279
a	O	1279
human	O	1279
beta	O	1279
(	O	1279
1	O	1279
)	O	1279
-	O	1279
subunit	O	1279
(	O	1279
hbeta	O	1279
(	O	1279
1	O	1279
)	O	1279
)	O	1279
on	O	1279
the	O	1279
heterologously	O	1279
expressed	O	1279
hh1	O	1279
mutation	O	1279
(	O	1279
t1620m	O	1279
)	O	1279
previously	O	1279
associated	O	1279
with	O	1279
ivf	B-Disease	1279
.	O	1279
methods	O	1280
and	O	1280
results	O	1280
when	O	1280
expressed	O	1280
alone	O	1280
in	O	1280
xenopus	O	1280
oocytes	O	1280
,	O	1280
t1620m	O	1280
exhibited	O	1280
no	O	1280
persistent	O	1280
currents	O	1280
,	O	1280
in	O	1280
contrast	O	1280
to	O	1280
the	O	1280
lqt3	B-Disease	1280
mutant	O	1280
channels	O	1280
,	O	1280
but	O	1280
the	O	1280
midpoint	O	1280
of	O	1280
steady	O	1280
-	O	1280
state	O	1280
inactivation	O	1280
(	O	1280
v	O	1280
(	O	1280
1	O	1280
/	O	1280
2	O	1280
)	O	1280
)	O	1280
was	O	1280
significantly	O	1280
shifted	O	1280
toward	O	1280
more	O	1280
positive	O	1280
potentials	O	1280
than	O	1280
for	O	1280
wild	O	1280
-	O	1280
type	O	1280
hh1	O	1280
.	O	1280
conclusions	O	1283
it	O	1283
is	O	1283
suggested	O	1283
that	O	1283
coexpression	O	1283
of	O	1283
hbeta	O	1283
(	O	1283
1	O	1283
)	O	1283
exposes	O	1283
a	O	1283
more	O	1283
severe	O	1283
functional	O	1283
defect	O	1283
that	O	1283
results	O	1283
in	O	1283
a	O	1283
greater	O	1283
overlap	O	1283
in	O	1283
the	O	1283
relationship	O	1283
between	O	1283
channel	O	1283
inactivation	O	1283
and	O	1283
activation	O	1283
(	O	1283
window	O	1283
current	O	1283
)	O	1283
in	O	1283
t1620m	O	1283
,	O	1283
which	O	1283
is	O	1283
proposed	O	1283
to	O	1283
be	O	1283
a	O	1283
potential	O	1283
pathophysiological	O	1283
mechanism	O	1283
of	O	1283
ivf	B-Disease	1283
in	O	1283
vivo	O	1283
.	O	1283
meiotic	O	1285
segregation	O	1285
analysis	O	1285
of	O	1285
rb1	O	1285
alleles	O	1285
in	O	1285
retinoblastoma	B-Disease	1285
pedigrees	O	1285
by	O	1285
use	O	1285
of	O	1285
single	O	1285
-	O	1285
sperm	O	1285
typing	O	1285
.	O	1285
in	O	1286
hereditary	B-Disease	1286
retinoblastoma	I-Disease	1286
,	O	1286
different	O	1286
epidemiological	O	1286
studies	O	1286
have	O	1286
indicated	O	1286
a	O	1286
preferential	O	1286
paternal	O	1286
transmission	O	1286
of	O	1286
mutant	O	1286
retinoblastoma	B-Disease	1286
alleles	O	1286
to	O	1286
offspring	O	1286
,	O	1286
suggesting	O	1286
the	O	1286
occurrence	O	1286
of	O	1286
a	O	1286
meiotic	O	1286
drive	O	1286
.	O	1286
to	O	1287
investigate	O	1287
this	O	1287
mechanism	O	1287
,	O	1287
we	O	1287
analyzed	O	1287
sperm	O	1287
samples	O	1287
from	O	1287
six	O	1287
individuals	O	1287
from	O	1287
five	O	1287
unrelated	O	1287
families	O	1287
affected	O	1287
with	O	1287
hereditary	B-Disease	1287
retinoblastoma	I-Disease	1287
.	O	1287
single	O	1288
-	O	1288
sperm	O	1288
typing	O	1288
techniques	O	1288
were	O	1288
performed	O	1288
for	O	1288
each	O	1288
sample	O	1288
by	O	1288
study	O	1288
of	O	1288
two	O	1288
informative	O	1288
short	O	1288
tandem	O	1288
repeats	O	1288
located	O	1288
either	O	1288
in	O	1288
or	O	1288
close	O	1288
to	O	1288
the	O	1288
retinoblastoma	B-Disease	1288
gene	O	1288
(	O	1288
rb1	O	1288
)	O	1288
.	O	1288
friedreich	B-Disease	1294
ataxia	I-Disease	1294
:	O	1294
an	O	1294
overview	O	1294
.	O	1294
friedreich	B-Disease	1295
ataxia	I-Disease	1295
,	O	1295
an	O	1295
autosomal	B-Disease	1295
recessive	I-Disease	1295
neurodegenerative	I-Disease	1295
disease	I-Disease	1295
,	O	1295
is	O	1295
the	O	1295
most	O	1295
common	O	1295
of	O	1295
the	O	1295
inherited	B-Disease	1295
ataxias	I-Disease	1295
.	O	1295
the	O	1296
recent	O	1296
discovery	O	1296
of	O	1296
the	O	1296
gene	O	1296
that	O	1296
is	O	1296
mutated	O	1296
in	O	1296
this	O	1296
condition	O	1296
,	O	1296
frda	O	1296
,	O	1296
has	O	1296
led	O	1296
to	O	1296
rapid	O	1296
advances	O	1296
in	O	1296
the	O	1296
understanding	O	1296
of	O	1296
the	O	1296
pathogenesis	O	1296
of	O	1296
friedreich	B-Disease	1296
ataxia	I-Disease	1296
.	O	1296
there	O	1299
is	O	1299
mounting	O	1299
evidence	O	1299
to	O	1299
suggest	O	1299
that	O	1299
friedreich	B-Disease	1299
ataxia	I-Disease	1299
is	O	1299
the	O	1299
result	O	1299
of	O	1299
accumulation	O	1299
of	O	1299
iron	O	1299
in	O	1299
mitochondria	O	1299
leading	O	1299
to	O	1299
excess	O	1299
production	O	1299
of	O	1299
free	O	1299
radicals	O	1299
,	O	1299
which	O	1299
then	O	1299
results	O	1299
in	O	1299
cellular	O	1299
damage	O	1299
and	O	1299
death	O	1299
.	O	1299
the	O	1301
discovery	O	1301
of	O	1301
the	O	1301
frda	B-Disease	1301
gene	O	1301
and	O	1301
its	O	1301
possible	O	1301
function	O	1301
has	O	1301
raised	O	1301
hope	O	1301
that	O	1301
rational	O	1301
therapeutic	O	1301
strategies	O	1301
will	O	1301
be	O	1301
developed	O	1301
.	O	1301
.	O	1301
x	B-Disease	1302
-	I-Disease	1302
linked	I-Disease	1302
retinoschisis	I-Disease	1302
with	O	1302
point	O	1302
mutations	O	1302
in	O	1302
the	O	1302
xlrs1	O	1302
gene	O	1302
.	O	1302
background	O	1303
x	B-Disease	1303
-	I-Disease	1303
linked	I-Disease	1303
retinoschisis	I-Disease	1303
(	O	1303
xlrs	B-Disease	1303
)	O	1303
is	O	1303
a	O	1303
relatively	O	1303
rare	O	1303
vitreoretinal	B-Disease	1303
dystrophy	I-Disease	1303
that	O	1303
causes	O	1303
visual	B-Disease	1303
loss	I-Disease	1303
in	O	1303
young	O	1303
men	O	1303
.	O	1303
objective	O	1305
to	O	1305
analyze	O	1305
japanese	O	1305
patients	O	1305
clinically	O	1305
diagnosed	O	1305
as	O	1305
having	O	1305
xlrs	B-Disease	1305
formutational	O	1305
changes	O	1305
in	O	1305
the	O	1305
xlrs1	O	1305
gene	O	1305
.	O	1305
methods	O	1306
ten	O	1306
patients	O	1306
with	O	1306
xlrs	B-Disease	1306
underwent	O	1306
full	O	1306
ophthalmologic	O	1306
examination	O	1306
,	O	1306
including	O	1306
slitlamp	O	1306
biomicroscopy	O	1306
and	O	1306
dilated	O	1306
funduscopy	O	1306
.	O	1306
conclusions	O	1312
the	O	1312
discovery	O	1312
of	O	1312
new	O	1312
point	O	1312
mutations	O	1312
in	O	1312
this	O	1312
study	O	1312
increases	O	1312
the	O	1312
available	O	1312
information	O	1312
regarding	O	1312
the	O	1312
spectrum	O	1312
of	O	1312
genetic	B-Disease	1312
abnormalities	I-Disease	1312
and	O	1312
clinical	O	1312
manifestations	O	1312
of	O	1312
xlrs	B-Disease	1312
.	O	1312
clinical	O	1314
relevance	O	1314
identification	O	1314
of	O	1314
mutations	O	1314
in	O	1314
the	O	1314
xlrs1	O	1314
gene	O	1314
and	O	1314
expanded	O	1314
information	O	1314
on	O	1314
clinical	O	1314
manifestations	O	1314
will	O	1314
facilitate	O	1314
early	O	1314
diagnosis	O	1314
,	O	1314
appropriate	O	1314
early	O	1314
therapy	O	1314
,	O	1314
and	O	1314
genetic	O	1314
counseling	O	1314
regarding	O	1314
the	O	1314
prognosis	O	1314
of	O	1314
xlrs	B-Disease	1314
.	O	1314
.	O	1314
ataxia	B-Disease	1316
-	I-Disease	1316
telangiectasia	I-Disease	1316
is	O	1316
a	O	1316
hereditary	B-Disease	1316
multisystemic	I-Disease	1316
disease	I-Disease	1316
resulting	O	1316
from	O	1316
mutations	O	1316
of	O	1316
ataxia	B-Disease	1316
telangiectasia	I-Disease	1316
,	O	1316
mutated	O	1316
(	O	1316
atm	O	1316
)	O	1316
and	O	1316
is	O	1316
characterized	O	1316
by	O	1316
neurodegeneration	B-Disease	1316
,	O	1316
cancer	B-Disease	1316
,	O	1316
immune	B-Disease	1316
defects	I-Disease	1316
,	O	1316
and	O	1316
hypersensitivity	B-Disease	1316
to	I-Disease	1316
ionizing	I-Disease	1316
radiation	I-Disease	1316
.	O	1316
the	O	1317
molecular	O	1317
details	O	1317
of	O	1317
atm	O	1317
function	O	1317
in	O	1317
the	O	1317
nervous	O	1317
system	O	1317
are	O	1317
unclear	O	1317
,	O	1317
although	O	1317
the	O	1317
neurological	B-Disease	1317
lesion	I-Disease	1317
in	O	1317
ataxia	B-Disease	1317
-	I-Disease	1317
telangiectasia	I-Disease	1317
becomes	O	1317
apparent	O	1317
early	O	1317
in	O	1317
life	O	1317
,	O	1317
suggesting	O	1317
a	O	1317
developmental	O	1317
origin	O	1317
.	O	1317
haim	B-Disease	1324
-	I-Disease	1324
munk	I-Disease	1324
syndrome	I-Disease	1324
and	O	1324
papillon	B-Disease	1324
-	I-Disease	1324
lefevre	I-Disease	1324
syndrome	I-Disease	1324
are	O	1324
allelic	O	1324
mutations	O	1324
in	O	1324
cathepsin	O	1324
c	O	1324
.	O	1324
of	O	1325
the	O	1325
many	O	1325
palmoplantar	B-Disease	1325
keratoderma	I-Disease	1325
(	I-Disease	1325
ppk	I-Disease	1325
)	I-Disease	1325
conditions	I-Disease	1325
,	O	1325
only	O	1325
papillon	B-Disease	1325
-	I-Disease	1325
lefevre	I-Disease	1325
syndrome	I-Disease	1325
(	O	1325
pls	B-Disease	1325
)	O	1325
and	O	1325
haim	B-Disease	1325
-	I-Disease	1325
munk	I-Disease	1325
syndrome	I-Disease	1325
(	O	1325
hms	B-Disease	1325
)	O	1325
are	O	1325
associated	O	1325
with	O	1325
premature	O	1325
periodontal	O	1325
destruction	O	1325
.	O	1325
although	O	1326
both	O	1326
pls	B-Disease	1326
and	O	1326
hms	B-Disease	1326
share	O	1326
the	O	1326
cardinal	O	1326
features	O	1326
of	O	1326
ppk	B-Disease	1326
and	O	1326
severe	O	1326
periodontitis	B-Disease	1326
,	O	1326
a	O	1326
number	O	1326
of	O	1326
additional	O	1326
findings	O	1326
are	O	1326
reported	O	1326
in	O	1326
hms	B-Disease	1326
including	O	1326
arachnodactyly	B-Disease	1326
,	O	1326
acro	B-Disease	1326
-	I-Disease	1326
osteolysis	I-Disease	1326
,	O	1326
atrophic	B-Disease	1326
changes	I-Disease	1326
of	I-Disease	1326
the	I-Disease	1326
nails	I-Disease	1326
,	O	1326
and	O	1326
a	O	1326
radiographic	B-Disease	1326
deformity	I-Disease	1326
of	I-Disease	1326
the	I-Disease	1326
fingers	I-Disease	1326
.	O	1326
while	O	1327
pls	B-Disease	1327
cases	O	1327
have	O	1327
been	O	1327
identified	O	1327
throughout	O	1327
the	O	1327
world	O	1327
,	O	1327
hms	B-Disease	1327
has	O	1327
only	O	1327
been	O	1327
described	O	1327
among	O	1327
descendants	O	1327
of	O	1327
a	O	1327
religious	O	1327
isolate	O	1327
originally	O	1327
from	O	1327
cochin	O	1327
,	O	1327
india	O	1327
.	O	1327
although	O	1329
autosomal	O	1329
recessive	O	1329
transmission	O	1329
of	O	1329
pls	B-Disease	1329
is	O	1329
evident	O	1329
,	O	1329
a	O	1329
more	O	1329
complex	O	1329
autosomal	O	1329
recessive	O	1329
pattern	O	1329
of	O	1329
inheritance	O	1329
with	O	1329
phenotypic	O	1329
influences	O	1329
from	O	1329
a	O	1329
closely	O	1329
linked	O	1329
modifying	O	1329
locus	O	1329
has	O	1329
been	O	1329
hypothesised	O	1329
for	O	1329
hms	B-Disease	1329
.	O	1329
recently	O	1330
,	O	1330
mutations	O	1330
of	O	1330
the	O	1330
cathepsin	O	1330
c	O	1330
gene	O	1330
have	O	1330
been	O	1330
identified	O	1330
as	O	1330
the	O	1330
underlying	O	1330
genetic	B-Disease	1330
defect	I-Disease	1330
in	O	1330
pls	B-Disease	1330
.	O	1330
to	O	1331
determine	O	1331
if	O	1331
a	O	1331
cathepsin	O	1331
c	O	1331
mutation	O	1331
is	O	1331
also	O	1331
responsible	O	1331
for	O	1331
hms	B-Disease	1331
,	O	1331
we	O	1331
sequenced	O	1331
the	O	1331
gene	O	1331
in	O	1331
affected	O	1331
and	O	1331
unaffected	O	1331
subjects	O	1331
from	O	1331
the	O	1331
cochin	O	1331
isolate	O	1331
in	O	1331
which	O	1331
both	O	1331
the	O	1331
pls	B-Disease	1331
and	O	1331
hms	B-Disease	1331
phenotypes	O	1331
appear	O	1331
.	O	1331
this	O	1333
mutation	O	1333
segregates	O	1333
with	O	1333
hms	B-Disease	1333
in	O	1333
four	O	1333
nuclear	O	1333
families	O	1333
.	O	1333
this	O	1335
finding	O	1335
supports	O	1335
simple	O	1335
autosomal	O	1335
recessive	O	1335
inheritance	O	1335
for	O	1335
hms	B-Disease	1335
in	O	1335
these	O	1335
families	O	1335
.	O	1335
we	O	1336
also	O	1336
report	O	1336
a	O	1336
mutation	O	1336
of	O	1336
the	O	1336
same	O	1336
exon	O	1336
6	O	1336
ctsc	O	1336
codon	O	1336
(	O	1336
2126c	O	1336
-	O	1336
-	O	1336
>	O	1336
t	O	1336
)	O	1336
in	O	1336
a	O	1336
turkish	O	1336
family	O	1336
with	O	1336
classical	O	1336
pls	B-Disease	1336
.	O	1336
these	O	1337
findings	O	1337
provide	O	1337
evidence	O	1337
that	O	1337
pls	B-Disease	1337
and	O	1337
hms	B-Disease	1337
are	O	1337
allelic	O	1337
variants	O	1337
of	O	1337
cathepsin	O	1337
c	O	1337
gene	O	1337
mutations	O	1337
.	O	1337
.	O	1337
atm	O	1338
-	O	1338
heterozygous	O	1338
germline	O	1338
mutations	O	1338
contribute	O	1338
to	O	1338
breast	B-Disease	1338
cancer	I-Disease	1338
-	O	1338
susceptibility	O	1338
.	O	1338
mutations	O	1341
in	O	1341
the	O	1341
atm	O	1341
gene	O	1341
are	O	1341
responsible	O	1341
for	O	1341
the	O	1341
autosomal	B-Disease	1341
recessive	I-Disease	1341
disorder	I-Disease	1341
ataxia	B-Disease	1341
-	I-Disease	1341
telangiectasia	I-Disease	1341
(	O	1341
a	B-Disease	1341
-	I-Disease	1341
t	I-Disease	1341
)	O	1341
(	O	1341
mim	O	1341
208900	O	1341
)	O	1341
.	O	1341
the	O	1342
finding	O	1342
that	O	1342
atm	O	1342
-	O	1342
heterozygotes	O	1342
have	O	1342
an	O	1342
increased	O	1342
relative	O	1342
risk	O	1342
for	O	1342
breast	B-Disease	1342
cancer	I-Disease	1342
was	O	1342
supported	O	1342
by	O	1342
some	O	1342
studies	O	1342
but	O	1342
not	O	1342
confirmed	O	1342
by	O	1342
others	O	1342
.	O	1342
in	O	1343
view	O	1343
of	O	1343
this	O	1343
discrepancy	O	1343
,	O	1343
we	O	1343
examined	O	1343
the	O	1343
frequency	O	1343
of	O	1343
atm	O	1343
germline	O	1343
mutations	O	1343
in	O	1343
a	O	1343
selected	O	1343
group	O	1343
of	O	1343
dutch	O	1343
patients	O	1343
with	O	1343
breast	B-Disease	1343
cancer	I-Disease	1343
.	O	1343
a	O	1345
high	O	1345
percentage	O	1345
of	O	1345
atm	O	1345
germline	O	1345
mutations	O	1345
was	O	1345
demonstrated	O	1345
among	O	1345
patients	O	1345
with	O	1345
sporadic	B-Disease	1345
breast	I-Disease	1345
cancer	I-Disease	1345
.	O	1345
the	O	1346
82	O	1346
patients	O	1346
included	O	1346
in	O	1346
this	O	1346
study	O	1346
had	O	1346
developed	O	1346
breast	B-Disease	1346
cancer	I-Disease	1346
at	O	1346
age	O	1346
<	O	1346
45	O	1346
and	O	1346
had	O	1346
survived	O	1346
>	O	1346
/	O	1346
=	O	1346
5	O	1346
years	O	1346
(	O	1346
mean	O	1346
15	O	1346
years	O	1346
)	O	1346
,	O	1346
and	O	1346
in	O	1346
33	O	1346
(	O	1346
40	O	1346
%	O	1346
)	O	1346
of	O	1346
the	O	1346
patients	O	1346
a	O	1346
contralateral	O	1346
breast	O	1346
tumor	O	1346
had	O	1346
been	O	1346
diagnosed	O	1346
.	O	1346
inherited	O	1355
g6pd	B-Disease	1355
deficiency	I-Disease	1355
is	O	1355
associated	O	1355
with	O	1355
either	O	1355
episodic	B-Disease	1355
hemolytic	I-Disease	1355
anemia	I-Disease	1355
(	O	1355
triggered	O	1355
by	O	1355
fava	O	1355
beans	O	1355
or	O	1355
other	O	1355
agents	O	1355
)	O	1355
or	O	1355
life	B-Disease	1355
-	I-Disease	1355
long	I-Disease	1355
hemolytic	I-Disease	1355
anemia	I-Disease	1355
.	O	1355
from	O	1357
the	O	1357
alignment	O	1357
of	O	1357
the	O	1357
amino	O	1357
acid	O	1357
(	O	1357
aa	O	1357
)	O	1357
sequence	O	1357
of	O	1357
52	O	1357
glucose	O	1357
6	O	1357
-	O	1357
phosphate	O	1357
dehydrogenase	O	1357
(	O	1357
g6pd	O	1357
)	O	1357
species	O	1357
from	O	1357
42	O	1357
different	O	1357
organisms	O	1357
,	O	1357
we	O	1357
found	O	1357
a	O	1357
striking	O	1357
correlation	O	1357
between	O	1357
the	O	1357
aa	O	1357
replacements	O	1357
that	O	1357
cause	O	1357
g6pd	B-Disease	1357
deficiency	I-Disease	1357
in	O	1357
humans	O	1357
and	O	1357
the	O	1357
sequence	O	1357
conservation	O	1357
of	O	1357
g6pd	O	1357
two	O	1357
-	O	1357
thirds	O	1357
of	O	1357
such	O	1357
replacements	O	1357
are	O	1357
in	O	1357
highly	O	1357
and	O	1357
moderately	O	1357
conserved	O	1357
(	O	1357
50	O	1357
-	O	1357
99	O	1357
%	O	1357
)	O	1357
aa	O	1357
;	O	1357
relatively	O	1357
few	O	1357
are	O	1357
in	O	1357
fully	O	1357
conserved	O	1357
aa	O	1357
(	O	1357
where	O	1357
they	O	1357
might	O	1357
be	O	1357
lethal	O	1357
)	O	1357
or	O	1357
in	O	1357
poorly	O	1357
conserved	O	1357
aa	O	1357
,	O	1357
where	O	1357
presumably	O	1357
they	O	1357
simply	O	1357
would	O	1357
not	O	1357
cause	O	1357
g6pd	B-Disease	1357
deficiency	I-Disease	1357
.	O	1357
constitutive	O	1361
and	O	1361
regulated	O	1361
modes	O	1361
of	O	1361
splicing	O	1361
produce	O	1361
six	O	1361
major	O	1361
myotonic	B-Disease	1361
dystrophy	I-Disease	1361
protein	O	1361
kinase	O	1361
(	O	1361
dmpk	O	1361
)	O	1361
isoforms	O	1361
with	O	1361
distinct	O	1361
properties	O	1361
.	O	1361
myotonic	B-Disease	1362
dystrophy	I-Disease	1362
(	O	1362
dm	B-Disease	1362
)	O	1362
is	O	1362
the	O	1362
most	O	1362
prevalent	O	1362
inherited	B-Disease	1362
neuromuscular	I-Disease	1362
disease	I-Disease	1362
in	O	1362
adults	O	1362
.	O	1362
the	O	1363
genetic	B-Disease	1363
defect	I-Disease	1363
is	O	1363
a	O	1363
ctg	O	1363
triplet	O	1363
repeat	O	1363
expansion	O	1363
in	O	1363
the	O	1363
3	O	1363
-	O	1363
untranslated	O	1363
region	O	1363
of	O	1363
the	O	1363
myotonic	B-Disease	1363
dystrophy	I-Disease	1363
protein	O	1363
kinase	O	1363
(	O	1363
dmpk	O	1363
)	O	1363
gene	O	1363
,	O	1363
consisting	O	1363
of	O	1363
15	O	1363
exons	O	1363
.	O	1363
information	O	1368
on	O	1368
dmpk	O	1368
mrna	O	1368
and	O	1368
protein	O	1368
isoform	O	1368
expression	O	1368
patterns	O	1368
will	O	1368
be	O	1368
useful	O	1368
for	O	1368
recognizing	O	1368
differential	O	1368
effects	O	1368
of	O	1368
(	O	1368
ctg	O	1368
)	O	1368
(	O	1368
n	O	1368
)	O	1368
expansion	O	1368
in	O	1368
dm	B-Disease	1368
manifestation	O	1368
.	O	1368
.	O	1368
genetic	O	1369
analysis	O	1369
,	O	1369
phenotypic	O	1369
diagnosis	O	1369
,	O	1369
and	O	1369
risk	O	1369
of	O	1369
venous	B-Disease	1369
thrombosis	I-Disease	1369
in	O	1369
families	O	1369
with	O	1369
inherited	O	1369
deficiencies	B-Disease	1369
of	I-Disease	1369
protein	I-Disease	1369
s	I-Disease	1369
.	O	1369
protein	B-Disease	1370
s	I-Disease	1370
deficiency	I-Disease	1370
is	O	1370
a	O	1370
recognized	O	1370
risk	O	1370
factor	O	1370
for	O	1370
venous	B-Disease	1370
thrombosis	I-Disease	1370
.	O	1370
of	O	1371
all	O	1371
the	O	1371
inherited	O	1371
thrombophilic	B-Disease	1371
conditions	I-Disease	1371
,	O	1371
it	O	1371
remains	O	1371
the	O	1371
most	O	1371
difficult	O	1371
to	O	1371
diagnose	O	1371
because	O	1371
of	O	1371
phenotypic	O	1371
variability	O	1371
,	O	1371
which	O	1371
can	O	1371
lead	O	1371
to	O	1371
inconclusive	O	1371
results	O	1371
.	O	1371
twenty	O	1373
-	O	1373
eight	O	1373
index	O	1373
patients	O	1373
with	O	1373
protein	B-Disease	1373
s	I-Disease	1373
deficiency	I-Disease	1373
and	O	1373
a	O	1373
pros1	B-Disease	1373
gene	I-Disease	1373
defect	I-Disease	1373
were	O	1373
studied	O	1373
,	O	1373
together	O	1373
with	O	1373
109	O	1373
first	O	1373
-	O	1373
degree	O	1373
relatives	O	1373
.	O	1373
in	O	1375
this	O	1375
group	O	1375
of	O	1375
relatives	O	1375
,	O	1375
a	O	1375
low	O	1375
free	O	1375
protein	O	1375
s	O	1375
level	O	1375
was	O	1375
the	O	1375
most	O	1375
reliable	O	1375
predictor	O	1375
of	O	1375
a	O	1375
pros1	B-Disease	1375
gene	I-Disease	1375
defect	I-Disease	1375
(	O	1375
sensitivity	O	1375
97	O	1375
.	O	1375
7	O	1375
%	O	1375
,	O	1375
specificity	O	1375
100	O	1375
%	O	1375
)	O	1375
.	O	1375
first	O	1376
-	O	1376
degree	O	1376
relatives	O	1376
with	O	1376
a	O	1376
pros1	B-Disease	1376
gene	I-Disease	1376
defect	I-Disease	1376
had	O	1376
a	O	1376
5	O	1376
.	O	1376
0	O	1377
-	O	1377
fold	O	1377
higher	O	1377
risk	O	1377
of	O	1377
thrombosis	B-Disease	1377
(	O	1377
95	O	1377
%	O	1377
confidence	O	1377
interval	O	1377
,	O	1377
1	O	1377
.	O	1377
5	O	1377
-	O	1377
16	O	1377
.	O	1377
8	O	1377
)	O	1377
than	O	1377
those	O	1377
with	O	1377
a	O	1377
normal	O	1377
pros1	O	1377
gene	O	1377
and	O	1377
no	O	1377
other	O	1377
recognized	O	1377
thrombophilic	B-Disease	1377
defect	I-Disease	1377
.	O	1377
although	O	1378
pregnancy	O	1378
/	O	1378
puerperium	O	1378
and	O	1378
immobility	O	1378
/	O	1378
trauma	B-Disease	1378
were	O	1378
important	O	1378
precipitating	O	1378
factors	O	1378
for	O	1378
thrombosis	B-Disease	1378
,	O	1378
almost	O	1378
half	O	1378
of	O	1378
the	O	1378
events	O	1378
were	O	1378
spontaneous	O	1378
.	O	1378
relatives	O	1379
with	O	1379
splice	O	1379
-	O	1379
site	O	1379
or	O	1379
major	O	1379
structural	O	1379
defects	B-Disease	1379
in	I-Disease	1379
the	I-Disease	1379
pros1	I-Disease	1379
gene	I-Disease	1379
were	O	1379
more	O	1379
likely	O	1379
to	O	1379
have	O	1379
had	O	1379
a	O	1379
thrombotic	O	1379
event	O	1379
and	O	1379
had	O	1379
significantly	O	1379
lower	O	1379
total	O	1379
and	O	1379
free	O	1379
protein	O	1379
s	O	1379
levels	O	1379
than	O	1379
those	O	1379
relatives	O	1379
having	O	1379
missense	O	1379
mutations	O	1379
.	O	1379
we	O	1380
conclude	O	1380
that	O	1380
persons	O	1380
with	O	1380
pros1	B-Disease	1380
gene	I-Disease	1380
defects	I-Disease	1380
and	O	1380
protein	B-Disease	1380
s	I-Disease	1380
deficiency	I-Disease	1380
are	O	1380
at	O	1380
increased	O	1380
risk	O	1380
of	O	1380
thrombosis	B-Disease	1380
and	O	1380
that	O	1380
free	O	1380
protein	O	1380
s	O	1380
estimation	O	1380
offers	O	1380
the	O	1380
most	O	1380
reliable	O	1380
way	O	1380
of	O	1380
diagnosing	O	1380
the	O	1380
deficiency	O	1380
.	O	1380
autoimmune	B-Disease	1382
lymphoproliferative	I-Disease	1382
syndrome	I-Disease	1382
(	O	1382
alps	B-Disease	1382
)	O	1382
in	O	1382
a	O	1382
child	O	1382
from	O	1382
consanguineous	O	1382
parents	O	1382
:	O	1382
a	O	1382
dominant	O	1382
or	O	1382
recessive	O	1382
disease	O	1382
?	O	1382
autoimmune	B-Disease	1383
lymphoproliferative	I-Disease	1383
syndrome	I-Disease	1383
(	O	1383
alps	B-Disease	1383
)	O	1383
is	O	1383
characterized	O	1383
by	O	1383
autoimmune	O	1383
features	O	1383
and	O	1383
lymphoproliferations	O	1383
and	O	1383
is	O	1383
generally	O	1383
caused	O	1383
by	O	1383
defective	O	1383
fas	O	1383
-	O	1383
mediated	O	1383
apoptosis	O	1383
.	O	1383
this	O	1384
report	O	1384
describes	O	1384
a	O	1384
child	O	1384
with	O	1384
clinical	O	1384
features	O	1384
of	O	1384
alps	B-Disease	1384
without	O	1384
detectable	O	1384
fas	O	1384
expression	O	1384
on	O	1384
freshly	O	1384
isolated	O	1384
blood	O	1384
leukocytes	O	1384
.	O	1384
the	O	1388
patient	O	1388
reported	O	1388
here	O	1388
is	O	1388
a	O	1388
human	O	1388
homologue	O	1388
of	O	1388
the	O	1388
fas	O	1388
-	O	1388
null	O	1388
mouse	O	1388
,	O	1388
inasmuch	O	1388
as	O	1388
she	O	1388
carries	O	1388
an	O	1388
autosomal	O	1388
homozygous	O	1388
mutation	O	1388
in	O	1388
the	O	1388
fas	O	1388
gene	O	1388
and	O	1388
she	O	1388
shows	O	1388
the	O	1388
severe	O	1388
and	O	1388
accelerated	O	1388
alps	B-Disease	1388
phenotype	O	1388
.	O	1388
the	O	1389
heterozygous	O	1389
family	O	1389
members	O	1389
did	O	1389
not	O	1389
have	O	1389
the	O	1389
alps	B-Disease	1389
phenotype	O	1389
,	O	1389
indicating	O	1389
that	O	1389
the	O	1389
disease	O	1389
-	O	1389
causing	O	1389
fas	O	1389
mutation	O	1389
in	O	1389
this	O	1389
family	O	1389
is	O	1389
autosomal	O	1389
recessive	O	1389
.	O	1389
.	O	1389
identification	O	1390
of	O	1390
novel	O	1390
imprinted	O	1390
transcripts	O	1390
in	O	1390
the	O	1390
prader	B-Disease	1390
-	I-Disease	1390
willi	I-Disease	1390
syndrome	I-Disease	1390
and	O	1390
angelman	B-Disease	1390
syndrome	I-Disease	1390
deletion	O	1390
region	O	1390
:	O	1390
further	O	1390
evidence	O	1390
for	O	1390
regional	O	1390
imprinting	O	1390
control	O	1390
.	O	1390
deletions	O	1391
and	O	1391
other	O	1391
abnormalities	O	1391
of	O	1391
human	O	1391
chromosome	O	1391
15q11	O	1391
-	O	1391
q13	O	1391
are	O	1391
associated	O	1391
with	O	1391
two	O	1391
developmental	O	1391
disorders	O	1391
,	O	1391
prader	B-Disease	1391
-	I-Disease	1391
willi	I-Disease	1391
syndrome	I-Disease	1391
(	O	1391
pws	B-Disease	1391
)	O	1391
and	O	1391
angelman	B-Disease	1391
syndrome	I-Disease	1391
(	O	1391
as	B-Disease	1391
)	O	1391
.	O	1391
loss	O	1392
of	O	1392
expression	O	1392
of	O	1392
imprinted	O	1392
,	O	1392
paternally	O	1392
expressed	O	1392
genes	O	1392
has	O	1392
been	O	1392
implicated	O	1392
in	O	1392
pws	B-Disease	1392
.	O	1392
however	O	1393
,	O	1393
the	O	1393
number	O	1393
of	O	1393
imprinted	O	1393
genes	O	1393
that	O	1393
contribute	O	1393
to	O	1393
pws	B-Disease	1393
,	O	1393
and	O	1393
the	O	1393
range	O	1393
over	O	1393
which	O	1393
the	O	1393
imprinting	O	1393
signal	O	1393
acts	O	1393
to	O	1393
silence	O	1393
one	O	1393
copy	O	1393
of	O	1393
the	O	1393
gene	O	1393
in	O	1393
a	O	1393
parent	O	1393
-	O	1393
of	O	1393
-	O	1393
origin	O	1393
-	O	1393
specific	O	1393
manner	O	1393
,	O	1393
are	O	1393
unknown	O	1393
.	O	1393
to	O	1394
identify	O	1394
additional	O	1394
imprinted	O	1394
genes	O	1394
that	O	1394
could	O	1394
contribute	O	1394
to	O	1394
the	O	1394
pws	B-Disease	1394
phenotype	O	1394
and	O	1394
to	O	1394
understand	O	1394
the	O	1394
regional	O	1394
control	O	1394
of	O	1394
imprinting	O	1394
in	O	1394
15q11	O	1394
-	O	1394
q13	O	1394
,	O	1394
we	O	1394
have	O	1394
constructed	O	1394
an	O	1394
imprinted	O	1394
transcript	O	1394
map	O	1394
of	O	1394
the	O	1394
pws	O	1394
-	O	1394
as	O	1394
deletion	O	1394
interval	O	1394
.	O	1394
combined	O	1401
analysis	O	1401
of	O	1401
hereditary	B-Disease	1401
prostate	I-Disease	1401
cancer	I-Disease	1401
linkage	O	1401
to	O	1401
1q24	O	1401
-	O	1401
25	O	1401
:	O	1401
results	O	1401
from	O	1401
772	O	1401
hereditary	B-Disease	1401
prostate	I-Disease	1401
cancer	I-Disease	1401
families	O	1401
from	O	1401
the	O	1401
international	O	1401
consortium	O	1401
for	O	1401
prostate	B-Disease	1401
cancer	I-Disease	1401
genetics	O	1401
.	O	1401
a	O	1402
previous	O	1402
linkage	O	1402
study	O	1402
provided	O	1402
evidence	O	1402
for	O	1402
a	O	1402
prostate	B-Disease	1402
cancer	I-Disease	1402
-	O	1402
susceptibility	O	1402
locus	O	1402
at	O	1402
1q24	O	1402
-	O	1402
25	O	1402
.	O	1402
in	O	1404
addition	O	1404
,	O	1404
evidence	O	1404
for	O	1404
locus	O	1404
heterogeneity	O	1404
has	O	1404
been	O	1404
provided	O	1404
by	O	1404
the	O	1404
identification	O	1404
of	O	1404
other	O	1404
putative	O	1404
hereditary	B-Disease	1404
prostate	I-Disease	1404
cancer	I-Disease	1404
loci	O	1404
on	O	1404
xq27	O	1404
-	O	1404
28	O	1404
,	O	1404
1q42	O	1404
-	O	1404
43	O	1404
,	O	1404
and	O	1404
1p36	O	1404
.	O	1404
the	O	1405
present	O	1405
study	O	1405
describes	O	1405
a	O	1405
combined	O	1405
analysis	O	1405
for	O	1405
six	O	1405
markers	O	1405
in	O	1405
the	O	1405
1q24	O	1405
-	O	1405
25	O	1405
region	O	1405
in	O	1405
772	O	1405
families	O	1405
affected	O	1405
by	O	1405
hereditary	B-Disease	1405
prostate	I-Disease	1405
cancer	I-Disease	1405
and	O	1405
ascertained	O	1405
by	O	1405
the	O	1405
members	O	1405
of	O	1405
the	O	1405
international	O	1405
consortium	O	1405
for	O	1405
prostate	B-Disease	1405
cancer	I-Disease	1405
genetics	O	1405
(	O	1405
icpcg	O	1405
)	O	1405
from	O	1405
north	O	1405
america	O	1405
,	O	1405
australia	O	1405
,	O	1405
finland	O	1405
,	O	1405
norway	O	1405
,	O	1405
sweden	O	1405
,	O	1405
and	O	1405
the	O	1405
united	O	1405
kingdom	O	1405
.	O	1405
these	O	1418
results	O	1418
support	O	1418
the	O	1418
finding	O	1418
of	O	1418
a	O	1418
prostate	B-Disease	1418
cancer	I-Disease	1418
-	O	1418
susceptibility	O	1418
gene	O	1418
linked	O	1418
to	O	1418
1q24	O	1418
-	O	1418
25	O	1418
,	O	1418
albeit	O	1418
in	O	1418
a	O	1418
defined	O	1418
subset	O	1418
of	O	1418
prostate	B-Disease	1418
cancer	I-Disease	1418
families	O	1418
.	O	1418
although	O	1419
hpc1	O	1419
accounts	O	1419
for	O	1419
only	O	1419
a	O	1419
small	O	1419
proportion	O	1419
of	O	1419
all	O	1419
families	O	1419
affected	O	1419
by	O	1419
hereditary	B-Disease	1419
prostate	I-Disease	1419
cancer	I-Disease	1419
,	O	1419
it	O	1419
appears	O	1419
to	O	1419
play	O	1419
a	O	1419
more	O	1419
prominent	O	1419
role	O	1419
in	O	1419
the	O	1419
subset	O	1419
of	O	1419
families	O	1419
with	O	1419
several	O	1419
members	O	1419
affected	O	1419
at	O	1419
an	O	1419
early	O	1419
age	O	1419
and	O	1419
with	O	1419
male	O	1419
-	O	1419
to	O	1419
-	O	1419
male	O	1419
disease	O	1419
transmission	O	1419
.	O	1419
a	O	1420
recurrent	O	1420
expansion	O	1420
of	O	1420
a	O	1420
maternal	O	1420
allele	O	1420
with	O	1420
36	O	1420
cag	O	1420
repeats	O	1420
causes	O	1420
huntington	B-Disease	1420
disease	I-Disease	1420
in	O	1420
two	O	1420
sisters	O	1420
.	O	1420
large	O	1421
intergenerational	O	1421
repeat	O	1421
expansions	O	1421
of	O	1421
the	O	1421
cag	O	1421
trinucleotide	O	1421
repeat	O	1421
in	O	1421
the	O	1421
hd	B-Disease	1421
gene	O	1421
have	O	1421
been	O	1421
well	O	1421
documented	O	1421
for	O	1421
the	O	1421
male	O	1421
germline	O	1421
.	O	1421
we	O	1422
describe	O	1422
a	O	1422
recurrent	O	1422
large	O	1422
expansion	O	1422
of	O	1422
a	O	1422
maternal	O	1422
allele	O	1422
with	O	1422
36	O	1422
cag	O	1422
repeats	O	1422
(	O	1422
to	O	1422
66	O	1422
and	O	1422
57	O	1422
repeats	O	1422
,	O	1422
respectively	O	1422
,	O	1422
in	O	1422
two	O	1422
daughters	O	1422
)	O	1422
associated	O	1422
with	O	1422
onset	O	1422
of	O	1422
huntington	B-Disease	1422
disease	I-Disease	1422
(	O	1422
hd	B-Disease	1422
)	O	1422
in	O	1422
the	O	1422
second	O	1422
and	O	1422
third	O	1422
decade	O	1422
in	O	1422
a	O	1422
family	O	1422
without	O	1422
history	O	1422
of	O	1422
hd	B-Disease	1422
.	O	1422
motor	B-Disease	1426
incoordination	I-Disease	1426
,	O	1426
immune	B-Disease	1426
deficiencies	I-Disease	1426
,	O	1426
and	O	1426
an	O	1426
increased	O	1426
risk	O	1426
of	O	1426
cancer	B-Disease	1426
are	O	1426
the	O	1426
characteristic	O	1426
features	O	1426
of	O	1426
the	O	1426
hereditary	B-Disease	1426
disease	I-Disease	1426
ataxia	B-Disease	1426
-	I-Disease	1426
telangiectasia	I-Disease	1426
(	O	1426
a	B-Disease	1426
-	I-Disease	1426
t	I-Disease	1426
)	O	1426
,	O	1426
which	O	1426
is	O	1426
caused	O	1426
by	O	1426
mutations	O	1426
in	O	1426
the	O	1426
atm	O	1426
gene	O	1426
.	O	1426
in	O	1428
contrast	O	1428
to	O	1428
other	O	1428
atm	O	1428
mutant	O	1428
mice	O	1428
,	O	1428
atm	O	1428
(	O	1428
y	O	1428
/	O	1428
y	O	1428
)	O	1428
mice	O	1428
show	O	1428
a	O	1428
lower	O	1428
incidence	O	1428
of	O	1428
thymic	B-Disease	1428
lymphoma	I-Disease	1428
and	O	1428
survive	O	1428
beyond	O	1428
a	O	1428
few	O	1428
months	O	1428
of	O	1428
age	O	1428
.	O	1428
atm	O	1429
(	O	1429
y	O	1429
/	O	1429
y	O	1429
)	O	1429
mice	O	1429
exhibit	O	1429
deficits	O	1429
in	O	1429
motor	O	1429
learning	O	1429
indicative	O	1429
of	O	1429
cerebellar	B-Disease	1429
dysfunction	I-Disease	1429
.	O	1429
even	O	1430
though	O	1430
we	O	1430
found	O	1430
no	O	1430
gross	O	1430
cerebellar	B-Disease	1430
degeneration	I-Disease	1430
in	O	1430
older	O	1430
atm	O	1430
(	O	1430
y	O	1430
/	O	1430
y	O	1430
)	O	1430
animals	O	1430
,	O	1430
ectopic	O	1430
and	O	1430
abnormally	O	1430
differentiated	O	1430
purkinje	O	1430
cells	O	1430
were	O	1430
apparent	O	1430
in	O	1430
mutant	O	1430
mice	O	1430
of	O	1430
all	O	1430
ages	O	1430
.	O	1430
these	O	1431
findings	O	1431
establish	O	1431
that	O	1431
some	O	1431
neuropathological	B-Disease	1431
abnormalities	I-Disease	1431
seen	O	1431
in	O	1431
a	B-Disease	1431
-	I-Disease	1431
t	I-Disease	1431
patients	O	1431
also	O	1431
are	O	1431
present	O	1431
in	O	1431
atm	O	1431
mutant	O	1431
mice	O	1431
.	O	1431
in	O	1432
addition	O	1432
,	O	1432
we	O	1432
report	O	1432
a	O	1432
previously	O	1432
unrecognized	O	1432
effect	O	1432
of	O	1432
atm	B-Disease	1432
deficiency	I-Disease	1432
on	O	1432
development	O	1432
or	O	1432
maintenance	O	1432
of	O	1432
cd4	O	1432
(	O	1432
+	O	1432
)	O	1432
8	O	1432
(	O	1432
+	O	1432
)	O	1432
thymocytes	O	1432
.	O	1432
we	O	1433
discuss	O	1433
these	O	1433
findings	O	1433
in	O	1433
the	O	1433
context	O	1433
of	O	1433
the	O	1433
hypothesis	O	1433
that	O	1433
abnormal	O	1433
development	O	1433
of	O	1433
purkinje	O	1433
cells	O	1433
and	O	1433
lymphocytes	O	1433
contributes	O	1433
to	O	1433
the	O	1433
pathogenesis	O	1433
of	O	1433
a	B-Disease	1433
-	I-Disease	1433
t	I-Disease	1433
.	O	1433
.	O	1433
novel	O	1434
mutations	O	1434
of	O	1434
the	O	1434
atp7b	O	1434
gene	O	1434
in	O	1434
japanese	O	1434
patients	O	1434
with	O	1434
wilson	B-Disease	1434
disease	I-Disease	1434
.	O	1434
wilson	B-Disease	1435
disease	I-Disease	1435
(	O	1435
wd	B-Disease	1435
)	O	1435
is	O	1435
an	O	1435
autosomal	B-Disease	1435
recessive	I-Disease	1435
disorder	I-Disease	1435
characterized	O	1435
by	O	1435
copper	O	1435
accumulation	O	1435
in	O	1435
the	O	1435
liver	O	1435
,	O	1435
brain	O	1435
,	O	1435
kidneys	O	1435
,	O	1435
and	O	1435
corneas	O	1435
,	O	1435
and	O	1435
culminating	O	1435
in	O	1435
copper	O	1435
toxication	O	1435
in	O	1435
these	O	1435
organs	O	1435
.	O	1435
in	O	1436
this	O	1436
study	O	1436
,	O	1436
we	O	1436
analyzed	O	1436
mutations	O	1436
of	O	1436
the	O	1436
responsible	O	1436
gene	O	1436
,	O	1436
atp7b	O	1436
,	O	1436
in	O	1436
four	O	1436
japanese	O	1436
patients	O	1436
with	O	1436
wd	B-Disease	1436
.	O	1436
therefore	O	1443
,	O	1443
the	O	1443
accumulation	O	1443
of	O	1443
the	O	1443
types	O	1443
of	O	1443
mutations	O	1443
in	O	1443
japanese	O	1443
patients	O	1443
with	O	1443
wd	B-Disease	1443
will	O	1443
facilitate	O	1443
the	O	1443
fast	O	1443
and	O	1443
effective	O	1443
genetic	O	1443
diagnosis	O	1443
of	O	1443
wd	B-Disease	1443
in	O	1443
japanese	O	1443
patients	O	1443
.	O	1443
.	O	1443
autoinhibition	O	1444
and	O	1444
activation	O	1444
mechanisms	O	1444
of	O	1444
the	O	1444
wiskott	B-Disease	1444
-	I-Disease	1444
aldrich	I-Disease	1444
syndrome	I-Disease	1444
protein	O	1444
.	O	1444
the	O	1445
rho	O	1445
-	O	1445
family	O	1445
gtpase	O	1445
,	O	1445
cdc42	O	1445
,	O	1445
can	O	1445
regulate	O	1445
the	O	1445
actin	O	1445
cytoskeleton	O	1445
through	O	1445
activation	O	1445
of	O	1445
wiskott	B-Disease	1445
-	I-Disease	1445
aldrich	I-Disease	1445
syndrome	I-Disease	1445
protein	O	1445
(	O	1445
wasp	O	1445
)	O	1445
family	O	1445
members	O	1445
.	O	1445
mutations	O	1452
in	O	1452
the	O	1452
brca1	O	1452
(	O	1452
ref	O	1452
.	O	1452
1	O	1452
)	O	1452
tumour	B-Disease	1452
suppressor	O	1452
gene	O	1452
are	O	1452
found	O	1452
in	O	1452
almost	O	1452
all	O	1452
of	O	1452
the	O	1452
families	O	1452
with	O	1452
inherited	B-Disease	1452
breast	I-Disease	1452
and	I-Disease	1452
ovarian	I-Disease	1452
cancers	I-Disease	1452
and	O	1452
about	O	1452
half	O	1452
of	O	1452
the	O	1452
families	O	1452
with	O	1452
only	O	1452
breast	B-Disease	1452
cancer	I-Disease	1452
.	O	1452
machado	B-Disease	1462
-	I-Disease	1462
joseph	I-Disease	1462
disease	I-Disease	1462
(	O	1462
mjd	B-Disease	1462
)	O	1462
belongs	O	1462
to	O	1462
a	O	1462
group	O	1462
of	O	1462
clinically	O	1462
and	O	1462
genetically	O	1462
heterogeneous	O	1462
neurodegenerative	B-Disease	1462
disorders	I-Disease	1462
characterized	O	1462
by	O	1462
progressive	B-Disease	1462
cerebellar	I-Disease	1462
ataxia	I-Disease	1462
.	O	1462
in	O	1464
caucasians	O	1464
,	O	1464
repeat	O	1464
expansions	O	1464
in	O	1464
the	O	1464
mjd1	O	1464
gene	O	1464
have	O	1464
also	O	1464
been	O	1464
found	O	1464
in	O	1464
patients	O	1464
with	O	1464
the	O	1464
clinically	O	1464
distinct	O	1464
autosomal	O	1464
dominant	O	1464
spinocerebellar	B-Disease	1464
ataxia	I-Disease	1464
type	I-Disease	1464
3	I-Disease	1464
(	O	1464
sca3	B-Disease	1464
)	O	1464
.	O	1464
analyzing	O	1474
the	O	1474
expression	O	1474
level	O	1474
of	O	1474
the	O	1474
sca3	O	1474
gene	O	1474
in	O	1474
several	O	1474
human	O	1474
brain	O	1474
sections	O	1474
revealed	O	1474
no	O	1474
significant	O	1474
higher	O	1474
mrna	O	1474
level	O	1474
in	O	1474
regions	O	1474
predominantly	O	1474
affected	O	1474
in	O	1474
mjd	B-Disease	1474
.	O	1474
thus	O	1475
additional	O	1475
molecules	O	1475
and	O	1475
/	O	1475
or	O	1475
regulatory	O	1475
events	O	1475
are	O	1475
necessary	O	1475
to	O	1475
explain	O	1475
the	O	1475
exclusive	O	1475
degeneration	B-Disease	1475
of	I-Disease	1475
certain	I-Disease	1475
brain	I-Disease	1475
areas	I-Disease	1475
.	O	1475
emerin	B-Disease	1476
,	I-Disease	1476
deficiency	I-Disease	1476
of	O	1476
which	O	1476
causes	O	1476
emery	B-Disease	1476
-	I-Disease	1476
dreifuss	I-Disease	1476
muscular	I-Disease	1476
dystrophy	I-Disease	1476
,	O	1476
is	O	1476
localized	O	1476
at	O	1476
the	O	1476
inner	O	1476
nuclear	O	1476
membrane	O	1476
.	O	1476
x	B-Disease	1477
-	I-Disease	1477
linked	I-Disease	1477
recessive	I-Disease	1477
emery	I-Disease	1477
-	I-Disease	1477
dreifuss	I-Disease	1477
muscular	I-Disease	1477
dystrophy	I-Disease	1477
(	O	1477
edmd	B-Disease	1477
)	O	1477
is	O	1477
an	O	1477
inherited	B-Disease	1477
muscle	I-Disease	1477
disorder	I-Disease	1477
characterized	O	1477
by	O	1477
the	O	1477
clinical	O	1477
triad	O	1477
of	O	1477
progressive	O	1477
wasting	B-Disease	1477
of	I-Disease	1477
humero	I-Disease	1477
-	I-Disease	1477
peroneal	I-Disease	1477
muscles	I-Disease	1477
,	O	1477
early	O	1477
contractures	B-Disease	1477
of	I-Disease	1477
the	I-Disease	1477
elbows	I-Disease	1477
,	I-Disease	1477
achilles	I-Disease	1477
tendons	I-Disease	1477
and	I-Disease	1477
postcervical	I-Disease	1477
muscles	I-Disease	1477
,	O	1477
and	O	1477
cardiac	B-Disease	1477
conduction	I-Disease	1477
block	I-Disease	1477
with	O	1477
a	O	1477
high	O	1477
risk	O	1477
of	O	1477
sudden	B-Disease	1477
death	I-Disease	1477
.	O	1477
the	O	1478
gene	O	1478
for	O	1478
edmd	B-Disease	1478
on	O	1478
xq28	O	1478
encodes	O	1478
a	O	1478
novel	O	1478
protein	O	1478
named	O	1478
emerin	O	1478
that	O	1478
localizes	O	1478
at	O	1478
the	O	1478
nuclear	O	1478
membrane	O	1478
of	O	1478
skeletal	O	1478
,	O	1478
cardiac	O	1478
and	O	1478
smooth	O	1478
muscles	O	1478
and	O	1478
some	O	1478
other	O	1478
non	O	1478
-	O	1478
muscle	O	1478
tissues	O	1478
.	O	1478
locus	O	1484
heterogeneity	O	1484
in	O	1484
friedreich	B-Disease	1484
ataxia	I-Disease	1484
.	O	1484
friedreich	B-Disease	1485
ataxia	I-Disease	1485
(	O	1485
frda	B-Disease	1485
)	O	1485
is	O	1485
the	O	1485
most	O	1485
common	O	1485
form	O	1485
of	O	1485
autosomal	B-Disease	1485
recessive	I-Disease	1485
ataxia	I-Disease	1485
.	O	1485
to	O	1487
date	O	1487
most	O	1487
data	O	1487
suggest	O	1487
locus	O	1487
homogeneity	O	1487
in	O	1487
frda	B-Disease	1487
.	O	1487
we	O	1488
now	O	1488
provide	O	1488
strong	O	1488
evidence	O	1488
of	O	1488
a	O	1488
second	O	1488
frda	B-Disease	1488
locus	O	1488
.	O	1488
studying	O	1489
two	O	1489
siblings	O	1489
with	O	1489
frda	B-Disease	1489
from	O	1489
two	O	1489
families	O	1489
we	O	1489
did	O	1489
not	O	1489
detect	O	1489
a	O	1489
mutation	O	1489
in	O	1489
stm7	O	1489
/	O	1489
x25	O	1489
.	O	1489
although	O	1491
the	O	1491
patients	O	1491
studied	O	1491
had	O	1491
typical	O	1491
frda	B-Disease	1491
,	O	1491
one	O	1491
sibpair	O	1491
had	O	1491
the	O	1491
uncommon	O	1491
symptom	O	1491
of	O	1491
retained	O	1491
tendon	O	1491
reflexes	O	1491
.	O	1491
in	O	1492
order	O	1492
to	O	1492
investigate	O	1492
whether	O	1492
retained	O	1492
tendon	O	1492
reflexes	O	1492
are	O	1492
characteristic	O	1492
of	O	1492
frda	B-Disease	1492
caused	O	1492
by	O	1492
the	O	1492
second	O	1492
locus	O	1492
,	O	1492
frda2	O	1492
,	O	1492
we	O	1492
studied	O	1492
an	O	1492
unrelated	O	1492
frda	B-Disease	1492
patient	O	1492
with	O	1492
retained	O	1492
tendon	O	1492
reflexes	O	1492
.	O	1492
the	O	1493
observation	O	1493
of	O	1493
typical	O	1493
mutations	O	1493
in	O	1493
stm7	O	1493
/	O	1493
x25	O	1493
(	O	1493
gaa	O	1493
expansions	O	1493
)	O	1493
in	O	1493
this	O	1493
patient	O	1493
demonstrates	O	1493
that	O	1493
the	O	1493
two	O	1493
genetically	O	1493
different	O	1493
forms	O	1493
of	O	1493
frda	B-Disease	1493
cannot	O	1493
be	O	1493
distinguished	O	1493
clinically	O	1493
.	O	1493
.	O	1493
glycerol	O	1494
as	O	1494
a	O	1494
correlate	O	1494
of	O	1494
impaired	B-Disease	1494
glucose	I-Disease	1494
tolerance	I-Disease	1494
:	O	1494
dissection	O	1494
of	O	1494
a	O	1494
complex	O	1494
system	O	1494
by	O	1494
use	O	1494
of	O	1494
a	O	1494
simple	O	1494
genetic	O	1494
trait	O	1494
.	O	1494
impaired	B-Disease	1496
glucose	I-Disease	1496
tolerance	I-Disease	1496
(	O	1496
igt	B-Disease	1496
)	O	1496
and	O	1496
hypertriglyceridemia	B-Disease	1496
are	O	1496
associated	O	1496
with	O	1496
an	O	1496
increased	O	1496
risk	O	1496
of	O	1496
diabetes	B-Disease	1496
mellitus	I-Disease	1496
and	O	1496
cardiovascular	B-Disease	1496
disease	I-Disease	1496
.	O	1496
the	O	1497
relationship	O	1497
between	O	1497
glycerol	O	1497
and	O	1497
the	O	1497
risk	O	1497
of	O	1497
igt	B-Disease	1497
,	O	1497
however	O	1497
,	O	1497
is	O	1497
poorly	O	1497
understood	O	1497
.	O	1497
family	O	1499
screening	O	1499
in	O	1499
the	O	1499
initial	O	1499
cohort	O	1499
identified	O	1499
18	O	1499
men	O	1499
from	O	1499
five	O	1499
families	O	1499
with	O	1499
severe	O	1499
hyperglycerolemia	B-Disease	1499
(	O	1499
values	O	1499
above	O	1499
2	O	1499
.	O	1499
0	O	1499
mmol	O	1499
/	O	1499
liter	O	1499
)	O	1499
and	O	1499
demonstrated	O	1499
an	O	1499
x	O	1499
-	O	1499
linked	O	1499
pattern	O	1499
of	O	1499
inheritance	O	1499
.	O	1499
clinical	O	1508
and	O	1508
molecular	O	1508
genetics	O	1508
of	O	1508
primary	B-Disease	1508
dystonias	I-Disease	1508
.	O	1508
primary	B-Disease	1509
dystonias	I-Disease	1509
are	O	1509
movement	B-Disease	1509
disorders	I-Disease	1509
with	O	1509
dystonia	B-Disease	1509
as	O	1509
a	O	1509
major	O	1509
symptom	O	1509
.	O	1509
to	O	1514
date	O	1514
gene	O	1514
loci	O	1514
have	O	1514
been	O	1514
identified	O	1514
in	O	1514
at	O	1514
least	O	1514
six	O	1514
autosomal	O	1514
dominant	O	1514
forms	O	1514
,	O	1514
i	O	1514
.	O	1514
e	O	1514
.	O	1514
,	O	1514
in	O	1514
idiopathic	B-Disease	1514
torsion	I-Disease	1514
dystonia	I-Disease	1514
(	O	1514
9q34	O	1514
)	O	1514
,	O	1514
focal	B-Disease	1514
dystonia	I-Disease	1514
(	O	1514
18p	O	1514
)	O	1514
,	O	1514
adult	O	1514
-	O	1514
onset	O	1514
idiopathic	B-Disease	1514
torsion	I-Disease	1514
dystonia	I-Disease	1514
of	O	1514
mixed	O	1514
type	O	1514
(	O	1514
8p21	O	1514
-	O	1514
q22	O	1514
)	O	1514
,	O	1514
dopa	B-Disease	1514
-	I-Disease	1514
responsive	I-Disease	1514
dystonia	I-Disease	1514
(	O	1514
14q22	O	1514
.	O	1514
1	O	1514
-	O	1514
q22	O	1514
.	O	1514
2	O	1514
)	O	1514
,	O	1514
and	O	1514
paroxysmal	B-Disease	1514
dystonic	I-Disease	1514
choreoathetosis	I-Disease	1514
(	O	1514
2q25	O	1514
-	O	1514
q33	O	1514
;	O	1514
1p21	O	1514
-	O	1514
p13	O	1514
.	O	1514
3	O	1514
)	O	1514
.	O	1514
1	O	1516
in	O	1516
the	O	1516
x	B-Disease	1516
-	I-Disease	1516
linked	I-Disease	1516
dystonia	I-Disease	1516
parkinsonism	I-Disease	1516
syndrome	I-Disease	1516
and	O	1516
to	O	1516
xq22	O	1516
in	O	1516
x	B-Disease	1516
-	I-Disease	1516
linked	I-Disease	1516
sensorineural	I-Disease	1516
deafness	I-Disease	1516
,	O	1516
dystonia	B-Disease	1516
,	O	1516
and	O	1516
mental	B-Disease	1516
retardation	I-Disease	1516
.	O	1516
mutations	O	1518
in	O	1518
a	O	1518
gene	O	1518
coding	O	1518
for	O	1518
an	O	1518
atp	O	1518
-	O	1518
binding	O	1518
protein	O	1518
were	O	1518
detected	O	1518
in	O	1518
idiopathic	B-Disease	1518
torsion	I-Disease	1518
dystonia	I-Disease	1518
(	O	1518
dyt1	O	1518
)	O	1518
,	O	1518
and	O	1518
the	O	1518
gtp	O	1518
cyclohydrolase	O	1518
1	O	1518
gene	O	1518
is	O	1518
mutated	O	1518
in	O	1518
dopa	B-Disease	1518
-	I-Disease	1518
responsive	I-Disease	1518
dystonia	I-Disease	1518
(	O	1518
dyt5	O	1518
)	O	1518
.	O	1518
in	O	1519
sensorineural	B-Disease	1519
deafness	I-Disease	1519
,	O	1519
dystonia	B-Disease	1519
,	O	1519
and	O	1519
mental	B-Disease	1519
retardation	I-Disease	1519
,	O	1519
mutations	O	1519
were	O	1519
found	O	1519
in	O	1519
the	O	1519
gene	O	1519
ddp	O	1519
coding	O	1519
for	O	1519
a	O	1519
polypeptide	O	1519
of	O	1519
unknown	O	1519
function	O	1519
.	O	1519
this	O	1520
article	O	1520
reviews	O	1520
the	O	1520
clinical	O	1520
and	O	1520
molecular	O	1520
genetics	O	1520
of	O	1520
primary	B-Disease	1520
dystonias	I-Disease	1520
,	O	1520
critically	O	1520
discusses	O	1520
present	O	1520
findings	O	1520
,	O	1520
and	O	1520
proposes	O	1520
referring	O	1520
to	O	1520
the	O	1520
known	O	1520
forms	O	1520
,	O	1520
most	O	1520
of	O	1520
which	O	1520
can	O	1520
be	O	1520
distinguished	O	1520
by	O	1520
genetic	O	1520
criteria	O	1520
,	O	1520
as	O	1520
dystonias	B-Disease	1520
1	I-Disease	1520
-	I-Disease	1520
12	I-Disease	1520
.	O	1520
determination	O	1521
of	O	1521
30	O	1521
x	B-Disease	1521
-	I-Disease	1521
linked	I-Disease	1521
adrenoleukodystrophy	I-Disease	1521
mutations	O	1521
,	O	1521
including	O	1521
15	O	1521
not	O	1521
previously	O	1521
described	O	1521
.	O	1521
x	B-Disease	1522
-	I-Disease	1522
linked	I-Disease	1522
adrenoleukodystrophy	I-Disease	1522
(	O	1522
x	B-Disease	1522
-	I-Disease	1522
ald	I-Disease	1522
)	O	1522
is	O	1522
the	O	1522
most	O	1522
frequent	O	1522
peroxisomal	B-Disease	1522
disease	I-Disease	1522
.	O	1522
of	O	1530
particular	O	1530
concern	O	1530
are	O	1530
female	O	1530
members	O	1530
of	O	1530
kindreds	O	1530
segregating	O	1530
x	B-Disease	1530
-	I-Disease	1530
ald	I-Disease	1530
mutations	O	1530
,	O	1530
because	O	1530
normal	O	1530
vlcfa	O	1530
levels	O	1530
do	O	1530
not	O	1530
guarantee	O	1530
lack	O	1530
of	O	1530
carrier	O	1530
status	O	1530
.	O	1530
we	O	1531
describe	O	1531
a	O	1531
fast	O	1531
method	O	1531
for	O	1531
detection	O	1531
of	O	1531
x	B-Disease	1531
-	I-Disease	1531
ald	I-Disease	1531
mutations	O	1531
.	O	1531
using	O	1533
this	O	1533
methodology	O	1533
we	O	1533
have	O	1533
found	O	1533
x	B-Disease	1533
-	I-Disease	1533
ald	I-Disease	1533
mutations	O	1533
in	O	1533
30	O	1533
kindreds	O	1533
,	O	1533
including	O	1533
15	O	1533
not	O	1533
previously	O	1533
reported	O	1533
.	O	1533
beta	O	1534
-	O	1534
galactosidase	O	1534
gene	O	1534
mutations	O	1534
affecting	O	1534
the	O	1534
lysosomal	O	1534
enzyme	O	1534
and	O	1534
the	O	1534
elastin	O	1534
-	O	1534
binding	O	1534
protein	O	1534
in	O	1534
gm1	B-Disease	1534
-	I-Disease	1534
gangliosidosis	I-Disease	1534
patients	O	1534
with	O	1534
cardiac	B-Disease	1534
involvement	I-Disease	1534
.	O	1534
gm1	B-Disease	1535
-	I-Disease	1535
gangliosidosis	I-Disease	1535
is	O	1535
a	O	1535
lysosomal	B-Disease	1535
storage	I-Disease	1535
disorder	I-Disease	1535
caused	O	1535
by	O	1535
deficiency	B-Disease	1535
of	I-Disease	1535
acid	I-Disease	1535
beta	I-Disease	1535
-	I-Disease	1535
galactosidase	I-Disease	1535
(	O	1535
glb1	O	1535
)	O	1535
.	O	1535
six	O	1537
of	O	1537
the	O	1537
eight	O	1537
patients	O	1537
with	O	1537
the	O	1537
infantile	O	1537
,	O	1537
severe	O	1537
form	O	1537
of	O	1537
the	O	1537
disease	O	1537
presented	O	1537
cardiac	B-Disease	1537
involvement	I-Disease	1537
,	O	1537
a	O	1537
feature	O	1537
rarely	O	1537
associated	O	1537
with	O	1537
gm1	B-Disease	1537
-	I-Disease	1537
gangliosidosis	I-Disease	1537
.	O	1537
interestingly	O	1539
,	O	1539
all	O	1539
patients	O	1539
with	O	1539
cardiac	B-Disease	1539
involvement	I-Disease	1539
were	O	1539
homozygous	O	1539
for	O	1539
one	O	1539
of	O	1539
these	O	1539
mutations	O	1539
r59h	O	1539
,	O	1539
y591c	O	1539
,	O	1539
y591n	O	1539
,	O	1539
or	O	1539
ivs14	O	1539
-	O	1539
2a	O	1539
>	O	1539
g	O	1539
.	O	1539
although	O	1541
we	O	1541
could	O	1541
not	O	1541
directly	O	1541
correlate	O	1541
the	O	1541
presence	O	1541
of	O	1541
cardiac	B-Disease	1541
abnormalities	I-Disease	1541
with	O	1541
specific	O	1541
genetic	B-Disease	1541
lesions	I-Disease	1541
,	O	1541
the	O	1541
mutations	O	1541
identified	O	1541
in	O	1541
patients	O	1541
with	O	1541
cardiomyopathy	B-Disease	1541
fell	O	1541
in	O	1541
the	O	1541
glb1	O	1541
cdna	O	1541
region	O	1541
common	O	1541
to	O	1541
the	O	1541
lysosomal	O	1541
enzyme	O	1541
and	O	1541
the	O	1541
hbeta	O	1541
-	O	1541
gal	O	1541
-	O	1541
related	O	1541
protein	O	1541
,	O	1541
also	O	1541
known	O	1541
as	O	1541
the	O	1541
elastin	O	1541
binding	O	1541
protein	O	1541
(	O	1541
ebp	O	1541
)	O	1541
.	O	1541
in	O	1543
vivo	O	1543
modulation	O	1543
of	O	1543
hmgic	O	1543
reduces	O	1543
obesity	B-Disease	1543
.	O	1543
it	O	1546
is	O	1546
disrupted	O	1546
and	O	1546
misexpressed	O	1546
in	O	1546
a	O	1546
number	O	1546
of	O	1546
mesenchymal	B-Disease	1546
tumour	I-Disease	1546
cell	O	1546
types	O	1546
,	O	1546
including	O	1546
fat	B-Disease	1546
-	I-Disease	1546
cell	I-Disease	1546
tumours	I-Disease	1546
(	O	1546
lipomas	B-Disease	1546
)	O	1546
.	O	1546
to	O	1548
study	O	1548
its	O	1548
role	O	1548
in	O	1548
adipogenesis	O	1548
and	O	1548
obesity	B-Disease	1548
,	O	1548
we	O	1548
examined	O	1548
hmgic	O	1548
expression	O	1548
in	O	1548
the	O	1548
adipose	O	1548
tissue	O	1548
of	O	1548
adult	O	1548
,	O	1548
obese	B-Disease	1548
mice	O	1548
.	O	1548
mice	O	1549
with	O	1549
a	O	1549
partial	B-Disease	1549
or	I-Disease	1549
complete	I-Disease	1549
deficiency	I-Disease	1549
of	I-Disease	1549
hmgic	I-Disease	1549
resisted	O	1549
diet	O	1549
-	O	1549
induced	O	1549
obesity	B-Disease	1549
.	O	1549
disruption	O	1550
of	O	1550
hmgic	O	1550
caused	O	1550
a	O	1550
reduction	O	1550
in	O	1550
the	O	1550
obesity	B-Disease	1550
induced	O	1550
by	O	1550
leptin	B-Disease	1550
deficiency	I-Disease	1550
(	O	1550
lepob	O	1550
/	O	1550
lepob	O	1550
)	O	1550
in	O	1550
a	O	1550
gene	O	1550
-	O	1550
dose	O	1550
-	O	1550
dependent	O	1550
manner	O	1550
.	O	1550
our	O	1551
studies	O	1551
implicate	O	1551
a	O	1551
role	O	1551
for	O	1551
hmgic	O	1551
in	O	1551
fat	O	1551
-	O	1551
cell	O	1551
proliferation	O	1551
,	O	1551
indicating	O	1551
that	O	1551
it	O	1551
may	O	1551
be	O	1551
an	O	1551
adipose	O	1551
-	O	1551
specific	O	1551
target	O	1551
for	O	1551
the	O	1551
treatment	O	1551
of	O	1551
obesity	B-Disease	1551
.	O	1551
.	O	1551
molecular	O	1552
analysis	O	1552
of	O	1552
the	O	1552
genotype	O	1552
-	O	1552
phenotype	O	1552
relationship	O	1552
in	O	1552
factor	B-Disease	1552
x	I-Disease	1552
deficiency	I-Disease	1552
.	O	1552
factor	B-Disease	1553
x	I-Disease	1553
deficiency	I-Disease	1553
is	O	1553
a	O	1553
rare	O	1553
haemorrhagic	B-Disease	1553
condition	I-Disease	1553
,	O	1553
normally	O	1553
inherited	O	1553
as	O	1553
an	O	1553
autosomal	O	1553
recessive	O	1553
trait	O	1553
,	O	1553
in	O	1553
which	O	1553
a	O	1553
variable	O	1553
clinical	O	1553
presentation	O	1553
correlates	O	1553
poorly	O	1553
with	O	1553
laboratory	O	1553
phenotype	O	1553
.	O	1553
the	O	1554
factor	O	1554
x	O	1554
(	O	1554
f10	O	1554
)	O	1554
genes	O	1554
of	O	1554
14	O	1554
unrelated	O	1554
individuals	O	1554
with	O	1554
factor	B-Disease	1554
x	I-Disease	1554
deficiency	I-Disease	1554
(	O	1554
12	O	1554
familial	O	1554
and	O	1554
two	O	1554
sporadic	O	1554
cases	O	1554
)	O	1554
were	O	1554
sequenced	O	1554
yielding	O	1554
a	O	1554
total	O	1554
of	O	1554
13	O	1554
novel	O	1554
mutations	O	1554
.	O	1554
transgenic	O	1562
mice	O	1562
expressing	O	1562
a	O	1562
truncated	O	1562
form	O	1562
of	O	1562
the	O	1562
high	O	1562
mobility	O	1562
group	O	1562
i	O	1562
-	O	1562
c	O	1562
protein	O	1562
develop	O	1562
adiposity	O	1562
and	O	1562
an	O	1562
abnormally	O	1562
high	O	1562
prevalence	O	1562
of	O	1562
lipomas	B-Disease	1562
.	O	1562
chromosomal	O	1563
translocations	O	1563
in	O	1563
human	O	1563
lipomas	B-Disease	1563
frequently	O	1563
create	O	1563
fusion	O	1563
transcripts	O	1563
encoding	O	1563
high	O	1563
mobility	O	1563
group	O	1563
(	O	1563
hmg	O	1563
)	O	1563
i	O	1563
-	O	1563
c	O	1563
dna	O	1563
-	O	1563
binding	O	1563
domains	O	1563
and	O	1563
c	O	1563
-	O	1563
terminal	O	1563
sequences	O	1563
from	O	1563
different	O	1563
presumed	O	1563
transcription	O	1563
factors	O	1563
,	O	1563
suggesting	O	1563
a	O	1563
potential	O	1563
role	O	1563
for	O	1563
hmg	O	1563
i	O	1563
-	O	1563
c	O	1563
in	O	1563
the	O	1563
development	O	1563
of	O	1563
lipomas	B-Disease	1563
.	O	1563
despite	O	1565
the	O	1565
ubiquitous	O	1565
expression	O	1565
of	O	1565
the	O	1565
truncated	O	1565
hmg	O	1565
i	O	1565
-	O	1565
c	O	1565
protein	O	1565
,	O	1565
the	O	1565
transgenic	O	1565
mice	O	1565
develop	O	1565
a	O	1565
selective	O	1565
abundance	O	1565
of	O	1565
fat	O	1565
tissue	O	1565
early	O	1565
in	O	1565
life	O	1565
,	O	1565
show	O	1565
marked	O	1565
adipose	B-Disease	1565
tissue	I-Disease	1565
inflammation	I-Disease	1565
,	O	1565
and	O	1565
have	O	1565
an	O	1565
abnormally	O	1565
high	O	1565
incidence	O	1565
of	O	1565
lipomas	B-Disease	1565
.	O	1565
these	O	1566
findings	O	1566
demonstrate	O	1566
that	O	1566
the	O	1566
dna	O	1566
-	O	1566
binding	O	1566
domains	O	1566
of	O	1566
hmg	O	1566
i	O	1566
-	O	1566
c	O	1566
,	O	1566
in	O	1566
the	O	1566
absence	O	1566
of	O	1566
a	O	1566
c	O	1566
-	O	1566
terminal	O	1566
fusion	O	1566
partner	O	1566
,	O	1566
are	O	1566
sufficient	O	1566
to	O	1566
perturb	O	1566
adipogenesis	O	1566
and	O	1566
predispose	O	1566
to	O	1566
lipomas	B-Disease	1566
.	O	1566
we	O	1567
provide	O	1567
data	O	1567
supporting	O	1567
the	O	1567
central	O	1567
utility	O	1567
of	O	1567
this	O	1567
animal	O	1567
model	O	1567
as	O	1567
a	O	1567
tool	O	1567
to	O	1567
understand	O	1567
the	O	1567
molecular	O	1567
mechanisms	O	1567
underlying	O	1567
the	O	1567
development	O	1567
of	O	1567
one	O	1567
of	O	1567
the	O	1567
most	O	1567
common	O	1567
kind	O	1567
of	O	1567
human	O	1567
benign	B-Disease	1567
tumors	I-Disease	1567
.	O	1567
.	O	1567
the	O	1569
rare	B-Disease	1569
diseases	I-Disease	1569
ataxia	B-Disease	1569
-	I-Disease	1569
telangiectasia	I-Disease	1569
(	O	1569
at	B-Disease	1569
)	O	1569
,	O	1569
caused	O	1569
by	O	1569
mutations	O	1569
in	O	1569
the	O	1569
atm	O	1569
gene	O	1569
,	O	1569
and	O	1569
nijmegen	B-Disease	1569
breakage	I-Disease	1569
syndrome	I-Disease	1569
(	O	1569
nbs	B-Disease	1569
)	O	1569
,	O	1569
with	O	1569
mutations	O	1569
in	O	1569
the	O	1569
p95	O	1569
/	O	1569
nbs1	O	1569
gene	O	1569
,	O	1569
share	O	1569
a	O	1569
variety	O	1569
of	O	1569
phenotypic	B-Disease	1569
abnormalities	I-Disease	1569
such	O	1569
as	O	1569
chromosomal	B-Disease	1569
instability	I-Disease	1569
,	O	1569
radiation	O	1569
sensitivity	O	1569
and	O	1569
defects	O	1569
in	O	1569
cell	O	1569
-	O	1569
cycle	O	1569
checkpoints	O	1569
in	O	1569
response	O	1569
to	O	1569
ionizing	O	1569
radiation	O	1569
.	O	1569
here	O	1571
,	O	1571
because	O	1571
of	O	1571
the	O	1571
similarities	O	1571
between	O	1571
at	B-Disease	1571
and	O	1571
nbs	B-Disease	1571
,	O	1571
we	O	1571
evaluated	O	1571
the	O	1571
functional	O	1571
interactions	O	1571
between	O	1571
atm	O	1571
and	O	1571
p95	O	1571
/	O	1571
nbs1	O	1571
.	O	1571
activation	O	1572
of	O	1572
the	O	1572
atm	O	1572
kinase	O	1572
by	O	1572
ionizing	O	1572
radiation	O	1572
and	O	1572
induction	O	1572
of	O	1572
atm	O	1572
-	O	1572
dependent	O	1572
responses	O	1572
in	O	1572
nbs	B-Disease	1572
cells	O	1572
indicated	O	1572
that	O	1572
p95	O	1572
/	O	1572
nbs1	O	1572
may	O	1572
not	O	1572
be	O	1572
required	O	1572
for	O	1572
signalling	O	1572
to	O	1572
atm	O	1572
after	O	1572
ionizing	O	1572
radiation	O	1572
.	O	1572
a	O	1574
p95	O	1574
/	O	1574
nbs1	O	1574
construct	O	1574
mutated	O	1574
at	O	1574
the	O	1574
atm	O	1574
phosphorylation	O	1574
site	O	1574
abrogated	O	1574
an	O	1574
s	O	1574
-	O	1574
phase	O	1574
checkpoint	O	1574
induced	O	1574
by	O	1574
ionizing	O	1574
radiation	O	1574
in	O	1574
normal	O	1574
cells	O	1574
and	O	1574
failed	O	1574
to	O	1574
compensate	O	1574
for	O	1574
this	O	1574
functional	O	1574
deficiency	O	1574
in	O	1574
nbs	B-Disease	1574
cells	O	1574
.	O	1574
understanding	O	1576
the	O	1576
molecular	O	1576
basis	O	1576
of	O	1576
fragile	B-Disease	1576
x	I-Disease	1576
syndrome	I-Disease	1576
.	O	1576
fragile	B-Disease	1577
x	I-Disease	1577
syndrome	I-Disease	1577
,	O	1577
a	O	1577
common	O	1577
form	O	1577
of	O	1577
inherited	B-Disease	1577
mental	I-Disease	1577
retardation	I-Disease	1577
,	O	1577
is	O	1577
mainly	O	1577
caused	O	1577
by	O	1577
massive	O	1577
expansion	O	1577
of	O	1577
cgg	O	1577
triplet	O	1577
repeats	O	1577
located	O	1577
in	O	1577
the	O	1577
5	O	1577
-	O	1577
untranslated	O	1577
region	O	1577
of	O	1577
the	O	1577
fragile	B-Disease	1577
x	I-Disease	1577
mental	I-Disease	1577
retardation	I-Disease	1577
-	O	1577
1	O	1577
(	O	1577
fmr1	O	1577
)	O	1577
gene	O	1577
.	O	1577
in	O	1578
patients	O	1578
with	O	1578
fragile	B-Disease	1578
x	I-Disease	1578
syndrome	I-Disease	1578
,	O	1578
the	O	1578
expanded	O	1578
cgg	O	1578
triplet	O	1578
repeats	O	1578
are	O	1578
hypermethylated	O	1578
and	O	1578
the	O	1578
expression	O	1578
of	O	1578
the	O	1578
fmr1	O	1578
gene	O	1578
is	O	1578
repressed	O	1578
,	O	1578
which	O	1578
leads	O	1578
to	O	1578
the	O	1578
absence	O	1578
of	O	1578
fmr1	O	1578
protein	O	1578
(	O	1578
fmrp	O	1578
)	O	1578
and	O	1578
subsequent	O	1578
mental	B-Disease	1578
retardation	I-Disease	1578
.	O	1578
haploinsufficiency	B-Disease	1583
of	I-Disease	1583
the	I-Disease	1583
transcription	I-Disease	1583
factors	I-Disease	1583
foxc1	I-Disease	1583
and	I-Disease	1583
foxc2	I-Disease	1583
results	O	1583
in	O	1583
aberrant	O	1583
ocular	O	1583
development	O	1583
.	O	1583
anterior	B-Disease	1584
segment	I-Disease	1584
developmental	I-Disease	1584
disorders	I-Disease	1584
,	O	1584
including	O	1584
axenfeld	B-Disease	1584
-	I-Disease	1584
rieger	I-Disease	1584
anomaly	I-Disease	1584
(	O	1584
ara	B-Disease	1584
)	O	1584
,	O	1584
variably	O	1584
associate	O	1584
with	O	1584
harmfully	O	1584
elevated	O	1584
intraocular	O	1584
pressure	O	1584
(	O	1584
iop	O	1584
)	O	1584
,	O	1584
which	O	1584
causes	O	1584
glaucoma	B-Disease	1584
.	O	1584
clinically	O	1585
observed	O	1585
dysgenesis	O	1585
does	O	1585
not	O	1585
correlate	O	1585
with	O	1585
iop	O	1585
,	O	1585
however	O	1585
,	O	1585
and	O	1585
the	O	1585
etiology	O	1585
of	O	1585
glaucoma	B-Disease	1585
development	O	1585
is	O	1585
not	O	1585
understood	O	1585
.	O	1585
mutations	O	1587
in	O	1587
the	O	1587
human	O	1587
homolog	O	1587
of	O	1587
foxc1	O	1587
,	O	1587
fkhl7	O	1587
,	O	1587
cause	O	1587
dominant	O	1587
anterior	B-Disease	1587
segment	I-Disease	1587
defects	I-Disease	1587
and	O	1587
glaucoma	B-Disease	1587
in	O	1587
various	O	1587
families	O	1587
.	O	1587
we	O	1588
show	O	1588
that	O	1588
foxc1	O	1588
(	O	1588
+	O	1588
/	O	1588
-	O	1588
)	O	1588
mice	O	1588
have	O	1588
anterior	B-Disease	1588
segment	I-Disease	1588
abnormalities	I-Disease	1588
similar	O	1588
to	O	1588
those	O	1588
reported	O	1588
in	O	1588
human	O	1588
patients	O	1588
.	O	1588
these	O	1589
abnormalities	O	1589
include	O	1589
small	O	1589
or	O	1589
absent	O	1589
schlemms	O	1589
canal	O	1589
,	O	1589
aberrantly	O	1589
developed	O	1589
trabecular	O	1589
meshwork	O	1589
,	O	1589
iris	B-Disease	1589
hypoplasia	I-Disease	1589
,	O	1589
severely	O	1589
eccentric	O	1589
pupils	O	1589
and	O	1589
displaced	O	1589
schwalbes	O	1589
line	O	1589
.	O	1589
similar	O	1594
abnormalities	O	1594
were	O	1594
found	O	1594
in	O	1594
foxc2	O	1594
(	O	1594
+	O	1594
/	O	1594
-	O	1594
)	O	1594
mice	O	1594
,	O	1594
but	O	1594
no	O	1594
disease	O	1594
-	O	1594
associated	O	1594
mutations	O	1594
were	O	1594
identified	O	1594
in	O	1594
the	O	1594
human	O	1594
homolog	O	1594
fkhl14	O	1594
in	O	1594
32	O	1594
ara	B-Disease	1594
patients	O	1594
.	O	1594
foxc1	O	1595
(	O	1595
+	O	1595
/	O	1595
-	O	1595
)	O	1595
and	O	1595
foxc2	O	1595
(	O	1595
+	O	1595
/	O	1595
-	O	1595
)	O	1595
mice	O	1595
are	O	1595
useful	O	1595
models	O	1595
for	O	1595
studying	O	1595
anterior	O	1595
segment	O	1595
development	O	1595
and	O	1595
its	O	1595
anomalies	O	1595
,	O	1595
and	O	1595
may	O	1595
allow	O	1595
identification	O	1595
of	O	1595
genes	O	1595
that	O	1595
interact	O	1595
with	O	1595
foxc1	O	1595
and	O	1595
foxc2	O	1595
(	O	1595
or	O	1595
fkhl7	O	1595
and	O	1595
fkhl14	O	1595
)	O	1595
to	O	1595
produce	O	1595
a	O	1595
phenotype	O	1595
with	O	1595
elevated	O	1595
iop	O	1595
and	O	1595
glaucoma	B-Disease	1595
.	O	1595
.	O	1595
(	O	1596
over	O	1596
)	O	1596
correction	O	1596
of	O	1596
fmr1	B-Disease	1596
deficiency	I-Disease	1596
with	O	1596
yac	O	1596
transgenics	O	1596
:	O	1596
behavioral	O	1596
and	O	1596
physical	O	1596
features	O	1596
.	O	1596
fragile	B-Disease	1597
x	I-Disease	1597
syndrome	I-Disease	1597
is	O	1597
a	O	1597
common	O	1597
cause	O	1597
of	O	1597
mental	B-Disease	1597
retardation	I-Disease	1597
involving	O	1597
loss	O	1597
of	O	1597
expression	O	1597
of	O	1597
the	O	1597
fmr1	O	1597
gene	O	1597
.	O	1597
fmr1	O	1599
knockout	O	1599
mice	O	1599
exhibit	O	1599
a	O	1599
phenotype	O	1599
with	O	1599
some	O	1599
similarities	O	1599
to	O	1599
humans	O	1599
,	O	1599
such	O	1599
as	O	1599
macroorchidism	B-Disease	1599
and	O	1599
behavioral	O	1599
abnormalities	O	1599
.	O	1599
as	O	1600
a	O	1600
step	O	1600
toward	O	1600
understanding	O	1600
the	O	1600
function	O	1600
of	O	1600
fmr1	O	1600
and	O	1600
the	O	1600
determination	O	1600
of	O	1600
the	O	1600
potential	O	1600
for	O	1600
therapeutic	O	1600
approaches	O	1600
to	O	1600
fragile	B-Disease	1600
x	I-Disease	1600
syndrome	I-Disease	1600
,	O	1600
yeast	O	1600
artificial	O	1600
chromosome	O	1600
(	O	1600
yac	O	1600
)	O	1600
transgenic	O	1600
mice	O	1600
were	O	1600
generated	O	1600
in	O	1600
order	O	1600
to	O	1600
determine	O	1600
whether	O	1600
the	O	1600
fmr1	O	1600
knockout	O	1600
mouse	O	1600
phenotype	O	1600
could	O	1600
be	O	1600
rescued	O	1600
.	O	1600
given	O	1604
the	O	1604
complex	O	1604
behavioral	O	1604
phenotype	O	1604
in	O	1604
fragile	B-Disease	1604
x	I-Disease	1604
patients	O	1604
and	O	1604
the	O	1604
mild	O	1604
phenotype	O	1604
previously	O	1604
reported	O	1604
for	O	1604
the	O	1604
fmr1	O	1604
knockout	O	1604
mouse	O	1604
,	O	1604
we	O	1604
performed	O	1604
a	O	1604
more	O	1604
thorough	O	1604
evaluation	O	1604
of	O	1604
the	O	1604
fmr1	O	1604
knockout	O	1604
phenotype	O	1604
using	O	1604
additional	O	1604
behavioral	O	1604
assays	O	1604
that	O	1604
had	O	1604
not	O	1604
previously	O	1604
been	O	1604
reported	O	1604
for	O	1604
this	O	1604
animal	O	1604
model	O	1604
.	O	1604
the	O	1605
mouse	O	1605
displayed	O	1605
reduced	O	1605
anxiety	B-Disease	1605
-	O	1605
related	O	1605
responses	O	1605
with	O	1605
increased	O	1605
exploratory	O	1605
behavior	O	1605
.	O	1605
these	O	1607
findings	O	1607
have	O	1607
significant	O	1607
implications	O	1607
for	O	1607
gene	O	1607
therapy	O	1607
for	O	1607
fragile	B-Disease	1607
x	I-Disease	1607
syndrome	I-Disease	1607
since	O	1607
overexpression	O	1607
of	O	1607
the	O	1607
gene	O	1607
may	O	1607
harbor	O	1607
its	O	1607
own	O	1607
phenotype	O	1607
.	O	1607
.	O	1607
transgenic	O	1608
mice	O	1608
carrying	O	1608
large	O	1608
human	O	1608
genomic	O	1608
sequences	O	1608
with	O	1608
expanded	O	1608
ctg	O	1608
repeat	O	1608
mimic	O	1608
closely	O	1608
the	O	1608
dm	B-Disease	1608
ctg	O	1608
repeat	O	1608
intergenerational	O	1608
and	O	1608
somatic	O	1608
instability	O	1608
.	O	1608
myotonic	B-Disease	1609
dystrophy	I-Disease	1609
(	O	1609
dm	B-Disease	1609
)	O	1609
is	O	1609
caused	O	1609
by	O	1609
a	O	1609
ctg	O	1609
repeat	O	1609
expansion	O	1609
in	O	1609
the	O	1609
3utr	O	1609
of	O	1609
the	O	1609
dm	B-Disease	1609
protein	O	1609
kinase	O	1609
(	O	1609
dmpk	O	1609
)	O	1609
gene	O	1609
.	O	1609
furthermore	O	1611
,	O	1611
tissues	O	1611
from	O	1611
dm	B-Disease	1611
patients	O	1611
exhibit	O	1611
somatic	O	1611
mosaicism	O	1611
that	O	1611
increases	O	1611
with	O	1611
age	O	1611
.	O	1611
we	O	1612
generated	O	1612
transgenic	O	1612
mice	O	1612
carrying	O	1612
large	O	1612
human	O	1612
genomic	O	1612
sequences	O	1612
with	O	1612
20	O	1612
,	O	1612
55	O	1612
or	O	1612
>	O	1612
300	O	1612
ctg	O	1612
,	O	1612
cloned	O	1612
from	O	1612
patients	O	1612
from	O	1612
the	O	1612
same	O	1612
affected	O	1612
dm	B-Disease	1612
family	O	1612
.	O	1612
although	O	1615
we	O	1615
did	O	1615
not	O	1615
observe	O	1615
dramatic	O	1615
expansions	O	1615
(	O	1615
or	O	1615
big	O	1615
jumps	O	1615
over	O	1615
several	O	1615
hundred	O	1615
ctg	O	1615
repeats	O	1615
)	O	1615
as	O	1615
in	O	1615
congenital	O	1615
forms	O	1615
of	O	1615
dm	B-Disease	1615
,	O	1615
our	O	1615
model	O	1615
carrying	O	1615
>	O	1615
300	O	1615
ctg	O	1615
is	O	1615
the	O	1615
first	O	1615
to	O	1615
show	O	1615
instability	O	1615
so	O	1615
close	O	1615
to	O	1615
the	O	1615
human	O	1615
dm	B-Disease	1615
situation	O	1615
.	O	1615
inactivation	O	1617
of	O	1617
the	O	1617
friedreich	B-Disease	1617
ataxia	I-Disease	1617
mouse	O	1617
gene	O	1617
leads	O	1617
to	O	1617
early	O	1617
embryonic	B-Disease	1617
lethality	I-Disease	1617
without	O	1617
iron	O	1617
accumulation	O	1617
.	O	1617
friedreich	B-Disease	1618
ataxia	I-Disease	1618
(	O	1618
frda	B-Disease	1618
)	O	1618
,	O	1618
the	O	1618
most	O	1618
common	O	1618
autosomal	B-Disease	1618
recessive	I-Disease	1618
ataxia	I-Disease	1618
,	O	1618
is	O	1618
caused	O	1618
in	O	1618
almost	O	1618
all	O	1618
cases	O	1618
by	O	1618
homozygous	O	1618
intronic	O	1618
expansions	O	1618
resulting	O	1618
in	O	1618
the	O	1618
loss	O	1618
of	O	1618
frataxin	O	1618
,	O	1618
a	O	1618
mitochondrial	O	1618
protein	O	1618
conserved	O	1618
through	O	1618
evolution	O	1618
,	O	1618
and	O	1618
involved	O	1618
in	O	1618
mitochondrial	O	1618
iron	O	1618
homeostasis	O	1618
.	O	1618
yeast	O	1619
knockout	O	1619
models	O	1619
,	O	1619
and	O	1619
histological	O	1619
and	O	1619
biochemical	O	1619
data	O	1619
from	O	1619
patient	O	1619
heart	O	1619
biopsies	O	1619
or	O	1619
autopsies	O	1619
indicate	O	1619
that	O	1619
the	O	1619
frataxin	O	1619
defect	O	1619
causes	O	1619
a	O	1619
specific	O	1619
iron	B-Disease	1619
-	I-Disease	1619
sulfur	I-Disease	1619
protein	I-Disease	1619
deficiency	I-Disease	1619
and	O	1619
mitochondrial	O	1619
iron	O	1619
accumulation	O	1619
leading	O	1619
to	O	1619
the	O	1619
pathological	O	1619
changes	O	1619
.	O	1619
to	O	1621
study	O	1621
the	O	1621
mechanism	O	1621
of	O	1621
the	O	1621
disease	O	1621
,	O	1621
we	O	1621
generated	O	1621
a	O	1621
mouse	O	1621
model	O	1621
by	O	1621
deletion	O	1621
of	O	1621
exon	O	1621
4	O	1621
leading	O	1621
to	O	1621
inactivation	O	1621
of	O	1621
the	O	1621
frda	B-Disease	1621
gene	O	1621
product	O	1621
.	O	1621
we	O	1622
show	O	1622
that	O	1622
homozygous	O	1622
deletions	O	1622
cause	O	1622
embryonic	B-Disease	1622
lethality	I-Disease	1622
a	O	1622
few	O	1622
days	O	1622
after	O	1622
implantation	O	1622
,	O	1622
demonstrating	O	1622
an	O	1622
important	O	1622
role	O	1622
for	O	1622
frataxin	O	1622
during	O	1622
early	O	1622
development	O	1622
.	O	1622
gaucher	B-Disease	1625
disease	I-Disease	1625
:	O	1625
the	O	1625
origins	O	1625
of	O	1625
the	O	1625
ashkenazi	O	1625
jewish	O	1625
n370s	O	1625
and	O	1625
84gg	O	1625
acid	O	1625
beta	O	1625
-	O	1625
glucosidase	O	1625
mutations	O	1625
.	O	1625
type	O	1626
1	O	1626
gaucher	B-Disease	1626
disease	I-Disease	1626
(	O	1626
gd	B-Disease	1626
)	O	1626
,	O	1626
a	O	1626
non	O	1626
-	O	1626
neuronopathic	O	1626
lysosomal	B-Disease	1626
storage	I-Disease	1626
disorder	I-Disease	1626
,	O	1626
results	O	1626
from	O	1626
the	O	1626
deficient	O	1626
activity	O	1626
of	O	1626
acid	O	1626
beta	O	1626
-	O	1626
glucosidase	O	1626
(	O	1626
gba	O	1626
)	O	1626
.	O	1626
hla	O	1638
b27	O	1638
and	O	1638
the	O	1638
genetics	O	1638
of	O	1638
ankylosing	B-Disease	1638
spondylitis	I-Disease	1638
.	O	1638
one	O	1639
hundred	O	1639
and	O	1639
twenty	O	1639
-	O	1639
eight	O	1639
of	O	1639
145	O	1639
patients	O	1639
with	O	1639
ankylosing	B-Disease	1639
spondylitis	I-Disease	1639
(	O	1639
as	B-Disease	1639
)	O	1639
were	O	1639
found	O	1639
to	O	1639
be	O	1639
hla	O	1639
b27	O	1639
positive	O	1639
.	O	1639
five	O	1640
patients	O	1640
had	O	1640
evidence	O	1640
of	O	1640
a	O	1640
sero	O	1640
-	O	1640
negative	O	1640
peripheral	B-Disease	1640
arthritis	I-Disease	1640
resembling	O	1640
peripheral	B-Disease	1640
psoriatic	I-Disease	1640
arthritis	I-Disease	1640
and	O	1640
3	O	1640
of	O	1640
these	O	1640
were	O	1640
b27	O	1640
negative	O	1640
.	O	1640
one	O	1641
further	O	1641
b27	O	1641
negative	O	1641
patients	O	1641
had	O	1641
a	O	1641
sister	O	1641
with	O	1641
ankylosing	B-Disease	1641
spondylitis	I-Disease	1641
and	O	1641
ulcerative	B-Disease	1641
colitis	I-Disease	1641
and	O	1641
a	O	1641
mother	O	1641
with	O	1641
ulcerative	B-Disease	1641
colitis	I-Disease	1641
.	O	1641
these	O	1643
findings	O	1643
are	O	1643
interpreted	O	1643
as	O	1643
suggesting	O	1643
some	O	1643
degree	O	1643
of	O	1643
clinical	O	1643
and	O	1643
genetic	O	1643
heterogeneity	O	1643
in	O	1643
ankylosing	B-Disease	1643
spondylitis	I-Disease	1643
with	O	1643
genes	O	1643
for	O	1643
psoriasis	B-Disease	1643
and	O	1643
inflammatory	B-Disease	1643
bowel	I-Disease	1643
disease	I-Disease	1643
being	O	1643
important	O	1643
in	O	1643
some	O	1643
individuals	O	1643
,	O	1643
particularly	O	1643
those	O	1643
who	O	1643
are	O	1643
b27	O	1643
negative	O	1643
.	O	1643
twenty	O	1644
-	O	1644
five	O	1644
first	O	1644
-	O	1644
degree	O	1644
relatives	O	1644
with	O	1644
ankylosing	B-Disease	1644
spondylitis	I-Disease	1644
were	O	1644
all	O	1644
b27	O	1644
positive	O	1644
.	O	1644
the	O	1645
only	O	1645
instance	O	1645
of	O	1645
disassociation	O	1645
of	O	1645
b27	O	1645
and	O	1645
spondylitis	B-Disease	1645
in	O	1645
a	O	1645
family	O	1645
was	O	1645
where	O	1645
the	O	1645
proband	O	1645
had	O	1645
ulcerative	B-Disease	1645
colitis	I-Disease	1645
as	O	1645
well	O	1645
as	O	1645
spondylitis	B-Disease	1645
.	O	1645
of	O	1646
13	O	1646
b27	O	1646
positive	O	1646
fathers	O	1646
3	O	1646
could	O	1646
be	O	1646
diagnosed	O	1646
as	O	1646
having	O	1646
definite	O	1646
ankylosing	B-Disease	1646
spondylitis	I-Disease	1646
(	O	1646
23	O	1646
%	O	1646
)	O	1646
.	O	1646
these	O	1647
findings	O	1647
are	O	1647
thought	O	1647
to	O	1647
provide	O	1647
evidence	O	1647
against	O	1647
the	O	1647
concept	O	1647
that	O	1647
the	O	1647
gene	O	1647
for	O	1647
ankylosing	B-Disease	1647
spondylitis	I-Disease	1647
is	O	1647
not	O	1647
b27	O	1647
but	O	1647
a	O	1647
closely	O	1647
linked	O	1647
gene	O	1647
and	O	1647
favour	O	1647
the	O	1647
occurrence	O	1647
of	O	1647
an	O	1647
environmental	O	1647
event	O	1647
affecting	O	1647
approximately	O	1647
one	O	1647
-	O	1647
fifth	O	1647
of	O	1647
b27	O	1647
positive	O	1647
males	O	1647
to	O	1647
result	O	1647
in	O	1647
disease	O	1647
.	O	1647
.	O	1647
founder	O	1648
mutations	O	1648
in	O	1648
the	O	1648
brca1	O	1648
gene	O	1648
in	O	1648
polish	O	1648
families	O	1648
with	O	1648
breast	B-Disease	1648
-	I-Disease	1648
ovarian	I-Disease	1648
cancer	I-Disease	1648
.	O	1648
the	O	1650
study	O	1650
group	O	1650
consisted	O	1650
of	O	1650
66	O	1650
polish	O	1650
families	O	1650
with	O	1650
cancer	B-Disease	1650
who	O	1650
have	O	1650
at	O	1650
least	O	1650
three	O	1650
related	O	1650
females	O	1650
affected	O	1650
with	O	1650
breast	B-Disease	1650
or	I-Disease	1650
ovarian	I-Disease	1650
cancer	I-Disease	1650
and	O	1650
who	O	1650
had	O	1650
cancer	B-Disease	1650
diagnosed	O	1650
,	O	1650
in	O	1650
at	O	1650
least	O	1650
one	O	1650
of	O	1650
the	O	1650
three	O	1650
affected	O	1650
females	O	1650
,	O	1650
at	O	1650
age	O	1650
<	O	1650
50	O	1650
years	O	1650
.	O	1650
a	O	1651
total	O	1651
of	O	1651
26	O	1651
families	O	1651
had	O	1651
both	O	1651
breast	B-Disease	1651
and	I-Disease	1651
ovarian	I-Disease	1651
cancers	I-Disease	1651
,	O	1651
4	O	1651
families	O	1651
had	O	1651
ovarian	B-Disease	1651
cancers	I-Disease	1651
only	O	1651
,	O	1651
and	O	1651
36	O	1651
families	O	1651
had	O	1651
breast	B-Disease	1651
cancers	I-Disease	1651
only	O	1651
.	O	1651
brca1	B-Disease	1656
abnormalities	I-Disease	1656
were	O	1656
identified	O	1656
in	O	1656
all	O	1656
four	O	1656
families	O	1656
with	O	1656
ovarian	B-Disease	1656
cancer	I-Disease	1656
only	O	1656
,	O	1656
in	O	1656
67	O	1656
%	O	1656
of	O	1656
27	O	1656
families	O	1656
with	O	1656
both	O	1656
breast	B-Disease	1656
and	I-Disease	1656
ovarian	I-Disease	1656
cancer	I-Disease	1656
,	O	1656
and	O	1656
in	O	1656
34	O	1656
%	O	1656
of	O	1656
35	O	1656
families	O	1656
with	O	1656
breast	B-Disease	1656
cancer	I-Disease	1656
only	O	1656
.	O	1656
the	O	1657
single	O	1657
family	O	1657
with	O	1657
a	O	1657
brca2	O	1657
mutation	O	1657
had	O	1657
the	O	1657
breast	B-Disease	1657
-	I-Disease	1657
ovarian	I-Disease	1657
cancer	I-Disease	1657
syndrome	I-Disease	1657
.	O	1657
three	O	1660
brca1	B-Disease	1660
abnormalities	I-Disease	1660
-	O	1660
5382insc	O	1660
,	O	1660
c61g	O	1660
,	O	1660
and	O	1660
4153dela	O	1660
-	O	1660
accounted	O	1660
for	O	1660
51	O	1660
%	O	1660
,	O	1660
20	O	1660
%	O	1660
,	O	1660
and	O	1660
11	O	1660
%	O	1660
of	O	1660
the	O	1660
identified	O	1660
mutations	O	1660
,	O	1660
respectively	O	1660
.	O	1660
.	O	1660
molecular	O	1661
basis	O	1661
of	O	1661
very	B-Disease	1661
long	I-Disease	1661
chain	I-Disease	1661
acyl	I-Disease	1661
-	I-Disease	1661
coa	I-Disease	1661
dehydrogenase	I-Disease	1661
deficiency	I-Disease	1661
in	O	1661
three	O	1661
israeli	O	1661
patients	O	1661
:	O	1661
identification	O	1661
of	O	1661
a	O	1661
complex	O	1661
mutant	O	1661
allele	O	1661
with	O	1661
p65l	O	1661
and	O	1661
k247q	O	1661
mutations	O	1661
,	O	1661
the	O	1661
former	O	1661
being	O	1661
an	O	1661
exonic	O	1661
mutation	O	1661
causing	O	1661
exon	O	1661
3	O	1661
skipping	O	1661
.	O	1661
very	B-Disease	1662
long	I-Disease	1662
chain	I-Disease	1662
acyl	I-Disease	1662
-	I-Disease	1662
coa	I-Disease	1662
dehydrogenase	I-Disease	1662
(	I-Disease	1662
vlcad	I-Disease	1662
)	I-Disease	1662
deficiency	I-Disease	1662
is	O	1662
a	O	1662
life	O	1662
-	O	1662
threatening	O	1662
disorder	O	1662
of	O	1662
mitochondrial	O	1662
fatty	O	1662
acid	O	1662
beta	O	1662
-	O	1662
oxidation	O	1662
.	O	1662
all	O	1664
patients	O	1664
had	O	1664
the	O	1664
severe	O	1664
childhood	O	1664
form	O	1664
of	O	1664
vlcad	B-Disease	1664
deficiency	I-Disease	1664
with	O	1664
early	O	1664
onset	O	1664
and	O	1664
high	O	1664
mortality	O	1664
.	O	1664
submicroscopic	O	1672
deletion	O	1672
in	O	1672
cousins	O	1672
with	O	1672
prader	B-Disease	1672
-	I-Disease	1672
willi	I-Disease	1672
syndrome	I-Disease	1672
causes	O	1672
a	O	1672
grandmatrilineal	O	1672
inheritance	O	1672
pattern	O	1672
:	O	1672
effects	O	1672
of	O	1672
imprinting	O	1672
.	O	1672
the	O	1673
prader	B-Disease	1673
-	I-Disease	1673
willi	I-Disease	1673
syndrome	I-Disease	1673
(	O	1673
pws	B-Disease	1673
)	O	1673
critical	O	1673
region	O	1673
on	O	1673
15q11	O	1673
-	O	1673
q13	O	1673
is	O	1673
subject	O	1673
to	O	1673
imprinting	O	1673
.	O	1673
pws	B-Disease	1674
becomes	O	1674
apparent	O	1674
when	O	1674
genes	O	1674
on	O	1674
the	O	1674
paternally	O	1674
inherited	O	1674
chromosome	O	1674
are	O	1674
not	O	1674
expressed	O	1674
.	O	1674
familial	B-Disease	1675
pws	I-Disease	1675
is	O	1675
rare	O	1675
.	O	1675
we	O	1676
report	O	1676
on	O	1676
a	O	1676
family	O	1676
in	O	1676
which	O	1676
a	O	1676
male	O	1676
and	O	1676
a	O	1676
female	O	1676
paternal	O	1676
first	O	1676
cousin	O	1676
both	O	1676
have	O	1676
pws	B-Disease	1676
with	O	1676
cytogenetically	O	1676
normal	O	1676
karyotypes	O	1676
.	O	1676
dna	O	1680
methylation	O	1680
analysis	O	1680
of	O	1680
d15s63	O	1680
is	O	1680
consistent	O	1680
with	O	1680
an	O	1680
abnormality	O	1680
of	O	1680
the	O	1680
imprinting	O	1680
center	O	1680
associated	O	1680
with	O	1680
pws	B-Disease	1680
.	O	1680
in	O	1682
this	O	1682
case	O	1682
,	O	1682
pws	B-Disease	1682
does	O	1682
not	O	1682
become	O	1682
evident	O	1682
as	O	1682
long	O	1682
as	O	1682
the	O	1682
deletion	O	1682
is	O	1682
passed	O	1682
through	O	1682
the	O	1682
matrilineal	O	1682
line	O	1682
.	O	1682
human	O	1684
glycine	O	1684
decarboxylase	O	1684
gene	O	1684
(	O	1684
gldc	O	1684
)	O	1684
and	O	1684
its	O	1684
highly	O	1684
conserved	O	1684
processed	O	1684
pseudogene	O	1684
(	O	1684
psigldc	O	1684
)	O	1684
:	O	1684
their	O	1684
structure	O	1684
and	O	1684
expression	O	1684
,	O	1684
and	O	1684
the	O	1684
identification	O	1684
of	O	1684
a	O	1684
large	O	1684
deletion	O	1684
in	O	1684
a	O	1684
family	O	1684
with	O	1684
nonketotic	B-Disease	1684
hyperglycinemia	I-Disease	1684
.	O	1684
mutations	O	1685
in	O	1685
the	O	1685
glycine	O	1685
decarboxylase	O	1685
gene	O	1685
(	O	1685
gldc	O	1685
)	O	1685
cause	O	1685
nonketotic	B-Disease	1685
hyperglycinemia	I-Disease	1685
(	O	1685
nkh	B-Disease	1685
)	O	1685
,	O	1685
an	O	1685
in	B-Disease	1685
-	I-Disease	1685
born	I-Disease	1685
error	I-Disease	1685
of	I-Disease	1685
metabolism	I-Disease	1685
characterized	O	1685
by	O	1685
severe	O	1685
neurological	B-Disease	1685
disturbance	I-Disease	1685
.	O	1685
we	O	1686
have	O	1686
determined	O	1686
the	O	1686
structure	O	1686
of	O	1686
gldc	O	1686
and	O	1686
of	O	1686
its	O	1686
pseudogene	O	1686
(	O	1686
psigldc	O	1686
)	O	1686
and	O	1686
studied	O	1686
their	O	1686
expression	O	1686
for	O	1686
a	O	1686
molecular	O	1686
analysis	O	1686
of	O	1686
nkh	B-Disease	1686
.	O	1686
we	O	1693
have	O	1693
also	O	1693
examined	O	1693
a	O	1693
patient	O	1693
with	O	1693
nkh	B-Disease	1693
with	O	1693
no	O	1693
detectable	O	1693
gldc	O	1693
mrna	O	1693
in	O	1693
his	O	1693
lymphoblasts	O	1693
.	O	1693
structural	O	1697
information	O	1697
of	O	1697
gldc	O	1697
and	O	1697
psigldc	O	1697
should	O	1697
facilitate	O	1697
the	O	1697
molecular	O	1697
analysis	O	1697
of	O	1697
nkh	B-Disease	1697
.	O	1697
prader	B-Disease	1699
-	I-Disease	1699
willi	I-Disease	1699
syndrome	I-Disease	1699
(	O	1699
pws	B-Disease	1699
)	O	1699
is	O	1699
a	O	1699
neurogenetic	B-Disease	1699
disease	I-Disease	1699
characterized	O	1699
by	O	1699
infantile	B-Disease	1699
hypotonia	I-Disease	1699
,	O	1699
gonadal	B-Disease	1699
hypoplasia	I-Disease	1699
,	O	1699
obsessive	O	1699
behaviour	O	1699
and	O	1699
neonatal	O	1699
feeding	O	1699
difficulties	O	1699
followed	O	1699
by	O	1699
hyperphagia	B-Disease	1699
,	O	1699
leading	O	1699
to	O	1699
profound	O	1699
obesity	B-Disease	1699
.	O	1699
pws	B-Disease	1700
is	O	1700
due	O	1700
to	O	1700
a	O	1700
lack	O	1700
of	O	1700
paternal	O	1700
genetic	O	1700
information	O	1700
at	O	1700
15q11	O	1700
-	O	1700
q13	O	1700
(	O	1700
ref	O	1700
.	O	1700
2	O	1700
)	O	1700
.	O	1700
five	O	1701
imprinted	O	1701
,	O	1701
paternally	O	1701
expressed	O	1701
genes	O	1701
map	O	1701
to	O	1701
the	O	1701
pws	B-Disease	1701
region	O	1701
,	O	1701
mkrn3	O	1701
(	O	1701
ref	O	1701
.	O	1701
3	O	1701
)	O	1701
,	O	1701
ndn	O	1701
(	O	1701
ref	O	1701
.	O	1701
4	O	1701
)	O	1701
,	O	1701
ndnl1	O	1701
(	O	1701
ref	O	1701
.	O	1701
5	O	1701
)	O	1701
,	O	1701
snrpn	O	1701
(	O	1701
refs	O	1701
6	O	1701
-	O	1701
8	O	1701
)	O	1701
and	O	1701
ipw	O	1701
(	O	1701
ref	O	1701
.	O	1701
9	O	1701
)	O	1701
,	O	1701
as	O	1701
well	O	1701
as	O	1701
two	O	1701
poorly	O	1701
characterized	O	1701
framents	O	1701
designated	O	1701
par	O	1701
-	O	1701
1	O	1701
and	O	1701
par	O	1701
-	O	1701
5	O	1701
(	O	1701
ref	O	1701
.	O	1701
10	O	1701
)	O	1701
.	O	1701
deletion	O	1703
of	O	1703
the	O	1703
snrpn	O	1703
promoter	O	1703
/	O	1703
exon	O	1703
1	O	1703
region	O	1703
(	O	1703
the	O	1703
pws	B-Disease	1703
ic	O	1703
element	O	1703
)	O	1703
appears	O	1703
to	O	1703
impair	O	1703
the	O	1703
establishment	O	1703
of	O	1703
the	O	1703
paternal	O	1703
imprint	O	1703
in	O	1703
the	O	1703
male	O	1703
germ	O	1703
line	O	1703
and	O	1703
leads	O	1703
to	O	1703
pws	B-Disease	1703
.	O	1703
here	O	1704
we	O	1704
report	O	1704
a	O	1704
pws	B-Disease	1704
family	O	1704
in	O	1704
which	O	1704
the	O	1704
father	O	1704
is	O	1704
mosaic	O	1704
for	O	1704
an	O	1704
ic	O	1704
deletion	O	1704
on	O	1704
his	O	1704
paternal	O	1704
chromosome	O	1704
.	O	1704
our	O	1707
studies	O	1707
demonstrate	O	1707
that	O	1707
the	O	1707
pws	B-Disease	1707
ic	O	1707
element	O	1707
is	O	1707
not	O	1707
only	O	1707
required	O	1707
for	O	1707
the	O	1707
establishment	O	1707
of	O	1707
the	O	1707
paternal	O	1707
imprint	O	1707
,	O	1707
but	O	1707
also	O	1707
for	O	1707
its	O	1707
postzygotic	O	1707
maintenance	O	1707
.	O	1707
.	O	1707
mice	O	1708
deficient	B-Disease	1708
in	I-Disease	1708
six5	I-Disease	1708
develop	O	1708
cataracts	B-Disease	1708
:	O	1708
implications	O	1708
for	O	1708
myotonic	B-Disease	1708
dystrophy	I-Disease	1708
.	O	1708
expansion	O	1709
of	O	1709
a	O	1709
ctg	O	1709
trinucleotide	O	1709
repeat	O	1709
in	O	1709
the	O	1709
3	O	1709
utr	O	1709
of	O	1709
the	O	1709
gene	O	1709
dmpk	O	1709
at	O	1709
the	O	1709
dm1	O	1709
locus	O	1709
on	O	1709
chromosome	O	1709
19	O	1709
causes	O	1709
myotonic	B-Disease	1709
dystrophy	I-Disease	1709
,	O	1709
a	O	1709
dominantly	B-Disease	1709
inherited	I-Disease	1709
disease	I-Disease	1709
characterized	O	1709
by	O	1709
skeletal	O	1709
muscle	B-Disease	1709
dystrophy	I-Disease	1709
and	O	1709
myotonia	B-Disease	1709
,	O	1709
cataracts	B-Disease	1709
and	O	1709
cardiac	B-Disease	1709
conduction	I-Disease	1709
defects	I-Disease	1709
.	O	1709
targeted	O	1710
deletion	O	1710
of	O	1710
dm15	O	1710
,	O	1710
the	O	1710
mouse	O	1710
orthologue	O	1710
of	O	1710
human	O	1710
dmpk	O	1710
,	O	1710
produced	O	1710
mice	O	1710
with	O	1710
a	O	1710
mild	O	1710
myopathy	B-Disease	1710
and	O	1710
cardiac	B-Disease	1710
conduction	I-Disease	1710
abnormalities	I-Disease	1710
,	O	1710
but	O	1710
without	O	1710
other	O	1710
features	O	1710
of	O	1710
myotonic	B-Disease	1710
dystrophy	I-Disease	1710
,	O	1710
such	O	1710
as	O	1710
myotonia	B-Disease	1710
and	O	1710
cataracts	B-Disease	1710
.	O	1710
to	O	1712
determine	O	1712
whether	O	1712
six5	B-Disease	1712
deficiency	I-Disease	1712
contributes	O	1712
to	O	1712
the	O	1712
myotonic	B-Disease	1712
dystrophy	I-Disease	1712
phenotype	O	1712
,	O	1712
we	O	1712
disrupted	O	1712
mouse	O	1712
six5	O	1712
by	O	1712
replacing	O	1712
the	O	1712
first	O	1712
exon	O	1712
with	O	1712
a	O	1712
beta	O	1712
-	O	1712
galactosidase	O	1712
reporter	O	1712
.	O	1712
homozygous	O	1714
mutant	O	1714
mice	O	1714
had	O	1714
no	O	1714
apparent	O	1714
abnormalities	B-Disease	1714
of	I-Disease	1714
skeletal	I-Disease	1714
muscle	I-Disease	1714
function	I-Disease	1714
,	O	1714
but	O	1714
developed	O	1714
lenticular	B-Disease	1714
opacities	I-Disease	1714
at	O	1714
a	O	1714
higher	O	1714
rate	O	1714
than	O	1714
controls	O	1714
.	O	1714
our	O	1715
results	O	1715
suggest	O	1715
that	O	1715
six5	B-Disease	1715
deficiency	I-Disease	1715
contributes	O	1715
to	O	1715
the	O	1715
cataract	B-Disease	1715
phenotype	O	1715
in	O	1715
myotonic	B-Disease	1715
dystrophy	I-Disease	1715
,	O	1715
and	O	1715
that	O	1715
myotonic	B-Disease	1715
dystrophy	I-Disease	1715
represents	O	1715
a	O	1715
multigenic	B-Disease	1715
disorder	I-Disease	1715
.	O	1715
.	O	1715
heterozygous	O	1716
loss	O	1716
of	O	1716
six5	O	1716
in	O	1716
mice	O	1716
is	O	1716
sufficient	O	1716
to	O	1716
cause	O	1716
ocular	O	1716
cataracts	B-Disease	1716
.	O	1716
myotonic	B-Disease	1717
dystrophy	I-Disease	1717
(	O	1717
dm	B-Disease	1717
)	O	1717
is	O	1717
an	O	1717
autosomal	B-Disease	1717
dominant	I-Disease	1717
disorder	I-Disease	1717
characterized	O	1717
by	O	1717
skeletal	O	1717
muscle	B-Disease	1717
wasting	I-Disease	1717
,	O	1717
myotonia	B-Disease	1717
,	O	1717
cardiac	B-Disease	1717
arrhythmia	I-Disease	1717
,	O	1717
hyperinsulinaemia	B-Disease	1717
,	O	1717
mental	B-Disease	1717
retardation	I-Disease	1717
and	O	1717
ocular	O	1717
cataracts	B-Disease	1717
.	O	1717
the	O	1718
genetic	B-Disease	1718
defect	I-Disease	1718
in	O	1718
dm	B-Disease	1718
is	O	1718
a	O	1718
ctg	O	1718
repeat	O	1718
expansion	O	1718
located	O	1718
in	O	1718
the	O	1718
3	O	1718
untranslated	O	1718
region	O	1718
of	O	1718
dmpk	O	1718
and	O	1718
5	O	1718
of	O	1718
a	O	1718
homeodomain	O	1718
-	O	1718
encoding	O	1718
gene	O	1718
,	O	1718
six5	O	1718
(	O	1718
formerly	O	1718
dmahp	O	1718
;	O	1718
refs	O	1718
2	O	1718
-	O	1718
5	O	1718
)	O	1718
.	O	1718
there	O	1719
are	O	1719
three	O	1719
mechanisms	O	1719
by	O	1719
which	O	1719
ctg	O	1719
expansion	O	1719
can	O	1719
result	O	1719
in	O	1719
dm	B-Disease	1719
.	O	1719
previous	O	1723
studies	O	1723
have	O	1723
demonstrated	O	1723
that	O	1723
a	O	1723
dose	O	1723
-	O	1723
dependent	O	1723
loss	O	1723
of	O	1723
dm15	O	1723
(	O	1723
the	O	1723
mouse	O	1723
dmpk	O	1723
homologue	O	1723
)	O	1723
in	O	1723
mice	O	1723
produces	O	1723
a	O	1723
partial	O	1723
dm	B-Disease	1723
phenotype	O	1723
characterized	O	1723
by	O	1723
decreased	O	1723
development	O	1723
of	O	1723
skeletal	O	1723
muscle	O	1723
force	O	1723
and	O	1723
cardiac	B-Disease	1723
conduction	I-Disease	1723
disorders	I-Disease	1723
.	O	1723
to	O	1724
test	O	1724
the	O	1724
role	O	1724
of	O	1724
six5	O	1724
loss	O	1724
in	O	1724
dm	B-Disease	1724
,	O	1724
we	O	1724
have	O	1724
analysed	O	1724
a	O	1724
strain	O	1724
of	O	1724
mice	O	1724
in	O	1724
which	O	1724
six5	O	1724
was	O	1724
deleted	O	1724
.	O	1724
our	O	1725
results	O	1725
demonstrate	O	1725
that	O	1725
the	O	1725
rate	O	1725
and	O	1725
severity	O	1725
of	O	1725
cataract	B-Disease	1725
formation	O	1725
is	O	1725
inversely	O	1725
related	O	1725
to	O	1725
six5	O	1725
dosage	O	1725
and	O	1725
is	O	1725
temporally	O	1725
progressive	O	1725
.	O	1725
thus	O	1727
,	O	1727
altered	O	1727
ion	O	1727
homeostasis	O	1727
within	O	1727
the	O	1727
lens	O	1727
may	O	1727
contribute	O	1727
to	O	1727
cataract	B-Disease	1727
formation	O	1727
.	O	1727
as	O	1728
ocular	O	1728
cataracts	B-Disease	1728
are	O	1728
a	O	1728
characteristic	O	1728
feature	O	1728
of	O	1728
dm	B-Disease	1728
,	O	1728
these	O	1728
results	O	1728
demonstrate	O	1728
that	O	1728
decreased	O	1728
six5	O	1728
transcription	O	1728
is	O	1728
important	O	1728
in	O	1728
the	O	1728
aetiology	O	1728
of	O	1728
dm	B-Disease	1728
.	O	1728
our	O	1729
data	O	1729
support	O	1729
the	O	1729
hypothesis	O	1729
that	O	1729
dm	B-Disease	1729
is	O	1729
a	O	1729
contiguous	O	1729
gene	O	1729
syndrome	O	1729
associated	O	1729
with	O	1729
the	O	1729
partial	O	1729
loss	O	1729
of	O	1729
both	O	1729
dmpk	O	1729
and	O	1729
six5	O	1729
.	O	1729
.	O	1729
mutations	O	1731
in	O	1731
the	O	1731
gene	O	1731
atm	O	1731
are	O	1731
responsible	O	1731
for	O	1731
the	O	1731
genetic	B-Disease	1731
disorder	I-Disease	1731
ataxia	B-Disease	1731
-	I-Disease	1731
telangiectasia	I-Disease	1731
(	O	1731
a	B-Disease	1731
-	I-Disease	1731
t	I-Disease	1731
)	O	1731
,	O	1731
which	O	1731
is	O	1731
characterized	O	1731
by	O	1731
cerebellar	B-Disease	1731
dysfunction	I-Disease	1731
,	O	1731
radiosensitivity	O	1731
,	O	1731
chromosomal	O	1731
instability	O	1731
and	O	1731
cancer	B-Disease	1731
predisposition	O	1731
.	O	1731
both	O	1732
the	O	1732
a	B-Disease	1732
-	I-Disease	1732
t	I-Disease	1732
phenotype	O	1732
and	O	1732
the	O	1732
similarity	O	1732
of	O	1732
the	O	1732
atm	O	1732
protein	O	1732
to	O	1732
other	O	1732
dna	O	1732
-	O	1732
damage	O	1732
sensors	O	1732
suggests	O	1732
a	O	1732
role	O	1732
for	O	1732
atm	O	1732
in	O	1732
biochemical	O	1732
pathways	O	1732
involved	O	1732
in	O	1732
the	O	1732
recognition	O	1732
,	O	1732
signalling	O	1732
and	O	1732
repair	O	1732
of	O	1732
dna	O	1732
double	O	1732
-	O	1732
strand	O	1732
breaks	O	1732
(	O	1732
dsbs	O	1732
)	O	1732
.	O	1732
there	O	1733
are	O	1733
strong	O	1733
parallels	O	1733
between	O	1733
the	O	1733
pattern	O	1733
of	O	1733
radiosensitivity	O	1733
,	O	1733
chromosomal	O	1733
instability	O	1733
and	O	1733
cancer	B-Disease	1733
predisposition	O	1733
in	O	1733
a	B-Disease	1733
-	I-Disease	1733
t	I-Disease	1733
patients	O	1733
and	O	1733
that	O	1733
in	O	1733
patients	O	1733
with	O	1733
nijmegen	B-Disease	1733
breakage	I-Disease	1733
syndrome	I-Disease	1733
(	O	1733
nbs	B-Disease	1733
)	O	1733
.	O	1733
the	O	1734
protein	O	1734
defective	O	1734
in	O	1734
nbs	B-Disease	1734
,	O	1734
nibrin	O	1734
(	O	1734
encoded	O	1734
by	O	1734
nbs1	O	1734
)	O	1734
,	O	1734
forms	O	1734
a	O	1734
complex	O	1734
with	O	1734
mre11	O	1734
and	O	1734
rad50	O	1734
(	O	1734
refs	O	1734
1	O	1734
,	O	1734
2	O	1734
)	O	1734
.	O	1734
the	O	1736
overlap	O	1736
between	O	1736
clinical	O	1736
and	O	1736
cellular	O	1736
phenotypes	O	1736
in	O	1736
a	B-Disease	1736
-	I-Disease	1736
t	I-Disease	1736
and	O	1736
nbs	B-Disease	1736
suggests	O	1736
that	O	1736
atm	O	1736
and	O	1736
nibrin	O	1736
may	O	1736
function	O	1736
in	O	1736
the	O	1736
same	O	1736
biochemical	O	1736
pathway	O	1736
.	O	1736
this	O	1738
response	O	1738
is	O	1738
abrogated	O	1738
in	O	1738
a	B-Disease	1738
-	I-Disease	1738
t	I-Disease	1738
cells	O	1738
that	O	1738
either	O	1738
do	O	1738
not	O	1738
express	O	1738
atm	O	1738
protein	O	1738
or	O	1738
express	O	1738
near	O	1738
full	O	1738
-	O	1738
length	O	1738
mutant	O	1738
protein	O	1738
.	O	1738
phosphorylation	O	1740
of	O	1740
this	O	1740
site	O	1740
appears	O	1740
to	O	1740
be	O	1740
functionally	O	1740
important	O	1740
because	O	1740
mutated	O	1740
nibrin	O	1740
(	O	1740
s343a	O	1740
)	O	1740
does	O	1740
not	O	1740
completely	O	1740
complement	O	1740
radiosensitivity	O	1740
in	O	1740
nbs	B-Disease	1740
cells	O	1740
.	O	1740
our	O	1742
data	O	1742
provide	O	1742
a	O	1742
biochemical	O	1742
explanation	O	1742
for	O	1742
the	O	1742
similarity	O	1742
in	O	1742
phenotype	O	1742
between	O	1742
a	B-Disease	1742
-	I-Disease	1742
t	I-Disease	1742
and	O	1742
nbs	B-Disease	1742
.	O	1742
.	O	1742
clinicopathologic	O	1743
features	O	1743
of	O	1743
brca	B-Disease	1743
-	I-Disease	1743
linked	I-Disease	1743
and	I-Disease	1743
sporadic	I-Disease	1743
ovarian	I-Disease	1743
cancer	I-Disease	1743
.	O	1743
context	O	1744
most	O	1744
hereditary	B-Disease	1744
ovarian	I-Disease	1744
cancers	I-Disease	1744
are	O	1744
associated	O	1744
with	O	1744
germline	O	1744
mutations	O	1744
in	O	1744
brca1	O	1744
or	O	1744
brca2	O	1744
.	O	1744
attempts	O	1745
to	O	1745
define	O	1745
the	O	1745
clinical	O	1745
significance	O	1745
of	O	1745
brca	O	1745
mutation	O	1745
status	O	1745
in	O	1745
ovarian	B-Disease	1745
cancer	I-Disease	1745
have	O	1745
produced	O	1745
conflicting	O	1745
results	O	1745
,	O	1745
especially	O	1745
regarding	O	1745
survival	O	1745
.	O	1745
objective	O	1746
to	O	1746
determine	O	1746
whether	O	1746
hereditary	B-Disease	1746
ovarian	I-Disease	1746
cancers	I-Disease	1746
have	O	1746
distinct	O	1746
clinical	O	1746
and	O	1746
pathological	O	1746
features	O	1746
compared	O	1746
with	O	1746
sporadic	B-Disease	1746
(	I-Disease	1746
nonhereditary	I-Disease	1746
)	I-Disease	1746
ovarian	I-Disease	1746
cancers	I-Disease	1746
.	O	1746
design	O	1747
and	O	1747
setting	O	1747
retrospective	O	1747
cohort	O	1747
study	O	1747
of	O	1747
a	O	1747
consecutive	O	1747
series	O	1747
of	O	1747
933	O	1747
ovarian	B-Disease	1747
cancers	I-Disease	1747
diagnosed	O	1747
and	O	1747
treated	O	1747
at	O	1747
our	O	1747
institution	O	1747
,	O	1747
which	O	1747
is	O	1747
a	O	1747
comprehensive	O	1747
cancer	B-Disease	1747
center	O	1747
as	O	1747
designated	O	1747
by	O	1747
the	O	1747
national	O	1747
cancer	B-Disease	1747
institute	O	1747
,	O	1747
over	O	1747
a	O	1747
12	O	1747
-	O	1747
year	O	1747
period	O	1747
(	O	1747
december	O	1747
1986	O	1747
to	O	1747
august	O	1747
1998	O	1747
)	O	1747
.	O	1747
the	O	1750
remaining	O	1750
101	O	1750
cases	O	1750
from	O	1750
the	O	1750
same	O	1750
series	O	1750
not	O	1750
associated	O	1750
with	O	1750
a	O	1750
brca	O	1750
mutation	O	1750
and	O	1750
2	O	1750
additional	O	1750
groups	O	1750
(	O	1750
gynecologic	O	1750
oncology	O	1750
group	O	1750
protocols	O	1750
52	O	1750
and	O	1750
111	O	1750
)	O	1750
with	O	1750
ovarian	B-Disease	1750
cancer	I-Disease	1750
from	O	1750
clinical	O	1750
trials	O	1750
(	O	1750
for	O	1750
the	O	1750
survival	O	1750
analysis	O	1750
)	O	1750
were	O	1750
included	O	1750
for	O	1750
comparison	O	1750
.	O	1750
results	O	1752
hereditary	B-Disease	1752
cancers	I-Disease	1752
were	O	1752
rarely	O	1752
diagnosed	O	1752
before	O	1752
age	O	1752
40	O	1752
years	O	1752
and	O	1752
were	O	1752
common	O	1752
after	O	1752
age	O	1752
60	O	1752
years	O	1752
,	O	1752
with	O	1752
mean	O	1752
age	O	1752
at	O	1752
diagnosis	O	1752
being	O	1752
significantly	O	1752
younger	O	1752
for	O	1752
brca1	O	1752
-	O	1752
vs	O	1752
brca2	O	1752
-	O	1752
linked	O	1752
patients	O	1752
(	O	1752
54	O	1752
vs	O	1752
62	O	1752
years	O	1752
;	O	1752
p	O	1752
=	O	1752
.	O	1752
04	O	1752
)	O	1752
.	O	1752
those	O	1755
with	O	1755
hereditary	B-Disease	1755
cancers	I-Disease	1755
had	O	1755
improved	O	1755
survival	O	1755
compared	O	1755
with	O	1755
the	O	1755
nonhereditary	O	1755
group	O	1755
(	O	1755
p	O	1755
=	O	1755
.	O	1755
004	O	1755
)	O	1755
.	O	1755
for	O	1756
stage	B-Disease	1756
iii	I-Disease	1756
cancers	I-Disease	1756
,	O	1756
brca	O	1756
mutation	O	1756
status	O	1756
was	O	1756
an	O	1756
independent	O	1756
prognostic	O	1756
variable	O	1756
(	O	1756
p	O	1756
=	O	1756
.	O	1756
03	O	1756
)	O	1756
.	O	1756
conclusions	O	1757
although	O	1757
brca	B-Disease	1757
-	I-Disease	1757
associated	I-Disease	1757
hereditary	I-Disease	1757
ovarian	I-Disease	1757
cancers	I-Disease	1757
in	O	1757
this	O	1757
population	O	1757
have	O	1757
surgical	O	1757
and	O	1757
pathological	O	1757
characteristics	O	1757
similar	O	1757
to	O	1757
those	O	1757
of	O	1757
sporadic	B-Disease	1757
cancers	I-Disease	1757
,	O	1757
advanced	B-Disease	1757
-	I-Disease	1757
stage	I-Disease	1757
hereditary	I-Disease	1757
cancer	I-Disease	1757
patients	O	1757
survive	O	1757
longer	O	1757
than	O	1757
nonhereditary	B-Disease	1757
cancer	I-Disease	1757
patients	O	1757
.	O	1757
age	O	1758
penetrance	O	1758
is	O	1758
greater	O	1758
for	O	1758
brca1	B-Disease	1758
-	I-Disease	1758
linked	I-Disease	1758
than	I-Disease	1758
for	I-Disease	1758
brca2	I-Disease	1758
-	I-Disease	1758
linked	I-Disease	1758
cancers	I-Disease	1758
in	O	1758
this	O	1758
population	O	1758
.	O	1758
the	O	1759
gene	O	1759
for	O	1759
familial	B-Disease	1759
mediterranean	I-Disease	1759
fever	I-Disease	1759
,	O	1759
mefv	O	1759
,	O	1759
is	O	1759
expressed	O	1759
in	O	1759
early	O	1759
leukocyte	O	1759
development	O	1759
and	O	1759
is	O	1759
regulated	O	1759
in	O	1759
response	O	1759
to	O	1759
inflammatory	O	1759
mediators	O	1759
.	O	1759
familial	B-Disease	1760
mediterranean	I-Disease	1760
fever	I-Disease	1760
(	O	1760
fmf	B-Disease	1760
)	O	1760
is	O	1760
a	O	1760
recessive	B-Disease	1760
disorder	I-Disease	1760
characterized	O	1760
by	O	1760
episodes	O	1760
of	O	1760
fever	B-Disease	1760
and	O	1760
neutrophil	B-Disease	1760
-	I-Disease	1760
mediated	I-Disease	1760
serosal	I-Disease	1760
inflammation	I-Disease	1760
.	O	1760
we	O	1761
recently	O	1761
identified	O	1761
the	O	1761
gene	O	1761
causing	O	1761
fmf	B-Disease	1761
,	O	1761
designated	O	1761
mefv	O	1761
,	O	1761
and	O	1761
found	O	1761
it	O	1761
to	O	1761
be	O	1761
expressed	O	1761
in	O	1761
mature	O	1761
neutrophils	O	1761
,	O	1761
suggesting	O	1761
that	O	1761
it	O	1761
functions	O	1761
as	O	1761
an	O	1761
inflammatory	O	1761
regulator	O	1761
.	O	1761
in	O	1769
vitro	O	1769
stimulation	O	1769
of	O	1769
monocytes	O	1769
with	O	1769
the	O	1769
proinflammatory	O	1769
agents	O	1769
interferon	O	1769
(	O	1769
ifn	O	1769
)	O	1769
gamma	O	1769
,	O	1769
tumor	B-Disease	1769
necrosis	O	1769
factor	O	1769
,	O	1769
and	O	1769
lipopolysaccharide	O	1769
induced	O	1769
mefv	O	1769
expression	O	1769
,	O	1769
whereas	O	1769
the	O	1769
antiinflammatory	O	1769
cytokines	O	1769
interleukin	O	1769
(	O	1769
il	O	1769
)	O	1769
4	O	1769
,	O	1769
il	O	1769
-	O	1769
10	O	1769
,	O	1769
and	O	1769
transforming	O	1769
growth	O	1769
factor	O	1769
beta	O	1769
inhibited	O	1769
such	O	1769
expression	O	1769
.	O	1769
biochemical	O	1774
and	O	1774
structural	O	1774
analysis	O	1774
of	O	1774
missense	O	1774
mutations	O	1774
in	O	1774
n	O	1774
-	O	1774
acetylgalactosamine	O	1774
-	O	1774
6	O	1774
-	O	1774
sulfate	O	1774
sulfatase	O	1774
causing	O	1774
mucopolysaccharidosis	B-Disease	1774
iva	I-Disease	1774
phenotypes	O	1774
.	O	1774
mucopolysaccharidosis	B-Disease	1775
iva	I-Disease	1775
(	O	1775
mps	B-Disease	1775
iva	I-Disease	1775
;	O	1775
omim	O	1775
#	O	1775
253000	O	1775
)	O	1775
,	O	1775
a	O	1775
lysosomal	B-Disease	1775
storage	I-Disease	1775
disorder	I-Disease	1775
caused	O	1775
by	O	1775
a	O	1775
deficiency	B-Disease	1775
of	I-Disease	1775
n	I-Disease	1775
-	I-Disease	1775
acetylgalactosamine	I-Disease	1775
-	I-Disease	1775
6	I-Disease	1775
-	I-Disease	1775
sulfate	I-Disease	1775
sulfatase	I-Disease	1775
(	O	1775
galns	O	1775
)	O	1775
,	O	1775
has	O	1775
variable	O	1775
clinical	O	1775
phenotypes	O	1775
.	O	1775
to	O	1776
date	O	1776
we	O	1776
have	O	1776
identified	O	1776
65	O	1776
missense	O	1776
mutations	O	1776
in	O	1776
the	O	1776
galns	O	1776
gene	O	1776
from	O	1776
mps	B-Disease	1776
iva	I-Disease	1776
patients	O	1776
,	O	1776
but	O	1776
the	O	1776
correlation	O	1776
between	O	1776
genotype	O	1776
and	O	1776
phenotype	O	1776
has	O	1776
remained	O	1776
unclear	O	1776
.	O	1776
these	O	1786
studies	O	1786
shed	O	1786
further	O	1786
light	O	1786
on	O	1786
the	O	1786
genotype	O	1786
-	O	1786
phenotype	O	1786
correlation	O	1786
of	O	1786
mps	B-Disease	1786
iva	I-Disease	1786
and	O	1786
structure	O	1786
-	O	1786
function	O	1786
relationship	O	1786
in	O	1786
the	O	1786
sulfatase	O	1786
family	O	1786
.	O	1786
mutations	O	1787
at	O	1787
the	O	1787
ataxia	B-Disease	1787
-	I-Disease	1787
telangiectasia	I-Disease	1787
locus	O	1787
and	O	1787
clinical	O	1787
phenotypes	O	1787
of	O	1787
a	B-Disease	1787
-	I-Disease	1787
t	I-Disease	1787
patients	O	1787
.	O	1787
mutations	O	1788
at	O	1788
the	O	1788
ataxia	B-Disease	1788
-	I-Disease	1788
telangiectasia	I-Disease	1788
(	O	1788
a	B-Disease	1788
-	I-Disease	1788
t	I-Disease	1788
)	O	1788
locus	O	1788
on	O	1788
chromosome	O	1788
band	O	1788
11q22	O	1788
cause	O	1788
a	O	1788
distinctive	O	1788
autosomal	B-Disease	1788
recessive	I-Disease	1788
syndrome	I-Disease	1788
in	O	1788
homozygotes	O	1788
and	O	1788
predispose	O	1788
heterozygotes	O	1788
to	O	1788
cancer	B-Disease	1788
,	O	1788
ischemic	B-Disease	1788
heart	I-Disease	1788
disease	I-Disease	1788
,	O	1788
and	O	1788
early	O	1788
mortality	O	1788
.	O	1788
pcr	O	1789
amplification	O	1789
from	O	1789
genomic	O	1789
dna	O	1789
and	O	1789
automated	O	1789
sequencing	O	1789
of	O	1789
the	O	1789
entire	O	1789
coding	O	1789
region	O	1789
(	O	1789
66	O	1789
exons	O	1789
)	O	1789
and	O	1789
splice	O	1789
junctions	O	1789
detected	O	1789
77	O	1789
mutations	O	1789
(	O	1789
85	O	1789
%	O	1789
)	O	1789
in	O	1789
90	O	1789
a	B-Disease	1789
-	I-Disease	1789
t	I-Disease	1789
chromosomes	O	1789
.	O	1789
heteroduplex	O	1790
analysis	O	1790
detected	O	1790
another	O	1790
42	O	1790
mutations	O	1790
at	O	1790
the	O	1790
a	B-Disease	1790
-	I-Disease	1790
t	I-Disease	1790
locus	O	1790
.	O	1790
most	O	1792
(	O	1792
58	O	1792
/	O	1792
71	O	1792
,	O	1792
82	O	1792
%	O	1792
)	O	1792
mutations	O	1792
were	O	1792
frameshift	O	1792
and	O	1792
nonsense	O	1792
mutations	O	1792
that	O	1792
are	O	1792
predicted	O	1792
to	O	1792
cause	O	1792
truncation	O	1792
of	O	1792
the	O	1792
a	B-Disease	1792
-	I-Disease	1792
t	I-Disease	1792
protein	O	1792
;	O	1792
the	O	1792
less	O	1792
common	O	1792
mutation	O	1792
types	O	1792
were	O	1792
missense	O	1792
(	O	1792
9	O	1792
/	O	1792
71	O	1792
,	O	1792
13	O	1792
%	O	1792
)	O	1792
,	O	1792
splicing	O	1792
(	O	1792
3	O	1792
/	O	1792
71	O	1792
,	O	1792
4	O	1792
%	O	1792
)	O	1792
and	O	1792
one	O	1792
in	O	1792
-	O	1792
frame	O	1792
deletion	O	1792
,	O	1792
2546	O	1792
3	O	1792
(	O	1792
1	O	1792
/	O	1792
71	O	1792
,	O	1792
1	O	1792
%	O	1792
)	O	1792
.	O	1792
the	O	1793
mean	O	1793
survival	O	1793
and	O	1793
height	O	1793
distribution	O	1793
of	O	1793
134	O	1793
a	B-Disease	1793
-	I-Disease	1793
t	I-Disease	1793
patients	O	1793
correlated	O	1793
significantly	O	1793
with	O	1793
the	O	1793
specific	O	1793
mutations	O	1793
present	O	1793
in	O	1793
the	O	1793
patients	O	1793
.	O	1793
alterations	O	1795
of	O	1795
the	O	1795
length	O	1795
or	O	1795
amino	O	1795
acid	O	1795
composition	O	1795
of	O	1795
the	O	1795
a	B-Disease	1795
-	I-Disease	1795
t	I-Disease	1795
gene	O	1795
product	O	1795
affect	O	1795
the	O	1795
a	B-Disease	1795
-	I-Disease	1795
t	I-Disease	1795
clinical	O	1795
phenotype	O	1795
in	O	1795
different	O	1795
ways	O	1795
.	O	1795
mutation	O	1796
analysis	O	1796
at	O	1796
the	O	1796
a	B-Disease	1796
-	I-Disease	1796
t	I-Disease	1796
locus	O	1796
may	O	1796
help	O	1796
estimate	O	1796
the	O	1796
prognosis	O	1796
of	O	1796
a	B-Disease	1796
-	I-Disease	1796
t	I-Disease	1796
patients	O	1796
.	O	1796
.	O	1796
isolation	O	1797
,	O	1797
genomic	O	1797
organization	O	1797
,	O	1797
and	O	1797
expression	O	1797
analysis	O	1797
of	O	1797
the	O	1797
mouse	O	1797
and	O	1797
rat	O	1797
homologs	O	1797
of	O	1797
mefv	O	1797
,	O	1797
the	O	1797
gene	O	1797
for	O	1797
familial	B-Disease	1797
mediterranean	I-Disease	1797
fever	I-Disease	1797
.	O	1797
familial	B-Disease	1798
mediterranean	I-Disease	1798
fever	I-Disease	1798
(	O	1798
fmf	B-Disease	1798
)	O	1798
is	O	1798
a	O	1798
recessive	B-Disease	1798
disorder	I-Disease	1798
characterized	O	1798
by	O	1798
episodes	O	1798
of	O	1798
fever	B-Disease	1798
with	O	1798
serositis	B-Disease	1798
or	O	1798
synovitis	B-Disease	1798
.	O	1798
recently	O	1799
the	O	1799
fmf	B-Disease	1799
gene	O	1799
(	O	1799
mefv	O	1799
)	O	1799
was	O	1799
cloned	O	1799
;	O	1799
the	O	1799
protein	O	1799
product	O	1799
,	O	1799
pyrin	O	1799
/	O	1799
marenostrin	O	1799
,	O	1799
is	O	1799
thought	O	1799
to	O	1799
regulate	O	1799
inflammation	O	1799
in	O	1799
myeloid	O	1799
cells	O	1799
.	O	1799
2	O	1805
domain	O	1805
,	O	1805
in	O	1805
which	O	1805
most	O	1805
fmf	B-Disease	1805
-	O	1805
associated	O	1805
mutations	O	1805
have	O	1805
been	O	1805
found	O	1805
in	O	1805
human	O	1805
mefv	O	1805
.	O	1805
additional	O	1811
copies	O	1811
of	O	1811
the	O	1811
proteolipid	O	1811
protein	O	1811
gene	O	1811
causing	O	1811
pelizaeus	B-Disease	1811
-	I-Disease	1811
merzbacher	I-Disease	1811
disease	I-Disease	1811
arise	O	1811
by	O	1811
separate	O	1811
integration	O	1811
into	O	1811
the	O	1811
x	O	1811
chromosome	O	1811
.	O	1811
mutations	O	1813
and	O	1813
duplications	O	1813
of	O	1813
this	O	1813
gene	O	1813
are	O	1813
associated	O	1813
with	O	1813
pelizaeus	B-Disease	1813
-	I-Disease	1813
merzbacher	I-Disease	1813
disease	I-Disease	1813
(	O	1813
pmd	B-Disease	1813
)	O	1813
.	O	1813
here	O	1814
we	O	1814
describe	O	1814
two	O	1814
new	O	1814
families	O	1814
in	O	1814
which	O	1814
males	O	1814
affected	O	1814
with	O	1814
pmd	B-Disease	1814
were	O	1814
found	O	1814
to	O	1814
have	O	1814
a	O	1814
copy	O	1814
of	O	1814
plp	O	1814
on	O	1814
the	O	1814
short	O	1814
arm	O	1814
of	O	1814
the	O	1814
x	O	1814
chromosome	O	1814
,	O	1814
in	O	1814
addition	O	1814
to	O	1814
a	O	1814
normal	O	1814
copy	O	1814
on	O	1814
xq22	O	1814
.	O	1814
in	O	1819
a	O	1819
second	O	1819
unrelated	O	1819
family	O	1819
with	O	1819
signs	O	1819
of	O	1819
pmd	B-Disease	1819
,	O	1819
cytogenetic	O	1819
analysis	O	1819
showed	O	1819
a	O	1819
pericentric	O	1819
inversion	O	1819
of	O	1819
the	O	1819
x	O	1819
chromosome	O	1819
.	O	1819
the	O	1823
identification	O	1823
of	O	1823
three	O	1823
separate	O	1823
families	O	1823
in	O	1823
which	O	1823
plp	O	1823
is	O	1823
duplicated	O	1823
at	O	1823
a	O	1823
noncontiguous	O	1823
site	O	1823
suggests	O	1823
that	O	1823
such	O	1823
duplications	O	1823
could	O	1823
be	O	1823
a	O	1823
relatively	O	1823
common	O	1823
but	O	1823
previously	O	1823
undetected	O	1823
cause	O	1823
of	O	1823
genetic	B-Disease	1823
disorders	I-Disease	1823
.	O	1823
to	O	1829
do	O	1829
this	O	1829
,	O	1829
a	O	1829
collaborative	O	1829
screening	O	1829
study	O	1829
was	O	1829
set	O	1829
up	O	1829
that	O	1829
involved	O	1829
39	O	1829
institutions	O	1829
from	O	1829
19	O	1829
countries	O	1829
and	O	1829
included	O	1829
3	O	1829
,	O	1829
580	O	1829
unrelated	O	1829
individuals	O	1829
with	O	1829
a	O	1829
family	O	1829
history	O	1829
of	O	1829
the	O	1829
disease	O	1829
and	O	1829
934	O	1829
early	O	1829
-	O	1829
onset	O	1829
breast	B-Disease	1829
and	I-Disease	1829
/	I-Disease	1829
or	I-Disease	1829
ovarian	I-Disease	1829
cancer	I-Disease	1829
cases	O	1829
.	O	1829
genotype	O	1833
-	O	1833
phenotype	O	1833
correlations	O	1833
in	O	1833
families	O	1833
with	O	1833
deletions	O	1833
in	O	1833
the	O	1833
von	B-Disease	1833
hippel	I-Disease	1833
-	I-Disease	1833
lindau	I-Disease	1833
(	O	1833
vhl	B-Disease	1833
)	O	1833
gene	O	1833
.	O	1833
von	B-Disease	1834
hippel	I-Disease	1834
-	I-Disease	1834
lindau	I-Disease	1834
(	I-Disease	1834
vhl	I-Disease	1834
)	I-Disease	1834
disease	I-Disease	1834
is	O	1834
a	O	1834
hereditary	B-Disease	1834
tumor	I-Disease	1834
syndrome	I-Disease	1834
characterized	O	1834
by	O	1834
predisposition	O	1834
for	O	1834
bilateral	B-Disease	1834
and	I-Disease	1834
multi	I-Disease	1834
-	I-Disease	1834
centric	I-Disease	1834
hemangioblastoma	I-Disease	1834
in	O	1834
the	O	1834
retina	O	1834
and	O	1834
central	O	1834
nervous	O	1834
system	O	1834
,	O	1834
pheochromocytoma	B-Disease	1834
,	O	1834
renal	B-Disease	1834
cell	I-Disease	1834
carcinoma	I-Disease	1834
,	O	1834
and	O	1834
cysts	B-Disease	1834
in	I-Disease	1834
the	I-Disease	1834
kidney	I-Disease	1834
,	I-Disease	1834
pancreas	I-Disease	1834
,	I-Disease	1834
and	I-Disease	1834
epididymis	I-Disease	1834
.	O	1834
we	O	1835
describe	O	1835
five	O	1835
families	O	1835
for	O	1835
which	O	1835
direct	O	1835
sequencing	O	1835
of	O	1835
the	O	1835
coding	O	1835
region	O	1835
of	O	1835
the	O	1835
vhl	B-Disease	1835
gene	O	1835
had	O	1835
failed	O	1835
to	O	1835
identify	O	1835
the	O	1835
family	O	1835
-	O	1835
specific	O	1835
mutation	O	1835
.	O	1835
further	O	1836
molecular	O	1836
analysis	O	1836
revealed	O	1836
deletions	O	1836
involving	O	1836
the	O	1836
vhl	B-Disease	1836
gene	O	1836
in	O	1836
each	O	1836
of	O	1836
these	O	1836
families	O	1836
.	O	1836
in	O	1838
the	O	1838
fifth	O	1838
family	O	1838
,	O	1838
fish	O	1838
analysis	O	1838
demonstrated	O	1838
the	O	1838
deletion	O	1838
of	O	1838
the	O	1838
entire	O	1838
vhl	B-Disease	1838
gene	O	1838
.	O	1838
our	O	1839
results	O	1839
show	O	1839
that	O	1839
(	O	1839
quantitative	O	1839
)	O	1839
southern	O	1839
blot	O	1839
analysis	O	1839
is	O	1839
a	O	1839
sensitive	O	1839
method	O	1839
for	O	1839
detecting	O	1839
germline	O	1839
deletions	O	1839
of	O	1839
the	O	1839
vhl	B-Disease	1839
gene	O	1839
and	O	1839
should	O	1839
be	O	1839
implemented	O	1839
in	O	1839
routine	O	1839
dna	O	1839
diagnosis	O	1839
for	O	1839
vhl	B-Disease	1839
disease	I-Disease	1839
.	O	1839
our	O	1840
data	O	1840
support	O	1840
the	O	1840
previously	O	1840
established	O	1840
observation	O	1840
that	O	1840
families	O	1840
with	O	1840
a	O	1840
germline	O	1840
deletion	O	1840
have	O	1840
a	O	1840
low	O	1840
risk	O	1840
for	O	1840
pheochromocytoma	B-Disease	1840
.	O	1840
further	O	1841
unraveling	O	1841
of	O	1841
genotype	O	1841
-	O	1841
phenotype	O	1841
correlations	O	1841
in	O	1841
vhl	B-Disease	1841
disease	I-Disease	1841
has	O	1841
revealed	O	1841
that	O	1841
families	O	1841
with	O	1841
a	O	1841
full	O	1841
or	O	1841
partial	O	1841
deletion	O	1841
of	O	1841
the	O	1841
vhl	B-Disease	1841
gene	O	1841
exhibit	O	1841
a	O	1841
phenotype	O	1841
with	O	1841
a	O	1841
preponderance	O	1841
of	O	1841
central	B-Disease	1841
nervous	I-Disease	1841
system	I-Disease	1841
hemangioblastoma	I-Disease	1841
.	O	1841
.	O	1841
age	O	1842
of	O	1842
the	O	1842
intronic	O	1842
gaa	O	1842
triplet	O	1842
repeat	O	1842
expansion	O	1842
mutation	O	1842
in	O	1842
friedreich	B-Disease	1842
ataxia	I-Disease	1842
.	O	1842
friedreich	B-Disease	1843
ataxia	I-Disease	1843
(	O	1843
frda	B-Disease	1843
)	O	1843
,	O	1843
the	O	1843
most	O	1843
frequently	O	1843
inherited	B-Disease	1843
ataxia	I-Disease	1843
,	O	1843
is	O	1843
due	O	1843
in	O	1843
the	O	1843
vast	O	1843
majority	O	1843
of	O	1843
cases	O	1843
to	O	1843
a	O	1843
large	O	1843
expansion	O	1843
of	O	1843
an	O	1843
intronic	O	1843
gaa	O	1843
repeat	O	1843
.	O	1843
using	O	1844
linkage	O	1844
disequilibrium	O	1844
analysis	O	1844
based	O	1844
on	O	1844
haplotype	O	1844
data	O	1844
of	O	1844
seven	O	1844
polymorphic	O	1844
markers	O	1844
close	O	1844
to	O	1844
the	O	1844
frataxin	O	1844
gene	O	1844
,	O	1844
the	O	1844
age	O	1844
of	O	1844
frda	B-Disease	1844
founding	O	1844
mutational	O	1844
event	O	1844
(	O	1844
s	O	1844
)	O	1844
is	O	1844
estimated	O	1844
to	O	1844
be	O	1844
at	O	1844
least	O	1844
682	O	1844
+	O	1844
/	O	1844
-	O	1844
203	O	1844
generations	O	1844
(	O	1844
95	O	1844
%	O	1844
confidence	O	1844
interval	O	1844
564	O	1844
-	O	1844
801	O	1844
g	O	1844
)	O	1844
,	O	1844
a	O	1844
dating	O	1844
which	O	1844
is	O	1844
consistent	O	1844
with	O	1844
little	O	1844
or	O	1844
no	O	1844
negative	O	1844
selection	O	1844
and	O	1844
provides	O	1844
further	O	1844
evidence	O	1844
for	O	1844
an	O	1844
ancient	O	1844
spread	O	1844
of	O	1844
a	O	1844
pre	O	1844
-	O	1844
mutation	O	1844
(	O	1844
at	O	1844
-	O	1844
risk	O	1844
alleles	O	1844
)	O	1844
in	O	1844
western	O	1844
europe	O	1844
.	O	1844
.	O	1844
functional	O	1845
link	O	1845
between	O	1845
ataxia	B-Disease	1845
-	I-Disease	1845
telangiectasia	I-Disease	1845
and	O	1845
nijmegen	B-Disease	1845
breakage	I-Disease	1845
syndrome	I-Disease	1845
gene	O	1845
products	O	1845
.	O	1845
ataxia	B-Disease	1846
-	I-Disease	1846
telangiectasia	I-Disease	1846
(	O	1846
a	B-Disease	1846
-	I-Disease	1846
t	I-Disease	1846
)	O	1846
and	O	1846
nijmegen	B-Disease	1846
breakage	I-Disease	1846
syndrome	I-Disease	1846
(	O	1846
nbs	B-Disease	1846
)	O	1846
are	O	1846
recessive	B-Disease	1846
genetic	I-Disease	1846
disorders	I-Disease	1846
with	O	1846
susceptibility	O	1846
to	O	1846
cancer	B-Disease	1846
and	O	1846
similar	O	1846
cellular	O	1846
phenotypes	O	1846
.	O	1846
the	O	1847
protein	O	1847
product	O	1847
of	O	1847
the	O	1847
gene	O	1847
responsible	O	1847
for	O	1847
a	B-Disease	1847
-	I-Disease	1847
t	I-Disease	1847
,	O	1847
designated	O	1847
atm	O	1847
,	O	1847
is	O	1847
a	O	1847
member	O	1847
of	O	1847
a	O	1847
family	O	1847
of	O	1847
kinases	O	1847
characterized	O	1847
by	O	1847
a	O	1847
carboxy	O	1847
-	O	1847
terminal	O	1847
phosphatidylinositol	O	1847
3	O	1847
-	O	1847
kinase	O	1847
-	O	1847
like	O	1847
domain	O	1847
.	O	1847
the	O	1848
nbs1	O	1848
protein	O	1848
is	O	1848
specifically	O	1848
mutated	O	1848
in	O	1848
patients	O	1848
with	O	1848
nijmegen	B-Disease	1848
breakage	I-Disease	1848
syndrome	I-Disease	1848
and	O	1848
forms	O	1848
a	O	1848
complex	O	1848
with	O	1848
the	O	1848
dna	O	1848
repair	O	1848
proteins	O	1848
rad50	O	1848
and	O	1848
mrel1	O	1848
.	O	1848
this	O	1852
response	O	1852
includes	O	1852
s	O	1852
-	O	1852
phase	O	1852
checkpoint	O	1852
activation	O	1852
,	O	1852
formation	O	1852
of	O	1852
the	O	1852
nbs1	O	1852
/	O	1852
mrel1	O	1852
/	O	1852
rad50	O	1852
nuclear	O	1852
foci	O	1852
and	O	1852
rescue	O	1852
of	O	1852
hypersensitivity	B-Disease	1852
to	I-Disease	1852
ionizing	I-Disease	1852
radiation	I-Disease	1852
.	O	1852
together	O	1853
,	O	1853
these	O	1853
results	O	1853
demonstrate	O	1853
a	O	1853
biochemical	O	1853
link	O	1853
between	O	1853
cell	O	1853
-	O	1853
cycle	O	1853
checkpoints	O	1853
activated	O	1853
by	O	1853
dna	O	1853
damage	O	1853
and	O	1853
dna	O	1853
repair	O	1853
in	O	1853
two	O	1853
genetic	B-Disease	1853
diseases	I-Disease	1853
with	O	1853
overlapping	O	1853
phenotypes	O	1853
.	O	1853
.	O	1853
homozygosity	O	1854
mapping	O	1854
in	O	1854
a	O	1854
family	O	1854
with	O	1854
microcephaly	B-Disease	1854
,	O	1854
mental	B-Disease	1854
retardation	I-Disease	1854
,	O	1854
and	O	1854
short	B-Disease	1854
stature	I-Disease	1854
to	O	1854
a	O	1854
cohen	B-Disease	1854
syndrome	I-Disease	1854
region	O	1854
on	O	1854
8q21	O	1854
.	O	1854
3	O	1854
-	O	1854
8q22	O	1854
.	O	1854
1	O	1854
:	O	1854
redefining	O	1854
a	O	1854
clinical	O	1854
entity	O	1854
.	O	1854
a	O	1855
syndrome	O	1855
of	O	1855
microcephaly	B-Disease	1855
,	O	1855
progressive	O	1855
postnatal	B-Disease	1855
growth	I-Disease	1855
deficiency	I-Disease	1855
,	O	1855
and	O	1855
mental	B-Disease	1855
retardation	I-Disease	1855
was	O	1855
observed	O	1855
in	O	1855
two	O	1855
brothers	O	1855
and	O	1855
their	O	1855
cousin	O	1855
from	O	1855
a	O	1855
multiply	O	1855
consanguineous	O	1855
kindred	O	1855
of	O	1855
lebanese	O	1855
descent	O	1855
.	O	1855
hypotonia	B-Disease	1856
,	O	1856
chorioretinal	B-Disease	1856
dystrophy	I-Disease	1856
,	O	1856
and	O	1856
myopia	B-Disease	1856
were	O	1856
also	O	1856
identified	O	1856
.	O	1856
because	O	1858
of	O	1858
absence	O	1858
of	O	1858
a	O	1858
distinctive	O	1858
facial	O	1858
appearance	O	1858
,	O	1858
the	O	1858
degree	O	1858
of	O	1858
mental	B-Disease	1858
retardation	I-Disease	1858
,	O	1858
and	O	1858
short	B-Disease	1858
stature	I-Disease	1858
,	O	1858
the	O	1858
initially	O	1858
considered	O	1858
clinical	O	1858
diagnosis	O	1858
of	O	1858
cohen	B-Disease	1858
syndrome	I-Disease	1858
was	O	1858
withdrawn	O	1858
and	O	1858
a	O	1858
novel	O	1858
genetic	O	1858
entity	O	1858
was	O	1858
assumed	O	1858
.	O	1858
intriguingly	O	1864
enough	O	1864
,	O	1864
the	O	1864
identified	O	1864
gene	O	1864
region	O	1864
overlaps	O	1864
the	O	1864
refined	O	1864
gene	O	1864
region	O	1864
for	O	1864
cohen	B-Disease	1864
syndrome	I-Disease	1864
(	O	1864
coh1	O	1864
)	O	1864
[	O	1864
kolehmainen	O	1864
et	O	1864
al	O	1864
.	O	1864
,	O	1864
1997	O	1864
euro	O	1864
j	O	1864
hum	O	1864
genet	O	1864
5	O	1864
206	O	1864
-	O	1864
213	O	1864
]	O	1864
.	O	1864
this	O	1865
fact	O	1865
encourages	O	1865
the	O	1865
hypothesis	O	1865
that	O	1865
the	O	1865
described	O	1865
kindred	O	1865
segregates	O	1865
for	O	1865
a	O	1865
variant	O	1865
of	O	1865
cohen	B-Disease	1865
syndrome	I-Disease	1865
and	O	1865
suggests	O	1865
a	O	1865
redefinition	O	1865
of	O	1865
its	O	1865
phenotype	O	1865
polymorphisms	O	1866
of	O	1866
the	O	1866
cyp2d6	O	1866
gene	O	1866
increase	O	1866
susceptibility	O	1866
to	O	1866
ankylosing	B-Disease	1866
spondylitis	I-Disease	1866
.	O	1866
ankylosing	B-Disease	1867
spondylitis	I-Disease	1867
(	O	1867
as	B-Disease	1867
)	O	1867
is	O	1867
a	O	1867
common	O	1867
and	O	1867
highly	O	1867
familial	O	1867
rheumatic	B-Disease	1867
disorder	I-Disease	1867
.	O	1867
previous	O	1870
linkage	O	1870
and	O	1870
association	O	1870
studies	O	1870
have	O	1870
suggested	O	1870
the	O	1870
presence	O	1870
of	O	1870
a	O	1870
susceptibility	O	1870
gene	O	1870
for	O	1870
as	B-Disease	1870
close	O	1870
to	O	1870
,	O	1870
or	O	1870
within	O	1870
,	O	1870
the	O	1870
cytochrome	O	1870
p450	O	1870
2d6	O	1870
gene	O	1870
(	O	1870
cyp2d6	O	1870
,	O	1870
debrisoquine	O	1870
hydroxylase	O	1870
)	O	1870
located	O	1870
at	O	1870
chromosome	O	1870
22q13	O	1870
.	O	1870
1	O	1870
.	O	1870
we	O	1871
performed	O	1871
a	O	1871
linkage	O	1871
study	O	1871
of	O	1871
chromosome	O	1871
22	O	1871
in	O	1871
200	O	1871
families	O	1871
with	O	1871
as	B-Disease	1871
affected	O	1871
sibling	O	1871
-	O	1871
pairs	O	1871
.	O	1871
for	O	1873
case	O	1873
-	O	1873
control	O	1873
studies	O	1873
,	O	1873
617	O	1873
unrelated	O	1873
individuals	O	1873
with	O	1873
as	B-Disease	1873
(	O	1873
361	O	1873
probands	O	1873
from	O	1873
sibling	O	1873
-	O	1873
pair	O	1873
and	O	1873
parent	O	1873
-	O	1873
case	O	1873
trio	O	1873
families	O	1873
and	O	1873
256	O	1873
unrelated	O	1873
non	O	1873
-	O	1873
familial	O	1873
sporadic	O	1873
cases	O	1873
)	O	1873
and	O	1873
402	O	1873
healthy	O	1873
ethnically	O	1873
matched	O	1873
controls	O	1873
were	O	1873
employed	O	1873
.	O	1873
homozygosity	O	1875
for	O	1875
poor	O	1875
metabolizer	O	1875
alleles	O	1875
was	O	1875
found	O	1875
to	O	1875
be	O	1875
associated	O	1875
with	O	1875
as	B-Disease	1875
.	O	1875
heterozygosity	O	1876
for	O	1876
the	O	1876
most	O	1876
frequent	O	1876
poor	O	1876
metabolizer	O	1876
allele	O	1876
(	O	1876
cyp2d6	O	1876
*	O	1876
4	O	1876
)	O	1876
was	O	1876
not	O	1876
associated	O	1876
with	O	1876
increased	O	1876
susceptibility	O	1876
to	O	1876
as	B-Disease	1876
.	O	1876
significant	O	1877
within	O	1877
-	O	1877
family	O	1877
association	O	1877
of	O	1877
cyp2d6	O	1877
*	O	1877
4	O	1877
alleles	O	1877
and	O	1877
as	B-Disease	1877
was	O	1877
demonstrated	O	1877
.	O	1877
weak	O	1878
linkage	O	1878
was	O	1878
also	O	1878
demonstrated	O	1878
between	O	1878
cyp2d6	O	1878
and	O	1878
as	B-Disease	1878
.	O	1878
we	O	1879
postulate	O	1879
that	O	1879
altered	O	1879
metabolism	O	1879
of	O	1879
a	O	1879
natural	O	1879
toxin	O	1879
or	O	1879
antigen	O	1879
by	O	1879
the	O	1879
cyp2d6	O	1879
gene	O	1879
may	O	1879
increase	O	1879
susceptibility	O	1879
to	O	1879
as	B-Disease	1879
.	O	1879
functional	O	1880
differences	O	1880
of	O	1880
the	O	1880
pds	B-Disease	1880
gene	O	1880
product	O	1880
are	O	1880
associated	O	1880
with	O	1880
phenotypic	O	1880
variation	O	1880
in	O	1880
patients	O	1880
with	O	1880
pendred	B-Disease	1880
syndrome	I-Disease	1880
and	O	1880
non	B-Disease	1880
-	I-Disease	1880
syndromic	I-Disease	1880
hearing	I-Disease	1880
loss	I-Disease	1880
(	O	1880
dfnb4	B-Disease	1880
)	O	1880
.	O	1880
the	O	1881
pds	B-Disease	1881
gene	O	1881
encodes	O	1881
a	O	1881
transmembrane	O	1881
protein	O	1881
,	O	1881
known	O	1881
as	O	1881
pendrin	O	1881
,	O	1881
which	O	1881
functions	O	1881
as	O	1881
a	O	1881
transporter	O	1881
of	O	1881
iodide	O	1881
and	O	1881
chloride	O	1881
.	O	1881
mutations	O	1882
in	O	1882
this	O	1882
gene	O	1882
are	O	1882
responsible	O	1882
for	O	1882
pendred	B-Disease	1882
syndrome	I-Disease	1882
and	O	1882
autosomal	B-Disease	1882
recessive	I-Disease	1882
non	I-Disease	1882
-	I-Disease	1882
syndromic	I-Disease	1882
hearing	I-Disease	1882
loss	I-Disease	1882
at	O	1882
the	O	1882
dfnb4	B-Disease	1882
locus	O	1882
on	O	1882
chromosome	O	1882
7q31	O	1882
.	O	1882
a	O	1883
screen	O	1883
of	O	1883
20	O	1883
individuals	O	1883
from	O	1883
the	O	1883
midwestern	O	1883
usa	O	1883
with	O	1883
non	B-Disease	1883
-	I-Disease	1883
syndromic	I-Disease	1883
hearing	I-Disease	1883
loss	I-Disease	1883
and	O	1883
dilated	O	1883
vestibular	O	1883
aqueducts	O	1883
identified	O	1883
three	O	1883
people	O	1883
(	O	1883
15	O	1883
%	O	1883
)	O	1883
with	O	1883
pds	B-Disease	1883
mutations	O	1883
.	O	1883
to	O	1884
determine	O	1884
whether	O	1884
pds	B-Disease	1884
mutations	O	1884
in	O	1884
individuals	O	1884
with	O	1884
pendred	B-Disease	1884
syndrome	I-Disease	1884
differ	O	1884
functionally	O	1884
from	O	1884
pds	B-Disease	1884
mutations	O	1884
in	O	1884
individuals	O	1884
with	O	1884
non	B-Disease	1884
-	I-Disease	1884
syndromic	I-Disease	1884
hearing	I-Disease	1884
loss	I-Disease	1884
,	O	1884
we	O	1884
compared	O	1884
three	O	1884
common	O	1884
pendred	B-Disease	1884
syndrome	I-Disease	1884
allele	O	1884
variants	O	1884
(	O	1884
l236p	O	1884
,	O	1884
t416p	O	1884
and	O	1884
e384g	O	1884
)	O	1884
,	O	1884
with	O	1884
three	O	1884
pds	B-Disease	1884
mutations	O	1884
reported	O	1884
only	O	1884
in	O	1884
individuals	O	1884
with	O	1884
non	B-Disease	1884
-	I-Disease	1884
syndromic	I-Disease	1884
hearing	I-Disease	1884
loss	I-Disease	1884
(	O	1884
v480d	O	1884
,	O	1884
v653a	O	1884
and	O	1884
i490l	O	1884
/	O	1884
g497s	O	1884
)	O	1884
.	O	1884
the	O	1885
mutations	O	1885
associated	O	1885
with	O	1885
pendred	B-Disease	1885
syndrome	I-Disease	1885
have	O	1885
complete	O	1885
loss	O	1885
of	O	1885
pendrin	O	1885
-	O	1885
induced	O	1885
chloride	O	1885
and	O	1885
iodide	O	1885
transport	O	1885
,	O	1885
while	O	1885
alleles	O	1885
unique	O	1885
to	O	1885
people	O	1885
with	O	1885
dfnb4	B-Disease	1885
are	O	1885
able	O	1885
to	O	1885
transport	O	1885
both	O	1885
iodide	O	1885
and	O	1885
chloride	O	1885
,	O	1885
albeit	O	1885
at	O	1885
a	O	1885
much	O	1885
lower	O	1885
level	O	1885
than	O	1885
wild	O	1885
-	O	1885
type	O	1885
pendrin	O	1885
.	O	1885
we	O	1886
hypothesize	O	1886
that	O	1886
this	O	1886
residual	O	1886
level	O	1886
of	O	1886
anion	O	1886
transport	O	1886
is	O	1886
sufficient	O	1886
to	O	1886
eliminate	O	1886
or	O	1886
postpone	O	1886
the	O	1886
onset	O	1886
of	O	1886
goiter	B-Disease	1886
in	O	1886
individuals	O	1886
with	O	1886
dfnb4	B-Disease	1886
.	O	1886
germline	O	1889
mutations	O	1889
are	O	1889
the	O	1889
major	O	1889
source	O	1889
of	O	1889
genetic	O	1889
variation	O	1889
that	O	1889
allows	O	1889
a	O	1889
species	O	1889
to	O	1889
evolve	O	1889
over	O	1889
time	O	1889
but	O	1889
at	O	1889
the	O	1889
cost	O	1889
of	O	1889
mendelian	B-Disease	1889
disease	I-Disease	1889
and	O	1889
genetic	O	1889
predisposition	O	1889
to	O	1889
multifactorial	B-Disease	1889
diseases	I-Disease	1889
.	O	1889
here	O	1891
,	O	1891
we	O	1891
compare	O	1891
the	O	1891
pattern	O	1891
of	O	1891
germline	O	1891
mutation	O	1891
in	O	1891
a	O	1891
population	O	1891
of	O	1891
hemophilia	B-Disease	1891
b	I-Disease	1891
patients	O	1891
from	O	1891
mainland	O	1891
china	O	1891
(	O	1891
n	O	1891
=	O	1891
66	O	1891
)	O	1891
to	O	1891
that	O	1891
in	O	1891
u	O	1891
.	O	1891
heterozygous	O	1896
mutations	O	1896
encoding	O	1896
abnormal	O	1896
forms	O	1896
of	O	1896
the	O	1896
death	O	1896
receptor	O	1896
fas	O	1896
dominantly	O	1896
interfere	O	1896
with	O	1896
fas	O	1896
-	O	1896
induced	O	1896
lymphocyte	O	1896
apoptosis	O	1896
in	O	1896
human	O	1896
autoimmune	B-Disease	1896
lymphoproliferative	I-Disease	1896
syndrome	I-Disease	1896
.	O	1896
determination	O	1900
of	O	1900
carrier	O	1900
status	O	1900
for	O	1900
the	O	1900
wiskott	B-Disease	1900
-	I-Disease	1900
aldrich	I-Disease	1900
syndrome	I-Disease	1900
by	O	1900
flow	O	1900
cytometric	O	1900
analysis	O	1900
of	O	1900
wiskott	B-Disease	1900
-	I-Disease	1900
aldrich	I-Disease	1900
syndrome	I-Disease	1900
protein	O	1900
expression	O	1900
in	O	1900
peripheral	O	1900
blood	O	1900
mononuclear	O	1900
cells	O	1900
.	O	1900
the	O	1901
wiskott	B-Disease	1901
-	I-Disease	1901
aldrich	I-Disease	1901
syndrome	I-Disease	1901
(	O	1901
was	B-Disease	1901
)	O	1901
is	O	1901
caused	O	1901
by	O	1901
defects	O	1901
in	O	1901
the	O	1901
was	B-Disease	1901
protein	O	1901
(	O	1901
wasp	O	1901
)	O	1901
gene	O	1901
on	O	1901
the	O	1901
x	O	1901
chromosome	O	1901
.	O	1901
previous	O	1902
study	O	1902
disclosed	O	1902
that	O	1902
flow	O	1902
cytometric	O	1902
analysis	O	1902
of	O	1902
intracellular	O	1902
wasp	O	1902
expression	O	1902
(	O	1902
fcm	O	1902
-	O	1902
wasp	O	1902
analysis	O	1902
)	O	1902
in	O	1902
lymphocytes	O	1902
was	O	1902
useful	O	1902
for	O	1902
the	O	1902
diagnosis	O	1902
of	O	1902
was	B-Disease	1902
patients	O	1902
.	O	1902
lymphocytes	O	1903
from	O	1903
all	O	1903
was	B-Disease	1903
patients	O	1903
showed	O	1903
waspdim	O	1903
instead	O	1903
of	O	1903
waspbright	O	1903
.	O	1903
here	O	1904
we	O	1904
report	O	1904
that	O	1904
fcm	O	1904
-	O	1904
wasp	O	1904
analysis	O	1904
in	O	1904
monocytes	O	1904
could	O	1904
be	O	1904
a	O	1904
useful	O	1904
tool	O	1904
for	O	1904
the	O	1904
was	B-Disease	1904
carrier	O	1904
diagnosis	O	1904
.	O	1904
monocytes	O	1905
from	O	1905
all	O	1905
nine	O	1905
was	B-Disease	1905
carriers	O	1905
showed	O	1905
varied	O	1905
population	O	1905
of	O	1905
waspdim	O	1905
together	O	1905
with	O	1905
waspbright	O	1905
.	O	1905
the	O	1908
difference	O	1908
of	O	1908
the	O	1908
waspdim	O	1908
population	O	1908
in	O	1908
monocytes	O	1908
and	O	1908
lymphocytes	O	1908
observed	O	1908
in	O	1908
was	B-Disease	1908
carriers	O	1908
suggests	O	1908
that	O	1908
wasp	O	1908
plays	O	1908
a	O	1908
more	O	1908
critical	O	1908
role	O	1908
in	O	1908
the	O	1908
development	O	1908
of	O	1908
lymphocytes	O	1908
than	O	1908
in	O	1908
that	O	1908
of	O	1908
monocytes	O	1908
.	O	1908
the	O	1909
present	O	1909
studies	O	1909
suggest	O	1909
that	O	1909
a	O	1909
skewed	O	1909
x	O	1909
-	O	1909
chromosomal	O	1909
inactivation	O	1909
pattern	O	1909
observed	O	1909
in	O	1909
was	B-Disease	1909
carrier	O	1909
peripheral	O	1909
blood	O	1909
cells	O	1909
is	O	1909
not	O	1909
fixed	O	1909
at	O	1909
the	O	1909
hemopoietic	O	1909
stem	O	1909
cell	O	1909
level	O	1909
but	O	1909
progresses	O	1909
after	O	1909
the	O	1909
lineage	O	1909
commitment	O	1909
.	O	1909
.	O	1909
restoration	O	1910
of	O	1910
photoreceptor	O	1910
ultrastructure	O	1910
and	O	1910
function	O	1910
in	O	1910
retinal	B-Disease	1910
degeneration	I-Disease	1910
slow	O	1910
mice	O	1910
by	O	1910
gene	O	1910
therapy	O	1910
.	O	1910
mutations	O	1913
in	O	1913
prph2	O	1913
have	O	1913
been	O	1913
shown	O	1913
to	O	1913
result	O	1913
in	O	1913
a	O	1913
variety	O	1913
of	O	1913
photoreceptor	B-Disease	1913
dystrophies	I-Disease	1913
,	O	1913
including	O	1913
autosomal	B-Disease	1913
dominant	I-Disease	1913
retinitis	I-Disease	1913
pigmentosa	I-Disease	1913
and	O	1913
macular	B-Disease	1913
dystrophy	I-Disease	1913
.	O	1913
a	O	1914
common	O	1914
feature	O	1914
of	O	1914
these	O	1914
diseases	O	1914
is	O	1914
the	O	1914
loss	O	1914
of	O	1914
photoreceptor	O	1914
function	O	1914
,	O	1914
also	O	1914
seen	O	1914
in	O	1914
the	O	1914
retinal	B-Disease	1914
degeneration	I-Disease	1914
slow	O	1914
(	O	1914
rds	O	1914
or	O	1914
prph2	O	1914
rd2	O	1914
/	O	1914
rd2	O	1914
)	O	1914
mouse	O	1914
,	O	1914
which	O	1914
is	O	1914
homozygous	O	1914
for	O	1914
a	O	1914
null	O	1914
mutation	O	1914
in	O	1914
prph2	O	1914
.	O	1914
mutations	O	1920
in	O	1920
the	O	1920
fibrinogen	O	1920
aalpha	O	1920
gene	O	1920
account	O	1920
for	O	1920
the	O	1920
majority	O	1920
of	O	1920
cases	O	1920
of	O	1920
congenital	B-Disease	1920
afibrinogenemia	I-Disease	1920
.	O	1920
congenital	B-Disease	1921
afibrinogenemia	I-Disease	1921
is	O	1921
a	O	1921
rare	O	1921
,	O	1921
autosomal	B-Disease	1921
,	I-Disease	1921
recessive	I-Disease	1921
disorder	I-Disease	1921
characterized	O	1921
by	O	1921
the	O	1921
complete	O	1921
absence	O	1921
of	O	1921
detectable	O	1921
fibrinogen	O	1921
.	O	1921
consequently	O	1929
,	O	1929
86	O	1929
%	O	1929
of	O	1929
afibrinogenemia	B-Disease	1929
alleles	O	1929
analyzed	O	1929
to	O	1929
date	O	1929
have	O	1929
truncating	O	1929
mutations	O	1929
of	O	1929
fga	O	1929
,	O	1929
though	O	1929
mutations	O	1929
in	O	1929
all	O	1929
3	O	1929
fibrinogen	O	1929
genes	O	1929
,	O	1929
fgg	O	1929
,	O	1929
fga	O	1929
,	O	1929
and	O	1929
fgb	O	1929
,	O	1929
might	O	1929
be	O	1929
predicted	O	1929
to	O	1929
cause	O	1929
congenital	B-Disease	1929
afibrinogenemia	I-Disease	1929
.	O	1929
.	O	1929
myotonic	B-Disease	1930
dystrophy	I-Disease	1930
:	O	1930
the	O	1930
role	O	1930
of	O	1930
the	O	1930
cug	O	1930
triplet	O	1930
repeats	O	1930
in	O	1930
splicing	O	1930
of	O	1930
a	O	1930
novel	O	1930
dmpk	O	1930
exon	O	1930
and	O	1930
altered	O	1930
cytoplasmic	O	1930
dmpk	O	1930
mrna	O	1930
isoform	O	1930
ratios	O	1930
.	O	1930
the	O	1931
mechanism	O	1931
by	O	1931
which	O	1931
(	O	1931
ctg	O	1931
)	O	1931
n	O	1931
expansion	O	1931
in	O	1931
the	O	1931
3	O	1931
utr	O	1931
of	O	1931
the	O	1931
dmpk	O	1931
gene	O	1931
causes	O	1931
myotonic	B-Disease	1931
dystrophy	I-Disease	1931
(	O	1931
dm	B-Disease	1931
)	O	1931
is	O	1931
unknown	O	1931
.	O	1931
in	O	1934
contrast	O	1934
to	O	1934
(	O	1934
cug	O	1934
)	O	1934
n	O	1934
containing	O	1934
mrnas	O	1934
,	O	1934
the	O	1934
novel	O	1934
isoform	O	1934
is	O	1934
not	O	1934
retained	O	1934
in	O	1934
the	O	1934
nucleus	O	1934
in	O	1934
dm	B-Disease	1934
cells	O	1934
,	O	1934
resulting	O	1934
in	O	1934
imbalances	O	1934
in	O	1934
relative	O	1934
levels	O	1934
of	O	1934
cytoplasmic	O	1934
dmpk	O	1934
mrna	O	1934
isoforms	O	1934
and	O	1934
a	O	1934
new	O	1934
dominant	O	1934
effect	O	1934
of	O	1934
the	O	1934
mutation	O	1934
on	O	1934
dmpk	O	1934
.	O	1934
.	O	1934
expression	O	1935
and	O	1935
imprinting	O	1935
of	O	1935
magel2	O	1935
suggest	O	1935
a	O	1935
role	O	1935
in	O	1935
prader	B-Disease	1935
-	I-Disease	1935
willi	I-Disease	1935
syndrome	I-Disease	1935
and	O	1935
the	O	1935
homologous	O	1935
murine	O	1935
imprinting	O	1935
phenotype	O	1935
.	O	1935
prader	B-Disease	1936
-	I-Disease	1936
willi	I-Disease	1936
syndrome	I-Disease	1936
(	O	1936
pws	B-Disease	1936
)	O	1936
is	O	1936
caused	O	1936
by	O	1936
the	O	1936
loss	O	1936
of	O	1936
expression	O	1936
of	O	1936
imprinted	O	1936
genes	O	1936
in	O	1936
chromosome	O	1936
15q11	O	1936
-	O	1936
q13	O	1936
.	O	1936
affected	O	1937
individuals	O	1937
exhibit	O	1937
neonatal	B-Disease	1937
hypotonia	I-Disease	1937
,	O	1937
developmental	B-Disease	1937
delay	I-Disease	1937
and	O	1937
childhood	B-Disease	1937
-	I-Disease	1937
onset	I-Disease	1937
obesity	I-Disease	1937
.	O	1937
necdin	O	1938
,	O	1938
a	O	1938
protein	O	1938
implicated	O	1938
in	O	1938
the	O	1938
terminal	O	1938
differentiation	O	1938
of	O	1938
neurons	O	1938
,	O	1938
is	O	1938
the	O	1938
only	O	1938
pws	B-Disease	1938
candidate	O	1938
gene	O	1938
to	O	1938
reduce	O	1938
viability	O	1938
when	O	1938
disrupted	O	1938
in	O	1938
a	O	1938
mouse	O	1938
model	O	1938
.	O	1938
in	O	1939
this	O	1939
study	O	1939
,	O	1939
we	O	1939
have	O	1939
characterized	O	1939
magel2	O	1939
(	O	1939
also	O	1939
known	O	1939
as	O	1939
ndnl1	O	1939
)	O	1939
,	O	1939
a	O	1939
gene	O	1939
with	O	1939
51	O	1939
%	O	1939
amino	O	1939
acid	O	1939
sequence	O	1939
similarity	O	1939
to	O	1939
necdin	O	1939
and	O	1939
located	O	1939
41	O	1939
kb	O	1939
distal	O	1939
to	O	1939
ndn	O	1939
in	O	1939
the	O	1939
pws	B-Disease	1939
deletion	O	1939
region	O	1939
.	O	1939
magel2	O	1940
is	O	1940
expressed	O	1940
predominantly	O	1940
in	O	1940
brain	O	1940
,	O	1940
the	O	1940
primary	O	1940
tissue	O	1940
affected	O	1940
in	O	1940
pws	B-Disease	1940
and	O	1940
in	O	1940
several	O	1940
fetal	O	1940
tissues	O	1940
as	O	1940
shown	O	1940
by	O	1940
northern	O	1940
blot	O	1940
analysis	O	1940
.	O	1940
magel2	O	1941
is	O	1941
imprinted	O	1941
with	O	1941
monoallelic	O	1941
expression	O	1941
in	O	1941
control	O	1941
brain	O	1941
,	O	1941
and	O	1941
paternal	O	1941
-	O	1941
only	O	1941
expression	O	1941
in	O	1941
the	O	1941
central	O	1941
nervous	O	1941
system	O	1941
as	O	1941
demonstrated	O	1941
by	O	1941
its	O	1941
lack	O	1941
of	O	1941
expression	O	1941
in	O	1941
brain	O	1941
from	O	1941
a	O	1941
pws	B-Disease	1941
-	O	1941
affected	O	1941
individual	O	1941
.	O	1941
we	O	1944
hypothesize	O	1944
that	O	1944
,	O	1944
although	O	1944
loss	O	1944
of	O	1944
necdin	O	1944
expression	O	1944
may	O	1944
be	O	1944
important	O	1944
in	O	1944
the	O	1944
neonatal	O	1944
presentation	O	1944
of	O	1944
pws	B-Disease	1944
,	O	1944
loss	O	1944
of	O	1944
magel2	O	1944
may	O	1944
be	O	1944
critical	O	1944
to	O	1944
abnormalities	B-Disease	1944
in	I-Disease	1944
brain	I-Disease	1944
development	I-Disease	1944
and	O	1944
dysmorphic	B-Disease	1944
features	I-Disease	1944
in	O	1944
individuals	O	1944
with	O	1944
pws	B-Disease	1944
.	O	1944
.	O	1944
retinoschisin	O	1945
,	O	1945
the	O	1945
x	B-Disease	1945
-	I-Disease	1945
linked	I-Disease	1945
retinoschisis	I-Disease	1945
protein	O	1945
,	O	1945
is	O	1945
a	O	1945
secreted	O	1945
photoreceptor	O	1945
protein	O	1945
,	O	1945
and	O	1945
is	O	1945
expressed	O	1945
and	O	1945
released	O	1945
by	O	1945
weri	O	1945
-	O	1945
rb1	O	1945
cells	O	1945
.	O	1945
x	B-Disease	1946
-	I-Disease	1946
linked	I-Disease	1946
retinoschisis	I-Disease	1946
is	O	1946
characterized	O	1946
by	O	1946
microcystic	O	1946
-	O	1946
like	O	1946
changes	O	1946
of	O	1946
the	O	1946
macular	O	1946
region	O	1946
and	O	1946
schisis	O	1946
within	O	1946
the	O	1946
inner	O	1946
retinal	O	1946
layers	O	1946
,	O	1946
leading	O	1946
to	O	1946
visual	B-Disease	1946
deterioration	I-Disease	1946
in	O	1946
males	O	1946
.	O	1946
furthermore	O	1953
,	O	1953
differentiated	O	1953
retinoblastoma	B-Disease	1953
cells	O	1953
(	O	1953
weri	O	1953
-	O	1953
rb1	O	1953
cells	O	1953
)	O	1953
were	O	1953
found	O	1953
to	O	1953
express	O	1953
rs1	O	1953
mrna	O	1953
and	O	1953
to	O	1953
release	O	1953
retinoschisin	O	1953
.	O	1953
thus	O	1955
,	O	1955
x	B-Disease	1955
-	I-Disease	1955
linked	I-Disease	1955
retinoschisis	I-Disease	1955
is	O	1955
caused	O	1955
by	O	1955
abnormalities	O	1955
in	O	1955
a	O	1955
putative	O	1955
secreted	O	1955
photoreceptor	O	1955
protein	O	1955
and	O	1955
is	O	1955
the	O	1955
first	O	1955
example	O	1955
of	O	1955
a	O	1955
secreted	O	1955
photo	O	1955
-	O	1955
receptor	O	1955
protein	O	1955
associated	O	1955
with	O	1955
a	O	1955
retinal	B-Disease	1955
dystrophy	I-Disease	1955
.	O	1955
.	O	1955
study	O	1956
of	O	1956
the	O	1956
voltage	O	1956
-	O	1956
gated	O	1956
sodium	O	1956
channel	O	1956
beta	O	1956
1	O	1956
subunit	O	1956
gene	O	1956
(	O	1956
scn1b	O	1956
)	O	1956
in	O	1956
the	O	1956
benign	B-Disease	1956
familial	I-Disease	1956
infantile	I-Disease	1956
convulsions	I-Disease	1956
syndrome	I-Disease	1956
(	O	1956
bfic	B-Disease	1956
)	O	1956
.	O	1956
benign	B-Disease	1957
familial	I-Disease	1957
infantile	I-Disease	1957
convulsions	I-Disease	1957
(	O	1957
bfic	B-Disease	1957
)	O	1957
is	O	1957
a	O	1957
rare	O	1957
autosomal	B-Disease	1957
dominant	I-Disease	1957
epilepsy	I-Disease	1957
syndrome	I-Disease	1957
.	O	1957
the	O	1960
seizures	O	1960
usually	O	1960
spontaneously	O	1960
cease	O	1960
after	O	1960
one	O	1960
year	O	1960
without	O	1960
treatment	O	1960
,	O	1960
leaving	O	1960
no	O	1960
neurological	B-Disease	1960
abnormalities	I-Disease	1960
.	O	1960
we	O	1961
have	O	1961
mapped	O	1961
bfic	B-Disease	1961
to	O	1961
chromosome	O	1961
19q	O	1961
in	O	1961
five	O	1961
italian	O	1961
pedigrees	O	1961
.	O	1961
the	O	1962
sodium	O	1962
channel	O	1962
beta1	O	1962
subunit	O	1962
gene	O	1962
(	O	1962
scn1b	O	1962
)	O	1962
maps	O	1962
to	O	1962
this	O	1962
candidate	O	1962
region	O	1962
and	O	1962
has	O	1962
been	O	1962
shown	O	1962
to	O	1962
be	O	1962
involved	O	1962
in	O	1962
one	O	1962
australian	O	1962
pedigree	O	1962
with	O	1962
generalized	B-Disease	1962
epilepsy	I-Disease	1962
and	I-Disease	1962
febrile	I-Disease	1962
seizures	I-Disease	1962
plus	I-Disease	1962
(	O	1962
gefs	O	1962
+	O	1962
)	O	1962
.	O	1962
bfic	B-Disease	1964
and	O	1964
gefs	O	1964
+	O	1964
have	O	1964
clinical	O	1964
features	O	1964
in	O	1964
common	O	1964
,	O	1964
therefore	O	1964
scn1b	O	1964
is	O	1964
a	O	1964
candidate	O	1964
gene	O	1964
for	O	1964
bfic	B-Disease	1964
.	O	1964
we	O	1965
studied	O	1965
scn1b	O	1965
exons	O	1965
1	O	1965
,	O	1965
2	O	1965
,	O	1965
3	O	1965
,	O	1965
4	O	1965
,	O	1965
and	O	1965
5	O	1965
,	O	1965
using	O	1965
four	O	1965
sscp	O	1965
methods	O	1965
in	O	1965
10	O	1965
caucasian	O	1965
bfic	B-Disease	1965
probands	O	1965
of	O	1965
western	O	1965
europe	O	1965
.	O	1965
one	O	1967
variant	O	1967
was	O	1967
identified	O	1967
in	O	1967
intron	O	1967
5	O	1967
(	O	1967
ivs5	O	1967
-	O	1967
10c	O	1967
>	O	1967
g	O	1967
)	O	1967
,	O	1967
which	O	1967
did	O	1967
not	O	1967
segregate	O	1967
with	O	1967
bfic	B-Disease	1967
and	O	1967
was	O	1967
observed	O	1967
in	O	1967
9	O	1967
.	O	1967
it	O	1970
was	O	1970
rare	O	1970
,	O	1970
as	O	1970
not	O	1970
observed	O	1970
in	O	1970
controls	O	1970
,	O	1970
but	O	1970
not	O	1970
segregating	O	1970
with	O	1970
the	O	1970
bfic	B-Disease	1970
phenotype	O	1970
.	O	1970
inactivation	O	1971
of	O	1971
germline	O	1971
mutant	O	1971
apc	B-Disease	1971
alleles	O	1971
by	O	1971
attenuated	O	1971
somatic	O	1971
mutations	O	1971
:	O	1971
a	O	1971
molecular	O	1971
genetic	O	1971
mechanism	O	1971
for	O	1971
attenuated	B-Disease	1971
familial	I-Disease	1971
adenomatous	I-Disease	1971
polyposis	I-Disease	1971
.	O	1971
germline	O	1972
mutations	O	1972
of	O	1972
the	O	1972
adenomatous	B-Disease	1972
polyposis	I-Disease	1972
coli	I-Disease	1972
(	I-Disease	1972
apc	I-Disease	1972
)	I-Disease	1972
tumor	I-Disease	1972
-	O	1972
suppressor	O	1972
gene	O	1972
result	O	1972
in	O	1972
familial	B-Disease	1972
adenomatous	I-Disease	1972
polyposis	I-Disease	1972
(	O	1972
fap	B-Disease	1972
)	O	1972
.	O	1972
patients	O	1973
with	O	1973
fap	B-Disease	1973
typically	O	1973
develop	O	1973
hundreds	O	1973
to	O	1973
thousands	O	1973
of	O	1973
benign	B-Disease	1973
colorectal	I-Disease	1973
tumors	I-Disease	1973
and	O	1973
early	O	1973
-	O	1973
onset	O	1973
colorectal	B-Disease	1973
cancer	I-Disease	1973
.	O	1973
a	O	1974
subset	O	1974
of	O	1974
germline	O	1974
apc	B-Disease	1974
mutations	O	1974
results	O	1974
in	O	1974
an	O	1974
attenuated	B-Disease	1974
fap	I-Disease	1974
(	O	1974
afap	B-Disease	1974
)	O	1974
phenotype	O	1974
,	O	1974
in	O	1974
which	O	1974
patients	O	1974
develop	O	1974
fewer	O	1974
tumors	B-Disease	1974
and	O	1974
develop	O	1974
them	O	1974
at	O	1974
an	O	1974
older	O	1974
age	O	1974
.	O	1974
although	O	1975
a	O	1975
genotype	O	1975
-	O	1975
phenotype	O	1975
correlation	O	1975
between	O	1975
the	O	1975
locations	O	1975
of	O	1975
apc	B-Disease	1975
germline	O	1975
mutations	O	1975
and	O	1975
the	O	1975
development	O	1975
of	O	1975
afap	B-Disease	1975
has	O	1975
been	O	1975
well	O	1975
documented	O	1975
,	O	1975
the	O	1975
mechanism	O	1975
for	O	1975
afap	B-Disease	1975
has	O	1975
not	O	1975
been	O	1975
well	O	1975
defined	O	1975
.	O	1975
we	O	1976
investigated	O	1976
the	O	1976
mechanism	O	1976
for	O	1976
afap	B-Disease	1976
in	O	1976
patients	O	1976
carrying	O	1976
a	O	1976
mutant	O	1976
apc	B-Disease	1976
allele	O	1976
(	O	1976
apc	O	1976
(	O	1976
as9	O	1976
)	O	1976
)	O	1976
that	O	1976
has	O	1976
a	O	1976
mutation	O	1976
in	O	1976
the	O	1976
alternatively	O	1976
spliced	O	1976
region	O	1976
of	O	1976
exon	O	1976
9	O	1976
.	O	1976
apc	O	1977
(	O	1977
as9	O	1977
)	O	1977
was	O	1977
found	O	1977
to	O	1977
down	O	1977
-	O	1977
regulate	O	1977
beta	O	1977
-	O	1977
catenin	O	1977
-	O	1977
regulated	O	1977
transcription	O	1977
,	O	1977
the	O	1977
major	O	1977
tumor	B-Disease	1977
-	O	1977
suppressor	O	1977
function	O	1977
of	O	1977
apc	O	1977
,	O	1977
as	O	1977
did	O	1977
the	O	1977
wild	O	1977
-	O	1977
type	O	1977
apc	O	1977
.	O	1977
mutation	O	1978
analysis	O	1978
showed	O	1978
that	O	1978
both	O	1978
apc	O	1978
(	O	1978
as9	O	1978
)	O	1978
and	O	1978
the	O	1978
wild	O	1978
-	O	1978
type	O	1978
apc	B-Disease	1978
alleles	O	1978
were	O	1978
somatically	O	1978
mutated	O	1978
in	O	1978
most	O	1978
colorectal	B-Disease	1978
tumors	I-Disease	1978
from	O	1978
these	O	1978
patients	O	1978
.	O	1978
functional	O	1979
analysis	O	1979
showed	O	1979
that	O	1979
4666insa	O	1979
,	O	1979
a	O	1979
common	O	1979
somatic	O	1979
mutation	O	1979
in	O	1979
apc	O	1979
(	O	1979
as9	O	1979
)	O	1979
in	O	1979
these	O	1979
tumors	B-Disease	1979
,	O	1979
did	O	1979
not	O	1979
inactivate	O	1979
the	O	1979
wild	O	1979
-	O	1979
type	O	1979
apc	O	1979
.	O	1979
our	O	1980
results	O	1980
indicate	O	1980
that	O	1980
carriers	O	1980
of	O	1980
apc	O	1980
(	O	1980
as9	O	1980
)	O	1980
develop	O	1980
fewer	O	1980
colorectal	B-Disease	1980
tumors	I-Disease	1980
than	O	1980
do	O	1980
typical	O	1980
patients	O	1980
with	O	1980
fap	B-Disease	1980
because	O	1980
somatic	O	1980
inactivation	O	1980
of	O	1980
both	O	1980
apc	B-Disease	1980
alleles	O	1980
is	O	1980
necessary	O	1980
for	O	1980
colorectal	O	1980
tumorigenesis	O	1980
.	O	1980
however	O	1981
,	O	1981
these	O	1981
patients	O	1981
develop	O	1981
colorectal	B-Disease	1981
tumors	I-Disease	1981
more	O	1981
frequently	O	1981
than	O	1981
does	O	1981
the	O	1981
general	O	1981
population	O	1981
because	O	1981
apc	O	1981
(	O	1981
as9	O	1981
)	O	1981
is	O	1981
inactivated	O	1981
by	O	1981
mutations	O	1981
that	O	1981
do	O	1981
not	O	1981
inactivate	O	1981
the	O	1981
wild	O	1981
-	O	1981
type	O	1981
apc	O	1981
.	O	1981
.	O	1981
iron	O	1982
-	O	1982
dependent	O	1982
self	O	1982
-	O	1982
assembly	O	1982
of	O	1982
recombinant	O	1982
yeast	O	1982
frataxin	O	1982
:	O	1982
implications	O	1982
for	O	1982
friedreich	B-Disease	1982
ataxia	I-Disease	1982
.	O	1982
frataxin	B-Disease	1983
deficiency	I-Disease	1983
is	O	1983
the	O	1983
primary	O	1983
cause	O	1983
of	O	1983
friedreich	B-Disease	1983
ataxia	I-Disease	1983
(	O	1983
frda	B-Disease	1983
)	O	1983
,	O	1983
an	O	1983
autosomal	B-Disease	1983
recessive	I-Disease	1983
cardiodegenerative	I-Disease	1983
and	I-Disease	1983
neurodegenerative	I-Disease	1983
disease	I-Disease	1983
.	O	1983
genetic	O	1985
inactivation	O	1985
of	O	1985
the	O	1985
yeast	O	1985
frataxin	O	1985
homologue	O	1985
(	O	1985
yfh1p	O	1985
)	O	1985
results	O	1985
in	O	1985
mitochondrial	B-Disease	1985
iron	I-Disease	1985
accumulation	I-Disease	1985
and	O	1985
hypersensitivity	B-Disease	1985
to	I-Disease	1985
oxidative	I-Disease	1985
stress	I-Disease	1985
.	O	1985
increased	O	1986
iron	O	1986
deposition	O	1986
and	O	1986
evidence	O	1986
of	O	1986
oxidative	O	1986
damage	O	1986
have	O	1986
also	O	1986
been	O	1986
observed	O	1986
in	O	1986
cardiac	O	1986
tissue	O	1986
and	O	1986
cultured	O	1986
fibroblasts	O	1986
from	O	1986
patients	O	1986
with	O	1986
frda	B-Disease	1986
.	O	1986
a	O	1999
mutation	O	1999
in	O	1999
the	O	1999
pleckstrin	O	1999
homology	O	1999
(	O	1999
ph	O	1999
)	O	1999
domain	O	1999
of	O	1999
the	O	1999
fgd1	O	1999
gene	O	1999
in	O	1999
an	O	1999
italian	O	1999
family	O	1999
with	O	1999
faciogenital	B-Disease	1999
dysplasia	I-Disease	1999
(	O	1999
aarskog	B-Disease	1999
-	I-Disease	1999
scott	I-Disease	1999
syndrome	I-Disease	1999
)	O	1999
.	O	1999
aarskog	B-Disease	2000
-	I-Disease	2000
scott	I-Disease	2000
syndrome	I-Disease	2000
(	O	2000
aas	B-Disease	2000
)	O	2000
is	O	2000
an	O	2000
x	B-Disease	2000
-	I-Disease	2000
linked	I-Disease	2000
disorder	I-Disease	2000
characterised	O	2000
by	O	2000
short	B-Disease	2000
stature	I-Disease	2000
and	O	2000
multiple	O	2000
facial	B-Disease	2000
,	I-Disease	2000
limb	I-Disease	2000
and	I-Disease	2000
genital	I-Disease	2000
abnormalities	I-Disease	2000
.	O	2000
a	O	2001
gene	O	2001
,	O	2001
fgd1	O	2001
,	O	2001
altered	O	2001
in	O	2001
a	O	2001
patient	O	2001
with	O	2001
aas	B-Disease	2001
phenotype	O	2001
,	O	2001
has	O	2001
been	O	2001
identified	O	2001
and	O	2001
found	O	2001
to	O	2001
encode	O	2001
a	O	2001
protein	O	2001
with	O	2001
homology	O	2001
to	O	2001
rho	O	2001
/	O	2001
rac	O	2001
guanine	O	2001
nucleotide	O	2001
exchange	O	2001
factors	O	2001
(	O	2001
rho	O	2001
/	O	2001
rac	O	2001
gef	O	2001
)	O	2001
.	O	2001
however	O	2002
,	O	2002
since	O	2002
this	O	2002
original	O	2002
report	O	2002
on	O	2002
identification	O	2002
of	O	2002
a	O	2002
mutated	O	2002
fgd1	O	2002
gene	O	2002
in	O	2002
an	O	2002
aas	B-Disease	2002
patient	O	2002
,	O	2002
no	O	2002
additional	O	2002
mutations	O	2002
in	O	2002
the	O	2002
fgd1	O	2002
gene	O	2002
have	O	2002
been	O	2002
described	O	2002
.	O	2002
we	O	2003
analysed	O	2003
13	O	2003
independent	O	2003
patients	O	2003
with	O	2003
clinical	O	2003
diagnosis	O	2003
of	O	2003
aas	B-Disease	2003
.	O	2003
the	O	2005
mutation	O	2005
was	O	2005
found	O	2005
to	O	2005
segregate	O	2005
with	O	2005
the	O	2005
aas	B-Disease	2005
phenotype	O	2005
in	O	2005
affected	O	2005
males	O	2005
and	O	2005
carrier	O	2005
females	O	2005
in	O	2005
the	O	2005
family	O	2005
of	O	2005
this	O	2005
patient	O	2005
.	O	2005
the	O	2007
same	O	2007
residue	O	2007
is	O	2007
often	O	2007
mutated	O	2007
in	O	2007
the	O	2007
brutons	O	2007
tyrosine	O	2007
kinase	O	2007
(	O	2007
btk	O	2007
)	O	2007
gene	O	2007
in	O	2007
patients	O	2007
with	O	2007
an	O	2007
x	B-Disease	2007
-	I-Disease	2007
linked	I-Disease	2007
agammaglobulinemia	I-Disease	2007
.	O	2007
huntington	B-Disease	2010
disease	I-Disease	2010
(	O	2010
hd	B-Disease	2010
)	O	2010
is	O	2010
caused	O	2010
by	O	2010
expansion	O	2010
of	O	2010
a	O	2010
glutamine	O	2010
repeat	O	2010
in	O	2010
the	O	2010
amino	O	2010
-	O	2010
terminal	O	2010
region	O	2010
of	O	2010
huntingtin	O	2010
.	O	2010
here	O	2012
we	O	2012
report	O	2012
that	O	2012
,	O	2012
in	O	2012
mutant	O	2012
mice	O	2012
expressing	O	2012
hd	B-Disease	2012
repeats	O	2012
,	O	2012
the	O	2012
production	O	2012
and	O	2012
aggregation	O	2012
of	O	2012
n	O	2012
-	O	2012
terminal	O	2012
huntingtin	O	2012
fragments	O	2012
preferentially	O	2012
occur	O	2012
in	O	2012
hd	B-Disease	2012
-	O	2012
affected	O	2012
neurons	O	2012
and	O	2012
their	O	2012
processes	O	2012
and	O	2012
axonal	O	2012
terminals	O	2012
.	O	2012
n	O	2013
-	O	2013
terminal	O	2013
fragments	O	2013
of	O	2013
mutant	O	2013
huntingtin	O	2013
form	O	2013
aggregates	O	2013
and	O	2013
induce	O	2013
neuritic	B-Disease	2013
degeneration	I-Disease	2013
in	O	2013
cultured	O	2013
striatal	O	2013
neurons	O	2013
.	O	2013
the	O	2015
specific	O	2015
processing	O	2015
and	O	2015
accumulation	O	2015
of	O	2015
toxic	O	2015
fragments	O	2015
of	O	2015
n	O	2015
-	O	2015
terminal	O	2015
huntingtin	O	2015
in	O	2015
hd	B-Disease	2015
-	O	2015
affected	O	2015
striatal	O	2015
neurons	O	2015
,	O	2015
especially	O	2015
in	O	2015
their	O	2015
neuronal	O	2015
processes	O	2015
and	O	2015
axonal	O	2015
terminals	O	2015
,	O	2015
may	O	2015
contribute	O	2015
to	O	2015
the	O	2015
selective	O	2015
neuropathology	O	2015
of	O	2015
hd	B-Disease	2015
.	O	2015
.	O	2015
brca1	O	2016
is	O	2016
associated	O	2016
with	O	2016
a	O	2016
human	O	2016
swi	O	2016
/	O	2016
snf	O	2016
-	O	2016
related	O	2016
complex	O	2016
:	O	2016
linking	O	2016
chromatin	O	2016
remodeling	O	2016
to	O	2016
breast	B-Disease	2016
cancer	I-Disease	2016
.	O	2016
germline	O	2017
mutations	O	2017
in	O	2017
the	O	2017
tumor	B-Disease	2017
suppressor	O	2017
gene	O	2017
,	O	2017
brca1	O	2017
,	O	2017
predispose	O	2017
individuals	O	2017
to	O	2017
breast	B-Disease	2017
and	I-Disease	2017
ovarian	I-Disease	2017
cancers	I-Disease	2017
.	O	2017
moreover	O	2021
,	O	2021
p53	O	2021
-	O	2021
mediated	O	2021
stimulation	O	2021
of	O	2021
transcription	O	2021
by	O	2021
brca1	O	2021
was	O	2021
completely	O	2021
abrogated	O	2021
by	O	2021
either	O	2021
a	O	2021
dominant	O	2021
-	O	2021
negative	O	2021
mutant	O	2021
of	O	2021
brg1	O	2021
or	O	2021
the	O	2021
cancer	B-Disease	2021
-	O	2021
causing	O	2021
deletion	O	2021
in	O	2021
exon	O	2021
11	O	2021
of	O	2021
brca1	O	2021
.	O	2021
asef	O	2023
,	O	2023
a	O	2023
link	O	2023
between	O	2023
the	O	2023
tumor	B-Disease	2023
suppressor	O	2023
apc	O	2023
and	O	2023
g	O	2023
-	O	2023
protein	O	2023
signaling	O	2023
.	O	2023
the	O	2024
adenomatous	B-Disease	2024
polyposis	I-Disease	2024
coli	I-Disease	2024
gene	O	2024
(	O	2024
apc	O	2024
)	O	2024
is	O	2024
mutated	O	2024
in	O	2024
familial	B-Disease	2024
adenomatous	I-Disease	2024
polyposis	I-Disease	2024
and	O	2024
in	O	2024
sporadic	O	2024
colorectal	B-Disease	2024
tumors	I-Disease	2024
.	O	2024
here	O	2025
the	O	2025
apc	B-Disease	2025
gene	O	2025
product	O	2025
is	O	2025
shown	O	2025
to	O	2025
bind	O	2025
through	O	2025
its	O	2025
armadillo	O	2025
repeat	O	2025
domain	O	2025
to	O	2025
a	O	2025
rac	O	2025
-	O	2025
specific	O	2025
guanine	O	2025
nucleotide	O	2025
exchange	O	2025
factor	O	2025
(	O	2025
gef	O	2025
)	O	2025
,	O	2025
termed	O	2025
asef	O	2025
.	O	2025
the	O	2030
axonal	O	2030
chemoattractant	O	2030
netrin	O	2030
-	O	2030
1	O	2030
guides	O	2030
spinal	O	2030
commissural	O	2030
axons	O	2030
by	O	2030
activating	O	2030
its	O	2030
receptor	O	2030
dcc	O	2030
(	O	2030
deleted	O	2030
in	O	2030
colorectal	B-Disease	2030
cancer	I-Disease	2030
)	O	2030
.	O	2030
myotonic	B-Disease	2034
dystrophy	I-Disease	2034
in	O	2034
transgenic	O	2034
mice	O	2034
expressing	O	2034
an	O	2034
expanded	O	2034
cug	O	2034
repeat	O	2034
.	O	2034
myotonic	B-Disease	2035
dystrophy	I-Disease	2035
(	O	2035
dm	B-Disease	2035
)	O	2035
,	O	2035
the	O	2035
most	O	2035
common	O	2035
form	O	2035
of	O	2035
muscular	B-Disease	2035
dystrophy	I-Disease	2035
in	O	2035
adult	O	2035
humans	O	2035
,	O	2035
results	O	2035
from	O	2035
expansion	O	2035
of	O	2035
a	O	2035
ctg	O	2035
repeat	O	2035
in	O	2035
the	O	2035
3	O	2035
untranslated	O	2035
region	O	2035
of	O	2035
the	O	2035
dmpk	O	2035
gene	O	2035
.	O	2035
mice	O	2038
that	O	2038
expressed	O	2038
expanded	O	2038
cug	O	2038
repeats	O	2038
developed	O	2038
myotonia	B-Disease	2038
and	O	2038
myopathy	B-Disease	2038
,	O	2038
whereas	O	2038
mice	O	2038
expressing	O	2038
a	O	2038
nonexpanded	O	2038
repeat	O	2038
did	O	2038
not	O	2038
.	O	2038
thus	O	2039
,	O	2039
transcripts	O	2039
with	O	2039
expanded	O	2039
cug	O	2039
repeats	O	2039
are	O	2039
sufficient	O	2039
to	O	2039
generate	O	2039
a	O	2039
dm	B-Disease	2039
phenotype	O	2039
.	O	2039
genomic	O	2041
rearrangements	O	2041
of	O	2041
the	O	2041
apc	B-Disease	2041
tumor	I-Disease	2041
-	O	2041
suppressor	O	2041
gene	O	2041
in	O	2041
familial	B-Disease	2041
adenomatous	I-Disease	2041
polyposis	I-Disease	2041
.	O	2041
germline	O	2042
mutations	O	2042
of	O	2042
the	O	2042
adenomatous	B-Disease	2042
polyposis	I-Disease	2042
coli	I-Disease	2042
(	I-Disease	2042
apc	I-Disease	2042
)	I-Disease	2042
tumor	I-Disease	2042
-	O	2042
suppressor	O	2042
gene	O	2042
result	O	2042
in	O	2042
the	O	2042
hereditary	B-Disease	2042
colorectal	I-Disease	2042
cancer	I-Disease	2042
syndrome	I-Disease	2042
familial	B-Disease	2042
adenomatous	I-Disease	2042
polyposis	I-Disease	2042
(	O	2042
fap	B-Disease	2042
)	O	2042
.	O	2042
almost	O	2043
all	O	2043
apc	B-Disease	2043
mutations	O	2043
that	O	2043
have	O	2043
been	O	2043
identified	O	2043
are	O	2043
single	O	2043
-	O	2043
nucleotide	O	2043
alterations	O	2043
,	O	2043
small	O	2043
insertions	O	2043
,	O	2043
or	O	2043
small	O	2043
deletions	O	2043
that	O	2043
would	O	2043
truncate	O	2043
the	O	2043
protein	O	2043
product	O	2043
of	O	2043
the	O	2043
gene	O	2043
.	O	2043
no	O	2044
well	O	2044
-	O	2044
characterized	O	2044
intragenic	O	2044
rearrangement	O	2044
of	O	2044
apc	O	2044
has	O	2044
been	O	2044
described	O	2044
,	O	2044
and	O	2044
the	O	2044
prevalence	O	2044
of	O	2044
this	O	2044
type	O	2044
of	O	2044
mutation	O	2044
in	O	2044
fap	B-Disease	2044
patients	O	2044
is	O	2044
not	O	2044
clear	O	2044
.	O	2044
we	O	2045
screened	O	2045
49	O	2045
potential	O	2045
fap	B-Disease	2045
families	O	2045
and	O	2045
identified	O	2045
26	O	2045
different	O	2045
germline	O	2045
apc	B-Disease	2045
mutations	O	2045
in	O	2045
30	O	2045
families	O	2045
.	O	2045
the	O	2053
identification	O	2053
of	O	2053
four	O	2053
genomic	O	2053
rearrangements	O	2053
among	O	2053
30	O	2053
mutations	O	2053
suggests	O	2053
that	O	2053
genomic	O	2053
rearrangements	O	2053
are	O	2053
frequent	O	2053
germline	O	2053
apc	B-Disease	2053
mutations	O	2053
.	O	2053
.	O	2053
detection	O	2054
of	O	2054
a	O	2054
novel	O	2054
missense	O	2054
mutation	O	2054
and	O	2054
second	O	2054
recurrent	O	2054
mutation	O	2054
in	O	2054
the	O	2054
cacna1a	O	2054
gene	O	2054
in	O	2054
individuals	O	2054
with	O	2054
ea	B-Disease	2054
-	I-Disease	2054
2	I-Disease	2054
and	O	2054
fhm	B-Disease	2054
.	O	2054
mutations	O	2055
in	O	2055
the	O	2055
brain	O	2055
specific	O	2055
p	O	2055
/	O	2055
q	O	2055
type	O	2055
ca2	O	2055
+	O	2055
channel	O	2055
alpha1	O	2055
subunit	O	2055
gene	O	2055
,	O	2055
cacna1a	O	2055
,	O	2055
have	O	2055
been	O	2055
identified	O	2055
in	O	2055
three	O	2055
clinically	O	2055
distinct	O	2055
disorders	O	2055
,	O	2055
viz	O	2055
.	O	2055
episodic	B-Disease	2055
ataxia	I-Disease	2055
type	I-Disease	2055
2	I-Disease	2055
(	O	2055
ea	B-Disease	2055
-	I-Disease	2055
2	I-Disease	2055
)	O	2055
,	O	2055
familial	B-Disease	2055
hemiplegic	I-Disease	2055
migraine	I-Disease	2055
(	O	2055
fhm	B-Disease	2055
)	O	2055
and	O	2055
spinocerebellar	B-Disease	2055
ataxia	I-Disease	2055
6	I-Disease	2055
(	O	2055
sca6	B-Disease	2055
)	O	2055
.	O	2055
for	O	2056
individuals	O	2056
with	O	2056
ea	B-Disease	2056
-	I-Disease	2056
2	I-Disease	2056
,	O	2056
the	O	2056
mutations	O	2056
described	O	2056
thus	O	2056
far	O	2056
are	O	2056
presumed	O	2056
to	O	2056
result	O	2056
in	O	2056
a	O	2056
truncated	O	2056
protein	O	2056
product	O	2056
.	O	2056
several	O	2057
different	O	2057
missense	O	2057
mutations	O	2057
have	O	2057
been	O	2057
identified	O	2057
in	O	2057
patients	O	2057
with	O	2057
fhm	B-Disease	2057
.	O	2057
we	O	2060
have	O	2060
characterised	O	2060
a	O	2060
novel	O	2060
missense	O	2060
mutation	O	2060
,	O	2060
g5260a	O	2060
,	O	2060
in	O	2060
exon	O	2060
32	O	2060
in	O	2060
a	O	2060
family	O	2060
segregating	O	2060
for	O	2060
ea	B-Disease	2060
-	I-Disease	2060
2	I-Disease	2060
.	O	2060
furthermore	O	2063
,	O	2063
this	O	2063
mutation	O	2063
has	O	2063
been	O	2063
detected	O	2063
in	O	2063
a	O	2063
family	O	2063
member	O	2063
with	O	2063
mild	O	2063
clinical	O	2063
signs	O	2063
including	O	2063
only	O	2063
migraine	B-Disease	2063
.	O	2063
additionally	O	2064
,	O	2064
a	O	2064
second	O	2064
previously	O	2064
identified	O	2064
recurrent	O	2064
muta	O	2064
tion	O	2064
,	O	2064
c2272t	O	2064
,	O	2064
in	O	2064
exon	O	2064
16	O	2064
has	O	2064
been	O	2064
discovered	O	2064
in	O	2064
a	O	2064
patient	O	2064
with	O	2064
fhm	B-Disease	2064
.	O	2064
.	O	2064
analbuminemia	B-Disease	2065
in	O	2065
a	O	2065
neonate	O	2065
.	O	2065
a	O	2066
small	O	2066
-	O	2066
for	O	2066
-	O	2066
gestational	O	2066
-	O	2066
age	O	2066
infant	O	2066
,	O	2066
found	O	2066
to	O	2066
have	O	2066
analbuminemia	B-Disease	2066
in	O	2066
the	O	2066
neonatal	O	2066
period	O	2066
,	O	2066
is	O	2066
reported	O	2066
and	O	2066
the	O	2066
twelve	O	2066
cases	O	2066
recorded	O	2066
in	O	2066
the	O	2066
world	O	2066
literature	O	2066
are	O	2066
reviewed	O	2066
.	O	2066
patients	O	2067
lacking	O	2067
this	O	2067
serum	O	2067
protein	O	2067
are	O	2067
essentially	O	2067
asymptomatic	O	2067
,	O	2067
apart	O	2067
from	O	2067
minimal	O	2067
ankle	B-Disease	2067
edema	I-Disease	2067
and	O	2067
ease	B-Disease	2067
of	I-Disease	2067
fatigue	I-Disease	2067
.	O	2067
apparent	O	2068
compensatory	O	2068
mechanisms	O	2068
which	O	2068
come	O	2068
into	O	2068
play	O	2068
when	O	2068
serum	O	2068
albumin	O	2068
is	O	2068
low	O	2068
include	O	2068
prolonged	O	2068
half	O	2068
-	O	2068
life	O	2068
of	O	2068
albumin	O	2068
and	O	2068
transferrin	O	2068
,	O	2068
an	O	2068
increase	O	2068
in	O	2068
serum	O	2068
globulins	O	2068
,	O	2068
beta	O	2068
lipoprotein	O	2068
,	O	2068
and	O	2068
glycoproteins	O	2068
,	O	2068
arterial	B-Disease	2068
hypotension	I-Disease	2068
with	O	2068
reduced	O	2068
capillary	O	2068
hydrostatic	O	2068
pressure	O	2068
,	O	2068
and	O	2068
the	O	2068
ability	O	2068
to	O	2068
respond	O	2068
with	O	2068
rapid	O	2068
sodium	O	2068
and	O	2068
chloride	O	2068
diuresis	O	2068
in	O	2068
response	O	2068
to	O	2068
small	O	2068
volume	O	2068
changes	O	2068
.	O	2068
histidinemia	B-Disease	2070
.	O	2070
two	O	2072
brothers	O	2072
,	O	2072
6	O	2072
and	O	2072
13	O	2072
years	O	2072
old	O	2072
,	O	2072
had	O	2072
histidinemia	B-Disease	2072
.	O	2072
carrier	O	2075
detection	O	2075
of	O	2075
pyruvate	B-Disease	2075
carboxylase	I-Disease	2075
deficiency	I-Disease	2075
in	O	2075
fibroblasts	O	2075
and	O	2075
lymphocytes	O	2075
.	O	2075
pyruvate	O	2076
carboxylase	O	2076
(	O	2076
e	O	2076
.	O	2076
c	O	2076
.	O	2076
6	O	2076
.	O	2076
4	O	2076
.	O	2076
1	O	2076
.	O	2076
1	O	2076
)	O	2076
activity	O	2076
was	O	2076
determined	O	2076
in	O	2076
the	O	2076
circulating	O	2076
peripheral	O	2076
lymphocytes	O	2076
and	O	2076
cultured	O	2076
skin	O	2076
fibroblasts	O	2076
from	O	2076
the	O	2076
family	O	2076
of	O	2076
a	O	2076
patient	O	2076
with	O	2076
hepatic	O	2076
,	O	2076
cerebral	O	2076
,	O	2076
renal	O	2076
cortical	O	2076
,	O	2076
leukocyte	O	2076
,	O	2076
and	O	2076
fibroblast	O	2076
pyruvate	B-Disease	2076
carboxylase	I-Disease	2076
deficiency	I-Disease	2076
(	O	2076
pc	B-Disease	2076
portland	I-Disease	2076
deficiency	I-Disease	2076
)	O	2076
.	O	2076
glucose	O	2081
-	O	2081
6	O	2081
-	O	2081
phosphate	O	2081
dehydrogenase	O	2081
variants	O	2081
from	O	2081
italian	O	2081
subjects	O	2081
associated	O	2081
with	O	2081
severe	B-Disease	2081
neonatal	I-Disease	2081
jaundice	I-Disease	2081
.	O	2081
screening	O	2082
for	O	2082
the	O	2082
g6pd	B-Disease	2082
deficiency	I-Disease	2082
was	O	2082
carried	O	2082
out	O	2082
at	O	2082
the	O	2082
maternity	O	2082
division	O	2082
of	O	2082
the	O	2082
galliera	O	2082
hospital	O	2082
in	O	2082
genoa	O	2082
,	O	2082
italy	O	2082
.	O	2082
two	O	2083
groups	O	2083
of	O	2083
subjects	O	2083
with	O	2083
hyperbilirubinaemia	B-Disease	2083
of	O	2083
non	O	2083
-	O	2083
immunological	O	2083
origin	O	2083
were	O	2083
examined	O	2083
(	O	2083
a	O	2083
)	O	2083
302	O	2083
newborn	O	2083
babies	O	2083
of	O	2083
sardinian	O	2083
extraction	O	2083
(	O	2083
on	O	2083
cord	O	2083
blood	O	2083
)	O	2083
and	O	2083
(	O	2083
b	O	2083
)	O	2083
201	O	2083
newborn	O	2083
babies	O	2083
of	O	2083
south	O	2083
italian	O	2083
ancestry	O	2083
(	O	2083
on	O	2083
peripheral	O	2083
blood	O	2083
)	O	2083
.	O	2083
in	O	2087
the	O	2087
present	O	2087
work	O	2087
these	O	2087
three	O	2087
cases	O	2087
,	O	2087
each	O	2087
with	O	2087
severe	B-Disease	2087
neonatal	I-Disease	2087
jaundice	I-Disease	2087
,	O	2087
are	O	2087
reported	O	2087
.	O	2087
cytogenetic	O	2090
investigations	O	2090
in	O	2090
families	O	2090
with	O	2090
ataxia	B-Disease	2090
-	I-Disease	2090
telangiectasia	I-Disease	2090
.	O	2090
chromosomal	O	2091
studies	O	2091
were	O	2091
performed	O	2091
on	O	2091
peripheral	O	2091
blood	O	2091
lymphocytes	O	2091
and	O	2091
cultured	O	2091
skin	O	2091
fibroblasts	O	2091
from	O	2091
five	O	2091
israeli	O	2091
-	O	2091
moroccan	O	2091
families	O	2091
with	O	2091
ataxia	B-Disease	2091
-	I-Disease	2091
telangiectasia	I-Disease	2091
.	O	2091
prenatal	O	2097
diagnosis	O	2097
of	O	2097
wolman	B-Disease	2097
disease	I-Disease	2097
.	O	2097
two	O	2098
pregnancies	O	2098
at	O	2098
risk	O	2098
for	O	2098
wolman	B-Disease	2098
disease	I-Disease	2098
were	O	2098
monitored	O	2098
by	O	2098
assay	O	2098
and	O	2098
electrophoresis	O	2098
of	O	2098
acid	O	2098
lipase	O	2098
in	O	2098
cultured	O	2098
amniotic	O	2098
-	O	2098
fluid	O	2098
cells	O	2098
.	O	2098
electrophoresis	O	2100
of	O	2100
cell	O	2100
extracts	O	2100
revealed	O	2100
the	O	2100
absence	O	2100
of	O	2100
the	O	2100
a	O	2100
form	O	2100
of	O	2100
acid	O	2100
lipase	O	2100
,	O	2100
consistent	O	2100
with	O	2100
the	O	2100
diagnosis	O	2100
of	O	2100
wolman	B-Disease	2100
disease	I-Disease	2100
.	O	2100
the	O	2105
results	O	2105
suggest	O	2105
that	O	2105
the	O	2105
prenatal	O	2105
diagnosis	O	2105
of	O	2105
wolman	B-Disease	2105
disease	I-Disease	2105
be	O	2105
made	O	2105
using	O	2105
the	O	2105
radioassay	O	2105
of	O	2105
acid	O	2105
lipase	O	2105
and	O	2105
/	O	2105
or	O	2105
electrophoresis	O	2105
.	O	2105
.	O	2105
malignant	B-Disease	2106
neoplasms	I-Disease	2106
in	O	2106
the	O	2106
families	O	2106
of	O	2106
patients	O	2106
with	O	2106
ataxia	B-Disease	2106
-	I-Disease	2106
telangiectasia	I-Disease	2106
.	O	2106
ataxia	B-Disease	2107
-	I-Disease	2107
telangiectasia	I-Disease	2107
(	O	2107
a	B-Disease	2107
-	I-Disease	2107
t	I-Disease	2107
)	O	2107
is	O	2107
an	O	2107
autosomal	B-Disease	2107
recessive	I-Disease	2107
syndrome	I-Disease	2107
associated	O	2107
with	O	2107
a	O	2107
greatly	O	2107
increased	O	2107
incidence	O	2107
of	O	2107
malignant	B-Disease	2107
neoplasms	I-Disease	2107
in	O	2107
homozygous	O	2107
affected	O	2107
individuals	O	2107
.	O	2107
heterozygotes	O	2108
for	O	2108
the	O	2108
gene	O	2108
for	O	2108
a	B-Disease	2108
-	I-Disease	2108
t	I-Disease	2108
are	O	2108
thought	O	2108
to	O	2108
comprise	O	2108
about	O	2108
1	O	2108
%	O	2108
of	O	2108
the	O	2108
general	O	2108
population	O	2108
and	O	2108
,	O	2108
therefore	O	2108
,	O	2108
it	O	2108
is	O	2108
important	O	2108
to	O	2108
know	O	2108
whether	O	2108
this	O	2108
gene	O	2108
also	O	2108
predisposes	O	2108
the	O	2108
heterozygous	O	2108
carrier	O	2108
to	O	2108
cancers	B-Disease	2108
.	O	2108
heterozygous	O	2109
carriers	O	2109
of	O	2109
this	O	2109
gene	O	2109
are	O	2109
common	O	2109
among	O	2109
the	O	2109
close	O	2109
relatives	O	2109
of	O	2109
patients	O	2109
with	O	2109
a	B-Disease	2109
-	I-Disease	2109
t	I-Disease	2109
,	O	2109
although	O	2109
individual	O	2109
carriers	O	2109
cannot	O	2109
be	O	2109
identified	O	2109
by	O	2109
any	O	2109
clinical	O	2109
criterion	O	2109
or	O	2109
laboratory	O	2109
test	O	2109
.	O	2109
for	O	2110
this	O	2110
reason	O	2110
,	O	2110
we	O	2110
compared	O	2110
the	O	2110
incidence	O	2110
of	O	2110
death	O	2110
from	O	2110
malignant	B-Disease	2110
neoplasms	I-Disease	2110
in	O	2110
2	O	2110
families	O	2110
of	O	2110
patients	O	2110
with	O	2110
a	B-Disease	2110
-	I-Disease	2110
t	I-Disease	2110
to	O	2110
that	O	2110
expected	O	2110
in	O	2110
a	O	2110
random	O	2110
sample	O	2110
of	O	2110
the	O	2110
general	O	2110
population	O	2110
.	O	2110
there	O	2111
were	O	2111
59	O	2111
deaths	O	2111
from	O	2111
malignant	B-Disease	2111
neoplasms	I-Disease	2111
in	O	2111
relatives	O	2111
dying	O	2111
before	O	2111
age	O	2111
75	O	2111
,	O	2111
compared	O	2111
to	O	2111
42	O	2111
.	O	2111
for	O	2113
a	B-Disease	2113
-	I-Disease	2113
t	I-Disease	2113
heterozygotes	O	2113
younger	O	2113
than	O	2113
age	O	2113
45	O	2113
,	O	2113
the	O	2113
risk	O	2113
of	O	2113
dying	O	2113
from	O	2113
a	O	2113
malignant	B-Disease	2113
neoplasm	I-Disease	2113
was	O	2113
estimated	O	2113
to	O	2113
be	O	2113
greater	O	2113
than	O	2113
5	O	2113
times	O	2113
the	O	2113
risk	O	2113
for	O	2113
the	O	2113
general	O	2113
population	O	2113
.	O	2113
a	B-Disease	2114
-	I-Disease	2114
t	I-Disease	2114
heterozygotes	O	2114
may	O	2114
comprise	O	2114
more	O	2114
than	O	2114
5	O	2114
%	O	2114
of	O	2114
all	O	2114
persons	O	2114
dying	O	2114
from	O	2114
a	O	2114
cancer	B-Disease	2114
before	O	2114
age	O	2114
45	O	2114
.	O	2114
the	O	2115
incidence	O	2115
of	O	2115
ovarian	B-Disease	2115
,	I-Disease	2115
gastric	I-Disease	2115
,	I-Disease	2115
and	I-Disease	2115
biliary	I-Disease	2115
system	I-Disease	2115
carcinomas	I-Disease	2115
and	O	2115
of	O	2115
leukemia	B-Disease	2115
and	O	2115
lymphoma	B-Disease	2115
was	O	2115
increased	O	2115
in	O	2115
these	O	2115
a	B-Disease	2115
-	I-Disease	2115
t	I-Disease	2115
families	O	2115
.	O	2115
other	O	2116
neoplasms	B-Disease	2116
that	O	2116
may	O	2116
be	O	2116
associated	O	2116
with	O	2116
this	O	2116
gene	O	2116
in	O	2116
heterozygotes	O	2116
include	O	2116
pancreatic	B-Disease	2116
,	I-Disease	2116
basal	I-Disease	2116
cell	I-Disease	2116
,	I-Disease	2116
colonic	I-Disease	2116
,	I-Disease	2116
breast	I-Disease	2116
,	I-Disease	2116
and	I-Disease	2116
cervical	I-Disease	2116
carcinomas	I-Disease	2116
.	O	2116
striking	O	2117
prevalence	O	2117
of	O	2117
ankylosing	B-Disease	2117
spondylitis	I-Disease	2117
in	O	2117
healthy	O	2117
w27	O	2117
positive	O	2117
males	O	2117
and	O	2117
females	O	2117
.	O	2117
ankylosing	B-Disease	2118
spondylitis	I-Disease	2118
is	O	2118
diagnosed	O	2118
once	O	2118
or	O	2118
twice	O	2118
in	O	2118
each	O	2118
1000	O	2118
males	O	2118
and	O	2118
one	O	2118
tenth	O	2118
as	O	2118
frequently	O	2118
in	O	2118
females	O	2118
,	O	2118
but	O	2118
the	O	2118
true	O	2118
prevalence	O	2118
is	O	2118
unknown	O	2118
.	O	2118
evaluation	O	2120
by	O	2120
postal	O	2120
questionnaires	O	2120
,	O	2120
and	O	2120
pelvic	O	2120
radiography	O	2120
of	O	2120
78	O	2120
hl	O	2120
-	O	2120
a	O	2120
27w	O	2120
-	O	2120
positive	O	2120
blood	O	2120
donors	O	2120
selected	O	2120
from	O	2120
a	O	2120
group	O	2120
of	O	2120
apparently	O	2120
healthy	O	2120
subjects	O	2120
revealed	O	2120
14	O	2120
who	O	2120
satisfied	O	2120
the	O	2120
criteria	O	2120
for	O	2120
definite	O	2120
ankylosing	B-Disease	2120
spondylitis	I-Disease	2120
.	O	2120
for	O	2123
a	O	2123
person	O	2123
of	O	2123
either	O	2123
sex	O	2123
with	O	2123
hl	O	2123
-	O	2123
a	O	2123
w27	O	2123
,	O	2123
there	O	2123
appears	O	2123
to	O	2123
be	O	2123
about	O	2123
a	O	2123
20	O	2123
per	O	2123
cent	O	2123
chance	O	2123
that	O	2123
ankylosing	B-Disease	2123
spondylitis	I-Disease	2123
will	O	2123
develop	O	2123
,	O	2123
suggesting	O	2123
a	O	2123
prevalence	O	2123
of	O	2123
10	O	2123
to	O	2123
15	O	2123
per	O	2123
thousand	O	2123
.	O	2123
analbuminemia	B-Disease	2125
in	O	2125
an	O	2125
american	O	2125
indian	O	2125
girl	O	2125
.	O	2125
analbuminemia	B-Disease	2126
was	O	2126
fortuitously	O	2126
detected	O	2126
in	O	2126
a	O	2126
nonedematous	O	2126
12	O	2126
-	O	2126
year	O	2126
-	O	2126
old	O	2126
american	O	2126
indian	O	2126
girl	O	2126
with	O	2126
atopic	B-Disease	2126
dermatitis	I-Disease	2126
,	O	2126
mild	O	2126
bronchial	B-Disease	2126
asthma	I-Disease	2126
,	O	2126
a	O	2126
mild	O	2126
seizure	B-Disease	2126
disorder	I-Disease	2126
,	O	2126
and	O	2126
hyperlipoproteinemia	B-Disease	2126
with	O	2126
a	O	2126
corneal	B-Disease	2126
arcus	I-Disease	2126
.	O	2126
the	O	2129
pedigree	O	2129
and	O	2129
clinical	O	2129
findings	O	2129
were	O	2129
compatible	O	2129
with	O	2129
autosomal	O	2129
recessive	O	2129
transmission	O	2129
of	O	2129
analbuminemia	B-Disease	2129
.	O	2129
gc	O	2132
-	O	2132
protein	O	2132
levels	O	2132
were	O	2132
normal	O	2132
in	O	2132
the	O	2132
patient	O	2132
and	O	2132
together	O	2132
with	O	2132
normal	O	2132
chromosomal	O	2132
banding	O	2132
studies	O	2132
make	O	2132
it	O	2132
unlikely	O	2132
that	O	2132
a	O	2132
chromosomal	O	2132
deletion	O	2132
caused	O	2132
analbuminemia	B-Disease	2132
.	O	2132
gc	O	2133
-	O	2133
types	O	2133
in	O	2133
the	O	2133
family	O	2133
were	O	2133
compatible	O	2133
with	O	2133
,	O	2133
but	O	2133
did	O	2133
not	O	2133
prove	O	2133
,	O	2133
linkage	O	2133
of	O	2133
analbuminemia	B-Disease	2133
to	O	2133
the	O	2133
gc	O	2133
-	O	2133
locus	O	2133
.	O	2133
these	O	2134
findings	O	2134
suggest	O	2134
a	O	2134
thalassemia	B-Disease	2134
-	O	2134
like	O	2134
mutation	O	2134
for	O	2134
this	O	2134
disorder	O	2134
.	O	2134
.	O	2134
deletion	O	2135
of	O	2135
the	O	2135
kit	O	2135
and	O	2135
pdgfra	O	2135
genes	O	2135
in	O	2135
a	O	2135
patient	O	2135
with	O	2135
piebaldism	B-Disease	2135
.	O	2135
we	O	2136
have	O	2136
previously	O	2136
shown	O	2136
that	O	2136
human	O	2136
piebaldism	B-Disease	2136
results	O	2136
from	O	2136
mutations	O	2136
of	O	2136
the	O	2136
kit	O	2136
gene	O	2136
,	O	2136
which	O	2136
encodes	O	2136
the	O	2136
receptor	O	2136
for	O	2136
the	O	2136
mast	O	2136
/	O	2136
stem	O	2136
cell	O	2136
growth	O	2136
factor	O	2136
and	O	2136
is	O	2136
located	O	2136
in	O	2136
chromosome	O	2136
segment	O	2136
4q12	O	2136
.	O	2136
using	O	2137
dna	O	2137
of	O	2137
a	O	2137
patient	O	2137
with	O	2137
piebaldism	B-Disease	2137
,	O	2137
mental	B-Disease	2137
retardation	I-Disease	2137
,	O	2137
and	O	2137
multiple	B-Disease	2137
congenital	I-Disease	2137
anomalies	I-Disease	2137
associated	O	2137
with	O	2137
a	O	2137
46	O	2137
,	O	2137
xy	O	2137
,	O	2137
del	O	2137
(	O	2137
4	O	2137
)	O	2137
(	O	2137
q12q21	O	2137
.	O	2137
1	O	2137
)	O	2137
karyotype	O	2137
,	O	2137
we	O	2137
carried	O	2137
out	O	2137
quantitative	O	2137
southern	O	2137
blot	O	2137
hybridization	O	2137
analyses	O	2137
of	O	2137
the	O	2137
kit	O	2137
gene	O	2137
and	O	2137
the	O	2137
adjacent	O	2137
pdgfra	O	2137
(	O	2137
platelet	O	2137
-	O	2137
derived	O	2137
growth	O	2137
factor	O	2137
receptor	O	2137
alpha	O	2137
subunit	O	2137
)	O	2137
genes	O	2137
.	O	2137
therefore	O	2139
,	O	2139
deletion	O	2139
of	O	2139
the	O	2139
kit	O	2139
and	O	2139
pdgfra	O	2139
genes	O	2139
may	O	2139
account	O	2139
for	O	2139
the	O	2139
piebald	B-Disease	2139
phenotype	O	2139
in	O	2139
this	O	2139
patient	O	2139
.	O	2139
a	O	2140
germ	O	2140
line	O	2140
mutation	O	2140
within	O	2140
the	O	2140
coding	O	2140
sequence	O	2140
for	O	2140
the	O	2140
putative	O	2140
5	O	2140
-	O	2140
phosphoribosyl	O	2140
-	O	2140
1	O	2140
-	O	2140
pyrophosphate	O	2140
binding	O	2140
site	O	2140
of	O	2140
hypoxanthine	O	2140
-	O	2140
guanine	O	2140
phosphoribosyltransferase	O	2140
(	O	2140
hprt	O	2140
)	O	2140
in	O	2140
a	O	2140
lesch	B-Disease	2140
-	I-Disease	2140
nyhan	I-Disease	2140
patient	O	2140
:	O	2140
missense	O	2140
mutations	O	2140
within	O	2140
a	O	2140
functionally	O	2140
important	O	2140
region	O	2140
probably	O	2140
cause	O	2140
disease	O	2140
.	O	2140
lesch	B-Disease	2141
-	I-Disease	2141
nyhan	I-Disease	2141
syndrome	I-Disease	2141
caused	O	2141
by	O	2141
a	O	2141
complete	B-Disease	2141
deficiency	I-Disease	2141
of	I-Disease	2141
hypoxanthine	I-Disease	2141
guanine	I-Disease	2141
phosphoribosyltransferase	I-Disease	2141
(	O	2141
hprt	O	2141
)	O	2141
is	O	2141
the	O	2141
result	O	2141
of	O	2141
a	O	2141
heterogeneous	O	2141
group	O	2141
of	O	2141
germ	O	2141
line	O	2141
mutations	O	2141
.	O	2141
we	O	2143
report	O	2143
here	O	2143
a	O	2143
newly	O	2143
identified	O	2143
hprt	O	2143
mutation	O	2143
in	O	2143
a	O	2143
japanese	O	2143
patient	O	2143
with	O	2143
lesch	B-Disease	2143
-	I-Disease	2143
nyhan	I-Disease	2143
syndrome	I-Disease	2143
.	O	2143
missense	O	2147
mutations	O	2147
in	O	2147
human	O	2147
hprt	B-Disease	2147
deficient	I-Disease	2147
patients	O	2147
thus	O	2147
far	O	2147
reported	O	2147
tend	O	2147
to	O	2147
accumulate	O	2147
in	O	2147
this	O	2147
functionally	O	2147
active	O	2147
region	O	2147
.	O	2147
characterisation	O	2150
of	O	2150
a	O	2150
new	O	2150
rare	O	2150
fragile	O	2150
site	O	2150
easily	O	2150
confused	O	2150
with	O	2150
the	O	2150
fragile	B-Disease	2150
x	I-Disease	2150
.	O	2150
the	O	2153
fragile	O	2153
site	O	2153
is	O	2153
not	O	2153
associated	O	2153
with	O	2153
mental	B-Disease	2153
retardation	I-Disease	2153
,	O	2153
it	O	2153
does	O	2153
not	O	2153
give	O	2153
abnormal	O	2153
results	O	2153
when	O	2153
subjected	O	2153
to	O	2153
southern	O	2153
analysis	O	2153
with	O	2153
probe	O	2153
pfxa3	O	2153
which	O	2153
detects	O	2153
the	O	2153
unstable	O	2153
dna	O	2153
sequence	O	2153
characteristic	O	2153
of	O	2153
fragile	B-Disease	2153
x	I-Disease	2153
syndrome	I-Disease	2153
.	O	2153
the	O	2155
distinction	O	2155
between	O	2155
the	O	2155
two	O	2155
fragile	O	2155
sites	O	2155
is	O	2155
important	O	2155
clinically	O	2155
since	O	2155
cytogenetic	O	2155
detection	O	2155
of	O	2155
fraxe	O	2155
,	O	2155
without	O	2155
molecular	O	2155
analysis	O	2155
,	O	2155
could	O	2155
result	O	2155
in	O	2155
misdiagnosis	O	2155
of	O	2155
fragile	B-Disease	2155
x	I-Disease	2155
syndrome	I-Disease	2155
.	O	2155
.	O	2155
the	O	2156
norrie	B-Disease	2156
disease	I-Disease	2156
gene	O	2156
maps	O	2156
to	O	2156
a	O	2156
150	O	2156
kb	O	2156
region	O	2156
on	O	2156
chromosome	O	2156
xp11	O	2156
.	O	2156
3	O	2156
.	O	2156
norrie	B-Disease	2157
disease	I-Disease	2157
is	O	2157
a	O	2157
human	O	2157
x	B-Disease	2157
-	I-Disease	2157
linked	I-Disease	2157
recessive	I-Disease	2157
disorder	I-Disease	2157
of	O	2157
unknown	O	2157
etiology	O	2157
characterized	O	2157
by	O	2157
congenital	B-Disease	2157
blindness	I-Disease	2157
,	O	2157
sensory	B-Disease	2157
neural	I-Disease	2157
deafness	I-Disease	2157
and	O	2157
mental	B-Disease	2157
retardation	I-Disease	2157
.	O	2157
we	O	2160
report	O	2160
here	O	2160
fine	O	2160
physical	O	2160
mapping	O	2160
of	O	2160
the	O	2160
obligate	O	2160
region	O	2160
containing	O	2160
the	O	2160
norrie	B-Disease	2160
disease	I-Disease	2160
gene	O	2160
(	O	2160
ndp	O	2160
)	O	2160
defined	O	2160
by	O	2160
a	O	2160
recombination	O	2160
and	O	2160
by	O	2160
the	O	2160
smallest	O	2160
submicroscopic	O	2160
chromosomal	O	2160
deletion	O	2160
associated	O	2160
with	O	2160
norrie	B-Disease	2160
disease	I-Disease	2160
identified	O	2160
to	O	2160
date	O	2160
.	O	2160
molecular	O	2170
basis	O	2170
of	O	2170
phenylketonuria	B-Disease	2170
and	O	2170
related	O	2170
hyperphenylalaninemias	B-Disease	2170
:	O	2170
mutations	O	2170
and	O	2170
polymorphisms	O	2170
in	O	2170
the	O	2170
human	O	2170
phenylalanine	O	2170
hydroxylase	O	2170
gene	O	2170
.	O	2170
mutations	O	2171
in	O	2171
the	O	2171
human	O	2171
phenylalanine	O	2171
hydroxylase	O	2171
gene	O	2171
producing	O	2171
phenylketonuria	B-Disease	2171
or	O	2171
hyperphenylalaninemia	B-Disease	2171
have	O	2171
now	O	2171
been	O	2171
identified	O	2171
in	O	2171
many	O	2171
patients	O	2171
from	O	2171
various	O	2171
ethnic	O	2171
groups	O	2171
.	O	2171
a	O	2180
glycine250	O	2180
-	O	2180
-	O	2180
>	O	2180
aspartate	O	2180
substitution	O	2180
in	O	2180
the	O	2180
alpha	O	2180
-	O	2180
subunit	O	2180
of	O	2180
hexosaminidase	O	2180
a	O	2180
causes	O	2180
juvenile	O	2180
-	O	2180
onset	O	2180
tay	B-Disease	2180
-	I-Disease	2180
sachs	I-Disease	2180
disease	I-Disease	2180
in	O	2180
a	O	2180
lebanese	O	2180
-	O	2180
canadian	O	2180
family	O	2180
.	O	2180
the	O	2181
mutation	O	2181
causing	O	2181
juvenile	O	2181
tay	B-Disease	2181
-	I-Disease	2181
sachs	I-Disease	2181
disease	I-Disease	2181
(	O	2181
tsd	B-Disease	2181
)	O	2181
in	O	2181
two	O	2181
sibs	O	2181
of	O	2181
lebanese	O	2181
-	O	2181
maronite	O	2181
origin	O	2181
is	O	2181
described	O	2181
.	O	2181
the	O	2189
predicted	O	2189
protein	O	2189
environment	O	2189
in	O	2189
which	O	2189
the	O	2189
mutation	O	2189
occurs	O	2189
is	O	2189
compared	O	2189
to	O	2189
that	O	2189
of	O	2189
the	O	2189
adult	O	2189
-	O	2189
onset	O	2189
tay	B-Disease	2189
-	I-Disease	2189
sachs	I-Disease	2189
disease	I-Disease	2189
mutation	O	2189
caused	O	2189
by	O	2189
a	O	2189
gly269	O	2189
-	O	2189
-	O	2189
>	O	2189
ser	O	2189
substitution	O	2189
in	O	2189
exon	O	2189
7	O	2189
.	O	2189
novel	O	2191
tay	B-Disease	2191
-	I-Disease	2191
sachs	I-Disease	2191
disease	I-Disease	2191
mutations	O	2191
from	O	2191
china	O	2191
.	O	2191
we	O	2192
describe	O	2192
three	O	2192
hexa	O	2192
mutations	O	2192
associated	O	2192
with	O	2192
infantile	O	2192
tay	B-Disease	2192
-	I-Disease	2192
sachs	I-Disease	2192
disease	I-Disease	2192
(	O	2192
tsd	B-Disease	2192
)	O	2192
in	O	2192
three	O	2192
unrelated	O	2192
nonconsanguineous	O	2192
chinese	O	2192
families	O	2192
.	O	2192
it	O	2204
has	O	2204
been	O	2204
reported	O	2204
in	O	2204
an	O	2204
italian	O	2204
tsd	B-Disease	2204
proband	O	2204
and	O	2204
causes	O	2204
defective	O	2204
intracellular	O	2204
transport	O	2204
of	O	2204
the	O	2204
alpha	O	2204
-	O	2204
subunit	O	2204
from	O	2204
the	O	2204
rough	O	2204
endoplasmic	O	2204
reticulum	O	2204
to	O	2204
the	O	2204
golgi	O	2204
apparatus	O	2204
.	O	2204
two	O	2205
missense	O	2205
mutations	O	2205
causing	O	2205
mild	O	2205
hyperphenylalaninemia	B-Disease	2205
associated	O	2205
with	O	2205
dna	O	2205
haplotype	O	2205
12	O	2205
.	O	2205
the	O	2206
genetic	B-Disease	2206
defects	I-Disease	2206
responsible	O	2206
for	O	2206
most	O	2206
phenylketonuria	B-Disease	2206
(	O	2206
pku	B-Disease	2206
)	O	2206
and	O	2206
hyperphenylalaninemia	B-Disease	2206
(	O	2206
hpa	B-Disease	2206
)	O	2206
cases	O	2206
are	O	2206
located	O	2206
in	O	2206
the	O	2206
phenylalanine	O	2206
hydroxylase	O	2206
(	O	2206
pah	O	2206
)	O	2206
gene	O	2206
.	O	2206
we	O	2209
hypothesized	O	2209
that	O	2209
there	O	2209
is	O	2209
at	O	2209
least	O	2209
one	O	2209
mild	O	2209
mutation	O	2209
linked	O	2209
to	O	2209
haplotype	O	2209
12	O	2209
in	O	2209
the	O	2209
swedish	O	2209
pku	B-Disease	2209
/	O	2209
hpa	B-Disease	2209
population	O	2209
,	O	2209
since	O	2209
7	O	2209
of	O	2209
8	O	2209
patients	O	2209
carrying	O	2209
haplotype	O	2209
12	O	2209
had	O	2209
mild	O	2209
hpa	B-Disease	2209
.	O	2209
mutations	O	2217
at	O	2217
the	O	2217
phenylalanine	O	2217
hydroxylase	O	2217
(	O	2217
pah	O	2217
)	O	2217
locus	O	2217
are	O	2217
the	O	2217
major	O	2217
cause	O	2217
of	O	2217
hyperphenylalaninemia	B-Disease	2217
.	O	2217
here	O	2219
we	O	2219
report	O	2219
(	O	2219
1	O	2219
)	O	2219
identification	O	2219
of	O	2219
another	O	2219
mutation	O	2219
,	O	2219
on	O	2219
a	O	2219
haplotype	O	2219
9	O	2219
chromosome	O	2219
,	O	2219
which	O	2219
converts	O	2219
codon	O	2219
65	O	2219
from	O	2219
isoleucine	O	2219
(	O	2219
att	O	2219
)	O	2219
to	O	2219
threonine	O	2219
(	O	2219
act	O	2219
)	O	2219
,	O	2219
(	O	2219
2	O	2219
)	O	2219
expression	O	2219
analysis	O	2219
of	O	2219
the	O	2219
i65t	O	2219
mutation	O	2219
in	O	2219
cos	O	2219
cells	O	2219
demonstrating	O	2219
75	O	2219
%	O	2219
loss	O	2219
of	O	2219
both	O	2219
immunoreactive	O	2219
protein	O	2219
and	O	2219
enzyme	O	2219
activity	O	2219
,	O	2219
and	O	2219
(	O	2219
3	O	2219
)	O	2219
expression	O	2219
analysis	O	2219
of	O	2219
the	O	2219
most	O	2219
prevalent	O	2219
pku	B-Disease	2219
allele	O	2219
(	O	2219
m1v	O	2219
)	O	2219
in	O	2219
eastern	O	2219
quebec	O	2219
,	O	2219
showing	O	2219
nondetectable	O	2219
levels	O	2219
of	O	2219
pah	O	2219
protein	O	2219
and	O	2219
activity	O	2219
,	O	2219
a	O	2219
finding	O	2219
compatible	O	2219
with	O	2219
a	O	2219
mutation	O	2219
in	O	2219
the	O	2219
translation	O	2219
initiation	O	2219
codon	O	2219
.	O	2219
homozygosity	O	2220
for	O	2220
m1v	O	2220
and	O	2220
codominant	O	2220
inheritance	O	2220
of	O	2220
i65t	O	2220
/	O	2220
r408w	O	2220
were	O	2220
both	O	2220
associated	O	2220
with	O	2220
classical	B-Disease	2220
phenylketonuria	I-Disease	2220
.	O	2220
.	O	2220
molecular	O	2221
basis	O	2221
of	O	2221
hexosaminidase	B-Disease	2221
a	I-Disease	2221
deficiency	I-Disease	2221
and	O	2221
pseudodeficiency	O	2221
in	O	2221
the	O	2221
berks	O	2221
county	O	2221
pennsylvania	O	2221
dutch	O	2221
.	O	2221
following	O	2222
the	O	2222
birth	O	2222
of	O	2222
two	O	2222
infants	O	2222
with	O	2222
tay	B-Disease	2222
-	I-Disease	2222
sachs	I-Disease	2222
disease	I-Disease	2222
(	O	2222
tsd	B-Disease	2222
)	O	2222
,	O	2222
a	O	2222
non	O	2222
-	O	2222
jewish	O	2222
,	O	2222
pennsylvania	O	2222
dutch	O	2222
kindred	O	2222
was	O	2222
screened	O	2222
for	O	2222
tsd	B-Disease	2222
carriers	O	2222
using	O	2222
the	O	2222
biochemical	O	2222
assay	O	2222
.	O	2222
a	O	2223
high	O	2223
frequency	O	2223
of	O	2223
individuals	O	2223
who	O	2223
appeared	O	2223
to	O	2223
be	O	2223
tsd	B-Disease	2223
heterozygotes	O	2223
was	O	2223
detected	O	2223
(	O	2223
kelly	O	2223
et	O	2223
al	O	2223
.	O	2223
,	O	2223
1975	O	2223
)	O	2223
.	O	2223
one	O	2226
allele	O	2226
,	O	2226
reported	O	2226
originally	O	2226
in	O	2226
a	O	2226
french	O	2226
tsd	B-Disease	2226
patient	O	2226
(	O	2226
akli	O	2226
et	O	2226
al	O	2226
.	O	2226
,	O	2226
1991	O	2226
)	O	2226
,	O	2226
is	O	2226
a	O	2226
gt	O	2226
-	O	2226
-	O	2226
>	O	2226
at	O	2226
transition	O	2226
at	O	2226
the	O	2226
donor	O	2226
splice	O	2226
-	O	2226
site	O	2226
of	O	2226
intron	O	2226
9	O	2226
.	O	2226
a	O	2230
mutation	O	2230
common	O	2230
in	O	2230
non	O	2230
-	O	2230
jewish	O	2230
tay	B-Disease	2230
-	I-Disease	2230
sachs	I-Disease	2230
disease	I-Disease	2230
:	O	2230
frequency	O	2230
and	O	2230
rna	O	2230
studies	O	2230
.	O	2230
tay	B-Disease	2231
-	I-Disease	2231
sachs	I-Disease	2231
disease	I-Disease	2231
(	O	2231
tsd	B-Disease	2231
)	O	2231
is	O	2231
an	O	2231
autosomal	B-Disease	2231
recessive	I-Disease	2231
genetic	I-Disease	2231
disorder	I-Disease	2231
resulting	O	2231
from	O	2231
mutation	O	2231
of	O	2231
the	O	2231
hexa	O	2231
gene	O	2231
encoding	O	2231
the	O	2231
alpha	O	2231
-	O	2231
subunit	O	2231
of	O	2231
the	O	2231
lysosomal	O	2231
enzyme	O	2231
,	O	2231
beta	O	2231
-	O	2231
n	O	2231
-	O	2231
acetylhexosaminidase	O	2231
a	O	2231
(	O	2231
hex	O	2231
a	O	2231
)	O	2231
.	O	2231
we	O	2232
have	O	2232
discovered	O	2232
that	O	2232
a	O	2232
tay	B-Disease	2232
-	I-Disease	2232
sachs	I-Disease	2232
mutation	O	2232
,	O	2232
ivs	O	2232
-	O	2232
9	O	2232
+	O	2232
1	O	2232
g	O	2232
-	O	2232
-	O	2232
>	O	2232
a	O	2232
,	O	2232
first	O	2232
detected	O	2232
by	O	2232
akli	O	2232
et	O	2232
al	O	2232
.	O	2232
it	O	2236
was	O	2236
not	O	2236
identified	O	2236
among	O	2236
12	O	2236
black	O	2236
american	O	2236
tsd	B-Disease	2236
alleles	O	2236
or	O	2236
in	O	2236
any	O	2236
of	O	2236
18	O	2236
ashkenazi	O	2236
jewish	O	2236
,	O	2236
enzyme	O	2236
-	O	2236
defined	O	2236
carriers	O	2236
who	O	2236
did	O	2236
not	O	2236
carry	O	2236
any	O	2236
of	O	2236
the	O	2236
mutations	O	2236
common	O	2236
to	O	2236
this	O	2236
population	O	2236
.	O	2236
together	O	2240
with	O	2240
a	O	2240
recently	O	2240
identified	O	2240
allele	O	2240
responsible	O	2240
for	O	2240
hex	O	2240
a	O	2240
pseudodeficiency	O	2240
(	O	2240
triggs	O	2240
-	O	2240
raine	O	2240
et	O	2240
al	O	2240
.	O	2240
am	O	2240
j	O	2240
hum	O	2240
genet	O	2240
,	O	2240
1992	O	2240
)	O	2240
,	O	2240
these	O	2240
two	O	2240
alleles	O	2240
accounted	O	2240
for	O	2240
almost	O	2240
50	O	2240
%	O	2240
(	O	2240
29	O	2240
/	O	2240
64	O	2240
)	O	2240
of	O	2240
tsd	B-Disease	2240
or	O	2240
carrier	O	2240
alleles	O	2240
ascertained	O	2240
by	O	2240
enzyme	O	2240
screening	O	2240
tests	O	2240
in	O	2240
non	O	2240
-	O	2240
jewish	O	2240
caucasians	O	2240
.	O	2240
.	O	2240
aberrant	O	2241
splicing	O	2241
of	O	2241
the	O	2241
chm	B-Disease	2241
gene	O	2241
is	O	2241
a	O	2241
significant	O	2241
cause	O	2241
of	O	2241
choroideremia	B-Disease	2241
.	O	2241
choroideremia	B-Disease	2242
(	O	2242
chm	B-Disease	2242
)	O	2242
is	O	2242
an	O	2242
x	B-Disease	2242
-	I-Disease	2242
linked	I-Disease	2242
progressive	I-Disease	2242
degeneration	I-Disease	2242
of	I-Disease	2242
the	I-Disease	2242
choroid	I-Disease	2242
and	I-Disease	2242
retina	I-Disease	2242
.	O	2242
12	O	2243
%	O	2243
of	O	2243
unrelated	O	2243
male	O	2243
patients	O	2243
carry	O	2243
deletions	O	2243
of	O	2243
the	O	2243
partially	O	2243
cloned	O	2243
chm	B-Disease	2243
gene	O	2243
.	O	2243
in	O	2244
finland	O	2244
,	O	2244
there	O	2244
are	O	2244
more	O	2244
than	O	2244
120	O	2244
living	O	2244
chm	B-Disease	2244
patients	O	2244
belonging	O	2244
to	O	2244
eight	O	2244
apparently	O	2244
unrelated	O	2244
pedigrees	O	2244
.	O	2244
molecular	O	2245
deletions	O	2245
involving	O	2245
the	O	2245
chm	B-Disease	2245
gene	O	2245
have	O	2245
been	O	2245
detected	O	2245
in	O	2245
three	O	2245
families	O	2245
.	O	2245
our	O	2249
findings	O	2249
provide	O	2249
additional	O	2249
evidence	O	2249
for	O	2249
the	O	2249
pathogenetic	O	2249
role	O	2249
of	O	2249
chm	B-Disease	2249
mutations	O	2249
and	O	2249
provide	O	2249
a	O	2249
diagnostic	O	2249
tool	O	2249
for	O	2249
one	O	2249
fifth	O	2249
of	O	2249
the	O	2249
worlds	O	2249
known	O	2249
chm	B-Disease	2249
patients	O	2249
.	O	2249
.	O	2249
germline	O	2250
intronic	O	2250
and	O	2250
exonic	O	2250
mutations	O	2250
in	O	2250
the	O	2250
wilms	B-Disease	2250
'	I-Disease	2250
tumour	I-Disease	2250
gene	O	2250
(	O	2250
wt1	O	2250
)	O	2250
affecting	O	2250
urogenital	O	2250
development	O	2250
.	O	2250
denys	B-Disease	2251
-	I-Disease	2251
drash	I-Disease	2251
syndrome	I-Disease	2251
is	O	2251
a	O	2251
rare	O	2251
human	O	2251
developmental	B-Disease	2251
disorder	I-Disease	2251
affecting	O	2251
the	O	2251
urogenital	O	2251
system	O	2251
and	O	2251
leading	O	2251
to	O	2251
renal	B-Disease	2251
failure	I-Disease	2251
,	O	2251
intersex	B-Disease	2251
disorders	I-Disease	2251
and	O	2251
wilms	B-Disease	2251
tumour	I-Disease	2251
.	O	2251
in	O	2252
this	O	2252
report	O	2252
,	O	2252
four	O	2252
individuals	O	2252
with	O	2252
this	O	2252
syndrome	O	2252
are	O	2252
described	O	2252
carrying	O	2252
germline	O	2252
point	O	2252
mutations	O	2252
in	O	2252
the	O	2252
wilms	B-Disease	2252
tumour	I-Disease	2252
suppressor	O	2252
gene	O	2252
,	O	2252
wt1	O	2252
.	O	2252
characterization	O	2256
of	O	2256
the	O	2256
myotonic	B-Disease	2256
dystrophy	I-Disease	2256
region	O	2256
predicts	O	2256
multiple	O	2256
protein	O	2256
isoform	O	2256
-	O	2256
encoding	O	2256
mrnas	O	2256
.	O	2256
the	O	2257
mutation	O	2257
underlying	O	2257
myotonic	B-Disease	2257
dystrophy	I-Disease	2257
(	O	2257
dm	B-Disease	2257
)	O	2257
has	O	2257
been	O	2257
identified	O	2257
as	O	2257
an	O	2257
expansion	O	2257
of	O	2257
a	O	2257
polymorphic	O	2257
ctg	O	2257
-	O	2257
repeat	O	2257
in	O	2257
a	O	2257
gene	O	2257
encoding	O	2257
protein	O	2257
kinase	O	2257
activity	O	2257
.	O	2257
characterization	O	2260
of	O	2260
the	O	2260
dm	B-Disease	2260
region	O	2260
of	O	2260
both	O	2260
species	O	2260
reveals	O	2260
another	O	2260
active	O	2260
gene	O	2260
(	O	2260
dmr	O	2260
-	O	2260
n9	O	2260
)	O	2260
in	O	2260
close	O	2260
proximity	O	2260
to	O	2260
the	O	2260
kinase	O	2260
gene	O	2260
.	O	2260
clinical	O	2262
manifestation	O	2262
of	O	2262
dm	B-Disease	2262
may	O	2262
be	O	2262
caused	O	2262
by	O	2262
the	O	2262
expanded	O	2262
ctg	O	2262
-	O	2262
repeat	O	2262
compromising	O	2262
the	O	2262
(	O	2262
alternative	O	2262
)	O	2262
expression	O	2262
of	O	2262
dm	O	2262
-	O	2262
kinase	O	2262
or	O	2262
dmr	O	2262
-	O	2262
n9	O	2262
proteins	O	2262
.	O	2262
.	O	2262
fragile	B-Disease	2263
x	I-Disease	2263
syndrome	I-Disease	2263
without	O	2263
ccg	O	2263
amplification	O	2263
has	O	2263
an	O	2263
fmr1	O	2263
deletion	O	2263
.	O	2263
we	O	2264
describe	O	2264
a	O	2264
patient	O	2264
with	O	2264
typical	O	2264
clinical	O	2264
features	O	2264
of	O	2264
the	O	2264
fragile	B-Disease	2264
x	I-Disease	2264
syndrome	I-Disease	2264
,	O	2264
but	O	2264
without	O	2264
cytogenetic	O	2264
expression	O	2264
of	O	2264
the	O	2264
fragile	B-Disease	2264
x	I-Disease	2264
or	O	2264
an	O	2264
amplified	O	2264
ccg	O	2264
trinucleotide	O	2264
repeat	O	2264
fragment	O	2264
.	O	2264
this	O	2267
finding	O	2267
confirms	O	2267
that	O	2267
the	O	2267
fragile	B-Disease	2267
x	I-Disease	2267
phenotype	O	2267
can	O	2267
exist	O	2267
,	O	2267
without	O	2267
amplification	O	2267
of	O	2267
the	O	2267
ccg	O	2267
repeat	O	2267
or	O	2267
cytogenetic	O	2267
expression	O	2267
of	O	2267
the	O	2267
fragile	B-Disease	2267
x	I-Disease	2267
,	O	2267
and	O	2267
that	O	2267
fragile	B-Disease	2267
x	I-Disease	2267
syndrome	I-Disease	2267
is	O	2267
a	O	2267
genetically	O	2267
homogeneous	O	2267
disorder	O	2267
involving	O	2267
fmr1	O	2267
.	O	2267
cloning	O	2269
of	O	2269
the	O	2269
huntington	B-Disease	2269
disease	I-Disease	2269
region	O	2269
in	O	2269
yeast	O	2269
artificial	O	2269
chromosomes	O	2269
.	O	2269
the	O	2270
gene	O	2270
responsible	O	2270
for	O	2270
huntington	B-Disease	2270
disease	I-Disease	2270
has	O	2270
been	O	2270
localized	O	2270
to	O	2270
a	O	2270
2	O	2270
.	O	2270
as	O	2272
part	O	2272
of	O	2272
a	O	2272
strategy	O	2272
to	O	2272
clone	O	2272
the	O	2272
hd	B-Disease	2272
gene	O	2272
on	O	2272
the	O	2272
basis	O	2272
of	O	2272
its	O	2272
chromosomal	O	2272
location	O	2272
,	O	2272
we	O	2272
isolated	O	2272
genomic	O	2272
dna	O	2272
from	O	2272
the	O	2272
hd	B-Disease	2272
region	O	2272
as	O	2272
a	O	2272
set	O	2272
of	O	2272
overlapping	O	2272
yeast	O	2272
artificial	O	2272
chromosome	O	2272
(	O	2272
yac	O	2272
)	O	2272
clones	O	2272
.	O	2272
we	O	2274
assembled	O	2274
the	O	2274
yac	O	2274
clones	O	2274
into	O	2274
overlapping	O	2274
sets	O	2274
by	O	2274
hybridizing	O	2274
them	O	2274
to	O	2274
a	O	2274
large	O	2274
number	O	2274
of	O	2274
dna	O	2274
probes	O	2274
from	O	2274
the	O	2274
hd	B-Disease	2274
region	O	2274
,	O	2274
including	O	2274
the	O	2274
stss	O	2274
.	O	2274
2	O	2277
mb	O	2277
of	O	2277
the	O	2277
hd	B-Disease	2277
region	O	2277
in	O	2277
yacs	O	2277
,	O	2277
including	O	2277
one	O	2277
continuous	O	2277
segment	O	2277
of	O	2277
2	O	2277
.	O	2277
0	O	2278
mb	O	2278
covering	O	2278
the	O	2278
region	O	2278
that	O	2278
most	O	2278
likely	O	2278
contains	O	2278
the	O	2278
hd	B-Disease	2278
gene	O	2278
.	O	2278
these	O	2281
clones	O	2281
provide	O	2281
reagents	O	2281
for	O	2281
the	O	2281
complete	O	2281
characterization	O	2281
of	O	2281
this	O	2281
region	O	2281
of	O	2281
the	O	2281
genome	O	2281
and	O	2281
for	O	2281
the	O	2281
eventual	O	2281
isolation	O	2281
of	O	2281
the	O	2281
hd	B-Disease	2281
gene	O	2281
.	O	2281
characterization	O	2282
of	O	2282
a	O	2282
yac	O	2282
containing	O	2282
part	O	2282
or	O	2282
all	O	2282
of	O	2282
the	O	2282
norrie	B-Disease	2282
disease	I-Disease	2282
locus	O	2282
.	O	2282
a	O	2289
series	O	2289
of	O	2289
subclones	O	2289
prepared	O	2289
from	O	2289
a	O	2289
phage	O	2289
library	O	2289
(	O	2289
lambda	O	2289
dash	O	2289
ii	O	2289
)	O	2289
of	O	2289
the	O	2289
yac	O	2289
have	O	2289
been	O	2289
characterised	O	2289
and	O	2289
have	O	2289
been	O	2289
employed	O	2289
to	O	2289
determine	O	2289
the	O	2289
end	O	2289
point	O	2289
of	O	2289
the	O	2289
deletion	O	2289
of	O	2289
a	O	2289
norrie	B-Disease	2289
disease	I-Disease	2289
(	O	2289
ndp	B-Disease	2289
)	O	2289
patient	O	2289
who	O	2289
has	O	2289
been	O	2289
shown	O	2289
to	O	2289
lack	O	2289
both	O	2289
dxs7	O	2289
and	O	2289
mao	O	2289
coding	O	2289
sequences	O	2289
.	O	2289
both	O	2292
mutations	O	2292
in	O	2292
g6pd	O	2292
a	O	2292
-	O	2292
are	O	2292
necessary	O	2292
to	O	2292
produce	O	2292
the	O	2292
g6pd	B-Disease	2292
deficient	I-Disease	2292
phenotype	O	2292
.	O	2292
the	O	2293
high	O	2293
prevalence	O	2293
of	O	2293
glucose	B-Disease	2293
6	I-Disease	2293
-	I-Disease	2293
phosphate	I-Disease	2293
dehydrogenase	I-Disease	2293
(	I-Disease	2293
g6pd	I-Disease	2293
)	I-Disease	2293
deficiency	I-Disease	2293
in	O	2293
african	O	2293
populations	O	2293
is	O	2293
due	O	2293
almost	O	2293
entirely	O	2293
to	O	2293
the	O	2293
enzyme	O	2293
variant	O	2293
a	O	2293
-	O	2293
,	O	2293
which	O	2293
differs	O	2293
from	O	2293
the	O	2293
wild	O	2293
-	O	2293
type	O	2293
g6pd	O	2293
b	O	2293
by	O	2293
two	O	2293
amino	O	2293
acid	O	2293
replacements	O	2293
,	O	2293
68	O	2293
val	O	2293
-	O	2293
-	O	2293
>	O	2293
met	O	2293
and	O	2293
126	O	2293
asn	O	2293
-	O	2293
-	O	2293
>	O	2293
asp	O	2293
.	O	2293
this	O	2298
could	O	2298
be	O	2298
because	O	2298
the	O	2298
68	O	2298
val	O	2298
-	O	2298
-	O	2298
>	O	2298
met	O	2298
mutation	O	2298
happened	O	2298
to	O	2298
arise	O	2298
in	O	2298
an	O	2298
a	O	2298
gene	O	2298
in	O	2298
the	O	2298
first	O	2298
instance	O	2298
,	O	2298
or	O	2298
because	O	2298
the	O	2298
68	O	2298
val	O	2298
-	O	2298
-	O	2298
>	O	2298
met	O	2298
mutation	O	2298
alone	O	2298
is	O	2298
not	O	2298
sufficient	O	2298
to	O	2298
cause	O	2298
g6pd	B-Disease	2298
deficiency	I-Disease	2298
.	O	2298
we	O	2304
infer	O	2304
that	O	2304
the	O	2304
coexistence	O	2304
of	O	2304
the	O	2304
two	O	2304
mutations	O	2304
is	O	2304
responsible	O	2304
for	O	2304
enzyme	B-Disease	2304
deficiency	I-Disease	2304
in	I-Disease	2304
g6pd	I-Disease	2304
a	O	2304
-	O	2304
because	O	2304
they	O	2304
act	O	2304
synergistically	O	2304
in	O	2304
causing	O	2304
instability	O	2304
of	O	2304
the	O	2304
enzyme	O	2304
.	O	2304
small	O	2305
nuclear	O	2305
ribonucleoprotein	O	2305
polypeptide	O	2305
n	O	2305
(	O	2305
snrpn	O	2305
)	O	2305
,	O	2305
an	O	2305
expressed	O	2305
gene	O	2305
in	O	2305
the	O	2305
prader	B-Disease	2305
-	I-Disease	2305
willi	I-Disease	2305
syndrome	I-Disease	2305
critical	O	2305
region	O	2305
.	O	2305
prader	B-Disease	2306
-	I-Disease	2306
willi	I-Disease	2306
syndrome	I-Disease	2306
(	O	2306
pws	B-Disease	2306
)	O	2306
is	O	2306
associated	O	2306
with	O	2306
paternally	O	2306
derived	O	2306
chromosomal	O	2306
deletions	O	2306
in	O	2306
region	O	2306
15q11	O	2306
-	O	2306
13	O	2306
or	O	2306
with	O	2306
maternal	B-Disease	2306
disomy	I-Disease	2306
for	I-Disease	2306
chromosome	I-Disease	2306
15	I-Disease	2306
.	O	2306
therefore	O	2307
,	O	2307
loss	O	2307
of	O	2307
the	O	2307
expressed	O	2307
paternal	O	2307
alleles	O	2307
of	O	2307
maternally	O	2307
imprinted	O	2307
genes	O	2307
must	O	2307
be	O	2307
responsible	O	2307
for	O	2307
the	O	2307
pws	B-Disease	2307
phenotype	O	2307
.	O	2307
furthermore	O	2309
,	O	2309
snrpn	O	2309
was	O	2309
mapped	O	2309
to	O	2309
the	O	2309
minimal	O	2309
deletion	O	2309
interval	O	2309
that	O	2309
is	O	2309
critical	O	2309
for	O	2309
pws	B-Disease	2309
.	O	2309
the	O	2310
fact	O	2310
that	O	2310
the	O	2310
mouse	O	2310
snrpn	O	2310
gene	O	2310
is	O	2310
maternally	O	2310
imprinted	O	2310
in	O	2310
brain	O	2310
suggests	O	2310
that	O	2310
loss	O	2310
of	O	2310
the	O	2310
paternally	O	2310
derived	O	2310
snrpn	O	2310
allele	O	2310
may	O	2310
be	O	2310
involved	O	2310
in	O	2310
the	O	2310
pws	B-Disease	2310
phenotype	O	2310
.	O	2310
.	O	2310
the	O	2311
presence	O	2311
of	O	2311
two	O	2311
different	O	2311
infantile	O	2311
tay	B-Disease	2311
-	I-Disease	2311
sachs	I-Disease	2311
disease	I-Disease	2311
mutations	O	2311
in	O	2311
a	O	2311
cajun	O	2311
population	O	2311
.	O	2311
a	O	2312
study	O	2312
was	O	2312
undertaken	O	2312
to	O	2312
characterize	O	2312
the	O	2312
mutation	O	2312
(	O	2312
s	O	2312
)	O	2312
responsible	O	2312
for	O	2312
tay	B-Disease	2312
-	I-Disease	2312
sachs	I-Disease	2312
disease	I-Disease	2312
(	O	2312
tsd	B-Disease	2312
)	O	2312
in	O	2312
a	O	2312
cajun	O	2312
population	O	2312
in	O	2312
southwest	O	2312
louisiana	O	2312
and	O	2312
to	O	2312
identify	O	2312
the	O	2312
origins	O	2312
of	O	2312
these	O	2312
mutations	O	2312
.	O	2312
eleven	O	2313
of	O	2313
12	O	2313
infantile	O	2313
tsd	B-Disease	2313
alleles	O	2313
examined	O	2313
in	O	2313
six	O	2313
families	O	2313
had	O	2313
the	O	2313
beta	O	2313
-	O	2313
hexosaminidase	O	2313
a	O	2313
(	O	2313
hex	O	2313
a	O	2313
)	O	2313
alpha	O	2313
-	O	2313
subunit	O	2313
exon	O	2313
11	O	2313
insertion	O	2313
mutation	O	2313
that	O	2313
is	O	2313
present	O	2313
in	O	2313
approximately	O	2313
70	O	2313
%	O	2313
of	O	2313
ashkenazi	O	2313
jewish	O	2313
tsd	B-Disease	2313
heterozygotes	O	2313
.	O	2313
to	O	2315
determine	O	2315
the	O	2315
origins	O	2315
of	O	2315
these	O	2315
two	O	2315
mutations	O	2315
in	O	2315
the	O	2315
cajun	O	2315
population	O	2315
,	O	2315
the	O	2315
tsd	B-Disease	2315
carrier	O	2315
status	O	2315
was	O	2315
enzymatically	O	2315
determined	O	2315
for	O	2315
90	O	2315
members	O	2315
of	O	2315
four	O	2315
of	O	2315
the	O	2315
six	O	2315
families	O	2315
,	O	2315
and	O	2315
extensive	O	2315
pedigrees	O	2315
were	O	2315
constructed	O	2315
for	O	2315
all	O	2315
carriers	O	2315
.	O	2315
mutations	O	2319
in	O	2319
the	O	2319
candidate	O	2319
gene	O	2319
for	O	2319
norrie	B-Disease	2319
disease	I-Disease	2319
.	O	2319
recently	O	2320
,	O	2320
we	O	2320
and	O	2320
others	O	2320
have	O	2320
isolated	O	2320
a	O	2320
candidate	O	2320
gene	O	2320
for	O	2320
x	B-Disease	2320
linked	I-Disease	2320
norrie	I-Disease	2320
disease	I-Disease	2320
(	O	2320
nd	B-Disease	2320
)	O	2320
which	O	2320
was	O	2320
found	O	2320
to	O	2320
be	O	2320
deleted	O	2320
or	O	2320
disrupted	O	2320
in	O	2320
several	O	2320
patients	O	2320
.	O	2320
as	O	2321
a	O	2321
prerequisite	O	2321
for	O	2321
the	O	2321
identification	O	2321
of	O	2321
point	O	2321
mutations	O	2321
in	O	2321
the	O	2321
nd	B-Disease	2321
gene	O	2321
we	O	2321
have	O	2321
established	O	2321
the	O	2321
exon	O	2321
-	O	2321
intron	O	2321
structure	O	2321
of	O	2321
this	O	2321
gene	O	2321
.	O	2321
these	O	2325
findings	O	2325
,	O	2325
and	O	2325
the	O	2325
absence	O	2325
of	O	2325
functionally	O	2325
relevant	O	2325
base	O	2325
changes	O	2325
in	O	2325
healthy	O	2325
controls	O	2325
,	O	2325
emphasize	O	2325
the	O	2325
causal	O	2325
role	O	2325
of	O	2325
this	O	2325
candidate	O	2325
gene	O	2325
in	O	2325
norrie	B-Disease	2325
disease	I-Disease	2325
and	O	2325
pave	O	2325
the	O	2325
way	O	2325
for	O	2325
reliable	O	2325
diagnosis	O	2325
and	O	2325
carrier	O	2325
detection	O	2325
.	O	2325
.	O	2325
co	O	2328
-	O	2328
amplification	O	2328
of	O	2328
11	O	2328
exons	O	2328
from	O	2328
genomic	O	2328
dna	O	2328
of	O	2328
duchenne	B-Disease	2328
and	I-Disease	2328
becker	I-Disease	2328
muscular	I-Disease	2328
dystrophy	I-Disease	2328
(	O	2328
dmd	B-Disease	2328
/	O	2328
bmd	B-Disease	2328
)	O	2328
patients	O	2328
with	O	2328
no	O	2328
deletion	O	2328
or	O	2328
duplication	O	2328
was	O	2328
performed	O	2328
and	O	2328
the	O	2328
samples	O	2328
subjected	O	2328
to	O	2328
multiple	O	2328
sscp	O	2328
analysis	O	2328
.	O	2328
we	O	2329
report	O	2329
the	O	2329
case	O	2329
of	O	2329
a	O	2329
nonsense	O	2329
mutation	O	2329
in	O	2329
a	O	2329
duchenne	B-Disease	2329
patient	O	2329
identified	O	2329
by	O	2329
this	O	2329
approach	O	2329
.	O	2329
high	O	2335
level	O	2335
expression	O	2335
of	O	2335
the	O	2335
nm23	O	2335
-	O	2335
h1	O	2335
gene	O	2335
,	O	2335
which	O	2335
encodes	O	2335
for	O	2335
a	O	2335
nucleoside	O	2335
diphosphate	O	2335
kinase	O	2335
,	O	2335
has	O	2335
been	O	2335
found	O	2335
to	O	2335
correlate	O	2335
with	O	2335
diminished	O	2335
metastasis	O	2335
in	O	2335
some	O	2335
tumors	B-Disease	2335
but	O	2335
not	O	2335
in	O	2335
others	O	2335
.	O	2335
in	O	2337
neuroblastoma	B-Disease	2337
,	O	2337
higher	O	2337
levels	O	2337
of	O	2337
p19	O	2337
/	O	2337
nm23	O	2337
,	O	2337
which	O	2337
are	O	2337
associated	O	2337
with	O	2337
amplification	O	2337
of	O	2337
the	O	2337
n	O	2337
-	O	2337
myc	O	2337
oncogene	O	2337
,	O	2337
large	O	2337
tumor	B-Disease	2337
mass	O	2337
,	O	2337
and	O	2337
metastasis	O	2337
,	O	2337
were	O	2337
observed	O	2337
in	O	2337
advanced	O	2337
stage	O	2337
tumors	B-Disease	2337
compared	O	2337
with	O	2337
limited	O	2337
stage	O	2337
disease	O	2337
.	O	2337
because	O	2338
of	O	2338
the	O	2338
variable	O	2338
expression	O	2338
of	O	2338
nm23	O	2338
-	O	2338
h1	O	2338
in	O	2338
different	O	2338
tumors	B-Disease	2338
,	O	2338
we	O	2338
have	O	2338
investigated	O	2338
the	O	2338
relationship	O	2338
between	O	2338
amounts	O	2338
of	O	2338
the	O	2338
protein	O	2338
and	O	2338
cell	O	2338
proliferation	O	2338
.	O	2338
the	O	2339
levels	O	2339
of	O	2339
p19	O	2339
/	O	2339
nm23	O	2339
were	O	2339
compared	O	2339
between	O	2339
resting	O	2339
and	O	2339
mitotically	O	2339
stimulated	O	2339
normal	O	2339
human	O	2339
pbls	O	2339
and	O	2339
in	O	2339
leukemia	B-Disease	2339
cells	O	2339
.	O	2339
in	O	2341
leukemia	B-Disease	2341
cells	O	2341
obtained	O	2341
from	O	2341
patients	O	2341
with	O	2341
different	O	2341
subtypes	O	2341
of	O	2341
acute	B-Disease	2341
leukemia	I-Disease	2341
,	O	2341
p19	O	2341
/	O	2341
nm23	O	2341
levels	O	2341
were	O	2341
also	O	2341
increased	O	2341
relative	O	2341
to	O	2341
resting	O	2341
normal	O	2341
lymphocytes	O	2341
.	O	2341
treatment	O	2342
of	O	2342
mitotically	O	2342
stimulated	O	2342
lymphocytes	O	2342
with	O	2342
cyclosporin	O	2342
,	O	2342
which	O	2342
inhibits	O	2342
proliferation	O	2342
,	O	2342
blocked	O	2342
the	O	2342
increase	O	2342
in	O	2342
p19	O	2342
/	O	2342
nm23	O	2342
;	O	2342
treatment	O	2342
of	O	2342
the	O	2342
leukemia	B-Disease	2342
cell	O	2342
line	O	2342
hl	O	2342
-	O	2342
60	O	2342
with	O	2342
dimethylsulfoxide	O	2342
,	O	2342
which	O	2342
induces	O	2342
terminal	O	2342
differentiation	O	2342
,	O	2342
resulted	O	2342
in	O	2342
diminished	O	2342
levels	O	2342
of	O	2342
p19	O	2342
/	O	2342
nm23	O	2342
.	O	2342
an	O	2344
intrachromosomal	O	2344
insertion	O	2344
causing	O	2344
5q22	O	2344
deletion	O	2344
and	O	2344
familial	B-Disease	2344
adenomatous	I-Disease	2344
polyposis	I-Disease	2344
coli	I-Disease	2344
in	O	2344
two	O	2344
generations	O	2344
.	O	2344
we	O	2345
report	O	2345
familial	B-Disease	2345
adenomatous	I-Disease	2345
polyposis	I-Disease	2345
coli	I-Disease	2345
(	O	2345
fapc	B-Disease	2345
)	O	2345
with	O	2345
epidermoid	B-Disease	2345
cysts	I-Disease	2345
,	O	2345
osteomata	B-Disease	2345
,	O	2345
and	O	2345
areas	O	2345
of	O	2345
congenital	B-Disease	2345
hypertrophy	I-Disease	2345
of	I-Disease	2345
the	I-Disease	2345
retinal	I-Disease	2345
pigment	I-Disease	2345
epithelium	I-Disease	2345
(	O	2345
chrpes	B-Disease	2345
)	O	2345
in	O	2345
a	O	2345
male	O	2345
patient	O	2345
and	O	2345
his	O	2345
maternal	O	2345
aunt	O	2345
,	O	2345
both	O	2345
of	O	2345
whom	O	2345
suffered	O	2345
a	O	2345
mild	O	2345
to	O	2345
moderate	O	2345
degree	O	2345
of	O	2345
mental	B-Disease	2345
handicap	I-Disease	2345
.	O	2345
as	O	2351
expected	O	2351
,	O	2351
the	O	2351
molecular	O	2351
analyses	O	2351
indicate	O	2351
loss	O	2351
of	O	2351
one	O	2351
allele	O	2351
at	O	2351
the	O	2351
mcc	O	2351
and	O	2351
apc	B-Disease	2351
loci	O	2351
.	O	2351
the	O	2352
apc	B-Disease	2352
gene	O	2352
is	O	2352
located	O	2352
within	O	2352
band	O	2352
5q22	O	2352
.	O	2352
chromosome	O	2354
mapping	O	2354
of	O	2354
the	O	2354
rod	O	2354
photoreceptor	O	2354
cgmp	O	2354
phosphodiesterase	O	2354
beta	O	2354
-	O	2354
subunit	O	2354
gene	O	2354
in	O	2354
mouse	O	2354
and	O	2354
human	O	2354
:	O	2354
tight	O	2354
linkage	O	2354
to	O	2354
the	O	2354
huntington	B-Disease	2354
disease	I-Disease	2354
region	O	2354
(	O	2354
4p16	O	2354
.	O	2354
3	O	2354
)	O	2354
.	O	2354
the	O	2355
retinal	B-Disease	2355
degeneration	I-Disease	2355
mouse	O	2355
(	O	2355
gene	O	2355
symbol	O	2355
,	O	2355
rd	O	2355
)	O	2355
is	O	2355
an	O	2355
animal	O	2355
model	O	2355
for	O	2355
certain	O	2355
forms	O	2355
of	O	2355
human	O	2355
hereditary	B-Disease	2355
retinopathies	I-Disease	2355
.	O	2355
3	O	2361
,	O	2361
very	O	2361
close	O	2361
to	O	2361
the	O	2361
huntington	B-Disease	2361
disease	I-Disease	2361
(	O	2361
hd	B-Disease	2361
)	O	2361
region	O	2361
.	O	2361
analysis	O	2362
of	O	2362
the	O	2362
comparative	O	2362
map	O	2362
for	O	2362
mice	O	2362
and	O	2362
humans	O	2362
shows	O	2362
that	O	2362
the	O	2362
mouse	O	2362
homologue	O	2362
of	O	2362
the	O	2362
hd	B-Disease	2362
gene	O	2362
will	O	2362
reside	O	2362
on	O	2362
chromosome	O	2362
5	O	2362
.	O	2362
3	O	2364
region	O	2364
is	O	2364
maintained	O	2364
but	O	2364
gene	O	2364
order	O	2364
is	O	2364
not	O	2364
,	O	2364
suggesting	O	2364
at	O	2364
least	O	2364
three	O	2364
possible	O	2364
sites	O	2364
for	O	2364
the	O	2364
corresponding	O	2364
mouse	O	2364
hd	B-Disease	2364
gene	O	2364
.	O	2364
coincident	O	2365
kaposi	B-Disease	2365
sarcoma	I-Disease	2365
and	O	2365
t	B-Disease	2365
-	I-Disease	2365
cell	I-Disease	2365
lymphoma	I-Disease	2365
in	O	2365
a	O	2365
patient	O	2365
with	O	2365
the	O	2365
wiskott	B-Disease	2365
-	I-Disease	2365
aldrich	I-Disease	2365
syndrome	I-Disease	2365
.	O	2365
a	O	2366
24	O	2366
year	O	2366
old	O	2366
male	O	2366
with	O	2366
a	O	2366
history	O	2366
of	O	2366
eczema	B-Disease	2366
,	O	2366
recurrent	O	2366
mild	O	2366
infections	O	2366
,	O	2366
and	O	2366
thrombocytopenia	B-Disease	2366
consistent	O	2366
with	O	2366
the	O	2366
wiskott	B-Disease	2366
-	I-Disease	2366
aldrich	I-Disease	2366
syndrome	I-Disease	2366
(	O	2366
was	B-Disease	2366
)	O	2366
presented	O	2366
with	O	2366
a	O	2366
mediastinal	O	2366
mass	O	2366
,	O	2366
generalized	O	2366
lymphadenopathy	B-Disease	2366
,	O	2366
splenomegaly	B-Disease	2366
,	O	2366
and	O	2366
severe	O	2366
thrombocytopenia	B-Disease	2366
.	O	2366
however	O	2369
,	O	2369
their	O	2369
proliferative	O	2369
responses	O	2369
to	O	2369
anti	O	2369
-	O	2369
cd43	O	2369
antibody	O	2369
and	O	2369
periodate	O	2369
were	O	2369
diminished	O	2369
,	O	2369
consistent	O	2369
with	O	2369
the	O	2369
clinical	O	2369
diagnosis	O	2369
of	O	2369
was	B-Disease	2369
.	O	2369
an	O	2370
initial	O	2370
inguinal	O	2370
lymph	O	2370
node	O	2370
biopsy	O	2370
surprisingly	O	2370
revealed	O	2370
kaposi	B-Disease	2370
sarcoma	I-Disease	2370
.	O	2370
however	O	2371
,	O	2371
following	O	2371
splenectomy	O	2371
to	O	2371
increase	O	2371
the	O	2371
platelet	O	2371
count	O	2371
,	O	2371
biopsy	O	2371
of	O	2371
the	O	2371
mediastinal	O	2371
mass	O	2371
revealed	O	2371
t	B-Disease	2371
-	I-Disease	2371
cell	I-Disease	2371
large	I-Disease	2371
cell	I-Disease	2371
lymphoma	I-Disease	2371
.	O	2371
studies	O	2372
of	O	2372
biopsied	O	2372
tissue	O	2372
for	O	2372
the	O	2372
presence	O	2372
of	O	2372
epstein	B-Disease	2372
-	I-Disease	2372
barr	I-Disease	2372
virus	I-Disease	2372
and	O	2372
cytomegalovirus	B-Disease	2372
were	O	2372
negative	O	2372
,	O	2372
as	O	2372
were	O	2372
studies	O	2372
of	O	2372
blood	O	2372
,	O	2372
including	O	2372
the	O	2372
polymerase	O	2372
chain	O	2372
reaction	O	2372
,	O	2372
for	O	2372
the	O	2372
presence	O	2372
of	O	2372
the	O	2372
human	B-Disease	2372
immunodeficiency	I-Disease	2372
virus	I-Disease	2372
(	O	2372
hiv	B-Disease	2372
)	O	2372
.	O	2372
this	O	2373
is	O	2373
the	O	2373
first	O	2373
report	O	2373
of	O	2373
kaposi	B-Disease	2373
sarcoma	I-Disease	2373
arising	O	2373
in	O	2373
a	O	2373
patient	O	2373
with	O	2373
a	O	2373
congenital	B-Disease	2373
immunodeficiency	I-Disease	2373
syndrome	I-Disease	2373
.	O	2373
although	O	2374
kaposi	B-Disease	2374
sarcoma	I-Disease	2374
can	O	2374
arise	O	2374
in	O	2374
the	O	2374
face	O	2374
of	O	2374
the	O	2374
severe	O	2374
immunosuppression	O	2374
that	O	2374
follows	O	2374
allograft	O	2374
transplantation	O	2374
and	O	2374
in	O	2374
patients	O	2374
infected	O	2374
with	O	2374
hiv	B-Disease	2374
,	O	2374
we	O	2374
postulate	O	2374
that	O	2374
longevity	O	2374
in	O	2374
the	O	2374
face	O	2374
of	O	2374
mild	O	2374
immunosuppression	O	2374
was	O	2374
the	O	2374
major	O	2374
factor	O	2374
in	O	2374
the	O	2374
development	O	2374
of	O	2374
kaposi	B-Disease	2374
sarcoma	I-Disease	2374
in	O	2374
this	O	2374
patient	O	2374
.	O	2374
.	O	2374
the	O	2375
apc	B-Disease	2375
gene	O	2375
,	O	2375
responsible	O	2375
for	O	2375
familial	B-Disease	2375
adenomatous	I-Disease	2375
polyposis	I-Disease	2375
,	O	2375
is	O	2375
mutated	O	2375
in	O	2375
human	O	2375
gastric	B-Disease	2375
cancer	I-Disease	2375
.	O	2375
although	O	2376
gastric	B-Disease	2376
cancer	I-Disease	2376
is	O	2376
the	O	2376
most	O	2376
common	O	2376
cancer	B-Disease	2376
in	O	2376
the	O	2376
world	O	2376
,	O	2376
genetic	O	2376
changes	O	2376
during	O	2376
its	O	2376
carcinogenesis	O	2376
are	O	2376
not	O	2376
well	O	2376
understood	O	2376
.	O	2376
since	O	2377
some	O	2377
gastric	B-Disease	2377
cancers	I-Disease	2377
are	O	2377
considered	O	2377
to	O	2377
originate	O	2377
from	O	2377
the	O	2377
intestinal	O	2377
metaplasia	O	2377
,	O	2377
it	O	2377
is	O	2377
likely	O	2377
that	O	2377
the	O	2377
adenomatous	B-Disease	2377
polyposis	I-Disease	2377
coli	I-Disease	2377
(	O	2377
apc	B-Disease	2377
)	O	2377
gene	O	2377
,	O	2377
the	O	2377
mutation	O	2377
of	O	2377
which	O	2377
causes	O	2377
adenomatous	B-Disease	2377
polyps	I-Disease	2377
in	I-Disease	2377
the	I-Disease	2377
colon	I-Disease	2377
,	O	2377
is	O	2377
associated	O	2377
with	O	2377
carcinogenesis	O	2377
of	O	2377
gastric	B-Disease	2377
cancer	I-Disease	2377
.	O	2377
based	O	2378
on	O	2378
this	O	2378
idea	O	2378
,	O	2378
dnas	O	2378
isolated	O	2378
from	O	2378
gastric	B-Disease	2378
cancers	I-Disease	2378
were	O	2378
examined	O	2378
by	O	2378
means	O	2378
of	O	2378
a	O	2378
rnase	O	2378
protection	O	2378
analysis	O	2378
coupled	O	2378
with	O	2378
polymerase	O	2378
chain	O	2378
reaction	O	2378
followed	O	2378
by	O	2378
sequencing	O	2378
of	O	2378
the	O	2378
polymerase	O	2378
chain	O	2378
reaction	O	2378
products	O	2378
.	O	2378
by	O	2379
screening	O	2379
nearly	O	2379
one	O	2379
-	O	2379
half	O	2379
of	O	2379
the	O	2379
coding	O	2379
region	O	2379
of	O	2379
the	O	2379
apc	B-Disease	2379
gene	O	2379
in	O	2379
44	O	2379
tumors	B-Disease	2379
,	O	2379
somatic	O	2379
mutations	O	2379
were	O	2379
detected	O	2379
in	O	2379
three	O	2379
tumors	B-Disease	2379
a	O	2379
missense	O	2379
mutation	O	2379
,	O	2379
a	O	2379
nonsense	O	2379
mutation	O	2379
,	O	2379
and	O	2379
a	O	2379
5	O	2379
-	O	2379
base	O	2379
pair	O	2379
deletion	O	2379
resulting	O	2379
in	O	2379
a	O	2379
frame	O	2379
shift	O	2379
which	O	2379
causes	O	2379
truncation	O	2379
of	O	2379
the	O	2379
gene	O	2379
product	O	2379
.	O	2379
these	O	2380
results	O	2380
suggest	O	2380
that	O	2380
the	O	2380
mutation	O	2380
of	O	2380
the	O	2380
apc	B-Disease	2380
gene	O	2380
also	O	2380
plays	O	2380
an	O	2380
important	O	2380
role	O	2380
during	O	2380
the	O	2380
carcinogenesis	O	2380
of	O	2380
at	O	2380
least	O	2380
some	O	2380
gastric	B-Disease	2380
cancers	I-Disease	2380
.	O	2380
.	O	2380
a	O	2381
71	O	2381
-	O	2381
kilodalton	O	2381
protein	O	2381
is	O	2381
a	O	2381
major	O	2381
product	O	2381
of	O	2381
the	O	2381
duchenne	B-Disease	2381
muscular	I-Disease	2381
dystrophy	I-Disease	2381
gene	O	2381
in	O	2381
brain	O	2381
and	O	2381
other	O	2381
nonmuscle	O	2381
tissues	O	2381
.	O	2381
the	O	2382
known	O	2382
duchenne	B-Disease	2382
muscular	I-Disease	2382
dystrophy	I-Disease	2382
(	O	2382
dmd	B-Disease	2382
)	O	2382
gene	O	2382
products	O	2382
,	O	2382
the	O	2382
muscle	O	2382
-	O	2382
and	O	2382
brain	O	2382
-	O	2382
type	O	2382
dystrophin	O	2382
isoforms	O	2382
,	O	2382
are	O	2382
427	O	2382
-	O	2382
kda	O	2382
proteins	O	2382
translated	O	2382
from	O	2382
14	O	2382
-	O	2382
kilobase	O	2382
(	O	2382
kb	O	2382
)	O	2382
mrnas	O	2382
.	O	2382
5	O	2384
-	O	2384
kb	O	2384
mrna	O	2384
that	O	2384
also	O	2384
is	O	2384
transcribed	O	2384
from	O	2384
the	O	2384
dmd	B-Disease	2384
gene	O	2384
.	O	2384
8	O	2387
-	O	2387
kda	O	2387
protein	O	2387
that	O	2387
is	O	2387
a	O	2387
major	O	2387
product	O	2387
of	O	2387
the	O	2387
dmd	B-Disease	2387
gene	O	2387
.	O	2387
this	O	2390
protein	O	2390
is	O	2390
the	O	2390
major	O	2390
dmd	B-Disease	2390
gene	O	2390
product	O	2390
in	O	2390
brain	O	2390
and	O	2390
other	O	2390
nonmuscle	O	2390
tissues	O	2390
but	O	2390
is	O	2390
undetectable	O	2390
in	O	2390
skeletal	O	2390
muscle	O	2390
extracts	O	2390
.	O	2390
correlation	O	2391
between	O	2391
the	O	2391
location	O	2391
of	O	2391
germ	O	2391
-	O	2391
line	O	2391
mutations	O	2391
in	O	2391
the	O	2391
apc	B-Disease	2391
gene	O	2391
and	O	2391
the	O	2391
number	O	2391
of	O	2391
colorectal	B-Disease	2391
polyps	I-Disease	2391
in	O	2391
familial	B-Disease	2391
adenomatous	I-Disease	2391
polyposis	I-Disease	2391
patients	O	2391
.	O	2391
recently	O	2392
we	O	2392
have	O	2392
isolated	O	2392
the	O	2392
adenomatous	B-Disease	2392
polyposis	I-Disease	2392
coli	I-Disease	2392
(	O	2392
apc	B-Disease	2392
)	O	2392
gene	O	2392
which	O	2392
causes	O	2392
familial	B-Disease	2392
adenomatous	I-Disease	2392
polyposis	I-Disease	2392
(	O	2392
fap	B-Disease	2392
)	O	2392
,	O	2392
and	O	2392
its	O	2392
germ	O	2392
-	O	2392
line	O	2392
mutations	O	2392
in	O	2392
a	O	2392
substantial	O	2392
number	O	2392
of	O	2392
fap	B-Disease	2392
patients	O	2392
have	O	2392
been	O	2392
identified	O	2392
.	O	2392
on	O	2393
the	O	2393
basis	O	2393
of	O	2393
this	O	2393
information	O	2393
,	O	2393
we	O	2393
compared	O	2393
the	O	2393
location	O	2393
of	O	2393
germ	O	2393
-	O	2393
line	O	2393
mutations	O	2393
in	O	2393
the	O	2393
apc	B-Disease	2393
gene	O	2393
in	O	2393
22	O	2393
unrelated	O	2393
patients	O	2393
(	O	2393
12	O	2393
of	O	2393
whom	O	2393
have	O	2393
been	O	2393
reported	O	2393
previously	O	2393
)	O	2393
with	O	2393
the	O	2393
number	O	2393
of	O	2393
colorectal	B-Disease	2393
polyps	I-Disease	2393
developed	O	2393
in	O	2393
fap	B-Disease	2393
patients	O	2393
;	O	2393
17	O	2393
were	O	2393
sparse	O	2393
types	O	2393
and	O	2393
five	O	2393
were	O	2393
profuse	O	2393
types	O	2393
.	O	2393
the	O	2395
location	O	2395
of	O	2395
the	O	2395
germ	O	2395
-	O	2395
line	O	2395
mutations	O	2395
seems	O	2395
to	O	2395
correlate	O	2395
with	O	2395
the	O	2395
two	O	2395
clinical	O	2395
types	O	2395
;	O	2395
germ	O	2395
-	O	2395
line	O	2395
mutations	O	2395
in	O	2395
five	O	2395
fap	B-Disease	2395
patients	O	2395
with	O	2395
profuse	O	2395
polyps	B-Disease	2395
were	O	2395
observed	O	2395
between	O	2395
codon	O	2395
1250	O	2395
and	O	2395
codon	O	2395
1464	O	2395
,	O	2395
whereas	O	2395
mutations	O	2395
in	O	2395
17	O	2395
fap	B-Disease	2395
patients	O	2395
with	O	2395
fewer	O	2395
polyps	B-Disease	2395
were	O	2395
observed	O	2395
in	O	2395
the	O	2395
other	O	2395
regions	O	2395
of	O	2395
the	O	2395
apc	B-Disease	2395
gene	O	2395
.	O	2395
the	O	2396
result	O	2396
suggests	O	2396
that	O	2396
the	O	2396
number	O	2396
of	O	2396
colorectal	B-Disease	2396
polyps	I-Disease	2396
in	O	2396
fap	B-Disease	2396
patients	O	2396
may	O	2396
be	O	2396
associated	O	2396
with	O	2396
a	O	2396
difference	O	2396
in	O	2396
the	O	2396
stability	O	2396
or	O	2396
biological	O	2396
function	O	2396
of	O	2396
the	O	2396
truncated	O	2396
apc	B-Disease	2396
protein	O	2396
.	O	2396
.	O	2396
identification	O	2397
and	O	2397
rapid	O	2397
detection	O	2397
of	O	2397
three	O	2397
tay	B-Disease	2397
-	I-Disease	2397
sachs	I-Disease	2397
mutations	O	2397
in	O	2397
the	O	2397
moroccan	O	2397
jewish	O	2397
population	O	2397
.	O	2397
infantile	O	2398
tay	B-Disease	2398
-	I-Disease	2398
sachs	I-Disease	2398
disease	I-Disease	2398
(	O	2398
tsd	B-Disease	2398
)	O	2398
is	O	2398
caused	O	2398
by	O	2398
mutations	O	2398
in	O	2398
the	O	2398
hexa	O	2398
gene	O	2398
that	O	2398
result	O	2398
in	O	2398
the	O	2398
complete	O	2398
absence	O	2398
of	O	2398
beta	O	2398
-	O	2398
hexosaminidase	O	2398
a	O	2398
activity	O	2398
.	O	2398
it	O	2399
is	O	2399
well	O	2399
known	O	2399
that	O	2399
an	O	2399
elevated	O	2399
frequency	O	2399
of	O	2399
tsd	B-Disease	2399
mutations	O	2399
exists	O	2399
among	O	2399
ashkenazi	O	2399
jews	O	2399
.	O	2399
more	O	2400
recently	O	2400
it	O	2400
has	O	2400
become	O	2400
apparent	O	2400
that	O	2400
elevated	O	2400
carrier	O	2400
frequencies	O	2400
for	O	2400
tsd	B-Disease	2400
also	O	2400
occur	O	2400
in	O	2400
several	O	2400
other	O	2400
ethnic	O	2400
groups	O	2400
,	O	2400
including	O	2400
moroccan	O	2400
jews	O	2400
,	O	2400
a	O	2400
subgroup	O	2400
of	O	2400
sephardic	O	2400
jews	O	2400
.	O	2400
elsewhere	O	2401
we	O	2401
reported	O	2401
an	O	2401
in	O	2401
-	O	2401
frame	O	2401
deletion	O	2401
of	O	2401
one	O	2401
of	O	2401
the	O	2401
two	O	2401
adjacent	O	2401
phenylalanine	O	2401
codons	O	2401
at	O	2401
position	O	2401
304	O	2401
or	O	2401
305	O	2401
(	O	2401
delta	O	2401
f304	O	2401
/	O	2401
305	O	2401
)	O	2401
in	O	2401
one	O	2401
hexa	O	2401
allele	O	2401
of	O	2401
a	O	2401
moroccan	O	2401
jewish	O	2401
tsd	B-Disease	2401
patient	O	2401
and	O	2401
in	O	2401
three	O	2401
obligate	O	2401
carriers	O	2401
from	O	2401
six	O	2401
unrelated	O	2401
moroccan	O	2401
jewish	O	2401
families	O	2401
.	O	2401
we	O	2402
have	O	2402
now	O	2402
identified	O	2402
two	O	2402
additional	O	2402
mutations	O	2402
within	O	2402
exon	O	2402
5	O	2402
of	O	2402
the	O	2402
hexa	O	2402
gene	O	2402
that	O	2402
account	O	2402
for	O	2402
the	O	2402
remaining	O	2402
tsd	B-Disease	2402
alleles	O	2402
in	O	2402
the	O	2402
patient	O	2402
and	O	2402
carriers	O	2402
.	O	2402
this	O	2405
mutation	O	2405
is	O	2405
at	O	2405
a	O	2405
cpg	O	2405
site	O	2405
in	O	2405
a	O	2405
japanese	O	2405
infant	O	2405
with	O	2405
tay	B-Disease	2405
-	I-Disease	2405
sachs	I-Disease	2405
disease	I-Disease	2405
and	O	2405
was	O	2405
described	O	2405
elsewhere	O	2405
.	O	2405
molecular	O	2408
characterization	O	2408
of	O	2408
glucose	B-Disease	2408
-	I-Disease	2408
6	I-Disease	2408
-	I-Disease	2408
phosphate	I-Disease	2408
dehydrogenase	I-Disease	2408
(	I-Disease	2408
g6pd	I-Disease	2408
)	I-Disease	2408
deficiency	I-Disease	2408
by	O	2408
natural	O	2408
and	O	2408
amplification	O	2408
created	O	2408
restriction	O	2408
sites	O	2408
:	O	2408
five	O	2408
mutations	O	2408
account	O	2408
for	O	2408
most	O	2408
g6pd	B-Disease	2408
deficiency	I-Disease	2408
cases	O	2408
in	O	2408
taiwan	O	2408
.	O	2408
we	O	2409
have	O	2409
developed	O	2409
a	O	2409
rapid	O	2409
and	O	2409
simple	O	2409
method	O	2409
to	O	2409
diagnose	O	2409
the	O	2409
molecular	O	2409
defects	O	2409
of	O	2409
glucose	B-Disease	2409
-	I-Disease	2409
6	I-Disease	2409
-	I-Disease	2409
phosphate	I-Disease	2409
dehydrogenase	I-Disease	2409
(	I-Disease	2409
g6pd	I-Disease	2409
)	I-Disease	2409
deficiency	I-Disease	2409
in	O	2409
chinese	O	2409
in	O	2409
taiwan	O	2409
.	O	2409
ninety	O	2411
-	O	2411
four	O	2411
chinese	O	2411
males	O	2411
with	O	2411
g6pd	B-Disease	2411
deficiency	I-Disease	2411
were	O	2411
studied	O	2411
.	O	2411
these	O	2419
results	O	2419
show	O	2419
that	O	2419
the	O	2419
former	O	2419
five	O	2419
mutations	O	2419
account	O	2419
for	O	2419
more	O	2419
than	O	2419
90	O	2419
%	O	2419
of	O	2419
g6pd	B-Disease	2419
deficiency	I-Disease	2419
cases	O	2419
in	O	2419
taiwan	O	2419
.	O	2419
eight	O	2422
novel	O	2422
inactivating	O	2422
germ	O	2422
line	O	2422
mutations	O	2422
at	O	2422
the	O	2422
apc	B-Disease	2422
gene	O	2422
identified	O	2422
by	O	2422
denaturing	O	2422
gradient	O	2422
gel	O	2422
electrophoresis	O	2422
.	O	2422
familial	B-Disease	2423
adenomatous	I-Disease	2423
polyposis	I-Disease	2423
(	O	2423
fap	B-Disease	2423
)	O	2423
is	O	2423
a	O	2423
dominantly	O	2423
inherited	O	2423
condition	O	2423
predisposing	O	2423
to	O	2423
colorectal	B-Disease	2423
cancer	I-Disease	2423
.	O	2423
the	O	2424
recent	O	2424
isolation	O	2424
of	O	2424
the	O	2424
responsible	O	2424
gene	O	2424
(	O	2424
adenomatous	B-Disease	2424
polyposis	I-Disease	2424
coli	I-Disease	2424
or	O	2424
apc	B-Disease	2424
)	O	2424
has	O	2424
facilitated	O	2424
the	O	2424
search	O	2424
for	O	2424
germ	O	2424
line	O	2424
mutations	O	2424
in	O	2424
affected	O	2424
individuals	O	2424
.	O	2424
dgge	O	2427
analysis	O	2427
of	O	2427
10	O	2427
apc	B-Disease	2427
exons	O	2427
(	O	2427
4	O	2427
,	O	2427
5	O	2427
,	O	2427
7	O	2427
,	O	2427
8	O	2427
,	O	2427
9	O	2427
,	O	2427
10	O	2427
,	O	2427
12	O	2427
,	O	2427
13	O	2427
,	O	2427
14	O	2427
,	O	2427
and	O	2427
part	O	2427
of	O	2427
15	O	2427
)	O	2427
in	O	2427
33	O	2427
unrelated	O	2427
dutch	O	2427
fap	B-Disease	2427
patients	O	2427
has	O	2427
led	O	2427
to	O	2427
the	O	2427
identification	O	2427
of	O	2427
eight	O	2427
novel	O	2427
germ	O	2427
line	O	2427
mutations	O	2427
resulting	O	2427
in	O	2427
stop	O	2427
codons	O	2427
or	O	2427
frameshifts	O	2427
.	O	2427
the	O	2428
results	O	2428
reported	O	2428
here	O	2428
indicate	O	2428
that	O	2428
(	O	2428
1	O	2428
)	O	2428
familial	B-Disease	2428
adenomatous	I-Disease	2428
polyposis	I-Disease	2428
is	O	2428
caused	O	2428
by	O	2428
an	O	2428
extremely	O	2428
heterogeneous	O	2428
spectrum	O	2428
of	O	2428
point	O	2428
mutations	O	2428
;	O	2428
(	O	2428
2	O	2428
)	O	2428
all	O	2428
the	O	2428
mutations	O	2428
found	O	2428
in	O	2428
this	O	2428
study	O	2428
are	O	2428
chain	O	2428
terminating	O	2428
;	O	2428
and	O	2428
(	O	2428
3	O	2428
)	O	2428
dgge	O	2428
represents	O	2428
a	O	2428
rapid	O	2428
and	O	2428
sensitive	O	2428
technique	O	2428
for	O	2428
the	O	2428
detection	O	2428
of	O	2428
mutations	O	2428
in	O	2428
the	O	2428
unusually	O	2428
large	O	2428
apc	B-Disease	2428
gene	O	2428
.	O	2428
on	O	2430
the	O	2430
other	O	2430
hand	O	2430
,	O	2430
the	O	2430
occurrence	O	2430
of	O	2430
an	O	2430
extremely	O	2430
heterogeneous	O	2430
spectrum	O	2430
of	O	2430
mutations	O	2430
spread	O	2430
throughout	O	2430
the	O	2430
entire	O	2430
length	O	2430
of	O	2430
the	O	2430
large	O	2430
apc	B-Disease	2430
gene	O	2430
among	O	2430
the	O	2430
fap	B-Disease	2430
patients	O	2430
indicates	O	2430
that	O	2430
this	O	2430
approach	O	2430
may	O	2430
not	O	2430
be	O	2430
useful	O	2430
as	O	2430
a	O	2430
rapid	O	2430
presymptomatic	O	2430
diagnostic	O	2430
procedure	O	2430
in	O	2430
a	O	2430
routine	O	2430
laboratory	O	2430
.	O	2430
such	O	2432
intragenic	O	2432
polymorphisms	O	2432
offer	O	2432
a	O	2432
practical	O	2432
approach	O	2432
to	O	2432
a	O	2432
more	O	2432
rapid	O	2432
procedure	O	2432
for	O	2432
presymptomatic	O	2432
diagnosis	O	2432
of	O	2432
fap	B-Disease	2432
by	O	2432
linkage	O	2432
analysis	O	2432
in	O	2432
informative	O	2432
families	O	2432
.	O	2432
.	O	2432
yeast	O	2433
artificial	O	2433
chromosomes	O	2433
for	O	2433
the	O	2433
molecular	O	2433
analysis	O	2433
of	O	2433
the	O	2433
familial	B-Disease	2433
polyposis	I-Disease	2433
apc	I-Disease	2433
gene	O	2433
region	O	2433
.	O	2433
1	O	2435
megabase	O	2435
pairs	O	2435
of	O	2435
dna	O	2435
around	O	2435
the	O	2435
mcc	O	2435
(	O	2435
for	O	2435
mutated	O	2435
in	O	2435
colorectal	B-Disease	2435
carcinoma	I-Disease	2435
)	O	2435
and	O	2435
apc	B-Disease	2435
(	O	2435
for	O	2435
adenomatous	B-Disease	2435
polyposis	I-Disease	2435
coli	I-Disease	2435
)	O	2435
genes	O	2435
at	O	2435
5q21	O	2435
have	O	2435
been	O	2435
isolated	O	2435
and	O	2435
characterized	O	2435
.	O	2435
starting	O	2436
from	O	2436
the	O	2436
mcc	O	2436
gene	O	2436
,	O	2436
a	O	2436
strategy	O	2436
was	O	2436
undertaken	O	2436
to	O	2436
identify	O	2436
constitutional	O	2436
submicroscopic	O	2436
deletions	O	2436
in	O	2436
familial	B-Disease	2436
adenomatous	I-Disease	2436
polyposis	I-Disease	2436
patients	O	2436
that	O	2436
might	O	2436
considerably	O	2436
narrow	O	2436
down	O	2436
the	O	2436
position	O	2436
of	O	2436
the	O	2436
apc	B-Disease	2436
gene	O	2436
.	O	2436
this	O	2439
screening	O	2439
approach	O	2439
led	O	2439
to	O	2439
the	O	2439
confirmation	O	2439
of	O	2439
a	O	2439
small	O	2439
heterozygous	O	2439
deletion	O	2439
in	O	2439
a	O	2439
polyposis	B-Disease	2439
patient	O	2439
that	O	2439
overlaps	O	2439
one	O	2439
of	O	2439
the	O	2439
two	O	2439
isolated	O	2439
yacs	O	2439
.	O	2439
this	O	2440
yac	O	2440
has	O	2440
been	O	2440
shown	O	2440
to	O	2440
contain	O	2440
the	O	2440
entire	O	2440
apc	B-Disease	2440
gene	O	2440
,	O	2440
in	O	2440
addition	O	2440
to	O	2440
a	O	2440
significant	O	2440
portion	O	2440
of	O	2440
dna	O	2440
flanking	O	2440
the	O	2440
5	O	2440
end	O	2440
of	O	2440
the	O	2440
gene	O	2440
,	O	2440
and	O	2440
should	O	2440
therefore	O	2440
prove	O	2440
a	O	2440
valuable	O	2440
resource	O	2440
for	O	2440
functional	O	2440
studies	O	2440
by	O	2440
transfer	O	2440
to	O	2440
colorectal	B-Disease	2440
tumor	I-Disease	2440
-	O	2440
derived	O	2440
cell	O	2440
lines	O	2440
.	O	2440
inherited	O	2441
wt1	O	2441
mutation	O	2441
in	O	2441
denys	B-Disease	2441
-	I-Disease	2441
drash	I-Disease	2441
syndrome	I-Disease	2441
.	O	2441
patients	O	2442
with	O	2442
the	O	2442
denys	B-Disease	2442
-	I-Disease	2442
drash	I-Disease	2442
syndrome	I-Disease	2442
(	O	2442
wilms	B-Disease	2442
tumor	I-Disease	2442
,	O	2442
genital	B-Disease	2442
anomalies	I-Disease	2442
,	O	2442
and	O	2442
nephropathy	B-Disease	2442
)	O	2442
have	O	2442
been	O	2442
demonstrated	O	2442
to	O	2442
carry	O	2442
de	O	2442
novo	O	2442
constitutional	O	2442
mutations	O	2442
in	O	2442
wt1	O	2442
,	O	2442
the	O	2442
wilms	B-Disease	2442
tumor	I-Disease	2442
gene	O	2442
at	O	2442
chromosome	O	2442
11p13	O	2442
.	O	2442
this	O	2445
observation	O	2445
indicates	O	2445
that	O	2445
the	O	2445
wt1	O	2445
exon	O	2445
9	O	2445
mutation	O	2445
affecting	O	2445
394arg	O	2445
demonstrated	O	2445
in	O	2445
over	O	2445
one	O	2445
-	O	2445
half	O	2445
of	O	2445
the	O	2445
patients	O	2445
with	O	2445
the	O	2445
denys	B-Disease	2445
-	I-Disease	2445
drash	I-Disease	2445
syndrome	I-Disease	2445
may	O	2445
exhibit	O	2445
incomplete	O	2445
penetrance	O	2445
.	O	2445
submicroscopic	O	2447
deletions	O	2447
at	O	2447
the	O	2447
wagr	B-Disease	2447
locus	O	2447
,	O	2447
revealed	O	2447
by	O	2447
nonradioactive	O	2447
in	O	2447
situ	O	2447
hybridization	O	2447
.	O	2447
fluorescence	O	2448
in	O	2448
situ	O	2448
hybridization	O	2448
(	O	2448
fish	O	2448
)	O	2448
with	O	2448
biotin	O	2448
-	O	2448
labeled	O	2448
probes	O	2448
mapping	O	2448
to	O	2448
11p13	O	2448
has	O	2448
been	O	2448
used	O	2448
for	O	2448
the	O	2448
molecular	O	2448
analysis	O	2448
of	O	2448
deletions	O	2448
of	O	2448
the	O	2448
wagr	B-Disease	2448
(	O	2448
wilms	B-Disease	2448
tumor	I-Disease	2448
,	O	2448
aniridia	B-Disease	2448
,	O	2448
genitourinary	B-Disease	2448
abnormalities	I-Disease	2448
,	O	2448
and	O	2448
mental	B-Disease	2448
retardation	I-Disease	2448
)	O	2448
locus	O	2448
.	O	2448
we	O	2449
have	O	2449
detected	O	2449
a	O	2449
submicroscopic	O	2449
11p13	O	2449
deletion	O	2449
in	O	2449
a	O	2449
child	O	2449
with	O	2449
inherited	O	2449
aniridia	B-Disease	2449
who	O	2449
subsequently	O	2449
presented	O	2449
with	O	2449
wilms	B-Disease	2449
tumor	I-Disease	2449
in	O	2449
a	O	2449
horseshoe	O	2449
kidney	O	2449
,	O	2449
only	O	2449
revealed	O	2449
at	O	2449
surgery	O	2449
.	O	2449
the	O	2450
mother	O	2450
,	O	2450
who	O	2450
has	O	2450
aniridia	B-Disease	2450
,	O	2450
was	O	2450
also	O	2450
found	O	2450
to	O	2450
carry	O	2450
a	O	2450
deletion	O	2450
including	O	2450
both	O	2450
the	O	2450
aniridia	B-Disease	2450
candidate	O	2450
gene	O	2450
(	O	2450
an2	O	2450
)	O	2450
and	O	2450
the	O	2450
wilms	B-Disease	2450
tumor	I-Disease	2450
predisposition	O	2450
gene	O	2450
(	O	2450
wt1	O	2450
)	O	2450
.	O	2450
this	O	2451
is	O	2451
therefore	O	2451
a	O	2451
rare	O	2451
case	O	2451
of	O	2451
an	O	2451
inherited	O	2451
wagr	B-Disease	2451
deletion	O	2451
.	O	2451
wilms	B-Disease	2452
tumor	I-Disease	2452
has	O	2452
so	O	2452
far	O	2452
only	O	2452
been	O	2452
associated	O	2452
with	O	2452
sporadic	O	2452
de	O	2452
novo	O	2452
aniridia	B-Disease	2452
cases	O	2452
.	O	2452
we	O	2453
have	O	2453
shown	O	2453
that	O	2453
a	O	2453
cosmid	O	2453
probe	O	2453
for	O	2453
a	O	2453
candidate	O	2453
aniridia	B-Disease	2453
gene	O	2453
,	O	2453
homologous	O	2453
to	O	2453
the	O	2453
mouse	O	2453
pax	O	2453
-	O	2453
6	O	2453
gene	O	2453
,	O	2453
is	O	2453
deleted	O	2453
in	O	2453
cell	O	2453
lines	O	2453
from	O	2453
aniridia	B-Disease	2453
patients	O	2453
with	O	2453
previously	O	2453
characterized	O	2453
deletions	O	2453
at	O	2453
11p13	O	2453
,	O	2453
while	O	2453
another	O	2453
cosmid	O	2453
marker	O	2453
mapping	O	2453
between	O	2453
two	O	2453
aniridia	B-Disease	2453
-	O	2453
associated	O	2453
translocation	O	2453
breakpoints	O	2453
(	O	2453
and	O	2453
hence	O	2453
a	O	2453
second	O	2453
candidate	O	2453
marker	O	2453
)	O	2453
is	O	2453
present	O	2453
on	O	2453
both	O	2453
chromosomes	O	2453
.	O	2453
linkage	O	2457
of	O	2457
gene	O	2457
for	O	2457
c2	B-Disease	2457
deficiency	I-Disease	2457
and	O	2457
the	O	2457
major	O	2457
histocompatibility	O	2457
complex	O	2457
mhc	O	2457
in	O	2457
man	O	2457
.	O	2457
close	O	2459
linkage	O	2459
between	O	2459
hl	O	2459
-	O	2459
a	O	2459
and	O	2459
c2	B-Disease	2459
deficiency	I-Disease	2459
was	O	2459
first	O	2459
reported	O	2459
by	O	2459
fu	O	2459
and	O	2459
co	O	2459
-	O	2459
workers	O	2459
in	O	2459
1974	O	2459
.	O	2459
we	O	2460
present	O	2460
here	O	2460
a	O	2460
pedigree	O	2460
of	O	2460
a	O	2460
31	O	2460
-	O	2460
year	O	2460
-	O	2460
old	O	2460
c2	B-Disease	2460
-	I-Disease	2460
deficient	I-Disease	2460
individual	O	2460
with	O	2460
clinical	O	2460
manifestations	O	2460
of	O	2460
hodgkins	B-Disease	2460
disease	I-Disease	2460
.	O	2460
in	O	2462
addition	O	2462
to	O	2462
close	O	2462
linkage	O	2462
between	O	2462
hl	O	2462
-	O	2462
a	O	2462
and	O	2462
c2	B-Disease	2462
deficiency	I-Disease	2462
,	O	2462
both	O	2462
parents	O	2462
were	O	2462
heterozygous	O	2462
for	O	2462
bf	O	2462
(	O	2462
hl	O	2462
-	O	2462
a	O	2462
linked	O	2462
,	O	2462
electrophoretic	O	2462
variation	O	2462
of	O	2462
b	O	2462
)	O	2462
.	O	2462
the	O	2463
two	O	2463
hl	O	2463
-	O	2463
a	O	2463
haplotypes	O	2463
closely	O	2463
linked	O	2463
to	O	2463
c2	B-Disease	2463
deficiency	I-Disease	2463
are	O	2463
different	O	2463
2	O	2463
,	O	2463
w18	O	2463
and	O	2463
w24	O	2463
,	O	2463
w18	O	2463
.	O	2463
screening	O	2465
for	O	2465
germ	O	2465
-	O	2465
line	O	2465
mutations	O	2465
in	O	2465
familial	B-Disease	2465
adenomatous	I-Disease	2465
polyposis	I-Disease	2465
patients	O	2465
:	O	2465
61	O	2465
new	O	2465
patients	O	2465
and	O	2465
a	O	2465
summary	O	2465
of	O	2465
150	O	2465
unrelated	O	2465
patients	O	2465
.	O	2465
we	O	2466
report	O	2466
here	O	2466
the	O	2466
result	O	2466
of	O	2466
a	O	2466
screening	O	2466
for	O	2466
germ	O	2466
-	O	2466
line	O	2466
mutations	O	2466
in	O	2466
the	O	2466
adenomatous	B-Disease	2466
polyposis	I-Disease	2466
coli	I-Disease	2466
(	O	2466
apc	B-Disease	2466
)	O	2466
gene	O	2466
in	O	2466
61	O	2466
new	O	2466
familial	B-Disease	2466
adenomatous	I-Disease	2466
polyposis	I-Disease	2466
(	O	2466
fap	B-Disease	2466
)	O	2466
patients	O	2466
as	O	2466
well	O	2466
as	O	2466
a	O	2466
summary	O	2466
of	O	2466
the	O	2466
results	O	2466
of	O	2466
150	O	2466
patients	O	2466
.	O	2466
examination	O	2467
of	O	2467
the	O	2467
entire	O	2467
coding	O	2467
region	O	2467
of	O	2467
the	O	2467
apc	B-Disease	2467
gene	O	2467
,	O	2467
based	O	2467
on	O	2467
a	O	2467
ribonuclease	O	2467
protection	O	2467
assay	O	2467
coupled	O	2467
with	O	2467
the	O	2467
polymerase	O	2467
chain	O	2467
reaction	O	2467
(	O	2467
pcr	O	2467
)	O	2467
,	O	2467
disclosed	O	2467
mutations	O	2467
that	O	2467
were	O	2467
considered	O	2467
to	O	2467
cause	O	2467
significant	O	2467
defects	O	2467
in	O	2467
the	O	2467
apc	B-Disease	2467
product	O	2467
in	O	2467
97	O	2467
of	O	2467
150	O	2467
unrelated	O	2467
fap	B-Disease	2467
patients	O	2467
.	O	2467
our	O	2468
findings	O	2468
revealed	O	2468
the	O	2468
following	O	2468
characteristics	O	2468
of	O	2468
the	O	2468
germ	O	2468
-	O	2468
line	O	2468
mutations	O	2468
of	O	2468
apc	O	2468
1	O	2468
)	O	2468
the	O	2468
great	O	2468
majority	O	2468
of	O	2468
the	O	2468
mutations	O	2468
were	O	2468
found	O	2468
to	O	2468
truncate	O	2468
the	O	2468
apc	B-Disease	2468
product	O	2468
;	O	2468
2	O	2468
)	O	2468
almost	O	2468
all	O	2468
of	O	2468
the	O	2468
mutations	O	2468
were	O	2468
located	O	2468
within	O	2468
the	O	2468
first	O	2468
half	O	2468
of	O	2468
the	O	2468
coding	O	2468
region	O	2468
;	O	2468
3	O	2468
)	O	2468
no	O	2468
correlation	O	2468
was	O	2468
observed	O	2468
between	O	2468
the	O	2468
locations	O	2468
of	O	2468
germ	O	2468
-	O	2468
line	O	2468
mutations	O	2468
and	O	2468
extracolonic	O	2468
manifestations	O	2468
in	O	2468
fap	B-Disease	2468
patients	O	2468
;	O	2468
4	O	2468
)	O	2468
more	O	2468
than	O	2468
80	O	2468
%	O	2468
of	O	2468
base	O	2468
substitutions	O	2468
in	O	2468
the	O	2468
apc	B-Disease	2468
gene	O	2468
were	O	2468
from	O	2468
cytosine	O	2468
to	O	2468
other	O	2468
nucleotides	O	2468
,	O	2468
nearly	O	2468
one	O	2468
-	O	2468
third	O	2468
of	O	2468
which	O	2468
occurred	O	2468
at	O	2468
the	O	2468
gpg	O	2468
site	O	2468
.	O	2468
our	O	2469
results	O	2469
provide	O	2469
information	O	2469
helpful	O	2469
to	O	2469
an	O	2469
understanding	O	2469
of	O	2469
the	O	2469
apc	B-Disease	2469
gene	O	2469
and	O	2469
will	O	2469
also	O	2469
contribute	O	2469
to	O	2469
presymptomatic	O	2469
diagnosis	O	2469
of	O	2469
members	O	2469
in	O	2469
fap	B-Disease	2469
families	O	2469
.	O	2469
.	O	2469
somatic	O	2470
mutations	O	2470
of	O	2470
the	O	2470
apc	B-Disease	2470
gene	O	2470
in	O	2470
colorectal	B-Disease	2470
tumors	I-Disease	2470
:	O	2470
mutation	O	2470
cluster	O	2470
region	O	2470
in	O	2470
the	O	2470
apc	B-Disease	2470
gene	O	2470
.	O	2470
we	O	2471
examined	O	2471
somatic	O	2471
mutations	O	2471
of	O	2471
the	O	2471
adenomatous	B-Disease	2471
polyposis	I-Disease	2471
coli	I-Disease	2471
(	O	2471
apc	B-Disease	2471
)	O	2471
gene	O	2471
in	O	2471
63	O	2471
colorectal	B-Disease	2471
tumors	I-Disease	2471
(	O	2471
16	O	2471
adenomas	B-Disease	2471
and	O	2471
47	O	2471
carcinomas	B-Disease	2471
)	O	2471
developed	O	2471
in	O	2471
familial	B-Disease	2471
adenomatous	I-Disease	2471
polyposis	I-Disease	2471
(	O	2471
fap	B-Disease	2471
)	O	2471
and	O	2471
non	O	2471
-	O	2471
fap	O	2471
patients	O	2471
.	O	2471
in	O	2472
addition	O	2472
to	O	2472
loss	O	2472
of	O	2472
heterozygosity	O	2472
(	O	2472
loh	O	2472
)	O	2472
at	O	2472
the	O	2472
apc	B-Disease	2472
locus	O	2472
in	O	2472
30	O	2472
tumors	B-Disease	2472
,	O	2472
43	O	2472
other	O	2472
somatic	O	2472
mutations	O	2472
were	O	2472
detected	O	2472
.	O	2472
twenty	O	2474
-	O	2474
two	O	2474
tumors	B-Disease	2474
had	O	2474
frameshift	O	2474
mutations	O	2474
due	O	2474
to	O	2474
deletion	O	2474
or	O	2474
insertion	O	2474
;	O	2474
nineteen	O	2474
of	O	2474
them	O	2474
were	O	2474
deletions	O	2474
of	O	2474
one	O	2474
to	O	2474
31	O	2474
bp	O	2474
and	O	2474
three	O	2474
were	O	2474
a	O	2474
1	O	2474
-	O	2474
bp	O	2474
insertion	O	2474
.	O	2474
one	O	2475
tumor	B-Disease	2475
had	O	2475
a	O	2475
1	O	2475
-	O	2475
bp	O	2475
deletion	O	2475
in	O	2475
an	O	2475
intron	O	2475
near	O	2475
the	O	2475
splicing	O	2475
site	O	2475
.	O	2475
hence	O	2476
,	O	2476
41	O	2476
(	O	2476
95	O	2476
%	O	2476
)	O	2476
of	O	2476
43	O	2476
mutations	O	2476
resulted	O	2476
in	O	2476
truncation	O	2476
of	O	2476
the	O	2476
apc	B-Disease	2476
protein	O	2476
.	O	2476
over	O	2477
60	O	2477
%	O	2477
of	O	2477
the	O	2477
somatic	O	2477
mutations	O	2477
in	O	2477
the	O	2477
apc	B-Disease	2477
gene	O	2477
were	O	2477
clustered	O	2477
within	O	2477
a	O	2477
small	O	2477
region	O	2477
of	O	2477
exon	O	2477
15	O	2477
,	O	2477
designated	O	2477
as	O	2477
mcr	O	2477
(	O	2477
mutation	O	2477
cluster	O	2477
region	O	2477
)	O	2477
,	O	2477
which	O	2477
accounted	O	2477
for	O	2477
less	O	2477
than	O	2477
10	O	2477
%	O	2477
of	O	2477
the	O	2477
coding	O	2477
region	O	2477
.	O	2477
combining	O	2478
these	O	2478
data	O	2478
and	O	2478
the	O	2478
results	O	2478
of	O	2478
loh	O	2478
,	O	2478
more	O	2478
than	O	2478
80	O	2478
%	O	2478
of	O	2478
tumors	B-Disease	2478
(	O	2478
14	O	2478
adenomas	B-Disease	2478
and	O	2478
39	O	2478
carcinomas	B-Disease	2478
)	O	2478
had	O	2478
at	O	2478
least	O	2478
one	O	2478
mutation	O	2478
in	O	2478
the	O	2478
apc	B-Disease	2478
gene	O	2478
,	O	2478
of	O	2478
which	O	2478
more	O	2478
than	O	2478
60	O	2478
%	O	2478
(	O	2478
9	O	2478
adenomas	B-Disease	2478
and	O	2478
23	O	2478
carcinomas	B-Disease	2478
)	O	2478
had	O	2478
two	O	2478
mutations	O	2478
.	O	2478
these	O	2479
results	O	2479
strongly	O	2479
suggest	O	2479
that	O	2479
somatic	O	2479
mutations	O	2479
of	O	2479
the	O	2479
apc	B-Disease	2479
gene	O	2479
are	O	2479
associated	O	2479
with	O	2479
development	O	2479
of	O	2479
a	O	2479
great	O	2479
majority	O	2479
of	O	2479
colorectal	B-Disease	2479
tumors	I-Disease	2479
.	O	2479
.	O	2479
constitutional	O	2480
mutations	O	2480
in	O	2480
the	O	2480
wt1	O	2480
gene	O	2480
in	O	2480
patients	O	2480
with	O	2480
denys	B-Disease	2480
-	I-Disease	2480
drash	I-Disease	2480
syndrome	I-Disease	2480
.	O	2480
the	O	2481
denys	B-Disease	2481
-	I-Disease	2481
drash	I-Disease	2481
syndrome	I-Disease	2481
is	O	2481
characterised	O	2481
by	O	2481
a	O	2481
typical	O	2481
nephropathy	B-Disease	2481
,	O	2481
genital	B-Disease	2481
abnormalities	I-Disease	2481
and	O	2481
also	O	2481
predisposes	O	2481
to	O	2481
the	O	2481
development	O	2481
of	O	2481
wilms	B-Disease	2481
tumor	I-Disease	2481
.	O	2481
these	O	2482
patients	O	2482
eventually	O	2482
go	O	2482
into	O	2482
end	O	2482
stage	O	2482
renal	B-Disease	2482
failure	I-Disease	2482
.	O	2482
a	O	2483
candidate	O	2483
wilms	B-Disease	2483
tumor	I-Disease	2483
gene	O	2483
,	O	2483
wt1	O	2483
,	O	2483
from	O	2483
the	O	2483
11p13	O	2483
chromosome	O	2483
region	O	2483
has	O	2483
recently	O	2483
been	O	2483
cloned	O	2483
.	O	2483
linkage	O	2494
disequilibrium	O	2494
mapping	O	2494
in	O	2494
isolated	O	2494
founder	O	2494
populations	O	2494
:	O	2494
diastrophic	B-Disease	2494
dysplasia	I-Disease	2494
in	O	2494
finland	O	2494
.	O	2494
using	O	2497
these	O	2497
methods	O	2497
,	O	2497
we	O	2497
report	O	2497
striking	O	2497
linkage	O	2497
disequilibrium	O	2497
for	O	2497
diastrophic	B-Disease	2497
dysplasia	I-Disease	2497
(	O	2497
dtd	B-Disease	2497
)	O	2497
in	O	2497
finland	O	2497
indicating	O	2497
that	O	2497
the	O	2497
dtd	B-Disease	2497
gene	O	2497
should	O	2497
lie	O	2497
within	O	2497
0	O	2497
.	O	2497
the	O	2500
wiskott	B-Disease	2500
-	I-Disease	2500
aldrich	I-Disease	2500
syndrome	I-Disease	2500
:	O	2500
refinement	O	2500
of	O	2500
the	O	2500
localization	O	2500
on	O	2500
xp	O	2500
and	O	2500
identification	O	2500
of	O	2500
another	O	2500
closely	O	2500
linked	O	2500
marker	O	2500
locus	O	2500
,	O	2500
oatl1	O	2500
.	O	2500
the	O	2501
wiskott	B-Disease	2501
-	I-Disease	2501
aldrich	I-Disease	2501
syndrome	I-Disease	2501
(	O	2501
was	B-Disease	2501
)	O	2501
has	O	2501
previously	O	2501
been	O	2501
mapped	O	2501
to	O	2501
the	O	2501
proximal	O	2501
short	O	2501
arm	O	2501
of	O	2501
the	O	2501
x	O	2501
chromosome	O	2501
between	O	2501
the	O	2501
dxs14	O	2501
and	O	2501
dxs7	O	2501
loci	O	2501
.	O	2501
in	O	2502
this	O	2502
study	O	2502
,	O	2502
further	O	2502
segregation	O	2502
analysis	O	2502
has	O	2502
been	O	2502
performed	O	2502
using	O	2502
a	O	2502
newly	O	2502
identified	O	2502
was	B-Disease	2502
family	O	2502
as	O	2502
well	O	2502
as	O	2502
an	O	2502
additional	O	2502
marker	O	2502
probe	O	2502
,	O	2502
hoatl1	O	2502
.	O	2502
the	O	2503
results	O	2503
indicate	O	2503
close	O	2503
linkage	O	2503
between	O	2503
the	O	2503
was	B-Disease	2503
and	O	2503
oatl1	O	2503
loci	O	2503
(	O	2503
z	O	2503
=	O	2503
6	O	2503
.	O	2503
08	O	2503
at	O	2503
theta	O	2503
=	O	2503
0	O	2503
.	O	2503
00	O	2503
)	O	2503
and	O	2503
localize	O	2503
the	O	2503
timp	O	2503
,	O	2503
oatl1	O	2503
,	O	2503
dxs255	O	2503
,	O	2503
and	O	2503
was	B-Disease	2503
loci	O	2503
distal	O	2503
to	O	2503
dxs146	O	2503
and	O	2503
the	O	2503
oatl1	O	2503
and	O	2503
was	B-Disease	2503
loci	O	2503
proximal	O	2503
to	O	2503
timp	O	2503
.	O	2503
these	O	2504
linkage	O	2504
data	O	2504
narrow	O	2504
the	O	2504
boundaries	O	2504
within	O	2504
which	O	2504
the	O	2504
was	B-Disease	2504
locus	O	2504
maps	O	2504
to	O	2504
the	O	2504
chromosomal	O	2504
region	O	2504
bracketed	O	2504
by	O	2504
timp	O	2504
and	O	2504
dxs146	O	2504
and	O	2504
support	O	2504
the	O	2504
loci	O	2504
order	O	2504
xpter	O	2504
-	O	2504
dxs7	O	2504
-	O	2504
timp	O	2504
-	O	2504
(	O	2504
oatl1	O	2504
,	O	2504
was	O	2504
,	O	2504
dxs255	O	2504
)	O	2504
-	O	2504
dxs146	O	2504
.	O	2504
detection	O	2505
of	O	2505
an	O	2505
unstable	O	2505
fragment	O	2505
of	O	2505
dna	O	2505
specific	O	2505
to	O	2505
individuals	O	2505
with	O	2505
myotonic	B-Disease	2505
dystrophy	I-Disease	2505
.	O	2505
myotonic	B-Disease	2506
dystrophy	I-Disease	2506
(	O	2506
dm	B-Disease	2506
)	O	2506
is	O	2506
the	O	2506
most	O	2506
common	O	2506
form	O	2506
of	O	2506
adult	O	2506
muscular	B-Disease	2506
dystrophy	I-Disease	2506
,	O	2506
with	O	2506
a	O	2506
prevalence	O	2506
of	O	2506
2	O	2506
-	O	2506
14	O	2506
per	O	2506
100	O	2506
,	O	2506
000	O	2506
individuals	O	2506
.	O	2506
the	O	2507
disease	O	2507
is	O	2507
characterized	O	2507
by	O	2507
progressive	O	2507
muscle	B-Disease	2507
weakness	I-Disease	2507
and	O	2507
sustained	B-Disease	2507
muscle	I-Disease	2507
contraction	I-Disease	2507
,	O	2507
often	O	2507
with	O	2507
a	O	2507
wide	O	2507
range	O	2507
of	O	2507
accompanying	O	2507
symptoms	O	2507
.	O	2507
it	O	2511
is	O	2511
flanked	O	2511
by	O	2511
the	O	2511
tightly	O	2511
linked	O	2511
genetic	O	2511
markers	O	2511
ercc1	O	2511
proximally	O	2511
and	O	2511
d19s51	O	2511
distally	O	2511
;	O	2511
these	O	2511
define	O	2511
the	O	2511
dm	B-Disease	2511
critical	O	2511
region	O	2511
.	O	2511
we	O	2514
postulate	O	2514
that	O	2514
this	O	2514
unstable	O	2514
dna	O	2514
sequence	O	2514
is	O	2514
the	O	2514
molecular	O	2514
feature	O	2514
that	O	2514
underlies	O	2514
dm	B-Disease	2514
.	O	2514
to	O	2517
learn	O	2517
about	O	2517
causative	O	2517
mechanisms	O	2517
,	O	2517
we	O	2517
have	O	2517
cloned	O	2517
and	O	2517
sequenced	O	2517
the	O	2517
breakpoints	O	2517
of	O	2517
a	O	2517
cytologically	O	2517
balanced	O	2517
constitutional	O	2517
reciprocal	O	2517
translocation	O	2517
,	O	2517
t	O	2517
(	O	2517
x	O	2517
;	O	2517
4	O	2517
)	O	2517
(	O	2517
p21	O	2517
.	O	2517
2	O	2517
;	O	2517
q31	O	2517
.	O	2517
22	O	2517
)	O	2517
,	O	2517
present	O	2517
in	O	2517
a	O	2517
girl	O	2517
with	O	2517
duchenne	B-Disease	2517
muscular	I-Disease	2517
dystrophy	I-Disease	2517
(	O	2517
dmd	B-Disease	2517
)	O	2517
.	O	2517
physical	O	2518
mapping	O	2518
of	O	2518
the	O	2518
derivative	O	2518
chromosomes	O	2518
,	O	2518
after	O	2518
their	O	2518
separation	O	2518
in	O	2518
somatic	O	2518
cell	O	2518
hybrids	O	2518
,	O	2518
reveals	O	2518
that	O	2518
the	O	2518
translocation	O	2518
disrupts	O	2518
the	O	2518
dmd	B-Disease	2518
gene	O	2518
in	O	2518
xp21	O	2518
within	O	2518
the	O	2518
18	O	2518
-	O	2518
kb	O	2518
intron	O	2518
16	O	2518
.	O	2518
a	O	2525
genetic	O	2525
etiology	O	2525
for	O	2525
digeorge	B-Disease	2525
syndrome	I-Disease	2525
:	O	2525
consistent	O	2525
deletions	O	2525
and	O	2525
microdeletions	O	2525
of	O	2525
22q11	O	2525
.	O	2525
digeorge	B-Disease	2526
syndrome	I-Disease	2526
(	O	2526
dgs	B-Disease	2526
)	O	2526
,	O	2526
a	O	2526
developmental	O	2526
field	O	2526
defect	O	2526
of	O	2526
the	O	2526
third	O	2526
and	O	2526
fourth	O	2526
pharyngeal	O	2526
pouches	O	2526
,	O	2526
is	O	2526
characterized	O	2526
by	O	2526
aplasia	B-Disease	2526
or	I-Disease	2526
hypoplasia	I-Disease	2526
of	I-Disease	2526
the	I-Disease	2526
thymus	I-Disease	2526
and	I-Disease	2526
parathyroid	I-Disease	2526
glands	I-Disease	2526
and	O	2526
by	O	2526
conotruncal	B-Disease	2526
cardiac	I-Disease	2526
malformations	I-Disease	2526
.	O	2526
cytogenetic	O	2527
studies	O	2527
support	O	2527
the	O	2527
presence	O	2527
of	O	2527
a	O	2527
dgs	B-Disease	2527
critical	O	2527
region	O	2527
in	O	2527
band	O	2527
22q11	O	2527
.	O	2527
in	O	2528
the	O	2528
present	O	2528
study	O	2528
,	O	2528
we	O	2528
report	O	2528
the	O	2528
results	O	2528
of	O	2528
clinical	O	2528
,	O	2528
cytogenetic	O	2528
,	O	2528
and	O	2528
molecular	O	2528
studies	O	2528
of	O	2528
14	O	2528
patients	O	2528
with	O	2528
dgs	B-Disease	2528
.	O	2528
a	O	2533
third	O	2533
locus	O	2533
,	O	2533
d22s66	O	2533
,	O	2533
is	O	2533
deleted	O	2533
in	O	2533
the	O	2533
eight	O	2533
dgs	B-Disease	2533
probands	O	2533
tested	O	2533
.	O	2533
on	O	2537
the	O	2537
basis	O	2537
of	O	2537
these	O	2537
families	O	2537
,	O	2537
and	O	2537
of	O	2537
six	O	2537
maternally	O	2537
and	O	2537
five	O	2537
paternally	O	2537
derived	O	2537
unbalanced	O	2537
-	O	2537
translocation	O	2537
dgs	B-Disease	2537
probands	O	2537
in	O	2537
the	O	2537
literature	O	2537
,	O	2537
parent	O	2537
of	O	2537
origin	O	2537
or	O	2537
imprinting	O	2537
does	O	2537
not	O	2537
appear	O	2537
to	O	2537
play	O	2537
an	O	2537
important	O	2537
role	O	2537
in	O	2537
the	O	2537
pathogenesis	O	2537
of	O	2537
dgs	B-Disease	2537
.	O	2537
deletion	O	2538
of	O	2538
the	O	2538
same	O	2538
three	O	2538
loci	O	2538
in	O	2538
all	O	2538
14	O	2538
dgs	B-Disease	2538
probands	O	2538
begins	O	2538
to	O	2538
delineate	O	2538
the	O	2538
region	O	2538
of	O	2538
chromosome	O	2538
22	O	2538
critical	O	2538
for	O	2538
dgs	B-Disease	2538
and	O	2538
confirms	O	2538
the	O	2538
hypothesis	O	2538
that	O	2538
submicroscopic	O	2538
deletions	O	2538
of	O	2538
22q11	O	2538
are	O	2538
etiologic	O	2538
in	O	2538
the	O	2538
vast	O	2538
majority	O	2538
of	O	2538
cases	O	2538
.	O	2538
.	O	2538
loss	O	2539
of	O	2539
normal	O	2539
allele	O	2539
of	O	2539
the	O	2539
apc	B-Disease	2539
gene	O	2539
in	O	2539
an	O	2539
adrenocortical	B-Disease	2539
carcinoma	I-Disease	2539
from	O	2539
a	O	2539
patient	O	2539
with	O	2539
familial	B-Disease	2539
adenomatous	I-Disease	2539
polyposis	I-Disease	2539
.	O	2539
endocrine	B-Disease	2540
neoplasms	I-Disease	2540
have	O	2540
been	O	2540
reported	O	2540
occasionally	O	2540
in	O	2540
patients	O	2540
with	O	2540
familial	B-Disease	2540
adenomatous	I-Disease	2540
polyposis	I-Disease	2540
(	O	2540
fap	B-Disease	2540
)	O	2540
.	O	2540
an	O	2541
adrenocorotical	B-Disease	2541
carcinoma	I-Disease	2541
was	O	2541
studied	O	2541
in	O	2541
a	O	2541
patient	O	2541
with	O	2541
a	O	2541
family	O	2541
history	O	2541
of	O	2541
fap	B-Disease	2541
.	O	2541
loss	O	2542
of	O	2542
heterozygosity	O	2542
(	O	2542
loh	O	2542
)	O	2542
in	O	2542
the	O	2542
region	O	2542
close	O	2542
to	O	2542
the	O	2542
adenomatous	B-Disease	2542
polyposis	I-Disease	2542
coli	I-Disease	2542
(	O	2542
apc	B-Disease	2542
)	O	2542
gene	O	2542
was	O	2542
detected	O	2542
in	O	2542
this	O	2542
carcinoma	B-Disease	2542
,	O	2542
and	O	2542
evidence	O	2542
was	O	2542
obtained	O	2542
that	O	2542
there	O	2542
was	O	2542
a	O	2542
loss	O	2542
of	O	2542
the	O	2542
normal	O	2542
allele	O	2542
of	O	2542
the	O	2542
apc	B-Disease	2542
gene	O	2542
.	O	2542
this	O	2543
is	O	2543
the	O	2543
first	O	2543
demonstration	O	2543
of	O	2543
loh	O	2543
at	O	2543
the	O	2543
apc	B-Disease	2543
locus	O	2543
in	O	2543
adrenocortical	B-Disease	2543
tumors	I-Disease	2543
.	O	2543
the	O	2544
present	O	2544
results	O	2544
and	O	2544
our	O	2544
previous	O	2544
data	O	2544
on	O	2544
loh	O	2544
in	O	2544
a	O	2544
recurring	O	2544
desmoid	B-Disease	2544
tumor	I-Disease	2544
suggest	O	2544
that	O	2544
the	O	2544
heterozygous	O	2544
mutant	O	2544
/	O	2544
wild	O	2544
-	O	2544
type	O	2544
condition	O	2544
of	O	2544
the	O	2544
apc	B-Disease	2544
gene	O	2544
may	O	2544
give	O	2544
rise	O	2544
to	O	2544
benign	B-Disease	2544
tumors	I-Disease	2544
,	O	2544
and	O	2544
that	O	2544
functional	O	2544
loss	O	2544
of	O	2544
this	O	2544
gene	O	2544
leads	O	2544
to	O	2544
development	O	2544
of	O	2544
tumors	B-Disease	2544
not	O	2544
only	O	2544
in	O	2544
the	O	2544
colon	O	2544
but	O	2544
also	O	2544
in	O	2544
other	O	2544
various	O	2544
parts	O	2544
of	O	2544
the	O	2544
body	O	2544
in	O	2544
fap	B-Disease	2544
patients	O	2544
.	O	2544
.	O	2544
oncogenic	O	2545
point	O	2545
mutations	O	2545
in	O	2545
exon	O	2545
20	O	2545
of	O	2545
the	O	2545
rb1	O	2545
gene	O	2545
in	O	2545
families	O	2545
showing	O	2545
incomplete	O	2545
penetrance	O	2545
and	O	2545
mild	O	2545
expression	O	2545
of	O	2545
the	O	2545
retinoblastoma	B-Disease	2545
phenotype	O	2545
.	O	2545
the	O	2546
retinoblastoma	B-Disease	2546
-	O	2546
predisposition	O	2546
gene	O	2546
,	O	2546
rb1	O	2546
,	O	2546
segregates	O	2546
as	O	2546
an	O	2546
autosomal	O	2546
dominant	O	2546
trait	O	2546
with	O	2546
high	O	2546
(	O	2546
90	O	2546
%	O	2546
)	O	2546
penetrance	O	2546
.	O	2546
certain	O	2547
families	O	2547
,	O	2547
however	O	2547
,	O	2547
show	O	2547
an	O	2547
unusual	O	2547
low	O	2547
-	O	2547
penetrance	O	2547
phenotype	O	2547
with	O	2547
many	O	2547
individuals	O	2547
being	O	2547
unaffected	O	2547
,	O	2547
unilaterally	O	2547
affected	O	2547
,	O	2547
or	O	2547
with	O	2547
evidence	O	2547
of	O	2547
spontaneously	O	2547
regressed	O	2547
tumors	B-Disease	2547
.	O	2547
late	O	2554
-	O	2554
onset	O	2554
metachromatic	B-Disease	2554
leukodystrophy	I-Disease	2554
:	O	2554
molecular	O	2554
pathology	O	2554
in	O	2554
two	O	2554
siblings	O	2554
.	O	2554
we	O	2555
report	O	2555
on	O	2555
a	O	2555
new	O	2555
allele	O	2555
at	O	2555
the	O	2555
arylsulfatase	O	2555
a	O	2555
(	O	2555
arsa	O	2555
)	O	2555
locus	O	2555
causing	O	2555
late	O	2555
-	O	2555
onset	O	2555
metachromatic	B-Disease	2555
leukodystrophy	I-Disease	2555
(	O	2555
mld	B-Disease	2555
)	O	2555
.	O	2555
in	O	2557
contrast	O	2557
to	O	2557
alleles	O	2557
that	O	2557
cause	O	2557
early	O	2557
-	O	2557
onset	O	2557
mld	B-Disease	2557
,	O	2557
the	O	2557
arginine84	O	2557
to	O	2557
glutamine	O	2557
substitution	O	2557
is	O	2557
associated	O	2557
with	O	2557
some	O	2557
residual	O	2557
arsa	O	2557
activity	O	2557
.	O	2557
a	O	2558
comparison	O	2558
of	O	2558
genotypes	O	2558
,	O	2558
arsa	O	2558
activities	O	2558
,	O	2558
and	O	2558
clinical	O	2558
data	O	2558
on	O	2558
4	O	2558
individuals	O	2558
carrying	O	2558
the	O	2558
allele	O	2558
of	O	2558
81	O	2558
patients	O	2558
with	O	2558
mld	B-Disease	2558
examined	O	2558
,	O	2558
further	O	2558
validates	O	2558
the	O	2558
concept	O	2558
that	O	2558
different	O	2558
degrees	O	2558
of	O	2558
residual	O	2558
arsa	O	2558
activity	O	2558
are	O	2558
the	O	2558
basis	O	2558
of	O	2558
phenotypical	O	2558
variation	O	2558
in	O	2558
mld	B-Disease	2558
.	O	2558
.	O	2558
trisomy	B-Disease	2559
15	I-Disease	2559
with	O	2559
loss	O	2559
of	O	2559
the	O	2559
paternal	O	2559
15	O	2559
as	O	2559
a	O	2559
cause	O	2559
of	O	2559
prader	B-Disease	2559
-	I-Disease	2559
willi	I-Disease	2559
syndrome	I-Disease	2559
due	O	2559
to	O	2559
maternal	B-Disease	2559
disomy	I-Disease	2559
.	O	2559
uniparental	B-Disease	2560
disomy	I-Disease	2560
has	O	2560
recently	O	2560
been	O	2560
recognized	O	2560
to	O	2560
cause	O	2560
human	O	2560
disorders	O	2560
,	O	2560
including	O	2560
prader	B-Disease	2560
-	I-Disease	2560
willi	I-Disease	2560
syndrome	I-Disease	2560
(	O	2560
pws	B-Disease	2560
)	O	2560
.	O	2560
we	O	2561
describe	O	2561
a	O	2561
particularly	O	2561
instructive	O	2561
case	O	2561
which	O	2561
raises	O	2561
important	O	2561
issues	O	2561
concerning	O	2561
the	O	2561
mechanisms	O	2561
producing	O	2561
uniparental	B-Disease	2561
disomy	I-Disease	2561
and	O	2561
whose	O	2561
evaluation	O	2561
provides	O	2561
evidence	O	2561
that	O	2561
trisomy	O	2561
may	O	2561
precede	O	2561
uniparental	B-Disease	2561
disomy	I-Disease	2561
in	O	2561
a	O	2561
fetus	O	2561
.	O	2561
chorionic	O	2562
villus	O	2562
sampling	O	2562
performed	O	2562
for	O	2562
advanced	O	2562
maternal	O	2562
age	O	2562
revealed	O	2562
trisomy	B-Disease	2562
15	I-Disease	2562
in	O	2562
all	O	2562
direct	O	2562
and	O	2562
cultured	O	2562
cells	O	2562
,	O	2562
though	O	2562
the	O	2562
fetus	O	2562
appeared	O	2562
normal	O	2562
.	O	2562
the	O	2564
child	O	2564
was	O	2564
hypotonic	B-Disease	2564
at	O	2564
birth	O	2564
,	O	2564
and	O	2564
high	O	2564
-	O	2564
resolution	O	2564
banding	O	2564
failed	O	2564
to	O	2564
reveal	O	2564
the	O	2564
deletion	O	2564
of	O	2564
15q11	O	2564
-	O	2564
13	O	2564
,	O	2564
a	O	2564
deletion	O	2564
which	O	2564
is	O	2564
found	O	2564
in	O	2564
50	O	2564
%	O	2564
-	O	2564
70	O	2564
%	O	2564
of	O	2564
patients	O	2564
with	O	2564
pws	B-Disease	2564
.	O	2564
over	O	2565
time	O	2565
,	O	2565
typical	O	2565
features	O	2565
of	O	2565
pws	B-Disease	2565
developed	O	2565
.	O	2565
maternal	O	2567
nondisjunction	O	2567
with	O	2567
fertilization	O	2567
of	O	2567
a	O	2567
disomic	O	2567
egg	O	2567
by	O	2567
a	O	2567
normal	O	2567
sperm	O	2567
,	O	2567
followed	O	2567
by	O	2567
loss	O	2567
of	O	2567
the	O	2567
paternal	O	2567
15	O	2567
,	O	2567
is	O	2567
a	O	2567
likely	O	2567
cause	O	2567
of	O	2567
confined	O	2567
placental	O	2567
mosaicism	O	2567
and	O	2567
uniparental	B-Disease	2567
disomy	I-Disease	2567
in	O	2567
this	O	2567
case	O	2567
of	O	2567
pws	B-Disease	2567
,	O	2567
and	O	2567
advanced	O	2567
maternal	O	2567
age	O	2567
may	O	2567
be	O	2567
a	O	2567
predisposing	O	2567
factor	O	2567
.	O	2567
.	O	2567
genetic	O	2568
heterogeneity	O	2568
in	O	2568
x	B-Disease	2568
-	I-Disease	2568
linked	I-Disease	2568
amelogenesis	I-Disease	2568
imperfecta	I-Disease	2568
.	O	2568
3	O	2571
encodes	O	2571
for	O	2571
the	O	2571
enamel	O	2571
protein	O	2571
amelogenin	O	2571
and	O	2571
has	O	2571
been	O	2571
implicated	O	2571
as	O	2571
the	O	2571
gene	O	2571
responsible	O	2571
for	O	2571
the	O	2571
inherited	B-Disease	2571
dental	I-Disease	2571
abnormality	I-Disease	2571
x	B-Disease	2571
-	I-Disease	2571
linked	I-Disease	2571
amelogenesis	I-Disease	2571
imperfecta	I-Disease	2571
(	O	2571
xai	B-Disease	2571
)	O	2571
.	O	2571
three	O	2572
families	O	2572
with	O	2572
xai	B-Disease	2572
have	O	2572
been	O	2572
investigated	O	2572
using	O	2572
polymorphic	O	2572
dna	O	2572
markers	O	2572
flanking	O	2572
the	O	2572
position	O	2572
of	O	2572
amelx	O	2572
.	O	2572
using	O	2573
two	O	2573
-	O	2573
point	O	2573
linkage	O	2573
analysis	O	2573
,	O	2573
linkage	O	2573
was	O	2573
established	O	2573
between	O	2573
xai	B-Disease	2573
and	O	2573
several	O	2573
of	O	2573
these	O	2573
markers	O	2573
in	O	2573
two	O	2573
families	O	2573
,	O	2573
with	O	2573
a	O	2573
combined	O	2573
lod	O	2573
score	O	2573
of	O	2573
6	O	2573
.	O	2573
this	O	2576
supports	O	2576
the	O	2576
involvement	O	2576
of	O	2576
amelx	O	2576
,	O	2576
located	O	2576
close	O	2576
to	O	2576
dxs16	O	2576
,	O	2576
in	O	2576
the	O	2576
xai	B-Disease	2576
disease	I-Disease	2576
process	O	2576
(	O	2576
aih1	O	2576
)	O	2576
in	O	2576
those	O	2576
families	O	2576
.	O	2576
there	O	2581
was	O	2581
significant	O	2581
evidence	O	2581
against	O	2581
linkage	O	2581
to	O	2581
this	O	2581
region	O	2581
in	O	2581
the	O	2581
third	O	2581
family	O	2581
,	O	2581
indicating	O	2581
locus	O	2581
heterogeneity	O	2581
in	O	2581
xai	B-Disease	2581
.	O	2581
multiple	O	2588
origins	O	2588
for	O	2588
phenylketonuria	B-Disease	2588
in	O	2588
europe	O	2588
.	O	2588
phenylketonuria	B-Disease	2589
(	O	2589
pku	B-Disease	2589
)	O	2589
,	O	2589
a	O	2589
disorder	B-Disease	2589
of	I-Disease	2589
amino	I-Disease	2589
acid	I-Disease	2589
metabolism	I-Disease	2589
prevalent	O	2589
among	O	2589
caucasians	O	2589
and	O	2589
other	O	2589
ethnic	O	2589
groups	O	2589
,	O	2589
is	O	2589
caused	O	2589
primarily	O	2589
by	O	2589
a	O	2589
deficiency	B-Disease	2589
of	I-Disease	2589
the	I-Disease	2589
hepatic	I-Disease	2589
enzyme	I-Disease	2589
phenylalanine	I-Disease	2589
hydroxylase	I-Disease	2589
(	O	2589
pah	O	2589
)	O	2589
.	O	2589
pku	B-Disease	2590
is	O	2590
a	O	2590
highly	O	2590
heterogeneous	O	2590
disorder	O	2590
,	O	2590
with	O	2590
more	O	2590
than	O	2590
60	O	2590
molecular	O	2590
lesions	O	2590
identified	O	2590
in	O	2590
the	O	2590
pah	O	2590
gene	O	2590
.	O	2590
the	O	2591
haplotype	O	2591
associations	O	2591
,	O	2591
relative	O	2591
frequencies	O	2591
,	O	2591
and	O	2591
distributions	O	2591
of	O	2591
five	O	2591
prevalent	O	2591
pah	O	2591
mutations	O	2591
(	O	2591
r158q	O	2591
,	O	2591
r261q	O	2591
,	O	2591
ivs10nt546	O	2591
,	O	2591
r408w	O	2591
,	O	2591
and	O	2591
ivs12n1	O	2591
)	O	2591
were	O	2591
established	O	2591
in	O	2591
a	O	2591
comprehensive	O	2591
european	O	2591
sample	O	2591
population	O	2591
and	O	2591
subsequently	O	2591
were	O	2591
examined	O	2591
to	O	2591
determine	O	2591
the	O	2591
potential	O	2591
roles	O	2591
of	O	2591
several	O	2591
genetic	O	2591
mechanisms	O	2591
in	O	2591
explaining	O	2591
the	O	2591
present	O	2591
distribution	O	2591
of	O	2591
the	O	2591
major	O	2591
pku	B-Disease	2591
alleles	O	2591
.	O	2591
together	O	2595
,	O	2595
these	O	2595
data	O	2595
suggest	O	2595
that	O	2595
there	O	2595
were	O	2595
multiple	O	2595
,	O	2595
geographically	O	2595
and	O	2595
ethnically	O	2595
distinct	O	2595
origins	O	2595
for	O	2595
pku	B-Disease	2595
within	O	2595
the	O	2595
european	O	2595
population	O	2595
.	O	2595
.	O	2595
complement	B-Disease	2596
factor	I-Disease	2596
2	I-Disease	2596
deficiency	I-Disease	2596
:	O	2596
a	O	2596
clinical	O	2596
and	O	2596
serological	O	2596
family	O	2596
study	O	2596
.	O	2596
inherited	B-Disease	2597
complement	I-Disease	2597
deficiencies	I-Disease	2597
are	O	2597
associated	O	2597
with	O	2597
a	O	2597
variety	O	2597
of	O	2597
connective	O	2597
tissue	O	2597
diseases	O	2597
.	O	2597
a	O	2598
family	O	2598
with	O	2598
inherited	B-Disease	2598
deficiency	I-Disease	2598
of	I-Disease	2598
complement	I-Disease	2598
factor	I-Disease	2598
2	I-Disease	2598
(	O	2598
c2	O	2598
)	O	2598
is	O	2598
described	O	2598
in	O	2598
which	O	2598
two	O	2598
family	O	2598
members	O	2598
with	O	2598
homozygous	O	2598
c2	B-Disease	2598
deficiency	I-Disease	2598
developed	O	2598
cutaneous	B-Disease	2598
vasculitis	I-Disease	2598
and	O	2598
sicca	B-Disease	2598
syndrome	I-Disease	2598
.	O	2598
the	O	2599
other	O	2599
family	O	2599
members	O	2599
had	O	2599
heterozygous	O	2599
c2	B-Disease	2599
deficiency	I-Disease	2599
and	O	2599
each	O	2599
member	O	2599
had	O	2599
the	O	2599
hla	O	2599
-	O	2599
a25	O	2599
,	O	2599
b18	O	2599
,	O	2599
dr2	O	2599
(	O	2599
w15	O	2599
)	O	2599
haplotype	O	2599
.	O	2599
the	O	2600
mother	O	2600
had	O	2600
seropositive	B-Disease	2600
rheumatoid	I-Disease	2600
arthritis	I-Disease	2600
.	O	2600
new	O	2602
variant	O	2602
in	O	2602
exon	O	2602
3	O	2602
of	O	2602
the	O	2602
proteolipid	O	2602
protein	O	2602
(	O	2602
plp	O	2602
)	O	2602
gene	O	2602
in	O	2602
a	O	2602
family	O	2602
with	O	2602
pelizaeus	B-Disease	2602
-	I-Disease	2602
merzbacher	I-Disease	2602
disease	I-Disease	2602
.	O	2602
a	O	2603
c	O	2603
-	O	2603
-	O	2603
greater	O	2603
than	O	2603
g	O	2603
transversion	O	2603
has	O	2603
been	O	2603
found	O	2603
in	O	2603
exon	O	2603
3	O	2603
of	O	2603
the	O	2603
plp	O	2603
gene	O	2603
of	O	2603
affected	O	2603
males	O	2603
and	O	2603
their	O	2603
mother	O	2603
in	O	2603
a	O	2603
single	O	2603
sibship	O	2603
with	O	2603
pelizaeus	B-Disease	2603
-	I-Disease	2603
merzbacher	I-Disease	2603
disease	I-Disease	2603
(	O	2603
pmd	B-Disease	2603
)	O	2603
.	O	2603
the	O	2608
cause	O	2608
of	O	2608
disease	O	2608
in	O	2608
this	O	2608
family	O	2608
remains	O	2608
unknown	O	2608
,	O	2608
but	O	2608
the	O	2608
association	O	2608
between	O	2608
this	O	2608
rare	O	2608
mutation	O	2608
and	O	2608
pmd	B-Disease	2608
is	O	2608
intriguing	O	2608
.	O	2608
uncoupling	O	2610
of	O	2610
hypomyelination	B-Disease	2610
and	O	2610
glial	B-Disease	2610
cell	I-Disease	2610
death	I-Disease	2610
by	O	2610
a	O	2610
mutation	O	2610
in	O	2610
the	O	2610
proteolipid	O	2610
protein	O	2610
gene	O	2610
.	O	2610
neurological	O	2612
mutant	O	2612
mice	O	2612
can	O	2612
often	O	2612
provide	O	2612
model	O	2612
systems	O	2612
for	O	2612
human	O	2612
genetic	B-Disease	2612
disorders	I-Disease	2612
.	O	2612
mutations	O	2613
of	O	2613
the	O	2613
x	O	2613
-	O	2613
chromosome	O	2613
-	O	2613
linked	O	2613
plp	O	2613
gene	O	2613
are	O	2613
lethal	O	2613
,	O	2613
identified	O	2613
first	O	2613
in	O	2613
the	O	2613
jimpy	O	2613
mouse	O	2613
and	O	2613
subsequently	O	2613
in	O	2613
patients	O	2613
with	O	2613
pelizaeus	B-Disease	2613
-	I-Disease	2613
merzbacher	I-Disease	2613
disease	I-Disease	2613
.	O	2613
the	O	2614
unexplained	O	2614
phenotype	O	2614
of	O	2614
these	O	2614
mutations	O	2614
includes	O	2614
degeneration	B-Disease	2614
and	I-Disease	2614
premature	I-Disease	2614
cell	I-Disease	2614
death	I-Disease	2614
of	I-Disease	2614
oligodendrocytes	I-Disease	2614
with	O	2614
associated	O	2614
hypomyelination	B-Disease	2614
.	O	2614
surprisingly	O	2616
,	O	2616
rumpshaker	O	2616
mice	O	2616
,	O	2616
although	O	2616
myelin	B-Disease	2616
-	I-Disease	2616
deficient	I-Disease	2616
,	O	2616
have	O	2616
normal	O	2616
longevity	O	2616
and	O	2616
a	O	2616
full	O	2616
complement	O	2616
of	O	2616
morphologically	O	2616
normal	O	2616
oligodendrocytes	O	2616
.	O	2616
hypomyelination	B-Disease	2617
can	O	2617
thus	O	2617
be	O	2617
genetically	O	2617
separated	O	2617
from	O	2617
the	O	2617
plp	O	2617
-	O	2617
dependent	O	2617
oligodendrocyte	B-Disease	2617
degeneration	I-Disease	2617
.	O	2617
we	O	2618
suggest	O	2618
that	O	2618
plp	O	2618
has	O	2618
a	O	2618
vital	O	2618
function	O	2618
in	O	2618
glial	O	2618
cell	O	2618
development	O	2618
,	O	2618
distinct	O	2618
from	O	2618
its	O	2618
later	O	2618
role	O	2618
in	O	2618
myelin	O	2618
assembly	O	2618
,	O	2618
and	O	2618
that	O	2618
this	O	2618
dichotomy	O	2618
of	O	2618
action	O	2618
may	O	2618
explain	O	2618
the	O	2618
clinical	O	2618
spectrum	O	2618
of	O	2618
pelizaeus	B-Disease	2618
-	I-Disease	2618
merzbacher	I-Disease	2618
disease	I-Disease	2618
.	O	2618
.	O	2618
a	O	2619
pseudodeficiency	O	2619
allele	O	2619
common	O	2619
in	O	2619
non	O	2619
-	O	2619
jewish	O	2619
tay	B-Disease	2619
-	I-Disease	2619
sachs	I-Disease	2619
carriers	O	2619
:	O	2619
implications	O	2619
for	O	2619
carrier	O	2619
screening	O	2619
.	O	2619
deficiency	B-Disease	2620
of	I-Disease	2620
beta	I-Disease	2620
-	I-Disease	2620
hexosaminidase	I-Disease	2620
a	I-Disease	2620
(	O	2620
hex	O	2620
a	O	2620
)	O	2620
activity	O	2620
typically	O	2620
results	O	2620
in	O	2620
tay	B-Disease	2620
-	I-Disease	2620
sachs	I-Disease	2620
disease	I-Disease	2620
.	O	2620
however	O	2621
,	O	2621
healthy	O	2621
subjects	O	2621
found	O	2621
to	O	2621
be	O	2621
deficient	B-Disease	2621
in	I-Disease	2621
hex	I-Disease	2621
a	I-Disease	2621
activity	O	2621
(	O	2621
i	O	2621
.	O	2621
e	O	2621
.	O	2621
,	O	2621
pseudodeficient	O	2621
)	O	2621
by	O	2621
means	O	2621
of	O	2621
in	O	2621
vitro	O	2621
biochemical	O	2621
tests	O	2621
have	O	2621
been	O	2621
described	O	2621
.	O	2621
we	O	2622
analyzed	O	2622
the	O	2622
hexa	O	2622
gene	O	2622
of	O	2622
one	O	2622
pseudodeficient	O	2622
subject	O	2622
and	O	2622
identified	O	2622
both	O	2622
a	O	2622
c739	O	2622
-	O	2622
to	O	2622
-	O	2622
t	O	2622
substitution	O	2622
that	O	2622
changes	O	2622
arg247	O	2622
-	O	2622
-	O	2622
-	O	2622
-	O	2622
trp	O	2622
on	O	2622
one	O	2622
allele	O	2622
and	O	2622
a	O	2622
previously	O	2622
identified	O	2622
tay	B-Disease	2622
-	I-Disease	2622
sachs	I-Disease	2622
disease	I-Disease	2622
mutation	O	2622
on	O	2622
the	O	2622
second	O	2622
allele	O	2622
.	O	2622
this	O	2624
allele	O	2624
accounted	O	2624
for	O	2624
32	O	2624
%	O	2624
(	O	2624
20	O	2624
/	O	2624
62	O	2624
)	O	2624
of	O	2624
non	O	2624
-	O	2624
jewish	O	2624
enzyme	O	2624
-	O	2624
defined	O	2624
tay	B-Disease	2624
-	I-Disease	2624
sachs	I-Disease	2624
disease	I-Disease	2624
carriers	O	2624
but	O	2624
for	O	2624
none	O	2624
of	O	2624
36	O	2624
jewish	O	2624
enzyme	O	2624
-	O	2624
defined	O	2624
carriers	O	2624
who	O	2624
did	O	2624
not	O	2624
have	O	2624
one	O	2624
of	O	2624
three	O	2624
known	O	2624
mutations	O	2624
common	O	2624
to	O	2624
this	O	2624
group	O	2624
.	O	2624
the	O	2625
c739	O	2625
-	O	2625
to	O	2625
-	O	2625
t	O	2625
allele	O	2625
,	O	2625
together	O	2625
with	O	2625
a	O	2625
true	O	2625
tay	B-Disease	2625
-	I-Disease	2625
sachs	I-Disease	2625
disease	I-Disease	2625
allele	O	2625
,	O	2625
causes	O	2625
hex	O	2625
a	O	2625
pseudodeficiency	O	2625
.	O	2625
given	O	2626
both	O	2626
the	O	2626
large	O	2626
proportion	O	2626
of	O	2626
non	O	2626
-	O	2626
jewish	O	2626
carriers	O	2626
with	O	2626
this	O	2626
allele	O	2626
and	O	2626
that	O	2626
standard	O	2626
biochemical	O	2626
screening	O	2626
cannot	O	2626
differentiate	O	2626
between	O	2626
heterozygotes	O	2626
for	O	2626
the	O	2626
c739	O	2626
-	O	2626
to	O	2626
-	O	2626
t	O	2626
mutations	O	2626
and	O	2626
tay	B-Disease	2626
-	I-Disease	2626
sachs	I-Disease	2626
disease	I-Disease	2626
carriers	O	2626
,	O	2626
dna	O	2626
testing	O	2626
for	O	2626
this	O	2626
mutation	O	2626
in	O	2626
at	O	2626
-	O	2626
risk	O	2626
couples	O	2626
is	O	2626
essential	O	2626
.	O	2626
pelizaeus	B-Disease	2627
-	I-Disease	2627
merzbacher	I-Disease	2627
disease	I-Disease	2627
:	O	2627
detection	O	2627
of	O	2627
mutations	O	2627
thr181	O	2627
-	O	2627
-	O	2627
-	O	2627
-	O	2627
pro	O	2627
and	O	2627
leu223	O	2627
-	O	2627
-	O	2627
-	O	2627
-	O	2627
pro	O	2627
in	O	2627
the	O	2627
proteolipid	O	2627
protein	O	2627
gene	O	2627
,	O	2627
and	O	2627
prenatal	O	2627
diagnosis	O	2627
.	O	2627
a	O	2628
family	O	2628
with	O	2628
an	O	2628
apparent	O	2628
history	O	2628
of	O	2628
x	O	2628
-	O	2628
linked	O	2628
pelizaeus	B-Disease	2628
-	I-Disease	2628
merzbacher	I-Disease	2628
disease	I-Disease	2628
presented	O	2628
for	O	2628
genetic	O	2628
counseling	O	2628
,	O	2628
requesting	O	2628
carrier	O	2628
detection	O	2628
and	O	2628
prenatal	O	2628
diagnosis	O	2628
.	O	2628
these	O	2636
results	O	2636
provide	O	2636
further	O	2636
examples	O	2636
of	O	2636
mutations	O	2636
in	O	2636
plp	O	2636
that	O	2636
cause	O	2636
pelizaeus	B-Disease	2636
-	I-Disease	2636
merzbacher	I-Disease	2636
disease	I-Disease	2636
and	O	2636
illustrate	O	2636
the	O	2636
value	O	2636
of	O	2636
sscp	O	2636
in	O	2636
genetic	O	2636
analysis	O	2636
.	O	2636
.	O	2636
von	B-Disease	2637
willebrand	I-Disease	2637
disease	I-Disease	2637
type	I-Disease	2637
b	I-Disease	2637
:	O	2637
a	O	2637
missense	O	2637
mutation	O	2637
selectively	O	2637
abolishes	O	2637
ristocetin	O	2637
-	O	2637
induced	O	2637
von	B-Disease	2637
willebrand	I-Disease	2637
factor	O	2637
binding	O	2637
to	O	2637
platelet	O	2637
glycoprotein	O	2637
ib	O	2637
.	O	2637
von	B-Disease	2638
willebrand	I-Disease	2638
factor	O	2638
(	O	2638
vwf	O	2638
)	O	2638
is	O	2638
a	O	2638
multimeric	O	2638
glycoprotein	O	2638
that	O	2638
mediates	O	2638
the	O	2638
adhesion	O	2638
of	O	2638
platelets	O	2638
to	O	2638
the	O	2638
subendothelium	O	2638
by	O	2638
binding	O	2638
to	O	2638
platelet	O	2638
glycoprotein	O	2638
ib	O	2638
.	O	2638
a	O	2640
missense	O	2640
mutation	O	2640
,	O	2640
gly	O	2640
-	O	2640
561	O	2640
-	O	2640
-	O	2640
>	O	2640
ser	O	2640
,	O	2640
was	O	2640
identified	O	2640
within	O	2640
the	O	2640
proposed	O	2640
glycoprotein	O	2640
ib	O	2640
binding	O	2640
domain	O	2640
of	O	2640
vwf	O	2640
in	O	2640
the	O	2640
proband	O	2640
with	O	2640
von	B-Disease	2640
willebrand	I-Disease	2640
disease	I-Disease	2640
type	I-Disease	2640
b	I-Disease	2640
,	O	2640
a	O	2640
unique	O	2640
variant	O	2640
characterized	O	2640
by	O	2640
no	O	2640
ristocetin	O	2640
-	O	2640
induced	O	2640
,	O	2640
but	O	2640
normal	O	2640
botrocetin	O	2640
-	O	2640
induced	O	2640
,	O	2640
binding	O	2640
to	O	2640
glycoprotein	O	2640
ib	O	2640
.	O	2640
the	O	2641
corresponding	O	2641
mutant	O	2641
recombinant	O	2641
protein	O	2641
,	O	2641
rvwf	O	2641
(	O	2641
g561s	O	2641
)	O	2641
,	O	2641
formed	O	2641
normal	O	2641
multimers	O	2641
and	O	2641
exhibited	O	2641
the	O	2641
same	O	2641
functional	O	2641
defect	O	2641
as	O	2641
the	O	2641
patients	O	2641
plasma	O	2641
vwf	O	2641
,	O	2641
confirming	O	2641
that	O	2641
this	O	2641
mutation	O	2641
causes	O	2641
von	B-Disease	2641
willebrand	I-Disease	2641
disease	I-Disease	2641
type	I-Disease	2641
b	I-Disease	2641
.	O	2641
the	O	2643
normal	O	2643
botrocetin	O	2643
-	O	2643
induced	O	2643
binding	O	2643
and	O	2643
the	O	2643
defective	O	2643
ristocetin	O	2643
-	O	2643
induced	O	2643
binding	O	2643
of	O	2643
rvwf	O	2643
(	O	2643
g561s	O	2643
)	O	2643
suggest	O	2643
that	O	2643
the	O	2643
primary	O	2643
defect	O	2643
in	O	2643
von	B-Disease	2643
willebrand	I-Disease	2643
disease	I-Disease	2643
type	I-Disease	2643
b	I-Disease	2643
may	O	2643
be	O	2643
a	O	2643
failure	O	2643
of	O	2643
normal	O	2643
allosteric	O	2643
regulation	O	2643
of	O	2643
the	O	2643
glycoprotein	O	2643
ib	O	2643
binding	O	2643
function	O	2643
of	O	2643
vwf	O	2643
.	O	2643
.	O	2643
typical	O	2644
and	O	2644
partial	O	2644
cat	B-Disease	2644
eye	I-Disease	2644
syndrome	I-Disease	2644
:	O	2644
identification	O	2644
of	O	2644
the	O	2644
marker	O	2644
chromosome	O	2644
by	O	2644
fish	O	2644
.	O	2644
three	O	2645
children	O	2645
are	O	2645
reported	O	2645
with	O	2645
typical	O	2645
cat	B-Disease	2645
eye	I-Disease	2645
syndrome	I-Disease	2645
(	O	2645
ces	B-Disease	2645
)	O	2645
and	O	2645
three	O	2645
more	O	2645
children	O	2645
with	O	2645
partial	O	2645
ces	B-Disease	2645
because	O	2645
of	O	2645
absence	O	2645
of	O	2645
coloboma	O	2645
,	O	2645
in	O	2645
which	O	2645
the	O	2645
supernumerary	O	2645
marker	O	2645
chromosome	O	2645
was	O	2645
studied	O	2645
by	O	2645
fish	O	2645
.	O	2645
using	O	2646
a	O	2646
genomic	O	2646
library	O	2646
,	O	2646
and	O	2646
also	O	2646
a	O	2646
centromeric	O	2646
and	O	2646
particularly	O	2646
a	O	2646
cosmid	O	2646
probe	O	2646
of	O	2646
22q11	O	2646
,	O	2646
partial	O	2646
tetrasomy	B-Disease	2646
was	O	2646
shown	O	2646
in	O	2646
all	O	2646
cases	O	2646
.	O	2646
.	O	2646
[	O	2647
genetic	O	2647
heterogeneity	O	2647
of	O	2647
g6pd	B-Disease	2647
deficiency	I-Disease	2647
:	O	2647
mutant	O	2647
alleles	O	2647
of	O	2647
g6pd	O	2647
in	O	2647
the	O	2647
shekii	O	2647
district	O	2647
of	O	2647
azerbaijan	O	2647
]	O	2647
examination	O	2648
on	O	2648
g6pd	B-Disease	2648
deficiency	I-Disease	2648
in	O	2648
349	O	2648
patients	O	2648
of	O	2648
shekii	O	2648
district	O	2648
hospital	O	2648
(	O	2648
azerbaijan	O	2648
)	O	2648
revealed	O	2648
16	O	2648
hemi	O	2648
-	O	2648
,	O	2648
4	O	2648
homo	O	2648
-	O	2648
and	O	2648
9	O	2648
heterozygotic	O	2648
carriers	O	2648
of	O	2648
the	O	2648
defect	O	2648
.	O	2648
carriers	O	2650
of	O	2650
g6pd	B-Disease	2650
deficiency	I-Disease	2650
are	O	2650
residents	O	2650
of	O	2650
11	O	2650
villages	O	2650
located	O	2650
in	O	2650
alasani	O	2650
-	O	2650
aphtalan	O	2650
valley	O	2650
,	O	2650
highly	O	2650
endemic	O	2650
with	O	2650
malaria	B-Disease	2650
in	O	2650
the	O	2650
past	O	2650
;	O	2650
nearly	O	2650
all	O	2650
marriages	O	2650
are	O	2650
endogamic	O	2650
.	O	2650
craniofrontonasal	B-Disease	2653
dysplasia	I-Disease	2653
.	O	2653
we	O	2654
report	O	2654
on	O	2654
nine	O	2654
patients	O	2654
with	O	2654
craniofrontonasal	B-Disease	2654
dysplasia	I-Disease	2654
(	O	2654
cfnd	B-Disease	2654
)	O	2654
.	O	2654
seven	O	2655
classical	O	2655
cases	O	2655
had	O	2655
facial	O	2655
features	O	2655
suggestive	O	2655
of	O	2655
frontonasal	B-Disease	2655
dysplasia	I-Disease	2655
and	O	2655
coronal	B-Disease	2655
craniosynostosis	I-Disease	2655
.	O	2655
extracranial	B-Disease	2656
abnormalities	I-Disease	2656
such	O	2656
as	O	2656
brittle	B-Disease	2656
nails	I-Disease	2656
with	I-Disease	2656
prominent	I-Disease	2656
longitudinal	I-Disease	2656
grooves	I-Disease	2656
or	O	2656
syndactyly	B-Disease	2656
of	I-Disease	2656
fingers	I-Disease	2656
and	I-Disease	2656
toes	I-Disease	2656
were	O	2656
observed	O	2656
in	O	2656
individual	O	2656
patients	O	2656
.	O	2656
hypotonia	B-Disease	2659
and	O	2659
laxity	B-Disease	2659
of	I-Disease	2659
joints	I-Disease	2659
are	O	2659
common	O	2659
and	O	2659
may	O	2659
necessitate	O	2659
supportive	O	2659
measures	O	2659
.	O	2659
mild	O	2660
developmental	B-Disease	2660
delay	I-Disease	2660
was	O	2660
noted	O	2660
in	O	2660
three	O	2660
out	O	2660
of	O	2660
six	O	2660
classical	O	2660
cases	O	2660
studied	O	2660
in	O	2660
detail	O	2660
.	O	2660
unlike	O	2661
almost	O	2661
all	O	2661
other	O	2661
x	B-Disease	2661
-	I-Disease	2661
linked	I-Disease	2661
disorders	I-Disease	2661
,	O	2661
clinical	O	2661
expression	O	2661
in	O	2661
cfnd	B-Disease	2661
is	O	2661
generally	O	2661
much	O	2661
more	O	2661
severe	O	2661
in	O	2661
females	O	2661
than	O	2661
in	O	2661
males	O	2661
.	O	2661
the	O	2663
intron	O	2663
7	O	2663
donor	O	2663
splice	O	2663
site	O	2663
transition	O	2663
:	O	2663
a	O	2663
second	O	2663
tay	B-Disease	2663
-	I-Disease	2663
sachs	I-Disease	2663
disease	I-Disease	2663
mutation	O	2663
in	O	2663
french	O	2663
canada	O	2663
.	O	2663
mutations	O	2664
at	O	2664
the	O	2664
hexosaminidase	O	2664
a	O	2664
(	O	2664
hexa	O	2664
)	O	2664
gene	O	2664
which	O	2664
cause	O	2664
tay	B-Disease	2664
-	I-Disease	2664
sachs	I-Disease	2664
disease	I-Disease	2664
(	O	2664
tsd	B-Disease	2664
)	O	2664
have	O	2664
elevated	O	2664
frequency	O	2664
in	O	2664
the	O	2664
ashkenazi	O	2664
jewish	O	2664
and	O	2664
french	O	2664
-	O	2664
canadian	O	2664
populations	O	2664
.	O	2664
we	O	2665
report	O	2665
a	O	2665
novel	O	2665
tsd	B-Disease	2665
allele	O	2665
in	O	2665
the	O	2665
french	O	2665
-	O	2665
canadian	O	2665
population	O	2665
associated	O	2665
with	O	2665
the	O	2665
infantile	O	2665
form	O	2665
of	O	2665
the	O	2665
disease	O	2665
.	O	2665
the	O	2668
intron	O	2668
7	O	2668
+	O	2668
1	O	2668
mutation	O	2668
occurs	O	2668
in	O	2668
the	O	2668
base	O	2668
adjacent	O	2668
to	O	2668
the	O	2668
site	O	2668
of	O	2668
the	O	2668
adult	O	2668
-	O	2668
onset	O	2668
tsd	B-Disease	2668
mutation	O	2668
(	O	2668
g805a	O	2668
)	O	2668
.	O	2668
this	O	2674
mutation	O	2674
thus	O	2674
has	O	2674
a	O	2674
different	O	2674
geographic	O	2674
centre	O	2674
of	O	2674
diffusion	O	2674
and	O	2674
is	O	2674
probably	O	2674
less	O	2674
common	O	2674
than	O	2674
the	O	2674
exon	O	2674
1	O	2674
deletion	O	2674
tsd	B-Disease	2674
mutation	O	2674
in	O	2674
french	O	2674
canadians	O	2674
.	O	2674
aspartylglucosaminuria	B-Disease	2677
(	O	2677
agu	B-Disease	2677
)	O	2677
is	O	2677
a	O	2677
recessive	O	2677
autosomally	O	2677
inherited	O	2677
lysosomal	B-Disease	2677
storage	I-Disease	2677
disorder	I-Disease	2677
due	O	2677
to	O	2677
deficiency	B-Disease	2677
of	I-Disease	2677
the	I-Disease	2677
enzyme	I-Disease	2677
aspartylglucosaminidase	I-Disease	2677
(	O	2677
aga	O	2677
)	O	2677
.	O	2677
resolution	O	2681
of	O	2681
the	O	2681
two	O	2681
loci	O	2681
for	O	2681
autosomal	O	2681
dominant	O	2681
aniridia	B-Disease	2681
,	O	2681
an1	O	2681
and	O	2681
an2	O	2681
,	O	2681
to	O	2681
a	O	2681
single	O	2681
locus	O	2681
on	O	2681
chromosome	O	2681
11p13	O	2681
.	O	2681
two	O	2682
distinct	O	2682
loci	O	2682
have	O	2682
been	O	2682
proposed	O	2682
for	O	2682
aniridia	B-Disease	2682
;	O	2682
an1	O	2682
for	O	2682
autosomal	O	2682
dominant	O	2682
aniridia	B-Disease	2682
on	O	2682
chromosome	O	2682
2p	O	2682
and	O	2682
an2	O	2682
for	O	2682
the	O	2682
aniridia	B-Disease	2682
in	O	2682
the	O	2682
wagr	B-Disease	2682
contiguous	I-Disease	2682
gene	I-Disease	2682
syndrome	I-Disease	2682
on	O	2682
chromosome	O	2682
11p13	O	2682
.	O	2682
in	O	2683
this	O	2683
report	O	2683
,	O	2683
the	O	2683
kindred	O	2683
segregating	O	2683
for	O	2683
autosomal	O	2683
dominant	O	2683
aniridia	B-Disease	2683
,	O	2683
which	O	2683
suggested	O	2683
linkage	O	2683
to	O	2683
acid	O	2683
phosphatase	O	2683
-	O	2683
1	O	2683
(	O	2683
acp1	O	2683
)	O	2683
and	O	2683
led	O	2683
to	O	2683
the	O	2683
assignment	O	2683
of	O	2683
the	O	2683
an1	O	2683
locus	O	2683
on	O	2683
chromosome	O	2683
2p	O	2683
,	O	2683
has	O	2683
been	O	2683
updated	O	2683
and	O	2683
expanded	O	2683
.	O	2683
linkage	O	2684
analysis	O	2684
between	O	2684
the	O	2684
aniridia	B-Disease	2684
phenotype	O	2684
and	O	2684
acp1	O	2684
does	O	2684
not	O	2684
support	O	2684
the	O	2684
original	O	2684
linkage	O	2684
results	O	2684
,	O	2684
excluding	O	2684
linkage	O	2684
up	O	2684
to	O	2684
theta	O	2684
=	O	2684
0	O	2684
.	O	2684
apob	O	2687
,	O	2687
d2s71	O	2687
,	O	2687
d2s5	O	2687
,	O	2687
and	O	2687
d2s1	O	2687
,	O	2687
also	O	2687
excluded	O	2687
linkage	O	2687
to	O	2687
aniridia	B-Disease	2687
.	O	2687
markers	O	2688
that	O	2688
have	O	2688
been	O	2688
isolated	O	2688
from	O	2688
the	O	2688
chromosome	O	2688
11p13	O	2688
region	O	2688
were	O	2688
then	O	2688
analyzed	O	2688
in	O	2688
this	O	2688
aniridia	B-Disease	2688
family	O	2688
.	O	2688
these	O	2701
data	O	2701
suggest	O	2701
that	O	2701
a	O	2701
locus	O	2701
for	O	2701
aniridia	B-Disease	2701
(	O	2701
an1	O	2701
)	O	2701
on	O	2701
chromosome	O	2701
2p	O	2701
has	O	2701
been	O	2701
misassigned	O	2701
and	O	2701
that	O	2701
this	O	2701
autosomal	O	2701
dominant	O	2701
aniridia	B-Disease	2701
family	O	2701
is	O	2701
segregating	O	2701
for	O	2701
an	O	2701
aniridia	B-Disease	2701
mutation	O	2701
linked	O	2701
to	O	2701
markers	O	2701
in	O	2701
the	O	2701
11p13	O	2701
region	O	2701
.	O	2701
fatal	O	2702
pyoderma	B-Disease	2702
gangrenosum	I-Disease	2702
in	O	2702
association	O	2702
with	O	2702
c7	B-Disease	2702
deficiency	I-Disease	2702
.	O	2702
although	O	2703
pyoderma	B-Disease	2703
gangrenosum	I-Disease	2703
(	O	2703
pg	B-Disease	2703
)	O	2703
is	O	2703
often	O	2703
associated	O	2703
with	O	2703
systemic	B-Disease	2703
diseases	I-Disease	2703
,	O	2703
it	O	2703
has	O	2703
not	O	2703
been	O	2703
reported	O	2703
in	O	2703
association	O	2703
with	O	2703
congenital	B-Disease	2703
complement	I-Disease	2703
deficiencies	I-Disease	2703
.	O	2703
we	O	2704
describe	O	2704
an	O	2704
aggressive	O	2704
and	O	2704
ultimately	O	2704
fatal	O	2704
case	O	2704
of	O	2704
pg	B-Disease	2704
in	O	2704
a	O	2704
patient	O	2704
with	O	2704
a	O	2704
congenital	O	2704
c7	B-Disease	2704
deficiency	I-Disease	2704
.	O	2704
deficiencies	B-Disease	2705
of	I-Disease	2705
c7	I-Disease	2705
can	O	2705
be	O	2705
associated	O	2705
with	O	2705
decreased	O	2705
neutrophil	O	2705
chemotaxis	O	2705
,	O	2705
phagocytosis	O	2705
,	O	2705
and	O	2705
opsonization	O	2705
,	O	2705
similar	O	2705
to	O	2705
the	O	2705
immunologic	B-Disease	2705
abnormalities	I-Disease	2705
described	O	2705
in	O	2705
patients	O	2705
with	O	2705
pg	B-Disease	2705
.	O	2705
our	O	2706
patients	O	2706
decreased	O	2706
complement	O	2706
level	O	2706
,	O	2706
if	O	2706
not	O	2706
directly	O	2706
related	O	2706
to	O	2706
the	O	2706
development	O	2706
of	O	2706
pg	B-Disease	2706
,	O	2706
may	O	2706
have	O	2706
contributed	O	2706
to	O	2706
the	O	2706
aggressive	O	2706
nature	O	2706
of	O	2706
her	O	2706
disease	O	2706
.	O	2706
.	O	2706
glucose	B-Disease	2708
-	I-Disease	2708
6	I-Disease	2708
-	I-Disease	2708
phosphate	I-Disease	2708
dehydrogenase	I-Disease	2708
(	I-Disease	2708
g6pd	I-Disease	2708
;	I-Disease	2708
ec	I-Disease	2708
1	I-Disease	2708
.	I-Disease	2708
1	I-Disease	2708
.	I-Disease	2708
1	I-Disease	2708
.	I-Disease	2708
49	I-Disease	2708
)	I-Disease	2708
deficiency	I-Disease	2708
is	O	2708
the	O	2708
most	O	2708
common	O	2708
human	O	2708
enzymopathy	B-Disease	2708
,	O	2708
affecting	O	2708
more	O	2708
than	O	2708
200	O	2708
million	O	2708
people	O	2708
worldwide	O	2708
.	O	2708
although	O	2709
greater	O	2709
than	O	2709
400	O	2709
variants	O	2709
have	O	2709
been	O	2709
described	O	2709
based	O	2709
on	O	2709
clinical	O	2709
and	O	2709
biochemical	O	2709
criteria	O	2709
,	O	2709
little	O	2709
is	O	2709
known	O	2709
about	O	2709
the	O	2709
molecular	O	2709
basis	O	2709
of	O	2709
these	O	2709
g6pd	B-Disease	2709
deficiencies	I-Disease	2709
.	O	2709
the	O	2720
1376	O	2720
g	O	2720
-	O	2720
-	O	2720
-	O	2720
-	O	2720
t	O	2720
mutation	O	2720
seems	O	2720
to	O	2720
be	O	2720
the	O	2720
dominant	O	2720
allele	O	2720
that	O	2720
causes	O	2720
g6pd	B-Disease	2720
deficiency	I-Disease	2720
in	O	2720
taiwan	O	2720
.	O	2720
our	O	2723
studies	O	2723
provide	O	2723
the	O	2723
direct	O	2723
proof	O	2723
of	O	2723
the	O	2723
genetic	O	2723
heterogeneity	O	2723
of	O	2723
g6pd	B-Disease	2723
deficiency	I-Disease	2723
in	O	2723
the	O	2723
chinese	O	2723
populations	O	2723
of	O	2723
taiwan	O	2723
and	O	2723
the	O	2723
pcr	O	2723
/	O	2723
re	O	2723
digestion	O	2723
method	O	2723
is	O	2723
suitable	O	2723
for	O	2723
simultaneous	O	2723
detection	O	2723
of	O	2723
the	O	2723
487	O	2723
g	O	2723
-	O	2723
-	O	2723
-	O	2723
-	O	2723
a	O	2723
and	O	2723
493	O	2723
a	O	2723
-	O	2723
-	O	2723
-	O	2723
-	O	2723
g	O	2723
mutations	O	2723
.	O	2723
an	O	2724
error	O	2724
in	O	2724
dystrophin	O	2724
mrna	O	2724
processing	O	2724
in	O	2724
golden	B-Disease	2724
retriever	I-Disease	2724
muscular	I-Disease	2724
dystrophy	I-Disease	2724
,	O	2724
an	O	2724
animal	O	2724
homologue	O	2724
of	O	2724
duchenne	B-Disease	2724
muscular	I-Disease	2724
dystrophy	I-Disease	2724
.	O	2724
golden	B-Disease	2725
retriever	I-Disease	2725
muscular	I-Disease	2725
dystrophy	I-Disease	2725
(	O	2725
grmd	B-Disease	2725
)	O	2725
is	O	2725
a	O	2725
spontaneous	O	2725
,	O	2725
x	O	2725
-	O	2725
linked	O	2725
,	O	2725
progressively	O	2725
fatal	O	2725
disease	O	2725
of	O	2725
dogs	O	2725
and	O	2725
is	O	2725
also	O	2725
a	O	2725
homologue	O	2725
of	O	2725
duchenne	B-Disease	2725
muscular	I-Disease	2725
dystrophy	I-Disease	2725
(	O	2725
dmd	B-Disease	2725
)	O	2725
.	O	2725
two	O	2726
-	O	2726
thirds	O	2726
of	O	2726
dmd	B-Disease	2726
patients	O	2726
carry	O	2726
detectable	O	2726
deletions	O	2726
in	O	2726
their	O	2726
dystrophin	O	2726
gene	O	2726
.	O	2726
the	O	2727
defect	O	2727
underlying	O	2727
the	O	2727
remaining	O	2727
one	O	2727
-	O	2727
third	O	2727
of	O	2727
dmd	B-Disease	2727
patients	O	2727
is	O	2727
undetermined	O	2727
.	O	2727
analysis	O	2728
of	O	2728
the	O	2728
canine	O	2728
dystrophin	O	2728
gene	O	2728
in	O	2728
normal	O	2728
and	O	2728
grmd	B-Disease	2728
dogs	O	2728
has	O	2728
failed	O	2728
to	O	2728
demonstrate	O	2728
any	O	2728
detectable	O	2728
loss	O	2728
of	O	2728
exons	O	2728
.	O	2728
here	O	2729
,	O	2729
we	O	2729
have	O	2729
demonstrated	O	2729
a	O	2729
rna	O	2729
processing	O	2729
error	O	2729
in	O	2729
grmd	B-Disease	2729
that	O	2729
results	O	2729
from	O	2729
a	O	2729
single	O	2729
base	O	2729
change	O	2729
in	O	2729
the	O	2729
3	O	2729
consensus	O	2729
splice	O	2729
site	O	2729
of	O	2729
intron	O	2729
6	O	2729
.	O	2729
this	O	2731
is	O	2731
the	O	2731
first	O	2731
example	O	2731
of	O	2731
dystrophin	B-Disease	2731
deficiency	I-Disease	2731
caused	O	2731
by	O	2731
a	O	2731
splice	O	2731
-	O	2731
site	O	2731
mutation	O	2731
.	O	2731
.	O	2731
type	B-Disease	2732
i	I-Disease	2732
human	I-Disease	2732
complement	I-Disease	2732
c2	I-Disease	2732
deficiency	I-Disease	2732
.	O	2732
two	O	2734
variants	O	2734
of	O	2734
a	O	2734
genetic	O	2734
deficiency	B-Disease	2734
of	I-Disease	2734
complement	I-Disease	2734
protein	I-Disease	2734
c2	I-Disease	2734
(	O	2734
c2d	O	2734
)	O	2734
have	O	2734
been	O	2734
previously	O	2734
identified	O	2734
.	O	2734
type	B-Disease	2736
i	I-Disease	2736
c2	I-Disease	2736
deficiency	I-Disease	2736
was	O	2736
described	O	2736
in	O	2736
a	O	2736
family	O	2736
in	O	2736
which	O	2736
the	O	2736
c2	O	2736
null	O	2736
allele	O	2736
(	O	2736
c2q0	O	2736
)	O	2736
is	O	2736
associated	O	2736
with	O	2736
the	O	2736
major	O	2736
histocompatibility	O	2736
haplotype	O	2736
/	O	2736
complotype	O	2736
hla	O	2736
-	O	2736
a25	O	2736
,	O	2736
b18	O	2736
,	O	2736
c2q0	O	2736
,	O	2736
bfs	O	2736
,	O	2736
c4a4	O	2736
,	O	2736
c4b2	O	2736
,	O	2736
drw2	O	2736
;	O	2736
this	O	2736
extended	O	2736
haplotype	O	2736
occurs	O	2736
in	O	2736
over	O	2736
90	O	2736
%	O	2736
of	O	2736
c2	B-Disease	2736
-	I-Disease	2736
deficient	I-Disease	2736
individuals	O	2736
(	O	2736
common	O	2736
complotype	O	2736
/	O	2736
haplotype	O	2736
)	O	2736
.	O	2736
to	O	2737
determine	O	2737
the	O	2737
molecular	O	2737
basis	O	2737
of	O	2737
type	B-Disease	2737
i	I-Disease	2737
c2	I-Disease	2737
deficiency	I-Disease	2737
,	O	2737
the	O	2737
c2	O	2737
gene	O	2737
and	O	2737
cdna	O	2737
were	O	2737
characterized	O	2737
from	O	2737
a	O	2737
homozygous	O	2737
type	B-Disease	2737
i	I-Disease	2737
c2	I-Disease	2737
-	I-Disease	2737
deficient	I-Disease	2737
individual	O	2737
with	O	2737
the	O	2737
common	O	2737
associated	O	2737
haplotype	O	2737
/	O	2737
complotype	O	2737
.	O	2737
in	O	2739
studies	O	2739
of	O	2739
eight	O	2739
kindred	O	2739
,	O	2739
the	O	2739
28	O	2739
-	O	2739
base	O	2739
pair	O	2739
deletion	O	2739
was	O	2739
observed	O	2739
in	O	2739
all	O	2739
c2q0	O	2739
alleles	O	2739
associated	O	2739
with	O	2739
the	O	2739
common	O	2739
type	O	2739
i	O	2739
deficient	O	2739
complotype	O	2739
/	O	2739
haplotype	O	2739
;	O	2739
this	O	2739
deletion	O	2739
was	O	2739
not	O	2739
present	O	2739
in	O	2739
normal	O	2739
c2	O	2739
nor	O	2739
in	O	2739
type	B-Disease	2739
ii	I-Disease	2739
c2	I-Disease	2739
-	I-Disease	2739
deficient	I-Disease	2739
genes	O	2739
.	O	2739
these	O	2740
data	O	2740
demonstrate	O	2740
that	O	2740
1	O	2740
)	O	2740
type	B-Disease	2740
i	I-Disease	2740
human	I-Disease	2740
complement	I-Disease	2740
c2	I-Disease	2740
deficiency	I-Disease	2740
is	O	2740
caused	O	2740
by	O	2740
a	O	2740
28	O	2740
-	O	2740
base	O	2740
pair	O	2740
genomic	O	2740
deletion	O	2740
that	O	2740
causes	O	2740
skipping	O	2740
of	O	2740
exon	O	2740
6	O	2740
during	O	2740
rna	O	2740
splicing	O	2740
,	O	2740
resulting	O	2740
in	O	2740
generation	O	2740
of	O	2740
a	O	2740
premature	O	2740
termination	O	2740
codon	O	2740
,	O	2740
2	O	2740
)	O	2740
the	O	2740
28	O	2740
-	O	2740
base	O	2740
pair	O	2740
deletion	O	2740
in	O	2740
the	O	2740
type	O	2740
i	O	2740
c2q0	O	2740
gene	O	2740
is	O	2740
strongly	O	2740
associated	O	2740
with	O	2740
the	O	2740
hla	O	2740
haplotype	O	2740
/	O	2740
complotype	O	2740
a25	O	2740
,	O	2740
b18	O	2740
,	O	2740
c2q0	O	2740
,	O	2740
bfs	O	2740
,	O	2740
c4a4	O	2740
,	O	2740
c4b2	O	2740
,	O	2740
drw2	O	2740
,	O	2740
suggesting	O	2740
that	O	2740
all	O	2740
c2	B-Disease	2740
-	I-Disease	2740
deficient	I-Disease	2740
individuals	O	2740
with	O	2740
this	O	2740
haplotype	O	2740
/	O	2740
complotype	O	2740
will	O	2740
harbor	O	2740
the	O	2740
28	O	2740
-	O	2740
base	O	2740
pair	O	2740
c2	O	2740
gene	O	2740
deletion	O	2740
,	O	2740
and	O	2740
3	O	2740
)	O	2740
type	B-Disease	2740
ii	I-Disease	2740
c2	I-Disease	2740
deficiency	I-Disease	2740
is	O	2740
caused	O	2740
by	O	2740
a	O	2740
different	O	2740
,	O	2740
as	O	2740
yet	O	2740
uncharacterized	O	2740
,	O	2740
molecular	O	2740
genetic	B-Disease	2740
defect	I-Disease	2740
.	O	2740
.	O	2740
molecular	O	2741
characterization	O	2741
of	O	2741
two	O	2741
galactosemia	B-Disease	2741
mutations	O	2741
and	O	2741
one	O	2741
polymorphism	O	2741
:	O	2741
implications	O	2741
for	O	2741
structure	O	2741
-	O	2741
function	O	2741
analysis	O	2741
of	O	2741
human	O	2741
galactose	O	2741
-	O	2741
1	O	2741
-	O	2741
phosphate	O	2741
uridyltransferase	O	2741
.	O	2741
we	O	2742
report	O	2742
here	O	2742
the	O	2742
molecular	O	2742
characterization	O	2742
of	O	2742
two	O	2742
galactosemia	B-Disease	2742
mutations	O	2742
,	O	2742
l74p	O	2742
and	O	2742
f171s	O	2742
,	O	2742
and	O	2742
one	O	2742
polymorphism	O	2742
,	O	2742
s135l	O	2742
,	O	2742
in	O	2742
human	O	2742
galactose	O	2742
-	O	2742
1	O	2742
-	O	2742
phosphate	O	2742
uridyltransferase	O	2742
(	O	2742
galt	O	2742
)	O	2742
.	O	2742
both	O	2743
galactosemia	B-Disease	2743
mutations	O	2743
result	O	2743
in	O	2743
reduced	O	2743
enzymatic	O	2743
activity	O	2743
when	O	2743
reconstructed	O	2743
in	O	2743
the	O	2743
cdna	O	2743
and	O	2743
overexpressed	O	2743
.	O	2743
our	O	2747
data	O	2747
further	O	2747
support	O	2747
the	O	2747
notion	O	2747
of	O	2747
molecular	O	2747
heterogeneity	O	2747
of	O	2747
galactosemia	B-Disease	2747
and	O	2747
suggest	O	2747
that	O	2747
galactosemia	B-Disease	2747
mutations	O	2747
and	O	2747
galt	O	2747
polymorphisms	O	2747
may	O	2747
be	O	2747
useful	O	2747
tools	O	2747
in	O	2747
highlighting	O	2747
different	O	2747
functional	O	2747
domains	O	2747
in	O	2747
human	O	2747
galt	O	2747
.	O	2747
.	O	2747
linkage	O	2748
relationship	O	2748
of	O	2748
c2	B-Disease	2748
deficiency	I-Disease	2748
,	O	2748
hla	O	2748
and	O	2748
glyoxalase	O	2748
i	O	2748
loci	O	2748
.	O	2748
immunogenetic	O	2749
analysis	O	2749
of	O	2749
a	O	2749
homozygous	O	2749
c2	B-Disease	2749
-	I-Disease	2749
deficient	I-Disease	2749
individual	O	2749
and	O	2749
family	O	2749
members	O	2749
demonstrated	O	2749
linkage	O	2749
of	O	2749
hla	O	2749
-	O	2749
a25	O	2749
,	O	2749
b18	O	2749
and	O	2749
c2o	O	2749
.	O	2749
hla	O	2750
-	O	2750
d	O	2750
typing	O	2750
showed	O	2750
that	O	2750
5	O	2750
members	O	2750
typed	O	2750
with	O	2750
homozygous	O	2750
dw2	O	2750
typing	O	2750
cells	O	2750
from	O	2750
an	O	2750
individual	O	2750
with	O	2750
c2	B-Disease	2750
deficiency	I-Disease	2750
but	O	2750
not	O	2750
with	O	2750
dw2	O	2750
typing	O	2750
cells	O	2750
from	O	2750
2	O	2750
individuals	O	2750
with	O	2750
normal	O	2750
c2	O	2750
.	O	2750
the	O	2751
homozygous	O	2751
c2	B-Disease	2751
-	I-Disease	2751
deficient	I-Disease	2751
propositus	O	2751
and	O	2751
brother	O	2751
were	O	2751
hla	O	2751
-	O	2751
a	O	2751
and	O	2751
b	O	2751
homozygous	O	2751
but	O	2751
heterozygous	O	2751
at	O	2751
the	O	2751
hla	O	2751
-	O	2751
d	O	2751
and	O	2751
glyoxalase	O	2751
i	O	2751
loci	O	2751
.	O	2751
germline	O	2755
mutations	O	2755
in	O	2755
the	O	2755
wilms	B-Disease	2755
'	I-Disease	2755
tumor	I-Disease	2755
suppressor	O	2755
gene	O	2755
are	O	2755
associated	O	2755
with	O	2755
abnormal	O	2755
urogenital	O	2755
development	O	2755
in	O	2755
denys	B-Disease	2755
-	I-Disease	2755
drash	I-Disease	2755
syndrome	I-Disease	2755
.	O	2755
denys	B-Disease	2756
-	I-Disease	2756
drash	I-Disease	2756
syndrome	I-Disease	2756
is	O	2756
a	O	2756
rare	O	2756
human	O	2756
condition	O	2756
in	O	2756
which	O	2756
severe	O	2756
urogenital	B-Disease	2756
aberrations	I-Disease	2756
result	O	2756
in	O	2756
renal	B-Disease	2756
failure	I-Disease	2756
,	O	2756
pseudohermaphroditism	B-Disease	2756
,	O	2756
and	O	2756
wilms	B-Disease	2756
tumor	I-Disease	2756
(	O	2756
nephroblastoma	B-Disease	2756
)	O	2756
.	O	2756
to	O	2757
investigate	O	2757
its	O	2757
possible	O	2757
role	O	2757
,	O	2757
we	O	2757
have	O	2757
analyzed	O	2757
the	O	2757
coding	O	2757
exons	O	2757
of	O	2757
the	O	2757
wilms	B-Disease	2757
tumor	I-Disease	2757
suppressor	O	2757
gene	O	2757
(	O	2757
wt1	O	2757
)	O	2757
for	O	2757
germline	O	2757
mutations	O	2757
.	O	2757
in	O	2758
ten	O	2758
independent	O	2758
cases	O	2758
of	O	2758
denys	B-Disease	2758
-	I-Disease	2758
drash	I-Disease	2758
syndrome	I-Disease	2758
,	O	2758
point	O	2758
mutations	O	2758
in	O	2758
the	O	2758
zinc	O	2758
finger	O	2758
domains	O	2758
of	O	2758
one	O	2758
wt1	O	2758
gene	O	2758
copy	O	2758
were	O	2758
found	O	2758
.	O	2758
wilms	B-Disease	2762
tumors	I-Disease	2762
from	O	2762
three	O	2762
individuals	O	2762
and	O	2762
one	O	2762
juvenile	O	2762
granulosa	O	2762
cell	O	2762
tumor	B-Disease	2762
demonstrate	O	2762
reduction	O	2762
to	O	2762
homozygosity	O	2762
for	O	2762
the	O	2762
mutated	O	2762
wt1	O	2762
allele	O	2762
.	O	2762
our	O	2763
results	O	2763
provide	O	2763
evidence	O	2763
of	O	2763
a	O	2763
direct	O	2763
role	O	2763
for	O	2763
wt1	O	2763
in	O	2763
denys	B-Disease	2763
-	I-Disease	2763
drash	I-Disease	2763
syndrome	I-Disease	2763
and	O	2763
thus	O	2763
urogenital	O	2763
system	O	2763
development	O	2763
.	O	2763
.	O	2763
linkage	O	2764
analysis	O	2764
in	O	2764
x	B-Disease	2764
-	I-Disease	2764
linked	I-Disease	2764
adrenoleukodystrophy	I-Disease	2764
and	O	2764
application	O	2764
in	O	2764
post	O	2764
-	O	2764
and	O	2764
prenatal	O	2764
diagnosis	O	2764
.	O	2764
we	O	2765
have	O	2765
performed	O	2765
linkage	O	2765
analysis	O	2765
with	O	2765
the	O	2765
dna	O	2765
markers	O	2765
dxs52	O	2765
and	O	2765
the	O	2765
clotting	O	2765
factor	O	2765
viii	O	2765
gene	O	2765
(	O	2765
f8c	O	2765
)	O	2765
,	O	2765
in	O	2765
several	O	2765
large	O	2765
families	O	2765
with	O	2765
x	B-Disease	2765
-	I-Disease	2765
linked	I-Disease	2765
adrenoleukodystrophy	I-Disease	2765
(	O	2765
ald	B-Disease	2765
)	O	2765
.	O	2765
f8c	O	2768
was	O	2768
also	O	2768
tightly	O	2768
linked	O	2768
to	O	2768
ald	B-Disease	2768
with	O	2768
a	O	2768
maximal	O	2768
lod	O	2768
score	O	2768
of	O	2768
7	O	2768
.	O	2768
multipoint	O	2770
linkage	O	2770
analysis	O	2770
with	O	2770
the	O	2770
markers	O	2770
dxs304	O	2770
,	O	2770
dxs52	O	2770
,	O	2770
and	O	2770
f8c	O	2770
indicated	O	2770
that	O	2770
both	O	2770
the	O	2770
gene	O	2770
for	O	2770
ald	B-Disease	2770
and	O	2770
for	O	2770
f8c	O	2770
are	O	2770
distal	O	2770
to	O	2770
dxs52	O	2770
.	O	2770
in	O	2771
four	O	2771
patients	O	2771
with	O	2771
ald	B-Disease	2771
,	O	2771
no	O	2771
major	O	2771
structural	O	2771
rearrangement	O	2771
in	O	2771
the	O	2771
xqter	O	2771
region	O	2771
was	O	2771
observed	O	2771
;	O	2771
in	O	2771
particular	O	2771
,	O	2771
there	O	2771
were	O	2771
no	O	2771
abnormalities	B-Disease	2771
in	I-Disease	2771
the	I-Disease	2771
vision	I-Disease	2771
blindness	I-Disease	2771
genes	I-Disease	2771
.	O	2771
two	O	2773
distinct	O	2773
mutations	O	2773
at	O	2773
a	O	2773
single	O	2773
bamhi	O	2773
site	O	2773
in	O	2773
phenylketonuria	B-Disease	2773
.	O	2773
classical	B-Disease	2774
phenylketonuria	I-Disease	2774
is	O	2774
an	O	2774
autosomal	B-Disease	2774
recessive	I-Disease	2774
disease	I-Disease	2774
caused	O	2774
by	O	2774
a	O	2774
deficiency	B-Disease	2774
of	I-Disease	2774
hepatic	I-Disease	2774
phenylalanine	I-Disease	2774
hydroxylase	I-Disease	2774
(	O	2774
pah	O	2774
)	O	2774
.	O	2774
the	O	2777
present	O	2777
study	O	2777
supports	O	2777
the	O	2777
view	O	2777
that	O	2777
the	O	2777
clinical	O	2777
heterogeneity	O	2777
in	O	2777
pku	B-Disease	2777
is	O	2777
accounted	O	2777
for	O	2777
by	O	2777
the	O	2777
large	O	2777
variety	O	2777
of	O	2777
mutant	O	2777
genotypes	O	2777
associated	O	2777
with	O	2777
pah	B-Disease	2777
deficiencies	I-Disease	2777
.	O	2777
.	O	2777
a	O	2785
detailed	O	2785
10	O	2785
-	O	2785
point	O	2785
map	O	2785
of	O	2785
the	O	2785
4p16	O	2785
region	O	2785
constructed	O	2785
from	O	2785
the	O	2785
ceph	O	2785
panel	O	2785
provides	O	2785
evidence	O	2785
for	O	2785
heterogeneity	O	2785
in	O	2785
the	O	2785
linkage	O	2785
maps	O	2785
constructed	O	2785
from	O	2785
families	O	2785
segregating	O	2785
for	O	2785
huntington	B-Disease	2785
disease	I-Disease	2785
(	O	2785
hd	B-Disease	2785
)	O	2785
.	O	2785
carrier	O	2787
detection	O	2787
and	O	2787
prenatal	O	2787
diagnosis	O	2787
of	O	2787
pelizaeus	B-Disease	2787
-	I-Disease	2787
merzbacher	I-Disease	2787
disease	I-Disease	2787
using	O	2787
a	O	2787
combination	O	2787
of	O	2787
anonymous	O	2787
dna	O	2787
polymorphisms	O	2787
and	O	2787
the	O	2787
proteolipid	O	2787
protein	O	2787
(	O	2787
plp	O	2787
)	O	2787
gene	O	2787
cdna	O	2787
.	O	2787
we	O	2788
report	O	2788
carrier	O	2788
identification	O	2788
and	O	2788
a	O	2788
prenatal	O	2788
diagnosis	O	2788
using	O	2788
dna	O	2788
polymorphisms	O	2788
in	O	2788
2	O	2788
families	O	2788
with	O	2788
x	B-Disease	2788
-	I-Disease	2788
linked	I-Disease	2788
pelizaeus	I-Disease	2788
-	I-Disease	2788
merzbacher	I-Disease	2788
disease	I-Disease	2788
(	O	2788
pmd	B-Disease	2788
)	O	2788
.	O	2788
in	O	2791
the	O	2791
case	O	2791
of	O	2791
the	O	2791
prenatal	O	2791
diagnosis	O	2791
,	O	2791
the	O	2791
fetus	O	2791
was	O	2791
shown	O	2791
by	O	2791
cytogenetic	O	2791
analysis	O	2791
to	O	2791
be	O	2791
a	O	2791
female	O	2791
,	O	2791
who	O	2791
we	O	2791
predict	O	2791
will	O	2791
be	O	2791
a	O	2791
noncarrier	O	2791
of	O	2791
pmd	B-Disease	2791
based	O	2791
on	O	2791
her	O	2791
genotype	O	2791
with	O	2791
the	O	2791
plp	O	2791
intragenic	O	2791
polymorphism	O	2791
.	O	2791
.	O	2791
identification	O	2792
of	O	2792
deletion	O	2792
mutations	O	2792
and	O	2792
three	O	2792
new	O	2792
genes	O	2792
at	O	2792
the	O	2792
familial	B-Disease	2792
polyposis	I-Disease	2792
locus	O	2792
.	O	2792
small	O	2793
(	O	2793
100	O	2793
-	O	2793
260	O	2793
kb	O	2793
)	O	2793
,	O	2793
nested	O	2793
deletions	O	2793
were	O	2793
characterized	O	2793
in	O	2793
dna	O	2793
from	O	2793
two	O	2793
unrelated	O	2793
patients	O	2793
with	O	2793
familial	B-Disease	2793
adenomatous	I-Disease	2793
polyposis	I-Disease	2793
coli	I-Disease	2793
(	O	2793
apc	B-Disease	2793
)	O	2793
.	O	2793
exclusion	O	2799
of	O	2799
linkage	O	2799
between	O	2799
familial	B-Disease	2799
mediterranean	I-Disease	2799
fever	I-Disease	2799
and	O	2799
the	O	2799
human	O	2799
serum	O	2799
amyloid	O	2799
a	O	2799
(	O	2799
saa	O	2799
)	O	2799
gene	O	2799
cluster	O	2799
.	O	2799
we	O	2800
studied	O	2800
the	O	2800
relationship	O	2800
between	O	2800
the	O	2800
autosomal	O	2800
recessive	O	2800
trait	O	2800
familial	B-Disease	2800
mediterranean	I-Disease	2800
fever	I-Disease	2800
(	O	2800
fmf	B-Disease	2800
)	O	2800
and	O	2800
the	O	2800
serum	O	2800
amyloid	O	2800
a	O	2800
(	O	2800
saa	O	2800
)	O	2800
genes	O	2800
by	O	2800
comparing	O	2800
alleles	O	2800
of	O	2800
a	O	2800
highly	O	2800
polymorphic	O	2800
dinucleotide	O	2800
repeat	O	2800
and	O	2800
a	O	2800
conventional	O	2800
restriction	O	2800
fragment	O	2800
length	O	2800
polymorphism	O	2800
(	O	2800
rflp	O	2800
)	O	2800
in	O	2800
the	O	2800
saa	O	2800
gene	O	2800
cluster	O	2800
in	O	2800
israeli	O	2800
fmf	B-Disease	2800
kindreds	O	2800
.	O	2800
by	O	2801
haplotype	O	2801
analysis	O	2801
,	O	2801
our	O	2801
data	O	2801
indicate	O	2801
a	O	2801
minimum	O	2801
crossover	O	2801
frequency	O	2801
of	O	2801
22	O	2801
%	O	2801
between	O	2801
the	O	2801
saa	O	2801
gene	O	2801
marker	O	2801
and	O	2801
fmf	B-Disease	2801
.	O	2801
4	O	2803
cm	O	2803
including	O	2803
and	O	2803
surrounding	O	2803
the	O	2803
saa	O	2803
gene	O	2803
cluster	O	2803
as	O	2803
the	O	2803
site	O	2803
of	O	2803
the	O	2803
fmf	B-Disease	2803
mutation	O	2803
although	O	2803
saa	O	2803
proteins	O	2803
are	O	2803
prominent	O	2803
physiologic	O	2803
markers	O	2803
of	O	2803
the	O	2803
acute	O	2803
attacks	O	2803
.	O	2803
prad1	O	2804
,	O	2804
a	O	2804
candidate	O	2804
bcl1	O	2804
oncogene	O	2804
:	O	2804
mapping	O	2804
and	O	2804
expression	O	2804
in	O	2804
centrocytic	B-Disease	2804
lymphoma	I-Disease	2804
.	O	2804
rearrangement	O	2805
of	O	2805
the	O	2805
bcl1	O	2805
(	O	2805
b	O	2805
-	O	2805
cell	O	2805
lymphoma	O	2805
1	O	2805
)	O	2805
region	O	2805
on	O	2805
chromosome	O	2805
11q13	O	2805
appears	O	2805
to	O	2805
be	O	2805
highly	O	2805
characteristic	O	2805
of	O	2805
centrocytic	B-Disease	2805
lymphoma	I-Disease	2805
and	O	2805
also	O	2805
is	O	2805
found	O	2805
infrequently	O	2805
in	O	2805
other	O	2805
b	B-Disease	2805
-	I-Disease	2805
cell	I-Disease	2805
neoplasms	I-Disease	2805
.	O	2805
prad1	O	2807
,	O	2807
previously	O	2807
designated	O	2807
d11s287e	O	2807
,	O	2807
was	O	2807
identified	O	2807
on	O	2807
11q13	O	2807
as	O	2807
a	O	2807
chromosomal	O	2807
breakpoint	O	2807
region	O	2807
rearranged	O	2807
with	O	2807
the	O	2807
parathyroid	O	2807
hormone	O	2807
gene	O	2807
in	O	2807
a	O	2807
subset	O	2807
of	O	2807
parathyroid	B-Disease	2807
adenomas	I-Disease	2807
;	O	2807
this	O	2807
highly	O	2807
conserved	O	2807
putative	O	2807
oncogene	O	2807
,	O	2807
which	O	2807
encodes	O	2807
a	O	2807
novel	O	2807
cyclin	O	2807
,	O	2807
has	O	2807
been	O	2807
linked	O	2807
to	O	2807
bcl1	O	2807
and	O	2807
implicated	O	2807
also	O	2807
in	O	2807
subsets	O	2807
of	O	2807
breast	B-Disease	2807
and	I-Disease	2807
squamous	I-Disease	2807
cell	I-Disease	2807
neoplasms	I-Disease	2807
with	O	2807
11q13	O	2807
amplification	O	2807
.	O	2807
prad1	O	2809
mrna	O	2809
is	O	2809
abundantly	O	2809
expressed	O	2809
in	O	2809
seven	O	2809
of	O	2809
seven	O	2809
centrocytic	B-Disease	2809
lymphomas	I-Disease	2809
(	O	2809
kiel	O	2809
classification	O	2809
)	O	2809
,	O	2809
in	O	2809
contrast	O	2809
to	O	2809
13	O	2809
closely	O	2809
related	O	2809
but	O	2809
noncentrocytic	B-Disease	2809
lymphomas	I-Disease	2809
.	O	2809
three	O	2810
of	O	2810
the	O	2810
seven	O	2810
centrocytic	B-Disease	2810
lymphomas	I-Disease	2810
had	O	2810
detectable	O	2810
bcl1	O	2810
dna	O	2810
rearrangement	O	2810
.	O	2810
its	O	2813
overexpression	O	2813
may	O	2813
be	O	2813
a	O	2813
key	O	2813
consequence	O	2813
of	O	2813
rearrangement	O	2813
of	O	2813
the	O	2813
bcl1	O	2813
vicinity	O	2813
in	O	2813
b	B-Disease	2813
-	I-Disease	2813
cell	I-Disease	2813
neoplasms	I-Disease	2813
and	O	2813
a	O	2813
unifying	O	2813
pathogenetic	O	2813
feature	O	2813
in	O	2813
centrocytic	B-Disease	2813
lymphoma	I-Disease	2813
.	O	2813
two	O	2814
new	O	2814
arylsulfatase	O	2814
a	O	2814
(	O	2814
arsa	O	2814
)	O	2814
mutations	O	2814
in	O	2814
a	O	2814
juvenile	O	2814
metachromatic	B-Disease	2814
leukodystrophy	I-Disease	2814
(	O	2814
mld	B-Disease	2814
)	O	2814
patient	O	2814
.	O	2814
fragments	O	2815
of	O	2815
the	O	2815
arylsulfatase	O	2815
a	O	2815
(	O	2815
arsa	O	2815
)	O	2815
gene	O	2815
from	O	2815
a	O	2815
patient	O	2815
with	O	2815
juvenile	O	2815
-	O	2815
onset	O	2815
metachromatic	B-Disease	2815
leukodystrophy	I-Disease	2815
(	O	2815
mld	B-Disease	2815
)	O	2815
were	O	2815
amplified	O	2815
by	O	2815
pcr	O	2815
and	O	2815
ligated	O	2815
into	O	2815
mp13	O	2815
cloning	O	2815
vectors	O	2815
.	O	2815
a	O	2824
collection	O	2824
of	O	2824
dna	O	2824
samples	O	2824
from	O	2824
known	O	2824
or	O	2824
suspected	O	2824
mld	B-Disease	2824
patients	O	2824
,	O	2824
members	O	2824
of	O	2824
their	O	2824
families	O	2824
,	O	2824
and	O	2824
normal	O	2824
controls	O	2824
was	O	2824
screened	O	2824
for	O	2824
these	O	2824
mutations	O	2824
.	O	2824
four	O	2825
additional	O	2825
individuals	O	2825
carrying	O	2825
each	O	2825
of	O	2825
the	O	2825
mutations	O	2825
were	O	2825
found	O	2825
among	O	2825
the	O	2825
nearly	O	2825
100	O	2825
mld	B-Disease	2825
patients	O	2825
in	O	2825
the	O	2825
sample	O	2825
.	O	2825
however	O	2828
,	O	2828
combinations	O	2828
with	O	2828
other	O	2828
mld	B-Disease	2828
mutations	O	2828
suggest	O	2828
that	O	2828
the	O	2828
point	O	2828
mutation	O	2828
in	O	2828
exon	O	2828
3	O	2828
does	O	2828
result	O	2828
in	O	2828
some	O	2828
residual	O	2828
enzyme	O	2828
activity	O	2828
and	O	2828
is	O	2828
associated	O	2828
with	O	2828
late	O	2828
-	O	2828
onset	O	2828
forms	O	2828
of	O	2828
the	O	2828
disease	O	2828
.	O	2828
the	O	2829
splice	O	2829
-	O	2829
site	O	2829
mutation	O	2829
following	O	2829
exon	O	2829
7	O	2829
produces	O	2829
late	O	2829
-	O	2829
infantile	O	2829
mld	B-Disease	2829
when	O	2829
combined	O	2829
with	O	2829
other	O	2829
enzyme	O	2829
-	O	2829
null	O	2829
mutations	O	2829
,	O	2829
implying	O	2829
that	O	2829
it	O	2829
is	O	2829
completely	O	2829
silent	O	2829
enzymatically	O	2829
.	O	2829
.	O	2829
analysis	O	2830
of	O	2830
x	O	2830
-	O	2830
chromosome	O	2830
inactivation	O	2830
and	O	2830
presumptive	O	2830
expression	O	2830
of	O	2830
the	O	2830
wiskott	B-Disease	2830
-	I-Disease	2830
aldrich	I-Disease	2830
syndrome	I-Disease	2830
(	O	2830
was	B-Disease	2830
)	O	2830
gene	O	2830
in	O	2830
hematopoietic	O	2830
cell	O	2830
lineages	O	2830
of	O	2830
a	O	2830
thrombocytopenic	O	2830
carrier	O	2830
female	O	2830
of	O	2830
was	B-Disease	2830
.	O	2830
we	O	2831
report	O	2831
on	O	2831
a	O	2831
thrombocytopenic	B-Disease	2831
female	O	2831
belonging	O	2831
to	O	2831
a	O	2831
pedigree	O	2831
with	O	2831
the	O	2831
wiskott	B-Disease	2831
-	I-Disease	2831
aldrich	I-Disease	2831
syndrome	I-Disease	2831
(	O	2831
was	B-Disease	2831
)	O	2831
.	O	2831
restriction	O	2832
fragment	O	2832
length	O	2832
polymorphism	O	2832
(	O	2832
rflp	O	2832
)	O	2832
analysis	O	2832
with	O	2832
probe	O	2832
m27	O	2832
beta	O	2832
,	O	2832
closely	O	2832
linked	O	2832
to	O	2832
the	O	2832
was	B-Disease	2832
gene	O	2832
,	O	2832
demonstrated	O	2832
that	O	2832
she	O	2832
is	O	2832
a	O	2832
carrier	O	2832
of	O	2832
was	B-Disease	2832
.	O	2832
both	O	2833
small	O	2833
-	O	2833
sized	O	2833
and	O	2833
normal	O	2833
-	O	2833
sized	O	2833
platelets	O	2833
were	O	2833
present	O	2833
,	O	2833
suggesting	O	2833
that	O	2833
,	O	2833
unlike	O	2833
the	O	2833
vast	O	2833
majority	O	2833
of	O	2833
was	B-Disease	2833
carriers	O	2833
,	O	2833
she	O	2833
does	O	2833
not	O	2833
manifest	O	2833
nonrandom	O	2833
x	O	2833
-	O	2833
chromosome	O	2833
inactivation	O	2833
in	O	2833
the	O	2833
thrombopoietic	O	2833
cell	O	2833
lineage	O	2833
.	O	2833
while	O	2835
this	O	2835
is	O	2835
the	O	2835
first	O	2835
complete	O	2835
report	O	2835
on	O	2835
the	O	2835
occurrence	O	2835
of	O	2835
thrombocytopenia	B-Disease	2835
in	O	2835
a	O	2835
carrier	O	2835
female	O	2835
of	O	2835
was	B-Disease	2835
as	O	2835
the	O	2835
result	O	2835
of	O	2835
atypical	O	2835
lyonization	O	2835
,	O	2835
it	O	2835
also	O	2835
suggests	O	2835
that	O	2835
expression	O	2835
of	O	2835
the	O	2835
was	B-Disease	2835
gene	O	2835
occurs	O	2835
at	O	2835
(	O	2835
or	O	2835
extends	O	2835
up	O	2835
to	O	2835
)	O	2835
a	O	2835
later	O	2835
stage	O	2835
than	O	2835
the	O	2835
multipotent	O	2835
stem	O	2835
cell	O	2835
along	O	2835
the	O	2835
hematopoietic	O	2835
differentiation	O	2835
pathway	O	2835
.	O	2835
.	O	2835
a	O	2836
new	O	2836
mutation	O	2836
in	O	2836
the	O	2836
proteolipid	O	2836
protein	O	2836
(	O	2836
plp	O	2836
)	O	2836
gene	O	2836
in	O	2836
a	O	2836
german	O	2836
family	O	2836
with	O	2836
pelizaeus	B-Disease	2836
-	I-Disease	2836
merzbacher	I-Disease	2836
disease	I-Disease	2836
.	O	2836
a	O	2837
c	O	2837
-	O	2837
to	O	2837
-	O	2837
t	O	2837
transition	O	2837
in	O	2837
exon	O	2837
4	O	2837
of	O	2837
the	O	2837
plp	O	2837
gene	O	2837
was	O	2837
found	O	2837
in	O	2837
2	O	2837
affected	O	2837
males	O	2837
and	O	2837
two	O	2837
obligate	O	2837
carriers	O	2837
in	O	2837
a	O	2837
german	O	2837
family	O	2837
with	O	2837
pelizaeus	B-Disease	2837
-	I-Disease	2837
merzbacher	I-Disease	2837
disease	I-Disease	2837
.	O	2837
a	O	2840
3	O	2840
-	O	2840
base	O	2840
pair	O	2840
in	O	2840
-	O	2840
frame	O	2840
deletion	O	2840
of	O	2840
the	O	2840
phenylalanine	O	2840
hydroxylase	O	2840
gene	O	2840
results	O	2840
in	O	2840
a	O	2840
kinetic	O	2840
variant	O	2840
of	O	2840
phenylketonuria	B-Disease	2840
.	O	2840
phenylketonuria	B-Disease	2841
(	O	2841
pku	B-Disease	2841
)	O	2841
is	O	2841
an	O	2841
autosomal	B-Disease	2841
recessive	I-Disease	2841
disease	I-Disease	2841
due	O	2841
to	O	2841
deficiency	B-Disease	2841
of	I-Disease	2841
a	I-Disease	2841
hepatic	I-Disease	2841
enzyme	I-Disease	2841
,	I-Disease	2841
phenylalanine	I-Disease	2841
hydroxylase	I-Disease	2841
(	O	2841
pah	O	2841
)	O	2841
.	O	2841
the	O	2842
absence	O	2842
of	O	2842
pah	O	2842
activity	O	2842
results	O	2842
in	O	2842
typical	O	2842
pku	B-Disease	2842
while	O	2842
persistence	O	2842
of	O	2842
a	O	2842
residual	O	2842
enzyme	O	2842
activity	O	2842
gives	O	2842
rise	O	2842
to	O	2842
variant	O	2842
forms	O	2842
of	O	2842
the	O	2842
disease	O	2842
.	O	2842
finally	O	2845
,	O	2845
since	O	2845
none	O	2845
of	O	2845
the	O	2845
98	O	2845
pku	B-Disease	2845
patients	O	2845
tested	O	2845
were	O	2845
found	O	2845
to	O	2845
carry	O	2845
this	O	2845
particular	O	2845
deletion	O	2845
,	O	2845
our	O	2845
study	O	2845
suggests	O	2845
that	O	2845
this	O	2845
molecular	O	2845
event	O	2845
probably	O	2845
occurred	O	2845
recently	O	2845
on	O	2845
the	O	2845
background	O	2845
of	O	2845
a	O	2845
haplotype	O	2845
2	O	2845
gene	O	2845
in	O	2845
portugal	O	2845
.	O	2845
.	O	2845
mutation	O	2846
of	O	2846
the	O	2846
kit	O	2846
(	O	2846
mast	O	2846
/	O	2846
stem	O	2846
cell	O	2846
growth	O	2846
factor	O	2846
receptor	O	2846
)	O	2846
protooncogene	O	2846
in	O	2846
human	O	2846
piebaldism	B-Disease	2846
.	O	2846
piebaldism	B-Disease	2847
is	O	2847
an	O	2847
autosomal	B-Disease	2847
dominant	I-Disease	2847
genetic	I-Disease	2847
disorder	I-Disease	2847
characterized	O	2847
by	O	2847
cogenital	O	2847
patches	O	2847
of	O	2847
skin	O	2847
and	O	2847
hair	O	2847
from	O	2847
which	O	2847
melanocytes	O	2847
are	O	2847
completely	O	2847
absent	O	2847
.	O	2847
we	O	2849
identified	O	2849
a	O	2849
kit	O	2849
gene	O	2849
mutation	O	2849
in	O	2849
a	O	2849
proband	O	2849
with	O	2849
classic	O	2849
autosomal	O	2849
dominant	O	2849
piebaldism	B-Disease	2849
.	O	2849
this	O	2851
substitution	O	2851
was	O	2851
not	O	2851
seen	O	2851
in	O	2851
any	O	2851
normal	O	2851
individuals	O	2851
and	O	2851
was	O	2851
completely	O	2851
linked	O	2851
to	O	2851
the	O	2851
piebald	B-Disease	2851
phenotype	O	2851
in	O	2851
the	O	2851
probands	O	2851
family	O	2851
.	O	2851
piebaldism	B-Disease	2852
in	O	2852
this	O	2852
family	O	2852
thus	O	2852
appears	O	2852
to	O	2852
be	O	2852
the	O	2852
human	O	2852
homologue	O	2852
to	O	2852
dominant	O	2852
white	O	2852
spotting	O	2852
(	O	2852
w	O	2852
)	O	2852
of	O	2852
the	O	2852
mouse	O	2852
.	O	2852
.	O	2852
genetic	O	2853
analysis	O	2853
of	O	2853
a	O	2853
japanese	O	2853
family	O	2853
with	O	2853
normotriglyceridemic	B-Disease	2853
abetalipoproteinemia	I-Disease	2853
indicates	O	2853
a	O	2853
lack	O	2853
of	O	2853
linkage	O	2853
to	O	2853
the	O	2853
apolipoprotein	O	2853
b	O	2853
gene	O	2853
.	O	2853
normotriglyceridemic	B-Disease	2854
abetalipoproteinemia	I-Disease	2854
is	O	2854
a	O	2854
rare	O	2854
familial	B-Disease	2854
disorder	I-Disease	2854
characterized	O	2854
by	O	2854
an	O	2854
isolated	O	2854
deficiency	B-Disease	2854
of	I-Disease	2854
apob	I-Disease	2854
-	I-Disease	2854
100	I-Disease	2854
.	O	2854
to	O	2856
elucidate	O	2856
the	O	2856
genetic	B-Disease	2856
abnormalities	I-Disease	2856
in	O	2856
this	O	2856
family	O	2856
,	O	2856
we	O	2856
studied	O	2856
the	O	2856
linkage	O	2856
of	O	2856
apob	O	2856
gene	O	2856
using	O	2856
three	O	2856
genetic	O	2856
markers	O	2856
.	O	2856
localisation	O	2860
of	O	2860
the	O	2860
gene	O	2860
for	O	2860
norrie	B-Disease	2860
disease	I-Disease	2860
to	O	2860
between	O	2860
dxs7	O	2860
and	O	2860
dxs426	O	2860
on	O	2860
xp	O	2860
.	O	2860
23	O	2863
,	O	2863
has	O	2863
been	O	2863
used	O	2863
to	O	2863
refine	O	2863
further	O	2863
the	O	2863
localisation	O	2863
of	O	2863
the	O	2863
gene	O	2863
for	O	2863
norrie	B-Disease	2863
disease	I-Disease	2863
(	O	2863
ndp	B-Disease	2863
)	O	2863
.	O	2863
the	O	2864
results	O	2864
from	O	2864
a	O	2864
multiply	O	2864
informative	O	2864
crossover	O	2864
localize	O	2864
the	O	2864
ndp	B-Disease	2864
gene	O	2864
proximal	O	2864
to	O	2864
dxs7	O	2864
.	O	2864
in	O	2865
conjunction	O	2865
with	O	2865
information	O	2865
from	O	2865
2	O	2865
ndp	B-Disease	2865
patients	O	2865
who	O	2865
have	O	2865
a	O	2865
deletion	O	2865
for	O	2865
dxs7	O	2865
but	O	2865
not	O	2865
for	O	2865
dsx426	O	2865
,	O	2865
our	O	2865
data	O	2865
indicate	O	2865
that	O	2865
the	O	2865
ndp	B-Disease	2865
gene	O	2865
lies	O	2865
between	O	2865
dxs7	O	2865
and	O	2865
dxs426	O	2865
on	O	2865
proximal	O	2865
xp	O	2865
.	O	2865
aberrant	O	2866
splicing	O	2866
of	O	2866
phenylalanine	O	2866
hydroxylase	O	2866
mrna	O	2866
:	O	2866
the	O	2866
major	O	2866
cause	O	2866
for	O	2866
phenylketonuria	B-Disease	2866
in	O	2866
parts	O	2866
of	O	2866
southern	O	2866
europe	O	2866
.	O	2866
because	O	2868
of	O	2868
the	O	2868
high	O	2868
frequency	O	2868
of	O	2868
these	O	2868
particular	O	2868
haplotypes	O	2868
in	O	2868
bulgaria	O	2868
,	O	2868
italy	O	2868
,	O	2868
and	O	2868
turkey	O	2868
,	O	2868
it	O	2868
appears	O	2868
to	O	2868
be	O	2868
one	O	2868
of	O	2868
the	O	2868
more	O	2868
frequent	O	2868
defects	O	2868
in	O	2868
the	O	2868
pah	O	2868
gene	O	2868
causing	O	2868
classical	O	2868
phenylketonuria	B-Disease	2868
in	O	2868
this	O	2868
part	O	2868
of	O	2868
europe	O	2868
.	O	2868
gardner	B-Disease	2873
syndrome	I-Disease	2873
in	O	2873
a	O	2873
boy	O	2873
with	O	2873
interstitial	O	2873
deletion	O	2873
of	O	2873
the	O	2873
long	O	2873
arm	O	2873
of	O	2873
chromosome	O	2873
5	O	2873
.	O	2873
we	O	2874
described	O	2874
a	O	2874
15	O	2874
-	O	2874
year	O	2874
-	O	2874
old	O	2874
boy	O	2874
with	O	2874
gardner	B-Disease	2874
syndrome	I-Disease	2874
(	O	2874
gs	B-Disease	2874
)	O	2874
,	O	2874
mental	B-Disease	2874
retardation	I-Disease	2874
,	O	2874
and	O	2874
craniofacial	B-Disease	2874
abnormalities	I-Disease	2874
.	O	2874
the	O	2876
breakpoints	O	2876
in	O	2876
the	O	2876
present	O	2876
case	O	2876
and	O	2876
in	O	2876
3	O	2876
previously	O	2876
reported	O	2876
5q	O	2876
-	O	2876
patients	O	2876
with	O	2876
adenomatous	B-Disease	2876
polyposis	I-Disease	2876
coli	I-Disease	2876
suggest	O	2876
that	O	2876
the	O	2876
gene	O	2876
responsible	O	2876
for	O	2876
gs	B-Disease	2876
/	O	2876
or	O	2876
familial	B-Disease	2876
polyposis	I-Disease	2876
coli	I-Disease	2876
(	O	2876
fpc	B-Disease	2876
)	O	2876
is	O	2876
in	O	2876
the	O	2876
5q22	O	2876
region	O	2876
,	O	2876
a	O	2876
result	O	2876
consistent	O	2876
with	O	2876
the	O	2876
findings	O	2876
of	O	2876
linkage	O	2876
studies	O	2876
huntington	B-Disease	2877
disease	I-Disease	2877
and	O	2877
childhood	O	2877
-	O	2877
onset	O	2877
tourette	B-Disease	2877
syndrome	I-Disease	2877
.	O	2877
a	O	2878
40	O	2878
-	O	2878
year	O	2878
-	O	2878
old	O	2878
man	O	2878
with	O	2878
childhood	O	2878
-	O	2878
onset	O	2878
tourette	B-Disease	2878
syndrome	I-Disease	2878
(	O	2878
ts	B-Disease	2878
)	O	2878
developed	O	2878
huntington	B-Disease	2878
disease	I-Disease	2878
(	O	2878
hd	B-Disease	2878
)	O	2878
.	O	2878
we	O	2879
believe	O	2879
this	O	2879
to	O	2879
be	O	2879
the	O	2879
first	O	2879
reported	O	2879
case	O	2879
of	O	2879
childhood	O	2879
-	O	2879
onset	O	2879
ts	B-Disease	2879
with	O	2879
adult	O	2879
onset	O	2879
hd	B-Disease	2879
.	O	2879
sequence	O	2881
of	O	2881
dna	O	2881
flanking	O	2881
the	O	2881
exons	O	2881
of	O	2881
the	O	2881
hexa	O	2881
gene	O	2881
,	O	2881
and	O	2881
identification	O	2881
of	O	2881
mutations	O	2881
in	O	2881
tay	B-Disease	2881
-	I-Disease	2881
sachs	I-Disease	2881
disease	I-Disease	2881
.	O	2881
the	O	2882
rapid	O	2882
identification	O	2882
of	O	2882
mutations	O	2882
causing	O	2882
tay	B-Disease	2882
-	I-Disease	2882
sachs	I-Disease	2882
disease	I-Disease	2882
requires	O	2882
the	O	2882
capacity	O	2882
to	O	2882
readily	O	2882
screen	O	2882
the	O	2882
regions	O	2882
of	O	2882
the	O	2882
hexa	O	2882
gene	O	2882
most	O	2882
likely	O	2882
to	O	2882
be	O	2882
affected	O	2882
by	O	2882
mutation	O	2882
.	O	2882
five	O	2885
novel	O	2885
mutations	O	2885
from	O	2885
tay	B-Disease	2885
-	I-Disease	2885
sachs	I-Disease	2885
disease	I-Disease	2885
patients	O	2885
were	O	2885
detected	O	2885
a	O	2885
5	O	2885
-	O	2885
bp	O	2885
deletion	O	2885
of	O	2885
tctcc	O	2885
in	O	2885
ivs	O	2885
-	O	2885
9	O	2885
;	O	2885
a	O	2885
2	O	2885
-	O	2885
bp	O	2885
deletion	O	2885
of	O	2885
tg	O	2885
in	O	2885
exon	O	2885
5	O	2885
;	O	2885
g78	O	2885
to	O	2885
a	O	2885
,	O	2885
giving	O	2885
a	O	2885
stop	O	2885
codon	O	2885
in	O	2885
exon	O	2885
1	O	2885
;	O	2885
g533	O	2885
to	O	2885
t	O	2885
in	O	2885
exon	O	2885
5	O	2885
,	O	2885
producing	O	2885
the	O	2885
third	O	2885
amino	O	2885
acid	O	2885
substitution	O	2885
detected	O	2885
at	O	2885
this	O	2885
site	O	2885
;	O	2885
and	O	2885
g	O	2885
to	O	2885
c	O	2885
at	O	2885
position	O	2885
1	O	2885
of	O	2885
ivs	O	2885
-	O	2885
2	O	2885
,	O	2885
expected	O	2885
to	O	2885
produce	O	2885
abnormal	O	2885
splicing	O	2885
.	O	2885
molecular	O	2887
characterization	O	2887
of	O	2887
two	O	2887
galactosemia	B-Disease	2887
mutations	O	2887
:	O	2887
correlation	O	2887
of	O	2887
mutations	O	2887
with	O	2887
highly	O	2887
conserved	O	2887
domains	O	2887
in	O	2887
galactose	O	2887
-	O	2887
1	O	2887
-	O	2887
phosphate	O	2887
uridyl	O	2887
transferase	O	2887
.	O	2887
galactosemia	B-Disease	2888
is	O	2888
an	O	2888
autosomal	B-Disease	2888
recessive	I-Disease	2888
disorder	I-Disease	2888
of	I-Disease	2888
human	I-Disease	2888
galactose	I-Disease	2888
metabolism	I-Disease	2888
caused	O	2888
by	O	2888
deficiency	B-Disease	2888
of	I-Disease	2888
the	I-Disease	2888
enzyme	I-Disease	2888
galactose	I-Disease	2888
-	I-Disease	2888
1	I-Disease	2888
-	I-Disease	2888
phosphate	I-Disease	2888
uridyl	I-Disease	2888
transferase	I-Disease	2888
(	O	2888
galt	O	2888
)	O	2888
.	O	2888
the	O	2893
arginine	O	2893
188	O	2893
mutation	O	2893
is	O	2893
the	O	2893
most	O	2893
common	O	2893
galactosemia	B-Disease	2893
mutation	O	2893
characterized	O	2893
to	O	2893
date	O	2893
.	O	2893
it	O	2894
accounts	O	2894
for	O	2894
one	O	2894
-	O	2894
fourth	O	2894
of	O	2894
the	O	2894
galactosemia	B-Disease	2894
alleles	O	2894
studied	O	2894
.	O	2894
our	O	2898
data	O	2898
provide	O	2898
further	O	2898
evidence	O	2898
for	O	2898
the	O	2898
heterogeneity	O	2898
of	O	2898
galactosemia	B-Disease	2898
at	O	2898
the	O	2898
molecular	O	2898
level	O	2898
,	O	2898
heterogeneity	O	2898
which	O	2898
might	O	2898
be	O	2898
related	O	2898
to	O	2898
the	O	2898
variable	O	2898
clinical	O	2898
outcome	O	2898
observed	O	2898
in	O	2898
this	O	2898
disorder	O	2898
.	O	2898
.	O	2898
hypoxanthine	B-Disease	2899
-	I-Disease	2899
guanine	I-Disease	2899
phosphoribosyltransferase	I-Disease	2899
deficiency	I-Disease	2899
:	O	2899
analysis	O	2899
of	O	2899
hprt	O	2899
mutations	O	2899
by	O	2899
direct	O	2899
sequencing	O	2899
and	O	2899
allele	O	2899
-	O	2899
specific	O	2899
amplification	O	2899
.	O	2899
the	O	2900
lesch	B-Disease	2900
-	I-Disease	2900
nyhan	I-Disease	2900
syndrome	I-Disease	2900
is	O	2900
a	O	2900
severe	O	2900
x	B-Disease	2900
chromosome	I-Disease	2900
-	I-Disease	2900
linked	I-Disease	2900
human	I-Disease	2900
disease	I-Disease	2900
caused	O	2900
by	O	2900
a	O	2900
virtual	O	2900
absence	B-Disease	2900
of	I-Disease	2900
hypoxanthine	I-Disease	2900
-	I-Disease	2900
guanine	I-Disease	2900
phosphoribosyltransferase	I-Disease	2900
(	I-Disease	2900
hprt	I-Disease	2900
)	I-Disease	2900
activity	I-Disease	2900
.	O	2900
a	O	2901
partial	O	2901
deficiency	O	2901
in	O	2901
the	O	2901
activity	O	2901
of	O	2901
this	O	2901
enzyme	O	2901
can	O	2901
result	O	2901
in	O	2901
gouty	B-Disease	2901
arthritis	I-Disease	2901
.	O	2901
to	O	2902
determine	O	2902
the	O	2902
genetic	O	2902
basis	O	2902
for	O	2902
reduction	O	2902
or	O	2902
loss	O	2902
of	O	2902
enzyme	O	2902
activity	O	2902
,	O	2902
we	O	2902
have	O	2902
amplified	O	2902
and	O	2902
sequenced	O	2902
the	O	2902
coding	O	2902
region	O	2902
of	O	2902
hprt	O	2902
cdna	O	2902
from	O	2902
four	O	2902
patients	O	2902
one	O	2902
with	O	2902
lesch	B-Disease	2902
-	I-Disease	2902
nyhan	I-Disease	2902
syndrome	I-Disease	2902
(	O	2902
hprtperth	O	2902
)	O	2902
and	O	2902
three	O	2902
with	O	2902
partial	B-Disease	2902
deficiencies	I-Disease	2902
of	I-Disease	2902
hprt	I-Disease	2902
activity	I-Disease	2902
,	O	2902
which	O	2902
have	O	2902
been	O	2902
designated	O	2902
hprturangan	O	2902
,	O	2902
hprtswan	O	2902
and	O	2902
hprttoowong	O	2902
.	O	2902
molecular	O	2907
and	O	2907
metabolic	O	2907
basis	O	2907
for	O	2907
the	O	2907
metabolic	B-Disease	2907
disorder	I-Disease	2907
normotriglyceridemic	B-Disease	2907
abetalipoproteinemia	I-Disease	2907
.	O	2907
we	O	2908
have	O	2908
previously	O	2908
described	O	2908
a	O	2908
disorder	O	2908
,	O	2908
normotriglyceridemic	B-Disease	2908
abetalipoproteinemia	I-Disease	2908
,	O	2908
that	O	2908
is	O	2908
characterized	O	2908
by	O	2908
the	O	2908
virtual	O	2908
absence	O	2908
of	O	2908
plasma	O	2908
low	O	2908
density	O	2908
lipoproteins	O	2908
and	O	2908
complete	O	2908
absence	O	2908
of	O	2908
apob	O	2908
-	O	2908
100	O	2908
,	O	2908
but	O	2908
with	O	2908
apparently	O	2908
normal	O	2908
secretion	O	2908
of	O	2908
triglyceride	O	2908
-	O	2908
rich	O	2908
lipoproteins	O	2908
containing	O	2908
apob	O	2908
-	O	2908
48	O	2908
.	O	2908
thus	O	2911
,	O	2911
this	O	2911
is	O	2911
a	O	2911
rare	O	2911
example	O	2911
of	O	2911
homozygous	B-Disease	2911
hypobetalipoproteinemia	I-Disease	2911
.	O	2911
a	O	2920
single	O	2920
origin	O	2920
of	O	2920
phenylketonuria	B-Disease	2920
in	O	2920
yemenite	O	2920
jews	O	2920
.	O	2920
phenylketonuria	B-Disease	2921
(	O	2921
pku	B-Disease	2921
)	O	2921
is	O	2921
a	O	2921
metabolic	B-Disease	2921
disease	I-Disease	2921
caused	O	2921
by	O	2921
recessive	O	2921
mutations	O	2921
of	O	2921
the	O	2921
gene	O	2921
encoding	O	2921
the	O	2921
hepatic	O	2921
enzyme	O	2921
phenylalanine	O	2921
hydroxylase	O	2921
(	O	2921
pah	O	2921
)	O	2921
.	O	2921
the	O	2922
incidence	O	2922
of	O	2922
pku	B-Disease	2922
varies	O	2922
widely	O	2922
across	O	2922
different	O	2922
geographic	O	2922
areas	O	2922
,	O	2922
and	O	2922
is	O	2922
highest	O	2922
(	O	2922
about	O	2922
1	O	2922
in	O	2922
5	O	2922
,	O	2922
000	O	2922
live	O	2922
births	O	2922
)	O	2922
in	O	2922
ireland	O	2922
and	O	2922
western	O	2922
scotland	O	2922
,	O	2922
and	O	2922
among	O	2922
yemenite	O	2922
jews	O	2922
.	O	2922
a	O	2923
limited	O	2923
number	O	2923
of	O	2923
point	O	2923
mutations	O	2923
account	O	2923
for	O	2923
most	O	2923
of	O	2923
the	O	2923
pku	B-Disease	2923
cases	O	2923
in	O	2923
the	O	2923
european	O	2923
population	O	2923
.	O	2923
here	O	2924
we	O	2924
report	O	2924
that	O	2924
a	O	2924
single	O	2924
molecular	O	2924
defect	O	2924
-	O	2924
-	O	2924
a	O	2924
deletion	O	2924
spanning	O	2924
the	O	2924
third	O	2924
exon	O	2924
of	O	2924
the	O	2924
pah	O	2924
gene	O	2924
-	O	2924
-	O	2924
is	O	2924
responsible	O	2924
for	O	2924
all	O	2924
the	O	2924
pku	B-Disease	2924
cases	O	2924
among	O	2924
the	O	2924
yemenite	O	2924
jews	O	2924
.	O	2924
although	O	2926
the	O	2926
deleted	O	2926
pah	O	2926
gene	O	2926
was	O	2926
traced	O	2926
to	O	2926
25	O	2926
different	O	2926
locations	O	2926
throughout	O	2926
yemen	O	2926
,	O	2926
family	O	2926
histories	O	2926
and	O	2926
official	O	2926
documents	O	2926
of	O	2926
the	O	2926
yemenite	O	2926
jewish	O	2926
community	O	2926
showed	O	2926
that	O	2926
the	O	2926
common	O	2926
ancestor	O	2926
of	O	2926
all	O	2926
the	O	2926
carriers	O	2926
of	O	2926
this	O	2926
genetic	B-Disease	2926
defect	I-Disease	2926
lived	O	2926
in	O	2926
sana	O	2926
,	O	2926
the	O	2926
capital	O	2926
of	O	2926
yemen	O	2926
,	O	2926
before	O	2926
the	O	2926
eighteenth	O	2926
century	O	2926
.	O	2926
.	O	2926
linkage	O	2927
of	O	2927
aspartylglucosaminuria	B-Disease	2927
(	O	2927
agu	B-Disease	2927
)	O	2927
to	O	2927
marker	O	2927
loci	O	2927
on	O	2927
the	O	2927
long	O	2927
arm	O	2927
of	O	2927
chromosome	O	2927
4	O	2927
.	O	2927
aspartylglucosaminuria	B-Disease	2928
(	O	2928
agu	B-Disease	2928
)	O	2928
is	O	2928
caused	O	2928
by	O	2928
deficient	O	2928
activity	O	2928
of	O	2928
the	O	2928
enzyme	O	2928
aspartylglucosaminidase	O	2928
(	O	2928
aga	O	2928
)	O	2928
.	O	2928
restriction	O	2931
fragment	O	2931
length	O	2931
polymorphism	O	2931
alleles	O	2931
for	O	2931
the	O	2931
adh2	O	2931
,	O	2931
adh3	O	2931
,	O	2931
egf	O	2931
,	O	2931
fg	O	2931
alpha	O	2931
and	O	2931
fg	O	2931
beta	O	2931
loci	O	2931
and	O	2931
blood	O	2931
group	O	2931
antigens	O	2931
for	O	2931
the	O	2931
mns	O	2931
locus	O	2931
were	O	2931
determined	O	2931
in	O	2931
a	O	2931
panel	O	2931
of	O	2931
12	O	2931
finnish	O	2931
agu	B-Disease	2931
families	O	2931
.	O	2931
loose	O	2934
linkage	O	2934
of	O	2934
the	O	2934
agu	B-Disease	2934
locus	O	2934
to	O	2934
the	O	2934
fg	O	2934
and	O	2934
mns	O	2934
loci	O	2934
was	O	2934
observed	O	2934
(	O	2934
z	O	2934
=	O	2934
1	O	2934
.	O	2934
16	O	2934
,	O	2934
z	O	2934
=	O	2934
1	O	2934
.	O	2934
39	O	2934
,	O	2934
respectively	O	2934
)	O	2934
.	O	2934
linkage	O	2939
relationships	O	2939
of	O	2939
the	O	2939
apolipoprotein	O	2939
c1	O	2939
gene	O	2939
and	O	2939
a	O	2939
cytochrome	O	2939
p450	O	2939
gene	O	2939
(	O	2939
cyp2a	O	2939
)	O	2939
to	O	2939
myotonic	B-Disease	2939
dystrophy	I-Disease	2939
.	O	2939
we	O	2940
have	O	2940
studied	O	2940
the	O	2940
genetic	O	2940
linkage	O	2940
of	O	2940
two	O	2940
markers	O	2940
,	O	2940
the	O	2940
apolipoprotein	O	2940
c1	O	2940
(	O	2940
apoc1	O	2940
)	O	2940
gene	O	2940
and	O	2940
a	O	2940
cytochrome	O	2940
p450	O	2940
(	O	2940
cyp2a	O	2940
)	O	2940
gene	O	2940
,	O	2940
in	O	2940
relation	O	2940
to	O	2940
the	O	2940
gene	O	2940
for	O	2940
myotonic	B-Disease	2940
dystrophy	I-Disease	2940
(	O	2940
dm	B-Disease	2940
)	O	2940
.	O	2940
genetic	O	2948
linkage	O	2948
map	O	2948
of	O	2948
six	O	2948
polymorphic	O	2948
dna	O	2948
markers	O	2948
around	O	2948
the	O	2948
gene	O	2948
for	O	2948
familial	B-Disease	2948
adenomatous	I-Disease	2948
polyposis	I-Disease	2948
on	O	2948
chromosome	O	2948
5	O	2948
.	O	2948
a	O	2949
genetic	O	2949
linkage	O	2949
map	O	2949
of	O	2949
six	O	2949
polymorphic	O	2949
dna	O	2949
markers	O	2949
close	O	2949
to	O	2949
the	O	2949
gene	O	2949
(	O	2949
apc	O	2949
)	O	2949
for	O	2949
familial	B-Disease	2949
adenomatous	I-Disease	2949
polyposis	I-Disease	2949
(	O	2949
fap	B-Disease	2949
)	O	2949
on	O	2949
chromosome	O	2949
5q	O	2949
is	O	2949
reported	O	2949
.	O	2949
one	O	2950
hundred	O	2950
fifty	O	2950
-	O	2950
five	O	2950
typed	O	2950
members	O	2950
of	O	2950
nine	O	2950
fap	B-Disease	2950
kindred	O	2950
provided	O	2950
more	O	2950
than	O	2950
90	O	2950
meioses	O	2950
for	O	2950
linkage	O	2950
analysis	O	2950
.	O	2950
48	O	2962
,	O	2962
but	O	2962
published	O	2962
deletion	O	2962
mapping	O	2962
in	O	2962
colorectal	B-Disease	2962
carcinomas	I-Disease	2962
and	O	2962
linkage	O	2962
analysis	O	2962
in	O	2962
fap	B-Disease	2962
suggest	O	2962
that	O	2962
yn5	O	2962
.	O	2962
44	O	2967
locus	O	2967
lies	O	2967
very	O	2967
close	O	2967
to	O	2967
the	O	2967
apc	B-Disease	2967
gene	O	2967
.	O	2967
these	O	2968
data	O	2968
not	O	2968
only	O	2968
allow	O	2968
use	O	2968
of	O	2968
flanking	O	2968
markers	O	2968
for	O	2968
presymptomatic	O	2968
diagnosis	O	2968
of	O	2968
fap	B-Disease	2968
but	O	2968
also	O	2968
provide	O	2968
a	O	2968
high	O	2968
-	O	2968
density	O	2968
map	O	2968
of	O	2968
the	O	2968
region	O	2968
for	O	2968
isolation	O	2968
of	O	2968
the	O	2968
apc	B-Disease	2968
gene	O	2968
itself	O	2968
and	O	2968
for	O	2968
further	O	2968
assessment	O	2968
of	O	2968
the	O	2968
role	O	2968
of	O	2968
chromosome	O	2968
5	O	2968
deletions	O	2968
in	O	2968
the	O	2968
biology	O	2968
of	O	2968
sporadic	O	2968
colorectal	B-Disease	2968
cancer	I-Disease	2968
.	O	2968
serum	O	2969
amyloid	O	2969
a	O	2969
and	O	2969
p	O	2969
protein	O	2969
genes	O	2969
in	O	2969
familial	B-Disease	2969
mediterranean	I-Disease	2969
fever	I-Disease	2969
.	O	2969
two	O	2970
recent	O	2970
studies	O	2970
have	O	2970
suggested	O	2970
the	O	2970
involvement	O	2970
of	O	2970
serum	O	2970
amyloid	O	2970
a	O	2970
(	O	2970
saa	O	2970
)	O	2970
and	O	2970
p	O	2970
(	O	2970
apcs	O	2970
)	O	2970
genes	O	2970
in	O	2970
familial	B-Disease	2970
mediterranean	I-Disease	2970
fever	I-Disease	2970
(	O	2970
mef	B-Disease	2970
)	O	2970
.	O	2970
to	O	2971
test	O	2971
the	O	2971
role	O	2971
of	O	2971
saa	O	2971
and	O	2971
apcs	O	2971
in	O	2971
mef	B-Disease	2971
and	O	2971
mef	B-Disease	2971
-	I-Disease	2971
amyloidosis	I-Disease	2971
,	O	2971
we	O	2971
studied	O	2971
17	O	2971
informative	O	2971
families	O	2971
(	O	2971
15	O	2971
armenians	O	2971
,	O	2971
2	O	2971
non	O	2971
-	O	2971
ashkenazi	O	2971
jews	O	2971
)	O	2971
and	O	2971
8	O	2971
mef	B-Disease	2971
patients	O	2971
with	O	2971
amyloidosis	B-Disease	2971
using	O	2971
a	O	2971
candidate	O	2971
gene	O	2971
approach	O	2971
.	O	2971
no	O	2972
evidence	O	2972
for	O	2972
any	O	2972
mef	B-Disease	2972
-	O	2972
associated	O	2972
polymorphism	O	2972
was	O	2972
found	O	2972
in	O	2972
any	O	2972
of	O	2972
the	O	2972
41	O	2972
armenian	O	2972
and	O	2972
jewish	O	2972
mef	B-Disease	2972
patients	O	2972
tested	O	2972
.	O	2972
our	O	2973
family	O	2973
studies	O	2973
allowed	O	2973
us	O	2973
to	O	2973
rule	O	2973
out	O	2973
tight	O	2973
linkage	O	2973
between	O	2973
saa	O	2973
and	O	2973
mef	B-Disease	2973
(	O	2973
lod	O	2973
score	O	2973
=	O	2973
-	O	2973
2	O	2973
.	O	2973
16	O	2973
,	O	2973
theta	O	2973
less	O	2973
than	O	2973
or	O	2973
equal	O	2973
to	O	2973
0	O	2973
.	O	2973
06	O	2973
)	O	2973
.	O	2973
for	O	2974
apcs	O	2974
we	O	2974
found	O	2974
that	O	2974
the	O	2974
allele	O	2974
frequency	O	2974
in	O	2974
the	O	2974
mef	B-Disease	2974
-	I-Disease	2974
amyloidosis	I-Disease	2974
patients	O	2974
was	O	2974
similar	O	2974
to	O	2974
that	O	2974
in	O	2974
18	O	2974
unrelated	O	2974
mef	B-Disease	2974
patients	O	2974
without	O	2974
amyloidosis	B-Disease	2974
and	O	2974
their	O	2974
33	O	2974
healthy	O	2974
parents	O	2974
.	O	2974
glucose	B-Disease	2976
-	I-Disease	2976
6	I-Disease	2976
-	I-Disease	2976
phosphate	I-Disease	2976
dehydrogenase	I-Disease	2976
(	I-Disease	2976
g6pd	I-Disease	2976
)	I-Disease	2976
deficiency	I-Disease	2976
appears	O	2976
to	O	2976
be	O	2976
fairly	O	2976
common	O	2976
in	O	2976
mexico	O	2976
.	O	2976
two	O	2979
other	O	2979
mexican	O	2979
males	O	2979
with	O	2979
g6pd	B-Disease	2979
deficiency	I-Disease	2979
were	O	2979
found	O	2979
to	O	2979
have	O	2979
the	O	2979
same	O	2979
mutation	O	2979
.	O	2979
hereditary	O	2982
deficiency	B-Disease	2982
of	I-Disease	2982
c5	I-Disease	2982
in	O	2982
association	O	2982
with	O	2982
discoid	B-Disease	2982
lupus	I-Disease	2982
erythematosus	I-Disease	2982
.	O	2982
a	O	2983
29	O	2983
-	O	2983
year	O	2983
-	O	2983
old	O	2983
woman	O	2983
with	O	2983
discoid	B-Disease	2983
lupus	I-Disease	2983
erythematosus	I-Disease	2983
had	O	2983
undetectable	O	2983
classic	O	2983
pathway	O	2983
complement	O	2983
activity	O	2983
.	O	2983
hypocomplementemia	B-Disease	2984
was	O	2984
due	O	2984
to	O	2984
selective	O	2984
deficiency	B-Disease	2984
of	I-Disease	2984
c5	I-Disease	2984
.	O	2984
to	O	2986
our	O	2986
knowledge	O	2986
this	O	2986
is	O	2986
the	O	2986
first	O	2986
documented	O	2986
case	O	2986
of	O	2986
an	O	2986
association	O	2986
between	O	2986
discoid	B-Disease	2986
lupus	I-Disease	2986
erythematosus	I-Disease	2986
and	O	2986
c5	B-Disease	2986
deficiency	I-Disease	2986
.	O	2986
.	O	2986
founder	O	2987
effect	O	2987
of	O	2987
a	O	2987
prevalent	O	2987
phenylketonuria	B-Disease	2987
mutation	O	2987
in	O	2987
the	O	2987
oriental	O	2987
population	O	2987
.	O	2987
a	O	2988
missense	O	2988
mutation	O	2988
has	O	2988
been	O	2988
identified	O	2988
in	O	2988
the	O	2988
human	O	2988
phenylalanine	O	2988
hydroxylase	O	2988
[	O	2988
pah	O	2988
;	O	2988
phenylalanine	O	2988
4	O	2988
-	O	2988
monooxygenase	O	2988
;	O	2988
l	O	2988
-	O	2988
phenylalanine	O	2988
,	O	2988
tetrahydrobiopterin	O	2988
oxygen	O	2988
oxidoreductase	O	2988
(	O	2988
4	O	2988
-	O	2988
hydroxylating	O	2988
)	O	2988
,	O	2988
ec	O	2988
1	O	2988
.	O	2988
14	O	2988
.	O	2988
16	O	2988
.	O	2988
1	O	2988
]	O	2988
gene	O	2988
in	O	2988
a	O	2988
chinese	O	2988
patient	O	2988
with	O	2988
classic	O	2988
phenylketonuria	B-Disease	2988
(	O	2988
pku	B-Disease	2988
)	O	2988
.	O	2988
this	O	2990
mutation	O	2990
(	O	2990
r413p	O	2990
)	O	2990
results	O	2990
in	O	2990
negligible	O	2990
enzymatic	O	2990
activity	O	2990
when	O	2990
expressed	O	2990
in	O	2990
heterologous	O	2990
mammalian	O	2990
cells	O	2990
and	O	2990
is	O	2990
compatible	O	2990
with	O	2990
a	O	2990
classic	O	2990
pku	B-Disease	2990
phenotype	O	2990
in	O	2990
the	O	2990
patient	O	2990
.	O	2990
8	O	2993
%	O	2993
of	O	2993
northern	O	2993
chinese	O	2993
and	O	2993
27	O	2993
%	O	2993
of	O	2993
japanese	O	2993
pku	B-Disease	2993
alleles	O	2993
,	O	2993
but	O	2993
it	O	2993
is	O	2993
rare	O	2993
in	O	2993
southern	O	2993
chinese	O	2993
(	O	2993
2	O	2993
.	O	2993
2	O	2993
%	O	2993
)	O	2993
and	O	2993
is	O	2993
absent	O	2993
in	O	2993
the	O	2993
caucasian	O	2993
population	O	2993
.	O	2993
our	O	2996
results	O	2996
are	O	2996
compatible	O	2996
with	O	2996
this	O	2996
hypothesis	O	2996
in	O	2996
that	O	2996
the	O	2996
pku	B-Disease	2996
mutation	O	2996
might	O	2996
have	O	2996
occurred	O	2996
in	O	2996
northern	O	2996
mongoloids	O	2996
and	O	2996
subsequently	O	2996
spread	O	2996
to	O	2996
the	O	2996
chinese	O	2996
and	O	2996
japanese	O	2996
populations	O	2996
.	O	2996
glucose	B-Disease	2997
/	I-Disease	2997
galactose	I-Disease	2997
malabsorption	I-Disease	2997
caused	O	2997
by	O	2997
a	O	2997
defect	O	2997
in	O	2997
the	O	2997
na	O	2997
+	O	2997
/	O	2997
glucose	O	2997
cotransporter	O	2997
.	O	2997
glucose	B-Disease	2998
/	I-Disease	2998
galactose	I-Disease	2998
malabsorption	I-Disease	2998
(	O	2998
ggm	B-Disease	2998
)	O	2998
is	O	2998
an	O	2998
autosomal	B-Disease	2998
recessive	I-Disease	2998
disease	I-Disease	2998
manifesting	O	2998
within	O	2998
the	O	2998
first	O	2998
weeks	O	2998
of	O	2998
life	O	2998
and	O	2998
characterized	O	2998
by	O	2998
a	O	2998
selective	O	2998
failure	O	2998
to	O	2998
absorb	O	2998
dietary	O	2998
glucose	O	2998
and	O	2998
galactose	O	2998
from	O	2998
the	O	2998
intestine	O	2998
.	O	2998
the	O	2999
consequent	O	2999
severe	O	2999
diarrhoea	B-Disease	2999
and	O	2999
dehydration	B-Disease	2999
are	O	2999
usually	O	2999
fatal	O	2999
unless	O	2999
these	O	2999
sugars	O	2999
are	O	2999
eliminated	O	2999
from	O	2999
the	O	2999
diet	O	2999
.	O	2999
intestinal	O	3000
biopsies	O	3000
of	O	3000
ggm	B-Disease	3000
patients	O	3000
have	O	3000
revealed	O	3000
a	O	3000
specific	O	3000
defect	O	3000
in	O	3000
na	O	3000
(	O	3000
+	O	3000
)	O	3000
-	O	3000
dependent	O	3000
absorption	O	3000
of	O	3000
glucose	O	3000
in	O	3000
the	O	3000
brush	O	3000
border	O	3000
.	O	3000
we	O	3004
have	O	3004
now	O	3004
amplified	O	3004
sglt1	O	3004
complementary	O	3004
dna	O	3004
and	O	3004
genomic	O	3004
dna	O	3004
from	O	3004
members	O	3004
of	O	3004
a	O	3004
family	O	3004
affected	O	3004
with	O	3004
ggm	B-Disease	3004
by	O	3004
the	O	3004
polymerase	O	3004
chain	O	3004
reaction	O	3004
.	O	3004
sequence	O	3005
analysis	O	3005
of	O	3005
the	O	3005
amplified	O	3005
products	O	3005
has	O	3005
revealed	O	3005
a	O	3005
single	O	3005
missense	O	3005
mutation	O	3005
in	O	3005
sglt1	O	3005
which	O	3005
cosegregates	O	3005
with	O	3005
the	O	3005
ggm	B-Disease	3005
phenotype	O	3005
and	O	3005
results	O	3005
in	O	3005
a	O	3005
complete	O	3005
loss	O	3005
of	O	3005
na	O	3005
(	O	3005
+	O	3005
)	O	3005
-	O	3005
dependent	O	3005
glucose	O	3005
transport	O	3005
in	O	3005
xenopus	O	3005
oocytes	O	3005
injected	O	3005
with	O	3005
this	O	3005
complementary	O	3005
rna	O	3005
.	O	3005
.	O	3005
a	O	3006
de	O	3006
novo	O	3006
unbalanced	O	3006
reciprocal	O	3006
translocation	O	3006
identified	O	3006
as	O	3006
paternal	O	3006
in	O	3006
origin	O	3006
in	O	3006
the	O	3006
prader	B-Disease	3006
-	I-Disease	3006
willi	I-Disease	3006
syndrome	I-Disease	3006
.	O	3006
interstitial	O	3007
cytogenetic	O	3007
deletions	O	3007
involving	O	3007
the	O	3007
paternally	O	3007
derived	O	3007
chromosome	O	3007
15q11	O	3007
-	O	3007
13	O	3007
have	O	3007
been	O	3007
described	O	3007
in	O	3007
patients	O	3007
with	O	3007
the	O	3007
prader	B-Disease	3007
-	I-Disease	3007
willi	I-Disease	3007
syndrome	I-Disease	3007
(	O	3007
pws	B-Disease	3007
)	O	3007
.	O	3007
we	O	3008
report	O	3008
a	O	3008
child	O	3008
with	O	3008
pws	B-Disease	3008
and	O	3008
a	O	3008
de	O	3008
novo	O	3008
unbalanced	O	3008
karyotype	O	3008
-	O	3008
45	O	3008
,	O	3008
xy	O	3008
,	O	3008
-	O	3008
9	O	3008
,	O	3008
-	O	3008
15	O	3008
,	O	3008
+	O	3008
der	O	3008
(	O	3008
9	O	3008
)	O	3008
t	O	3008
(	O	3008
9	O	3008
;	O	3008
15	O	3008
)	O	3008
(	O	3008
q34	O	3008
;	O	3008
q13	O	3008
)	O	3008
.	O	3008
molecular	O	3009
studies	O	3009
with	O	3009
the	O	3009
dna	O	3009
probe	O	3009
pml34	O	3009
confirmed	O	3009
that	O	3009
only	O	3009
a	O	3009
single	O	3009
prader	B-Disease	3009
willi	I-Disease	3009
critical	O	3009
region	O	3009
(	O	3009
pwcr	O	3009
15q11	O	3009
.	O	3009
2	O	3009
-	O	3009
q12	O	3009
)	O	3009
copy	O	3009
was	O	3009
present	O	3009
.	O	3009
localisation	O	3012
of	O	3012
the	O	3012
myotonic	B-Disease	3012
dystrophy	I-Disease	3012
locus	O	3012
to	O	3012
19q13	O	3012
.	O	3012
2	O	3012
-	O	3012
19q13	O	3012
.	O	3012
3	O	3012
and	O	3012
its	O	3012
relationship	O	3012
to	O	3012
twelve	O	3012
polymorphic	O	3012
loci	O	3012
on	O	3012
19q	O	3012
.	O	3012
we	O	3014
report	O	3014
here	O	3014
the	O	3014
linkage	O	3014
relationship	O	3014
of	O	3014
the	O	3014
myotonic	B-Disease	3014
dystrophy	I-Disease	3014
(	O	3014
dm	B-Disease	3014
)	O	3014
locus	O	3014
to	O	3014
twelve	O	3014
of	O	3014
these	O	3014
markers	O	3014
as	O	3014
studied	O	3014
in	O	3014
45	O	3014
families	O	3014
with	O	3014
dm	B-Disease	3014
.	O	3014
ten	O	3016
of	O	3016
the	O	3016
twelve	O	3016
markers	O	3016
have	O	3016
been	O	3016
shown	O	3016
to	O	3016
be	O	3016
proximal	O	3016
to	O	3016
the	O	3016
dm	B-Disease	3016
gene	O	3016
and	O	3016
two	O	3016
,	O	3016
prkcg	O	3016
and	O	3016
d19s22	O	3016
,	O	3016
distal	O	3016
but	O	3016
at	O	3016
distances	O	3016
of	O	3016
approximately	O	3016
25	O	3016
cm	O	3016
and	O	3016
15	O	3016
cm	O	3016
,	O	3016
respectively	O	3016
.	O	3016
the	O	3017
closest	O	3017
proximal	O	3017
markers	O	3017
are	O	3017
apoc2	O	3017
(	O	3017
apolipoprotein	O	3017
c	O	3017
-	O	3017
ii	O	3017
)	O	3017
and	O	3017
ckm	O	3017
(	O	3017
creatine	O	3017
kinase	O	3017
,	O	3017
muscle	O	3017
)	O	3017
approximately	O	3017
3	O	3017
cm	O	3017
and	O	3017
2	O	3017
cm	O	3017
from	O	3017
the	O	3017
dm	B-Disease	3017
gene	O	3017
respectively	O	3017
,	O	3017
in	O	3017
the	O	3017
order	O	3017
apoc2	O	3017
-	O	3017
ckm	O	3017
-	O	3017
dm	O	3017
.	O	3017
the	O	3018
distance	O	3018
between	O	3018
apoc2	O	3018
,	O	3018
ckm	O	3018
and	O	3018
dm	B-Disease	3018
(	O	3018
of	O	3018
the	O	3018
order	O	3018
of	O	3018
2	O	3018
million	O	3018
base	O	3018
pairs	O	3018
)	O	3018
and	O	3018
their	O	3018
known	O	3018
orientation	O	3018
should	O	3018
permit	O	3018
directional	O	3018
chromosome	O	3018
walking	O	3018
and	O	3018
jumping	O	3018
.	O	3018
the	O	3019
data	O	3019
presented	O	3019
here	O	3019
should	O	3019
enable	O	3019
us	O	3019
to	O	3019
determine	O	3019
whether	O	3019
or	O	3019
not	O	3019
new	O	3019
markers	O	3019
are	O	3019
distal	O	3019
to	O	3019
apoc2	O	3019
/	O	3019
ckm	O	3019
and	O	3019
thus	O	3019
potentially	O	3019
flank	O	3019
the	O	3019
dm	B-Disease	3019
gene	O	3019
.	O	3019
.	O	3019
the	O	3021
human	O	3021
gene	O	3021
for	O	3021
histidase	O	3021
(	O	3021
histidine	O	3021
ammonia	O	3021
-	O	3021
lyase	O	3021
;	O	3021
hal	O	3021
)	O	3021
,	O	3021
the	O	3021
enzyme	O	3021
deficient	O	3021
in	O	3021
histidinemia	B-Disease	3021
,	O	3021
was	O	3021
assigned	O	3021
to	O	3021
human	O	3021
chromosome	O	3021
12	O	3021
by	O	3021
southern	O	3021
blot	O	3021
analysis	O	3021
of	O	3021
human	O	3021
x	O	3021
mouse	O	3021
somatic	O	3021
cell	O	3021
hybrid	O	3021
dna	O	3021
.	O	3021
determination	O	3028
of	O	3028
the	O	3028
mutations	O	3028
responsible	O	3028
for	O	3028
the	O	3028
lesch	B-Disease	3028
-	I-Disease	3028
nyhan	I-Disease	3028
syndrome	I-Disease	3028
in	O	3028
17	O	3028
subjects	O	3028
.	O	3028
the	O	3032
direct	O	3032
sequencing	O	3032
of	O	3032
the	O	3032
polymerase	O	3032
chain	O	3032
reaction	O	3032
-	O	3032
amplified	O	3032
product	O	3032
of	O	3032
reverse	O	3032
-	O	3032
transcribed	O	3032
hprt	O	3032
mrna	O	3032
enabled	O	3032
the	O	3032
rapid	O	3032
identification	O	3032
of	O	3032
the	O	3032
mutations	O	3032
found	O	3032
in	O	3032
17	O	3032
previously	O	3032
uncharacterized	O	3032
cell	O	3032
lines	O	3032
derived	O	3032
from	O	3032
patients	O	3032
with	O	3032
the	O	3032
lesch	B-Disease	3032
-	I-Disease	3032
nyhan	I-Disease	3032
syndrome	I-Disease	3032
.	O	3032
.	O	3032
linkage	O	3033
of	O	3033
dna	O	3033
markers	O	3033
at	O	3033
xq28	O	3033
to	O	3033
adrenoleukodystrophy	B-Disease	3033
and	O	3033
adrenomyeloneuropathy	B-Disease	3033
present	O	3033
within	O	3033
the	O	3033
same	O	3033
family	O	3033
.	O	3033
we	O	3034
present	O	3034
a	O	3034
large	O	3034
kindred	O	3034
that	O	3034
contained	O	3034
patients	O	3034
with	O	3034
either	O	3034
adrenoleukodystrophy	B-Disease	3034
(	O	3034
ald	B-Disease	3034
)	O	3034
or	O	3034
adrenomyeloneuropathy	B-Disease	3034
(	O	3034
amn	B-Disease	3034
)	O	3034
.	O	3034
the	O	3035
pedigree	O	3035
clearly	O	3035
supported	O	3035
the	O	3035
x	O	3035
-	O	3035
linked	O	3035
mode	O	3035
of	O	3035
inheritance	O	3035
of	O	3035
the	O	3035
nonneonatal	O	3035
form	O	3035
of	O	3035
ald	B-Disease	3035
/	O	3035
amn	B-Disease	3035
.	O	3035
analysis	O	3036
with	O	3036
dna	O	3036
markers	O	3036
at	O	3036
xq28	O	3036
suggested	O	3036
segregation	O	3036
of	O	3036
both	O	3036
ald	B-Disease	3036
and	O	3036
amn	B-Disease	3036
with	O	3036
an	O	3036
identical	O	3036
haplotype	O	3036
.	O	3036
this	O	3037
indicated	O	3037
that	O	3037
nonneonatal	O	3037
ald	B-Disease	3037
and	O	3037
amn	B-Disease	3037
are	O	3037
caused	O	3037
by	O	3037
a	O	3037
mutation	O	3037
in	O	3037
the	O	3037
same	O	3037
gene	O	3037
at	O	3037
xq28	O	3037
.	O	3037
it	O	3038
showed	O	3038
,	O	3038
furthermore	O	3038
,	O	3038
that	O	3038
phenotypic	O	3038
differences	O	3038
between	O	3038
ald	B-Disease	3038
and	O	3038
amn	B-Disease	3038
are	O	3038
not	O	3038
necessarily	O	3038
the	O	3038
consequence	O	3038
of	O	3038
allelic	O	3038
heterogeneity	O	3038
due	O	3038
to	O	3038
different	O	3038
mutations	O	3038
within	O	3038
the	O	3038
same	O	3038
gene	O	3038
.	O	3038
the	O	3039
maximal	O	3039
lod	O	3039
score	O	3039
for	O	3039
linkage	O	3039
of	O	3039
the	O	3039
ald	B-Disease	3039
/	O	3039
amn	B-Disease	3039
gene	O	3039
and	O	3039
the	O	3039
multiallelic	O	3039
anonymous	O	3039
dna	O	3039
marker	O	3039
at	O	3039
dxs52	O	3039
was	O	3039
3	O	3039
.	O	3039
skewed	O	3043
x	O	3043
inactivation	O	3043
in	O	3043
a	O	3043
female	O	3043
mz	O	3043
twin	O	3043
results	O	3043
in	O	3043
duchenne	B-Disease	3043
muscular	I-Disease	3043
dystrophy	I-Disease	3043
.	O	3043
one	O	3044
of	O	3044
female	O	3044
mz	O	3044
twins	O	3044
presented	O	3044
with	O	3044
muscular	B-Disease	3044
dystrophy	I-Disease	3044
.	O	3044
physical	O	3045
examination	O	3045
,	O	3045
creatine	O	3045
phosphokinase	O	3045
levels	O	3045
,	O	3045
and	O	3045
muscle	O	3045
biopsy	O	3045
were	O	3045
consistent	O	3045
with	O	3045
duchenne	B-Disease	3045
muscular	I-Disease	3045
dystrophy	I-Disease	3045
(	O	3045
dmd	B-Disease	3045
)	O	3045
.	O	3045
however	O	3046
,	O	3046
because	O	3046
of	O	3046
her	O	3046
sex	O	3046
she	O	3046
was	O	3046
diagnosed	O	3046
as	O	3046
having	O	3046
limb	B-Disease	3046
-	I-Disease	3046
girdle	I-Disease	3046
muscular	I-Disease	3046
dystrophy	I-Disease	3046
.	O	3046
with	O	3047
cdna	O	3047
probes	O	3047
to	O	3047
the	O	3047
dmd	B-Disease	3047
gene	O	3047
,	O	3047
a	O	3047
gene	O	3047
deletion	O	3047
was	O	3047
detected	O	3047
in	O	3047
the	O	3047
twins	O	3047
and	O	3047
their	O	3047
mother	O	3047
.	O	3047
these	O	3052
data	O	3052
indicate	O	3052
that	O	3052
the	O	3052
affected	O	3052
twin	O	3052
is	O	3052
a	O	3052
manifesting	O	3052
carrier	O	3052
of	O	3052
an	O	3052
abnormal	O	3052
dmd	B-Disease	3052
gene	O	3052
,	O	3052
her	O	3052
myopathy	B-Disease	3052
being	O	3052
a	O	3052
direct	O	3052
result	O	3052
of	O	3052
underexpression	O	3052
of	O	3052
dystrophin	O	3052
.	O	3052
cytogenetic	O	3053
analysis	O	3053
revealed	O	3053
normal	O	3053
karyotypes	O	3053
,	O	3053
eliminating	O	3053
the	O	3053
possibility	O	3053
of	O	3053
a	O	3053
translocation	O	3053
affecting	O	3053
dmd	B-Disease	3053
gene	O	3053
function	O	3053
.	O	3053
both	O	3054
linkage	O	3054
analysis	O	3054
and	O	3054
dna	O	3054
fingerprint	O	3054
analysis	O	3054
revealed	O	3054
that	O	3054
each	O	3054
twin	O	3054
has	O	3054
two	O	3054
different	O	3054
x	O	3054
chromosomes	O	3054
,	O	3054
eliminating	O	3054
the	O	3054
possibility	O	3054
of	O	3054
uniparental	B-Disease	3054
disomy	I-Disease	3054
as	O	3054
a	O	3054
mechanism	O	3054
for	O	3054
dmd	B-Disease	3054
expression	O	3054
.	O	3054
adrenoleukodystrophy	B-Disease	3056
and	O	3056
adrenomyeloneuropathy	B-Disease	3056
associated	O	3056
with	O	3056
partial	O	3056
adrenal	B-Disease	3056
insufficiency	I-Disease	3056
in	O	3056
three	O	3056
generations	O	3056
of	O	3056
a	O	3056
kindred	O	3056
.	O	3056
four	O	3057
cases	O	3057
of	O	3057
adrenoleukodystrophy	B-Disease	3057
(	O	3057
ald	B-Disease	3057
)	O	3057
and	O	3057
one	O	3057
case	O	3057
of	O	3057
adrenomyeloneuropathy	B-Disease	3057
(	O	3057
amn	B-Disease	3057
)	O	3057
have	O	3057
developed	O	3057
in	O	3057
a	O	3057
kindred	O	3057
over	O	3057
three	O	3057
generations	O	3057
demonstrating	O	3057
that	O	3057
amn	B-Disease	3057
is	O	3057
a	O	3057
clinical	O	3057
variant	O	3057
of	O	3057
ald	B-Disease	3057
.	O	3057
pituitary	O	3058
-	O	3058
adrenal	O	3058
function	O	3058
studies	O	3058
were	O	3058
performed	O	3058
in	O	3058
10	O	3058
family	O	3058
members	O	3058
,	O	3058
including	O	3058
two	O	3058
affected	O	3058
males	O	3058
and	O	3058
four	O	3058
females	O	3058
identified	O	3058
as	O	3058
carriers	O	3058
of	O	3058
ald	B-Disease	3058
/	O	3058
amn	B-Disease	3058
.	O	3058
no	O	3059
pituitary	B-Disease	3059
-	I-Disease	3059
adrenal	I-Disease	3059
abnormality	I-Disease	3059
was	O	3059
found	O	3059
in	O	3059
the	O	3059
carriers	O	3059
.	O	3059
however	O	3060
,	O	3060
basal	O	3060
morning	O	3060
plasma	O	3060
adrenocorticotropic	O	3060
hormone	O	3060
(	O	3060
acth	O	3060
)	O	3060
levels	O	3060
were	O	3060
markedly	O	3060
elevated	O	3060
in	O	3060
the	O	3060
two	O	3060
males	O	3060
with	O	3060
ald	B-Disease	3060
and	O	3060
amn	B-Disease	3060
,	O	3060
despite	O	3060
the	O	3060
fact	O	3060
that	O	3060
they	O	3060
had	O	3060
no	O	3060
clinical	O	3060
signs	O	3060
of	O	3060
adrenal	B-Disease	3060
insufficiency	I-Disease	3060
and	O	3060
that	O	3060
morning	O	3060
plasma	O	3060
cortisol	O	3060
levels	O	3060
and	O	3060
their	O	3060
response	O	3060
to	O	3060
maximal	O	3060
exogenous	O	3060
acth	O	3060
stimulation	O	3060
appeared	O	3060
to	O	3060
be	O	3060
normal	O	3060
.	O	3060
thus	O	3062
,	O	3062
people	O	3062
with	O	3062
ald	B-Disease	3062
and	O	3062
amn	B-Disease	3062
may	O	3062
have	O	3062
subclinical	O	3062
partial	O	3062
adrenocrotical	B-Disease	3062
insufficiency	I-Disease	3062
.	O	3062
no	O	3063
other	O	3063
endocrinologic	B-Disease	3063
dysfunction	I-Disease	3063
was	O	3063
identified	O	3063
.	O	3063
.	O	3063
regional	O	3064
localisation	O	3064
of	O	3064
the	O	3064
friedreich	B-Disease	3064
ataxia	I-Disease	3064
locus	O	3064
to	O	3064
human	O	3064
chromosome	O	3064
9q13	O	3064
-	O	3064
-	O	3064
-	O	3064
-	O	3064
q21	O	3064
.	O	3064
1	O	3064
.	O	3064
we	O	3065
have	O	3065
previously	O	3065
assigned	O	3065
the	O	3065
friedreich	B-Disease	3065
ataxia	I-Disease	3065
locus	O	3065
(	O	3065
frda	O	3065
)	O	3065
to	O	3065
chromosome	O	3065
9	O	3065
;	O	3065
the	O	3065
current	O	3065
maximal	O	3065
lod	O	3065
score	O	3065
between	O	3065
frda	O	3065
and	O	3065
mct112	O	3065
(	O	3065
d9s15	O	3065
)	O	3065
is	O	3065
greater	O	3065
than	O	3065
50	O	3065
at	O	3065
a	O	3065
recombination	O	3065
fraction	O	3065
of	O	3065
theta	O	3065
=	O	3065
0	O	3065
.	O	3065
we	O	3074
recently	O	3074
described	O	3074
a	O	3074
japanese	O	3074
family	O	3074
with	O	3074
increased	O	3074
hdl	O	3074
levels	O	3074
and	O	3074
cetp	B-Disease	3074
deficiency	I-Disease	3074
due	O	3074
to	O	3074
a	O	3074
splicing	O	3074
defect	O	3074
of	O	3074
the	O	3074
cetp	O	3074
gene	O	3074
.	O	3074
family	O	3079
members	O	3079
homozygous	O	3079
for	O	3079
cetp	B-Disease	3079
deficiency	I-Disease	3079
(	O	3079
n	O	3079
=	O	3079
10	O	3079
)	O	3079
had	O	3079
moderate	O	3079
hypercholesterolemia	B-Disease	3079
(	O	3079
mean	O	3079
total	O	3079
cholesterol	O	3079
level	O	3079
[	O	3079
+	O	3079
/	O	3079
-	O	3079
sd	O	3079
]	O	3079
,	O	3079
7	O	3079
.	O	3079
01	O	3079
+	O	3079
/	O	3079
-	O	3079
0	O	3079
.	O	3079
83	O	3079
mmol	O	3079
per	O	3079
liter	O	3079
)	O	3079
,	O	3079
markedly	O	3079
increased	O	3079
levels	O	3079
of	O	3079
hdl	O	3079
cholesterol	O	3079
(	O	3079
4	O	3079
.	O	3079
24	O	3079
+	O	3079
/	O	3079
-	O	3079
1	O	3079
.	O	3079
01	O	3079
mmol	O	3079
per	O	3079
liter	O	3079
)	O	3079
and	O	3079
apolipoprotein	O	3079
a	O	3079
-	O	3079
i	O	3079
,	O	3079
and	O	3079
decreased	O	3079
levels	O	3079
of	O	3079
low	O	3079
-	O	3079
density	O	3079
lipoprotein	O	3079
cholesterol	O	3079
(	O	3079
1	O	3079
.	O	3079
99	O	3079
+	O	3079
/	O	3079
-	O	3079
0	O	3079
.	O	3079
80	O	3079
mmol	O	3079
per	O	3079
liter	O	3079
)	O	3079
and	O	3079
apolipoprotein	O	3079
b	O	3079
.	O	3079
cetp	B-Disease	3081
deficiency	I-Disease	3081
was	O	3081
not	O	3081
found	O	3081
in	O	3081
six	O	3081
unrelated	O	3081
subjects	O	3081
with	O	3081
elevated	O	3081
hdl	O	3081
cholesterol	O	3081
levels	O	3081
who	O	3081
were	O	3081
from	O	3081
different	O	3081
parts	O	3081
of	O	3081
the	O	3081
united	O	3081
states	O	3081
.	O	3081
cetp	B-Disease	3083
deficiency	I-Disease	3083
appears	O	3083
to	O	3083
be	O	3083
a	O	3083
frequent	O	3083
cause	O	3083
of	O	3083
increased	O	3083
hdl	O	3083
levels	O	3083
in	O	3083
the	O	3083
population	O	3083
of	O	3083
japan	O	3083
,	O	3083
possibly	O	3083
because	O	3083
of	O	3083
a	O	3083
founder	O	3083
effect	O	3083
.	O	3083
there	O	3085
was	O	3085
no	O	3085
evidence	O	3085
of	O	3085
premature	B-Disease	3085
atherosclerosis	I-Disease	3085
in	O	3085
the	O	3085
families	O	3085
with	O	3085
cetp	B-Disease	3085
deficiency	I-Disease	3085
.	O	3085
in	O	3086
fact	O	3086
,	O	3086
the	O	3086
lipoprotein	O	3086
profile	O	3086
of	O	3086
persons	O	3086
with	O	3086
cetp	B-Disease	3086
deficiency	I-Disease	3086
is	O	3086
potentially	O	3086
antiatherogenic	O	3086
and	O	3086
may	O	3086
be	O	3086
associated	O	3086
with	O	3086
an	O	3086
increased	O	3086
life	O	3086
span	O	3086
.	O	3086
further	O	3087
mapping	O	3087
of	O	3087
an	O	3087
ataxia	B-Disease	3087
-	I-Disease	3087
telangiectasia	I-Disease	3087
locus	O	3087
to	O	3087
the	O	3087
chromosome	O	3087
11q23	O	3087
region	O	3087
.	O	3087
we	O	3088
recently	O	3088
mapped	O	3088
the	O	3088
gene	O	3088
for	O	3088
ataxia	B-Disease	3088
-	I-Disease	3088
telangiectasia	I-Disease	3088
group	O	3088
a	O	3088
(	O	3088
ata	O	3088
)	O	3088
to	O	3088
chromosome	O	3088
11q22	O	3088
-	O	3088
23	O	3088
by	O	3088
linkage	O	3088
analysis	O	3088
,	O	3088
using	O	3088
the	O	3088
genetic	O	3088
markers	O	3088
thy1	O	3088
and	O	3088
pynb3	O	3088
.	O	3088
the	O	3091
present	O	3091
paper	O	3091
describes	O	3091
further	O	3091
mapping	O	3091
of	O	3091
the	O	3091
at	B-Disease	3091
locus	O	3091
by	O	3091
means	O	3091
of	O	3091
a	O	3091
panel	O	3091
of	O	3091
10	O	3091
markers	O	3091
that	O	3091
span	O	3091
approximately	O	3091
60	O	3091
cm	O	3091
in	O	3091
the	O	3091
11q22	O	3091
-	O	3091
23	O	3091
region	O	3091
centered	O	3091
around	O	3091
s144	O	3091
and	O	3091
thy1	O	3091
.	O	3091
location	O	3092
scores	O	3092
indicate	O	3092
that	O	3092
three	O	3092
contiguous	O	3092
subsegments	O	3092
within	O	3092
the	O	3092
[	O	3092
s144	O	3092
-	O	3092
thy1	O	3092
]	O	3092
segment	O	3092
,	O	3092
as	O	3092
well	O	3092
as	O	3092
three	O	3092
contiguous	O	3092
segments	O	3092
telomeric	O	3092
to	O	3092
thy1	O	3092
,	O	3092
are	O	3092
each	O	3092
unlikely	O	3092
to	O	3092
contain	O	3092
the	O	3092
at	B-Disease	3092
locus	O	3092
,	O	3092
while	O	3092
the	O	3092
more	O	3092
centromeric	O	3092
[	O	3092
stmy	O	3092
-	O	3092
s144	O	3092
]	O	3092
segment	O	3092
is	O	3092
most	O	3092
likely	O	3092
to	O	3092
contain	O	3092
the	O	3092
at	B-Disease	3092
locus	O	3092
.	O	3092
these	O	3093
data	O	3093
,	O	3093
together	O	3093
with	O	3093
recent	O	3093
refinements	O	3093
in	O	3093
the	O	3093
linkage	O	3093
and	O	3093
physical	O	3093
maps	O	3093
of	O	3093
11q22	O	3093
-	O	3093
23	O	3093
,	O	3093
place	O	3093
the	O	3093
at	B-Disease	3093
locus	O	3093
at	O	3093
11q23	O	3093
.	O	3093
recurrent	O	3094
meningitis	B-Disease	3094
in	O	3094
a	O	3094
patient	O	3094
with	O	3094
congenital	B-Disease	3094
deficiency	I-Disease	3094
of	I-Disease	3094
the	I-Disease	3094
c9	I-Disease	3094
component	I-Disease	3094
of	I-Disease	3094
complement	I-Disease	3094
.	O	3094
first	O	3095
case	O	3095
of	O	3095
c9	B-Disease	3095
deficiency	I-Disease	3095
in	O	3095
europe	O	3095
.	O	3095
we	O	3096
describe	O	3096
the	O	3096
first	O	3096
cases	O	3096
,	O	3096
to	O	3096
our	O	3096
knowledge	O	3096
,	O	3096
of	O	3096
c9	B-Disease	3096
deficiency	I-Disease	3096
in	O	3096
europe	O	3096
that	O	3096
were	O	3096
detected	O	3096
in	O	3096
a	O	3096
swiss	O	3096
family	O	3096
,	O	3096
of	O	3096
which	O	3096
two	O	3096
members	O	3096
-	O	3096
-	O	3096
one	O	3096
with	O	3096
a	O	3096
complete	O	3096
deficiency	O	3096
and	O	3096
the	O	3096
other	O	3096
with	O	3096
approximately	O	3096
half	O	3096
-	O	3096
normal	O	3096
c9	O	3096
levels	O	3096
-	O	3096
-	O	3096
experienced	O	3096
bacterial	B-Disease	3096
meningitis	I-Disease	3096
.	O	3096
the	O	3097
index	O	3097
patient	O	3097
,	O	3097
a	O	3097
56	O	3097
-	O	3097
year	O	3097
-	O	3097
old	O	3097
white	O	3097
man	O	3097
with	O	3097
a	O	3097
history	O	3097
of	O	3097
purulent	B-Disease	3097
meningitis	I-Disease	3097
at	O	3097
the	O	3097
age	O	3097
of	O	3097
23	O	3097
years	O	3097
,	O	3097
presented	O	3097
with	O	3097
an	O	3097
acute	B-Disease	3097
meningococcal	I-Disease	3097
meningitis	I-Disease	3097
.	O	3097
no	O	3098
impairment	B-Disease	3098
of	I-Disease	3098
cellular	I-Disease	3098
immunity	I-Disease	3098
or	O	3098
immunoglobulin	B-Disease	3098
deficiency	I-Disease	3098
could	O	3098
be	O	3098
found	O	3098
.	O	3098
complement	O	3099
assays	O	3099
showed	O	3099
a	O	3099
complete	B-Disease	3099
deficiency	I-Disease	3099
of	I-Disease	3099
the	I-Disease	3099
c9	I-Disease	3099
component	I-Disease	3099
,	O	3099
while	O	3099
the	O	3099
other	O	3099
individual	O	3099
component	O	3099
levels	O	3099
were	O	3099
normal	O	3099
and	O	3099
the	O	3099
hemolytic	O	3099
activity	O	3099
(	O	3099
measured	O	3099
using	O	3099
the	O	3099
ch50	O	3099
assay	O	3099
)	O	3099
was	O	3099
only	O	3099
slightly	O	3099
reduced	O	3099
.	O	3099
a	O	3100
family	O	3100
study	O	3100
revealed	O	3100
complete	B-Disease	3100
c9	I-Disease	3100
deficiency	I-Disease	3100
in	O	3100
the	O	3100
patients	O	3100
healthy	O	3100
brother	O	3100
and	O	3100
half	O	3100
-	O	3100
normal	O	3100
c9	O	3100
concentrations	O	3100
in	O	3100
his	O	3100
sister	O	3100
,	O	3100
his	O	3100
son	O	3100
(	O	3100
who	O	3100
also	O	3100
had	O	3100
experienced	O	3100
an	O	3100
episode	O	3100
of	O	3100
bacterial	B-Disease	3100
meningitis	I-Disease	3100
)	O	3100
,	O	3100
and	O	3100
his	O	3100
niece	O	3100
,	O	3100
consistent	O	3100
with	O	3100
an	O	3100
inherited	O	3100
c9	B-Disease	3100
deficiency	I-Disease	3100
.	O	3100
this	O	3101
first	O	3101
case	O	3101
of	O	3101
recurrent	B-Disease	3101
meningitis	I-Disease	3101
in	O	3101
a	O	3101
white	O	3101
patient	O	3101
with	O	3101
complete	B-Disease	3101
c9	I-Disease	3101
deficiency	I-Disease	3101
suggests	O	3101
that	O	3101
this	O	3101
complement	B-Disease	3101
defect	I-Disease	3101
may	O	3101
also	O	3101
be	O	3101
a	O	3101
risk	O	3101
factor	O	3101
for	O	3101
bacterial	B-Disease	3101
,	I-Disease	3101
especially	I-Disease	3101
neisserial	I-Disease	3101
,	I-Disease	3101
infections	I-Disease	3101
.	O	3101
.	O	3101
detection	O	3102
of	O	3102
98	O	3102
%	O	3102
of	O	3102
dmd	B-Disease	3102
/	O	3102
bmd	B-Disease	3102
gene	O	3102
deletions	O	3102
by	O	3102
polymerase	O	3102
chain	O	3102
reaction	O	3102
.	O	3102
when	O	3104
used	O	3104
in	O	3104
conjunction	O	3104
with	O	3104
an	O	3104
existing	O	3104
primer	O	3104
set	O	3104
,	O	3104
these	O	3104
two	O	3104
multiplex	O	3104
reactions	O	3104
detect	O	3104
about	O	3104
98	O	3104
%	O	3104
of	O	3104
deletions	O	3104
in	O	3104
patients	O	3104
with	O	3104
duchenne	B-Disease	3104
or	I-Disease	3104
becker	I-Disease	3104
muscular	I-Disease	3104
dystrophy	I-Disease	3104
(	O	3104
dmd	B-Disease	3104
,	O	3104
bmd	B-Disease	3104
)	O	3104
.	O	3104
thus	O	3106
,	O	3106
use	O	3106
of	O	3106
these	O	3106
pcr	O	3106
-	O	3106
based	O	3106
assays	O	3106
will	O	3106
allow	O	3106
deletion	O	3106
detection	O	3106
and	O	3106
prenatal	O	3106
diagnosis	O	3106
for	O	3106
most	O	3106
dmd	B-Disease	3106
/	O	3106
bmd	B-Disease	3106
patients	O	3106
in	O	3106
a	O	3106
fraction	O	3106
of	O	3106
the	O	3106
time	O	3106
required	O	3106
for	O	3106
southern	O	3106
blot	O	3106
analysis	O	3106
.	O	3106
.	O	3106
of	O	3110
these	O	3110
,	O	3110
31	O	3110
had	O	3110
severe	O	3110
g6pd	B-Disease	3110
deficiency	I-Disease	3110
,	O	3110
nine	O	3110
had	O	3110
mild	O	3110
to	O	3110
moderate	O	3110
deficiency	O	3110
,	O	3110
and	O	3110
three	O	3110
had	O	3110
a	O	3110
non	O	3110
-	O	3110
deficient	O	3110
electrophoretic	O	3110
variant	O	3110
.	O	3110
the	O	3111
overall	O	3111
rate	O	3111
of	O	3111
g6pd	B-Disease	3111
deficiency	I-Disease	3111
was	O	3111
2	O	3111
.	O	3111
the	O	3113
frequency	O	3113
of	O	3113
g6pd	B-Disease	3113
deficiency	I-Disease	3113
,	O	3113
ranging	O	3113
from	O	3113
7	O	3113
.	O	3113
biochemical	O	3115
characterization	O	3115
has	O	3115
shown	O	3115
that	O	3115
most	O	3115
of	O	3115
the	O	3115
g6pd	B-Disease	3115
deficiency	I-Disease	3115
in	O	3115
this	O	3115
population	O	3115
is	O	3115
accounted	O	3115
for	O	3115
by	O	3115
g6pd	O	3115
mediterranean	O	3115
.	O	3115
these	O	3117
data	O	3117
provide	O	3117
further	O	3117
evidence	O	3117
for	O	3117
the	O	3117
marked	O	3117
genetic	O	3117
heterogeneity	O	3117
of	O	3117
g6pd	B-Disease	3117
deficiency	I-Disease	3117
within	O	3117
a	O	3117
relatively	O	3117
narrow	O	3117
geographic	O	3117
area	O	3117
and	O	3117
they	O	3117
prove	O	3117
the	O	3117
presence	O	3117
in	O	3117
the	O	3117
italian	O	3117
peninsula	O	3117
of	O	3117
a	O	3117
gene	O	3117
(	O	3117
gda	O	3117
-	O	3117
)	O	3117
regarded	O	3117
as	O	3117
characteristically	O	3117
african	O	3117
.	O	3117
deficiency	B-Disease	3118
of	I-Disease	3118
the	I-Disease	3118
murine	I-Disease	3118
fifth	I-Disease	3118
complement	I-Disease	3118
component	I-Disease	3118
(	I-Disease	3118
c5	I-Disease	3118
)	I-Disease	3118
.	O	3118
to	O	3120
ascertain	O	3120
the	O	3120
molecular	O	3120
mechanism	O	3120
that	O	3120
causes	O	3120
murine	O	3120
c5	B-Disease	3120
deficiency	I-Disease	3120
,	O	3120
genomic	O	3120
and	O	3120
cdna	O	3120
libraries	O	3120
were	O	3120
constructed	O	3120
from	O	3120
mouse	O	3120
liver	O	3120
dna	O	3120
and	O	3120
mrna	O	3120
employing	O	3120
the	O	3120
congenic	O	3120
strains	O	3120
b10	O	3120
.	O	3120
d2	O	3122
/	O	3122
osnj	O	3122
that	O	3122
are	O	3122
sufficient	O	3122
and	O	3122
deficient	B-Disease	3122
for	I-Disease	3122
c5	I-Disease	3122
,	O	3122
respectively	O	3122
.	O	3122
genomic	O	3123
fragments	O	3123
were	O	3123
isolated	O	3123
which	O	3123
correspond	O	3123
to	O	3123
pvuii	O	3123
and	O	3123
hindiii	O	3123
restriction	O	3123
fragment	O	3123
length	O	3123
polymorphisms	O	3123
associated	O	3123
with	O	3123
c5	B-Disease	3123
deficiency	I-Disease	3123
.	O	3123
sequence	O	3124
analyses	O	3124
demonstrated	O	3124
that	O	3124
each	O	3124
of	O	3124
these	O	3124
polymorphisms	O	3124
resulted	O	3124
from	O	3124
single	O	3124
base	O	3124
pair	O	3124
substitutions	O	3124
and	O	3124
that	O	3124
neither	O	3124
substitution	O	3124
would	O	3124
probably	O	3124
cause	O	3124
or	O	3124
contribute	O	3124
to	O	3124
the	O	3124
c5	B-Disease	3124
deficiency	I-Disease	3124
.	O	3124
six	O	3129
c5	B-Disease	3129
-	I-Disease	3129
deficient	I-Disease	3129
strains	O	3129
,	O	3129
a	O	3129
/	O	3129
hej	O	3129
,	O	3129
akr	O	3129
/	O	3129
j	O	3129
,	O	3129
dba	O	3129
/	O	3129
2j	O	3129
,	O	3129
nzb	O	3129
/	O	3129
b1nj	O	3129
,	O	3129
swr	O	3129
/	O	3129
j	O	3129
,	O	3129
and	O	3129
b10	O	3129
.	O	3129
these	O	3133
data	O	3133
demonstrate	O	3133
that	O	3133
1	O	3133
)	O	3133
there	O	3133
is	O	3133
an	O	3133
identical	O	3133
2	O	3133
-	O	3133
base	O	3133
pair	O	3133
deletion	O	3133
in	O	3133
an	O	3133
exon	O	3133
of	O	3133
the	O	3133
c5	O	3133
gene	O	3133
in	O	3133
several	O	3133
different	O	3133
c5	B-Disease	3133
-	I-Disease	3133
deficient	I-Disease	3133
mouse	O	3133
strains	O	3133
;	O	3133
2	O	3133
)	O	3133
the	O	3133
mrna	O	3133
transcribed	O	3133
from	O	3133
the	O	3133
c5d	O	3133
gene	O	3133
retains	O	3133
this	O	3133
deletion	O	3133
;	O	3133
and	O	3133
3	O	3133
)	O	3133
this	O	3133
mutation	O	3133
should	O	3133
result	O	3133
in	O	3133
c5	B-Disease	3133
protein	I-Disease	3133
deficiency	I-Disease	3133
.	O	3133
molecular	O	3134
genetics	O	3134
of	O	3134
pku	B-Disease	3134
in	O	3134
eastern	O	3134
europe	O	3134
:	O	3134
a	O	3134
nonsense	O	3134
mutation	O	3134
associated	O	3134
with	O	3134
haplotype	O	3134
4	O	3134
of	O	3134
the	O	3134
phenylalanine	O	3134
hydroxylase	O	3134
gene	O	3134
.	O	3134
phenylketonuria	B-Disease	3135
(	O	3135
pku	B-Disease	3135
)	O	3135
is	O	3135
a	O	3135
genetic	B-Disease	3135
disorder	I-Disease	3135
secondary	O	3135
to	O	3135
a	O	3135
deficiency	B-Disease	3135
of	I-Disease	3135
hepatic	I-Disease	3135
phenylalanine	I-Disease	3135
hydroxylase	I-Disease	3135
(	O	3135
pah	O	3135
)	O	3135
.	O	3135
a	O	3137
new	O	3137
molecular	B-Disease	3137
lesion	I-Disease	3137
has	O	3137
been	O	3137
identified	O	3137
in	O	3137
exon	O	3137
7	O	3137
of	O	3137
the	O	3137
pah	O	3137
gene	O	3137
in	O	3137
a	O	3137
hungarian	O	3137
pku	B-Disease	3137
patient	O	3137
by	O	3137
direct	O	3137
sequencing	O	3137
of	O	3137
pcr	O	3137
-	O	3137
amplified	O	3137
dna	O	3137
.	O	3137
the	O	3141
red	O	3141
-	O	3141
green	O	3141
visual	O	3141
pigment	O	3141
gene	O	3141
region	O	3141
in	O	3141
adrenoleukodystrophy	B-Disease	3141
.	O	3141
although	O	3142
recent	O	3142
data	O	3142
established	O	3142
that	O	3142
a	O	3142
specific	O	3142
very	O	3142
-	O	3142
long	O	3142
-	O	3142
chain	O	3142
fatty	O	3142
acyl	O	3142
-	O	3142
coa	O	3142
synthetase	O	3142
is	O	3142
defective	O	3142
in	O	3142
x	B-Disease	3142
-	I-Disease	3142
linked	I-Disease	3142
adrenoleukodystrophy	I-Disease	3142
(	O	3142
ald	B-Disease	3142
)	O	3142
,	O	3142
the	O	3142
ald	B-Disease	3142
gene	O	3142
is	O	3142
still	O	3142
unidentified	O	3142
.	O	3142
the	O	3143
ald	B-Disease	3143
locus	O	3143
has	O	3143
been	O	3143
mapped	O	3143
to	O	3143
xq28	O	3143
,	O	3143
like	O	3143
the	O	3143
red	O	3143
and	O	3143
green	O	3143
color	O	3143
pigment	O	3143
genes	O	3143
.	O	3143
abnormal	B-Disease	3144
color	I-Disease	3144
vision	I-Disease	3144
has	O	3144
been	O	3144
observed	O	3144
in	O	3144
12	O	3144
of	O	3144
27	O	3144
patients	O	3144
with	O	3144
adrenomyeloneuropathy	B-Disease	3144
(	O	3144
amn	B-Disease	3144
)	O	3144
,	O	3144
a	O	3144
milder	O	3144
form	O	3144
of	O	3144
ald	B-Disease	3144
.	O	3144
furthermore	O	3145
,	O	3145
rearrangements	O	3145
of	O	3145
the	O	3145
color	O	3145
vision	O	3145
gene	O	3145
cluster	O	3145
were	O	3145
found	O	3145
in	O	3145
four	O	3145
of	O	3145
eight	O	3145
ald	B-Disease	3145
kindreds	O	3145
.	O	3145
this	O	3146
led	O	3146
us	O	3146
to	O	3146
propose	O	3146
that	O	3146
a	O	3146
single	O	3146
dna	O	3146
rearrangement	O	3146
could	O	3146
underlie	O	3146
both	O	3146
ald	B-Disease	3146
and	O	3146
abnormal	B-Disease	3146
color	I-Disease	3146
vision	I-Disease	3146
in	O	3146
these	O	3146
patients	O	3146
.	O	3146
study	O	3147
of	O	3147
34	O	3147
french	O	3147
ald	B-Disease	3147
patients	O	3147
failed	O	3147
to	O	3147
reveal	O	3147
a	O	3147
higher	O	3147
than	O	3147
expected	O	3147
frequency	O	3147
of	O	3147
green	O	3147
/	O	3147
red	O	3147
visual	O	3147
pigment	O	3147
rearrangements	O	3147
3	O	3147
to	O	3147
the	O	3147
red	O	3147
/	O	3147
green	O	3147
color	O	3147
vision	O	3147
gene	O	3147
complex	O	3147
.	O	3147
the	O	3148
previous	O	3148
report	O	3148
of	O	3148
such	O	3148
rearrangements	O	3148
was	O	3148
based	O	3148
on	O	3148
small	O	3148
numbers	O	3148
and	O	3148
lack	O	3148
of	O	3148
knowledge	O	3148
that	O	3148
the	O	3148
frequency	O	3148
of	O	3148
abnormal	O	3148
color	O	3148
vision	O	3148
arrays	O	3148
on	O	3148
molecular	O	3148
analysis	O	3148
was	O	3148
twice	O	3148
as	O	3148
high	O	3148
as	O	3148
expected	O	3148
on	O	3148
the	O	3148
basis	O	3148
of	O	3148
the	O	3148
frequency	O	3148
of	O	3148
phenotypic	B-Disease	3148
color	I-Disease	3148
vision	I-Disease	3148
defects	I-Disease	3148
.	O	3148
the	O	3150
r	O	3150
/	O	3150
gcp	O	3150
region	O	3150
was	O	3150
also	O	3150
analyzed	O	3150
in	O	3150
29	O	3150
french	O	3150
and	O	3150
seven	O	3150
north	O	3150
american	O	3150
ald	B-Disease	3150
patients	O	3150
by	O	3150
using	O	3150
six	O	3150
genomic	O	3150
dna	O	3150
probes	O	3150
,	O	3150
isolated	O	3150
from	O	3150
a	O	3150
cosmid	O	3150
walk	O	3150
,	O	3150
that	O	3150
flank	O	3150
the	O	3150
color	O	3150
vision	O	3150
genes	O	3150
.	O	3150
one	O	3152
of	O	3152
the	O	3152
eight	O	3152
previously	O	3152
reported	O	3152
ald	B-Disease	3152
individuals	O	3152
has	O	3152
a	O	3152
long	O	3152
deletion	O	3152
5	O	3152
of	O	3152
the	O	3152
red	O	3152
pigment	O	3152
gene	O	3152
,	O	3152
a	O	3152
deletion	O	3152
causing	O	3152
blue	O	3152
cone	O	3152
monochromacy	O	3152
.	O	3152
this	O	3153
finding	O	3153
and	O	3153
the	O	3153
previous	O	3153
findings	O	3153
of	O	3153
a	O	3153
45	O	3153
%	O	3153
frequency	O	3153
of	O	3153
phenotypic	O	3153
color	O	3153
vision	O	3153
defects	O	3153
in	O	3153
patients	O	3153
with	O	3153
amn	B-Disease	3153
may	O	3153
suggest	O	3153
that	O	3153
the	O	3153
ald	B-Disease	3153
/	O	3153
amn	B-Disease	3153
gene	O	3153
lies	O	3153
5	O	3153
to	O	3153
the	O	3153
red	O	3153
pigment	O	3153
gene	O	3153
and	O	3153
that	O	3153
the	O	3153
frequent	O	3153
phenotypic	O	3153
color	B-Disease	3153
vision	I-Disease	3153
anomalies	I-Disease	3153
owe	O	3153
their	O	3153
origin	O	3153
to	O	3153
deleted	O	3153
dna	O	3153
that	O	3153
includes	O	3153
regulatory	O	3153
genes	O	3153
for	O	3153
color	O	3153
vision	O	3153
.	O	3153
it	O	3154
is	O	3154
possible	O	3154
,	O	3154
however	O	3154
,	O	3154
that	O	3154
phenotypic	O	3154
color	B-Disease	3154
vision	I-Disease	3154
anomalies	I-Disease	3154
in	O	3154
amn	B-Disease	3154
may	O	3154
be	O	3154
phenocopies	O	3154
secondary	O	3154
to	O	3154
retinal	O	3154
or	O	3154
neural	O	3154
involvement	O	3154
by	O	3154
the	O	3154
disease	O	3154
.	O	3154
paroxysmal	B-Disease	3156
nocturnal	I-Disease	3156
haemoglobinuria	I-Disease	3156
with	O	3156
coexisting	O	3156
deficiency	B-Disease	3156
of	I-Disease	3156
the	I-Disease	3156
ninth	I-Disease	3156
component	I-Disease	3156
of	I-Disease	3156
complement	I-Disease	3156
:	O	3156
lack	O	3156
of	O	3156
massive	O	3156
haemolytic	B-Disease	3156
attack	I-Disease	3156
.	O	3156
a	O	3157
47	O	3157
-	O	3157
year	O	3157
-	O	3157
old	O	3157
woman	O	3157
with	O	3157
paroxysmal	B-Disease	3157
nocturnal	I-Disease	3157
haemoglobinuria	I-Disease	3157
(	O	3157
pnh	B-Disease	3157
)	O	3157
was	O	3157
found	O	3157
to	O	3157
have	O	3157
an	O	3157
inherited	B-Disease	3157
deficiency	I-Disease	3157
in	I-Disease	3157
the	I-Disease	3157
ninth	I-Disease	3157
complement	I-Disease	3157
component	I-Disease	3157
(	O	3157
c9	O	3157
)	O	3157
.	O	3157
surprisingly	O	3160
,	O	3160
she	O	3160
has	O	3160
suffered	O	3160
only	O	3160
mild	O	3160
haemolysis	B-Disease	3160
and	O	3160
has	O	3160
never	O	3160
experienced	O	3160
massive	O	3160
spontaneous	O	3160
haemolysis	B-Disease	3160
.	O	3160
gross	O	3161
haemoglobinuria	B-Disease	3161
and	O	3161
jaundice	B-Disease	3161
occurred	O	3161
only	O	3161
after	O	3161
receiving	O	3161
postoperative	O	3161
transfusion	O	3161
of	O	3161
whole	O	3161
blood	O	3161
.	O	3161
these	O	3166
observations	O	3166
indicated	O	3166
that	O	3166
c9	O	3166
may	O	3166
play	O	3166
a	O	3166
critical	O	3166
role	O	3166
in	O	3166
haemolytic	B-Disease	3166
attacks	I-Disease	3166
in	O	3166
patients	O	3166
with	O	3166
pnh	B-Disease	3166
and	O	3166
that	O	3166
characteristic	O	3166
haemolysis	B-Disease	3166
in	O	3166
pnh	B-Disease	3166
may	O	3166
be	O	3166
tempered	O	3166
by	O	3166
coexisting	O	3166
c9	B-Disease	3166
deficiency	I-Disease	3166
.	O	3166
.	O	3166
duplicational	O	3167
mutation	O	3167
at	O	3167
the	O	3167
duchenne	B-Disease	3167
muscular	I-Disease	3167
dystrophy	I-Disease	3167
locus	O	3167
:	O	3167
its	O	3167
frequency	O	3167
,	O	3167
distribution	O	3167
,	O	3167
origin	O	3167
,	O	3167
and	O	3167
phenotypegenotype	O	3167
correlation	O	3167
.	O	3167
partial	O	3168
gene	O	3168
deletion	O	3168
is	O	3168
the	O	3168
major	O	3168
cause	O	3168
of	O	3168
mutation	O	3168
leading	O	3168
to	O	3168
duchenne	B-Disease	3168
muscular	I-Disease	3168
dystrophy	I-Disease	3168
(	O	3168
dmd	B-Disease	3168
)	O	3168
and	O	3168
becker	B-Disease	3168
muscular	I-Disease	3168
dystrophy	I-Disease	3168
(	O	3168
bmd	B-Disease	3168
)	O	3168
.	O	3168
we	O	3170
have	O	3170
conducted	O	3170
a	O	3170
survey	O	3170
for	O	3170
duplication	O	3170
in	O	3170
72	O	3170
unrelated	O	3170
nondeletion	O	3170
patients	O	3170
,	O	3170
analyzed	O	3170
by	O	3170
southern	O	3170
blot	O	3170
hybridization	O	3170
with	O	3170
clones	O	3170
representing	O	3170
the	O	3170
entire	O	3170
dmd	B-Disease	3170
cdna	O	3170
.	O	3170
a	O	3174
shift	O	3174
of	O	3174
the	O	3174
reading	O	3174
frame	O	3174
was	O	3174
predicted	O	3174
in	O	3174
four	O	3174
of	O	3174
the	O	3174
six	O	3174
dmd	B-Disease	3174
cases	O	3174
and	O	3174
in	O	3174
one	O	3174
of	O	3174
the	O	3174
two	O	3174
intermediate	O	3174
cases	O	3174
,	O	3174
while	O	3174
the	O	3174
reading	O	3174
frame	O	3174
remained	O	3174
uninterrupted	O	3174
in	O	3174
both	O	3174
bmd	B-Disease	3174
cases	O	3174
.	O	3174
glucose	O	3178
6	O	3178
-	O	3178
phosphate	O	3178
dehydrogenase	O	3178
variants	O	3178
:	O	3178
gd	O	3178
(	O	3178
+	O	3178
)	O	3178
alexandra	O	3178
associated	O	3178
with	O	3178
neonatal	B-Disease	3178
jaundice	I-Disease	3178
and	O	3178
gd	O	3178
(	O	3178
-	O	3178
)	O	3178
camperdown	O	3178
in	O	3178
a	O	3178
young	O	3178
man	O	3178
with	O	3178
lamellar	B-Disease	3178
cataracts	I-Disease	3178
.	O	3178
the	O	3180
first	O	3180
,	O	3180
of	O	3180
italian	O	3180
extraction	O	3180
,	O	3180
suffered	O	3180
from	O	3180
severe	O	3180
neonatal	B-Disease	3180
jaundice	I-Disease	3180
following	O	3180
maternal	O	3180
ingestion	O	3180
of	O	3180
fresh	O	3180
broad	O	3180
beans	O	3180
(	O	3180
vicia	O	3180
fava	O	3180
)	O	3180
both	O	3180
prenatally	O	3180
and	O	3180
postnatally	O	3180
the	O	3180
expression	O	3180
of	O	3180
the	O	3180
enzymatic	O	3180
defect	O	3180
was	O	3180
much	O	3180
more	O	3180
severe	O	3180
in	O	3180
the	O	3180
neonatal	O	3180
period	O	3180
than	O	3180
on	O	3180
retesting	O	3180
in	O	3180
adolescence	O	3180
,	O	3180
when	O	3180
biochemical	O	3180
characterization	O	3180
showed	O	3180
unique	O	3180
features	O	3180
which	O	3180
justify	O	3180
designation	O	3180
as	O	3180
a	O	3180
new	O	3180
variant	O	3180
gd	O	3180
(	O	3180
+	O	3180
)	O	3180
alexandra	O	3180
.	O	3180
the	O	3181
second	O	3181
patient	O	3181
,	O	3181
a	O	3181
boy	O	3181
of	O	3181
maltese	O	3181
extraction	O	3181
who	O	3181
was	O	3181
found	O	3181
to	O	3181
have	O	3181
bilateral	B-Disease	3181
lamellar	I-Disease	3181
cataracts	I-Disease	3181
at	O	3181
the	O	3181
age	O	3181
of	O	3181
4	O	3181
years	O	3181
,	O	3181
was	O	3181
identified	O	3181
as	O	3181
g6pd	B-Disease	3181
deficient	I-Disease	3181
only	O	3181
as	O	3181
a	O	3181
result	O	3181
of	O	3181
a	O	3181
survey	O	3181
of	O	3181
children	O	3181
of	O	3181
mediterranean	O	3181
origin	O	3181
with	O	3181
unexplained	O	3181
cataract	B-Disease	3181
formation	O	3181
;	O	3181
he	O	3181
has	O	3181
approximately	O	3181
15	O	3181
%	O	3181
of	O	3181
normal	O	3181
enzyme	O	3181
activity	O	3181
,	O	3181
with	O	3181
another	O	3181
unique	O	3181
combination	O	3181
of	O	3181
biochemical	O	3181
characteristics	O	3181
which	O	3181
has	O	3181
led	O	3181
to	O	3181
its	O	3181
designation	O	3181
as	O	3181
gd	O	3181
(	O	3181
-	O	3181
)	O	3181
camperdown	O	3181
.	O	3181
although	O	3182
this	O	3182
association	O	3182
may	O	3182
be	O	3182
coincidental	O	3182
,	O	3182
it	O	3182
prompts	O	3182
further	O	3182
attention	O	3182
to	O	3182
the	O	3182
possibility	O	3182
that	O	3182
under	O	3182
certain	O	3182
circumstances	O	3182
g6pd	B-Disease	3182
deficiency	I-Disease	3182
may	O	3182
favor	O	3182
cataract	B-Disease	3182
formation	O	3182
.	O	3182
statistical	O	3184
analysis	O	3184
of	O	3184
the	O	3184
two	O	3184
stage	O	3184
mutation	O	3184
model	O	3184
in	O	3184
von	B-Disease	3184
hippel	I-Disease	3184
-	I-Disease	3184
lindau	I-Disease	3184
disease	I-Disease	3184
,	O	3184
and	O	3184
in	O	3184
sporadic	B-Disease	3184
cerebellar	I-Disease	3184
haemangioblastoma	I-Disease	3184
and	O	3184
renal	B-Disease	3184
cell	I-Disease	3184
carcinoma	I-Disease	3184
.	O	3184
analysis	O	3185
of	O	3185
the	O	3185
age	O	3185
incidence	O	3185
curves	O	3185
for	O	3185
unilateral	B-Disease	3185
and	I-Disease	3185
bilateral	I-Disease	3185
retinoblastoma	I-Disease	3185
led	O	3185
knudson	O	3185
to	O	3185
propose	O	3185
that	O	3185
hereditary	B-Disease	3185
tumours	I-Disease	3185
may	O	3185
arise	O	3185
by	O	3185
a	O	3185
single	O	3185
event	O	3185
and	O	3185
sporadic	B-Disease	3185
tumours	I-Disease	3185
by	O	3185
a	O	3185
two	O	3185
stage	O	3185
mutation	O	3185
process	O	3185
.	O	3185
it	O	3186
has	O	3186
been	O	3186
suggested	O	3186
recently	O	3186
that	O	3186
sporadic	B-Disease	3186
renal	I-Disease	3186
cell	I-Disease	3186
carcinoma	I-Disease	3186
may	O	3186
arise	O	3186
from	O	3186
a	O	3186
two	O	3186
stage	O	3186
mutation	O	3186
process	O	3186
.	O	3186
we	O	3187
analysed	O	3187
the	O	3187
age	O	3187
incidence	O	3187
curves	O	3187
for	O	3187
symptomatic	O	3187
renal	B-Disease	3187
cell	I-Disease	3187
carcinoma	I-Disease	3187
(	O	3187
n	O	3187
=	O	3187
26	O	3187
)	O	3187
and	O	3187
cerebellar	B-Disease	3187
haemangioblastoma	I-Disease	3187
(	O	3187
n	O	3187
=	O	3187
68	O	3187
)	O	3187
in	O	3187
109	O	3187
patients	O	3187
with	O	3187
von	B-Disease	3187
hippel	I-Disease	3187
-	I-Disease	3187
lindau	I-Disease	3187
(	I-Disease	3187
vhl	I-Disease	3187
)	I-Disease	3187
disease	I-Disease	3187
,	O	3187
and	O	3187
compared	O	3187
them	O	3187
to	O	3187
104	O	3187
patients	O	3187
with	O	3187
sporadic	B-Disease	3187
renal	I-Disease	3187
cell	I-Disease	3187
carcinoma	I-Disease	3187
and	O	3187
43	O	3187
patients	O	3187
with	O	3187
sporadic	B-Disease	3187
cerebellar	I-Disease	3187
haemangioblastoma	I-Disease	3187
.	O	3187
the	O	3188
age	O	3188
incidence	O	3188
curves	O	3188
for	O	3188
renal	B-Disease	3188
cell	I-Disease	3188
carcinoma	I-Disease	3188
and	O	3188
cerebellar	B-Disease	3188
haemangioblastoma	I-Disease	3188
in	O	3188
vhl	B-Disease	3188
disease	I-Disease	3188
were	O	3188
compatible	O	3188
with	O	3188
a	O	3188
single	O	3188
mutation	O	3188
model	O	3188
,	O	3188
whereas	O	3188
the	O	3188
age	O	3188
incidence	O	3188
curves	O	3188
for	O	3188
sporadic	B-Disease	3188
renal	I-Disease	3188
cell	I-Disease	3188
carcinoma	I-Disease	3188
and	O	3188
cerebellar	B-Disease	3188
haemangioblastoma	I-Disease	3188
suggested	O	3188
a	O	3188
two	O	3188
stage	O	3188
mutation	O	3188
process	O	3188
.	O	3188
these	O	3189
data	O	3189
are	O	3189
compatible	O	3189
with	O	3189
the	O	3189
vhl	B-Disease	3189
gene	O	3189
functioning	O	3189
as	O	3189
a	O	3189
recessive	O	3189
tumour	B-Disease	3189
suppressor	O	3189
gene	O	3189
.	O	3189
sporadic	B-Disease	3190
cerebellar	I-Disease	3190
haemangioblastoma	I-Disease	3190
and	O	3190
some	O	3190
renal	B-Disease	3190
cell	I-Disease	3190
carcinoma	I-Disease	3190
may	O	3190
arise	O	3190
from	O	3190
somatic	O	3190
mutations	O	3190
inactivating	O	3190
both	O	3190
alleles	O	3190
at	O	3190
the	O	3190
vhl	B-Disease	3190
locus	O	3190
.	O	3190
.	O	3190
screening	O	3191
for	O	3191
carriers	O	3191
of	O	3191
tay	B-Disease	3191
-	I-Disease	3191
sachs	I-Disease	3191
disease	I-Disease	3191
among	O	3191
ashkenazi	O	3191
jews	O	3191
.	O	3191
the	O	3194
prevention	O	3194
of	O	3194
tay	B-Disease	3194
-	I-Disease	3194
sachs	I-Disease	3194
disease	I-Disease	3194
(	O	3194
gm2	B-Disease	3194
gangliosidosis	I-Disease	3194
,	I-Disease	3194
type	I-Disease	3194
1	I-Disease	3194
)	O	3194
depends	O	3194
on	O	3194
the	O	3194
identification	O	3194
of	O	3194
carriers	O	3194
of	O	3194
the	O	3194
gene	O	3194
for	O	3194
this	O	3194
autosomal	B-Disease	3194
recessive	I-Disease	3194
disorder	I-Disease	3194
.	O	3194
we	O	3195
compared	O	3195
the	O	3195
enzyme	O	3195
-	O	3195
based	O	3195
test	O	3195
widely	O	3195
used	O	3195
in	O	3195
screening	O	3195
for	O	3195
tay	B-Disease	3195
-	I-Disease	3195
sachs	I-Disease	3195
disease	I-Disease	3195
with	O	3195
a	O	3195
test	O	3195
based	O	3195
on	O	3195
analysis	O	3195
of	O	3195
dna	O	3195
.	O	3195
we	O	3196
developed	O	3196
methods	O	3196
to	O	3196
detect	O	3196
the	O	3196
three	O	3196
mutations	O	3196
in	O	3196
the	O	3196
hexa	O	3196
gene	O	3196
that	O	3196
occur	O	3196
with	O	3196
high	O	3196
frequency	O	3196
among	O	3196
ashkenazi	O	3196
jews	O	3196
two	O	3196
mutations	O	3196
cause	O	3196
infantile	O	3196
tay	B-Disease	3196
-	I-Disease	3196
sachs	I-Disease	3196
disease	I-Disease	3196
,	O	3196
and	O	3196
the	O	3196
third	O	3196
causes	O	3196
the	O	3196
adult	O	3196
-	O	3196
onset	O	3196
form	O	3196
of	O	3196
the	O	3196
disease	O	3196
.	O	3196
among	O	3199
62	O	3199
ashkenazi	O	3199
obligate	O	3199
carriers	O	3199
of	O	3199
tay	B-Disease	3199
-	I-Disease	3199
sachs	I-Disease	3199
disease	I-Disease	3199
,	O	3199
the	O	3199
three	O	3199
specific	O	3199
mutations	O	3199
accounted	O	3199
for	O	3199
all	O	3199
but	O	3199
one	O	3199
of	O	3199
the	O	3199
mutant	O	3199
alleles	O	3199
(	O	3199
98	O	3199
percent	O	3199
)	O	3199
.	O	3199
the	O	3205
increased	O	3205
specificity	O	3205
and	O	3205
predictive	O	3205
value	O	3205
of	O	3205
the	O	3205
dna	O	3205
-	O	3205
based	O	3205
test	O	3205
make	O	3205
it	O	3205
a	O	3205
useful	O	3205
adjunct	O	3205
to	O	3205
the	O	3205
diagnostic	O	3205
tests	O	3205
currently	O	3205
used	O	3205
to	O	3205
screen	O	3205
for	O	3205
carriers	O	3205
of	O	3205
tay	B-Disease	3205
-	I-Disease	3205
sachs	I-Disease	3205
disease	I-Disease	3205
.	O	3205
total	B-Disease	3206
deficiency	I-Disease	3206
of	I-Disease	3206
plasma	I-Disease	3206
cholesteryl	I-Disease	3206
ester	I-Disease	3206
transfer	I-Disease	3206
protein	I-Disease	3206
in	O	3206
subjects	O	3206
homozygous	O	3206
and	O	3206
heterozygous	O	3206
for	O	3206
the	O	3206
intron	O	3206
14	O	3206
splicing	O	3206
defect	O	3206
.	O	3206
the	O	3207
molecular	O	3207
basis	O	3207
of	O	3207
cholesteryl	B-Disease	3207
ester	I-Disease	3207
transfer	I-Disease	3207
protein	I-Disease	3207
(	I-Disease	3207
cetp	I-Disease	3207
)	I-Disease	3207
deficiency	I-Disease	3207
was	O	3207
investigated	O	3207
in	O	3207
4	O	3207
unrelated	O	3207
cetp	B-Disease	3207
-	I-Disease	3207
deficient	I-Disease	3207
families	O	3207
.	O	3207
thus	O	3215
,	O	3215
other	O	3215
genetic	B-Disease	3215
defects	I-Disease	3215
or	O	3215
metabolic	O	3215
factors	O	3215
influencing	O	3215
cetp	O	3215
expression	O	3215
are	O	3215
implicated	O	3215
.	O	3215
the	O	3216
data	O	3216
suggest	O	3216
that	O	3216
the	O	3216
g	O	3216
-	O	3216
to	O	3216
-	O	3216
a	O	3216
mutation	O	3216
may	O	3216
be	O	3216
common	O	3216
in	O	3216
human	O	3216
plasma	O	3216
cetp	B-Disease	3216
deficiency	I-Disease	3216
.	O	3216
glucose	B-Disease	3219
-	I-Disease	3219
6	I-Disease	3219
-	I-Disease	3219
phosphate	I-Disease	3219
dehydrogenase	I-Disease	3219
(	I-Disease	3219
g6pd	I-Disease	3219
;	I-Disease	3219
e	I-Disease	3219
.	I-Disease	3219
c	I-Disease	3219
.	I-Disease	3219
1	I-Disease	3219
.	I-Disease	3219
1	I-Disease	3219
.	I-Disease	3219
1	I-Disease	3219
.	I-Disease	3219
49	I-Disease	3219
)	I-Disease	3219
deficiency	I-Disease	3219
is	O	3219
the	O	3219
most	O	3219
common	O	3219
human	O	3219
enzymopathy	B-Disease	3219
;	O	3219
more	O	3219
than	O	3219
300	O	3219
different	O	3219
biochemical	O	3219
variants	O	3219
of	O	3219
the	O	3219
enzyme	O	3219
have	O	3219
been	O	3219
described	O	3219
.	O	3219
in	O	3220
many	O	3220
parts	O	3220
of	O	3220
the	O	3220
world	O	3220
the	O	3220
mediterranean	O	3220
type	O	3220
of	O	3220
g6pd	B-Disease	3220
deficiency	I-Disease	3220
is	O	3220
prevalent	O	3220
.	O	3220
a	O	3228
normal	O	3228
male	O	3228
with	O	3228
an	O	3228
inherited	O	3228
deletion	O	3228
of	O	3228
one	O	3228
exon	O	3228
within	O	3228
the	O	3228
dmd	B-Disease	3228
gene	O	3228
.	O	3228
we	O	3229
describe	O	3229
two	O	3229
brothers	O	3229
with	O	3229
identical	O	3229
inherited	O	3229
deletions	O	3229
of	O	3229
one	O	3229
single	O	3229
exon	O	3229
within	O	3229
the	O	3229
middle	O	3229
of	O	3229
the	O	3229
dmd	B-Disease	3229
gene	O	3229
;	O	3229
one	O	3229
brother	O	3229
has	O	3229
becker	B-Disease	3229
muscular	I-Disease	3229
dystrophy	I-Disease	3229
diagnosed	O	3229
at	O	3229
11	O	3229
years	O	3229
of	O	3229
age	O	3229
,	O	3229
whereas	O	3229
the	O	3229
older	O	3229
brother	O	3229
is	O	3229
normal	O	3229
at	O	3229
18	O	3229
.	O	3229
these	O	3230
results	O	3230
have	O	3230
implications	O	3230
for	O	3230
genetic	O	3230
counselling	O	3230
and	O	3230
prenatal	O	3230
diagnosis	O	3230
in	O	3230
families	O	3230
with	O	3230
becker	B-Disease	3230
muscular	I-Disease	3230
dystrophy	I-Disease	3230
.	O	3230
.	O	3230
duchenne	B-Disease	3231
muscular	I-Disease	3231
dystrophy	I-Disease	3231
gene	O	3231
expression	O	3231
in	O	3231
normal	O	3231
and	O	3231
diseased	O	3231
human	O	3231
muscle	O	3231
.	O	3231
a	O	3232
probe	O	3232
for	O	3232
the	O	3232
5	O	3232
end	O	3232
of	O	3232
the	O	3232
duchenne	B-Disease	3232
muscular	I-Disease	3232
dystrophy	I-Disease	3232
(	O	3232
dmd	B-Disease	3232
)	O	3232
gene	O	3232
was	O	3232
used	O	3232
to	O	3232
study	O	3232
expression	O	3232
of	O	3232
the	O	3232
gene	O	3232
in	O	3232
normal	O	3232
human	O	3232
muscle	O	3232
,	O	3232
myogenic	O	3232
cell	O	3232
cultures	O	3232
,	O	3232
and	O	3232
muscle	O	3232
from	O	3232
patients	O	3232
with	O	3232
dmd	B-Disease	3232
.	O	3232
in	O	3234
dmd	B-Disease	3234
muscle	O	3234
,	O	3234
expression	O	3234
of	O	3234
this	O	3234
portion	O	3234
of	O	3234
the	O	3234
gene	O	3234
was	O	3234
also	O	3234
revealed	O	3234
by	O	3234
in	O	3234
situ	O	3234
rna	O	3234
hybridization	O	3234
,	O	3234
particularly	O	3234
in	O	3234
regenerating	O	3234
muscle	O	3234
fibers	O	3234
.	O	3234
.	O	3234
molecular	O	3235
and	O	3235
phenotypic	O	3235
analysis	O	3235
of	O	3235
patients	O	3235
with	O	3235
deletions	O	3235
within	O	3235
the	O	3235
deletion	O	3235
-	O	3235
rich	O	3235
region	O	3235
of	O	3235
the	O	3235
duchenne	B-Disease	3235
muscular	I-Disease	3235
dystrophy	I-Disease	3235
(	O	3235
dmd	B-Disease	3235
)	O	3235
gene	O	3235
.	O	3235
eighty	O	3236
unrelated	O	3236
individuals	O	3236
with	O	3236
duchenne	B-Disease	3236
muscular	I-Disease	3236
dystrophy	I-Disease	3236
(	O	3236
dmd	B-Disease	3236
)	O	3236
or	O	3236
becker	B-Disease	3236
muscular	I-Disease	3236
dystrophy	I-Disease	3236
(	O	3236
bmd	B-Disease	3236
)	O	3236
were	O	3236
found	O	3236
to	O	3236
have	O	3236
deletions	O	3236
in	O	3236
the	O	3236
major	O	3236
deletion	O	3236
-	O	3236
rich	O	3236
region	O	3236
of	O	3236
the	O	3236
dmd	B-Disease	3236
locus	O	3236
.	O	3236
thirty	O	3241
-	O	3241
eight	O	3241
independent	O	3241
patients	O	3241
were	O	3241
old	O	3241
enough	O	3241
to	O	3241
be	O	3241
classified	O	3241
as	O	3241
dmd	B-Disease	3241
,	O	3241
bmd	B-Disease	3241
,	O	3241
or	O	3241
intermediate	O	3241
phenotype	O	3241
and	O	3241
had	O	3241
deletions	O	3241
of	O	3241
exons	O	3241
with	O	3241
sequenced	O	3241
intron	O	3241
/	O	3241
exon	O	3241
boundaries	O	3241
.	O	3241
of	O	3242
these	O	3242
,	O	3242
eight	O	3242
bmd	B-Disease	3242
patients	O	3242
and	O	3242
one	O	3242
intermediate	O	3242
patient	O	3242
had	O	3242
gene	O	3242
deletions	O	3242
predicted	O	3242
to	O	3242
leave	O	3242
the	O	3242
reading	O	3242
frame	O	3242
intact	O	3242
,	O	3242
while	O	3242
21	O	3242
dmd	B-Disease	3242
patients	O	3242
,	O	3242
7	O	3242
intermediate	O	3242
patients	O	3242
,	O	3242
and	O	3242
1	O	3242
bmd	B-Disease	3242
patient	O	3242
had	O	3242
gene	O	3242
deletions	O	3242
predicted	O	3242
to	O	3242
disrupt	O	3242
the	O	3242
reading	O	3242
frame	O	3242
.	O	3242
chromosome	O	3246
translocations	O	3246
involving	O	3246
11p13	O	3246
have	O	3246
been	O	3246
associated	O	3246
with	O	3246
familial	B-Disease	3246
aniridia	I-Disease	3246
in	O	3246
two	O	3246
kindreds	O	3246
highlighting	O	3246
the	O	3246
chromosomal	O	3246
localization	O	3246
of	O	3246
the	O	3246
an2	O	3246
locus	O	3246
.	O	3246
this	O	3247
locus	O	3247
is	O	3247
also	O	3247
part	O	3247
of	O	3247
the	O	3247
wagr	B-Disease	3247
complex	O	3247
(	O	3247
wilms	B-Disease	3247
tumor	I-Disease	3247
,	O	3247
aniridia	B-Disease	3247
,	O	3247
genitourinary	B-Disease	3247
abnormalities	I-Disease	3247
,	O	3247
and	O	3247
mental	B-Disease	3247
retardation	I-Disease	3247
)	O	3247
.	O	3247
linkage	O	3251
analysis	O	3251
of	O	3251
the	O	3251
apolipoprotein	O	3251
c2	O	3251
gene	O	3251
and	O	3251
myotonic	B-Disease	3251
dystrophy	I-Disease	3251
on	O	3251
human	O	3251
chromosome	O	3251
19	O	3251
reveals	O	3251
linkage	O	3251
disequilibrium	O	3251
in	O	3251
a	O	3251
french	O	3251
-	O	3251
canadian	O	3251
population	O	3251
.	O	3251
the	O	3252
gene	O	3252
for	O	3252
human	O	3252
apolipoprotein	O	3252
c2	O	3252
(	O	3252
apoc2	O	3252
)	O	3252
,	O	3252
situated	O	3252
on	O	3252
the	O	3252
proximal	O	3252
long	O	3252
arm	O	3252
of	O	3252
chromosome	O	3252
19	O	3252
,	O	3252
is	O	3252
closely	O	3252
linked	O	3252
to	O	3252
the	O	3252
gene	O	3252
for	O	3252
the	O	3252
most	O	3252
common	O	3252
form	O	3252
of	O	3252
adult	O	3252
muscular	B-Disease	3252
dystrophy	I-Disease	3252
,	O	3252
myotonic	B-Disease	3252
dystrophy	I-Disease	3252
(	O	3252
dm	B-Disease	3252
)	O	3252
.	O	3252
we	O	3254
have	O	3254
conducted	O	3254
a	O	3254
comprehensive	O	3254
dm	B-Disease	3254
linkage	O	3254
study	O	3254
utilizing	O	3254
all	O	3254
six	O	3254
rflps	O	3254
and	O	3254
involving	O	3254
50	O	3254
families	O	3254
and	O	3254
372	O	3254
individuals	O	3254
.	O	3254
this	O	3260
represents	O	3260
the	O	3260
first	O	3260
evidence	O	3260
of	O	3260
linkage	O	3260
disequilibrium	O	3260
between	O	3260
apoc2	O	3260
and	O	3260
the	O	3260
dm	B-Disease	3260
locus	O	3260
.	O	3260
phenylalanine	O	3261
hydroxylase	O	3261
gene	O	3261
haplotypes	O	3261
in	O	3261
polynesians	O	3261
:	O	3261
evolutionary	O	3261
origins	O	3261
and	O	3261
absence	O	3261
of	O	3261
alleles	O	3261
associated	O	3261
with	O	3261
severe	O	3261
phenylketonuria	B-Disease	3261
.	O	3261
the	O	3266
absence	O	3266
of	O	3266
severe	O	3266
phenylketonuria	B-Disease	3266
(	O	3266
pku	B-Disease	3266
)	O	3266
in	O	3266
both	O	3266
polynesians	O	3266
and	O	3266
southeast	O	3266
asians	O	3266
is	O	3266
consistent	O	3266
with	O	3266
the	O	3266
lack	O	3266
of	O	3266
pah	O	3266
haplotypes	O	3266
2	O	3266
and	O	3266
3	O	3266
,	O	3266
on	O	3266
which	O	3266
the	O	3266
severe	O	3266
pku	B-Disease	3266
mutants	O	3266
have	O	3266
arisen	O	3266
among	O	3266
caucasians	O	3266
.	O	3266
.	O	3266
preferential	O	3267
germline	O	3267
mutation	O	3267
of	O	3267
the	O	3267
paternal	O	3267
allele	O	3267
in	O	3267
retinoblastoma	B-Disease	3267
.	O	3267
the	O	3268
event	O	3268
triggering	O	3268
malignant	O	3268
proliferation	O	3268
in	O	3268
70	O	3268
%	O	3268
of	O	3268
retinoblastoma	B-Disease	3268
tumours	I-Disease	3268
is	O	3268
loss	O	3268
of	O	3268
heterozygosity	O	3268
for	O	3268
chromosome	O	3268
13q14	O	3268
,	O	3268
whereby	O	3268
the	O	3268
normal	O	3268
retinoblastoma	B-Disease	3268
gene	O	3268
(	O	3268
rb1	O	3268
)	O	3268
allele	O	3268
is	O	3268
lost	O	3268
and	O	3268
an	O	3268
already	O	3268
mutated	O	3268
rb1	O	3268
allele	O	3268
remains	O	3268
in	O	3268
the	O	3268
tumour	B-Disease	3268
.	O	3268
most	O	3270
bilateral	O	3270
patients	O	3270
have	O	3270
no	O	3270
family	O	3270
history	O	3270
of	O	3270
retinoblastoma	B-Disease	3270
and	O	3270
are	O	3270
presumed	O	3270
to	O	3270
have	O	3270
new	O	3270
germline	O	3270
mutations	O	3270
which	O	3270
arose	O	3270
in	O	3270
the	O	3270
egg	O	3270
,	O	3270
sperm	O	3270
or	O	3270
early	O	3270
embryo	O	3270
.	O	3270
we	O	3271
have	O	3271
determined	O	3271
the	O	3271
parental	O	3271
origin	O	3271
of	O	3271
the	O	3271
retained	O	3271
allele	O	3271
in	O	3271
nine	O	3271
retinoblastoma	B-Disease	3271
tumours	I-Disease	3271
from	O	3271
eight	O	3271
unrelated	O	3271
non	O	3271
-	O	3271
familial	O	3271
cases	O	3271
by	O	3271
using	O	3271
rb1	O	3271
-	O	3271
linked	O	3271
genetic	O	3271
markers	O	3271
.	O	3271
six	O	3272
tumours	B-Disease	3272
retained	O	3272
the	O	3272
paternal	O	3272
allele	O	3272
and	O	3272
three	O	3272
retained	O	3272
the	O	3272
maternal	O	3272
allele	O	3272
.	O	3272
of	O	3273
the	O	3273
three	O	3273
unilateral	B-Disease	3273
tumours	I-Disease	3273
,	O	3273
only	O	3273
one	O	3273
retained	O	3273
the	O	3273
paternal	O	3273
rb1	O	3273
allele	O	3273
.	O	3273
thus	O	3274
,	O	3274
there	O	3274
is	O	3274
no	O	3274
evidence	O	3274
that	O	3274
the	O	3274
paternal	O	3274
rb1	O	3274
allele	O	3274
is	O	3274
preferentially	O	3274
retained	O	3274
in	O	3274
retinoblastoma	B-Disease	3274
,	O	3274
as	O	3274
has	O	3274
been	O	3274
suggested	O	3274
to	O	3274
be	O	3274
the	O	3274
case	O	3274
in	O	3274
osteosarcoma	B-Disease	3274
.	O	3274
by	O	3275
contrast	O	3275
,	O	3275
tumours	B-Disease	3275
from	O	3275
four	O	3275
of	O	3275
the	O	3275
five	O	3275
bilateral	O	3275
patients	O	3275
retained	O	3275
the	O	3275
paternal	O	3275
rb1	O	3275
allele	O	3275
.	O	3275
haplotype	O	3277
analysis	O	3277
of	O	3277
the	O	3277
phenylalanine	O	3277
hydroxylase	O	3277
gene	O	3277
in	O	3277
turkish	O	3277
phenylketonuria	B-Disease	3277
families	O	3277
.	O	3277
we	O	3278
have	O	3278
estimated	O	3278
the	O	3278
haplotype	O	3278
distribution	O	3278
of	O	3278
mutant	O	3278
and	O	3278
normal	O	3278
phenylalanine	O	3278
hydroxylase	O	3278
(	O	3278
pah	O	3278
)	O	3278
alleles	O	3278
for	O	3278
17	O	3278
turkish	O	3278
phenylketonuria	B-Disease	3278
(	O	3278
pku	B-Disease	3278
)	O	3278
families	O	3278
20	O	3278
normal	O	3278
and	O	3278
27	O	3278
mutated	O	3278
pah	O	3278
alleles	O	3278
could	O	3278
be	O	3278
identified	O	3278
.	O	3278
two	O	3282
of	O	3282
the	O	3282
eight	O	3282
polymorphic	O	3282
sites	O	3282
were	O	3282
in	O	3282
association	O	3282
with	O	3282
pku	B-Disease	3282
.	O	3282
huntington	B-Disease	3284
disease	I-Disease	3284
:	O	3284
no	O	3284
evidence	O	3284
for	O	3284
locus	O	3284
heterogeneity	O	3284
.	O	3284
a	O	3285
total	O	3285
of	O	3285
63	O	3285
families	O	3285
with	O	3285
huntington	B-Disease	3285
disease	I-Disease	3285
(	O	3285
hd	B-Disease	3285
)	O	3285
were	O	3285
examined	O	3285
for	O	3285
linkage	O	3285
between	O	3285
hd	B-Disease	3285
and	O	3285
g8	O	3285
(	O	3285
d4s10	O	3285
)	O	3285
.	O	3285
these	O	3297
data	O	3297
suggest	O	3297
that	O	3297
there	O	3297
is	O	3297
only	O	3297
one	O	3297
hd	B-Disease	3297
locus	O	3297
,	O	3297
although	O	3297
a	O	3297
second	O	3297
rare	O	3297
locus	O	3297
cannot	O	3297
be	O	3297
ruled	O	3297
out	O	3297
.	O	3297
haplotype	O	3298
and	O	3298
multipoint	O	3298
linkage	O	3298
analysis	O	3298
in	O	3298
finnish	O	3298
choroideremia	B-Disease	3298
families	O	3298
.	O	3298
multipoint	O	3299
linkage	O	3299
analysis	O	3299
of	O	3299
choroideremia	B-Disease	3299
(	O	3299
tcd	B-Disease	3299
)	O	3299
and	O	3299
seven	O	3299
x	O	3299
chromosomal	O	3299
restriction	O	3299
fragment	O	3299
length	O	3299
polymorphisms	O	3299
(	O	3299
rflps	O	3299
)	O	3299
was	O	3299
carried	O	3299
out	O	3299
in	O	3299
18	O	3299
finnish	O	3299
tcd	B-Disease	3299
families	O	3299
.	O	3299
the	O	3300
data	O	3300
place	O	3300
tcd	B-Disease	3300
distal	O	3300
to	O	3300
pgk	O	3300
and	O	3300
dxs72	O	3300
,	O	3300
very	O	3300
close	O	3300
to	O	3300
dxys1	O	3300
and	O	3300
dxys5	O	3300
(	O	3300
zmax	O	3300
=	O	3300
24	O	3300
at	O	3300
theta	O	3300
=	O	3300
0	O	3300
)	O	3300
and	O	3300
proximal	O	3300
to	O	3300
dxys4	O	3300
and	O	3300
dxys12	O	3300
.	O	3300
all	O	3302
the	O	3302
tcd	B-Disease	3302
males	O	3302
and	O	3302
carrier	O	3302
females	O	3302
studied	O	3302
have	O	3302
the	O	3302
same	O	3302
dxys1	O	3302
allele	O	3302
in	O	3302
coupling	O	3302
with	O	3302
tcd	B-Disease	3302
.	O	3302
in	O	3303
northeastern	O	3303
finland	O	3303
,	O	3303
66	O	3303
/	O	3303
69	O	3303
chromosomes	O	3303
carrying	O	3303
tcd	B-Disease	3303
had	O	3303
the	O	3303
same	O	3303
haplotype	O	3303
at	O	3303
loci	O	3303
dxs72	O	3303
,	O	3303
dxys1	O	3303
,	O	3303
dxys4	O	3303
,	O	3303
and	O	3303
dxys12	O	3303
.	O	3303
the	O	3304
same	O	3304
haplotype	O	3304
is	O	3304
seen	O	3304
in	O	3304
only	O	3304
15	O	3304
/	O	3304
99	O	3304
chromosomes	O	3304
not	O	3304
carrying	O	3304
tcd	B-Disease	3304
.	O	3304
moreover	O	3305
,	O	3305
in	O	3305
71	O	3305
/	O	3305
104	O	3305
non	O	3305
-	O	3305
tcd	O	3305
chromosomes	O	3305
,	O	3305
the	O	3305
haplotype	O	3305
at	O	3305
six	O	3305
marker	O	3305
loci	O	3305
is	O	3305
different	O	3305
from	O	3305
those	O	3305
seen	O	3305
in	O	3305
any	O	3305
of	O	3305
the	O	3305
76	O	3305
tcd	B-Disease	3305
chromosomes	O	3305
.	O	3305
this	O	3306
supports	O	3306
the	O	3306
previously	O	3306
described	O	3306
hypothesis	O	3306
that	O	3306
the	O	3306
large	O	3306
northern	O	3306
finnish	O	3306
choroideremia	B-Disease	3306
pedigrees	O	3306
,	O	3306
comprising	O	3306
a	O	3306
total	O	3306
of	O	3306
over	O	3306
80	O	3306
living	O	3306
patients	O	3306
representing	O	3306
more	O	3306
than	O	3306
a	O	3306
fifth	O	3306
of	O	3306
all	O	3306
tcd	B-Disease	3306
patients	O	3306
described	O	3306
worldwide	O	3306
,	O	3306
carry	O	3306
the	O	3306
same	O	3306
mutation	O	3306
.	O	3306
autosomal	O	3308
dominant	O	3308
aniridia	B-Disease	3308
linked	O	3308
to	O	3308
the	O	3308
chromosome	O	3308
11p13	O	3308
markers	O	3308
catalase	O	3308
and	O	3308
d11s151	O	3308
in	O	3308
a	O	3308
large	O	3308
dutch	O	3308
family	O	3308
.	O	3308
in	O	3309
a	O	3309
large	O	3309
pedigree	O	3309
with	O	3309
autosomal	O	3309
dominant	O	3309
aniridia	B-Disease	3309
,	O	3309
we	O	3309
found	O	3309
close	O	3309
linkage	O	3309
between	O	3309
the	O	3309
aniridia	B-Disease	3309
locus	O	3309
an2	O	3309
and	O	3309
the	O	3309
markers	O	3309
catalase	O	3309
(	O	3309
cat	O	3309
)	O	3309
(	O	3309
zeta	O	3309
=	O	3309
7	O	3309
.	O	3309
27	O	3309
at	O	3309
theta	O	3309
=	O	3309
0	O	3309
.	O	3309
00	O	3309
)	O	3309
and	O	3309
d11s151	O	3309
(	O	3309
zeta	O	3309
=	O	3309
3	O	3309
.	O	3309
86	O	3309
at	O	3309
theta	O	3309
=	O	3309
0	O	3309
.	O	3309
10	O	3309
)	O	3309
flanking	O	3309
the	O	3309
an2	O	3309
locus	O	3309
on	O	3309
11p13	O	3309
.	O	3309
we	O	3311
conclude	O	3311
that	O	3311
the	O	3311
autosomal	O	3311
dominant	O	3311
aniridia	B-Disease	3311
in	O	3311
this	O	3311
family	O	3311
is	O	3311
due	O	3311
to	O	3311
a	O	3311
mutation	O	3311
at	O	3311
the	O	3311
an2	O	3311
locus	O	3311
on	O	3311
11p13	O	3311
.	O	3311
we	O	3312
have	O	3312
excluded	O	3312
linkage	O	3312
(	O	3312
zeta	O	3312
less	O	3312
than	O	3312
-	O	3312
2	O	3312
at	O	3312
theta	O	3312
less	O	3312
than	O	3312
0	O	3312
.	O	3312
18	O	3312
)	O	3312
between	O	3312
the	O	3312
aniridia	B-Disease	3312
and	O	3312
the	O	3312
chromosome	O	3312
2p25	O	3312
marker	O	3312
d2s1	O	3312
(	O	3312
linked	O	3312
to	O	3312
acp1	O	3312
)	O	3312
.	O	3312
recombination	O	3313
events	O	3313
that	O	3313
locate	O	3313
myotonic	B-Disease	3313
dystrophy	I-Disease	3313
distal	O	3313
to	O	3313
apoc2	O	3313
on	O	3313
19q	O	3313
.	O	3313
we	O	3314
previously	O	3314
reported	O	3314
a	O	3314
recombination	O	3314
in	O	3314
an	O	3314
individual	O	3314
with	O	3314
myotonic	B-Disease	3314
dystrophy	I-Disease	3314
(	O	3314
dm	B-Disease	3314
)	O	3314
which	O	3314
placed	O	3314
the	O	3314
markers	O	3314
d19s19	O	3314
and	O	3314
apoc2	O	3314
on	O	3314
the	O	3314
same	O	3314
side	O	3314
of	O	3314
the	O	3314
dm	B-Disease	3314
locus	O	3314
.	O	3314
haplotyping	O	3315
of	O	3315
this	O	3315
family	O	3315
with	O	3315
more	O	3315
recently	O	3315
characterized	O	3315
probes	O	3315
which	O	3315
are	O	3315
either	O	3315
tightly	O	3315
linked	O	3315
to	O	3315
dm	B-Disease	3315
or	O	3315
distal	O	3315
to	O	3315
the	O	3315
linkage	O	3315
group	O	3315
at	O	3315
q13	O	3315
.	O	3315
2	O	3316
shows	O	3316
that	O	3316
the	O	3316
dm	B-Disease	3316
locus	O	3316
is	O	3316
distal	O	3316
to	O	3316
apoc2	O	3316
.	O	3316
this	O	3317
is	O	3317
confirmed	O	3317
by	O	3317
other	O	3317
recombinants	O	3317
where	O	3317
dm	B-Disease	3317
segregates	O	3317
with	O	3317
distal	O	3317
probes	O	3317
.	O	3317
additional	O	3318
marker	O	3318
to	O	3318
marker	O	3318
recombinations	O	3318
in	O	3318
unaffected	O	3318
individuals	O	3318
are	O	3318
reported	O	3318
and	O	3318
support	O	3318
the	O	3318
order	O	3318
and	O	3318
orientation	O	3318
of	O	3318
the	O	3318
dm	B-Disease	3318
linkage	O	3318
group	O	3318
as	O	3318
pter	O	3318
-	O	3318
(	O	3318
insr	O	3318
,	O	3318
ldlr	O	3318
,	O	3318
s9	O	3318
)	O	3318
-	O	3318
(	O	3318
s19	O	3318
,	O	3318
bcl3	O	3318
,	O	3318
apoc2	O	3318
)	O	3318
-	O	3318
(	O	3318
ckmm	O	3318
,	O	3318
dm	O	3318
)	O	3318
-	O	3318
(	O	3318
s22	O	3318
,	O	3318
+	O	3318
+	O	3318
+	O	3318
prkcg	O	3318
)	O	3318
-	O	3318
qter	O	3318
.	O	3318
the	O	3319
data	O	3319
presented	O	3319
here	O	3319
cannot	O	3319
determine	O	3319
whether	O	3319
dm	B-Disease	3319
is	O	3319
proximal	O	3319
or	O	3319
distal	O	3319
to	O	3319
ckmm	O	3319
.	O	3319
the	O	3320
consequences	O	3320
of	O	3320
this	O	3320
probe	O	3320
order	O	3320
for	O	3320
antenatal	O	3320
diagnosis	O	3320
and	O	3320
future	O	3320
research	O	3320
aiming	O	3320
to	O	3320
isolate	O	3320
the	O	3320
gene	O	3320
which	O	3320
is	O	3320
affected	O	3320
in	O	3320
dm	B-Disease	3320
are	O	3320
discussed	O	3320
.	O	3320
inactivation	O	3322
of	O	3322
both	O	3322
alleles	O	3322
of	O	3322
the	O	3322
rb1	O	3322
gene	O	3322
during	O	3322
normal	O	3322
retinal	O	3322
development	O	3322
initiates	O	3322
the	O	3322
formation	O	3322
of	O	3322
a	O	3322
retinoblastoma	B-Disease	3322
(	I-Disease	3322
rb	I-Disease	3322
)	I-Disease	3322
tumor	I-Disease	3322
.	O	3322
to	O	3323
identify	O	3323
the	O	3323
mutations	O	3323
which	O	3323
inactivate	O	3323
rb1	O	3323
,	O	3323
21	O	3323
rb	B-Disease	3323
tumors	I-Disease	3323
isolated	O	3323
from	O	3323
19	O	3323
patients	O	3323
were	O	3323
analyzed	O	3323
with	O	3323
the	O	3323
polymerase	O	3323
chain	O	3323
reaction	O	3323
or	O	3323
an	O	3323
rnase	O	3323
protection	O	3323
assay	O	3323
or	O	3323
both	O	3323
.	O	3323
mutations	O	3324
were	O	3324
identified	O	3324
in	O	3324
13	O	3324
of	O	3324
21	O	3324
rb	B-Disease	3324
tumors	I-Disease	3324
;	O	3324
in	O	3324
8	O	3324
tumors	B-Disease	3324
,	O	3324
the	O	3324
precise	O	3324
errors	O	3324
in	O	3324
nucleotide	O	3324
sequence	O	3324
were	O	3324
characterized	O	3324
.	O	3324
we	O	3326
were	O	3326
unable	O	3326
to	O	3326
detect	O	3326
expression	O	3326
of	O	3326
the	O	3326
mutant	O	3326
allele	O	3326
in	O	3326
lymphoblasts	O	3326
of	O	3326
three	O	3326
bilaterally	O	3326
affected	O	3326
patients	O	3326
,	O	3326
although	O	3326
the	O	3326
mutation	O	3326
was	O	3326
present	O	3326
in	O	3326
the	O	3326
genomic	O	3326
dna	O	3326
and	O	3326
transcripts	O	3326
containing	O	3326
the	O	3326
mutations	O	3326
were	O	3326
obvious	O	3326
in	O	3326
the	O	3326
rb	B-Disease	3326
tumors	I-Disease	3326
in	O	3326
the	O	3326
absence	O	3326
of	O	3326
a	O	3326
normal	O	3326
rb1	O	3326
allele	O	3326
.	O	3326
partial	O	3328
deletion	O	3328
8q	O	3328
without	O	3328
langer	B-Disease	3328
-	I-Disease	3328
giedion	I-Disease	3328
syndrome	I-Disease	3328
:	O	3328
a	O	3328
recognisable	O	3328
syndrome	O	3328
.	O	3328
the	O	3331
clinical	O	3331
features	O	3331
were	O	3331
similar	O	3331
and	O	3331
there	O	3331
were	O	3331
no	O	3331
obvious	O	3331
stigmata	O	3331
of	O	3331
langer	B-Disease	3331
-	I-Disease	3331
giedion	I-Disease	3331
syndrome	I-Disease	3331
(	O	3331
lgs	B-Disease	3331
)	O	3331
.	O	3331
there	O	3332
are	O	3332
three	O	3332
other	O	3332
cases	O	3332
reported	O	3332
with	O	3332
a	O	3332
deletion	O	3332
of	O	3332
chromosome	O	3332
8	O	3332
at	O	3332
approximately	O	3332
the	O	3332
same	O	3332
breakpoint	O	3332
,	O	3332
one	O	3332
without	O	3332
lgs	B-Disease	3332
and	O	3332
some	O	3332
similarities	O	3332
to	O	3332
our	O	3332
cases	O	3332
,	O	3332
the	O	3332
other	O	3332
two	O	3332
with	O	3332
lgs	B-Disease	3332
.	O	3332
our	O	3333
findings	O	3333
would	O	3333
support	O	3333
the	O	3333
observation	O	3333
that	O	3333
the	O	3333
critical	O	3333
segment	O	3333
for	O	3333
the	O	3333
assignment	O	3333
of	O	3333
lgs	B-Disease	3333
is	O	3333
proximal	O	3333
to	O	3333
or	O	3333
involves	O	3333
the	O	3333
proximal	O	3333
part	O	3333
of	O	3333
8q24	O	3333
.	O	3333
1	O	3334
,	O	3334
but	O	3334
a	O	3334
review	O	3334
of	O	3334
published	O	3334
reports	O	3334
suggests	O	3334
that	O	3334
the	O	3334
aetiology	O	3334
of	O	3334
lgs	B-Disease	3334
may	O	3334
be	O	3334
a	O	3334
more	O	3334
complex	O	3334
issue	O	3334
myotonic	B-Disease	3335
dystrophy	I-Disease	3335
is	O	3335
closely	O	3335
linked	O	3335
to	O	3335
the	O	3335
gene	O	3335
for	O	3335
muscle	O	3335
-	O	3335
type	O	3335
creatine	O	3335
kinase	O	3335
(	O	3335
ckmm	O	3335
)	O	3335
.	O	3335
we	O	3336
have	O	3336
studied	O	3336
genetic	O	3336
linkage	O	3336
between	O	3336
the	O	3336
gene	O	3336
for	O	3336
creatine	O	3336
kinase	O	3336
muscle	O	3336
type	O	3336
(	O	3336
ckmm	O	3336
)	O	3336
and	O	3336
the	O	3336
gene	O	3336
for	O	3336
myotonic	B-Disease	3336
dystrophy	I-Disease	3336
(	O	3336
dm	B-Disease	3336
)	O	3336
.	O	3336
in	O	3337
a	O	3337
panel	O	3337
of	O	3337
65	O	3337
myotonic	B-Disease	3337
dystrophy	I-Disease	3337
families	O	3337
from	O	3337
canada	O	3337
and	O	3337
the	O	3337
netherlands	O	3337
,	O	3337
a	O	3337
maximum	O	3337
lod	O	3337
score	O	3337
(	O	3337
zmax	O	3337
)	O	3337
of	O	3337
22	O	3337
.	O	3337
this	O	3341
establishes	O	3341
ckmm	O	3341
as	O	3341
a	O	3341
useful	O	3341
marker	O	3341
for	O	3341
myotonic	B-Disease	3341
dystrophy	I-Disease	3341
color	B-Disease	3342
vision	I-Disease	3342
defects	I-Disease	3342
in	O	3342
adrenomyeloneuropathy	B-Disease	3342
.	O	3342
the	O	3343
relationship	O	3343
between	O	3343
abnormal	B-Disease	3343
color	I-Disease	3343
vision	I-Disease	3343
and	O	3343
adrenomyeloneuropathy	B-Disease	3343
(	O	3343
amn	B-Disease	3343
)	O	3343
was	O	3343
investigated	O	3343
in	O	3343
27	O	3343
amn	B-Disease	3343
patients	O	3343
and	O	3343
31	O	3343
age	O	3343
-	O	3343
matched	O	3343
controls	O	3343
by	O	3343
using	O	3343
the	O	3343
farnsworth	O	3343
-	O	3343
munsell	O	3343
100	O	3343
hue	O	3343
test	O	3343
.	O	3343
the	O	3345
axes	O	3345
of	O	3345
bipolarity	O	3345
determined	O	3345
by	O	3345
the	O	3345
testing	O	3345
differed	O	3345
widely	O	3345
between	O	3345
the	O	3345
patients	O	3345
with	O	3345
abnormal	O	3345
scores	O	3345
,	O	3345
compatible	O	3345
with	O	3345
the	O	3345
notion	O	3345
that	O	3345
different	O	3345
alterations	O	3345
in	O	3345
visual	O	3345
pigment	O	3345
genes	O	3345
occur	O	3345
in	O	3345
different	O	3345
amn	B-Disease	3345
kindreds	O	3345
.	O	3345
these	O	3346
observations	O	3346
confirm	O	3346
our	O	3346
earlier	O	3346
impression	O	3346
that	O	3346
the	O	3346
frequency	O	3346
of	O	3346
abnormal	B-Disease	3346
color	I-Disease	3346
vision	I-Disease	3346
is	O	3346
increased	O	3346
in	O	3346
these	O	3346
kindreds	O	3346
,	O	3346
and	O	3346
it	O	3346
supports	O	3346
our	O	3346
contentions	O	3346
that	O	3346
(	O	3346
1	O	3346
)	O	3346
amn	B-Disease	3346
(	O	3346
and	O	3346
its	O	3346
companion	O	3346
,	O	3346
adrenoleukodystrophy	B-Disease	3346
)	O	3346
are	O	3346
very	O	3346
closely	O	3346
linked	O	3346
to	O	3346
the	O	3346
visual	O	3346
pigment	O	3346
loci	O	3346
at	O	3346
xq28	O	3346
and	O	3346
(	O	3346
2	O	3346
)	O	3346
this	O	3346
proximity	O	3346
might	O	3346
provide	O	3346
the	O	3346
opportunity	O	3346
to	O	3346
observe	O	3346
contiguous	B-Disease	3346
gene	I-Disease	3346
defects	I-Disease	3346
.	O	3346
.	O	3346
molecular	O	3347
analysis	O	3347
of	O	3347
a	O	3347
female	O	3347
lesch	B-Disease	3347
-	I-Disease	3347
nyhan	I-Disease	3347
patient	O	3347
.	O	3347
we	O	3348
report	O	3348
the	O	3348
identification	O	3348
of	O	3348
a	O	3348
female	O	3348
patient	O	3348
with	O	3348
the	O	3348
x	O	3348
-	O	3348
linked	O	3348
recessive	O	3348
lesch	B-Disease	3348
-	I-Disease	3348
nyhan	I-Disease	3348
syndrome	I-Disease	3348
(	O	3348
hypoxanthine	B-Disease	3348
phosphoribosyltransferase	I-Disease	3348
[	I-Disease	3348
hprt	I-Disease	3348
]	I-Disease	3348
deficiency	I-Disease	3348
)	O	3348
.	O	3348
pelizaeus	B-Disease	3354
-	I-Disease	3354
merzbacher	I-Disease	3354
disease	I-Disease	3354
:	O	3354
an	O	3354
x	B-Disease	3354
-	I-Disease	3354
linked	I-Disease	3354
neurologic	I-Disease	3354
disorder	I-Disease	3354
of	I-Disease	3354
myelin	I-Disease	3354
metabolism	I-Disease	3354
with	O	3354
a	O	3354
novel	O	3354
mutation	O	3354
in	O	3354
the	O	3354
gene	O	3354
encoding	O	3354
proteolipid	O	3354
protein	O	3354
.	O	3354
the	O	3355
nosology	O	3355
of	O	3355
the	O	3355
inborn	B-Disease	3355
errors	I-Disease	3355
of	I-Disease	3355
myelin	I-Disease	3355
metabolism	I-Disease	3355
has	O	3355
been	O	3355
stymied	O	3355
by	O	3355
the	O	3355
lack	O	3355
of	O	3355
molecular	O	3355
genetic	O	3355
analysis	O	3355
.	O	3355
historically	O	3356
,	O	3356
pelizaeus	B-Disease	3356
-	I-Disease	3356
merzbacher	I-Disease	3356
disease	I-Disease	3356
has	O	3356
encompassed	O	3356
a	O	3356
host	O	3356
of	O	3356
neurologic	B-Disease	3356
disorders	I-Disease	3356
that	O	3356
present	O	3356
with	O	3356
a	O	3356
deficit	B-Disease	3356
of	I-Disease	3356
myelin	I-Disease	3356
,	O	3356
the	O	3356
membrane	O	3356
elaborated	O	3356
by	O	3356
glial	O	3356
cells	O	3356
that	O	3356
encircles	O	3356
and	O	3356
successively	O	3356
enwraps	O	3356
axons	O	3356
.	O	3356
we	O	3357
describe	O	3357
here	O	3357
a	O	3357
pelizaeus	B-Disease	3357
-	I-Disease	3357
merzbacher	I-Disease	3357
pedigree	O	3357
of	O	3357
the	O	3357
classical	O	3357
type	O	3357
,	O	3357
with	O	3357
x	O	3357
-	O	3357
linked	O	3357
inheritance	O	3357
,	O	3357
a	O	3357
typical	O	3357
clinical	O	3357
progression	O	3357
,	O	3357
and	O	3357
a	O	3357
pathologic	O	3357
loss	O	3357
of	O	3357
myelinating	O	3357
cells	O	3357
and	O	3357
myelin	O	3357
in	O	3357
the	O	3357
central	O	3357
nervous	O	3357
system	O	3357
.	O	3357
to	O	3358
discriminate	O	3358
variants	O	3358
of	O	3358
pelizaeus	B-Disease	3358
-	I-Disease	3358
merzbacher	I-Disease	3358
disease	I-Disease	3358
,	O	3358
a	O	3358
set	O	3358
of	O	3358
oligonucleotide	O	3358
primers	O	3358
was	O	3358
constructed	O	3358
to	O	3358
polymerase	O	3358
-	O	3358
chain	O	3358
-	O	3358
reaction	O	3358
(	O	3358
pcr	O	3358
)	O	3358
amplify	O	3358
and	O	3358
sequence	O	3358
the	O	3358
gene	O	3358
encoding	O	3358
proteolipid	O	3358
protein	O	3358
(	O	3358
plp	O	3358
)	O	3358
,	O	3358
a	O	3358
structural	O	3358
protein	O	3358
that	O	3358
comprises	O	3358
half	O	3358
of	O	3358
the	O	3358
protein	O	3358
of	O	3358
the	O	3358
myelin	O	3358
sheath	O	3358
.	O	3358
our	O	3360
results	O	3360
delineate	O	3360
the	O	3360
clinical	O	3360
features	O	3360
of	O	3360
pelizaeus	B-Disease	3360
-	I-Disease	3360
merzbacher	I-Disease	3360
disease	I-Disease	3360
,	O	3360
define	O	3360
the	O	3360
possible	O	3360
molecular	O	3360
pathology	O	3360
of	O	3360
this	O	3360
dysmyelinating	B-Disease	3360
disorder	I-Disease	3360
,	O	3360
and	O	3360
address	O	3360
the	O	3360
molecular	O	3360
classification	O	3360
of	O	3360
inborn	B-Disease	3360
errors	I-Disease	3360
of	I-Disease	3360
myelin	I-Disease	3360
metabolism	I-Disease	3360
.	O	3360
patients	O	3361
with	O	3361
the	O	3361
classical	O	3361
form	O	3361
(	O	3361
type	O	3361
i	O	3361
)	O	3361
and	O	3361
the	O	3361
more	O	3361
severely	O	3361
affected	O	3361
,	O	3361
connatal	O	3361
variant	O	3361
of	O	3361
pelizaeus	B-Disease	3361
-	I-Disease	3361
merzbacher	I-Disease	3361
disease	I-Disease	3361
(	I-Disease	3361
type	I-Disease	3361
ii	I-Disease	3361
)	I-Disease	3361
would	O	3361
be	O	3361
predicted	O	3361
to	O	3361
display	O	3361
mutation	O	3361
at	O	3361
the	O	3361
plp	O	3361
locus	O	3361
.	O	3361
the	O	3362
other	O	3362
variants	O	3362
(	O	3362
types	O	3362
iii	O	3362
-	O	3362
vi	O	3362
)	O	3362
,	O	3362
which	O	3362
have	O	3362
sometimes	O	3362
been	O	3362
categorized	O	3362
as	O	3362
pelizaeus	B-Disease	3362
-	I-Disease	3362
merzbacher	I-Disease	3362
disease	I-Disease	3362
,	O	3362
may	O	3362
represent	O	3362
mutations	O	3362
in	O	3362
genes	O	3362
encoding	O	3362
other	O	3362
structural	O	3362
myelin	O	3362
proteins	O	3362
or	O	3362
proteins	O	3362
critical	O	3362
to	O	3362
myelination	O	3362
.	O	3362
.	O	3362
molecular	O	3363
basis	O	3363
of	O	3363
human	O	3363
von	B-Disease	3363
willebrand	I-Disease	3363
disease	I-Disease	3363
:	O	3363
analysis	O	3363
of	O	3363
platelet	O	3363
von	B-Disease	3363
willebrand	I-Disease	3363
factor	O	3363
mrna	O	3363
.	O	3363
von	B-Disease	3364
willebrand	I-Disease	3364
disease	I-Disease	3364
(	O	3364
vwd	B-Disease	3364
)	O	3364
,	O	3364
the	O	3364
most	O	3364
common	O	3364
inherited	B-Disease	3364
bleeding	I-Disease	3364
disorder	I-Disease	3364
in	O	3364
humans	O	3364
,	O	3364
can	O	3364
result	O	3364
from	O	3364
either	O	3364
a	O	3364
quantitative	O	3364
or	O	3364
a	O	3364
qualitative	O	3364
defect	O	3364
in	O	3364
the	O	3364
adhesive	O	3364
glycoprotein	O	3364
,	O	3364
von	B-Disease	3364
willebrand	I-Disease	3364
factor	O	3364
(	O	3364
vwf	O	3364
)	O	3364
.	O	3364
molecular	O	3365
studies	O	3365
of	O	3365
vwd	B-Disease	3365
have	O	3365
been	O	3365
limited	O	3365
by	O	3365
the	O	3365
large	O	3365
size	O	3365
of	O	3365
the	O	3365
vwf	O	3365
gene	O	3365
and	O	3365
difficulty	O	3365
in	O	3365
obtaining	O	3365
the	O	3365
vwf	O	3365
mrna	O	3365
from	O	3365
patients	O	3365
.	O	3365
in	O	3368
two	O	3368
type	B-Disease	3368
iia	I-Disease	3368
vwd	I-Disease	3368
patients	O	3368
,	O	3368
two	O	3368
different	O	3368
but	O	3368
adjacent	O	3368
missense	O	3368
mutations	O	3368
were	O	3368
identified	O	3368
,	O	3368
the	O	3368
locations	O	3368
of	O	3368
which	O	3368
may	O	3368
identify	O	3368
an	O	3368
important	O	3368
vwf	O	3368
functional	O	3368
domain	O	3368
.	O	3368
expression	O	3369
in	O	3369
heterologous	O	3369
cells	O	3369
of	O	3369
recombinant	O	3369
vwf	O	3369
containing	O	3369
one	O	3369
of	O	3369
these	O	3369
latter	O	3369
mutations	O	3369
reproduced	O	3369
the	O	3369
characteristic	O	3369
structural	O	3369
abnormality	O	3369
seen	O	3369
in	O	3369
type	B-Disease	3369
iia	I-Disease	3369
vwd	I-Disease	3369
plasma	O	3369
.	O	3369
.	O	3369
familial	B-Disease	3370
deficiency	I-Disease	3370
of	I-Disease	3370
the	I-Disease	3370
seventh	I-Disease	3370
component	I-Disease	3370
of	I-Disease	3370
complement	I-Disease	3370
associated	O	3370
with	O	3370
recurrent	O	3370
meningococcal	B-Disease	3370
infections	I-Disease	3370
.	O	3370
we	O	3371
describe	O	3371
an	O	3371
11	O	3371
-	O	3371
year	O	3371
-	O	3371
old	O	3371
girl	O	3371
suffering	O	3371
from	O	3371
recurrent	B-Disease	3371
meningitis	I-Disease	3371
with	O	3371
a	O	3371
complete	O	3371
absence	B-Disease	3371
of	I-Disease	3371
the	I-Disease	3371
seventh	I-Disease	3371
component	I-Disease	3371
of	I-Disease	3371
complement	I-Disease	3371
(	O	3371
c7	O	3371
)	O	3371
.	O	3371
the	O	3375
relatives	O	3375
(	O	3375
parents	O	3375
and	O	3375
one	O	3375
sister	O	3375
)	O	3375
had	O	3375
half	O	3375
-	O	3375
normal	O	3375
levels	O	3375
of	O	3375
both	O	3375
immunochemically	O	3375
and	O	3375
functionally	O	3375
determined	O	3375
c7	O	3375
,	O	3375
indicating	O	3375
a	O	3375
heterozygous	O	3375
state	O	3375
for	O	3375
c7	B-Disease	3375
deficiency	I-Disease	3375
.	O	3375
.	O	3375
translocation	O	3376
t	O	3376
(	O	3376
5	O	3376
;	O	3376
11	O	3376
)	O	3376
(	O	3376
q13	O	3376
.	O	3376
1	O	3376
;	O	3376
p13	O	3376
)	O	3376
associated	O	3376
with	O	3376
familial	O	3376
isolated	B-Disease	3376
aniridia	I-Disease	3376
.	O	3376
a	O	3377
father	O	3377
and	O	3377
daughter	O	3377
with	O	3377
isolated	B-Disease	3377
aniridia	I-Disease	3377
were	O	3377
observed	O	3377
to	O	3377
have	O	3377
an	O	3377
apparently	O	3377
balanced	O	3377
,	O	3377
reciprocal	O	3377
translocation	O	3377
involving	O	3377
chromosomes	O	3377
5	O	3377
and	O	3377
11	O	3377
[	O	3377
t	O	3377
(	O	3377
5	O	3377
;	O	3377
11	O	3377
)	O	3377
(	O	3377
q13	O	3377
.	O	3377
1	O	3377
;	O	3377
p13	O	3377
)	O	3377
]	O	3377
.	O	3377
this	O	3379
finding	O	3379
,	O	3379
in	O	3379
association	O	3379
with	O	3379
3	O	3379
other	O	3379
instances	O	3379
of	O	3379
single	O	3379
breaks	O	3379
at	O	3379
11p13	O	3379
and	O	3379
aniridia	B-Disease	3379
,	O	3379
supports	O	3379
the	O	3379
assignment	O	3379
of	O	3379
an2	O	3379
to	O	3379
11p13	O	3379
.	O	3379
homozygous	B-Disease	3380
hypobetalipoproteinemia	I-Disease	3380
:	O	3380
a	O	3380
disease	O	3380
distinct	O	3380
from	O	3380
abetalipoproproteinemia	B-Disease	3380
at	O	3380
the	O	3380
molecular	O	3380
level	O	3380
.	O	3380
apob	O	3381
dna	O	3381
,	O	3381
rna	O	3381
,	O	3381
and	O	3381
protein	O	3381
from	O	3381
two	O	3381
patients	O	3381
with	O	3381
homozygous	B-Disease	3381
hypobetalipoproteinemia	I-Disease	3381
(	O	3381
hbl	B-Disease	3381
)	O	3381
were	O	3381
evaluated	O	3381
and	O	3381
compared	O	3381
with	O	3381
normal	O	3381
individuals	O	3381
.	O	3381
northern	O	3383
and	O	3383
slot	O	3383
blot	O	3383
analyses	O	3383
of	O	3383
total	O	3383
liver	O	3383
mrna	O	3383
from	O	3383
hbl	B-Disease	3383
patients	O	3383
documented	O	3383
a	O	3383
normal	O	3383
size	O	3383
apob	O	3383
mrna	O	3383
that	O	3383
was	O	3383
present	O	3383
in	O	3383
greatly	O	3383
reduced	O	3383
quantities	O	3383
.	O	3383
apob	O	3384
protein	O	3384
was	O	3384
detected	O	3384
within	O	3384
hbl	B-Disease	3384
hepatocytes	O	3384
utilizing	O	3384
immunohistochemical	O	3384
techniques	O	3384
;	O	3384
however	O	3384
,	O	3384
it	O	3384
was	O	3384
markedly	O	3384
reduced	O	3384
in	O	3384
quantity	O	3384
when	O	3384
compared	O	3384
with	O	3384
control	O	3384
samples	O	3384
.	O	3384
no	O	3385
apob	O	3385
was	O	3385
detectable	O	3385
in	O	3385
the	O	3385
plasma	O	3385
of	O	3385
hbl	B-Disease	3385
individuals	O	3385
with	O	3385
an	O	3385
elisa	O	3385
assay	O	3385
.	O	3385
these	O	3386
data	O	3386
are	O	3386
most	O	3386
consistent	O	3386
with	O	3386
a	O	3386
mutation	O	3386
in	O	3386
the	O	3386
coding	O	3386
portion	O	3386
of	O	3386
the	O	3386
apob	O	3386
gene	O	3386
in	O	3386
hbl	B-Disease	3386
patients	O	3386
,	O	3386
leading	O	3386
to	O	3386
an	O	3386
abnormal	O	3386
apob	O	3386
protein	O	3386
and	O	3386
apob	O	3386
mrna	O	3386
instability	O	3386
.	O	3386
these	O	3387
results	O	3387
are	O	3387
distinct	O	3387
from	O	3387
those	O	3387
previously	O	3387
noted	O	3387
in	O	3387
abetalipoproteinemia	B-Disease	3387
,	O	3387
which	O	3387
was	O	3387
characterized	O	3387
by	O	3387
an	O	3387
elevated	O	3387
level	O	3387
of	O	3387
hepatic	O	3387
apob	O	3387
mrna	O	3387
and	O	3387
accumulation	O	3387
of	O	3387
intracellular	O	3387
hepatic	O	3387
apob	O	3387
protein	O	3387
.	O	3387
.	O	3387
spontaneous	O	3388
reversion	O	3388
of	O	3388
novel	O	3388
lesch	B-Disease	3388
-	I-Disease	3388
nyhan	I-Disease	3388
mutation	O	3388
by	O	3388
hprt	O	3388
gene	O	3388
rearrangement	O	3388
.	O	3388
molecular	O	3389
analysis	O	3389
of	O	3389
an	O	3389
unusual	O	3389
patient	O	3389
with	O	3389
the	O	3389
lesch	B-Disease	3389
-	I-Disease	3389
nyhan	I-Disease	3389
syndrome	I-Disease	3389
has	O	3389
suggested	O	3389
that	O	3389
the	O	3389
mutation	O	3389
is	O	3389
due	O	3389
to	O	3389
a	O	3389
partial	O	3389
hprt	O	3389
gene	O	3389
duplication	O	3389
.	O	3389
growth	O	3393
of	O	3393
epstein	B-Disease	3393
-	I-Disease	3393
barr	I-Disease	3393
virus	O	3393
-	O	3393
transformed	O	3393
lymphoblasts	O	3393
from	O	3393
this	O	3393
patient	O	3393
in	O	3393
selective	O	3393
medium	O	3393
has	O	3393
permitted	O	3393
isolation	O	3393
of	O	3393
spontaneous	O	3393
hprt	O	3393
+	O	3393
revertants	O	3393
of	O	3393
this	O	3393
mutation	O	3393
.	O	3393
this	O	3396
may	O	3396
explain	O	3396
the	O	3396
relatively	O	3396
mild	O	3396
symptoms	O	3396
of	O	3396
the	O	3396
lesch	B-Disease	3396
-	I-Disease	3396
nyhan	I-Disease	3396
syndrome	I-Disease	3396
exhibited	O	3396
by	O	3396
this	O	3396
patient	O	3396
.	O	3396
.	O	3396
complex	B-Disease	3397
glycerol	I-Disease	3397
kinase	I-Disease	3397
deficiency	I-Disease	3397
:	O	3397
molecular	O	3397
-	O	3397
genetic	O	3397
,	O	3397
cytogenetic	O	3397
,	O	3397
and	O	3397
clinical	O	3397
studies	O	3397
of	O	3397
five	O	3397
japanese	O	3397
patients	O	3397
.	O	3397
five	O	3398
male	O	3398
japanese	O	3398
patients	O	3398
with	O	3398
complex	B-Disease	3398
glycerol	I-Disease	3398
kinase	I-Disease	3398
deficiency	I-Disease	3398
(	O	3398
cgkd	B-Disease	3398
)	O	3398
and	O	3398
their	O	3398
relatives	O	3398
were	O	3398
studied	O	3398
clinically	O	3398
,	O	3398
cytogenetically	O	3398
,	O	3398
and	O	3398
molecular	O	3398
-	O	3398
genetically	O	3398
.	O	3398
all	O	3399
patients	O	3399
had	O	3399
muscular	B-Disease	3399
dystrophy	I-Disease	3399
or	O	3399
muscle	B-Disease	3399
weakness	I-Disease	3399
,	O	3399
mental	B-Disease	3399
retardation	I-Disease	3399
,	O	3399
congenital	B-Disease	3399
adrenal	I-Disease	3399
hypoplasia	I-Disease	3399
,	O	3399
and	O	3399
glycerol	B-Disease	3399
kinase	I-Disease	3399
deficiency	I-Disease	3399
.	O	3399
a	O	3404
comparison	O	3404
of	O	3404
the	O	3404
clinical	O	3404
manifestations	O	3404
of	O	3404
the	O	3404
present	O	3404
five	O	3404
patients	O	3404
and	O	3404
reported	O	3404
cgkd	B-Disease	3404
or	O	3404
duchenne	B-Disease	3404
muscular	I-Disease	3404
dystrophy	I-Disease	3404
(	O	3404
dmd	B-Disease	3404
)	O	3404
patients	O	3404
with	O	3404
dna	O	3404
deletion	O	3404
suggests	O	3404
the	O	3404
existence	O	3404
of	O	3404
a	O	3404
certain	O	3404
gene	O	3404
responsible	O	3404
for	O	3404
gonadotropin	B-Disease	3404
deficiency	I-Disease	3404
(	O	3404
gtd	B-Disease	3404
)	O	3404
.	O	3404
the	O	3405
result	O	3405
of	O	3405
the	O	3405
present	O	3405
study	O	3405
and	O	3405
results	O	3405
of	O	3405
previous	O	3405
studies	O	3405
suggest	O	3405
that	O	3405
genes	O	3405
for	O	3405
ornithine	O	3405
transcarbamylase	O	3405
(	O	3405
otc	O	3405
)	O	3405
,	O	3405
dmd	B-Disease	3405
,	O	3405
and	O	3405
gk	O	3405
and	O	3405
putative	O	3405
genes	O	3405
responsible	O	3405
for	O	3405
congenital	B-Disease	3405
adrenal	I-Disease	3405
hypoplasia	I-Disease	3405
(	O	3405
ahc	B-Disease	3405
)	O	3405
and	O	3405
gtd	B-Disease	3405
are	O	3405
arranged	O	3405
from	O	3405
telomere	O	3405
to	O	3405
centromere	O	3405
as	O	3405
pter	O	3405
-	O	3405
-	O	3405
gtd	O	3405
-	O	3405
-	O	3405
ahc	O	3405
-	O	3405
-	O	3405
gk	O	3405
-	O	3405
-	O	3405
dmd	O	3405
-	O	3405
-	O	3405
otc	O	3405
-	O	3405
-	O	3405
cen	O	3405
genetically	O	3406
determined	O	3406
low	O	3406
c4	O	3406
:	O	3406
a	O	3406
predisposing	O	3406
factor	O	3406
to	O	3406
autoimmune	B-Disease	3406
chronic	I-Disease	3406
active	I-Disease	3406
hepatitis	I-Disease	3406
.	O	3406
of	O	3407
26	O	3407
patients	O	3407
with	O	3407
autoimmune	B-Disease	3407
chronic	I-Disease	3407
active	I-Disease	3407
hepatitis	I-Disease	3407
(	O	3407
cah	B-Disease	3407
)	O	3407
starting	O	3407
in	O	3407
childhood	O	3407
18	O	3407
(	O	3407
69	O	3407
%	O	3407
)	O	3407
had	O	3407
low	O	3407
c4	O	3407
and	O	3407
5	O	3407
(	O	3407
19	O	3407
%	O	3407
)	O	3407
had	O	3407
low	O	3407
c3	O	3407
serum	O	3407
levels	O	3407
.	O	3407
these	O	3412
results	O	3412
suggest	O	3412
that	O	3412
low	O	3412
c4	O	3412
levels	O	3412
in	O	3412
cah	B-Disease	3412
are	O	3412
genetically	O	3412
determined	O	3412
.	O	3412
c4	O	3413
phenotyping	O	3413
in	O	3413
20	O	3413
patients	O	3413
and	O	3413
in	O	3413
26	O	3413
parents	O	3413
showed	O	3413
that	O	3413
90	O	3413
%	O	3413
and	O	3413
81	O	3413
%	O	3413
,	O	3413
respectively	O	3413
,	O	3413
had	O	3413
null	O	3413
allotypes	O	3413
at	O	3413
either	O	3413
the	O	3413
c4a	O	3413
or	O	3413
c4b	O	3413
locus	O	3413
compared	O	3413
with	O	3413
59	O	3413
%	O	3413
in	O	3413
controls	O	3413
,	O	3413
indicating	O	3413
that	O	3413
defective	O	3413
expression	O	3413
of	O	3413
structural	O	3413
genes	O	3413
may	O	3413
contribute	O	3413
to	O	3413
the	O	3413
observed	O	3413
c4	B-Disease	3413
deficiency	I-Disease	3413
.	O	3413
.	O	3413
an	O	3414
amino	O	3414
-	O	3414
acid	O	3414
substitution	O	3414
involved	O	3414
in	O	3414
phenylketonuria	B-Disease	3414
is	O	3414
in	O	3414
linkage	O	3414
disequilibrium	O	3414
with	O	3414
dna	O	3414
haplotype	O	3414
2	O	3414
.	O	3414
phenylketonuria	B-Disease	3415
(	O	3415
pku	B-Disease	3415
)	O	3415
is	O	3415
an	O	3415
autosomal	B-Disease	3415
recessive	I-Disease	3415
human	I-Disease	3415
genetic	I-Disease	3415
disorder	I-Disease	3415
caused	O	3415
by	O	3415
a	O	3415
deficiency	B-Disease	3415
of	I-Disease	3415
hepatic	I-Disease	3415
phenylalanine	I-Disease	3415
hydroxylase	I-Disease	3415
(	O	3415
pah	O	3415
,	O	3415
phenylalanine	O	3415
4	O	3415
-	O	3415
monooxygenase	O	3415
,	O	3415
ec	O	3415
1	O	3415
.	O	3415
14	O	3415
.	O	3415
16	O	3415
.	O	3415
1	O	3415
)	O	3415
.	O	3415
pku	B-Disease	3416
is	O	3416
a	O	3416
common	O	3416
inborn	B-Disease	3416
error	I-Disease	3416
of	I-Disease	3416
amino	I-Disease	3416
-	I-Disease	3416
acid	I-Disease	3416
metabolism	I-Disease	3416
in	O	3416
caucasian	O	3416
populations	O	3416
and	O	3416
approximately	O	3416
1	O	3416
in	O	3416
50	O	3416
individuals	O	3416
are	O	3416
carriers	O	3416
of	O	3416
a	O	3416
pku	B-Disease	3416
allele	O	3416
.	O	3416
to	O	3417
define	O	3417
the	O	3417
molecular	O	3417
basis	O	3417
of	O	3417
pku	B-Disease	3417
,	O	3417
we	O	3417
characterized	O	3417
twelve	O	3417
restriction	O	3417
fragment	O	3417
-	O	3417
length	O	3417
polymorphism	O	3417
(	O	3417
rflp	O	3417
)	O	3417
haplotypes	O	3417
of	O	3417
the	O	3417
pah	O	3417
locus	O	3417
in	O	3417
the	O	3417
northern	O	3417
european	O	3417
population	O	3417
and	O	3417
observed	O	3417
that	O	3417
90	O	3417
%	O	3417
of	O	3417
the	O	3417
pku	B-Disease	3417
alleles	O	3417
in	O	3417
this	O	3417
population	O	3417
are	O	3417
confined	O	3417
to	O	3417
four	O	3417
common	O	3417
rflp	O	3417
haplotypes	O	3417
.	O	3417
we	O	3419
now	O	3419
report	O	3419
the	O	3419
molecular	B-Disease	3419
lesion	I-Disease	3419
associated	O	3419
with	O	3419
the	O	3419
rflp	O	3419
haplotype	O	3419
2	O	3419
mutant	O	3419
allele	O	3419
.	O	3419
choroideremia	B-Disease	3422
:	O	3422
close	O	3422
linkage	O	3422
to	O	3422
dxys1	O	3422
and	O	3422
dxys12	O	3422
demonstrated	O	3422
by	O	3422
segregation	O	3422
analysis	O	3422
and	O	3422
historical	O	3422
-	O	3422
genealogical	O	3422
evidence	O	3422
.	O	3422
linkage	O	3423
studies	O	3423
using	O	3423
restriction	O	3423
fragment	O	3423
length	O	3423
polymorphisms	O	3423
were	O	3423
conducted	O	3423
in	O	3423
the	O	3423
x	B-Disease	3423
-	I-Disease	3423
linked	I-Disease	3423
disorder	I-Disease	3423
,	O	3423
choroideremia	B-Disease	3423
,	O	3423
designated	O	3423
tcd	B-Disease	3423
for	O	3423
progressive	B-Disease	3423
tapeto	I-Disease	3423
-	I-Disease	3423
choroidal	I-Disease	3423
dystrophy	I-Disease	3423
.	O	3423
in	O	3425
addition	O	3425
,	O	3425
locus	O	3425
dxys12	O	3425
was	O	3425
found	O	3425
to	O	3425
be	O	3425
closely	O	3425
linked	O	3425
with	O	3425
tcd	B-Disease	3425
(	O	3425
lod	O	3425
3	O	3425
.	O	3425
31	O	3425
at	O	3425
0	O	3425
recombination	O	3425
distance	O	3425
)	O	3425
.	O	3425
all	O	3428
36	O	3428
patients	O	3428
and	O	3428
48	O	3428
carriers	O	3428
tested	O	3428
from	O	3428
the	O	3428
three	O	3428
kindreds	O	3428
had	O	3428
the	O	3428
same	O	3428
haplotype	O	3428
(	O	3428
tcd	B-Disease	3428
/	O	3428
dxys1	O	3428
,	O	3428
11kb	O	3428
/	O	3428
dxys12	O	3428
,	O	3428
1	O	3428
.	O	3428
6kb	O	3428
)	O	3428
.	O	3428
given	O	3429
that	O	3429
at	O	3429
least	O	3429
105	O	3429
female	O	3429
meioses	O	3429
transmitting	O	3429
tcd	B-Disease	3429
have	O	3429
occurred	O	3429
since	O	3429
1650	O	3429
in	O	3429
these	O	3429
kindreds	O	3429
,	O	3429
extremely	O	3429
close	O	3429
linkage	O	3429
between	O	3429
tcd	B-Disease	3429
,	O	3429
dxys1	O	3429
and	O	3429
dxys12	O	3429
is	O	3429
suggested	O	3429
.	O	3429
the	O	3430
above	O	3430
haplotype	O	3430
is	O	3430
a	O	3430
very	O	3430
useful	O	3430
diagnostic	O	3430
tool	O	3430
in	O	3430
these	O	3430
tcd	B-Disease	3430
families	O	3430
.	O	3430
von	B-Disease	3432
hippel	I-Disease	3432
-	I-Disease	3432
lindau	I-Disease	3432
disease	I-Disease	3432
maps	O	3432
to	O	3432
the	O	3432
region	O	3432
of	O	3432
chromosome	O	3432
3	O	3432
associated	O	3432
with	O	3432
renal	B-Disease	3432
cell	I-Disease	3432
carcinoma	I-Disease	3432
.	O	3432
von	B-Disease	3433
hippel	I-Disease	3433
-	I-Disease	3433
lindau	I-Disease	3433
disease	I-Disease	3433
(	O	3433
vhl	B-Disease	3433
)	O	3433
is	O	3433
an	O	3433
autosomal	B-Disease	3433
dominant	I-Disease	3433
disorder	I-Disease	3433
with	O	3433
inherited	O	3433
susceptibility	O	3433
to	O	3433
various	O	3433
forms	O	3433
of	O	3433
cancer	B-Disease	3433
,	O	3433
including	O	3433
hemangioblastomas	B-Disease	3433
of	O	3433
the	O	3433
central	O	3433
nervous	O	3433
system	O	3433
,	O	3433
phaeochromocytomas	B-Disease	3433
,	O	3433
pancreatic	B-Disease	3433
malignancies	I-Disease	3433
,	O	3433
and	O	3433
renal	B-Disease	3433
cell	I-Disease	3433
carcinomas	I-Disease	3433
.	O	3433
renal	B-Disease	3434
cell	I-Disease	3434
carcinomas	I-Disease	3434
constitute	O	3434
a	O	3434
particularly	O	3434
frequent	O	3434
cause	O	3434
of	O	3434
death	O	3434
in	O	3434
this	O	3434
disorder	O	3434
,	O	3434
occurring	O	3434
as	O	3434
bilateral	B-Disease	3434
and	I-Disease	3434
multifocal	I-Disease	3434
tumours	I-Disease	3434
,	O	3434
and	O	3434
presenting	O	3434
at	O	3434
an	O	3434
earlier	O	3434
age	O	3434
than	O	3434
in	O	3434
sporadic	O	3434
,	O	3434
non	O	3434
-	O	3434
familial	O	3434
cases	O	3434
of	O	3434
this	O	3434
tumour	B-Disease	3434
type	O	3434
.	O	3434
we	O	3435
report	O	3435
here	O	3435
that	O	3435
the	O	3435
vhl	B-Disease	3435
gene	O	3435
is	O	3435
linked	O	3435
to	O	3435
the	O	3435
locus	O	3435
encoding	O	3435
the	O	3435
human	O	3435
homologoue	O	3435
of	O	3435
the	O	3435
raf1	O	3435
oncogene	O	3435
,	O	3435
which	O	3435
maps	O	3435
to	O	3435
chromosome	O	3435
3p25	O	3435
(	O	3435
ref	O	3435
.	O	3435
4	O	3435
)	O	3435
.	O	3435
crossovers	O	3436
with	O	3436
the	O	3436
vhl	B-Disease	3436
locus	O	3436
suggest	O	3436
that	O	3436
the	O	3436
defect	O	3436
responsible	O	3436
for	O	3436
the	O	3436
vhl	B-Disease	3436
phenotype	O	3436
is	O	3436
not	O	3436
a	O	3436
mutation	O	3436
in	O	3436
the	O	3436
raf1	O	3436
gene	O	3436
itself	O	3436
.	O	3436
an	O	3437
alternative	O	3437
or	O	3437
prior	O	3437
event	O	3437
to	O	3437
oncogene	O	3437
activation	O	3437
in	O	3437
tumour	B-Disease	3437
formation	O	3437
may	O	3437
be	O	3437
the	O	3437
inactivation	O	3437
of	O	3437
a	O	3437
putative	O	3437
tumour	B-Disease	3437
suppressor	O	3437
which	O	3437
can	O	3437
be	O	3437
associated	O	3437
with	O	3437
both	O	3437
the	O	3437
inherited	B-Disease	3437
and	I-Disease	3437
sporadic	I-Disease	3437
forms	I-Disease	3437
of	I-Disease	3437
the	I-Disease	3437
cancer	I-Disease	3437
.	O	3437
sporadic	B-Disease	3438
renal	I-Disease	3438
cell	I-Disease	3438
carcinomas	I-Disease	3438
have	O	3438
previously	O	3438
been	O	3438
associated	O	3438
with	O	3438
the	O	3438
loss	O	3438
of	O	3438
regions	O	3438
on	O	3438
chromosome	O	3438
3p	O	3438
(	O	3438
refs	O	3438
5	O	3438
,	O	3438
6	O	3438
)	O	3438
.	O	3438
consequently	O	3439
,	O	3439
sporadic	O	3439
and	O	3439
vhl	O	3439
-	O	3439
associated	O	3439
forms	O	3439
of	O	3439
renal	B-Disease	3439
cell	I-Disease	3439
carcinoma	I-Disease	3439
might	O	3439
both	O	3439
result	O	3439
from	O	3439
alterations	O	3439
causing	O	3439
loss	O	3439
of	O	3439
function	O	3439
of	O	3439
the	O	3439
same	O	3439
tumour	B-Disease	3439
suppressor	O	3439
gene	O	3439
on	O	3439
this	O	3439
chromosome	O	3439
.	O	3439
.	O	3439
tightly	O	3440
linked	O	3440
flanking	O	3440
markers	O	3440
for	O	3440
the	O	3440
lowe	B-Disease	3440
oculocerebrorenal	I-Disease	3440
syndrome	I-Disease	3440
,	O	3440
with	O	3440
application	O	3440
to	O	3440
carrier	O	3440
assessment	O	3440
.	O	3440
the	O	3441
lowe	B-Disease	3441
oculocerebrorenal	I-Disease	3441
syndrome	I-Disease	3441
(	O	3441
ocrl	B-Disease	3441
)	O	3441
is	O	3441
characterized	O	3441
by	O	3441
congenital	O	3441
cataract	B-Disease	3441
,	O	3441
mental	B-Disease	3441
retardation	I-Disease	3441
,	O	3441
and	O	3441
defective	B-Disease	3441
renal	I-Disease	3441
tubular	I-Disease	3441
function	I-Disease	3441
.	O	3441
a	O	3442
map	O	3442
assignment	O	3442
of	O	3442
ocrl	B-Disease	3442
to	O	3442
xq24	O	3442
-	O	3442
q26	O	3442
has	O	3442
been	O	3442
made	O	3442
previously	O	3442
by	O	3442
linkage	O	3442
analysis	O	3442
with	O	3442
dxs42	O	3442
at	O	3442
xq24	O	3442
-	O	3442
q26	O	3442
(	O	3442
theta	O	3442
=	O	3442
0	O	3442
,	O	3442
z	O	3442
=	O	3442
5	O	3442
.	O	3442
09	O	3442
)	O	3442
and	O	3442
with	O	3442
dxs10	O	3442
at	O	3442
xq26	O	3442
(	O	3442
theta	O	3442
=	O	3442
0	O	3442
,	O	3442
z	O	3442
=	O	3442
6	O	3442
.	O	3442
45	O	3442
)	O	3442
.	O	3442
with	O	3444
additional	O	3444
ocrl	B-Disease	3444
families	O	3444
made	O	3444
informative	O	3444
for	O	3444
dxs42	O	3444
,	O	3444
theta	O	3444
remained	O	3444
0	O	3444
with	O	3444
z	O	3444
=	O	3444
6	O	3444
.	O	3444
evidence	O	3448
for	O	3448
placing	O	3448
ocrl	O	3448
at	O	3448
xq25	O	3448
also	O	3448
comes	O	3448
from	O	3448
a	O	3448
female	O	3448
with	O	3448
lowe	B-Disease	3448
syndrome	I-Disease	3448
and	O	3448
an	O	3448
x	O	3448
;	O	3448
3	O	3448
translocation	O	3448
.	O	3448
the	O	3452
markers	O	3452
dxs10	O	3452
and	O	3452
dxs42	O	3452
therefore	O	3452
show	O	3452
tight	O	3452
linkage	O	3452
with	O	3452
ocrl	B-Disease	3452
in	O	3452
six	O	3452
families	O	3452
and	O	3452
flank	O	3452
the	O	3452
xq25	O	3452
breakpoint	O	3452
in	O	3452
a	O	3452
female	O	3452
patient	O	3452
with	O	3452
an	O	3452
x	O	3452
;	O	3452
3	O	3452
translocation	O	3452
.	O	3452
linkage	O	3453
analysis	O	3453
with	O	3453
flanking	O	3453
markers	O	3453
was	O	3453
used	O	3453
to	O	3453
assess	O	3453
ocrl	B-Disease	3453
carrier	O	3453
status	O	3453
in	O	3453
women	O	3453
at	O	3453
risk	O	3453
.	O	3453
identification	O	3455
of	O	3455
a	O	3455
single	O	3455
nucleotide	O	3455
change	O	3455
in	O	3455
the	O	3455
hypoxanthine	O	3455
-	O	3455
guanine	O	3455
phosphoribosyltransferase	O	3455
gene	O	3455
(	O	3455
hprtyale	O	3455
)	O	3455
responsible	O	3455
for	O	3455
lesch	B-Disease	3455
-	I-Disease	3455
nyhan	I-Disease	3455
syndrome	I-Disease	3455
.	O	3455
complete	O	3456
deficiency	B-Disease	3456
of	I-Disease	3456
hypoxanthine	I-Disease	3456
-	I-Disease	3456
guanine	I-Disease	3456
phosphoribosyltransferase	I-Disease	3456
(	O	3456
hprt	O	3456
)	O	3456
causes	O	3456
the	O	3456
lesch	B-Disease	3456
-	I-Disease	3456
nyhan	I-Disease	3456
syndrome	I-Disease	3456
.	O	3456
previous	O	3457
characterization	O	3457
of	O	3457
a	O	3457
mutant	O	3457
form	O	3457
of	O	3457
hprt	O	3457
,	O	3457
hprtyale	O	3457
,	O	3457
from	O	3457
a	O	3457
subject	O	3457
with	O	3457
the	O	3457
lesch	B-Disease	3457
-	I-Disease	3457
nyhan	I-Disease	3457
syndrome	I-Disease	3457
revealed	O	3457
normal	O	3457
mrna	O	3457
and	O	3457
protein	O	3457
concentrations	O	3457
,	O	3457
no	O	3457
residual	O	3457
catalytic	O	3457
activity	O	3457
,	O	3457
and	O	3457
cathodal	O	3457
migration	O	3457
upon	O	3457
page	O	3457
.	O	3457
g6pd	B-Disease	3466
deficiency	I-Disease	3466
in	O	3466
different	O	3466
geographical	O	3466
areas	O	3466
appears	O	3466
to	O	3466
have	O	3466
arisen	O	3466
through	O	3466
independent	O	3466
mutational	O	3466
events	O	3466
,	O	3466
but	O	3466
within	O	3466
the	O	3466
same	O	3466
population	O	3466
it	O	3466
may	O	3466
also	O	3466
be	O	3466
heterogeneous	O	3466
.	O	3466
we	O	3468
cloned	O	3468
and	O	3468
sequenced	O	3468
the	O	3468
four	O	3468
g6pd	O	3468
variants	O	3468
from	O	3468
sardinia	O	3468
and	O	3468
found	O	3468
that	O	3468
only	O	3468
two	O	3468
mutations	O	3468
are	O	3468
responsible	O	3468
for	O	3468
g6pd	B-Disease	3468
deficiency	I-Disease	3468
in	O	3468
this	O	3468
area	O	3468
one	O	3468
mutation	O	3468
is	O	3468
the	O	3468
cause	O	3468
of	O	3468
the	O	3468
g6pd	B-Disease	3468
seattle	I-Disease	3468
-	I-Disease	3468
like	I-Disease	3468
phenotype	I-Disease	3468
,	O	3468
a	O	3468
milder	O	3468
form	O	3468
of	O	3468
g6pd	B-Disease	3468
deficiency	I-Disease	3468
;	O	3468
the	O	3468
other	O	3468
mutation	O	3468
is	O	3468
responsible	O	3468
for	O	3468
all	O	3468
forms	O	3468
of	O	3468
very	O	3468
severe	O	3468
g6pd	B-Disease	3468
deficiency	I-Disease	3468
in	O	3468
sardinia	O	3468
and	O	3468
,	O	3468
possibly	O	3468
,	O	3468
in	O	3468
the	O	3468
mediterranean	O	3468
.	O	3468
.	O	3468
chronic	B-Disease	3469
nonspherocytic	I-Disease	3469
hemolytic	I-Disease	3469
anemia	I-Disease	3469
(	O	3469
cnsha	B-Disease	3469
)	O	3469
and	O	3469
glucose	B-Disease	3469
6	I-Disease	3469
phosphate	I-Disease	3469
dehydrogenase	I-Disease	3469
(	I-Disease	3469
g6pd	I-Disease	3469
)	I-Disease	3469
deficiency	I-Disease	3469
in	O	3469
a	O	3469
patient	O	3469
with	O	3469
familial	B-Disease	3469
amyloidotic	I-Disease	3469
polyneuropathy	I-Disease	3469
(	O	3469
fap	B-Disease	3469
)	O	3469
.	O	3469
a	O	3471
new	O	3471
glucose	O	3471
-	O	3471
6	O	3471
-	O	3471
phosphate	O	3471
dehydrogenase	O	3471
(	O	3471
g6pd	O	3471
)	O	3471
variant	O	3471
with	O	3471
severe	O	3471
erythrocytic	B-Disease	3471
g6pd	I-Disease	3471
deficiency	I-Disease	3471
and	O	3471
a	O	3471
unique	O	3471
ph	O	3471
optimum	O	3471
is	O	3471
described	O	3471
in	O	3471
a	O	3471
young	O	3471
patient	O	3471
with	O	3471
chronic	B-Disease	3471
nonspherocytic	I-Disease	3471
hemolytic	I-Disease	3471
anemia	I-Disease	3471
(	O	3471
cnsha	B-Disease	3471
)	O	3471
and	O	3471
familial	B-Disease	3471
amyloidotic	I-Disease	3471
polyneuropathy	I-Disease	3471
(	O	3471
fap	B-Disease	3471
)	O	3471
.	O	3471
chronic	B-Disease	3472
hemolysis	I-Disease	3472
was	O	3472
present	O	3472
in	O	3472
the	O	3472
absence	O	3472
of	O	3472
infections	O	3472
,	O	3472
oxidant	O	3472
drugs	O	3472
or	O	3472
ingestion	O	3472
of	O	3472
faba	O	3472
beans	O	3472
.	O	3472
molecular	O	3479
detection	O	3479
of	O	3479
chromosomal	O	3479
translocations	O	3479
that	O	3479
disrupt	O	3479
the	O	3479
putative	O	3479
retinoblastoma	B-Disease	3479
susceptibility	O	3479
locus	O	3479
.	O	3479
a	O	3480
candidate	O	3480
dna	O	3480
sequence	O	3480
with	O	3480
many	O	3480
of	O	3480
the	O	3480
properties	O	3480
predicted	O	3480
for	O	3480
the	O	3480
retinoblastoma	B-Disease	3480
susceptibility	O	3480
(	O	3480
rb1	O	3480
)	O	3480
locus	O	3480
has	O	3480
been	O	3480
cloned	O	3480
(	O	3480
s	O	3480
.	O	3480
h	O	3480
.	O	3480
friend	O	3480
,	O	3480
r	O	3480
.	O	3480
bernards	O	3480
,	O	3480
s	O	3480
.	O	3480
rogelj	O	3480
,	O	3480
r	O	3480
.	O	3480
a	O	3480
.	O	3480
weinberg	O	3480
,	O	3480
j	O	3480
.	O	3480
m	O	3480
.	O	3480
rapaport	O	3480
,	O	3480
d	O	3480
.	O	3480
m	O	3480
.	O	3480
albert	O	3480
,	O	3480
and	O	3480
t	O	3480
.	O	3480
p	O	3480
.	O	3480
dryja	O	3480
,	O	3480
nature	O	3480
[	O	3480
london	O	3480
]	O	3480
323	O	3480
643	O	3480
-	O	3480
645	O	3480
,	O	3480
1986	O	3480
)	O	3480
.	O	3480
here	O	3482
we	O	3482
used	O	3482
field	O	3482
inversion	O	3482
gel	O	3482
electrophoresis	O	3482
(	O	3482
fige	O	3482
)	O	3482
to	O	3482
construct	O	3482
a	O	3482
restriction	O	3482
map	O	3482
of	O	3482
approximately	O	3482
1	O	3482
,	O	3482
000	O	3482
kb	O	3482
of	O	3482
dna	O	3482
surrounding	O	3482
the	O	3482
rb1	O	3482
locus	O	3482
and	O	3482
to	O	3482
detect	O	3482
the	O	3482
translocation	O	3482
breakpoints	O	3482
in	O	3482
three	O	3482
retinoblastoma	B-Disease	3482
patients	O	3482
.	O	3482
the	O	3487
detection	O	3487
and	O	3487
mapping	O	3487
of	O	3487
the	O	3487
translocation	O	3487
breakpoints	O	3487
of	O	3487
all	O	3487
three	O	3487
retinoblastoma	B-Disease	3487
patients	O	3487
to	O	3487
within	O	3487
the	O	3487
putative	O	3487
rb1	O	3487
gene	O	3487
substantiated	O	3487
the	O	3487
authenticity	O	3487
of	O	3487
this	O	3487
candidate	O	3487
sequence	O	3487
and	O	3487
demonstrated	O	3487
the	O	3487
utility	O	3487
of	O	3487
fige	O	3487
in	O	3487
detecting	O	3487
chromosomal	O	3487
rearrangements	O	3487
affecting	O	3487
this	O	3487
locus	O	3487
.	O	3487
inherited	O	3488
c3	B-Disease	3488
deficiency	I-Disease	3488
with	O	3488
recurrent	O	3488
infections	O	3488
and	O	3488
glomerulonephritis	B-Disease	3488
.	O	3488
a	O	3489
10	O	3489
-	O	3489
year	O	3489
-	O	3489
old	O	3489
laotian	O	3489
boy	O	3489
had	O	3489
homozygous	O	3489
deficiency	B-Disease	3489
of	I-Disease	3489
the	I-Disease	3489
third	I-Disease	3489
component	I-Disease	3489
of	I-Disease	3489
complement	I-Disease	3489
and	O	3489
recurrent	O	3489
bacterial	B-Disease	3489
infections	I-Disease	3489
beginning	O	3489
at	O	3489
age	O	3489
5	O	3489
months	O	3489
.	O	3489
in	O	3492
vitro	O	3492
addition	O	3492
of	O	3492
purified	O	3492
c3	O	3492
to	O	3492
patient	O	3492
serum	O	3492
restored	O	3492
hemolytic	O	3492
complement	O	3492
to	O	3492
normal	O	3492
levels	O	3492
,	O	3492
and	O	3492
plasma	O	3492
infusion	O	3492
during	O	3492
each	O	3492
of	O	3492
four	O	3492
episodes	O	3492
of	O	3492
pneumonia	B-Disease	3492
significantly	O	3492
enhanced	O	3492
serum	O	3492
opsonic	O	3492
activity	O	3492
for	O	3492
as	O	3492
long	O	3492
as	O	3492
36	O	3492
hours	O	3492
.	O	3492
a	O	3493
renal	O	3493
biopsy	O	3493
specimen	O	3493
revealed	O	3493
mesangiopathic	B-Disease	3493
glomerulonephritis	I-Disease	3493
,	O	3493
although	O	3493
significant	O	3493
levels	O	3493
of	O	3493
circulating	O	3493
igg	O	3493
immune	O	3493
complexes	O	3493
were	O	3493
not	O	3493
detected	O	3493
.	O	3493
these	O	3494
findings	O	3494
further	O	3494
support	O	3494
the	O	3494
association	O	3494
of	O	3494
c3	B-Disease	3494
deficiency	I-Disease	3494
with	O	3494
immune	B-Disease	3494
-	I-Disease	3494
complex	I-Disease	3494
disease	I-Disease	3494
and	O	3494
suggest	O	3494
that	O	3494
plasma	O	3494
infusion	O	3494
may	O	3494
be	O	3494
an	O	3494
adjunct	O	3494
to	O	3494
antibiotic	O	3494
therapy	O	3494
in	O	3494
the	O	3494
management	O	3494
of	O	3494
severe	O	3494
pyogenic	B-Disease	3494
infections	I-Disease	3494
in	O	3494
patients	O	3494
with	O	3494
c3	B-Disease	3494
deficiency	I-Disease	3494
.	O	3494
.	O	3494
a	O	3497
deficiency	B-Disease	3497
of	I-Disease	3497
aat	I-Disease	3497
in	O	3497
individuals	O	3497
homozygous	O	3497
for	O	3497
the	O	3497
pi	O	3497
z	O	3497
allele	O	3497
occurs	O	3497
in	O	3497
about	O	3497
1	O	3497
in	O	3497
2	O	3497
,	O	3497
000	O	3497
-	O	3497
8	O	3497
,	O	3497
000	O	3497
caucasians	O	3497
and	O	3497
is	O	3497
associated	O	3497
with	O	3497
an	O	3497
increased	O	3497
risk	O	3497
of	O	3497
early	O	3497
adult	O	3497
onset	O	3497
emphysema	B-Disease	3497
and	O	3497
liver	B-Disease	3497
disease	I-Disease	3497
in	O	3497
childhood	O	3497
.	O	3497
segregation	O	3502
analysis	O	3502
of	O	3502
a	O	3502
marker	O	3502
localised	O	3502
xp21	O	3502
.	O	3502
2	O	3502
-	O	3502
xp21	O	3502
.	O	3502
3	O	3502
in	O	3502
duchenne	B-Disease	3502
and	I-Disease	3502
becker	I-Disease	3502
muscular	I-Disease	3502
dystrophy	I-Disease	3502
families	O	3502
.	O	3502
3	O	3505
,	O	3505
has	O	3505
been	O	3505
studied	O	3505
in	O	3505
kindreds	O	3505
segregating	O	3505
for	O	3505
duchenne	B-Disease	3505
muscular	I-Disease	3505
dystrophy	I-Disease	3505
(	O	3505
dmd	B-Disease	3505
)	O	3505
and	O	3505
becker	B-Disease	3505
muscular	I-Disease	3505
dystrophy	I-Disease	3505
(	O	3505
bmd	B-Disease	3505
)	O	3505
.	O	3505
in	O	3506
dmd	B-Disease	3506
families	O	3506
four	O	3506
crossovers	O	3506
were	O	3506
observed	O	3506
in	O	3506
38	O	3506
informative	O	3506
meioses	O	3506
between	O	3506
c7	O	3506
and	O	3506
the	O	3506
dmd	B-Disease	3506
locus	O	3506
(	O	3506
theta	O	3506
=	O	3506
0	O	3506
.	O	3506
12	O	3506
,	O	3506
z	O	3506
max	O	3506
=	O	3506
+	O	3506
2	O	3506
.	O	3506
72	O	3506
)	O	3506
.	O	3506
in	O	3507
bmd	B-Disease	3507
families	O	3507
no	O	3507
recombinants	O	3507
were	O	3507
observed	O	3507
in	O	3507
the	O	3507
16	O	3507
informative	O	3507
meioses	O	3507
studied	O	3507
.	O	3507
c7	O	3512
and	O	3512
754	O	3512
thus	O	3512
provide	O	3512
good	O	3512
bridging	O	3512
markers	O	3512
for	O	3512
the	O	3512
diagnosis	O	3512
of	O	3512
dmd	B-Disease	3512
and	O	3512
bmd	B-Disease	3512
isolation	O	3513
of	O	3513
molecular	O	3513
probes	O	3513
associated	O	3513
with	O	3513
the	O	3513
chromosome	O	3513
15	O	3513
instability	O	3513
in	O	3513
the	O	3513
prader	B-Disease	3513
-	I-Disease	3513
willi	I-Disease	3513
syndrome	I-Disease	3513
.	O	3513
flow	O	3514
cytometry	O	3514
and	O	3514
recombinant	O	3514
dna	O	3514
techniques	O	3514
have	O	3514
been	O	3514
used	O	3514
to	O	3514
obtain	O	3514
reagents	O	3514
for	O	3514
a	O	3514
molecular	O	3514
analysis	O	3514
of	O	3514
the	O	3514
prader	B-Disease	3514
-	I-Disease	3514
willi	I-Disease	3514
syndrome	I-Disease	3514
(	O	3514
pws	B-Disease	3514
)	O	3514
.	O	3514
2	O	3519
and	O	3519
are	O	3519
shown	O	3519
to	O	3519
be	O	3519
deleted	O	3519
in	O	3519
dna	O	3519
of	O	3519
one	O	3519
of	O	3519
two	O	3519
patients	O	3519
examined	O	3519
with	O	3519
the	O	3519
pws	B-Disease	3519
.	O	3519
2	O	3523
may	O	3523
elucidate	O	3523
the	O	3523
molecular	O	3523
basis	O	3523
for	O	3523
the	O	3523
instability	O	3523
of	O	3523
this	O	3523
chromosomal	O	3523
region	O	3523
in	O	3523
patients	O	3523
with	O	3523
the	O	3523
pws	B-Disease	3523
or	O	3523
other	O	3523
diseases	O	3523
associated	O	3523
with	O	3523
chromosomal	B-Disease	3523
abnormalities	I-Disease	3523
in	O	3523
the	O	3523
proximal	O	3523
long	O	3523
arm	O	3523
of	O	3523
human	O	3523
chromosome	O	3523
15	O	3523
analysis	O	3524
of	O	3524
deletions	O	3524
in	O	3524
dna	O	3524
from	O	3524
patients	O	3524
with	O	3524
becker	B-Disease	3524
and	I-Disease	3524
duchenne	I-Disease	3524
muscular	I-Disease	3524
dystrophy	I-Disease	3524
.	O	3524
duchenne	B-Disease	3525
muscular	I-Disease	3525
dystrophy	I-Disease	3525
(	O	3525
dmd	B-Disease	3525
)	O	3525
is	O	3525
an	O	3525
x	B-Disease	3525
-	I-Disease	3525
linked	I-Disease	3525
recessive	I-Disease	3525
genetic	I-Disease	3525
disorder	I-Disease	3525
for	O	3525
which	O	3525
the	O	3525
biochemical	O	3525
defect	O	3525
is	O	3525
as	O	3525
yet	O	3525
unknown	O	3525
.	O	3525
both	O	3527
of	O	3527
these	O	3527
cloned	O	3527
segments	O	3527
were	O	3527
described	O	3527
as	O	3527
tightly	O	3527
linked	O	3527
to	O	3527
the	O	3527
locus	O	3527
and	O	3527
were	O	3527
capable	O	3527
of	O	3527
detecting	O	3527
deletions	O	3527
in	O	3527
the	O	3527
dna	O	3527
of	O	3527
boys	O	3527
affected	O	3527
with	O	3527
dmd	B-Disease	3527
.	O	3527
in	O	3528
an	O	3528
attempt	O	3528
to	O	3528
determine	O	3528
more	O	3528
precisely	O	3528
the	O	3528
occurrence	O	3528
of	O	3528
these	O	3528
deletions	O	3528
within	O	3528
a	O	3528
large	O	3528
population	O	3528
of	O	3528
dmd	B-Disease	3528
patients	O	3528
and	O	3528
the	O	3528
accuracy	O	3528
of	O	3528
one	O	3528
of	O	3528
the	O	3528
segments	O	3528
,	O	3528
dxs164	O	3528
(	O	3528
pert87	O	3528
)	O	3528
,	O	3528
in	O	3528
determining	O	3528
the	O	3528
inheritance	O	3528
of	O	3528
the	O	3528
dmd	B-Disease	3528
x	O	3528
chromosome	O	3528
,	O	3528
the	O	3528
subclones	O	3528
1	O	3528
,	O	3528
8	O	3528
and	O	3528
15	O	3528
were	O	3528
made	O	3528
available	O	3528
to	O	3528
many	O	3528
investigators	O	3528
throughout	O	3528
the	O	3528
world	O	3528
.	O	3528
here	O	3529
we	O	3529
describe	O	3529
the	O	3529
combined	O	3529
results	O	3529
of	O	3529
more	O	3529
than	O	3529
20	O	3529
research	O	3529
laboratories	O	3529
with	O	3529
respect	O	3529
to	O	3529
the	O	3529
occurrence	O	3529
of	O	3529
deletions	O	3529
at	O	3529
the	O	3529
dxs164	O	3529
locus	O	3529
in	O	3529
dna	O	3529
samples	O	3529
isolated	O	3529
from	O	3529
patients	O	3529
with	O	3529
dmd	B-Disease	3529
and	O	3529
becker	B-Disease	3529
muscular	I-Disease	3529
dystrophy	I-Disease	3529
(	O	3529
bmd	B-Disease	3529
)	O	3529
.	O	3529
the	O	3530
results	O	3530
indicate	O	3530
that	O	3530
the	O	3530
dxs164	O	3530
locus	O	3530
apparently	O	3530
recombines	O	3530
with	O	3530
dmd	B-Disease	3530
5	O	3530
%	O	3530
of	O	3530
the	O	3530
time	O	3530
,	O	3530
but	O	3530
is	O	3530
probably	O	3530
located	O	3530
between	O	3530
independent	O	3530
sites	O	3530
of	O	3530
mutation	O	3530
which	O	3530
yield	O	3530
dmd	B-Disease	3530
.	O	3530
the	O	3531
breakpoints	O	3531
of	O	3531
some	O	3531
deletions	O	3531
are	O	3531
delineated	O	3531
within	O	3531
the	O	3531
dxs164	O	3531
locus	O	3531
,	O	3531
and	O	3531
it	O	3531
is	O	3531
evident	O	3531
that	O	3531
the	O	3531
deletions	O	3531
at	O	3531
the	O	3531
dmd	B-Disease	3531
locus	O	3531
are	O	3531
frequent	O	3531
and	O	3531
extremely	O	3531
large	O	3531
.	O	3531
.	O	3531
a	O	3532
potential	O	3532
animal	O	3532
model	O	3532
for	O	3532
lesch	B-Disease	3532
-	I-Disease	3532
nyhan	I-Disease	3532
syndrome	I-Disease	3532
through	O	3532
introduction	O	3532
of	O	3532
hprt	O	3532
mutations	O	3532
into	O	3532
mice	O	3532
.	O	3532
the	O	3533
human	O	3533
lesch	B-Disease	3533
-	I-Disease	3533
nyhan	I-Disease	3533
syndrome	I-Disease	3533
is	O	3533
a	O	3533
rare	O	3533
neurological	B-Disease	3533
and	I-Disease	3533
behavioural	I-Disease	3533
disorder	I-Disease	3533
,	O	3533
affecting	O	3533
only	O	3533
males	O	3533
,	O	3533
which	O	3533
is	O	3533
caused	O	3533
by	O	3533
an	O	3533
inherited	B-Disease	3533
deficiency	I-Disease	3533
in	O	3533
the	O	3533
level	O	3533
of	O	3533
activity	O	3533
of	O	3533
the	O	3533
purine	O	3533
salvage	O	3533
enzyme	O	3533
hypoxanthine	O	3533
-	O	3533
guanosine	O	3533
phosphoribosyl	O	3533
transferase	O	3533
(	O	3533
hprt	O	3533
)	O	3533
.	O	3533
how	O	3534
the	O	3534
resulting	O	3534
alterations	O	3534
in	O	3534
purine	O	3534
metabolism	O	3534
lead	O	3534
to	O	3534
the	O	3534
severe	O	3534
symptoms	O	3534
characteristic	O	3534
of	O	3534
lesch	B-Disease	3534
-	I-Disease	3534
nyhan	I-Disease	3534
patients	O	3534
is	O	3534
still	O	3534
not	O	3534
understood	O	3534
.	O	3534
to	O	3536
derive	O	3536
an	O	3536
animal	O	3536
model	O	3536
for	O	3536
the	O	3536
lesch	B-Disease	3536
-	I-Disease	3536
nyhan	I-Disease	3536
syndrome	I-Disease	3536
,	O	3536
we	O	3536
have	O	3536
used	O	3536
cultured	O	3536
mouse	O	3536
embryonic	O	3536
stem	O	3536
cells	O	3536
,	O	3536
mutagenized	O	3536
by	O	3536
retroviral	O	3536
insertion	O	3536
and	O	3536
selected	O	3536
for	O	3536
loss	O	3536
of	O	3536
hprt	O	3536
activity	O	3536
,	O	3536
to	O	3536
construct	O	3536
chimaeric	O	3536
mice	O	3536
.	O	3536
two	O	3537
clonal	O	3537
lines	O	3537
carrying	O	3537
different	O	3537
mutant	O	3537
hprt	O	3537
alleles	O	3537
have	O	3537
given	O	3537
rise	O	3537
to	O	3537
germ	O	3537
cells	O	3537
in	O	3537
chimaeras	O	3537
,	O	3537
allowing	O	3537
the	O	3537
derivation	O	3537
of	O	3537
strains	O	3537
of	O	3537
mutant	O	3537
mice	O	3537
having	O	3537
the	O	3537
same	O	3537
biochemical	O	3537
defect	O	3537
as	O	3537
lesch	B-Disease	3537
-	I-Disease	3537
nyhan	I-Disease	3537
patients	O	3537
.	O	3537
re	O	3539
-	O	3539
evaluation	O	3539
of	O	3539
the	O	3539
sublocalization	O	3539
of	O	3539
esterase	O	3539
d	O	3539
and	O	3539
its	O	3539
relation	O	3539
to	O	3539
the	O	3539
retinoblastoma	B-Disease	3539
locus	O	3539
by	O	3539
in	O	3539
situ	O	3539
hybridization	O	3539
.	O	3539
a	O	3546
deletion	O	3546
in	O	3546
an	O	3546
individual	O	3546
with	O	3546
retinoblastoma	B-Disease	3546
was	O	3546
reported	O	3546
to	O	3546
separate	O	3546
the	O	3546
closely	O	3546
linked	O	3546
esd	O	3546
and	O	3546
retinoblastoma	B-Disease	3546
(	O	3546
rb1	O	3546
)	O	3546
loci	O	3546
,	O	3546
placing	O	3546
esd	O	3546
proximal	O	3546
to	O	3546
rb1	O	3546
.	O	3546
hereditary	B-Disease	3550
c2	I-Disease	3550
deficiency	I-Disease	3550
associated	O	3550
with	O	3550
common	O	3550
variable	O	3550
immunodeficiency	B-Disease	3550
.	O	3550
homozygous	O	3551
c2	B-Disease	3551
deficiency	I-Disease	3551
in	O	3551
a	O	3551
19	O	3551
-	O	3551
year	O	3551
-	O	3551
old	O	3551
boy	O	3551
was	O	3551
associated	O	3551
with	O	3551
variable	O	3551
immunodeficiency	B-Disease	3551
manifested	O	3551
by	O	3551
marked	O	3551
hypoimmunoglobulinemia	B-Disease	3551
and	O	3551
impaired	O	3551
antibody	O	3551
responses	O	3551
,	O	3551
normal	O	3551
circulating	O	3551
b	O	3551
lymphocytes	O	3551
,	O	3551
and	O	3551
subnormal	O	3551
t	O	3551
-	O	3551
cell	O	3551
functions	O	3551
.	O	3551
neither	O	3552
antilymphocytic	O	3552
autoantibodies	O	3552
nor	O	3552
chromosomal	B-Disease	3552
abnormalities	I-Disease	3552
were	O	3552
found	O	3552
.	O	3552
serum	O	3553
immunoglobulin	O	3553
levels	O	3553
were	O	3553
within	O	3553
normal	O	3553
limits	O	3553
in	O	3553
his	O	3553
parents	O	3553
and	O	3553
brother	O	3553
who	O	3553
were	O	3553
heterozygous	O	3553
for	O	3553
c2	B-Disease	3553
deficiency	I-Disease	3553
.	O	3553
mild	O	3555
and	O	3555
severe	O	3555
muscular	B-Disease	3555
dystrophy	I-Disease	3555
associated	O	3555
with	O	3555
deletions	O	3555
in	O	3555
xp21	O	3555
of	O	3555
the	O	3555
human	O	3555
x	O	3555
chromosome	O	3555
.	O	3555
we	O	3556
have	O	3556
analysed	O	3556
over	O	3556
300	O	3556
patients	O	3556
suffering	O	3556
from	O	3556
duchenne	B-Disease	3556
or	I-Disease	3556
becker	I-Disease	3556
muscular	I-Disease	3556
dystrophy	I-Disease	3556
(	O	3556
dmd	B-Disease	3556
or	O	3556
bmd	B-Disease	3556
)	O	3556
.	O	3556
these	O	3559
loci	O	3559
have	O	3559
been	O	3559
shown	O	3559
to	O	3559
lie	O	3559
within	O	3559
the	O	3559
dmd	B-Disease	3559
region	O	3559
covering	O	3559
several	O	3559
hundred	O	3559
kilobases	O	3559
(	O	3559
kb	O	3559
)	O	3559
of	O	3559
dna	O	3559
.	O	3559
one	O	3560
mildly	O	3560
affected	O	3560
bmd	B-Disease	3560
patient	O	3560
possesses	O	3560
a	O	3560
deletion	O	3560
of	O	3560
at	O	3560
least	O	3560
110	O	3560
kb	O	3560
including	O	3560
exons	O	3560
of	O	3560
the	O	3560
dmd	B-Disease	3560
gene	O	3560
.	O	3560
other	O	3561
patients	O	3561
with	O	3561
similar	O	3561
exon	O	3561
deletions	O	3561
,	O	3561
or	O	3561
smaller	O	3561
deletions	O	3561
,	O	3561
show	O	3561
the	O	3561
more	O	3561
severe	O	3561
phenotype	O	3561
typical	O	3561
of	O	3561
dmd	B-Disease	3561
.	O	3561
patterns	O	3564
of	O	3564
exon	O	3564
deletions	O	3564
in	O	3564
duchenne	B-Disease	3564
and	I-Disease	3564
becker	I-Disease	3564
muscular	I-Disease	3564
dystrophy	I-Disease	3564
.	O	3564
a	O	3565
panel	O	3565
of	O	3565
patients	O	3565
with	O	3565
duchenne	B-Disease	3565
and	I-Disease	3565
becker	I-Disease	3565
muscular	I-Disease	3565
dystrophy	I-Disease	3565
(	O	3565
dmd	B-Disease	3565
and	O	3565
bmd	B-Disease	3565
)	O	3565
has	O	3565
been	O	3565
screened	O	3565
with	O	3565
the	O	3565
cdna	O	3565
probes	O	3565
cf56a	O	3565
and	O	3565
cf23a	O	3565
,	O	3565
which	O	3565
detect	O	3565
exons	O	3565
in	O	3565
the	O	3565
central	O	3565
part	O	3565
of	O	3565
the	O	3565
dmd	B-Disease	3565
gene	O	3565
.	O	3565
the	O	3567
deletions	O	3567
were	O	3567
mapped	O	3567
and	O	3567
prove	O	3567
to	O	3567
be	O	3567
heterogeneous	O	3567
in	O	3567
size	O	3567
and	O	3567
extent	O	3567
,	O	3567
particularly	O	3567
in	O	3567
dmd	B-Disease	3567
.	O	3567
deletions	O	3568
specific	O	3568
to	O	3568
dmd	B-Disease	3568
and	O	3568
to	O	3568
bmd	B-Disease	3568
are	O	3568
described	O	3568
.	O	3568
half	O	3569
of	O	3569
all	O	3569
bmd	B-Disease	3569
patients	O	3569
have	O	3569
a	O	3569
deletion	O	3569
of	O	3569
one	O	3569
particular	O	3569
small	O	3569
group	O	3569
of	O	3569
exons	O	3569
;	O	3569
smaller	O	3569
deletions	O	3569
within	O	3569
this	O	3569
same	O	3569
group	O	3569
produce	O	3569
the	O	3569
more	O	3569
severe	O	3569
dmd	B-Disease	3569
.	O	3569
.	O	3569
hereditary	B-Disease	3570
deficiency	I-Disease	3570
of	I-Disease	3570
the	I-Disease	3570
third	I-Disease	3570
component	I-Disease	3570
of	I-Disease	3570
complement	I-Disease	3570
in	O	3570
a	O	3570
child	O	3570
with	O	3570
fever	B-Disease	3570
,	O	3570
skin	B-Disease	3570
rash	I-Disease	3570
,	O	3570
and	O	3570
arthralgias	B-Disease	3570
:	O	3570
response	O	3570
to	O	3570
transfusion	O	3570
of	O	3570
whole	O	3570
blood	O	3570
.	O	3570
a	O	3571
previously	O	3571
well	O	3571
34	O	3571
-	O	3571
month	O	3571
-	O	3571
old	O	3571
male	O	3571
presenting	O	3571
with	O	3571
fever	B-Disease	3571
,	O	3571
skin	B-Disease	3571
rash	I-Disease	3571
,	O	3571
and	O	3571
arthralgias	B-Disease	3571
was	O	3571
found	O	3571
to	O	3571
lack	O	3571
c3	O	3571
by	O	3571
immunochemical	O	3571
(	O	3571
undetectable	O	3571
)	O	3571
and	O	3571
hemolytic	O	3571
(	O	3571
1	O	3571
%	O	3571
normal	O	3571
)	O	3571
assays	O	3571
.	O	3571
a	O	3577
transfusion	O	3577
of	O	3577
320	O	3577
ml	O	3577
1	O	3577
-	O	3577
hour	O	3577
-	O	3577
old	O	3577
normal	O	3577
whole	O	3577
blood	O	3577
on	O	3577
the	O	3577
fifty	O	3577
-	O	3577
second	O	3577
day	O	3577
resulted	O	3577
in	O	3577
transitory	O	3577
elevation	O	3577
of	O	3577
the	O	3577
c3	O	3577
level	O	3577
to	O	3577
25	O	3577
mg	O	3577
/	O	3577
dl	O	3577
with	O	3577
a	O	3577
fall	O	3577
-	O	3577
off	O	3577
(	O	3577
approximately	O	3577
2	O	3577
1	O	3577
/	O	3577
2	O	3577
%	O	3577
per	O	3577
hour	O	3577
)	O	3577
to	O	3577
undetectable	O	3577
levels	O	3577
by	O	3577
69	O	3577
hours	O	3577
;	O	3577
it	O	3577
was	O	3577
followed	O	3577
by	O	3577
disappearance	O	3577
of	O	3577
the	O	3577
skin	B-Disease	3577
rash	I-Disease	3577
and	O	3577
arthralgias	B-Disease	3577
and	O	3577
return	O	3577
to	O	3577
normal	O	3577
of	O	3577
the	O	3577
previously	O	3577
elevated	O	3577
temperature	O	3577
and	O	3577
crp	O	3577
levels	O	3577
.	O	3577
c3	O	3578
levels	O	3578
in	O	3578
family	O	3578
members	O	3578
(	O	3578
seven	O	3578
of	O	3578
24	O	3578
half	O	3578
-	O	3578
normal	O	3578
)	O	3578
,	O	3578
lack	O	3578
of	O	3578
anti	O	3578
-	O	3578
c3	O	3578
activity	O	3578
,	O	3578
normal	O	3578
c3b	O	3578
-	O	3578
ina	O	3578
levels	O	3578
and	O	3578
a	O	3578
normal	O	3578
rate	O	3578
of	O	3578
catabolism	O	3578
of	O	3578
transfused	O	3578
c3	O	3578
indicated	O	3578
that	O	3578
the	O	3578
deficiency	O	3578
was	O	3578
inherited	O	3578
with	O	3578
autosomal	O	3578
codominance	O	3578
and	O	3578
involved	O	3578
decreased	B-Disease	3578
synthesis	I-Disease	3578
of	I-Disease	3578
c3	I-Disease	3578
.	O	3578
thus	O	3579
,	O	3579
this	O	3579
child	O	3579
is	O	3579
a	O	3579
unique	O	3579
individual	O	3579
with	O	3579
inherited	B-Disease	3579
c3	I-Disease	3579
deficiency	I-Disease	3579
presenting	O	3579
with	O	3579
absence	O	3579
of	O	3579
repeated	O	3579
infections	O	3579
,	O	3579
whose	O	3579
symptoms	O	3579
of	O	3579
fever	B-Disease	3579
,	O	3579
skin	B-Disease	3579
rash	I-Disease	3579
,	O	3579
and	O	3579
arthralgia	B-Disease	3579
were	O	3579
abated	O	3579
by	O	3579
whole	O	3579
blood	O	3579
transfusion	O	3579
.	O	3579
.	O	3579
erythrocyte	O	3581
glucose	O	3581
-	O	3581
6	O	3581
-	O	3581
phosphate	O	3581
dehydrogenase	O	3581
(	O	3581
g6pd	O	3581
)	O	3581
was	O	3581
characterized	O	3581
in	O	3581
blood	O	3581
samples	O	3581
obtained	O	3581
from	O	3581
97	O	3581
randomly	O	3581
selected	O	3581
males	O	3581
with	O	3581
enzyme	B-Disease	3581
deficiency	I-Disease	3581
from	O	3581
various	O	3581
regions	O	3581
of	O	3581
guangdong	O	3581
province	O	3581
,	O	3581
china	O	3581
.	O	3581
the	O	3585
results	O	3585
demonstrated	O	3585
that	O	3585
the	O	3585
genetic	O	3585
heterogeneity	O	3585
of	O	3585
g6pd	B-Disease	3585
deficiency	I-Disease	3585
was	O	3585
high	O	3585
in	O	3585
this	O	3585
area	O	3585
.	O	3585
.	O	3585
homozygous	O	3586
and	O	3586
heterozygous	O	3586
deletions	O	3586
of	O	3586
the	O	3586
von	B-Disease	3586
willebrand	I-Disease	3586
factor	O	3586
gene	O	3586
in	O	3586
patients	O	3586
and	O	3586
carriers	O	3586
of	O	3586
severe	B-Disease	3586
von	I-Disease	3586
willebrand	I-Disease	3586
disease	I-Disease	3586
.	O	3586
severe	B-Disease	3587
von	I-Disease	3587
willebrand	I-Disease	3587
disease	I-Disease	3587
is	O	3587
characterized	O	3587
by	O	3587
undetectable	O	3587
or	O	3587
trace	O	3587
quantities	O	3587
of	O	3587
von	B-Disease	3587
willebrand	I-Disease	3587
factor	O	3587
in	O	3587
plasma	O	3587
and	O	3587
tissue	O	3587
stores	O	3587
.	O	3587
the	O	3592
second	O	3592
group	O	3592
was	O	3592
comprised	O	3592
of	O	3592
a	O	3592
family	O	3592
in	O	3592
which	O	3592
there	O	3592
was	O	3592
a	O	3592
complete	O	3592
heterozygous	O	3592
deletion	O	3592
of	O	3592
the	O	3592
vwf	O	3592
gene	O	3592
in	O	3592
the	O	3592
proband	O	3592
and	O	3592
one	O	3592
asymptomatic	O	3592
parent	O	3592
,	O	3592
suggesting	O	3592
that	O	3592
a	O	3592
different	O	3592
type	O	3592
of	O	3592
genetic	B-Disease	3592
abnormality	I-Disease	3592
was	O	3592
inherited	O	3592
from	O	3592
the	O	3592
other	O	3592
parent	O	3592
.	O	3592
thus	O	3593
,	O	3593
the	O	3593
patient	O	3593
appeared	O	3593
to	O	3593
be	O	3593
doubly	O	3593
heterozygous	O	3593
for	O	3593
interacting	O	3593
genetic	B-Disease	3593
abnormalities	I-Disease	3593
affecting	O	3593
vwf	O	3593
expression	O	3593
.	O	3593
these	O	3596
techniques	O	3596
should	O	3596
prove	O	3596
useful	O	3596
in	O	3596
identifying	O	3596
carriers	O	3596
of	O	3596
severe	B-Disease	3596
von	I-Disease	3596
willebrand	I-Disease	3596
disease	I-Disease	3596
and	O	3596
also	O	3596
in	O	3596
defining	O	3596
patients	O	3596
predictably	O	3596
at	O	3596
risk	O	3596
of	O	3596
developing	O	3596
alloantibodies	O	3596
to	O	3596
vwf	O	3596
.	O	3596
sjogren	B-Disease	3597
-	I-Disease	3597
larsson	I-Disease	3597
syndrome	I-Disease	3597
.	O	3597
lipid	O	3599
metabolism	O	3599
was	O	3599
studied	O	3599
in	O	3599
cultured	O	3599
skin	O	3599
fibroblasts	O	3599
from	O	3599
patients	O	3599
with	O	3599
the	O	3599
inherited	B-Disease	3599
disorder	I-Disease	3599
,	O	3599
sjogren	B-Disease	3599
-	I-Disease	3599
larsson	I-Disease	3599
syndrome	I-Disease	3599
(	O	3599
sls	B-Disease	3599
)	O	3599
.	O	3599
intact	O	3600
sls	B-Disease	3600
fibroblasts	O	3600
incubated	O	3600
in	O	3600
the	O	3600
presence	O	3600
of	O	3600
[	O	3600
1	O	3600
-	O	3600
14c	O	3600
]	O	3600
palmitate	O	3600
accumulated	O	3600
more	O	3600
radioactive	O	3600
hexadecanol	O	3600
than	O	3600
did	O	3600
normal	O	3600
cells	O	3600
,	O	3600
whereas	O	3600
incorporation	O	3600
of	O	3600
radioactivity	O	3600
into	O	3600
other	O	3600
cellular	O	3600
lipids	O	3600
was	O	3600
unaltered	O	3600
.	O	3600
the	O	3601
hexadecanol	O	3601
content	O	3601
of	O	3601
sls	B-Disease	3601
fibroblasts	O	3601
was	O	3601
abnormally	O	3601
elevated	O	3601
.	O	3601
the	O	3603
half	O	3603
-	O	3603
life	O	3603
of	O	3603
intracellular	O	3603
hexadecanol	O	3603
loaded	O	3603
into	O	3603
sls	B-Disease	3603
fibroblasts	O	3603
was	O	3603
increased	O	3603
(	O	3603
70	O	3603
min	O	3603
)	O	3603
compared	O	3603
with	O	3603
normal	O	3603
(	O	3603
15	O	3603
min	O	3603
)	O	3603
,	O	3603
and	O	3603
intact	O	3603
sls	B-Disease	3603
fibroblasts	O	3603
showed	O	3603
impaired	O	3603
oxidation	O	3603
of	O	3603
[	O	3603
14c	O	3603
]	O	3603
-	O	3603
hexadecanol	O	3603
to	O	3603
fatty	O	3603
acid	O	3603
.	O	3603
fatty	O	3604
alcohol	O	3604
nad	O	3604
+	O	3604
oxidoreductase	O	3604
,	O	3604
the	O	3604
enzyme	O	3604
catalyzing	O	3604
this	O	3604
reaction	O	3604
,	O	3604
was	O	3604
deficient	O	3604
in	O	3604
sls	B-Disease	3604
fibroblasts	O	3604
.	O	3604
mean	O	3605
total	O	3605
activity	O	3605
in	O	3605
sls	B-Disease	3605
fibroblasts	O	3605
(	O	3605
n	O	3605
=	O	3605
5	O	3605
)	O	3605
was	O	3605
13	O	3605
%	O	3605
of	O	3605
that	O	3605
in	O	3605
normal	O	3605
fibroblasts	O	3605
,	O	3605
and	O	3605
palmitoyl	O	3605
coa	O	3605
-	O	3605
inhibitable	O	3605
activity	O	3605
was	O	3605
1	O	3605
%	O	3605
of	O	3605
normal	O	3605
.	O	3605
fibroblasts	O	3606
from	O	3606
two	O	3606
obligate	O	3606
sls	B-Disease	3606
heterozygotes	O	3606
had	O	3606
enzyme	O	3606
activities	O	3606
intermediate	O	3606
between	O	3606
that	O	3606
in	O	3606
normal	O	3606
fibroblasts	O	3606
and	O	3606
individuals	O	3606
with	O	3606
sls	B-Disease	3606
.	O	3606
these	O	3607
results	O	3607
suggest	O	3607
that	O	3607
the	O	3607
primary	O	3607
defect	O	3607
in	O	3607
sls	B-Disease	3607
is	O	3607
deficiency	B-Disease	3607
of	I-Disease	3607
fatty	I-Disease	3607
alcohol	I-Disease	3607
nad	I-Disease	3607
+	I-Disease	3607
oxidoreductase	I-Disease	3607
.	O	3607
sls	B-Disease	3608
represents	O	3608
the	O	3608
first	O	3608
inherited	B-Disease	3608
disorder	I-Disease	3608
in	O	3608
man	O	3608
associated	O	3608
with	O	3608
an	O	3608
isolated	O	3608
abnormality	B-Disease	3608
in	I-Disease	3608
fatty	I-Disease	3608
alcohol	I-Disease	3608
metabolism	I-Disease	3608
.	O	3608
.	O	3608
germinal	O	3609
mosaicism	O	3609
in	O	3609
duchenne	B-Disease	3609
muscular	I-Disease	3609
dystrophy	I-Disease	3609
.	O	3609
we	O	3610
have	O	3610
identified	O	3610
a	O	3610
duchenne	B-Disease	3610
muscular	I-Disease	3610
dystrophy	I-Disease	3610
(	O	3610
dmd	B-Disease	3610
)	O	3610
pedigree	O	3610
where	O	3610
the	O	3610
disease	O	3610
is	O	3610
associated	O	3610
with	O	3610
a	O	3610
molecular	O	3610
deletion	O	3610
within	O	3610
the	O	3610
dmd	B-Disease	3610
locus	O	3610
.	O	3610
nebulin	O	3614
seen	O	3614
in	O	3614
dmd	B-Disease	3614
males	O	3614
including	O	3614
one	O	3614
patient	O	3614
with	O	3614
a	O	3614
large	O	3614
dna	O	3614
deletion	O	3614
encompassing	O	3614
the	O	3614
dmd	B-Disease	3614
gene	O	3614
.	O	3614
the	O	3615
presence	O	3615
of	O	3615
nebulin	O	3615
in	O	3615
a	O	3615
muscle	O	3615
specimen	O	3615
from	O	3615
a	O	3615
patient	O	3615
with	O	3615
duchenne	B-Disease	3615
muscular	I-Disease	3615
dystrophy	I-Disease	3615
(	O	3615
dmd	B-Disease	3615
)	O	3615
due	O	3615
to	O	3615
a	O	3615
large	O	3615
deletion	O	3615
precludes	O	3615
the	O	3615
possibility	O	3615
that	O	3615
this	O	3615
protein	O	3615
is	O	3615
the	O	3615
dmd	B-Disease	3615
gene	O	3615
product	O	3615
.	O	3615
.	O	3615
expression	O	3616
of	O	3616
the	O	3616
murine	O	3616
duchenne	B-Disease	3616
muscular	I-Disease	3616
dystrophy	I-Disease	3616
gene	O	3616
in	O	3616
muscle	O	3616
and	O	3616
brain	O	3616
.	O	3616
5	O	3618
kilobases	O	3618
of	O	3618
the	O	3618
murine	O	3618
duchenne	B-Disease	3618
muscular	I-Disease	3618
dystrophy	I-Disease	3618
(	O	3618
dmd	O	3618
)	O	3618
messenger	O	3618
rna	O	3618
(	O	3618
mrna	O	3618
)	O	3618
.	O	3618
dmd	O	3620
mrna	O	3620
is	O	3620
also	O	3620
present	O	3620
,	O	3620
but	O	3620
at	O	3620
much	O	3620
lower	O	3620
than	O	3620
normal	O	3620
levels	O	3620
,	O	3620
in	O	3620
both	O	3620
the	O	3620
muscle	O	3620
and	O	3620
brain	O	3620
of	O	3620
three	O	3620
different	O	3620
strains	O	3620
of	O	3620
dystrophic	B-Disease	3620
mdx	O	3620
mice	O	3620
.	O	3620
the	O	3621
identification	O	3621
of	O	3621
dmd	O	3621
mrna	O	3621
in	O	3621
brain	O	3621
raises	O	3621
the	O	3621
possibility	O	3621
of	O	3621
a	O	3621
relation	O	3621
between	O	3621
human	O	3621
duchenne	B-Disease	3621
muscular	I-Disease	3621
dystrophy	I-Disease	3621
(	O	3621
dmd	B-Disease	3621
)	O	3621
gene	O	3621
expression	O	3621
and	O	3621
the	O	3621
mental	B-Disease	3621
retardation	I-Disease	3621
found	O	3621
in	O	3621
some	O	3621
dmd	B-Disease	3621
males	O	3621
.	O	3621
glucose	B-Disease	3623
6	I-Disease	3623
-	I-Disease	3623
phosphate	I-Disease	3623
dehydrogenase	I-Disease	3623
deficiency	I-Disease	3623
and	O	3623
incidence	O	3623
of	O	3623
hematologic	B-Disease	3623
malignancy	I-Disease	3623
.	O	3623
we	O	3624
have	O	3624
evaluated	O	3624
the	O	3624
hypothesis	O	3624
of	O	3624
a	O	3624
negative	O	3624
association	O	3624
between	O	3624
glucose	B-Disease	3624
6	I-Disease	3624
-	I-Disease	3624
phosphate	I-Disease	3624
dehydrogenase	I-Disease	3624
(	I-Disease	3624
g6pd	I-Disease	3624
)	I-Disease	3624
deficiency	I-Disease	3624
and	O	3624
cancer	B-Disease	3624
in	O	3624
a	O	3624
cohort	O	3624
of	O	3624
481	O	3624
sardinian	O	3624
males	O	3624
with	O	3624
hematological	B-Disease	3624
malignancies	I-Disease	3624
.	O	3624
the	O	3625
frequency	O	3625
of	O	3625
g6pd	B-Disease	3625
deficiency	I-Disease	3625
in	O	3625
the	O	3625
patients	O	3625
was	O	3625
not	O	3625
different	O	3625
from	O	3625
the	O	3625
incidence	O	3625
in	O	3625
a	O	3625
group	O	3625
of	O	3625
16	O	3625
,	O	3625
219	O	3625
controls	O	3625
.	O	3625
the	O	3626
same	O	3626
conclusion	O	3626
resulted	O	3626
from	O	3626
the	O	3626
comparison	O	3626
of	O	3626
the	O	3626
frequency	O	3626
of	O	3626
expression	O	3626
of	O	3626
the	O	3626
gdb	O	3626
gene	O	3626
in	O	3626
23	O	3626
heterozygous	O	3626
women	O	3626
having	O	3626
a	O	3626
clonal	O	3626
hematologic	B-Disease	3626
disease	I-Disease	3626
and	O	3626
a	O	3626
control	O	3626
group	O	3626
of	O	3626
37	O	3626
healthy	O	3626
heterozygotes	O	3626
.	O	3626
therefore	O	3627
at	O	3627
present	O	3627
there	O	3627
is	O	3627
no	O	3627
evidence	O	3627
that	O	3627
g6pd	B-Disease	3627
deficiency	I-Disease	3627
has	O	3627
a	O	3627
protective	O	3627
effect	O	3627
against	O	3627
development	O	3627
of	O	3627
hematologic	B-Disease	3627
neoplasms	I-Disease	3627
.	O	3627
.	O	3627
hepatoblastoma	B-Disease	3628
,	O	3628
pigmented	B-Disease	3628
ocular	I-Disease	3628
fundus	I-Disease	3628
lesions	I-Disease	3628
and	O	3628
jaw	B-Disease	3628
lesions	I-Disease	3628
in	O	3628
gardner	B-Disease	3628
syndrome	I-Disease	3628
.	O	3628
hepatoblastoma	B-Disease	3629
is	O	3629
a	O	3629
rare	O	3629
neoplasm	B-Disease	3629
of	O	3629
infants	O	3629
and	O	3629
children	O	3629
only	O	3629
recently	O	3629
documented	O	3629
in	O	3629
association	O	3629
with	O	3629
hereditary	B-Disease	3629
adenomatous	I-Disease	3629
polyposis	I-Disease	3629
of	I-Disease	3629
the	I-Disease	3629
colon	I-Disease	3629
[	O	3629
kingston	O	3629
et	O	3629
al	O	3629
.	O	3629
,	O	3629
1983	O	3629
]	O	3629
.	O	3629
we	O	3630
report	O	3630
four	O	3630
children	O	3630
with	O	3630
hepatoblastoma	B-Disease	3630
from	O	3630
four	O	3630
unrelated	O	3630
families	O	3630
with	O	3630
gardner	B-Disease	3630
syndrome	I-Disease	3630
(	O	3630
gs	B-Disease	3630
)	O	3630
.	O	3630
one	O	3631
child	O	3631
,	O	3631
now	O	3631
19	O	3631
years	O	3631
old	O	3631
,	O	3631
survived	O	3631
after	O	3631
a	O	3631
resection	O	3631
of	O	3631
a	O	3631
hepatoblastoma	B-Disease	3631
in	O	3631
infancy	O	3631
and	O	3631
recently	O	3631
was	O	3631
found	O	3631
to	O	3631
have	O	3631
gs	B-Disease	3631
.	O	3631
he	O	3632
has	O	3632
an	O	3632
associated	O	3632
odontoma	B-Disease	3632
and	O	3632
pigmented	B-Disease	3632
ocular	I-Disease	3632
fundus	I-Disease	3632
lesions	I-Disease	3632
,	O	3632
both	O	3632
of	O	3632
which	O	3632
have	O	3632
been	O	3632
shown	O	3632
to	O	3632
be	O	3632
clinical	O	3632
markers	O	3632
of	O	3632
gs	B-Disease	3632
.	O	3632
many	O	3633
individuals	O	3633
in	O	3633
these	O	3633
four	O	3633
gs	B-Disease	3633
families	O	3633
,	O	3633
both	O	3633
affected	O	3633
and	O	3633
at	O	3633
risk	O	3633
,	O	3633
have	O	3633
osteomatous	B-Disease	3633
jaw	I-Disease	3633
lesions	I-Disease	3633
and	O	3633
pigmented	B-Disease	3633
ocular	I-Disease	3633
fundus	I-Disease	3633
lesions	I-Disease	3633
.	O	3633
a	O	3634
search	O	3634
for	O	3634
colonic	B-Disease	3634
polyps	I-Disease	3634
should	O	3634
be	O	3634
made	O	3634
in	O	3634
families	O	3634
of	O	3634
infants	O	3634
and	O	3634
children	O	3634
with	O	3634
hepatoblastoma	B-Disease	3634
.	O	3634
if	O	3635
the	O	3635
child	O	3635
survives	O	3635
,	O	3635
he	O	3635
or	O	3635
she	O	3635
should	O	3635
be	O	3635
monitored	O	3635
for	O	3635
the	O	3635
later	O	3635
appearance	O	3635
of	O	3635
colonic	B-Disease	3635
polyps	I-Disease	3635
.	O	3635
the	O	3636
finding	O	3636
of	O	3636
jaw	B-Disease	3636
lesions	I-Disease	3636
and	O	3636
/	O	3636
or	O	3636
pigmented	B-Disease	3636
ocular	I-Disease	3636
fundus	I-Disease	3636
lesions	I-Disease	3636
in	O	3636
relatives	O	3636
at	O	3636
risk	O	3636
are	O	3636
indications	O	3636
of	O	3636
the	O	3636
possible	O	3636
presence	O	3636
of	O	3636
the	O	3636
gs	B-Disease	3636
gene	O	3636
.	O	3636
identification	O	3637
of	O	3637
an	O	3637
altered	O	3637
splice	O	3637
site	O	3637
in	O	3637
ashkenazi	O	3637
tay	B-Disease	3637
-	I-Disease	3637
sachs	I-Disease	3637
disease	I-Disease	3637
.	O	3637
tay	B-Disease	3638
-	I-Disease	3638
sachs	I-Disease	3638
disease	I-Disease	3638
is	O	3638
an	O	3638
autosomal	B-Disease	3638
recessive	I-Disease	3638
genetic	I-Disease	3638
disorder	I-Disease	3638
resulting	O	3638
from	O	3638
mutation	O	3638
of	O	3638
the	O	3638
hexa	O	3638
gene	O	3638
encoding	O	3638
the	O	3638
alpha	O	3638
-	O	3638
subunit	O	3638
of	O	3638
the	O	3638
lysosomal	O	3638
enzyme	O	3638
,	O	3638
beta	O	3638
-	O	3638
n	O	3638
-	O	3638
acetylhexosaminidase	O	3638
a	O	3638
(	O	3638
ref	O	3638
.	O	3638
1	O	3638
)	O	3638
.	O	3638
a	O	3642
test	O	3642
for	O	3642
the	O	3642
mutant	O	3642
allele	O	3642
based	O	3642
on	O	3642
amplification	O	3642
of	O	3642
dna	O	3642
by	O	3642
the	O	3642
polymerase	O	3642
chain	O	3642
rection	O	3642
and	O	3642
cleavage	O	3642
of	O	3642
a	O	3642
ddei	O	3642
restriction	O	3642
site	O	3642
generated	O	3642
by	O	3642
the	O	3642
mutation	O	3642
revealed	O	3642
that	O	3642
this	O	3642
case	O	3642
and	O	3642
two	O	3642
other	O	3642
cases	O	3642
of	O	3642
the	O	3642
ashkenazi	O	3642
,	O	3642
infantile	O	3642
form	O	3642
of	O	3642
tay	B-Disease	3642
-	I-Disease	3642
sachs	I-Disease	3642
disease	I-Disease	3642
are	O	3642
heterozygous	O	3642
for	O	3642
two	O	3642
different	O	3642
mutations	O	3642
.	O	3642
x	B-Disease	3644
-	I-Disease	3644
linked	I-Disease	3644
glucose	I-Disease	3644
-	I-Disease	3644
6	I-Disease	3644
-	I-Disease	3644
phosphate	I-Disease	3644
dehydrogenase	I-Disease	3644
deficiency	I-Disease	3644
in	O	3644
mus	O	3644
musculus	O	3644
.	O	3644
a	O	3645
mouse	O	3645
with	O	3645
x	B-Disease	3645
-	I-Disease	3645
linked	I-Disease	3645
glucose	I-Disease	3645
-	I-Disease	3645
6	I-Disease	3645
-	I-Disease	3645
phosphate	I-Disease	3645
dehydrogenase	I-Disease	3645
(	I-Disease	3645
g6pd	I-Disease	3645
)	I-Disease	3645
deficiency	I-Disease	3645
has	O	3645
been	O	3645
recovered	O	3645
in	O	3645
offspring	O	3645
of	O	3645
1	O	3645
-	O	3645
ethyl	O	3645
-	O	3645
1	O	3645
-	O	3645
nitrosourea	O	3645
-	O	3645
treated	O	3645
male	O	3645
mice	O	3645
.	O	3645
this	O	3651
is	O	3651
presently	O	3651
the	O	3651
only	O	3651
animal	O	3651
model	O	3651
for	O	3651
x	B-Disease	3651
-	I-Disease	3651
linked	I-Disease	3651
g6pd	I-Disease	3651
deficiency	I-Disease	3651
in	O	3651
humans	O	3651
.	O	3651
.	O	3651
diverse	O	3652
point	O	3652
mutations	O	3652
in	O	3652
the	O	3652
human	O	3652
glucose	O	3652
-	O	3652
6	O	3652
-	O	3652
phosphate	O	3652
dehydrogenase	O	3652
gene	O	3652
cause	O	3652
enzyme	B-Disease	3652
deficiency	I-Disease	3652
and	O	3652
mild	O	3652
or	O	3652
severe	O	3652
hemolytic	B-Disease	3652
anemia	I-Disease	3652
.	O	3652
glucose	B-Disease	3653
-	I-Disease	3653
6	I-Disease	3653
-	I-Disease	3653
phosphate	I-Disease	3653
dehydrogenase	I-Disease	3653
(	I-Disease	3653
g6pd	I-Disease	3653
;	I-Disease	3653
ec	I-Disease	3653
1	I-Disease	3653
.	I-Disease	3653
1	I-Disease	3653
.	I-Disease	3653
1	I-Disease	3653
.	I-Disease	3653
49	I-Disease	3653
)	I-Disease	3653
deficiency	I-Disease	3653
is	O	3653
a	O	3653
common	O	3653
genetic	B-Disease	3653
abnormality	I-Disease	3653
affecting	O	3653
an	O	3653
estimated	O	3653
400	O	3653
million	O	3653
people	O	3653
worldwide	O	3653
.	O	3653
the	O	3658
other	O	3658
six	O	3658
mutants	O	3658
investigated	O	3658
were	O	3658
all	O	3658
associated	O	3658
with	O	3658
enzyme	B-Disease	3658
deficiency	I-Disease	3658
.	O	3658
in	O	3659
one	O	3659
of	O	3659
the	O	3659
commonest	O	3659
,	O	3659
g6pd	O	3659
mediterranean	O	3659
,	O	3659
which	O	3659
is	O	3659
associated	O	3659
with	O	3659
favism	B-Disease	3659
among	O	3659
other	O	3659
clinical	O	3659
manifestations	O	3659
,	O	3659
a	O	3659
single	O	3659
amino	O	3659
acid	O	3659
replacement	O	3659
was	O	3659
found	O	3659
(	O	3659
serine	O	3659
-	O	3659
-	O	3659
-	O	3659
-	O	3659
phenylalanine	O	3659
)	O	3659
it	O	3659
must	O	3659
be	O	3659
responsible	O	3659
for	O	3659
the	O	3659
decreased	O	3659
stability	O	3659
and	O	3659
the	O	3659
reduced	O	3659
catalytic	O	3659
efficiency	O	3659
of	O	3659
this	O	3659
enzyme	O	3659
.	O	3659
single	O	3660
point	O	3660
mutations	O	3660
were	O	3660
also	O	3660
found	O	3660
in	O	3660
g6pd	O	3660
metaponto	O	3660
(	O	3660
southern	O	3660
italy	O	3660
)	O	3660
and	O	3660
in	O	3660
g6pd	O	3660
ilesha	O	3660
(	O	3660
nigeria	O	3660
)	O	3660
,	O	3660
which	O	3660
are	O	3660
asymptomatic	O	3660
,	O	3660
and	O	3660
in	O	3660
g6pd	O	3660
chatham	O	3660
,	O	3660
which	O	3660
was	O	3660
observed	O	3660
in	O	3660
an	O	3660
indian	O	3660
boy	O	3660
with	O	3660
neonatal	B-Disease	3660
jaundice	I-Disease	3660
.	O	3660
in	O	3662
g6pd	O	3662
santiago	O	3662
,	O	3662
a	O	3662
de	O	3662
novo	O	3662
mutation	O	3662
(	O	3662
glycine	O	3662
-	O	3662
-	O	3662
-	O	3662
-	O	3662
arginine	O	3662
)	O	3662
is	O	3662
associated	O	3662
with	O	3662
severe	O	3662
chronic	O	3662
hemolytic	B-Disease	3662
anemia	I-Disease	3662
.	O	3662
thus	O	3664
,	O	3664
diverse	O	3664
point	O	3664
mutations	O	3664
may	O	3664
account	O	3664
largely	O	3664
for	O	3664
the	O	3664
phenotypic	O	3664
heterogeneity	O	3664
of	O	3664
g6pd	B-Disease	3664
deficiency	I-Disease	3664
.	O	3664
tight	O	3665
linkage	O	3665
between	O	3665
myotonic	B-Disease	3665
dystrophy	I-Disease	3665
and	O	3665
apolipoprotein	O	3665
e	O	3665
genes	O	3665
revealed	O	3665
with	O	3665
allele	O	3665
-	O	3665
specific	O	3665
oligonucleotides	O	3665
.	O	3665
in	O	3666
16	O	3666
families	O	3666
with	O	3666
myotonic	B-Disease	3666
dystrophy	I-Disease	3666
(	O	3666
dm	B-Disease	3666
)	O	3666
a	O	3666
novel	O	3666
approach	O	3666
based	O	3666
on	O	3666
use	O	3666
of	O	3666
allele	O	3666
-	O	3666
specific	O	3666
oligonucleotides	O	3666
has	O	3666
been	O	3666
employed	O	3666
to	O	3666
study	O	3666
the	O	3666
linkage	O	3666
relationship	O	3666
between	O	3666
the	O	3666
apolipoprotein	O	3666
e	O	3666
(	O	3666
apoe	O	3666
)	O	3666
gene	O	3666
and	O	3666
dm	B-Disease	3666
.	O	3666
these	O	3673
results	O	3673
suggest	O	3673
that	O	3673
,	O	3673
in	O	3673
addition	O	3673
to	O	3673
apoc2	O	3673
,	O	3673
apoe	O	3673
is	O	3673
a	O	3673
useful	O	3673
marker	O	3673
for	O	3673
presymptomatic	O	3673
dm	B-Disease	3673
diagnosis	O	3673
.	O	3673
regional	O	3674
localization	O	3674
of	O	3674
polymorphic	O	3674
dna	O	3674
loci	O	3674
on	O	3674
the	O	3674
proximal	O	3674
long	O	3674
arm	O	3674
of	O	3674
the	O	3674
x	O	3674
chromosome	O	3674
using	O	3674
deletions	O	3674
associated	O	3674
with	O	3674
choroideremia	B-Disease	3674
.	O	3674
in	O	3675
two	O	3675
unrelated	O	3675
families	O	3675
,	O	3675
males	O	3675
have	O	3675
been	O	3675
identified	O	3675
who	O	3675
suffer	O	3675
from	O	3675
choroideremia	B-Disease	3675
and	O	3675
at	O	3675
the	O	3675
same	O	3675
time	O	3675
have	O	3675
an	O	3675
interstitial	O	3675
deletion	O	3675
on	O	3675
the	O	3675
proximal	O	3675
long	O	3675
arm	O	3675
of	O	3675
the	O	3675
x	O	3675
chromosome	O	3675
.	O	3675
by	O	3677
southern	O	3677
blot	O	3677
analysis	O	3677
we	O	3677
have	O	3677
mapped	O	3677
ten	O	3677
different	O	3677
polymorphic	O	3677
dna	O	3677
loci	O	3677
relative	O	3677
to	O	3677
the	O	3677
position	O	3677
of	O	3677
the	O	3677
deletion	O	3677
and	O	3677
the	O	3677
choroideremia	B-Disease	3677
locus	O	3677
tcd	O	3677
.	O	3677
retroviral	O	3680
-	O	3680
mediated	O	3680
gene	O	3680
transfer	O	3680
of	O	3680
human	O	3680
phenylalanine	O	3680
hydroxylase	O	3680
into	O	3680
nih	O	3680
3t3	O	3680
and	O	3680
hepatoma	B-Disease	3680
cells	O	3680
.	O	3680
phenylketonuria	B-Disease	3681
(	O	3681
pku	B-Disease	3681
)	O	3681
is	O	3681
caused	O	3681
by	O	3681
deficiency	B-Disease	3681
of	I-Disease	3681
the	I-Disease	3681
hepatic	I-Disease	3681
enzyme	I-Disease	3681
phenylalanine	I-Disease	3681
hydroxylase	I-Disease	3681
(	O	3681
pah	O	3681
)	O	3681
.	O	3681
the	O	3686
recombinant	O	3686
virus	O	3686
is	O	3686
also	O	3686
capable	O	3686
of	O	3686
infecting	O	3686
a	O	3686
mouse	O	3686
hepatoma	B-Disease	3686
cell	O	3686
line	O	3686
that	O	3686
does	O	3686
not	O	3686
normally	O	3686
synthesize	O	3686
pah	O	3686
.	O	3686
pah	O	3687
activity	O	3687
is	O	3687
present	O	3687
in	O	3687
the	O	3687
cellular	O	3687
extracts	O	3687
and	O	3687
the	O	3687
entire	O	3687
hydroxylation	O	3687
system	O	3687
is	O	3687
reconstituted	O	3687
in	O	3687
the	O	3687
hepatoma	B-Disease	3687
cells	O	3687
infected	O	3687
with	O	3687
the	O	3687
recombinant	O	3687
viruses	O	3687
.	O	3687
thus	O	3688
,	O	3688
recombinant	O	3688
viruses	O	3688
containing	O	3688
human	O	3688
pah	O	3688
cdna	O	3688
provide	O	3688
a	O	3688
means	O	3688
for	O	3688
introducing	O	3688
functional	O	3688
pah	O	3688
into	O	3688
mammalian	O	3688
cells	O	3688
of	O	3688
hepatic	O	3688
origin	O	3688
and	O	3688
can	O	3688
potentially	O	3688
be	O	3688
introduced	O	3688
into	O	3688
whole	O	3688
animals	O	3688
as	O	3688
a	O	3688
model	O	3688
for	O	3688
somatic	O	3688
gene	O	3688
therapy	O	3688
for	O	3688
pku	B-Disease	3688
.	O	3688
.	O	3688
estimation	O	3689
of	O	3689
the	O	3689
male	O	3689
to	O	3689
female	O	3689
ratio	O	3689
of	O	3689
mutation	O	3689
rates	O	3689
from	O	3689
the	O	3689
segregation	O	3689
of	O	3689
x	O	3689
-	O	3689
chromosomal	O	3689
dna	O	3689
haplotypes	O	3689
in	O	3689
duchenne	B-Disease	3689
muscular	I-Disease	3689
dystrophy	I-Disease	3689
families	O	3689
.	O	3689
a	O	3690
novel	O	3690
procedure	O	3690
is	O	3690
presented	O	3690
to	O	3690
estimate	O	3690
the	O	3690
ratio	O	3690
of	O	3690
male	O	3690
to	O	3690
female	O	3690
mutation	O	3690
rates	O	3690
for	O	3690
duchenne	B-Disease	3690
muscular	I-Disease	3690
dystrophy	I-Disease	3690
(	O	3690
dmd	B-Disease	3690
)	O	3690
.	O	3690
x	O	3691
-	O	3691
specific	O	3691
restriction	O	3691
fragment	O	3691
length	O	3691
polymorphisms	O	3691
are	O	3691
used	O	3691
to	O	3691
establish	O	3691
dna	O	3691
haplotypes	O	3691
in	O	3691
three	O	3691
-	O	3691
generation	O	3691
dmd	B-Disease	3691
families	O	3691
.	O	3691
from	O	3692
the	O	3692
proportion	O	3692
of	O	3692
dmd	B-Disease	3692
patients	O	3692
who	O	3692
have	O	3692
inherited	O	3692
their	O	3692
maternal	O	3692
grandfathers	O	3692
x	O	3692
chromosome	O	3692
,	O	3692
the	O	3692
ratio	O	3692
of	O	3692
mutation	O	3692
rates	O	3692
can	O	3692
be	O	3692
calculated	O	3692
.	O	3692
deletions	O	3694
of	O	3694
a	O	3694
dna	O	3694
sequence	O	3694
in	O	3694
retinoblastomas	B-Disease	3694
and	O	3694
mesenchymal	B-Disease	3694
tumors	I-Disease	3694
:	O	3694
organization	O	3694
of	O	3694
the	O	3694
sequence	O	3694
and	O	3694
its	O	3694
encoded	O	3694
protein	O	3694
.	O	3694
retinoblastoma	B-Disease	3695
is	O	3695
a	O	3695
childhood	B-Disease	3695
tumor	I-Disease	3695
that	O	3695
can	O	3695
arise	O	3695
because	O	3695
of	O	3695
mutant	O	3695
alleles	O	3695
acquired	O	3695
as	O	3695
somatic	O	3695
or	O	3695
germinal	O	3695
mutations	O	3695
.	O	3695
we	O	3698
have	O	3698
reported	O	3698
isolation	O	3698
of	O	3698
a	O	3698
cdna	O	3698
fragment	O	3698
that	O	3698
recognizes	O	3698
chromosomal	O	3698
sequences	O	3698
possessing	O	3698
many	O	3698
of	O	3698
the	O	3698
attributes	O	3698
of	O	3698
the	O	3698
retinoblastoma	B-Disease	3698
gene	O	3698
associated	O	3698
with	O	3698
the	O	3698
rb1	O	3698
locus	O	3698
.	O	3698
we	O	3699
now	O	3699
report	O	3699
that	O	3699
this	O	3699
segment	O	3699
is	O	3699
additionally	O	3699
the	O	3699
target	O	3699
of	O	3699
somatic	O	3699
mutations	O	3699
in	O	3699
mesenchymal	B-Disease	3699
tumors	I-Disease	3699
among	O	3699
patients	O	3699
having	O	3699
no	O	3699
apparent	O	3699
predisposition	O	3699
to	O	3699
retinoblastoma	B-Disease	3699
and	O	3699
no	O	3699
previous	O	3699
evidence	O	3699
of	O	3699
retinoblastoma	B-Disease	3699
.	O	3699
these	O	3700
tumors	B-Disease	3700
provide	O	3700
additional	O	3700
evidence	O	3700
that	O	3700
the	O	3700
cloned	O	3700
sequences	O	3700
are	O	3700
representative	O	3700
of	O	3700
a	O	3700
gene	O	3700
that	O	3700
is	O	3700
a	O	3700
frequent	O	3700
target	O	3700
of	O	3700
inactivation	O	3700
during	O	3700
tumorigenesis	O	3700
.	O	3700
treatment	O	3702
of	O	3702
duchenne	B-Disease	3702
muscular	I-Disease	3702
dystrophy	I-Disease	3702
with	O	3702
growth	O	3702
hormone	O	3702
inhibitors	O	3702
.	O	3702
a	O	3703
controlled	O	3703
,	O	3703
double	O	3703
-	O	3703
blind	O	3703
therapeutic	O	3703
trial	O	3703
with	O	3703
the	O	3703
drug	O	3703
mazindol	O	3703
,	O	3703
a	O	3703
growth	O	3703
hormone	O	3703
inhibitor	O	3703
,	O	3703
was	O	3703
performed	O	3703
in	O	3703
a	O	3703
pair	O	3703
of	O	3703
7	O	3703
1	O	3703
/	O	3703
2	O	3703
year	O	3703
-	O	3703
old	O	3703
monozygotic	O	3703
twins	O	3703
,	O	3703
with	O	3703
duchenne	B-Disease	3703
muscular	I-Disease	3703
dystrophy	I-Disease	3703
(	O	3703
dmd	B-Disease	3703
)	O	3703
.	O	3703
the	O	3704
rationale	O	3704
for	O	3704
this	O	3704
trial	O	3704
was	O	3704
based	O	3704
on	O	3704
a	O	3704
patient	O	3704
(	O	3704
reported	O	3704
previously	O	3704
)	O	3704
affected	O	3704
simultaneously	O	3704
with	O	3704
dmd	B-Disease	3704
and	O	3704
growth	B-Disease	3704
hormone	I-Disease	3704
(	I-Disease	3704
gh	I-Disease	3704
)	I-Disease	3704
deficiency	I-Disease	3704
,	O	3704
who	O	3704
is	O	3704
showing	O	3704
a	O	3704
benign	O	3704
course	O	3704
of	O	3704
the	O	3704
dystrophic	B-Disease	3704
process	I-Disease	3704
and	O	3704
is	O	3704
still	O	3704
walking	O	3704
at	O	3704
18	O	3704
years	O	3704
.	O	3704
these	O	3708
results	O	3708
strongly	O	3708
suggest	O	3708
that	O	3708
treatment	O	3708
with	O	3708
a	O	3708
gh	O	3708
inhibitor	O	3708
is	O	3708
beneficial	O	3708
for	O	3708
dmd	B-Disease	3708
patients	O	3708
.	O	3708
.	O	3708
identification	O	3709
and	O	3709
localization	O	3709
of	O	3709
mutations	O	3709
at	O	3709
the	O	3709
lesch	B-Disease	3709
-	I-Disease	3709
nyhan	I-Disease	3709
locus	O	3709
by	O	3709
ribonuclease	O	3709
a	O	3709
cleavage	O	3709
.	O	3709
the	O	3712
recently	O	3712
described	O	3712
ribonuclease	O	3712
a	O	3712
cleavage	O	3712
procedure	O	3712
,	O	3712
with	O	3712
a	O	3712
polyuridylic	O	3712
acid	O	3712
-	O	3712
paper	O	3712
affinity	O	3712
chromatography	O	3712
step	O	3712
,	O	3712
has	O	3712
been	O	3712
used	O	3712
to	O	3712
identify	O	3712
the	O	3712
mutational	O	3712
lesions	O	3712
in	O	3712
the	O	3712
hypoxanthine	O	3712
phosphoribosyltransferase	O	3712
(	O	3712
hprt	O	3712
)	O	3712
messenger	O	3712
rnas	O	3712
of	O	3712
patients	O	3712
with	O	3712
lesch	B-Disease	3712
-	I-Disease	3712
nyhan	I-Disease	3712
syndrome	I-Disease	3712
.	O	3712
distinctive	O	3713
ribonuclease	O	3713
a	O	3713
cleavage	O	3713
patterns	O	3713
were	O	3713
identified	O	3713
in	O	3713
messenger	O	3713
rna	O	3713
from	O	3713
5	O	3713
of	O	3713
14	O	3713
lesch	B-Disease	3713
-	I-Disease	3713
nyhan	I-Disease	3713
patients	O	3713
who	O	3713
were	O	3713
chosen	O	3713
because	O	3713
no	O	3713
hprt	O	3713
southern	O	3713
or	O	3713
northern	O	3713
blotting	O	3713
pattern	O	3713
changes	O	3713
had	O	3713
been	O	3713
found	O	3713
.	O	3713
this	O	3714
approach	O	3714
now	O	3714
allows	O	3714
hprt	O	3714
mutation	O	3714
detection	O	3714
in	O	3714
50	O	3714
percent	O	3714
of	O	3714
the	O	3714
cases	O	3714
of	O	3714
lesch	B-Disease	3714
-	I-Disease	3714
nyhan	I-Disease	3714
syndrome	I-Disease	3714
.	O	3714
two	O	3716
new	O	3716
variants	O	3716
of	O	3716
glucose	O	3716
-	O	3716
6	O	3716
-	O	3716
phosphate	O	3716
dehydrogenase	O	3716
associated	O	3716
with	O	3716
hereditary	B-Disease	3716
non	I-Disease	3716
-	I-Disease	3716
spherocytic	I-Disease	3716
hemolytic	I-Disease	3716
anemia	I-Disease	3716
:	O	3716
g6pd	O	3716
wayne	O	3716
and	O	3716
g6pd	O	3716
huron	O	3716
.	O	3716
two	O	3717
new	O	3717
deficient	O	3717
variants	O	3717
of	O	3717
glucose	O	3717
-	O	3717
6	O	3717
-	O	3717
phosphate	O	3717
dehydrogenase	O	3717
(	O	3717
g6pd	O	3717
)	O	3717
causing	O	3717
hereditary	B-Disease	3717
nonspherocytic	I-Disease	3717
hemolytic	I-Disease	3717
anemia	I-Disease	3717
(	O	3717
hnsha	B-Disease	3717
)	O	3717
are	O	3717
described	O	3717
.	O	3717
the	O	3720
patients	O	3720
with	O	3720
g6pd	O	3720
huron	O	3720
were	O	3720
under	O	3720
medical	O	3720
observation	O	3720
for	O	3720
a	O	3720
considerable	O	3720
period	O	3720
of	O	3720
time	O	3720
without	O	3720
the	O	3720
diagnosis	O	3720
of	O	3720
g6pd	B-Disease	3720
deficiency	I-Disease	3720
being	O	3720
entertained	O	3720
because	O	3720
the	O	3720
family	O	3720
was	O	3720
of	O	3720
northern	O	3720
european	O	3720
origin	O	3720
.	O	3720
since	O	3721
sporadic	O	3721
variants	O	3721
of	O	3721
g6pd	O	3721
causing	O	3721
hnsha	B-Disease	3721
show	O	3721
no	O	3721
special	O	3721
racial	O	3721
predilection	O	3721
,	O	3721
the	O	3721
diagnosis	O	3721
of	O	3721
g6pd	B-Disease	3721
deficiency	I-Disease	3721
should	O	3721
always	O	3721
be	O	3721
considered	O	3721
in	O	3721
patients	O	3721
with	O	3721
this	O	3721
syndrome	O	3721
.	O	3721
.	O	3721
sialophorin	O	3722
,	O	3722
a	O	3722
surface	O	3722
sialoglycoprotein	O	3722
defective	O	3722
in	O	3722
the	O	3722
wiskott	B-Disease	3722
-	I-Disease	3722
aldrich	I-Disease	3722
syndrome	I-Disease	3722
,	O	3722
is	O	3722
involved	O	3722
in	O	3722
human	O	3722
t	O	3722
lymphocyte	O	3722
proliferation	O	3722
.	O	3722
the	O	3723
mab	O	3723
l10	O	3723
was	O	3723
used	O	3723
to	O	3723
determine	O	3723
the	O	3723
distribution	O	3723
and	O	3723
the	O	3723
function	O	3723
of	O	3723
sialophorin	O	3723
,	O	3723
the	O	3723
heavily	O	3723
glycosylated	O	3723
surface	O	3723
molecule	O	3723
that	O	3723
is	O	3723
deficient	O	3723
/	O	3723
defective	O	3723
in	O	3723
lymphocytes	O	3723
of	O	3723
patients	O	3723
with	O	3723
the	O	3723
x	B-Disease	3723
-	I-Disease	3723
linked	I-Disease	3723
immunodeficiency	I-Disease	3723
wiskott	I-Disease	3723
-	I-Disease	3723
aldrich	I-Disease	3723
syndrome	I-Disease	3723
.	O	3723
hypopigmentation	B-Disease	3730
in	O	3730
the	O	3730
prader	B-Disease	3730
-	I-Disease	3730
willi	I-Disease	3730
syndrome	I-Disease	3730
.	O	3730
cutaneous	B-Disease	3731
and	I-Disease	3731
ocular	I-Disease	3731
pigmentation	I-Disease	3731
were	O	3731
evaluated	O	3731
in	O	3731
29	O	3731
individuals	O	3731
with	O	3731
the	O	3731
prader	B-Disease	3731
-	I-Disease	3731
willi	I-Disease	3731
syndrome	I-Disease	3731
(	O	3731
pws	B-Disease	3731
)	O	3731
.	O	3731
criteria	O	3732
for	O	3732
hypopigmentation	B-Disease	3732
included	O	3732
the	O	3732
presence	O	3732
of	O	3732
type	O	3732
i	O	3732
or	O	3732
ii	O	3732
skin	O	3732
,	O	3732
the	O	3732
lightest	O	3732
skin	O	3732
type	O	3732
in	O	3732
the	O	3732
family	O	3732
by	O	3732
history	O	3732
,	O	3732
and	O	3732
iris	O	3732
translucency	O	3732
on	O	3732
globe	O	3732
transillumination	O	3732
.	O	3732
on	O	3733
the	O	3733
basis	O	3733
of	O	3733
these	O	3733
criteria	O	3733
,	O	3733
48	O	3733
%	O	3733
of	O	3733
the	O	3733
pws	B-Disease	3733
individuals	O	3733
were	O	3733
hypopigmented	B-Disease	3733
.	O	3733
the	O	3734
presence	O	3734
of	O	3734
hypopigmentation	B-Disease	3734
correlated	O	3734
with	O	3734
a	O	3734
small	O	3734
interstitial	O	3734
deletion	O	3734
on	O	3734
the	O	3734
proximal	O	3734
long	O	3734
arm	O	3734
of	O	3734
chromosome	O	3734
15	O	3734
;	O	3734
however	O	3734
,	O	3734
this	O	3734
deletion	O	3734
was	O	3734
also	O	3734
found	O	3734
in	O	3734
individuals	O	3734
who	O	3734
did	O	3734
not	O	3734
meet	O	3734
the	O	3734
full	O	3734
criteria	O	3734
for	O	3734
hypopigmentation	B-Disease	3734
.	O	3734
hairbulb	O	3735
tyrosinase	O	3735
activity	O	3735
and	O	3735
glutathione	O	3735
content	O	3735
,	O	3735
as	O	3735
well	O	3735
as	O	3735
urine	O	3735
cysteinyldopa	O	3735
excretion	O	3735
,	O	3735
were	O	3735
low	O	3735
in	O	3735
pws	B-Disease	3735
individuals	O	3735
with	O	3735
and	O	3735
without	O	3735
hypopigmentation	B-Disease	3735
and	O	3735
did	O	3735
not	O	3735
separate	O	3735
these	O	3735
two	O	3735
groups	O	3735
.	O	3735
we	O	3736
conclude	O	3736
that	O	3736
hypopigmentation	B-Disease	3736
is	O	3736
found	O	3736
in	O	3736
a	O	3736
significant	O	3736
proportion	O	3736
of	O	3736
individuals	O	3736
with	O	3736
pws	B-Disease	3736
and	O	3736
that	O	3736
the	O	3736
hypopigmentation	B-Disease	3736
may	O	3736
be	O	3736
associated	O	3736
with	O	3736
a	O	3736
deletion	O	3736
of	O	3736
the	O	3736
long	O	3736
arm	O	3736
of	O	3736
chromosome	O	3736
15	O	3736
.	O	3736
the	O	3737
mechanism	O	3737
for	O	3737
the	O	3737
hypopigmentation	B-Disease	3737
is	O	3737
unknown	O	3737
.	O	3737
.	O	3737
phenotype	O	3738
heterogeneity	O	3738
among	O	3738
hemizygotes	O	3738
in	O	3738
a	O	3738
family	O	3738
biochemically	O	3738
screened	O	3738
for	O	3738
adrenoleukodystrophy	B-Disease	3738
.	O	3738
we	O	3739
report	O	3739
on	O	3739
two	O	3739
clinically	O	3739
,	O	3739
neurologically	O	3739
normal	O	3739
relatives	O	3739
of	O	3739
a	O	3739
boy	O	3739
affected	O	3739
by	O	3739
adrenoleukodystrophy	B-Disease	3739
(	O	3739
ald	B-Disease	3739
)	O	3739
;	O	3739
they	O	3739
were	O	3739
found	O	3739
repeatedly	O	3739
to	O	3739
have	O	3739
the	O	3739
biochemical	O	3739
defect	O	3739
of	O	3739
an	O	3739
ald	B-Disease	3739
hemizygote	O	3739
.	O	3739
while	O	3741
no	O	3741
evidence	O	3741
of	O	3741
neurologic	B-Disease	3741
disease	I-Disease	3741
(	O	3741
leukodystrophy	B-Disease	3741
or	O	3741
myeloneuropathy	B-Disease	3741
)	O	3741
was	O	3741
present	O	3741
in	O	3741
these	O	3741
hemizygotes	O	3741
,	O	3741
adrenocortical	B-Disease	3741
insufficiency	I-Disease	3741
provoking	O	3741
compensatory	O	3741
high	O	3741
acth	O	3741
release	O	3741
was	O	3741
found	O	3741
in	O	3741
both	O	3741
.	O	3741
these	O	3742
findings	O	3742
should	O	3742
be	O	3742
taken	O	3742
into	O	3742
consideration	O	3742
when	O	3742
counseling	O	3742
families	O	3742
in	O	3742
which	O	3742
cases	O	3742
with	O	3742
clinically	O	3742
expressed	O	3742
ald	B-Disease	3742
are	O	3742
represented	O	3742
in	O	3742
several	O	3742
generations	O	3742
.	O	3742
.	O	3742
the	O	3743
mapping	O	3743
of	O	3743
a	O	3743
cdna	O	3743
from	O	3743
the	O	3743
human	O	3743
x	B-Disease	3743
-	I-Disease	3743
linked	I-Disease	3743
duchenne	I-Disease	3743
muscular	I-Disease	3743
dystrophy	I-Disease	3743
gene	O	3743
to	O	3743
the	O	3743
mouse	O	3743
x	O	3743
chromosome	O	3743
.	O	3743
the	O	3744
recent	O	3744
discovery	O	3744
of	O	3744
sequences	O	3744
at	O	3744
the	O	3744
site	O	3744
of	O	3744
the	O	3744
duchenne	B-Disease	3744
muscular	I-Disease	3744
dystrophy	I-Disease	3744
(	O	3744
dmd	B-Disease	3744
)	O	3744
gene	O	3744
in	O	3744
humans	O	3744
has	O	3744
opened	O	3744
up	O	3744
the	O	3744
possibility	O	3744
of	O	3744
a	O	3744
detailed	O	3744
molecular	O	3744
analysis	O	3744
of	O	3744
the	O	3744
genes	O	3744
in	O	3744
humans	O	3744
and	O	3744
in	O	3744
related	O	3744
mammalian	O	3744
species	O	3744
.	O	3744
until	O	3745
relatively	O	3745
recently	O	3745
,	O	3745
there	O	3745
was	O	3745
no	O	3745
obvious	O	3745
mouse	O	3745
model	O	3745
of	O	3745
this	O	3745
genetic	B-Disease	3745
disease	I-Disease	3745
for	O	3745
the	O	3745
development	O	3745
of	O	3745
therapeutic	O	3745
strategies	O	3745
.	O	3745
the	O	3746
identification	O	3746
of	O	3746
a	O	3746
mouse	O	3746
x	O	3746
-	O	3746
linked	O	3746
mutant	O	3746
showing	O	3746
muscular	B-Disease	3746
dystrophy	I-Disease	3746
,	O	3746
mdx	O	3746
,	O	3746
has	O	3746
provided	O	3746
a	O	3746
candidate	O	3746
mouse	O	3746
genetic	O	3746
homologue	O	3746
to	O	3746
the	O	3746
dmd	B-Disease	3746
locus	O	3746
;	O	3746
the	O	3746
relatively	O	3746
mild	O	3746
pathological	O	3746
features	O	3746
of	O	3746
mdx	O	3746
suggest	O	3746
it	O	3746
may	O	3746
have	O	3746
more	O	3746
in	O	3746
common	O	3746
with	O	3746
mutations	O	3746
of	O	3746
the	O	3746
becker	B-Disease	3746
muscular	I-Disease	3746
dystrophy	I-Disease	3746
type	O	3746
at	O	3746
the	O	3746
same	O	3746
human	O	3746
locus	O	3746
,	O	3746
however	O	3746
.	O	3746
but	O	3747
the	O	3747
close	O	3747
genetic	O	3747
linkage	O	3747
of	O	3747
mdx	O	3747
to	O	3747
g6pd	O	3747
and	O	3747
hprt	O	3747
on	O	3747
the	O	3747
mouse	O	3747
x	O	3747
chromosome	O	3747
,	O	3747
coupled	O	3747
with	O	3747
its	O	3747
comparatively	O	3747
mild	O	3747
pathology	O	3747
,	O	3747
have	O	3747
suggested	O	3747
that	O	3747
the	O	3747
mdx	O	3747
mutation	O	3747
may	O	3747
instead	O	3747
correspond	O	3747
to	O	3747
emery	B-Disease	3747
dreifuss	I-Disease	3747
muscular	I-Disease	3747
dystrophy	I-Disease	3747
which	O	3747
itself	O	3747
is	O	3747
closely	O	3747
linked	O	3747
to	O	3747
dna	O	3747
markers	O	3747
at	O	3747
xq28	O	3747
-	O	3747
qter	O	3747
in	O	3747
the	O	3747
region	O	3747
of	O	3747
g6pd	O	3747
on	O	3747
the	O	3747
human	O	3747
x	O	3747
chromosome	O	3747
.	O	3747
using	O	3748
an	O	3748
interspecific	O	3748
mouse	O	3748
domesticus	O	3748
/	O	3748
spretus	O	3748
cross	O	3748
,	O	3748
segregating	O	3748
for	O	3748
a	O	3748
variety	O	3748
of	O	3748
markers	O	3748
on	O	3748
the	O	3748
mouse	O	3748
x	O	3748
chromosome	O	3748
,	O	3748
we	O	3748
have	O	3748
positioned	O	3748
on	O	3748
the	O	3748
mouse	O	3748
x	O	3748
chromosome	O	3748
sequences	O	3748
homologous	O	3748
to	O	3748
a	O	3748
dmd	B-Disease	3748
cdna	O	3748
clone	O	3748
.	O	3748
these	O	3749
sequences	O	3749
map	O	3749
provocatively	O	3749
close	O	3749
to	O	3749
the	O	3749
mdx	O	3749
mutation	O	3749
and	O	3749
unexpectedly	O	3749
distant	O	3749
from	O	3749
sparse	O	3749
fur	O	3749
,	O	3749
spf	O	3749
,	O	3749
the	O	3749
mouse	O	3749
homologue	O	3749
of	O	3749
otc	O	3749
(	O	3749
ornithine	O	3749
transcarbamylase	O	3749
)	O	3749
which	O	3749
is	O	3749
closely	O	3749
linked	O	3749
to	O	3749
dmd	B-Disease	3749
on	O	3749
the	O	3749
human	O	3749
x	O	3749
chromosome	O	3749
.	O	3749
.	O	3749
localization	O	3750
of	O	3750
the	O	3750
region	O	3750
homologous	O	3750
to	O	3750
the	O	3750
duchenne	B-Disease	3750
muscular	I-Disease	3750
dystrophy	I-Disease	3750
locus	O	3750
on	O	3750
the	O	3750
mouse	O	3750
x	O	3750
chromosome	O	3750
.	O	3750
recent	O	3751
progress	O	3751
has	O	3751
resulted	O	3751
in	O	3751
part	O	3751
of	O	3751
the	O	3751
gene	O	3751
mutated	O	3751
in	O	3751
duchenne	B-Disease	3751
and	I-Disease	3751
the	I-Disease	3751
milder	I-Disease	3751
becker	I-Disease	3751
muscular	I-Disease	3751
dystrophies	I-Disease	3751
being	O	3751
cloned	O	3751
and	O	3751
has	O	3751
suggested	O	3751
that	O	3751
the	O	3751
gene	O	3751
itself	O	3751
extends	O	3751
over	O	3751
1	O	3751
,	O	3751
000	O	3751
to	O	3751
2	O	3751
,	O	3751
000	O	3751
kilobases	O	3751
(	O	3751
kb	O	3751
)	O	3751
.	O	3751
the	O	3753
mouse	O	3753
mdx	O	3753
mutation	O	3753
affects	O	3753
muscle	O	3753
and	O	3753
confers	O	3753
a	O	3753
mild	O	3753
dystrophic	B-Disease	3753
syndrome	I-Disease	3753
,	O	3753
but	O	3753
it	O	3753
is	O	3753
not	O	3753
clear	O	3753
whether	O	3753
this	O	3753
mutation	O	3753
is	O	3753
equivalent	O	3753
to	O	3753
duchenne	B-Disease	3753
/	I-Disease	3753
becker	I-Disease	3753
muscular	I-Disease	3753
dystrophy	I-Disease	3753
in	O	3753
man	O	3753
.	O	3753
here	O	3754
we	O	3754
describe	O	3754
the	O	3754
use	O	3754
of	O	3754
two	O	3754
sequences	O	3754
from	O	3754
the	O	3754
human	O	3754
duchenne	B-Disease	3754
muscular	I-Disease	3754
dystrophy	I-Disease	3754
(	O	3754
dmd	B-Disease	3754
)	O	3754
gene	O	3754
that	O	3754
cross	O	3754
-	O	3754
hybridize	O	3754
to	O	3754
mouse	O	3754
x	O	3754
-	O	3754
linked	O	3754
sequences	O	3754
to	O	3754
localize	O	3754
the	O	3754
gene	O	3754
homologous	O	3754
to	O	3754
dmd	B-Disease	3754
in	O	3754
the	O	3754
mouse	O	3754
.	O	3754
by	O	3756
analogy	O	3756
with	O	3756
the	O	3756
human	O	3756
x	O	3756
-	O	3756
chromosome	O	3756
,	O	3756
we	O	3756
conclude	O	3756
that	O	3756
the	O	3756
region	O	3756
in	O	3756
the	O	3756
mouse	O	3756
around	O	3756
the	O	3756
g6pd	O	3756
and	O	3756
st14	O	3756
-	O	3756
1	O	3756
loci	O	3756
may	O	3756
contain	O	3756
two	O	3756
genes	O	3756
corresponding	O	3756
to	O	3756
distinct	O	3756
human	O	3756
myopathies	B-Disease	3756
emery	B-Disease	3756
dreifuss	I-Disease	3756
muscular	I-Disease	3756
dystrophy	I-Disease	3756
which	O	3756
is	O	3756
known	O	3756
to	O	3756
be	O	3756
closely	O	3756
linked	O	3756
to	O	3756
st14	O	3756
-	O	3756
1	O	3756
in	O	3756
man	O	3756
and	O	3756
the	O	3756
dmd	B-Disease	3756
homologue	O	3756
described	O	3756
here	O	3756
.	O	3756
.	O	3756
gt	O	3757
to	O	3757
at	O	3757
transition	O	3757
at	O	3757
a	O	3757
splice	O	3757
donor	O	3757
site	O	3757
causes	O	3757
skipping	O	3757
of	O	3757
the	O	3757
preceding	O	3757
exon	O	3757
in	O	3757
phenylketonuria	B-Disease	3757
.	O	3757
classical	B-Disease	3758
phenylketonuria	I-Disease	3758
(	O	3758
pku	B-Disease	3758
)	O	3758
is	O	3758
an	O	3758
autosomal	B-Disease	3758
recessive	I-Disease	3758
human	I-Disease	3758
genetic	I-Disease	3758
disorder	I-Disease	3758
caused	O	3758
by	O	3758
a	O	3758
deficiency	B-Disease	3758
of	I-Disease	3758
hepatic	I-Disease	3758
phenylalanine	I-Disease	3758
hydroxylase	I-Disease	3758
(	O	3758
pah	O	3758
)	O	3758
.	O	3758
we	O	3759
isolated	O	3759
several	O	3759
mutant	O	3759
pah	O	3759
cdna	O	3759
clones	O	3759
from	O	3759
a	O	3759
pku	B-Disease	3759
carrier	O	3759
individual	O	3759
and	O	3759
showed	O	3759
that	O	3759
they	O	3759
contained	O	3759
an	O	3759
internal	O	3759
116	O	3759
base	O	3759
pair	O	3759
deletion	O	3759
,	O	3759
corresponding	O	3759
precisely	O	3759
to	O	3759
exon	O	3759
12	O	3759
of	O	3759
the	O	3759
human	O	3759
chromosomal	O	3759
pah	O	3759
gene	O	3759
.	O	3759
conservation	O	3764
of	O	3764
the	O	3764
duchenne	B-Disease	3764
muscular	I-Disease	3764
dystrophy	I-Disease	3764
gene	O	3764
in	O	3764
mice	O	3764
and	O	3764
humans	O	3764
.	O	3764
a	O	3765
portion	O	3765
of	O	3765
the	O	3765
duchenne	B-Disease	3765
muscular	I-Disease	3765
dystrophy	I-Disease	3765
(	O	3765
dmd	B-Disease	3765
)	O	3765
gene	O	3765
transcript	O	3765
from	O	3765
human	O	3765
fetal	O	3765
skeletal	O	3765
muscle	O	3765
and	O	3765
mouse	O	3765
adult	O	3765
heart	O	3765
was	O	3765
sequenced	O	3765
,	O	3765
representing	O	3765
approximately	O	3765
25	O	3765
percent	O	3765
of	O	3765
the	O	3765
total	O	3765
,	O	3765
14	O	3765
-	O	3765
kb	O	3765
dmd	B-Disease	3765
transcript	O	3765
.	O	3765
the	O	3767
amino	O	3767
acid	O	3767
sequence	O	3767
that	O	3767
is	O	3767
predicted	O	3767
from	O	3767
this	O	3767
portion	O	3767
of	O	3767
the	O	3767
dmd	B-Disease	3767
gene	O	3767
indicates	O	3767
that	O	3767
the	O	3767
protein	O	3767
product	O	3767
might	O	3767
serve	O	3767
a	O	3767
structural	O	3767
role	O	3767
in	O	3767
muscle	O	3767
,	O	3767
but	O	3767
the	O	3767
abundance	O	3767
and	O	3767
tissue	O	3767
distribution	O	3767
of	O	3767
the	O	3767
messenger	O	3767
rna	O	3767
suggests	O	3767
that	O	3767
the	O	3767
dmd	B-Disease	3767
protein	O	3767
is	O	3767
not	O	3767
nebulin	O	3767
.	O	3767
.	O	3767
familial	O	3768
prader	B-Disease	3768
-	I-Disease	3768
willi	I-Disease	3768
syndrome	I-Disease	3768
with	O	3768
apparently	O	3768
normal	O	3768
chromosomes	O	3768
.	O	3768
we	O	3769
report	O	3769
on	O	3769
4	O	3769
sibs	O	3769
(	O	3769
2f	O	3769
,	O	3769
2m	O	3769
)	O	3769
with	O	3769
prader	B-Disease	3769
-	I-Disease	3769
willi	I-Disease	3769
syndrome	I-Disease	3769
(	O	3769
pws	B-Disease	3769
)	O	3769
.	O	3769
the	O	3771
other	O	3771
child	O	3771
had	O	3771
died	O	3771
at	O	3771
age	O	3771
10	O	3771
months	O	3771
with	O	3771
a	O	3771
history	O	3771
and	O	3771
clinical	O	3771
findings	O	3771
typical	O	3771
of	O	3771
first	O	3771
phase	O	3771
of	O	3771
pws	B-Disease	3771
.	O	3771
the	O	3773
implications	O	3773
of	O	3773
this	O	3773
unusual	O	3773
familial	O	3773
occurrence	O	3773
for	O	3773
our	O	3773
understanding	O	3773
of	O	3773
pws	B-Disease	3773
are	O	3773
discussed	O	3773
.	O	3773
.	O	3773
nebulin	O	3774
and	O	3774
titin	O	3774
expression	O	3774
in	O	3774
duchenne	B-Disease	3774
muscular	I-Disease	3774
dystrophy	I-Disease	3774
appears	O	3774
normal	O	3774
.	O	3774
monoclonal	O	3775
antibodies	O	3775
which	O	3775
recognize	O	3775
different	O	3775
epitopes	O	3775
on	O	3775
either	O	3775
titin	O	3775
or	O	3775
nebulin	O	3775
show	O	3775
normal	O	3775
staining	O	3775
patterns	O	3775
on	O	3775
frozen	O	3775
sections	O	3775
of	O	3775
three	O	3775
muscle	O	3775
biopsies	O	3775
of	O	3775
duchenne	B-Disease	3775
muscular	I-Disease	3775
dystrophy	I-Disease	3775
(	O	3775
dmd	B-Disease	3775
)	O	3775
.	O	3775
since	O	3777
the	O	3777
donor	O	3777
of	O	3777
one	O	3777
of	O	3777
these	O	3777
biopsies	O	3777
has	O	3777
a	O	3777
large	O	3777
deletion	O	3777
of	O	3777
the	O	3777
5	O	3777
-	O	3777
region	O	3777
of	O	3777
the	O	3777
dmd	B-Disease	3777
gene	O	3777
,	O	3777
our	O	3777
results	O	3777
argue	O	3777
against	O	3777
the	O	3777
recent	O	3777
proposal	O	3777
that	O	3777
nebulin	O	3777
is	O	3777
the	O	3777
gene	O	3777
mutated	O	3777
in	O	3777
dmd	B-Disease	3777
.	O	3777
.	O	3777
heterozygous	B-Disease	3778
c2	I-Disease	3778
deficiency	I-Disease	3778
associated	O	3778
with	O	3778
angioedema	B-Disease	3778
,	O	3778
myasthenia	B-Disease	3778
gravis	I-Disease	3778
,	O	3778
and	O	3778
systemic	B-Disease	3778
lupus	I-Disease	3778
erythematosus	I-Disease	3778
.	O	3778
we	O	3779
describe	O	3779
a	O	3779
patient	O	3779
with	O	3779
myasthenia	B-Disease	3779
gravis	I-Disease	3779
,	O	3779
systemic	B-Disease	3779
lupus	I-Disease	3779
erythematosus	I-Disease	3779
,	O	3779
and	O	3779
angioedema	B-Disease	3779
associated	O	3779
with	O	3779
heterozygous	O	3779
complement	B-Disease	3779
factor	I-Disease	3779
2	I-Disease	3779
(	I-Disease	3779
c2	I-Disease	3779
)	I-Disease	3779
deficiency	I-Disease	3779
.	O	3779
the	O	3780
significance	O	3780
of	O	3780
this	O	3780
association	O	3780
is	O	3780
controversial	O	3780
,	O	3780
though	O	3780
the	O	3780
association	O	3780
of	O	3780
c2	B-Disease	3780
deficiency	I-Disease	3780
with	O	3780
certain	O	3780
histocompatibility	O	3780
antigens	O	3780
suggests	O	3780
possible	O	3780
linkage	O	3780
to	O	3780
immune	O	3780
response	O	3780
genes	O	3780
.	O	3780
to	O	3781
our	O	3781
knowledge	O	3781
this	O	3781
is	O	3781
the	O	3781
first	O	3781
report	O	3781
of	O	3781
heterozygous	O	3781
c2	B-Disease	3781
deficiency	I-Disease	3781
in	O	3781
association	O	3781
with	O	3781
this	O	3781
combination	O	3781
of	O	3781
autoimmune	B-Disease	3781
disorders	I-Disease	3781
,	O	3781
and	O	3781
we	O	3781
discuss	O	3781
the	O	3781
aetiological	O	3781
implications	O	3781
.	O	3781
.	O	3781
genetic	O	3782
analysis	O	3782
of	O	3782
an	O	3782
inherited	O	3782
deficiency	B-Disease	3782
of	I-Disease	3782
the	I-Disease	3782
third	I-Disease	3782
component	I-Disease	3782
of	I-Disease	3782
complement	I-Disease	3782
in	O	3782
brittany	O	3782
spaniel	O	3782
dogs	O	3782
.	O	3782
genetically	O	3783
determined	O	3783
c3	B-Disease	3783
deficiency	I-Disease	3783
in	O	3783
brittany	O	3783
spaniel	O	3783
dogs	O	3783
shares	O	3783
a	O	3783
number	O	3783
of	O	3783
biochemical	O	3783
and	O	3783
clinical	O	3783
characteristics	O	3783
with	O	3783
the	O	3783
human	O	3783
disorder	O	3783
.	O	3783
in	O	3784
humans	O	3784
,	O	3784
the	O	3784
gene	O	3784
for	O	3784
c3	B-Disease	3784
deficiency	I-Disease	3784
is	O	3784
a	O	3784
null	O	3784
gene	O	3784
that	O	3784
is	O	3784
allelic	O	3784
to	O	3784
the	O	3784
structural	O	3784
gene	O	3784
for	O	3784
c3	O	3784
and	O	3784
is	O	3784
not	O	3784
linked	O	3784
to	O	3784
the	O	3784
major	O	3784
histocompatibility	O	3784
locus	O	3784
.	O	3784
the	O	3785
current	O	3785
study	O	3785
used	O	3785
allotype	O	3785
analysis	O	3785
of	O	3785
canine	O	3785
c3	O	3785
in	O	3785
order	O	3785
to	O	3785
demonstrate	O	3785
that	O	3785
the	O	3785
gene	O	3785
for	O	3785
c3	B-Disease	3785
deficiency	I-Disease	3785
in	O	3785
these	O	3785
dogs	O	3785
is	O	3785
also	O	3785
a	O	3785
null	O	3785
gene	O	3785
allelic	O	3785
to	O	3785
the	O	3785
structural	O	3785
gene	O	3785
for	O	3785
c3	O	3785
.	O	3785
in	O	3786
addition	O	3786
,	O	3786
preliminary	O	3786
pedigree	O	3786
analysis	O	3786
suggests	O	3786
that	O	3786
the	O	3786
gene	O	3786
for	O	3786
canine	O	3786
c3	B-Disease	3786
deficiency	I-Disease	3786
is	O	3786
apparently	O	3786
not	O	3786
closely	O	3786
linked	O	3786
to	O	3786
the	O	3786
major	O	3786
histocompatibility	O	3786
complex	O	3786
of	O	3786
the	O	3786
dog	O	3786
.	O	3786
thus	O	3787
,	O	3787
it	O	3787
appears	O	3787
that	O	3787
c3	B-Disease	3787
deficiency	I-Disease	3787
in	O	3787
brittany	O	3787
spaniel	O	3787
dogs	O	3787
not	O	3787
only	O	3787
shares	O	3787
biochemical	O	3787
and	O	3787
clinical	O	3787
features	O	3787
with	O	3787
c3	B-Disease	3787
deficiency	I-Disease	3787
in	O	3787
humans	O	3787
,	O	3787
but	O	3787
also	O	3787
shares	O	3787
some	O	3787
genetic	O	3787
characteristics	O	3787
with	O	3787
the	O	3787
human	O	3787
disorder	O	3787
.	O	3787
.	O	3787
phenylketonuria	B-Disease	3789
(	O	3789
pku	B-Disease	3789
)	O	3789
is	O	3789
caused	O	3789
by	O	3789
a	O	3789
genetic	O	3789
deficiency	B-Disease	3789
of	I-Disease	3789
the	I-Disease	3789
enzyme	I-Disease	3789
phenylalanine	I-Disease	3789
hydroxylase	I-Disease	3789
(	O	3789
pah	O	3789
)	O	3789
.	O	3789
these	O	3792
results	O	3792
support	O	3792
the	O	3792
use	O	3792
of	O	3792
the	O	3792
human	O	3792
pah	O	3792
probe	O	3792
in	O	3792
prenatal	O	3792
diagnosis	O	3792
and	O	3792
detection	O	3792
of	O	3792
carriers	O	3792
,	O	3792
to	O	3792
provide	O	3792
new	O	3792
opportunities	O	3792
for	O	3792
the	O	3792
biochemical	O	3792
characterization	O	3792
of	O	3792
normal	O	3792
and	O	3792
mutant	O	3792
enzymes	O	3792
,	O	3792
and	O	3792
in	O	3792
the	O	3792
investigation	O	3792
of	O	3792
alternative	O	3792
genetic	O	3792
therapies	O	3792
for	O	3792
pku	B-Disease	3792
.	O	3792
.	O	3792
regional	O	3793
mapping	O	3793
of	O	3793
the	O	3793
phenylalanine	O	3793
hydroxylase	O	3793
gene	O	3793
and	O	3793
the	O	3793
phenylketonuria	B-Disease	3793
locus	O	3793
in	O	3793
the	O	3793
human	O	3793
genome	O	3793
.	O	3793
phenylketonuria	B-Disease	3794
(	O	3794
pku	B-Disease	3794
)	O	3794
is	O	3794
an	O	3794
autosomal	B-Disease	3794
recessive	I-Disease	3794
disorder	I-Disease	3794
of	O	3794
amino	O	3794
acid	O	3794
metabolism	O	3794
caused	O	3794
by	O	3794
a	O	3794
deficiency	B-Disease	3794
of	I-Disease	3794
the	I-Disease	3794
hepatic	I-Disease	3794
enzyme	I-Disease	3794
phenylalanine	I-Disease	3794
hydroxylase	I-Disease	3794
(	O	3794
pah	O	3794
;	O	3794
phenylalanine	O	3794
4	O	3794
-	O	3794
monooxygenase	O	3794
,	O	3794
ec	O	3794
1	O	3794
.	O	3794
14	O	3794
.	O	3794
16	O	3794
.	O	3794
1	O	3794
)	O	3794
.	O	3794
results	O	3800
of	O	3800
these	O	3800
experiments	O	3800
demonstrated	O	3800
that	O	3800
the	O	3800
region	O	3800
on	O	3800
chromosome	O	3800
12	O	3800
containing	O	3800
the	O	3800
pah	O	3800
gene	O	3800
and	O	3800
the	O	3800
pku	B-Disease	3800
locus	O	3800
in	O	3800
man	O	3800
is	O	3800
12q22	O	3800
-	O	3800
-	O	3800
-	O	3800
-	O	3800
12q24	O	3800
.	O	3800
heterogeneity	O	3803
of	O	3803
type	B-Disease	3803
i	I-Disease	3803
von	I-Disease	3803
willebrand	I-Disease	3803
disease	I-Disease	3803
:	O	3803
evidence	O	3803
for	O	3803
a	O	3803
subgroup	O	3803
with	O	3803
an	O	3803
abnormal	O	3803
von	B-Disease	3803
willebrand	I-Disease	3803
factor	O	3803
.	O	3803
type	B-Disease	3804
i	I-Disease	3804
von	I-Disease	3804
willebrand	I-Disease	3804
disease	I-Disease	3804
(	O	3804
vwd	B-Disease	3804
)	O	3804
is	O	3804
characterized	O	3804
by	O	3804
equally	O	3804
low	O	3804
plasma	O	3804
concentrations	O	3804
of	O	3804
von	B-Disease	3804
willebrand	I-Disease	3804
factor	O	3804
antigen	O	3804
(	O	3804
vwf	O	3804
ag	O	3804
)	O	3804
and	O	3804
ristocetin	O	3804
cofactor	O	3804
(	O	3804
ricof	O	3804
)	O	3804
and	O	3804
by	O	3804
the	O	3804
presence	O	3804
of	O	3804
all	O	3804
vwf	O	3804
multimers	O	3804
in	O	3804
sodium	O	3804
dodecyl	O	3804
sulfate	O	3804
(	O	3804
sds	O	3804
)	O	3804
-	O	3804
agarose	O	3804
gel	O	3804
electrophoresis	O	3804
.	O	3804
these	O	3810
findings	O	3810
demonstrated	O	3810
that	O	3810
there	O	3810
can	O	3810
be	O	3810
an	O	3810
abnormal	O	3810
vwf	O	3810
(	O	3810
ricof	O	3810
less	O	3810
than	O	3810
vwf	O	3810
ag	O	3810
)	O	3810
even	O	3810
in	O	3810
type	B-Disease	3810
i	I-Disease	3810
vwd	I-Disease	3810
,	O	3810
coexisting	O	3810
with	O	3810
a	O	3810
complete	O	3810
set	O	3810
of	O	3810
vwf	O	3810
multimers	O	3810
(	O	3810
platelet	O	3810
discordant	O	3810
)	O	3810
;	O	3810
that	O	3810
the	O	3810
abnormal	O	3810
vwf	O	3810
can	O	3810
be	O	3810
shown	O	3810
more	O	3810
clearly	O	3810
in	O	3810
platelets	O	3810
than	O	3810
in	O	3810
plasma	O	3810
or	O	3810
else	O	3810
in	O	3810
plasma	O	3810
after	O	3810
ddavp	O	3810
infusion	O	3810
;	O	3810
and	O	3810
that	O	3810
ddavp	O	3810
normalizes	O	3810
the	O	3810
bt	O	3810
only	O	3810
in	O	3810
those	O	3810
patients	O	3810
with	O	3810
normal	O	3810
platelet	O	3810
levels	O	3810
of	O	3810
both	O	3810
vwf	O	3810
ag	O	3810
and	O	3810
ricof	O	3810
(	O	3810
platelet	O	3810
normal	O	3810
)	O	3810
.	O	3810
.	O	3810
genetic	O	3811
analysis	O	3811
in	O	3811
families	O	3811
with	O	3811
van	B-Disease	3811
der	I-Disease	3811
woude	I-Disease	3811
syndrome	I-Disease	3811
.	O	3811
we	O	3812
have	O	3812
brought	O	3812
together	O	3812
information	O	3812
on	O	3812
864	O	3812
affected	O	3812
individuals	O	3812
in	O	3812
164	O	3812
families	O	3812
(	O	3812
including	O	3812
three	O	3812
new	O	3812
pedigrees	O	3812
)	O	3812
reported	O	3812
in	O	3812
the	O	3812
137	O	3812
year	O	3812
period	O	3812
since	O	3812
1845	O	3812
when	O	3812
demarquay	O	3812
first	O	3812
described	O	3812
a	O	3812
family	O	3812
with	O	3812
what	O	3812
was	O	3812
later	O	3812
called	O	3812
van	B-Disease	3812
der	I-Disease	3812
woude	I-Disease	3812
syndrome	I-Disease	3812
(	O	3812
vws	B-Disease	3812
)	O	3812
.	O	3812
both	O	3813
types	O	3813
of	O	3813
oral	B-Disease	3813
cleft	I-Disease	3813
,	O	3813
cleft	B-Disease	3813
palate	I-Disease	3813
(	O	3813
cp	B-Disease	3813
)	O	3813
and	O	3813
cleft	B-Disease	3813
lip	I-Disease	3813
with	O	3813
or	O	3813
without	O	3813
cp	B-Disease	3813
(	O	3813
clp	B-Disease	3813
)	O	3813
,	O	3813
segregate	O	3813
in	O	3813
these	O	3813
families	O	3813
together	O	3813
with	O	3813
lower	O	3813
lip	B-Disease	3813
pits	I-Disease	3813
or	O	3813
fistulae	B-Disease	3813
in	O	3813
an	O	3813
autosomal	O	3813
dominant	O	3813
mode	O	3813
with	O	3813
high	O	3813
penetrance	O	3813
estimated	O	3813
to	O	3813
be	O	3813
k	O	3813
=	O	3813
.	O	3813
cleft	O	3816
types	O	3816
(	O	3816
clp	B-Disease	3816
and	O	3816
cp	B-Disease	3816
)	O	3816
occur	O	3816
in	O	3816
vws	B-Disease	3816
in	O	3816
the	O	3816
same	O	3816
proportions	O	3816
as	O	3816
in	O	3816
the	O	3816
general	O	3816
non	O	3816
-	O	3816
vws	O	3816
population	O	3816
,	O	3816
ie	O	3816
,	O	3816
about	O	3816
twice	O	3816
as	O	3816
many	O	3816
cleft	O	3816
-	O	3816
bearing	O	3816
individuals	O	3816
have	O	3816
clp	B-Disease	3816
as	O	3816
have	O	3816
cp	B-Disease	3816
.	O	3816
on	O	3817
the	O	3817
other	O	3817
hand	O	3817
,	O	3817
we	O	3817
do	O	3817
not	O	3817
find	O	3817
the	O	3817
usually	O	3817
observed	O	3817
excess	O	3817
of	O	3817
females	O	3817
with	O	3817
cp	B-Disease	3817
and	O	3817
excess	O	3817
of	O	3817
males	O	3817
with	O	3817
clp	B-Disease	3817
;	O	3817
in	O	3817
vws	B-Disease	3817
the	O	3817
sex	O	3817
ratios	O	3817
are	O	3817
more	O	3817
nearly	O	3817
equal	O	3817
.	O	3817
lip	B-Disease	3818
pits	I-Disease	3818
also	O	3818
are	O	3818
equally	O	3818
distributed	O	3818
between	O	3818
the	O	3818
sexes	O	3818
.	O	3818
affected	O	3819
males	O	3819
and	O	3819
females	O	3819
are	O	3819
equally	O	3819
likely	O	3819
to	O	3819
transmit	O	3819
vws	B-Disease	3819
.	O	3819
the	O	3821
expression	O	3821
of	O	3821
vws	B-Disease	3821
is	O	3821
significantly	O	3821
modified	O	3821
by	O	3821
the	O	3821
genetic	O	3821
background	O	3821
more	O	3821
extreme	O	3821
phenotypes	O	3821
in	O	3821
parents	O	3821
tend	O	3821
to	O	3821
produce	O	3821
more	O	3821
extreme	O	3821
expression	O	3821
in	O	3821
their	O	3821
children	O	3821
.	O	3821
for	O	3822
a	O	3822
vws	B-Disease	3822
gene	O	3822
carrier	O	3822
the	O	3822
relative	O	3822
risk	O	3822
of	O	3822
transmitting	O	3822
a	O	3822
cleft	O	3822
is	O	3822
26	O	3822
.	O	3822
45	O	3823
%	O	3823
;	O	3823
that	O	3823
of	O	3823
transmitting	O	3823
lower	O	3823
lip	B-Disease	3823
pits	I-Disease	3823
is	O	3823
23	O	3823
.	O	3823
three	O	3825
pedigrees	O	3825
of	O	3825
lip	B-Disease	3825
pits	I-Disease	3825
in	O	3825
the	O	3825
literature	O	3825
show	O	3825
no	O	3825
clefts	O	3825
among	O	3825
a	O	3825
significant	O	3825
number	O	3825
of	O	3825
affected	O	3825
individuals	O	3825
.	O	3825
control	O	3826
of	O	3826
gene	O	3826
expression	O	3826
in	O	3826
vws	B-Disease	3826
in	O	3826
the	O	3826
three	O	3826
target	O	3826
tissues	O	3826
appears	O	3826
to	O	3826
be	O	3826
independent	O	3826
and	O	3826
separately	O	3826
designated	O	3826
.	O	3826
mutation	O	3827
rate	O	3827
of	O	3827
the	O	3827
vws	B-Disease	3827
gene	O	3827
is	O	3827
calculated	O	3827
to	O	3827
be	O	3827
1	O	3827
.	O	3827
hereditary	B-Disease	3829
c7	I-Disease	3829
deficiency	I-Disease	3829
.	O	3829
the	O	3831
serum	O	3831
of	O	3831
a	O	3831
44	O	3831
-	O	3831
yr	O	3831
-	O	3831
old	O	3831
woman	O	3831
of	O	3831
french	O	3831
-	O	3831
canadian	O	3831
descent	O	3831
having	O	3831
a	O	3831
b	O	3831
-	O	3831
27	O	3831
positive	O	3831
ankylosing	B-Disease	3831
spondylitis	I-Disease	3831
was	O	3831
deficient	B-Disease	3831
in	I-Disease	3831
the	I-Disease	3831
seventh	I-Disease	3831
component	I-Disease	3831
of	I-Disease	3831
complement	I-Disease	3831
(	O	3831
c7	O	3831
)	O	3831
as	O	3831
determined	O	3831
by	O	3831
hemolytic	O	3831
and	O	3831
immunochemical	O	3831
methods	O	3831
.	O	3831
the	O	3835
seven	O	3835
other	O	3835
siblings	O	3835
were	O	3835
heterozygous	O	3835
for	O	3835
c7	B-Disease	3835
deficiency	I-Disease	3835
,	O	3835
while	O	3835
the	O	3835
paternal	O	3835
aunt	O	3835
had	O	3835
a	O	3835
normal	O	3835
c7	O	3835
level	O	3835
.	O	3835
studies	O	3837
of	O	3837
the	O	3837
hla	O	3837
antigens	O	3837
in	O	3837
all	O	3837
the	O	3837
22	O	3837
subjects	O	3837
and	O	3837
in	O	3837
three	O	3837
spouses	O	3837
indicated	O	3837
no	O	3837
close	O	3837
linkage	O	3837
between	O	3837
the	O	3837
cm	B-Disease	3837
deficienty	I-Disease	3837
and	O	3837
the	O	3837
hla	O	3837
system	O	3837
.	O	3837
in	O	3838
addition	O	3838
,	O	3838
the	O	3838
simultaneous	O	3838
occurrence	O	3838
of	O	3838
two	O	3838
hereditary	O	3838
complement	B-Disease	3838
deficiencies	I-Disease	3838
(	I-Disease	3838
c2	I-Disease	3838
and	I-Disease	3838
c7	I-Disease	3838
)	I-Disease	3838
was	O	3838
discovered	O	3838
in	O	3838
one	O	3838
family	O	3838
of	O	3838
this	O	3838
remarkable	O	3838
kindred	O	3838
.	O	3838
.	O	3838
genetic	O	3839
defect	B-Disease	3839
in	I-Disease	3839
secretion	I-Disease	3839
of	I-Disease	3839
complement	I-Disease	3839
c5	I-Disease	3839
in	O	3839
mice	O	3839
.	O	3839
a	O	3840
genetic	O	3840
deficiency	B-Disease	3840
of	I-Disease	3840
the	I-Disease	3840
fifth	I-Disease	3840
(	I-Disease	3840
c5	I-Disease	3840
)	I-Disease	3840
component	I-Disease	3840
of	I-Disease	3840
complement1	I-Disease	3840
-	I-Disease	3840
3	I-Disease	3840
,	O	3840
a	O	3840
serum	O	3840
glycoprotein	O	3840
of	O	3840
molecular	O	3840
weight	O	3840
(	O	3840
mw	O	3840
)	O	3840
220	O	3840
,	O	3840
000	O	3840
(	O	3840
ref	O	3840
.	O	3840
4	O	3840
)	O	3840
,	O	3840
has	O	3840
been	O	3840
found	O	3840
in	O	3840
39	O	3840
%	O	3840
of	O	3840
inbred	O	3840
strains	O	3840
of	O	3840
mice3	O	3840
.	O	3840
using	O	3848
similar	O	3848
methods	O	3848
,	O	3848
we	O	3848
now	O	3848
find	O	3848
that	O	3848
c5	B-Disease	3848
deficiency	I-Disease	3848
in	O	3848
each	O	3848
of	O	3848
five	O	3848
different	O	3848
mouse	O	3848
strains	O	3848
(	O	3848
akr	O	3848
,	O	3848
swr	O	3848
,	O	3848
dba	O	3848
/	O	3848
2j8	O	3848
a	O	3848
/	O	3848
hej	O	3848
and	O	3848
b10	O	3848
.	O	3848
d2	O	3848
/	O	3848
old	O	3848
line	O	3848
)	O	3848
is	O	3848
due	O	3848
to	O	3848
a	O	3848
failure	O	3848
in	O	3848
secretion	O	3848
of	O	3848
c5	O	3848
protein	O	3848
and	O	3848
not	O	3848
to	O	3848
a	O	3848
failure	O	3848
in	O	3848
biosynthesis	O	3848
of	O	3848
pro	O	3848
-	O	3848
c5	O	3848
recurrent	O	3849
meningococcal	B-Disease	3849
meningitis	I-Disease	3849
with	O	3849
absence	B-Disease	3849
of	I-Disease	3849
the	I-Disease	3849
sixth	I-Disease	3849
component	I-Disease	3849
of	I-Disease	3849
complement	I-Disease	3849
:	O	3849
an	O	3849
evaluation	O	3849
of	O	3849
underlying	O	3849
immunologic	O	3849
mechanisms	O	3849
.	O	3849
a	O	3850
51	O	3850
/	O	3850
2	O	3850
-	O	3850
year	O	3850
-	O	3850
old	O	3850
black	O	3850
girl	O	3850
with	O	3850
recurrent	O	3850
meningococcal	B-Disease	3850
meningitis	I-Disease	3850
and	O	3850
absence	B-Disease	3850
of	I-Disease	3850
the	I-Disease	3850
sixth	I-Disease	3850
component	I-Disease	3850
of	I-Disease	3850
complement	I-Disease	3850
(	O	3850
c6	O	3850
)	O	3850
is	O	3850
reported	O	3850
.	O	3850
to	O	3851
explore	O	3851
the	O	3851
pathogenesis	O	3851
of	O	3851
recurrent	O	3851
neisserial	B-Disease	3851
infections	I-Disease	3851
in	O	3851
c6	B-Disease	3851
deficiency	I-Disease	3851
,	O	3851
a	O	3851
detailed	O	3851
analysis	O	3851
of	O	3851
her	O	3851
immune	O	3851
competence	O	3851
was	O	3851
conducted	O	3851
.	O	3851
in	O	3853
addition	O	3853
,	O	3853
her	O	3853
c6	B-Disease	3853
-	I-Disease	3853
deficient	I-Disease	3853
serum	O	3853
was	O	3853
indistinguishable	O	3853
from	O	3853
normal	O	3853
serum	O	3853
in	O	3853
a	O	3853
complement	O	3853
-	O	3853
dependent	O	3853
assay	O	3853
of	O	3853
phagocyte	O	3853
bactericidal	O	3853
activity	O	3853
.	O	3853
absent	O	3854
bacteriolysis	O	3854
remains	O	3854
the	O	3854
only	O	3854
consistent	O	3854
defect	O	3854
associated	O	3854
with	O	3854
recurrent	O	3854
neisserial	B-Disease	3854
infections	I-Disease	3854
and	O	3854
absence	O	3854
of	O	3854
one	O	3854
of	O	3854
the	O	3854
late	O	3854
-	O	3854
acting	O	3854
complement	O	3854
components	O	3854
.	O	3854
.	O	3854
deficiency	B-Disease	3855
of	I-Disease	3855
the	I-Disease	3855
fifth	I-Disease	3855
component	I-Disease	3855
of	I-Disease	3855
complement	I-Disease	3855
in	O	3855
human	O	3855
subjects	O	3855
.	O	3855
the	O	3857
discovery	O	3857
of	O	3857
a	O	3857
large	O	3857
kindred	O	3857
with	O	3857
a	O	3857
heritable	O	3857
deficiency	B-Disease	3857
of	I-Disease	3857
the	I-Disease	3857
fifth	I-Disease	3857
component	I-Disease	3857
of	I-Disease	3857
complement	I-Disease	3857
(	O	3857
c5	O	3857
)	O	3857
has	O	3857
permitted	O	3857
the	O	3857
accumulation	O	3857
of	O	3857
new	O	3857
clinical	O	3857
,	O	3857
genetic	O	3857
and	O	3857
immunologic	O	3857
data	O	3857
concerning	O	3857
the	O	3857
role	O	3857
of	O	3857
c5	O	3857
in	O	3857
human	O	3857
subjects	O	3857
.	O	3857
the	O	3858
proband	O	3858
,	O	3858
who	O	3858
has	O	3858
had	O	3858
nine	O	3858
episodes	O	3858
of	O	3858
disseminated	O	3858
gonococcal	B-Disease	3858
infection	I-Disease	3858
,	O	3858
has	O	3858
a	O	3858
hemolytic	O	3858
c5	O	3858
level	O	3858
of	O	3858
approximately	O	3858
0	O	3858
.	O	3858
no	O	3863
chemotactic	O	3863
activity	O	3863
for	O	3863
polymorphonuclear	O	3863
leukocytes	O	3863
could	O	3863
be	O	3863
generated	O	3863
in	O	3863
the	O	3863
c5	B-Disease	3863
-	I-Disease	3863
deficient	I-Disease	3863
serums	O	3863
upon	O	3863
activation	O	3863
of	O	3863
either	O	3863
the	O	3863
classic	O	3863
or	O	3863
alternative	O	3863
pathways	O	3863
,	O	3863
again	O	3863
demonstrating	O	3863
the	O	3863
importance	O	3863
of	O	3863
c5	O	3863
in	O	3863
human	O	3863
subjects	O	3863
for	O	3863
the	O	3863
production	O	3863
of	O	3863
chemotactic	O	3863
factors	O	3863
.	O	3863
no	O	3867
linkage	O	3867
for	O	3867
c5	B-Disease	3867
deficiency	I-Disease	3867
and	O	3867
the	O	3867
a	O	3867
or	O	3867
b	O	3867
loci	O	3867
of	O	3867
the	O	3867
major	O	3867
histocompatibility	O	3867
complex	O	3867
could	O	3867
be	O	3867
found	O	3867
.	O	3867
these	O	3868
data	O	3868
suggest	O	3868
an	O	3868
autosomal	O	3868
codominant	O	3868
mode	O	3868
of	O	3868
inheritance	O	3868
of	O	3868
c5	B-Disease	3868
deficiency	I-Disease	3868
.	O	3868
deficiency	B-Disease	3869
of	I-Disease	3869
c5	I-Disease	3869
is	O	3869
compatible	O	3869
with	O	3869
good	O	3869
health	O	3869
,	O	3869
but	O	3869
it	O	3869
can	O	3869
be	O	3869
associated	O	3869
with	O	3869
repeated	O	3869
disseminated	O	3869
gonococcal	B-Disease	3869
infection	I-Disease	3869
a	O	3871
total	O	3871
of	O	3871
3000	O	3871
men	O	3871
living	O	3871
in	O	3871
yamaguchi	O	3871
were	O	3871
screened	O	3871
for	O	3871
glucose	B-Disease	3871
-	I-Disease	3871
6	I-Disease	3871
-	I-Disease	3871
phosphate	I-Disease	3871
dehydrogenase	I-Disease	3871
(	I-Disease	3871
g6pd	I-Disease	3871
)	I-Disease	3871
deficiency	I-Disease	3871
using	O	3871
beutlers	O	3871
spot	O	3871
test	O	3871
and	O	3871
three	O	3871
types	O	3871
of	O	3871
starch	O	3871
gel	O	3871
electrophoresis	O	3871
.	O	3871
fifteen	O	3875
g6pd	B-Disease	3875
-	I-Disease	3875
deficient	I-Disease	3875
variants	O	3875
were	O	3875
found	O	3875
at	O	3875
the	O	3875
rate	O	3875
of	O	3875
0	O	3875
.	O	3875
these	O	3878
three	O	3878
variants	O	3878
had	O	3878
a	O	3878
mild	O	3878
to	O	3878
moderate	O	3878
g6pd	B-Disease	3878
deficiency	I-Disease	3878
and	O	3878
were	O	3878
not	O	3878
associated	O	3878
with	O	3878
any	O	3878
clinical	O	3878
signs	O	3878
.	O	3878
utilization	O	3883
of	O	3883
purines	O	3883
by	O	3883
an	O	3883
hprt	O	3883
variant	O	3883
in	O	3883
an	O	3883
intelligent	O	3883
,	O	3883
nonmutilative	O	3883
patient	O	3883
with	O	3883
features	O	3883
of	O	3883
the	O	3883
lesch	B-Disease	3883
-	I-Disease	3883
nyhan	I-Disease	3883
syndrome	I-Disease	3883
.	O	3883
b	O	3886
.	O	3886
,	O	3886
was	O	3886
among	O	3886
the	O	3886
first	O	3886
reported	O	3886
with	O	3886
hyperuricemia	B-Disease	3886
and	O	3886
central	B-Disease	3886
nervous	I-Disease	3886
system	I-Disease	3886
symptoms	I-Disease	3886
.	O	3886
he	O	3887
has	O	3887
been	O	3887
found	O	3887
to	O	3887
have	O	3887
a	O	3887
variant	O	3887
of	O	3887
hypoxanthine	O	3887
guanine	O	3887
phosphoribosyl	O	3887
transferase	O	3887
(	O	3887
hprt	O	3887
;	O	3887
e	O	3887
.	O	3887
c	O	3887
.	O	3887
2	O	3887
.	O	3887
4	O	3887
.	O	3887
2	O	3887
.	O	3887
8	O	3887
)	O	3887
distinct	O	3887
from	O	3887
the	O	3887
enzyme	O	3887
present	O	3887
in	O	3887
patients	O	3887
with	O	3887
the	O	3887
lesch	B-Disease	3887
-	I-Disease	3887
nyhan	I-Disease	3887
syndrome	I-Disease	3887
.	O	3887
the	O	3888
patient	O	3888
had	O	3888
chroeoathetosis	B-Disease	3888
,	O	3888
spasticity	B-Disease	3888
,	O	3888
dysarthric	B-Disease	3888
speech	I-Disease	3888
,	O	3888
and	O	3888
hyperuricemia	B-Disease	3888
.	O	3888
in	O	3892
contrast	O	3892
,	O	3892
cells	O	3892
from	O	3892
patients	O	3892
with	O	3892
the	O	3892
lesch	B-Disease	3892
-	I-Disease	3892
nyhan	I-Disease	3892
syndrome	I-Disease	3892
were	O	3892
virtually	O	3892
completely	O	3892
unable	O	3892
to	O	3892
convert	O	3892
hypoxanthine	O	3892
to	O	3892
nucleotides	O	3892
.	O	3892
the	O	3894
growth	O	3894
of	O	3894
the	O	3894
cultured	O	3894
fibroblasts	O	3894
of	O	3894
this	O	3894
patient	O	3894
was	O	3894
intermediate	O	3894
in	O	3894
media	O	3894
containing	O	3894
hypoxanthine	O	3894
aminopterin	O	3894
thymidine	O	3894
(	O	3894
hat	O	3894
)	O	3894
,	O	3894
whereas	O	3894
the	O	3894
growth	O	3894
of	O	3894
lesch	B-Disease	3894
-	I-Disease	3894
nyhan	I-Disease	3894
cells	O	3894
was	O	3894
inhibited	O	3894
and	O	3894
normal	O	3894
cells	O	3894
grew	O	3894
normally	O	3894
.	O	3894
similarly	O	3895
in	O	3895
8	O	3895
-	O	3895
azaguanine	O	3895
,	O	3895
6	O	3895
-	O	3895
thioguanine	O	3895
,	O	3895
and	O	3895
8	O	3895
-	O	3895
azahypoxanthine	O	3895
,	O	3895
the	O	3895
growth	O	3895
of	O	3895
the	O	3895
patients	O	3895
cells	O	3895
was	O	3895
intermediate	O	3895
between	O	3895
normal	O	3895
and	O	3895
lesch	B-Disease	3895
-	I-Disease	3895
nyhan	I-Disease	3895
cells	O	3895
.	O	3895
they	O	3897
document	O	3897
that	O	3897
this	O	3897
famous	O	3897
patient	O	3897
did	O	3897
not	O	3897
have	O	3897
the	O	3897
lesch	B-Disease	3897
-	I-Disease	3897
nyhan	I-Disease	3897
syndrome	I-Disease	3897
localisation	O	3898
of	O	3898
the	O	3898
becker	B-Disease	3898
muscular	I-Disease	3898
dystrophy	I-Disease	3898
gene	O	3898
on	O	3898
the	O	3898
short	O	3898
arm	O	3898
of	O	3898
the	O	3898
x	O	3898
chromosome	O	3898
by	O	3898
linkage	O	3898
to	O	3898
cloned	O	3898
dna	O	3898
sequences	O	3898
.	O	3898
a	O	3899
linkage	O	3899
study	O	3899
in	O	3899
30	O	3899
becker	B-Disease	3899
muscular	I-Disease	3899
dystrophy	I-Disease	3899
(	O	3899
bmd	B-Disease	3899
)	O	3899
kindreds	O	3899
using	O	3899
three	O	3899
cloned	O	3899
dna	O	3899
sequences	O	3899
from	O	3899
the	O	3899
x	O	3899
chromosome	O	3899
which	O	3899
demonstrate	O	3899
restriction	O	3899
fragment	O	3899
length	O	3899
polymorphisms	O	3899
(	O	3899
rflps	O	3899
)	O	3899
,	O	3899
suggests	O	3899
that	O	3899
the	O	3899
bmd	B-Disease	3899
gene	O	3899
is	O	3899
located	O	3899
on	O	3899
the	O	3899
short	O	3899
arm	O	3899
of	O	3899
the	O	3899
x	O	3899
chromosome	O	3899
,	O	3899
in	O	3899
the	O	3899
p21	O	3899
region	O	3899
.	O	3899
the	O	3900
genes	O	3900
for	O	3900
becker	B-Disease	3900
and	I-Disease	3900
duchenne	I-Disease	3900
dystrophies	I-Disease	3900
must	O	3900
therefore	O	3900
be	O	3900
closely	O	3900
linked	O	3900
,	O	3900
if	O	3900
not	O	3900
allelic	O	3900
,	O	3900
and	O	3900
any	O	3900
future	O	3900
dna	O	3900
probes	O	3900
found	O	3900
to	O	3900
be	O	3900
of	O	3900
practical	O	3900
use	O	3900
in	O	3900
one	O	3900
disorder	O	3900
should	O	3900
be	O	3900
equally	O	3900
applicable	O	3900
to	O	3900
the	O	3900
other	O	3900
.	O	3900
molecular	O	3902
evidence	O	3902
for	O	3902
new	O	3902
mutation	O	3902
at	O	3902
the	O	3902
hprt	O	3902
locus	O	3902
in	O	3902
lesch	B-Disease	3902
-	I-Disease	3902
nyhan	I-Disease	3902
patients	O	3902
.	O	3902
partial	O	3904
hprt	B-Disease	3904
deficiencies	I-Disease	3904
are	O	3904
associated	O	3904
with	O	3904
gouty	B-Disease	3904
arthritis	I-Disease	3904
,	O	3904
while	O	3904
absence	O	3904
of	O	3904
activity	O	3904
results	O	3904
in	O	3904
lesch	B-Disease	3904
-	I-Disease	3904
nyhan	I-Disease	3904
syndrome	I-Disease	3904
(	O	3904
l	B-Disease	3904
-	I-Disease	3904
n	I-Disease	3904
)	O	3904
.	O	3904
l	B-Disease	3905
-	I-Disease	3905
n	I-Disease	3905
patients	O	3905
fail	O	3905
to	O	3905
reproduce	O	3905
and	O	3905
the	O	3905
heterozygous	O	3905
state	O	3905
appears	O	3905
to	O	3905
confer	O	3905
no	O	3905
selective	O	3905
advantage	O	3905
.	O	3905
thus	O	3906
,	O	3906
haldanes	O	3906
principle	O	3906
predicts	O	3906
that	O	3906
new	O	3906
mutations	O	3906
at	O	3906
the	O	3906
hprt	O	3906
locus	O	3906
must	O	3906
occur	O	3906
frequently	O	3906
in	O	3906
order	O	3906
for	O	3906
l	B-Disease	3906
-	I-Disease	3906
n	I-Disease	3906
syndrome	I-Disease	3906
to	O	3906
be	O	3906
maintained	O	3906
in	O	3906
the	O	3906
population	O	3906
.	O	3906
this	O	3907
constant	O	3907
introduction	O	3907
of	O	3907
new	O	3907
mutations	O	3907
would	O	3907
be	O	3907
expected	O	3907
to	O	3907
result	O	3907
in	O	3907
a	O	3907
heterogeneous	O	3907
collection	O	3907
of	O	3907
genetic	B-Disease	3907
lesions	I-Disease	3907
,	O	3907
some	O	3907
of	O	3907
which	O	3907
may	O	3907
be	O	3907
novel	O	3907
.	O	3907
as	O	3908
we	O	3908
report	O	3908
here	O	3908
,	O	3908
the	O	3908
mutations	O	3908
in	O	3908
the	O	3908
hprt	O	3908
gene	O	3908
of	O	3908
seven	O	3908
l	B-Disease	3908
-	I-Disease	3908
n	I-Disease	3908
patients	O	3908
,	O	3908
selected	O	3908
from	O	3908
an	O	3908
initial	O	3908
survey	O	3908
of	O	3908
28	O	3908
patients	O	3908
,	O	3908
have	O	3908
been	O	3908
characterized	O	3908
and	O	3908
all	O	3908
were	O	3908
found	O	3908
to	O	3908
be	O	3908
distinctly	O	3908
different	O	3908
,	O	3908
as	O	3908
predicted	O	3908
.	O	3908
allelic	O	3911
exclusion	O	3911
of	O	3911
glucose	O	3911
-	O	3911
6	O	3911
-	O	3911
phosphate	O	3911
dehydrogenase	O	3911
in	O	3911
platelets	O	3911
and	O	3911
t	O	3911
lymphocytes	O	3911
from	O	3911
a	O	3911
wiskott	B-Disease	3911
-	I-Disease	3911
aldrich	I-Disease	3911
syndrome	I-Disease	3911
carrier	O	3911
.	O	3911
an	O	3912
obligate	O	3912
carrier	O	3912
of	O	3912
the	O	3912
wiskott	B-Disease	3912
-	I-Disease	3912
aldrich	I-Disease	3912
syndrome	I-Disease	3912
(	O	3912
was	B-Disease	3912
)	O	3912
who	O	3912
was	O	3912
also	O	3912
heterozygous	O	3912
for	O	3912
the	O	3912
a	O	3912
and	O	3912
b	O	3912
types	O	3912
of	O	3912
x	O	3912
-	O	3912
linked	O	3912
glucose	O	3912
-	O	3912
6	O	3912
-	O	3912
phosphate	O	3912
dehydrogenase	O	3912
was	O	3912
found	O	3912
.	O	3912
with	O	3913
her	O	3913
it	O	3913
became	O	3913
possible	O	3913
to	O	3913
determine	O	3913
whether	O	3913
allelic	O	3913
exclusion	O	3913
occurs	O	3913
in	O	3913
particular	O	3913
cell	O	3913
-	O	3913
types	O	3913
of	O	3913
the	O	3913
was	B-Disease	3913
carrier	O	3913
.	O	3913
these	O	3916
findings	O	3916
suggest	O	3916
that	O	3916
selection	O	3916
against	O	3916
the	O	3916
was	B-Disease	3916
gene	O	3916
occurs	O	3916
in	O	3916
platelets	O	3916
and	O	3916
thymus	O	3916
-	O	3916
derived	O	3916
t	O	3916
lymphocytes	O	3916
and	O	3916
that	O	3916
the	O	3916
defects	O	3916
associated	O	3916
with	O	3916
was	B-Disease	3916
expressed	O	3916
in	O	3916
these	O	3916
cell	O	3916
-	O	3916
types	O	3916
may	O	3916
be	O	3916
implicated	O	3916
in	O	3916
the	O	3916
genesis	O	3916
of	O	3916
the	O	3916
wiskott	B-Disease	3916
-	I-Disease	3916
aldrich	I-Disease	3916
syndrome	I-Disease	3916
.	O	3916
.	O	3916
complement	B-Disease	3917
deficiency	I-Disease	3917
and	O	3917
nephritis	B-Disease	3917
.	O	3917
a	O	3919
family	O	3919
is	O	3919
described	O	3919
in	O	3919
which	O	3919
three	O	3919
children	O	3919
had	O	3919
homozygous	O	3919
deficiency	B-Disease	3919
of	I-Disease	3919
c3	I-Disease	3919
and	O	3919
in	O	3919
which	O	3919
both	O	3919
parents	O	3919
and	O	3919
two	O	3919
other	O	3919
children	O	3919
were	O	3919
heterozygous	O	3919
for	O	3919
the	O	3919
c3	O	3919
null	O	3919
gene	O	3919
.	O	3919
one	O	3920
child	O	3920
with	O	3920
heterozygous	O	3920
c3	B-Disease	3920
deficiency	I-Disease	3920
was	O	3920
found	O	3920
to	O	3920
have	O	3920
membranoproliferative	O	3920
glomerulonephritis	B-Disease	3920
;	O	3920
proteinuria	B-Disease	3920
and	O	3920
/	O	3920
or	O	3920
microscopical	O	3920
haematuria	B-Disease	3920
was	O	3920
present	O	3920
in	O	3920
all	O	3920
three	O	3920
homozygous	O	3920
c3	B-Disease	3920
-	I-Disease	3920
deficient	I-Disease	3920
children	O	3920
.	O	3920
all	O	3921
children	O	3921
with	O	3921
homozygous	O	3921
or	O	3921
heterozygous	O	3921
c3	B-Disease	3921
deficiency	I-Disease	3921
were	O	3921
,	O	3921
to	O	3921
a	O	3921
varying	O	3921
degree	O	3921
,	O	3921
susceptible	O	3921
to	O	3921
infection	O	3921
.	O	3921
the	O	3922
only	O	3922
child	O	3922
of	O	3922
the	O	3922
family	O	3922
with	O	3922
normal	O	3922
complement	O	3922
had	O	3922
no	O	3922
increased	O	3922
risk	O	3922
of	O	3922
infection	O	3922
and	O	3922
no	O	3922
renal	B-Disease	3922
disease	I-Disease	3922
.	O	3922
this	O	3923
family	O	3923
study	O	3923
provides	O	3923
further	O	3923
support	O	3923
for	O	3923
the	O	3923
proposal	O	3923
that	O	3923
c3	B-Disease	3923
deficiency	I-Disease	3923
predisposes	O	3923
to	O	3923
nephritis	B-Disease	3923
.	O	3923
.	O	3923
heterogeneity	O	3924
of	O	3924
glucose	B-Disease	3924
-	I-Disease	3924
6	I-Disease	3924
-	I-Disease	3924
phosphate	I-Disease	3924
dehydrogenase	I-Disease	3924
deficiency	I-Disease	3924
in	O	3924
algeria	O	3924
.	O	3924
glucose	B-Disease	3926
-	I-Disease	3926
6	I-Disease	3926
-	I-Disease	3926
phosphate	I-Disease	3926
dehydrogenase	I-Disease	3926
(	I-Disease	3926
g6pd	I-Disease	3926
)	I-Disease	3926
deficiency	I-Disease	3926
was	O	3926
found	O	3926
in	O	3926
3	O	3926
.	O	3926
g6pd	B-Disease	3934
deficiency	I-Disease	3934
is	O	3934
heterogeneous	O	3934
in	O	3934
northern	O	3934
algeria	O	3934
where	O	3934
autochtonous	O	3934
variants	O	3934
seem	O	3934
to	O	3934
prevail	O	3934
.	O	3934
glucose	B-Disease	3936
-	I-Disease	3936
6	I-Disease	3936
-	I-Disease	3936
phosphate	I-Disease	3936
dehydrogenase	I-Disease	3936
deficiency	I-Disease	3936
inhibits	O	3936
in	O	3936
vitro	O	3936
growth	O	3936
of	O	3936
plasmodium	O	3936
falciparum	O	3936
.	O	3936
glucose	B-Disease	3937
-	I-Disease	3937
6	I-Disease	3937
-	I-Disease	3937
phosphate	I-Disease	3937
dehydrogenase	I-Disease	3937
(	I-Disease	3937
g6pd	I-Disease	3937
;	I-Disease	3937
ec	I-Disease	3937
1	I-Disease	3937
.	I-Disease	3937
1	I-Disease	3937
.	I-Disease	3937
1	I-Disease	3937
.	I-Disease	3937
49	I-Disease	3937
)	I-Disease	3937
-	I-Disease	3937
deficient	I-Disease	3937
red	O	3937
blood	O	3937
cells	O	3937
from	O	3937
male	O	3937
hemizygotes	O	3937
and	O	3937
female	O	3937
heterozygotes	O	3937
from	O	3937
the	O	3937
island	O	3937
of	O	3937
sardinia	O	3937
were	O	3937
studied	O	3937
for	O	3937
their	O	3937
ability	O	3937
to	O	3937
support	O	3937
growth	O	3937
in	O	3937
vitro	O	3937
of	O	3937
the	O	3937
malaria	B-Disease	3937
-	O	3937
causing	O	3937
organism	O	3937
plasmodium	O	3937
falciparum	O	3937
.	O	3937
parasite	O	3938
growth	O	3938
was	O	3938
approximately	O	3938
one	O	3938
-	O	3938
third	O	3938
of	O	3938
normal	O	3938
in	O	3938
both	O	3938
hemi	O	3938
-	O	3938
and	O	3938
heterozygotes	O	3938
for	O	3938
g6pd	B-Disease	3938
deficiency	I-Disease	3938
.	O	3938
in	O	3939
sardinians	O	3939
with	O	3939
the	O	3939
beta	O	3939
0	O	3939
-	O	3939
thalassemia	O	3939
trait	O	3939
,	O	3939
parasite	O	3939
growth	O	3939
was	O	3939
normal	O	3939
except	O	3939
when	O	3939
g6pd	B-Disease	3939
deficiency	I-Disease	3939
occurred	O	3939
together	O	3939
with	O	3939
the	O	3939
thalassemia	B-Disease	3939
trait	O	3939
.	O	3939
the	O	3940
data	O	3940
support	O	3940
the	O	3940
hypothesis	O	3940
that	O	3940
g6pd	B-Disease	3940
deficiency	I-Disease	3940
may	O	3940
confer	O	3940
a	O	3940
selective	O	3940
advantage	O	3940
in	O	3940
a	O	3940
malarious	B-Disease	3940
area	O	3940
;	O	3940
the	O	3940
female	O	3940
heterozygote	O	3940
may	O	3940
be	O	3940
at	O	3940
a	O	3940
particular	O	3940
advantage	O	3940
because	O	3940
resistance	O	3940
to	O	3940
malaria	B-Disease	3940
equals	O	3940
that	O	3940
of	O	3940
male	O	3940
hemizygotes	O	3940
,	O	3940
but	O	3940
the	O	3940
risk	O	3940
of	O	3940
fatal	B-Disease	3940
hemolysis	I-Disease	3940
may	O	3940
be	O	3940
less	O	3940
.	O	3940
bone	O	3943
marrow	O	3943
transplant	O	3943
in	O	3943
adrenoleukodystrophy	B-Disease	3943
.	O	3943
an	O	3944
allogeneic	O	3944
bone	O	3944
marrow	O	3944
transplant	O	3944
(	O	3944
bmt	O	3944
)	O	3944
from	O	3944
a	O	3944
normal	O	3944
hla	O	3944
identical	O	3944
sibling	O	3944
donor	O	3944
was	O	3944
performed	O	3944
in	O	3944
a	O	3944
13	O	3944
-	O	3944
year	O	3944
-	O	3944
old	O	3944
boy	O	3944
with	O	3944
rapidly	O	3944
progressive	O	3944
adrenoleukodystrophy	B-Disease	3944
(	O	3944
ald	B-Disease	3944
)	O	3944
.	O	3944
engraftment	O	3945
and	O	3945
complete	O	3945
hematologic	O	3945
recovery	O	3945
occurred	O	3945
within	O	3945
4	O	3945
weeks	O	3945
,	O	3945
but	O	3945
neurologic	B-Disease	3945
deterioration	I-Disease	3945
continued	O	3945
.	O	3945
the	O	3946
patient	O	3946
died	O	3946
of	O	3946
an	O	3946
adenovirus	B-Disease	3946
infection	I-Disease	3946
141	O	3946
days	O	3946
after	O	3946
bmt	O	3946
.	O	3946
ald	B-Disease	3947
is	O	3947
characterized	O	3947
by	O	3947
abnormally	O	3947
high	O	3947
plasma	O	3947
levels	O	3947
of	O	3947
very	O	3947
long	O	3947
chain	O	3947
fatty	O	3947
acids	O	3947
(	O	3947
vlcfa	O	3947
)	O	3947
as	O	3947
a	O	3947
result	O	3947
of	O	3947
impaired	O	3947
capacity	O	3947
to	O	3947
degrade	O	3947
them	O	3947
.	O	3947
in	O	3950
28	O	3950
families	O	3950
with	O	3950
g6pd	B-Disease	3950
deficiency	I-Disease	3950
living	O	3950
in	O	3950
3	O	3950
settlements	O	3950
of	O	3950
shekii	O	3950
district	O	3950
of	O	3950
azerbaijan	O	3950
11	O	3950
g6pd	O	3950
variants	O	3950
of	O	3950
ii	O	3950
and	O	3950
iii	O	3950
classes	O	3950
differing	O	3950
by	O	3950
kinetic	O	3950
properties	O	3950
were	O	3950
identified	O	3950
according	O	3950
who	O	3950
program	O	3950
.	O	3950
adrenoleukodystrophy	B-Disease	3955
:	O	3955
survey	O	3955
of	O	3955
303	O	3955
cases	O	3955
:	O	3955
biochemistry	O	3955
,	O	3955
diagnosis	O	3955
,	O	3955
and	O	3955
therapy	O	3955
.	O	3955
adrenoleukodystrophy	B-Disease	3956
(	O	3956
ald	B-Disease	3956
)	O	3956
is	O	3956
a	O	3956
genetically	O	3956
determined	O	3956
disorder	O	3956
associated	O	3956
with	O	3956
progressive	B-Disease	3956
central	I-Disease	3956
demyelination	I-Disease	3956
and	O	3956
adrenal	B-Disease	3956
cortical	I-Disease	3956
insufficiency	I-Disease	3956
.	O	3956
this	O	3958
degradation	O	3958
normally	O	3958
takes	O	3958
place	O	3958
in	O	3958
a	O	3958
subcellular	O	3958
organelle	O	3958
called	O	3958
the	O	3958
peroxisome	O	3958
,	O	3958
and	O	3958
ald	B-Disease	3958
,	O	3958
together	O	3958
with	O	3958
zellwegers	B-Disease	3958
cerebrohepatorenal	I-Disease	3958
syndrome	I-Disease	3958
,	O	3958
is	O	3958
now	O	3958
considered	O	3958
to	O	3958
belong	O	3958
to	O	3958
the	O	3958
newly	O	3958
formed	O	3958
category	O	3958
of	O	3958
peroxisomal	B-Disease	3958
disorders	I-Disease	3958
.	O	3958
we	O	3960
have	O	3960
identified	O	3960
303	O	3960
patients	O	3960
with	O	3960
ald	B-Disease	3960
in	O	3960
217	O	3960
kindreds	O	3960
.	O	3960
sixty	O	3962
percent	O	3962
of	O	3962
patients	O	3962
had	O	3962
childhood	O	3962
ald	B-Disease	3962
and	O	3962
17	O	3962
%	O	3962
adrenomyeloneuropathy	B-Disease	3962
,	O	3962
both	O	3962
of	O	3962
which	O	3962
are	O	3962
x	O	3962
-	O	3962
linked	O	3962
,	O	3962
with	O	3962
the	O	3962
gene	O	3962
mapped	O	3962
to	O	3962
xq28	O	3962
.	O	3962
neonatal	B-Disease	3963
ald	I-Disease	3963
,	O	3963
a	O	3963
distinct	O	3963
entity	O	3963
with	O	3963
autosomal	O	3963
recessive	O	3963
inheritance	O	3963
and	O	3963
points	O	3963
of	O	3963
resemblance	O	3963
to	O	3963
zellwegers	B-Disease	3963
syndrome	I-Disease	3963
,	O	3963
accounted	O	3963
for	O	3963
7	O	3963
%	O	3963
of	O	3963
the	O	3963
cases	O	3963
.	O	3963
although	O	3964
excess	O	3964
c26	O	3964
0	O	3964
in	O	3964
the	O	3964
brain	O	3964
of	O	3964
patients	O	3964
with	O	3964
ald	B-Disease	3964
is	O	3964
partially	O	3964
of	O	3964
dietary	O	3964
origin	O	3964
,	O	3964
dietary	O	3964
c26	O	3964
0	O	3964
restriction	O	3964
did	O	3964
not	O	3964
produce	O	3964
clear	O	3964
benefit	O	3964
.	O	3964
considerable	O	3967
genetic	O	3967
heterogeneity	O	3967
in	O	3967
g6pd	O	3967
was	O	3967
found	O	3967
in	O	3967
the	O	3967
bulgarian	O	3967
population	O	3967
-	O	3967
14	O	3967
g6pd	O	3967
variants	O	3967
isolated	O	3967
from	O	3967
117	O	3967
hemizygous	O	3967
carriers	O	3967
of	O	3967
g6pd	B-Disease	3967
deficiency	I-Disease	3967
.	O	3967
clinical	O	3971
use	O	3971
of	O	3971
dna	O	3971
markers	O	3971
linked	O	3971
to	O	3971
the	O	3971
gene	O	3971
for	O	3971
duchenne	B-Disease	3971
muscular	I-Disease	3971
dystrophy	I-Disease	3971
.	O	3971
seventy	O	3972
families	O	3972
with	O	3972
duchenne	B-Disease	3972
muscular	I-Disease	3972
dystrophy	I-Disease	3972
(	O	3972
dmd	B-Disease	3972
)	O	3972
known	O	3972
to	O	3972
the	O	3972
institute	O	3972
of	O	3972
child	O	3972
health	O	3972
fall	O	3972
into	O	3972
three	O	3972
categories	O	3972
with	O	3972
respect	O	3972
to	O	3972
potential	O	3972
linkage	O	3972
analysis	O	3972
with	O	3972
the	O	3972
x	O	3972
chromosome	O	3972
dna	O	3972
markers	O	3972
rc8	O	3972
and	O	3972
l1	O	3972
.	O	3972
28	O	3973
that	O	3973
bridge	O	3973
the	O	3973
dmd	B-Disease	3973
gene	O	3973
.	O	3973
here	O	3975
prediction	O	3975
and	O	3975
exclusion	O	3975
of	O	3975
dmd	B-Disease	3975
gene	O	3975
transmission	O	3975
may	O	3975
be	O	3975
possible	O	3975
,	O	3975
the	O	3975
accuracy	O	3975
being	O	3975
dependent	O	3975
on	O	3975
the	O	3975
closeness	O	3975
of	O	3975
the	O	3975
linkage	O	3975
of	O	3975
the	O	3975
dna	O	3975
marker	O	3975
(	O	3975
s	O	3975
)	O	3975
to	O	3975
the	O	3975
dmd	B-Disease	3975
gene	O	3975
;	O	3975
an	O	3975
illustrative	O	3975
case	O	3975
is	O	3975
reported	O	3975
.	O	3975
given	O	3977
an	O	3977
informative	O	3977
restriction	O	3977
fragment	O	3977
length	O	3977
polymorphism	O	3977
(	O	3977
rflp	O	3977
)	O	3977
,	O	3977
the	O	3977
probability	O	3977
that	O	3977
the	O	3977
boy	O	3977
represents	O	3977
a	O	3977
new	O	3977
mutation	O	3977
can	O	3977
be	O	3977
reassessed	O	3977
;	O	3977
it	O	3977
is	O	3977
also	O	3977
possible	O	3977
to	O	3977
exclude	O	3977
the	O	3977
dmd	B-Disease	3977
gene	O	3977
in	O	3977
a	O	3977
sister	O	3977
.	O	3977
here	O	3979
exclusion	O	3979
of	O	3979
the	O	3979
dmd	B-Disease	3979
gene	O	3979
in	O	3979
a	O	3979
sister	O	3979
may	O	3979
be	O	3979
possible	O	3979
.	O	3979
the	O	3981
linkage	O	3981
analysis	O	3981
required	O	3981
is	O	3981
described	O	3981
,	O	3981
and	O	3981
the	O	3981
need	O	3981
to	O	3981
check	O	3981
dmd	B-Disease	3981
families	O	3981
for	O	3981
informative	O	3981
rflps	O	3981
is	O	3981
stressed	O	3981
.	O	3981
family	O	3982
studies	O	3982
in	O	3982
bechterew	B-Disease	3982
'	I-Disease	3982
s	I-Disease	3982
syndrome	I-Disease	3982
(	O	3982
ankylosing	B-Disease	3982
spondylitis	I-Disease	3982
)	O	3982
iii	O	3982
.	O	3982
the	O	3984
results	O	3984
of	O	3984
segregation	O	3984
analyses	O	3984
in	O	3984
75	O	3984
families	O	3984
where	O	3984
the	O	3984
proband	O	3984
had	O	3984
ankylosing	B-Disease	3984
spondylitis	I-Disease	3984
,	O	3984
are	O	3984
presented	O	3984
.	O	3984
the	O	3987
results	O	3987
were	O	3987
in	O	3987
agreement	O	3987
with	O	3987
our	O	3987
hypothesis	O	3987
that	O	3987
ankylosing	B-Disease	3987
spondylitis	I-Disease	3987
is	O	3987
part	O	3987
of	O	3987
a	O	3987
syndrome	O	3987
where	O	3987
different	O	3987
genetic	O	3987
factors	O	3987
interact	O	3987
.	O	3987
such	O	3988
known	O	3988
factors	O	3988
are	O	3988
hla	O	3988
b27	O	3988
associated	O	3988
disease	O	3988
susceptibility	O	3988
,	O	3988
susceptibility	O	3988
to	O	3988
psoriatic	B-Disease	3988
arthropathy	I-Disease	3988
and	O	3988
susceptibility	O	3988
to	O	3988
entero	B-Disease	3988
-	I-Disease	3988
arthropathy	I-Disease	3988
.	O	3988
radiographical	O	3989
sacro	B-Disease	3989
-	I-Disease	3989
iliitis	I-Disease	3989
was	O	3989
restricted	O	3989
to	O	3989
hla	O	3989
b27	O	3989
positive	O	3989
relatives	O	3989
,	O	3989
and	O	3989
was	O	3989
more	O	3989
frequently	O	3989
found	O	3989
in	O	3989
relatives	O	3989
to	O	3989
probands	O	3989
with	O	3989
psoriasis	B-Disease	3989
than	O	3989
in	O	3989
relatives	O	3989
to	O	3989
probands	O	3989
without	O	3989
psoriasis	B-Disease	3989
.	O	3989
the	O	3992
phenotypic	O	3992
expressions	O	3992
of	O	3992
the	O	3992
different	O	3992
genetic	O	3992
predispositions	O	3992
involved	O	3992
,	O	3992
include	O	3992
sacro	B-Disease	3992
-	I-Disease	3992
iliitis	I-Disease	3992
,	O	3992
psoriasis	B-Disease	3992
,	O	3992
acute	B-Disease	3992
anterior	I-Disease	3992
uveitis	I-Disease	3992
,	O	3992
peripheral	O	3992
arthropathy	B-Disease	3992
and	O	3992
inflammatory	B-Disease	3992
bowel	I-Disease	3992
disease	I-Disease	3992
.	O	3992
we	O	3993
suggest	O	3993
the	O	3993
descriptive	O	3993
name	O	3993
hereditary	B-Disease	3993
multifocal	I-Disease	3993
relapsing	I-Disease	3993
inflammation	I-Disease	3993
(	O	3993
hemri	B-Disease	3993
)	O	3993
for	O	3993
this	O	3993
syndrome	O	3993
.	O	3993
ankylosing	B-Disease	3994
spondylitis	I-Disease	3994
,	O	3994
psoriatic	B-Disease	3994
arthropathy	I-Disease	3994
and	O	3994
entero	B-Disease	3994
-	I-Disease	3994
arthropathy	I-Disease	3994
may	O	3994
be	O	3994
regarded	O	3994
as	O	3994
clinical	O	3994
sub	O	3994
-	O	3994
types	O	3994
of	O	3994
the	O	3994
syndrome	O	3994
.	O	3994
.	O	3994
prader	B-Disease	3995
-	I-Disease	3995
willi	I-Disease	3995
syndrome	I-Disease	3995
and	O	3995
chromosome	O	3995
15	O	3995
.	O	3995
a	O	3997
chromosome	B-Disease	3997
15	I-Disease	3997
anomaly	I-Disease	3997
was	O	3997
observed	O	3997
in	O	3997
12	O	3997
of	O	3997
20	O	3997
patients	O	3997
,	O	3997
17	O	3997
of	O	3997
whom	O	3997
were	O	3997
clinically	O	3997
suspected	O	3997
of	O	3997
having	O	3997
prader	B-Disease	3997
-	I-Disease	3997
willi	I-Disease	3997
syndrome	I-Disease	3997
(	O	3997
pws	B-Disease	3997
)	O	3997
.	O	3997
the	O	3998
clinical	O	3998
features	O	3998
of	O	3998
eight	O	3998
cases	O	3998
with	O	3998
15q11	O	3998
-	O	3998
12	O	3998
deletion	O	3998
were	O	3998
very	O	3998
similar	O	3998
to	O	3998
those	O	3998
originally	O	3998
described	O	3998
in	O	3998
pws	B-Disease	3998
.	O	3998
on	O	3999
the	O	3999
other	O	3999
hand	O	3999
,	O	3999
the	O	3999
group	O	3999
of	O	3999
normal	O	3999
karyotype	O	3999
patients	O	3999
is	O	3999
heterogeneous	O	3999
,	O	3999
and	O	3999
their	O	3999
features	O	3999
do	O	3999
not	O	3999
strictly	O	3999
correspond	O	3999
to	O	3999
the	O	3999
clinical	O	3999
definition	O	3999
of	O	3999
pws	B-Disease	3999
.	O	3999
however	O	4000
,	O	4000
the	O	4000
hypothesis	O	4000
that	O	4000
pws	B-Disease	4000
is	O	4000
associated	O	4000
with	O	4000
deletion	O	4000
of	O	4000
15q11	O	4000
-	O	4000
12	O	4000
can	O	4000
neither	O	4000
explain	O	4000
the	O	4000
apparently	O	4000
balanced	O	4000
translocations	O	4000
of	O	4000
chromosome	O	4000
15	O	4000
nor	O	4000
account	O	4000
for	O	4000
the	O	4000
small	O	4000
supernumerary	O	4000
metacentric	O	4000
chromosomes	O	4000
corresponding	O	4000
to	O	4000
an	O	4000
isochromosome	O	4000
15	O	4000
for	O	4000
band	O	4000
15q11	O	4000
observed	O	4000
in	O	4000
some	O	4000
cases	O	4000
.	O	4000
.	O	4000
the	O	4001
tay	B-Disease	4001
-	I-Disease	4001
sachs	I-Disease	4001
disease	I-Disease	4001
gene	O	4001
in	O	4001
north	O	4001
american	O	4001
jewish	O	4001
populations	O	4001
:	O	4001
geographic	O	4001
variations	O	4001
and	O	4001
origin	O	4001
.	O	4001
from	O	4002
data	O	4002
collected	O	4002
in	O	4002
a	O	4002
north	O	4002
american	O	4002
tay	B-Disease	4002
-	I-Disease	4002
sachs	I-Disease	4002
disease	I-Disease	4002
(	O	4002
tsd	B-Disease	4002
)	O	4002
heterozygote	O	4002
screening	O	4002
program	O	4002
,	O	4002
the	O	4002
tsd	B-Disease	4002
carrier	O	4002
frequency	O	4002
among	O	4002
46	O	4002
,	O	4002
304	O	4002
jewish	O	4002
individuals	O	4002
was	O	4002
found	O	4002
to	O	4002
be	O	4002
.	O	4002
this	O	4004
frequency	O	4004
is	O	4004
consistent	O	4004
with	O	4004
earlier	O	4004
estimates	O	4004
based	O	4004
on	O	4004
tsd	B-Disease	4004
incidence	O	4004
data	O	4004
.	O	4004
tsd	B-Disease	4005
carrier	O	4005
frequencies	O	4005
were	O	4005
then	O	4005
examined	O	4005
by	O	4005
single	O	4005
country	O	4005
and	O	4005
single	O	4005
region	O	4005
of	O	4005
origin	O	4005
in	O	4005
28	O	4005
,	O	4005
029	O	4005
jews	O	4005
within	O	4005
this	O	4005
sample	O	4005
for	O	4005
whom	O	4005
such	O	4005
data	O	4005
were	O	4005
available	O	4005
for	O	4005
analysis	O	4005
.	O	4005
jews	O	4006
with	O	4006
polish	O	4006
and	O	4006
/	O	4006
or	O	4006
russian	O	4006
ancestry	O	4006
constituted	O	4006
88	O	4006
%	O	4006
of	O	4006
this	O	4006
sample	O	4006
and	O	4006
had	O	4006
a	O	4006
tsd	B-Disease	4006
carrier	O	4006
frequency	O	4006
of	O	4006
.	O	4006
no	O	4008
tsd	B-Disease	4008
carriers	O	4008
were	O	4008
observed	O	4008
among	O	4008
the	O	4008
166	O	4008
jews	O	4008
of	O	4008
near	O	4008
eastern	O	4008
origins	O	4008
.	O	4008
relative	O	4009
to	O	4009
jews	O	4009
of	O	4009
polish	O	4009
and	O	4009
russian	O	4009
origins	O	4009
,	O	4009
there	O	4009
was	O	4009
at	O	4009
least	O	4009
a	O	4009
twofold	O	4009
increase	O	4009
in	O	4009
the	O	4009
tsd	B-Disease	4009
carrier	O	4009
frequency	O	4009
in	O	4009
jews	O	4009
of	O	4009
austrian	O	4009
,	O	4009
hungarian	O	4009
,	O	4009
and	O	4009
czechoslovakian	O	4009
origins	O	4009
(	O	4009
p	O	4009
less	O	4009
than	O	4009
.	O	4009
005	O	4009
)	O	4009
.	O	4009
these	O	4010
findings	O	4010
suggest	O	4010
that	O	4010
the	O	4010
tsd	B-Disease	4010
gene	O	4010
proliferated	O	4010
among	O	4010
the	O	4010
antecedents	O	4010
of	O	4010
modern	O	4010
ashkenazi	O	4010
jewry	O	4010
after	O	4010
the	O	4010
second	O	4010
diaspora	O	4010
(	O	4010
70	O	4010
a	O	4010
.	O	4010
d	O	4010
.	O	4010
)	O	4010
and	O	4010
before	O	4010
their	O	4010
major	O	4010
migrations	O	4010
to	O	4010
regions	O	4010
of	O	4010
poland	O	4010
and	O	4010
russia	O	4010
(	O	4010
before	O	4010
1100	O	4010
a	O	4010
.	O	4010
d	O	4010
.	O	4010
)	O	4010
.	O	4010
human	O	4011
deficiency	B-Disease	4011
of	I-Disease	4011
the	I-Disease	4011
sixth	I-Disease	4011
component	I-Disease	4011
of	I-Disease	4011
complement	I-Disease	4011
in	O	4011
a	O	4011
patient	O	4011
with	O	4011
meningococcal	B-Disease	4011
meningitis	I-Disease	4011
and	O	4011
no	O	4011
haemostasis	B-Disease	4011
abnormality	I-Disease	4011
.	O	4011
a	O	4012
case	O	4012
of	O	4012
human	O	4012
complete	O	4012
c6	B-Disease	4012
deficiency	I-Disease	4012
is	O	4012
reported	O	4012
.	O	4012
the	O	4013
patient	O	4013
,	O	4013
a	O	4013
31	O	4013
year	O	4013
old	O	4013
white	O	4013
male	O	4013
,	O	4013
was	O	4013
seen	O	4013
on	O	4013
the	O	4013
occasion	O	4013
of	O	4013
an	O	4013
isolated	O	4013
episode	O	4013
of	O	4013
meningococcal	B-Disease	4013
meningitis	I-Disease	4013
.	O	4013
no	O	4015
hemostatic	B-Disease	4015
abnormalities	I-Disease	4015
were	O	4015
observed	O	4015
.	O	4015
.	O	4015
absence	B-Disease	4016
of	I-Disease	4016
the	I-Disease	4016
seventh	I-Disease	4016
component	I-Disease	4016
of	I-Disease	4016
complement	I-Disease	4016
in	O	4016
a	O	4016
patient	O	4016
with	O	4016
chronic	B-Disease	4016
meningococcemia	I-Disease	4016
presenting	O	4016
as	O	4016
vasculitis	B-Disease	4016
.	O	4016
a	O	4017
previously	O	4017
healthy	O	4017
40	O	4017
-	O	4017
year	O	4017
-	O	4017
old	O	4017
man	O	4017
presenting	O	4017
with	O	4017
fever	B-Disease	4017
,	O	4017
arthritis	B-Disease	4017
,	O	4017
and	O	4017
cutaneous	B-Disease	4017
vasculitis	I-Disease	4017
was	O	4017
found	O	4017
to	O	4017
have	O	4017
chronic	B-Disease	4017
meningococcemia	I-Disease	4017
.	O	4017
evaluation	O	4018
of	O	4018
his	O	4018
complement	O	4018
system	O	4018
showed	O	4018
an	O	4018
absence	O	4018
of	O	4018
functional	O	4018
and	O	4018
antigenic	O	4018
c7	O	4018
,	O	4018
compatible	O	4018
with	O	4018
a	O	4018
complete	O	4018
deficiency	B-Disease	4018
of	I-Disease	4018
the	I-Disease	4018
seventh	I-Disease	4018
component	I-Disease	4018
of	I-Disease	4018
complement	I-Disease	4018
.	O	4018
study	O	4019
of	O	4019
the	O	4019
patients	O	4019
family	O	4019
spanning	O	4019
four	O	4019
generations	O	4019
showed	O	4019
heterozygous	O	4019
deficiency	B-Disease	4019
of	I-Disease	4019
c7	I-Disease	4019
in	O	4019
five	O	4019
members	O	4019
.	O	4019
chronic	B-Disease	4020
neisserial	I-Disease	4020
infection	I-Disease	4020
can	O	4020
be	O	4020
associated	O	4020
with	O	4020
c7	B-Disease	4020
deficiency	I-Disease	4020
and	O	4020
must	O	4020
be	O	4020
distinguished	O	4020
from	O	4020
other	O	4020
causes	O	4020
of	O	4020
cutaneous	B-Disease	4020
vasculitis	I-Disease	4020
.	O	4020
.	O	4020
familial	B-Disease	4021
discoid	I-Disease	4021
lupus	I-Disease	4021
erythematosus	I-Disease	4021
associated	O	4021
with	O	4021
heterozygote	O	4021
c2	B-Disease	4021
deficiency	I-Disease	4021
.	O	4021
two	O	4022
siblings	O	4022
with	O	4022
chronic	B-Disease	4022
discoid	I-Disease	4022
lupus	I-Disease	4022
erythematosus	I-Disease	4022
and	O	4022
several	O	4022
family	O	4022
members	O	4022
were	O	4022
found	O	4022
with	O	4022
heterozygous	O	4022
c2	B-Disease	4022
deficiency	I-Disease	4022
.	O	4022
linkage	O	4024
studies	O	4024
in	O	4024
this	O	4024
family	O	4024
suggested	O	4024
a	O	4024
close	O	4024
linkage	O	4024
between	O	4024
the	O	4024
c2	B-Disease	4024
deficiency	I-Disease	4024
gene	O	4024
and	O	4024
genes	O	4024
coding	O	4024
for	O	4024
b18	O	4024
,	O	4024
dw2	O	4024
,	O	4024
and	O	4024
bfs	O	4024
antigens	O	4024
.	O	4024
severe	B-Disease	4026
-	I-Disease	4026
glucose	I-Disease	4026
-	I-Disease	4026
6	I-Disease	4026
-	I-Disease	4026
phosphate	I-Disease	4026
dehydrogenase	I-Disease	4026
(	I-Disease	4026
g6pd	I-Disease	4026
)	I-Disease	4026
deficiency	I-Disease	4026
associated	O	4026
with	O	4026
chronic	O	4026
hemolytic	B-Disease	4026
anemia	I-Disease	4026
,	O	4026
granulocyte	B-Disease	4026
dysfunction	I-Disease	4026
,	O	4026
and	O	4026
increased	O	4026
susceptibility	O	4026
to	O	4026
infections	O	4026
:	O	4026
description	O	4026
of	O	4026
a	O	4026
new	O	4026
molecular	O	4026
variant	O	4026
(	O	4026
g6pd	O	4026
barcelona	O	4026
)	O	4026
.	O	4026
molecular	O	4027
,	O	4027
kinetic	O	4027
,	O	4027
and	O	4027
functional	O	4027
studies	O	4027
were	O	4027
carried	O	4027
out	O	4027
on	O	4027
erythrocytes	O	4027
and	O	4027
leukocytes	O	4027
in	O	4027
a	O	4027
spanish	O	4027
male	O	4027
with	O	4027
g6pd	B-Disease	4027
deficiency	I-Disease	4027
,	O	4027
congenital	B-Disease	4027
nonspherocytic	I-Disease	4027
hemolytic	I-Disease	4027
anemia	I-Disease	4027
(	O	4027
cnsha	B-Disease	4027
)	O	4027
,	O	4027
and	O	4027
increased	O	4027
susceptibility	O	4027
to	O	4027
infections	O	4027
.	O	4027
the	O	4033
molecular	O	4033
characteristics	O	4033
of	O	4033
g6pd	O	4033
in	O	4033
the	O	4033
patient	O	4033
differed	O	4033
from	O	4033
those	O	4033
of	O	4033
all	O	4033
previously	O	4033
reported	O	4033
variants	O	4033
associated	O	4033
with	O	4033
cnsha	B-Disease	4033
,	O	4033
so	O	4033
the	O	4033
present	O	4033
variant	O	4033
was	O	4033
provisionally	O	4033
called	O	4033
g6pd	O	4033
barcelona	O	4033
to	O	4033
distinguish	O	4033
it	O	4033
from	O	4033
other	O	4033
g6pd	O	4033
variants	O	4033
previously	O	4033
described	O	4033
.	O	4033
possible	O	4034
mechanisms	O	4034
for	O	4034
the	O	4034
severe	O	4034
deficiency	B-Disease	4034
of	I-Disease	4034
g6pd	I-Disease	4034
in	O	4034
erythrocytes	O	4034
and	O	4034
granulocytes	O	4034
was	O	4034
investigated	O	4034
by	O	4034
studies	O	4034
on	O	4034
the	O	4034
immunologic	O	4034
specific	O	4034
activity	O	4034
of	O	4034
the	O	4034
mutant	O	4034
enzyme	O	4034
.	O	4034
glucose	B-Disease	4035
-	I-Disease	4035
6	I-Disease	4035
-	I-Disease	4035
phosphate	I-Disease	4035
dehydrogenase	I-Disease	4035
deficiency	I-Disease	4035
in	O	4035
papua	O	4035
new	O	4035
guinea	O	4035
.	O	4035
twenty	O	4038
-	O	4038
six	O	4038
g6pd	B-Disease	4038
deficient	I-Disease	4038
individuals	O	4038
were	O	4038
identified	O	4038
.	O	4038
this	O	4040
study	O	4040
illustrates	O	4040
the	O	4040
extreme	O	4040
heterogeneity	O	4040
of	O	4040
g6pd	B-Disease	4040
deficiency	I-Disease	4040
among	O	4040
the	O	4040
people	O	4040
of	O	4040
papua	O	4040
new	O	4040
guinea	O	4040
.	O	4040
.	O	4040
heterogeneity	O	4041
of	O	4041
mediterranean	O	4041
type	O	4041
glucose	B-Disease	4041
-	I-Disease	4041
6	I-Disease	4041
-	I-Disease	4041
phosphate	I-Disease	4041
dehydrogenase	I-Disease	4041
(	I-Disease	4041
g6pd	I-Disease	4041
)	I-Disease	4041
deficiency	I-Disease	4041
in	O	4041
spain	O	4041
and	O	4041
description	O	4041
of	O	4041
two	O	4041
new	O	4041
variants	O	4041
associated	O	4041
with	O	4041
favism	B-Disease	4041
.	O	4041
subjects	O	4046
were	O	4046
from	O	4046
multiple	O	4046
geographic	O	4046
regions	O	4046
within	O	4046
spain	O	4046
,	O	4046
and	O	4046
all	O	4046
suffered	O	4046
from	O	4046
hemolytic	B-Disease	4046
anemia	I-Disease	4046
,	O	4046
either	O	4046
acute	O	4046
(	O	4046
34	O	4046
cases	O	4046
)	O	4046
or	O	4046
chronic	O	4046
nonspherocytic	O	4046
(	O	4046
2	O	4046
cases	O	4046
)	O	4046
.	O	4046
the	O	4051
present	O	4051
study	O	4051
constitutes	O	4051
the	O	4051
first	O	4051
attempt	O	4051
to	O	4051
characterize	O	4051
the	O	4051
deficient	B-Disease	4051
g6pd	I-Disease	4051
variants	O	4051
found	O	4051
in	O	4051
spain	O	4051
and	O	4051
supplies	O	4051
new	O	4051
data	O	4051
on	O	4051
the	O	4051
relationship	O	4051
between	O	4051
molecular	O	4051
characteristics	O	4051
of	O	4051
deficient	O	4051
variants	O	4051
and	O	4051
their	O	4051
clinical	O	4051
manifestations	O	4051
.	O	4051
the	O	4052
most	O	4052
important	O	4052
findings	O	4052
can	O	4052
be	O	4052
summarized	O	4052
as	O	4052
follows	O	4052
(	O	4052
1	O	4052
)	O	4052
the	O	4052
spanish	O	4052
population	O	4052
is	O	4052
characterized	O	4052
by	O	4052
an	O	4052
important	O	4052
heterogeneity	O	4052
in	O	4052
g6pd	B-Disease	4052
deficiency	I-Disease	4052
.	O	4052
(	O	4054
3	O	4054
)	O	4054
favism	B-Disease	4054
has	O	4054
been	O	4054
observed	O	4054
associated	O	4054
with	O	4054
all	O	4054
kinds	O	4054
of	O	4054
variants	O	4054
described	O	4054
here	O	4054
.	O	4054
(	O	4055
4	O	4055
)	O	4055
g6pd	O	4055
betica	O	4055
,	O	4055
which	O	4055
is	O	4055
the	O	4055
most	O	4055
frequent	O	4055
variant	O	4055
found	O	4055
in	O	4055
subjects	O	4055
of	O	4055
southern	O	4055
spanish	O	4055
origin	O	4055
,	O	4055
has	O	4055
been	O	4055
observed	O	4055
associated	O	4055
with	O	4055
favism	B-Disease	4055
in	O	4055
all	O	4055
cases	O	4055
except	O	4055
one	O	4055
.	O	4055
a	O	4056
new	O	4056
glucose	O	4056
-	O	4056
6	O	4056
-	O	4056
phosphate	O	4056
dehydrogenase	O	4056
variant	O	4056
(	O	4056
g6pd	O	4056
nagano	O	4056
)	O	4056
associated	O	4056
with	O	4056
congenital	B-Disease	4056
hemolytic	I-Disease	4056
anemia	I-Disease	4056
.	O	4056
a	O	4057
new	O	4057
glucose	O	4057
-	O	4057
6	O	4057
-	O	4057
phosphate	O	4057
dehydrogenase	O	4057
(	O	4057
g6pd	O	4057
)	O	4057
variant	O	4057
associated	O	4057
with	O	4057
chronic	B-Disease	4057
nonspherocytic	I-Disease	4057
hemolytic	I-Disease	4057
anemia	I-Disease	4057
was	O	4057
reported	O	4057
.	O	4057
the	O	4058
patient	O	4058
,	O	4058
a	O	4058
6	O	4058
-	O	4058
year	O	4058
-	O	4058
old	O	4058
japanese	O	4058
male	O	4058
,	O	4058
was	O	4058
noticed	O	4058
to	O	4058
have	O	4058
hemolytic	B-Disease	4058
anemia	I-Disease	4058
soon	O	4058
after	O	4058
birth	O	4058
,	O	4058
and	O	4058
a	O	4058
diagnosis	O	4058
of	O	4058
g6pd	B-Disease	4058
deficiency	I-Disease	4058
was	O	4058
made	O	4058
at	O	4058
the	O	4058
age	O	4058
of	O	4058
2	O	4058
.	O	4058
he	O	4059
had	O	4059
episodes	O	4059
of	O	4059
hemolytic	B-Disease	4059
crisis	I-Disease	4059
several	O	4059
times	O	4059
after	O	4059
upper	B-Disease	4059
respiratory	I-Disease	4059
infection	I-Disease	4059
.	O	4059
infection	O	4064
-	O	4064
induced	O	4064
hemolysis	B-Disease	4064
and	O	4064
chronic	B-Disease	4064
hemolytic	I-Disease	4064
anemia	I-Disease	4064
seem	O	4064
to	O	4064
be	O	4064
due	O	4064
to	O	4064
markedly	O	4064
impaired	O	4064
enzyme	O	4064
activity	O	4064
and	O	4064
thermal	O	4064
instability	O	4064
.	O	4064
heterozygous	O	4065
c2	B-Disease	4065
-	I-Disease	4065
deficiency	I-Disease	4065
and	O	4065
myasthenia	B-Disease	4065
gravis	I-Disease	4065
.	O	4065
complement	B-Disease	4066
deficiency	I-Disease	4066
states	O	4066
in	O	4066
myasthenia	B-Disease	4066
gravis	I-Disease	4066
(	O	4066
mg	B-Disease	4066
)	O	4066
have	O	4066
not	O	4066
been	O	4066
reported	O	4066
previously	O	4066
.	O	4066
we	O	4067
describe	O	4067
a	O	4067
19	O	4067
-	O	4067
year	O	4067
-	O	4067
old	O	4067
woman	O	4067
with	O	4067
typical	O	4067
mg	B-Disease	4067
and	O	4067
heterozygous	O	4067
c2	B-Disease	4067
deficiency	I-Disease	4067
,	O	4067
along	O	4067
with	O	4067
hla	O	4067
typing	O	4067
of	O	4067
the	O	4067
patient	O	4067
and	O	4067
her	O	4067
immediate	O	4067
family	O	4067
.	O	4067
.	O	4067
adrenoleukodystrophy	B-Disease	4068
:	O	4068
increased	O	4068
plasma	O	4068
content	O	4068
of	O	4068
saturated	O	4068
very	O	4068
long	O	4068
chain	O	4068
fatty	O	4068
acids	O	4068
.	O	4068
with	O	4069
a	O	4069
new	O	4069
method	O	4069
we	O	4069
measured	O	4069
the	O	4069
saturated	O	4069
very	O	4069
long	O	4069
chain	O	4069
fatty	O	4069
acids	O	4069
in	O	4069
the	O	4069
plasma	O	4069
of	O	4069
adrenoleukodystrophy	B-Disease	4069
(	O	4069
ald	B-Disease	4069
)	O	4069
hemizygotes	O	4069
,	O	4069
ald	B-Disease	4069
heterozygotes	O	4069
,	O	4069
and	O	4069
controls	O	4069
.	O	4069
ald	B-Disease	4070
hemizygotes	O	4070
showed	O	4070
increased	O	4070
levels	O	4070
of	O	4070
hexacosanoate	O	4070
(	O	4070
c26	O	4070
fatty	O	4070
acid	O	4070
)	O	4070
which	O	4070
represented	O	4070
0	O	4070
.	O	4070
c26	O	4076
levels	O	4076
were	O	4076
also	O	4076
increased	O	4076
in	O	4076
most	O	4076
ald	B-Disease	4076
heterozygotes	O	4076
,	O	4076
with	O	4076
a	O	4076
mean	O	4076
level	O	4076
0	O	4076
.	O	4076
abnormal	O	4080
high	O	4080
density	O	4080
lipoproteins	O	4080
in	O	4080
cerebrotendinous	B-Disease	4080
xanthomatosis	I-Disease	4080
.	O	4080
the	O	4081
plasma	O	4081
lipoprotein	O	4081
profiles	O	4081
and	O	4081
high	O	4081
density	O	4081
lipoproteins	O	4081
(	O	4081
hdl	O	4081
)	O	4081
were	O	4081
characterized	O	4081
in	O	4081
patients	O	4081
with	O	4081
the	O	4081
genetic	B-Disease	4081
disease	I-Disease	4081
cerebrotendinous	B-Disease	4081
xanthomatosis	I-Disease	4081
(	O	4081
ctx	B-Disease	4081
)	O	4081
.	O	4081
abnormalities	B-Disease	4082
in	I-Disease	4082
the	I-Disease	4082
hdl	I-Disease	4082
may	O	4082
contribute	O	4082
to	O	4082
their	O	4082
increased	O	4082
atherogenesis	O	4082
and	O	4082
excessive	O	4082
deposits	O	4082
of	O	4082
tissue	O	4082
sterols	O	4082
in	O	4082
the	O	4082
presence	O	4082
of	O	4082
low	O	4082
or	O	4082
low	O	4082
-	O	4082
normal	O	4082
concentrations	O	4082
of	O	4082
plasma	O	4082
cholesterol	O	4082
(	O	4082
165	O	4082
+	O	4082
/	O	4082
-	O	4082
25	O	4082
mg	O	4082
/	O	4082
dl	O	4082
)	O	4082
and	O	4082
low	O	4082
density	O	4082
lipoproteins	O	4082
(	O	4082
ldl	O	4082
)	O	4082
.	O	4082
the	O	4083
mean	O	4083
hdl	O	4083
-	O	4083
cholesterol	O	4083
concentration	O	4083
in	O	4083
the	O	4083
ctx	B-Disease	4083
plasmas	O	4083
was	O	4083
14	O	4083
.	O	4083
the	O	4088
ratio	O	4088
of	O	4088
apoprotein	O	4088
(	O	4088
apo	O	4088
)	O	4088
to	O	4088
total	O	4088
cholesterol	O	4088
in	O	4088
the	O	4088
hdl	O	4088
of	O	4088
ctx	B-Disease	4088
was	O	4088
two	O	4088
to	O	4088
three	O	4088
times	O	4088
greater	O	4088
than	O	4088
normal	O	4088
.	O	4088
in	O	4089
the	O	4089
ctx	B-Disease	4089
hdl	O	4089
,	O	4089
the	O	4089
ratio	O	4089
of	O	4089
apoai	O	4089
to	O	4089
apoaii	O	4089
was	O	4089
high	O	4089
,	O	4089
the	O	4089
proportion	O	4089
of	O	4089
apoc	O	4089
low	O	4089
,	O	4089
and	O	4089
a	O	4089
normally	O	4089
minor	O	4089
form	O	4089
of	O	4089
apoai	O	4089
increased	O	4089
relative	O	4089
to	O	4089
other	O	4089
forms	O	4089
.	O	4089
the	O	4091
abnormalities	O	4091
in	O	4091
lipoprotein	O	4091
distribution	O	4091
profile	O	4091
and	O	4091
composition	O	4091
of	O	4091
the	O	4091
plasma	O	4091
hdl	O	4091
result	O	4091
from	O	4091
metabolic	O	4091
defects	O	4091
that	O	4091
are	O	4091
not	O	4091
understood	O	4091
but	O	4091
may	O	4091
be	O	4091
linked	O	4091
to	O	4091
the	O	4091
genetic	B-Disease	4091
defect	I-Disease	4091
in	O	4091
bile	O	4091
acid	O	4091
synthesis	O	4091
in	O	4091
ctx	B-Disease	4091
.	O	4091
genetics	O	4093
of	O	4093
cerebrotendinous	B-Disease	4093
xanthomatosis	I-Disease	4093
(	O	4093
ctx	B-Disease	4093
)	O	4093
:	O	4093
an	O	4093
autosomal	O	4093
recessive	O	4093
trait	O	4093
with	O	4093
high	O	4093
gene	O	4093
frequency	O	4093
in	O	4093
sephardim	O	4093
of	O	4093
moroccan	O	4093
origin	O	4093
.	O	4093
we	O	4094
described	O	4094
6	O	4094
patients	O	4094
(	O	4094
from	O	4094
3	O	4094
families	O	4094
)	O	4094
affected	O	4094
with	O	4094
cerebrotendinous	B-Disease	4094
xanthomatosis	I-Disease	4094
(	O	4094
ctx	B-Disease	4094
)	O	4094
.	O	4094
in	O	4096
view	O	4096
of	O	4096
the	O	4096
small	O	4096
number	O	4096
of	O	4096
ctx	B-Disease	4096
patients	O	4096
diagnosed	O	4096
in	O	4096
the	O	4096
world	O	4096
(	O	4096
a	O	4096
total	O	4096
of	O	4096
50	O	4096
including	O	4096
our	O	4096
6	O	4096
patients	O	4096
)	O	4096
,	O	4096
we	O	4096
are	O	4096
probably	O	4096
dealing	O	4096
with	O	4096
an	O	4096
ethnic	O	4096
subgroup	O	4096
with	O	4096
a	O	4096
high	O	4096
ctx	O	4096
gene	O	4096
frequency	O	4096
,	O	4096
which	O	4096
we	O	4096
have	O	4096
estimated	O	4096
to	O	4096
be	O	4096
1	O	4096
/	O	4096
108	O	4096
.	O	4096
since	O	4097
there	O	4097
are	O	4097
differences	O	4097
in	O	4097
expression	O	4097
in	O	4097
this	O	4097
disease	O	4097
,	O	4097
we	O	4097
recommend	O	4097
cholestanol	O	4097
study	O	4097
in	O	4097
cases	O	4097
of	O	4097
undiagnosed	O	4097
cataract	B-Disease	4097
or	O	4097
tendinous	B-Disease	4097
xanthomas	I-Disease	4097
in	O	4097
childhood	O	4097
or	O	4097
early	O	4097
adolescence	O	4097
.	O	4097
the	O	4098
diagnosis	O	4098
in	O	4098
ctx	B-Disease	4098
is	O	4098
important	O	4098
not	O	4098
only	O	4098
for	O	4098
genetic	O	4098
counseling	O	4098
,	O	4098
but	O	4098
also	O	4098
in	O	4098
veiw	O	4098
of	O	4098
possible	O	4098
treatment	O	4098
.	O	4098
.	O	4098
all	O	4101
of	O	4101
them	O	4101
were	O	4101
found	O	4101
in	O	4101
italian	O	4101
males	O	4101
and	O	4101
all	O	4101
were	O	4101
associated	O	4101
with	O	4101
enzyme	B-Disease	4101
deficiency	I-Disease	4101
,	O	4101
but	O	4101
only	O	4101
two	O	4101
with	O	4101
signs	O	4101
of	O	4101
haemolysis	B-Disease	4101
.	O	4101
these	O	4102
and	O	4102
other	O	4102
variants	O	4102
reported	O	4102
in	O	4102
the	O	4102
literature	O	4102
,	O	4102
which	O	4102
must	O	4102
thus	O	4102
far	O	4102
be	O	4102
regarded	O	4102
as	O	4102
sporadic	O	4102
,	O	4102
are	O	4102
found	O	4102
to	O	4102
map	O	4102
in	O	4102
parts	O	4102
of	O	4102
italy	O	4102
where	O	4102
common	O	4102
types	O	4102
of	O	4102
g6pd	B-Disease	4102
deficiency	I-Disease	4102
are	O	4102
also	O	4102
prevalent	O	4102
.	O	4102
.	O	4102
ten	O	4104
variants	O	4104
of	O	4104
erythrocyte	O	4104
glucose	O	4104
-	O	4104
6	O	4104
-	O	4104
phosphate	O	4104
dehydrogenase	O	4104
were	O	4104
identified	O	4104
in	O	4104
22	O	4104
patients	O	4104
with	O	4104
g6pd	B-Disease	4104
deficiency	I-Disease	4104
from	O	4104
three	O	4104
districts	O	4104
of	O	4104
bulgaria	O	4104
.	O	4104
nephropathy	B-Disease	4107
in	O	4107
the	O	4107
wiskott	B-Disease	4107
-	I-Disease	4107
aldrich	I-Disease	4107
syndrome	I-Disease	4107
.	O	4107
nephropathy	B-Disease	4108
was	O	4108
detected	O	4108
in	O	4108
five	O	4108
of	O	4108
32	O	4108
patients	O	4108
with	O	4108
the	O	4108
wiskott	B-Disease	4108
-	I-Disease	4108
aldrich	I-Disease	4108
syndrome	I-Disease	4108
who	O	4108
were	O	4108
participating	O	4108
in	O	4108
a	O	4108
study	O	4108
of	O	4108
transfer	O	4108
factor	O	4108
(	O	4108
tf	O	4108
)	O	4108
therapy	O	4108
.	O	4108
in	O	4109
two	O	4109
patients	O	4109
,	O	4109
nephropathy	B-Disease	4109
was	O	4109
present	O	4109
before	O	4109
tf	O	4109
and	O	4109
did	O	4109
not	O	4109
appear	O	4109
changed	O	4109
by	O	4109
tf	O	4109
therapy	O	4109
.	O	4109
one	O	4110
of	O	4110
these	O	4110
patients	O	4110
subsequently	O	4110
developed	O	4110
progressive	O	4110
renal	B-Disease	4110
failure	I-Disease	4110
requiring	O	4110
dialysis	O	4110
beginning	O	4110
5	O	4110
1	O	4110
/	O	4110
2	O	4110
years	O	4110
after	O	4110
tf	O	4110
therapy	O	4110
.	O	4110
an	O	4113
additional	O	4113
patient	O	4113
was	O	4113
identified	O	4113
who	O	4113
died	O	4113
with	O	4113
renal	B-Disease	4113
failure	I-Disease	4113
without	O	4113
having	O	4113
received	O	4113
tf	O	4113
.	O	4113
the	O	4114
results	O	4114
suggest	O	4114
that	O	4114
renal	B-Disease	4114
failure	I-Disease	4114
occurs	O	4114
in	O	4114
the	O	4114
wiskott	B-Disease	4114
-	I-Disease	4114
aldrich	I-Disease	4114
syndrome	I-Disease	4114
more	O	4114
frequently	O	4114
than	O	4114
generally	O	4114
recognized	O	4114
and	O	4114
that	O	4114
administration	O	4114
of	O	4114
tf	O	4114
may	O	4114
precipitate	O	4114
or	O	4114
accelerate	O	4114
the	O	4114
renal	B-Disease	4114
disease	I-Disease	4114
in	O	4114
patients	O	4114
with	O	4114
this	O	4114
syndrome	O	4114
.	O	4114
.	O	4114
wiskott	B-Disease	4115
-	I-Disease	4115
aldrich	I-Disease	4115
syndrome	I-Disease	4115
:	O	4115
cellular	O	4115
impairments	O	4115
and	O	4115
their	O	4115
implication	O	4115
for	O	4115
carrier	O	4115
detection	O	4115
.	O	4115
a	O	4116
family	O	4116
in	O	4116
which	O	4116
two	O	4116
male	O	4116
siblings	O	4116
were	O	4116
affected	O	4116
with	O	4116
wiskott	B-Disease	4116
-	I-Disease	4116
aldrich	I-Disease	4116
syndrome	I-Disease	4116
(	O	4116
was	B-Disease	4116
)	O	4116
was	O	4116
studied	O	4116
using	O	4116
g	O	4116
-	O	4116
6	O	4116
-	O	4116
pd	O	4116
isoenzymes	O	4116
as	O	4116
an	O	4116
x	O	4116
-	O	4116
linked	O	4116
marker	O	4116
in	O	4116
order	O	4116
to	O	4116
investigate	O	4116
the	O	4116
nature	O	4116
of	O	4116
cellular	O	4116
abnormalities	O	4116
.	O	4116
isolated	O	4117
peripheral	O	4117
blood	O	4117
cell	O	4117
types	O	4117
from	O	4117
the	O	4117
doubly	O	4117
heterozygous	O	4117
mother	O	4117
of	O	4117
the	O	4117
affected	O	4117
males	O	4117
seemingly	O	4117
failed	O	4117
to	O	4117
express	O	4117
the	O	4117
g	O	4117
-	O	4117
6	O	4117
-	O	4117
pd	O	4117
allele	O	4117
in	O	4117
cis	O	4117
position	O	4117
with	O	4117
the	O	4117
was	B-Disease	4117
allele	O	4117
while	O	4117
her	O	4117
cultured	O	4117
skin	O	4117
fibroblasts	O	4117
expressed	O	4117
both	O	4117
g	O	4117
-	O	4117
6	O	4117
-	O	4117
pd	O	4117
alleles	O	4117
.	O	4117
in	O	4119
vitro	O	4119
culture	O	4119
of	O	4119
hemopoietic	O	4119
progenitor	O	4119
cells	O	4119
of	O	4119
the	O	4119
heterozygous	O	4119
mother	O	4119
showed	O	4119
that	O	4119
the	O	4119
majority	O	4119
of	O	4119
progenitor	O	4119
cells	O	4119
did	O	4119
not	O	4119
express	O	4119
the	O	4119
was	B-Disease	4119
allele	O	4119
.	O	4119
however	O	4120
,	O	4120
a	O	4120
small	O	4120
number	O	4120
of	O	4120
cells	O	4120
expressing	O	4120
the	O	4120
g	O	4120
-	O	4120
6	O	4120
-	O	4120
pd	O	4120
type	O	4120
linked	O	4120
with	O	4120
the	O	4120
was	B-Disease	4120
allele	O	4120
were	O	4120
detected	O	4120
.	O	4120
this	O	4122
observation	O	4122
suggests	O	4122
that	O	4122
selection	O	4122
against	O	4122
cells	O	4122
expressing	O	4122
the	O	4122
wiskott	B-Disease	4122
-	I-Disease	4122
aldrich	I-Disease	4122
defect	I-Disease	4122
takes	O	4122
place	O	4122
in	O	4122
the	O	4122
hemopoietic	O	4122
system	O	4122
of	O	4122
the	O	4122
heterozygous	O	4122
female	O	4122
and	O	4122
offers	O	4122
a	O	4122
possible	O	4122
means	O	4122
of	O	4122
carrier	O	4122
detection	O	4122
in	O	4122
some	O	4122
women	O	4122
.	O	4122
linkage	O	4123
studies	O	4123
in	O	4123
this	O	4123
family	O	4123
revealed	O	4123
one	O	4123
example	O	4123
of	O	4123
probable	O	4123
recombination	O	4123
between	O	4123
the	O	4123
loci	O	4123
for	O	4123
was	B-Disease	4123
and	O	4123
g	O	4123
-	O	4123
6	O	4123
-	O	4123
pd	O	4123
among	O	4123
three	O	4123
informative	O	4123
subjects	O	4123
,	O	4123
suggesting	O	4123
that	O	4123
these	O	4123
two	O	4123
loci	O	4123
may	O	4123
not	O	4123
be	O	4123
closely	O	4123
linked	O	4123
on	O	4123
the	O	4123
x	O	4123
-	O	4123
chromosome	O	4123
.	O	4123
.	O	4123
a	O	4124
new	O	4124
ct	O	4124
pattern	O	4124
in	O	4124
adrenoleukodystrophy	B-Disease	4124
.	O	4124
a	O	4125
new	O	4125
ct	O	4125
pattern	O	4125
was	O	4125
observed	O	4125
in	O	4125
2	O	4125
patients	O	4125
with	O	4125
adrenoleukodystrophy	B-Disease	4125
(	O	4125
ald	B-Disease	4125
)	O	4125
.	O	4125
this	O	4127
is	O	4127
different	O	4127
from	O	4127
numerous	O	4127
previous	O	4127
descriptions	O	4127
of	O	4127
the	O	4127
ct	O	4127
pattern	O	4127
in	O	4127
ald	B-Disease	4127
.	O	4127
type	B-Disease	4128
ii	I-Disease	4128
ald	I-Disease	4128
does	O	4128
not	O	4128
appear	O	4128
to	O	4128
have	O	4128
been	O	4128
seen	O	4128
in	O	4128
any	O	4128
other	O	4128
leukoencephalopathy	B-Disease	4128
and	O	4128
is	O	4128
probably	O	4128
specific	O	4128
for	O	4128
a	O	4128
phenotypic	O	4128
variant	O	4128
or	O	4128
an	O	4128
evolving	O	4128
stage	O	4128
of	O	4128
ald	B-Disease	4128
.	O	4128
.	O	4128
further	O	4129
evidence	O	4129
for	O	4129
heterogeneity	O	4129
of	O	4129
glucose	B-Disease	4129
-	I-Disease	4129
6	I-Disease	4129
-	I-Disease	4129
phosphate	I-Disease	4129
dehydrogenase	I-Disease	4129
deficiency	I-Disease	4129
in	O	4129
papua	O	4129
new	O	4129
guinea	O	4129
.	O	4129
th	O	4132
data	O	4132
presented	O	4132
here	O	4132
together	O	4132
with	O	4132
those	O	4132
of	O	4132
previously	O	4132
published	O	4132
studies	O	4132
demonstrate	O	4132
a	O	4132
degree	O	4132
of	O	4132
heterogeneity	O	4132
of	O	4132
g6pd	B-Disease	4132
deficiency	I-Disease	4132
that	O	4132
is	O	4132
much	O	4132
higher	O	4132
than	O	4132
that	O	4132
in	O	4132
other	O	4132
regions	O	4132
of	O	4132
the	O	4132
world	O	4132
where	O	4132
g6pd	B-Disease	4132
deficiency	I-Disease	4132
is	O	4132
common	O	4132
.	O	4132
.	O	4132
increased	O	4133
incidence	O	4133
of	O	4133
cataracts	B-Disease	4133
in	O	4133
male	O	4133
subjects	O	4133
deficient	B-Disease	4133
in	I-Disease	4133
glucose	I-Disease	4133
-	I-Disease	4133
6	I-Disease	4133
-	I-Disease	4133
phosphate	I-Disease	4133
dehydrogenase	I-Disease	4133
.	O	4133
glucose	B-Disease	4134
-	I-Disease	4134
6	I-Disease	4134
-	I-Disease	4134
phosphate	I-Disease	4134
dehydrogenase	I-Disease	4134
(	I-Disease	4134
g6pd	I-Disease	4134
)	I-Disease	4134
deficiency	I-Disease	4134
in	O	4134
rbcs	O	4134
was	O	4134
found	O	4134
significantly	O	4134
more	O	4134
frequently	O	4134
in	O	4134
210	O	4134
male	O	4134
cataractous	B-Disease	4134
patients	O	4134
than	O	4134
in	O	4134
672	O	4134
control	O	4134
subjects	O	4134
of	O	4134
sardinian	O	4134
origin	O	4134
.	O	4134
the	O	4135
frequency	O	4135
of	O	4135
the	O	4135
deficiency	O	4135
was	O	4135
increasingly	O	4135
higher	O	4135
in	O	4135
presenile	O	4135
cataracts	B-Disease	4135
.	O	4135
in	O	4136
the	O	4136
g6pd	B-Disease	4136
-	I-Disease	4136
deficient	I-Disease	4136
group	O	4136
,	O	4136
the	O	4136
incidence	O	4136
of	O	4136
cortical	B-Disease	4136
and	I-Disease	4136
total	I-Disease	4136
cataracts	I-Disease	4136
was	O	4136
also	O	4136
increased	O	4136
.	O	4136
moreover	O	4138
,	O	4138
g6pd	B-Disease	4138
deficiency	I-Disease	4138
should	O	4138
be	O	4138
added	O	4138
to	O	4138
other	O	4138
conditions	O	4138
,	O	4138
such	O	4138
as	O	4138
the	O	4138
galactosemic	B-Disease	4138
states	O	4138
and	O	4138
riboflavin	B-Disease	4138
deficiency	I-Disease	4138
,	O	4138
where	O	4138
cataracts	B-Disease	4138
represent	O	4138
a	O	4138
sensitive	O	4138
indicator	O	4138
of	O	4138
metabolic	B-Disease	4138
abnormalities	I-Disease	4138
of	O	4138
the	O	4138
rbc	O	4138
.	O	4138
.	O	4138
molecular	O	4139
basis	O	4139
of	O	4139
human	O	4139
mitochondrial	O	4139
very	B-Disease	4139
-	I-Disease	4139
long	I-Disease	4139
-	I-Disease	4139
chain	I-Disease	4139
acyl	I-Disease	4139
-	I-Disease	4139
coa	I-Disease	4139
dehydrogenase	I-Disease	4139
deficiency	I-Disease	4139
causing	O	4139
cardiomyopathy	B-Disease	4139
and	O	4139
sudden	B-Disease	4139
death	I-Disease	4139
in	O	4139
childhood	O	4139
.	O	4139
defects	O	4141
in	O	4141
enzymes	O	4141
of	O	4141
the	O	4141
beta	O	4141
-	O	4141
oxidation	O	4141
pathway	O	4141
cause	O	4141
sudden	B-Disease	4141
,	I-Disease	4141
unexplained	I-Disease	4141
death	I-Disease	4141
in	O	4141
childhood	O	4141
,	O	4141
acute	O	4141
hepatic	B-Disease	4141
encephalopathy	I-Disease	4141
or	O	4141
liver	B-Disease	4141
failure	I-Disease	4141
,	O	4141
skeletal	B-Disease	4141
myopathy	I-Disease	4141
,	O	4141
and	O	4141
cardiomyopathy	B-Disease	4141
.	O	4141
polymerase	O	4144
chain	O	4144
reaction	O	4144
amplification	O	4144
of	O	4144
vlcad	O	4144
mrna	O	4144
and	O	4144
genomic	O	4144
exons	O	4144
defined	O	4144
the	O	4144
molecular	O	4144
defects	O	4144
in	O	4144
two	O	4144
patients	O	4144
with	O	4144
vlcad	B-Disease	4144
deficiency	I-Disease	4144
who	O	4144
presented	O	4144
with	O	4144
unexplained	O	4144
cardiac	B-Disease	4144
arrest	I-Disease	4144
and	O	4144
cardiomyopathy	B-Disease	4144
.	O	4144
this	O	4147
initial	O	4147
delineation	O	4147
of	O	4147
human	O	4147
mutations	O	4147
in	O	4147
vlcad	O	4147
suggests	O	4147
that	O	4147
vlcad	B-Disease	4147
deficiency	I-Disease	4147
reduces	O	4147
myocardial	O	4147
fatty	O	4147
acid	O	4147
beta	O	4147
-	O	4147
oxidation	O	4147
and	O	4147
energy	O	4147
production	O	4147
and	O	4147
is	O	4147
associated	O	4147
with	O	4147
cardiomyopathy	B-Disease	4147
and	O	4147
sudden	B-Disease	4147
death	I-Disease	4147
in	O	4147
childhood	O	4147
.	O	4147
aberrant	O	4148
subcellular	O	4148
localization	O	4148
of	O	4148
brca1	O	4148
in	O	4148
breast	B-Disease	4148
cancer	I-Disease	4148
.	O	4148
the	O	4149
brca1	O	4149
gene	O	4149
product	O	4149
was	O	4149
identified	O	4149
as	O	4149
a	O	4149
220	O	4149
-	O	4149
kilodalton	O	4149
nuclear	O	4149
phosphoprotein	O	4149
in	O	4149
normal	O	4149
cells	O	4149
,	O	4149
including	O	4149
breast	O	4149
ductal	O	4149
epithelial	O	4149
cells	O	4149
,	O	4149
and	O	4149
in	O	4149
18	O	4149
of	O	4149
20	O	4149
tumor	B-Disease	4149
cell	O	4149
lines	O	4149
derived	O	4149
from	O	4149
tissues	O	4149
other	O	4149
than	O	4149
breast	O	4149
and	O	4149
ovary	O	4149
.	O	4149
in	O	4150
16	O	4150
of	O	4150
17	O	4150
breast	B-Disease	4150
and	I-Disease	4150
ovarian	I-Disease	4150
cancer	I-Disease	4150
lines	O	4150
and	O	4150
17	O	4150
of	O	4150
17	O	4150
samples	O	4150
of	O	4150
cells	O	4150
obtained	O	4150
from	O	4150
malignant	O	4150
effusions	O	4150
,	O	4150
however	O	4150
,	O	4150
brca1	O	4150
localized	O	4150
mainly	O	4150
in	O	4150
cytoplasm	O	4150
.	O	4150
absence	O	4151
of	O	4151
brca1	O	4151
or	O	4151
aberrant	O	4151
subcellular	O	4151
location	O	4151
was	O	4151
also	O	4151
observed	O	4151
to	O	4151
a	O	4151
variable	O	4151
extent	O	4151
in	O	4151
histological	O	4151
sections	O	4151
of	O	4151
many	O	4151
breast	B-Disease	4151
cancer	I-Disease	4151
biopsies	O	4151
.	O	4151
these	O	4152
findings	O	4152
suggest	O	4152
that	O	4152
brca1	B-Disease	4152
abnormalities	I-Disease	4152
may	O	4152
be	O	4152
involved	O	4152
in	O	4152
the	O	4152
pathogenesis	O	4152
of	O	4152
many	O	4152
breast	B-Disease	4152
cancers	I-Disease	4152
,	O	4152
sporadic	O	4152
as	O	4152
well	O	4152
as	O	4152
familial	O	4152
.	O	4152
.	O	4152
mapping	O	4153
of	O	4153
the	O	4153
mouse	O	4153
homologue	O	4153
of	O	4153
the	O	4153
wilson	B-Disease	4153
disease	I-Disease	4153
gene	O	4153
to	O	4153
mouse	O	4153
chromosome	O	4153
8	O	4153
.	O	4153
atp7b	O	4154
,	O	4154
the	O	4154
gene	O	4154
altered	O	4154
in	O	4154
wilson	B-Disease	4154
disease	I-Disease	4154
(	O	4154
wd	B-Disease	4154
)	O	4154
patients	O	4154
,	O	4154
lies	O	4154
in	O	4154
a	O	4154
block	O	4154
of	O	4154
homology	O	4154
shared	O	4154
between	O	4154
human	O	4154
chromosome	O	4154
13q14	O	4154
and	O	4154
the	O	4154
central	O	4154
region	O	4154
of	O	4154
mouse	O	4154
chromosome	O	4154
14	O	4154
.	O	4154
this	O	4159
assignment	O	4159
suggests	O	4159
a	O	4159
possible	O	4159
location	O	4159
for	O	4159
the	O	4159
toxic	O	4159
milk	O	4159
mutation	O	4159
in	O	4159
the	O	4159
mouse	O	4159
,	O	4159
which	O	4159
has	O	4159
been	O	4159
proposed	O	4159
as	O	4159
a	O	4159
homologue	O	4159
of	O	4159
wd	B-Disease	4159
.	O	4159
.	O	4159
germline	O	4160
mutations	O	4160
of	O	4160
the	O	4160
brca1	O	4160
gene	O	4160
in	O	4160
breast	B-Disease	4160
and	I-Disease	4160
ovarian	I-Disease	4160
cancer	I-Disease	4160
families	O	4160
provide	O	4160
evidence	O	4160
for	O	4160
a	O	4160
genotype	O	4160
-	O	4160
phenotype	O	4160
correlation	O	4160
.	O	4160
mutations	O	4161
in	O	4161
the	O	4161
brca1	O	4161
gene	O	4161
,	O	4161
discovered	O	4161
in	O	4161
1994	O	4161
,	O	4161
are	O	4161
associated	O	4161
with	O	4161
an	O	4161
80	O	4161
-	O	4161
90	O	4161
%	O	4161
lifetime	O	4161
risk	O	4161
of	O	4161
breast	B-Disease	4161
cancer	I-Disease	4161
.	O	4161
we	O	4162
have	O	4162
analysed	O	4162
60	O	4162
families	O	4162
with	O	4162
a	O	4162
history	O	4162
of	O	4162
breast	B-Disease	4162
and	I-Disease	4162
/	I-Disease	4162
or	I-Disease	4162
ovarian	I-Disease	4162
cancer	I-Disease	4162
for	O	4162
germline	O	4162
mutations	O	4162
in	O	4162
brca1	O	4162
.	O	4162
we	O	4164
observed	O	4164
a	O	4164
significant	O	4164
correlation	O	4164
between	O	4164
the	O	4164
location	O	4164
of	O	4164
the	O	4164
mutation	O	4164
in	O	4164
the	O	4164
gene	O	4164
and	O	4164
the	O	4164
ratio	O	4164
of	O	4164
breast	B-Disease	4164
to	I-Disease	4164
ovarian	I-Disease	4164
cancer	I-Disease	4164
incidence	O	4164
within	O	4164
each	O	4164
family	O	4164
.	O	4164
our	O	4165
data	O	4165
suggest	O	4165
a	O	4165
transition	O	4165
in	O	4165
risk	O	4165
such	O	4165
that	O	4165
mutations	O	4165
in	O	4165
the	O	4165
3	O	4165
third	O	4165
of	O	4165
the	O	4165
gene	O	4165
are	O	4165
associated	O	4165
with	O	4165
a	O	4165
lower	O	4165
proportion	O	4165
of	O	4165
ovarian	B-Disease	4165
cancer	I-Disease	4165
.	O	4165
hereditary	O	4167
deficiency	B-Disease	4167
of	I-Disease	4167
the	I-Disease	4167
seventh	I-Disease	4167
component	I-Disease	4167
of	I-Disease	4167
complement	I-Disease	4167
and	O	4167
recurrent	O	4167
meningococcal	B-Disease	4167
infection	I-Disease	4167
:	O	4167
investigations	O	4167
of	O	4167
an	O	4167
irish	O	4167
family	O	4167
using	O	4167
a	O	4167
novel	O	4167
haemolytic	O	4167
screening	O	4167
assay	O	4167
for	O	4167
complement	O	4167
activity	O	4167
and	O	4167
c7	O	4167
m	O	4167
/	O	4167
n	O	4167
allotyping	O	4167
.	O	4167
terminal	B-Disease	4168
complement	I-Disease	4168
component	I-Disease	4168
deficiency	I-Disease	4168
predisposes	O	4168
to	O	4168
meningococcal	B-Disease	4168
infection	I-Disease	4168
and	O	4168
is	O	4168
inherited	O	4168
in	O	4168
an	O	4168
autosomal	O	4168
co	O	4168
-	O	4168
dominant	O	4168
manner	O	4168
.	O	4168
an	O	4169
irish	O	4169
family	O	4169
is	O	4169
described	O	4169
,	O	4169
in	O	4169
which	O	4169
2	O	4169
of	O	4169
3	O	4169
brothers	O	4169
had	O	4169
recurrent	O	4169
meningococcal	B-Disease	4169
infection	I-Disease	4169
.	O	4169
a	O	4170
novel	O	4170
screening	O	4170
assay	O	4170
was	O	4170
used	O	4170
to	O	4170
investigate	O	4170
for	O	4170
terminal	B-Disease	4170
complement	I-Disease	4170
deficiency	I-Disease	4170
and	O	4170
the	O	4170
2	O	4170
affected	O	4170
brothers	O	4170
were	O	4170
found	O	4170
to	O	4170
be	O	4170
completely	B-Disease	4170
deficient	I-Disease	4170
in	I-Disease	4170
the	I-Disease	4170
seventh	I-Disease	4170
component	I-Disease	4170
of	I-Disease	4170
complement	I-Disease	4170
(	O	4170
c7	O	4170
)	O	4170
.	O	4170
c7	O	4172
m	O	4172
/	O	4172
n	O	4172
protein	O	4172
polymorphism	O	4172
allotyping	O	4172
,	O	4172
used	O	4172
to	O	4172
investigate	O	4172
the	O	4172
segregation	O	4172
of	O	4172
the	O	4172
c7	B-Disease	4172
deficiency	I-Disease	4172
genes	O	4172
,	O	4172
showed	O	4172
that	O	4172
the	O	4172
apparently	O	4172
complement	O	4172
sufficient	O	4172
brother	O	4172
was	O	4172
heterozygous	O	4172
c7	B-Disease	4172
deficient	I-Disease	4172
and	O	4172
a	O	4172
carrier	O	4172
of	O	4172
one	O	4172
of	O	4172
the	O	4172
deficiency	O	4172
genes	O	4172
.	O	4172
complement	O	4173
screening	O	4173
should	O	4173
be	O	4173
carried	O	4173
out	O	4173
in	O	4173
any	O	4173
individual	O	4173
suffering	O	4173
recurrent	O	4173
meningococcal	B-Disease	4173
infection	I-Disease	4173
or	O	4173
infection	O	4173
with	O	4173
an	O	4173
uncommon	O	4173
meningococcal	B-Disease	4173
serogroup	O	4173
.	O	4173
identification	O	4174
of	O	4174
complement	B-Disease	4174
deficient	I-Disease	4174
patients	O	4174
allows	O	4174
the	O	4174
implementation	O	4174
of	O	4174
strategies	O	4174
to	O	4174
prevent	O	4174
recurrent	O	4174
infection	O	4174
.	O	4174
.	O	4174
molecular	O	4175
basis	O	4175
of	O	4175
subtotal	B-Disease	4175
complement	I-Disease	4175
c6	I-Disease	4175
deficiency	I-Disease	4175
.	O	4175
individuals	O	4177
with	O	4177
subtotal	B-Disease	4177
complement	I-Disease	4177
c6	I-Disease	4177
deficiency	I-Disease	4177
possess	O	4177
a	O	4177
c6	O	4177
molecule	O	4177
that	O	4177
is	O	4177
14	O	4177
%	O	4177
shorter	O	4177
than	O	4177
normal	O	4177
c6	O	4177
and	O	4177
present	O	4177
in	O	4177
low	O	4177
but	O	4177
detectable	O	4177
concentrations	O	4177
(	O	4177
1	O	4177
-	O	4177
2	O	4177
%	O	4177
of	O	4177
the	O	4177
normal	O	4177
mean	O	4177
)	O	4177
.	O	4177
interestingly	O	4185
,	O	4185
all	O	4185
three	O	4185
subjects	O	4185
were	O	4185
probably	O	4185
heterozygous	O	4185
for	O	4185
both	O	4185
subtotal	B-Disease	4185
c6	I-Disease	4185
and	I-Disease	4185
complete	I-Disease	4185
c6	I-Disease	4185
deficiency	I-Disease	4185
.	O	4185
myotonic	B-Disease	4186
dystrophy	I-Disease	4186
:	O	4186
evidence	O	4186
for	O	4186
a	O	4186
possible	O	4186
dominant	O	4186
-	O	4186
negative	O	4186
rna	O	4186
mutation	O	4186
.	O	4186
the	O	4187
trinucleotide	O	4187
expansion	O	4187
mutation	O	4187
causing	O	4187
myotonic	B-Disease	4187
dystrophy	I-Disease	4187
is	O	4187
in	O	4187
the	O	4187
3	O	4187
untranslated	O	4187
region	O	4187
of	O	4187
a	O	4187
protein	O	4187
kinase	O	4187
gene	O	4187
.	O	4187
the	O	4188
molecular	O	4188
mechanisms	O	4188
by	O	4188
which	O	4188
the	O	4188
expanded	O	4188
repeat	O	4188
causes	O	4188
the	O	4188
clinically	O	4188
variable	O	4188
and	O	4188
multisystemic	B-Disease	4188
disease	I-Disease	4188
,	O	4188
myotonic	B-Disease	4188
dystrophy	I-Disease	4188
,	O	4188
are	O	4188
not	O	4188
understood	O	4188
.	O	4188
here	O	4190
we	O	4190
use	O	4190
muscle	O	4190
biopsies	O	4190
from	O	4190
classical	O	4190
adult	O	4190
-	O	4190
onset	O	4190
myotonic	B-Disease	4190
dystrophy	I-Disease	4190
patients	O	4190
to	O	4190
study	O	4190
the	O	4190
accumulation	O	4190
of	O	4190
transcripts	O	4190
from	O	4190
both	O	4190
the	O	4190
normal	O	4190
and	O	4190
expanded	O	4190
dm	B-Disease	4190
kinase	O	4190
genes	O	4190
in	O	4190
patient	O	4190
muscle	O	4190
,	O	4190
and	O	4190
compare	O	4190
the	O	4190
results	O	4190
to	O	4190
normal	O	4190
and	O	4190
myopathic	B-Disease	4190
controls	O	4190
.	O	4190
we	O	4191
found	O	4191
relatively	O	4191
small	O	4191
decreases	O	4191
of	O	4191
dm	B-Disease	4191
kinase	O	4191
rna	O	4191
in	O	4191
the	O	4191
total	O	4191
rna	O	4191
pool	O	4191
from	O	4191
muscle	O	4191
;	O	4191
however	O	4191
,	O	4191
these	O	4191
reductions	O	4191
were	O	4191
not	O	4191
disease	O	4191
specific	O	4191
.	O	4191
analysis	O	4192
of	O	4192
poly	O	4192
(	O	4192
a	O	4192
)	O	4192
+	O	4192
rna	O	4192
showed	O	4192
dramatic	O	4192
decreases	O	4192
of	O	4192
both	O	4192
the	O	4192
mutant	O	4192
and	O	4192
normal	O	4192
dm	B-Disease	4192
kinase	O	4192
rnas	O	4192
,	O	4192
and	O	4192
these	O	4192
changes	O	4192
were	O	4192
disease	O	4192
-	O	4192
specific	O	4192
.	O	4192
our	O	4193
findings	O	4193
are	O	4193
consistent	O	4193
with	O	4193
a	O	4193
novel	O	4193
molecular	O	4193
pathogenetic	O	4193
mechanism	O	4193
for	O	4193
myotonic	B-Disease	4193
dystrophy	I-Disease	4193
both	O	4193
the	O	4193
normal	O	4193
and	O	4193
expanded	O	4193
dm	B-Disease	4193
kinase	O	4193
genes	O	4193
are	O	4193
transcribed	O	4193
in	O	4193
patient	O	4193
muscle	O	4193
,	O	4193
but	O	4193
the	O	4193
abnormal	O	4193
expansion	O	4193
-	O	4193
containing	O	4193
rna	O	4193
has	O	4193
a	O	4193
dominant	O	4193
effect	O	4193
on	O	4193
rna	O	4193
metabolism	O	4193
by	O	4193
preventing	O	4193
the	O	4193
accumulation	O	4193
of	O	4193
poly	O	4193
(	O	4193
a	O	4193
)	O	4193
+	O	4193
rna	O	4193
.	O	4193
the	O	4194
ability	O	4194
of	O	4194
the	O	4194
expansion	O	4194
mutation	O	4194
to	O	4194
alter	O	4194
accumulation	O	4194
of	O	4194
poly	O	4194
(	O	4194
a	O	4194
)	O	4194
+	O	4194
rna	O	4194
in	O	4194
trans	O	4194
suggests	O	4194
that	O	4194
myotonic	B-Disease	4194
dystrophy	I-Disease	4194
may	O	4194
be	O	4194
the	O	4194
first	O	4194
example	O	4194
of	O	4194
a	O	4194
dominant	O	4194
-	O	4194
negative	O	4194
mutation	O	4194
manifested	O	4194
at	O	4194
the	O	4194
rna	O	4194
level	O	4194
.	O	4194
.	O	4194
a	O	4195
strong	O	4195
candidate	O	4195
for	O	4195
the	O	4195
breast	B-Disease	4195
and	I-Disease	4195
ovarian	I-Disease	4195
cancer	I-Disease	4195
susceptibility	O	4195
gene	O	4195
brca1	O	4195
.	O	4195
a	O	4196
strong	O	4196
candidate	O	4196
for	O	4196
the	O	4196
17q	O	4196
-	O	4196
linked	O	4196
brca1	O	4196
gene	O	4196
,	O	4196
which	O	4196
influences	O	4196
susceptibility	O	4196
to	O	4196
breast	B-Disease	4196
and	I-Disease	4196
ovarian	I-Disease	4196
cancer	I-Disease	4196
,	O	4196
has	O	4196
been	O	4196
identified	O	4196
by	O	4196
positional	O	4196
cloning	O	4196
methods	O	4196
.	O	4196
identification	O	4201
of	O	4201
brca1	O	4201
should	O	4201
facilitate	O	4201
early	O	4201
diagnosis	O	4201
of	O	4201
breast	B-Disease	4201
and	I-Disease	4201
ovarian	I-Disease	4201
cancer	I-Disease	4201
susceptibility	O	4201
in	O	4201
some	O	4201
individuals	O	4201
as	O	4201
well	O	4201
as	O	4201
a	O	4201
better	O	4201
understanding	O	4201
of	O	4201
breast	B-Disease	4201
cancer	I-Disease	4201
biology	O	4201
.	O	4201
.	O	4201
molecular	O	4202
characterization	O	4202
of	O	4202
galactosemia	B-Disease	4202
(	O	4202
type	O	4202
1	O	4202
)	O	4202
mutations	O	4202
in	O	4202
japanese	O	4202
.	O	4202
we	O	4203
characterized	O	4203
two	O	4203
novel	O	4203
mutations	O	4203
of	O	4203
the	O	4203
galactose	O	4203
-	O	4203
1	O	4203
-	O	4203
phosphate	O	4203
uridyltransferase	O	4203
(	O	4203
galt	O	4203
)	O	4203
gene	O	4203
in	O	4203
two	O	4203
japanese	O	4203
patients	O	4203
with	O	4203
galt	B-Disease	4203
deficiency	I-Disease	4203
and	O	4203
identified	O	4203
n314d	O	4203
and	O	4203
r333w	O	4203
mutations	O	4203
,	O	4203
previously	O	4203
found	O	4203
in	O	4203
caucasians	O	4203
.	O	4203
in	O	4207
seven	O	4207
japanese	O	4207
families	O	4207
(	O	4207
14	O	4207
alleles	O	4207
for	O	4207
classic	O	4207
form	O	4207
and	O	4207
one	O	4207
allele	O	4207
for	O	4207
duarte	O	4207
variant	O	4207
)	O	4207
with	O	4207
galt	B-Disease	4207
deficiency	I-Disease	4207
,	O	4207
the	O	4207
r231h	O	4207
and	O	4207
318a	O	4207
-	O	4207
-	O	4207
>	O	4207
g	O	4207
mutations	O	4207
were	O	4207
found	O	4207
only	O	4207
on	O	4207
both	O	4207
alleles	O	4207
of	O	4207
the	O	4207
proband	O	4207
.	O	4207
we	O	4211
speculate	O	4211
that	O	4211
classic	B-Disease	4211
galactosemia	I-Disease	4211
mutations	O	4211
appear	O	4211
to	O	4211
differ	O	4211
between	O	4211
japanese	O	4211
and	O	4211
caucasian	O	4211
patients	O	4211
.	O	4211
our	O	4212
limited	O	4212
data	O	4212
set	O	4212
on	O	4212
galactosemia	B-Disease	4212
mutations	O	4212
in	O	4212
japanese	O	4212
suggests	O	4212
that	O	4212
the	O	4212
n314d	O	4212
galt	O	4212
mutation	O	4212
encoding	O	4212
the	O	4212
duarte	O	4212
variant	O	4212
arose	O	4212
before	O	4212
asian	O	4212
and	O	4212
caucasian	O	4212
people	O	4212
diverged	O	4212
and	O	4212
that	O	4212
classic	B-Disease	4212
galactosemia	I-Disease	4212
mutations	O	4212
arose	O	4212
and	O	4212
/	O	4212
or	O	4212
accumulated	O	4212
after	O	4212
the	O	4212
divergence	O	4212
of	O	4212
asian	O	4212
and	O	4212
caucasian	O	4212
populations	O	4212
.	O	4212
.	O	4212
three	O	4213
novel	O	4213
aniridia	B-Disease	4213
mutations	O	4213
in	O	4213
the	O	4213
human	O	4213
pax6	O	4213
gene	O	4213
.	O	4213
aniridia	B-Disease	4214
(	O	4214
iris	B-Disease	4214
hypoplasia	I-Disease	4214
)	O	4214
is	O	4214
an	O	4214
autosomal	B-Disease	4214
dominant	I-Disease	4214
congenital	I-Disease	4214
disorder	I-Disease	4214
of	I-Disease	4214
the	I-Disease	4214
eye	I-Disease	4214
.	O	4214
mutations	O	4215
in	O	4215
the	O	4215
human	O	4215
aniridia	B-Disease	4215
(	O	4215
pax6	O	4215
)	O	4215
gene	O	4215
have	O	4215
now	O	4215
been	O	4215
identified	O	4215
in	O	4215
many	O	4215
patients	O	4215
from	O	4215
various	O	4215
ethnic	O	4215
groups	O	4215
.	O	4215
in	O	4216
the	O	4216
study	O	4216
reported	O	4216
here	O	4216
we	O	4216
describe	O	4216
pax6	O	4216
mutations	O	4216
in	O	4216
one	O	4216
sporadic	O	4216
and	O	4216
five	O	4216
familial	O	4216
cases	O	4216
with	O	4216
aniridia	B-Disease	4216
.	O	4216
one	O	4218
pax6	O	4218
mutation	O	4218
found	O	4218
in	O	4218
the	O	4218
pst	O	4218
region	O	4218
was	O	4218
associated	O	4218
with	O	4218
cataracts	B-Disease	4218
in	O	4218
an	O	4218
aniridia	B-Disease	4218
family	O	4218
.	O	4218
another	O	4219
splice	O	4219
mutation	O	4219
in	O	4219
the	O	4219
pst	O	4219
domain	O	4219
occurred	O	4219
in	O	4219
an	O	4219
aniridia	B-Disease	4219
patient	O	4219
with	O	4219
anosmia	B-Disease	4219
(	O	4219
inability	O	4219
to	O	4219
smell	O	4219
)	O	4219
.	O	4219
the	O	4220
six	O	4220
new	O	4220
aniridia	B-Disease	4220
cases	O	4220
reported	O	4220
here	O	4220
have	O	4220
mutations	O	4220
predicted	O	4220
to	O	4220
generate	O	4220
incomplete	O	4220
pax6	O	4220
proteins	O	4220
.	O	4220
these	O	4221
results	O	4221
support	O	4221
the	O	4221
theory	O	4221
that	O	4221
human	O	4221
aniridia	B-Disease	4221
is	O	4221
caused	O	4221
by	O	4221
haploinsufficiency	B-Disease	4221
of	I-Disease	4221
pax6	I-Disease	4221
.	O	4221
.	O	4221
since	O	4223
brca1	O	4223
,	O	4223
the	O	4223
first	O	4223
major	O	4223
gene	O	4223
responsible	O	4223
for	O	4223
inherited	B-Disease	4223
breast	I-Disease	4223
cancer	I-Disease	4223
,	O	4223
was	O	4223
cloned	O	4223
,	O	4223
more	O	4223
than	O	4223
50	O	4223
unique	O	4223
mutations	O	4223
have	O	4223
been	O	4223
detected	O	4223
in	O	4223
the	O	4223
germline	O	4223
of	O	4223
individuals	O	4223
with	O	4223
breast	B-Disease	4223
and	I-Disease	4223
ovarian	I-Disease	4223
cancer	I-Disease	4223
.	O	4223
in	O	4224
high	O	4224
-	O	4224
risk	O	4224
pedigrees	O	4224
,	O	4224
female	O	4224
carriers	O	4224
of	O	4224
brca1	O	4224
mutations	O	4224
have	O	4224
an	O	4224
80	O	4224
-	O	4224
90	O	4224
%	O	4224
lifetime	O	4224
risk	O	4224
of	O	4224
breast	B-Disease	4224
cancer	I-Disease	4224
,	O	4224
and	O	4224
a	O	4224
40	O	4224
-	O	4224
50	O	4224
%	O	4224
risk	O	4224
of	O	4224
ovarian	B-Disease	4224
cancer	I-Disease	4224
.	O	4224
however	O	4225
,	O	4225
the	O	4225
mutation	O	4225
stats	O	4225
of	O	4225
individuals	O	4225
unselected	O	4225
for	O	4225
breast	B-Disease	4225
or	I-Disease	4225
ovarian	I-Disease	4225
cancer	I-Disease	4225
has	O	4225
not	O	4225
been	O	4225
determined	O	4225
,	O	4225
and	O	4225
it	O	4225
is	O	4225
not	O	4225
known	O	4225
whether	O	4225
mutations	O	4225
in	O	4225
such	O	4225
individuals	O	4225
confer	O	4225
the	O	4225
same	O	4225
risk	O	4225
of	O	4225
cancer	B-Disease	4225
as	O	4225
in	O	4225
individuals	O	4225
from	O	4225
the	O	4225
high	O	4225
-	O	4225
risk	O	4225
families	O	4225
studied	O	4225
so	O	4225
far	O	4225
.	O	4225
following	O	4226
the	O	4226
finding	O	4226
of	O	4226
a	O	4226
185delag	O	4226
frameshift	O	4226
mutation	O	4226
in	O	4226
several	O	4226
ashkenazi	O	4226
jewish	O	4226
breast	O	4226
/	O	4226
ovarian	O	4226
families	O	4226
,	O	4226
we	O	4226
have	O	4226
determined	O	4226
the	O	4226
frequency	O	4226
of	O	4226
this	O	4226
mutation	O	4226
in	O	4226
858	O	4226
ashkenazim	O	4226
seeking	O	4226
genetic	O	4226
testing	O	4226
for	O	4226
conditions	O	4226
unrelated	O	4226
to	O	4226
cancer	B-Disease	4226
,	O	4226
and	O	4226
in	O	4226
815	O	4226
reference	O	4226
individuals	O	4226
not	O	4226
selected	O	4226
for	O	4226
ethnic	O	4226
origin	O	4226
.	O	4226
our	O	4229
results	O	4229
suggest	O	4229
that	O	4229
one	O	4229
in	O	4229
a	O	4229
hundred	O	4229
women	O	4229
of	O	4229
ashkenazi	O	4229
descent	O	4229
may	O	4229
be	O	4229
at	O	4229
especially	O	4229
high	O	4229
risk	O	4229
of	O	4229
developing	O	4229
breast	B-Disease	4229
and	I-Disease	4229
/	I-Disease	4229
or	I-Disease	4229
ovarian	I-Disease	4229
cancer	I-Disease	4229
.	O	4229
the	O	4231
huntington	B-Disease	4231
disease	I-Disease	4231
(	O	4231
hd	B-Disease	4231
)	O	4231
phenotype	O	4231
is	O	4231
associated	O	4231
with	O	4231
expansion	O	4231
of	O	4231
a	O	4231
trinucleotide	O	4231
repeat	O	4231
in	O	4231
the	O	4231
it15	O	4231
gene	O	4231
,	O	4231
which	O	4231
is	O	4231
predicted	O	4231
to	O	4231
encode	O	4231
a	O	4231
348	O	4231
-	O	4231
kda	O	4231
protein	O	4231
named	O	4231
huntington	O	4231
.	O	4231
in	O	4234
lymphoblastoid	O	4234
cell	O	4234
lines	O	4234
from	O	4234
juvenile	O	4234
-	O	4234
onset	O	4234
heterozygote	O	4234
hd	B-Disease	4234
cases	O	4234
,	O	4234
both	O	4234
normal	O	4234
and	O	4234
mutant	O	4234
huntingtin	O	4234
are	O	4234
expressed	O	4234
,	O	4234
and	O	4234
increasing	O	4234
repeat	O	4234
expansion	O	4234
leads	O	4234
to	O	4234
lower	O	4234
levels	O	4234
of	O	4234
the	O	4234
mutant	O	4234
protein	O	4234
.	O	4234
in	O	4236
the	O	4236
human	O	4236
striatum	O	4236
,	O	4236
huntingtin	O	4236
is	O	4236
enriched	O	4236
in	O	4236
a	O	4236
patch	O	4236
-	O	4236
like	O	4236
distribution	O	4236
,	O	4236
potentially	O	4236
corresponding	O	4236
to	O	4236
the	O	4236
first	O	4236
areas	O	4236
affected	O	4236
in	O	4236
hd	B-Disease	4236
.	O	4236
marked	O	4240
phenotypic	O	4240
heterogeneity	O	4240
associated	O	4240
with	O	4240
expansion	O	4240
of	O	4240
a	O	4240
cag	O	4240
repeat	O	4240
sequence	O	4240
at	O	4240
the	O	4240
spinocerebellar	B-Disease	4240
ataxia	I-Disease	4240
3	I-Disease	4240
/	I-Disease	4240
machado	I-Disease	4240
-	I-Disease	4240
joseph	I-Disease	4240
disease	I-Disease	4240
locus	O	4240
.	O	4240
the	O	4241
spinocerebellar	B-Disease	4241
ataxia	I-Disease	4241
3	I-Disease	4241
locus	O	4241
(	O	4241
sca3	B-Disease	4241
)	O	4241
for	O	4241
type	B-Disease	4241
i	I-Disease	4241
autosomal	I-Disease	4241
dominant	I-Disease	4241
cerebellar	I-Disease	4241
ataxia	I-Disease	4241
(	O	4241
adca	B-Disease	4241
type	I-Disease	4241
i	I-Disease	4241
)	O	4241
,	O	4241
a	O	4241
clinically	O	4241
and	O	4241
genetically	O	4241
heterogeneous	O	4241
group	O	4241
of	O	4241
neurodegenerative	B-Disease	4241
disorders	I-Disease	4241
,	O	4241
has	O	4241
been	O	4241
mapped	O	4241
to	O	4241
chromosome	O	4241
14q32	O	4241
.	O	4241
adca	B-Disease	4243
type	I-Disease	4243
i	I-Disease	4243
patients	O	4243
from	O	4243
families	O	4243
segregating	O	4243
sca3	B-Disease	4243
share	O	4243
clinical	O	4243
features	O	4243
in	O	4243
common	O	4243
with	O	4243
those	O	4243
with	O	4243
machado	B-Disease	4243
-	I-Disease	4243
joseph	I-Disease	4243
disease	I-Disease	4243
(	O	4243
mjd	B-Disease	4243
)	O	4243
,	O	4243
the	O	4243
gene	O	4243
of	O	4243
which	O	4243
maps	O	4243
to	O	4243
the	O	4243
same	O	4243
region	O	4243
.	O	4243
we	O	4244
show	O	4244
here	O	4244
that	O	4244
the	O	4244
disease	O	4244
gene	O	4244
segregating	O	4244
in	O	4244
each	O	4244
of	O	4244
three	O	4244
french	O	4244
adca	B-Disease	4244
type	I-Disease	4244
i	I-Disease	4244
kindreds	O	4244
and	O	4244
in	O	4244
a	O	4244
french	O	4244
family	O	4244
with	O	4244
neuropathological	O	4244
findings	O	4244
suggesting	O	4244
the	O	4244
ataxochoreic	O	4244
form	O	4244
of	O	4244
dentatorubropallidoluysian	B-Disease	4244
atrophy	I-Disease	4244
carries	O	4244
an	O	4244
expanded	O	4244
cag	O	4244
repeat	O	4244
sequence	O	4244
located	O	4244
at	O	4244
the	O	4244
same	O	4244
locus	O	4244
as	O	4244
that	O	4244
for	O	4244
mjd	B-Disease	4244
.	O	4244
overexpression	O	4248
of	O	4248
dm20	O	4248
messenger	O	4248
rna	O	4248
in	O	4248
two	O	4248
brothers	O	4248
with	O	4248
pelizaeus	B-Disease	4248
-	I-Disease	4248
merzbacher	I-Disease	4248
disease	I-Disease	4248
.	O	4248
pelizaeus	B-Disease	4249
-	I-Disease	4249
merzbacher	I-Disease	4249
disease	I-Disease	4249
is	O	4249
a	O	4249
rare	B-Disease	4249
,	I-Disease	4249
sex	I-Disease	4249
-	I-Disease	4249
linked	I-Disease	4249
recessive	I-Disease	4249
,	I-Disease	4249
dysmyelinating	I-Disease	4249
disease	I-Disease	4249
of	I-Disease	4249
the	I-Disease	4249
central	I-Disease	4249
nervous	I-Disease	4249
system	I-Disease	4249
that	O	4249
has	O	4249
been	O	4249
associated	O	4249
with	O	4249
mutations	O	4249
in	O	4249
the	O	4249
myelin	O	4249
proteolipid	O	4249
protein	O	4249
(	O	4249
plp	O	4249
)	O	4249
gene	O	4249
.	O	4249
only	O	4250
25	O	4250
%	O	4250
of	O	4250
patients	O	4250
studied	O	4250
with	O	4250
pelizaeus	B-Disease	4250
-	I-Disease	4250
merzbacher	I-Disease	4250
disease	I-Disease	4250
have	O	4250
exonic	O	4250
mutations	O	4250
in	O	4250
this	O	4250
gene	O	4250
,	O	4250
the	O	4250
underlying	O	4250
cause	O	4250
of	O	4250
the	O	4250
disease	O	4250
in	O	4250
the	O	4250
remaining	O	4250
patients	O	4250
is	O	4250
unknown	O	4250
.	O	4250
we	O	4253
studied	O	4253
cultured	O	4253
skin	O	4253
fibroblasts	O	4253
from	O	4253
2	O	4253
brothers	O	4253
with	O	4253
pelizaeus	B-Disease	4253
-	I-Disease	4253
merzbacher	I-Disease	4253
disease	I-Disease	4253
who	O	4253
exhibited	O	4253
no	O	4253
detectable	O	4253
exonic	O	4253
mutation	O	4253
of	O	4253
the	O	4253
plp	O	4253
gene	O	4253
.	O	4253
our	O	4256
findings	O	4256
suggest	O	4256
that	O	4256
in	O	4256
some	O	4256
patients	O	4256
,	O	4256
pelizaeus	B-Disease	4256
-	I-Disease	4256
merzbacher	I-Disease	4256
disease	I-Disease	4256
is	O	4256
caused	O	4256
by	O	4256
overexpression	O	4256
of	O	4256
plp	O	4256
gene	O	4256
transcripts	O	4256
,	O	4256
and	O	4256
that	O	4256
in	O	4256
these	O	4256
families	O	4256
a	O	4256
50	O	4256
%	O	4256
increase	O	4256
of	O	4256
dm20	O	4256
messenger	O	4256
rna	O	4256
in	O	4256
females	O	4256
,	O	4256
relative	O	4256
to	O	4256
the	O	4256
increase	O	4256
in	O	4256
affected	O	4256
males	O	4256
,	O	4256
can	O	4256
identify	O	4256
a	O	4256
female	O	4256
carrier	O	4256
.	O	4256
.	O	4256
the	O	4257
wiskott	B-Disease	4257
-	I-Disease	4257
aldrich	I-Disease	4257
syndrome	I-Disease	4257
and	O	4257
x	B-Disease	4257
-	I-Disease	4257
linked	I-Disease	4257
congenital	I-Disease	4257
thrombocytopenia	I-Disease	4257
are	O	4257
caused	O	4257
by	O	4257
mutations	O	4257
of	O	4257
the	O	4257
same	O	4257
gene	O	4257
.	O	4257
the	O	4258
wiskott	B-Disease	4258
-	I-Disease	4258
aldrich	I-Disease	4258
syndrome	I-Disease	4258
(	O	4258
was	B-Disease	4258
)	O	4258
is	O	4258
an	O	4258
x	B-Disease	4258
-	I-Disease	4258
linked	I-Disease	4258
recessive	I-Disease	4258
disorder	I-Disease	4258
characterized	O	4258
by	O	4258
thrombocytopenia	B-Disease	4258
,	O	4258
small	O	4258
platelets	O	4258
,	O	4258
eczema	B-Disease	4258
,	O	4258
recurrent	O	4258
infections	O	4258
,	O	4258
and	O	4258
immunodeficiency	B-Disease	4258
.	O	4258
besides	O	4259
the	O	4259
classic	O	4259
was	B-Disease	4259
phenotype	O	4259
,	O	4259
there	O	4259
is	O	4259
a	O	4259
group	O	4259
of	O	4259
patients	O	4259
with	O	4259
congenital	B-Disease	4259
x	I-Disease	4259
-	I-Disease	4259
linked	I-Disease	4259
thrombocytopenia	I-Disease	4259
(	O	4259
xlt	B-Disease	4259
)	O	4259
who	O	4259
have	O	4259
small	O	4259
platelets	O	4259
but	O	4259
only	O	4259
transient	O	4259
eczema	B-Disease	4259
,	O	4259
if	O	4259
any	O	4259
,	O	4259
and	O	4259
minimal	O	4259
immune	B-Disease	4259
deficiency	I-Disease	4259
.	O	4259
because	O	4260
the	O	4260
gene	O	4260
responsible	O	4260
for	O	4260
was	B-Disease	4260
has	O	4260
been	O	4260
sequenced	O	4260
,	O	4260
it	O	4260
was	O	4260
possible	O	4260
to	O	4260
correlate	O	4260
the	O	4260
was	B-Disease	4260
phenotypes	O	4260
with	O	4260
was	B-Disease	4260
gene	O	4260
mutations	O	4260
.	O	4260
using	O	4261
a	O	4261
fingerprinting	O	4261
screening	O	4261
technique	O	4261
,	O	4261
we	O	4261
determined	O	4261
the	O	4261
approximate	O	4261
location	O	4261
of	O	4261
the	O	4261
mutation	O	4261
in	O	4261
13	O	4261
unrelated	O	4261
was	B-Disease	4261
patients	O	4261
with	O	4261
mild	O	4261
to	O	4261
severe	O	4261
clinical	O	4261
symptoms	O	4261
.	O	4261
direct	O	4262
sequence	O	4262
analysis	O	4262
of	O	4262
cdna	O	4262
and	O	4262
genomic	O	4262
dna	O	4262
obtained	O	4262
from	O	4262
patient	O	4262
-	O	4262
derived	O	4262
cell	O	4262
lines	O	4262
showed	O	4262
12	O	4262
unique	O	4262
mutations	O	4262
distributed	O	4262
throughout	O	4262
the	O	4262
was	B-Disease	4262
gene	O	4262
,	O	4262
including	O	4262
insertions	O	4262
,	O	4262
deletions	O	4262
,	O	4262
and	O	4262
point	O	4262
mutations	O	4262
resulting	O	4262
in	O	4262
amino	O	4262
acid	O	4262
substitutions	O	4262
,	O	4262
termination	O	4262
,	O	4262
exon	O	4262
skipping	O	4262
,	O	4262
or	O	4262
splicing	O	4262
defects	O	4262
.	O	4262
of	O	4263
4	O	4263
unrelated	O	4263
patients	O	4263
with	O	4263
the	O	4263
xlt	B-Disease	4263
phenotype	O	4263
,	O	4263
3	O	4263
had	O	4263
missense	O	4263
mutations	O	4263
affecting	O	4263
exon	O	4263
2	O	4263
and	O	4263
1	O	4263
had	O	4263
a	O	4263
splice	O	4263
-	O	4263
site	O	4263
mutation	O	4263
affecting	O	4263
exon	O	4263
9	O	4263
.	O	4263
patients	O	4264
with	O	4264
classic	O	4264
was	B-Disease	4264
had	O	4264
more	O	4264
complex	O	4264
mutations	O	4264
,	O	4264
resulting	O	4264
in	O	4264
termination	O	4264
codons	O	4264
,	O	4264
frameshift	O	4264
,	O	4264
and	O	4264
early	O	4264
termination	O	4264
.	O	4264
these	O	4265
findings	O	4265
provide	O	4265
direct	O	4265
evidence	O	4265
that	O	4265
xlt	B-Disease	4265
and	O	4265
was	B-Disease	4265
are	O	4265
caused	O	4265
by	O	4265
mutations	O	4265
of	O	4265
the	O	4265
same	O	4265
gene	O	4265
and	O	4265
suggest	O	4265
that	O	4265
severe	O	4265
clinical	O	4265
phenotypes	O	4265
are	O	4265
associated	O	4265
with	O	4265
complex	O	4265
mutations	O	4265
.	O	4265
.	O	4265
myotonia	B-Disease	4266
levior	I-Disease	4266
is	O	4266
a	O	4266
chloride	B-Disease	4266
channel	I-Disease	4266
disorder	I-Disease	4266
.	O	4266
the	O	4267
group	O	4267
of	O	4267
dominant	B-Disease	4267
non	I-Disease	4267
-	I-Disease	4267
dystrophic	I-Disease	4267
myotonias	I-Disease	4267
,	O	4267
comprising	O	4267
disorders	O	4267
characterized	O	4267
by	O	4267
clinically	O	4267
similar	O	4267
forms	O	4267
of	O	4267
myogenic	O	4267
muscle	O	4267
stiffness	O	4267
,	O	4267
is	O	4267
genetically	O	4267
inhomogeneous	O	4267
.	O	4267
dominant	B-Disease	4268
myotonia	I-Disease	4268
congenita	I-Disease	4268
(	O	4268
thomsens	B-Disease	4268
disease	I-Disease	4268
)	O	4268
is	O	4268
linked	O	4268
to	O	4268
clcn1	O	4268
,	O	4268
the	O	4268
gene	O	4268
encoding	O	4268
the	O	4268
major	O	4268
muscle	O	4268
chloride	O	4268
channel	O	4268
,	O	4268
localized	O	4268
on	O	4268
chromosome	O	4268
7q35	O	4268
.	O	4268
in	O	4269
contrast	O	4269
,	O	4269
dominant	B-Disease	4269
myotonias	I-Disease	4269
sensitive	O	4269
to	O	4269
potassium	O	4269
are	O	4269
caused	O	4269
by	O	4269
point	O	4269
mutations	O	4269
in	O	4269
scn4a	O	4269
on	O	4269
chromosome	O	4269
17q	O	4269
,	O	4269
the	O	4269
gene	O	4269
for	O	4269
the	O	4269
alpha	O	4269
subunit	O	4269
of	O	4269
the	O	4269
adult	O	4269
skeletal	O	4269
muscle	O	4269
sodium	O	4269
channel	O	4269
.	O	4269
no	O	4270
linkage	O	4270
or	O	4270
molecular	O	4270
genetic	O	4270
data	O	4270
are	O	4270
as	O	4270
yet	O	4270
available	O	4270
on	O	4270
myotonia	B-Disease	4270
levior	I-Disease	4270
characterized	O	4270
by	O	4270
milder	O	4270
symptoms	O	4270
and	O	4270
later	O	4270
onset	O	4270
of	O	4270
myotonia	B-Disease	4270
than	O	4270
in	O	4270
thomsens	B-Disease	4270
disease	I-Disease	4270
,	O	4270
and	O	4270
absence	O	4270
of	O	4270
muscle	B-Disease	4270
hypertrophy	I-Disease	4270
.	O	4270
we	O	4271
report	O	4271
a	O	4271
clcn1	O	4271
gln	O	4271
-	O	4271
552	O	4271
-	O	4271
arg	O	4271
substitution	O	4271
for	O	4271
a	O	4271
family	O	4271
with	O	4271
dominant	O	4271
inheritance	O	4271
previously	O	4271
diagnosed	O	4271
to	O	4271
have	O	4271
myotonia	B-Disease	4271
levior	I-Disease	4271
.	O	4271
thus	O	4272
,	O	4272
this	O	4272
disorder	O	4272
appears	O	4272
as	O	4272
a	O	4272
variant	O	4272
of	O	4272
thomsens	B-Disease	4272
disease	I-Disease	4272
due	O	4272
to	O	4272
mutations	O	4272
leading	O	4272
to	O	4272
low	O	4272
clinical	O	4272
expressivity	O	4272
.	O	4272
in	O	4274
another	O	4274
family	O	4274
previously	O	4274
diagnosed	O	4274
as	O	4274
having	O	4274
thomsens	B-Disease	4274
disease	I-Disease	4274
,	O	4274
we	O	4274
unexpectedly	O	4274
found	O	4274
a	O	4274
clcn1	O	4274
14	O	4274
bp	O	4274
deletion	O	4274
known	O	4274
to	O	4274
cause	O	4274
recessive	B-Disease	4274
myotonia	I-Disease	4274
,	O	4274
and	O	4274
a	O	4274
rare	O	4274
trp	O	4274
-	O	4274
118	O	4274
-	O	4274
gly	O	4274
polymorphism	O	4274
.	O	4274
.	O	4274
southern	O	4275
analysis	O	4275
reveals	O	4275
a	O	4275
large	O	4275
deletion	O	4275
at	O	4275
the	O	4275
hypoxanthine	O	4275
phosphoribosyltransferase	O	4275
locus	O	4275
in	O	4275
a	O	4275
patient	O	4275
with	O	4275
lesch	B-Disease	4275
-	I-Disease	4275
nyhan	I-Disease	4275
syndrome	I-Disease	4275
.	O	4275
whole	O	4276
genomic	O	4276
hprt	O	4276
clones	O	4276
were	O	4276
used	O	4276
in	O	4276
southern	O	4276
analysis	O	4276
to	O	4276
screen	O	4276
the	O	4276
integrity	O	4276
of	O	4276
the	O	4276
hprt	O	4276
gene	O	4276
in	O	4276
a	O	4276
family	O	4276
that	O	4276
includes	O	4276
a	O	4276
patient	O	4276
with	O	4276
hprt	B-Disease	4276
enzyme	I-Disease	4276
deficiency	I-Disease	4276
causal	O	4276
to	O	4276
lesch	B-Disease	4276
-	I-Disease	4276
nyhan	I-Disease	4276
syndrome	I-Disease	4276
.	O	4276
characterisation	O	4279
of	O	4279
molecular	O	4279
defects	O	4279
in	O	4279
x	B-Disease	4279
-	I-Disease	4279
linked	I-Disease	4279
amelogenesis	I-Disease	4279
imperfecta	I-Disease	4279
(	O	4279
aih1	O	4279
)	O	4279
.	O	4279
disturbances	O	4281
of	O	4281
enamel	O	4281
formation	O	4281
occur	O	4281
in	O	4281
amelogenesis	B-Disease	4281
imperfecta	I-Disease	4281
,	O	4281
a	O	4281
clinically	O	4281
heterogenous	O	4281
group	O	4281
of	O	4281
inherited	B-Disease	4281
disorders	I-Disease	4281
characterised	O	4281
by	O	4281
defective	O	4281
enamel	O	4281
biomineralisation	O	4281
.	O	4281
an	O	4282
amelogenin	O	4282
gene	O	4282
,	O	4282
amgx	O	4282
,	O	4282
has	O	4282
been	O	4282
mapped	O	4282
to	O	4282
the	O	4282
short	O	4282
of	O	4282
the	O	4282
x	O	4282
chromosome	O	4282
(	O	4282
xp22	O	4282
.	O	4282
1	O	4282
-	O	4282
p22	O	4282
.	O	4282
3	O	4282
)	O	4282
and	O	4282
has	O	4282
been	O	4282
implicated	O	4282
in	O	4282
the	O	4282
molecular	O	4282
pathology	O	4282
of	O	4282
x	B-Disease	4282
-	I-Disease	4282
linked	I-Disease	4282
amelogenesis	I-Disease	4282
imperfecta	I-Disease	4282
(	O	4282
aih1	B-Disease	4282
)	O	4282
.	O	4282
we	O	4283
have	O	4283
identified	O	4283
three	O	4283
families	O	4283
exhibiting	O	4283
aih1	B-Disease	4283
and	O	4283
screened	O	4283
the	O	4283
amgx	O	4283
gene	O	4283
for	O	4283
mutations	O	4283
using	O	4283
single	O	4283
-	O	4283
strand	O	4283
conformational	O	4283
polymorphism	O	4283
analysis	O	4283
and	O	4283
dna	O	4283
sequencing	O	4283
.	O	4283
frequency	O	4286
of	O	4286
exon	O	4286
15	O	4286
missense	O	4286
mutation	O	4286
(	O	4286
442d	O	4286
:	O	4286
g	O	4286
)	O	4286
in	O	4286
cholesteryl	O	4286
ester	O	4286
transfer	O	4286
protein	O	4286
gene	O	4286
in	O	4286
hyperalphalipoproteinemic	B-Disease	4286
japanese	O	4286
subjects	O	4286
.	O	4286
the	O	4288
hyperalphalipoproteinemia	B-Disease	4288
caused	O	4288
by	O	4288
cetp	B-Disease	4288
deficiency	I-Disease	4288
is	O	4288
fairly	O	4288
common	O	4288
in	O	4288
japan	O	4288
and	O	4288
one	O	4288
of	O	4288
the	O	4288
most	O	4288
common	O	4288
mutations	O	4288
in	O	4288
the	O	4288
cetp	O	4288
gene	O	4288
is	O	4288
the	O	4288
splicing	O	4288
defect	O	4288
of	O	4288
the	O	4288
intron	O	4288
14	O	4288
,	O	4288
the	O	4288
allelic	O	4288
frequency	O	4288
of	O	4288
which	O	4288
has	O	4288
been	O	4288
shown	O	4288
to	O	4288
be	O	4288
0	O	4288
.	O	4288
in	O	4291
the	O	4291
current	O	4291
study	O	4291
,	O	4291
we	O	4291
determined	O	4291
the	O	4291
frequency	O	4291
of	O	4291
this	O	4291
new	O	4291
mutation	O	4291
in	O	4291
japanese	O	4291
hyperalphalipoproteinemic	B-Disease	4291
(	O	4291
hdl	O	4291
-	O	4291
cholesterol	O	4291
>	O	4291
or	O	4291
=	O	4291
100	O	4291
mg	O	4291
/	O	4291
dl	O	4291
)	O	4291
subjects	O	4291
.	O	4291
among	O	4293
117	O	4293
japanese	O	4293
hyperalphalipoproteinemic	B-Disease	4293
subjects	O	4293
(	O	4293
hdl	O	4293
-	O	4293
cholesterol	O	4293
;	O	4293
116	O	4293
.	O	4293
7	O	4293
+	O	4293
/	O	4293
-	O	4293
16	O	4293
.	O	4293
5	O	4293
mg	O	4293
/	O	4293
dl	O	4293
,	O	4293
mean	O	4293
+	O	4293
/	O	4293
-	O	4293
s	O	4293
.	O	4293
d	O	4293
.	O	4293
)	O	4293
without	O	4293
the	O	4293
intron	O	4293
14	O	4293
splice	O	4293
defect	O	4293
,	O	4293
three	O	4293
homozygotes	O	4293
(	O	4293
2	O	4293
.	O	4293
5	O	4293
%	O	4293
)	O	4293
and	O	4293
34	O	4293
heterozygotes	O	4293
(	O	4293
29	O	4293
.	O	4293
1	O	4293
%	O	4293
)	O	4293
were	O	4293
found	O	4293
to	O	4293
have	O	4293
the	O	4293
442d	O	4293
g	O	4293
mutation	O	4293
.	O	4293
one	O	4296
of	O	4296
the	O	4296
homozygotes	O	4296
for	O	4296
the	O	4296
442d	O	4296
g	O	4296
mutation	O	4296
was	O	4296
the	O	4296
patient	O	4296
previously	O	4296
described	O	4296
by	O	4296
us	O	4296
as	O	4296
having	O	4296
hyperalphalipoproteinemia	B-Disease	4296
with	O	4296
corneal	B-Disease	4296
opacity	I-Disease	4296
and	O	4296
coronary	B-Disease	4296
heart	I-Disease	4296
disease	I-Disease	4296
.	O	4296
this	O	4297
was	O	4297
the	O	4297
first	O	4297
reported	O	4297
subject	O	4297
homozygous	O	4297
for	O	4297
the	O	4297
cetp	B-Disease	4297
deficiency	I-Disease	4297
who	O	4297
also	O	4297
demonstrated	O	4297
atherosclerotic	B-Disease	4297
symptoms	I-Disease	4297
.	O	4297
mucopolysaccharidosis	B-Disease	4300
type	I-Disease	4300
iva	I-Disease	4300
:	O	4300
common	O	4300
double	O	4300
deletion	O	4300
in	O	4300
the	O	4300
n	O	4300
-	O	4300
acetylgalactosamine	O	4300
-	O	4300
6	O	4300
-	O	4300
sulfatase	O	4300
gene	O	4300
(	O	4300
galns	O	4300
)	O	4300
.	O	4300
mucopolysaccharidosis	B-Disease	4301
iva	I-Disease	4301
(	O	4301
mps	B-Disease	4301
iva	I-Disease	4301
)	O	4301
is	O	4301
an	O	4301
autosomal	B-Disease	4301
recessive	I-Disease	4301
disorder	I-Disease	4301
caused	O	4301
by	O	4301
a	O	4301
deficiency	B-Disease	4301
in	I-Disease	4301
n	I-Disease	4301
-	I-Disease	4301
acetylgalactosamine	I-Disease	4301
-	I-Disease	4301
6	I-Disease	4301
-	I-Disease	4301
sulfatase	I-Disease	4301
(	O	4301
galns	O	4301
)	O	4301
.	O	4301
detection	O	4311
of	O	4311
eight	O	4311
brca1	O	4311
mutations	O	4311
in	O	4311
10	O	4311
breast	B-Disease	4311
/	I-Disease	4311
ovarian	I-Disease	4311
cancer	I-Disease	4311
families	O	4311
,	O	4311
including	O	4311
1	O	4311
family	O	4311
with	O	4311
male	B-Disease	4311
breast	I-Disease	4311
cancer	I-Disease	4311
.	O	4311
genetic	O	4312
epidemiological	O	4312
evidence	O	4312
suggests	O	4312
that	O	4312
mutations	O	4312
in	O	4312
brca1	O	4312
may	O	4312
be	O	4312
responsible	O	4312
for	O	4312
approximately	O	4312
one	O	4312
half	O	4312
of	O	4312
early	O	4312
onset	O	4312
familial	B-Disease	4312
breast	I-Disease	4312
cancer	I-Disease	4312
and	O	4312
the	O	4312
majority	O	4312
of	O	4312
familial	B-Disease	4312
breast	I-Disease	4312
/	I-Disease	4312
ovarian	I-Disease	4312
cancer	I-Disease	4312
.	O	4312
the	O	4313
recent	O	4313
cloning	O	4313
of	O	4313
brca1	O	4313
allows	O	4313
for	O	4313
the	O	4313
direct	O	4313
detection	O	4313
of	O	4313
mutations	O	4313
,	O	4313
but	O	4313
the	O	4313
feasibility	O	4313
of	O	4313
presymptomatic	O	4313
screening	O	4313
for	O	4313
cancer	B-Disease	4313
susceptibility	O	4313
is	O	4313
unknown	O	4313
.	O	4313
we	O	4314
analyzed	O	4314
genomic	O	4314
dna	O	4314
from	O	4314
one	O	4314
affected	O	4314
individual	O	4314
from	O	4314
each	O	4314
of	O	4314
24	O	4314
families	O	4314
with	O	4314
at	O	4314
least	O	4314
three	O	4314
cases	O	4314
of	O	4314
ovarian	B-Disease	4314
or	I-Disease	4314
breast	I-Disease	4314
cancer	I-Disease	4314
,	O	4314
using	O	4314
sscp	O	4314
assays	O	4314
.	O	4314
a	O	4318
frameshift	O	4318
mutation	O	4318
was	O	4318
detected	O	4318
in	O	4318
a	O	4318
male	O	4318
proband	O	4318
affected	O	4318
with	O	4318
both	O	4318
breast	B-Disease	4318
and	I-Disease	4318
prostate	I-Disease	4318
cancer	I-Disease	4318
.	O	4318
a	O	4319
40	O	4319
-	O	4319
bp	O	4319
deletion	O	4319
was	O	4319
detected	O	4319
in	O	4319
a	O	4319
patient	O	4319
who	O	4319
developed	O	4319
intra	B-Disease	4319
-	I-Disease	4319
abdominal	I-Disease	4319
carcinomatosis	I-Disease	4319
1	O	4319
year	O	4319
after	O	4319
prophylactic	O	4319
oophorectomy	O	4319
.	O	4319
these	O	4321
results	O	4321
provide	O	4321
further	O	4321
evidence	O	4321
that	O	4321
inherited	B-Disease	4321
breast	I-Disease	4321
and	I-Disease	4321
ovarian	I-Disease	4321
cancer	I-Disease	4321
can	O	4321
occur	O	4321
as	O	4321
a	O	4321
consequence	O	4321
of	O	4321
a	O	4321
wide	O	4321
array	O	4321
of	O	4321
brca1	O	4321
mutations	O	4321
.	O	4321
the	O	4323
finding	O	4323
of	O	4323
a	O	4323
mutation	O	4323
in	O	4323
a	O	4323
family	O	4323
with	O	4323
male	B-Disease	4323
breast	I-Disease	4323
cancer	I-Disease	4323
,	O	4323
not	O	4323
previously	O	4323
thought	O	4323
to	O	4323
be	O	4323
related	O	4323
to	O	4323
brca1	O	4323
,	O	4323
also	O	4323
illustrates	O	4323
the	O	4323
potential	O	4323
difficulties	O	4323
of	O	4323
genetic	O	4323
counseling	O	4323
for	O	4323
individuals	O	4323
known	O	4323
to	O	4323
carry	O	4323
mutations	O	4323
.	O	4323
.	O	4323
natural	O	4324
selection	O	4324
of	O	4324
hemi	O	4324
-	O	4324
and	O	4324
heterozygotes	O	4324
for	O	4324
g6pd	B-Disease	4324
deficiency	I-Disease	4324
in	O	4324
africa	O	4324
by	O	4324
resistance	O	4324
to	O	4324
severe	O	4324
malaria	B-Disease	4324
.	O	4324
glucose	B-Disease	4325
-	I-Disease	4325
6	I-Disease	4325
-	I-Disease	4325
phosphate	I-Disease	4325
dehydrogenase	I-Disease	4325
(	I-Disease	4325
g6pd	I-Disease	4325
)	I-Disease	4325
deficiency	I-Disease	4325
,	O	4325
the	O	4325
most	O	4325
common	O	4325
enzymopathy	B-Disease	4325
of	O	4325
humans	O	4325
,	O	4325
affects	O	4325
over	O	4325
400	O	4325
million	O	4325
people	O	4325
.	O	4325
the	O	4326
geographical	O	4326
correlation	O	4326
of	O	4326
its	O	4326
distribution	O	4326
with	O	4326
the	O	4326
historical	O	4326
endemicity	O	4326
of	O	4326
malaria	B-Disease	4326
suggests	O	4326
that	O	4326
this	O	4326
disorder	O	4326
has	O	4326
risen	O	4326
in	O	4326
frequency	O	4326
through	O	4326
natural	O	4326
selection	O	4326
by	O	4326
malaria	B-Disease	4326
.	O	4326
however	O	4327
,	O	4327
attempts	O	4327
to	O	4327
confirm	O	4327
that	O	4327
g6pd	B-Disease	4327
deficiency	I-Disease	4327
is	O	4327
protective	O	4327
in	O	4327
case	O	4327
-	O	4327
control	O	4327
studies	O	4327
of	O	4327
malaria	B-Disease	4327
have	O	4327
yielded	O	4327
conflicting	O	4327
results	O	4327
.	O	4327
hence	O	4328
,	O	4328
for	O	4328
this	O	4328
x	B-Disease	4328
-	I-Disease	4328
linked	I-Disease	4328
disorder	I-Disease	4328
,	O	4328
it	O	4328
is	O	4328
unclear	O	4328
whether	O	4328
both	O	4328
male	O	4328
hemizygotes	O	4328
and	O	4328
female	O	4328
heterozygotes	O	4328
are	O	4328
protected	O	4328
or	O	4328
,	O	4328
as	O	4328
frequently	O	4328
suggested	O	4328
,	O	4328
only	O	4328
females	O	4328
.	O	4328
here	O	4330
we	O	4330
report	O	4330
that	O	4330
,	O	4330
in	O	4330
two	O	4330
large	O	4330
case	O	4330
-	O	4330
control	O	4330
studies	O	4330
of	O	4330
over	O	4330
2	O	4330
,	O	4330
000	O	4330
african	O	4330
children	O	4330
,	O	4330
the	O	4330
common	O	4330
african	O	4330
form	O	4330
of	O	4330
g6pd	B-Disease	4330
deficiency	I-Disease	4330
(	O	4330
g6pd	B-Disease	4330
a	I-Disease	4330
-	I-Disease	4330
)	O	4330
is	O	4330
associated	O	4330
with	O	4330
a	O	4330
46	O	4330
-	O	4330
58	O	4330
%	O	4330
reduction	O	4330
in	O	4330
risk	O	4330
of	O	4330
severe	O	4330
malaria	B-Disease	4330
for	O	4330
both	O	4330
female	O	4330
heterozygotes	O	4330
and	O	4330
male	O	4330
hemizygotes	O	4330
.	O	4330
a	O	4331
mathematical	O	4331
model	O	4331
incorporating	O	4331
the	O	4331
measured	O	4331
selective	O	4331
advantage	O	4331
against	O	4331
malaria	B-Disease	4331
suggests	O	4331
that	O	4331
a	O	4331
counterbalancing	O	4331
selective	O	4331
disadvantage	O	4331
,	O	4331
associated	O	4331
with	O	4331
this	O	4331
enzyme	B-Disease	4331
deficiency	I-Disease	4331
,	O	4331
has	O	4331
retarded	O	4331
its	O	4331
rise	O	4331
in	O	4331
frequency	O	4331
in	O	4331
malaria	B-Disease	4331
-	O	4331
endemic	O	4331
regions	O	4331
.	O	4331
although	O	4332
g6pd	B-Disease	4332
deficiency	I-Disease	4332
is	O	4332
now	O	4332
regarded	O	4332
as	O	4332
a	O	4332
generally	O	4332
benign	O	4332
disorder	O	4332
,	O	4332
in	O	4332
earlier	O	4332
environmental	O	4332
conditions	O	4332
it	O	4332
could	O	4332
have	O	4332
been	O	4332
significantly	O	4332
disadvantageous	O	4332
.	O	4332
.	O	4332
the	O	4333
alveolar	B-Disease	4333
rhabdomyosarcoma	I-Disease	4333
pax3	O	4333
/	O	4333
fkhr	O	4333
fusion	O	4333
protein	O	4333
is	O	4333
a	O	4333
transcriptional	O	4333
activator	O	4333
.	O	4333
chimeric	O	4334
transcription	O	4334
factors	O	4334
,	O	4334
created	O	4334
by	O	4334
gene	O	4334
fusions	O	4334
as	O	4334
the	O	4334
result	O	4334
of	O	4334
chromosomal	O	4334
translocations	O	4334
,	O	4334
have	O	4334
been	O	4334
implicated	O	4334
in	O	4334
the	O	4334
pathogenesis	O	4334
of	O	4334
several	O	4334
pathologically	O	4334
disparate	O	4334
solid	B-Disease	4334
tumors	I-Disease	4334
.	O	4334
the	O	4335
pax3	O	4335
/	O	4335
fkhr	O	4335
fusion	O	4335
gene	O	4335
,	O	4335
formed	O	4335
by	O	4335
a	O	4335
t	O	4335
(	O	4335
2	O	4335
;	O	4335
13	O	4335
)	O	4335
(	O	4335
q35	O	4335
;	O	4335
q14	O	4335
)	O	4335
in	O	4335
alveolar	B-Disease	4335
rhabdomyosarcoma	I-Disease	4335
,	O	4335
encodes	O	4335
a	O	4335
hybrid	O	4335
protein	O	4335
that	O	4335
contains	O	4335
both	O	4335
pax3	O	4335
dna	O	4335
binding	O	4335
domains	O	4335
,	O	4335
the	O	4335
paired	O	4335
box	O	4335
and	O	4335
homeodomain	O	4335
,	O	4335
linked	O	4335
to	O	4335
the	O	4335
bisected	O	4335
dna	O	4335
binding	O	4335
domain	O	4335
of	O	4335
fkhr	O	4335
,	O	4335
a	O	4335
member	O	4335
of	O	4335
the	O	4335
forkhead	O	4335
family	O	4335
of	O	4335
transcription	O	4335
factors	O	4335
.	O	4335
we	O	4338
show	O	4338
that	O	4338
the	O	4338
native	O	4338
pax3	O	4338
/	O	4338
fkhr	O	4338
protein	O	4338
present	O	4338
in	O	4338
tumor	B-Disease	4338
cells	O	4338
with	O	4338
this	O	4338
translocation	O	4338
has	O	4338
transcriptional	O	4338
characteristics	O	4338
similar	O	4338
to	O	4338
the	O	4338
in	O	4338
vitro	O	4338
expressed	O	4338
protein	O	4338
.	O	4338
a	O	4340
p16ink4a	O	4340
-	O	4340
insensitive	O	4340
cdk4	O	4340
mutant	O	4340
targeted	O	4340
by	O	4340
cytolytic	O	4340
t	O	4340
lymphocytes	O	4340
in	O	4340
a	O	4340
human	O	4340
melanoma	B-Disease	4340
.	O	4340
a	O	4341
mutated	O	4341
cyclin	O	4341
-	O	4341
dependent	O	4341
kinase	O	4341
4	O	4341
(	O	4341
cdk4	O	4341
)	O	4341
was	O	4341
identified	O	4341
as	O	4341
a	O	4341
tumor	B-Disease	4341
-	O	4341
specific	O	4341
antigen	O	4341
recognized	O	4341
by	O	4341
hla	O	4341
-	O	4341
a2	O	4341
.	O	4341
1	O	4342
-	O	4342
restricted	O	4342
autologous	O	4342
cytolytic	O	4342
t	O	4342
lymphocytes	O	4342
(	O	4342
ctls	O	4342
)	O	4342
in	O	4342
a	O	4342
human	O	4342
melanoma	B-Disease	4342
.	O	4342
the	O	4343
mutated	O	4343
cdk4	O	4343
allele	O	4343
was	O	4343
present	O	4343
in	O	4343
autologous	O	4343
cultured	O	4343
melanoma	B-Disease	4343
cells	O	4343
and	O	4343
metastasis	O	4343
tissue	O	4343
,	O	4343
but	O	4343
not	O	4343
in	O	4343
the	O	4343
patients	O	4343
lymphocytes	O	4343
.	O	4343
the	O	4345
same	O	4345
mutation	O	4345
was	O	4345
found	O	4345
in	O	4345
one	O	4345
additional	O	4345
melanoma	B-Disease	4345
among	O	4345
28	O	4345
melanomas	B-Disease	4345
analyzed	O	4345
.	O	4345
these	O	4346
results	O	4346
suggest	O	4346
that	O	4346
mutation	O	4346
of	O	4346
cdk4	O	4346
can	O	4346
create	O	4346
a	O	4346
tumor	B-Disease	4346
-	O	4346
specific	O	4346
antigen	O	4346
and	O	4346
can	O	4346
disrupt	O	4346
the	O	4346
cell	O	4346
-	O	4346
cycle	O	4346
regulation	O	4346
exerted	O	4346
by	O	4346
the	O	4346
tumor	B-Disease	4346
suppressor	O	4346
p16ink4a	O	4346
.	O	4346
.	O	4346
more	O	4348
than	O	4348
75	O	4348
%	O	4348
of	O	4348
the	O	4348
reported	O	4348
mutations	O	4348
in	O	4348
the	O	4348
hereditary	B-Disease	4348
breast	I-Disease	4348
and	I-Disease	4348
ovarian	I-Disease	4348
cancer	I-Disease	4348
gene	O	4348
,	O	4348
brca1	O	4348
,	O	4348
result	O	4348
in	O	4348
truncated	O	4348
proteins	O	4348
.	O	4348
in	O	4350
45	O	4350
patients	O	4350
from	O	4350
breast	B-Disease	4350
and	I-Disease	4350
/	I-Disease	4350
or	I-Disease	4350
ovarian	I-Disease	4350
cancer	I-Disease	4350
families	O	4350
we	O	4350
found	O	4350
six	O	4350
novel	O	4350
mutations	O	4350
two	O	4350
single	O	4350
nucleotide	O	4350
insertions	O	4350
,	O	4350
three	O	4350
small	O	4350
deletions	O	4350
(	O	4350
1	O	4350
-	O	4350
5	O	4350
bp	O	4350
)	O	4350
and	O	4350
a	O	4350
nonsense	O	4350
mutation	O	4350
identified	O	4350
two	O	4350
unrelated	O	4350
families	O	4350
.	O	4350
pcr	O	4357
-	O	4357
amplified	O	4357
vlcad	O	4357
cdnas	O	4357
were	O	4357
sequenced	O	4357
in	O	4357
cultured	O	4357
fibroblasts	O	4357
from	O	4357
two	O	4357
vlcad	B-Disease	4357
-	I-Disease	4357
deficient	I-Disease	4357
patients	O	4357
.	O	4357
this	O	4360
is	O	4360
the	O	4360
first	O	4360
demonstration	O	4360
of	O	4360
a	O	4360
mutation	O	4360
causing	O	4360
vlcad	B-Disease	4360
deficiency	I-Disease	4360
.	O	4360
quantitative	O	4361
cdna	O	4361
expression	O	4361
of	O	4361
normal	O	4361
human	O	4361
vlcad	O	4361
was	O	4361
performed	O	4361
in	O	4361
the	O	4361
patients	O	4361
fibroblasts	O	4361
,	O	4361
using	O	4361
vaccinia	O	4361
viral	O	4361
system	O	4361
,	O	4361
which	O	4361
demonstrated	O	4361
that	O	4361
the	O	4361
deficiency	B-Disease	4361
of	I-Disease	4361
the	I-Disease	4361
normal	I-Disease	4361
vlcad	I-Disease	4361
protein	I-Disease	4361
causes	O	4361
impaired	O	4361
long	O	4361
-	O	4361
chain	O	4361
fatty	O	4361
acid	O	4361
beta	O	4361
-	O	4361
oxidation	O	4361
activity	O	4361
in	O	4361
the	O	4361
patients	O	4361
fibroblasts	O	4361
.	O	4361
in	O	4362
patient	O	4362
fibroblasts	O	4362
,	O	4362
raising	O	4362
vlcad	O	4362
activity	O	4362
to	O	4362
approximately	O	4362
20	O	4362
%	O	4362
of	O	4362
normal	O	4362
control	O	4362
fibroblast	O	4362
activity	O	4362
raised	O	4362
palmitic	O	4362
acid	O	4362
beta	O	4362
-	O	4362
oxidation	O	4362
flux	O	4362
to	O	4362
the	O	4362
level	O	4362
found	O	4362
in	O	4362
control	O	4362
fibroblasts	O	4362
,	O	4362
which	O	4362
may	O	4362
offer	O	4362
important	O	4362
information	O	4362
for	O	4362
the	O	4362
rational	O	4362
design	O	4362
of	O	4362
future	O	4362
somatic	O	4362
gene	O	4362
therapy	O	4362
for	O	4362
vlcad	B-Disease	4362
deficiency	I-Disease	4362
.	O	4362
.	O	4362
brain	B-Disease	4363
disease	I-Disease	4363
and	O	4363
molecular	O	4363
analysis	O	4363
in	O	4363
myotonic	B-Disease	4363
dystrophy	I-Disease	4363
.	O	4363
abnormal	O	4364
amplification	O	4364
of	O	4364
a	O	4364
ctg	O	4364
repeat	O	4364
on	O	4364
chromosome	O	4364
19	O	4364
is	O	4364
the	O	4364
molecular	O	4364
basis	O	4364
of	O	4364
myotonic	B-Disease	4364
dystrophy	I-Disease	4364
(	O	4364
dm	B-Disease	4364
)	O	4364
.	O	4364
we	O	4366
performed	O	4366
extensive	O	4366
cognitive	O	4366
testing	O	4366
,	O	4366
cerebral	O	4366
magnetic	O	4366
resonance	O	4366
imaging	O	4366
(	O	4366
mri	O	4366
)	O	4366
and	O	4366
a	O	4366
molecular	O	4366
analysis	O	4366
in	O	4366
28	O	4366
cases	O	4366
of	O	4366
dm	B-Disease	4366
to	O	4366
determine	O	4366
the	O	4366
relationship	O	4366
between	O	4366
the	O	4366
molecular	O	4366
defect	O	4366
and	O	4366
brain	B-Disease	4366
disease	I-Disease	4366
.	O	4366
fourteen	O	4368
patients	O	4368
had	O	4368
subcortical	O	4368
white	B-Disease	4368
matter	I-Disease	4368
lesions	I-Disease	4368
on	O	4368
mri	O	4368
,	O	4368
14	O	4368
had	O	4368
cerebral	B-Disease	4368
atrophy	I-Disease	4368
.	O	4368
disease	O	4371
duration	O	4371
influenced	O	4371
the	O	4371
appearance	O	4371
and	O	4371
amount	O	4371
of	O	4371
white	B-Disease	4371
matter	I-Disease	4371
lesions	I-Disease	4371
on	O	4371
mri	O	4371
.	O	4371
quantification	O	4372
of	O	4372
ctg	O	4372
repeat	O	4372
size	O	4372
may	O	4372
allow	O	4372
an	O	4372
early	O	4372
estimate	O	4372
on	O	4372
the	O	4372
probability	O	4372
of	O	4372
brain	O	4372
involvement	O	4372
in	O	4372
dm	B-Disease	4372
;	O	4372
cognitive	B-Disease	4372
dysfunction	I-Disease	4372
is	O	4372
associated	O	4372
with	O	4372
white	B-Disease	4372
matter	I-Disease	4372
lesions	I-Disease	4372
and	O	4372
cerebral	B-Disease	4372
atrophy	I-Disease	4372
later	O	4372
on	O	4372
in	O	4372
the	O	4372
course	O	4372
.	O	4372
.	O	4372
mutations	O	4373
in	O	4373
the	O	4373
gene	O	4373
for	O	4373
x	B-Disease	4373
-	I-Disease	4373
linked	I-Disease	4373
adrenoleukodystrophy	I-Disease	4373
in	O	4373
patients	O	4373
with	O	4373
different	O	4373
clinical	O	4373
phenotypes	O	4373
.	O	4373
recently	O	4374
,	O	4374
the	O	4374
gene	O	4374
for	O	4374
the	O	4374
most	O	4374
common	O	4374
peroxisomal	B-Disease	4374
disorder	I-Disease	4374
,	O	4374
x	B-Disease	4374
-	I-Disease	4374
linked	I-Disease	4374
adrenoleukodystrophy	I-Disease	4374
(	O	4374
x	B-Disease	4374
-	I-Disease	4374
ald	I-Disease	4374
)	O	4374
,	O	4374
has	O	4374
been	O	4374
described	O	4374
encoding	O	4374
a	O	4374
peroxisomal	O	4374
membrane	O	4374
transporter	O	4374
protein	O	4374
.	O	4374
we	O	4375
analyzed	O	4375
the	O	4375
entire	O	4375
protein	O	4375
-	O	4375
coding	O	4375
sequence	O	4375
of	O	4375
this	O	4375
gene	O	4375
by	O	4375
reverse	O	4375
-	O	4375
transcription	O	4375
pcr	O	4375
,	O	4375
sscp	O	4375
,	O	4375
and	O	4375
dna	O	4375
sequencing	O	4375
in	O	4375
five	O	4375
patients	O	4375
with	O	4375
different	O	4375
clinical	O	4375
expression	O	4375
of	O	4375
x	B-Disease	4375
-	I-Disease	4375
ald	I-Disease	4375
and	O	4375
in	O	4375
their	O	4375
female	O	4375
relatives	O	4375
;	O	4375
these	O	4375
clinical	O	4375
expressions	O	4375
were	O	4375
cerebral	O	4375
childhood	O	4375
ald	B-Disease	4375
,	O	4375
adrenomyeloneuropathy	B-Disease	4375
(	O	4375
amn	B-Disease	4375
)	O	4375
,	O	4375
addison	B-Disease	4375
disease	I-Disease	4375
only	I-Disease	4375
(	O	4375
ado	B-Disease	4375
)	O	4375
phenotype	O	4375
.	O	4375
in	O	4376
the	O	4376
three	O	4376
patients	O	4376
exhibiting	O	4376
the	O	4376
classical	O	4376
picture	O	4376
of	O	4376
severe	O	4376
childhood	O	4376
ald	B-Disease	4376
we	O	4376
identified	O	4376
in	O	4376
the	O	4376
5	O	4376
portion	O	4376
of	O	4376
the	O	4376
x	B-Disease	4376
-	I-Disease	4376
ald	I-Disease	4376
gene	O	4376
a	O	4376
38	O	4376
-	O	4376
bp	O	4376
deletion	O	4376
that	O	4376
causes	O	4376
a	O	4376
frameshift	O	4376
mutation	O	4376
,	O	4376
a	O	4376
3	O	4376
-	O	4376
bp	O	4376
deletion	O	4376
leading	O	4376
to	O	4376
a	O	4376
deletion	O	4376
of	O	4376
an	O	4376
amino	O	4376
acid	O	4376
in	O	4376
the	O	4376
atp	O	4376
-	O	4376
binding	O	4376
domain	O	4376
of	O	4376
the	O	4376
ald	B-Disease	4376
protein	O	4376
,	O	4376
and	O	4376
a	O	4376
missense	O	4376
mutation	O	4376
.	O	4376
in	O	4377
the	O	4377
patient	O	4377
with	O	4377
the	O	4377
clinical	O	4377
phenotype	O	4377
of	O	4377
amn	B-Disease	4377
,	O	4377
a	O	4377
nonsense	O	4377
mutation	O	4377
in	O	4377
codon	O	4377
212	O	4377
,	O	4377
along	O	4377
with	O	4377
a	O	4377
second	O	4377
site	O	4377
mutation	O	4377
at	O	4377
codon	O	4377
178	O	4377
,	O	4377
was	O	4377
observed	O	4377
.	O	4377
analysis	O	4378
of	O	4378
the	O	4378
patient	O	4378
with	O	4378
the	O	4378
ado	B-Disease	4378
phenotype	O	4378
revealed	O	4378
a	O	4378
further	O	4378
missense	O	4378
mutation	O	4378
at	O	4378
a	O	4378
highly	O	4378
conserved	O	4378
position	O	4378
in	O	4378
the	O	4378
aldp	O	4378
/	O	4378
pmp70	O	4378
comparison	O	4378
.	O	4378
the	O	4379
disruptive	O	4379
nature	O	4379
of	O	4379
two	O	4379
mutations	O	4379
(	O	4379
i	O	4379
.	O	4379
e	O	4379
.	O	4379
,	O	4379
the	O	4379
frameshift	O	4379
and	O	4379
the	O	4379
nonsense	O	4379
mutation	O	4379
)	O	4379
in	O	4379
patients	O	4379
with	O	4379
biochemically	O	4379
proved	O	4379
childhood	O	4379
ald	B-Disease	4379
and	O	4379
amn	B-Disease	4379
further	O	4379
strongly	O	4379
supports	O	4379
the	O	4379
hypothesis	O	4379
that	O	4379
alterations	O	4379
in	O	4379
this	O	4379
gene	O	4379
play	O	4379
a	O	4379
crucial	O	4379
role	O	4379
in	O	4379
the	O	4379
pathogenesis	O	4379
of	O	4379
x	B-Disease	4379
-	I-Disease	4379
ald	I-Disease	4379
.	O	4379
since	O	4380
the	O	4380
current	O	4380
biochemical	O	4380
techniques	O	4380
for	O	4380
x	B-Disease	4380
-	I-Disease	4380
ald	I-Disease	4380
carrier	O	4380
detection	O	4380
in	O	4380
affected	O	4380
families	O	4380
lack	O	4380
sufficient	O	4380
reliability	O	4380
,	O	4380
our	O	4380
procedure	O	4380
described	O	4380
for	O	4380
systematic	O	4380
mutation	O	4380
scanning	O	4380
is	O	4380
also	O	4380
capable	O	4380
of	O	4380
improving	O	4380
genetic	O	4380
counseling	O	4380
and	O	4380
prenatal	O	4380
diagnosis	O	4380
duchenne	B-Disease	4381
muscular	I-Disease	4381
dystrophy	I-Disease	4381
and	O	4381
myotonic	B-Disease	4381
dystrophy	I-Disease	4381
in	O	4381
the	O	4381
same	O	4381
patient	O	4381
.	O	4381
we	O	4382
report	O	4382
on	O	4382
the	O	4382
first	O	4382
patient	O	4382
identified	O	4382
with	O	4382
myotonic	B-Disease	4382
dystrophy	I-Disease	4382
and	O	4382
duchenne	B-Disease	4382
muscular	I-Disease	4382
dystrophy	I-Disease	4382
(	O	4382
dmd	B-Disease	4382
)	O	4382
.	O	4382
the	O	4383
family	O	4383
of	O	4383
the	O	4383
propositus	O	4383
had	O	4383
a	O	4383
strong	O	4383
history	O	4383
of	O	4383
myotonic	B-Disease	4383
dystrophy	I-Disease	4383
,	O	4383
and	O	4383
there	O	4383
was	O	4383
an	O	4383
intrafamilial	O	4383
pathological	O	4383
expansion	O	4383
of	O	4383
the	O	4383
responsible	O	4383
ctg	O	4383
repeat	O	4383
between	O	4383
the	O	4383
mildly	O	4383
affected	O	4383
mother	O	4383
(	O	4383
160	O	4383
repeats	O	4383
;	O	4383
normal	O	4383
27	O	4383
repeats	O	4383
)	O	4383
and	O	4383
her	O	4383
more	O	4383
severely	O	4383
affected	O	4383
son	O	4383
(	O	4383
650	O	4383
repeats	O	4383
)	O	4383
,	O	4383
and	O	4383
his	O	4383
sister	O	4383
(	O	4383
650	O	4383
repeats	O	4383
)	O	4383
.	O	4383
the	O	4384
propositus	O	4384
was	O	4384
an	O	4384
isolated	O	4384
case	O	4384
of	O	4384
duchenne	B-Disease	4384
muscular	I-Disease	4384
dystrophy	I-Disease	4384
with	O	4384
marked	O	4384
dystrophin	B-Disease	4384
deficiency	I-Disease	4384
in	O	4384
muscle	O	4384
biopsy	O	4384
.	O	4384
myotonic	B-Disease	4386
dystrophy	I-Disease	4386
could	O	4386
interfere	O	4386
to	O	4386
some	O	4386
extent	O	4386
with	O	4386
the	O	4386
progression	O	4386
of	O	4386
duchenne	B-Disease	4386
dystrophy	I-Disease	4386
.	O	4386
twelve	O	4388
percent	O	4388
of	O	4388
dystrophin	O	4388
revertant	O	4388
fibers	O	4388
as	O	4388
observed	O	4388
by	O	4388
immunohistochemistry	O	4388
could	O	4388
be	O	4388
sufficient	O	4388
to	O	4388
ameliorate	O	4388
typical	O	4388
dmd	B-Disease	4388
clinical	O	4388
severity	O	4388
,	O	4388
or	O	4388
the	O	4388
patient	O	4388
may	O	4388
present	O	4388
a	O	4388
somatic	O	4388
mosaic	O	4388
.	O	4388
age	O	4390
at	O	4390
diagnosis	O	4390
as	O	4390
an	O	4390
indicator	O	4390
of	O	4390
eligibility	O	4390
for	O	4390
brca1	O	4390
dna	O	4390
testing	O	4390
in	O	4390
familial	B-Disease	4390
breast	I-Disease	4390
cancer	I-Disease	4390
.	O	4390
we	O	4391
searched	O	4391
for	O	4391
criteria	O	4391
that	O	4391
could	O	4391
indicate	O	4391
breast	B-Disease	4391
cancer	I-Disease	4391
families	O	4391
with	O	4391
a	O	4391
high	O	4391
prior	O	4391
probability	O	4391
of	O	4391
being	O	4391
caused	O	4391
by	O	4391
the	O	4391
breast	B-Disease	4391
/	I-Disease	4391
ovarian	I-Disease	4391
cancer	I-Disease	4391
susceptibility	O	4391
locus	O	4391
brca1	O	4391
on	O	4391
chromosome	O	4391
17	O	4391
.	O	4391
to	O	4392
this	O	4392
end	O	4392
,	O	4392
we	O	4392
performed	O	4392
a	O	4392
linkage	O	4392
study	O	4392
with	O	4392
59	O	4392
consecutively	O	4392
collected	O	4392
dutch	O	4392
breast	B-Disease	4392
cancer	I-Disease	4392
families	O	4392
,	O	4392
including	O	4392
16	O	4392
with	O	4392
at	O	4392
least	O	4392
one	O	4392
case	O	4392
of	O	4392
ovarian	B-Disease	4392
cancer	I-Disease	4392
.	O	4392
we	O	4393
used	O	4393
an	O	4393
intake	O	4393
cut	O	4393
-	O	4393
off	O	4393
of	O	4393
at	O	4393
least	O	4393
three	O	4393
first	O	4393
-	O	4393
degree	O	4393
relatives	O	4393
with	O	4393
breast	B-Disease	4393
and	I-Disease	4393
/	I-Disease	4393
or	I-Disease	4393
ovarian	I-Disease	4393
cancer	I-Disease	4393
at	O	4393
any	O	4393
age	O	4393
.	O	4393
significant	O	4394
evidence	O	4394
for	O	4394
linkage	O	4394
was	O	4394
found	O	4394
only	O	4394
among	O	4394
the	O	4394
13	O	4394
breast	B-Disease	4394
cancer	I-Disease	4394
families	O	4394
with	O	4394
a	O	4394
mean	O	4394
age	O	4394
at	O	4394
diagnosis	O	4394
of	O	4394
less	O	4394
than	O	4394
45	O	4394
years	O	4394
.	O	4394
an	O	4395
unexpectedly	O	4395
low	O	4395
proportion	O	4395
of	O	4395
the	O	4395
breast	B-Disease	4395
-	I-Disease	4395
ovarian	I-Disease	4395
cancer	I-Disease	4395
families	O	4395
were	O	4395
estimated	O	4395
to	O	4395
be	O	4395
linked	O	4395
to	O	4395
brca1	O	4395
,	O	4395
which	O	4395
could	O	4395
be	O	4395
due	O	4395
to	O	4395
a	O	4395
founder	O	4395
effect	O	4395
in	O	4395
the	O	4395
dutch	O	4395
population	O	4395
.	O	4395
given	O	4396
the	O	4396
expected	O	4396
logistical	O	4396
problems	O	4396
in	O	4396
clinical	O	4396
management	O	4396
now	O	4396
that	O	4396
brca1	O	4396
has	O	4396
been	O	4396
identified	O	4396
,	O	4396
we	O	4396
propose	O	4396
an	O	4396
interim	O	4396
period	O	4396
in	O	4396
which	O	4396
only	O	4396
families	O	4396
with	O	4396
a	O	4396
strong	O	4396
positive	O	4396
family	O	4396
history	O	4396
for	O	4396
early	O	4396
onset	O	4396
breast	B-Disease	4396
and	I-Disease	4396
/	I-Disease	4396
or	I-Disease	4396
ovarian	I-Disease	4396
cancer	I-Disease	4396
will	O	4396
be	O	4396
offered	O	4396
brca1	O	4396
mutation	O	4396
testing	O	4396
.	O	4396
.	O	4396
linkage	O	4397
analysis	O	4397
of	O	4397
26	O	4397
canadian	O	4397
breast	B-Disease	4397
and	I-Disease	4397
breast	I-Disease	4397
-	I-Disease	4397
ovarian	I-Disease	4397
cancer	I-Disease	4397
families	O	4397
.	O	4397
we	O	4398
have	O	4398
examined	O	4398
26	O	4398
canadian	O	4398
families	O	4398
with	O	4398
hereditary	B-Disease	4398
breast	I-Disease	4398
or	I-Disease	4398
ovarian	I-Disease	4398
cancer	I-Disease	4398
for	O	4398
linkage	O	4398
to	O	4398
markers	O	4398
flanking	O	4398
the	O	4398
brca1	O	4398
gene	O	4398
on	O	4398
chromosome	O	4398
17q12	O	4398
-	O	4398
q21	O	4398
.	O	4398
of	O	4399
the	O	4399
15	O	4399
families	O	4399
that	O	4399
contain	O	4399
cases	O	4399
of	O	4399
ovarian	B-Disease	4399
cancer	I-Disease	4399
,	O	4399
94	O	4399
%	O	4399
were	O	4399
estimated	O	4399
to	O	4399
be	O	4399
linked	O	4399
to	O	4399
brca1	O	4399
.	O	4399
in	O	4400
contrast	O	4400
,	O	4400
there	O	4400
was	O	4400
no	O	4400
overall	O	4400
evidence	O	4400
of	O	4400
linkage	O	4400
in	O	4400
the	O	4400
group	O	4400
of	O	4400
10	O	4400
families	O	4400
with	O	4400
breast	B-Disease	4400
cancer	I-Disease	4400
without	O	4400
ovarian	B-Disease	4400
cancer	I-Disease	4400
.	O	4400
a	O	4401
genetic	O	4401
recombinant	O	4401
in	O	4401
a	O	4401
breast	B-Disease	4401
-	I-Disease	4401
ovarian	I-Disease	4401
cancer	I-Disease	4401
family	O	4401
indicates	O	4401
a	O	4401
placement	O	4401
of	O	4401
brca1	O	4401
telomeric	O	4401
to	O	4401
d17s776	O	4401
,	O	4401
and	O	4401
helps	O	4401
to	O	4401
define	O	4401
the	O	4401
region	O	4401
of	O	4401
assignment	O	4401
of	O	4401
the	O	4401
cancer	B-Disease	4401
susceptibility	O	4401
gene	O	4401
.	O	4401
other	O	4402
cancers	B-Disease	4402
of	O	4402
interest	O	4402
that	O	4402
appeared	O	4402
in	O	4402
the	O	4402
brca1	O	4402
-	O	4402
linked	O	4402
families	O	4402
included	O	4402
primary	B-Disease	4402
peritoneal	I-Disease	4402
cancer	I-Disease	4402
,	O	4402
cancer	B-Disease	4402
of	I-Disease	4402
the	I-Disease	4402
fallopian	I-Disease	4402
tube	I-Disease	4402
,	O	4402
and	O	4402
malignant	B-Disease	4402
melanoma	I-Disease	4402
.	O	4402
.	O	4402
structural	O	4403
analysis	O	4403
of	O	4403
the	O	4403
5	O	4403
'	O	4403
region	O	4403
of	O	4403
mouse	O	4403
and	O	4403
human	O	4403
huntington	B-Disease	4403
disease	I-Disease	4403
genes	O	4403
reveals	O	4403
conservation	O	4403
of	O	4403
putative	O	4403
promoter	O	4403
region	O	4403
and	O	4403
di	O	4403
-	O	4403
and	O	4403
trinucleotide	O	4403
polymorphisms	O	4403
.	O	4403
we	O	4404
have	O	4404
previously	O	4404
cloned	O	4404
and	O	4404
characterized	O	4404
the	O	4404
murine	O	4404
homologue	O	4404
of	O	4404
the	O	4404
huntington	B-Disease	4404
disease	I-Disease	4404
(	O	4404
hd	B-Disease	4404
)	O	4404
gene	O	4404
and	O	4404
shown	O	4404
that	O	4404
it	O	4404
maps	O	4404
to	O	4404
mouse	O	4404
chromosome	O	4404
5	O	4404
within	O	4404
a	O	4404
region	O	4404
of	O	4404
conserved	O	4404
synteny	O	4404
with	O	4404
human	O	4404
chromosome	O	4404
4p16	O	4404
.	O	4404
here	O	4406
we	O	4406
present	O	4406
a	O	4406
detailed	O	4406
comparison	O	4406
of	O	4406
the	O	4406
sequence	O	4406
of	O	4406
the	O	4406
putative	O	4406
promoter	O	4406
and	O	4406
the	O	4406
organization	O	4406
of	O	4406
the	O	4406
5	O	4406
genomic	O	4406
region	O	4406
of	O	4406
the	O	4406
murine	O	4406
(	O	4406
hdh	O	4406
)	O	4406
and	O	4406
human	O	4406
hd	B-Disease	4406
genes	O	4406
encompassing	O	4406
the	O	4406
first	O	4406
five	O	4406
exons	O	4406
.	O	4406
two	O	4408
dinucleotide	O	4408
(	O	4408
ct	O	4408
)	O	4408
and	O	4408
one	O	4408
trinucleotide	O	4408
intronic	O	4408
polymorphism	O	4408
in	O	4408
hdh	O	4408
and	O	4408
an	O	4408
intronic	O	4408
ca	O	4408
polymorphism	O	4408
in	O	4408
the	O	4408
hd	B-Disease	4408
gene	O	4408
were	O	4408
identified	O	4408
.	O	4408
comparison	O	4409
of	O	4409
940	O	4409
-	O	4409
bp	O	4409
sequence	O	4409
5	O	4409
to	O	4409
the	O	4409
putative	O	4409
translation	O	4409
start	O	4409
site	O	4409
reveals	O	4409
a	O	4409
highly	O	4409
conserved	O	4409
region	O	4409
(	O	4409
78	O	4409
.	O	4409
8	O	4409
%	O	4409
nucleotide	O	4409
identity	O	4409
)	O	4409
between	O	4409
hdh	O	4409
and	O	4409
the	O	4409
hd	B-Disease	4409
gene	O	4409
from	O	4409
nucleotide	O	4409
-	O	4409
56	O	4409
to	O	4409
-	O	4409
206	O	4409
(	O	4409
of	O	4409
hdh	O	4409
)	O	4409
.	O	4409
neither	O	4410
hdh	O	4410
nor	O	4410
the	O	4410
hd	B-Disease	4410
gene	O	4410
have	O	4410
typical	O	4410
tata	O	4410
or	O	4410
ccaat	O	4410
elements	O	4410
,	O	4410
but	O	4410
both	O	4410
show	O	4410
one	O	4410
putative	O	4410
ap2	O	4410
binding	O	4410
site	O	4410
and	O	4410
numerous	O	4410
potential	O	4410
sp1	O	4410
binding	O	4410
sites	O	4410
.	O	4410
the	O	4411
high	O	4411
sequence	O	4411
identity	O	4411
between	O	4411
hdh	O	4411
and	O	4411
the	O	4411
hd	B-Disease	4411
gene	O	4411
for	O	4411
approximately	O	4411
200	O	4411
bp	O	4411
5	O	4411
to	O	4411
the	O	4411
putative	O	4411
translation	O	4411
start	O	4411
site	O	4411
indicates	O	4411
that	O	4411
these	O	4411
sequences	O	4411
may	O	4411
play	O	4411
a	O	4411
role	O	4411
in	O	4411
regulating	O	4411
expression	O	4411
of	O	4411
the	O	4411
huntington	B-Disease	4411
disease	I-Disease	4411
gene	O	4411
the	O	4412
protein	O	4412
deficient	O	4412
in	O	4412
lowe	B-Disease	4412
syndrome	I-Disease	4412
is	O	4412
a	O	4412
phosphatidylinositol	O	4412
-	O	4412
4	O	4412
,	O	4412
5	O	4412
-	O	4412
bisphosphate	O	4412
5	O	4412
-	O	4412
phosphatase	O	4412
.	O	4412
lowe	B-Disease	4413
syndrome	I-Disease	4413
,	O	4413
also	O	4413
known	O	4413
as	O	4413
oculocerebrorenal	B-Disease	4413
syndrome	I-Disease	4413
,	O	4413
is	O	4413
caused	O	4413
by	O	4413
mutations	O	4413
in	O	4413
the	O	4413
x	O	4413
chromosome	O	4413
-	O	4413
encoded	O	4413
ocrl	O	4413
gene	O	4413
.	O	4413
deficiency	O	4424
of	O	4424
this	O	4424
enzyme	O	4424
apparently	O	4424
causes	O	4424
the	O	4424
protean	O	4424
manifestations	O	4424
of	O	4424
lowe	B-Disease	4424
syndrome	I-Disease	4424
.	O	4424
.	O	4424
new	O	4425
founder	O	4425
haplotypes	O	4425
at	O	4425
the	O	4425
myotonic	B-Disease	4425
dystrophy	I-Disease	4425
locus	O	4425
in	O	4425
southern	O	4425
africa	O	4425
.	O	4425
the	O	4426
association	O	4426
between	O	4426
normal	O	4426
alleles	O	4426
at	O	4426
the	O	4426
ctg	O	4426
repeat	O	4426
and	O	4426
two	O	4426
nearby	O	4426
polymorphisms	O	4426
in	O	4426
the	O	4426
myotonin	O	4426
protein	O	4426
kinase	O	4426
gene	O	4426
,	O	4426
the	O	4426
alu	O	4426
insertion	O	4426
/	O	4426
deletion	O	4426
polymorphism	O	4426
and	O	4426
the	O	4426
myotonic	B-Disease	4426
dystrophy	I-Disease	4426
kinase	O	4426
(	O	4426
dmk	O	4426
)	O	4426
(	O	4426
g	O	4426
/	O	4426
t	O	4426
)	O	4426
intron	O	4426
9	O	4426
/	O	4426
hinfi	O	4426
polymorphism	O	4426
,	O	4426
has	O	4426
been	O	4426
analyzed	O	4426
in	O	4426
south	O	4426
african	O	4426
negroids	O	4426
,	O	4426
a	O	4426
population	O	4426
in	O	4426
which	O	4426
myotonic	B-Disease	4426
dystrophy	I-Disease	4426
(	O	4426
dm	B-Disease	4426
)	O	4426
has	O	4426
not	O	4426
been	O	4426
described	O	4426
.	O	4426
these	O	4431
data	O	4431
provide	O	4431
support	O	4431
for	O	4431
the	O	4431
out	O	4431
of	O	4431
africa	O	4431
model	O	4431
for	O	4431
the	O	4431
origin	O	4431
of	O	4431
modern	O	4431
humans	O	4431
and	O	4431
suggest	O	4431
that	O	4431
the	O	4431
rare	O	4431
ancestral	O	4431
dm	B-Disease	4431
mutation	O	4431
event	O	4431
may	O	4431
have	O	4431
occurred	O	4431
after	O	4431
the	O	4431
migration	O	4431
from	O	4431
africa	O	4431
,	O	4431
hence	O	4431
the	O	4431
absence	O	4431
of	O	4431
dm	B-Disease	4431
in	O	4431
sub	O	4431
-	O	4431
saharan	O	4431
negroid	O	4431
peoples	O	4431
.	O	4431
.	O	4431
discordant	O	4432
clinical	O	4432
outcome	O	4432
in	O	4432
myotonic	B-Disease	4432
dystrophy	I-Disease	4432
relatives	O	4432
showing	O	4432
(	O	4432
ctg	O	4432
)	O	4432
n	O	4432
>	O	4432
700	O	4432
repeats	O	4432
.	O	4432
a	O	4433
myotonic	B-Disease	4433
dystrophy	I-Disease	4433
(	O	4433
dm	B-Disease	4433
)	O	4433
family	O	4433
is	O	4433
described	O	4433
in	O	4433
which	O	4433
discordant	O	4433
dm	B-Disease	4433
phenotypes	O	4433
were	O	4433
found	O	4433
in	O	4433
the	O	4433
children	O	4433
of	O	4433
two	O	4433
affected	O	4433
sisters	O	4433
with	O	4433
similar	O	4433
ctg	O	4433
expansion	O	4433
and	O	4433
clinical	O	4433
manifestations	O	4433
.	O	4433
in	O	4434
this	O	4434
family	O	4434
,	O	4434
congenital	O	4434
as	O	4434
well	O	4434
as	O	4434
early	O	4434
severe	O	4434
childhood	O	4434
and	O	4434
later	O	4434
childhood	O	4434
onset	O	4434
dm	B-Disease	4434
coexist	O	4434
.	O	4434
this	O	4435
observation	O	4435
strengthens	O	4435
the	O	4435
limited	O	4435
ability	O	4435
of	O	4435
lymphocytes	O	4435
ctg	O	4435
repeat	O	4435
number	O	4435
analysis	O	4435
in	O	4435
predicting	O	4435
genotype	O	4435
-	O	4435
phenotype	O	4435
correlations	O	4435
in	O	4435
dm	B-Disease	4435
patients	O	4435
.	O	4435
.	O	4435
the	O	4441
seven	O	4441
deficient	O	4441
fibroblast	O	4441
lines	O	4441
were	O	4441
characterized	O	4441
by	O	4441
measuring	O	4441
acyl	O	4441
-	O	4441
coenzyme	O	4441
a	O	4441
dehydrogenation	O	4441
activities	O	4441
,	O	4441
overall	O	4441
palmitic	O	4441
acid	O	4441
oxidation	O	4441
,	O	4441
and	O	4441
vlcad	O	4441
protein	O	4441
synthesis	O	4441
using	O	4441
pulse	O	4441
-	O	4441
chase	O	4441
,	O	4441
further	O	4441
confirming	O	4441
the	O	4441
diagnosis	O	4441
of	O	4441
vlcad	B-Disease	4441
deficiency	I-Disease	4441
.	O	4441
clinically	O	4443
,	O	4443
all	O	4443
patients	O	4443
with	O	4443
vlcad	B-Disease	4443
deficiency	I-Disease	4443
exhibited	O	4443
cardiac	B-Disease	4443
disease	I-Disease	4443
.	O	4443
at	O	4444
least	O	4444
four	O	4444
of	O	4444
them	O	4444
presented	O	4444
with	O	4444
hypertrophic	B-Disease	4444
cardiomyopathy	I-Disease	4444
.	O	4444
this	O	4445
frequency	O	4445
(	O	4445
>	O	4445
57	O	4445
%	O	4445
)	O	4445
was	O	4445
much	O	4445
higher	O	4445
than	O	4445
that	O	4445
observed	O	4445
in	O	4445
patients	O	4445
with	O	4445
other	O	4445
disorders	O	4445
of	O	4445
mitochondrial	O	4445
long	O	4445
-	O	4445
chain	O	4445
fatty	O	4445
acid	O	4445
oxidation	O	4445
that	O	4445
may	O	4445
be	O	4445
accompanied	O	4445
by	O	4445
cardiac	B-Disease	4445
disease	I-Disease	4445
in	O	4445
infants	O	4445
.	O	4445
.	O	4445
hereditary	B-Disease	4446
deficiency	I-Disease	4446
of	I-Disease	4446
the	I-Disease	4446
fifth	I-Disease	4446
component	I-Disease	4446
of	I-Disease	4446
complement	I-Disease	4446
in	O	4446
man	O	4446
.	O	4446
biological	O	4448
properties	O	4448
of	O	4448
c5	B-Disease	4448
-	I-Disease	4448
deficient	I-Disease	4448
human	O	4448
serum	O	4448
.	O	4448
the	O	4449
first	O	4449
known	O	4449
human	O	4449
kindred	O	4449
with	O	4449
hereditary	B-Disease	4449
deficiency	I-Disease	4449
of	I-Disease	4449
the	I-Disease	4449
fifth	I-Disease	4449
component	I-Disease	4449
of	I-Disease	4449
complement	I-Disease	4449
(	O	4449
c5	O	4449
)	O	4449
was	O	4449
documented	O	4449
in	O	4449
the	O	4449
accompanying	O	4449
report	O	4449
.	O	4449
this	O	4450
study	O	4450
examines	O	4450
several	O	4450
biological	O	4450
properties	O	4450
of	O	4450
c5	B-Disease	4450
-	I-Disease	4450
deficient	I-Disease	4450
(	O	4450
c5d	B-Disease	4450
)	O	4450
human	O	4450
serum	O	4450
,	O	4450
particularly	O	4450
sera	O	4450
obtained	O	4450
from	O	4450
two	O	4450
c5d	B-Disease	4450
homozygotes	O	4450
.	O	4450
the	O	4451
proband	O	4451
,	O	4451
who	O	4451
has	O	4451
inactive	O	4451
systemic	B-Disease	4451
lupus	I-Disease	4451
erythematosus	I-Disease	4451
is	O	4451
completely	O	4451
lacking	O	4451
c5	O	4451
,	O	4451
while	O	4451
her	O	4451
healthy	O	4451
half	O	4451
-	O	4451
sister	O	4451
has	O	4451
1	O	4451
-	O	4451
2	O	4451
%	O	4451
of	O	4451
normal	O	4451
levels	O	4451
.	O	4451
sera	O	4454
from	O	4454
eight	O	4454
family	O	4454
members	O	4454
who	O	4454
were	O	4454
apparently	O	4454
heterozygous	O	4454
for	O	4454
c5	B-Disease	4454
deficiency	I-Disease	4454
gave	O	4454
normal	O	4454
chemotactic	O	4454
scores	O	4454
.	O	4454
the	O	4455
ability	O	4455
of	O	4455
c5d	B-Disease	4455
serum	O	4455
to	O	4455
opsonize	O	4455
saccharomyces	O	4455
cerevisiae	O	4455
(	O	4455
bakers	O	4455
yeast	O	4455
)	O	4455
or	O	4455
candida	O	4455
albicans	O	4455
for	O	4455
ingestion	O	4455
by	O	4455
normal	O	4455
neutrophils	O	4455
was	O	4455
completely	O	4455
normal	O	4455
.	O	4455
in	O	4456
addition	O	4456
,	O	4456
c5d	B-Disease	4456
serum	O	4456
was	O	4456
capable	O	4456
of	O	4456
promoting	O	4456
normal	O	4456
phagocytosis	O	4456
and	O	4456
intracellular	O	4456
killing	O	4456
of	O	4456
staphylococcus	O	4456
aureus	O	4456
.	O	4456
the	O	4457
probands	O	4457
serum	O	4457
was	O	4457
incapable	O	4457
of	O	4457
mediating	O	4457
lysis	O	4457
of	O	4457
erythrocytes	O	4457
from	O	4457
a	O	4457
patient	O	4457
with	O	4457
paroxysmal	B-Disease	4457
nocturnal	I-Disease	4457
hemoglobinuria	I-Disease	4457
in	O	4457
both	O	4457
the	O	4457
sucrose	O	4457
hemolysia	O	4457
and	O	4457
acid	O	4457
hemolysis	O	4457
tests	O	4457
,	O	4457
and	O	4457
also	O	4457
lacked	O	4457
bactericidal	O	4457
activity	O	4457
against	O	4457
sensitized	O	4457
or	O	4457
unsensitized	O	4457
salmonella	O	4457
typhi	O	4457
.	O	4457
human	O	4460
peroxisomal	O	4460
targeting	O	4460
signal	O	4460
-	O	4460
1	O	4460
receptor	O	4460
restores	O	4460
peroxisomal	O	4460
protein	O	4460
import	O	4460
in	O	4460
cells	O	4460
from	O	4460
patients	O	4460
with	O	4460
fatal	O	4460
peroxisomal	B-Disease	4460
disorders	I-Disease	4460
.	O	4460
human	O	4462
patients	O	4462
with	O	4462
fatal	O	4462
generalized	O	4462
peroxisomal	B-Disease	4462
deficiency	I-Disease	4462
disorders	I-Disease	4462
fall	O	4462
into	O	4462
at	O	4462
least	O	4462
nine	O	4462
genetic	O	4462
complementation	O	4462
groups	O	4462
.	O	4462
the	O	4472
pts1r	O	4472
cdna	O	4472
also	O	4472
complements	O	4472
the	O	4472
pts1	B-Disease	4472
protein	I-Disease	4472
-	I-Disease	4472
import	I-Disease	4472
defect	I-Disease	4472
in	O	4472
skin	O	4472
fibroblasts	O	4472
from	O	4472
patients	O	4472
-	O	4472
-	O	4472
belonging	O	4472
to	O	4472
complementation	O	4472
group	O	4472
two	O	4472
-	O	4472
-	O	4472
diagnosed	O	4472
as	O	4472
having	O	4472
neonatal	B-Disease	4472
adrenoleukodystrophy	I-Disease	4472
or	O	4472
zellweger	B-Disease	4472
syndrome	I-Disease	4472
.	O	4472
the	O	4473
pts1r	O	4473
gene	O	4473
has	O	4473
been	O	4473
localized	O	4473
to	O	4473
a	O	4473
chromosomal	O	4473
location	O	4473
where	O	4473
no	O	4473
other	O	4473
peroxisomal	B-Disease	4473
disorder	I-Disease	4473
genes	O	4473
are	O	4473
known	O	4473
to	O	4473
map	O	4473
.	O	4473
our	O	4474
findings	O	4474
represent	O	4474
the	O	4474
only	O	4474
case	O	4474
in	O	4474
which	O	4474
the	O	4474
molecular	O	4474
basis	O	4474
of	O	4474
the	O	4474
protein	B-Disease	4474
-	I-Disease	4474
import	I-Disease	4474
deficiency	I-Disease	4474
in	O	4474
human	O	4474
peroxisomal	B-Disease	4474
disorders	I-Disease	4474
is	O	4474
understood	O	4474
.	O	4474
spectrum	O	4475
of	O	4475
germline	O	4475
mutations	O	4475
in	O	4475
the	O	4475
rb1	O	4475
gene	O	4475
:	O	4475
a	O	4475
study	O	4475
of	O	4475
232	O	4475
patients	O	4475
with	O	4475
hereditary	B-Disease	4475
and	I-Disease	4475
non	I-Disease	4475
hereditary	I-Disease	4475
retinoblastoma	I-Disease	4475
.	O	4475
germline	O	4476
mutations	O	4476
in	O	4476
the	O	4476
rb1	O	4476
gene	O	4476
confer	O	4476
hereditary	O	4476
predisposition	O	4476
to	O	4476
retinoblastoma	B-Disease	4476
.	O	4476
we	O	4477
have	O	4477
performed	O	4477
a	O	4477
mutation	O	4477
survey	O	4477
of	O	4477
the	O	4477
rb1	O	4477
gene	O	4477
in	O	4477
232	O	4477
patients	O	4477
with	O	4477
hereditary	B-Disease	4477
or	I-Disease	4477
non	I-Disease	4477
hereditary	I-Disease	4477
retinoblastoma	I-Disease	4477
.	O	4477
the	O	4482
spectrum	O	4482
of	O	4482
mutations	O	4482
presented	O	4482
here	O	4482
should	O	4482
help	O	4482
to	O	4482
improve	O	4482
the	O	4482
clinical	O	4482
management	O	4482
of	O	4482
retinoblastoma	B-Disease	4482
and	O	4482
to	O	4482
understand	O	4482
the	O	4482
molecular	O	4482
mechanisms	O	4482
leading	O	4482
to	O	4482
tumorigenesis	O	4482
.	O	4482
.	O	4482
aniridia	B-Disease	4483
-	O	4483
associated	O	4483
cytogenetic	O	4483
rearrangements	O	4483
suggest	O	4483
that	O	4483
a	O	4483
position	O	4483
effect	O	4483
may	O	4483
cause	O	4483
the	O	4483
mutant	O	4483
phenotype	O	4483
.	O	4483
current	O	4484
evidence	O	4484
suggests	O	4484
that	O	4484
aniridia	B-Disease	4484
(	O	4484
absence	B-Disease	4484
of	I-Disease	4484
iris	I-Disease	4484
)	O	4484
is	O	4484
caused	O	4484
by	O	4484
loss	O	4484
of	O	4484
function	O	4484
of	O	4484
one	O	4484
copy	O	4484
of	O	4484
the	O	4484
pax6	O	4484
gene	O	4484
,	O	4484
which	O	4484
maps	O	4484
to	O	4484
11p13	O	4484
.	O	4484
we	O	4485
present	O	4485
the	O	4485
further	O	4485
characterisation	O	4485
of	O	4485
two	O	4485
aniridia	B-Disease	4485
pedigrees	O	4485
in	O	4485
which	O	4485
the	O	4485
disease	O	4485
segregates	O	4485
with	O	4485
chromosomal	O	4485
rearrangements	O	4485
which	O	4485
involve	O	4485
11p13	O	4485
but	O	4485
do	O	4485
not	O	4485
disrupt	O	4485
the	O	4485
pax6	O	4485
gene	O	4485
.	O	4485
somatic	O	4489
mutations	O	4489
in	O	4489
the	O	4489
brca1	O	4489
gene	O	4489
in	O	4489
sporadic	B-Disease	4489
ovarian	I-Disease	4489
tumours	I-Disease	4489
.	O	4489
the	O	4490
brca1	O	4490
gene	O	4490
on	O	4490
chromosome	O	4490
17q21	O	4490
is	O	4490
responsible	O	4490
for	O	4490
an	O	4490
autosomal	B-Disease	4490
dominant	I-Disease	4490
syndrome	I-Disease	4490
of	O	4490
increased	O	4490
susceptibility	O	4490
to	O	4490
breast	B-Disease	4490
and	I-Disease	4490
ovarian	I-Disease	4490
cancer	I-Disease	4490
but	O	4490
no	O	4490
somatic	O	4490
mutations	O	4490
in	O	4490
tumours	B-Disease	4490
have	O	4490
yet	O	4490
been	O	4490
described	O	4490
.	O	4490
to	O	4491
study	O	4491
the	O	4491
potential	O	4491
role	O	4491
of	O	4491
brca1	O	4491
in	O	4491
sporadic	O	4491
carcinogenesis	O	4491
,	O	4491
we	O	4491
analysed	O	4491
the	O	4491
genomic	O	4491
dna	O	4491
of	O	4491
tumour	B-Disease	4491
and	O	4491
normal	O	4491
fractions	O	4491
of	O	4491
47	O	4491
ovarian	B-Disease	4491
cancers	I-Disease	4491
for	O	4491
mutations	O	4491
in	O	4491
brca1	O	4491
using	O	4491
the	O	4491
single	O	4491
-	O	4491
strand	O	4491
conformation	O	4491
polymorphism	O	4491
technique	O	4491
.	O	4491
we	O	4492
now	O	4492
describe	O	4492
somatic	O	4492
mutations	O	4492
in	O	4492
the	O	4492
dna	O	4492
of	O	4492
four	O	4492
tumours	B-Disease	4492
which	O	4492
also	O	4492
had	O	4492
loss	O	4492
of	O	4492
heterozygosity	O	4492
(	O	4492
loh	O	4492
)	O	4492
at	O	4492
a	O	4492
brca1	O	4492
intragenic	O	4492
marker	O	4492
.	O	4492
our	O	4493
data	O	4493
support	O	4493
a	O	4493
tumour	B-Disease	4493
suppressor	O	4493
mechanism	O	4493
for	O	4493
brca1	O	4493
;	O	4493
somatic	O	4493
mutations	O	4493
and	O	4493
loh	O	4493
may	O	4493
result	O	4493
in	O	4493
inactivation	O	4493
of	O	4493
brca1	O	4493
in	O	4493
at	O	4493
least	O	4493
a	O	4493
small	O	4493
number	O	4493
of	O	4493
ovarian	B-Disease	4493
cancers	I-Disease	4493
.	O	4493
.	O	4493
decreased	O	4494
expression	O	4494
of	O	4494
brca1	O	4494
accelerates	O	4494
growth	O	4494
and	O	4494
is	O	4494
often	O	4494
present	O	4494
during	O	4494
sporadic	B-Disease	4494
breast	I-Disease	4494
cancer	I-Disease	4494
progression	O	4494
.	O	4494
we	O	4495
have	O	4495
characterized	O	4495
expression	O	4495
of	O	4495
the	O	4495
familial	B-Disease	4495
breast	I-Disease	4495
and	I-Disease	4495
ovarian	I-Disease	4495
cancer	I-Disease	4495
gene	O	4495
,	O	4495
brca1	O	4495
,	O	4495
in	O	4495
cases	O	4495
of	O	4495
non	B-Disease	4495
-	I-Disease	4495
hereditary	I-Disease	4495
(	I-Disease	4495
sporadic	I-Disease	4495
)	I-Disease	4495
breast	I-Disease	4495
cancer	I-Disease	4495
and	O	4495
analyzed	O	4495
the	O	4495
effect	O	4495
of	O	4495
antisense	O	4495
inhibition	O	4495
of	O	4495
brca1	O	4495
on	O	4495
the	O	4495
proliferative	O	4495
rate	O	4495
of	O	4495
mammary	O	4495
epithelial	O	4495
cells	O	4495
.	O	4495
brca1	O	4496
mrna	O	4496
levels	O	4496
are	O	4496
markedly	O	4496
decreased	O	4496
during	O	4496
the	O	4496
transition	O	4496
from	O	4496
carcinoma	B-Disease	4496
in	I-Disease	4496
situ	I-Disease	4496
to	O	4496
invasive	B-Disease	4496
cancer	I-Disease	4496
.	O	4496
these	O	4498
studies	O	4498
suggest	O	4498
that	O	4498
brca1	O	4498
may	O	4498
normally	O	4498
serve	O	4498
as	O	4498
a	O	4498
negative	O	4498
regulator	O	4498
of	O	4498
mammary	O	4498
epithelial	O	4498
cell	O	4498
growth	O	4498
whose	O	4498
function	O	4498
is	O	4498
compromised	O	4498
in	O	4498
breast	B-Disease	4498
cancer	I-Disease	4498
either	O	4498
by	O	4498
direct	O	4498
mutation	O	4498
or	O	4498
alterations	O	4498
in	O	4498
gene	O	4498
expression	O	4498
.	O	4498
.	O	4498
additional	O	4499
case	O	4499
of	O	4499
female	O	4499
monozygotic	O	4499
twins	O	4499
discordant	O	4499
for	O	4499
the	O	4499
clinical	O	4499
manifestations	O	4499
of	O	4499
duchenne	B-Disease	4499
muscular	I-Disease	4499
dystrophy	I-Disease	4499
due	O	4499
to	O	4499
opposite	O	4499
x	O	4499
-	O	4499
chromosome	O	4499
inactivation	O	4499
.	O	4499
a	O	4500
pair	O	4500
of	O	4500
female	O	4500
monozygotic	O	4500
(	O	4500
mz	O	4500
)	O	4500
twins	O	4500
,	O	4500
heterozygous	O	4500
carriers	O	4500
for	O	4500
a	O	4500
deletion	O	4500
in	O	4500
the	O	4500
dmd	B-Disease	4500
gene	O	4500
and	O	4500
discordant	O	4500
for	O	4500
the	O	4500
clinical	O	4500
manifestations	O	4500
of	O	4500
duchenne	B-Disease	4500
muscular	I-Disease	4500
dystrophy	I-Disease	4500
,	O	4500
were	O	4500
analyzed	O	4500
by	O	4500
molecular	O	4500
studies	O	4500
,	O	4500
in	O	4500
situ	O	4500
hybridization	O	4500
,	O	4500
and	O	4500
methylation	O	4500
pattern	O	4500
of	O	4500
x	O	4500
chromosomes	O	4500
to	O	4500
search	O	4500
for	O	4500
opposite	O	4500
x	O	4500
inactivation	O	4500
as	O	4500
an	O	4500
explanation	O	4500
of	O	4500
their	O	4500
clinical	O	4500
discordance	O	4500
.	O	4500
a	O	4502
review	O	4502
shows	O	4502
that	O	4502
mz	O	4502
female	O	4502
twins	O	4502
discordant	O	4502
for	O	4502
x	B-Disease	4502
-	I-Disease	4502
linked	I-Disease	4502
diseases	I-Disease	4502
are	O	4502
not	O	4502
uncommon	O	4502
.	O	4502
x	B-Disease	4504
-	I-Disease	4504
linked	I-Disease	4504
adrenoleukodystrophy	I-Disease	4504
(	O	4504
ald	B-Disease	4504
)	O	4504
:	O	4504
a	O	4504
novel	O	4504
mutation	O	4504
of	O	4504
the	O	4504
ald	B-Disease	4504
gene	O	4504
in	O	4504
6	O	4504
members	O	4504
of	O	4504
a	O	4504
family	O	4504
presenting	O	4504
with	O	4504
5	O	4504
different	O	4504
phenotypes	O	4504
.	O	4504
fragments	O	4505
of	O	4505
the	O	4505
adrenoleukodystrophy	B-Disease	4505
(	O	4505
ald	B-Disease	4505
)	O	4505
cdna	O	4505
from	O	4505
a	O	4505
patient	O	4505
with	O	4505
adolescent	B-Disease	4505
ald	I-Disease	4505
were	O	4505
amplified	O	4505
by	O	4505
polymerase	O	4505
chain	O	4505
reaction	O	4505
and	O	4505
subcloned	O	4505
.	O	4505
bidirectional	O	4506
sequencing	O	4506
of	O	4506
the	O	4506
entire	O	4506
coding	O	4506
ald	B-Disease	4506
gene	O	4506
disclosed	O	4506
a	O	4506
cytosine	O	4506
to	O	4506
guanine	O	4506
transversion	O	4506
at	O	4506
nucleotide	O	4506
1451	O	4506
in	O	4506
exon	O	4506
five	O	4506
,	O	4506
resulting	O	4506
in	O	4506
substitution	O	4506
of	O	4506
proline	O	4506
484	O	4506
by	O	4506
arginine	O	4506
.	O	4506
five	O	4507
of	O	4507
nine	O	4507
siblings	O	4507
of	O	4507
the	O	4507
patient	O	4507
,	O	4507
comprising	O	4507
two	O	4507
cerebral	B-Disease	4507
ald	I-Disease	4507
,	O	4507
one	O	4507
adrenomyeloneuropathy	B-Disease	4507
,	O	4507
one	O	4507
addison	B-Disease	4507
only	I-Disease	4507
as	O	4507
well	O	4507
as	O	4507
the	O	4507
symptomatic	O	4507
mother	O	4507
(	O	4507
all	O	4507
accumulating	O	4507
very	O	4507
long	O	4507
chain	O	4507
fatty	O	4507
acids	O	4507
)	O	4507
carried	O	4507
this	O	4507
mutation	O	4507
,	O	4507
which	O	4507
was	O	4507
not	O	4507
found	O	4507
in	O	4507
the	O	4507
unaffected	O	4507
persons	O	4507
,	O	4507
in	O	4507
five	O	4507
unrelated	O	4507
ald	B-Disease	4507
patients	O	4507
,	O	4507
and	O	4507
in	O	4507
twenty	O	4507
controls	O	4507
.	O	4507
novel	O	4509
mutation	O	4509
at	O	4509
the	O	4509
initiation	O	4509
codon	O	4509
in	O	4509
the	O	4509
norrie	B-Disease	4509
disease	I-Disease	4509
gene	O	4509
in	O	4509
two	O	4509
japanese	O	4509
families	O	4509
.	O	4509
we	O	4510
have	O	4510
identified	O	4510
a	O	4510
new	O	4510
mutation	O	4510
of	O	4510
norrie	B-Disease	4510
disease	I-Disease	4510
(	O	4510
nd	B-Disease	4510
)	O	4510
gene	O	4510
in	O	4510
two	O	4510
japanese	O	4510
males	O	4510
from	O	4510
unrelated	O	4510
families	O	4510
;	O	4510
they	O	4510
showed	O	4510
typical	O	4510
ocular	O	4510
features	O	4510
of	O	4510
nd	B-Disease	4510
but	O	4510
no	O	4510
mental	B-Disease	4510
retardation	I-Disease	4510
or	O	4510
hearing	B-Disease	4510
impairment	I-Disease	4510
.	O	4510
a	O	4511
mutation	O	4511
was	O	4511
found	O	4511
in	O	4511
both	O	4511
patients	O	4511
at	O	4511
the	O	4511
initiation	O	4511
codon	O	4511
of	O	4511
exon	O	4511
2	O	4511
of	O	4511
the	O	4511
nd	B-Disease	4511
gene	O	4511
(	O	4511
atg	O	4511
to	O	4511
gtg	O	4511
)	O	4511
,	O	4511
with	O	4511
otherwise	O	4511
normal	O	4511
nucleotide	O	4511
sequences	O	4511
.	O	4511
the	O	4513
mutation	O	4513
of	O	4513
the	O	4513
initiation	O	4513
codon	O	4513
would	O	4513
cause	O	4513
the	O	4513
failure	O	4513
of	O	4513
nd	B-Disease	4513
gene	O	4513
expression	O	4513
or	O	4513
a	O	4513
defect	O	4513
in	O	4513
translation	O	4513
thereby	O	4513
truncating	O	4513
the	O	4513
amino	O	4513
terminus	O	4513
of	O	4513
nd	B-Disease	4513
protein	O	4513
.	O	4513
in	O	4514
view	O	4514
of	O	4514
the	O	4514
rarity	O	4514
and	O	4514
marked	O	4514
heterogeneity	O	4514
of	O	4514
mutations	O	4514
in	O	4514
the	O	4514
nd	B-Disease	4514
gene	O	4514
,	O	4514
the	O	4514
present	O	4514
apparently	O	4514
unrelated	O	4514
japanese	O	4514
families	O	4514
who	O	4514
have	O	4514
lived	O	4514
in	O	4514
the	O	4514
same	O	4514
area	O	4514
for	O	4514
over	O	4514
two	O	4514
centuries	O	4514
presumably	O	4514
share	O	4514
the	O	4514
origin	O	4514
of	O	4514
the	O	4514
mutation	O	4514
.	O	4514
.	O	4514
anticipation	O	4515
resulting	O	4515
in	O	4515
elimination	O	4515
of	O	4515
the	O	4515
myotonic	B-Disease	4515
dystrophy	I-Disease	4515
gene	O	4515
:	O	4515
a	O	4515
follow	O	4515
up	O	4515
study	O	4515
of	O	4515
one	O	4515
extended	O	4515
family	O	4515
.	O	4515
we	O	4516
have	O	4516
re	O	4516
-	O	4516
examined	O	4516
an	O	4516
extended	O	4516
myotonic	B-Disease	4516
dystrophy	I-Disease	4516
(	O	4516
dm	B-Disease	4516
)	O	4516
family	O	4516
,	O	4516
previously	O	4516
described	O	4516
in	O	4516
1955	O	4516
,	O	4516
in	O	4516
order	O	4516
to	O	4516
study	O	4516
the	O	4516
long	O	4516
term	O	4516
effects	O	4516
of	O	4516
anticipation	O	4516
in	O	4516
dm	B-Disease	4516
and	O	4516
in	O	4516
particular	O	4516
the	O	4516
implications	O	4516
for	O	4516
families	O	4516
affected	O	4516
by	O	4516
this	O	4516
disease	O	4516
.	O	4516
clinical	O	4518
anticipation	O	4518
,	O	4518
defined	O	4518
as	O	4518
the	O	4518
cascade	O	4518
of	O	4518
mild	O	4518
,	O	4518
adult	O	4518
,	O	4518
childhood	O	4518
,	O	4518
or	O	4518
congenital	B-Disease	4518
disease	I-Disease	4518
in	O	4518
subsequent	O	4518
generations	O	4518
,	O	4518
appeared	O	4518
to	O	4518
be	O	4518
a	O	4518
relentless	O	4518
process	O	4518
,	O	4518
occurring	O	4518
in	O	4518
all	O	4518
affected	O	4518
branches	O	4518
of	O	4518
the	O	4518
family	O	4518
.	O	4518
gene	O	4523
loss	O	4523
in	O	4523
the	O	4523
patient	O	4523
group	O	4523
was	O	4523
complete	O	4523
,	O	4523
owing	O	4523
to	O	4523
infertility	B-Disease	4523
of	O	4523
the	O	4523
male	O	4523
patients	O	4523
with	O	4523
adult	O	4523
onset	O	4523
disease	O	4523
and	O	4523
the	O	4523
fact	O	4523
that	O	4523
mentally	B-Disease	4523
retarded	I-Disease	4523
patients	O	4523
did	O	4523
not	O	4523
procreate	O	4523
.	O	4523
therefore	O	4527
it	O	4527
is	O	4527
highly	O	4527
probable	O	4527
that	O	4527
the	O	4527
dm	B-Disease	4527
gene	O	4527
will	O	4527
be	O	4527
eliminated	O	4527
from	O	4527
this	O	4527
pedigree	O	4527
within	O	4527
one	O	4527
generation	O	4527
.	O	4527
the	O	4528
high	O	4528
population	O	4528
frequency	O	4528
of	O	4528
dm	B-Disease	4528
can	O	4528
at	O	4528
present	O	4528
not	O	4528
be	O	4528
explained	O	4528
by	O	4528
the	O	4528
contribution	O	4528
of	O	4528
asymptomatic	O	4528
cases	O	4528
in	O	4528
the	O	4528
younger	O	4528
generations	O	4528
of	O	4528
known	O	4528
families	O	4528
,	O	4528
but	O	4528
is	O	4528
probably	O	4528
caused	O	4528
by	O	4528
the	O	4528
events	O	4528
in	O	4528
the	O	4528
ancestral	O	4528
generations	O	4528
.	O	4528
.	O	4528
the	O	4529
gene	O	4529
for	O	4529
spinal	B-Disease	4529
cerebellar	I-Disease	4529
ataxia	I-Disease	4529
3	O	4529
(	O	4529
sca3	O	4529
)	O	4529
is	O	4529
located	O	4529
in	O	4529
a	O	4529
region	O	4529
of	O	4529
approximately	O	4529
3	O	4529
cm	O	4529
on	O	4529
chromosome	O	4529
14q24	O	4529
.	O	4529
3	O	4529
-	O	4529
q32	O	4529
.	O	4529
2	O	4529
.	O	4529
sca3	O	4530
,	O	4530
the	O	4530
gene	O	4530
for	O	4530
spinal	B-Disease	4530
cerebellar	I-Disease	4530
ataxia	I-Disease	4530
3	O	4530
,	O	4530
was	O	4530
recently	O	4530
mapped	O	4530
to	O	4530
a	O	4530
15	O	4530
-	O	4530
cm	O	4530
interval	O	4530
between	O	4530
d14s67	O	4530
and	O	4530
d14s81	O	4530
on	O	4530
chromosome	O	4530
14q	O	4530
,	O	4530
by	O	4530
linkage	O	4530
analysis	O	4530
in	O	4530
two	O	4530
families	O	4530
of	O	4530
french	O	4530
ancestry	O	4530
.	O	4530
2	O	4541
containing	O	4541
the	O	4541
gene	O	4541
for	O	4541
the	O	4541
machado	B-Disease	4541
-	I-Disease	4541
joseph	I-Disease	4541
disease	I-Disease	4541
,	O	4541
which	O	4541
is	O	4541
clinically	O	4541
related	O	4541
to	O	4541
the	O	4541
phenotype	O	4541
determined	O	4541
by	O	4541
sca3	O	4541
,	O	4541
but	O	4541
it	O	4541
cannot	O	4541
yet	O	4541
be	O	4541
concluded	O	4541
that	O	4541
both	O	4541
diseases	O	4541
result	O	4541
from	O	4541
alterations	O	4541
of	O	4541
the	O	4541
same	O	4541
gene	O	4541
an	O	4542
evaluation	O	4542
of	O	4542
genetic	O	4542
heterogeneity	O	4542
in	O	4542
145	O	4542
breast	B-Disease	4542
-	I-Disease	4542
ovarian	I-Disease	4542
cancer	I-Disease	4542
families	O	4542
.	O	4542
breast	B-Disease	4543
cancer	I-Disease	4543
linkage	O	4543
consortium	O	4543
.	O	4543
the	O	4544
breast	B-Disease	4544
-	I-Disease	4544
ovary	I-Disease	4544
cancer	I-Disease	4544
-	I-Disease	4544
family	I-Disease	4544
syndrome	I-Disease	4544
is	O	4544
a	O	4544
dominant	O	4544
predisposition	O	4544
to	O	4544
cancer	B-Disease	4544
of	I-Disease	4544
the	I-Disease	4544
breast	I-Disease	4544
and	I-Disease	4544
ovaries	I-Disease	4544
which	O	4544
has	O	4544
been	O	4544
mapped	O	4544
to	O	4544
chromosome	O	4544
region	O	4544
17q12	O	4544
-	O	4544
q21	O	4544
.	O	4544
the	O	4545
majority	O	4545
,	O	4545
but	O	4545
not	O	4545
all	O	4545
,	O	4545
of	O	4545
breast	B-Disease	4545
-	I-Disease	4545
ovary	I-Disease	4545
cancer	I-Disease	4545
families	O	4545
show	O	4545
linkage	O	4545
to	O	4545
this	O	4545
susceptibility	O	4545
locus	O	4545
,	O	4545
designated	O	4545
brca1	O	4545
.	O	4545
we	O	4546
report	O	4546
here	O	4546
the	O	4546
results	O	4546
of	O	4546
a	O	4546
linkage	O	4546
analysis	O	4546
of	O	4546
145	O	4546
families	O	4546
with	O	4546
both	O	4546
breast	B-Disease	4546
and	I-Disease	4546
ovarian	I-Disease	4546
cancer	I-Disease	4546
.	O	4546
these	O	4547
families	O	4547
contain	O	4547
either	O	4547
a	O	4547
total	O	4547
of	O	4547
three	O	4547
or	O	4547
more	O	4547
cases	O	4547
of	O	4547
early	O	4547
-	O	4547
onset	O	4547
(	O	4547
before	O	4547
age	O	4547
60	O	4547
years	O	4547
)	O	4547
breast	B-Disease	4547
cancer	I-Disease	4547
or	O	4547
ovarian	B-Disease	4547
cancer	I-Disease	4547
.	O	4547
all	O	4548
families	O	4548
contained	O	4548
at	O	4548
least	O	4548
one	O	4548
case	O	4548
of	O	4548
ovarian	B-Disease	4548
cancer	I-Disease	4548
.	O	4548
none	O	4550
of	O	4550
the	O	4550
13	O	4550
families	O	4550
with	O	4550
cases	O	4550
of	O	4550
male	B-Disease	4550
breast	I-Disease	4550
cancer	I-Disease	4550
appear	O	4550
to	O	4550
be	O	4550
linked	O	4550
,	O	4550
but	O	4550
it	O	4550
is	O	4550
estimated	O	4550
that	O	4550
92	O	4550
%	O	4550
(	O	4550
95	O	4550
%	O	4550
confidence	O	4550
interval	O	4550
76	O	4550
%	O	4550
-	O	4550
100	O	4550
%	O	4550
)	O	4550
of	O	4550
families	O	4550
with	O	4550
no	O	4550
male	B-Disease	4550
breast	I-Disease	4550
cancer	I-Disease	4550
and	O	4550
with	O	4550
two	O	4550
or	O	4550
more	O	4550
ovarian	B-Disease	4550
cancers	I-Disease	4550
are	O	4550
linked	O	4550
to	O	4550
brca1	O	4550
.	O	4550
these	O	4551
data	O	4551
suggest	O	4551
that	O	4551
the	O	4551
breast	B-Disease	4551
-	I-Disease	4551
ovarian	I-Disease	4551
cancer	I-Disease	4551
-	I-Disease	4551
family	I-Disease	4551
syndrome	I-Disease	4551
is	O	4551
genetically	O	4551
heterogeneous	O	4551
.	O	4551
however	O	4552
,	O	4552
the	O	4552
large	O	4552
majority	O	4552
of	O	4552
families	O	4552
with	O	4552
early	O	4552
-	O	4552
onset	O	4552
breast	B-Disease	4552
cancer	I-Disease	4552
and	O	4552
with	O	4552
two	O	4552
or	O	4552
more	O	4552
cases	O	4552
of	O	4552
ovarian	B-Disease	4552
cancer	I-Disease	4552
are	O	4552
likely	O	4552
to	O	4552
be	O	4552
due	O	4552
to	O	4552
brca1	O	4552
mutations	O	4552
.	O	4552
.	O	4552
molecular	O	4553
basis	O	4553
of	O	4553
essential	B-Disease	4553
fructosuria	I-Disease	4553
:	O	4553
molecular	O	4553
cloning	O	4553
and	O	4553
mutational	O	4553
analysis	O	4553
of	O	4553
human	O	4553
ketohexokinase	O	4553
(	O	4553
fructokinase	O	4553
)	O	4553
.	O	4553
essential	B-Disease	4554
fructosuria	I-Disease	4554
is	O	4554
one	O	4554
of	O	4554
the	O	4554
oldest	O	4554
known	O	4554
inborn	B-Disease	4554
errors	I-Disease	4554
of	I-Disease	4554
metabolism	I-Disease	4554
.	O	4554
it	O	4555
is	O	4555
a	O	4555
benign	O	4555
condition	O	4555
which	O	4555
is	O	4555
believed	O	4555
to	O	4555
result	O	4555
from	O	4555
deficiency	B-Disease	4555
of	I-Disease	4555
hepatic	I-Disease	4555
fructokinase	I-Disease	4555
(	O	4555
ketohexokinase	O	4555
,	O	4555
khk	O	4555
,	O	4555
e	O	4555
.	O	4555
c	O	4555
.	O	4555
2	O	4555
.	O	4555
7	O	4555
.	O	4555
1	O	4555
.	O	4555
3	O	4555
)	O	4555
.	O	4555
despite	O	4557
the	O	4557
early	O	4557
recognition	O	4557
of	O	4557
this	O	4557
disorder	O	4557
,	O	4557
the	O	4557
primary	O	4557
structure	O	4557
of	O	4557
human	O	4557
khk	O	4557
and	O	4557
the	O	4557
molecular	O	4557
basis	O	4557
of	O	4557
essential	B-Disease	4557
fructosuria	I-Disease	4557
have	O	4557
not	O	4557
been	O	4557
previously	O	4557
defined	O	4557
.	O	4557
direct	O	4561
evidence	O	4561
that	O	4561
mutation	O	4561
of	O	4561
the	O	4561
khk	O	4561
structural	O	4561
gene	O	4561
is	O	4561
the	O	4561
cause	O	4561
of	O	4561
essential	B-Disease	4561
fructosuria	I-Disease	4561
was	O	4561
also	O	4561
obtained	O	4561
.	O	4561
in	O	4562
a	O	4562
well	O	4562
-	O	4562
characterized	O	4562
family	O	4562
,	O	4562
in	O	4562
which	O	4562
three	O	4562
of	O	4562
eight	O	4562
siblings	O	4562
have	O	4562
fructosuria	B-Disease	4562
,	O	4562
all	O	4562
affected	O	4562
individuals	O	4562
are	O	4562
compound	O	4562
heterozygotes	O	4562
for	O	4562
two	O	4562
mutations	O	4562
gly40arg	O	4562
and	O	4562
ala43thr	O	4562
.	O	4562
homozygous	O	4566
presence	O	4566
of	O	4566
the	O	4566
crossover	O	4566
(	O	4566
fusion	O	4566
gene	O	4566
)	O	4566
mutation	O	4566
identified	O	4566
in	O	4566
a	O	4566
type	B-Disease	4566
ii	I-Disease	4566
gaucher	I-Disease	4566
disease	I-Disease	4566
fetus	O	4566
:	O	4566
is	O	4566
this	O	4566
analogous	O	4566
to	O	4566
the	O	4566
gaucher	O	4566
knock	O	4566
-	O	4566
out	O	4566
mouse	O	4566
model	O	4566
?	O	4566
gaucher	B-Disease	4567
disease	I-Disease	4567
(	O	4567
gd	B-Disease	4567
)	O	4567
is	O	4567
an	O	4567
inherited	O	4567
deficiency	B-Disease	4567
of	I-Disease	4567
beta	I-Disease	4567
-	I-Disease	4567
glucocerebrosidase	I-Disease	4567
(	O	4567
ec	O	4567
3	O	4567
.	O	4567
1	O	4567
.	O	4567
2	O	4567
.	O	4567
45	O	4567
,	O	4567
gene	O	4567
symbol	O	4567
gba	O	4567
)	O	4567
.	O	4567
in	O	4568
type	B-Disease	4568
i	I-Disease	4568
gd	I-Disease	4568
,	O	4568
the	O	4568
cns	O	4568
is	O	4568
not	O	4568
involved	O	4568
(	O	4568
nonneuronopathic	O	4568
)	O	4568
,	O	4568
whereas	O	4568
in	O	4568
type	B-Disease	4568
ii	I-Disease	4568
gd	I-Disease	4568
(	O	4568
acute	O	4568
neuronopathic	O	4568
)	O	4568
cns	O	4568
involvement	O	4568
is	O	4568
early	O	4568
and	O	4568
rapidly	O	4568
progressive	O	4568
,	O	4568
while	O	4568
in	O	4568
type	B-Disease	4568
iii	I-Disease	4568
gd	I-Disease	4568
(	O	4568
subacute	O	4568
neuronopathic	O	4568
)	O	4568
cns	O	4568
involvement	O	4568
occurs	O	4568
later	O	4568
and	O	4568
is	O	4568
slowly	O	4568
progressive	O	4568
.	O	4568
the	O	4569
t6433c	O	4569
(	O	4569
l444p	O	4569
)	O	4569
substitution	O	4569
is	O	4569
prevalent	O	4569
in	O	4569
type	B-Disease	4569
gd	I-Disease	4569
ii	I-Disease	4569
.	O	4569
using	O	4574
this	O	4574
procedure	O	4574
we	O	4574
demonstrated	O	4574
the	O	4574
fusion	O	4574
gene	O	4574
in	O	4574
homozygous	O	4574
form	O	4574
for	O	4574
the	O	4574
first	O	4574
time	O	4574
,	O	4574
in	O	4574
a	O	4574
macedonian	O	4574
/	O	4574
ashkenazi	O	4574
jewish	O	4574
gd	B-Disease	4574
type	I-Disease	4574
ii	I-Disease	4574
fetus	O	4574
.	O	4574
a	O	4577
previous	O	4577
conceptus	O	4577
in	O	4577
this	O	4577
family	O	4577
was	O	4577
stillborn	B-Disease	4577
at	O	4577
36	O	4577
weeks	O	4577
,	O	4577
with	O	4577
features	O	4577
of	O	4577
severe	O	4577
type	B-Disease	4577
ii	I-Disease	4577
gd	I-Disease	4577
.	O	4577
late	O	4580
infantile	O	4580
metachromatic	B-Disease	4580
leukodystrophy	I-Disease	4580
in	O	4580
israel	O	4580
.	O	4580
metachromatic	B-Disease	4581
leukodystrophy	I-Disease	4581
(	O	4581
mld	B-Disease	4581
)	O	4581
is	O	4581
a	O	4581
neurodegenerative	B-Disease	4581
disease	I-Disease	4581
in	O	4581
which	O	4581
the	O	4581
lysosomal	O	4581
enzyme	O	4581
,	O	4581
aryl	O	4581
sulfatase	O	4581
a	O	4581
(	O	4581
arsa	O	4581
)	O	4581
is	O	4581
deficient	O	4581
.	O	4581
the	O	4583
gene	O	4583
of	O	4583
arsa	O	4583
has	O	4583
been	O	4583
cloned	O	4583
and	O	4583
up	O	4583
to	O	4583
now	O	4583
eight	O	4583
mutations	O	4583
causing	O	4583
mld	B-Disease	4583
have	O	4583
been	O	4583
reported	O	4583
.	O	4583
in	O	4586
israel	O	4586
,	O	4586
late	O	4586
infantile	O	4586
mld	B-Disease	4586
was	O	4586
found	O	4586
to	O	4586
be	O	4586
very	O	4586
frequent	O	4586
in	O	4586
a	O	4586
small	O	4586
jewish	O	4586
isolate	O	4586
,	O	4586
the	O	4586
habbanite	O	4586
jews	O	4586
(	O	4586
1	O	4586
/	O	4586
75	O	4586
live	O	4586
births	O	4586
)	O	4586
.	O	4586
mld	B-Disease	4589
is	O	4589
also	O	4589
frequent	O	4589
among	O	4589
moslem	O	4589
arabs	O	4589
in	O	4589
jerusalem	O	4589
.	O	4589
this	O	4591
mutation	O	4591
has	O	4591
been	O	4591
reported	O	4591
in	O	4591
patients	O	4591
with	O	4591
the	O	4591
late	O	4591
infantile	O	4591
mld	B-Disease	4591
from	O	4591
different	O	4591
ethnic	O	4591
groups	O	4591
.	O	4591
knowledge	O	4593
of	O	4593
the	O	4593
different	O	4593
mutations	O	4593
causing	O	4593
mld	B-Disease	4593
in	O	4593
these	O	4593
defined	O	4593
populations	O	4593
will	O	4593
allow	O	4593
a	O	4593
carrier	O	4593
screening	O	4593
program	O	4593
to	O	4593
be	O	4593
carried	O	4593
out	O	4593
and	O	4593
prevent	O	4593
the	O	4593
birth	O	4593
of	O	4593
additional	O	4593
affected	O	4593
children	O	4593
.	O	4593
.	O	4593
a	O	4594
single	O	4594
amino	O	4594
acid	O	4594
substitution	O	4594
(	O	4594
g103d	O	4594
)	O	4594
in	O	4594
the	O	4594
type	O	4594
ii	O	4594
collagen	O	4594
triple	O	4594
helix	O	4594
produces	O	4594
kniest	B-Disease	4594
dysplasia	I-Disease	4594
.	O	4594
kniest	B-Disease	4595
dysplasia	I-Disease	4595
is	O	4595
a	O	4595
moderately	O	4595
severe	O	4595
chondrodysplasia	B-Disease	4595
phenotype	O	4595
that	O	4595
results	O	4595
from	O	4595
mutations	O	4595
in	O	4595
the	O	4595
gene	O	4595
for	O	4595
type	O	4595
ii	O	4595
collagen	O	4595
,	O	4595
col2a1	O	4595
.	O	4595
characteristics	O	4596
of	O	4596
the	O	4596
disorder	O	4596
include	O	4596
a	O	4596
short	B-Disease	4596
trunk	I-Disease	4596
and	I-Disease	4596
extremities	I-Disease	4596
,	O	4596
mid	B-Disease	4596
-	I-Disease	4596
face	I-Disease	4596
hypoplasia	I-Disease	4596
,	O	4596
cleft	B-Disease	4596
palate	I-Disease	4596
,	O	4596
myopia	B-Disease	4596
,	O	4596
retinal	B-Disease	4596
detachment	I-Disease	4596
,	O	4596
and	O	4596
hearing	B-Disease	4596
loss	I-Disease	4596
.	O	4596
recently	O	4597
,	O	4597
deletions	O	4597
of	O	4597
all	O	4597
or	O	4597
part	O	4597
of	O	4597
exon	O	4597
12	O	4597
have	O	4597
been	O	4597
identified	O	4597
in	O	4597
individuals	O	4597
with	O	4597
kniest	B-Disease	4597
dysplasia	I-Disease	4597
,	O	4597
suggesting	O	4597
that	O	4597
mutations	O	4597
within	O	4597
this	O	4597
region	O	4597
of	O	4597
the	O	4597
protein	O	4597
may	O	4597
primarily	O	4597
result	O	4597
in	O	4597
the	O	4597
kniest	B-Disease	4597
dysplasia	I-Disease	4597
phenotype	O	4597
.	O	4597
we	O	4598
used	O	4598
sscp	O	4598
to	O	4598
analyze	O	4598
an	O	4598
amplified	O	4598
genomic	O	4598
dna	O	4598
fragment	O	4598
containing	O	4598
exon	O	4598
12	O	4598
from	O	4598
seven	O	4598
individuals	O	4598
with	O	4598
kniest	B-Disease	4598
dysplasia	I-Disease	4598
.	O	4598
these	O	4603
data	O	4603
demonstrate	O	4603
that	O	4603
point	O	4603
mutations	O	4603
which	O	4603
result	O	4603
in	O	4603
single	O	4603
amino	O	4603
acid	O	4603
substitutions	O	4603
can	O	4603
produce	O	4603
kniest	B-Disease	4603
dysplasia	I-Disease	4603
and	O	4603
further	O	4603
support	O	4603
the	O	4603
hypothesis	O	4603
that	O	4603
alteration	O	4603
of	O	4603
a	O	4603
domain	O	4603
,	O	4603
which	O	4603
includes	O	4603
the	O	4603
region	O	4603
encoded	O	4603
by	O	4603
exon	O	4603
12	O	4603
,	O	4603
in	O	4603
the	O	4603
type	O	4603
ii	O	4603
collagen	O	4603
protein	O	4603
leads	O	4603
to	O	4603
this	O	4603
disorder	O	4603
.	O	4603
.	O	4603
cag	O	4604
expansions	O	4604
in	O	4604
a	O	4604
novel	O	4604
gene	O	4604
for	O	4604
machado	B-Disease	4604
-	I-Disease	4604
joseph	I-Disease	4604
disease	I-Disease	4604
at	O	4604
chromosome	O	4604
14q32	O	4604
.	O	4604
1	O	4604
.	O	4604
1	O	4606
,	O	4606
the	O	4606
genetic	O	4606
locus	O	4606
for	O	4606
machado	B-Disease	4606
-	I-Disease	4606
joseph	I-Disease	4606
disease	I-Disease	4606
(	O	4606
mjd	B-Disease	4606
)	O	4606
.	O	4606
in	O	4607
normal	O	4607
individuals	O	4607
the	O	4607
gene	O	4607
contains	O	4607
between	O	4607
13	O	4607
and	O	4607
36	O	4607
cag	O	4607
repeats	O	4607
,	O	4607
whereas	O	4607
most	O	4607
of	O	4607
the	O	4607
clinically	O	4607
diagnosed	O	4607
patients	O	4607
and	O	4607
all	O	4607
of	O	4607
the	O	4607
affected	O	4607
members	O	4607
of	O	4607
a	O	4607
family	O	4607
with	O	4607
the	O	4607
clinical	O	4607
and	O	4607
pathological	O	4607
diagnosis	O	4607
of	O	4607
mjd	B-Disease	4607
show	O	4607
expansion	O	4607
of	O	4607
the	O	4607
repeat	O	4607
-	O	4607
number	O	4607
(	O	4607
from	O	4607
68	O	4607
-	O	4607
79	O	4607
)	O	4607
.	O	4607
these	O	4609
results	O	4609
raise	O	4609
the	O	4609
possibility	O	4609
that	O	4609
similar	O	4609
abnormalities	O	4609
in	O	4609
related	O	4609
genes	O	4609
may	O	4609
give	O	4609
rise	O	4609
to	O	4609
diseases	O	4609
similar	O	4609
to	O	4609
mjd	B-Disease	4609
.	O	4609
mutations	O	4610
in	O	4610
the	O	4610
brca1	O	4610
gene	O	4610
in	O	4610
families	O	4610
with	O	4610
early	O	4610
-	O	4610
onset	O	4610
breast	B-Disease	4610
and	I-Disease	4610
ovarian	I-Disease	4610
cancer	I-Disease	4610
.	O	4610
we	O	4611
analysed	O	4611
50	O	4611
probands	O	4611
with	O	4611
a	O	4611
family	O	4611
history	O	4611
of	O	4611
breast	B-Disease	4611
and	I-Disease	4611
/	I-Disease	4611
or	I-Disease	4611
ovarian	I-Disease	4611
cancer	I-Disease	4611
for	O	4611
germline	O	4611
mutations	O	4611
in	O	4611
the	O	4611
coding	O	4611
region	O	4611
of	O	4611
the	O	4611
brca1	O	4611
candidate	O	4611
gene	O	4611
,	O	4611
using	O	4611
single	O	4611
-	O	4611
strand	O	4611
conformation	O	4611
polymorphism	O	4611
(	O	4611
sscp	O	4611
)	O	4611
analysis	O	4611
on	O	4611
pcr	O	4611
-	O	4611
amplified	O	4611
genomic	O	4611
dna	O	4611
.	O	4611
these	O	4614
data	O	4614
are	O	4614
consistent	O	4614
with	O	4614
a	O	4614
tumour	B-Disease	4614
suppressor	O	4614
model	O	4614
,	O	4614
and	O	4614
support	O	4614
the	O	4614
notion	O	4614
that	O	4614
this	O	4614
candidate	O	4614
gene	O	4614
is	O	4614
in	O	4614
fact	O	4614
brca1	O	4614
.	O	4614
confirmation	O	4616
of	O	4616
brca1	O	4616
by	O	4616
analysis	O	4616
of	O	4616
germline	O	4616
mutations	O	4616
linked	O	4616
to	O	4616
breast	B-Disease	4616
and	I-Disease	4616
ovarian	I-Disease	4616
cancer	I-Disease	4616
in	O	4616
ten	O	4616
families	O	4616
.	O	4616
we	O	4617
provide	O	4617
genetic	O	4617
evidence	O	4617
supporting	O	4617
the	O	4617
identity	O	4617
of	O	4617
the	O	4617
candidate	O	4617
gene	O	4617
for	O	4617
brca1	O	4617
through	O	4617
the	O	4617
characterization	O	4617
of	O	4617
germline	O	4617
mutations	O	4617
in	O	4617
63	O	4617
breast	B-Disease	4617
cancer	I-Disease	4617
patients	O	4617
and	O	4617
10	O	4617
ovarian	B-Disease	4617
cancer	I-Disease	4617
patients	O	4617
in	O	4617
ten	O	4617
families	O	4617
with	O	4617
cancer	B-Disease	4617
linked	O	4617
to	O	4617
chromosome	O	4617
17q21	O	4617
.	O	4617
the	O	4622
four	O	4622
families	O	4622
with	O	4622
both	O	4622
breast	B-Disease	4622
and	I-Disease	4622
ovarian	I-Disease	4622
cancer	I-Disease	4622
had	O	4622
chain	O	4622
termination	O	4622
mutations	O	4622
in	O	4622
the	O	4622
n	O	4622
-	O	4622
terminal	O	4622
half	O	4622
of	O	4622
the	O	4622
protein	O	4622
.	O	4622
.	O	4622
high	O	4623
resolution	O	4623
genetic	O	4623
analysis	O	4623
suggests	O	4623
one	O	4623
ancestral	O	4623
predisposing	O	4623
haplotype	O	4623
for	O	4623
the	O	4623
origin	O	4623
of	O	4623
the	O	4623
myotonic	B-Disease	4623
dystrophy	I-Disease	4623
mutation	O	4623
.	O	4623
the	O	4624
mutation	O	4624
causing	O	4624
myotonic	B-Disease	4624
dystrophy	I-Disease	4624
(	O	4624
dm	B-Disease	4624
)	O	4624
has	O	4624
been	O	4624
identified	O	4624
as	O	4624
an	O	4624
amplification	O	4624
of	O	4624
an	O	4624
unstable	O	4624
trinucleotide	O	4624
(	O	4624
ctg	O	4624
)	O	4624
n	O	4624
repeat	O	4624
in	O	4624
over	O	4624
99	O	4624
%	O	4624
of	O	4624
the	O	4624
global	O	4624
dm	B-Disease	4624
population	O	4624
.	O	4624
it	O	4625
is	O	4625
in	O	4625
complete	O	4625
linkage	O	4625
disequilibrium	O	4625
with	O	4625
an	O	4625
alu	O	4625
element	O	4625
polymorphism	O	4625
within	O	4625
the	O	4625
dm	B-Disease	4625
kinase	O	4625
gene	O	4625
,	O	4625
suggesting	O	4625
that	O	4625
dm	B-Disease	4625
is	O	4625
a	O	4625
consequence	O	4625
of	O	4625
one	O	4625
or	O	4625
few	O	4625
ancestral	O	4625
mutations	O	4625
.	O	4625
a	O	4626
recent	O	4626
analysis	O	4626
utilizing	O	4626
this	O	4626
polymorphism	O	4626
as	O	4626
well	O	4626
as	O	4626
a	O	4626
flanking	O	4626
dinucleotide	O	4626
marker	O	4626
,	O	4626
suggested	O	4626
that	O	4626
similar	O	4626
to	O	4626
fragile	B-Disease	4626
x	I-Disease	4626
syndrome	I-Disease	4626
,	O	4626
dm	B-Disease	4626
exhibited	O	4626
a	O	4626
founder	O	4626
effect	O	4626
(	O	4626
imbert	O	4626
et	O	4626
al	O	4626
.	O	4626
,	O	4626
1993	O	4626
nature	O	4626
genet	O	4626
.	O	4626
4	O	4626
,	O	4626
72	O	4626
-	O	4626
76	O	4626
)	O	4626
.	O	4626
in	O	4627
contrast	O	4627
,	O	4627
the	O	4627
low	O	4627
reproductive	O	4627
fitness	O	4627
of	O	4627
individuals	O	4627
with	O	4627
congenital	O	4627
dm	B-Disease	4627
(	O	4627
the	O	4627
endpoint	O	4627
of	O	4627
genetic	O	4627
anticipation	O	4627
in	O	4627
myotonic	B-Disease	4627
dystrophy	I-Disease	4627
)	O	4627
suggests	O	4627
a	O	4627
higher	O	4627
rate	O	4627
of	O	4627
new	O	4627
mutations	O	4627
.	O	4627
we	O	4628
present	O	4628
a	O	4628
high	O	4628
resolution	O	4628
genetic	O	4628
analysis	O	4628
of	O	4628
the	O	4628
dm	B-Disease	4628
locus	O	4628
using	O	4628
pcr	O	4628
based	O	4628
assays	O	4628
of	O	4628
nine	O	4628
polymorphisms	O	4628
,	O	4628
spanning	O	4628
a	O	4628
physical	O	4628
distance	O	4628
of	O	4628
30	O	4628
kb	O	4628
,	O	4628
within	O	4628
and	O	4628
immediately	O	4628
flanking	O	4628
the	O	4628
dm	B-Disease	4628
kinase	O	4628
gene	O	4628
.	O	4628
the	O	4629
persistent	O	4629
complete	O	4629
allelic	O	4629
association	O	4629
of	O	4629
the	O	4629
dm	B-Disease	4629
mutation	O	4629
with	O	4629
all	O	4629
these	O	4629
polymorphisms	O	4629
provides	O	4629
further	O	4629
support	O	4629
to	O	4629
previous	O	4629
observations	O	4629
and	O	4629
suggests	O	4629
more	O	4629
strongly	O	4629
that	O	4629
the	O	4629
dm	B-Disease	4629
mutation	O	4629
occurred	O	4629
on	O	4629
the	O	4629
background	O	4629
of	O	4629
a	O	4629
particular	O	4629
haplotype	O	4629
in	O	4629
which	O	4629
the	O	4629
(	O	4629
ctg	O	4629
)	O	4629
n	O	4629
repeat	O	4629
became	O	4629
inherently	O	4629
unstable	O	4629
and	O	4629
therefore	O	4629
predisposed	O	4629
to	O	4629
amplification	O	4629
.	O	4629
genetic	O	4630
instability	O	4630
in	O	4630
human	O	4630
ovarian	B-Disease	4630
cancer	I-Disease	4630
cell	O	4630
lines	O	4630
.	O	4630
we	O	4631
have	O	4631
analyzed	O	4631
the	O	4631
stability	O	4631
of	O	4631
microsatellites	O	4631
in	O	4631
cell	O	4631
lines	O	4631
derived	O	4631
from	O	4631
human	O	4631
ovarian	B-Disease	4631
cancers	I-Disease	4631
and	O	4631
found	O	4631
that	O	4631
5	O	4631
out	O	4631
of	O	4631
10	O	4631
of	O	4631
the	O	4631
ovarian	B-Disease	4631
tumor	I-Disease	4631
cell	O	4631
lines	O	4631
are	O	4631
genetically	O	4631
unstable	O	4631
at	O	4631
the	O	4631
majority	O	4631
of	O	4631
the	O	4631
loci	O	4631
analyzed	O	4631
.	O	4631
in	O	4632
clones	O	4632
and	O	4632
subclones	O	4632
derived	O	4632
serially	O	4632
from	O	4632
one	O	4632
of	O	4632
these	O	4632
cell	O	4632
lines	O	4632
(	O	4632
2774	O	4632
;	O	4632
serous	B-Disease	4632
cystadenocarcinoma	I-Disease	4632
)	O	4632
,	O	4632
a	O	4632
very	O	4632
high	O	4632
proportion	O	4632
of	O	4632
microsatellites	O	4632
distributed	O	4632
in	O	4632
many	O	4632
different	O	4632
regions	O	4632
of	O	4632
the	O	4632
genome	O	4632
change	O	4632
their	O	4632
size	O	4632
in	O	4632
a	O	4632
mercurial	O	4632
fashion	O	4632
.	O	4632
we	O	4633
conclude	O	4633
that	O	4633
genomic	O	4633
instability	O	4633
in	O	4633
ovarian	B-Disease	4633
tumors	I-Disease	4633
is	O	4633
a	O	4633
dynamic	O	4633
and	O	4633
ongoing	O	4633
process	O	4633
whose	O	4633
high	O	4633
frequency	O	4633
may	O	4633
have	O	4633
been	O	4633
previously	O	4633
underestimated	O	4633
by	O	4633
pcr	O	4633
-	O	4633
based	O	4633
allelotyping	O	4633
of	O	4633
bulk	O	4633
tumor	B-Disease	4633
tissue	O	4633
.	O	4633
we	O	4634
have	O	4634
identified	O	4634
the	O	4634
source	O	4634
of	O	4634
the	O	4634
genetic	O	4634
instability	O	4634
in	O	4634
one	O	4634
ovarian	B-Disease	4634
tumor	I-Disease	4634
as	O	4634
a	O	4634
point	O	4634
mutation	O	4634
(	O	4634
r524p	O	4634
)	O	4634
in	O	4634
the	O	4634
human	O	4634
mismatch	O	4634
-	O	4634
repair	O	4634
gene	O	4634
msh2	O	4634
(	O	4634
salmonella	O	4634
muts	O	4634
homologue	O	4634
)	O	4634
,	O	4634
which	O	4634
has	O	4634
recently	O	4634
been	O	4634
shown	O	4634
to	O	4634
be	O	4634
involved	O	4634
in	O	4634
hereditary	B-Disease	4634
nonpolyposis	I-Disease	4634
colorectal	I-Disease	4634
cancer	I-Disease	4634
.	O	4634
however	O	4636
the	O	4636
wild	O	4636
-	O	4636
type	O	4636
allele	O	4636
was	O	4636
lost	O	4636
at	O	4636
some	O	4636
point	O	4636
early	O	4636
during	O	4636
tumorigenesis	O	4636
so	O	4636
that	O	4636
dna	O	4636
isolated	O	4636
either	O	4636
from	O	4636
the	O	4636
patients	O	4636
ovarian	B-Disease	4636
tumor	I-Disease	4636
or	O	4636
from	O	4636
the	O	4636
2774	O	4636
cell	O	4636
line	O	4636
carries	O	4636
only	O	4636
the	O	4636
mutant	O	4636
allele	O	4636
of	O	4636
the	O	4636
human	O	4636
msh2	O	4636
gene	O	4636
.	O	4636
the	O	4637
genetic	O	4637
instability	O	4637
observed	O	4637
in	O	4637
the	O	4637
tumor	B-Disease	4637
and	O	4637
cell	O	4637
line	O	4637
dna	O	4637
,	O	4637
together	O	4637
with	O	4637
the	O	4637
germ	O	4637
-	O	4637
line	O	4637
mutation	O	4637
in	O	4637
a	O	4637
mismatch	O	4637
-	O	4637
repair	O	4637
gene	O	4637
,	O	4637
suggest	O	4637
that	O	4637
the	O	4637
msh2	O	4637
gene	O	4637
is	O	4637
involved	O	4637
in	O	4637
the	O	4637
onset	O	4637
and	O	4637
/	O	4637
or	O	4637
progression	O	4637
in	O	4637
a	O	4637
subset	O	4637
of	O	4637
ovarian	B-Disease	4637
cancer	I-Disease	4637
.	O	4637
.	O	4637
brca1	O	4638
mutations	O	4638
in	O	4638
primary	O	4638
breast	B-Disease	4638
and	I-Disease	4638
ovarian	I-Disease	4638
carcinomas	I-Disease	4638
.	O	4638
loss	O	4639
of	O	4639
heterozygosity	O	4639
data	O	4639
from	O	4639
familial	B-Disease	4639
tumors	I-Disease	4639
suggest	O	4639
that	O	4639
brca1	O	4639
,	O	4639
a	O	4639
gene	O	4639
that	O	4639
confers	O	4639
susceptibility	O	4639
to	O	4639
ovarian	B-Disease	4639
and	I-Disease	4639
early	I-Disease	4639
-	I-Disease	4639
onset	I-Disease	4639
breast	B-Disease	4639
cancer	I-Disease	4639
,	O	4639
encodes	O	4639
a	O	4639
tumor	B-Disease	4639
suppressor	O	4639
.	O	4639
the	O	4640
brca1	O	4640
region	O	4640
is	O	4640
also	O	4640
subject	O	4640
to	O	4640
allelic	O	4640
loss	O	4640
in	O	4640
sporadic	B-Disease	4640
breast	I-Disease	4640
and	I-Disease	4640
ovarian	I-Disease	4640
cancers	I-Disease	4640
,	O	4640
an	O	4640
indication	O	4640
that	O	4640
brca1	O	4640
mutations	O	4640
may	O	4640
occur	O	4640
somatically	O	4640
in	O	4640
these	O	4640
tumors	B-Disease	4640
.	O	4640
the	O	4641
brca1	O	4641
coding	O	4641
region	O	4641
was	O	4641
examined	O	4641
for	O	4641
mutations	O	4641
in	O	4641
primary	O	4641
breast	B-Disease	4641
and	I-Disease	4641
ovarian	I-Disease	4641
tumors	I-Disease	4641
that	O	4641
show	O	4641
allele	O	4641
loss	O	4641
at	O	4641
the	O	4641
brca1	O	4641
locus	O	4641
.	O	4641
mutations	O	4642
were	O	4642
detected	O	4642
in	O	4642
3	O	4642
of	O	4642
32	O	4642
breast	O	4642
and	O	4642
1	O	4642
of	O	4642
12	O	4642
ovarian	B-Disease	4642
carcinomas	I-Disease	4642
;	O	4642
all	O	4642
four	O	4642
mutations	O	4642
were	O	4642
germline	O	4642
alterations	O	4642
and	O	4642
occurred	O	4642
in	O	4642
early	O	4642
-	O	4642
onset	O	4642
cancers	B-Disease	4642
.	O	4642
these	O	4643
results	O	4643
suggest	O	4643
that	O	4643
mutation	O	4643
of	O	4643
brca1	O	4643
may	O	4643
not	O	4643
be	O	4643
critical	O	4643
in	O	4643
the	O	4643
development	O	4643
of	O	4643
the	O	4643
majority	O	4643
of	O	4643
breast	B-Disease	4643
and	I-Disease	4643
ovarian	I-Disease	4643
cancers	I-Disease	4643
that	O	4643
arise	O	4643
in	O	4643
the	O	4643
absence	O	4643
of	O	4643
a	O	4643
mutant	O	4643
germline	O	4643
allele	O	4643
.	O	4643
.	O	4643
pax6	O	4644
gene	O	4644
dosage	O	4644
effect	O	4644
in	O	4644
a	O	4644
family	O	4644
with	O	4644
congenital	B-Disease	4644
cataracts	I-Disease	4644
,	O	4644
aniridia	B-Disease	4644
,	O	4644
anophthalmia	B-Disease	4644
and	O	4644
central	B-Disease	4644
nervous	I-Disease	4644
system	I-Disease	4644
defects	I-Disease	4644
.	O	4644
the	O	4645
human	O	4645
eye	O	4645
malformation	O	4645
aniridia	B-Disease	4645
results	O	4645
from	O	4645
haploinsufficiency	B-Disease	4645
of	I-Disease	4645
pax6	I-Disease	4645
,	O	4645
a	O	4645
paired	O	4645
box	O	4645
dna	O	4645
-	O	4645
binding	O	4645
protein	O	4645
.	O	4645
to	O	4646
study	O	4646
this	O	4646
dosage	O	4646
effect	O	4646
,	O	4646
we	O	4646
characterized	O	4646
two	O	4646
pax6	O	4646
mutations	O	4646
in	O	4646
a	O	4646
family	O	4646
segregating	O	4646
aniridia	B-Disease	4646
and	O	4646
a	O	4646
milder	O	4646
syndrome	O	4646
consisting	O	4646
of	O	4646
congenital	B-Disease	4646
cataracts	I-Disease	4646
and	O	4646
late	O	4646
onset	O	4646
corneal	B-Disease	4646
dystrophy	I-Disease	4646
.	O	4646
a	O	4649
compound	O	4649
heterozygote	O	4649
had	O	4649
severe	O	4649
craniofacial	B-Disease	4649
and	I-Disease	4649
central	I-Disease	4649
nervous	I-Disease	4649
system	I-Disease	4649
defects	I-Disease	4649
and	O	4649
no	B-Disease	4649
eyes	I-Disease	4649
.	O	4649
we	O	4652
have	O	4652
constructed	O	4652
a	O	4652
physical	O	4652
map	O	4652
of	O	4652
a	O	4652
4	O	4652
cm	O	4652
region	O	4652
on	O	4652
chromosome	O	4652
17q12	O	4652
-	O	4652
21	O	4652
that	O	4652
contains	O	4652
the	O	4652
hereditary	B-Disease	4652
breast	I-Disease	4652
and	I-Disease	4652
ovarian	I-Disease	4652
cancer	I-Disease	4652
gene	O	4652
brca1	O	4652
.	O	4652
two	O	4655
genes	O	4655
that	O	4655
lie	O	4655
within	O	4655
a	O	4655
narrow	O	4655
region	O	4655
defined	O	4655
by	O	4655
meiotic	O	4655
breakpoints	O	4655
in	O	4655
brca1	O	4655
patients	O	4655
have	O	4655
been	O	4655
sequenced	O	4655
in	O	4655
breast	B-Disease	4655
cancer	I-Disease	4655
patients	O	4655
without	O	4655
revealing	O	4655
any	O	4655
deleterious	O	4655
mutations	O	4655
.	O	4655
the	O	4657
lec	O	4657
rat	O	4657
has	O	4657
a	O	4657
deletion	O	4657
in	O	4657
the	O	4657
copper	O	4657
transporting	O	4657
atpase	O	4657
gene	O	4657
homologous	O	4657
to	O	4657
the	O	4657
wilson	B-Disease	4657
disease	I-Disease	4657
gene	O	4657
.	O	4657
the	O	4658
long	O	4658
-	O	4658
evans	O	4658
cinnamon	O	4658
(	O	4658
lec	O	4658
)	O	4658
rat	O	4658
shows	O	4658
similarity	O	4658
to	O	4658
wilson	B-Disease	4658
disease	I-Disease	4658
in	O	4658
many	O	4658
clinical	O	4658
and	O	4658
biochemical	O	4658
features	O	4658
.	O	4658
we	O	4659
have	O	4659
cloned	O	4659
cdnas	O	4659
for	O	4659
the	O	4659
rat	O	4659
gene	O	4659
(	O	4659
atp7b	O	4659
)	O	4659
homologous	O	4659
to	O	4659
the	O	4659
human	O	4659
wilson	B-Disease	4659
disease	I-Disease	4659
gene	O	4659
(	O	4659
atp7b	O	4659
)	O	4659
and	O	4659
have	O	4659
used	O	4659
them	O	4659
to	O	4659
identify	O	4659
a	O	4659
partial	O	4659
deletion	O	4659
in	O	4659
the	O	4659
atp7b	O	4659
gene	O	4659
in	O	4659
the	O	4659
lec	O	4659
rat	O	4659
.	O	4659
our	O	4661
results	O	4661
provide	O	4661
convincing	O	4661
evidence	O	4661
for	O	4661
defining	O	4661
the	O	4661
lec	O	4661
rat	O	4661
as	O	4661
an	O	4661
animal	O	4661
model	O	4661
for	O	4661
wilson	B-Disease	4661
disease	I-Disease	4661
.	O	4661
this	O	4662
model	O	4662
will	O	4662
be	O	4662
important	O	4662
for	O	4662
studying	O	4662
liver	O	4662
pathophysiology	O	4662
,	O	4662
for	O	4662
developing	O	4662
therapy	O	4662
for	O	4662
wilson	B-Disease	4662
disease	I-Disease	4662
and	O	4662
for	O	4662
studying	O	4662
the	O	4662
pathway	O	4662
of	O	4662
copper	O	4662
transport	O	4662
and	O	4662
its	O	4662
possible	O	4662
interaction	O	4662
with	O	4662
other	O	4662
heavy	O	4662
metals	O	4662
.	O	4662
.	O	4662
genomic	O	4663
organization	O	4663
of	O	4663
the	O	4663
adrenoleukodystrophy	B-Disease	4663
gene	O	4663
.	O	4663
adrenoleukodystrophy	B-Disease	4664
(	O	4664
ald	B-Disease	4664
)	O	4664
,	O	4664
the	O	4664
most	O	4664
frequent	O	4664
peroxisomal	B-Disease	4664
disorder	I-Disease	4664
,	O	4664
is	O	4664
a	O	4664
severe	O	4664
neurodegenerative	B-Disease	4664
disease	I-Disease	4664
associated	O	4664
with	O	4664
an	O	4664
impairment	B-Disease	4664
of	I-Disease	4664
very	I-Disease	4664
long	I-Disease	4664
chain	I-Disease	4664
fatty	I-Disease	4664
acids	I-Disease	4664
beta	I-Disease	4664
-	I-Disease	4664
oxidation	I-Disease	4664
.	O	4664
we	O	4665
have	O	4665
recently	O	4665
identified	O	4665
by	O	4665
positional	O	4665
cloning	O	4665
the	O	4665
gene	O	4665
responsible	O	4665
for	O	4665
ald	B-Disease	4665
,	O	4665
located	O	4665
in	O	4665
xq28	O	4665
.	O	4665
we	O	4667
report	O	4667
here	O	4667
a	O	4667
detailed	O	4667
characterization	O	4667
of	O	4667
the	O	4667
ald	B-Disease	4667
gene	O	4667
structure	O	4667
.	O	4667
to	O	4669
facilitate	O	4669
the	O	4669
detection	O	4669
of	O	4669
mutations	O	4669
in	O	4669
ald	B-Disease	4669
patients	O	4669
,	O	4669
we	O	4669
have	O	4669
determined	O	4669
the	O	4669
intronic	O	4669
sequences	O	4669
flanking	O	4669
the	O	4669
exons	O	4669
as	O	4669
well	O	4669
as	O	4669
the	O	4669
sequence	O	4669
of	O	4669
the	O	4669
3	O	4669
untranslated	O	4669
region	O	4669
and	O	4669
of	O	4669
the	O	4669
immediate	O	4669
5	O	4669
promoter	O	4669
region	O	4669
.	O	4669
the	O	4671
ald	B-Disease	4671
gene	O	4671
has	O	4671
been	O	4671
positioned	O	4671
on	O	4671
a	O	4671
pulsed	O	4671
-	O	4671
field	O	4671
map	O	4671
between	O	4671
dxs15	O	4671
and	O	4671
the	O	4671
l1cam	O	4671
gene	O	4671
,	O	4671
about	O	4671
650	O	4671
kb	O	4671
upstream	O	4671
from	O	4671
the	O	4671
color	O	4671
pigment	O	4671
genes	O	4671
.	O	4671
the	O	4672
frequent	O	4672
occurrence	O	4672
of	O	4672
color	O	4672
vision	O	4672
anomalies	O	4672
observed	O	4672
in	O	4672
patients	O	4672
with	O	4672
adrenomyeloneuropathy	B-Disease	4672
(	O	4672
the	O	4672
adult	O	4672
onset	O	4672
form	O	4672
of	O	4672
ald	B-Disease	4672
)	O	4672
thus	O	4672
does	O	4672
not	O	4672
represent	O	4672
a	O	4672
contiguous	B-Disease	4672
gene	I-Disease	4672
syndrome	I-Disease	4672
but	O	4672
a	O	4672
secondary	O	4672
manifestation	O	4672
of	O	4672
ald	B-Disease	4672
.	O	4672
.	O	4672
the	O	4673
murine	O	4673
homologues	O	4673
of	O	4673
the	O	4673
huntington	B-Disease	4673
disease	I-Disease	4673
gene	O	4673
(	O	4673
hdh	O	4673
)	O	4673
and	O	4673
the	O	4673
alpha	O	4673
-	O	4673
adducin	O	4673
gene	O	4673
(	O	4673
add1	O	4673
)	O	4673
map	O	4673
to	O	4673
mouse	O	4673
chromosome	O	4673
5	O	4673
within	O	4673
a	O	4673
region	O	4673
of	O	4673
conserved	O	4673
synteny	O	4673
with	O	4673
human	O	4673
chromosome	O	4673
4p16	O	4673
.	O	4673
3	O	4673
.	O	4673
huntington	B-Disease	4674
disease	I-Disease	4674
(	O	4674
hd	B-Disease	4674
)	O	4674
is	O	4674
a	O	4674
severe	O	4674
autosomal	B-Disease	4674
dominant	I-Disease	4674
neurodegenerative	I-Disease	4674
disorder	I-Disease	4674
associated	O	4674
with	O	4674
a	O	4674
novel	O	4674
gene	O	4674
(	O	4674
it15	O	4674
)	O	4674
.	O	4674
genetic	O	4679
cholesteryl	B-Disease	4679
ester	I-Disease	4679
transfer	I-Disease	4679
protein	I-Disease	4679
deficiency	I-Disease	4679
caused	O	4679
by	O	4679
two	O	4679
prevalent	O	4679
mutations	O	4679
as	O	4679
a	O	4679
major	O	4679
determinant	O	4679
of	O	4679
increased	O	4679
levels	O	4679
of	O	4679
high	O	4679
density	O	4679
lipoprotein	O	4679
cholesterol	O	4679
.	O	4679
we	O	4681
previously	O	4681
described	O	4681
plasma	O	4681
cholesteryl	B-Disease	4681
ester	I-Disease	4681
transfer	I-Disease	4681
protein	I-Disease	4681
(	I-Disease	4681
cetp	I-Disease	4681
)	I-Disease	4681
deficiency	I-Disease	4681
due	O	4681
to	O	4681
an	O	4681
intron	O	4681
14	O	4681
g	O	4681
(	O	4681
+	O	4681
1	O	4681
)	O	4681
-	O	4681
to	O	4681
-	O	4681
a	O	4681
mutation	O	4681
(	O	4681
int14	O	4681
a	O	4681
)	O	4681
in	O	4681
several	O	4681
families	O	4681
with	O	4681
very	O	4681
high	O	4681
hdl	O	4681
-	O	4681
c	O	4681
levels	O	4681
in	O	4681
japan	O	4681
.	O	4681
cetp	B-Disease	4692
deficiency	I-Disease	4692
,	O	4692
reflecting	O	4692
two	O	4692
prevalent	O	4692
mutations	O	4692
(	O	4692
d442g	O	4692
and	O	4692
int14	O	4692
a	O	4692
)	O	4692
,	O	4692
is	O	4692
the	O	4692
first	O	4692
example	O	4692
of	O	4692
a	O	4692
genetic	B-Disease	4692
deficiency	I-Disease	4692
state	O	4692
which	O	4692
is	O	4692
sufficiently	O	4692
common	O	4692
to	O	4692
explain	O	4692
a	O	4692
significant	O	4692
fraction	O	4692
of	O	4692
the	O	4692
variation	O	4692
in	O	4692
hdl	O	4692
-	O	4692
c	O	4692
in	O	4692
the	O	4692
general	O	4692
population	O	4692
.	O	4692
.	O	4692
treatment	O	4693
of	O	4693
cerebrotendinous	B-Disease	4693
xanthomatosis	I-Disease	4693
:	O	4693
effects	O	4693
of	O	4693
chenodeoxycholic	O	4693
acid	O	4693
,	O	4693
pravastatin	O	4693
,	O	4693
and	O	4693
combined	O	4693
use	O	4693
.	O	4693
treatments	O	4694
by	O	4694
oral	O	4694
administration	O	4694
of	O	4694
chenodeoxycholic	O	4694
acid	O	4694
(	O	4694
cdca	O	4694
)	O	4694
alone	O	4694
,	O	4694
3	O	4694
-	O	4694
hydroxy	O	4694
-	O	4694
3	O	4694
-	O	4694
methylglutaryl	O	4694
(	O	4694
hmg	O	4694
)	O	4694
coa	O	4694
reductase	O	4694
inhibitor	O	4694
(	O	4694
pravastatin	O	4694
)	O	4694
alone	O	4694
,	O	4694
and	O	4694
combination	O	4694
of	O	4694
the	O	4694
two	O	4694
drugs	O	4694
were	O	4694
attempted	O	4694
for	O	4694
7	O	4694
patients	O	4694
with	O	4694
cerebrotendinous	B-Disease	4694
xanthomatosis	I-Disease	4694
(	O	4694
ctx	B-Disease	4694
)	O	4694
.	O	4694
the	O	4703
combination	O	4703
of	O	4703
cdca	O	4703
and	O	4703
pravastatin	O	4703
was	O	4703
a	O	4703
good	O	4703
treatment	O	4703
for	O	4703
ctx	B-Disease	4703
,	O	4703
based	O	4703
on	O	4703
the	O	4703
improvement	O	4703
of	O	4703
serum	O	4703
lipoprotein	O	4703
metabolism	O	4703
,	O	4703
the	O	4703
suppression	O	4703
of	O	4703
cholesterol	O	4703
synthesis	O	4703
,	O	4703
and	O	4703
reductions	O	4703
of	O	4703
cholestanol	O	4703
and	O	4703
plant	O	4703
sterol	O	4703
levels	O	4703
.	O	4703
in	O	4704
all	O	4704
of	O	4704
7	O	4704
patients	O	4704
,	O	4704
the	O	4704
progression	O	4704
of	O	4704
disease	O	4704
was	O	4704
arrested	O	4704
,	O	4704
but	O	4704
dramatic	O	4704
effects	O	4704
on	O	4704
clinical	O	4704
manifestations	O	4704
,	O	4704
xanthoma	B-Disease	4704
,	O	4704
and	O	4704
electrophysiological	O	4704
findings	O	4704
could	O	4704
not	O	4704
be	O	4704
found	O	4704
after	O	4704
the	O	4704
treatment	O	4704
of	O	4704
these	O	4704
drugs	O	4704
mutation	O	4705
spectrum	O	4705
in	O	4705
the	O	4705
chm	B-Disease	4705
gene	O	4705
of	O	4705
danish	O	4705
and	O	4705
swedish	O	4705
choroideremia	B-Disease	4705
patients	O	4705
.	O	4705
the	O	4706
recent	O	4706
isolation	O	4706
of	O	4706
the	O	4706
complete	O	4706
open	O	4706
reading	O	4706
frame	O	4706
of	O	4706
the	O	4706
choroideremia	B-Disease	4706
(	O	4706
chm	B-Disease	4706
)	O	4706
gene	O	4706
and	O	4706
the	O	4706
characterization	O	4706
of	O	4706
the	O	4706
exon	O	4706
-	O	4706
intron	O	4706
boundaries	O	4706
has	O	4706
paved	O	4706
the	O	4706
way	O	4706
to	O	4706
mutation	O	4706
detection	O	4706
in	O	4706
patients	O	4706
with	O	4706
classical	O	4706
choroideremia	B-Disease	4706
.	O	4706
causative	O	4708
mutations	O	4708
in	O	4708
the	O	4708
chm	B-Disease	4708
gene	O	4708
were	O	4708
detected	O	4708
in	O	4708
at	O	4708
least	O	4708
12	O	4708
families	O	4708
,	O	4708
indicating	O	4708
that	O	4708
a	O	4708
substantial	O	4708
part	O	4708
of	O	4708
the	O	4708
mutations	O	4708
can	O	4708
be	O	4708
identified	O	4708
by	O	4708
this	O	4708
approach	O	4708
.	O	4708
thus	O	4710
,	O	4710
in	O	4710
one	O	4710
patient	O	4710
,	O	4710
the	O	4710
deletion	O	4710
resulted	O	4710
in	O	4710
the	O	4710
absence	O	4710
of	O	4710
only	O	4710
one	O	4710
exon	O	4710
,	O	4710
while	O	4710
in	O	4710
another	O	4710
the	O	4710
deletion	O	4710
comprised	O	4710
the	O	4710
entire	O	4710
chm	B-Disease	4710
gene	O	4710
.	O	4710
interestingly	O	4713
,	O	4713
all	O	4713
chm	B-Disease	4713
gene	O	4713
mutations	O	4713
detected	O	4713
thus	O	4713
far	O	4713
in	O	4713
choroideremia	B-Disease	4713
patients	O	4713
give	O	4713
rise	O	4713
to	O	4713
the	O	4713
introduction	O	4713
of	O	4713
a	O	4713
premature	O	4713
stop	O	4713
codon	O	4713
.	O	4713
.	O	4713
predominance	O	4714
of	O	4714
the	O	4714
adrenomyeloneuropathy	B-Disease	4714
phenotype	O	4714
of	O	4714
x	B-Disease	4714
-	I-Disease	4714
linked	I-Disease	4714
adrenoleukodystrophy	I-Disease	4714
in	O	4714
the	O	4714
netherlands	O	4714
:	O	4714
a	O	4714
survey	O	4714
of	O	4714
30	O	4714
kindreds	O	4714
.	O	4714
x	B-Disease	4715
-	I-Disease	4715
linked	I-Disease	4715
adrenoleukodystrophy	I-Disease	4715
(	O	4715
x	B-Disease	4715
-	I-Disease	4715
ald	I-Disease	4715
)	O	4715
is	O	4715
an	O	4715
inherited	B-Disease	4715
disorder	I-Disease	4715
of	O	4715
peroxisomal	O	4715
beta	O	4715
-	O	4715
oxidation	O	4715
associated	O	4715
with	O	4715
accumulation	O	4715
of	O	4715
saturated	O	4715
very	O	4715
long	O	4715
-	O	4715
chain	O	4715
fatty	O	4715
acids	O	4715
,	O	4715
which	O	4715
results	O	4715
in	O	4715
central	O	4715
and	O	4715
peripheral	O	4715
demyelination	B-Disease	4715
and	O	4715
in	O	4715
impaired	B-Disease	4715
function	I-Disease	4715
of	I-Disease	4715
adrenal	I-Disease	4715
cortex	I-Disease	4715
and	I-Disease	4715
testes	I-Disease	4715
.	O	4715
the	O	4716
phenotypic	O	4716
expression	O	4716
is	O	4716
highly	O	4716
variable	O	4716
,	O	4716
childhood	B-Disease	4716
cerebral	I-Disease	4716
ald	I-Disease	4716
(	O	4716
ccald	B-Disease	4716
)	O	4716
and	O	4716
adrenomyeloneuropathy	B-Disease	4716
(	O	4716
amn	B-Disease	4716
)	O	4716
being	O	4716
the	O	4716
main	O	4716
variants	O	4716
.	O	4716
we	O	4717
explored	O	4717
the	O	4717
30	O	4717
dutch	O	4717
kindreds	O	4717
well	O	4717
known	O	4717
to	O	4717
the	O	4717
dutch	O	4717
x	B-Disease	4717
-	I-Disease	4717
ald	I-Disease	4717
/	O	4717
amn	B-Disease	4717
study	O	4717
group	O	4717
and	O	4717
phenotyped	O	4717
77	O	4717
male	O	4717
patients	O	4717
35	O	4717
(	O	4717
46	O	4717
%	O	4717
)	O	4717
had	O	4717
amn	B-Disease	4717
and	O	4717
24	O	4717
(	O	4717
31	O	4717
%	O	4717
)	O	4717
ccald	B-Disease	4717
or	O	4717
adolescent	B-Disease	4717
cerebral	I-Disease	4717
ald	I-Disease	4717
(	O	4717
adolcald	B-Disease	4717
)	O	4717
.	O	4717
these	O	4718
percentages	O	4718
differ	O	4718
significantly	O	4718
from	O	4718
previous	O	4718
reports	O	4718
,	O	4718
in	O	4718
which	O	4718
25	O	4718
to	O	4718
28	O	4718
%	O	4718
of	O	4718
the	O	4718
patients	O	4718
developed	O	4718
amn	B-Disease	4718
and	O	4718
53	O	4718
to	O	4718
57	O	4718
%	O	4718
ccald	B-Disease	4718
or	O	4718
adolcald	B-Disease	4718
.	O	4718
our	O	4719
findings	O	4719
indicate	O	4719
that	O	4719
-	O	4719
-	O	4719
at	O	4719
least	O	4719
in	O	4719
the	O	4719
netherlands	O	4719
-	O	4719
-	O	4719
amn	B-Disease	4719
may	O	4719
be	O	4719
the	O	4719
most	O	4719
frequent	O	4719
phenotype	O	4719
of	O	4719
x	B-Disease	4719
-	I-Disease	4719
ald	I-Disease	4719
.	O	4719
.	O	4719
adrenoleukodystrophy	B-Disease	4720
gene	O	4720
encodes	O	4720
an	O	4720
80	O	4720
kda	O	4720
membrane	O	4720
protein	O	4720
.	O	4720
an	O	4721
antibody	O	4721
against	O	4721
the	O	4721
synthetic	O	4721
c	O	4721
-	O	4721
terminal	O	4721
peptides	O	4721
deduced	O	4721
from	O	4721
the	O	4721
cdna	O	4721
of	O	4721
the	O	4721
gene	O	4721
responsible	O	4721
for	O	4721
x	B-Disease	4721
-	I-Disease	4721
linked	I-Disease	4721
adrenoleukodystrophy	I-Disease	4721
(	O	4721
ald	B-Disease	4721
)	O	4721
was	O	4721
produced	O	4721
to	O	4721
characterize	O	4721
the	O	4721
product	O	4721
of	O	4721
the	O	4721
ald	B-Disease	4721
gene	O	4721
.	O	4721
the	O	4722
antibody	O	4722
reacted	O	4722
with	O	4722
the	O	4722
80	O	4722
kda	O	4722
band	O	4722
protein	O	4722
in	O	4722
control	O	4722
fibroblasts	O	4722
,	O	4722
while	O	4722
no	O	4722
bands	O	4722
were	O	4722
detected	O	4722
in	O	4722
the	O	4722
fibroblasts	O	4722
from	O	4722
a	O	4722
patient	O	4722
with	O	4722
ald	B-Disease	4722
(	O	4722
#	O	4722
163	O	4722
)	O	4722
,	O	4722
in	O	4722
which	O	4722
mrna	O	4722
of	O	4722
the	O	4722
ald	B-Disease	4722
gene	O	4722
was	O	4722
undetectable	O	4722
based	O	4722
on	O	4722
northern	O	4722
blot	O	4722
analysis	O	4722
.	O	4722
these	O	4726
data	O	4726
thus	O	4726
indicate	O	4726
that	O	4726
the	O	4726
ald	B-Disease	4726
gene	O	4726
encodes	O	4726
an	O	4726
80	O	4726
kda	O	4726
membrane	O	4726
protein	O	4726
.	O	4726
.	O	4726
isolation	O	4727
of	O	4727
the	O	4727
gene	O	4727
for	O	4727
mcleod	B-Disease	4727
syndrome	I-Disease	4727
that	O	4727
encodes	O	4727
a	O	4727
novel	O	4727
membrane	O	4727
transport	O	4727
protein	O	4727
.	O	4727
mcleod	B-Disease	4728
syndrome	I-Disease	4728
is	O	4728
an	O	4728
x	B-Disease	4728
-	I-Disease	4728
linked	I-Disease	4728
multisystem	I-Disease	4728
disorder	I-Disease	4728
characterized	O	4728
by	O	4728
abnormalities	O	4728
in	O	4728
the	O	4728
neuromuscular	O	4728
and	O	4728
hematopoietic	O	4728
systems	O	4728
.	O	4728
we	O	4729
have	O	4729
assembled	O	4729
a	O	4729
cosmid	O	4729
contig	O	4729
of	O	4729
360	O	4729
kb	O	4729
that	O	4729
encompasses	O	4729
the	O	4729
mcleod	B-Disease	4729
gene	O	4729
locus	O	4729
.	O	4729
the	O	4731
mrna	O	4731
expression	O	4731
pattern	O	4731
of	O	4731
one	O	4731
of	O	4731
them	O	4731
,	O	4731
designated	O	4731
as	O	4731
xk	O	4731
,	O	4731
correlates	O	4731
closely	O	4731
to	O	4731
the	O	4731
mcleod	B-Disease	4731
phenotype	O	4731
.	O	4731
nucleotide	O	4733
sequence	O	4733
analysis	O	4733
of	O	4733
xk	O	4733
from	O	4733
two	O	4733
unrelated	O	4733
mcleod	B-Disease	4733
patients	O	4733
has	O	4733
identified	O	4733
point	O	4733
mutations	O	4733
at	O	4733
conserved	O	4733
splice	O	4733
donor	O	4733
and	O	4733
acceptor	O	4733
sites	O	4733
.	O	4733
these	O	4734
findings	O	4734
provide	O	4734
direct	O	4734
evidence	O	4734
that	O	4734
xk	O	4734
is	O	4734
responsible	O	4734
for	O	4734
mcleod	B-Disease	4734
syndrome	I-Disease	4734
.	O	4734
.	O	4734
x	B-Disease	4735
-	I-Disease	4735
linked	I-Disease	4735
spastic	I-Disease	4735
paraplegia	I-Disease	4735
and	O	4735
pelizaeus	B-Disease	4735
-	I-Disease	4735
merzbacher	I-Disease	4735
disease	I-Disease	4735
are	O	4735
allelic	B-Disease	4735
disorders	I-Disease	4735
at	O	4735
the	O	4735
proteolipid	O	4735
protein	O	4735
locus	O	4735
.	O	4735
three	O	4736
forms	O	4736
of	O	4736
x	B-Disease	4736
-	I-Disease	4736
linked	I-Disease	4736
spastic	I-Disease	4736
paraplegia	I-Disease	4736
(	O	4736
spg	B-Disease	4736
)	O	4736
have	O	4736
been	O	4736
defined	O	4736
.	O	4736
a	O	4738
rare	O	4738
x	B-Disease	4738
-	I-Disease	4738
linked	I-Disease	4738
dysmyelinating	I-Disease	4738
disorder	I-Disease	4738
of	O	4738
the	O	4738
central	O	4738
nervous	O	4738
system	O	4738
,	O	4738
pelizaeus	B-Disease	4738
-	I-Disease	4738
merzbacher	I-Disease	4738
disease	I-Disease	4738
(	O	4738
pmd	B-Disease	4738
)	O	4738
,	O	4738
has	O	4738
also	O	4738
been	O	4738
mapped	O	4738
to	O	4738
xq21	O	4738
-	O	4738
q22	O	4738
,	O	4738
and	O	4738
is	O	4738
caused	O	4738
by	O	4738
mutations	O	4738
in	O	4738
the	O	4738
proteolipid	O	4738
protein	O	4738
gene	O	4738
(	O	4738
plp	O	4738
)	O	4738
which	O	4738
encodes	O	4738
two	O	4738
myelin	O	4738
proteins	O	4738
,	O	4738
plp	O	4738
and	O	4738
dm20	O	4738
.	O	4738
it	O	4741
appears	O	4741
,	O	4741
therefore	O	4741
,	O	4741
that	O	4741
spg2	O	4741
and	O	4741
pmd	B-Disease	4741
are	O	4741
allelic	B-Disease	4741
disorders	I-Disease	4741
canavan	B-Disease	4742
disease	I-Disease	4742
:	O	4742
mutations	O	4742
among	O	4742
jewish	O	4742
and	O	4742
non	O	4742
-	O	4742
jewish	O	4742
patients	O	4742
.	O	4742
canavan	B-Disease	4743
disease	I-Disease	4743
is	O	4743
an	O	4743
autosomal	B-Disease	4743
recessive	I-Disease	4743
leukodystrophy	I-Disease	4743
caused	O	4743
by	O	4743
the	O	4743
deficiency	B-Disease	4743
of	I-Disease	4743
aspartoacylase	I-Disease	4743
(	O	4743
aspa	O	4743
)	O	4743
.	O	4743
of	O	4752
the	O	4752
128	O	4752
unrelated	O	4752
canavan	B-Disease	4752
chromosomes	O	4752
analyzed	O	4752
,	O	4752
88	O	4752
were	O	4752
from	O	4752
probands	O	4752
of	O	4752
ashkenazi	O	4752
jewish	O	4752
descent	O	4752
.	O	4752
8	O	4755
%	O	4755
of	O	4755
the	O	4755
canavan	B-Disease	4755
chromosomes	O	4755
of	O	4755
ashkenazi	O	4755
jewish	O	4755
origin	O	4755
.	O	4755
predominant	O	4757
occurrence	O	4757
of	O	4757
certain	O	4757
mutations	O	4757
among	O	4757
ashkenazi	O	4757
jewish	O	4757
and	O	4757
non	O	4757
-	O	4757
jewish	O	4757
patients	O	4757
with	O	4757
canavan	B-Disease	4757
disease	I-Disease	4757
would	O	4757
suggest	O	4757
a	O	4757
founding	O	4757
-	O	4757
father	O	4757
effect	O	4757
in	O	4757
propagation	O	4757
of	O	4757
these	O	4757
mutant	O	4757
chromosomes	O	4757
intelligence	O	4758
quotient	O	4758
profile	O	4758
in	O	4758
myotonic	B-Disease	4758
dystrophy	I-Disease	4758
,	O	4758
intergenerational	O	4758
deficit	O	4758
,	O	4758
and	O	4758
correlation	O	4758
with	O	4758
ctg	O	4758
amplification	O	4758
.	O	4758
an	O	4759
abbreviated	O	4759
wechsler	O	4759
adult	O	4759
intelligence	O	4759
scale	O	4759
revised	O	4759
(	O	4759
wais	O	4759
-	O	4759
r	O	4759
)	O	4759
was	O	4759
used	O	4759
to	O	4759
assess	O	4759
verbal	O	4759
and	O	4759
arithmetical	O	4759
cognitive	O	4759
performance	O	4759
in	O	4759
55	O	4759
subjects	O	4759
with	O	4759
myotonic	B-Disease	4759
dystrophy	I-Disease	4759
(	O	4759
dm	B-Disease	4759
)	O	4759
,	O	4759
covering	O	4759
all	O	4759
grades	O	4759
of	O	4759
disease	O	4759
severity	O	4759
,	O	4759
and	O	4759
31	O	4759
controls	O	4759
at	O	4759
50	O	4759
%	O	4759
risk	O	4759
of	O	4759
inheriting	O	4759
dm	B-Disease	4759
.	O	4759
significant	O	4761
iq	O	4761
differences	O	4761
were	O	4761
found	O	4761
between	O	4761
(	O	4761
1	O	4761
)	O	4761
all	O	4761
55	O	4761
dm	B-Disease	4761
subjects	O	4761
(	O	4761
mean	O	4761
90	O	4761
.	O	4761
2	O	4761
,	O	4761
sd	O	4761
16	O	4761
.	O	4761
1	O	4761
)	O	4761
and	O	4761
31	O	4761
controls	O	4761
(	O	4761
102	O	4761
.	O	4761
6	O	4761
,	O	4761
sd	O	4761
9	O	4761
.	O	4761
4	O	4761
)	O	4761
,	O	4761
with	O	4761
no	O	4761
sex	O	4761
differences	O	4761
in	O	4761
either	O	4761
group	O	4761
;	O	4761
(	O	4761
2	O	4761
)	O	4761
15	O	4761
affected	O	4761
parents	O	4761
(	O	4761
99	O	4761
.	O	4761
3	O	4761
,	O	4761
sd	O	4761
12	O	4761
.	O	4761
2	O	4761
)	O	4761
and	O	4761
their	O	4761
affected	O	4761
children	O	4761
(	O	4761
88	O	4761
.	O	4761
1	O	4761
,	O	4761
sd	O	4761
17	O	4761
.	O	4761
2	O	4761
)	O	4761
,	O	4761
where	O	4761
significance	O	4761
was	O	4761
dependent	O	4761
on	O	4761
parental	O	4761
sex	O	4761
being	O	4761
female	O	4761
;	O	4761
and	O	4761
(	O	4761
3	O	4761
)	O	4761
15	O	4761
pairs	O	4761
of	O	4761
affected	O	4761
sibs	O	4761
(	O	4761
89	O	4761
.	O	4761
6	O	4761
,	O	4761
sd	O	4761
13	O	4761
.	O	4761
2	O	4761
)	O	4761
and	O	4761
their	O	4761
normal	O	4761
sibs	O	4761
(	O	4761
100	O	4761
.	O	4761
2	O	4761
,	O	4761
sd	O	4761
7	O	4761
.	O	4761
6	O	4761
)	O	4761
.	O	4761
the	O	4764
correlation	O	4764
of	O	4764
iq	O	4764
difference	O	4764
and	O	4764
ctg	O	4764
expansion	O	4764
difference	O	4764
in	O	4764
both	O	4764
the	O	4764
dm	B-Disease	4764
parent	O	4764
-	O	4764
child	O	4764
pairs	O	4764
and	O	4764
normal	O	4764
sib	O	4764
-	O	4764
affected	O	4764
sib	O	4764
pairs	O	4764
was	O	4764
poor	O	4764
,	O	4764
indicating	O	4764
that	O	4764
ctg	O	4764
expansion	O	4764
is	O	4764
not	O	4764
a	O	4764
reliable	O	4764
predictor	O	4764
of	O	4764
iq	O	4764
either	O	4764
in	O	4764
individual	O	4764
persons	O	4764
or	O	4764
families	O	4764
.	O	4764
further	O	4765
analysis	O	4765
of	O	4765
cognitive	O	4765
function	O	4765
in	O	4765
dm	B-Disease	4765
is	O	4765
required	O	4765
to	O	4765
clarify	O	4765
specific	O	4765
deficits	O	4765
characteristic	O	4765
of	O	4765
this	O	4765
patient	O	4765
group	O	4765
adenomatous	B-Disease	4766
polyposis	I-Disease	4766
coli	I-Disease	4766
and	O	4766
a	O	4766
cytogenetic	O	4766
deletion	O	4766
of	O	4766
chromosome	O	4766
5	O	4766
resulting	O	4766
from	O	4766
a	O	4766
maternal	O	4766
intrachromosomal	O	4766
insertion	O	4766
.	O	4766
we	O	4767
present	O	4767
the	O	4767
clinical	O	4767
and	O	4767
laboratory	O	4767
findings	O	4767
in	O	4767
an	O	4767
institutionalised	O	4767
adult	O	4767
patient	O	4767
originally	O	4767
referred	O	4767
for	O	4767
autism	B-Disease	4767
.	O	4767
a	O	4768
high	O	4768
risk	O	4768
of	O	4768
colorectal	B-Disease	4768
cancer	I-Disease	4768
was	O	4768
predicted	O	4768
when	O	4768
an	O	4768
interstitial	O	4768
deletion	O	4768
of	O	4768
the	O	4768
long	O	4768
arm	O	4768
of	O	4768
chromosome	O	4768
5	O	4768
,	O	4768
del	O	4768
(	O	4768
5	O	4768
)	O	4768
(	O	4768
q15q22	O	4768
.	O	4768
3	O	4768
)	O	4768
,	O	4768
was	O	4768
detected	O	4768
in	O	4768
her	O	4768
lymphocytes	O	4768
and	O	4768
deletion	O	4768
of	O	4768
the	O	4768
mcc	O	4768
and	O	4768
apc	B-Disease	4768
genes	O	4768
confirmed	O	4768
by	O	4768
molecular	O	4768
analysis	O	4768
.	O	4768
adenomatous	B-Disease	4769
polyposis	I-Disease	4769
coli	I-Disease	4769
and	O	4769
carcinoma	B-Disease	4769
of	I-Disease	4769
the	I-Disease	4769
rectum	I-Disease	4769
were	O	4769
subsequently	O	4769
diagnosed	O	4769
in	O	4769
the	O	4769
patient	O	4769
.	O	4769
she	O	4770
was	O	4770
profoundly	O	4770
mentally	B-Disease	4770
retarded	I-Disease	4770
,	O	4770
autistic	B-Disease	4770
,	O	4770
and	O	4770
had	O	4770
minor	O	4770
dysmorphic	B-Disease	4770
features	I-Disease	4770
consistent	O	4770
with	O	4770
those	O	4770
of	O	4770
previous	O	4770
patients	O	4770
with	O	4770
similar	O	4770
deletions	O	4770
.	O	4770
this	O	4772
family	O	4772
further	O	4772
confirms	O	4772
the	O	4772
cytogenetic	O	4772
mapping	O	4772
of	O	4772
both	O	4772
mcc	O	4772
and	O	4772
apc	B-Disease	4772
genes	O	4772
to	O	4772
5q22	O	4772
and	O	4772
comparison	O	4772
with	O	4772
other	O	4772
recent	O	4772
cases	O	4772
suggests	O	4772
that	O	4772
both	O	4772
genes	O	4772
and	O	4772
their	O	4772
closely	O	4772
linked	O	4772
markers	O	4772
lie	O	4772
within	O	4772
the	O	4772
5q22	O	4772
.	O	4772
familial	B-Disease	4774
male	I-Disease	4774
breast	I-Disease	4774
cancer	I-Disease	4774
is	O	4774
not	O	4774
linked	O	4774
to	O	4774
the	O	4774
brca1	O	4774
locus	O	4774
on	O	4774
chromosome	O	4774
17q	O	4774
.	O	4774
breast	B-Disease	4775
cancer	I-Disease	4775
in	O	4775
men	O	4775
is	O	4775
about	O	4775
a	O	4775
hundredfold	O	4775
less	O	4775
common	O	4775
than	O	4775
in	O	4775
women	O	4775
and	O	4775
this	O	4775
has	O	4775
hindered	O	4775
research	O	4775
into	O	4775
its	O	4775
genetic	O	4775
basis	O	4775
.	O	4775
we	O	4776
have	O	4776
examined	O	4776
22	O	4776
families	O	4776
with	O	4776
at	O	4776
least	O	4776
one	O	4776
case	O	4776
of	O	4776
male	B-Disease	4776
breast	I-Disease	4776
cancer	I-Disease	4776
for	O	4776
linkage	O	4776
to	O	4776
the	O	4776
hereditary	B-Disease	4776
breast	I-Disease	4776
and	I-Disease	4776
ovarian	I-Disease	4776
cancer	I-Disease	4776
locus	O	4776
,	O	4776
brca1	O	4776
,	O	4776
on	O	4776
chromosome	O	4776
17q	O	4776
.	O	4776
our	O	4778
results	O	4778
indicate	O	4778
that	O	4778
there	O	4778
is	O	4778
a	O	4778
gene	O	4778
(	O	4778
s	O	4778
)	O	4778
other	O	4778
than	O	4778
brca1	O	4778
which	O	4778
predisposes	O	4778
to	O	4778
early	O	4778
-	O	4778
onset	O	4778
breast	B-Disease	4778
cancer	I-Disease	4778
in	O	4778
women	O	4778
and	O	4778
which	O	4778
confers	O	4778
a	O	4778
higher	O	4778
risk	O	4778
of	O	4778
male	B-Disease	4778
breast	I-Disease	4778
cancer	I-Disease	4778
.	O	4778
identification	O	4779
of	O	4779
additional	O	4779
pedigrees	O	4779
that	O	4779
include	O	4779
cases	O	4779
of	O	4779
male	B-Disease	4779
breast	I-Disease	4779
cancer	I-Disease	4779
may	O	4779
therefore	O	4779
facilitate	O	4779
the	O	4779
mapping	O	4779
and	O	4779
isolation	O	4779
of	O	4779
this	O	4779
gene	O	4779
.	O	4779
the	O	4780
ews	O	4780
gene	O	4780
,	O	4780
involved	O	4780
in	O	4780
ewing	B-Disease	4780
family	I-Disease	4780
of	I-Disease	4780
tumors	I-Disease	4780
,	O	4780
malignant	B-Disease	4780
melanoma	I-Disease	4780
of	I-Disease	4780
soft	I-Disease	4780
parts	I-Disease	4780
and	O	4780
desmoplastic	B-Disease	4780
small	I-Disease	4780
round	I-Disease	4780
cell	I-Disease	4780
tumors	I-Disease	4780
,	O	4780
codes	O	4780
for	O	4780
an	O	4780
rna	O	4780
binding	O	4780
protein	O	4780
with	O	4780
novel	O	4780
regulatory	O	4780
domains	O	4780
.	O	4780
the	O	4781
ews	O	4781
gene	O	4781
,	O	4781
which	O	4781
maps	O	4781
to	O	4781
band	O	4781
q12	O	4781
of	O	4781
human	O	4781
chromosome	O	4781
22	O	4781
,	O	4781
is	O	4781
involved	O	4781
in	O	4781
a	O	4781
wide	O	4781
variety	O	4781
of	O	4781
human	O	4781
solid	B-Disease	4781
tumors	I-Disease	4781
including	O	4781
ewing	B-Disease	4781
sarcoma	I-Disease	4781
,	O	4781
related	O	4781
primitive	O	4781
neuroectodermal	B-Disease	4781
tumors	I-Disease	4781
,	O	4781
malignant	B-Disease	4781
melanoma	I-Disease	4781
of	I-Disease	4781
soft	I-Disease	4781
parts	I-Disease	4781
and	O	4781
desmoplastic	B-Disease	4781
small	I-Disease	4781
round	I-Disease	4781
cell	I-Disease	4781
tumors	I-Disease	4781
.	O	4781
in	O	4782
these	O	4782
tumors	B-Disease	4782
,	O	4782
the	O	4782
ews	O	4782
is	O	4782
fused	O	4782
to	O	4782
genes	O	4782
encoding	O	4782
transcriptional	O	4782
activators	O	4782
/	O	4782
repressors	O	4782
,	O	4782
like	O	4782
fli	O	4782
-	O	4782
1	O	4782
or	O	4782
erg	O	4782
or	O	4782
atf	O	4782
1	O	4782
or	O	4782
wt1	O	4782
.	O	4782
an	O	4790
ews	O	4790
-	O	4790
erg	O	4790
chimeric	O	4790
protein	O	4790
,	O	4790
which	O	4790
is	O	4790
found	O	4790
in	O	4790
ewings	B-Disease	4790
sarcoma	I-Disease	4790
cells	O	4790
,	O	4790
functions	O	4790
as	O	4790
a	O	4790
transcriptional	O	4790
activator	O	4790
.	O	4790
canavan	B-Disease	4792
disease	I-Disease	4792
:	O	4792
genomic	O	4792
organization	O	4792
and	O	4792
localization	O	4792
of	O	4792
human	O	4792
aspa	O	4792
to	O	4792
17p13	O	4792
-	O	4792
ter	O	4792
and	O	4792
conservation	O	4792
of	O	4792
the	O	4792
aspa	O	4792
gene	O	4792
during	O	4792
evolution	O	4792
.	O	4792
canavan	B-Disease	4793
disease	I-Disease	4793
,	O	4793
or	O	4793
spongy	B-Disease	4793
degeneration	I-Disease	4793
of	I-Disease	4793
the	I-Disease	4793
brain	I-Disease	4793
,	O	4793
is	O	4793
a	O	4793
severe	O	4793
leukodystrophy	B-Disease	4793
caused	O	4793
by	O	4793
the	O	4793
deficiency	B-Disease	4793
of	I-Disease	4793
aspartoacylase	I-Disease	4793
(	O	4793
aspa	O	4793
)	O	4793
.	O	4793
recently	O	4794
,	O	4794
a	O	4794
missense	O	4794
mutation	O	4794
was	O	4794
identified	O	4794
in	O	4794
human	O	4794
aspa	O	4794
coding	O	4794
sequence	O	4794
from	O	4794
patients	O	4794
with	O	4794
canavan	B-Disease	4794
disease	I-Disease	4794
.	O	4794
it	O	4805
should	O	4805
now	O	4805
be	O	4805
possible	O	4805
to	O	4805
identify	O	4805
mutations	O	4805
in	O	4805
the	O	4805
noncoding	O	4805
genomic	O	4805
sequences	O	4805
that	O	4805
lead	O	4805
to	O	4805
canavan	B-Disease	4805
disease	I-Disease	4805
and	O	4805
to	O	4805
study	O	4805
the	O	4805
regulation	O	4805
of	O	4805
aspa	O	4805
.	O	4805
.	O	4805
myotonic	B-Disease	4806
dystrophy	I-Disease	4806
:	O	4806
size	O	4806
-	O	4806
and	O	4806
sex	O	4806
-	O	4806
dependent	O	4806
dynamics	O	4806
of	O	4806
ctg	O	4806
meiotic	O	4806
instability	O	4806
,	O	4806
and	O	4806
somatic	O	4806
mosaicism	O	4806
.	O	4806
myotonic	B-Disease	4807
dystrophy	I-Disease	4807
(	O	4807
dm	B-Disease	4807
)	O	4807
is	O	4807
a	O	4807
progressive	O	4807
neuromuscular	B-Disease	4807
disorder	I-Disease	4807
which	O	4807
results	O	4807
from	O	4807
elongations	O	4807
of	O	4807
an	O	4807
unstable	O	4807
(	O	4807
ctg	O	4807
)	O	4807
n	O	4807
repeat	O	4807
,	O	4807
located	O	4807
in	O	4807
the	O	4807
3	O	4807
untranslated	O	4807
region	O	4807
of	O	4807
the	O	4807
dm	B-Disease	4807
gene	O	4807
.	O	4807
our	O	4811
observation	O	4811
of	O	4811
differently	O	4811
sized	O	4811
repeats	O	4811
in	O	4811
various	O	4811
dm	B-Disease	4811
tissues	O	4811
from	O	4811
the	O	4811
same	O	4811
individual	O	4811
may	O	4811
explain	O	4811
why	O	4811
the	O	4811
size	O	4811
of	O	4811
the	O	4811
mutation	O	4811
observed	O	4811
in	O	4811
lymphocytes	O	4811
does	O	4811
not	O	4811
necessarily	O	4811
correlate	O	4811
with	O	4811
the	O	4811
severity	O	4811
and	O	4811
nature	O	4811
of	O	4811
symptoms	O	4811
.	O	4811
through	O	4812
a	O	4812
molecular	O	4812
and	O	4812
genetic	O	4812
study	O	4812
of	O	4812
142	O	4812
families	O	4812
including	O	4812
418	O	4812
dm	B-Disease	4812
patients	O	4812
,	O	4812
we	O	4812
have	O	4812
investigated	O	4812
the	O	4812
dynamics	O	4812
of	O	4812
the	O	4812
ctg	O	4812
repeat	O	4812
meiotic	O	4812
instability	O	4812
.	O	4812
illegitimate	O	4821
transcription	O	4821
of	O	4821
the	O	4821
phenylalanine	O	4821
hydroxylase	O	4821
gene	O	4821
in	O	4821
lymphocytes	O	4821
for	O	4821
identification	O	4821
of	O	4821
mutations	O	4821
in	O	4821
phenylketonuria	B-Disease	4821
.	O	4821
taking	O	4822
advantage	O	4822
of	O	4822
the	O	4822
illegitimate	O	4822
transcription	O	4822
of	O	4822
the	O	4822
phenylalanine	O	4822
hydroxylase	O	4822
(	O	4822
pah	O	4822
)	O	4822
gene	O	4822
,	O	4822
we	O	4822
have	O	4822
been	O	4822
able	O	4822
to	O	4822
analyse	O	4822
the	O	4822
pah	O	4822
cdna	O	4822
sequence	O	4822
of	O	4822
hyperphenylalaninemic	B-Disease	4822
children	O	4822
in	O	4822
circulating	O	4822
lymphocytes	O	4822
.	O	4822
the	O	4826
present	O	4826
study	O	4826
supports	O	4826
the	O	4826
view	O	4826
that	O	4826
circulating	O	4826
lymphocytes	O	4826
give	O	4826
easy	O	4826
access	O	4826
to	O	4826
pah	O	4826
gene	O	4826
transcripts	O	4826
whose	O	4826
nucleotide	O	4826
sequence	O	4826
is	O	4826
identical	O	4826
to	O	4826
that	O	4826
reported	O	4826
in	O	4826
liver	O	4826
and	O	4826
therefore	O	4826
represent	O	4826
a	O	4826
useful	O	4826
tool	O	4826
for	O	4826
molecular	O	4826
genetic	O	4826
studies	O	4826
in	O	4826
phenylketonuria	B-Disease	4826
.	O	4826
.	O	4826
high	O	4827
residual	O	4827
arylsulfatase	O	4827
a	O	4827
(	O	4827
arsa	O	4827
)	O	4827
activity	O	4827
in	O	4827
a	O	4827
patient	O	4827
with	O	4827
late	B-Disease	4827
-	I-Disease	4827
infantile	I-Disease	4827
metachromatic	I-Disease	4827
leukodystrophy	I-Disease	4827
.	O	4827
we	O	4828
identified	O	4828
a	O	4828
patient	O	4828
suffering	O	4828
from	O	4828
late	B-Disease	4828
-	I-Disease	4828
infantile	I-Disease	4828
metachromatic	I-Disease	4828
leukodystrophy	I-Disease	4828
(	O	4828
mld	B-Disease	4828
)	O	4828
who	O	4828
has	O	4828
a	O	4828
residual	O	4828
arylsulfatase	O	4828
a	O	4828
(	O	4828
arsa	O	4828
)	O	4828
activity	O	4828
of	O	4828
about	O	4828
10	O	4828
%	O	4828
.	O	4828
fibroblasts	O	4829
of	O	4829
the	O	4829
patient	O	4829
show	O	4829
significant	O	4829
sulfatide	O	4829
degradation	O	4829
activity	O	4829
exceeding	O	4829
that	O	4829
of	O	4829
adult	B-Disease	4829
mld	I-Disease	4829
patients	O	4829
.	O	4829
these	O	4833
findings	O	4833
are	O	4833
in	O	4833
contrast	O	4833
to	O	4833
previous	O	4833
results	O	4833
showing	O	4833
that	O	4833
the	O	4833
late	B-Disease	4833
-	I-Disease	4833
infantile	I-Disease	4833
type	I-Disease	4833
of	I-Disease	4833
mld	I-Disease	4833
is	O	4833
always	O	4833
associated	O	4833
with	O	4833
the	O	4833
complete	O	4833
absence	O	4833
of	O	4833
arsa	O	4833
activity	O	4833
.	O	4833
an	O	4835
arylsulfatase	O	4835
a	O	4835
(	O	4835
arsa	O	4835
)	O	4835
missense	O	4835
mutation	O	4835
(	O	4835
t274m	O	4835
)	O	4835
causing	O	4835
late	B-Disease	4835
-	I-Disease	4835
infantile	I-Disease	4835
metachromatic	I-Disease	4835
leukodystrophy	I-Disease	4835
.	O	4835
metachromatic	B-Disease	4836
leukodystrophy	I-Disease	4836
(	O	4836
mld	B-Disease	4836
)	O	4836
is	O	4836
an	O	4836
autosomal	B-Disease	4836
recessive	I-Disease	4836
lysosomal	I-Disease	4836
storage	I-Disease	4836
disorder	I-Disease	4836
caused	O	4836
by	O	4836
a	O	4836
deficiency	B-Disease	4836
of	I-Disease	4836
arylsulfatase	I-Disease	4836
a	I-Disease	4836
(	O	4836
arsa	O	4836
;	O	4836
ec	O	4836
3	O	4836
.	O	4836
1	O	4836
.	O	4836
6	O	4836
.	O	4836
8	O	4836
)	O	4836
.	O	4836
the	O	4837
8	O	4837
arsa	O	4837
exons	O	4837
and	O	4837
adjacent	O	4837
intron	O	4837
boundaries	O	4837
from	O	4837
a	O	4837
patient	O	4837
with	O	4837
late	B-Disease	4837
-	I-Disease	4837
infantile	I-Disease	4837
metachromatic	I-Disease	4837
leukodystrophy	I-Disease	4837
were	O	4837
polymerase	O	4837
chain	O	4837
reaction	O	4837
(	O	4837
pcr	O	4837
)	O	4837
amplified	O	4837
in	O	4837
seven	O	4837
discrete	O	4837
reactions	O	4837
.	O	4837
analysis	O	4840
of	O	4840
a	O	4840
further	O	4840
29	O	4840
mld	B-Disease	4840
patients	O	4840
revealed	O	4840
the	O	4840
presence	O	4840
of	O	4840
five	O	4840
additional	O	4840
homozygotes	O	4840
for	O	4840
t274m	O	4840
.	O	4840
mutations	O	4844
in	O	4844
the	O	4844
pax6	O	4844
gene	O	4844
in	O	4844
patients	O	4844
with	O	4844
hereditary	O	4844
aniridia	B-Disease	4844
.	O	4844
the	O	4845
14	O	4845
exons	O	4845
of	O	4845
the	O	4845
pax6	O	4845
gene	O	4845
have	O	4845
been	O	4845
analysed	O	4845
exon	O	4845
-	O	4845
by	O	4845
-	O	4845
exon	O	4845
using	O	4845
sscp	O	4845
in	O	4845
6	O	4845
aniridia	B-Disease	4845
families	O	4845
.	O	4845
this	O	4853
data	O	4853
strongly	O	4853
supports	O	4853
the	O	4853
candidature	O	4853
of	O	4853
pax6	O	4853
as	O	4853
the	O	4853
gene	O	4853
responsible	O	4853
for	O	4853
hereditary	O	4853
aniridia	B-Disease	4853
.	O	4853
.	O	4853
three	O	4854
novel	O	4854
mutations	O	4854
in	O	4854
five	O	4854
unrelated	O	4854
subjects	O	4854
with	O	4854
hereditary	O	4854
protein	B-Disease	4854
s	I-Disease	4854
deficiency	I-Disease	4854
type	I-Disease	4854
i	I-Disease	4854
.	O	4854
a	O	4855
panel	O	4855
of	O	4855
eight	O	4855
unrelated	O	4855
subjects	O	4855
with	O	4855
inherited	O	4855
type	B-Disease	4855
i	I-Disease	4855
protein	I-Disease	4855
s	I-Disease	4855
deficiency	I-Disease	4855
was	O	4855
screened	O	4855
for	O	4855
mutations	O	4855
in	O	4855
the	O	4855
pros1	O	4855
gene	O	4855
.	O	4855
the	O	4864
latter	O	4864
indicates	O	4864
that	O	4864
a	O	4864
mrna	O	4864
based	O	4864
approach	O	4864
is	O	4864
not	O	4864
feasible	O	4864
for	O	4864
the	O	4864
genetic	O	4864
analysis	O	4864
of	O	4864
protein	B-Disease	4864
s	I-Disease	4864
deficiency	I-Disease	4864
type	I-Disease	4864
i	I-Disease	4864
.	O	4864
.	O	4864
characteristics	O	4865
of	O	4865
intergenerational	O	4865
contractions	O	4865
of	O	4865
the	O	4865
ctg	O	4865
repeat	O	4865
in	O	4865
myotonic	B-Disease	4865
dystrophy	I-Disease	4865
.	O	4865
in	O	4866
myotonic	B-Disease	4866
dystrophy	I-Disease	4866
(	O	4866
dm	B-Disease	4866
)	O	4866
,	O	4866
the	O	4866
size	O	4866
of	O	4866
a	O	4866
ctg	O	4866
repeat	O	4866
in	O	4866
the	O	4866
dm	B-Disease	4866
kinase	O	4866
gene	O	4866
generally	O	4866
increases	O	4866
in	O	4866
successive	O	4866
generations	O	4866
with	O	4866
clinical	O	4866
evidence	O	4866
of	O	4866
anticipation	O	4866
.	O	4866
we	O	4868
examined	O	4868
1	O	4868
,	O	4868
489	O	4868
dm	B-Disease	4868
parent	O	4868
-	O	4868
offspring	O	4868
pairs	O	4868
,	O	4868
of	O	4868
which	O	4868
95	O	4868
(	O	4868
6	O	4868
.	O	4868
4	O	4868
%	O	4868
)	O	4868
showed	O	4868
such	O	4868
contractions	O	4868
in	O	4868
peripheral	O	4868
blood	O	4868
leukocytes	O	4868
(	O	4868
pbl	O	4868
)	O	4868
.	O	4868
it	O	4870
is	O	4870
surprising	O	4870
that	O	4870
anticipation	O	4870
occurred	O	4870
in	O	4870
27	O	4870
(	O	4870
48	O	4870
%	O	4870
)	O	4870
of	O	4870
these	O	4870
56	O	4870
pairs	O	4870
,	O	4870
while	O	4870
none	O	4870
clearly	O	4870
showed	O	4870
a	O	4870
later	O	4870
onset	O	4870
of	O	4870
dm	B-Disease	4870
in	O	4870
the	O	4870
symptomatic	O	4870
offspring	O	4870
.	O	4870
sixteen	O	4874
dm	B-Disease	4874
parents	O	4874
had	O	4874
multiple	O	4874
dm	B-Disease	4874
offspring	O	4874
with	O	4874
the	O	4874
ctg	O	4874
repeat	O	4874
contractions	O	4874
.	O	4874
this	O	4875
frequency	O	4875
was	O	4875
higher	O	4875
than	O	4875
the	O	4875
frequency	O	4875
expected	O	4875
from	O	4875
the	O	4875
probability	O	4875
of	O	4875
the	O	4875
repeat	O	4875
contractions	O	4875
(	O	4875
6	O	4875
.	O	4875
4	O	4875
%	O	4875
)	O	4875
and	O	4875
the	O	4875
size	O	4875
of	O	4875
dm	B-Disease	4875
sib	O	4875
population	O	4875
(	O	4875
1	O	4875
.	O	4875
54	O	4875
dm	B-Disease	4875
offspring	O	4875
per	O	4875
dm	B-Disease	4875
parent	O	4875
,	O	4875
in	O	4875
968	O	4875
dm	B-Disease	4875
parents	O	4875
)	O	4875
.	O	4875
we	O	4876
conclude	O	4876
that	O	4876
(	O	4876
1	O	4876
)	O	4876
intergenerational	O	4876
contractions	O	4876
of	O	4876
the	O	4876
ctg	O	4876
repeat	O	4876
in	O	4876
leukocyte	O	4876
dna	O	4876
frequently	O	4876
accompanies	O	4876
apparent	O	4876
anticipation	O	4876
,	O	4876
especially	O	4876
when	O	4876
dm	B-Disease	4876
is	O	4876
maternally	O	4876
transmitted	O	4876
,	O	4876
and	O	4876
(	O	4876
2	O	4876
)	O	4876
the	O	4876
paternal	O	4876
origin	O	4876
of	O	4876
the	O	4876
repeat	O	4876
and	O	4876
the	O	4876
presence	O	4876
of	O	4876
the	O	4876
repeat	O	4876
contraction	O	4876
in	O	4876
a	O	4876
sibling	O	4876
increase	O	4876
the	O	4876
probability	O	4876
of	O	4876
the	O	4876
ctg	O	4876
repeat	O	4876
contraction	O	4876
gonosomal	O	4877
mosaicism	O	4877
in	O	4877
myotonic	B-Disease	4877
dystrophy	I-Disease	4877
patients	O	4877
:	O	4877
involvement	O	4877
of	O	4877
mitotic	O	4877
events	O	4877
in	O	4877
(	O	4877
ctg	O	4877
)	O	4877
n	O	4877
repeat	O	4877
variation	O	4877
and	O	4877
selection	O	4877
against	O	4877
extreme	O	4877
expansion	O	4877
in	O	4877
sperm	O	4877
.	O	4877
myotonic	B-Disease	4878
dystrophy	I-Disease	4878
(	O	4878
dm	B-Disease	4878
)	O	4878
is	O	4878
caused	O	4878
by	O	4878
abnormal	O	4878
expansion	O	4878
of	O	4878
a	O	4878
polymorphic	O	4878
(	O	4878
ctg	O	4878
)	O	4878
n	O	4878
repeat	O	4878
,	O	4878
located	O	4878
in	O	4878
the	O	4878
dm	B-Disease	4878
protein	O	4878
kinase	O	4878
gene	O	4878
.	O	4878
we	O	4879
determined	O	4879
the	O	4879
(	O	4879
ctg	O	4879
)	O	4879
n	O	4879
repeat	O	4879
lengths	O	4879
in	O	4879
a	O	4879
broad	O	4879
range	O	4879
of	O	4879
tissue	O	4879
dnas	O	4879
from	O	4879
patients	O	4879
with	O	4879
mild	O	4879
,	O	4879
classical	O	4879
,	O	4879
or	O	4879
congenital	O	4879
manifestation	O	4879
of	O	4879
dm	B-Disease	4879
.	O	4879
differences	O	4880
in	O	4880
the	O	4880
repeat	O	4880
length	O	4880
were	O	4880
seen	O	4880
in	O	4880
somatic	O	4880
tissues	O	4880
from	O	4880
single	O	4880
dm	B-Disease	4880
individuals	O	4880
and	O	4880
twins	O	4880
.	O	4880
we	O	4885
conclude	O	4885
that	O	4885
dm	B-Disease	4885
patients	O	4885
can	O	4885
be	O	4885
considered	O	4885
gonosomal	O	4885
mosaics	O	4885
,	O	4885
i	O	4885
.	O	4885
a	O	4890
model	O	4890
explaining	O	4890
mitotic	O	4890
instability	O	4890
and	O	4890
sex	O	4890
-	O	4890
dependent	O	4890
segregation	O	4890
phenomena	O	4890
in	O	4890
dm	B-Disease	4890
manifestation	O	4890
is	O	4890
discussed	O	4890
regionally	O	4891
clustered	O	4891
apc	B-Disease	4891
mutations	O	4891
are	O	4891
associated	O	4891
with	O	4891
a	O	4891
severe	O	4891
phenotype	O	4891
and	O	4891
occur	O	4891
at	O	4891
a	O	4891
high	O	4891
frequency	O	4891
in	O	4891
new	O	4891
mutation	O	4891
cases	O	4891
of	O	4891
adenomatous	B-Disease	4891
polyposis	I-Disease	4891
coli	I-Disease	4891
.	O	4891
germline	O	4892
mutation	O	4892
in	O	4892
apc	O	4892
at	O	4892
5q21	O	4892
-	O	4892
22	O	4892
results	O	4892
in	O	4892
the	O	4892
dominantly	O	4892
inherited	O	4892
syndrome	O	4892
adenomatous	B-Disease	4892
polyposis	I-Disease	4892
coli	I-Disease	4892
(	O	4892
apc	B-Disease	4892
)	O	4892
.	O	4892
eighteen	O	4896
patients	O	4896
had	O	4896
no	O	4896
family	O	4896
history	O	4896
of	O	4896
the	O	4896
disease	O	4896
;	O	4896
of	O	4896
these	O	4896
11	O	4896
were	O	4896
classified	O	4896
as	O	4896
having	O	4896
a	O	4896
severe	O	4896
phenotype	O	4896
,	O	4896
based	O	4896
on	O	4896
an	O	4896
early	O	4896
age	O	4896
at	O	4896
presentation	O	4896
or	O	4896
cancer	B-Disease	4896
development	O	4896
.	O	4896
a	O	4898
5	O	4898
bp	O	4898
deletion	O	4898
at	O	4898
codon	O	4898
1309	O	4898
reported	O	4898
to	O	4898
occur	O	4898
in	O	4898
10	O	4898
-	O	4898
15	O	4898
%	O	4898
of	O	4898
unselected	O	4898
apc	B-Disease	4898
patients	O	4898
worldwide	O	4898
,	O	4898
was	O	4898
found	O	4898
in	O	4898
5	O	4898
of	O	4898
the	O	4898
18	O	4898
new	O	4898
mutation	O	4898
cases	O	4898
and	O	4898
4	O	4898
of	O	4898
the	O	4898
27	O	4898
familial	O	4898
cases	O	4898
all	O	4898
nine	O	4898
were	O	4898
classed	O	4898
as	O	4898
severe	O	4898
.	O	4898
in	O	4900
contrast	O	4900
all	O	4900
of	O	4900
the	O	4900
apc	B-Disease	4900
mutations	O	4900
detected	O	4900
in	O	4900
affected	O	4900
individuals	O	4900
with	O	4900
an	O	4900
average	O	4900
phenotype	O	4900
were	O	4900
located	O	4900
prior	O	4900
to	O	4900
codon	O	4900
1309	O	4900
.	O	4900
mutations	O	4902
at	O	4902
the	O	4902
pax6	O	4902
locus	O	4902
are	O	4902
found	O	4902
in	O	4902
heterogeneous	O	4902
anterior	B-Disease	4902
segment	I-Disease	4902
malformations	I-Disease	4902
including	O	4902
peters	B-Disease	4902
'	I-Disease	4902
anomaly	I-Disease	4902
.	O	4902
mutation	O	4903
or	O	4903
deletion	O	4903
of	O	4903
the	O	4903
pax6	O	4903
gene	O	4903
underlies	O	4903
many	O	4903
cases	O	4903
of	O	4903
aniridia	B-Disease	4903
.	O	4903
three	O	4904
lines	O	4904
of	O	4904
evidence	O	4904
now	O	4904
converge	O	4904
to	O	4904
implicate	O	4904
pax6	O	4904
more	O	4904
widely	O	4904
in	O	4904
anterior	B-Disease	4904
segment	I-Disease	4904
malformations	I-Disease	4904
including	O	4904
peters	B-Disease	4904
anomaly	I-Disease	4904
.	O	4904
first	O	4905
,	O	4905
a	O	4905
child	O	4905
with	O	4905
peters	B-Disease	4905
anomaly	I-Disease	4905
is	O	4905
deleted	O	4905
for	O	4905
one	O	4905
copy	O	4905
of	O	4905
pax6	O	4905
.	O	4905
second	O	4906
,	O	4906
affected	O	4906
members	O	4906
of	O	4906
a	O	4906
family	O	4906
with	O	4906
dominantly	O	4906
inherited	O	4906
anterior	B-Disease	4906
segment	I-Disease	4906
malformations	I-Disease	4906
,	O	4906
including	O	4906
peters	B-Disease	4906
anomaly	I-Disease	4906
are	O	4906
heterozygous	O	4906
for	O	4906
an	O	4906
r26g	O	4906
mutation	O	4906
in	O	4906
the	O	4906
pax6	O	4906
paired	O	4906
box	O	4906
.	O	4906
third	O	4907
,	O	4907
a	O	4907
proportion	O	4907
of	O	4907
sey	O	4907
/	O	4907
+	O	4907
smalleye	O	4907
mice	O	4907
,	O	4907
heterozygous	O	4907
for	O	4907
a	O	4907
nonsense	O	4907
mutation	O	4907
in	O	4907
murine	O	4907
pax	O	4907
-	O	4907
6	O	4907
,	O	4907
have	O	4907
an	O	4907
ocular	O	4907
phenotype	O	4907
resembling	O	4907
peters	B-Disease	4907
anomaly	I-Disease	4907
.	O	4907
we	O	4908
therefore	O	4908
propose	O	4908
that	O	4908
a	O	4908
variety	O	4908
of	O	4908
anterior	B-Disease	4908
segment	I-Disease	4908
anomalies	I-Disease	4908
may	O	4908
be	O	4908
associated	O	4908
with	O	4908
pax6	O	4908
mutations	O	4908
.	O	4908
.	O	4908
huntington	B-Disease	4909
disease	I-Disease	4909
without	O	4909
cag	O	4909
expansion	O	4909
:	O	4909
phenocopies	O	4909
or	O	4909
errors	O	4909
in	O	4909
assignment	O	4909
?	O	4909
huntington	B-Disease	4910
disease	I-Disease	4910
(	O	4910
hd	B-Disease	4910
)	O	4910
has	O	4910
been	O	4910
shown	O	4910
to	O	4910
be	O	4910
associated	O	4910
with	O	4910
an	O	4910
expanded	O	4910
cag	O	4910
repeat	O	4910
within	O	4910
a	O	4910
novel	O	4910
gene	O	4910
on	O	4910
4p16	O	4910
.	O	4910
the	O	4913
reasons	O	4913
for	O	4913
not	O	4913
observing	O	4913
expansion	O	4913
in	O	4913
affected	O	4913
individuals	O	4913
are	O	4913
important	O	4913
for	O	4913
determining	O	4913
the	O	4913
sensitivity	O	4913
of	O	4913
using	O	4913
repeat	O	4913
length	O	4913
both	O	4913
for	O	4913
diagnosis	O	4913
of	O	4913
affected	O	4913
patients	O	4913
and	O	4913
for	O	4913
predictive	O	4913
testing	O	4913
programs	O	4913
and	O	4913
may	O	4913
have	O	4913
biological	O	4913
relevance	O	4913
for	O	4913
the	O	4913
understanding	O	4913
of	O	4913
the	O	4913
molecular	O	4913
mechanism	O	4913
underlying	O	4913
hd	B-Disease	4913
.	O	4913
the	O	4915
remaining	O	4915
12	O	4915
patients	O	4915
represent	O	4915
possible	O	4915
phenocopies	O	4915
for	O	4915
hd	B-Disease	4915
.	O	4915
mutations	O	4918
in	O	4918
the	O	4918
hd	B-Disease	4918
gene	O	4918
that	O	4918
are	O	4918
other	O	4918
than	O	4918
cag	O	4918
expansion	O	4918
have	O	4918
not	O	4918
been	O	4918
excluded	O	4918
for	O	4918
the	O	4918
remaining	O	4918
eight	O	4918
cases	O	4918
;	O	4918
however	O	4918
,	O	4918
in	O	4918
as	O	4918
many	O	4918
as	O	4918
seven	O	4918
of	O	4918
these	O	4918
persons	O	4918
,	O	4918
retrospective	O	4918
review	O	4918
of	O	4918
these	O	4918
patients	O	4918
clinical	O	4918
features	O	4918
identified	O	4918
characteristics	O	4918
not	O	4918
typical	O	4918
for	O	4918
hd	B-Disease	4918
.	O	4918
this	O	4919
study	O	4919
shows	O	4919
that	O	4919
on	O	4919
rare	O	4919
occasions	O	4919
mutations	O	4919
in	O	4919
other	O	4919
,	O	4919
as	O	4919
-	O	4919
yet	O	4919
-	O	4919
undefined	O	4919
genes	O	4919
can	O	4919
present	O	4919
with	O	4919
a	O	4919
clinical	O	4919
phenotype	O	4919
very	O	4919
similar	O	4919
to	O	4919
that	O	4919
of	O	4919
hd	B-Disease	4919
frequent	O	4920
detection	O	4920
of	O	4920
codon	O	4920
877	O	4920
mutation	O	4920
in	O	4920
the	O	4920
androgen	O	4920
receptor	O	4920
gene	O	4920
in	O	4920
advanced	B-Disease	4920
prostate	I-Disease	4920
cancers	I-Disease	4920
.	O	4920
prostatic	O	4921
tissue	O	4921
specimens	O	4921
derived	O	4921
from	O	4921
transurethral	O	4921
resections	O	4921
of	O	4921
patients	O	4921
with	O	4921
metastatic	B-Disease	4921
prostate	I-Disease	4921
cancer	I-Disease	4921
were	O	4921
analyzed	O	4921
for	O	4921
genetic	O	4921
alterations	O	4921
in	O	4921
the	O	4921
hormone	O	4921
-	O	4921
binding	O	4921
domain	O	4921
of	O	4921
the	O	4921
androgen	O	4921
receptor	O	4921
(	O	4921
ar	O	4921
)	O	4921
gene	O	4921
.	O	4921
this	O	4923
same	O	4923
ar	O	4923
mutation	O	4923
has	O	4923
been	O	4923
reported	O	4923
previously	O	4923
in	O	4923
a	O	4923
metastatic	B-Disease	4923
prostate	I-Disease	4923
cancer	I-Disease	4923
cell	O	4923
line	O	4923
,	O	4923
lncap	O	4923
,	O	4923
where	O	4923
this	O	4923
mutation	O	4923
confers	O	4923
upon	O	4923
the	O	4923
ar	O	4923
an	O	4923
altered	O	4923
ligand	O	4923
-	O	4923
binding	O	4923
specificity	O	4923
which	O	4923
is	O	4923
stimulated	O	4923
by	O	4923
estrogens	O	4923
,	O	4923
progestagens	O	4923
,	O	4923
and	O	4923
antiandrogens	O	4923
.	O	4923
it	O	4924
is	O	4924
possible	O	4924
that	O	4924
analogous	O	4924
to	O	4924
an	O	4924
activated	O	4924
/	O	4924
altered	O	4924
growth	O	4924
factor	O	4924
receptor	O	4924
oncogene	O	4924
,	O	4924
codon	O	4924
877	O	4924
mutant	O	4924
ar	O	4924
with	O	4924
altered	O	4924
ligand	O	4924
binding	O	4924
may	O	4924
provide	O	4924
a	O	4924
selective	O	4924
growth	O	4924
advantage	O	4924
in	O	4924
the	O	4924
genesis	O	4924
of	O	4924
a	O	4924
subset	O	4924
of	O	4924
advanced	B-Disease	4924
prostate	I-Disease	4924
cancer	I-Disease	4924
.	O	4924
although	O	4925
estrogens	O	4925
are	O	4925
used	O	4925
infrequently	O	4925
,	O	4925
antiandrogens	O	4925
are	O	4925
used	O	4925
increasingly	O	4925
in	O	4925
hormonal	O	4925
therapy	O	4925
for	O	4925
patients	O	4925
with	O	4925
advanced	B-Disease	4925
prostate	I-Disease	4925
cancer	I-Disease	4925
.	O	4925
the	O	4927
human	O	4927
gene	O	4927
for	O	4927
alkaptonuria	B-Disease	4927
(	O	4927
aku	B-Disease	4927
)	O	4927
maps	O	4927
to	O	4927
chromosome	O	4927
3q	O	4927
.	O	4927
alkaptonuria	B-Disease	4928
(	O	4928
aku	B-Disease	4928
;	O	4928
mckusick	O	4928
no	O	4928
.	O	4928
203500	O	4928
)	O	4928
is	O	4928
a	O	4928
rare	O	4928
autosomal	B-Disease	4928
recessive	I-Disease	4928
disorder	I-Disease	4928
caused	O	4928
by	O	4928
the	O	4928
lack	O	4928
of	O	4928
homogentisic	O	4928
acid	O	4928
oxidase	O	4928
activity	O	4928
.	O	4928
ochronosis	B-Disease	4930
is	O	4930
the	O	4930
predominant	O	4930
clinical	O	4930
complication	O	4930
of	O	4930
the	O	4930
disease	O	4930
leading	O	4930
to	O	4930
ochronotic	B-Disease	4930
arthropathy	I-Disease	4930
,	O	4930
dark	O	4930
urine	O	4930
,	O	4930
pigment	O	4930
changes	O	4930
of	O	4930
the	O	4930
skin	O	4930
,	O	4930
and	O	4930
other	O	4930
clinical	O	4930
features	O	4930
.	O	4930
a	O	4931
mutation	O	4931
causing	O	4931
alkaptonuria	B-Disease	4931
in	O	4931
the	O	4931
mouse	O	4931
has	O	4931
mapped	O	4931
to	O	4931
chromosome	O	4931
16	O	4931
.	O	4931
considering	O	4932
conserved	O	4932
synteny	O	4932
,	O	4932
we	O	4932
were	O	4932
able	O	4932
to	O	4932
map	O	4932
the	O	4932
human	O	4932
gene	O	4932
to	O	4932
chromosome	O	4932
3q	O	4932
in	O	4932
six	O	4932
alkaptonuria	B-Disease	4932
pedigrees	O	4932
of	O	4932
slovak	O	4932
origin	O	4932
.	O	4932
.	O	4932
an	O	4935
sglt1	O	4935
missense	O	4935
mutation	O	4935
underlies	O	4935
hereditary	B-Disease	4935
glucose	I-Disease	4935
/	I-Disease	4935
galactose	I-Disease	4935
malabsorption	I-Disease	4935
,	O	4935
characterized	O	4935
by	O	4935
potentially	O	4935
fatal	O	4935
diarrhea	B-Disease	4935
;	O	4935
conversely	O	4935
,	O	4935
oral	O	4935
rehydration	O	4935
therapy	O	4935
exploits	O	4935
normal	O	4935
transport	O	4935
to	O	4935
alleviate	O	4935
life	O	4935
-	O	4935
threatening	O	4935
diarrhea	B-Disease	4935
of	O	4935
infectious	O	4935
origin	O	4935
.	O	4935
a	O	4940
new	O	4940
missense	O	4940
mutation	O	4940
in	O	4940
exon	O	4940
1	O	4940
causing	O	4940
glucose	B-Disease	4940
/	I-Disease	4940
galactose	I-Disease	4940
malabsorption	I-Disease	4940
is	O	4940
also	O	4940
described	O	4940
.	O	4940
these	O	4942
data	O	4942
facilitate	O	4942
the	O	4942
search	O	4942
for	O	4942
new	O	4942
glucose	B-Disease	4942
/	I-Disease	4942
galactose	I-Disease	4942
malabsorption	I-Disease	4942
-	O	4942
related	O	4942
mutations	O	4942
in	O	4942
this	O	4942
important	O	4942
gene	O	4942
and	O	4942
provide	O	4942
a	O	4942
basis	O	4942
for	O	4942
future	O	4942
evolutionary	O	4942
comparisons	O	4942
with	O	4942
other	O	4942
na	O	4942
(	O	4942
+	O	4942
)	O	4942
-	O	4942
dependent	O	4942
cotransporters	O	4942
.	O	4942
.	O	4942
four	O	4943
novel	O	4943
pepd	O	4943
alleles	O	4943
causing	O	4943
prolidase	B-Disease	4943
deficiency	I-Disease	4943
.	O	4943
mutations	O	4944
at	O	4944
the	O	4944
pepd	O	4944
locus	O	4944
cause	O	4944
prolidase	B-Disease	4944
deficiency	I-Disease	4944
(	O	4944
mckusick	O	4944
170100	O	4944
)	O	4944
,	O	4944
a	O	4944
rare	O	4944
autosomal	B-Disease	4944
recessive	I-Disease	4944
disorder	I-Disease	4944
characterized	O	4944
by	O	4944
iminodipeptiduria	B-Disease	4944
,	O	4944
skin	B-Disease	4944
ulcers	I-Disease	4944
,	O	4944
mental	B-Disease	4944
retardation	I-Disease	4944
,	O	4944
and	O	4944
recurrent	O	4944
infections	O	4944
.	O	4944
our	O	4952
results	O	4952
indicate	O	4952
that	O	4952
the	O	4952
severe	O	4952
form	O	4952
of	O	4952
prolidase	B-Disease	4952
deficiency	I-Disease	4952
is	O	4952
caused	O	4952
by	O	4952
multiple	O	4952
pepd	O	4952
alleles	O	4952
.	O	4952
recombinations	O	4954
in	O	4954
individuals	O	4954
homozygous	O	4954
by	O	4954
descent	O	4954
localize	O	4954
the	O	4954
friedreich	B-Disease	4954
ataxia	I-Disease	4954
locus	O	4954
in	O	4954
a	O	4954
cloned	O	4954
450	O	4954
-	O	4954
kb	O	4954
interval	O	4954
.	O	4954
the	O	4955
locus	O	4955
for	O	4955
friedreich	B-Disease	4955
ataxia	I-Disease	4955
(	O	4955
frda	B-Disease	4955
)	O	4955
,	O	4955
a	O	4955
severe	O	4955
neurodegenerative	B-Disease	4955
disease	I-Disease	4955
,	O	4955
is	O	4955
tightly	O	4955
linked	O	4955
to	O	4955
markers	O	4955
d9s5	O	4955
and	O	4955
d9s15	O	4955
,	O	4955
and	O	4955
analysis	O	4955
of	O	4955
rare	O	4955
recombination	O	4955
events	O	4955
has	O	4955
suggested	O	4955
the	O	4955
order	O	4955
cen	O	4955
-	O	4955
frda	O	4955
-	O	4955
d9s5	O	4955
-	O	4955
d9s15	O	4955
-	O	4955
qter	O	4955
.	O	4955
in	O	4957
order	O	4957
to	O	4957
map	O	4957
these	O	4957
markers	O	4957
with	O	4957
respect	O	4957
to	O	4957
the	O	4957
frda	B-Disease	4957
locus	O	4957
,	O	4957
all	O	4957
within	O	4957
a	O	4957
1	O	4957
-	O	4957
cm	O	4957
confidence	O	4957
interval	O	4957
,	O	4957
we	O	4957
sought	O	4957
to	O	4957
increase	O	4957
the	O	4957
genetic	O	4957
information	O	4957
of	O	4957
available	O	4957
frda	B-Disease	4957
families	O	4957
by	O	4957
considering	O	4957
homozygosity	O	4957
by	O	4957
descent	O	4957
and	O	4957
association	O	4957
with	O	4957
founder	O	4957
haplotypes	O	4957
in	O	4957
isolated	O	4957
populations	O	4957
.	O	4957
this	O	4958
approach	O	4958
allowed	O	4958
us	O	4958
to	O	4958
identify	O	4958
one	O	4958
phase	O	4958
-	O	4958
known	O	4958
recombination	O	4958
and	O	4958
one	O	4958
probable	O	4958
historic	O	4958
recombination	O	4958
on	O	4958
haplotypes	O	4958
from	O	4958
reunion	O	4958
island	O	4958
patients	O	4958
,	O	4958
both	O	4958
of	O	4958
which	O	4958
place	O	4958
three	O	4958
of	O	4958
the	O	4958
five	O	4958
markers	O	4958
proximal	O	4958
to	O	4958
frda	B-Disease	4958
.	O	4958
this	O	4959
represents	O	4959
the	O	4959
first	O	4959
identification	O	4959
of	O	4959
close	O	4959
frda	B-Disease	4959
flanking	O	4959
markers	O	4959
on	O	4959
the	O	4959
centromeric	O	4959
side	O	4959
.	O	4959
taken	O	4961
together	O	4961
,	O	4961
the	O	4961
results	O	4961
place	O	4961
the	O	4961
frda	B-Disease	4961
locus	O	4961
in	O	4961
a	O	4961
450	O	4961
-	O	4961
kb	O	4961
interval	O	4961
,	O	4961
which	O	4961
is	O	4961
small	O	4961
enough	O	4961
for	O	4961
direct	O	4961
search	O	4961
of	O	4961
candidate	O	4961
genes	O	4961
.	O	4961
investigation	O	4963
of	O	4963
thermoregulatory	O	4963
characteristics	O	4963
in	O	4963
patients	O	4963
with	O	4963
prader	B-Disease	4963
-	I-Disease	4963
willi	I-Disease	4963
syndrome	I-Disease	4963
.	O	4963
a	O	4964
survey	O	4964
instrument	O	4964
is	O	4964
used	O	4964
to	O	4964
assess	O	4964
temperature	O	4964
regulation	O	4964
characteristics	O	4964
in	O	4964
children	O	4964
with	O	4964
prader	B-Disease	4964
-	I-Disease	4964
willi	I-Disease	4964
syndrome	I-Disease	4964
(	O	4964
pws	B-Disease	4964
)	O	4964
compared	O	4964
to	O	4964
3	O	4964
control	O	4964
groups	O	4964
sibs	O	4964
of	O	4964
pws	B-Disease	4964
patients	O	4964
(	O	4964
sib	O	4964
)	O	4964
,	O	4964
neurodevelopmentally	B-Disease	4964
handicapped	I-Disease	4964
children	O	4964
(	O	4964
nd	O	4964
)	O	4964
,	O	4964
and	O	4964
age	O	4964
and	O	4964
gender	O	4964
matched	O	4964
well	O	4964
children	O	4964
(	O	4964
wc	O	4964
)	O	4964
.	O	4964
significant	O	4965
differences	O	4965
were	O	4965
found	O	4965
between	O	4965
pws	B-Disease	4965
patients	O	4965
,	O	4965
sib	O	4965
controls	O	4965
,	O	4965
and	O	4965
wc	O	4965
controls	O	4965
in	O	4965
the	O	4965
prevalence	O	4965
of	O	4965
febrile	O	4965
convulsions	O	4965
,	O	4965
fever	O	4965
-	O	4965
associated	O	4965
symptoms	O	4965
,	O	4965
and	O	4965
temperature	O	4965
less	O	4965
than	O	4965
94	O	4965
degrees	O	4965
f	O	4965
.	O	4965
no	O	4966
differences	O	4966
were	O	4966
noted	O	4966
in	O	4966
any	O	4966
variable	O	4966
between	O	4966
the	O	4966
pws	B-Disease	4966
patients	O	4966
and	O	4966
the	O	4966
nd	O	4966
controls	O	4966
,	O	4966
suggesting	O	4966
that	O	4966
these	O	4966
abnormalities	O	4966
are	O	4966
not	O	4966
unique	O	4966
to	O	4966
pws	B-Disease	4966
,	O	4966
but	O	4966
can	O	4966
occur	O	4966
in	O	4966
any	O	4966
neurodevelopmentally	B-Disease	4966
handicapped	I-Disease	4966
individual	O	4966
,	O	4966
further	O	4966
suggesting	O	4966
these	O	4966
do	O	4966
not	O	4966
necessarily	O	4966
reflect	O	4966
syndrome	O	4966
-	O	4966
specific	O	4966
hypothalamic	B-Disease	4966
abnormalities	I-Disease	4966
.	O	4966
.	O	4966
phenotypic	O	4967
variation	O	4967
including	O	4967
retinitis	B-Disease	4967
pigmentosa	I-Disease	4967
,	O	4967
pattern	B-Disease	4967
dystrophy	I-Disease	4967
,	O	4967
and	O	4967
fundus	B-Disease	4967
flavimaculatus	I-Disease	4967
in	O	4967
a	O	4967
single	O	4967
family	O	4967
with	O	4967
a	O	4967
deletion	O	4967
of	O	4967
codon	O	4967
153	O	4967
or	O	4967
154	O	4967
of	O	4967
the	O	4967
peripherin	O	4967
/	O	4967
rds	O	4967
gene	O	4967
.	O	4967
background	O	4968
and	O	4968
objectives	O	4968
mutations	O	4968
of	O	4968
the	O	4968
peripherin	O	4968
/	O	4968
rds	O	4968
gene	O	4968
have	O	4968
been	O	4968
reported	O	4968
in	O	4968
autosomal	B-Disease	4968
dominant	I-Disease	4968
retinitis	I-Disease	4968
pigmentosa	I-Disease	4968
,	O	4968
pattern	O	4968
macular	B-Disease	4968
dystrophy	I-Disease	4968
,	O	4968
and	O	4968
retinitis	B-Disease	4968
punctata	I-Disease	4968
albescens	I-Disease	4968
.	O	4968
results	O	4973
the	O	4973
mother	O	4973
presented	O	4973
at	O	4973
age	O	4973
63	O	4973
years	O	4973
with	O	4973
a	O	4973
profoundly	O	4973
abnormal	O	4973
electroretinogram	O	4973
(	O	4973
erg	O	4973
)	O	4973
and	O	4973
adult	O	4973
-	O	4973
onset	O	4973
retinitis	B-Disease	4973
pigmentosa	I-Disease	4973
that	O	4973
progressed	O	4973
dramatically	O	4973
over	O	4973
12	O	4973
years	O	4973
,	O	4973
with	O	4973
marked	O	4973
loss	O	4973
of	O	4973
peripheral	O	4973
visual	O	4973
field	O	4973
.	O	4973
one	O	4974
daughter	O	4974
developed	O	4974
pattern	B-Disease	4974
macular	I-Disease	4974
dystrophy	I-Disease	4974
at	O	4974
age	O	4974
31	O	4974
years	O	4974
.	O	4974
another	O	4976
daughter	O	4976
presented	O	4976
at	O	4976
age	O	4976
42	O	4976
years	O	4976
with	O	4976
macular	B-Disease	4976
degeneration	I-Disease	4976
and	O	4976
over	O	4976
10	O	4976
years	O	4976
developed	O	4976
the	O	4976
clinical	O	4976
picture	O	4976
of	O	4976
fundus	B-Disease	4976
flavimaculatus	I-Disease	4976
.	O	4976
the	O	4978
son	O	4978
had	O	4978
onset	O	4978
of	O	4978
macular	B-Disease	4978
degeneration	I-Disease	4978
at	O	4978
age	O	4978
44	O	4978
years	O	4978
.	O	4978
pericentral	B-Disease	4979
scotomas	I-Disease	4979
were	O	4979
present	O	4979
and	O	4979
the	O	4979
erg	O	4979
was	O	4979
markedly	O	4979
abnormal	O	4979
.	O	4979
in	O	4986
two	O	4986
patients	O	4986
with	O	4986
the	O	4986
autosomal	B-Disease	4986
recessive	I-Disease	4986
disease	I-Disease	4986
glucose	I-Disease	4986
/	I-Disease	4986
galactose	I-Disease	4986
malabsorption	I-Disease	4986
,	O	4986
the	O	4986
underlying	O	4986
cause	O	4986
was	O	4986
found	O	4986
to	O	4986
be	O	4986
a	O	4986
missense	O	4986
mutation	O	4986
in	O	4986
sglt1	O	4986
,	O	4986
and	O	4986
the	O	4986
asp28	O	4986
-	O	4986
-	O	4986
>	O	4986
asn	O	4986
change	O	4986
was	O	4986
demonstrated	O	4986
in	O	4986
vitro	O	4986
to	O	4986
eliminate	O	4986
sglt1	O	4986
transport	O	4986
activity	O	4986
.	O	4986
1	O	4989
,	O	4989
and	O	4989
provide	O	4989
an	O	4989
example	O	4989
of	O	4989
the	O	4989
utility	O	4989
of	O	4989
the	O	4989
sglt1	O	4989
probe	O	4989
as	O	4989
a	O	4989
diagnostic	O	4989
for	O	4989
genetic	B-Disease	4989
diseases	I-Disease	4989
associated	O	4989
with	O	4989
translocations	O	4989
of	O	4989
chromosome	O	4989
22	O	4989
.	O	4989
restriction	O	4990
of	O	4990
ocular	O	4990
fundus	O	4990
lesions	O	4990
to	O	4990
a	O	4990
specific	O	4990
subgroup	O	4990
of	O	4990
apc	B-Disease	4990
mutations	O	4990
in	O	4990
adenomatous	B-Disease	4990
polyposis	I-Disease	4990
coli	I-Disease	4990
patients	O	4990
.	O	4990
in	O	4991
humans	O	4991
,	O	4991
alteration	O	4991
of	O	4991
the	O	4991
tumor	B-Disease	4991
suppressor	O	4991
gene	O	4991
,	O	4991
apc	B-Disease	4991
,	O	4991
causes	O	4991
adenomatous	B-Disease	4991
polyposis	I-Disease	4991
coli	I-Disease	4991
,	O	4991
a	O	4991
condition	O	4991
causing	O	4991
predisposition	O	4991
to	O	4991
colorectal	B-Disease	4991
cancer	I-Disease	4991
.	O	4991
the	O	4992
syndrome	O	4992
inconsistently	O	4992
associates	O	4992
characteristic	O	4992
patches	O	4992
of	O	4992
congenital	B-Disease	4992
hypertrophy	I-Disease	4992
of	I-Disease	4992
the	I-Disease	4992
retinal	I-Disease	4992
pigment	I-Disease	4992
epithelium	I-Disease	4992
(	O	4992
chrpe	B-Disease	4992
)	O	4992
.	O	4992
ocular	O	4993
examination	O	4993
revealed	O	4993
that	O	4993
patients	O	4993
expressing	O	4993
chrpe	B-Disease	4993
tend	O	4993
to	O	4993
cluster	O	4993
within	O	4993
specific	O	4993
families	O	4993
.	O	4993
the	O	4994
exact	O	4994
apc	B-Disease	4994
mutation	O	4994
was	O	4994
identified	O	4994
in	O	4994
42	O	4994
unrelated	O	4994
patients	O	4994
.	O	4994
the	O	4996
extent	O	4996
of	O	4996
chrpe	B-Disease	4996
was	O	4996
found	O	4996
to	O	4996
be	O	4996
dependent	O	4996
on	O	4996
the	O	4996
position	O	4996
of	O	4996
the	O	4996
mutation	O	4996
along	O	4996
the	O	4996
coding	O	4996
sequence	O	4996
.	O	4996
chrpe	B-Disease	4997
lesions	O	4997
are	O	4997
almost	O	4997
always	O	4997
absent	O	4997
if	O	4997
the	O	4997
mutation	O	4997
occurs	O	4997
before	O	4997
exon	O	4997
9	O	4997
,	O	4997
but	O	4997
are	O	4997
systematically	O	4997
present	O	4997
if	O	4997
it	O	4997
occurs	O	4997
after	O	4997
this	O	4997
exon	O	4997
.	O	4997
thus	O	4998
,	O	4998
the	O	4998
range	O	4998
of	O	4998
phenotypic	O	4998
expression	O	4998
observed	O	4998
among	O	4998
affected	O	4998
patients	O	4998
may	O	4998
result	O	4998
in	O	4998
part	O	4998
from	O	4998
different	O	4998
allelic	O	4998
manifestations	O	4998
of	O	4998
apc	B-Disease	4998
mutations	O	4998
.	O	4998
.	O	4998
the	O	5001
authors	O	5001
earlier	O	5001
findings	O	5001
of	O	5001
a	O	5001
negative	O	5001
electroretinogram	O	5001
(	O	5001
erg	O	5001
)	O	5001
in	O	5001
a	O	5001
boy	O	5001
with	O	5001
duchenne	B-Disease	5001
muscular	I-Disease	5001
dystrophy	I-Disease	5001
(	O	5001
dmd	B-Disease	5001
)	O	5001
led	O	5001
them	O	5001
to	O	5001
investigate	O	5001
dystrophin	O	5001
gene	O	5001
deletions	O	5001
and	O	5001
ergs	O	5001
in	O	5001
five	O	5001
boys	O	5001
with	O	5001
dmd	B-Disease	5001
.	O	5001
the	O	5002
authors	O	5002
wanted	O	5002
to	O	5002
determined	O	5002
whether	O	5002
there	O	5002
were	O	5002
similar	O	5002
erg	O	5002
findings	O	5002
in	O	5002
an	O	5002
animal	O	5002
model	O	5002
for	O	5002
dmd	B-Disease	5002
,	O	5002
the	O	5002
mdx	O	5002
mouse	O	5002
.	O	5002
ganzfeld	O	5004
ergs	O	5004
were	O	5004
recorded	O	5004
in	O	5004
five	O	5004
boys	O	5004
with	O	5004
dmd	B-Disease	5004
after	O	5004
a	O	5004
complete	O	5004
ophthalmic	O	5004
examination	O	5004
.	O	5004
the	O	5012
authors	O	5012
believe	O	5012
the	O	5012
unique	O	5012
erg	O	5012
recorded	O	5012
for	O	5012
the	O	5012
human	O	5012
subjects	O	5012
is	O	5012
a	O	5012
manifestation	O	5012
of	O	5012
dmd	B-Disease	5012
associated	O	5012
with	O	5012
defects	O	5012
at	O	5012
the	O	5012
dystrophin	O	5012
gene	O	5012
locus	O	5012
and	O	5012
represents	O	5012
a	O	5012
new	O	5012
clinical	O	5012
entity	O	5012
.	O	5012
the	O	5014
erg	O	5014
shows	O	5014
promise	O	5014
of	O	5014
becoming	O	5014
a	O	5014
noninvasive	O	5014
diagnostic	O	5014
tool	O	5014
for	O	5014
dmd	B-Disease	5014
and	O	5014
its	O	5014
milder	O	5014
allelic	O	5014
forms	O	5014
.	O	5014
.	O	5014
association	O	5015
of	O	5015
the	O	5015
apc	B-Disease	5015
tumor	I-Disease	5015
suppressor	O	5015
protein	O	5015
with	O	5015
catenins	O	5015
.	O	5015
mutations	O	5016
of	O	5016
apc	O	5016
appear	O	5016
to	O	5016
initiate	O	5016
sporadic	O	5016
and	O	5016
inherited	O	5016
forms	O	5016
of	O	5016
human	O	5016
colorectal	B-Disease	5016
cancer	I-Disease	5016
.	O	5016
although	O	5017
these	O	5017
mutations	O	5017
have	O	5017
been	O	5017
well	O	5017
characterized	O	5017
,	O	5017
little	O	5017
is	O	5017
known	O	5017
about	O	5017
the	O	5017
function	O	5017
of	O	5017
the	O	5017
apc	B-Disease	5017
gene	O	5017
product	O	5017
.	O	5017
two	O	5018
cellular	O	5018
proteins	O	5018
that	O	5018
associate	O	5018
with	O	5018
apc	B-Disease	5018
were	O	5018
identified	O	5018
by	O	5018
nucleotide	O	5018
sequence	O	5018
analysis	O	5018
and	O	5018
peptide	O	5018
mapping	O	5018
as	O	5018
the	O	5018
e	O	5018
-	O	5018
cadherin	O	5018
-	O	5018
associated	O	5018
proteins	O	5018
alpha	O	5018
-	O	5018
and	O	5018
beta	O	5018
-	O	5018
catenin	O	5018
.	O	5018
these	O	5020
results	O	5020
suggest	O	5020
an	O	5020
important	O	5020
link	O	5020
between	O	5020
tumor	B-Disease	5020
initiation	O	5020
and	O	5020
cell	O	5020
adhesion	O	5020
.	O	5020
.	O	5020
difference	O	5021
in	O	5021
methylation	O	5021
patterns	O	5021
within	O	5021
the	O	5021
d15s9	O	5021
region	O	5021
of	O	5021
chromosome	O	5021
15q11	O	5021
-	O	5021
13	O	5021
in	O	5021
first	O	5021
cousins	O	5021
with	O	5021
angelman	B-Disease	5021
syndrome	I-Disease	5021
and	O	5021
prader	B-Disease	5021
-	I-Disease	5021
willi	I-Disease	5021
syndrome	I-Disease	5021
.	O	5021
abnormalities	O	5022
of	O	5022
chromosome	O	5022
region	O	5022
15q11	O	5022
-	O	5022
13	O	5022
are	O	5022
associated	O	5022
with	O	5022
angelman	B-Disease	5022
syndrome	I-Disease	5022
(	O	5022
as	B-Disease	5022
)	O	5022
and	O	5022
prader	B-Disease	5022
-	I-Disease	5022
willi	I-Disease	5022
syndrome	I-Disease	5022
(	O	5022
pws	B-Disease	5022
)	O	5022
.	O	5022
differences	O	5023
between	O	5023
the	O	5023
methylation	O	5023
patterns	O	5023
of	O	5023
the	O	5023
region	O	5023
of	O	5023
chromosome	O	5023
15q11	O	5023
-	O	5023
13	O	5023
which	O	5023
hybridizes	O	5023
to	O	5023
the	O	5023
highly	O	5023
conserved	O	5023
dna	O	5023
,	O	5023
dn34	O	5023
,	O	5023
in	O	5023
normal	O	5023
individuals	O	5023
and	O	5023
in	O	5023
patients	O	5023
with	O	5023
as	B-Disease	5023
and	O	5023
pws	B-Disease	5023
have	O	5023
been	O	5023
described	O	5023
.	O	5023
we	O	5024
report	O	5024
on	O	5024
a	O	5024
family	O	5024
in	O	5024
which	O	5024
first	O	5024
cousins	O	5024
are	O	5024
affected	O	5024
by	O	5024
as	B-Disease	5024
and	O	5024
pws	B-Disease	5024
as	O	5024
a	O	5024
result	O	5024
of	O	5024
a	O	5024
familial	O	5024
paracentric	O	5024
inversion	O	5024
of	O	5024
15q11	O	5024
-	O	5024
q13	O	5024
.	O	5024
haplotype	O	5026
studies	O	5026
in	O	5026
wilson	B-Disease	5026
disease	I-Disease	5026
.	O	5026
in	O	5027
51	O	5027
families	O	5027
with	O	5027
wilson	B-Disease	5027
disease	I-Disease	5027
,	O	5027
we	O	5027
have	O	5027
studied	O	5027
dna	O	5027
haplotypes	O	5027
of	O	5027
dinucleotide	O	5027
repeat	O	5027
polymorphisms	O	5027
(	O	5027
ca	O	5027
repeats	O	5027
)	O	5027
in	O	5027
the	O	5027
13q14	O	5027
.	O	5027
3	O	5028
region	O	5028
,	O	5028
to	O	5028
examine	O	5028
these	O	5028
markers	O	5028
for	O	5028
association	O	5028
with	O	5028
the	O	5028
wilson	B-Disease	5028
disease	I-Disease	5028
gene	O	5028
(	O	5028
wnd	B-Disease	5028
)	O	5028
.	O	5028
in	O	5029
addition	O	5029
to	O	5029
a	O	5029
marker	O	5029
(	O	5029
d13s133	O	5029
)	O	5029
described	O	5029
elsewhere	O	5029
,	O	5029
we	O	5029
have	O	5029
developed	O	5029
three	O	5029
new	O	5029
highly	O	5029
polymorphic	O	5029
markers	O	5029
(	O	5029
d13s314	O	5029
,	O	5029
d13s315	O	5029
,	O	5029
and	O	5029
d13s316	O	5029
)	O	5029
close	O	5029
to	O	5029
the	O	5029
wnd	B-Disease	5029
locus	O	5029
.	O	5029
we	O	5030
have	O	5030
examined	O	5030
the	O	5030
distribution	O	5030
of	O	5030
marker	O	5030
alleles	O	5030
at	O	5030
the	O	5030
loci	O	5030
studied	O	5030
and	O	5030
have	O	5030
found	O	5030
that	O	5030
d13s314	O	5030
,	O	5030
d13s133	O	5030
,	O	5030
and	O	5030
d13s316	O	5030
each	O	5030
show	O	5030
nonrandom	O	5030
distribution	O	5030
on	O	5030
chromosomes	O	5030
carrying	O	5030
the	O	5030
wnd	B-Disease	5030
mutation	O	5030
.	O	5030
we	O	5031
have	O	5031
studied	O	5031
haplotypes	O	5031
of	O	5031
these	O	5031
three	O	5031
markers	O	5031
and	O	5031
have	O	5031
found	O	5031
that	O	5031
there	O	5031
are	O	5031
highly	O	5031
significant	O	5031
differences	O	5031
between	O	5031
wnd	B-Disease	5031
and	O	5031
normal	O	5031
haplotypes	O	5031
in	O	5031
northern	O	5031
european	O	5031
families	O	5031
.	O	5031
these	O	5032
findings	O	5032
have	O	5032
important	O	5032
implications	O	5032
for	O	5032
mutation	O	5032
detection	O	5032
and	O	5032
molecular	O	5032
diagnosis	O	5032
in	O	5032
families	O	5032
with	O	5032
wilson	B-Disease	5032
disease	I-Disease	5032
.	O	5032
we	O	5034
have	O	5034
analyzed	O	5034
a	O	5034
single	O	5034
multi	O	5034
-	O	5034
affected	O	5034
breast	B-Disease	5034
/	I-Disease	5034
ovarian	I-Disease	5034
cancer	I-Disease	5034
pedigree	O	5034
(	O	5034
bov3	O	5034
)	O	5034
and	O	5034
have	O	5034
shown	O	5034
consistent	O	5034
inheritance	O	5034
of	O	5034
markers	O	5034
on	O	5034
chromosome	O	5034
17q	O	5034
with	O	5034
the	O	5034
disease	O	5034
confirming	O	5034
that	O	5034
this	O	5034
family	O	5034
is	O	5034
due	O	5034
to	O	5034
the	O	5034
brca1	O	5034
gene	O	5034
.	O	5034
analysis	O	5035
of	O	5035
17q	O	5035
haplotypes	O	5035
shows	O	5035
a	O	5035
recombination	O	5035
event	O	5035
in	O	5035
a	O	5035
bilateral	O	5035
breast	B-Disease	5035
cancer	I-Disease	5035
case	O	5035
which	O	5035
suggests	O	5035
that	O	5035
the	O	5035
brca1	O	5035
gene	O	5035
lies	O	5035
distal	O	5035
to	O	5035
d17s857	O	5035
;	O	5035
d17s857	O	5035
is	O	5035
thus	O	5035
the	O	5035
new	O	5035
proximal	O	5035
boundary	O	5035
for	O	5035
the	O	5035
region	O	5035
containing	O	5035
brca1	O	5035
.	O	5035
all	O	5038
seven	O	5038
breast	B-Disease	5038
tumour	I-Disease	5038
/	O	5038
blood	O	5038
pairs	O	5038
examined	O	5038
from	O	5038
this	O	5038
family	O	5038
show	O	5038
loss	O	5038
of	O	5038
heterozygosity	O	5038
in	O	5038
the	O	5038
tumours	B-Disease	5038
.	O	5038
the	O	5039
allel	O	5039
retained	O	5039
in	O	5039
each	O	5039
tumour	B-Disease	5039
was	O	5039
from	O	5039
the	O	5039
disease	O	5039
-	O	5039
bearing	O	5039
chromosome	O	5039
implicating	O	5039
brca1	O	5039
as	O	5039
a	O	5039
tumour	B-Disease	5039
suppressor	O	5039
gene	O	5039
.	O	5039
myotonic	B-Disease	5042
dystrophy	I-Disease	5042
kinase	O	5042
is	O	5042
a	O	5042
component	O	5042
of	O	5042
neuromuscular	O	5042
junctions	O	5042
.	O	5042
the	O	5043
clinical	O	5043
manifestation	O	5043
of	O	5043
myotonic	B-Disease	5043
dystrophy	I-Disease	5043
(	O	5043
dm	B-Disease	5043
)	O	5043
is	O	5043
correlated	O	5043
to	O	5043
the	O	5043
extent	O	5043
of	O	5043
expansion	O	5043
of	O	5043
an	O	5043
unstable	O	5043
[	O	5043
ctg	O	5043
]	O	5043
n	O	5043
dna	O	5043
motif	O	5043
.	O	5043
recent	O	5044
studies	O	5044
have	O	5044
demonstrated	O	5044
that	O	5044
this	O	5044
trinucleotide	O	5044
motif	O	5044
forms	O	5044
part	O	5044
of	O	5044
the	O	5044
last	O	5044
,	O	5044
3	O	5044
untranslated	O	5044
exon	O	5044
of	O	5044
a	O	5044
gene	O	5044
which	O	5044
potentially	O	5044
encodes	O	5044
multiple	O	5044
protein	O	5044
isoforms	O	5044
of	O	5044
a	O	5044
serine	O	5044
/	O	5044
threonine	O	5044
protein	O	5044
kinase	O	5044
(	O	5044
myotonic	B-Disease	5044
dystrophy	I-Disease	5044
protein	O	5044
kinase	O	5044
,	O	5044
dm	O	5044
-	O	5044
pk	O	5044
)	O	5044
.	O	5044
immunoreactive	O	5046
dm	O	5046
-	O	5046
kinase	O	5046
protein	O	5046
of	O	5046
53	O	5046
kd	O	5046
is	O	5046
present	O	5046
at	O	5046
low	O	5046
levels	O	5046
in	O	5046
skeletal	O	5046
and	O	5046
cardiac	O	5046
muscle	O	5046
extracts	O	5046
of	O	5046
dm	B-Disease	5046
patients	O	5046
and	O	5046
normal	O	5046
controls	O	5046
.	O	5046
strikingly	O	5049
,	O	5049
presence	O	5049
of	O	5049
the	O	5049
protein	O	5049
can	O	5049
also	O	5049
be	O	5049
demonstrated	O	5049
for	O	5049
nmjs	O	5049
of	O	5049
muscular	O	5049
tissues	O	5049
of	O	5049
adult	O	5049
and	O	5049
congenital	O	5049
cases	O	5049
of	O	5049
dm	B-Disease	5049
,	O	5049
with	O	5049
no	O	5049
gross	O	5049
changes	O	5049
in	O	5049
structural	O	5049
organisation	O	5049
.	O	5049
our	O	5050
findings	O	5050
provide	O	5050
a	O	5050
basis	O	5050
for	O	5050
further	O	5050
characterisation	O	5050
of	O	5050
the	O	5050
role	O	5050
of	O	5050
the	O	5050
kinase	O	5050
in	O	5050
protein	O	5050
assembly	O	5050
processes	O	5050
or	O	5050
signal	O	5050
mediation	O	5050
at	O	5050
synaptic	O	5050
sites	O	5050
and	O	5050
ultimately	O	5050
for	O	5050
the	O	5050
understanding	O	5050
of	O	5050
the	O	5050
complex	O	5050
pathophysiology	O	5050
of	O	5050
dm	B-Disease	5050
.	O	5050
.	O	5050
markedly	O	5051
accelerated	O	5051
catabolism	O	5051
of	O	5051
apolipoprotein	O	5051
a	O	5051
-	O	5051
ii	O	5051
(	O	5051
apoa	O	5051
-	O	5051
ii	O	5051
)	O	5051
and	O	5051
high	O	5051
density	O	5051
lipoproteins	O	5051
containing	O	5051
apoa	O	5051
-	O	5051
ii	O	5051
in	O	5051
classic	O	5051
lecithin	O	5051
:	O	5051
cholesterol	B-Disease	5051
acyltransferase	I-Disease	5051
deficiency	I-Disease	5051
and	O	5051
fish	B-Disease	5051
-	I-Disease	5051
eye	I-Disease	5051
disease	I-Disease	5051
.	O	5051
classic	B-Disease	5052
(	I-Disease	5052
complete	I-Disease	5052
)	I-Disease	5052
lecithin	I-Disease	5052
cholesterol	I-Disease	5052
acyltransferase	I-Disease	5052
(	I-Disease	5052
lcat	I-Disease	5052
)	I-Disease	5052
deficiency	I-Disease	5052
and	O	5052
fish	B-Disease	5052
-	I-Disease	5052
eye	I-Disease	5052
disease	I-Disease	5052
(	O	5052
partial	B-Disease	5052
lcat	I-Disease	5052
deficiency	I-Disease	5052
)	O	5052
are	O	5052
genetic	O	5052
syndromes	O	5052
associated	O	5052
with	O	5052
markedly	O	5052
decreased	O	5052
plasma	O	5052
levels	O	5052
of	O	5052
high	O	5052
density	O	5052
lipoprotein	O	5052
(	O	5052
hdl	O	5052
)	O	5052
cholesterol	O	5052
but	O	5052
not	O	5052
with	O	5052
an	O	5052
increased	O	5052
risk	O	5052
of	O	5052
atherosclerotic	B-Disease	5052
cardiovascular	I-Disease	5052
disease	I-Disease	5052
.	O	5052
we	O	5053
investigated	O	5053
the	O	5053
metabolism	O	5053
of	O	5053
the	O	5053
hdl	O	5053
apolipoproteins	O	5053
(	O	5053
apo	O	5053
)	O	5053
apoa	O	5053
-	O	5053
i	O	5053
and	O	5053
apoa	O	5053
-	O	5053
ii	O	5053
in	O	5053
a	O	5053
total	O	5053
of	O	5053
five	O	5053
patients	O	5053
with	O	5053
lcat	B-Disease	5053
deficiency	I-Disease	5053
,	O	5053
one	O	5053
with	O	5053
classic	B-Disease	5053
lcat	I-Disease	5053
deficiency	I-Disease	5053
and	O	5053
four	O	5053
with	O	5053
fish	B-Disease	5053
-	I-Disease	5053
eye	I-Disease	5053
disease	I-Disease	5053
.	O	5053
in	O	5063
summary	O	5063
,	O	5063
genetic	O	5063
syndromes	O	5063
of	O	5063
either	O	5063
complete	B-Disease	5063
or	I-Disease	5063
partial	I-Disease	5063
lcat	I-Disease	5063
deficiency	I-Disease	5063
result	O	5063
in	O	5063
low	O	5063
levels	O	5063
of	O	5063
hdl	O	5063
through	O	5063
preferential	O	5063
hypercatabolism	O	5063
of	O	5063
apoa	O	5063
-	O	5063
ii	O	5063
and	O	5063
hdl	O	5063
particles	O	5063
containing	O	5063
apoa	O	5063
-	O	5063
ii	O	5063
.	O	5063
because	O	5064
lpa	O	5064
-	O	5064
i	O	5064
has	O	5064
been	O	5064
proposed	O	5064
to	O	5064
be	O	5064
more	O	5064
protective	O	5064
than	O	5064
lpa	O	5064
-	O	5064
i	O	5064
a	O	5064
-	O	5064
ii	O	5064
against	O	5064
atherosclerosis	B-Disease	5064
,	O	5064
this	O	5064
selective	O	5064
effect	O	5064
on	O	5064
the	O	5064
metabolism	O	5064
of	O	5064
lpa	O	5064
-	O	5064
i	O	5064
a	O	5064
-	O	5064
ii	O	5064
may	O	5064
provide	O	5064
a	O	5064
potential	O	5064
explanation	O	5064
why	O	5064
patients	O	5064
with	O	5064
classic	B-Disease	5064
lcat	I-Disease	5064
deficiency	I-Disease	5064
and	O	5064
fish	B-Disease	5064
-	I-Disease	5064
eye	I-Disease	5064
disease	I-Disease	5064
are	O	5064
not	O	5064
at	O	5064
increased	O	5064
risk	O	5064
for	O	5064
premature	O	5064
atherosclerosis	B-Disease	5064
despite	O	5064
markedly	O	5064
decreased	O	5064
levels	O	5064
of	O	5064
hdl	O	5064
cholesterol	O	5064
and	O	5064
apoa	O	5064
-	O	5064
i	O	5064
x	B-Disease	5065
linked	I-Disease	5065
recessive	I-Disease	5065
thrombocytopenia	I-Disease	5065
.	O	5065
a	O	5066
saudi	O	5066
arab	O	5066
boy	O	5066
presented	O	5066
in	O	5066
early	O	5066
childhood	O	5066
with	O	5066
thrombocytopenia	B-Disease	5066
,	O	5066
morphologically	O	5066
large	O	5066
and	O	5066
normal	O	5066
sized	O	5066
platelets	O	5066
,	O	5066
increased	O	5066
mean	O	5066
platelet	O	5066
volume	O	5066
,	O	5066
and	O	5066
a	O	5066
hypermegakaryocytic	O	5066
bone	O	5066
marrow	O	5066
.	O	5066
there	O	5067
was	O	5067
no	O	5067
clinical	O	5067
and	O	5067
laboratory	O	5067
evidence	O	5067
of	O	5067
any	O	5067
significant	O	5067
immunological	B-Disease	5067
abnormalities	I-Disease	5067
.	O	5067
similar	O	5068
findings	O	5068
in	O	5068
two	O	5068
other	O	5068
brothers	O	5068
suggested	O	5068
strongly	O	5068
that	O	5068
they	O	5068
were	O	5068
all	O	5068
suffering	O	5068
from	O	5068
an	O	5068
x	B-Disease	5068
linked	I-Disease	5068
recessive	I-Disease	5068
thrombocytopenic	I-Disease	5068
disorder	I-Disease	5068
.	O	5068
results	O	5069
of	O	5069
dna	O	5069
analysis	O	5069
with	O	5069
the	O	5069
probe	O	5069
m27	O	5069
beta	O	5069
are	O	5069
consistent	O	5069
with	O	5069
x	O	5069
linkage	O	5069
and	O	5069
indicate	O	5069
also	O	5069
that	O	5069
the	O	5069
locus	O	5069
of	O	5069
the	O	5069
relevant	O	5069
gene	O	5069
lies	O	5069
close	O	5069
to	O	5069
or	O	5069
is	O	5069
identical	O	5069
to	O	5069
the	O	5069
locus	O	5069
of	O	5069
the	O	5069
gene	O	5069
for	O	5069
the	O	5069
wiskott	B-Disease	5069
-	I-Disease	5069
aldrich	I-Disease	5069
syndrome	I-Disease	5069
(	O	5069
was	B-Disease	5069
)	O	5069
.	O	5069
because	O	5070
of	O	5070
various	O	5070
features	O	5070
which	O	5070
include	O	5070
the	O	5070
presence	O	5070
of	O	5070
large	O	5070
and	O	5070
normal	O	5070
sized	O	5070
platelets	O	5070
(	O	5070
rather	O	5070
than	O	5070
small	O	5070
platelets	O	5070
)	O	5070
and	O	5070
freedom	O	5070
from	O	5070
significant	O	5070
immune	B-Disease	5070
deficiencies	I-Disease	5070
,	O	5070
it	O	5070
is	O	5070
likely	O	5070
that	O	5070
the	O	5070
x	B-Disease	5070
linked	I-Disease	5070
recessive	I-Disease	5070
thrombocytopenia	I-Disease	5070
in	O	5070
this	O	5070
family	O	5070
is	O	5070
an	O	5070
isolated	O	5070
entity	O	5070
quite	O	5070
distinct	O	5070
from	O	5070
the	O	5070
classical	O	5070
was	B-Disease	5070
phenotype	O	5070
.	O	5070
however	O	5071
,	O	5071
a	O	5071
modified	O	5071
expression	O	5071
of	O	5071
the	O	5071
was	B-Disease	5071
gene	O	5071
producing	O	5071
a	O	5071
mild	O	5071
phenotypic	O	5071
variant	O	5071
cannot	O	5071
be	O	5071
excluded	O	5071
entirely	O	5071
.	O	5071
.	O	5071
macular	B-Disease	5072
dystrophy	I-Disease	5072
associated	O	5072
with	O	5072
mutations	O	5072
at	O	5072
codon	O	5072
172	O	5072
in	O	5072
the	O	5072
human	O	5072
retinal	B-Disease	5072
degeneration	I-Disease	5072
slow	O	5072
gene	O	5072
.	O	5072
background	O	5073
recently	O	5073
,	O	5073
mutations	O	5073
in	O	5073
the	O	5073
retinal	B-Disease	5073
degeneration	I-Disease	5073
slow	O	5073
(	O	5073
rds	O	5073
)	O	5073
gene	O	5073
which	O	5073
codes	O	5073
for	O	5073
peripherin	O	5073
-	O	5073
rds	O	5073
have	O	5073
been	O	5073
implicated	O	5073
as	O	5073
a	O	5073
cause	O	5073
of	O	5073
autosomal	B-Disease	5073
dominant	I-Disease	5073
retinitis	I-Disease	5073
pigmentosa	I-Disease	5073
.	O	5073
mutations	O	5075
at	O	5075
codon	O	5075
172	O	5075
of	O	5075
the	O	5075
rds	O	5075
gene	O	5075
have	O	5075
been	O	5075
identified	O	5075
in	O	5075
three	O	5075
families	O	5075
with	O	5075
autosomal	O	5075
dominantly	O	5075
inherited	O	5075
,	O	5075
progressive	O	5075
macular	B-Disease	5075
dystrophy	I-Disease	5075
.	O	5075
results	O	5077
in	O	5077
all	O	5077
but	O	5077
one	O	5077
affected	O	5077
member	O	5077
,	O	5077
symptoms	O	5077
of	O	5077
progressive	O	5077
central	O	5077
visual	B-Disease	5077
loss	I-Disease	5077
developed	O	5077
in	O	5077
the	O	5077
third	O	5077
or	O	5077
fourth	O	5077
decade	O	5077
of	O	5077
life	O	5077
accompanied	O	5077
by	O	5077
central	B-Disease	5077
scotoma	I-Disease	5077
and	O	5077
well	O	5077
-	O	5077
demarcated	O	5077
atrophy	B-Disease	5077
of	I-Disease	5077
the	I-Disease	5077
retinal	I-Disease	5077
pigment	I-Disease	5077
epithelium	I-Disease	5077
and	O	5077
choriocapillaris	B-Disease	5077
of	I-Disease	5077
the	I-Disease	5077
macula	I-Disease	5077
.	O	5077
conclusion	O	5083
these	O	5083
results	O	5083
indicate	O	5083
that	O	5083
mutations	O	5083
in	O	5083
the	O	5083
rds	O	5083
gene	O	5083
can	O	5083
be	O	5083
expressed	O	5083
as	O	5083
a	O	5083
macular	B-Disease	5083
dystrophy	I-Disease	5083
,	O	5083
with	O	5083
evidence	O	5083
of	O	5083
primary	O	5083
cone	B-Disease	5083
dysfunction	I-Disease	5083
and	O	5083
preservation	O	5083
of	O	5083
peripheral	O	5083
rod	O	5083
function	O	5083
.	O	5083
.	O	5083
anonymous	O	5084
marker	O	5084
loci	O	5084
within	O	5084
400	O	5084
kb	O	5084
of	O	5084
hla	O	5084
-	O	5084
a	O	5084
generate	O	5084
haplotypes	O	5084
in	O	5084
linkage	O	5084
disequilibrium	O	5084
with	O	5084
the	O	5084
hemochromatosis	B-Disease	5084
gene	O	5084
(	O	5084
hfe	O	5084
)	O	5084
the	O	5085
hemochromatosis	B-Disease	5085
gene	O	5085
(	O	5085
hfe	O	5085
)	O	5085
maps	O	5085
to	O	5085
6p21	O	5085
.	O	5085
the	O	5087
unambiguous	O	5087
identification	O	5087
of	O	5087
a	O	5087
crossover	O	5087
event	O	5087
within	O	5087
hemochromatosis	B-Disease	5087
families	O	5087
is	O	5087
very	O	5087
difficult	O	5087
;	O	5087
it	O	5087
is	O	5087
particularly	O	5087
hampered	O	5087
by	O	5087
the	O	5087
variability	O	5087
of	O	5087
the	O	5087
phenotypic	O	5087
expression	O	5087
as	O	5087
well	O	5087
as	O	5087
by	O	5087
the	O	5087
sex	O	5087
-	O	5087
and	O	5087
age	O	5087
-	O	5087
related	O	5087
penetrance	O	5087
of	O	5087
the	O	5087
disease	O	5087
.	O	5087
in	O	5090
the	O	5090
present	O	5090
report	O	5090
,	O	5090
66	O	5090
hemochromatosis	B-Disease	5090
families	O	5090
yielding	O	5090
151	O	5090
hemochromatosis	B-Disease	5090
chromosomes	O	5090
and	O	5090
182	O	5090
normal	O	5090
chromosomes	O	5090
were	O	5090
rflp	O	5090
-	O	5090
typed	O	5090
with	O	5090
a	O	5090
battery	O	5090
of	O	5090
probes	O	5090
,	O	5090
including	O	5090
two	O	5090
newly	O	5090
derived	O	5090
polymorphic	O	5090
markers	O	5090
from	O	5090
the	O	5090
6	O	5090
.	O	5090
additionally	O	5099
,	O	5099
hemochromatosis	B-Disease	5099
haplotypes	O	5099
possessing	O	5099
hla	O	5099
-	O	5099
a11	O	5099
and	O	5099
the	O	5099
low	O	5099
-	O	5099
frequency	O	5099
hla	O	5099
-	O	5099
f	O	5099
polymorphism	O	5099
(	O	5099
allele	O	5099
2	O	5099
)	O	5099
are	O	5099
supportive	O	5099
of	O	5099
a	O	5099
separate	O	5099
founder	O	5099
chromosome	O	5099
containing	O	5099
a	O	5099
second	O	5099
,	O	5099
independently	O	5099
arising	O	5099
mutant	O	5099
allele	O	5099
.	O	5099
overall	O	5100
,	O	5100
the	O	5100
establishment	O	5100
of	O	5100
a	O	5100
likely	O	5100
hemochromatosis	B-Disease	5100
critical	O	5100
region	O	5100
centromeric	O	5100
boundary	O	5100
and	O	5100
the	O	5100
identification	O	5100
of	O	5100
a	O	5100
linkage	O	5100
-	O	5100
disequilibrium	O	5100
zone	O	5100
both	O	5100
significantly	O	5100
contribute	O	5100
to	O	5100
a	O	5100
reduction	O	5100
in	O	5100
the	O	5100
amount	O	5100
of	O	5100
dna	O	5100
required	O	5100
to	O	5100
be	O	5100
searched	O	5100
for	O	5100
novel	O	5100
coding	O	5100
sequences	O	5100
constituting	O	5100
the	O	5100
hfe	B-Disease	5100
defect	I-Disease	5100
genomic	O	5101
structure	O	5101
of	O	5101
the	O	5101
ews	O	5101
gene	O	5101
and	O	5101
its	O	5101
relationship	O	5101
to	O	5101
ewsr1	O	5101
,	O	5101
a	O	5101
site	O	5101
of	O	5101
tumor	B-Disease	5101
-	O	5101
associated	O	5101
chromosome	O	5101
translocation	O	5101
.	O	5101
the	O	5102
ews	O	5102
gene	O	5102
has	O	5102
been	O	5102
identified	O	5102
based	O	5102
on	O	5102
its	O	5102
location	O	5102
at	O	5102
the	O	5102
chromosome	O	5102
22	O	5102
breakpoint	O	5102
of	O	5102
the	O	5102
t	O	5102
(	O	5102
11	O	5102
;	O	5102
22	O	5102
)	O	5102
(	O	5102
q24	O	5102
;	O	5102
q12	O	5102
)	O	5102
translocation	O	5102
that	O	5102
characterizes	O	5102
ewing	B-Disease	5102
sarcoma	I-Disease	5102
and	O	5102
related	O	5102
neuroectodermal	B-Disease	5102
tumors	I-Disease	5102
.	O	5102
positions	O	5109
of	O	5109
the	O	5109
chromosome	O	5109
22	O	5109
breakpoints	O	5109
were	O	5109
determined	O	5109
for	O	5109
19	O	5109
ewing	B-Disease	5109
tumors	I-Disease	5109
.	O	5109
norrie	B-Disease	5111
disease	I-Disease	5111
gene	O	5111
:	O	5111
characterization	O	5111
of	O	5111
deletions	O	5111
and	O	5111
possible	O	5111
function	O	5111
.	O	5111
positional	O	5112
cloning	O	5112
experiments	O	5112
have	O	5112
resulted	O	5112
recently	O	5112
in	O	5112
the	O	5112
isolation	O	5112
of	O	5112
a	O	5112
candidate	O	5112
gene	O	5112
for	O	5112
norrie	B-Disease	5112
disease	I-Disease	5112
(	O	5112
pseudoglioma	B-Disease	5112
;	O	5112
ndp	B-Disease	5112
)	O	5112
,	O	5112
a	O	5112
severe	O	5112
x	B-Disease	5112
-	I-Disease	5112
linked	I-Disease	5112
neurodevelopmental	I-Disease	5112
disorder	I-Disease	5112
.	O	5112
here	O	5113
we	O	5113
report	O	5113
the	O	5113
isolation	O	5113
and	O	5113
analysis	O	5113
of	O	5113
human	O	5113
genomic	O	5113
dna	O	5113
clones	O	5113
encompassing	O	5113
the	O	5113
ndp	B-Disease	5113
gene	O	5113
.	O	5113
detailed	O	5115
analysis	O	5115
of	O	5115
genomic	O	5115
deletions	O	5115
in	O	5115
norrie	B-Disease	5115
patients	O	5115
shows	O	5115
that	O	5115
they	O	5115
are	O	5115
heterogeneous	O	5115
,	O	5115
both	O	5115
in	O	5115
size	O	5115
and	O	5115
in	O	5115
position	O	5115
.	O	5115
by	O	5116
pcr	O	5116
analysis	O	5116
,	O	5116
we	O	5116
found	O	5116
that	O	5116
expression	O	5116
of	O	5116
the	O	5116
ndp	B-Disease	5116
gene	O	5116
was	O	5116
not	O	5116
confined	O	5116
to	O	5116
the	O	5116
eye	O	5116
or	O	5116
to	O	5116
the	O	5116
brain	O	5116
.	O	5116
an	O	5117
extensive	O	5117
dna	O	5117
and	O	5117
protein	O	5117
sequence	O	5117
comparison	O	5117
between	O	5117
the	O	5117
human	O	5117
ndp	B-Disease	5117
gene	O	5117
and	O	5117
related	O	5117
genes	O	5117
from	O	5117
the	O	5117
database	O	5117
revealed	O	5117
homology	O	5117
with	O	5117
cysteine	O	5117
-	O	5117
rich	O	5117
protein	O	5117
-	O	5117
binding	O	5117
domains	O	5117
of	O	5117
immediate	O	5117
-	O	5117
-	O	5117
early	O	5117
genes	O	5117
implicated	O	5117
in	O	5117
the	O	5117
regulation	O	5117
of	O	5117
cell	O	5117
proliferation	O	5117
.	O	5117
the	O	5119
normal	O	5119
huntington	B-Disease	5119
disease	I-Disease	5119
(	O	5119
hd	B-Disease	5119
)	O	5119
allele	O	5119
,	O	5119
or	O	5119
a	O	5119
closely	O	5119
linked	O	5119
gene	O	5119
,	O	5119
influences	O	5119
age	O	5119
at	O	5119
onset	O	5119
of	O	5119
hd	B-Disease	5119
.	O	5119
we	O	5120
evaluated	O	5120
the	O	5120
hypothesis	O	5120
that	O	5120
huntington	B-Disease	5120
disease	I-Disease	5120
(	O	5120
hd	B-Disease	5120
)	O	5120
is	O	5120
influenced	O	5120
by	O	5120
the	O	5120
normal	O	5120
hd	B-Disease	5120
allele	O	5120
by	O	5120
comparing	O	5120
transmission	O	5120
patterns	O	5120
of	O	5120
genetically	O	5120
linked	O	5120
markers	O	5120
at	O	5120
the	O	5120
d4s10	O	5120
locus	O	5120
in	O	5120
the	O	5120
normal	O	5120
parent	O	5120
against	O	5120
age	O	5120
at	O	5120
onset	O	5120
in	O	5120
the	O	5120
affected	O	5120
offspring	O	5120
.	O	5120
these	O	5123
findings	O	5123
suggest	O	5123
that	O	5123
the	O	5123
expression	O	5123
of	O	5123
hd	B-Disease	5123
is	O	5123
modulated	O	5123
by	O	5123
the	O	5123
normal	O	5123
hd	B-Disease	5123
allele	O	5123
or	O	5123
by	O	5123
a	O	5123
closely	O	5123
linked	O	5123
locus	O	5123
.	O	5123
.	O	5123
further	O	5124
investigation	O	5124
of	O	5124
the	O	5124
hexa	O	5124
gene	O	5124
intron	O	5124
9	O	5124
donor	O	5124
splice	O	5124
site	O	5124
mutation	O	5124
frequently	O	5124
found	O	5124
in	O	5124
non	O	5124
-	O	5124
jewish	O	5124
tay	B-Disease	5124
-	I-Disease	5124
sachs	I-Disease	5124
disease	I-Disease	5124
patients	O	5124
from	O	5124
the	O	5124
british	O	5124
isles	O	5124
.	O	5124
in	O	5125
a	O	5125
previous	O	5125
study	O	5125
we	O	5125
found	O	5125
that	O	5125
a	O	5125
tay	B-Disease	5125
-	I-Disease	5125
sachs	I-Disease	5125
disease	I-Disease	5125
(	O	5125
tsd	B-Disease	5125
)	O	5125
causing	O	5125
mutation	O	5125
in	O	5125
the	O	5125
intron	O	5125
9	O	5125
donor	O	5125
splice	O	5125
site	O	5125
of	O	5125
the	O	5125
hexa	O	5125
gene	O	5125
occurs	O	5125
at	O	5125
high	O	5125
frequency	O	5125
in	O	5125
non	O	5125
-	O	5125
jewish	O	5125
patients	O	5125
and	O	5125
carriers	O	5125
from	O	5125
the	O	5125
british	O	5125
isles	O	5125
.	O	5125
we	O	5127
have	O	5127
now	O	5127
tested	O	5127
,	O	5127
in	O	5127
a	O	5127
blind	O	5127
study	O	5127
,	O	5127
26	O	5127
american	O	5127
tsd	B-Disease	5127
carriers	O	5127
and	O	5127
28	O	5127
non	O	5127
-	O	5127
carriers	O	5127
who	O	5127
have	O	5127
british	O	5127
ancestry	O	5127
for	O	5127
the	O	5127
intron	O	5127
9	O	5127
splice	O	5127
site	O	5127
mutation	O	5127
.	O	5127
all	O	5129
six	O	5129
had	O	5129
irish	O	5129
ancestry	O	5129
,	O	5129
compared	O	5129
with	O	5129
nine	O	5129
of	O	5129
the	O	5129
20	O	5129
other	O	5129
(	O	5129
intron	O	5129
9	O	5129
mutation	O	5129
negative	O	5129
)	O	5129
tsd	B-Disease	5129
carriers	O	5129
(	O	5129
p	O	5129
<	O	5129
0	O	5129
.	O	5129
05	O	5129
)	O	5129
.	O	5129
these	O	5130
results	O	5130
confirm	O	5130
the	O	5130
previously	O	5130
found	O	5130
high	O	5130
frequency	O	5130
of	O	5130
the	O	5130
intron	O	5130
9	O	5130
mutation	O	5130
in	O	5130
non	O	5130
-	O	5130
jewish	O	5130
tsd	B-Disease	5130
families	O	5130
of	O	5130
british	O	5130
isles	O	5130
,	O	5130
particularly	O	5130
irish	O	5130
,	O	5130
origin	O	5130
,	O	5130
and	O	5130
reinforce	O	5130
the	O	5130
need	O	5130
to	O	5130
screen	O	5130
such	O	5130
families	O	5130
for	O	5130
this	O	5130
mutation	O	5130
.	O	5130
molecular	O	5131
mechanisms	O	5131
of	O	5131
oncogenic	O	5131
mutations	O	5131
in	O	5131
tumors	B-Disease	5131
from	O	5131
patients	O	5131
with	O	5131
bilateral	B-Disease	5131
and	I-Disease	5131
unilateral	I-Disease	5131
retinoblastoma	I-Disease	5131
.	O	5131
the	O	5132
rb1	O	5132
gene	O	5132
from	O	5132
12	O	5132
human	O	5132
retinoblastoma	B-Disease	5132
tumors	I-Disease	5132
has	O	5132
been	O	5132
analyzed	O	5132
exon	O	5132
-	O	5132
by	O	5132
-	O	5132
exon	O	5132
with	O	5132
the	O	5132
single	O	5132
-	O	5132
strand	O	5132
conformation	O	5132
polymorphism	O	5132
technique	O	5132
.	O	5132
mutations	O	5133
were	O	5133
found	O	5133
in	O	5133
all	O	5133
tumors	B-Disease	5133
,	O	5133
and	O	5133
one	O	5133
-	O	5133
third	O	5133
of	O	5133
the	O	5133
tumors	B-Disease	5133
had	O	5133
independent	O	5133
mutations	O	5133
in	O	5133
both	O	5133
alleles	O	5133
neither	O	5133
of	O	5133
which	O	5133
were	O	5133
found	O	5133
in	O	5133
the	O	5133
germ	O	5133
line	O	5133
,	O	5133
confirming	O	5133
their	O	5133
true	O	5133
sporadic	O	5133
nature	O	5133
.	O	5133
in	O	5134
the	O	5134
remaining	O	5134
two	O	5134
-	O	5134
thirds	O	5134
of	O	5134
the	O	5134
tumors	B-Disease	5134
only	O	5134
one	O	5134
mutation	O	5134
was	O	5134
found	O	5134
,	O	5134
consistent	O	5134
with	O	5134
the	O	5134
loss	O	5134
-	O	5134
of	O	5134
-	O	5134
heterozygosity	O	5134
theory	O	5134
of	O	5134
tumorigenesis	O	5134
.	O	5134
pax6	O	5140
mutations	O	5140
in	O	5140
aniridia	B-Disease	5140
.	O	5140
aniridia	B-Disease	5141
is	O	5141
a	O	5141
congenital	B-Disease	5141
malformation	I-Disease	5141
of	I-Disease	5141
the	I-Disease	5141
eye	I-Disease	5141
,	O	5141
chiefly	O	5141
characterised	O	5141
by	O	5141
iris	B-Disease	5141
hypoplasia	I-Disease	5141
,	O	5141
which	O	5141
can	O	5141
cause	O	5141
blindness	B-Disease	5141
.	O	5141
the	O	5142
pax6	O	5142
gene	O	5142
was	O	5142
isolated	O	5142
as	O	5142
a	O	5142
candidate	O	5142
aniridia	B-Disease	5142
gene	O	5142
by	O	5142
positional	O	5142
cloning	O	5142
from	O	5142
the	O	5142
smallest	O	5142
region	O	5142
of	O	5142
overlap	O	5142
of	O	5142
aniridia	B-Disease	5142
-	O	5142
associated	O	5142
deletions	O	5142
.	O	5142
subsequently	O	5143
pax6	O	5143
intragenic	O	5143
mutations	O	5143
were	O	5143
demonstrated	O	5143
in	O	5143
smalleye	O	5143
,	O	5143
a	O	5143
mouse	O	5143
mutant	O	5143
which	O	5143
is	O	5143
an	O	5143
animal	O	5143
model	O	5143
for	O	5143
aniridia	B-Disease	5143
,	O	5143
and	O	5143
six	O	5143
human	O	5143
aniridia	B-Disease	5143
patients	O	5143
.	O	5143
in	O	5144
this	O	5144
paper	O	5144
we	O	5144
describe	O	5144
four	O	5144
additional	O	5144
pax6	O	5144
point	O	5144
mutations	O	5144
in	O	5144
aniridia	B-Disease	5144
patients	O	5144
,	O	5144
both	O	5144
sporadic	O	5144
and	O	5144
familial	O	5144
.	O	5144
in	O	5146
addition	O	5146
,	O	5146
the	O	5146
frequency	O	5146
at	O	5146
which	O	5146
we	O	5146
have	O	5146
found	O	5146
pax6	O	5146
mutations	O	5146
suggests	O	5146
that	O	5146
lesions	O	5146
in	O	5146
pax6	O	5146
will	O	5146
account	O	5146
for	O	5146
most	O	5146
cases	O	5146
of	O	5146
aniridia	B-Disease	5146
.	O	5146
.	O	5146
autosomal	B-Disease	5148
dominant	I-Disease	5148
neurohypophyseal	I-Disease	5148
diabetes	I-Disease	5148
insipidus	I-Disease	5148
is	O	5148
a	O	5148
familial	O	5148
form	O	5148
of	O	5148
diabetes	B-Disease	5148
insipidus	I-Disease	5148
.	O	5148
this	O	5149
disorder	O	5149
is	O	5149
associated	O	5149
with	O	5149
variable	O	5149
levels	O	5149
of	O	5149
arginine	O	5149
vasopressin	O	5149
(	O	5149
avp	O	5149
)	O	5149
and	O	5149
diabetes	B-Disease	5149
insipidus	I-Disease	5149
of	O	5149
varying	O	5149
severity	O	5149
,	O	5149
which	O	5149
responds	O	5149
to	O	5149
exogenous	O	5149
avp	O	5149
.	O	5149
to	O	5150
determine	O	5150
the	O	5150
molecular	O	5150
basis	O	5150
of	O	5150
autosomal	B-Disease	5150
dominant	I-Disease	5150
neurohypophyseal	I-Disease	5150
diabetes	I-Disease	5150
insipidus	I-Disease	5150
,	O	5150
the	O	5150
avp	O	5150
genes	O	5150
of	O	5150
members	O	5150
of	O	5150
a	O	5150
large	O	5150
kindred	O	5150
were	O	5150
analyzed	O	5150
.	O	5150
germinal	O	5153
mosaicism	O	5153
in	O	5153
a	O	5153
duchenne	B-Disease	5153
muscular	I-Disease	5153
dystrophy	I-Disease	5153
family	O	5153
:	O	5153
implications	O	5153
for	O	5153
genetic	O	5153
counselling	O	5153
.	O	5153
in	O	5154
this	O	5154
study	O	5154
we	O	5154
describe	O	5154
a	O	5154
three	O	5154
-	O	5154
generation	O	5154
family	O	5154
in	O	5154
which	O	5154
two	O	5154
siblings	O	5154
were	O	5154
affected	O	5154
by	O	5154
duchenne	B-Disease	5154
muscular	I-Disease	5154
dystrophy	I-Disease	5154
(	O	5154
dmd	B-Disease	5154
)	O	5154
.	O	5154
immunohistochemical	O	5155
analysis	O	5155
of	O	5155
muscle	O	5155
dystrophin	O	5155
and	O	5155
haplotype	O	5155
analysis	O	5155
of	O	5155
the	O	5155
dmd	B-Disease	5155
locus	O	5155
revealed	O	5155
that	O	5155
the	O	5155
x	O	5155
chromosome	O	5155
carrying	O	5155
the	O	5155
dmd	B-Disease	5155
gene	O	5155
was	O	5155
transmitted	O	5155
from	O	5155
the	O	5155
healthy	O	5155
maternal	O	5155
grandfather	O	5155
to	O	5155
his	O	5155
three	O	5155
daughters	O	5155
,	O	5155
including	O	5155
the	O	5155
probands	O	5155
mother	O	5155
.	O	5155
these	O	5156
findings	O	5156
indicate	O	5156
that	O	5156
the	O	5156
grandfather	O	5156
was	O	5156
a	O	5156
germinal	O	5156
mosaic	O	5156
for	O	5156
the	O	5156
dmd	B-Disease	5156
gene	O	5156
.	O	5156
genetic	O	5159
mapping	O	5159
of	O	5159
the	O	5159
breast	B-Disease	5159
-	I-Disease	5159
ovarian	I-Disease	5159
cancer	I-Disease	5159
syndrome	I-Disease	5159
to	O	5159
a	O	5159
small	O	5159
interval	O	5159
on	O	5159
chromosome	O	5159
17q12	O	5159
-	O	5159
21	O	5159
:	O	5159
exclusion	O	5159
of	O	5159
candidate	O	5159
genes	O	5159
edh17b2	O	5159
and	O	5159
rara	O	5159
.	O	5159
a	O	5160
susceptibility	O	5160
gene	O	5160
for	O	5160
hereditary	B-Disease	5160
breast	I-Disease	5160
-	I-Disease	5160
ovarian	I-Disease	5160
cancer	I-Disease	5160
,	O	5160
brca1	O	5160
,	O	5160
has	O	5160
been	O	5160
assigned	O	5160
by	O	5160
linkage	O	5160
analysis	O	5160
to	O	5160
chromosome	O	5160
17q21	O	5160
.	O	5160
we	O	5162
have	O	5162
typed	O	5162
22	O	5162
breast	B-Disease	5162
and	I-Disease	5162
breast	I-Disease	5162
-	I-Disease	5162
ovarian	I-Disease	5162
cancer	I-Disease	5162
families	O	5162
with	O	5162
eight	O	5162
polymorphisms	O	5162
from	O	5162
the	O	5162
chromosome	O	5162
17q12	O	5162
-	O	5162
21	O	5162
region	O	5162
,	O	5162
including	O	5162
two	O	5162
in	O	5162
the	O	5162
edh17b2	O	5162
gene	O	5162
.	O	5162
genetic	O	5163
recombination	O	5163
with	O	5163
the	O	5163
breast	B-Disease	5163
cancer	I-Disease	5163
trait	O	5163
excludes	O	5163
rara	O	5163
from	O	5163
further	O	5163
consideration	O	5163
as	O	5163
a	O	5163
candidate	O	5163
gene	O	5163
for	O	5163
brca1	O	5163
.	O	5163
mutations	O	5166
in	O	5166
the	O	5166
edh17b2	O	5166
gene	O	5166
,	O	5166
therefore	O	5166
do	O	5166
not	O	5166
appear	O	5166
to	O	5166
be	O	5166
responsible	O	5166
for	O	5166
the	O	5166
hereditary	B-Disease	5166
breast	I-Disease	5166
-	I-Disease	5166
ovarian	I-Disease	5166
cancer	I-Disease	5166
syndrome	I-Disease	5166
.	O	5166
plasma	O	5169
hdl	O	5169
are	O	5169
a	O	5169
negative	O	5169
risk	O	5169
factor	O	5169
for	O	5169
atherosclerosis	B-Disease	5169
.	O	5169
subjects	O	5171
with	O	5171
homozygous	O	5171
cetp	B-Disease	5171
deficiency	I-Disease	5171
caused	O	5171
by	O	5171
a	O	5171
gene	O	5171
splicing	O	5171
defect	O	5171
have	O	5171
markedly	O	5171
elevated	O	5171
hdl	O	5171
;	O	5171
however	O	5171
,	O	5171
heterozygotes	O	5171
have	O	5171
only	O	5171
mild	O	5171
increases	O	5171
in	O	5171
hdl	O	5171
.	O	5171
familial	B-Disease	5177
mediterranean	I-Disease	5177
fever	I-Disease	5177
in	O	5177
the	O	5177
colchicine	O	5177
era	O	5177
:	O	5177
the	O	5177
fate	O	5177
of	O	5177
one	O	5177
family	O	5177
.	O	5177
in	O	5178
order	O	5178
to	O	5178
demonstrate	O	5178
the	O	5178
effect	O	5178
of	O	5178
prophylactic	O	5178
colchicine	O	5178
treatment	O	5178
on	O	5178
the	O	5178
natural	O	5178
history	O	5178
of	O	5178
familial	B-Disease	5178
mediterranean	I-Disease	5178
fever	I-Disease	5178
(	O	5178
fmf	B-Disease	5178
)	O	5178
,	O	5178
a	O	5178
family	O	5178
is	O	5178
presented	O	5178
with	O	5178
6	O	5178
out	O	5178
of	O	5178
9	O	5178
siblings	O	5178
affected	O	5178
by	O	5178
fmf	B-Disease	5178
.	O	5178
each	O	5179
patient	O	5179
represents	O	5179
a	O	5179
different	O	5179
stage	O	5179
of	O	5179
the	O	5179
amyloidotic	B-Disease	5179
kidney	I-Disease	5179
disease	I-Disease	5179
of	O	5179
fmf	B-Disease	5179
and	O	5179
the	O	5179
effect	O	5179
of	O	5179
continuous	O	5179
colchicine	O	5179
treatment	O	5179
on	O	5179
its	O	5179
course	O	5179
.	O	5179
detection	O	5181
of	O	5181
a	O	5181
new	O	5181
submicroscopic	O	5181
norrie	B-Disease	5181
disease	I-Disease	5181
deletion	O	5181
interval	O	5181
with	O	5181
a	O	5181
novel	O	5181
dna	O	5181
probe	O	5181
isolated	O	5181
by	O	5181
differential	O	5181
alu	O	5181
pcr	O	5181
fingerprint	O	5181
cloning	O	5181
.	O	5181
this	O	5185
novel	O	5185
sequence	O	5185
,	O	5185
cpxr318	O	5185
(	O	5185
dxs742	O	5185
)	O	5185
,	O	5185
detects	O	5185
a	O	5185
new	O	5185
submicroscopic	O	5185
deletion	O	5185
interval	O	5185
at	O	5185
the	O	5185
norrie	B-Disease	5185
disease	I-Disease	5185
locus	O	5185
(	O	5185
ndp	O	5185
)	O	5185
.	O	5185
finally	O	5188
,	O	5188
dxs742	O	5188
,	O	5188
dsx7	O	5188
,	O	5188
dxs77	O	5188
,	O	5188
and	O	5188
maoa	O	5188
were	O	5188
integrated	O	5188
into	O	5188
a	O	5188
physical	O	5188
map	O	5188
spanning	O	5188
the	O	5188
norrie	B-Disease	5188
disease	I-Disease	5188
locus	O	5188
putative	O	5189
x	B-Disease	5189
-	I-Disease	5189
linked	I-Disease	5189
adrenoleukodystrophy	I-Disease	5189
gene	O	5189
shares	O	5189
unexpected	O	5189
homology	O	5189
with	O	5189
abc	O	5189
transporters	O	5189
.	O	5189
adrenoleukodystrophy	B-Disease	5190
(	O	5190
ald	B-Disease	5190
)	O	5190
is	O	5190
an	O	5190
x	B-Disease	5190
-	I-Disease	5190
linked	I-Disease	5190
disease	I-Disease	5190
affecting	O	5190
1	O	5190
/	O	5190
20	O	5190
,	O	5190
000	O	5190
males	O	5190
either	O	5190
as	O	5190
cerebral	B-Disease	5190
ald	I-Disease	5190
in	O	5190
childhood	O	5190
or	O	5190
as	O	5190
adrenomyeloneuropathy	B-Disease	5190
(	O	5190
amn	B-Disease	5190
)	O	5190
in	O	5190
adults	O	5190
.	O	5190
childhood	O	5191
ald	B-Disease	5191
is	O	5191
the	O	5191
more	O	5191
severe	O	5191
form	O	5191
,	O	5191
with	O	5191
onset	O	5191
of	O	5191
neurological	O	5191
symptoms	O	5191
between	O	5191
5	O	5191
-	O	5191
12	O	5191
years	O	5191
of	O	5191
age	O	5191
.	O	5191
central	B-Disease	5192
nervous	I-Disease	5192
system	I-Disease	5192
demyelination	I-Disease	5192
progresses	O	5192
rapidly	O	5192
and	O	5192
death	O	5192
occurs	O	5192
within	O	5192
a	O	5192
few	O	5192
years	O	5192
.	O	5192
amn	B-Disease	5193
is	O	5193
a	O	5193
milder	O	5193
form	O	5193
of	O	5193
the	O	5193
disease	O	5193
with	O	5193
onset	O	5193
at	O	5193
15	O	5193
-	O	5193
30	O	5193
years	O	5193
of	O	5193
age	O	5193
and	O	5193
a	O	5193
more	O	5193
progressive	O	5193
course	O	5193
.	O	5193
adrenal	B-Disease	5194
insufficiency	I-Disease	5194
(	O	5194
addisons	B-Disease	5194
disease	I-Disease	5194
)	O	5194
may	O	5194
remain	O	5194
the	O	5194
only	O	5194
clinical	O	5194
manifestation	O	5194
of	O	5194
ald	B-Disease	5194
.	O	5194
the	O	5195
principal	O	5195
biochemical	O	5195
abnormality	O	5195
of	O	5195
ald	B-Disease	5195
is	O	5195
the	O	5195
accumulation	O	5195
of	O	5195
very	O	5195
-	O	5195
long	O	5195
-	O	5195
chain	O	5195
fatty	O	5195
acids	O	5195
(	O	5195
vlcfa	O	5195
)	O	5195
because	O	5195
of	O	5195
impaired	O	5195
beta	O	5195
-	O	5195
oxidation	O	5195
in	O	5195
peroxisomes	O	5195
.	O	5195
the	O	5196
normal	O	5196
oxidation	O	5196
of	O	5196
vlcfa	O	5196
-	O	5196
coa	O	5196
in	O	5196
patients	O	5196
fibroblasts	O	5196
suggested	O	5196
that	O	5196
the	O	5196
gene	O	5196
coding	O	5196
for	O	5196
the	O	5196
vlcfa	O	5196
-	O	5196
coa	O	5196
synthetase	O	5196
could	O	5196
be	O	5196
a	O	5196
candidate	O	5196
gene	O	5196
for	O	5196
ald	B-Disease	5196
.	O	5196
here	O	5197
we	O	5197
use	O	5197
positional	O	5197
cloning	O	5197
to	O	5197
identify	O	5197
a	O	5197
gene	O	5197
partially	O	5197
deleted	O	5197
in	O	5197
6	O	5197
of	O	5197
85	O	5197
independent	O	5197
patients	O	5197
with	O	5197
ald	B-Disease	5197
.	O	5197
an	O	5199
identical	O	5199
deletion	O	5199
was	O	5199
detected	O	5199
in	O	5199
two	O	5199
brothers	O	5199
presenting	O	5199
with	O	5199
different	O	5199
clinical	O	5199
ald	B-Disease	5199
phenotypes	O	5199
.	O	5199
targeted	O	5202
modification	O	5202
of	O	5202
the	O	5202
apolipoprotein	O	5202
b	O	5202
gene	O	5202
results	O	5202
in	O	5202
hypobetalipoproteinemia	B-Disease	5202
and	O	5202
developmental	B-Disease	5202
abnormalities	I-Disease	5202
in	O	5202
mice	O	5202
.	O	5202
familial	B-Disease	5203
hypobetalipoproteinemia	I-Disease	5203
is	O	5203
an	O	5203
autosomal	B-Disease	5203
codominant	I-Disease	5203
disorder	I-Disease	5203
resulting	O	5203
in	O	5203
a	O	5203
dramatic	O	5203
reduction	O	5203
in	O	5203
plasma	O	5203
concentrations	O	5203
of	O	5203
apolipoprotein	O	5203
(	O	5203
apo	O	5203
)	O	5203
b	O	5203
,	O	5203
cholesterol	O	5203
,	O	5203
and	O	5203
beta	O	5203
-	O	5203
migrating	O	5203
lipoproteins	O	5203
.	O	5203
a	O	5204
benefit	O	5204
of	O	5204
hypobetalipoproteinemia	B-Disease	5204
is	O	5204
that	O	5204
mildly	O	5204
affected	O	5204
individuals	O	5204
may	O	5204
be	O	5204
protected	O	5204
from	O	5204
coronary	B-Disease	5204
vascular	I-Disease	5204
disease	I-Disease	5204
.	O	5204
mice	O	5206
containing	O	5206
this	O	5206
allele	O	5206
display	O	5206
all	O	5206
of	O	5206
the	O	5206
hallmarks	O	5206
of	O	5206
human	O	5206
hypobetalipoproteinemia	B-Disease	5206
they	O	5206
produce	O	5206
a	O	5206
truncated	O	5206
apob	O	5206
protein	O	5206
,	O	5206
apob70	O	5206
,	O	5206
and	O	5206
have	O	5206
markedly	O	5206
decreased	O	5206
plasma	O	5206
concentrations	O	5206
of	O	5206
apob	O	5206
,	O	5206
beta	O	5206
-	O	5206
lipoproteins	O	5206
,	O	5206
and	O	5206
total	O	5206
cholesterol	O	5206
.	O	5206
in	O	5207
addition	O	5207
,	O	5207
the	O	5207
mice	O	5207
manifest	O	5207
several	O	5207
characteristics	O	5207
that	O	5207
are	O	5207
occasionally	O	5207
observed	O	5207
in	O	5207
human	O	5207
hypobetalipoproteinemia	B-Disease	5207
,	O	5207
including	O	5207
reduced	O	5207
plasma	O	5207
triglyceride	O	5207
concentrations	O	5207
,	O	5207
fasting	O	5207
chylomicronemia	B-Disease	5207
,	O	5207
and	O	5207
reduced	O	5207
high	O	5207
density	O	5207
lipoprotein	O	5207
cholesterol	O	5207
.	O	5207
an	O	5208
unexpected	O	5208
finding	O	5208
is	O	5208
that	O	5208
the	O	5208
modified	O	5208
apob	O	5208
allele	O	5208
is	O	5208
strongly	O	5208
associated	O	5208
with	O	5208
exencephalus	B-Disease	5208
and	O	5208
hydrocephalus	B-Disease	5208
.	O	5208
these	O	5209
mice	O	5209
should	O	5209
help	O	5209
increase	O	5209
our	O	5209
understanding	O	5209
of	O	5209
hypobetalipoproteinemia	B-Disease	5209
,	O	5209
atherogenesis	B-Disease	5209
,	O	5209
and	O	5209
the	O	5209
etiology	O	5209
of	O	5209
exencephalus	B-Disease	5209
and	O	5209
hydrocephalus	B-Disease	5209
.	O	5209
.	O	5209
a	O	5210
novel	O	5210
disease	O	5210
with	O	5210
deficiency	B-Disease	5210
of	I-Disease	5210
mitochondrial	I-Disease	5210
very	I-Disease	5210
-	I-Disease	5210
long	I-Disease	5210
-	I-Disease	5210
chain	I-Disease	5210
acyl	I-Disease	5210
-	I-Disease	5210
coa	I-Disease	5210
dehydrogenase	I-Disease	5210
.	O	5210
two	O	5212
of	O	5212
the	O	5212
patients	O	5212
,	O	5212
4	O	5212
-	O	5212
5	O	5212
month	O	5212
old	O	5212
boys	O	5212
,	O	5212
were	O	5212
found	O	5212
to	O	5212
have	O	5212
a	O	5212
novel	O	5212
disease	O	5212
,	O	5212
vlcad	B-Disease	5212
deficiency	I-Disease	5212
,	O	5212
as	O	5212
judged	O	5212
from	O	5212
the	O	5212
results	O	5212
of	O	5212
very	O	5212
low	O	5212
palmitoyl	O	5212
-	O	5212
coa	O	5212
dehydrogenase	O	5212
activity	O	5212
and	O	5212
the	O	5212
lack	O	5212
of	O	5212
immunoreactivity	O	5212
toward	O	5212
antibody	O	5212
raised	O	5212
to	O	5212
purified	O	5212
vlcad	O	5212
.	O	5212
.	O	5212
molecular	O	5213
characterization	O	5213
of	O	5213
glucose	B-Disease	5213
-	I-Disease	5213
6	I-Disease	5213
-	I-Disease	5213
phosphate	I-Disease	5213
dehydrogenase	I-Disease	5213
(	I-Disease	5213
g6pd	I-Disease	5213
)	I-Disease	5213
deficiency	I-Disease	5213
in	O	5213
patients	O	5213
of	O	5213
chinese	O	5213
descent	O	5213
and	O	5213
identification	O	5213
of	O	5213
new	O	5213
base	O	5213
substitutions	O	5213
in	O	5213
the	O	5213
human	O	5213
g6pd	O	5213
gene	O	5213
.	O	5213
the	O	5214
underlying	O	5214
dna	O	5214
changes	O	5214
associated	O	5214
with	O	5214
glucose	B-Disease	5214
-	I-Disease	5214
6	I-Disease	5214
-	I-Disease	5214
phosphate	I-Disease	5214
dehydrogenase	I-Disease	5214
(	I-Disease	5214
g6pd	I-Disease	5214
)	I-Disease	5214
-	I-Disease	5214
deficient	I-Disease	5214
asians	O	5214
have	O	5214
not	O	5214
been	O	5214
extensively	O	5214
investigated	O	5214
.	O	5214
to	O	5215
fill	O	5215
this	O	5215
gap	O	5215
,	O	5215
we	O	5215
sequenced	O	5215
the	O	5215
g6pd	O	5215
gene	O	5215
of	O	5215
43	O	5215
g6pd	B-Disease	5215
-	I-Disease	5215
deficient	I-Disease	5215
chinese	O	5215
whose	O	5215
g6pd	O	5215
was	O	5215
well	O	5215
characterized	O	5215
biochemically	O	5215
.	O	5215
these	O	5218
five	O	5218
nucleotide	O	5218
substitutions	O	5218
account	O	5218
for	O	5218
over	O	5218
83	O	5218
%	O	5218
of	O	5218
our	O	5218
43	O	5218
g6pd	B-Disease	5218
-	I-Disease	5218
deficient	I-Disease	5218
samples	O	5218
and	O	5218
these	O	5218
substitutions	O	5218
have	O	5218
not	O	5218
been	O	5218
reported	O	5218
in	O	5218
non	O	5218
-	O	5218
asians	O	5218
.	O	5218
the	O	5220
substitutions	O	5220
at	O	5220
cdna	O	5220
1376	O	5220
and	O	5220
1388	O	5220
account	O	5220
for	O	5220
over	O	5220
50	O	5220
%	O	5220
of	O	5220
the	O	5220
43	O	5220
samples	O	5220
examined	O	5220
indicating	O	5220
a	O	5220
high	O	5220
prevalence	O	5220
of	O	5220
these	O	5220
two	O	5220
alleles	O	5220
among	O	5220
g6pd	B-Disease	5220
-	I-Disease	5220
deficient	I-Disease	5220
chinese	O	5220
.	O	5220
our	O	5221
findings	O	5221
add	O	5221
support	O	5221
to	O	5221
the	O	5221
notion	O	5221
that	O	5221
diverse	O	5221
point	O	5221
mutations	O	5221
may	O	5221
account	O	5221
largely	O	5221
for	O	5221
much	O	5221
of	O	5221
the	O	5221
phenotypic	O	5221
heterogeneity	O	5221
of	O	5221
g6pd	B-Disease	5221
deficiency	I-Disease	5221
.	O	5221
.	O	5221
identification	O	5222
of	O	5222
mutations	O	5222
in	O	5222
danish	O	5222
choroideremia	B-Disease	5222
families	O	5222
.	O	5222
we	O	5223
have	O	5223
searched	O	5223
for	O	5223
mutations	O	5223
in	O	5223
the	O	5223
choroideremia	B-Disease	5223
gene	O	5223
(	O	5223
chm	B-Disease	5223
)	O	5223
in	O	5223
patients	O	5223
from	O	5223
12	O	5223
danish	O	5223
families	O	5223
in	O	5223
which	O	5223
chm	B-Disease	5223
is	O	5223
segregating	O	5223
.	O	5223
structure	O	5226
and	O	5226
genomic	O	5226
sequence	O	5226
of	O	5226
the	O	5226
myotonic	B-Disease	5226
dystrophy	I-Disease	5226
(	O	5226
dm	B-Disease	5226
kinase	O	5226
)	O	5226
gene	O	5226
.	O	5226
the	O	5227
mutation	O	5227
causing	O	5227
myotonic	B-Disease	5227
dystrophy	I-Disease	5227
(	O	5227
dm	B-Disease	5227
)	O	5227
has	O	5227
recently	O	5227
been	O	5227
identified	O	5227
as	O	5227
an	O	5227
unstable	O	5227
ctg	O	5227
trinucleotide	O	5227
repeat	O	5227
located	O	5227
in	O	5227
the	O	5227
3	O	5227
untranslated	O	5227
region	O	5227
of	O	5227
a	O	5227
gene	O	5227
encoding	O	5227
for	O	5227
a	O	5227
protein	O	5227
with	O	5227
putative	O	5227
serine	O	5227
-	O	5227
threonine	O	5227
protein	O	5227
kinase	O	5227
activity	O	5227
.	O	5227
in	O	5228
this	O	5228
report	O	5228
we	O	5228
present	O	5228
the	O	5228
genomic	O	5228
sequences	O	5228
of	O	5228
the	O	5228
human	O	5228
and	O	5228
murine	O	5228
dm	B-Disease	5228
kinase	O	5228
gene	O	5228
.	O	5228
a	O	5229
comparison	O	5229
of	O	5229
these	O	5229
sequences	O	5229
with	O	5229
each	O	5229
other	O	5229
and	O	5229
with	O	5229
known	O	5229
cdna	O	5229
sequences	O	5229
from	O	5229
both	O	5229
species	O	5229
,	O	5229
led	O	5229
us	O	5229
to	O	5229
predict	O	5229
a	O	5229
translation	O	5229
initiation	O	5229
codon	O	5229
,	O	5229
as	O	5229
well	O	5229
as	O	5229
determine	O	5229
the	O	5229
organization	O	5229
of	O	5229
the	O	5229
dm	B-Disease	5229
kinase	O	5229
gene	O	5229
.	O	5229
several	O	5230
polymorphisms	O	5230
within	O	5230
the	O	5230
human	O	5230
dm	B-Disease	5230
kinase	O	5230
gene	O	5230
have	O	5230
been	O	5230
identified	O	5230
,	O	5230
and	O	5230
pcr	O	5230
assays	O	5230
to	O	5230
detect	O	5230
two	O	5230
of	O	5230
these	O	5230
are	O	5230
described	O	5230
.	O	5230
the	O	5231
complete	O	5231
sequence	O	5231
and	O	5231
characterization	O	5231
of	O	5231
the	O	5231
structure	O	5231
of	O	5231
the	O	5231
dm	B-Disease	5231
kinase	O	5231
gene	O	5231
,	O	5231
as	O	5231
well	O	5231
as	O	5231
the	O	5231
identification	O	5231
of	O	5231
novel	O	5231
polymorphisms	O	5231
within	O	5231
the	O	5231
gene	O	5231
,	O	5231
represent	O	5231
an	O	5231
important	O	5231
step	O	5231
in	O	5231
a	O	5231
further	O	5231
understanding	O	5231
of	O	5231
the	O	5231
genetics	O	5231
of	O	5231
myotonic	B-Disease	5231
dystrophy	I-Disease	5231
and	O	5231
the	O	5231
molecular	O	5231
biology	O	5231
of	O	5231
the	O	5231
gene	O	5231
.	O	5231
.	O	5231
autosomal	O	5232
recessive	O	5232
transmission	O	5232
of	O	5232
hemophilia	B-Disease	5232
a	I-Disease	5232
due	O	5232
to	O	5232
a	O	5232
von	B-Disease	5232
willebrand	I-Disease	5232
factor	O	5232
mutation	O	5232
.	O	5232
the	O	5233
differential	O	5233
diagnosis	O	5233
of	O	5233
the	O	5233
genetic	B-Disease	5233
bleeding	I-Disease	5233
disorders	I-Disease	5233
,	O	5233
hemophilia	B-Disease	5233
a	I-Disease	5233
and	O	5233
von	B-Disease	5233
willebrand	I-Disease	5233
disease	I-Disease	5233
,	O	5233
is	O	5233
occasionally	O	5233
confounded	O	5233
by	O	5233
the	O	5233
close	O	5233
molecular	O	5233
relationship	O	5233
of	O	5233
coagulation	O	5233
factor	O	5233
viii	O	5233
and	O	5233
von	B-Disease	5233
willebrand	I-Disease	5233
factor	O	5233
(	O	5233
vwf	O	5233
)	O	5233
.	O	5233
this	O	5234
report	O	5234
describes	O	5234
the	O	5234
autosomal	O	5234
inheritance	O	5234
of	O	5234
a	O	5234
hemophilia	B-Disease	5234
a	I-Disease	5234
phenotype	O	5234
due	O	5234
to	O	5234
a	O	5234
mutation	O	5234
of	O	5234
vwf	O	5234
that	O	5234
results	O	5234
in	O	5234
defective	O	5234
factor	O	5234
viii	O	5234
binding	O	5234
.	O	5234
however	O	5241
,	O	5241
the	O	5241
mutant	O	5241
failed	O	5241
to	O	5241
bind	O	5241
factor	O	5241
viii	O	5241
,	O	5241
demonstrating	O	5241
that	O	5241
the	O	5241
mutation	O	5241
was	O	5241
functionally	O	5241
related	O	5241
to	O	5241
the	O	5241
observed	O	5241
hemophilia	B-Disease	5241
phenotype	O	5241
.	O	5241
the	O	5242
family	O	5242
we	O	5242
describe	O	5242
demonstrates	O	5242
the	O	5242
recessive	O	5242
inheritance	O	5242
of	O	5242
a	O	5242
recently	O	5242
recognized	O	5242
class	O	5242
of	O	5242
genetic	O	5242
bleeding	O	5242
disorders	O	5242
,	O	5242
we	O	5242
call	O	5242
autosomal	O	5242
hemophilia	B-Disease	5242
.	O	5242
we	O	5243
conclude	O	5243
that	O	5243
vwf	O	5243
mutation	O	5243
may	O	5243
be	O	5243
an	O	5243
under	O	5243
recognized	O	5243
cause	O	5243
of	O	5243
hemophilia	B-Disease	5243
,	O	5243
especially	O	5243
in	O	5243
cases	O	5243
where	O	5243
the	O	5243
inheritance	O	5243
pattern	O	5243
is	O	5243
not	O	5243
consistent	O	5243
with	O	5243
x	O	5243
-	O	5243
linked	O	5243
transmission	O	5243
.	O	5243
somatic	O	5244
von	B-Disease	5244
hippel	I-Disease	5244
-	I-Disease	5244
lindau	I-Disease	5244
mutation	O	5244
in	O	5244
clear	O	5244
cell	O	5244
papillary	B-Disease	5244
cystadenoma	I-Disease	5244
of	I-Disease	5244
the	I-Disease	5244
epididymis	I-Disease	5244
.	O	5244
papillary	B-Disease	5245
cystadenoma	I-Disease	5245
of	I-Disease	5245
the	I-Disease	5245
epididymis	I-Disease	5245
is	O	5245
an	O	5245
uncommon	O	5245
benign	O	5245
lesion	O	5245
that	O	5245
may	O	5245
occur	O	5245
sporadically	O	5245
or	O	5245
as	O	5245
a	O	5245
manifestation	O	5245
of	O	5245
von	B-Disease	5245
hippel	I-Disease	5245
-	I-Disease	5245
lindau	I-Disease	5245
(	I-Disease	5245
vhl	I-Disease	5245
)	I-Disease	5245
disease	I-Disease	5245
.	O	5245
neither	O	5246
immunohistochemical	O	5246
studies	O	5246
nor	O	5246
molecular	O	5246
genetic	O	5246
analyses	O	5246
of	O	5246
the	O	5246
vhl	B-Disease	5246
gene	O	5246
have	O	5246
been	O	5246
reported	O	5246
previously	O	5246
for	O	5246
this	O	5246
lesion	O	5246
.	O	5246
the	O	5247
authors	O	5247
describe	O	5247
two	O	5247
cases	O	5247
of	O	5247
clear	O	5247
cell	O	5247
papillary	B-Disease	5247
cystadenoma	I-Disease	5247
of	I-Disease	5247
the	I-Disease	5247
epididymis	I-Disease	5247
,	O	5247
both	O	5247
of	O	5247
which	O	5247
were	O	5247
initially	O	5247
confused	O	5247
with	O	5247
metastatic	B-Disease	5247
renal	I-Disease	5247
cell	I-Disease	5247
carcinoma	I-Disease	5247
.	O	5247
because	O	5250
clear	O	5250
cell	O	5250
papillary	B-Disease	5250
cystadenoma	I-Disease	5250
is	O	5250
similar	O	5250
to	O	5250
renal	B-Disease	5250
cell	I-Disease	5250
carcinoma	I-Disease	5250
histologically	O	5250
,	O	5250
and	O	5250
because	O	5250
both	O	5250
occur	O	5250
as	O	5250
components	O	5250
of	O	5250
the	O	5250
von	B-Disease	5250
hippel	I-Disease	5250
-	I-Disease	5250
lindau	I-Disease	5250
disease	I-Disease	5250
complex	O	5250
,	O	5250
the	O	5250
authors	O	5250
analyzed	O	5250
both	O	5250
cases	O	5250
for	O	5250
the	O	5250
presence	O	5250
of	O	5250
mutations	O	5250
in	O	5250
the	O	5250
vhl	B-Disease	5250
gene	O	5250
.	O	5250
a	O	5251
somatic	O	5251
vhl	B-Disease	5251
gene	O	5251
mutation	O	5251
was	O	5251
detected	O	5251
in	O	5251
one	O	5251
of	O	5251
the	O	5251
two	O	5251
tumors	B-Disease	5251
by	O	5251
polymerase	O	5251
chain	O	5251
reaction	O	5251
followed	O	5251
by	O	5251
single	O	5251
-	O	5251
strand	O	5251
conformation	O	5251
polymorphism	O	5251
analysis	O	5251
.	O	5251
as	O	5253
the	O	5253
vhl	B-Disease	5253
gene	O	5253
is	O	5253
believed	O	5253
to	O	5253
function	O	5253
as	O	5253
a	O	5253
tumor	B-Disease	5253
suppressor	O	5253
gene	O	5253
,	O	5253
vhl	B-Disease	5253
gene	O	5253
mutations	O	5253
may	O	5253
play	O	5253
a	O	5253
role	O	5253
in	O	5253
the	O	5253
initiation	O	5253
of	O	5253
tumorigenesis	O	5253
in	O	5253
sporadic	O	5253
cystadenomas	B-Disease	5253
of	I-Disease	5253
the	I-Disease	5253
epididymis	I-Disease	5253
.	O	5253
identification	O	5254
of	O	5254
wasp	O	5254
mutations	O	5254
in	O	5254
patients	O	5254
with	O	5254
wiskott	B-Disease	5254
-	I-Disease	5254
aldrich	I-Disease	5254
syndrome	I-Disease	5254
and	O	5254
isolated	B-Disease	5254
thrombocytopenia	I-Disease	5254
reveals	O	5254
allelic	O	5254
heterogeneity	O	5254
at	O	5254
the	O	5254
was	B-Disease	5254
locus	O	5254
.	O	5254
mutation	O	5255
in	O	5255
the	O	5255
gene	O	5255
encoding	O	5255
the	O	5255
recently	O	5255
isolated	O	5255
wasp	O	5255
protein	O	5255
has	O	5255
now	O	5255
been	O	5255
identified	O	5255
as	O	5255
the	O	5255
genetic	B-Disease	5255
defect	I-Disease	5255
responsible	O	5255
for	O	5255
the	O	5255
x	B-Disease	5255
-	I-Disease	5255
linked	I-Disease	5255
wiskott	I-Disease	5255
-	I-Disease	5255
aldrich	I-Disease	5255
syndrome	I-Disease	5255
(	O	5255
was	B-Disease	5255
)	O	5255
,	O	5255
a	O	5255
primary	O	5255
immunodeficiency	B-Disease	5255
disease	I-Disease	5255
associated	O	5255
with	O	5255
extensive	O	5255
phenotypic	O	5255
variability	O	5255
.	O	5255
to	O	5256
elucidate	O	5256
the	O	5256
range	O	5256
of	O	5256
wasp	O	5256
mutations	O	5256
responsible	O	5256
for	O	5256
was	B-Disease	5256
,	O	5256
we	O	5256
used	O	5256
pcr	O	5256
-	O	5256
sscp	O	5256
analysis	O	5256
to	O	5256
screen	O	5256
for	O	5256
wasp	O	5256
gene	O	5256
mutation	O	5256
in	O	5256
19	O	5256
unrelated	O	5256
boys	O	5256
with	O	5256
the	O	5256
diagnosis	O	5256
of	O	5256
classical	O	5256
or	O	5256
attenuated	O	5256
was	B-Disease	5256
or	O	5256
isolated	B-Disease	5256
thrombocytopenia	I-Disease	5256
.	O	5256
however	O	5258
,	O	5258
a	O	5258
missense	O	5258
mutation	O	5258
which	O	5258
results	O	5258
in	O	5258
substitution	O	5258
of	O	5258
the	O	5258
arginine	O	5258
at	O	5258
was	B-Disease	5258
codon	O	5258
86	O	5258
was	O	5258
identified	O	5258
in	O	5258
three	O	5258
boys	O	5258
with	O	5258
severe	O	5258
was	B-Disease	5258
as	O	5258
well	O	5258
as	O	5258
in	O	5258
one	O	5258
boy	O	5258
presenting	O	5258
with	O	5258
thrombocytopenia	B-Disease	5258
alone	O	5258
.	O	5258
while	O	5259
the	O	5259
three	O	5259
mutations	O	5259
found	O	5259
in	O	5259
the	O	5259
isolated	B-Disease	5259
thrombocytopenia	I-Disease	5259
patients	O	5259
leave	O	5259
the	O	5259
reading	O	5259
frame	O	5259
intact	O	5259
,	O	5259
about	O	5259
one	O	5259
-	O	5259
half	O	5259
of	O	5259
the	O	5259
gene	O	5259
alterations	O	5259
detected	O	5259
in	O	5259
both	O	5259
severe	O	5259
and	O	5259
attenuated	O	5259
was	B-Disease	5259
patients	O	5259
result	O	5259
in	O	5259
frameshifted	O	5259
transcript	O	5259
and	O	5259
premature	O	5259
translation	O	5259
termination	O	5259
.	O	5259
these	O	5260
findings	O	5260
therefore	O	5260
confirm	O	5260
the	O	5260
association	O	5260
of	O	5260
was	B-Disease	5260
with	O	5260
wasp	O	5260
mutation	O	5260
and	O	5260
identify	O	5260
wasp	O	5260
mutation	O	5260
as	O	5260
a	O	5260
cause	O	5260
for	O	5260
isolated	O	5260
congenital	B-Disease	5260
thrombocytopenia	I-Disease	5260
in	O	5260
males	O	5260
.	O	5260
while	O	5261
the	O	5261
wasp	O	5261
gene	O	5261
defects	O	5261
responsible	O	5261
for	O	5261
isolated	B-Disease	5261
thrombocytopenia	I-Disease	5261
and	O	5261
other	O	5261
mild	O	5261
presentations	O	5261
of	O	5261
was	B-Disease	5261
do	O	5261
not	O	5261
appear	O	5261
distinct	O	5261
from	O	5261
those	O	5261
resulting	O	5261
in	O	5261
severe	O	5261
was	B-Disease	5261
,	O	5261
these	O	5261
data	O	5261
indicate	O	5261
that	O	5261
analysis	O	5261
of	O	5261
wasp	O	5261
gene	O	5261
mutation	O	5261
provides	O	5261
a	O	5261
valuable	O	5261
tool	O	5261
for	O	5261
distinguishing	O	5261
the	O	5261
spectrum	O	5261
of	O	5261
was	B-Disease	5261
patients	O	5261
and	O	5261
the	O	5261
subset	O	5261
of	O	5261
males	O	5261
with	O	5261
isolated	B-Disease	5261
thrombocytopenia	I-Disease	5261
who	O	5261
represent	O	5261
mild	O	5261
cases	O	5261
of	O	5261
was	B-Disease	5261
.	O	5261
.	O	5261
wasp	O	5262
gene	O	5262
mutations	O	5262
in	O	5262
wiskott	B-Disease	5262
-	I-Disease	5262
aldrich	I-Disease	5262
syndrome	I-Disease	5262
and	O	5262
x	B-Disease	5262
-	I-Disease	5262
linked	I-Disease	5262
thrombocytopenia	I-Disease	5262
.	O	5262
23	O	5264
and	O	5264
shown	O	5264
to	O	5264
be	O	5264
mutated	O	5264
in	O	5264
three	O	5264
patients	O	5264
with	O	5264
the	O	5264
wiskott	B-Disease	5264
-	I-Disease	5264
aldrich	I-Disease	5264
syndrome	I-Disease	5264
(	O	5264
was	B-Disease	5264
)	O	5264
.	O	5264
four	O	5268
amino	O	5268
acid	O	5268
substitutions	O	5268
,	O	5268
leu27phe	O	5268
,	O	5268
thr48ile	O	5268
,	O	5268
val75met	O	5268
and	O	5268
arg477lys	O	5268
,	O	5268
were	O	5268
found	O	5268
in	O	5268
patients	O	5268
with	O	5268
congenital	B-Disease	5268
thrombocytopenia	I-Disease	5268
and	O	5268
no	O	5268
clinically	O	5268
evident	O	5268
immune	O	5268
defect	O	5268
indicating	O	5268
that	O	5268
the	O	5268
wasp	O	5268
gene	O	5268
is	O	5268
the	O	5268
site	O	5268
for	O	5268
mutations	O	5268
in	O	5268
x	B-Disease	5268
-	I-Disease	5268
linked	I-Disease	5268
thrombocytopenia	I-Disease	5268
as	O	5268
well	O	5268
as	O	5268
in	O	5268
was	B-Disease	5268
.	O	5268
a	O	5269
t	O	5269
-	O	5269
cell	O	5269
line	O	5269
from	O	5269
a	O	5269
was	B-Disease	5269
patient	O	5269
contained	O	5269
two	O	5269
independent	O	5269
dna	O	5269
alterations	O	5269
,	O	5269
a	O	5269
constitutional	O	5269
frameshift	O	5269
mutation	O	5269
,	O	5269
also	O	5269
present	O	5269
in	O	5269
peripheral	O	5269
blood	O	5269
leukocytes	O	5269
from	O	5269
the	O	5269
patient	O	5269
,	O	5269
and	O	5269
compensatory	O	5269
splice	O	5269
site	O	5269
mutation	O	5269
unique	O	5269
to	O	5269
the	O	5269
cell	O	5269
line	O	5269
.	O	5269
evidence	O	5271
for	O	5271
inter	O	5271
-	O	5271
generational	O	5271
instability	O	5271
in	O	5271
the	O	5271
cag	O	5271
repeat	O	5271
in	O	5271
the	O	5271
mjd1	O	5271
gene	O	5271
and	O	5271
for	O	5271
conserved	O	5271
haplotypes	O	5271
at	O	5271
flanking	O	5271
markers	O	5271
amongst	O	5271
japanese	O	5271
and	O	5271
caucasian	O	5271
subjects	O	5271
with	O	5271
machado	B-Disease	5271
-	I-Disease	5271
joseph	I-Disease	5271
disease	I-Disease	5271
.	O	5271
the	O	5272
size	O	5272
of	O	5272
the	O	5272
(	O	5272
cag	O	5272
)	O	5272
n	O	5272
repeat	O	5272
array	O	5272
in	O	5272
the	O	5272
3	O	5272
'	O	5272
end	O	5272
of	O	5272
the	O	5272
mjd1	O	5272
gene	O	5272
and	O	5272
the	O	5272
haplotype	O	5272
at	O	5272
a	O	5272
series	O	5272
of	O	5272
microsatellite	O	5272
markers	O	5272
surrounding	O	5272
the	O	5272
mjd1	O	5272
gene	O	5272
were	O	5272
examined	O	5272
in	O	5272
a	O	5272
large	O	5272
cohort	O	5272
of	O	5272
japanese	O	5272
and	O	5272
caucasian	O	5272
subjects	O	5272
affected	O	5272
with	O	5272
machado	B-Disease	5272
-	I-Disease	5272
joseph	I-Disease	5272
disease	I-Disease	5272
(	O	5272
mjd	B-Disease	5272
)	O	5272
.	O	5272
first	O	5274
,	O	5274
mjd	B-Disease	5274
is	O	5274
associated	O	5274
with	O	5274
expansion	O	5274
fo	O	5274
the	O	5274
array	O	5274
from	O	5274
the	O	5274
normal	O	5274
range	O	5274
of	O	5274
14	O	5274
-	O	5274
37	O	5274
repeats	O	5274
to	O	5274
68	O	5274
-	O	5274
84	O	5274
repeats	O	5274
in	O	5274
most	O	5274
japanese	O	5274
and	O	5274
caucasian	O	5274
subjects	O	5274
,	O	5274
but	O	5274
no	O	5274
subjects	O	5274
were	O	5274
observed	O	5274
with	O	5274
expansions	O	5274
intermediate	O	5274
in	O	5274
size	O	5274
between	O	5274
those	O	5274
of	O	5274
the	O	5274
normal	O	5274
and	O	5274
mjd	B-Disease	5274
affected	O	5274
groups	O	5274
.	O	5274
second	O	5275
,	O	5275
the	O	5275
expanded	O	5275
allele	O	5275
associated	O	5275
with	O	5275
mjd	B-Disease	5275
displays	O	5275
inter	O	5275
-	O	5275
generational	O	5275
instability	O	5275
,	O	5275
particularly	O	5275
in	O	5275
male	O	5275
meioses	O	5275
,	O	5275
and	O	5275
this	O	5275
instability	O	5275
was	O	5275
associated	O	5275
with	O	5275
the	O	5275
clinical	O	5275
phenomenon	O	5275
of	O	5275
anticipation	O	5275
.	O	5275
third	O	5276
,	O	5276
the	O	5276
size	O	5276
of	O	5276
the	O	5276
expanded	O	5276
allele	O	5276
is	O	5276
not	O	5276
only	O	5276
inversely	O	5276
correlated	O	5276
with	O	5276
the	O	5276
age	O	5276
-	O	5276
of	O	5276
-	O	5276
onset	O	5276
of	O	5276
mjd	B-Disease	5276
(	O	5276
r	O	5276
=	O	5276
-	O	5276
0	O	5276
.	O	5276
738	O	5276
,	O	5276
p	O	5276
<	O	5276
0	O	5276
.	O	5276
001	O	5276
)	O	5276
,	O	5276
but	O	5276
is	O	5276
also	O	5276
correlated	O	5276
with	O	5276
the	O	5276
frequency	O	5276
of	O	5276
other	O	5276
clinical	O	5276
features	O	5276
[	O	5276
e	O	5276
.	O	5276
g	O	5276
.	O	5276
pseudoexophthalmos	O	5276
and	O	5276
pyramidal	O	5276
signs	O	5276
were	O	5276
more	O	5276
frequent	O	5276
in	O	5276
subjects	O	5276
with	O	5276
large	O	5276
repeats	O	5276
(	O	5276
p	O	5276
<	O	5276
0	O	5276
.	O	5276
001	O	5276
and	O	5276
p	O	5276
<	O	5276
0	O	5276
.	O	5276
05	O	5276
respectively	O	5276
)	O	5276
]	O	5276
.	O	5276
fourth	O	5277
,	O	5277
the	O	5277
disease	O	5277
phenotype	O	5277
is	O	5277
significantly	O	5277
more	O	5277
severe	O	5277
and	O	5277
had	O	5277
an	O	5277
early	O	5277
age	O	5277
of	O	5277
onset	O	5277
(	O	5277
16	O	5277
years	O	5277
)	O	5277
in	O	5277
a	O	5277
subject	O	5277
homozygous	O	5277
for	O	5277
the	O	5277
expanded	O	5277
allele	O	5277
,	O	5277
which	O	5277
contrasts	O	5277
with	O	5277
huntington	B-Disease	5277
disease	I-Disease	5277
and	O	5277
suggests	O	5277
that	O	5277
the	O	5277
expanded	O	5277
allele	O	5277
in	O	5277
the	O	5277
mjd1	O	5277
gene	O	5277
could	O	5277
exert	O	5277
its	O	5277
effect	O	5277
either	O	5277
by	O	5277
a	O	5277
dominant	O	5277
negative	O	5277
effect	O	5277
(	O	5277
putatively	O	5277
excluded	O	5277
in	O	5277
hd	B-Disease	5277
)	O	5277
or	O	5277
by	O	5277
a	O	5277
gain	O	5277
of	O	5277
function	O	5277
effect	O	5277
as	O	5277
proposed	O	5277
for	O	5277
hd	B-Disease	5277
.	O	5277
finally	O	5278
,	O	5278
japanese	O	5278
and	O	5278
caucasian	O	5278
subjects	O	5278
affected	O	5278
with	O	5278
mjd	B-Disease	5278
share	O	5278
haplotypes	O	5278
at	O	5278
several	O	5278
markers	O	5278
surrounding	O	5278
the	O	5278
mjd1	O	5278
gene	O	5278
,	O	5278
which	O	5278
are	O	5278
uncommon	O	5278
in	O	5278
the	O	5278
normal	O	5278
japanese	O	5278
and	O	5278
caucasian	O	5278
population	O	5278
,	O	5278
and	O	5278
which	O	5278
suggests	O	5278
the	O	5278
existence	O	5278
either	O	5278
of	O	5278
common	O	5278
founders	O	5278
in	O	5278
these	O	5278
populations	O	5278
or	O	5278
of	O	5278
chromosomes	O	5278
susceptible	O	5278
to	O	5278
pathologic	O	5278
expansion	O	5278
of	O	5278
the	O	5278
cag	O	5278
repeat	O	5278
in	O	5278
the	O	5278
mjd1	O	5278
gene	O	5278
.	O	5278
a	O	5279
4	O	5279
-	O	5279
megabase	O	5279
yac	O	5279
contig	O	5279
that	O	5279
spans	O	5279
the	O	5279
langer	B-Disease	5279
-	I-Disease	5279
giedion	I-Disease	5279
syndrome	I-Disease	5279
region	O	5279
on	O	5279
human	O	5279
chromosome	O	5279
8q24	O	5279
.	O	5279
1	O	5279
:	O	5279
use	O	5279
in	O	5279
refining	O	5279
the	O	5279
location	O	5279
of	O	5279
the	O	5279
trichorhinophalangeal	B-Disease	5279
syndrome	I-Disease	5279
and	O	5279
multiple	O	5279
exostoses	O	5279
genes	O	5279
(	O	5279
trps1	O	5279
and	O	5279
ext1	O	5279
)	O	5279
.	O	5279
1	O	5281
and	O	5281
used	O	5281
this	O	5281
map	O	5281
to	O	5281
refine	O	5281
the	O	5281
locations	O	5281
of	O	5281
the	O	5281
genes	O	5281
responsible	O	5281
for	O	5281
langer	B-Disease	5281
-	I-Disease	5281
giedion	I-Disease	5281
syndrome	I-Disease	5281
.	O	5281
the	O	5283
minimal	O	5283
region	O	5283
of	O	5283
overlap	O	5283
of	O	5283
langer	B-Disease	5283
-	I-Disease	5283
giedion	I-Disease	5283
syndrome	I-Disease	5283
deletions	O	5283
,	O	5283
previously	O	5283
identified	O	5283
by	O	5283
analysis	O	5283
of	O	5283
15	O	5283
patients	O	5283
,	O	5283
was	O	5283
placed	O	5283
on	O	5283
the	O	5283
map	O	5283
by	O	5283
analysis	O	5283
of	O	5283
2	O	5283
patients	O	5283
whose	O	5283
deletions	O	5283
define	O	5283
the	O	5283
endpoints	O	5283
.	O	5283
the	O	5284
chromosome	O	5284
8	O	5284
breakpoint	O	5284
of	O	5284
a	O	5284
balanced	O	5284
t	O	5284
(	O	5284
8	O	5284
;	O	5284
9	O	5284
)	O	5284
(	O	5284
q24	O	5284
.	O	5284
11	O	5284
;	O	5284
q33	O	5284
.	O	5284
3	O	5284
)	O	5284
translocation	O	5284
from	O	5284
a	O	5284
patient	O	5284
with	O	5284
trichorhinophalangeal	B-Disease	5284
syndrome	I-Disease	5284
(	O	5284
trps	B-Disease	5284
i	O	5284
)	O	5284
was	O	5284
found	O	5284
to	O	5284
be	O	5284
located	O	5284
just	O	5284
within	O	5284
the	O	5284
proximal	O	5284
end	O	5284
of	O	5284
the	O	5284
minimal	O	5284
deletion	O	5284
region	O	5284
.	O	5284
3	O	5287
in	O	5287
a	O	5287
patient	O	5287
with	O	5287
multiple	O	5287
exostoses	O	5287
was	O	5287
found	O	5287
to	O	5287
overlap	O	5287
the	O	5287
distal	O	5287
end	O	5287
of	O	5287
the	O	5287
lgs	B-Disease	5287
deletion	O	5287
region	O	5287
,	O	5287
indicating	O	5287
that	O	5287
the	O	5287
ext1	O	5287
gene	O	5287
is	O	5287
distal	O	5287
to	O	5287
the	O	5287
trps1	O	5287
gene	O	5287
and	O	5287
supporting	O	5287
the	O	5287
hypothesis	O	5287
that	O	5287
langer	B-Disease	5287
-	I-Disease	5287
giedion	I-Disease	5287
syndrome	I-Disease	5287
is	O	5287
due	O	5287
to	O	5287
loss	O	5287
of	O	5287
functional	O	5287
copies	O	5287
of	O	5287
both	O	5287
the	O	5287
trps1	O	5287
and	O	5287
the	O	5287
ext1	O	5287
genes	O	5287
brca1	O	5288
mutations	O	5288
in	O	5288
a	O	5288
population	O	5288
-	O	5288
based	O	5288
sample	O	5288
of	O	5288
young	O	5288
women	O	5288
with	O	5288
breast	B-Disease	5288
cancer	I-Disease	5288
.	O	5288
inherited	O	5290
mutations	O	5290
in	O	5290
the	O	5290
brca1	O	5290
gene	O	5290
are	O	5290
associated	O	5290
with	O	5290
a	O	5290
high	O	5290
risk	O	5290
of	O	5290
breast	B-Disease	5290
and	I-Disease	5290
ovarian	I-Disease	5290
cancer	I-Disease	5290
in	O	5290
some	O	5290
families	O	5290
.	O	5290
however	O	5291
,	O	5291
little	O	5291
is	O	5291
known	O	5291
about	O	5291
the	O	5291
contribution	O	5291
of	O	5291
brca1	O	5291
mutations	O	5291
to	O	5291
breast	B-Disease	5291
cancer	I-Disease	5291
in	O	5291
the	O	5291
general	O	5291
population	O	5291
.	O	5291
we	O	5292
analyzed	O	5292
dna	O	5292
samples	O	5292
from	O	5292
women	O	5292
enrolled	O	5292
in	O	5292
a	O	5292
population	O	5292
-	O	5292
based	O	5292
study	O	5292
of	O	5292
early	O	5292
-	O	5292
onset	O	5292
breast	B-Disease	5292
cancer	I-Disease	5292
to	O	5292
assess	O	5292
the	O	5292
spectrum	O	5292
and	O	5292
frequency	O	5292
of	O	5292
germ	O	5292
-	O	5292
line	O	5292
brca1	O	5292
mutations	O	5292
in	O	5292
young	O	5292
women	O	5292
with	O	5292
breast	B-Disease	5292
cancer	I-Disease	5292
.	O	5292
we	O	5294
studied	O	5294
80	O	5294
women	O	5294
in	O	5294
whom	O	5294
breast	B-Disease	5294
cancer	I-Disease	5294
was	O	5294
diagnosed	O	5294
before	O	5294
the	O	5294
age	O	5294
of	O	5294
35	O	5294
,	O	5294
and	O	5294
who	O	5294
were	O	5294
not	O	5294
selected	O	5294
on	O	5294
the	O	5294
basis	O	5294
of	O	5294
family	O	5294
history	O	5294
.	O	5294
two	O	5300
of	O	5300
the	O	5300
mutations	O	5300
and	O	5300
three	O	5300
of	O	5300
the	O	5300
rare	O	5300
sequence	O	5300
variants	O	5300
were	O	5300
found	O	5300
among	O	5300
the	O	5300
39	O	5300
women	O	5300
who	O	5300
reported	O	5300
no	O	5300
family	O	5300
history	O	5300
of	O	5300
breast	B-Disease	5300
or	I-Disease	5300
ovarian	I-Disease	5300
cancer	I-Disease	5300
.	O	5300
alterations	O	5303
in	O	5303
brca1	O	5303
were	O	5303
identified	O	5303
in	O	5303
approximately	O	5303
10	O	5303
percent	O	5303
of	O	5303
this	O	5303
cohort	O	5303
of	O	5303
young	O	5303
women	O	5303
with	O	5303
breast	B-Disease	5303
cancer	I-Disease	5303
.	O	5303
the	O	5304
risk	O	5304
of	O	5304
harboring	O	5304
a	O	5304
mutation	O	5304
was	O	5304
not	O	5304
limited	O	5304
to	O	5304
women	O	5304
with	O	5304
family	O	5304
histories	O	5304
of	O	5304
breast	B-Disease	5304
or	I-Disease	5304
ovarian	I-Disease	5304
cancer	I-Disease	5304
.	O	5304
thirty	O	5308
-	O	5308
seven	O	5308
families	O	5308
with	O	5308
four	O	5308
or	O	5308
more	O	5308
cases	O	5308
of	O	5308
breast	B-Disease	5308
cancer	I-Disease	5308
or	O	5308
breast	B-Disease	5308
and	I-Disease	5308
ovarian	I-Disease	5308
cancer	I-Disease	5308
were	O	5308
analyzed	O	5308
for	O	5308
mutations	O	5308
in	O	5308
brca1	O	5308
.	O	5308
expressivity	O	5311
of	O	5311
185delag	O	5311
in	O	5311
these	O	5311
families	O	5311
varied	O	5311
,	O	5311
from	O	5311
early	O	5311
-	O	5311
onset	O	5311
breast	B-Disease	5311
cancer	I-Disease	5311
without	O	5311
ovarian	B-Disease	5311
cancer	I-Disease	5311
.	O	5311
in	O	5313
one	O	5313
family	O	5313
,	O	5313
penetrance	O	5313
was	O	5313
complete	O	5313
,	O	5313
with	O	5313
females	O	5313
developing	O	5313
early	O	5313
-	O	5313
onset	O	5313
breast	B-Disease	5313
cancer	I-Disease	5313
or	O	5313
ovarian	B-Disease	5313
cancer	I-Disease	5313
and	O	5313
the	O	5313
male	O	5313
carrier	O	5313
developing	O	5313
prostatic	B-Disease	5313
cancer	I-Disease	5313
,	O	5313
whereas	O	5313
,	O	5313
in	O	5313
the	O	5313
other	O	5313
family	O	5313
,	O	5313
penetrance	O	5313
was	O	5313
incomplete	O	5313
and	O	5313
only	O	5313
breast	B-Disease	5313
cancer	I-Disease	5313
occurred	O	5313
,	O	5313
diagnosed	O	5313
at	O	5313
ages	O	5313
38	O	5313
-	O	5313
81	O	5313
years	O	5313
.	O	5313
two	O	5314
novel	O	5314
nonsense	O	5314
mutations	O	5314
led	O	5314
to	O	5314
the	O	5314
loss	O	5314
of	O	5314
mutant	O	5314
brca1	O	5314
transcript	O	5314
in	O	5314
families	O	5314
with	O	5314
10	O	5314
and	O	5314
6	O	5314
cases	O	5314
of	O	5314
early	O	5314
-	O	5314
onset	O	5314
breast	B-Disease	5314
cancer	I-Disease	5314
and	O	5314
ovarian	B-Disease	5314
cancer	I-Disease	5314
.	O	5314
overall	O	5317
in	O	5317
our	O	5317
series	O	5317
,	O	5317
brca1	O	5317
mutations	O	5317
have	O	5317
been	O	5317
detected	O	5317
in	O	5317
26	O	5317
families	O	5317
16	O	5317
with	O	5317
positive	O	5317
brca1	O	5317
lod	O	5317
scores	O	5317
,	O	5317
7	O	5317
with	O	5317
negative	O	5317
lod	O	5317
scores	O	5317
(	O	5317
reflecting	O	5317
multiple	O	5317
sporadic	O	5317
breast	B-Disease	5317
cancers	I-Disease	5317
)	O	5317
,	O	5317
and	O	5317
3	O	5317
not	O	5317
tested	O	5317
for	O	5317
linkage	O	5317
.	O	5317
deficiency	B-Disease	5320
of	I-Disease	5320
glucose	I-Disease	5320
-	I-Disease	5320
6	I-Disease	5320
-	I-Disease	5320
phosphate	I-Disease	5320
dehydrogenase	I-Disease	5320
(	O	5320
g6pd	O	5320
)	O	5320
is	O	5320
usually	O	5320
found	O	5320
at	O	5320
high	O	5320
frequencies	O	5320
in	O	5320
areas	O	5320
of	O	5320
the	O	5320
world	O	5320
where	O	5320
malaria	B-Disease	5320
has	O	5320
been	O	5320
endemic	O	5320
.	O	5320
the	O	5321
frequency	O	5321
and	O	5321
genetic	O	5321
basis	O	5321
of	O	5321
g6pd	B-Disease	5321
deficiency	I-Disease	5321
have	O	5321
been	O	5321
studied	O	5321
in	O	5321
africa	O	5321
,	O	5321
around	O	5321
the	O	5321
mediterranean	O	5321
,	O	5321
and	O	5321
in	O	5321
the	O	5321
far	O	5321
east	O	5321
,	O	5321
but	O	5321
little	O	5321
such	O	5321
information	O	5321
is	O	5321
available	O	5321
about	O	5321
the	O	5321
situation	O	5321
in	O	5321
india	O	5321
.	O	5321
to	O	5322
determine	O	5322
the	O	5322
extent	O	5322
of	O	5322
heterogeneity	O	5322
of	O	5322
g6pd	O	5322
,	O	5322
we	O	5322
have	O	5322
studied	O	5322
several	O	5322
different	O	5322
indian	O	5322
populations	O	5322
by	O	5322
screening	O	5322
for	O	5322
g6pd	B-Disease	5322
deficiency	I-Disease	5322
,	O	5322
followed	O	5322
by	O	5322
molecular	O	5322
analysis	O	5322
of	O	5322
deficient	O	5322
alleles	O	5322
.	O	5322
the	O	5323
frequency	O	5323
of	O	5323
g6pd	B-Disease	5323
deficiency	I-Disease	5323
varies	O	5323
between	O	5323
3	O	5323
%	O	5323
and	O	5323
15	O	5323
%	O	5323
in	O	5323
different	O	5323
tribal	O	5323
and	O	5323
urban	O	5323
groups	O	5323
.	O	5323
remarkably	O	5324
,	O	5324
a	O	5324
previously	O	5324
unreported	O	5324
deficient	O	5324
variant	O	5324
,	O	5324
g6pd	O	5324
orissa	O	5324
(	O	5324
44	O	5324
ala	O	5324
-	O	5324
-	O	5324
>	O	5324
gly	O	5324
)	O	5324
,	O	5324
is	O	5324
responsible	O	5324
for	O	5324
most	O	5324
of	O	5324
the	O	5324
g6pd	B-Disease	5324
deficiency	I-Disease	5324
in	O	5324
tribal	O	5324
indian	O	5324
populations	O	5324
but	O	5324
is	O	5324
not	O	5324
found	O	5324
in	O	5324
urban	O	5324
populations	O	5324
,	O	5324
where	O	5324
most	O	5324
of	O	5324
the	O	5324
g6pd	B-Disease	5324
deficiency	I-Disease	5324
is	O	5324
due	O	5324
to	O	5324
the	O	5324
g6pd	O	5324
mediterranean	O	5324
(	O	5324
188	O	5324
ser	O	5324
-	O	5324
-	O	5324
>	O	5324
phe	O	5324
)	O	5324
variant	O	5324
.	O	5324
evidence	O	5327
for	O	5327
linkage	O	5327
of	O	5327
bipolar	B-Disease	5327
disorder	I-Disease	5327
to	O	5327
chromosome	O	5327
18	O	5327
with	O	5327
a	O	5327
parent	O	5327
-	O	5327
of	O	5327
-	O	5327
origin	O	5327
effect	O	5327
.	O	5327
a	O	5328
susceptibility	O	5328
gene	O	5328
on	O	5328
chromosome	O	5328
18	O	5328
and	O	5328
a	O	5328
parent	O	5328
-	O	5328
of	O	5328
-	O	5328
origin	O	5328
effect	O	5328
have	O	5328
been	O	5328
suggested	O	5328
for	O	5328
bipolar	B-Disease	5328
affective	I-Disease	5328
disorder	I-Disease	5328
(	O	5328
bpad	B-Disease	5328
)	O	5328
.	O	5328
we	O	5329
have	O	5329
studied	O	5329
28	O	5329
nuclear	O	5329
families	O	5329
selected	O	5329
for	O	5329
apparent	O	5329
unilineal	O	5329
transmission	O	5329
of	O	5329
the	O	5329
bpad	B-Disease	5329
phenotype	O	5329
,	O	5329
by	O	5329
using	O	5329
31	O	5329
polymorphic	O	5329
markers	O	5329
spanning	O	5329
chromosome	O	5329
18	O	5329
.	O	5329
our	O	5337
results	O	5337
provide	O	5337
further	O	5337
support	O	5337
for	O	5337
linkage	O	5337
of	O	5337
bpad	B-Disease	5337
to	O	5337
chromosome	O	5337
18	O	5337
and	O	5337
the	O	5337
first	O	5337
molecular	O	5337
evidence	O	5337
for	O	5337
a	O	5337
parent	O	5337
-	O	5337
of	O	5337
-	O	5337
origin	O	5337
effect	O	5337
operating	O	5337
in	O	5337
this	O	5337
disorder	O	5337
.	O	5337
a	O	5339
prevalent	O	5339
mutation	O	5339
for	O	5339
galactosemia	B-Disease	5339
among	O	5339
black	O	5339
americans	O	5339
.	O	5339
objective	O	5340
to	O	5340
define	O	5340
the	O	5340
mutation	O	5340
causing	O	5340
galactosemia	B-Disease	5340
in	O	5340
patients	O	5340
of	O	5340
black	O	5340
american	O	5340
origin	O	5340
who	O	5340
have	O	5340
no	O	5340
galactose	O	5340
-	O	5340
1	O	5340
-	O	5340
phosphate	O	5340
uridyltransferase	O	5340
(	O	5340
galt	O	5340
)	O	5340
activity	O	5340
in	O	5340
erythrocytes	O	5340
but	O	5340
good	O	5340
clinical	O	5340
outcome	O	5340
.	O	5340
results	O	5344
we	O	5344
found	O	5344
a	O	5344
48	O	5344
%	O	5344
prevalence	O	5344
of	O	5344
the	O	5344
s135l	O	5344
mutation	O	5344
among	O	5344
17	O	5344
black	O	5344
american	O	5344
patients	O	5344
with	O	5344
classic	B-Disease	5344
galactosemia	I-Disease	5344
and	O	5344
a	O	5344
1	O	5344
%	O	5344
prevalence	O	5344
in	O	5344
a	O	5344
population	O	5344
of	O	5344
50	O	5344
black	O	5344
americans	O	5344
without	O	5344
galactosemia	B-Disease	5344
.	O	5344
the	O	5345
s135l	O	5345
mutation	O	5345
was	O	5345
not	O	5345
found	O	5345
in	O	5345
84	O	5345
white	O	5345
patients	O	5345
with	O	5345
g	O	5345
/	O	5345
g	O	5345
galactosemia	B-Disease	5345
nor	O	5345
in	O	5345
87	O	5345
white	O	5345
control	O	5345
subjects	O	5345
without	O	5345
galactosemia	B-Disease	5345
.	O	5345
conclusions	O	5347
the	O	5347
s135l	O	5347
mutation	O	5347
in	O	5347
the	O	5347
galt	O	5347
gene	O	5347
is	O	5347
a	O	5347
prevalent	O	5347
cause	O	5347
of	O	5347
galactosemia	B-Disease	5347
among	O	5347
black	O	5347
patients	O	5347
.	O	5347
a	O	5349
high	O	5349
incidence	O	5349
of	O	5349
brca1	O	5349
mutations	O	5349
in	O	5349
20	O	5349
breast	B-Disease	5349
-	I-Disease	5349
ovarian	I-Disease	5349
cancer	I-Disease	5349
families	O	5349
.	O	5349
we	O	5350
have	O	5350
analyzed	O	5350
20	O	5350
breast	B-Disease	5350
-	I-Disease	5350
ovarian	I-Disease	5350
cancer	I-Disease	5350
families	O	5350
,	O	5350
the	O	5350
majority	O	5350
of	O	5350
which	O	5350
show	O	5350
positive	O	5350
evidence	O	5350
of	O	5350
linkage	O	5350
to	O	5350
chromosome	O	5350
17q12	O	5350
for	O	5350
germ	O	5350
-	O	5350
line	O	5350
mutations	O	5350
in	O	5350
the	O	5350
brca1	O	5350
gene	O	5350
.	O	5350
brca1	O	5351
mutations	O	5351
cosegregating	O	5351
with	O	5351
breast	B-Disease	5351
and	I-Disease	5351
ovarian	I-Disease	5351
cancer	I-Disease	5351
susceptibility	O	5351
were	O	5351
identified	O	5351
in	O	5351
16	O	5351
families	O	5351
,	O	5351
including	O	5351
1	O	5351
family	O	5351
with	O	5351
a	O	5351
case	O	5351
of	O	5351
male	B-Disease	5351
breast	I-Disease	5351
cancer	I-Disease	5351
.	O	5351
it	O	5358
is	O	5358
expected	O	5358
that	O	5358
the	O	5358
majority	O	5358
of	O	5358
clear	O	5358
examples	O	5358
of	O	5358
the	O	5358
breast	B-Disease	5358
-	I-Disease	5358
ovarian	I-Disease	5358
syndrome	I-Disease	5358
will	O	5358
be	O	5358
associated	O	5358
with	O	5358
germ	O	5358
-	O	5358
line	O	5358
mutations	O	5358
in	O	5358
the	O	5358
coding	O	5358
region	O	5358
of	O	5358
brca1	O	5358
.	O	5358
.	O	5358
brca1	B-Disease	5359
deficiency	I-Disease	5359
results	O	5359
in	O	5359
early	O	5359
embryonic	B-Disease	5359
lethality	I-Disease	5359
characterized	O	5359
by	O	5359
neuroepithelial	B-Disease	5359
abnormalities	I-Disease	5359
.	O	5359
the	O	5360
breast	B-Disease	5360
and	I-Disease	5360
ovarian	I-Disease	5360
cancer	I-Disease	5360
susceptibility	O	5360
gene	O	5360
,	O	5360
brca1	O	5360
,	O	5360
has	O	5360
been	O	5360
cloned	O	5360
and	O	5360
shown	O	5360
to	O	5360
encode	O	5360
a	O	5360
zinc	O	5360
-	O	5360
finger	O	5360
protein	O	5360
of	O	5360
unknown	O	5360
function	O	5360
.	O	5360
mutations	O	5361
in	O	5361
brca1	O	5361
account	O	5361
for	O	5361
at	O	5361
least	O	5361
80	O	5361
%	O	5361
of	O	5361
families	O	5361
with	O	5361
both	O	5361
breast	B-Disease	5361
and	I-Disease	5361
ovarian	I-Disease	5361
cancer	I-Disease	5361
,	O	5361
as	O	5361
well	O	5361
as	O	5361
some	O	5361
non	O	5361
-	O	5361
familial	O	5361
sporadic	O	5361
ovarian	B-Disease	5361
cancers	I-Disease	5361
.	O	5361
the	O	5362
loss	O	5362
of	O	5362
wild	O	5362
-	O	5362
type	O	5362
brca1	O	5362
in	O	5362
tumours	B-Disease	5362
of	O	5362
individuals	O	5362
carrying	O	5362
one	O	5362
nonfunctional	O	5362
brca1	O	5362
allele	O	5362
suggests	O	5362
that	O	5362
brca1	O	5362
encodes	O	5362
a	O	5362
tumour	B-Disease	5362
suppressor	O	5362
that	O	5362
may	O	5362
inhibit	O	5362
the	O	5362
proliferation	O	5362
of	O	5362
mammary	O	5362
epithelial	O	5362
cells	O	5362
.	O	5362
to	O	5363
examine	O	5363
the	O	5363
role	O	5363
of	O	5363
brca1	O	5363
in	O	5363
normal	O	5363
tissue	O	5363
growth	O	5363
and	O	5363
differentiation	O	5363
,	O	5363
and	O	5363
to	O	5363
generate	O	5363
a	O	5363
potential	O	5363
model	O	5363
for	O	5363
the	O	5363
cancer	B-Disease	5363
susceptibility	O	5363
associated	O	5363
with	O	5363
loss	O	5363
of	O	5363
brca1	O	5363
function	O	5363
,	O	5363
we	O	5363
have	O	5363
created	O	5363
a	O	5363
mouse	O	5363
line	O	5363
carrying	O	5363
a	O	5363
mutation	O	5363
in	O	5363
one	O	5363
brca1	O	5363
allele	O	5363
.	O	5363
abnormalities	O	5365
in	O	5365
brca1	B-Disease	5365
-	I-Disease	5365
deficient	I-Disease	5365
embryos	O	5365
were	O	5365
most	O	5365
evident	O	5365
in	O	5365
the	O	5365
neural	O	5365
tube	O	5365
,	O	5365
with	O	5365
40	O	5365
%	O	5365
of	O	5365
the	O	5365
embryos	O	5365
presenting	O	5365
with	O	5365
varying	O	5365
degrees	O	5365
of	O	5365
spina	B-Disease	5365
bifida	I-Disease	5365
and	O	5365
anencephaly	B-Disease	5365
.	O	5365
in	O	5366
addition	O	5366
,	O	5366
the	O	5366
neuroepithelium	O	5366
in	O	5366
brca1	B-Disease	5366
-	I-Disease	5366
deficient	I-Disease	5366
embryos	O	5366
appeared	O	5366
disorganized	O	5366
,	O	5366
with	O	5366
signs	O	5366
of	O	5366
both	O	5366
rapid	O	5366
proliferation	O	5366
and	O	5366
excessive	O	5366
cell	O	5366
death	O	5366
.	O	5366
.	O	5366
identification	O	5367
of	O	5367
mutations	O	5367
in	O	5367
the	O	5367
ald	O	5367
-	O	5367
gene	O	5367
of	O	5367
20	O	5367
families	O	5367
with	O	5367
adrenoleukodystrophy	B-Disease	5367
/	O	5367
adrenomyeloneuropathy	B-Disease	5367
.	O	5367
adrenoleukodystrophy	B-Disease	5368
(	O	5368
ald	B-Disease	5368
)	O	5368
,	O	5368
an	O	5368
x	B-Disease	5368
-	I-Disease	5368
linked	I-Disease	5368
inherited	I-Disease	5368
metabolic	I-Disease	5368
disorder	I-Disease	5368
,	O	5368
is	O	5368
the	O	5368
most	O	5368
frequent	O	5368
inborn	B-Disease	5368
peroxisomal	I-Disease	5368
disease	I-Disease	5368
.	O	5368
it	O	5369
leads	O	5369
to	O	5369
demyelination	B-Disease	5369
in	I-Disease	5369
the	I-Disease	5369
central	I-Disease	5369
and	I-Disease	5369
peripheral	I-Disease	5369
nervous	I-Disease	5369
system	I-Disease	5369
.	O	5369
the	O	5371
ald	B-Disease	5371
gene	O	5371
has	O	5371
been	O	5371
recently	O	5371
identified	O	5371
and	O	5371
encodes	O	5371
a	O	5371
745	O	5371
-	O	5371
amino	O	5371
-	O	5371
acid	O	5371
protein	O	5371
.	O	5371
we	O	5372
screened	O	5372
patients	O	5372
with	O	5372
adrenoleukodystrophy	B-Disease	5372
/	O	5372
adrenomyeloneuropathy	B-Disease	5372
(	O	5372
ald	B-Disease	5372
/	O	5372
amn	B-Disease	5372
)	O	5372
from	O	5372
20	O	5372
kindreds	O	5372
for	O	5372
mutations	O	5372
in	O	5372
the	O	5372
ald	B-Disease	5372
gene	O	5372
.	O	5372
eleven	O	5373
missense	O	5373
and	O	5373
two	O	5373
nonsense	O	5373
mutations	O	5373
,	O	5373
five	O	5373
deletions	O	5373
,	O	5373
and	O	5373
one	O	5373
insertion	O	5373
were	O	5373
detected	O	5373
by	O	5373
direct	O	5373
sequencing	O	5373
of	O	5373
eight	O	5373
reverse	O	5373
transcribed	O	5373
fragments	O	5373
of	O	5373
the	O	5373
ald	B-Disease	5373
-	O	5373
gene	O	5373
mrna	O	5373
.	O	5373
the	O	5377
mutations	O	5377
were	O	5377
not	O	5377
detected	O	5377
in	O	5377
the	O	5377
ald	B-Disease	5377
gene	O	5377
of	O	5377
30	O	5377
healthy	O	5377
persons	O	5377
.	O	5377
.	O	5377
the	O	5378
murine	O	5378
homolog	O	5378
of	O	5378
the	O	5378
human	O	5378
breast	B-Disease	5378
and	I-Disease	5378
ovarian	I-Disease	5378
cancer	I-Disease	5378
susceptibility	O	5378
gene	O	5378
brca1	O	5378
maps	O	5378
to	O	5378
mouse	O	5378
chromosome	O	5378
11d	O	5378
.	O	5378
the	O	5379
recently	O	5379
cloned	O	5379
human	O	5379
breast	B-Disease	5379
and	I-Disease	5379
ovarian	I-Disease	5379
cancer	I-Disease	5379
susceptibility	O	5379
gene	O	5379
,	O	5379
brca1	O	5379
,	O	5379
is	O	5379
located	O	5379
on	O	5379
human	O	5379
chromosome	O	5379
17q21	O	5379
.	O	5379
atelosteogenesis	B-Disease	5388
type	I-Disease	5388
ii	I-Disease	5388
is	O	5388
caused	O	5388
by	O	5388
mutations	O	5388
in	O	5388
the	O	5388
diastrophic	B-Disease	5388
dysplasia	I-Disease	5388
sulfate	O	5388
-	O	5388
transporter	O	5388
gene	O	5388
(	O	5388
dtdst	O	5388
)	O	5388
:	O	5388
evidence	O	5388
for	O	5388
a	O	5388
phenotypic	O	5388
series	O	5388
involving	O	5388
three	O	5388
chondrodysplasias	B-Disease	5388
.	O	5388
atelosteogenesis	B-Disease	5389
type	I-Disease	5389
ii	I-Disease	5389
(	O	5389
ao	B-Disease	5389
ii	I-Disease	5389
)	O	5389
is	O	5389
a	O	5389
neonatally	O	5389
lethal	O	5389
chondrodysplasia	B-Disease	5389
whose	O	5389
clinical	O	5389
and	O	5389
histological	O	5389
characteristics	O	5389
resemble	O	5389
those	O	5389
of	O	5389
another	O	5389
chondrodysplasia	B-Disease	5389
,	O	5389
the	O	5389
much	O	5389
less	O	5389
severe	O	5389
diastrophic	B-Disease	5389
dysplasia	I-Disease	5389
(	O	5389
dtd	B-Disease	5389
)	O	5389
.	O	5389
dtd	B-Disease	5391
is	O	5391
caused	O	5391
by	O	5391
mutations	O	5391
in	O	5391
the	O	5391
recently	O	5391
identified	O	5391
diastrophic	B-Disease	5391
dysplasia	I-Disease	5391
sulfate	O	5391
-	O	5391
transporter	O	5391
gene	O	5391
(	O	5391
dtdst	O	5391
)	O	5391
.	O	5391
here	O	5392
,	O	5392
we	O	5392
report	O	5392
that	O	5392
aoii	B-Disease	5392
patients	O	5392
also	O	5392
have	O	5392
dtdst	O	5392
mutations	O	5392
,	O	5392
which	O	5392
lead	O	5392
to	O	5392
defective	O	5392
uptake	O	5392
of	O	5392
inorganic	O	5392
sulfate	O	5392
and	O	5392
insufficient	O	5392
sulfation	O	5392
of	O	5392
macromolecules	O	5392
by	O	5392
patient	O	5392
mesenchymal	O	5392
cells	O	5392
in	O	5392
vitro	O	5392
.	O	5392
together	O	5393
with	O	5393
our	O	5393
recent	O	5393
observation	O	5393
that	O	5393
a	O	5393
third	O	5393
even	O	5393
more	O	5393
severe	O	5393
chondrodysplasia	B-Disease	5393
,	O	5393
achondrogenesis	O	5393
type	O	5393
ib	O	5393
,	O	5393
is	O	5393
also	O	5393
caused	O	5393
by	O	5393
mutations	O	5393
in	O	5393
dtdst	O	5393
,	O	5393
these	O	5393
results	O	5393
demonstrate	O	5393
a	O	5393
phenotypic	O	5393
series	O	5393
of	O	5393
three	O	5393
chondrodysplasias	B-Disease	5393
of	O	5393
increasing	O	5393
severity	O	5393
caused	O	5393
by	O	5393
lesions	O	5393
in	O	5393
a	O	5393
single	O	5393
sulfate	O	5393
-	O	5393
transporter	O	5393
gene	O	5393
.	O	5393
several	O	5396
brca1	O	5396
mutations	O	5396
have	O	5396
now	O	5396
been	O	5396
found	O	5396
to	O	5396
occur	O	5396
in	O	5396
geographically	O	5396
diverse	O	5396
breast	B-Disease	5396
and	I-Disease	5396
ovarian	I-Disease	5396
cancer	I-Disease	5396
families	O	5396
.	O	5396
to	O	5397
investigate	O	5397
mutation	O	5397
origin	O	5397
and	O	5397
mutation	O	5397
-	O	5397
specific	O	5397
phenotypes	O	5397
due	O	5397
to	O	5397
brca1	O	5397
,	O	5397
we	O	5397
constructed	O	5397
a	O	5397
haplotype	O	5397
of	O	5397
nine	O	5397
polymorphic	O	5397
markers	O	5397
within	O	5397
or	O	5397
immediately	O	5397
flanking	O	5397
the	O	5397
brca1	O	5397
locus	O	5397
in	O	5397
a	O	5397
set	O	5397
of	O	5397
61	O	5397
breast	B-Disease	5397
/	I-Disease	5397
ovarian	I-Disease	5397
cancer	I-Disease	5397
families	O	5397
selected	O	5397
for	O	5397
having	O	5397
one	O	5397
of	O	5397
six	O	5397
recurrent	O	5397
brca1	O	5397
mutations	O	5397
.	O	5397
a	O	5399
comparison	O	5399
of	O	5399
the	O	5399
six	O	5399
mutations	O	5399
in	O	5399
the	O	5399
relative	O	5399
proportions	O	5399
of	O	5399
cases	O	5399
of	O	5399
breast	B-Disease	5399
and	I-Disease	5399
ovarian	I-Disease	5399
cancer	I-Disease	5399
was	O	5399
suggestive	O	5399
of	O	5399
an	O	5399
effect	O	5399
(	O	5399
p	O	5399
=	O	5399
.	O	5399
069	O	5399
)	O	5399
,	O	5399
with	O	5399
57	O	5399
%	O	5399
of	O	5399
women	O	5399
presumed	O	5399
affected	O	5399
because	O	5399
of	O	5399
the	O	5399
1294	O	5399
del	O	5399
40	O	5399
brca1	O	5399
mutation	O	5399
having	O	5399
ovarian	B-Disease	5399
cancer	I-Disease	5399
,	O	5399
compared	O	5399
with	O	5399
14	O	5399
%	O	5399
of	O	5399
affected	O	5399
women	O	5399
with	O	5399
the	O	5399
splice	O	5399
-	O	5399
site	O	5399
mutation	O	5399
in	O	5399
intron	O	5399
5	O	5399
of	O	5399
brca1	O	5399
.	O	5399
the	O	5404
brca1	O	5404
gene	O	5404
is	O	5404
in	O	5404
large	O	5404
part	O	5404
responsible	O	5404
for	O	5404
hereditary	B-Disease	5404
human	I-Disease	5404
breast	I-Disease	5404
and	I-Disease	5404
ovarian	I-Disease	5404
cancer	I-Disease	5404
.	O	5404
the	O	5410
isolation	O	5410
of	O	5410
the	O	5410
mouse	O	5410
brca1	O	5410
homologue	O	5410
will	O	5410
facilitate	O	5410
the	O	5410
creation	O	5410
of	O	5410
mouse	O	5410
models	O	5410
for	O	5410
germline	O	5410
brca1	B-Disease	5410
defects	I-Disease	5410
.	O	5410
.	O	5410
emerin	B-Disease	5411
deficiency	I-Disease	5411
at	O	5411
the	O	5411
nuclear	O	5411
membrane	O	5411
in	O	5411
patients	O	5411
with	O	5411
emery	B-Disease	5411
-	I-Disease	5411
dreifuss	I-Disease	5411
muscular	I-Disease	5411
dystrophy	I-Disease	5411
.	O	5411
mutations	O	5412
in	O	5412
the	O	5412
sta	O	5412
gene	O	5412
at	O	5412
the	O	5412
xq28	O	5412
locus	O	5412
have	O	5412
been	O	5412
found	O	5412
in	O	5412
patients	O	5412
with	O	5412
x	B-Disease	5412
-	I-Disease	5412
linked	I-Disease	5412
emery	I-Disease	5412
-	I-Disease	5412
dreifuss	I-Disease	5412
muscular	I-Disease	5412
dystrophy	I-Disease	5412
(	O	5412
edmd	B-Disease	5412
)	O	5412
.	O	5412
using	O	5415
both	O	5415
antisera	O	5415
,	O	5415
we	O	5415
found	O	5415
positive	O	5415
nuclear	O	5415
membrane	O	5415
staining	O	5415
in	O	5415
skeletal	O	5415
,	O	5415
cardiac	O	5415
and	O	5415
smooth	O	5415
muscles	O	5415
in	O	5415
the	O	5415
normal	O	5415
controls	O	5415
and	O	5415
in	O	5415
patients	O	5415
with	O	5415
neuromuscular	B-Disease	5415
diseases	I-Disease	5415
other	O	5415
than	O	5415
edmd	B-Disease	5415
.	O	5415
in	O	5416
contrast	O	5416
,	O	5416
a	O	5416
deficiency	O	5416
in	O	5416
immunofluorescent	O	5416
staining	O	5416
of	O	5416
skeletal	O	5416
and	O	5416
cardiac	O	5416
muscle	O	5416
from	O	5416
edmd	B-Disease	5416
patients	O	5416
was	O	5416
observed	O	5416
.	O	5416
together	O	5418
,	O	5418
our	O	5418
findings	O	5418
suggest	O	5418
the	O	5418
specific	O	5418
deficiency	B-Disease	5418
of	I-Disease	5418
emerin	I-Disease	5418
in	O	5418
the	O	5418
nuclear	O	5418
membrane	O	5418
of	O	5418
muscle	O	5418
cells	O	5418
in	O	5418
patients	O	5418
with	O	5418
edmd	B-Disease	5418
.	O	5418
.	O	5418
growth	B-Disease	5419
retardation	I-Disease	5419
and	O	5419
tumour	B-Disease	5419
inhibition	O	5419
by	O	5419
brca1	O	5419
.	O	5419
inherited	O	5420
mutations	O	5420
in	O	5420
brca1	O	5420
predispose	O	5420
to	O	5420
breast	B-Disease	5420
and	I-Disease	5420
ovarian	I-Disease	5420
cancer	I-Disease	5420
,	O	5420
but	O	5420
the	O	5420
role	O	5420
of	O	5420
brca1	O	5420
in	O	5420
sporadic	O	5420
breast	B-Disease	5420
and	I-Disease	5420
ovarian	I-Disease	5420
cancer	I-Disease	5420
has	O	5420
previously	O	5420
been	O	5420
elusive	O	5420
.	O	5420
here	O	5421
,	O	5421
we	O	5421
show	O	5421
that	O	5421
retroviral	O	5421
transfer	O	5421
of	O	5421
the	O	5421
wild	O	5421
-	O	5421
type	O	5421
brca1	O	5421
gene	O	5421
inhibits	O	5421
growth	O	5421
in	O	5421
vitro	O	5421
of	O	5421
all	O	5421
breast	B-Disease	5421
and	I-Disease	5421
ovarian	I-Disease	5421
cancer	I-Disease	5421
cell	O	5421
lines	O	5421
tested	O	5421
,	O	5421
but	O	5421
not	O	5421
colon	B-Disease	5421
or	I-Disease	5421
lung	I-Disease	5421
cancer	I-Disease	5421
cells	O	5421
or	O	5421
fibroblasts	O	5421
.	O	5421
mutant	O	5422
brca1	O	5422
has	O	5422
no	O	5422
effect	O	5422
on	O	5422
growth	O	5422
of	O	5422
breast	B-Disease	5422
cancer	I-Disease	5422
cells	O	5422
;	O	5422
ovarian	B-Disease	5422
cancer	I-Disease	5422
cell	O	5422
growth	O	5422
is	O	5422
not	O	5422
affected	O	5422
by	O	5422
brca1	O	5422
mutations	O	5422
in	O	5422
the	O	5422
5	O	5422
portion	O	5422
of	O	5422
the	O	5422
gene	O	5422
,	O	5422
but	O	5422
is	O	5422
inhibited	O	5422
by	O	5422
3	O	5422
brca1	O	5422
mutations	O	5422
.	O	5422
development	O	5423
of	O	5423
mcf	B-Disease	5423
-	I-Disease	5423
7	I-Disease	5423
tumours	I-Disease	5423
in	O	5423
nude	O	5423
mice	O	5423
is	O	5423
inhibited	O	5423
when	O	5423
mcf	O	5423
-	O	5423
7	O	5423
cells	O	5423
are	O	5423
transfected	O	5423
with	O	5423
wild	O	5423
-	O	5423
type	O	5423
,	O	5423
but	O	5423
not	O	5423
mutant	O	5423
,	O	5423
brca1	O	5423
.	O	5423
most	O	5424
importantly	O	5424
,	O	5424
among	O	5424
mice	O	5424
with	O	5424
established	O	5424
mcf	B-Disease	5424
-	I-Disease	5424
7	I-Disease	5424
tumours	I-Disease	5424
,	O	5424
peritoneal	O	5424
treatment	O	5424
with	O	5424
a	O	5424
retroviral	O	5424
vector	O	5424
expressing	O	5424
wild	O	5424
-	O	5424
type	O	5424
brca1	O	5424
significantly	O	5424
inhibits	O	5424
tumour	B-Disease	5424
growth	O	5424
and	O	5424
increased	O	5424
survival	O	5424
.	O	5424
clustering	O	5425
of	O	5425
missense	O	5425
mutations	O	5425
in	O	5425
the	O	5425
ataxia	B-Disease	5425
-	I-Disease	5425
telangiectasia	I-Disease	5425
gene	O	5425
in	O	5425
a	O	5425
sporadic	B-Disease	5425
t	I-Disease	5425
-	I-Disease	5425
cell	I-Disease	5425
leukaemia	I-Disease	5425
.	O	5425
ataxia	B-Disease	5426
-	I-Disease	5426
telangiectasia	I-Disease	5426
(	O	5426
a	B-Disease	5426
-	I-Disease	5426
t	I-Disease	5426
)	O	5426
is	O	5426
a	O	5426
recessive	B-Disease	5426
multi	I-Disease	5426
-	I-Disease	5426
system	I-Disease	5426
disorder	I-Disease	5426
caused	O	5426
by	O	5426
mutations	O	5426
in	O	5426
the	O	5426
atm	O	5426
gene	O	5426
at	O	5426
11q22	O	5426
-	O	5426
q23	O	5426
(	O	5426
ref	O	5426
.	O	5426
3	O	5426
)	O	5426
.	O	5426
the	O	5427
risk	O	5427
of	O	5427
cancer	B-Disease	5427
,	O	5427
especially	O	5427
lymphoid	B-Disease	5427
neoplasias	I-Disease	5427
,	O	5427
is	O	5427
substantially	O	5427
elevated	O	5427
in	O	5427
a	B-Disease	5427
-	I-Disease	5427
t	I-Disease	5427
patients	O	5427
and	O	5427
has	O	5427
long	O	5427
been	O	5427
associated	O	5427
with	O	5427
chromosomal	O	5427
instability	O	5427
.	O	5427
by	O	5428
analysing	O	5428
tumour	B-Disease	5428
dna	O	5428
from	O	5428
patients	O	5428
with	O	5428
sporadic	B-Disease	5428
t	I-Disease	5428
-	I-Disease	5428
cell	I-Disease	5428
prolymphocytic	I-Disease	5428
leukaemia	I-Disease	5428
(	O	5428
t	B-Disease	5428
-	I-Disease	5428
pll	I-Disease	5428
)	O	5428
,	O	5428
a	O	5428
rare	O	5428
clonal	B-Disease	5428
malignancy	I-Disease	5428
with	O	5428
similarities	O	5428
to	O	5428
a	O	5428
mature	B-Disease	5428
t	I-Disease	5428
-	I-Disease	5428
cell	I-Disease	5428
leukaemia	I-Disease	5428
seen	O	5428
in	O	5428
a	B-Disease	5428
-	I-Disease	5428
t	I-Disease	5428
,	O	5428
we	O	5428
demonstrate	O	5428
a	O	5428
high	O	5428
frequency	O	5428
of	O	5428
atm	O	5428
mutations	O	5428
in	O	5428
t	B-Disease	5428
-	I-Disease	5428
pll	I-Disease	5428
.	O	5428
in	O	5429
marked	O	5429
contrast	O	5429
to	O	5429
the	O	5429
atm	O	5429
mutation	O	5429
pattern	O	5429
in	O	5429
a	B-Disease	5429
-	I-Disease	5429
t	I-Disease	5429
,	O	5429
the	O	5429
most	O	5429
frequent	O	5429
nucleotide	O	5429
changes	O	5429
in	O	5429
this	O	5429
leukaemia	B-Disease	5429
were	O	5429
missense	O	5429
mutations	O	5429
.	O	5429
two	O	5432
of	O	5432
seventeen	O	5432
mutated	O	5432
t	B-Disease	5432
-	I-Disease	5432
pll	I-Disease	5432
samples	O	5432
had	O	5432
a	O	5432
previously	O	5432
reported	O	5432
a	B-Disease	5432
-	I-Disease	5432
t	I-Disease	5432
allele	O	5432
.	O	5432
in	O	5433
contrast	O	5433
,	O	5433
no	O	5433
mutations	O	5433
were	O	5433
detected	O	5433
in	O	5433
the	O	5433
p53	O	5433
gene	O	5433
,	O	5433
suggesting	O	5433
that	O	5433
this	O	5433
tumour	B-Disease	5433
suppressor	O	5433
is	O	5433
not	O	5433
frequently	O	5433
altered	O	5433
in	O	5433
this	O	5433
leukaemia	B-Disease	5433
.	O	5433
occasional	O	5434
missense	O	5434
mutations	O	5434
in	O	5434
atm	O	5434
were	O	5434
also	O	5434
found	O	5434
in	O	5434
tumour	B-Disease	5434
dna	O	5434
from	O	5434
patients	O	5434
with	O	5434
b	B-Disease	5434
-	I-Disease	5434
cell	I-Disease	5434
non	I-Disease	5434
-	I-Disease	5434
hodgkins	I-Disease	5434
lymphomas	I-Disease	5434
(	O	5434
b	B-Disease	5434
-	I-Disease	5434
nhl	I-Disease	5434
)	O	5434
and	O	5434
a	O	5434
b	B-Disease	5434
-	I-Disease	5434
nhl	I-Disease	5434
cell	O	5434
line	O	5434
.	O	5434
the	O	5435
evidence	O	5435
of	O	5435
a	O	5435
significant	O	5435
proportion	O	5435
of	O	5435
loss	O	5435
-	O	5435
of	O	5435
-	O	5435
function	O	5435
mutations	O	5435
and	O	5435
a	O	5435
complete	O	5435
absence	O	5435
of	O	5435
the	O	5435
normal	O	5435
copy	O	5435
of	O	5435
atm	O	5435
in	O	5435
the	O	5435
majority	O	5435
of	O	5435
mutated	O	5435
tumours	B-Disease	5435
establishes	O	5435
somatic	O	5435
inactivation	O	5435
of	O	5435
this	O	5435
gene	O	5435
in	O	5435
the	O	5435
pathogenesis	O	5435
of	O	5435
sporadic	B-Disease	5435
t	I-Disease	5435
-	I-Disease	5435
pll	I-Disease	5435
and	O	5435
suggests	O	5435
that	O	5435
atm	O	5435
acts	O	5435
as	O	5435
a	O	5435
tumour	B-Disease	5435
suppressor	O	5435
.	O	5435
as	O	5436
constitutional	O	5436
dna	O	5436
was	O	5436
not	O	5436
available	O	5436
,	O	5436
a	O	5436
putative	O	5436
hereditary	O	5436
predisposition	O	5436
to	O	5436
t	B-Disease	5436
-	I-Disease	5436
pll	I-Disease	5436
will	O	5436
require	O	5436
further	O	5436
investigation	O	5436
.	O	5436
.	O	5436
myotonic	B-Disease	5437
dystrophy	I-Disease	5437
protein	O	5437
kinase	O	5437
is	O	5437
involved	O	5437
in	O	5437
the	O	5437
modulation	O	5437
of	O	5437
the	O	5437
ca2	O	5437
+	O	5437
homeostasis	O	5437
in	O	5437
skeletal	O	5437
muscle	O	5437
cells	O	5437
.	O	5437
myotonic	B-Disease	5438
dystrophy	I-Disease	5438
(	O	5438
dm	B-Disease	5438
)	O	5438
,	O	5438
the	O	5438
most	O	5438
prevalent	O	5438
muscular	B-Disease	5438
disorder	I-Disease	5438
in	O	5438
adults	O	5438
,	O	5438
is	O	5438
caused	O	5438
by	O	5438
(	O	5438
ctg	O	5438
)	O	5438
n	O	5438
-	O	5438
repeat	O	5438
expansion	O	5438
in	O	5438
a	O	5438
gene	O	5438
encoding	O	5438
a	O	5438
protein	O	5438
kinase	O	5438
(	O	5438
dm	B-Disease	5438
protein	O	5438
kinase	O	5438
;	O	5438
dmpk	O	5438
)	O	5438
and	O	5438
involves	O	5438
changes	O	5438
in	O	5438
cytoarchitecture	O	5438
and	O	5438
ion	O	5438
homeostasis	O	5438
.	O	5438
constitutional	O	5445
rb1	O	5445
-	O	5445
gene	O	5445
mutations	O	5445
in	O	5445
patients	O	5445
with	O	5445
isolated	O	5445
unilateral	B-Disease	5445
retinoblastoma	I-Disease	5445
.	O	5445
in	O	5446
most	O	5446
patients	O	5446
with	O	5446
isolated	O	5446
unilateral	B-Disease	5446
retinoblastoma	I-Disease	5446
,	O	5446
tumor	B-Disease	5446
development	O	5446
is	O	5446
initiated	O	5446
by	O	5446
somatic	O	5446
inactivation	O	5446
of	O	5446
both	O	5446
alleles	O	5446
of	O	5446
the	O	5446
rb1	O	5446
gene	O	5446
.	O	5446
however	O	5447
,	O	5447
some	O	5447
of	O	5447
these	O	5447
patients	O	5447
can	O	5447
transmit	O	5447
retinoblastoma	B-Disease	5447
predisposition	O	5447
to	O	5447
their	O	5447
offspring	O	5447
.	O	5447
to	O	5448
determine	O	5448
the	O	5448
frequency	O	5448
and	O	5448
nature	O	5448
of	O	5448
constitutional	O	5448
rb1	O	5448
-	O	5448
gene	O	5448
mutations	O	5448
in	O	5448
patients	O	5448
with	O	5448
isolated	O	5448
unilateral	B-Disease	5448
retinoblastoma	I-Disease	5448
,	O	5448
we	O	5448
analyzed	O	5448
dna	O	5448
from	O	5448
peripheral	O	5448
blood	O	5448
and	O	5448
from	O	5448
tumor	B-Disease	5448
tissue	O	5448
.	O	5448
the	O	5449
analysis	O	5449
of	O	5449
tumors	B-Disease	5449
from	O	5449
54	O	5449
(	O	5449
71	O	5449
%	O	5449
)	O	5449
of	O	5449
76	O	5449
informative	O	5449
patients	O	5449
showed	O	5449
loss	O	5449
of	O	5449
constitutional	O	5449
heterozygosity	O	5449
(	O	5449
loh	O	5449
)	O	5449
at	O	5449
intragenic	O	5449
loci	O	5449
.	O	5449
for	O	5451
39	O	5451
randomly	O	5451
selected	O	5451
tumors	B-Disease	5451
,	O	5451
sscp	O	5451
,	O	5451
hetero	O	5451
-	O	5451
duplex	O	5451
analysis	O	5451
,	O	5451
sequencing	O	5451
,	O	5451
and	O	5451
southern	O	5451
blot	O	5451
analysis	O	5451
were	O	5451
used	O	5451
to	O	5451
identify	O	5451
mutations	O	5451
.	O	5451
mutations	O	5452
were	O	5452
detected	O	5452
in	O	5452
21	O	5452
(	O	5452
91	O	5452
%	O	5452
)	O	5452
of	O	5452
23	O	5452
tumors	B-Disease	5452
with	O	5452
loh	O	5452
.	O	5452
in	O	5453
6	O	5453
(	O	5453
38	O	5453
%	O	5453
)	O	5453
of	O	5453
16	O	5453
tumors	B-Disease	5453
without	O	5453
loh	O	5453
,	O	5453
one	O	5453
mutation	O	5453
was	O	5453
detected	O	5453
,	O	5453
and	O	5453
in	O	5453
9	O	5453
(	O	5453
56	O	5453
%	O	5453
)	O	5453
of	O	5453
the	O	5453
tumors	B-Disease	5453
without	O	5453
loh	O	5453
,	O	5453
both	O	5453
mutations	O	5453
were	O	5453
found	O	5453
.	O	5453
thus	O	5454
,	O	5454
a	O	5454
total	O	5454
of	O	5454
45	O	5454
mutations	O	5454
were	O	5454
identified	O	5454
in	O	5454
tumors	B-Disease	5454
of	O	5454
36	O	5454
patients	O	5454
.	O	5454
in	O	5459
2	O	5459
patients	O	5459
without	O	5459
a	O	5459
detectable	O	5459
mutation	O	5459
in	O	5459
peripheral	O	5459
blood	O	5459
,	O	5459
mosaicism	O	5459
was	O	5459
suggested	O	5459
because	O	5459
1	O	5459
of	O	5459
the	O	5459
patients	O	5459
showed	O	5459
multifocal	O	5459
tumors	B-Disease	5459
and	O	5459
the	O	5459
other	O	5459
later	O	5459
developed	O	5459
bilateral	B-Disease	5459
retinoblastoma	I-Disease	5459
.	O	5459
in	O	5460
conclusion	O	5460
,	O	5460
our	O	5460
results	O	5460
emphasize	O	5460
that	O	5460
the	O	5460
manifestation	O	5460
and	O	5460
transmissibility	O	5460
of	O	5460
retinoblastoma	B-Disease	5460
depend	O	5460
on	O	5460
the	O	5460
nature	O	5460
of	O	5460
the	O	5460
first	O	5460
mutation	O	5460
,	O	5460
its	O	5460
time	O	5460
in	O	5460
development	O	5460
,	O	5460
and	O	5460
the	O	5460
number	O	5460
and	O	5460
types	O	5460
of	O	5460
cells	O	5460
that	O	5460
are	O	5460
affected	O	5460
.	O	5460
.	O	5460
hereditary	B-Disease	5461
deficiency	I-Disease	5461
of	I-Disease	5461
the	I-Disease	5461
fifth	I-Disease	5461
component	I-Disease	5461
of	I-Disease	5461
complement	I-Disease	5461
in	O	5461
man	O	5461
.	O	5461
the	O	5464
first	O	5464
recognized	O	5464
human	O	5464
kindred	O	5464
with	O	5464
hereditary	B-Disease	5464
deficiency	I-Disease	5464
of	I-Disease	5464
the	I-Disease	5464
fifth	I-Disease	5464
component	I-Disease	5464
of	I-Disease	5464
complement	I-Disease	5464
(	O	5464
c5	O	5464
)	O	5464
is	O	5464
described	O	5464
.	O	5464
the	O	5465
proband	O	5465
,	O	5465
a	O	5465
20	O	5465
-	O	5465
year	O	5465
-	O	5465
old	O	5465
black	O	5465
female	O	5465
with	O	5465
systemic	B-Disease	5465
lupus	I-Disease	5465
erythematosus	I-Disease	5465
since	O	5465
age	O	5465
11	O	5465
,	O	5465
lacked	O	5465
serum	O	5465
hemolytic	O	5465
complement	O	5465
activity	O	5465
,	O	5465
even	O	5465
during	O	5465
remission	O	5465
.	O	5465
c5	O	5470
levels	O	5470
of	O	5470
other	O	5470
family	O	5470
members	O	5470
were	O	5470
either	O	5470
normal	O	5470
or	O	5470
approximately	O	5470
half	O	5470
-	O	5470
normal	O	5470
,	O	5470
consistent	O	5470
with	O	5470
autosomal	O	5470
codominant	O	5470
inheritance	O	5470
of	O	5470
the	O	5470
gene	O	5470
determining	O	5470
c5	B-Disease	5470
deficiency	I-Disease	5470
.	O	5470
normal	O	5471
hemolytic	O	5471
titers	O	5471
were	O	5471
restored	O	5471
to	O	5471
both	O	5471
homozygous	O	5471
c5	B-Disease	5471
-	I-Disease	5471
deficient	I-Disease	5471
(	O	5471
c5d	B-Disease	5471
)	O	5471
sera	O	5471
by	O	5471
addition	O	5471
of	O	5471
highly	O	5471
purified	O	5471
human	O	5471
c5	O	5471
.	O	5471
in	O	5472
specific	O	5472
c5	O	5472
titrations	O	5472
,	O	5472
however	O	5472
,	O	5472
it	O	5472
was	O	5472
noted	O	5472
that	O	5472
when	O	5472
limited	O	5472
amounts	O	5472
of	O	5472
c5	O	5472
were	O	5472
assayed	O	5472
in	O	5472
the	O	5472
presence	O	5472
of	O	5472
low	O	5472
dilutions	O	5472
of	O	5472
either	O	5472
c5d	B-Disease	5472
serum	O	5472
,	O	5472
curving	O	5472
rather	O	5472
than	O	5472
linear	O	5472
dose	O	5472
-	O	5472
response	O	5472
plots	O	5472
were	O	5472
consistently	O	5472
obtained	O	5472
,	O	5472
suggesting	O	5472
some	O	5472
inhibitory	O	5472
effect	O	5472
.	O	5472
further	O	5473
studies	O	5473
suggested	O	5473
that	O	5473
low	O	5473
dilutions	O	5473
of	O	5473
c5d	B-Disease	5473
serum	O	5473
contain	O	5473
a	O	5473
factor	O	5473
(	O	5473
or	O	5473
factors	O	5473
)	O	5473
interfering	O	5473
at	O	5473
some	O	5473
step	O	5473
in	O	5473
the	O	5473
hemolytic	O	5473
assay	O	5473
of	O	5473
c5	O	5473
,	O	5473
rather	O	5473
than	O	5473
a	O	5473
true	O	5473
c5	O	5473
inhibitor	O	5473
or	O	5473
inactivator	O	5473
.	O	5473
of	O	5474
clinical	O	5474
interest	O	5474
are	O	5474
(	O	5474
a	O	5474
)	O	5474
the	O	5474
documentation	O	5474
of	O	5474
membranous	O	5474
glomerulonephritis	B-Disease	5474
,	O	5474
vasculitis	B-Disease	5474
,	O	5474
and	O	5474
arthritis	B-Disease	5474
in	O	5474
an	O	5474
individual	O	5474
lacking	O	5474
c5	O	5474
(	O	5474
and	O	5474
its	O	5474
biologic	O	5474
functions	O	5474
)	O	5474
,	O	5474
and	O	5474
(	O	5474
b	O	5474
)	O	5474
a	O	5474
remarkable	O	5474
propensity	O	5474
to	O	5474
bacterial	B-Disease	5474
infections	I-Disease	5474
in	O	5474
the	O	5474
proband	O	5474
,	O	5474
even	O	5474
during	O	5474
periods	O	5474
of	O	5474
low	O	5474
-	O	5474
dose	O	5474
or	O	5474
alternate	O	5474
-	O	5474
day	O	5474
corticosteroid	O	5474
therapy	O	5474
.	O	5474
other	O	5475
observations	O	5475
indicate	O	5475
that	O	5475
the	O	5475
c5d	B-Disease	5475
state	O	5475
is	O	5475
compatible	O	5475
with	O	5475
normal	O	5475
coagulation	O	5475
function	O	5475
and	O	5475
the	O	5475
capacity	O	5475
to	O	5475
mount	O	5475
a	O	5475
neutrophilic	O	5475
leukocytosis	O	5475
during	O	5475
pyogenic	B-Disease	5475
infection	I-Disease	5475
.	O	5475
.	O	5475
susceptibility	O	5476
to	O	5476
ankylosing	B-Disease	5476
spondylitis	I-Disease	5476
in	O	5476
twins	O	5476
:	O	5476
the	O	5476
role	O	5476
of	O	5476
genes	O	5476
,	O	5476
hla	O	5476
,	O	5476
and	O	5476
the	O	5476
environment	O	5476
.	O	5476
objective	O	5477
to	O	5477
determine	O	5477
the	O	5477
relative	O	5477
effects	O	5477
of	O	5477
genetic	O	5477
and	O	5477
environmental	O	5477
factors	O	5477
in	O	5477
susceptibility	O	5477
to	O	5477
ankylosing	B-Disease	5477
spondylitis	I-Disease	5477
(	O	5477
as	B-Disease	5477
)	O	5477
.	O	5477
methods	O	5478
twins	O	5478
with	O	5478
as	B-Disease	5478
were	O	5478
identified	O	5478
from	O	5478
the	O	5478
royal	O	5478
national	O	5478
hospital	O	5478
for	O	5478
rheumatic	B-Disease	5478
diseases	I-Disease	5478
database	O	5478
.	O	5478
genetic	O	5481
and	O	5481
environmental	O	5481
variance	O	5481
components	O	5481
were	O	5481
assessed	O	5481
with	O	5481
the	O	5481
program	O	5481
mx	O	5481
,	O	5481
using	O	5481
data	O	5481
from	O	5481
this	O	5481
and	O	5481
previous	O	5481
studies	O	5481
of	O	5481
twins	O	5481
with	O	5481
as	B-Disease	5481
.	O	5481
conclusion	O	5486
susceptibility	O	5486
to	O	5486
as	B-Disease	5486
is	O	5486
largely	O	5486
genetically	O	5486
determined	O	5486
,	O	5486
and	O	5486
the	O	5486
environmental	O	5486
trigger	O	5486
for	O	5486
the	O	5486
disease	O	5486
is	O	5486
probably	O	5486
ubiquitous	O	5486
.	O	5486
hla	O	5487
-	O	5487
b27	O	5487
accounts	O	5487
for	O	5487
a	O	5487
minority	O	5487
of	O	5487
the	O	5487
overall	O	5487
genetic	O	5487
susceptibility	O	5487
to	O	5487
as	B-Disease	5487
.	O	5487
germ	O	5489
-	O	5489
line	O	5489
mutations	O	5489
of	O	5489
the	O	5489
brca1	O	5489
gene	O	5489
predispose	O	5489
women	O	5489
to	O	5489
early	O	5489
-	O	5489
onset	O	5489
breast	B-Disease	5489
and	I-Disease	5489
ovarian	I-Disease	5489
cancer	I-Disease	5489
by	O	5489
compromising	O	5489
the	O	5489
genes	O	5489
presumptive	O	5489
function	O	5489
as	O	5489
a	O	5489
tumor	B-Disease	5489
suppressor	O	5489
.	O	5489
this	O	5498
cell	O	5498
cycle	O	5498
-	O	5498
dependent	O	5498
colocalization	O	5498
of	O	5498
bard1	O	5498
and	O	5498
brca1	O	5498
indicates	O	5498
a	O	5498
role	O	5498
for	O	5498
bard1	O	5498
in	O	5498
brca1	O	5498
-	O	5498
mediated	O	5498
tumor	B-Disease	5498
suppression	O	5498
.	O	5498
recent	O	5500
studies	O	5500
have	O	5500
shown	O	5500
that	O	5500
hereditary	B-Disease	5500
hemochromatosis	I-Disease	5500
(	O	5500
hh	B-Disease	5500
)	O	5500
is	O	5500
likely	O	5500
to	O	5500
be	O	5500
caused	O	5500
by	O	5500
homozygosity	O	5500
for	O	5500
a	O	5500
cys282tyr	O	5500
mutation	O	5500
in	O	5500
the	O	5500
hfe	O	5500
gene	O	5500
located	O	5500
4	O	5500
.	O	5500
comparisons	O	5507
with	O	5507
allele	O	5507
frequencies	O	5507
based	O	5507
on	O	5507
prevalence	O	5507
estimates	O	5507
of	O	5507
hh	B-Disease	5507
showed	O	5507
some	O	5507
disagreements	O	5507
with	O	5507
the	O	5507
rflp	O	5507
data	O	5507
,	O	5507
particularly	O	5507
in	O	5507
finns	O	5507
.	O	5507
the	O	5508
newly	O	5508
described	O	5508
hfe	O	5508
marker	O	5508
provides	O	5508
a	O	5508
new	O	5508
approach	O	5508
to	O	5508
the	O	5508
screening	O	5508
of	O	5508
hh	B-Disease	5508
as	O	5508
well	O	5508
as	O	5508
studies	O	5508
of	O	5508
the	O	5508
relationship	O	5508
between	O	5508
the	O	5508
hfe	O	5508
tyr	O	5508
allele	O	5508
and	O	5508
different	O	5508
disorders	O	5508
including	O	5508
cancer	B-Disease	5508
autosomal	B-Disease	5509
dominant	I-Disease	5509
neurohypophyseal	I-Disease	5509
diabetes	I-Disease	5509
insipidus	I-Disease	5509
associated	O	5509
with	O	5509
a	O	5509
missense	O	5509
mutation	O	5509
encoding	O	5509
gly23	O	5509
-	O	5509
-	O	5509
>	O	5509
val	O	5509
in	O	5509
neurophysin	O	5509
ii	O	5509
.	O	5509
autosomal	B-Disease	5510
dominant	I-Disease	5510
neurohypophyseal	I-Disease	5510
diabetes	I-Disease	5510
insipidus	I-Disease	5510
(	O	5510
adndi	B-Disease	5510
)	O	5510
is	O	5510
an	O	5510
inherited	B-Disease	5510
disease	I-Disease	5510
caused	O	5510
by	O	5510
progressive	O	5510
degeneration	O	5510
of	O	5510
the	O	5510
magnocellular	O	5510
neurons	O	5510
of	O	5510
the	O	5510
hypothalamus	O	5510
leading	O	5510
to	O	5510
decreased	O	5510
ability	O	5510
to	O	5510
produce	O	5510
the	O	5510
hormone	O	5510
arginine	O	5510
vasopressin	O	5510
(	O	5510
avp	O	5510
)	O	5510
.	O	5510
affected	O	5511
individuals	O	5511
are	O	5511
not	O	5511
symptomatic	O	5511
at	O	5511
birth	O	5511
,	O	5511
but	O	5511
usually	O	5511
develop	O	5511
diabetes	B-Disease	5511
insipidus	I-Disease	5511
at	O	5511
1	O	5511
-	O	5511
6	O	5511
yr	O	5511
of	O	5511
age	O	5511
.	O	5511
the	O	5512
genetic	O	5512
locus	O	5512
of	O	5512
the	O	5512
disease	O	5512
is	O	5512
the	O	5512
avp	O	5512
-	O	5512
neurophysin	O	5512
ii	O	5512
(	O	5512
npii	O	5512
)	O	5512
gene	O	5512
,	O	5512
and	O	5512
mutations	O	5512
that	O	5512
cause	O	5512
adndi	B-Disease	5512
have	O	5512
been	O	5512
found	O	5512
in	O	5512
both	O	5512
the	O	5512
signal	O	5512
peptide	O	5512
of	O	5512
the	O	5512
prepro	O	5512
-	O	5512
avp	O	5512
-	O	5512
npii	O	5512
precursor	O	5512
and	O	5512
within	O	5512
npii	O	5512
itself	O	5512
.	O	5512
this	O	5516
mutation	O	5516
may	O	5516
be	O	5516
valuable	O	5516
for	O	5516
developing	O	5516
models	O	5516
of	O	5516
dominantly	B-Disease	5516
inherited	I-Disease	5516
neurodegeneration	I-Disease	5516
,	O	5516
as	O	5516
the	O	5516
early	O	5516
age	O	5516
of	O	5516
onset	O	5516
of	O	5516
symptoms	O	5516
suggests	O	5516
that	O	5516
this	O	5516
mutation	O	5516
may	O	5516
be	O	5516
particularly	O	5516
deleterious	O	5516
to	O	5516
the	O	5516
magnocellular	O	5516
neuron	O	5516
.	O	5516
.	O	5516
frequent	O	5517
inactivation	O	5517
of	O	5517
pten	O	5517
/	O	5517
mmac1	O	5517
in	O	5517
primary	O	5517
prostate	B-Disease	5517
cancer	I-Disease	5517
.	O	5517
sporadic	B-Disease	5518
prostate	I-Disease	5518
carcinoma	I-Disease	5518
is	O	5518
the	O	5518
most	O	5518
common	O	5518
male	B-Disease	5518
cancer	I-Disease	5518
in	O	5518
the	O	5518
western	O	5518
world	O	5518
,	O	5518
yet	O	5518
many	O	5518
of	O	5518
the	O	5518
major	O	5518
genetic	O	5518
events	O	5518
involved	O	5518
in	O	5518
the	O	5518
progression	O	5518
of	O	5518
this	O	5518
often	O	5518
fatal	O	5518
cancer	B-Disease	5518
remain	O	5518
to	O	5518
be	O	5518
elucidated	O	5518
.	O	5518
numerous	O	5519
cytogenetic	O	5519
and	O	5519
allelotype	O	5519
studies	O	5519
have	O	5519
reported	O	5519
frequent	O	5519
loss	O	5519
of	O	5519
heterozygosity	O	5519
on	O	5519
chromosomal	O	5519
arm	O	5519
10q	O	5519
in	O	5519
sporadic	B-Disease	5519
prostate	I-Disease	5519
cancer	I-Disease	5519
.	O	5519
a	O	5521
new	O	5521
tumor	B-Disease	5521
suppressor	O	5521
gene	O	5521
,	O	5521
pten	O	5521
/	O	5521
mmac1	O	5521
,	O	5521
was	O	5521
isolated	O	5521
recently	O	5521
at	O	5521
this	O	5521
region	O	5521
of	O	5521
chromosome	O	5521
10q23	O	5521
and	O	5521
found	O	5521
to	O	5521
be	O	5521
inactivated	O	5521
by	O	5521
mutation	O	5521
in	O	5521
three	O	5521
prostate	B-Disease	5521
cancer	I-Disease	5521
cell	O	5521
lines	O	5521
.	O	5521
we	O	5522
screened	O	5522
80	O	5522
prostate	B-Disease	5522
tumors	I-Disease	5522
by	O	5522
microsatellite	O	5522
analysis	O	5522
and	O	5522
found	O	5522
chromosome	O	5522
10q23	O	5522
to	O	5522
be	O	5522
deleted	O	5522
in	O	5522
23	O	5522
cases	O	5522
.	O	5522
the	O	5524
identification	O	5524
of	O	5524
the	O	5524
second	O	5524
mutational	O	5524
event	O	5524
in	O	5524
10	O	5524
(	O	5524
43	O	5524
%	O	5524
)	O	5524
tumors	B-Disease	5524
establishes	O	5524
pten	O	5524
/	O	5524
mmac1	O	5524
as	O	5524
a	O	5524
main	O	5524
inactivation	O	5524
target	O	5524
of	O	5524
10q	O	5524
loss	O	5524
in	O	5524
sporadic	B-Disease	5524
prostate	I-Disease	5524
cancer	I-Disease	5524
.	O	5524
.	O	5524
risk	O	5525
reversals	O	5525
in	O	5525
predictive	O	5525
testing	O	5525
for	O	5525
huntington	B-Disease	5525
disease	I-Disease	5525
.	O	5525
the	O	5526
first	O	5526
predictive	O	5526
testing	O	5526
for	O	5526
huntington	B-Disease	5526
disease	I-Disease	5526
(	O	5526
hd	B-Disease	5526
)	O	5526
was	O	5526
based	O	5526
on	O	5526
analysis	O	5526
of	O	5526
linked	O	5526
polymorphic	O	5526
dna	O	5526
markers	O	5526
to	O	5526
estimate	O	5526
the	O	5526
likelihood	O	5526
of	O	5526
inheriting	O	5526
the	O	5526
mutation	O	5526
for	O	5526
hd	B-Disease	5526
.	O	5526
with	O	5528
direct	O	5528
tests	O	5528
for	O	5528
the	O	5528
hd	B-Disease	5528
mutation	O	5528
,	O	5528
we	O	5528
have	O	5528
assessed	O	5528
the	O	5528
accuracy	O	5528
of	O	5528
results	O	5528
obtained	O	5528
by	O	5528
linkage	O	5528
approaches	O	5528
when	O	5528
requested	O	5528
to	O	5528
do	O	5528
so	O	5528
by	O	5528
the	O	5528
test	O	5528
individuals	O	5528
.	O	5528
a	O	5532
novel	O	5532
common	O	5532
missense	O	5532
mutation	O	5532
g301c	O	5532
in	O	5532
the	O	5532
n	O	5532
-	O	5532
acetylgalactosamine	O	5532
-	O	5532
6	O	5532
-	O	5532
sulfate	O	5532
sulfatase	O	5532
gene	O	5532
in	O	5532
mucopolysaccharidosis	B-Disease	5532
iva	I-Disease	5532
.	O	5532
mucopolysaccharidosis	B-Disease	5533
iva	I-Disease	5533
(	O	5533
mps	B-Disease	5533
iva	I-Disease	5533
)	O	5533
is	O	5533
an	O	5533
autosomal	B-Disease	5533
recessive	I-Disease	5533
lysosomal	I-Disease	5533
storage	I-Disease	5533
disorder	I-Disease	5533
caused	O	5533
by	O	5533
a	O	5533
genetic	B-Disease	5533
defect	I-Disease	5533
in	O	5533
n	O	5533
-	O	5533
acetylgalactosamine	O	5533
-	O	5533
6	O	5533
-	O	5533
sulfate	O	5533
sulfatase	O	5533
(	O	5533
galns	O	5533
)	O	5533
.	O	5533
to	O	5535
characterize	O	5535
the	O	5535
mutational	O	5535
spectrum	O	5535
in	O	5535
various	O	5535
ethnic	O	5535
groups	O	5535
,	O	5535
mutations	O	5535
in	O	5535
the	O	5535
galns	O	5535
gene	O	5535
in	O	5535
colombian	O	5535
mps	B-Disease	5535
iva	I-Disease	5535
patients	O	5535
were	O	5535
investigated	O	5535
,	O	5535
and	O	5535
genetic	O	5535
backgrounds	O	5535
were	O	5535
extensively	O	5535
analyzed	O	5535
to	O	5535
identify	O	5535
racial	O	5535
origin	O	5535
,	O	5535
based	O	5535
on	O	5535
mitochondrial	O	5535
dna	O	5535
(	O	5535
mtdna	O	5535
)	O	5535
lineages	O	5535
.	O	5535
three	O	5536
novel	O	5536
missense	O	5536
mutations	O	5536
never	O	5536
identified	O	5536
previously	O	5536
in	O	5536
other	O	5536
populations	O	5536
and	O	5536
found	O	5536
in	O	5536
16	O	5536
out	O	5536
of	O	5536
19	O	5536
colombian	O	5536
mps	B-Disease	5536
iva	I-Disease	5536
unrelated	O	5536
alleles	O	5536
account	O	5536
for	O	5536
84	O	5536
.	O	5536
low	O	5543
frequency	O	5543
of	O	5543
brca1	O	5543
germline	O	5543
mutations	O	5543
in	O	5543
45	O	5543
german	O	5543
breast	B-Disease	5543
/	I-Disease	5543
ovarian	I-Disease	5543
cancer	I-Disease	5543
families	O	5543
.	O	5543
in	O	5544
this	O	5544
study	O	5544
we	O	5544
investigated	O	5544
45	O	5544
german	O	5544
breast	B-Disease	5544
/	I-Disease	5544
ovarian	I-Disease	5544
cancer	I-Disease	5544
families	O	5544
for	O	5544
germline	O	5544
mutations	O	5544
in	O	5544
the	O	5544
brca1	O	5544
gene	O	5544
.	O	5544
we	O	5545
identified	O	5545
four	O	5545
germline	O	5545
mutations	O	5545
in	O	5545
three	O	5545
breast	B-Disease	5545
cancer	I-Disease	5545
families	O	5545
and	O	5545
in	O	5545
one	O	5545
breast	B-Disease	5545
-	I-Disease	5545
ovarian	I-Disease	5545
cancer	I-Disease	5545
family	O	5545
.	O	5545
among	O	5545
these	O	5545
were	O	5545
one	O	5545
frameshift	O	5545
mutation	O	5545
,	O	5545
one	O	5545
nonsense	O	5545
mutation	O	5545
,	O	5545
one	O	5545
novel	O	5545
splice	O	5545
site	O	5545
mutation	O	5545
,	O	5545
and	O	5545
one	O	5545
missense	O	5545
mutation	O	5545
.	O	5545
these	O	5552
findings	O	5552
show	O	5552
that	O	5552
brca1	O	5552
is	O	5552
implicated	O	5552
in	O	5552
a	O	5552
small	O	5552
fraction	O	5552
of	O	5552
breast	B-Disease	5552
/	I-Disease	5552
ovarian	I-Disease	5552
cancer	I-Disease	5552
families	O	5552
suggesting	O	5552
the	O	5552
involvement	O	5552
of	O	5552
another	O	5552
susceptibility	O	5552
gene	O	5552
(	O	5552
s	O	5552
)	O	5552
paternal	O	5553
transmission	O	5553
of	O	5553
congenital	B-Disease	5553
myotonic	I-Disease	5553
dystrophy	I-Disease	5553
.	O	5553
we	O	5554
report	O	5554
a	O	5554
rare	O	5554
case	O	5554
of	O	5554
paternally	O	5554
transmitted	O	5554
congenital	B-Disease	5554
myotonic	I-Disease	5554
dystrophy	I-Disease	5554
(	O	5554
dm	B-Disease	5554
)	O	5554
.	O	5554
the	O	5555
proband	O	5555
is	O	5555
a	O	5555
23	O	5555
year	O	5555
old	O	5555
,	O	5555
mentally	B-Disease	5555
retarded	I-Disease	5555
male	O	5555
who	O	5555
suffers	O	5555
severe	O	5555
muscular	B-Disease	5555
weakness	I-Disease	5555
.	O	5555
his	O	5557
two	O	5557
sibs	O	5557
suffer	O	5557
from	O	5557
childhood	O	5557
onset	O	5557
dm	B-Disease	5557
.	O	5557
their	O	5558
late	O	5558
father	O	5558
had	O	5558
the	O	5558
adult	O	5558
type	O	5558
of	O	5558
dm	B-Disease	5558
,	O	5558
with	O	5558
onset	O	5558
around	O	5558
30	O	5558
years	O	5558
.	O	5558
only	O	5559
six	O	5559
other	O	5559
cases	O	5559
of	O	5559
paternal	O	5559
transmission	O	5559
of	O	5559
congenital	B-Disease	5559
dm	I-Disease	5559
have	O	5559
been	O	5559
reported	O	5559
recently	O	5559
.	O	5559
we	O	5560
review	O	5560
the	O	5560
sex	O	5560
related	O	5560
effects	O	5560
on	O	5560
transmission	O	5560
of	O	5560
congenital	B-Disease	5560
dm	I-Disease	5560
.	O	5560
decreased	O	5561
fertility	O	5561
of	O	5561
males	O	5561
with	O	5561
adult	O	5561
onset	O	5561
dm	B-Disease	5561
and	O	5561
contraction	O	5561
of	O	5561
the	O	5561
repeat	O	5561
upon	O	5561
male	O	5561
transmission	O	5561
contribute	O	5561
to	O	5561
the	O	5561
almost	O	5561
absent	O	5561
occurrence	O	5561
of	O	5561
paternal	O	5561
transmission	O	5561
of	O	5561
congenital	B-Disease	5561
dm	I-Disease	5561
.	O	5561
also	O	5562
the	O	5562
fathers	O	5562
of	O	5562
the	O	5562
reported	O	5562
congenitally	O	5562
affected	O	5562
children	O	5562
showed	O	5562
,	O	5562
on	O	5562
average	O	5562
,	O	5562
shorter	O	5562
ctg	O	5562
repeat	O	5562
lengths	O	5562
and	O	5562
hence	O	5562
less	O	5562
severe	O	5562
clinical	O	5562
symptoms	O	5562
than	O	5562
the	O	5562
mothers	O	5562
of	O	5562
children	O	5562
with	O	5562
congenital	B-Disease	5562
dm	I-Disease	5562
.	O	5562
we	O	5563
conclude	O	5563
that	O	5563
paternal	O	5563
transmission	O	5563
of	O	5563
congenital	B-Disease	5563
dm	I-Disease	5563
is	O	5563
rare	O	5563
and	O	5563
preferentially	O	5563
occurs	O	5563
with	O	5563
onset	O	5563
of	O	5563
dm	B-Disease	5563
past	O	5563
30	O	5563
years	O	5563
in	O	5563
the	O	5563
father	O	5563
.	O	5563
.	O	5563
the	O	5564
rb1	O	5564
gene	O	5564
mutation	O	5564
in	O	5564
a	O	5564
child	O	5564
with	O	5564
ectopic	B-Disease	5564
intracranial	I-Disease	5564
retinoblastoma	I-Disease	5564
.	O	5564
the	O	5565
rb1	O	5565
gene	O	5565
mutation	O	5565
was	O	5565
investigated	O	5565
in	O	5565
a	O	5565
child	O	5565
with	O	5565
ectopic	B-Disease	5565
intracranial	I-Disease	5565
retinoblastoma	I-Disease	5565
using	O	5565
dna	O	5565
obtained	O	5565
from	O	5565
both	O	5565
the	O	5565
pineal	B-Disease	5565
and	I-Disease	5565
retinal	I-Disease	5565
tumours	I-Disease	5565
of	O	5565
the	O	5565
patient	O	5565
.	O	5565
a	O	5566
nonsense	O	5566
mutation	O	5566
in	O	5566
exon	O	5566
17	O	5566
(	O	5566
codon	O	5566
556	O	5566
)	O	5566
of	O	5566
the	O	5566
rb1	O	5566
gene	O	5566
was	O	5566
found	O	5566
to	O	5566
be	O	5566
present	O	5566
homozygously	O	5566
in	O	5566
both	O	5566
the	O	5566
retinal	B-Disease	5566
and	I-Disease	5566
the	I-Disease	5566
pineal	I-Disease	5566
tumours	I-Disease	5566
.	O	5566
the	O	5569
mutation	O	5569
is	O	5569
in	O	5569
an	O	5569
area	O	5569
of	O	5569
the	O	5569
gene	O	5569
that	O	5569
encodes	O	5569
the	O	5569
protein	O	5569
-	O	5569
binding	O	5569
region	O	5569
known	O	5569
as	O	5569
the	O	5569
pocket	O	5569
region	O	5569
and	O	5569
has	O	5569
been	O	5569
detected	O	5569
in	O	5569
other	O	5569
cases	O	5569
of	O	5569
retinoblastoma	B-Disease	5569
.	O	5569
.	O	5569
appreciable	O	5571
beta	O	5571
hexosaminidase	O	5571
a	O	5571
(	O	5571
hex	O	5571
a	O	5571
)	O	5571
activity	O	5571
has	O	5571
been	O	5571
detected	O	5571
in	O	5571
cultured	O	5571
skin	O	5571
fibroblasts	O	5571
and	O	5571
melanoma	B-Disease	5571
tissue	O	5571
from	O	5571
healthy	O	5571
individuals	O	5571
previously	O	5571
reported	O	5571
as	O	5571
having	O	5571
deficiency	B-Disease	5571
of	I-Disease	5571
hex	I-Disease	5571
a	I-Disease	5571
activity	O	5571
indistinguishable	O	5571
from	O	5571
that	O	5571
of	O	5571
patients	O	5571
with	O	5571
tay	B-Disease	5571
-	I-Disease	5571
sachs	I-Disease	5571
disease	I-Disease	5571
(	O	5571
tsd	B-Disease	5571
)	O	5571
.	O	5571
previous	O	5575
family	O	5575
studies	O	5575
suggested	O	5575
that	O	5575
these	O	5575
individuals	O	5575
may	O	5575
be	O	5575
compound	O	5575
heterozygotes	O	5575
for	O	5575
the	O	5575
common	O	5575
mutant	O	5575
tsd	B-Disease	5575
gene	O	5575
and	O	5575
a	O	5575
rare	O	5575
(	O	5575
allelic	O	5575
)	O	5575
mutant	O	5575
gene	O	5575
.	O	5575
heterozygotes	O	5577
for	O	5577
the	O	5577
rare	O	5577
mutant	O	5577
may	O	5577
be	O	5577
indistinguishable	O	5577
from	O	5577
heterozygotes	O	5577
for	O	5577
the	O	5577
common	O	5577
tsd	B-Disease	5577
mutant	O	5577
.	O	5577
however	O	5578
,	O	5578
direct	O	5578
visualization	O	5578
and	O	5578
quantitation	O	5578
of	O	5578
hex	O	5578
a	O	5578
by	O	5578
the	O	5578
methods	O	5578
described	O	5578
may	O	5578
prevent	O	5578
false	O	5578
-	O	5578
positive	O	5578
prenatal	O	5578
diagnosis	O	5578
of	O	5578
tsd	B-Disease	5578
in	O	5578
fetuses	O	5578
having	O	5578
the	O	5578
incomplete	O	5578
hex	B-Disease	5578
a	I-Disease	5578
deficiency	I-Disease	5578
of	O	5578
the	O	5578
type	O	5578
described	O	5578
in	O	5578
the	O	5578
four	O	5578
healthy	O	5578
individuals	O	5578
the	O	5579
tumor	B-Disease	5579
suppressor	O	5579
gene	O	5579
smad4	O	5579
/	O	5579
dpc4	O	5579
is	O	5579
required	O	5579
for	O	5579
gastrulation	O	5579
and	O	5579
later	O	5579
for	O	5579
anterior	O	5579
development	O	5579
of	O	5579
the	O	5579
mouse	O	5579
embryo	O	5579
.	O	5579
mutations	O	5580
in	O	5580
the	O	5580
smad4	O	5580
/	O	5580
dpc4	O	5580
tumor	B-Disease	5580
suppressor	O	5580
gene	O	5580
,	O	5580
a	O	5580
key	O	5580
signal	O	5580
transducer	O	5580
in	O	5580
most	O	5580
tgfbeta	O	5580
-	O	5580
related	O	5580
pathways	O	5580
,	O	5580
are	O	5580
involved	O	5580
in	O	5580
50	O	5580
%	O	5580
of	O	5580
pancreatic	B-Disease	5580
cancers	I-Disease	5580
.	O	5580
growth	B-Disease	5584
retardation	I-Disease	5584
of	O	5584
the	O	5584
smad4	O	5584
-	O	5584
deficient	O	5584
embryos	O	5584
results	O	5584
from	O	5584
reduced	O	5584
cell	O	5584
proliferation	O	5584
rather	O	5584
than	O	5584
increased	O	5584
apoptosis	O	5584
.	O	5584
aggregation	O	5585
of	O	5585
mutant	O	5585
smad4	O	5585
es	O	5585
cells	O	5585
with	O	5585
wild	O	5585
-	O	5585
type	O	5585
tetraploid	O	5585
morulae	O	5585
rescues	O	5585
the	O	5585
gastrulation	B-Disease	5585
defect	I-Disease	5585
.	O	5585
these	O	5586
results	O	5586
indicate	O	5586
that	O	5586
smad4	O	5586
is	O	5586
initially	O	5586
required	O	5586
for	O	5586
the	O	5586
differentiation	O	5586
of	O	5586
the	O	5586
visceral	O	5586
endoderm	O	5586
and	O	5586
that	O	5586
the	O	5586
gastrulation	B-Disease	5586
defect	I-Disease	5586
in	O	5586
the	O	5586
epiblast	O	5586
is	O	5586
secondary	O	5586
and	O	5586
non	O	5586
-	O	5586
cell	O	5586
autonomous	O	5586
.	O	5586
prevalence	O	5588
of	O	5588
p16	O	5588
and	O	5588
cdk4	O	5588
germline	O	5588
mutations	O	5588
in	O	5588
48	O	5588
melanoma	B-Disease	5588
-	O	5588
prone	O	5588
families	O	5588
in	O	5588
france	O	5588
.	O	5588
the	O	5589
french	O	5589
familial	B-Disease	5589
melanoma	I-Disease	5589
study	O	5589
group	O	5589
.	O	5589
germline	O	5590
mutations	O	5590
in	O	5590
the	O	5590
p16	O	5590
and	O	5590
cdk4	O	5590
genes	O	5590
have	O	5590
been	O	5590
reported	O	5590
in	O	5590
a	O	5590
subset	O	5590
of	O	5590
melanoma	B-Disease	5590
pedigrees	O	5590
,	O	5590
but	O	5590
their	O	5590
prevalence	O	5590
is	O	5590
not	O	5590
well	O	5590
known	O	5590
.	O	5590
we	O	5591
searched	O	5591
for	O	5591
such	O	5591
germline	O	5591
mutations	O	5591
in	O	5591
48	O	5591
french	O	5591
melanoma	B-Disease	5591
-	O	5591
prone	O	5591
families	O	5591
selected	O	5591
according	O	5591
to	O	5591
two	O	5591
major	O	5591
criteria	O	5591
families	O	5591
with	O	5591
at	O	5591
least	O	5591
three	O	5591
affected	O	5591
members	O	5591
(	O	5591
n	O	5591
=	O	5591
20	O	5591
)	O	5591
or	O	5591
families	O	5591
with	O	5591
two	O	5591
affected	O	5591
members	O	5591
,	O	5591
one	O	5591
of	O	5591
them	O	5591
affected	O	5591
before	O	5591
the	O	5591
age	O	5591
of	O	5591
50	O	5591
(	O	5591
n	O	5591
=	O	5591
28	O	5591
)	O	5591
,	O	5591
and	O	5591
one	O	5591
additional	O	5591
minor	O	5591
criterion	O	5591
.	O	5591
in	O	5594
summary	O	5594
,	O	5594
our	O	5594
results	O	5594
show	O	5594
frequent	O	5594
involvement	O	5594
of	O	5594
the	O	5594
p16	O	5594
gene	O	5594
in	O	5594
familial	B-Disease	5594
melanoma	I-Disease	5594
and	O	5594
confirm	O	5594
the	O	5594
role	O	5594
of	O	5594
the	O	5594
cdk4	O	5594
gene	O	5594
as	O	5594
a	O	5594
melanoma	B-Disease	5594
-	O	5594
predisposing	O	5594
gene	O	5594
.	O	5594
.	O	5594
progression	O	5595
of	O	5595
somatic	O	5595
ctg	O	5595
repeat	O	5595
length	O	5595
heterogeneity	O	5595
in	O	5595
the	O	5595
blood	O	5595
cells	O	5595
of	O	5595
myotonic	B-Disease	5595
dystrophy	I-Disease	5595
patients	O	5595
.	O	5595
the	O	5596
genetic	O	5596
basis	O	5596
of	O	5596
myotonic	B-Disease	5596
dystrophy	I-Disease	5596
(	O	5596
dm	B-Disease	5596
)	O	5596
is	O	5596
the	O	5596
expansion	O	5596
of	O	5596
an	O	5596
unstable	O	5596
ctg	O	5596
repeat	O	5596
in	O	5596
the	O	5596
34	O	5596
utr	O	5596
of	O	5596
the	O	5596
dm	B-Disease	5596
protein	O	5596
kinase	O	5596
gene	O	5596
on	O	5596
chromosome	O	5596
19	O	5596
.	O	5596
one	O	5597
of	O	5597
the	O	5597
principal	O	5597
features	O	5597
of	O	5597
the	O	5597
dm	B-Disease	5597
mutation	O	5597
is	O	5597
an	O	5597
extraordinarily	O	5597
high	O	5597
level	O	5597
of	O	5597
somatic	O	5597
mosaicism	O	5597
,	O	5597
due	O	5597
to	O	5597
an	O	5597
extremely	O	5597
high	O	5597
degree	O	5597
of	O	5597
somatic	O	5597
instability	O	5597
both	O	5597
within	O	5597
and	O	5597
between	O	5597
different	O	5597
tissues	O	5597
.	O	5597
in	O	5600
order	O	5600
to	O	5600
further	O	5600
characterize	O	5600
the	O	5600
dynamics	O	5600
of	O	5600
dm	B-Disease	5600
ctg	O	5600
repeat	O	5600
somatic	O	5600
instability	O	5600
,	O	5600
we	O	5600
have	O	5600
studied	O	5600
repeat	O	5600
length	O	5600
changes	O	5600
over	O	5600
time	O	5600
in	O	5600
111	O	5600
myotonic	B-Disease	5600
dystrophy	I-Disease	5600
patients	O	5600
with	O	5600
varying	O	5600
clinical	O	5600
severity	O	5600
and	O	5600
ctg	O	5600
repeat	O	5600
size	O	5600
over	O	5600
time	O	5600
intervals	O	5600
of	O	5600
1	O	5600
-	O	5600
7	O	5600
years	O	5600
.	O	5600
aspartylglucosaminuria	B-Disease	5603
among	O	5603
palestinian	O	5603
arabs	O	5603
.	O	5603
aspartylglucosaminuria	B-Disease	5604
(	O	5604
agu	B-Disease	5604
)	O	5604
is	O	5604
a	O	5604
rare	O	5604
disorder	B-Disease	5604
of	I-Disease	5604
glycoprotein	I-Disease	5604
metabolism	I-Disease	5604
caused	O	5604
by	O	5604
the	O	5604
deficiency	B-Disease	5604
of	I-Disease	5604
the	I-Disease	5604
lysosomal	I-Disease	5604
enzyme	I-Disease	5604
aspartylglucosaminidase	I-Disease	5604
(	O	5604
aga	O	5604
)	O	5604
.	O	5604
agu	B-Disease	5605
is	O	5605
inherited	O	5605
as	O	5605
an	O	5605
autosomal	O	5605
recessive	O	5605
trait	O	5605
and	O	5605
occurs	O	5605
with	O	5605
a	O	5605
high	O	5605
frequency	O	5605
in	O	5605
finland	O	5605
because	O	5605
of	O	5605
a	O	5605
founder	O	5605
effect	O	5605
.	O	5605
while	O	5606
very	O	5606
few	O	5606
patients	O	5606
with	O	5606
agu	B-Disease	5606
have	O	5606
been	O	5606
reported	O	5606
from	O	5606
non	O	5606
-	O	5606
finnish	O	5606
origin	O	5606
,	O	5606
we	O	5606
diagnosed	O	5606
the	O	5606
disorder	O	5606
in	O	5606
8	O	5606
patients	O	5606
originating	O	5606
from	O	5606
3	O	5606
unrelated	O	5606
families	O	5606
,	O	5606
all	O	5606
palestinian	O	5606
arabs	O	5606
from	O	5606
the	O	5606
region	O	5606
of	O	5606
jerusalem	O	5606
.	O	5606
the	O	5607
clinical	O	5607
diagnosis	O	5607
of	O	5607
agu	B-Disease	5607
is	O	5607
often	O	5607
difficult	O	5607
,	O	5607
in	O	5607
particular	O	5607
early	O	5607
in	O	5607
the	O	5607
course	O	5607
of	O	5607
the	O	5607
disease	O	5607
,	O	5607
and	O	5607
most	O	5607
of	O	5607
the	O	5607
patients	O	5607
are	O	5607
diagnosed	O	5607
after	O	5607
the	O	5607
age	O	5607
of	O	5607
5	O	5607
years	O	5607
.	O	5607
detection	O	5609
of	O	5609
heterozygous	O	5609
carriers	O	5609
of	O	5609
the	O	5609
ataxia	B-Disease	5609
-	I-Disease	5609
telangiectasia	I-Disease	5609
(	O	5609
atm	O	5609
)	O	5609
gene	O	5609
by	O	5609
g2	O	5609
phase	O	5609
chromosomal	O	5609
radiosensitivity	O	5609
of	O	5609
peripheral	O	5609
blood	O	5609
lymphocytes	O	5609
.	O	5609
in	O	5610
ataxia	B-Disease	5610
-	I-Disease	5610
telangiectasia	I-Disease	5610
(	O	5610
a	B-Disease	5610
-	I-Disease	5610
t	I-Disease	5610
)	O	5610
patients	O	5610
,	O	5610
mutations	O	5610
in	O	5610
a	O	5610
single	O	5610
gene	O	5610
,	O	5610
atm	O	5610
,	O	5610
result	O	5610
in	O	5610
an	O	5610
autosomal	B-Disease	5610
recessive	I-Disease	5610
syndrome	I-Disease	5610
that	O	5610
embraces	O	5610
a	O	5610
variety	O	5610
of	O	5610
clinical	O	5610
features	O	5610
and	O	5610
manifests	O	5610
extreme	O	5610
radiosensitivity	O	5610
and	O	5610
a	O	5610
strong	O	5610
pre	O	5610
-	O	5610
disposition	O	5610
to	O	5610
malignancy	B-Disease	5610
.	O	5610
heterozygotes	O	5611
for	O	5611
the	O	5611
atm	O	5611
gene	O	5611
have	O	5611
no	O	5611
clinical	O	5611
expression	O	5611
of	O	5611
a	B-Disease	5611
-	I-Disease	5611
t	I-Disease	5611
but	O	5611
may	O	5611
be	O	5611
cancer	B-Disease	5611
prone	O	5611
with	O	5611
a	O	5611
moderate	O	5611
increase	O	5611
in	O	5611
in	O	5611
vitro	O	5611
radiosensitivity	O	5611
.	O	5611
we	O	5612
performed	O	5612
a	O	5612
blind	O	5612
chromosomal	O	5612
analysis	O	5612
on	O	5612
g2	O	5612
-	O	5612
phase	O	5612
lymphocytes	O	5612
from	O	5612
7	O	5612
unrelated	O	5612
a	B-Disease	5612
-	I-Disease	5612
t	I-Disease	5612
patients	O	5612
,	O	5612
13	O	5612
obligate	O	5612
a	B-Disease	5612
-	I-Disease	5612
t	I-Disease	5612
heterozygotes	O	5612
(	O	5612
parents	O	5612
of	O	5612
the	O	5612
patients	O	5612
)	O	5612
,	O	5612
and	O	5612
14	O	5612
normal	O	5612
controls	O	5612
following	O	5612
x	O	5612
-	O	5612
irradiation	O	5612
with	O	5612
1	O	5612
gy	O	5612
in	O	5612
order	O	5612
to	O	5612
evaluate	O	5612
this	O	5612
cytogenetic	O	5612
method	O	5612
as	O	5612
a	O	5612
tool	O	5612
for	O	5612
detection	O	5612
of	O	5612
atm	O	5612
carriers	O	5612
.	O	5612
both	O	5613
a	B-Disease	5613
-	I-Disease	5613
t	I-Disease	5613
homozygotes	O	5613
and	O	5613
heterozygotes	O	5613
showed	O	5613
significantly	O	5613
increased	O	5613
levels	O	5613
of	O	5613
radiation	O	5613
-	O	5613
induced	O	5613
chromatid	O	5613
damage	O	5613
relative	O	5613
to	O	5613
that	O	5613
of	O	5613
normal	O	5613
controls	O	5613
.	O	5613
these	O	5614
results	O	5614
show	O	5614
that	O	5614
the	O	5614
g2	O	5614
-	O	5614
phase	O	5614
chromosomal	O	5614
radiosensitivity	O	5614
assay	O	5614
can	O	5614
be	O	5614
used	O	5614
for	O	5614
the	O	5614
detection	O	5614
of	O	5614
a	B-Disease	5614
-	I-Disease	5614
t	I-Disease	5614
heterozygotes	O	5614
.	O	5614
in	O	5615
combination	O	5615
with	O	5615
molecular	O	5615
genetic	O	5615
analyses	O	5615
,	O	5615
this	O	5615
test	O	5615
may	O	5615
be	O	5615
of	O	5615
value	O	5615
in	O	5615
studies	O	5615
of	O	5615
familial	B-Disease	5615
and	I-Disease	5615
sporadic	I-Disease	5615
cancers	I-Disease	5615
aimed	O	5615
at	O	5615
determination	O	5615
of	O	5615
the	O	5615
potential	O	5615
involvement	O	5615
of	O	5615
atm	O	5615
mutations	O	5615
in	O	5615
tumor	B-Disease	5615
risk	O	5615
or	O	5615
development	O	5615
.	O	5615
.	O	5615
ataxia	B-Disease	5616
-	I-Disease	5616
telangiectasia	I-Disease	5616
:	O	5616
identification	O	5616
and	O	5616
detection	O	5616
of	O	5616
founder	O	5616
-	O	5616
effect	O	5616
mutations	O	5616
in	O	5616
the	O	5616
atm	O	5616
gene	O	5616
in	O	5616
ethnic	O	5616
populations	O	5616
.	O	5616
to	O	5617
facilitate	O	5617
the	O	5617
evaluation	O	5617
of	O	5617
atm	O	5617
heterozygotes	O	5617
for	O	5617
susceptibility	O	5617
to	O	5617
other	O	5617
diseases	O	5617
,	O	5617
such	O	5617
as	O	5617
breast	B-Disease	5617
cancer	I-Disease	5617
,	O	5617
we	O	5617
have	O	5617
attempted	O	5617
to	O	5617
define	O	5617
the	O	5617
most	O	5617
common	O	5617
mutations	O	5617
and	O	5617
their	O	5617
frequencies	O	5617
in	O	5617
ataxia	B-Disease	5617
-	I-Disease	5617
telangiectasia	I-Disease	5617
(	O	5617
a	B-Disease	5617
-	I-Disease	5617
t	I-Disease	5617
)	O	5617
homozygotes	O	5617
from	O	5617
10	O	5617
ethnic	O	5617
populations	O	5617
.	O	5617
these	O	5624
assays	O	5624
should	O	5624
facilitate	O	5624
screening	O	5624
for	O	5624
a	B-Disease	5624
-	I-Disease	5624
t	I-Disease	5624
heterozygotes	O	5624
in	O	5624
the	O	5624
populations	O	5624
studied	O	5624
.	O	5624
.	O	5624
the	O	5625
von	B-Disease	5625
hippel	I-Disease	5625
-	I-Disease	5625
lindau	I-Disease	5625
tumor	I-Disease	5625
suppressor	O	5625
gene	O	5625
is	O	5625
required	O	5625
for	O	5625
cell	O	5625
cycle	O	5625
exit	O	5625
upon	O	5625
serum	O	5625
withdrawal	O	5625
.	O	5625
the	O	5626
inactivation	O	5626
of	O	5626
the	O	5626
von	B-Disease	5626
hippel	I-Disease	5626
-	I-Disease	5626
lindau	I-Disease	5626
(	I-Disease	5626
vhl	I-Disease	5626
)	I-Disease	5626
tumor	I-Disease	5626
suppressor	O	5626
gene	O	5626
predisposes	O	5626
affected	O	5626
individuals	O	5626
to	O	5626
the	O	5626
human	O	5626
vhl	B-Disease	5626
cancer	I-Disease	5626
syndrome	I-Disease	5626
and	O	5626
is	O	5626
associated	O	5626
with	O	5626
sporadic	B-Disease	5626
renal	I-Disease	5626
cell	I-Disease	5626
carcinomas	I-Disease	5626
(	O	5626
rcc	B-Disease	5626
)	O	5626
and	O	5626
brain	B-Disease	5626
hemangioblastomas	I-Disease	5626
.	O	5626
vhl	O	5627
-	O	5627
negative	O	5627
786	O	5627
-	O	5627
0	O	5627
rcc	B-Disease	5627
cells	O	5627
are	O	5627
tumorigenic	O	5627
in	O	5627
nude	O	5627
mice	O	5627
which	O	5627
is	O	5627
suppressed	O	5627
by	O	5627
the	O	5627
reintroduction	O	5627
of	O	5627
vhl	B-Disease	5627
.	O	5627
the	O	5629
786	O	5629
-	O	5629
0	O	5629
cell	O	5629
line	O	5629
,	O	5629
like	O	5629
many	O	5629
cancer	B-Disease	5629
cells	O	5629
,	O	5629
fails	O	5629
to	O	5629
exit	O	5629
the	O	5629
cell	O	5629
cycle	O	5629
upon	O	5629
serum	O	5629
withdrawal	O	5629
.	O	5629
here	O	5630
,	O	5630
it	O	5630
is	O	5630
shown	O	5630
that	O	5630
reintroduction	O	5630
of	O	5630
the	O	5630
wild	O	5630
-	O	5630
type	O	5630
vhl	B-Disease	5630
gene	O	5630
restores	O	5630
the	O	5630
ability	O	5630
of	O	5630
vhl	O	5630
-	O	5630
negative	O	5630
rcc	B-Disease	5630
cancer	I-Disease	5630
cells	O	5630
to	O	5630
exit	O	5630
the	O	5630
cell	O	5630
cycle	O	5630
and	O	5630
enter	O	5630
g0	O	5630
/	O	5630
quiescence	O	5630
in	O	5630
low	O	5630
serum	O	5630
.	O	5630
both	O	5631
vhl	O	5631
-	O	5631
positive	O	5631
and	O	5631
vhl	O	5631
-	O	5631
negative	O	5631
rcc	B-Disease	5631
cells	O	5631
exit	O	5631
the	O	5631
cell	O	5631
cycle	O	5631
by	O	5631
contact	O	5631
inhibition	O	5631
.	O	5631
the	O	5632
cyclin	O	5632
-	O	5632
dependent	O	5632
kinase	O	5632
inhibitor	O	5632
,	O	5632
p27	O	5632
,	O	5632
accumulates	O	5632
upon	O	5632
serum	O	5632
withdrawal	O	5632
,	O	5632
only	O	5632
in	O	5632
the	O	5632
presence	O	5632
of	O	5632
vhl	B-Disease	5632
,	O	5632
as	O	5632
a	O	5632
result	O	5632
of	O	5632
the	O	5632
stabilization	O	5632
of	O	5632
the	O	5632
protein	O	5632
.	O	5632
we	O	5633
propose	O	5633
that	O	5633
the	O	5633
loss	O	5633
of	O	5633
wild	O	5633
-	O	5633
type	O	5633
vhl	B-Disease	5633
gene	O	5633
results	O	5633
in	O	5633
a	O	5633
specific	O	5633
cellular	O	5633
defect	O	5633
in	O	5633
serum	O	5633
-	O	5633
dependent	O	5633
growth	O	5633
control	O	5633
,	O	5633
which	O	5633
may	O	5633
initiate	O	5633
tumor	B-Disease	5633
formation	O	5633
.	O	5633
this	O	5634
is	O	5634
corrected	O	5634
by	O	5634
the	O	5634
reintroduction	O	5634
of	O	5634
wild	O	5634
-	O	5634
type	O	5634
vhl	B-Disease	5634
,	O	5634
implicating	O	5634
vhl	B-Disease	5634
as	O	5634
the	O	5634
first	O	5634
tumor	B-Disease	5634
suppressor	O	5634
involved	O	5634
in	O	5634
the	O	5634
regulation	O	5634
of	O	5634
cell	O	5634
cycle	O	5634
exit	O	5634
,	O	5634
which	O	5634
is	O	5634
consistent	O	5634
with	O	5634
its	O	5634
gatekeeper	O	5634
function	O	5634
in	O	5634
the	O	5634
kidney	O	5634
.	O	5634
.	O	5634
piebaldism	B-Disease	5635
with	O	5635
deafness	B-Disease	5635
:	O	5635
molecular	O	5635
evidence	O	5635
for	O	5635
an	O	5635
expanded	O	5635
syndrome	O	5635
.	O	5635
in	O	5636
a	O	5636
south	O	5636
african	O	5636
girl	O	5636
of	O	5636
xhosa	O	5636
stock	O	5636
with	O	5636
severe	O	5636
piebaldism	B-Disease	5636
and	O	5636
profound	O	5636
congenital	O	5636
sensorineural	B-Disease	5636
deafness	I-Disease	5636
we	O	5636
identified	O	5636
a	O	5636
novel	O	5636
missense	O	5636
substitution	O	5636
at	O	5636
a	O	5636
highly	O	5636
conserved	O	5636
residue	O	5636
in	O	5636
the	O	5636
intracellular	O	5636
kinase	O	5636
domain	O	5636
of	O	5636
the	O	5636
kit	O	5636
proto	O	5636
-	O	5636
oncogene	O	5636
,	O	5636
r796g	O	5636
.	O	5636
though	O	5637
auditory	B-Disease	5637
anomalies	I-Disease	5637
have	O	5637
been	O	5637
observed	O	5637
in	O	5637
mice	O	5637
with	O	5637
dominant	O	5637
white	O	5637
spotting	O	5637
(	O	5637
w	O	5637
)	O	5637
due	O	5637
to	O	5637
kit	O	5637
mutations	O	5637
,	O	5637
deafness	B-Disease	5637
is	O	5637
not	O	5637
typical	O	5637
in	O	5637
human	O	5637
piebaldism	B-Disease	5637
.	O	5637
thus	O	5638
,	O	5638
the	O	5638
occurrence	O	5638
of	O	5638
sensorineural	B-Disease	5638
deafness	I-Disease	5638
in	O	5638
this	O	5638
patient	O	5638
extends	O	5638
considerably	O	5638
the	O	5638
phenotypic	O	5638
range	O	5638
of	O	5638
piebaldism	B-Disease	5638
due	O	5638
to	O	5638
kit	O	5638
gene	O	5638
mutation	O	5638
in	O	5638
humans	O	5638
and	O	5638
tightens	O	5638
the	O	5638
clinical	O	5638
similarity	O	5638
between	O	5638
piebaldism	B-Disease	5638
and	O	5638
the	O	5638
various	O	5638
forms	O	5638
of	O	5638
waardenburg	B-Disease	5638
syndrome	I-Disease	5638
.	O	5638
.	O	5638
cycloheximide	O	5639
facilitates	O	5639
the	O	5639
identification	O	5639
of	O	5639
aberrant	O	5639
transcripts	O	5639
resulting	O	5639
from	O	5639
a	O	5639
novel	O	5639
splice	O	5639
-	O	5639
site	O	5639
mutation	O	5639
in	O	5639
col17a1	O	5639
in	O	5639
a	O	5639
patient	O	5639
with	O	5639
generalized	O	5639
atrophic	B-Disease	5639
benign	I-Disease	5639
epidermolysis	I-Disease	5639
bullosa	I-Disease	5639
.	O	5639
patients	O	5640
with	O	5640
generalized	O	5640
atrophic	B-Disease	5640
benign	I-Disease	5640
epidermolysis	I-Disease	5640
bullosa	I-Disease	5640
often	O	5640
show	O	5640
decreased	O	5640
expression	O	5640
of	O	5640
type	O	5640
xvii	O	5640
collagen	O	5640
,	O	5640
a	O	5640
transmembrane	O	5640
hemidesmosomal	O	5640
protein	O	5640
encoded	O	5640
by	O	5640
col17a1	O	5640
.	O	5640
this	O	5641
report	O	5641
documents	O	5641
a	O	5641
novel	O	5641
splice	O	5641
-	O	5641
site	O	5641
mutation	O	5641
in	O	5641
col17a1	O	5641
in	O	5641
a	O	5641
patient	O	5641
with	O	5641
generalized	O	5641
atrophic	B-Disease	5641
benign	I-Disease	5641
epidermolysis	I-Disease	5641
bullosa	I-Disease	5641
,	O	5641
and	O	5641
applies	O	5641
a	O	5641
new	O	5641
methodology	O	5641
to	O	5641
define	O	5641
and	O	5641
characterize	O	5641
the	O	5641
resulting	O	5641
mrna	O	5641
splice	O	5641
variants	O	5641
.	O	5641
a	O	5649
deletion	O	5649
mutation	O	5649
in	O	5649
col17a1	O	5649
in	O	5649
five	O	5649
austrian	O	5649
families	O	5649
with	O	5649
generalized	O	5649
atrophic	B-Disease	5649
benign	I-Disease	5649
epidermolysis	I-Disease	5649
bullosa	I-Disease	5649
represents	O	5649
propagation	O	5649
of	O	5649
an	O	5649
ancestral	O	5649
allele	O	5649
.	O	5649
patients	O	5650
with	O	5650
generalized	O	5650
atrophic	B-Disease	5650
benign	I-Disease	5650
epidermolysis	I-Disease	5650
bullosa	I-Disease	5650
,	O	5650
a	O	5650
usually	O	5650
nonlethal	O	5650
form	O	5650
of	O	5650
junctional	B-Disease	5650
epidermolysis	I-Disease	5650
bullosa	I-Disease	5650
,	O	5650
have	O	5650
generalized	O	5650
blistering	B-Disease	5650
,	O	5650
nail	B-Disease	5650
dystrophy	I-Disease	5650
,	O	5650
patchy	B-Disease	5650
alopecia	I-Disease	5650
,	O	5650
and	O	5650
dental	B-Disease	5650
abnormalities	I-Disease	5650
.	O	5650
skin	B-Disease	5651
fragility	I-Disease	5651
in	O	5651
most	O	5651
cases	O	5651
is	O	5651
due	O	5651
to	O	5651
mutations	O	5651
in	O	5651
the	O	5651
gene	O	5651
encoding	O	5651
type	O	5651
xvii	O	5651
collagen	O	5651
(	O	5651
col17a1	O	5651
)	O	5651
.	O	5651
recently	O	5652
,	O	5652
we	O	5652
reported	O	5652
five	O	5652
austrian	O	5652
families	O	5652
with	O	5652
generalized	O	5652
atrophic	B-Disease	5652
benign	I-Disease	5652
epidermolysis	I-Disease	5652
bullosa	I-Disease	5652
who	O	5652
share	O	5652
the	O	5652
same	O	5652
col17a1	O	5652
mutation	O	5652
.	O	5652
the	O	5661
haptoglobin	O	5661
-	O	5661
gene	O	5661
deletion	O	5661
responsible	O	5661
for	O	5661
anhaptoglobinemia	B-Disease	5661
.	O	5661
we	O	5662
have	O	5662
found	O	5662
an	O	5662
allelic	O	5662
deletion	O	5662
of	O	5662
the	O	5662
haptoglobin	O	5662
(	O	5662
hp	O	5662
)	O	5662
gene	O	5662
from	O	5662
an	O	5662
individual	O	5662
with	O	5662
anhaptoglobinemia	B-Disease	5662
.	O	5662
southern	O	5664
blot	O	5664
and	O	5664
pcr	O	5664
analyses	O	5664
have	O	5664
indicated	O	5664
that	O	5664
the	O	5664
individual	O	5664
with	O	5664
anhaptoglobinemia	B-Disease	5664
was	O	5664
homozygous	O	5664
for	O	5664
the	O	5664
gene	O	5664
deletion	O	5664
and	O	5664
that	O	5664
the	O	5664
gene	O	5664
deletion	O	5664
was	O	5664
included	O	5664
at	O	5664
least	O	5664
from	O	5664
the	O	5664
promoter	O	5664
region	O	5664
of	O	5664
hp	O	5664
to	O	5664
hpr	O	5664
alpha	O	5664
but	O	5664
not	O	5664
to	O	5664
hpr	O	5664
beta	O	5664
(	O	5664
hpdel	O	5664
)	O	5664
.	O	5664
in	O	5665
addition	O	5665
,	O	5665
we	O	5665
found	O	5665
seven	O	5665
individuals	O	5665
with	O	5665
hypohaptoglobinemia	B-Disease	5665
in	O	5665
three	O	5665
families	O	5665
,	O	5665
and	O	5665
the	O	5665
genotypes	O	5665
of	O	5665
six	O	5665
of	O	5665
the	O	5665
seven	O	5665
individuals	O	5665
were	O	5665
found	O	5665
to	O	5665
be	O	5665
hp2	O	5665
/	O	5665
hpdel	O	5665
.	O	5665
the	O	5666
phenotypes	O	5666
and	O	5666
genotypes	O	5666
in	O	5666
one	O	5666
of	O	5666
these	O	5666
three	O	5666
families	O	5666
showed	O	5666
the	O	5666
father	O	5666
to	O	5666
be	O	5666
hypohaptoglobinemic	B-Disease	5666
(	O	5666
hp2	O	5666
)	O	5666
and	O	5666
hp2	O	5666
/	O	5666
hpdel	O	5666
,	O	5666
the	O	5666
mother	O	5666
to	O	5666
be	O	5666
hp2	O	5666
-	O	5666
1	O	5666
and	O	5666
hp1	O	5666
/	O	5666
hp2	O	5666
,	O	5666
one	O	5666
of	O	5666
the	O	5666
two	O	5666
children	O	5666
to	O	5666
be	O	5666
hypohaptoglobinemic	B-Disease	5666
(	O	5666
hp2	O	5666
)	O	5666
and	O	5666
hp2	O	5666
/	O	5666
hpdel	O	5666
,	O	5666
and	O	5666
the	O	5666
other	O	5666
child	O	5666
to	O	5666
be	O	5666
hp1	O	5666
and	O	5666
hp1	O	5666
/	O	5666
hpdel	O	5666
,	O	5666
showing	O	5666
an	O	5666
anomalous	O	5666
inheritance	O	5666
of	O	5666
hp	O	5666
phenotypes	O	5666
in	O	5666
the	O	5666
child	O	5666
with	O	5666
hp1	O	5666
.	O	5666
on	O	5670
the	O	5670
basis	O	5670
of	O	5670
the	O	5670
present	O	5670
study	O	5670
,	O	5670
the	O	5670
mechanism	O	5670
of	O	5670
anhaptoglobinemia	B-Disease	5670
and	O	5670
the	O	5670
mechanism	O	5670
of	O	5670
anomalous	O	5670
inheritance	O	5670
of	O	5670
hp	O	5670
phenotypes	O	5670
were	O	5670
well	O	5670
explained	O	5670
.	O	5670
however	O	5671
,	O	5671
the	O	5671
mechanism	O	5671
of	O	5671
hypohaptoglobinemia	B-Disease	5671
remains	O	5671
unknown	O	5671
atm	O	5672
mutations	O	5672
and	O	5672
phenotypes	O	5672
in	O	5672
ataxia	B-Disease	5672
-	I-Disease	5672
telangiectasia	I-Disease	5672
families	O	5672
in	O	5672
the	O	5672
british	O	5672
isles	O	5672
:	O	5672
expression	O	5672
of	O	5672
mutant	O	5672
atm	O	5672
and	O	5672
the	O	5672
risk	O	5672
of	O	5672
leukemia	B-Disease	5672
,	O	5672
lymphoma	B-Disease	5672
,	O	5672
and	O	5672
breast	B-Disease	5672
cancer	I-Disease	5672
.	O	5672
we	O	5673
report	O	5673
the	O	5673
spectrum	O	5673
of	O	5673
59	O	5673
atm	O	5673
mutations	O	5673
observed	O	5673
in	O	5673
ataxia	B-Disease	5673
-	I-Disease	5673
telangiectasia	I-Disease	5673
(	O	5673
a	B-Disease	5673
-	I-Disease	5673
t	I-Disease	5673
)	O	5673
patients	O	5673
in	O	5673
the	O	5673
british	O	5673
isles	O	5673
.	O	5673
of	O	5674
51	O	5674
atm	O	5674
mutations	O	5674
identified	O	5674
in	O	5674
families	O	5674
native	O	5674
to	O	5674
the	O	5674
british	O	5674
isles	O	5674
,	O	5674
11	O	5674
were	O	5674
founder	O	5674
mutations	O	5674
,	O	5674
and	O	5674
2	O	5674
of	O	5674
these	O	5674
11	O	5674
conferred	O	5674
a	O	5674
milder	O	5674
clinical	O	5674
phenotype	O	5674
with	O	5674
respect	O	5674
to	O	5674
both	O	5674
cerebellar	B-Disease	5674
degeneration	I-Disease	5674
and	O	5674
cellular	O	5674
features	O	5674
.	O	5674
we	O	5675
report	O	5675
,	O	5675
in	O	5675
two	O	5675
a	B-Disease	5675
-	I-Disease	5675
t	I-Disease	5675
families	O	5675
,	O	5675
an	O	5675
atm	O	5675
mutation	O	5675
(	O	5675
7271t	O	5675
-	O	5675
-	O	5675
>	O	5675
g	O	5675
)	O	5675
that	O	5675
may	O	5675
be	O	5675
associated	O	5675
with	O	5675
an	O	5675
increased	O	5675
risk	O	5675
of	O	5675
breast	B-Disease	5675
cancer	I-Disease	5675
in	O	5675
both	O	5675
homozygotes	O	5675
and	O	5675
heterozygotes	O	5675
(	O	5675
relative	O	5675
risk	O	5675
12	O	5675
.	O	5675
7	O	5675
;	O	5675
p	O	5675
=	O	5675
.	O	5675
0025	O	5675
)	O	5675
,	O	5675
although	O	5675
there	O	5675
is	O	5675
a	O	5675
less	O	5675
severe	O	5675
a	B-Disease	5675
-	I-Disease	5675
t	I-Disease	5675
phenotype	O	5675
in	O	5675
terms	O	5675
of	O	5675
the	O	5675
degree	O	5675
of	O	5675
cerebellar	B-Disease	5675
degeneration	I-Disease	5675
.	O	5675
in	O	5677
addition	O	5677
,	O	5677
we	O	5677
have	O	5677
studied	O	5677
18	O	5677
a	B-Disease	5677
-	I-Disease	5677
t	I-Disease	5677
patients	O	5677
,	O	5677
in	O	5677
15	O	5677
families	O	5677
,	O	5677
who	O	5677
developed	O	5677
leukemia	B-Disease	5677
,	O	5677
lymphoma	B-Disease	5677
,	O	5677
preleukemic	O	5677
t	O	5677
-	O	5677
cell	O	5677
proliferation	O	5677
,	O	5677
or	O	5677
hodgkin	B-Disease	5677
lymphoma	I-Disease	5677
,	O	5677
mostly	O	5677
in	O	5677
childhood	O	5677
.	O	5677
we	O	5679
also	O	5679
show	O	5679
that	O	5679
25	O	5679
%	O	5679
of	O	5679
all	O	5679
a	B-Disease	5679
-	I-Disease	5679
t	I-Disease	5679
patients	O	5679
carried	O	5679
in	O	5679
-	O	5679
frame	O	5679
deletions	O	5679
or	O	5679
missense	O	5679
mutations	O	5679
,	O	5679
many	O	5679
of	O	5679
which	O	5679
were	O	5679
also	O	5679
associated	O	5679
with	O	5679
expression	O	5679
of	O	5679
mutant	O	5679
atm	O	5679
protein	O	5679
.	O	5679
the	O	5680
dmpk	O	5680
gene	O	5680
of	O	5680
severely	O	5680
affected	O	5680
myotonic	B-Disease	5680
dystrophy	I-Disease	5680
patients	O	5680
is	O	5680
hypermethylated	O	5680
proximal	O	5680
to	O	5680
the	O	5680
largely	O	5680
expanded	O	5680
ctg	O	5680
repeat	O	5680
.	O	5680
using	O	5681
methylation	O	5681
-	O	5681
sensitive	O	5681
restriction	O	5681
enzymes	O	5681
,	O	5681
we	O	5681
characterized	O	5681
the	O	5681
methylation	O	5681
pattern	O	5681
on	O	5681
the	O	5681
5	O	5681
side	O	5681
of	O	5681
the	O	5681
ctg	O	5681
repeat	O	5681
in	O	5681
the	O	5681
dmpk	O	5681
gene	O	5681
of	O	5681
normal	O	5681
individuals	O	5681
and	O	5681
of	O	5681
patients	O	5681
affected	O	5681
with	O	5681
myotonic	B-Disease	5681
dystrophy	I-Disease	5681
,	O	5681
showing	O	5681
expansions	O	5681
of	O	5681
the	O	5681
repetitive	O	5681
sequence	O	5681
.	O	5681
the	O	5687
hemochromatosis	B-Disease	5687
gene	O	5687
product	O	5687
complexes	O	5687
with	O	5687
the	O	5687
transferrin	O	5687
receptor	O	5687
and	O	5687
lowers	O	5687
its	O	5687
affinity	O	5687
for	O	5687
ligand	O	5687
binding	O	5687
.	O	5687
we	O	5688
recently	O	5688
reported	O	5688
the	O	5688
positional	O	5688
cloning	O	5688
of	O	5688
a	O	5688
candidate	O	5688
gene	O	5688
for	O	5688
hereditary	B-Disease	5688
hemochromatosis	I-Disease	5688
called	O	5688
hfe	O	5688
.	O	5688
these	O	5699
results	O	5699
establish	O	5699
a	O	5699
molecular	O	5699
link	O	5699
between	O	5699
hfe	O	5699
and	O	5699
a	O	5699
key	O	5699
protein	O	5699
involved	O	5699
in	O	5699
iron	O	5699
transport	O	5699
,	O	5699
the	O	5699
tfr	O	5699
,	O	5699
and	O	5699
raise	O	5699
the	O	5699
possibility	O	5699
that	O	5699
alterations	O	5699
in	O	5699
this	O	5699
regulatory	O	5699
mechanism	O	5699
may	O	5699
play	O	5699
a	O	5699
role	O	5699
in	O	5699
the	O	5699
pathogenesis	O	5699
of	O	5699
hereditary	B-Disease	5699
hemochromatosis	I-Disease	5699
.	O	5699
.	O	5699
the	O	5701
ube3a	O	5701
gene	O	5701
encodes	O	5701
the	O	5701
e6	O	5701
-	O	5701
ap	O	5701
ubiquitin	O	5701
-	O	5701
protein	O	5701
ligase	O	5701
and	O	5701
has	O	5701
recently	O	5701
been	O	5701
shown	O	5701
to	O	5701
be	O	5701
mutated	O	5701
in	O	5701
angelman	B-Disease	5701
syndrome	I-Disease	5701
patients	O	5701
who	O	5701
lack	O	5701
15q11	O	5701
-	O	5701
q13	O	5701
deletions	O	5701
or	O	5701
chromosome	O	5701
15	O	5701
paternal	O	5701
uniparental	B-Disease	5701
disomy	I-Disease	5701
.	O	5701
mutation	O	5709
spectrum	O	5709
and	O	5709
genotype	O	5709
-	O	5709
phenotype	O	5709
analyses	O	5709
in	O	5709
cowden	B-Disease	5709
disease	I-Disease	5709
and	O	5709
bannayan	B-Disease	5709
-	I-Disease	5709
zonana	I-Disease	5709
syndrome	I-Disease	5709
,	O	5709
two	O	5709
hamartoma	B-Disease	5709
syndromes	I-Disease	5709
with	O	5709
germline	O	5709
pten	O	5709
mutation	O	5709
.	O	5709
the	O	5710
tumour	B-Disease	5710
suppressor	O	5710
gene	O	5710
pten	O	5710
,	O	5710
which	O	5710
maps	O	5710
to	O	5710
10q23	O	5710
.	O	5710
3	O	5711
and	O	5711
encodes	O	5711
a	O	5711
403	O	5711
amino	O	5711
acid	O	5711
dual	O	5711
specificity	O	5711
phosphatase	O	5711
(	O	5711
protein	O	5711
tyrosine	O	5711
phosphatase	O	5711
;	O	5711
ptpase	O	5711
)	O	5711
,	O	5711
was	O	5711
shown	O	5711
recently	O	5711
to	O	5711
play	O	5711
a	O	5711
broad	O	5711
role	O	5711
in	O	5711
human	O	5711
malignancy	B-Disease	5711
.	O	5711
somatic	O	5712
pten	O	5712
deletions	O	5712
and	O	5712
mutations	O	5712
were	O	5712
observed	O	5712
in	O	5712
sporadic	B-Disease	5712
breast	I-Disease	5712
,	I-Disease	5712
brain	I-Disease	5712
,	I-Disease	5712
prostate	I-Disease	5712
and	I-Disease	5712
kidney	I-Disease	5712
cancer	I-Disease	5712
cell	O	5712
lines	O	5712
and	O	5712
in	O	5712
several	O	5712
primary	O	5712
tumours	B-Disease	5712
such	O	5712
as	O	5712
endometrial	B-Disease	5712
carcinomas	I-Disease	5712
,	O	5712
malignant	B-Disease	5712
melanoma	I-Disease	5712
and	O	5712
thyroid	B-Disease	5712
tumours	I-Disease	5712
.	O	5712
in	O	5713
addition	O	5713
,	O	5713
pten	O	5713
was	O	5713
identified	O	5713
as	O	5713
the	O	5713
susceptibility	O	5713
gene	O	5713
for	O	5713
two	O	5713
hamartoma	B-Disease	5713
syndromes	I-Disease	5713
cowden	B-Disease	5713
disease	I-Disease	5713
(	O	5713
cd	B-Disease	5713
;	O	5713
mim	O	5713
158350	O	5713
)	O	5713
and	O	5713
bannayan	B-Disease	5713
-	I-Disease	5713
zonana	I-Disease	5713
(	I-Disease	5713
bzs	I-Disease	5713
)	I-Disease	5713
or	I-Disease	5713
ruvalcaba	I-Disease	5713
-	I-Disease	5713
riley	I-Disease	5713
-	I-Disease	5713
smith	I-Disease	5713
syndrome	I-Disease	5713
(	O	5713
mim	O	5713
153480	O	5713
)	O	5713
.	O	5713
constitutive	O	5714
dna	O	5714
from	O	5714
37	O	5714
cd	B-Disease	5714
families	O	5714
and	O	5714
seven	O	5714
bzs	B-Disease	5714
families	O	5714
was	O	5714
screened	O	5714
for	O	5714
germline	O	5714
pten	O	5714
mutations	O	5714
.	O	5714
pten	O	5715
mutations	O	5715
were	O	5715
identified	O	5715
in	O	5715
30	O	5715
of	O	5715
37	O	5715
(	O	5715
81	O	5715
%	O	5715
)	O	5715
cd	B-Disease	5715
families	O	5715
,	O	5715
including	O	5715
missense	O	5715
and	O	5715
nonsense	O	5715
point	O	5715
mutations	O	5715
,	O	5715
deletions	O	5715
,	O	5715
insertions	O	5715
,	O	5715
a	O	5715
deletion	O	5715
/	O	5715
insertion	O	5715
and	O	5715
splice	O	5715
site	O	5715
mutations	O	5715
.	O	5715
a	O	5717
hot	O	5717
spot	O	5717
for	O	5717
pten	O	5717
mutation	O	5717
in	O	5717
cd	B-Disease	5717
was	O	5717
identified	O	5717
in	O	5717
exon	O	5717
5	O	5717
that	O	5717
contains	O	5717
the	O	5717
ptpase	O	5717
core	O	5717
motif	O	5717
,	O	5717
with	O	5717
13	O	5717
of	O	5717
30	O	5717
(	O	5717
43	O	5717
%	O	5717
)	O	5717
cd	B-Disease	5717
mutations	O	5717
identified	O	5717
in	O	5717
this	O	5717
exon	O	5717
.	O	5717
germline	O	5719
pten	O	5719
mutations	O	5719
were	O	5719
identified	O	5719
in	O	5719
four	O	5719
of	O	5719
seven	O	5719
(	O	5719
57	O	5719
%	O	5719
)	O	5719
bzs	B-Disease	5719
families	O	5719
studied	O	5719
.	O	5719
it	O	5721
is	O	5721
also	O	5721
worthy	O	5721
of	O	5721
note	O	5721
that	O	5721
a	O	5721
single	O	5721
nonsense	O	5721
point	O	5721
mutation	O	5721
,	O	5721
r233x	O	5721
,	O	5721
was	O	5721
observed	O	5721
in	O	5721
the	O	5721
germline	O	5721
dna	O	5721
from	O	5721
two	O	5721
unrelated	O	5721
cd	B-Disease	5721
families	O	5721
and	O	5721
one	O	5721
bzs	B-Disease	5721
family	O	5721
.	O	5721
genotype	O	5722
-	O	5722
phenotype	O	5722
studies	O	5722
were	O	5722
not	O	5722
performed	O	5722
on	O	5722
this	O	5722
small	O	5722
group	O	5722
of	O	5722
bzs	B-Disease	5722
families	O	5722
.	O	5722
however	O	5723
,	O	5723
genotype	O	5723
-	O	5723
phenotype	O	5723
analysis	O	5723
inthe	O	5723
group	O	5723
of	O	5723
cd	B-Disease	5723
families	O	5723
revealed	O	5723
two	O	5723
possible	O	5723
associations	O	5723
worthy	O	5723
of	O	5723
follow	O	5723
-	O	5723
up	O	5723
in	O	5723
independent	O	5723
analyses	O	5723
.	O	5723
the	O	5724
first	O	5724
was	O	5724
an	O	5724
association	O	5724
noted	O	5724
in	O	5724
the	O	5724
group	O	5724
of	O	5724
cd	B-Disease	5724
families	O	5724
with	O	5724
breast	B-Disease	5724
disease	I-Disease	5724
.	O	5724
specifically	O	5726
and	O	5726
more	O	5726
directly	O	5726
,	O	5726
an	O	5726
association	O	5726
was	O	5726
also	O	5726
observed	O	5726
between	O	5726
the	O	5726
presence	O	5726
of	O	5726
a	O	5726
pten	O	5726
mutation	O	5726
and	O	5726
malignant	B-Disease	5726
breast	I-Disease	5726
disease	I-Disease	5726
.	O	5726
however	O	5728
,	O	5728
these	O	5728
observations	O	5728
would	O	5728
need	O	5728
to	O	5728
be	O	5728
confirmed	O	5728
by	O	5728
studying	O	5728
a	O	5728
larger	O	5728
number	O	5728
of	O	5728
cd	B-Disease	5728
families	O	5728
.	O	5728
molecular	O	5729
defects	O	5729
leading	O	5729
to	O	5729
human	O	5729
complement	B-Disease	5729
component	I-Disease	5729
c6	I-Disease	5729
deficiency	I-Disease	5729
in	O	5729
an	O	5729
african	O	5729
-	O	5729
american	O	5729
family	O	5729
.	O	5729
complement	B-Disease	5730
component	I-Disease	5730
c6	I-Disease	5730
deficiency	I-Disease	5730
(	O	5730
c6d	B-Disease	5730
)	O	5730
was	O	5730
diagnosed	O	5730
in	O	5730
a	O	5730
16	O	5730
-	O	5730
year	O	5730
-	O	5730
old	O	5730
african	O	5730
-	O	5730
american	O	5730
male	O	5730
with	O	5730
meningococcal	B-Disease	5730
meningitis	I-Disease	5730
.	O	5730
the	O	5731
patients	O	5731
father	O	5731
and	O	5731
two	O	5731
brothers	O	5731
also	O	5731
had	O	5731
c6d	B-Disease	5731
,	O	5731
but	O	5731
gave	O	5731
no	O	5731
history	O	5731
of	O	5731
meningitis	B-Disease	5731
or	O	5731
other	O	5731
neisserial	B-Disease	5731
infection	I-Disease	5731
.	O	5731
the	O	5733
first	O	5733
,	O	5733
1195delc	O	5733
located	O	5733
in	O	5733
exon	O	5733
7	O	5733
,	O	5733
is	O	5733
a	O	5733
novel	O	5733
mutation	O	5733
,	O	5733
while	O	5733
the	O	5733
second	O	5733
,	O	5733
1936delg	O	5733
in	O	5733
exon	O	5733
12	O	5733
,	O	5733
has	O	5733
been	O	5733
described	O	5733
before	O	5733
to	O	5733
cause	O	5733
c6d	B-Disease	5733
in	O	5733
an	O	5733
unrelated	O	5733
african	O	5733
-	O	5733
american	O	5733
individual	O	5733
.	O	5733
mutations	O	5737
in	O	5737
pax6	O	5737
are	O	5737
responsible	O	5737
for	O	5737
human	O	5737
aniridia	B-Disease	5737
and	O	5737
have	O	5737
also	O	5737
been	O	5737
found	O	5737
in	O	5737
patients	O	5737
with	O	5737
peters	B-Disease	5737
anomaly	I-Disease	5737
,	O	5737
with	O	5737
congenital	B-Disease	5737
cataracts	I-Disease	5737
,	O	5737
with	O	5737
autosomal	B-Disease	5737
dominant	I-Disease	5737
keratitis	I-Disease	5737
,	O	5737
and	O	5737
with	O	5737
isolated	B-Disease	5737
foveal	I-Disease	5737
hypoplasia	I-Disease	5737
.	O	5737
no	O	5738
locus	O	5738
other	O	5738
than	O	5738
chromosome	O	5738
11p13	O	5738
has	O	5738
been	O	5738
implicated	O	5738
in	O	5738
aniridia	B-Disease	5738
,	O	5738
and	O	5738
pax6	O	5738
is	O	5738
clearly	O	5738
the	O	5738
major	O	5738
,	O	5738
if	O	5738
not	O	5738
only	O	5738
,	O	5738
gene	O	5738
responsible	O	5738
.	O	5738
genetic	O	5744
heterogeneity	O	5744
and	O	5744
penetrance	O	5744
analysis	O	5744
of	O	5744
the	O	5744
brca1	O	5744
and	O	5744
brca2	O	5744
genes	O	5744
in	O	5744
breast	B-Disease	5744
cancer	I-Disease	5744
families	O	5744
.	O	5744
the	O	5745
breast	B-Disease	5745
cancer	I-Disease	5745
linkage	O	5745
consortium	O	5745
.	O	5745
the	O	5746
contribution	O	5746
of	O	5746
brca1	O	5746
and	O	5746
brca2	O	5746
to	O	5746
inherited	B-Disease	5746
breast	I-Disease	5746
cancer	I-Disease	5746
was	O	5746
assessed	O	5746
by	O	5746
linkage	O	5746
and	O	5746
mutation	O	5746
analysis	O	5746
in	O	5746
237	O	5746
families	O	5746
,	O	5746
each	O	5746
with	O	5746
at	O	5746
least	O	5746
four	O	5746
cases	O	5746
of	O	5746
breast	B-Disease	5746
cancer	I-Disease	5746
,	O	5746
collected	O	5746
by	O	5746
the	O	5746
breast	B-Disease	5746
cancer	I-Disease	5746
linkage	O	5746
consortium	O	5746
.	O	5746
families	O	5747
were	O	5747
included	O	5747
without	O	5747
regard	O	5747
to	O	5747
the	O	5747
occurrence	O	5747
of	O	5747
ovarian	B-Disease	5747
or	I-Disease	5747
other	I-Disease	5747
cancers	I-Disease	5747
.	O	5747
the	O	5749
majority	O	5749
(	O	5749
81	O	5749
%	O	5749
)	O	5749
of	O	5749
the	O	5749
breast	B-Disease	5749
-	I-Disease	5749
ovarian	I-Disease	5749
cancer	I-Disease	5749
families	O	5749
were	O	5749
due	O	5749
to	O	5749
brca1	O	5749
,	O	5749
with	O	5749
most	O	5749
others	O	5749
(	O	5749
14	O	5749
%	O	5749
)	O	5749
due	O	5749
to	O	5749
brca2	O	5749
.	O	5749
conversely	O	5750
,	O	5750
the	O	5750
majority	O	5750
of	O	5750
families	O	5750
with	O	5750
male	B-Disease	5750
and	I-Disease	5750
female	I-Disease	5750
breast	I-Disease	5750
cancer	I-Disease	5750
were	O	5750
due	O	5750
to	O	5750
brca2	O	5750
(	O	5750
76	O	5750
%	O	5750
)	O	5750
.	O	5750
the	O	5751
largest	O	5751
proportion	O	5751
(	O	5751
67	O	5751
%	O	5751
)	O	5751
of	O	5751
families	O	5751
due	O	5751
to	O	5751
other	O	5751
genes	O	5751
was	O	5751
found	O	5751
in	O	5751
families	O	5751
with	O	5751
four	O	5751
or	O	5751
five	O	5751
cases	O	5751
of	O	5751
female	O	5751
breast	B-Disease	5751
cancer	I-Disease	5751
only	O	5751
.	O	5751
the	O	5756
estimated	O	5756
cumulative	O	5756
risk	O	5756
of	O	5756
breast	B-Disease	5756
cancer	I-Disease	5756
reached	O	5756
28	O	5756
%	O	5756
(	O	5756
95	O	5756
%	O	5756
ci	O	5756
9	O	5756
%	O	5756
-	O	5756
44	O	5756
%	O	5756
)	O	5756
by	O	5756
age	O	5756
50	O	5756
years	O	5756
and	O	5756
84	O	5756
%	O	5756
(	O	5756
95	O	5756
%	O	5756
ci	O	5756
43	O	5756
%	O	5756
-	O	5756
95	O	5756
%	O	5756
)	O	5756
by	O	5756
age	O	5756
70	O	5756
years	O	5756
.	O	5756
the	O	5757
corresponding	O	5757
ovarian	B-Disease	5757
cancer	I-Disease	5757
risks	O	5757
were	O	5757
0	O	5757
.	O	5757
the	O	5759
lifetime	O	5759
risk	O	5759
of	O	5759
breast	B-Disease	5759
cancer	I-Disease	5759
appears	O	5759
similar	O	5759
to	O	5759
the	O	5759
risk	O	5759
in	O	5759
brca1	O	5759
carriers	O	5759
,	O	5759
but	O	5759
there	O	5759
was	O	5759
some	O	5759
suggestion	O	5759
of	O	5759
a	O	5759
lower	O	5759
risk	O	5759
in	O	5759
brca2	O	5759
carriers	O	5759
<	O	5759
50	O	5759
years	O	5759
of	O	5759
age	O	5759
.	O	5759
eye	B-Disease	5760
movement	I-Disease	5760
abnormalities	I-Disease	5760
correlate	O	5760
with	O	5760
genotype	O	5760
in	O	5760
autosomal	O	5760
dominant	O	5760
cerebellar	B-Disease	5760
ataxia	I-Disease	5760
type	I-Disease	5760
i	I-Disease	5760
.	O	5760
we	O	5761
compared	O	5761
horizontal	O	5761
eye	O	5761
movements	O	5761
(	O	5761
visually	O	5761
guided	O	5761
saccades	O	5761
,	O	5761
antisaccades	O	5761
,	O	5761
and	O	5761
smooth	O	5761
pursuit	O	5761
)	O	5761
in	O	5761
control	O	5761
subjects	O	5761
(	O	5761
n	O	5761
=	O	5761
14	O	5761
)	O	5761
and	O	5761
patients	O	5761
with	O	5761
three	O	5761
forms	O	5761
of	O	5761
autosomal	O	5761
dominant	O	5761
cerebellar	B-Disease	5761
ataxias	I-Disease	5761
type	I-Disease	5761
i	I-Disease	5761
spinocerebellar	B-Disease	5761
ataxias	I-Disease	5761
1	I-Disease	5761
and	I-Disease	5761
2	I-Disease	5761
(	O	5761
sca1	B-Disease	5761
,	O	5761
n	O	5761
=	O	5761
11	O	5761
;	O	5761
sca2	B-Disease	5761
,	O	5761
n	O	5761
=	O	5761
10	O	5761
)	O	5761
and	O	5761
sca3	B-Disease	5761
/	O	5761
machado	B-Disease	5761
-	I-Disease	5761
joseph	I-Disease	5761
disease	I-Disease	5761
(	O	5761
mjd	B-Disease	5761
)	O	5761
(	O	5761
n	O	5761
=	O	5761
16	O	5761
)	O	5761
.	O	5761
in	O	5762
sca1	B-Disease	5762
,	O	5762
saccade	O	5762
amplitude	O	5762
was	O	5762
significantly	O	5762
increased	O	5762
,	O	5762
resulting	O	5762
in	O	5762
hypermetria	B-Disease	5762
.	O	5762
in	O	5764
sca2	B-Disease	5764
,	O	5764
saccade	O	5764
velocity	O	5764
was	O	5764
markedly	O	5764
decreased	O	5764
.	O	5764
in	O	5767
sca3	B-Disease	5767
,	O	5767
gaze	B-Disease	5767
-	I-Disease	5767
evoked	I-Disease	5767
nystagmus	I-Disease	5767
was	O	5767
often	O	5767
present	O	5767
as	O	5767
was	O	5767
saccade	O	5767
hypometria	O	5767
and	O	5767
smooth	O	5767
pursuit	O	5767
gain	O	5767
was	O	5767
markedly	O	5767
decreased	O	5767
.	O	5767
three	O	5768
major	O	5768
criteria	O	5768
,	O	5768
saccade	O	5768
amplitude	O	5768
,	O	5768
saccade	O	5768
velocity	O	5768
,	O	5768
and	O	5768
presence	O	5768
of	O	5768
gaze	B-Disease	5768
-	I-Disease	5768
evoked	I-Disease	5768
nystagmus	I-Disease	5768
,	O	5768
permitted	O	5768
the	O	5768
correct	O	5768
assignment	O	5768
of	O	5768
90	O	5768
%	O	5768
of	O	5768
the	O	5768
sca1	B-Disease	5768
,	O	5768
90	O	5768
%	O	5768
of	O	5768
the	O	5768
sca2	B-Disease	5768
,	O	5768
and	O	5768
93	O	5768
%	O	5768
of	O	5768
the	O	5768
patients	O	5768
with	O	5768
sca3	B-Disease	5768
to	O	5768
their	O	5768
genetically	O	5768
confirmed	O	5768
patient	O	5768
group	O	5768
and	O	5768
,	O	5768
therefore	O	5768
,	O	5768
may	O	5768
help	O	5768
orient	O	5768
diagnoses	O	5768
of	O	5768
sca1	B-Disease	5768
,	O	5768
sca2	B-Disease	5768
,	O	5768
and	O	5768
sca3	B-Disease	5768
at	O	5768
early	O	5768
clinical	O	5768
stages	O	5768
of	O	5768
the	O	5768
diseases	O	5768
.	O	5768
.	O	5768
genetic	O	5769
basis	O	5769
and	O	5769
molecular	O	5769
mechanism	O	5769
for	O	5769
idiopathic	B-Disease	5769
ventricular	I-Disease	5769
fibrillation	I-Disease	5769
.	O	5769
ventricular	B-Disease	5770
fibrillation	I-Disease	5770
causes	O	5770
more	O	5770
than	O	5770
300	O	5770
,	O	5770
000	O	5770
sudden	O	5770
deaths	O	5770
each	O	5770
year	O	5770
in	O	5770
the	O	5770
usa	O	5770
alone	O	5770
.	O	5770
in	O	5771
approximately	O	5771
5	O	5771
-	O	5771
12	O	5771
%	O	5771
of	O	5771
these	O	5771
cases	O	5771
,	O	5771
there	O	5771
are	O	5771
no	O	5771
demonstrable	O	5771
cardiac	O	5771
or	O	5771
non	O	5771
-	O	5771
cardiac	O	5771
causes	O	5771
to	O	5771
account	O	5771
for	O	5771
the	O	5771
episode	O	5771
,	O	5771
which	O	5771
is	O	5771
therefore	O	5771
classified	O	5771
as	O	5771
idiopathic	B-Disease	5771
ventricular	I-Disease	5771
fibrillation	I-Disease	5771
(	O	5771
ivf	B-Disease	5771
)	O	5771
.	O	5771
a	O	5772
distinct	O	5772
group	O	5772
of	O	5772
ivf	B-Disease	5772
patients	O	5772
has	O	5772
been	O	5772
found	O	5772
to	O	5772
present	O	5772
with	O	5772
a	O	5772
characteristic	O	5772
electrocardiographic	O	5772
pattern	O	5772
.	O	5772
because	O	5773
of	O	5773
the	O	5773
small	O	5773
size	O	5773
of	O	5773
most	O	5773
pedigrees	O	5773
and	O	5773
the	O	5773
high	O	5773
incidence	O	5773
of	O	5773
sudden	B-Disease	5773
death	I-Disease	5773
,	O	5773
however	O	5773
,	O	5773
molecular	O	5773
genetic	O	5773
studies	O	5773
of	O	5773
ivf	B-Disease	5773
have	O	5773
not	O	5773
yet	O	5773
been	O	5773
done	O	5773
.	O	5773
because	O	5774
ivf	B-Disease	5774
causes	O	5774
cardiac	O	5774
rhythm	O	5774
disturbance	O	5774
,	O	5774
we	O	5774
investigated	O	5774
whether	O	5774
malfunction	O	5774
of	O	5774
ion	O	5774
channels	O	5774
could	O	5774
cause	O	5774
the	O	5774
disorder	O	5774
by	O	5774
studying	O	5774
mutations	O	5774
in	O	5774
the	O	5774
cardiac	O	5774
sodium	O	5774
channel	O	5774
gene	O	5774
scn5a	O	5774
.	O	5774
we	O	5775
have	O	5775
now	O	5775
identified	O	5775
a	O	5775
missense	O	5775
mutation	O	5775
,	O	5775
a	O	5775
splice	O	5775
-	O	5775
donor	O	5775
mutation	O	5775
,	O	5775
and	O	5775
a	O	5775
frameshift	O	5775
mutation	O	5775
in	O	5775
the	O	5775
coding	O	5775
region	O	5775
of	O	5775
scn5a	O	5775
in	O	5775
three	O	5775
ivf	B-Disease	5775
families	O	5775
.	O	5775
our	O	5777
results	O	5777
indicate	O	5777
that	O	5777
mutations	O	5777
in	O	5777
cardiac	O	5777
ion	O	5777
-	O	5777
channel	O	5777
genes	O	5777
contribute	O	5777
to	O	5777
the	O	5777
risk	O	5777
of	O	5777
developing	O	5777
ivf	B-Disease	5777
.	O	5777
.	O	5777
molecular	O	5778
heterogeneity	O	5778
in	O	5778
mucopolysaccharidosis	B-Disease	5778
iva	I-Disease	5778
in	O	5778
australia	O	5778
and	O	5778
northern	O	5778
ireland	O	5778
:	O	5778
nine	O	5778
novel	O	5778
mutations	O	5778
including	O	5778
t312s	O	5778
,	O	5778
a	O	5778
common	O	5778
allele	O	5778
that	O	5778
confers	O	5778
a	O	5778
mild	O	5778
phenotype	O	5778
.	O	5778
mucopolysaccharidosis	B-Disease	5779
iva	I-Disease	5779
(	O	5779
mps	B-Disease	5779
iva	I-Disease	5779
)	O	5779
is	O	5779
an	O	5779
autosomal	B-Disease	5779
recessive	I-Disease	5779
lysosomal	I-Disease	5779
storage	I-Disease	5779
disorder	I-Disease	5779
caused	O	5779
by	O	5779
a	O	5779
genetic	B-Disease	5779
defect	I-Disease	5779
in	O	5779
n	O	5779
-	O	5779
acetylgalactosamine	O	5779
-	O	5779
6	O	5779
-	O	5779
sulfate	O	5779
sulfatase	O	5779
(	O	5779
galns	O	5779
)	O	5779
.	O	5779
previous	O	5780
studies	O	5780
of	O	5780
patients	O	5780
from	O	5780
a	O	5780
british	O	5780
-	O	5780
irish	O	5780
population	O	5780
showed	O	5780
that	O	5780
the	O	5780
i113f	O	5780
mutation	O	5780
is	O	5780
the	O	5780
most	O	5780
common	O	5780
single	O	5780
mutation	O	5780
among	O	5780
mps	B-Disease	5780
iva	I-Disease	5780
patients	O	5780
and	O	5780
produces	O	5780
a	O	5780
severe	O	5780
clinical	O	5780
phenotype	O	5780
.	O	5780
we	O	5781
studied	O	5781
mutations	O	5781
in	O	5781
the	O	5781
galns	O	5781
gene	O	5781
from	O	5781
23	O	5781
additional	O	5781
mps	B-Disease	5781
iva	I-Disease	5781
patients	O	5781
(	O	5781
15	O	5781
from	O	5781
australia	O	5781
,	O	5781
8	O	5781
from	O	5781
northern	O	5781
ireland	O	5781
)	O	5781
,	O	5781
with	O	5781
various	O	5781
clinical	O	5781
phenotypes	O	5781
(	O	5781
severe	O	5781
,	O	5781
16	O	5781
cases	O	5781
;	O	5781
intermediate	O	5781
,	O	5781
4	O	5781
cases	O	5781
;	O	5781
mild	O	5781
,	O	5781
3	O	5781
cases	O	5781
)	O	5781
.	O	5781
these	O	5790
data	O	5790
provide	O	5790
further	O	5790
evidence	O	5790
for	O	5790
extensive	O	5790
allelic	O	5790
heterogeneity	O	5790
in	O	5790
mps	B-Disease	5790
iva	I-Disease	5790
in	O	5790
british	O	5790
-	O	5790
irish	O	5790
patients	O	5790
and	O	5790
provide	O	5790
evidence	O	5790
for	O	5790
their	O	5790
transmission	O	5790
to	O	5790
australia	O	5790
by	O	5790
british	O	5790
-	O	5790
irish	O	5790
migrants	O	5790
.	O	5790
.	O	5790
identification	O	5791
of	O	5791
constitutional	O	5791
wt1	O	5791
mutations	O	5791
,	O	5791
in	O	5791
patients	O	5791
with	O	5791
isolated	O	5791
diffuse	B-Disease	5791
mesangial	I-Disease	5791
sclerosis	I-Disease	5791
,	O	5791
and	O	5791
analysis	O	5791
of	O	5791
genotype	O	5791
/	O	5791
phenotype	O	5791
correlations	O	5791
by	O	5791
use	O	5791
of	O	5791
a	O	5791
computerized	O	5791
mutation	O	5791
database	O	5791
.	O	5791
constitutional	O	5792
mutations	O	5792
of	O	5792
the	O	5792
wt1	O	5792
gene	O	5792
,	O	5792
encoding	O	5792
a	O	5792
zinc	O	5792
-	O	5792
finger	O	5792
transcription	O	5792
factor	O	5792
involved	O	5792
in	O	5792
renal	O	5792
and	O	5792
gonadal	O	5792
development	O	5792
,	O	5792
are	O	5792
found	O	5792
in	O	5792
most	O	5792
patients	O	5792
with	O	5792
denys	B-Disease	5792
-	I-Disease	5792
drash	I-Disease	5792
syndrome	I-Disease	5792
(	O	5792
dds	B-Disease	5792
)	O	5792
,	O	5792
or	O	5792
diffuse	B-Disease	5792
mesangial	I-Disease	5792
sclerosis	I-Disease	5792
(	O	5792
dms	B-Disease	5792
)	O	5792
associated	O	5792
with	O	5792
pseudohermaphroditism	B-Disease	5792
and	O	5792
/	O	5792
or	O	5792
wilms	B-Disease	5792
tumor	I-Disease	5792
(	O	5792
wt	B-Disease	5792
)	O	5792
.	O	5792
most	O	5793
mutations	O	5793
in	O	5793
dds	B-Disease	5793
patients	O	5793
lie	O	5793
in	O	5793
exon	O	5793
8	O	5793
or	O	5793
exon	O	5793
9	O	5793
,	O	5793
encoding	O	5793
zinc	O	5793
finger	O	5793
2	O	5793
or	O	5793
zinc	O	5793
finger	O	5793
3	O	5793
,	O	5793
respectively	O	5793
,	O	5793
with	O	5793
a	O	5793
hot	O	5793
spot	O	5793
(	O	5793
r394w	O	5793
)	O	5793
in	O	5793
exon	O	5793
9	O	5793
.	O	5793
we	O	5794
analyzed	O	5794
a	O	5794
series	O	5794
of	O	5794
24	O	5794
patients	O	5794
,	O	5794
10	O	5794
with	O	5794
isolated	B-Disease	5794
dms	I-Disease	5794
(	O	5794
idms	B-Disease	5794
)	O	5794
,	O	5794
10	O	5794
with	O	5794
dds	B-Disease	5794
,	O	5794
and	O	5794
4	O	5794
with	O	5794
urogenital	B-Disease	5794
abnormalities	I-Disease	5794
and	O	5794
/	O	5794
or	O	5794
wt	B-Disease	5794
.	O	5794
we	O	5795
report	O	5795
wt1	O	5795
heterozygous	O	5795
mutations	O	5795
in	O	5795
16	O	5795
patients	O	5795
,	O	5795
4	O	5795
of	O	5795
whom	O	5795
presented	O	5795
with	O	5795
idms	B-Disease	5795
.	O	5795
one	O	5796
male	O	5796
and	O	5796
two	O	5796
female	O	5796
idms	B-Disease	5796
patients	O	5796
with	O	5796
wt1	O	5796
mutations	O	5796
underwent	O	5796
normal	O	5796
puberty	O	5796
.	O	5796
two	O	5797
mutations	O	5797
associated	O	5797
with	O	5797
idms	B-Disease	5797
are	O	5797
different	O	5797
from	O	5797
those	O	5797
described	O	5797
in	O	5797
dds	B-Disease	5797
patients	O	5797
.	O	5797
no	O	5798
wt1	O	5798
mutations	O	5798
were	O	5798
detected	O	5798
in	O	5798
the	O	5798
six	O	5798
other	O	5798
idms	B-Disease	5798
patients	O	5798
,	O	5798
suggesting	O	5798
genetic	O	5798
heterogeneity	O	5798
of	O	5798
this	O	5798
disease	O	5798
.	O	5798
this	O	5800
demonstrated	O	5800
(	O	5800
1	O	5800
)	O	5800
the	O	5800
association	O	5800
between	O	5800
mutations	O	5800
in	O	5800
exons	O	5800
8	O	5800
and	O	5800
9	O	5800
and	O	5800
dms	B-Disease	5800
;	O	5800
(	O	5800
2	O	5800
)	O	5800
among	O	5800
patients	O	5800
with	O	5800
dms	B-Disease	5800
,	O	5800
a	O	5800
higher	O	5800
frequency	O	5800
of	O	5800
exon	O	5800
8	O	5800
mutations	O	5800
among	O	5800
46	O	5800
,	O	5800
xy	O	5800
patients	O	5800
with	O	5800
female	O	5800
phenotype	O	5800
than	O	5800
among	O	5800
46	O	5800
,	O	5800
xy	O	5800
patients	O	5800
with	O	5800
sexual	O	5800
ambiguity	O	5800
or	O	5800
male	O	5800
phenotype	O	5800
;	O	5800
and	O	5800
(	O	5800
3	O	5800
)	O	5800
statistically	O	5800
significant	O	5800
evidence	O	5800
that	O	5800
mutations	O	5800
in	O	5800
exons	O	5800
8	O	5800
and	O	5800
9	O	5800
preferentially	O	5800
affect	O	5800
amino	O	5800
acids	O	5800
with	O	5800
different	O	5800
functions	O	5800
.	O	5800
.	O	5800
the	O	5802
185delag	O	5802
mutation	O	5802
in	O	5802
brca1	O	5802
is	O	5802
detected	O	5802
in	O	5802
ashkenazi	O	5802
jews	O	5802
both	O	5802
in	O	5802
familial	B-Disease	5802
breast	I-Disease	5802
and	I-Disease	5802
ovarian	I-Disease	5802
cancer	I-Disease	5802
and	O	5802
in	O	5802
the	O	5802
general	O	5802
population	O	5802
.	O	5802
brca1	O	5808
allelic	O	5808
patterns	O	5808
were	O	5808
determined	O	5808
for	O	5808
four	O	5808
of	O	5808
these	O	5808
individuals	O	5808
and	O	5808
for	O	5808
12	O	5808
additional	O	5808
non	O	5808
-	O	5808
ashkenazi	O	5808
185delag	O	5808
mutation	O	5808
carriers	O	5808
who	O	5808
had	O	5808
breast	B-Disease	5808
/	I-Disease	5808
ovarian	I-Disease	5808
cancer	I-Disease	5808
.	O	5808
crystal	O	5813
structure	O	5813
of	O	5813
the	O	5813
hemochromatosis	B-Disease	5813
protein	O	5813
hfe	O	5813
and	O	5813
characterization	O	5813
of	O	5813
its	O	5813
interaction	O	5813
with	O	5813
transferrin	O	5813
receptor	O	5813
.	O	5813
hfe	O	5814
is	O	5814
an	O	5814
mhc	O	5814
-	O	5814
related	O	5814
protein	O	5814
that	O	5814
is	O	5814
mutated	O	5814
in	O	5814
the	O	5814
iron	B-Disease	5814
-	I-Disease	5814
overload	I-Disease	5814
disease	I-Disease	5814
hereditary	B-Disease	5814
hemochromatosis	I-Disease	5814
.	O	5814
6	O	5817
a	O	5817
crystal	O	5817
structure	O	5817
of	O	5817
hfe	O	5817
reveals	O	5817
the	O	5817
locations	O	5817
of	O	5817
hemochromatosis	B-Disease	5817
mutations	O	5817
and	O	5817
a	O	5817
patch	O	5817
of	O	5817
histidines	O	5817
that	O	5817
could	O	5817
be	O	5817
involved	O	5817
in	O	5817
ph	O	5817
-	O	5817
dependent	O	5817
interactions	O	5817
.	O	5817
identification	O	5820
of	O	5820
three	O	5820
novel	O	5820
mutations	O	5820
and	O	5820
a	O	5820
high	O	5820
frequency	O	5820
of	O	5820
the	O	5820
arg778leu	O	5820
mutation	O	5820
in	O	5820
korean	O	5820
patients	O	5820
with	O	5820
wilson	B-Disease	5820
disease	I-Disease	5820
.	O	5820
four	O	5821
mutations	O	5821
-	O	5821
-	O	5821
r778l	O	5821
,	O	5821
a874v	O	5821
,	O	5821
l1083f	O	5821
,	O	5821
and	O	5821
2304delc	O	5821
-	O	5821
-	O	5821
in	O	5821
the	O	5821
copper	O	5821
-	O	5821
transporting	O	5821
enzyme	O	5821
,	O	5821
p	O	5821
-	O	5821
type	O	5821
atpase	O	5821
(	O	5821
atp7b	O	5821
)	O	5821
,	O	5821
were	O	5821
identified	O	5821
in	O	5821
korean	O	5821
patients	O	5821
with	O	5821
wilson	B-Disease	5821
disease	I-Disease	5821
.	O	5821
since	O	5825
a	O	5825
mutation	O	5825
at	O	5825
cdna	O	5825
nucleotide	O	5825
2302	O	5825
(	O	5825
2302insc	O	5825
)	O	5825
had	O	5825
been	O	5825
previously	O	5825
described	O	5825
,	O	5825
this	O	5825
region	O	5825
of	O	5825
the	O	5825
atp7b	O	5825
gene	O	5825
may	O	5825
be	O	5825
susceptible	O	5825
to	O	5825
gene	O	5825
rearrangements	O	5825
causing	O	5825
wilson	B-Disease	5825
disease	I-Disease	5825
.	O	5825
disruption	O	5826
of	O	5826
splicing	O	5826
regulated	O	5826
by	O	5826
a	O	5826
cug	O	5826
-	O	5826
binding	O	5826
protein	O	5826
in	O	5826
myotonic	B-Disease	5826
dystrophy	I-Disease	5826
.	O	5826
myotonic	B-Disease	5827
dystrophy	I-Disease	5827
(	O	5827
dm	B-Disease	5827
)	O	5827
is	O	5827
caused	O	5827
by	O	5827
a	O	5827
ctg	O	5827
expansion	O	5827
in	O	5827
the	O	5827
3	O	5827
untranslated	O	5827
region	O	5827
of	O	5827
the	O	5827
dm	B-Disease	5827
gene	O	5827
.	O	5827
one	O	5828
model	O	5828
of	O	5828
dm	B-Disease	5828
pathogenesis	O	5828
suggests	O	5828
that	O	5828
rnas	O	5828
from	O	5828
the	O	5828
expanded	O	5828
allele	O	5828
create	O	5828
a	O	5828
gain	O	5828
-	O	5828
of	O	5828
-	O	5828
function	O	5828
mutation	O	5828
by	O	5828
the	O	5828
inappropriate	O	5828
binding	O	5828
of	O	5828
proteins	O	5828
to	O	5828
the	O	5828
cug	O	5828
repeats	O	5828
.	O	5828
splicing	O	5831
of	O	5831
ctnt	O	5831
was	O	5831
disrupted	O	5831
in	O	5831
dm	B-Disease	5831
striated	O	5831
muscle	O	5831
and	O	5831
in	O	5831
normal	O	5831
cells	O	5831
expressing	O	5831
transcripts	O	5831
that	O	5831
contain	O	5831
cug	O	5831
repeats	O	5831
.	O	5831
altered	O	5832
expression	O	5832
of	O	5832
genes	O	5832
regulated	O	5832
posttranscriptionally	O	5832
by	O	5832
cug	O	5832
-	O	5832
bp	O	5832
therefore	O	5832
may	O	5832
contribute	O	5832
to	O	5832
dm	B-Disease	5832
pathogenesis	O	5832
.	O	5832
.	O	5832
identification	O	5833
of	O	5833
a	O	5833
novel	O	5833
nonsense	O	5833
mutation	O	5833
and	O	5833
a	O	5833
missense	O	5833
substitution	O	5833
in	O	5833
the	O	5833
vasopressin	O	5833
-	O	5833
neurophysin	O	5833
ii	O	5833
gene	O	5833
in	O	5833
two	O	5833
spanish	O	5833
kindreds	O	5833
with	O	5833
familial	B-Disease	5833
neurohypophyseal	I-Disease	5833
diabetes	I-Disease	5833
insipidus	I-Disease	5833
.	O	5833
familial	B-Disease	5834
neurohypophyseal	I-Disease	5834
diabetes	I-Disease	5834
insipidus	I-Disease	5834
(	O	5834
fndi	B-Disease	5834
)	O	5834
is	O	5834
an	O	5834
autosomal	B-Disease	5834
dominant	I-Disease	5834
disease	I-Disease	5834
caused	O	5834
by	O	5834
deficiency	O	5834
in	O	5834
the	O	5834
antidiuretic	O	5834
hormone	O	5834
arginine	O	5834
vasopressin	O	5834
(	O	5834
avp	O	5834
)	O	5834
encoded	O	5834
by	O	5834
the	O	5834
avp	O	5834
-	O	5834
neurophysin	O	5834
ii	O	5834
(	O	5834
avp	O	5834
-	O	5834
npii	O	5834
)	O	5834
gene	O	5834
on	O	5834
chromosome	O	5834
20p13	O	5834
.	O	5834
in	O	5835
this	O	5835
study	O	5835
,	O	5835
we	O	5835
analyzed	O	5835
two	O	5835
families	O	5835
with	O	5835
fndi	B-Disease	5835
using	O	5835
direct	O	5835
automated	O	5835
fluorescent	O	5835
,	O	5835
solid	O	5835
phase	O	5835
,	O	5835
single	O	5835
-	O	5835
stranded	O	5835
dna	O	5835
sequencing	O	5835
of	O	5835
pcr	O	5835
-	O	5835
amplified	O	5835
avp	O	5835
-	O	5835
npii	O	5835
dna	O	5835
.	O	5835
this	O	5839
missense	O	5839
mutation	O	5839
,	O	5839
which	O	5839
replaces	O	5839
ala	O	5839
with	O	5839
thr	O	5839
,	O	5839
is	O	5839
frequent	O	5839
among	O	5839
fndi	B-Disease	5839
patients	O	5839
and	O	5839
is	O	5839
thought	O	5839
to	O	5839
reduce	O	5839
the	O	5839
efficiency	O	5839
of	O	5839
cleavage	O	5839
by	O	5839
signal	O	5839
peptidases	O	5839
.	O	5839
.	O	5839
genetic	O	5840
heterogeneity	O	5840
of	O	5840
saethre	B-Disease	5840
-	I-Disease	5840
chotzen	I-Disease	5840
syndrome	I-Disease	5840
,	O	5840
due	O	5840
to	O	5840
twist	O	5840
and	O	5840
fgfr	O	5840
mutations	O	5840
.	O	5840
thirty	O	5841
-	O	5841
two	O	5841
unrelated	O	5841
patients	O	5841
with	O	5841
features	O	5841
of	O	5841
saethre	B-Disease	5841
-	I-Disease	5841
chotzen	I-Disease	5841
syndrome	I-Disease	5841
,	O	5841
a	O	5841
common	O	5841
autosomal	B-Disease	5841
dominant	I-Disease	5841
condition	I-Disease	5841
of	O	5841
craniosynostosis	B-Disease	5841
and	O	5841
limb	B-Disease	5841
anomalies	I-Disease	5841
,	O	5841
were	O	5841
screened	O	5841
for	O	5841
mutations	O	5841
in	O	5841
twist	O	5841
,	O	5841
fgfr2	O	5841
,	O	5841
and	O	5841
fgfr3	O	5841
.	O	5841
to	O	5844
date	O	5844
,	O	5844
our	O	5844
detection	O	5844
rate	O	5844
for	O	5844
twist	O	5844
or	O	5844
fgfr	O	5844
mutations	O	5844
is	O	5844
68	O	5844
%	O	5844
in	O	5844
our	O	5844
saethre	B-Disease	5844
-	I-Disease	5844
chotzen	I-Disease	5844
syndrome	I-Disease	5844
patients	O	5844
,	O	5844
including	O	5844
our	O	5844
five	O	5844
patients	O	5844
elsewhere	O	5844
reported	O	5844
with	O	5844
twist	O	5844
mutations	O	5844
.	O	5844
the	O	5846
most	O	5846
common	O	5846
phenotypic	O	5846
features	O	5846
,	O	5846
present	O	5846
in	O	5846
more	O	5846
than	O	5846
a	O	5846
third	O	5846
of	O	5846
our	O	5846
patients	O	5846
with	O	5846
twist	O	5846
mutations	O	5846
,	O	5846
are	O	5846
coronal	B-Disease	5846
synostosis	I-Disease	5846
,	O	5846
brachycephaly	B-Disease	5846
,	O	5846
low	B-Disease	5846
frontal	I-Disease	5846
hairline	I-Disease	5846
,	O	5846
facial	B-Disease	5846
asymmetry	I-Disease	5846
,	O	5846
ptosis	B-Disease	5846
,	O	5846
hypertelorism	B-Disease	5846
,	O	5846
broad	B-Disease	5846
great	I-Disease	5846
toes	I-Disease	5846
,	O	5846
and	O	5846
clinodactyly	B-Disease	5846
.	O	5846
the	O	5848
overlap	O	5848
in	O	5848
clinical	O	5848
features	O	5848
and	O	5848
the	O	5848
presence	O	5848
,	O	5848
in	O	5848
the	O	5848
same	O	5848
genes	O	5848
,	O	5848
of	O	5848
mutations	O	5848
for	O	5848
more	O	5848
than	O	5848
one	O	5848
craniosynostotic	B-Disease	5848
condition	I-Disease	5848
-	O	5848
such	O	5848
as	O	5848
saethre	B-Disease	5848
-	I-Disease	5848
chotzen	I-Disease	5848
,	I-Disease	5848
crouzon	I-Disease	5848
,	I-Disease	5848
and	I-Disease	5848
pfeiffer	I-Disease	5848
syndromes	I-Disease	5848
-	O	5848
support	O	5848
the	O	5848
hypothesis	O	5848
that	O	5848
twist	O	5848
and	O	5848
fgfrs	O	5848
are	O	5848
components	O	5848
of	O	5848
the	O	5848
same	O	5848
molecular	O	5848
pathway	O	5848
involved	O	5848
in	O	5848
the	O	5848
modulation	O	5848
of	O	5848
craniofacial	O	5848
and	O	5848
limb	O	5848
development	O	5848
in	O	5848
humans	O	5848
.	O	5848
.	O	5848
mutation	O	5849
analysis	O	5849
of	O	5849
ube3a	O	5849
in	O	5849
angelman	B-Disease	5849
syndrome	I-Disease	5849
patients	O	5849
.	O	5849
angelman	B-Disease	5850
syndrome	I-Disease	5850
(	O	5850
as	B-Disease	5850
)	O	5850
is	O	5850
caused	O	5850
by	O	5850
chromosome	O	5850
15q11	O	5850
-	O	5850
q13	O	5850
deletions	O	5850
of	O	5850
maternal	O	5850
origin	O	5850
,	O	5850
by	O	5850
paternal	O	5850
uniparental	B-Disease	5850
disomy	I-Disease	5850
(	O	5850
upd	B-Disease	5850
)	O	5850
15	O	5850
,	O	5850
by	O	5850
imprinting	O	5850
defects	O	5850
,	O	5850
and	O	5850
by	O	5850
mutations	O	5850
in	O	5850
the	O	5850
ube3a	O	5850
gene	O	5850
.	O	5850
here	O	5852
we	O	5852
describe	O	5852
ube3a	O	5852
coding	O	5852
-	O	5852
region	O	5852
mutations	O	5852
detected	O	5852
by	O	5852
sscp	O	5852
analysis	O	5852
in	O	5852
13	O	5852
as	B-Disease	5852
individuals	O	5852
or	O	5852
families	O	5852
.	O	5852
in	O	5856
two	O	5856
familial	O	5856
cases	O	5856
and	O	5856
one	O	5856
sporadic	O	5856
case	O	5856
,	O	5856
mosaicism	O	5856
for	O	5856
ube3a	O	5856
mutations	O	5856
was	O	5856
detected	O	5856
in	O	5856
the	O	5856
mother	O	5856
of	O	5856
three	O	5856
as	B-Disease	5856
sons	O	5856
,	O	5856
in	O	5856
the	O	5856
maternal	O	5856
grandfather	O	5856
of	O	5856
two	O	5856
as	B-Disease	5856
first	O	5856
cousins	O	5856
,	O	5856
and	O	5856
in	O	5856
the	O	5856
mother	O	5856
of	O	5856
an	O	5856
as	B-Disease	5856
daughter	O	5856
.	O	5856
the	O	5858
hemochromatosis	B-Disease	5858
845	O	5858
g	O	5858
-	O	5858
-	O	5858
>	O	5858
a	O	5858
and	O	5858
187	O	5858
c	O	5858
-	O	5858
-	O	5858
>	O	5858
g	O	5858
mutations	O	5858
:	O	5858
prevalence	O	5858
in	O	5858
non	O	5858
-	O	5858
caucasian	O	5858
populations	O	5858
.	O	5858
hemochromatosis	B-Disease	5859
,	O	5859
the	O	5859
inherited	B-Disease	5859
disorder	I-Disease	5859
of	I-Disease	5859
iron	I-Disease	5859
metabolism	I-Disease	5859
,	O	5859
leads	O	5859
,	O	5859
if	O	5859
untreated	O	5859
,	O	5859
to	O	5859
progressive	O	5859
iron	B-Disease	5859
overload	I-Disease	5859
and	O	5859
premature	B-Disease	5859
death	I-Disease	5859
.	O	5859
the	O	5860
hemochromatosis	B-Disease	5860
gene	O	5860
,	O	5860
hfe	O	5860
,	O	5860
recently	O	5860
has	O	5860
been	O	5860
identified	O	5860
,	O	5860
and	O	5860
characterization	O	5860
of	O	5860
this	O	5860
gene	O	5860
has	O	5860
shown	O	5860
that	O	5860
it	O	5860
contains	O	5860
two	O	5860
mutations	O	5860
that	O	5860
result	O	5860
in	O	5860
amino	O	5860
acid	O	5860
substitutions	O	5860
-	O	5860
cdna	O	5860
nucleotides	O	5860
845	O	5860
g	O	5860
-	O	5860
-	O	5860
>	O	5860
a	O	5860
(	O	5860
c282y	O	5860
)	O	5860
and	O	5860
187	O	5860
c	O	5860
-	O	5860
-	O	5860
>	O	5860
g	O	5860
(	O	5860
h63d	O	5860
)	O	5860
.	O	5860
although	O	5861
hemochromatosis	B-Disease	5861
is	O	5861
common	O	5861
in	O	5861
caucasians	O	5861
,	O	5861
affecting	O	5861
>	O	5861
=	O	5861
1	O	5861
/	O	5861
300	O	5861
individuals	O	5861
of	O	5861
northern	O	5861
european	O	5861
origin	O	5861
,	O	5861
it	O	5861
has	O	5861
not	O	5861
been	O	5861
recognized	O	5861
in	O	5861
other	O	5861
populations	O	5861
.	O	5861
genotype	O	5868
-	O	5868
phenotype	O	5868
correlations	O	5868
in	O	5868
attenuated	B-Disease	5868
adenomatous	I-Disease	5868
polyposis	I-Disease	5868
coli	I-Disease	5868
.	O	5868
germ	O	5869
-	O	5869
line	O	5869
mutations	O	5869
of	O	5869
the	O	5869
tumor	B-Disease	5869
suppressor	O	5869
apc	O	5869
are	O	5869
implicated	O	5869
in	O	5869
attenuated	B-Disease	5869
adenomatous	I-Disease	5869
polyposis	I-Disease	5869
coli	I-Disease	5869
(	O	5869
aapc	B-Disease	5869
)	O	5869
,	O	5869
a	O	5869
variant	O	5869
of	O	5869
familial	B-Disease	5869
adenomatous	I-Disease	5869
polyposis	I-Disease	5869
(	O	5869
fap	B-Disease	5869
)	O	5869
.	O	5869
aapc	B-Disease	5870
is	O	5870
recognized	O	5870
by	O	5870
the	O	5870
occurrence	O	5870
of	O	5870
<	O	5870
100	O	5870
colonic	B-Disease	5870
adenomas	I-Disease	5870
and	O	5870
a	O	5870
later	O	5870
onset	O	5870
of	O	5870
colorectal	B-Disease	5870
cancer	I-Disease	5870
(	O	5870
age	O	5870
>	O	5870
40	O	5870
years	O	5870
)	O	5870
.	O	5870
the	O	5871
aim	O	5871
of	O	5871
this	O	5871
study	O	5871
was	O	5871
to	O	5871
assess	O	5871
genotype	O	5871
-	O	5871
phenotype	O	5871
correlations	O	5871
in	O	5871
aapc	B-Disease	5871
families	O	5871
.	O	5871
by	O	5872
protein	O	5872
-	O	5872
truncation	O	5872
test	O	5872
(	O	5872
ptt	O	5872
)	O	5872
assay	O	5872
,	O	5872
the	O	5872
entire	O	5872
coding	O	5872
region	O	5872
of	O	5872
the	O	5872
apc	B-Disease	5872
gene	O	5872
was	O	5872
screened	O	5872
in	O	5872
affected	O	5872
individuals	O	5872
from	O	5872
11	O	5872
aapc	B-Disease	5872
kindreds	O	5872
,	O	5872
and	O	5872
their	O	5872
phenotypic	O	5872
differences	O	5872
were	O	5872
examined	O	5872
.	O	5872
five	O	5873
novel	O	5873
germ	O	5873
-	O	5873
line	O	5873
apc	B-Disease	5873
mutations	O	5873
were	O	5873
identified	O	5873
in	O	5873
seven	O	5873
kindreds	O	5873
.	O	5873
mutations	O	5874
were	O	5874
located	O	5874
in	O	5874
three	O	5874
different	O	5874
regions	O	5874
of	O	5874
the	O	5874
apc	B-Disease	5874
gene	O	5874
(	O	5874
1	O	5874
)	O	5874
at	O	5874
the	O	5874
5	O	5874
end	O	5874
spanning	O	5874
exons	O	5874
4	O	5874
and	O	5874
5	O	5874
,	O	5874
(	O	5874
2	O	5874
)	O	5874
within	O	5874
exon	O	5874
9	O	5874
,	O	5874
and	O	5874
(	O	5874
3	O	5874
)	O	5874
at	O	5874
the	O	5874
3	O	5874
distal	O	5874
end	O	5874
of	O	5874
the	O	5874
gene	O	5874
.	O	5874
variability	O	5875
in	O	5875
the	O	5875
number	O	5875
of	O	5875
colorectal	B-Disease	5875
adenomas	I-Disease	5875
was	O	5875
most	O	5875
apparent	O	5875
in	O	5875
individuals	O	5875
with	O	5875
mutations	O	5875
in	O	5875
region	O	5875
1	O	5875
,	O	5875
and	O	5875
upper	O	5875
-	O	5875
gastrointestinal	O	5875
manifestations	O	5875
were	O	5875
more	O	5875
severe	O	5875
in	O	5875
them	O	5875
.	O	5875
in	O	5876
individuals	O	5876
with	O	5876
mutations	O	5876
in	O	5876
either	O	5876
region	O	5876
2	O	5876
or	O	5876
region	O	5876
3	O	5876
,	O	5876
the	O	5876
average	O	5876
number	O	5876
of	O	5876
adenomas	B-Disease	5876
tended	O	5876
to	O	5876
be	O	5876
lower	O	5876
than	O	5876
those	O	5876
in	O	5876
individuals	O	5876
with	O	5876
mutations	O	5876
in	O	5876
region	O	5876
1	O	5876
,	O	5876
although	O	5876
age	O	5876
at	O	5876
diagnosis	O	5876
was	O	5876
similar	O	5876
.	O	5876
in	O	5877
all	O	5877
aapc	B-Disease	5877
kindreds	O	5877
,	O	5877
a	O	5877
predominance	O	5877
of	O	5877
right	O	5877
-	O	5877
sided	O	5877
colorectal	B-Disease	5877
adenomas	I-Disease	5877
and	O	5877
rectal	B-Disease	5877
polyp	I-Disease	5877
sparing	O	5877
was	O	5877
observed	O	5877
.	O	5877
no	O	5878
desmoid	B-Disease	5878
tumors	I-Disease	5878
were	O	5878
found	O	5878
in	O	5878
these	O	5878
kindreds	O	5878
.	O	5878
our	O	5879
data	O	5879
suggest	O	5879
that	O	5879
,	O	5879
in	O	5879
aapc	B-Disease	5879
families	O	5879
,	O	5879
the	O	5879
location	O	5879
of	O	5879
the	O	5879
apc	B-Disease	5879
mutation	O	5879
may	O	5879
partially	O	5879
predict	O	5879
specific	O	5879
phenotypic	O	5879
expression	O	5879
.	O	5879
this	O	5880
should	O	5880
help	O	5880
in	O	5880
the	O	5880
design	O	5880
of	O	5880
tailored	O	5880
clinical	O	5880
-	O	5880
management	O	5880
protocols	O	5880
in	O	5880
this	O	5880
subset	O	5880
of	O	5880
fap	B-Disease	5880
patients	O	5880
.	O	5880
.	O	5880
wilms	B-Disease	5881
'	I-Disease	5881
tumor	I-Disease	5881
1	O	5881
and	O	5881
dax	O	5881
-	O	5881
1	O	5881
modulate	O	5881
the	O	5881
orphan	O	5881
nuclear	O	5881
receptor	O	5881
sf	O	5881
-	O	5881
1	O	5881
in	O	5881
sex	O	5881
-	O	5881
specific	O	5881
gene	O	5881
expression	O	5881
.	O	5881
products	O	5882
of	O	5882
steroidogenic	O	5882
factor	O	5882
1	O	5882
(	O	5882
sf	O	5882
-	O	5882
1	O	5882
)	O	5882
and	O	5882
wilms	B-Disease	5882
tumor	I-Disease	5882
1	O	5882
(	O	5882
wt1	O	5882
)	O	5882
genes	O	5882
are	O	5882
essential	O	5882
for	O	5882
mammalian	O	5882
gonadogenesis	O	5882
prior	O	5882
to	O	5882
sexual	O	5882
differentiation	O	5882
.	O	5882
in	O	5885
contrast	O	5885
,	O	5885
wt1	O	5885
missense	O	5885
mutations	O	5885
,	O	5885
associated	O	5885
with	O	5885
male	B-Disease	5885
pseudohermaphroditism	I-Disease	5885
in	O	5885
denys	B-Disease	5885
-	I-Disease	5885
drash	I-Disease	5885
syndrome	I-Disease	5885
,	O	5885
fail	O	5885
to	O	5885
synergize	O	5885
with	O	5885
sf	O	5885
-	O	5885
1	O	5885
.	O	5885
a	O	5888
mouse	O	5888
model	O	5888
for	O	5888
prader	B-Disease	5888
-	I-Disease	5888
willi	I-Disease	5888
syndrome	I-Disease	5888
imprinting	O	5888
-	O	5888
centre	O	5888
mutations	O	5888
.	O	5888
deletion	O	5890
of	O	5890
this	O	5890
ic	O	5890
abolishes	O	5890
local	O	5890
paternally	O	5890
derived	O	5890
gene	O	5890
expression	O	5890
and	O	5890
results	O	5890
in	O	5890
prader	B-Disease	5890
-	I-Disease	5890
willi	I-Disease	5890
syndrome	I-Disease	5890
(	O	5890
pws	B-Disease	5890
)	O	5890
.	O	5890
we	O	5891
have	O	5891
created	O	5891
two	O	5891
deletion	O	5891
mutations	O	5891
in	O	5891
mice	O	5891
to	O	5891
understand	O	5891
pws	B-Disease	5891
and	O	5891
the	O	5891
mechanism	O	5891
of	O	5891
this	O	5891
ic	O	5891
.	O	5891
mice	O	5892
harbouring	O	5892
an	O	5892
intragenic	O	5892
deletion	O	5892
in	O	5892
snrpn	O	5892
are	O	5892
phenotypically	O	5892
normal	O	5892
,	O	5892
suggesting	O	5892
that	O	5892
mutations	O	5892
of	O	5892
snrpn	O	5892
are	O	5892
not	O	5892
sufficient	O	5892
to	O	5892
induce	O	5892
pws	B-Disease	5892
.	O	5892
mice	O	5893
with	O	5893
a	O	5893
larger	O	5893
deletion	O	5893
involving	O	5893
both	O	5893
snrpn	O	5893
and	O	5893
the	O	5893
putative	O	5893
pws	O	5893
-	O	5893
ic	O	5893
lack	O	5893
expression	O	5893
of	O	5893
the	O	5893
imprinted	O	5893
genes	O	5893
zfp127	O	5893
(	O	5893
mouse	O	5893
homologue	O	5893
of	O	5893
znf127	O	5893
)	O	5893
,	O	5893
ndn	O	5893
and	O	5893
ipw	O	5893
,	O	5893
and	O	5893
manifest	O	5893
several	O	5893
phenotypes	O	5893
common	O	5893
to	O	5893
pws	B-Disease	5893
infants	O	5893
.	O	5893
mutations	O	5895
of	O	5895
the	O	5895
atm	O	5895
gene	O	5895
detected	O	5895
in	O	5895
japanese	O	5895
ataxia	B-Disease	5895
-	I-Disease	5895
telangiectasia	I-Disease	5895
patients	O	5895
:	O	5895
possible	O	5895
preponderance	O	5895
of	O	5895
the	O	5895
two	O	5895
founder	O	5895
mutations	O	5895
4612del165	O	5895
and	O	5895
7883del5	O	5895
.	O	5895
3	O	5897
has	O	5897
recently	O	5897
been	O	5897
identified	O	5897
as	O	5897
the	O	5897
gene	O	5897
responsible	O	5897
for	O	5897
the	O	5897
human	O	5897
recessive	B-Disease	5897
disease	I-Disease	5897
ataxia	B-Disease	5897
-	I-Disease	5897
telangiectasia	I-Disease	5897
(	O	5897
a	B-Disease	5897
-	I-Disease	5897
t	I-Disease	5897
)	O	5897
.	O	5897
in	O	5898
order	O	5898
to	O	5898
define	O	5898
the	O	5898
types	O	5898
of	O	5898
disease	O	5898
-	O	5898
causing	O	5898
atm	O	5898
mutations	O	5898
in	O	5898
japanese	O	5898
a	B-Disease	5898
-	I-Disease	5898
t	I-Disease	5898
patients	O	5898
as	O	5898
well	O	5898
as	O	5898
to	O	5898
look	O	5898
for	O	5898
possible	O	5898
mutational	O	5898
hotspots	O	5898
,	O	5898
reverse	O	5898
-	O	5898
transcribed	O	5898
rna	O	5898
derived	O	5898
from	O	5898
ten	O	5898
patients	O	5898
belonging	O	5898
to	O	5898
eight	O	5898
unrelated	O	5898
japanese	O	5898
a	B-Disease	5898
-	I-Disease	5898
t	I-Disease	5898
families	O	5898
was	O	5898
analyzed	O	5898
for	O	5898
mutations	O	5898
by	O	5898
the	O	5898
restriction	O	5898
endonuclease	O	5898
fingerprinting	O	5898
method	O	5898
.	O	5898
w474c	O	5907
amino	O	5907
acid	O	5907
substitution	O	5907
affects	O	5907
early	O	5907
processing	O	5907
of	O	5907
the	O	5907
alpha	O	5907
-	O	5907
subunit	O	5907
of	O	5907
beta	O	5907
-	O	5907
hexosaminidase	O	5907
a	O	5907
and	O	5907
is	O	5907
associated	O	5907
with	O	5907
subacute	O	5907
g	B-Disease	5907
(	I-Disease	5907
m2	I-Disease	5907
)	I-Disease	5907
gangliosidosis	I-Disease	5907
.	O	5907
mutations	O	5908
in	O	5908
the	O	5908
hexa	O	5908
gene	O	5908
,	O	5908
encoding	O	5908
the	O	5908
alpha	O	5908
-	O	5908
subunit	O	5908
of	O	5908
beta	O	5908
-	O	5908
hexosaminidase	O	5908
a	O	5908
(	O	5908
hex	O	5908
a	O	5908
)	O	5908
,	O	5908
that	O	5908
abolish	O	5908
hex	O	5908
a	O	5908
enzyme	O	5908
activity	O	5908
cause	O	5908
tay	B-Disease	5908
-	I-Disease	5908
sachs	I-Disease	5908
disease	I-Disease	5908
(	O	5908
tsd	B-Disease	5908
)	O	5908
,	O	5908
the	O	5908
fatal	O	5908
infantile	B-Disease	5908
form	I-Disease	5908
of	I-Disease	5908
g	I-Disease	5908
(	I-Disease	5908
m2	I-Disease	5908
)	I-Disease	5908
gangliosidosis	I-Disease	5908
,	I-Disease	5908
type	I-Disease	5908
1	I-Disease	5908
.	O	5908
we	O	5910
identified	O	5910
a	O	5910
1422	O	5910
g	O	5910
-	O	5910
-	O	5910
>	O	5910
c	O	5910
(	O	5910
amino	O	5910
acid	O	5910
w474c	O	5910
)	O	5910
substitution	O	5910
in	O	5910
the	O	5910
first	O	5910
position	O	5910
of	O	5910
exon	O	5910
13	O	5910
of	O	5910
hexa	O	5910
of	O	5910
a	O	5910
non	O	5910
-	O	5910
jewish	O	5910
proband	O	5910
who	O	5910
manifested	O	5910
a	O	5910
subacute	O	5910
variant	O	5910
of	O	5910
g	B-Disease	5910
(	I-Disease	5910
m2	I-Disease	5910
)	I-Disease	5910
gangliosidosis	I-Disease	5910
.	O	5910
when	O	5913
the	O	5913
w474c	O	5913
-	O	5913
containing	O	5913
alpha	O	5913
-	O	5913
subunit	O	5913
was	O	5913
transiently	O	5913
co	O	5913
-	O	5913
expressed	O	5913
with	O	5913
the	O	5913
beta	O	5913
-	O	5913
subunit	O	5913
to	O	5913
produce	O	5913
hex	O	5913
a	O	5913
(	O	5913
alphabeta	O	5913
)	O	5913
in	O	5913
cos	O	5913
-	O	5913
7	O	5913
cells	O	5913
,	O	5913
the	O	5913
mature	O	5913
alpha	O	5913
-	O	5913
subunit	O	5913
was	O	5913
present	O	5913
,	O	5913
but	O	5913
its	O	5913
level	O	5913
was	O	5913
much	O	5913
lower	O	5913
than	O	5913
that	O	5913
from	O	5913
normal	O	5913
alpha	O	5913
-	O	5913
subunit	O	5913
transfections	O	5913
,	O	5913
although	O	5913
higher	O	5913
than	O	5913
in	O	5913
those	O	5913
cells	O	5913
transfected	O	5913
with	O	5913
an	O	5913
alpha	O	5913
-	O	5913
subunit	O	5913
associated	O	5913
with	O	5913
infantile	O	5913
tsd	B-Disease	5913
.	O	5913
we	O	5915
conclude	O	5915
that	O	5915
the	O	5915
1422	O	5915
g	O	5915
-	O	5915
-	O	5915
>	O	5915
c	O	5915
mutation	O	5915
is	O	5915
the	O	5915
cause	O	5915
of	O	5915
hex	B-Disease	5915
a	I-Disease	5915
enzyme	I-Disease	5915
deficiency	I-Disease	5915
in	O	5915
the	O	5915
proband	O	5915
.	O	5915
the	O	5916
resulting	O	5916
w474c	O	5916
substitution	O	5916
clearly	O	5916
interferes	O	5916
with	O	5916
alpha	O	5916
-	O	5916
subunit	O	5916
processing	O	5916
,	O	5916
but	O	5916
because	O	5916
the	O	5916
base	O	5916
substitution	O	5916
falls	O	5916
at	O	5916
the	O	5916
first	O	5916
position	O	5916
of	O	5916
exon	O	5916
13	O	5916
,	O	5916
aberrant	O	5916
splicing	O	5916
may	O	5916
also	O	5916
contribute	O	5916
to	O	5916
hex	B-Disease	5916
a	I-Disease	5916
deficiency	I-Disease	5916
in	O	5916
this	O	5916
proband	O	5916
.	O	5916
.	O	5916
two	O	5917
frequent	O	5917
missense	O	5917
mutations	O	5917
in	O	5917
pendred	B-Disease	5917
syndrome	I-Disease	5917
.	O	5917
pendred	B-Disease	5918
syndrome	I-Disease	5918
is	O	5918
an	O	5918
autosomal	B-Disease	5918
recessive	I-Disease	5918
disorder	I-Disease	5918
characterized	O	5918
by	O	5918
early	O	5918
childhood	O	5918
deafness	B-Disease	5918
and	O	5918
goiter	B-Disease	5918
.	O	5918
we	O	5921
performed	O	5921
mutation	O	5921
analysis	O	5921
of	O	5921
the	O	5921
pds	B-Disease	5921
gene	O	5921
in	O	5921
patients	O	5921
from	O	5921
14	O	5921
pendred	B-Disease	5921
families	O	5921
originating	O	5921
from	O	5921
seven	O	5921
countries	O	5921
and	O	5921
identified	O	5921
all	O	5921
mutations	O	5921
.	O	5921
pendred	B-Disease	5925
patients	O	5925
in	O	5925
three	O	5925
non	O	5925
-	O	5925
consanguineous	O	5925
families	O	5925
were	O	5925
shown	O	5925
to	O	5925
be	O	5925
compound	O	5925
heterozygotes	O	5925
for	O	5925
l236p	O	5925
and	O	5925
t416p	O	5925
.	O	5925
the	O	5927
identification	O	5927
of	O	5927
two	O	5927
frequent	O	5927
pds	B-Disease	5927
mutations	O	5927
will	O	5927
facilitate	O	5927
the	O	5927
molecular	O	5927
diagnosis	O	5927
of	O	5927
pendred	B-Disease	5927
syndrome	I-Disease	5927
.	O	5927
insertional	O	5928
mutation	O	5928
by	O	5928
transposable	O	5928
element	O	5928
,	O	5928
l1	O	5928
,	O	5928
in	O	5928
the	O	5928
dmd	B-Disease	5928
gene	O	5928
results	O	5928
in	O	5928
x	B-Disease	5928
-	I-Disease	5928
linked	I-Disease	5928
dilated	I-Disease	5928
cardiomyopathy	I-Disease	5928
.	O	5928
x	B-Disease	5929
-	I-Disease	5929
linked	I-Disease	5929
dilated	I-Disease	5929
cardiomyopathy	I-Disease	5929
(	O	5929
xldcm	B-Disease	5929
)	O	5929
is	O	5929
a	O	5929
clinical	O	5929
phenotype	O	5929
of	O	5929
dystrophinopathy	B-Disease	5929
which	O	5929
is	O	5929
characterized	O	5929
by	O	5929
preferential	O	5929
myocardial	B-Disease	5929
involvement	I-Disease	5929
without	O	5929
any	O	5929
overt	O	5929
clinical	O	5929
signs	O	5929
of	O	5929
skeletal	B-Disease	5929
myopathy	I-Disease	5929
.	O	5929
to	O	5930
date	O	5930
,	O	5930
several	O	5930
mutations	O	5930
in	O	5930
the	O	5930
duchenne	B-Disease	5930
muscular	I-Disease	5930
dystrophy	I-Disease	5930
gene	O	5930
,	O	5930
dmd	O	5930
,	O	5930
have	O	5930
been	O	5930
identified	O	5930
in	O	5930
patients	O	5930
with	O	5930
xldcm	B-Disease	5930
,	O	5930
but	O	5930
a	O	5930
pathogenic	O	5930
correlation	O	5930
of	O	5930
these	O	5930
cardiospecific	O	5930
mutations	O	5930
in	O	5930
dmd	O	5930
with	O	5930
the	O	5930
xldcm	B-Disease	5930
phenotype	O	5930
has	O	5930
remained	O	5930
to	O	5930
be	O	5930
elucidated	O	5930
.	O	5930
we	O	5931
report	O	5931
here	O	5931
the	O	5931
identification	O	5931
of	O	5931
a	O	5931
unique	O	5931
de	O	5931
novo	O	5931
l1	O	5931
insertion	O	5931
in	O	5931
the	O	5931
muscle	O	5931
exon	O	5931
1	O	5931
in	O	5931
dmd	O	5931
in	O	5931
three	O	5931
xldcm	B-Disease	5931
patients	O	5931
from	O	5931
two	O	5931
unrelated	O	5931
japanese	O	5931
families	O	5931
.	O	5931
we	O	5933
speculate	O	5933
that	O	5933
this	O	5933
insertion	O	5933
of	O	5933
an	O	5933
l1	O	5933
sequence	O	5933
in	O	5933
dmd	O	5933
is	O	5933
responsible	O	5933
for	O	5933
some	O	5933
of	O	5933
the	O	5933
population	O	5933
of	O	5933
japanese	O	5933
patients	O	5933
with	O	5933
xldcm	B-Disease	5933
.	O	5933
.	O	5933
severe	O	5934
early	O	5934
-	O	5934
onset	O	5934
obesity	B-Disease	5934
,	O	5934
adrenal	B-Disease	5934
insufficiency	I-Disease	5934
and	O	5934
red	O	5934
hair	O	5934
pigmentation	O	5934
caused	O	5934
by	O	5934
pomc	O	5934
mutations	O	5934
in	O	5934
humans	O	5934
.	O	5934
while	O	5936
a	O	5936
few	O	5936
cases	O	5936
of	O	5936
isolated	O	5936
acth	B-Disease	5936
deficiency	I-Disease	5936
have	O	5936
been	O	5936
reported	O	5936
(	O	5936
omim	O	5936
201400	O	5936
)	O	5936
,	O	5936
an	O	5936
inherited	O	5936
pomc	O	5936
defect	O	5936
has	O	5936
not	O	5936
been	O	5936
described	O	5936
so	O	5936
far	O	5936
.	O	5936
recent	O	5937
studies	O	5937
in	O	5937
animal	O	5937
models	O	5937
elucidated	O	5937
a	O	5937
central	O	5937
role	O	5937
of	O	5937
alpha	O	5937
-	O	5937
msh	O	5937
in	O	5937
the	O	5937
regulation	O	5937
of	O	5937
food	O	5937
intake	O	5937
by	O	5937
activation	O	5937
of	O	5937
the	O	5937
brain	O	5937
melanocortin	O	5937
-	O	5937
4	O	5937
-	O	5937
receptor	O	5937
(	O	5937
mc4	O	5937
-	O	5937
r	O	5937
;	O	5937
refs	O	5937
3	O	5937
-	O	5937
5	O	5937
)	O	5937
and	O	5937
the	O	5937
linkage	O	5937
of	O	5937
human	O	5937
obesity	B-Disease	5937
to	O	5937
chromosome	O	5937
2	O	5937
in	O	5937
close	O	5937
proximity	O	5937
to	O	5937
the	O	5937
pomc	O	5937
locus	O	5937
,	O	5937
led	O	5937
to	O	5937
the	O	5937
proposal	O	5937
of	O	5937
an	O	5937
association	O	5937
of	O	5937
pomc	O	5937
with	O	5937
human	O	5937
obesity	B-Disease	5937
.	O	5937
the	O	5938
dual	O	5938
role	O	5938
of	O	5938
alpha	O	5938
-	O	5938
msh	O	5938
in	O	5938
regulating	O	5938
food	O	5938
intake	O	5938
and	O	5938
influencing	O	5938
hair	O	5938
pigmentation	O	5938
predicts	O	5938
that	O	5938
the	O	5938
phenotype	O	5938
associated	O	5938
with	O	5938
a	O	5938
defect	O	5938
in	O	5938
pomc	O	5938
function	O	5938
would	O	5938
include	O	5938
obesity	B-Disease	5938
,	O	5938
alteration	O	5938
in	O	5938
pigmentation	O	5938
and	O	5938
acth	B-Disease	5938
deficiency	I-Disease	5938
.	O	5938
these	O	5942
findings	O	5942
represent	O	5942
the	O	5942
first	O	5942
examples	O	5942
of	O	5942
a	O	5942
genetic	B-Disease	5942
defect	I-Disease	5942
within	O	5942
the	O	5942
pomc	O	5942
gene	O	5942
and	O	5942
define	O	5942
a	O	5942
new	O	5942
monogenic	B-Disease	5942
endocrine	I-Disease	5942
disorder	I-Disease	5942
resulting	O	5942
in	O	5942
early	O	5942
-	O	5942
onset	O	5942
obesity	B-Disease	5942
,	O	5942
adrenal	B-Disease	5942
insufficiency	I-Disease	5942
and	O	5942
red	O	5942
hair	O	5942
pigmentation	O	5942
.	O	5942
.	O	5942
a	O	5943
european	O	5943
multicenter	O	5943
study	O	5943
of	O	5943
phenylalanine	B-Disease	5943
hydroxylase	I-Disease	5943
deficiency	I-Disease	5943
:	O	5943
classification	O	5943
of	O	5943
105	O	5943
mutations	O	5943
and	O	5943
a	O	5943
general	O	5943
system	O	5943
for	O	5943
genotype	O	5943
-	O	5943
based	O	5943
prediction	O	5943
of	O	5943
metabolic	O	5943
phenotype	O	5943
.	O	5943
phenylketonuria	B-Disease	5944
(	O	5944
pku	B-Disease	5944
)	O	5944
and	O	5944
mild	B-Disease	5944
hyperphenylalaninemia	I-Disease	5944
(	O	5944
mhp	B-Disease	5944
)	O	5944
are	O	5944
allelic	B-Disease	5944
disorders	I-Disease	5944
caused	O	5944
by	O	5944
mutations	O	5944
in	O	5944
the	O	5944
gene	O	5944
encoding	O	5944
phenylalanine	O	5944
hydroxylase	O	5944
(	O	5944
pah	O	5944
)	O	5944
.	O	5944
previous	O	5945
studies	O	5945
have	O	5945
suggested	O	5945
that	O	5945
the	O	5945
highly	O	5945
variable	O	5945
metabolic	O	5945
phenotypes	O	5945
of	O	5945
pah	B-Disease	5945
deficiency	I-Disease	5945
correlate	O	5945
with	O	5945
pah	O	5945
genotypes	O	5945
.	O	5945
our	O	5951
data	O	5951
indicate	O	5951
that	O	5951
the	O	5951
pah	O	5951
-	O	5951
mutation	O	5951
genotype	O	5951
is	O	5951
the	O	5951
main	O	5951
determinant	O	5951
of	O	5951
metabolic	O	5951
phenotype	O	5951
in	O	5951
most	O	5951
patients	O	5951
with	O	5951
pah	B-Disease	5951
deficiency	I-Disease	5951
.	O	5951
in	O	5952
the	O	5952
present	O	5952
study	O	5952
,	O	5952
the	O	5952
classification	O	5952
of	O	5952
105	O	5952
pah	O	5952
mutations	O	5952
may	O	5952
allow	O	5952
the	O	5952
prediction	O	5952
of	O	5952
the	O	5952
biochemical	O	5952
phenotype	O	5952
in	O	5952
>	O	5952
10	O	5952
,	O	5952
000	O	5952
genotypes	O	5952
,	O	5952
which	O	5952
may	O	5952
be	O	5952
useful	O	5952
for	O	5952
the	O	5952
management	O	5952
of	O	5952
hyperphenylalaninemia	B-Disease	5952
in	O	5952
newborns	O	5952
.	O	5952
somatic	O	5953
instability	O	5953
of	O	5953
the	O	5953
ctg	O	5953
repeat	O	5953
in	O	5953
mice	O	5953
transgenic	O	5953
for	O	5953
the	O	5953
myotonic	B-Disease	5953
dystrophy	I-Disease	5953
region	O	5953
is	O	5953
age	O	5953
dependent	O	5953
but	O	5953
not	O	5953
correlated	O	5953
to	O	5953
the	O	5953
relative	O	5953
intertissue	O	5953
transcription	O	5953
levels	O	5953
and	O	5953
proliferative	O	5953
capacities	O	5953
.	O	5953
a	O	5954
(	O	5954
ctg	O	5954
)	O	5954
nexpansion	O	5954
in	O	5954
the	O	5954
3	O	5954
-	O	5954
untranslated	O	5954
region	O	5954
(	O	5954
utr	O	5954
)	O	5954
of	O	5954
the	O	5954
dm	O	5954
protein	O	5954
kinase	O	5954
gene	O	5954
(	O	5954
dmpk	O	5954
)	O	5954
is	O	5954
responsible	O	5954
for	O	5954
causing	O	5954
myotonic	B-Disease	5954
dystrophy	I-Disease	5954
(	O	5954
dm	B-Disease	5954
)	O	5954
.	O	5954
the	O	5957
trinucleotide	O	5957
repeat	O	5957
instability	O	5957
mechanisms	O	5957
involved	O	5957
in	O	5957
dm	B-Disease	5957
and	O	5957
other	O	5957
human	O	5957
genetic	B-Disease	5957
diseases	I-Disease	5957
are	O	5957
unknown	O	5957
.	O	5957
we	O	5958
studied	O	5958
somatic	O	5958
instability	O	5958
by	O	5958
measuring	O	5958
the	O	5958
ctg	O	5958
repeat	O	5958
length	O	5958
at	O	5958
several	O	5958
ages	O	5958
in	O	5958
various	O	5958
tissues	O	5958
of	O	5958
transgenic	O	5958
mice	O	5958
carrying	O	5958
a	O	5958
(	O	5958
ctg	O	5958
)	O	5958
55expansion	O	5958
surrounded	O	5958
by	O	5958
45	O	5958
kb	O	5958
of	O	5958
the	O	5958
human	O	5958
dm	B-Disease	5958
region	O	5958
,	O	5958
using	O	5958
small	O	5958
-	O	5958
pool	O	5958
pcr	O	5958
.	O	5958
as	O	5960
observed	O	5960
in	O	5960
some	O	5960
of	O	5960
the	O	5960
tissues	O	5960
of	O	5960
dm	B-Disease	5960
patients	O	5960
,	O	5960
there	O	5960
is	O	5960
a	O	5960
tendency	O	5960
for	O	5960
repeat	O	5960
length	O	5960
and	O	5960
somatic	O	5960
mosaicism	O	5960
to	O	5960
increase	O	5960
with	O	5960
the	O	5960
age	O	5960
of	O	5960
the	O	5960
mouse	O	5960
.	O	5960
a	O	5963
novel	O	5963
missense	O	5963
mutation	O	5963
in	O	5963
patients	O	5963
from	O	5963
a	O	5963
retinoblastoma	B-Disease	5963
pedigree	O	5963
showing	O	5963
only	O	5963
mild	O	5963
expression	O	5963
of	O	5963
the	O	5963
tumor	B-Disease	5963
phenotype	O	5963
.	O	5963
we	O	5964
have	O	5964
used	O	5964
single	O	5964
strand	O	5964
conformation	O	5964
polymorphism	O	5964
analysis	O	5964
to	O	5964
study	O	5964
the	O	5964
27	O	5964
exons	O	5964
of	O	5964
the	O	5964
rb1	O	5964
gene	O	5964
in	O	5964
individuals	O	5964
from	O	5964
a	O	5964
family	O	5964
showing	O	5964
mild	O	5964
expression	O	5964
of	O	5964
the	O	5964
retinoblastoma	B-Disease	5964
phenotype	O	5964
.	O	5964
in	O	5965
this	O	5965
family	O	5965
affected	O	5965
individuals	O	5965
developed	O	5965
unilateral	B-Disease	5965
tumors	I-Disease	5965
and	O	5965
,	O	5965
as	O	5965
a	O	5965
result	O	5965
of	O	5965
linkage	O	5965
analysis	O	5965
,	O	5965
unaffected	O	5965
mutation	O	5965
carriers	O	5965
were	O	5965
also	O	5965
identified	O	5965
within	O	5965
the	O	5965
pedigree	O	5965
.	O	5965
analysis	O	5968
of	O	5968
all	O	5968
family	O	5968
members	O	5968
demonstrated	O	5968
that	O	5968
the	O	5968
missense	O	5968
mutation	O	5968
co	O	5968
-	O	5968
segregated	O	5968
with	O	5968
patients	O	5968
with	O	5968
tumors	B-Disease	5968
or	O	5968
who	O	5968
,	O	5968
as	O	5968
a	O	5968
result	O	5968
of	O	5968
linkage	O	5968
analysis	O	5968
had	O	5968
been	O	5968
predicted	O	5968
to	O	5968
carry	O	5968
the	O	5968
predisposing	O	5968
mutation	O	5968
.	O	5968
maternal	B-Disease	5970
disomy	I-Disease	5970
and	O	5970
prader	B-Disease	5970
-	I-Disease	5970
willi	I-Disease	5970
syndrome	I-Disease	5970
consistent	O	5970
with	O	5970
gamete	O	5970
complementation	O	5970
in	O	5970
a	O	5970
case	O	5970
of	O	5970
familial	O	5970
translocation	O	5970
(	O	5970
3	O	5970
;	O	5970
15	O	5970
)	O	5970
(	O	5970
p25	O	5970
;	O	5970
q11	O	5970
.	O	5970
2	O	5970
)	O	5970
.	O	5970
maternal	B-Disease	5971
uniparental	I-Disease	5971
disomy	I-Disease	5971
(	I-Disease	5971
upd	I-Disease	5971
)	I-Disease	5971
for	I-Disease	5971
chromosome	I-Disease	5971
15	I-Disease	5971
is	O	5971
responsible	O	5971
for	O	5971
an	O	5971
estimated	O	5971
30	O	5971
%	O	5971
of	O	5971
cases	O	5971
of	O	5971
prader	B-Disease	5971
-	I-Disease	5971
willi	I-Disease	5971
syndrome	I-Disease	5971
(	O	5971
pws	B-Disease	5971
)	O	5971
.	O	5971
we	O	5972
report	O	5972
on	O	5972
an	O	5972
unusual	O	5972
case	O	5972
of	O	5972
maternal	B-Disease	5972
disomy	I-Disease	5972
15	I-Disease	5972
in	O	5972
pws	B-Disease	5972
that	O	5972
is	O	5972
most	O	5972
consistent	O	5972
with	O	5972
adjacent	O	5972
-	O	5972
1	O	5972
segregation	O	5972
of	O	5972
a	O	5972
paternal	O	5972
t	O	5972
(	O	5972
3	O	5972
;	O	5972
15	O	5972
)	O	5972
(	O	5972
p25	O	5972
;	O	5972
q11	O	5972
.	O	5972
2	O	5972
)	O	5972
with	O	5972
simultaneous	O	5972
maternal	O	5972
meiotic	O	5972
nondisjunction	O	5972
for	O	5972
chromosome	O	5972
15	O	5972
.	O	5972
the	O	5973
patient	O	5973
(	O	5973
j	O	5973
.	O	5973
b	O	5973
.	O	5973
)	O	5973
,	O	5973
a	O	5973
17	O	5973
-	O	5973
year	O	5973
-	O	5973
old	O	5973
white	O	5973
male	O	5973
with	O	5973
pws	B-Disease	5973
,	O	5973
was	O	5973
found	O	5973
to	O	5973
have	O	5973
47	O	5973
chromosomes	O	5973
with	O	5973
a	O	5973
supernumerary	O	5973
,	O	5973
paternal	O	5973
der	O	5973
(	O	5973
15	O	5973
)	O	5973
consisting	O	5973
of	O	5973
the	O	5973
short	O	5973
arm	O	5973
and	O	5973
the	O	5973
proximal	O	5973
long	O	5973
arm	O	5973
of	O	5973
chromosome	O	5973
15	O	5973
,	O	5973
and	O	5973
distal	O	5973
chromosome	O	5973
arm	O	5973
3p	O	5973
.	O	5973
fluorescent	O	5975
in	O	5975
situ	O	5975
hybridization	O	5975
analysis	O	5975
demonstrated	O	5975
that	O	5975
the	O	5975
pws	B-Disease	5975
critical	O	5975
region	O	5975
resided	O	5975
on	O	5975
the	O	5975
derivative	O	5975
chromosome	O	5975
3	O	5975
and	O	5975
that	O	5975
there	O	5975
was	O	5975
no	O	5975
deletion	O	5975
of	O	5975
the	O	5975
pws	B-Disease	5975
region	O	5975
on	O	5975
the	O	5975
normal	O	5975
pair	O	5975
of	O	5975
15s	O	5975
present	O	5975
in	O	5975
j	O	5975
.	O	5975
maternal	B-Disease	5979
disomy	I-Disease	5979
was	O	5979
confirmed	O	5979
by	O	5979
polymerase	O	5979
chain	O	5979
reaction	O	5979
analysis	O	5979
of	O	5979
microsatellite	O	5979
repeats	O	5979
at	O	5979
the	O	5979
gamma	O	5979
-	O	5979
aminobutyric	O	5979
acid	O	5979
receptor	O	5979
beta3	O	5979
subunit	O	5979
(	O	5979
gabrb3	O	5979
)	O	5979
locus	O	5979
.	O	5979
uniparental	B-Disease	5981
disomy	I-Disease	5981
associated	O	5981
with	O	5981
unbalanced	O	5981
segregation	O	5981
of	O	5981
non	O	5981
-	O	5981
robertsonian	O	5981
translocations	O	5981
has	O	5981
been	O	5981
reported	O	5981
previously	O	5981
but	O	5981
has	O	5981
not	O	5981
,	O	5981
to	O	5981
our	O	5981
knowledge	O	5981
,	O	5981
been	O	5981
observed	O	5981
in	O	5981
a	O	5981
case	O	5981
of	O	5981
pws	B-Disease	5981
.	O	5981
furthermore	O	5982
,	O	5982
our	O	5982
findings	O	5982
are	O	5982
best	O	5982
interpreted	O	5982
as	O	5982
true	O	5982
gamete	O	5982
complementation	O	5982
resulting	O	5982
in	O	5982
maternal	B-Disease	5982
upd	I-Disease	5982
15	I-Disease	5982
and	O	5982
pws	B-Disease	5982
schwartz	B-Disease	5983
-	I-Disease	5983
jampel	I-Disease	5983
syndrome	I-Disease	5983
type	I-Disease	5983
2	I-Disease	5983
and	O	5983
stuve	B-Disease	5983
-	I-Disease	5983
wiedemann	I-Disease	5983
syndrome	I-Disease	5983
:	O	5983
a	O	5983
case	O	5983
for	O	5983
lumping	O	5983
.	O	5983
recent	O	5984
studies	O	5984
demonstrated	O	5984
the	O	5984
existence	O	5984
of	O	5984
a	O	5984
genetically	O	5984
distinct	O	5984
,	O	5984
usually	O	5984
lethal	O	5984
form	O	5984
of	O	5984
the	O	5984
schwartz	B-Disease	5984
-	I-Disease	5984
jampel	I-Disease	5984
syndrome	I-Disease	5984
(	O	5984
sjs	B-Disease	5984
)	O	5984
of	O	5984
myotonia	B-Disease	5984
and	O	5984
skeletal	B-Disease	5984
dysplasia	I-Disease	5984
,	O	5984
which	O	5984
we	O	5984
called	O	5984
sjs	B-Disease	5984
type	I-Disease	5984
2	I-Disease	5984
.	O	5984
this	O	5985
disorder	O	5985
is	O	5985
reminiscent	O	5985
of	O	5985
another	O	5985
rare	O	5985
condition	O	5985
,	O	5985
the	O	5985
stuve	B-Disease	5985
-	I-Disease	5985
wiedemann	I-Disease	5985
syndrome	I-Disease	5985
(	O	5985
sws	B-Disease	5985
)	O	5985
,	O	5985
which	O	5985
comprises	O	5985
campomelia	B-Disease	5985
at	O	5985
birth	O	5985
with	O	5985
skeletal	B-Disease	5985
dysplasia	I-Disease	5985
,	O	5985
contractures	B-Disease	5985
,	O	5985
and	O	5985
early	B-Disease	5985
death	I-Disease	5985
.	O	5985
to	O	5986
test	O	5986
for	O	5986
possible	O	5986
nosologic	O	5986
identity	O	5986
between	O	5986
these	O	5986
disorders	O	5986
,	O	5986
we	O	5986
reviewed	O	5986
the	O	5986
literature	O	5986
and	O	5986
obtained	O	5986
a	O	5986
follow	O	5986
-	O	5986
up	O	5986
of	O	5986
the	O	5986
only	O	5986
two	O	5986
surviving	O	5986
patients	O	5986
,	O	5986
one	O	5986
with	O	5986
sjs	B-Disease	5986
type	I-Disease	5986
2	I-Disease	5986
at	O	5986
age	O	5986
10	O	5986
years	O	5986
and	O	5986
another	O	5986
with	O	5986
sws	B-Disease	5986
at	O	5986
age	O	5986
7	O	5986
years	O	5986
.	O	5986
patients	O	5987
reported	O	5987
as	O	5987
having	O	5987
either	O	5987
neonatal	O	5987
sjs	B-Disease	5987
or	O	5987
sws	B-Disease	5987
presented	O	5987
a	O	5987
combination	O	5987
of	O	5987
a	O	5987
severe	O	5987
,	O	5987
prenatal	O	5987
-	O	5987
onset	O	5987
neuromuscular	B-Disease	5987
disorder	I-Disease	5987
(	O	5987
with	O	5987
congenital	B-Disease	5987
joint	I-Disease	5987
contractures	I-Disease	5987
,	O	5987
respiratory	O	5987
and	O	5987
feeding	O	5987
difficulties	O	5987
,	O	5987
tendency	O	5987
to	O	5987
hyperthermia	B-Disease	5987
,	O	5987
and	O	5987
frequent	O	5987
death	O	5987
in	O	5987
infancy	O	5987
)	O	5987
with	O	5987
a	O	5987
distinct	O	5987
campomelic	B-Disease	5987
-	I-Disease	5987
metaphyseal	I-Disease	5987
skeletal	I-Disease	5987
dysplasia	I-Disease	5987
.	O	5987
the	O	5989
follow	O	5989
-	O	5989
up	O	5989
observation	O	5989
of	O	5989
an	O	5989
identical	O	5989
and	O	5989
unique	O	5989
pattern	O	5989
of	O	5989
progressive	O	5989
bone	B-Disease	5989
dysplasia	I-Disease	5989
in	O	5989
the	O	5989
two	O	5989
patients	O	5989
(	O	5989
one	O	5989
with	O	5989
sjs	B-Disease	5989
type	I-Disease	5989
2	I-Disease	5989
,	O	5989
one	O	5989
with	O	5989
sws	B-Disease	5989
)	O	5989
surviving	O	5989
beyond	O	5989
infancy	O	5989
adds	O	5989
to	O	5989
the	O	5989
evidence	O	5989
in	O	5989
favor	O	5989
of	O	5989
identity	O	5989
.	O	5989
the	O	5990
hypothesis	O	5990
that	O	5990
sws	B-Disease	5990
and	O	5990
sjs	B-Disease	5990
type	I-Disease	5990
2	I-Disease	5990
are	O	5990
the	O	5990
same	O	5990
disorder	O	5990
should	O	5990
be	O	5990
testable	O	5990
by	O	5990
molecular	O	5990
methods	O	5990
.	O	5990
.	O	5990
a	O	5991
mouse	O	5991
model	O	5991
of	O	5991
severe	O	5991
von	B-Disease	5991
willebrand	I-Disease	5991
disease	I-Disease	5991
:	O	5991
defects	O	5991
in	O	5991
hemostasis	O	5991
and	O	5991
thrombosis	B-Disease	5991
.	O	5991
von	B-Disease	5992
willebrand	I-Disease	5992
factor	I-Disease	5992
(	I-Disease	5992
vwf	I-Disease	5992
)	I-Disease	5992
deficiency	I-Disease	5992
causes	O	5992
severe	O	5992
von	B-Disease	5992
willebrand	I-Disease	5992
disease	I-Disease	5992
in	O	5992
humans	O	5992
.	O	5992
vwf	B-Disease	5994
-	I-Disease	5994
deficient	I-Disease	5994
mice	O	5994
appeared	O	5994
normal	O	5994
at	O	5994
birth	O	5994
;	O	5994
they	O	5994
were	O	5994
viable	O	5994
and	O	5994
fertile	O	5994
.	O	5994
neither	O	5995
vwf	O	5995
nor	O	5995
vwf	O	5995
propolypeptide	O	5995
(	O	5995
von	B-Disease	5995
willebrand	I-Disease	5995
antigen	O	5995
ii	O	5995
)	O	5995
were	O	5995
detectable	O	5995
in	O	5995
plasma	O	5995
,	O	5995
platelets	O	5995
,	O	5995
or	O	5995
endothelial	O	5995
cells	O	5995
of	O	5995
the	O	5995
homozygous	O	5995
mutant	O	5995
mice	O	5995
.	O	5995
defective	O	5998
thrombosis	B-Disease	5998
in	O	5998
mutant	O	5998
mice	O	5998
was	O	5998
also	O	5998
evident	O	5998
in	O	5998
an	O	5998
in	O	5998
vivo	O	5998
model	O	5998
of	O	5998
vascular	B-Disease	5998
injury	I-Disease	5998
.	O	5998
we	O	6000
conclude	O	6000
that	O	6000
these	O	6000
mice	O	6000
very	O	6000
closely	O	6000
mimic	O	6000
severe	O	6000
human	O	6000
von	B-Disease	6000
willebrand	I-Disease	6000
disease	I-Disease	6000
and	O	6000
will	O	6000
be	O	6000
very	O	6000
useful	O	6000
for	O	6000
investigating	O	6000
the	O	6000
role	O	6000
of	O	6000
vwf	O	6000
in	O	6000
normal	O	6000
physiology	O	6000
and	O	6000
in	O	6000
disease	O	6000
models	O	6000
.	O	6000
.	O	6000
oral	O	6001
contraceptives	O	6001
and	O	6001
the	O	6001
risk	O	6001
of	O	6001
hereditary	B-Disease	6001
ovarian	I-Disease	6001
cancer	I-Disease	6001
.	O	6001
hereditary	B-Disease	6002
ovarian	I-Disease	6002
cancer	I-Disease	6002
clinical	O	6002
study	O	6002
group	O	6002
.	O	6002
background	O	6003
women	O	6003
with	O	6003
mutations	O	6003
in	O	6003
either	O	6003
the	O	6003
brca1	O	6003
or	O	6003
the	O	6003
brca2	O	6003
gene	O	6003
have	O	6003
a	O	6003
high	O	6003
lifetime	O	6003
risk	O	6003
of	O	6003
ovarian	B-Disease	6003
cancer	I-Disease	6003
.	O	6003
oral	O	6004
contraceptives	O	6004
protect	O	6004
against	O	6004
ovarian	B-Disease	6004
cancer	I-Disease	6004
in	O	6004
general	O	6004
,	O	6004
but	O	6004
it	O	6004
is	O	6004
not	O	6004
known	O	6004
whether	O	6004
they	O	6004
also	O	6004
protect	O	6004
against	O	6004
hereditary	B-Disease	6004
forms	I-Disease	6004
of	I-Disease	6004
ovarian	I-Disease	6004
cancer	I-Disease	6004
.	O	6004
methods	O	6005
we	O	6005
enrolled	O	6005
207	O	6005
women	O	6005
with	O	6005
hereditary	B-Disease	6005
ovarian	I-Disease	6005
cancer	I-Disease	6005
and	O	6005
161	O	6005
of	O	6005
their	O	6005
sisters	O	6005
as	O	6005
controls	O	6005
in	O	6005
a	O	6005
case	O	6005
-	O	6005
control	O	6005
study	O	6005
.	O	6005
results	O	6009
the	O	6009
adjusted	O	6009
odds	O	6009
ratio	O	6009
for	O	6009
ovarian	B-Disease	6009
cancer	I-Disease	6009
associated	O	6009
with	O	6009
any	O	6009
past	O	6009
use	O	6009
of	O	6009
oral	O	6009
contraceptives	O	6009
was	O	6009
0	O	6009
.	O	6009
oral	O	6012
-	O	6012
contraceptive	O	6012
use	O	6012
protected	O	6012
against	O	6012
ovarian	B-Disease	6012
cancer	I-Disease	6012
both	O	6012
for	O	6012
carriers	O	6012
of	O	6012
the	O	6012
brca1	O	6012
mutation	O	6012
(	O	6012
odds	O	6012
ratio	O	6012
,	O	6012
0	O	6012
.	O	6012
5	O	6012
;	O	6012
95	O	6012
percent	O	6012
confidence	O	6012
interval	O	6012
,	O	6012
0	O	6012
.	O	6012
3	O	6012
to	O	6012
0	O	6012
.	O	6012
9	O	6012
)	O	6012
and	O	6012
for	O	6012
carriers	O	6012
of	O	6012
the	O	6012
brca2	O	6012
mutation	O	6012
(	O	6012
odds	O	6012
ratio	O	6012
,	O	6012
0	O	6012
.	O	6012
4	O	6012
;	O	6012
95	O	6012
percent	O	6012
confidence	O	6012
interval	O	6012
,	O	6012
0	O	6012
.	O	6012
2	O	6012
to	O	6012
1	O	6012
.	O	6012
1	O	6012
)	O	6012
.	O	6012
conclusions	O	6013
oral	O	6013
-	O	6013
contraceptive	O	6013
use	O	6013
may	O	6013
reduce	O	6013
the	O	6013
risk	O	6013
of	O	6013
ovarian	B-Disease	6013
cancer	I-Disease	6013
in	O	6013
women	O	6013
with	O	6013
pathogenic	O	6013
mutations	O	6013
in	O	6013
the	O	6013
brca1	O	6013
or	O	6013
brca2	O	6013
gene	O	6013
a	O	6014
japanese	O	6014
family	O	6014
with	O	6014
adrenoleukodystrophy	B-Disease	6014
with	O	6014
a	O	6014
codon	O	6014
291	O	6014
deletion	O	6014
:	O	6014
a	O	6014
clinical	O	6014
,	O	6014
biochemical	O	6014
,	O	6014
pathological	O	6014
,	O	6014
and	O	6014
genetic	O	6014
report	O	6014
.	O	6014
we	O	6015
report	O	6015
a	O	6015
japanese	O	6015
family	O	6015
with	O	6015
adrenoleukodystrophy	B-Disease	6015
(	O	6015
ald	B-Disease	6015
)	O	6015
with	O	6015
a	O	6015
three	O	6015
base	O	6015
pair	O	6015
deletion	O	6015
(	O	6015
delgag	O	6015
291	O	6015
)	O	6015
in	O	6015
the	O	6015
ald	B-Disease	6015
gene	O	6015
.	O	6015
while	O	6017
the	O	6017
proband	O	6017
(	O	6017
patient	O	6017
1	O	6017
)	O	6017
was	O	6017
classified	O	6017
as	O	6017
having	O	6017
a	O	6017
rare	O	6017
intermediate	O	6017
type	O	6017
of	O	6017
adult	O	6017
cerebral	O	6017
and	O	6017
cerebello	O	6017
-	O	6017
brain	O	6017
stem	O	6017
forms	O	6017
,	O	6017
his	O	6017
younger	O	6017
brother	O	6017
(	O	6017
patient	O	6017
2	O	6017
)	O	6017
and	O	6017
nephew	O	6017
(	O	6017
patient	O	6017
3	O	6017
)	O	6017
had	O	6017
a	O	6017
childhood	O	6017
ald	B-Disease	6017
type	O	6017
.	O	6017
the	O	6019
tau	O	6019
level	O	6019
in	O	6019
the	O	6019
cerebrospinal	O	6019
fluid	O	6019
(	O	6019
csf	O	6019
)	O	6019
in	O	6019
patient	O	6019
1	O	6019
was	O	6019
as	O	6019
high	O	6019
as	O	6019
that	O	6019
of	O	6019
patients	O	6019
with	O	6019
alzheimers	B-Disease	6019
disease	I-Disease	6019
(	O	6019
ad	B-Disease	6019
)	O	6019
.	O	6019
his	O	6020
brain	O	6020
magnetic	O	6020
resonance	O	6020
image	O	6020
(	O	6020
mri	O	6020
)	O	6020
showed	O	6020
abnormalities	B-Disease	6020
in	I-Disease	6020
the	I-Disease	6020
bilateral	I-Disease	6020
cerebellar	I-Disease	6020
hemispheres	I-Disease	6020
and	O	6020
brain	O	6020
stem	O	6020
,	O	6020
but	O	6020
not	O	6020
in	O	6020
the	O	6020
cerebral	O	6020
white	O	6020
matter	O	6020
,	O	6020
where	O	6020
marked	O	6020
reductions	O	6020
of	O	6020
the	O	6020
cerebral	O	6020
blood	O	6020
flow	O	6020
and	O	6020
oxygen	O	6020
metabolism	O	6020
were	O	6020
clearly	O	6020
demonstrated	O	6020
by	O	6020
positron	O	6020
emission	O	6020
tomography	O	6020
(	O	6020
pet	O	6020
)	O	6020
.	O	6020
in	O	6021
patients	O	6021
2	O	6021
and	O	6021
3	O	6021
,	O	6021
the	O	6021
autopsy	O	6021
findings	O	6021
showed	O	6021
massive	O	6021
demyelination	B-Disease	6021
of	I-Disease	6021
the	I-Disease	6021
cerebral	I-Disease	6021
white	I-Disease	6021
matter	I-Disease	6021
with	O	6021
sparing	O	6021
of	O	6021
the	O	6021
u	O	6021
-	O	6021
fibers	O	6021
,	O	6021
compatible	O	6021
with	O	6021
the	O	6021
findings	O	6021
of	O	6021
childhood	O	6021
ald	B-Disease	6021
.	O	6021
the	O	6023
findings	O	6023
in	O	6023
this	O	6023
family	O	6023
suggest	O	6023
that	O	6023
delgag291	O	6023
is	O	6023
part	O	6023
of	O	6023
the	O	6023
cause	O	6023
of	O	6023
japanese	O	6023
ald	B-Disease	6023
with	O	6023
phenotypic	O	6023
variations	O	6023
.	O	6023
moreover	O	6024
,	O	6024
although	O	6024
the	O	6024
scale	O	6024
of	O	6024
the	O	6024
study	O	6024
is	O	6024
limited	O	6024
,	O	6024
there	O	6024
is	O	6024
a	O	6024
possibility	O	6024
that	O	6024
pet	O	6024
can	O	6024
detect	O	6024
an	O	6024
insidious	B-Disease	6024
lesion	I-Disease	6024
which	O	6024
is	O	6024
undetectable	O	6024
by	O	6024
computed	O	6024
tomogram	O	6024
(	O	6024
ct	O	6024
)	O	6024
or	O	6024
mri	O	6024
analysis	O	6024
,	O	6024
and	O	6024
that	O	6024
the	O	6024
higher	O	6024
level	O	6024
of	O	6024
tau	O	6024
reflects	O	6024
the	O	6024
process	O	6024
of	O	6024
neuronal	B-Disease	6024
degeneration	I-Disease	6024
in	O	6024
ald	B-Disease	6024
.	O	6024
nonsense	O	6026
mutation	O	6026
in	O	6026
exon	O	6026
4	O	6026
of	O	6026
human	O	6026
complement	O	6026
c9	O	6026
gene	O	6026
is	O	6026
the	O	6026
major	O	6026
cause	O	6026
of	O	6026
japanese	O	6026
complement	B-Disease	6026
c9	I-Disease	6026
deficiency	I-Disease	6026
.	O	6026
deficiency	B-Disease	6027
of	I-Disease	6027
the	I-Disease	6027
ninth	I-Disease	6027
component	I-Disease	6027
of	I-Disease	6027
human	I-Disease	6027
complement	I-Disease	6027
(	O	6027
c9	O	6027
)	O	6027
is	O	6027
the	O	6027
most	O	6027
common	O	6027
complement	B-Disease	6027
deficiency	I-Disease	6027
in	O	6027
japan	O	6027
but	O	6027
is	O	6027
rare	O	6027
in	O	6027
other	O	6027
countries	O	6027
.	O	6027
we	O	6028
studied	O	6028
the	O	6028
molecular	O	6028
basis	O	6028
of	O	6028
c9	B-Disease	6028
deficiency	I-Disease	6028
in	O	6028
four	O	6028
japanese	O	6028
c9	B-Disease	6028
-	I-Disease	6028
deficient	I-Disease	6028
patients	O	6028
who	O	6028
had	O	6028
suffered	O	6028
from	O	6028
meningococcal	B-Disease	6028
meningitis	I-Disease	6028
.	O	6028
direct	O	6029
sequencing	O	6029
of	O	6029
amplified	O	6029
c9	O	6029
cdna	O	6029
and	O	6029
dna	O	6029
revealed	O	6029
a	O	6029
nonsense	O	6029
substitution	O	6029
(	O	6029
cga	O	6029
-	O	6029
-	O	6029
>	O	6029
tga	O	6029
)	O	6029
at	O	6029
codon	O	6029
95	O	6029
in	O	6029
exon	O	6029
4	O	6029
in	O	6029
the	O	6029
four	O	6029
c9	B-Disease	6029
-	I-Disease	6029
deficient	I-Disease	6029
individuals	O	6029
.	O	6029
the	O	6031
common	O	6031
mutation	O	6031
at	O	6031
codon	O	6031
95	O	6031
in	O	6031
exon	O	6031
4	O	6031
might	O	6031
be	O	6031
responsible	O	6031
for	O	6031
most	O	6031
japanese	O	6031
c9	B-Disease	6031
deficiency	I-Disease	6031
.	O	6031
.	O	6031
the	O	6033
breast	B-Disease	6033
and	I-Disease	6033
ovarian	I-Disease	6033
cancer	I-Disease	6033
susceptibility	O	6033
gene	O	6033
brca1	O	6033
encodes	O	6033
a	O	6033
zinc	O	6033
finger	O	6033
protein	O	6033
of	O	6033
unknown	O	6033
function	O	6033
.	O	6033
here	O	6035
,	O	6035
it	O	6035
is	O	6035
shown	O	6035
that	O	6035
mouse	O	6035
embryonic	O	6035
stem	O	6035
cells	O	6035
deficient	B-Disease	6035
in	I-Disease	6035
brca1	I-Disease	6035
are	O	6035
defective	O	6035
in	O	6035
the	O	6035
ability	O	6035
to	O	6035
carry	O	6035
out	O	6035
transcription	O	6035
-	O	6035
coupled	O	6035
repair	O	6035
of	O	6035
oxidative	O	6035
dna	O	6035
damage	O	6035
,	O	6035
and	O	6035
are	O	6035
hypersensitive	O	6035
to	O	6035
ionizing	O	6035
radiation	O	6035
and	O	6035
hydrogen	O	6035
peroxide	O	6035
.	O	6035
heterozygous	O	6040
mutations	O	6040
in	O	6040
the	O	6040
human	O	6040
pax6	O	6040
gene	O	6040
result	O	6040
in	O	6040
various	O	6040
phenotypes	O	6040
,	O	6040
including	O	6040
aniridia	B-Disease	6040
,	O	6040
peters	B-Disease	6040
anomaly	I-Disease	6040
,	O	6040
autosomal	B-Disease	6040
dominant	I-Disease	6040
keratitis	I-Disease	6040
,	O	6040
and	O	6040
familial	B-Disease	6040
foveal	I-Disease	6040
dysplasia	I-Disease	6040
.	O	6040
it	O	6041
is	O	6041
believed	O	6041
that	O	6041
the	O	6041
mutated	O	6041
allele	O	6041
of	O	6041
pax6	O	6041
produces	O	6041
an	O	6041
inactive	O	6041
protein	O	6041
and	O	6041
aniridia	B-Disease	6041
is	O	6041
caused	O	6041
due	O	6041
to	O	6041
genetic	O	6041
haploinsufficiency	O	6041
.	O	6041
however	O	6042
,	O	6042
several	O	6042
truncation	O	6042
mutations	O	6042
have	O	6042
been	O	6042
found	O	6042
to	O	6042
occur	O	6042
in	O	6042
the	O	6042
c	O	6042
-	O	6042
terminal	O	6042
half	O	6042
of	O	6042
pax6	O	6042
in	O	6042
patients	O	6042
with	O	6042
aniridia	B-Disease	6042
resulting	O	6042
in	O	6042
mutant	O	6042
proteins	O	6042
that	O	6042
retain	O	6042
the	O	6042
dna	O	6042
-	O	6042
binding	O	6042
domains	O	6042
but	O	6042
have	O	6042
lost	O	6042
most	O	6042
of	O	6042
the	O	6042
transactivation	O	6042
domain	O	6042
.	O	6042
these	O	6047
results	O	6047
provide	O	6047
a	O	6047
new	O	6047
insight	O	6047
into	O	6047
the	O	6047
role	O	6047
of	O	6047
mutant	O	6047
pax6	O	6047
in	O	6047
causing	O	6047
aniridia	B-Disease	6047
.	O	6047
.	O	6047
reversal	O	6048
of	O	6048
severe	O	6048
hypertrophic	B-Disease	6048
cardiomyopathy	I-Disease	6048
and	O	6048
excellent	O	6048
neuropsychologic	O	6048
outcome	O	6048
in	O	6048
very	B-Disease	6048
-	I-Disease	6048
long	I-Disease	6048
-	I-Disease	6048
chain	I-Disease	6048
acyl	I-Disease	6048
-	I-Disease	6048
coenzyme	I-Disease	6048
a	I-Disease	6048
dehydrogenase	I-Disease	6048
deficiency	I-Disease	6048
.	O	6048
very	B-Disease	6049
-	I-Disease	6049
long	I-Disease	6049
-	I-Disease	6049
chain	I-Disease	6049
acyl	I-Disease	6049
-	I-Disease	6049
coenzyme	I-Disease	6049
a	I-Disease	6049
dehydrogenase	I-Disease	6049
(	I-Disease	6049
vlcad	I-Disease	6049
)	I-Disease	6049
deficiency	I-Disease	6049
is	O	6049
a	O	6049
disorder	O	6049
of	O	6049
fatty	O	6049
acid	O	6049
beta	O	6049
oxidation	O	6049
that	O	6049
reportedly	O	6049
has	O	6049
high	O	6049
rates	O	6049
of	O	6049
morbidity	O	6049
and	O	6049
mortality	O	6049
.	O	6049
we	O	6050
describe	O	6050
the	O	6050
outcome	O	6050
of	O	6050
a	O	6050
5	O	6050
-	O	6050
year	O	6050
-	O	6050
old	O	6050
girl	O	6050
with	O	6050
vlcad	B-Disease	6050
deficiency	I-Disease	6050
who	O	6050
was	O	6050
first	O	6050
seen	O	6050
at	O	6050
5	O	6050
months	O	6050
of	O	6050
age	O	6050
with	O	6050
severe	O	6050
hypertrophic	B-Disease	6050
cardiomyopathy	I-Disease	6050
,	O	6050
hepatomegaly	B-Disease	6050
,	O	6050
encephalopathy	B-Disease	6050
,	O	6050
and	O	6050
hypotonia	B-Disease	6050
.	O	6050
biochemical	O	6051
studies	O	6051
indicated	O	6051
vlcad	B-Disease	6051
deficiency	I-Disease	6051
caused	O	6051
by	O	6051
a	O	6051
stable	O	6051
yet	O	6051
inactive	O	6051
enzyme	O	6051
.	O	6051
clinical	O	6055
recognition	O	6055
of	O	6055
vlcad	B-Disease	6055
deficiency	I-Disease	6055
is	O	6055
important	O	6055
because	O	6055
it	O	6055
is	O	6055
one	O	6055
of	O	6055
the	O	6055
few	O	6055
directly	O	6055
treatable	O	6055
causes	O	6055
of	O	6055
cardiomyopathy	B-Disease	6055
in	O	6055
children	O	6055
.	O	6055
.	O	6055
a	O	6057
gene	O	6057
encoding	O	6057
a	O	6057
novel	O	6057
transmembrane	O	6057
protein	O	6057
was	O	6057
identified	O	6057
by	O	6057
dna	O	6057
sequence	O	6057
analysis	O	6057
within	O	6057
the	O	6057
insulin	B-Disease	6057
-	I-Disease	6057
dependent	I-Disease	6057
diabetes	I-Disease	6057
mellitus	I-Disease	6057
(	O	6057
iddm	B-Disease	6057
)	O	6057
locus	O	6057
iddm4	O	6057
on	O	6057
chromosome	O	6057
11q13	O	6057
.	O	6057
based	O	6058
on	O	6058
its	O	6058
chromosomal	O	6058
position	O	6058
,	O	6058
this	O	6058
gene	O	6058
is	O	6058
a	O	6058
candidate	O	6058
for	O	6058
conferring	O	6058
susceptibility	O	6058
to	O	6058
diabetes	B-Disease	6058
.	O	6058
the	O	6063
apc	B-Disease	6063
variants	O	6063
i1307k	O	6063
and	O	6063
e1317q	O	6063
are	O	6063
associated	O	6063
with	O	6063
colorectal	B-Disease	6063
tumors	I-Disease	6063
,	O	6063
but	O	6063
not	O	6063
always	O	6063
with	O	6063
a	O	6063
family	O	6063
history	O	6063
.	O	6063
classical	O	6064
familial	B-Disease	6064
adenomatous	I-Disease	6064
polyposis	I-Disease	6064
(	O	6064
fap	B-Disease	6064
)	O	6064
is	O	6064
a	O	6064
high	O	6064
-	O	6064
penetrance	O	6064
autosomal	B-Disease	6064
dominant	I-Disease	6064
disease	I-Disease	6064
that	O	6064
predisposes	O	6064
to	O	6064
hundreds	O	6064
or	O	6064
thousands	O	6064
of	O	6064
colorectal	B-Disease	6064
adenomas	I-Disease	6064
and	I-Disease	6064
carcinoma	I-Disease	6064
and	O	6064
that	O	6064
results	O	6064
from	O	6064
truncating	O	6064
mutations	O	6064
in	O	6064
the	O	6064
apc	B-Disease	6064
gene	O	6064
.	O	6064
a	O	6065
variant	O	6065
of	O	6065
fap	B-Disease	6065
is	O	6065
attenuated	B-Disease	6065
adenomatous	I-Disease	6065
polyposis	I-Disease	6065
coli	I-Disease	6065
,	O	6065
which	O	6065
results	O	6065
from	O	6065
germ	O	6065
-	O	6065
line	O	6065
mutations	O	6065
in	O	6065
the	O	6065
5	O	6065
and	O	6065
3	O	6065
regions	O	6065
of	O	6065
the	O	6065
apc	B-Disease	6065
gene	O	6065
.	O	6065
attenuated	B-Disease	6066
adenomatous	I-Disease	6066
polyposis	I-Disease	6066
coli	I-Disease	6066
patients	O	6066
have	O	6066
colorectal	B-Disease	6066
adenomas	I-Disease	6066
(	O	6066
typically	O	6066
fewer	O	6066
than	O	6066
100	O	6066
)	O	6066
without	O	6066
the	O	6066
florid	O	6066
phenotype	O	6066
of	O	6066
classical	O	6066
fap	B-Disease	6066
.	O	6066
another	O	6067
group	O	6067
of	O	6067
patients	O	6067
with	O	6067
multiple	O	6067
adenomas	B-Disease	6067
has	O	6067
no	O	6067
mutations	O	6067
in	O	6067
the	O	6067
apc	B-Disease	6067
gene	O	6067
,	O	6067
and	O	6067
their	O	6067
phenotype	O	6067
probably	O	6067
results	O	6067
from	O	6067
variation	O	6067
at	O	6067
a	O	6067
locus	O	6067
,	O	6067
or	O	6067
loci	O	6067
,	O	6067
elsewhere	O	6067
in	O	6067
the	O	6067
genome	O	6067
.	O	6067
recently	O	6068
,	O	6068
however	O	6068
,	O	6068
a	O	6068
missense	O	6068
variant	O	6068
of	O	6068
apc	B-Disease	6068
(	O	6068
i1307k	O	6068
)	O	6068
was	O	6068
described	O	6068
that	O	6068
confers	O	6068
an	O	6068
increased	O	6068
risk	O	6068
of	O	6068
colorectal	B-Disease	6068
tumors	I-Disease	6068
,	O	6068
including	O	6068
multiple	O	6068
adenomas	B-Disease	6068
,	O	6068
in	O	6068
ashkenazim	O	6068
.	O	6068
we	O	6069
have	O	6069
studied	O	6069
a	O	6069
set	O	6069
of	O	6069
164	O	6069
patients	O	6069
with	O	6069
multiple	O	6069
colorectal	B-Disease	6069
adenomas	I-Disease	6069
and	I-Disease	6069
/	I-Disease	6069
or	I-Disease	6069
carcinoma	I-Disease	6069
and	O	6069
analyzed	O	6069
codons	O	6069
1263	O	6069
-	O	6069
1377	O	6069
(	O	6069
exon	O	6069
15g	O	6069
)	O	6069
of	O	6069
the	O	6069
apc	B-Disease	6069
gene	O	6069
for	O	6069
germ	O	6069
-	O	6069
line	O	6069
variants	O	6069
.	O	6069
four	O	6071
patients	O	6071
had	O	6071
a	O	6071
germ	O	6071
-	O	6071
line	O	6071
e1317q	O	6071
missense	O	6071
variant	O	6071
of	O	6071
apc	O	6071
that	O	6071
was	O	6071
not	O	6071
present	O	6071
in	O	6071
controls	O	6071
;	O	6071
one	O	6071
of	O	6071
these	O	6071
individuals	O	6071
had	O	6071
an	O	6071
unusually	O	6071
large	O	6071
number	O	6071
of	O	6071
metaplastic	B-Disease	6071
polyps	I-Disease	6071
of	I-Disease	6071
the	I-Disease	6071
colorectum	I-Disease	6071
.	O	6071
there	O	6072
is	O	6072
increasing	O	6072
evidence	O	6072
that	O	6072
there	O	6072
exist	O	6072
germ	O	6072
-	O	6072
line	O	6072
variants	O	6072
of	O	6072
the	O	6072
apc	B-Disease	6072
gene	O	6072
that	O	6072
predispose	O	6072
to	O	6072
the	O	6072
development	O	6072
of	O	6072
multiple	O	6072
colorectal	B-Disease	6072
adenomas	I-Disease	6072
and	I-Disease	6072
carcinoma	I-Disease	6072
,	O	6072
but	O	6072
without	O	6072
the	O	6072
florid	O	6072
phenotype	O	6072
of	O	6072
classical	O	6072
fap	B-Disease	6072
,	O	6072
and	O	6072
possibly	O	6072
with	O	6072
importance	O	6072
for	O	6072
colorectal	B-Disease	6072
cancer	I-Disease	6072
risk	O	6072
in	O	6072
the	O	6072
general	O	6072
population	O	6072
.	O	6072
.	O	6072
genomic	O	6073
structure	O	6073
of	O	6073
the	O	6073
human	O	6073
congenital	B-Disease	6073
chloride	I-Disease	6073
diarrhea	I-Disease	6073
(	O	6073
cld	B-Disease	6073
)	O	6073
gene	O	6073
.	O	6073
congenital	B-Disease	6074
chloride	I-Disease	6074
diarrhea	I-Disease	6074
(	O	6074
cld	B-Disease	6074
)	O	6074
is	O	6074
caused	O	6074
by	O	6074
mutations	O	6074
in	O	6074
a	O	6074
gene	O	6074
which	O	6074
encodes	O	6074
an	O	6074
intestinal	O	6074
anion	O	6074
transporter	O	6074
.	O	6074
we	O	6075
report	O	6075
here	O	6075
the	O	6075
complete	O	6075
genomic	O	6075
organization	O	6075
of	O	6075
the	O	6075
human	O	6075
cld	B-Disease	6075
gene	O	6075
which	O	6075
spans	O	6075
approximately	O	6075
39kb	O	6075
,	O	6075
and	O	6075
comprises	O	6075
21	O	6075
exons	O	6075
.	O	6075
the	O	6078
genomic	O	6078
structure	O	6078
was	O	6078
determined	O	6078
using	O	6078
dna	O	6078
from	O	6078
several	O	6078
sources	O	6078
including	O	6078
multiple	O	6078
large	O	6078
-	O	6078
insert	O	6078
libaries	O	6078
and	O	6078
genomic	O	6078
dna	O	6078
from	O	6078
finnish	O	6078
cld	B-Disease	6078
patients	O	6078
and	O	6078
controls	O	6078
.	O	6078
genomic	O	6080
sequencing	O	6080
of	O	6080
a	O	6080
bac	O	6080
clone	O	6080
h	O	6080
_	O	6080
rg364p16	O	6080
revealed	O	6080
the	O	6080
presence	O	6080
of	O	6080
another	O	6080
,	O	6080
highly	O	6080
homologous	O	6080
gene	O	6080
3	O	6080
of	O	6080
the	O	6080
cld	B-Disease	6080
gene	O	6080
,	O	6080
with	O	6080
a	O	6080
similar	O	6080
genomic	O	6080
structure	O	6080
,	O	6080
recently	O	6080
identified	O	6080
as	O	6080
the	O	6080
pendred	B-Disease	6080
syndrome	I-Disease	6080
gene	O	6080
(	O	6080
pds	B-Disease	6080
)	O	6080
.	O	6080
.	O	6080
the	O	6081
apci1307k	O	6081
allele	O	6081
and	O	6081
cancer	B-Disease	6081
risk	O	6081
in	O	6081
a	O	6081
community	O	6081
-	O	6081
based	O	6081
study	O	6081
of	O	6081
ashkenazi	O	6081
jews	O	6081
.	O	6081
mutations	O	6082
in	O	6082
apc	O	6082
are	O	6082
classically	O	6082
associated	O	6082
with	O	6082
familial	B-Disease	6082
adenomatous	I-Disease	6082
polyposis	I-Disease	6082
(	O	6082
fap	B-Disease	6082
)	O	6082
,	O	6082
a	O	6082
highly	O	6082
penetrant	O	6082
autosomal	B-Disease	6082
dominant	I-Disease	6082
disorder	I-Disease	6082
characterized	O	6082
by	O	6082
multiple	O	6082
intestinal	O	6082
polyps	B-Disease	6082
and	O	6082
,	O	6082
without	O	6082
surgical	O	6082
intervention	O	6082
,	O	6082
the	O	6082
development	O	6082
of	O	6082
colorectal	B-Disease	6082
cancer	I-Disease	6082
(	O	6082
crc	B-Disease	6082
)	O	6082
.	O	6082
apc	B-Disease	6083
is	O	6083
a	O	6083
tumour	O	6083
-	O	6083
suppressor	O	6083
gene	O	6083
,	O	6083
and	O	6083
somatic	O	6083
loss	O	6083
occurs	O	6083
in	O	6083
tumours	B-Disease	6083
.	O	6083
1	O	6086
%	O	6086
of	O	6086
unselected	O	6086
ashkenazi	O	6086
jews	O	6086
and	O	6086
higher	O	6086
proportions	O	6086
of	O	6086
ashkenazim	O	6086
with	O	6086
family	O	6086
or	O	6086
personal	O	6086
histories	O	6086
of	O	6086
crc	B-Disease	6086
(	O	6086
ref	O	6086
.	O	6086
2	O	6086
)	O	6086
.	O	6086
to	O	6087
evaluate	O	6087
the	O	6087
role	O	6087
of	O	6087
i1307k	O	6087
in	O	6087
cancer	B-Disease	6087
,	O	6087
we	O	6087
genotyped	O	6087
5	O	6087
,	O	6087
081	O	6087
ashkenazi	O	6087
volunteers	O	6087
in	O	6087
a	O	6087
community	O	6087
survey	O	6087
.	O	6087
risk	O	6088
of	O	6088
developing	O	6088
colorectal	B-Disease	6088
,	I-Disease	6088
breast	I-Disease	6088
and	I-Disease	6088
other	I-Disease	6088
cancers	I-Disease	6088
were	O	6088
compared	O	6088
between	O	6088
genotyped	O	6088
i1307k	O	6088
carriers	O	6088
and	O	6088
non	O	6088
-	O	6088
carriers	O	6088
and	O	6088
their	O	6088
first	O	6088
-	O	6088
degree	O	6088
relatives	O	6088
.	O	6088
sperm	O	6089
dna	O	6089
analysis	O	6089
in	O	6089
a	O	6089
friedreich	B-Disease	6089
ataxia	I-Disease	6089
premutation	O	6089
carrier	O	6089
suggests	O	6089
both	O	6089
meiotic	O	6089
and	O	6089
mitotic	O	6089
expansion	O	6089
in	O	6089
the	O	6089
frda	B-Disease	6089
gene	O	6089
.	O	6089
friedreich	B-Disease	6090
ataxia	I-Disease	6090
is	O	6090
usually	O	6090
caused	O	6090
by	O	6090
an	O	6090
expansion	O	6090
of	O	6090
a	O	6090
gaa	O	6090
trinucleotide	O	6090
repeat	O	6090
in	O	6090
intron	O	6090
1	O	6090
of	O	6090
the	O	6090
frda	B-Disease	6090
gene	O	6090
.	O	6090
the	O	6098
r496h	O	6098
mutation	O	6098
of	O	6098
arylsulfatase	O	6098
a	O	6098
does	O	6098
not	O	6098
cause	O	6098
metachromatic	B-Disease	6098
leukodystrophy	I-Disease	6098
.	O	6098
deficiency	B-Disease	6099
of	I-Disease	6099
arylsulfatase	I-Disease	6099
a	I-Disease	6099
(	O	6099
arsa	O	6099
)	O	6099
enzyme	O	6099
activity	O	6099
causes	O	6099
metachromatic	B-Disease	6099
leukodystrophy	I-Disease	6099
(	O	6099
mld	B-Disease	6099
)	O	6099
.	O	6099
a	O	6100
number	O	6100
of	O	6100
arsa	O	6100
gene	O	6100
mutations	O	6100
responsible	O	6100
for	O	6100
mld	B-Disease	6100
have	O	6100
been	O	6100
identified	O	6100
.	O	6100
recently	O	6101
,	O	6101
the	O	6101
r496h	O	6101
mutation	O	6101
of	O	6101
arsa	O	6101
was	O	6101
proposed	O	6101
to	O	6101
be	O	6101
a	O	6101
cause	O	6101
of	O	6101
mld	B-Disease	6101
(	O	6101
draghia	O	6101
et	O	6101
al	O	6101
.	O	6101
,	O	6101
1997	O	6101
)	O	6101
.	O	6101
it	O	6104
is	O	6104
therefore	O	6104
concluded	O	6104
that	O	6104
the	O	6104
r496h	O	6104
mutation	O	6104
of	O	6104
arsa	O	6104
does	O	6104
not	O	6104
negatively	O	6104
influence	O	6104
the	O	6104
activity	O	6104
of	O	6104
arsa	O	6104
and	O	6104
is	O	6104
not	O	6104
a	O	6104
cause	O	6104
of	O	6104
mld	B-Disease	6104
down	O	6105
-	O	6105
regulation	O	6105
of	O	6105
transmembrane	O	6105
carbonic	O	6105
anhydrases	O	6105
in	O	6105
renal	B-Disease	6105
cell	I-Disease	6105
carcinoma	I-Disease	6105
cell	O	6105
lines	O	6105
by	O	6105
wild	O	6105
-	O	6105
type	O	6105
von	B-Disease	6105
hippel	I-Disease	6105
-	I-Disease	6105
lindau	I-Disease	6105
transgenes	O	6105
.	O	6105
to	O	6106
discover	O	6106
genes	O	6106
involved	O	6106
in	O	6106
von	B-Disease	6106
hippel	I-Disease	6106
-	I-Disease	6106
lindau	I-Disease	6106
(	O	6106
vhl	B-Disease	6106
)	O	6106
-	O	6106
mediated	O	6106
carcinogenesis	O	6106
,	O	6106
we	O	6106
used	O	6106
renal	B-Disease	6106
cell	I-Disease	6106
carcinoma	I-Disease	6106
cell	O	6106
lines	O	6106
stably	O	6106
transfected	O	6106
with	O	6106
wild	O	6106
-	O	6106
type	O	6106
vhl	O	6106
-	O	6106
expressing	O	6106
transgenes	O	6106
.	O	6106
reintroduced	O	6109
wild	O	6109
-	O	6109
type	O	6109
vhl	B-Disease	6109
strongly	O	6109
inhibited	O	6109
the	O	6109
overexpression	O	6109
of	O	6109
the	O	6109
ca12	O	6109
gene	O	6109
in	O	6109
the	O	6109
parental	O	6109
renal	B-Disease	6109
cell	I-Disease	6109
carcinoma	I-Disease	6109
cell	O	6109
lines	O	6109
.	O	6109
although	O	6111
both	O	6111
domains	O	6111
of	O	6111
the	O	6111
vhl	B-Disease	6111
protein	O	6111
contribute	O	6111
to	O	6111
regulation	O	6111
of	O	6111
ca12	O	6111
expression	O	6111
,	O	6111
the	O	6111
elongin	O	6111
binding	O	6111
domain	O	6111
alone	O	6111
could	O	6111
effectively	O	6111
regulate	O	6111
ca9	O	6111
expression	O	6111
.	O	6111
2	O	6113
respectively	O	6113
,	O	6113
regions	O	6113
prone	O	6113
to	O	6113
amplification	O	6113
in	O	6113
some	O	6113
human	O	6113
cancers	B-Disease	6113
.	O	6113
additional	O	6114
experiments	O	6114
are	O	6114
needed	O	6114
to	O	6114
define	O	6114
the	O	6114
role	O	6114
of	O	6114
ca	O	6114
ix	O	6114
and	O	6114
ca	O	6114
xii	O	6114
enzymes	O	6114
in	O	6114
the	O	6114
regulation	O	6114
of	O	6114
ph	O	6114
in	O	6114
the	O	6114
extracellular	O	6114
microenvironment	O	6114
and	O	6114
its	O	6114
potential	O	6114
impact	O	6114
on	O	6114
cancer	B-Disease	6114
cell	O	6114
growth	O	6114
.	O	6114
a	O	6115
gene	O	6115
encoding	O	6115
a	O	6115
transmembrane	O	6115
protein	O	6115
is	O	6115
mutated	O	6115
in	O	6115
patients	O	6115
with	O	6115
diabetes	B-Disease	6115
mellitus	I-Disease	6115
and	O	6115
optic	B-Disease	6115
atrophy	I-Disease	6115
(	O	6115
wolfram	B-Disease	6115
syndrome	I-Disease	6115
)	O	6115
.	O	6115
wolfram	B-Disease	6116
syndrome	I-Disease	6116
(	O	6116
wfs	B-Disease	6116
;	O	6116
omim	O	6116
222300	O	6116
)	O	6116
is	O	6116
an	O	6116
autosomal	B-Disease	6116
recessive	I-Disease	6116
neurodegenerative	I-Disease	6116
disorder	I-Disease	6116
defined	O	6116
by	O	6116
young	O	6116
-	O	6116
onset	O	6116
non	O	6116
-	O	6116
immune	O	6116
insulin	B-Disease	6116
-	I-Disease	6116
dependent	I-Disease	6116
diabetes	I-Disease	6116
mellitus	I-Disease	6116
and	O	6116
progressive	O	6116
optic	B-Disease	6116
atrophy	I-Disease	6116
.	O	6116
on	O	6118
the	O	6118
basis	O	6118
of	O	6118
meiotic	O	6118
recombinants	O	6118
and	O	6118
disease	O	6118
-	O	6118
associated	O	6118
haplotypes	O	6118
,	O	6118
the	O	6118
wfs	B-Disease	6118
gene	O	6118
was	O	6118
localized	O	6118
to	O	6118
a	O	6118
bac	O	6118
/	O	6118
p1	O	6118
contig	O	6118
of	O	6118
less	O	6118
than	O	6118
250	O	6118
kb	O	6118
.	O	6118
mutations	O	6119
in	O	6119
a	O	6119
novel	O	6119
gene	O	6119
(	O	6119
wfs1	O	6119
)	O	6119
encoding	O	6119
a	O	6119
putative	O	6119
transmembrane	O	6119
protein	O	6119
were	O	6119
found	O	6119
in	O	6119
all	O	6119
affected	O	6119
individuals	O	6119
in	O	6119
six	O	6119
wfs	B-Disease	6119
families	O	6119
,	O	6119
and	O	6119
these	O	6119
mutations	O	6119
were	O	6119
associated	O	6119
with	O	6119
the	O	6119
disease	O	6119
phenotype	O	6119
.	O	6119
stable	O	6121
interaction	O	6121
between	O	6121
the	O	6121
products	O	6121
of	O	6121
the	O	6121
brca1	O	6121
and	O	6121
brca2	O	6121
tumor	B-Disease	6121
suppressor	O	6121
genes	O	6121
in	O	6121
mitotic	O	6121
and	O	6121
meiotic	O	6121
cells	O	6121
.	O	6121
brca1	O	6122
and	O	6122
brca2	O	6122
account	O	6122
for	O	6122
most	O	6122
cases	O	6122
of	O	6122
familial	O	6122
,	O	6122
early	O	6122
onset	O	6122
breast	B-Disease	6122
and	I-Disease	6122
/	I-Disease	6122
or	I-Disease	6122
ovarian	I-Disease	6122
cancer	I-Disease	6122
and	O	6122
encode	O	6122
products	O	6122
that	O	6122
each	O	6122
interact	O	6122
with	O	6122
hrad51	O	6122
.	O	6122
dysfunction	O	6126
of	O	6126
this	O	6126
pathway	O	6126
may	O	6126
be	O	6126
a	O	6126
general	O	6126
phenomenon	O	6126
in	O	6126
the	O	6126
majority	O	6126
of	O	6126
cases	O	6126
of	O	6126
hereditary	B-Disease	6126
breast	I-Disease	6126
and	I-Disease	6126
/	I-Disease	6126
or	I-Disease	6126
ovarian	I-Disease	6126
cancer	I-Disease	6126
.	O	6126
.	O	6126
a	O	6128
novel	O	6128
c	O	6128
to	O	6128
a	O	6128
mutation	O	6128
in	O	6128
the	O	6128
sterol	O	6128
27	O	6128
-	O	6128
hydroxylase	O	6128
gene	O	6128
(	O	6128
cyp27	O	6128
)	O	6128
was	O	6128
identified	O	6128
by	O	6128
sequencing	O	6128
amplified	O	6128
cyp27	O	6128
gene	O	6128
products	O	6128
from	O	6128
a	O	6128
patient	O	6128
with	O	6128
cerebrotendinous	B-Disease	6128
xanthomatosis	I-Disease	6128
(	O	6128
ctx	B-Disease	6128
)	O	6128
.	O	6128
our	O	6134
data	O	6134
suggest	O	6134
that	O	6134
the	O	6134
c	O	6134
to	O	6134
a	O	6134
mutation	O	6134
at	O	6134
the	O	6134
penultimate	O	6134
nucleotide	O	6134
of	O	6134
exon	O	6134
6	O	6134
of	O	6134
the	O	6134
cyp27	O	6134
gene	O	6134
not	O	6134
only	O	6134
causes	O	6134
the	O	6134
deficiency	B-Disease	6134
in	I-Disease	6134
the	I-Disease	6134
sterol	I-Disease	6134
27	I-Disease	6134
-	I-Disease	6134
hydroxylase	I-Disease	6134
activity	I-Disease	6134
,	O	6134
but	O	6134
also	O	6134
partially	O	6134
leads	O	6134
to	O	6134
alternative	O	6134
pre	O	6134
-	O	6134
mrna	O	6134
splicing	O	6134
of	O	6134
the	O	6134
gene	O	6134
.	O	6134
atm	O	6136
germline	O	6136
mutations	O	6136
in	O	6136
classical	O	6136
ataxia	B-Disease	6136
-	I-Disease	6136
telangiectasia	I-Disease	6136
patients	O	6136
in	O	6136
the	O	6136
dutch	O	6136
population	O	6136
.	O	6136
germline	O	6137
mutations	O	6137
in	O	6137
the	O	6137
atm	O	6137
gene	O	6137
are	O	6137
responsible	O	6137
for	O	6137
the	O	6137
autosomal	B-Disease	6137
recessive	I-Disease	6137
disorder	I-Disease	6137
ataxia	B-Disease	6137
-	I-Disease	6137
telangiectasia	I-Disease	6137
(	O	6137
a	B-Disease	6137
-	I-Disease	6137
t	I-Disease	6137
)	O	6137
.	O	6137
in	O	6138
our	O	6138
study	O	6138
,	O	6138
we	O	6138
have	O	6138
determined	O	6138
the	O	6138
atm	O	6138
mutation	O	6138
spectrum	O	6138
in	O	6138
19	O	6138
classical	O	6138
a	B-Disease	6138
-	I-Disease	6138
t	I-Disease	6138
patients	O	6138
,	O	6138
including	O	6138
some	O	6138
immigrant	O	6138
populations	O	6138
,	O	6138
as	O	6138
well	O	6138
as	O	6138
12	O	6138
of	O	6138
dutch	O	6138
ethnic	O	6138
origin	O	6138
.	O	6138
the	O	6145
most	O	6145
frequently	O	6145
found	O	6145
mutation	O	6145
,	O	6145
identified	O	6145
in	O	6145
three	O	6145
unrelated	O	6145
turkish	O	6145
a	B-Disease	6145
-	I-Disease	6145
t	I-Disease	6145
individuals	O	6145
,	O	6145
was	O	6145
previously	O	6145
described	O	6145
to	O	6145
be	O	6145
a	O	6145
turkish	O	6145
a	B-Disease	6145
-	I-Disease	6145
t	I-Disease	6145
founder	O	6145
mutation	O	6145
.	O	6145
all	O	6149
patients	O	6149
manifested	O	6149
classical	O	6149
a	B-Disease	6149
-	I-Disease	6149
t	I-Disease	6149
and	O	6149
increased	O	6149
cellular	O	6149
radioresistant	O	6149
dna	O	6149
synthesis	O	6149
.	O	6149
determination	O	6150
of	O	6150
the	O	6150
genomic	O	6150
structure	O	6150
of	O	6150
the	O	6150
col4a4	O	6150
gene	O	6150
and	O	6150
of	O	6150
novel	O	6150
mutations	O	6150
causing	O	6150
autosomal	B-Disease	6150
recessive	I-Disease	6150
alport	I-Disease	6150
syndrome	I-Disease	6150
.	O	6150
autosomal	B-Disease	6151
recessive	I-Disease	6151
alport	I-Disease	6151
syndrome	I-Disease	6151
is	O	6151
a	O	6151
progressive	O	6151
hematuric	B-Disease	6151
glomerulonephritis	I-Disease	6151
characterized	O	6151
by	O	6151
glomerular	B-Disease	6151
basement	I-Disease	6151
membrane	I-Disease	6151
abnormalities	I-Disease	6151
and	O	6151
associated	O	6151
with	O	6151
mutations	O	6151
in	O	6151
either	O	6151
the	O	6151
col4a3	O	6151
or	O	6151
the	O	6151
col4a4	O	6151
gene	O	6151
,	O	6151
which	O	6151
encode	O	6151
the	O	6151
alpha3	O	6151
and	O	6151
alpha4	O	6151
type	O	6151
iv	O	6151
collagen	O	6151
chains	O	6151
,	O	6151
respectively	O	6151
.	O	6151
we	O	6153
report	O	6153
here	O	6153
the	O	6153
complete	O	6153
characterization	O	6153
of	O	6153
the	O	6153
48	O	6153
exons	O	6153
of	O	6153
the	O	6153
col4a4	O	6153
gene	O	6153
,	O	6153
a	O	6153
comprehensive	O	6153
gene	O	6153
screen	O	6153
,	O	6153
and	O	6153
the	O	6153
subsequent	O	6153
detection	O	6153
of	O	6153
10	O	6153
novel	O	6153
mutations	O	6153
in	O	6153
eight	O	6153
patients	O	6153
diagnosed	O	6153
with	O	6153
autosomal	B-Disease	6153
recessive	I-Disease	6153
alport	I-Disease	6153
syndrome	I-Disease	6153
.	O	6153
founder	O	6157
brca1	O	6157
and	O	6157
brca2	O	6157
mutations	O	6157
in	O	6157
french	O	6157
canadian	O	6157
breast	B-Disease	6157
and	I-Disease	6157
ovarian	I-Disease	6157
cancer	I-Disease	6157
families	O	6157
.	O	6157
we	O	6158
have	O	6158
identified	O	6158
four	O	6158
mutations	O	6158
in	O	6158
each	O	6158
of	O	6158
the	O	6158
breast	B-Disease	6158
cancer	I-Disease	6158
-	O	6158
susceptibility	O	6158
genes	O	6158
,	O	6158
brca1	O	6158
and	O	6158
brca2	O	6158
,	O	6158
in	O	6158
french	O	6158
canadian	O	6158
breast	B-Disease	6158
cancer	I-Disease	6158
and	O	6158
breast	B-Disease	6158
/	I-Disease	6158
ovarian	I-Disease	6158
cancer	I-Disease	6158
families	O	6158
from	O	6158
quebec	O	6158
.	O	6158
to	O	6159
identify	O	6159
founder	O	6159
effects	O	6159
,	O	6159
we	O	6159
examined	O	6159
independently	O	6159
ascertained	O	6159
french	O	6159
canadian	O	6159
cancer	B-Disease	6159
families	O	6159
for	O	6159
the	O	6159
distribution	O	6159
of	O	6159
these	O	6159
eight	O	6159
mutations	O	6159
.	O	6159
7x	O	6165
greater	O	6165
if	O	6165
one	O	6165
or	O	6165
more	O	6165
cases	O	6165
of	O	6165
ovarian	B-Disease	6165
cancer	I-Disease	6165
were	O	6165
also	O	6165
present	O	6165
in	O	6165
the	O	6165
family	O	6165
.	O	6165
3x	O	6167
greater	O	6167
if	O	6167
there	O	6167
were	O	6167
at	O	6167
least	O	6167
five	O	6167
cases	O	6167
of	O	6167
breast	B-Disease	6167
cancer	I-Disease	6167
in	O	6167
the	O	6167
family	O	6167
.	O	6167
interestingly	O	6168
,	O	6168
the	O	6168
presence	O	6168
of	O	6168
a	O	6168
breast	B-Disease	6168
cancer	I-Disease	6168
case	O	6168
<	O	6168
36	O	6168
years	O	6168
of	O	6168
age	O	6168
was	O	6168
strongly	O	6168
predictive	O	6168
of	O	6168
the	O	6168
presence	O	6168
of	O	6168
any	O	6168
of	O	6168
the	O	6168
eight	O	6168
mutations	O	6168
screened	O	6168
.	O	6168
the	O	6170
identification	O	6170
of	O	6170
common	O	6170
brca1	O	6170
and	O	6170
brca2	O	6170
mutations	O	6170
will	O	6170
facilitate	O	6170
carrier	O	6170
detection	O	6170
in	O	6170
french	O	6170
canadian	O	6170
breast	B-Disease	6170
cancer	I-Disease	6170
and	O	6170
breast	B-Disease	6170
/	I-Disease	6170
ovarian	I-Disease	6170
cancer	I-Disease	6170
families	O	6170
.	O	6170
are	O	6171
dp71	O	6171
and	O	6171
dp140	O	6171
brain	O	6171
dystrophin	O	6171
isoforms	O	6171
related	O	6171
to	O	6171
cognitive	B-Disease	6171
impairment	I-Disease	6171
in	O	6171
duchenne	B-Disease	6171
muscular	I-Disease	6171
dystrophy	I-Disease	6171
?	O	6171
molecular	O	6172
study	O	6172
and	O	6172
neuropsychological	O	6172
analysis	O	6172
were	O	6172
performed	O	6172
concurrently	O	6172
on	O	6172
49	O	6172
patients	O	6172
with	O	6172
duchenne	B-Disease	6172
muscular	I-Disease	6172
dystrophy	I-Disease	6172
(	O	6172
dmd	B-Disease	6172
)	O	6172
in	O	6172
order	O	6172
to	O	6172
find	O	6172
a	O	6172
molecular	O	6172
explanation	O	6172
for	O	6172
the	O	6172
cognitive	B-Disease	6172
impairment	I-Disease	6172
observed	O	6172
in	O	6172
most	O	6172
dmd	B-Disease	6172
patients	O	6172
.	O	6172
complete	O	6173
analysis	O	6173
of	O	6173
the	O	6173
dystrophin	O	6173
gene	O	6173
was	O	6173
performed	O	6173
to	O	6173
define	O	6173
the	O	6173
localization	O	6173
of	O	6173
deletions	O	6173
and	O	6173
duplications	O	6173
in	O	6173
relation	O	6173
to	O	6173
the	O	6173
different	O	6173
dmd	B-Disease	6173
promoters	O	6173
.	O	6173
comparison	O	6176
of	O	6176
molecular	O	6176
and	O	6176
psychometric	O	6176
findings	O	6176
demonstrated	O	6176
that	O	6176
deletions	O	6176
and	O	6176
duplications	O	6176
that	O	6176
were	O	6176
localized	O	6176
in	O	6176
the	O	6176
distal	O	6176
part	O	6176
of	O	6176
the	O	6176
gene	O	6176
seemed	O	6176
to	O	6176
be	O	6176
preferentially	O	6176
associated	O	6176
with	O	6176
cognitive	B-Disease	6176
impairment	I-Disease	6176
.	O	6176
two	O	6177
altered	O	6177
dp71	O	6177
transcripts	O	6177
and	O	6177
two	O	6177
deleted	O	6177
dp140	O	6177
dna	O	6177
sequences	O	6177
were	O	6177
found	O	6177
in	O	6177
four	O	6177
patients	O	6177
with	O	6177
severe	O	6177
cerebral	B-Disease	6177
dysfunction	I-Disease	6177
.	O	6177
these	O	6178
findings	O	6178
suggest	O	6178
that	O	6178
some	O	6178
sequences	O	6178
located	O	6178
in	O	6178
the	O	6178
distal	O	6178
part	O	6178
of	O	6178
the	O	6178
gene	O	6178
and	O	6178
,	O	6178
in	O	6178
particular	O	6178
,	O	6178
some	O	6178
dmd	B-Disease	6178
isoforms	O	6178
expressed	O	6178
in	O	6178
the	O	6178
brain	O	6178
may	O	6178
be	O	6178
related	O	6178
to	O	6178
the	O	6178
cognitive	B-Disease	6178
impairment	I-Disease	6178
associated	O	6178
with	O	6178
dmd	B-Disease	6178
.	O	6178
.	O	6178
i1307k	O	6179
apc	O	6179
and	O	6179
hmlh1	O	6179
mutations	O	6179
in	O	6179
a	O	6179
non	O	6179
-	O	6179
jewish	O	6179
family	O	6179
with	O	6179
hereditary	B-Disease	6179
non	I-Disease	6179
-	I-Disease	6179
polyposis	I-Disease	6179
colorectal	I-Disease	6179
cancer	I-Disease	6179
.	O	6179
we	O	6180
describe	O	6180
a	O	6180
french	O	6180
canadian	O	6180
hereditary	B-Disease	6180
non	I-Disease	6180
-	I-Disease	6180
polyposis	I-Disease	6180
colorectal	I-Disease	6180
cancer	I-Disease	6180
(	O	6180
hnpcc	B-Disease	6180
)	O	6180
kindred	O	6180
which	O	6180
carries	O	6180
a	O	6180
novel	O	6180
truncating	O	6180
mutation	O	6180
in	O	6180
hmlh1	O	6180
.	O	6180
interestingly	O	6181
,	O	6181
the	O	6181
i1307k	O	6181
apc	O	6181
polymorphism	O	6181
,	O	6181
associated	O	6181
with	O	6181
an	O	6181
increased	O	6181
risk	O	6181
of	O	6181
colorectal	B-Disease	6181
cancer	I-Disease	6181
,	O	6181
is	O	6181
also	O	6181
present	O	6181
in	O	6181
this	O	6181
family	O	6181
.	O	6181
in	O	6183
addition	O	6183
,	O	6183
in	O	6183
this	O	6183
family	O	6183
,	O	6183
there	O	6183
appears	O	6183
to	O	6183
be	O	6183
no	O	6183
relationship	O	6183
between	O	6183
the	O	6183
i1307k	O	6183
polymorphism	O	6183
and	O	6183
the	O	6183
presence	O	6183
or	O	6183
absence	O	6183
of	O	6183
cancer	B-Disease	6183
.	O	6183
.	O	6183
identification	O	6184
of	O	6184
a	O	6184
novel	O	6184
mutation	O	6184
of	O	6184
the	O	6184
cpo	O	6184
gene	O	6184
in	O	6184
a	O	6184
japanese	O	6184
hereditary	B-Disease	6184
coproporphyria	I-Disease	6184
family	O	6184
.	O	6184
hereditary	B-Disease	6185
coproporphyria	I-Disease	6185
(	O	6185
hcp	B-Disease	6185
)	O	6185
is	O	6185
an	O	6185
autosomal	B-Disease	6185
dominant	I-Disease	6185
disease	I-Disease	6185
characterized	O	6185
by	O	6185
a	O	6185
deficiency	B-Disease	6185
of	I-Disease	6185
coproporphyrinogen	I-Disease	6185
oxidase	I-Disease	6185
(	O	6185
cpo	O	6185
)	O	6185
caused	O	6185
by	O	6185
a	O	6185
mutation	O	6185
in	O	6185
the	O	6185
cpo	O	6185
gene	O	6185
.	O	6185
only	O	6186
11	O	6186
mutations	O	6186
of	O	6186
the	O	6186
gene	O	6186
have	O	6186
been	O	6186
reported	O	6186
in	O	6186
hcp	B-Disease	6186
patients	O	6186
.	O	6186
human	B-Disease	6192
complement	I-Disease	6192
factor	I-Disease	6192
h	I-Disease	6192
deficiency	I-Disease	6192
associated	O	6192
with	O	6192
hemolytic	B-Disease	6192
uremic	I-Disease	6192
syndrome	I-Disease	6192
.	O	6192
this	O	6193
study	O	6193
reports	O	6193
on	O	6193
six	O	6193
cases	O	6193
of	O	6193
deficiency	B-Disease	6193
in	I-Disease	6193
the	I-Disease	6193
human	I-Disease	6193
complement	I-Disease	6193
regulatory	I-Disease	6193
protein	I-Disease	6193
factor	I-Disease	6193
h	I-Disease	6193
(	O	6193
fh	O	6193
)	O	6193
in	O	6193
the	O	6193
context	O	6193
of	O	6193
an	O	6193
acute	B-Disease	6193
renal	I-Disease	6193
disease	I-Disease	6193
.	O	6193
five	O	6194
of	O	6194
the	O	6194
cases	O	6194
were	O	6194
observed	O	6194
in	O	6194
children	O	6194
presenting	O	6194
with	O	6194
idiopathic	O	6194
hemolytic	B-Disease	6194
uremic	I-Disease	6194
syndrome	I-Disease	6194
(	O	6194
hus	B-Disease	6194
)	O	6194
.	O	6194
factor	B-Disease	6198
h	I-Disease	6198
deficiency	I-Disease	6198
is	O	6198
the	O	6198
only	O	6198
complement	B-Disease	6198
deficiency	I-Disease	6198
associated	O	6198
with	O	6198
hus	B-Disease	6198
.	O	6198
these	O	6199
observations	O	6199
suggest	O	6199
a	O	6199
role	O	6199
for	O	6199
fh	O	6199
and	O	6199
/	O	6199
or	O	6199
fh	O	6199
receptors	O	6199
in	O	6199
the	O	6199
pathogenesis	O	6199
of	O	6199
idiopathic	O	6199
hus	B-Disease	6199
.	O	6199
.	O	6199
further	O	6200
evidence	O	6200
for	O	6200
a	O	6200
major	O	6200
ancient	O	6200
mutation	O	6200
underlying	O	6200
myotonic	B-Disease	6200
dystrophy	I-Disease	6200
from	O	6200
linkage	O	6200
disequilibrium	O	6200
studies	O	6200
in	O	6200
the	O	6200
japanese	O	6200
population	O	6200
.	O	6200
the	O	6201
myotonic	B-Disease	6201
dystrophy	I-Disease	6201
(	O	6201
dm	B-Disease	6201
)	O	6201
mutation	O	6201
is	O	6201
an	O	6201
unstable	O	6201
(	O	6201
ctg	O	6201
)	O	6201
n	O	6201
repeat	O	6201
,	O	6201
present	O	6201
at	O	6201
a	O	6201
copy	O	6201
number	O	6201
of	O	6201
5	O	6201
-	O	6201
37	O	6201
repeats	O	6201
on	O	6201
normal	O	6201
chromosomes	O	6201
but	O	6201
amplified	O	6201
to	O	6201
50	O	6201
-	O	6201
3000	O	6201
copies	O	6201
on	O	6201
dm	B-Disease	6201
chromosomes	O	6201
.	O	6201
previous	O	6202
findings	O	6202
in	O	6202
caucasian	O	6202
populations	O	6202
of	O	6202
a	O	6202
dm	B-Disease	6202
founder	O	6202
chromosome	O	6202
raise	O	6202
a	O	6202
question	O	6202
about	O	6202
the	O	6202
molecular	O	6202
events	O	6202
involved	O	6202
in	O	6202
the	O	6202
expansion	O	6202
mutation	O	6202
.	O	6202
to	O	6203
investigate	O	6203
whether	O	6203
a	O	6203
founder	O	6203
chromosome	O	6203
for	O	6203
the	O	6203
dm	B-Disease	6203
mutation	O	6203
exists	O	6203
in	O	6203
the	O	6203
japanese	O	6203
population	O	6203
,	O	6203
we	O	6203
genotyped	O	6203
families	O	6203
using	O	6203
polymorphic	O	6203
markers	O	6203
near	O	6203
the	O	6203
(	O	6203
ctg	O	6203
)	O	6203
n	O	6203
repeat	O	6203
region	O	6203
and	O	6203
constructed	O	6203
haplotypes	O	6203
.	O	6203
six	O	6204
different	O	6204
haplotypes	O	6204
were	O	6204
found	O	6204
and	O	6204
dm	B-Disease	6204
alleles	O	6204
were	O	6204
always	O	6204
haplotype	O	6204
a	O	6204
.	O	6204
to	O	6205
find	O	6205
an	O	6205
origin	O	6205
of	O	6205
the	O	6205
(	O	6205
ctg	O	6205
)	O	6205
n	O	6205
repeat	O	6205
mutation	O	6205
and	O	6205
to	O	6205
investigate	O	6205
the	O	6205
mechanism	O	6205
of	O	6205
the	O	6205
expansion	O	6205
mutation	O	6205
in	O	6205
the	O	6205
japanese	O	6205
population	O	6205
we	O	6205
have	O	6205
studied	O	6205
90	O	6205
japanese	O	6205
dm	B-Disease	6205
families	O	6205
comprising	O	6205
190	O	6205
affected	O	6205
and	O	6205
130	O	6205
unaffected	O	6205
members	O	6205
.	O	6205
these	O	6207
data	O	6207
support	O	6207
multistep	O	6207
models	O	6207
of	O	6207
triplet	O	6207
repeat	O	6207
expansion	O	6207
that	O	6207
have	O	6207
been	O	6207
proposed	O	6207
for	O	6207
both	O	6207
dm	B-Disease	6207
and	O	6207
friedreichs	B-Disease	6207
ataxia	I-Disease	6207
.	O	6207
.	O	6207
the	O	6208
molecular	O	6208
basis	O	6208
of	O	6208
c6	B-Disease	6208
deficiency	I-Disease	6208
in	O	6208
the	O	6208
western	O	6208
cape	O	6208
,	O	6208
south	O	6208
africa	O	6208
.	O	6208
deficiency	B-Disease	6209
of	I-Disease	6209
the	I-Disease	6209
sixth	I-Disease	6209
component	I-Disease	6209
of	I-Disease	6209
human	I-Disease	6209
complement	I-Disease	6209
(	O	6209
c6	O	6209
)	O	6209
has	O	6209
been	O	6209
reported	O	6209
in	O	6209
a	O	6209
number	O	6209
of	O	6209
families	O	6209
from	O	6209
the	O	6209
western	O	6209
cape	O	6209
,	O	6209
south	O	6209
africa	O	6209
.	O	6209
meningococcal	B-Disease	6210
disease	I-Disease	6210
is	O	6210
endemic	O	6210
in	O	6210
the	O	6210
cape	O	6210
and	O	6210
almost	O	6210
all	O	6210
pedigrees	O	6210
of	O	6210
total	O	6210
c6	B-Disease	6210
deficiency	I-Disease	6210
(	O	6210
c6q0	O	6210
)	O	6210
have	O	6210
been	O	6210
ascertained	O	6210
because	O	6210
of	O	6210
recurrent	O	6210
disease	O	6210
.	O	6210
we	O	6215
have	O	6215
also	O	6215
observed	O	6215
the	O	6215
879delg	O	6215
defect	O	6215
in	O	6215
two	O	6215
dutch	O	6215
c6	B-Disease	6215
-	I-Disease	6215
deficient	I-Disease	6215
kindreds	O	6215
,	O	6215
but	O	6215
the	O	6215
879delg	O	6215
defect	O	6215
in	O	6215
the	O	6215
cape	O	6215
probably	O	6215
did	O	6215
not	O	6215
come	O	6215
from	O	6215
the	O	6215
netherlands	O	6215
.	O	6215
.	O	6215
complement	B-Disease	6216
c7	I-Disease	6216
deficiency	I-Disease	6216
:	O	6216
seven	O	6216
further	O	6216
molecular	O	6216
defects	O	6216
and	O	6216
their	O	6216
associated	O	6216
marker	O	6216
haplotypes	O	6216
.	O	6216
seven	O	6217
further	O	6217
molecular	O	6217
bases	O	6217
of	O	6217
c7	B-Disease	6217
deficiency	I-Disease	6217
are	O	6217
described	O	6217
.	O	6217
the	O	6221
c6	O	6221
/	O	6221
c7	O	6221
marker	O	6221
haplotypes	O	6221
associated	O	6221
with	O	6221
most	O	6221
c7	B-Disease	6221
defects	I-Disease	6221
are	O	6221
tabulated	O	6221
.	O	6221
.	O	6221
a	O	6222
genome	O	6222
-	O	6222
wide	O	6222
search	O	6222
for	O	6222
chromosomal	O	6222
loci	O	6222
linked	O	6222
to	O	6222
mental	O	6222
health	O	6222
wellness	O	6222
in	O	6222
relatives	O	6222
at	O	6222
high	O	6222
risk	O	6222
for	O	6222
bipolar	B-Disease	6222
affective	I-Disease	6222
disorder	I-Disease	6222
among	O	6222
the	O	6222
old	O	6222
order	O	6222
amish	O	6222
.	O	6222
bipolar	B-Disease	6223
affective	I-Disease	6223
disorder	I-Disease	6223
(	O	6223
bpad	B-Disease	6223
;	O	6223
manic	B-Disease	6223
-	I-Disease	6223
depressive	I-Disease	6223
illness	I-Disease	6223
)	O	6223
is	O	6223
characterized	O	6223
by	O	6223
episodes	O	6223
of	O	6223
mania	B-Disease	6223
and	O	6223
/	O	6223
or	O	6223
hypomania	B-Disease	6223
interspersed	O	6223
with	O	6223
periods	O	6223
of	O	6223
depression	B-Disease	6223
.	O	6223
compelling	O	6224
evidence	O	6224
supports	O	6224
a	O	6224
significant	O	6224
genetic	O	6224
component	O	6224
in	O	6224
the	O	6224
susceptibility	O	6224
to	O	6224
develop	O	6224
bpad	B-Disease	6224
.	O	6224
to	O	6225
date	O	6225
,	O	6225
however	O	6225
,	O	6225
linkage	O	6225
studies	O	6225
have	O	6225
attempted	O	6225
only	O	6225
to	O	6225
identify	O	6225
chromosomal	O	6225
loci	O	6225
that	O	6225
cause	O	6225
or	O	6225
increase	O	6225
the	O	6225
risk	O	6225
of	O	6225
developing	O	6225
bpad	B-Disease	6225
.	O	6225
to	O	6226
determine	O	6226
whether	O	6226
there	O	6226
could	O	6226
be	O	6226
protective	O	6226
alleles	O	6226
that	O	6226
prevent	O	6226
or	O	6226
reduce	O	6226
the	O	6226
risk	O	6226
of	O	6226
developing	O	6226
bpad	B-Disease	6226
,	O	6226
similar	O	6226
to	O	6226
what	O	6226
is	O	6226
observed	O	6226
in	O	6226
other	O	6226
genetic	B-Disease	6226
disorders	I-Disease	6226
,	O	6226
we	O	6226
used	O	6226
mental	O	6226
health	O	6226
wellness	O	6226
(	O	6226
absence	O	6226
of	O	6226
any	O	6226
psychiatric	B-Disease	6226
disorder	I-Disease	6226
)	O	6226
as	O	6226
the	O	6226
phenotype	O	6226
in	O	6226
our	O	6226
genome	O	6226
-	O	6226
wide	O	6226
linkage	O	6226
scan	O	6226
of	O	6226
several	O	6226
large	O	6226
multigeneration	O	6226
old	O	6226
order	O	6226
amish	O	6226
pedigrees	O	6226
exhibiting	O	6226
an	O	6226
extremely	O	6226
high	O	6226
incidence	O	6226
of	O	6226
bpad	B-Disease	6226
.	O	6226
these	O	6228
findings	O	6228
are	O	6228
consistent	O	6228
with	O	6228
the	O	6228
hypothesis	O	6228
that	O	6228
certain	O	6228
alleles	O	6228
could	O	6228
prevent	O	6228
or	O	6228
modify	O	6228
the	O	6228
clinical	O	6228
manifestations	O	6228
of	O	6228
bpad	B-Disease	6228
and	O	6228
perhaps	O	6228
other	O	6228
related	O	6228
affective	B-Disease	6228
disorders	I-Disease	6228
.	O	6228
segregation	O	6229
distortion	O	6229
in	O	6229
myotonic	B-Disease	6229
dystrophy	I-Disease	6229
.	O	6229
myotonic	B-Disease	6230
dystrophy	I-Disease	6230
(	O	6230
dm	B-Disease	6230
)	O	6230
is	O	6230
an	O	6230
autosomal	B-Disease	6230
dominant	I-Disease	6230
disease	I-Disease	6230
which	O	6230
,	O	6230
in	O	6230
the	O	6230
typical	O	6230
pedigree	O	6230
,	O	6230
shows	O	6230
a	O	6230
three	O	6230
generation	O	6230
anticipation	O	6230
cascade	O	6230
.	O	6230
this	O	6231
results	O	6231
in	O	6231
infertility	B-Disease	6231
and	O	6231
congenital	B-Disease	6231
myotonic	I-Disease	6231
dystrophy	I-Disease	6231
(	O	6231
cdm	B-Disease	6231
)	O	6231
with	O	6231
the	O	6231
disappearance	O	6231
of	O	6231
dm	B-Disease	6231
in	O	6231
that	O	6231
pedigree	O	6231
.	O	6231
the	O	6232
concept	O	6232
of	O	6232
segregation	O	6232
distortion	O	6232
,	O	6232
where	O	6232
there	O	6232
is	O	6232
preferential	O	6232
transmission	O	6232
of	O	6232
the	O	6232
larger	O	6232
allele	O	6232
at	O	6232
the	O	6232
dm	B-Disease	6232
locus	O	6232
,	O	6232
has	O	6232
been	O	6232
put	O	6232
forward	O	6232
to	O	6232
explain	O	6232
partially	O	6232
the	O	6232
maintenance	O	6232
of	O	6232
dm	B-Disease	6232
in	O	6232
the	O	6232
population	O	6232
.	O	6232
in	O	6233
a	O	6233
survey	O	6233
of	O	6233
dm	B-Disease	6233
in	O	6233
northern	O	6233
ireland	O	6233
,	O	6233
59	O	6233
pedigrees	O	6233
were	O	6233
ascertained	O	6233
.	O	6233
sibships	O	6234
where	O	6234
the	O	6234
status	O	6234
of	O	6234
all	O	6234
the	O	6234
members	O	6234
had	O	6234
been	O	6234
identified	O	6234
were	O	6234
examined	O	6234
to	O	6234
determine	O	6234
the	O	6234
transmission	O	6234
of	O	6234
the	O	6234
dm	B-Disease	6234
expansion	O	6234
from	O	6234
affected	O	6234
parents	O	6234
to	O	6234
their	O	6234
offspring	O	6234
.	O	6234
studies	O	6238
on	O	6238
meiotic	O	6238
drive	O	6238
in	O	6238
dm	B-Disease	6238
have	O	6238
shown	O	6238
increased	O	6238
transmission	O	6238
of	O	6238
the	O	6238
larger	O	6238
allele	O	6238
at	O	6238
the	O	6238
dm	B-Disease	6238
locus	O	6238
in	O	6238
non	O	6238
-	O	6238
dm	O	6238
heterozygotes	O	6238
for	O	6238
ctgn	O	6238
.	O	6238
this	O	6239
study	O	6239
provides	O	6239
further	O	6239
evidence	O	6239
that	O	6239
the	O	6239
dm	B-Disease	6239
expansion	O	6239
tends	O	6239
to	O	6239
be	O	6239
transmitted	O	6239
preferentially	O	6239
.	O	6239
diagnosis	O	6240
of	O	6240
hemochromatosis	B-Disease	6240
.	O	6240
if	O	6241
untreated	O	6241
,	O	6241
hemochromatosis	B-Disease	6241
can	O	6241
cause	O	6241
serious	O	6241
illness	O	6241
and	O	6241
early	B-Disease	6241
death	I-Disease	6241
,	O	6241
but	O	6241
the	O	6241
disease	O	6241
is	O	6241
still	O	6241
substantially	O	6241
under	O	6241
-	O	6241
diagnosed	O	6241
.	O	6241
once	O	6243
the	O	6243
diagnosis	O	6243
is	O	6243
suspected	O	6243
,	O	6243
physicians	O	6243
must	O	6243
use	O	6243
serum	O	6243
ferritin	O	6243
levels	O	6243
and	O	6243
hepatic	O	6243
iron	O	6243
stores	O	6243
on	O	6243
liver	O	6243
biopsy	O	6243
specimens	O	6243
to	O	6243
assess	O	6243
patients	O	6243
for	O	6243
the	O	6243
presence	O	6243
of	O	6243
iron	B-Disease	6243
overload	I-Disease	6243
.	O	6243
liver	O	6244
biopsy	O	6244
is	O	6244
also	O	6244
used	O	6244
to	O	6244
establish	O	6244
the	O	6244
presence	O	6244
or	O	6244
absence	O	6244
of	O	6244
cirrhosis	B-Disease	6244
,	O	6244
which	O	6244
can	O	6244
affect	O	6244
prognosis	O	6244
and	O	6244
management	O	6244
.	O	6244
a	O	6245
dna	O	6245
-	O	6245
based	O	6245
test	O	6245
for	O	6245
the	O	6245
hfe	O	6245
gene	O	6245
is	O	6245
commercially	O	6245
available	O	6245
,	O	6245
but	O	6245
its	O	6245
place	O	6245
in	O	6245
the	O	6245
diagnosis	O	6245
of	O	6245
hemochromatosis	B-Disease	6245
is	O	6245
still	O	6245
being	O	6245
evaluated	O	6245
.	O	6245
currently	O	6246
,	O	6246
the	O	6246
most	O	6246
useful	O	6246
role	O	6246
for	O	6246
this	O	6246
test	O	6246
is	O	6246
in	O	6246
the	O	6246
detection	O	6246
of	O	6246
hemochromatosis	B-Disease	6246
in	O	6246
the	O	6246
family	O	6246
members	O	6246
of	O	6246
patients	O	6246
with	O	6246
a	O	6246
proven	O	6246
case	O	6246
of	O	6246
the	O	6246
disease	O	6246
.	O	6246
it	O	6247
is	O	6247
crucial	O	6247
to	O	6247
diagnose	O	6247
hemochromatosis	B-Disease	6247
before	O	6247
hepatic	B-Disease	6247
cirrhosis	I-Disease	6247
develops	O	6247
because	O	6247
phlebotomy	O	6247
therapy	O	6247
can	O	6247
avert	O	6247
serious	O	6247
chronic	O	6247
disease	O	6247
and	O	6247
can	O	6247
even	O	6247
lead	O	6247
to	O	6247
normal	O	6247
life	O	6247
expectancy	O	6247
.	O	6247
.	O	6247
prevalence	O	6248
of	O	6248
the	O	6248
i1307k	O	6248
apc	B-Disease	6248
gene	O	6248
variant	O	6248
in	O	6248
israeli	O	6248
jews	O	6248
of	O	6248
differing	O	6248
ethnic	O	6248
origin	O	6248
and	O	6248
risk	O	6248
for	O	6248
colorectal	B-Disease	6248
cancer	I-Disease	6248
.	O	6248
background	O	6249
&	O	6249
aims	O	6249
israeli	O	6249
jews	O	6249
of	O	6249
european	O	6249
birth	O	6249
,	O	6249
i	O	6249
.	O	6249
e	O	6249
.	O	6249
,	O	6249
ashkenazim	O	6249
,	O	6249
have	O	6249
the	O	6249
highest	O	6249
colorectal	B-Disease	6249
cancer	I-Disease	6249
incidence	O	6249
of	O	6249
any	O	6249
israeli	O	6249
ethnic	O	6249
group	O	6249
.	O	6249
the	O	6250
i1307k	O	6250
apc	B-Disease	6250
gene	O	6250
variant	O	6250
was	O	6250
found	O	6250
in	O	6250
6	O	6250
.	O	6250
1	O	6251
%	O	6251
of	O	6251
american	O	6251
jews	O	6251
,	O	6251
28	O	6251
%	O	6251
of	O	6251
their	O	6251
familial	O	6251
colorectal	B-Disease	6251
cancer	I-Disease	6251
cases	O	6251
,	O	6251
but	O	6251
not	O	6251
in	O	6251
non	O	6251
-	O	6251
jews	O	6251
.	O	6251
we	O	6252
assessed	O	6252
the	O	6252
i1307k	O	6252
prevalence	O	6252
in	O	6252
israeli	O	6252
jews	O	6252
of	O	6252
differing	O	6252
ethnic	O	6252
origin	O	6252
and	O	6252
risk	O	6252
for	O	6252
colorectal	B-Disease	6252
cancer	I-Disease	6252
.	O	6252
methods	O	6253
dna	O	6253
samples	O	6253
from	O	6253
500	O	6253
unrelated	O	6253
jews	O	6253
of	O	6253
european	O	6253
or	O	6253
non	O	6253
-	O	6253
european	O	6253
origin	O	6253
,	O	6253
with	O	6253
or	O	6253
without	O	6253
a	O	6253
personal	O	6253
and	O	6253
/	O	6253
or	O	6253
family	O	6253
history	O	6253
of	O	6253
neoplasia	B-Disease	6253
,	O	6253
were	O	6253
examined	O	6253
for	O	6253
the	O	6253
i1307k	O	6253
variant	O	6253
by	O	6253
the	O	6253
allele	O	6253
-	O	6253
specific	O	6253
oligonucleotide	O	6253
(	O	6253
aso	O	6253
)	O	6253
method	O	6253
.	O	6253
results	O	6254
in	O	6254
persons	O	6254
at	O	6254
average	O	6254
risk	O	6254
for	O	6254
colorectal	B-Disease	6254
cancer	I-Disease	6254
,	O	6254
i1307k	O	6254
was	O	6254
found	O	6254
in	O	6254
5	O	6254
.	O	6254
4	O	6258
%	O	6258
of	O	6258
52	O	6258
ashkenazi	O	6258
israelis	O	6258
with	O	6258
familial	O	6258
cancer	B-Disease	6258
(	O	6258
p	O	6258
=	O	6258
0	O	6258
.	O	6258
02	O	6258
)	O	6258
and	O	6258
was	O	6258
not	O	6258
detected	O	6258
in	O	6258
51	O	6258
non	O	6258
-	O	6258
european	O	6258
jews	O	6258
at	O	6258
increased	O	6258
cancer	B-Disease	6258
risk	O	6258
.	O	6258
colorectal	B-Disease	6259
neoplasia	I-Disease	6259
occurred	O	6259
personally	O	6259
or	O	6259
in	O	6259
the	O	6259
families	O	6259
of	O	6259
13	O	6259
of	O	6259
20	O	6259
ashkenazi	O	6259
i1307k	O	6259
carriers	O	6259
,	O	6259
8	O	6259
of	O	6259
whom	O	6259
also	O	6259
had	O	6259
a	O	6259
personal	O	6259
or	O	6259
family	O	6259
history	O	6259
of	O	6259
noncolonic	O	6259
neoplasia	B-Disease	6259
.	O	6259
conclusions	O	6260
the	O	6260
i1307k	O	6260
apc	O	6260
variant	O	6260
may	O	6260
represent	O	6260
a	O	6260
susceptibility	O	6260
gene	O	6260
for	O	6260
colorectal	B-Disease	6260
,	I-Disease	6260
or	I-Disease	6260
other	I-Disease	6260
,	I-Disease	6260
cancers	I-Disease	6260
in	O	6260
ashkenazi	O	6260
jews	O	6260
,	O	6260
and	O	6260
partially	O	6260
explains	O	6260
the	O	6260
higher	O	6260
incidence	O	6260
of	O	6260
colorectal	B-Disease	6260
cancer	I-Disease	6260
in	O	6260
european	O	6260
israelis	O	6260
.	O	6260
systematic	O	6261
analysis	O	6261
of	O	6261
coproporphyrinogen	O	6261
oxidase	O	6261
gene	O	6261
defects	O	6261
in	O	6261
hereditary	B-Disease	6261
coproporphyria	I-Disease	6261
and	O	6261
mutation	O	6261
update	O	6261
.	O	6261
hereditary	B-Disease	6262
coproporphyria	I-Disease	6262
(	O	6262
hc	B-Disease	6262
)	O	6262
is	O	6262
an	O	6262
acute	O	6262
hepatic	B-Disease	6262
porphyria	I-Disease	6262
with	O	6262
autosomal	O	6262
dominant	O	6262
inheritance	O	6262
caused	O	6262
by	O	6262
deficient	B-Disease	6262
activity	I-Disease	6262
of	I-Disease	6262
coproporphyrinogen	I-Disease	6262
iii	I-Disease	6262
oxidase	I-Disease	6262
(	O	6262
cpo	O	6262
)	O	6262
.	O	6262
clinical	O	6263
manifestations	O	6263
of	O	6263
the	O	6263
disease	O	6263
are	O	6263
characterized	O	6263
by	O	6263
acute	O	6263
attacks	O	6263
of	O	6263
neurological	B-Disease	6263
dysfunction	I-Disease	6263
often	O	6263
precipitated	O	6263
by	O	6263
drugs	O	6263
,	O	6263
fasting	O	6263
,	O	6263
cyclical	O	6263
hormonal	O	6263
changes	O	6263
,	O	6263
or	O	6263
infectious	B-Disease	6263
diseases	I-Disease	6263
.	O	6263
the	O	6265
seven	O	6265
exons	O	6265
,	O	6265
the	O	6265
exon	O	6265
/	O	6265
intron	O	6265
boundaries	O	6265
and	O	6265
part	O	6265
of	O	6265
3	O	6265
noncoding	O	6265
sequence	O	6265
of	O	6265
the	O	6265
cpo	O	6265
gene	O	6265
were	O	6265
systematically	O	6265
analyzed	O	6265
by	O	6265
an	O	6265
exon	O	6265
-	O	6265
by	O	6265
-	O	6265
exon	O	6265
denaturing	O	6265
gradient	O	6265
gel	O	6265
electrophoresis	O	6265
(	O	6265
dgge	O	6265
)	O	6265
strategy	O	6265
followed	O	6265
by	O	6265
direct	O	6265
sequencing	O	6265
in	O	6265
seven	O	6265
unrelated	O	6265
heterozygous	O	6265
hc	B-Disease	6265
patients	O	6265
from	O	6265
france	O	6265
,	O	6265
holland	O	6265
,	O	6265
and	O	6265
czech	O	6265
republic	O	6265
.	O	6265
five	O	6271
intragenic	O	6271
dimorphisms	O	6271
are	O	6271
now	O	6271
well	O	6271
characterized	O	6271
and	O	6271
the	O	6271
high	O	6271
degree	O	6271
of	O	6271
allelic	O	6271
heterogeneity	O	6271
in	O	6271
hc	B-Disease	6271
is	O	6271
demonstrated	O	6271
with	O	6271
seven	O	6271
new	O	6271
different	O	6271
mutations	O	6271
making	O	6271
a	O	6271
total	O	6271
of	O	6271
nineteen	O	6271
cpo	O	6271
gene	B-Disease	6271
defects	I-Disease	6271
reported	O	6271
so	O	6271
far	O	6271
.	O	6271
.	O	6271
coincidence	O	6272
of	O	6272
two	O	6272
novel	O	6272
arylsulfatase	O	6272
a	O	6272
alleles	O	6272
and	O	6272
mutation	O	6272
459	O	6272
+	O	6272
1g	O	6272
>	O	6272
a	O	6272
within	O	6272
a	O	6272
family	O	6272
with	O	6272
metachromatic	B-Disease	6272
leukodystrophy	I-Disease	6272
:	O	6272
molecular	O	6272
basis	O	6272
of	O	6272
phenotypic	O	6272
heterogeneity	O	6272
.	O	6272
in	O	6273
a	O	6273
family	O	6273
with	O	6273
three	O	6273
siblings	O	6273
,	O	6273
one	O	6273
developed	O	6273
classical	O	6273
late	O	6273
infantile	O	6273
metachromatic	B-Disease	6273
leukodystrophy	I-Disease	6273
(	O	6273
mld	B-Disease	6273
)	O	6273
,	O	6273
fatal	O	6273
at	O	6273
age	O	6273
5	O	6273
years	O	6273
,	O	6273
with	O	6273
deficient	O	6273
arylsulfatase	O	6273
a	O	6273
(	O	6273
arsa	O	6273
)	O	6273
activity	O	6273
and	O	6273
increased	O	6273
galactosylsulfatide	O	6273
(	O	6273
gs	O	6273
)	O	6273
excretion	O	6273
.	O	6273
the	O	6274
two	O	6274
other	O	6274
siblings	O	6274
,	O	6274
apparently	O	6274
healthy	O	6274
at	O	6274
12	O	6274
(	O	6274
1	O	6274
/	O	6274
2	O	6274
)	O	6274
and	O	6274
15	O	6274
years	O	6274
,	O	6274
respectively	O	6274
,	O	6274
and	O	6274
their	O	6274
father	O	6274
,	O	6274
apparently	O	6274
healthy	O	6274
as	O	6274
well	O	6274
,	O	6274
presented	O	6274
arsa	O	6274
and	O	6274
gs	O	6274
values	O	6274
within	O	6274
the	O	6274
range	O	6274
of	O	6274
mld	B-Disease	6274
patients	O	6274
.	O	6274
mutation	O	6279
a464v	O	6279
was	O	6279
not	O	6279
found	O	6279
in	O	6279
18	O	6279
unrelated	O	6279
mld	B-Disease	6279
patients	O	6279
and	O	6279
50	O	6279
controls	O	6279
.	O	6279
a464v	O	6280
,	O	6280
although	O	6280
clearly	O	6280
modifying	O	6280
arsa	O	6280
and	O	6280
gs	O	6280
levels	O	6280
,	O	6280
apparently	O	6280
bears	O	6280
little	O	6280
significance	O	6280
for	O	6280
clinical	O	6280
manifestation	O	6280
of	O	6280
mld	B-Disease	6280
,	O	6280
mimicking	O	6280
the	O	6280
frequent	O	6280
arsa	O	6280
pseudodeficiency	O	6280
allele	O	6280
.	O	6280
our	O	6281
results	O	6281
demonstrate	O	6281
that	O	6281
in	O	6281
certain	O	6281
genetic	O	6281
conditions	O	6281
mld	B-Disease	6281
-	O	6281
like	O	6281
arsa	O	6281
and	O	6281
gs	O	6281
values	O	6281
need	O	6281
not	O	6281
be	O	6281
paralleled	O	6281
by	O	6281
clinical	O	6281
disease	O	6281
,	O	6281
a	O	6281
finding	O	6281
with	O	6281
serious	O	6281
diagnostic	O	6281
and	O	6281
prognostic	O	6281
implications	O	6281
.	O	6281
human	O	6283
mlh1	O	6283
deficiency	O	6283
predisposes	O	6283
to	O	6283
hematological	B-Disease	6283
malignancy	I-Disease	6283
and	O	6283
neurofibromatosis	B-Disease	6283
type	I-Disease	6283
1	I-Disease	6283
.	O	6283
heterozygous	O	6284
germ	O	6284
-	O	6284
line	O	6284
mutations	O	6284
in	O	6284
the	O	6284
dna	O	6284
mismatch	O	6284
repair	O	6284
genes	O	6284
lead	O	6284
to	O	6284
hereditary	B-Disease	6284
nonpolyposis	I-Disease	6284
colorectal	I-Disease	6284
cancer	I-Disease	6284
.	O	6284
we	O	6286
have	O	6286
identified	O	6286
three	O	6286
offspring	O	6286
in	O	6286
a	O	6286
hereditary	B-Disease	6286
nonpolyposis	I-Disease	6286
colorectal	I-Disease	6286
cancer	I-Disease	6286
family	O	6286
who	O	6286
developed	O	6286
hematological	B-Disease	6286
malignancy	I-Disease	6286
at	O	6286
a	O	6286
very	O	6286
early	O	6286
age	O	6286
,	O	6286
and	O	6286
at	O	6286
least	O	6286
two	O	6286
of	O	6286
them	O	6286
displayed	O	6286
signs	O	6286
of	O	6286
neurofibromatosis	B-Disease	6286
type	I-Disease	6286
1	I-Disease	6286
(	O	6286
nf1	B-Disease	6286
)	O	6286
.	O	6286
thus	O	6288
,	O	6288
a	O	6288
homozygous	O	6288
germ	O	6288
-	O	6288
line	O	6288
mlh1	O	6288
mutation	O	6288
and	O	6288
consequent	O	6288
mismatch	O	6288
repair	O	6288
deficiency	O	6288
results	O	6288
in	O	6288
a	O	6288
mutator	O	6288
phenotype	O	6288
characterized	O	6288
by	O	6288
leukemia	B-Disease	6288
and	O	6288
/	O	6288
or	O	6288
lymphoma	B-Disease	6288
associated	O	6288
with	O	6288
neurofibromatosis	B-Disease	6288
type	I-Disease	6288
1	I-Disease	6288
.	O	6288
.	O	6288
missense	O	6289
mutations	O	6289
in	O	6289
the	O	6289
most	O	6289
ancient	O	6289
residues	O	6289
of	O	6289
the	O	6289
pax6	O	6289
paired	O	6289
domain	O	6289
underlie	O	6289
a	O	6289
spectrum	O	6289
of	O	6289
human	O	6289
congenital	B-Disease	6289
eye	I-Disease	6289
malformations	I-Disease	6289
.	O	6289
mutations	O	6290
of	O	6290
the	O	6290
human	O	6290
pax6	O	6290
gene	O	6290
underlie	O	6290
aniridia	B-Disease	6290
(	O	6290
congenital	B-Disease	6290
absence	I-Disease	6290
of	I-Disease	6290
the	I-Disease	6290
iris	I-Disease	6290
)	O	6290
,	O	6290
a	O	6290
rare	O	6290
dominant	O	6290
malformation	B-Disease	6290
of	I-Disease	6290
the	I-Disease	6290
eye	I-Disease	6290
.	O	6290
the	O	6291
spectrum	O	6291
of	O	6291
pax6	O	6291
mutations	O	6291
in	O	6291
aniridia	B-Disease	6291
patients	O	6291
is	O	6291
highly	O	6291
biased	O	6291
,	O	6291
with	O	6291
92	O	6291
%	O	6291
of	O	6291
all	O	6291
reported	O	6291
mutations	O	6291
leading	O	6291
to	O	6291
premature	O	6291
truncation	O	6291
of	O	6291
the	O	6291
protein	O	6291
(	O	6291
nonsense	O	6291
,	O	6291
splicing	O	6291
,	O	6291
insertions	O	6291
and	O	6291
deletions	O	6291
)	O	6291
and	O	6291
just	O	6291
2	O	6291
%	O	6291
leading	O	6291
to	O	6291
substitution	O	6291
of	O	6291
one	O	6291
amino	O	6291
acid	O	6291
by	O	6291
another	O	6291
(	O	6291
missense	O	6291
)	O	6291
.	O	6291
the	O	6292
extraordinary	O	6292
conservation	O	6292
of	O	6292
the	O	6292
pax6	O	6292
protein	O	6292
at	O	6292
the	O	6292
amino	O	6292
acid	O	6292
level	O	6292
amongst	O	6292
vertebrates	O	6292
predicts	O	6292
that	O	6292
pathological	O	6292
missense	O	6292
mutations	O	6292
should	O	6292
in	O	6292
fact	O	6292
be	O	6292
common	O	6292
even	O	6292
though	O	6292
they	O	6292
are	O	6292
hardly	O	6292
ever	O	6292
seen	O	6292
in	O	6292
aniridia	B-Disease	6292
patients	O	6292
.	O	6292
this	O	6293
indicates	O	6293
that	O	6293
there	O	6293
is	O	6293
a	O	6293
heavy	O	6293
ascertainment	O	6293
bias	O	6293
in	O	6293
the	O	6293
selection	O	6293
of	O	6293
patients	O	6293
for	O	6293
pax6	O	6293
mutation	O	6293
analysis	O	6293
and	O	6293
that	O	6293
the	O	6293
missing	O	6293
pax6	O	6293
missense	O	6293
mutations	O	6293
frequently	O	6293
may	O	6293
underlie	O	6293
phenotypes	O	6293
distinct	O	6293
from	O	6293
textbook	O	6293
aniridia	B-Disease	6293
.	O	6293
here	O	6294
we	O	6294
present	O	6294
four	O	6294
novel	O	6294
pax6	O	6294
missense	O	6294
mutations	O	6294
,	O	6294
two	O	6294
in	O	6294
association	O	6294
with	O	6294
atypical	O	6294
phenotypes	O	6294
ectopia	B-Disease	6294
pupillae	I-Disease	6294
(	O	6294
displaced	B-Disease	6294
pupils	I-Disease	6294
)	O	6294
and	O	6294
congenital	B-Disease	6294
nystagmus	I-Disease	6294
(	O	6294
searching	B-Disease	6294
gaze	I-Disease	6294
)	O	6294
,	O	6294
and	O	6294
two	O	6294
in	O	6294
association	O	6294
with	O	6294
more	O	6294
recognizable	O	6294
aniridia	B-Disease	6294
phenotypes	O	6294
.	O	6294
our	O	6296
results	O	6296
support	O	6296
the	O	6296
hypothesis	O	6296
that	O	6296
the	O	6296
under	O	6296
-	O	6296
representation	O	6296
of	O	6296
missense	O	6296
mutations	O	6296
is	O	6296
caused	O	6296
by	O	6296
ascertainment	O	6296
bias	O	6296
and	O	6296
suggest	O	6296
that	O	6296
a	O	6296
substantial	O	6296
burden	O	6296
of	O	6296
pax6	B-Disease	6296
-	I-Disease	6296
related	I-Disease	6296
disease	I-Disease	6296
remains	O	6296
to	O	6296
be	O	6296
uncovered	O	6296
.	O	6296
.	O	6296
the	O	6297
chromosomal	O	6297
order	O	6297
of	O	6297
genes	O	6297
controlling	O	6297
the	O	6297
major	O	6297
histocompatibility	O	6297
complex	O	6297
,	O	6297
properdin	O	6297
factor	O	6297
b	O	6297
,	O	6297
and	O	6297
deficiency	B-Disease	6297
of	I-Disease	6297
the	I-Disease	6297
second	I-Disease	6297
component	I-Disease	6297
of	I-Disease	6297
complement	I-Disease	6297
.	O	6297
the	O	6298
relationship	O	6298
of	O	6298
the	O	6298
genes	O	6298
coding	O	6298
for	O	6298
hla	O	6298
to	O	6298
those	O	6298
coding	O	6298
for	O	6298
properdin	O	6298
factor	O	6298
b	O	6298
allotypes	O	6298
and	O	6298
for	O	6298
deficiency	B-Disease	6298
of	I-Disease	6298
the	I-Disease	6298
second	I-Disease	6298
component	I-Disease	6298
of	I-Disease	6298
complement	I-Disease	6298
(	O	6298
c2	O	6298
)	O	6298
was	O	6298
studied	O	6298
in	O	6298
families	O	6298
of	O	6298
patients	O	6298
with	O	6298
connective	O	6298
tissue	O	6298
disorders	O	6298
.	O	6298
patients	O	6299
were	O	6299
selected	O	6299
because	O	6299
they	O	6299
were	O	6299
heterozygous	O	6299
or	O	6299
homozygous	O	6299
for	O	6299
c2	B-Disease	6299
deficiency	I-Disease	6299
.	O	6299
12	O	6300
families	O	6300
with	O	6300
15	O	6300
matings	O	6300
informative	O	6300
for	O	6300
c2	B-Disease	6300
deficiency	I-Disease	6300
were	O	6300
found	O	6300
.	O	6300
of	O	6301
57	O	6301
informative	O	6301
meioses	O	6301
,	O	6301
two	O	6301
crossovers	O	6301
were	O	6301
noted	O	6301
between	O	6301
the	O	6301
c2	B-Disease	6301
deficiency	I-Disease	6301
gene	O	6301
and	O	6301
the	O	6301
hla	O	6301
-	O	6301
b	O	6301
gene	O	6301
,	O	6301
with	O	6301
a	O	6301
recombinant	O	6301
fraction	O	6301
of	O	6301
0	O	6301
.	O	6301
a	O	6303
lod	O	6303
score	O	6303
of	O	6303
13	O	6303
was	O	6303
calculated	O	6303
for	O	6303
linkage	O	6303
between	O	6303
c2	B-Disease	6303
deficiency	I-Disease	6303
and	O	6303
hla	O	6303
-	O	6303
b	O	6303
at	O	6303
a	O	6303
maximum	O	6303
likelihood	O	6303
value	O	6303
of	O	6303
the	O	6303
recombinant	O	6303
fraction	O	6303
of	O	6303
0	O	6303
.	O	6303
these	O	6311
studies	O	6311
suggest	O	6311
that	O	6311
the	O	6311
genes	O	6311
for	O	6311
factor	O	6311
b	O	6311
and	O	6311
c2	B-Disease	6311
deficiency	I-Disease	6311
are	O	6311
located	O	6311
outside	O	6311
those	O	6311
for	O	6311
hla	O	6311
,	O	6311
that	O	6311
the	O	6311
order	O	6311
of	O	6311
genese	O	6311
is	O	6311
hla	O	6311
-	O	6311
a	O	6311
,	O	6311
-	O	6311
b	O	6311
,	O	6311
-	O	6311
d	O	6311
,	O	6311
factor	O	6311
b	O	6311
allotype	O	6311
,	O	6311
c2	B-Disease	6311
deficiency	I-Disease	6311
,	O	6311
that	O	6311
the	O	6311
genes	O	6311
coding	O	6311
for	O	6311
c2	B-Disease	6311
deficiency	I-Disease	6311
and	O	6311
factor	O	6311
b	O	6311
allotypes	O	6311
are	O	6311
approximately	O	6311
3	O	6311
-	O	6311
-	O	6311
5	O	6311
centimorgans	O	6311
from	O	6311
the	O	6311
hla	O	6311
-	O	6311
a	O	6311
and	O	6311
hla	O	6311
-	O	6311
b	O	6311
loci	O	6311
,	O	6311
and	O	6311
that	O	6311
the	O	6311
apparent	O	6311
lack	O	6311
of	O	6311
recombinants	O	6311
between	O	6311
the	O	6311
factor	O	6311
b	O	6311
gene	O	6311
and	O	6311
c2	B-Disease	6311
deficiency	I-Disease	6311
gene	O	6311
suggests	O	6311
that	O	6311
these	O	6311
two	O	6311
genes	O	6311
lie	O	6311
in	O	6311
close	O	6311
proximity	O	6311
to	O	6311
one	O	6311
another	O	6311
.	O	6311
distribution	O	6312
of	O	6312
emerin	O	6312
and	O	6312
lamins	O	6312
in	O	6312
the	O	6312
heart	O	6312
and	O	6312
implications	O	6312
for	O	6312
emery	B-Disease	6312
-	I-Disease	6312
dreifuss	I-Disease	6312
muscular	I-Disease	6312
dystrophy	I-Disease	6312
.	O	6312
emerin	O	6313
is	O	6313
a	O	6313
nuclear	O	6313
membrane	O	6313
protein	O	6313
which	O	6313
is	O	6313
missing	O	6313
or	O	6313
defective	O	6313
in	O	6313
emery	B-Disease	6313
-	I-Disease	6313
dreifuss	I-Disease	6313
muscular	I-Disease	6313
dystrophy	I-Disease	6313
(	O	6313
edmd	B-Disease	6313
)	O	6313
.	O	6313
these	O	6318
results	O	6318
would	O	6318
not	O	6318
be	O	6318
expected	O	6318
if	O	6318
immunostaining	O	6318
at	O	6318
intercalated	O	6318
discs	O	6318
were	O	6318
due	O	6318
to	O	6318
a	O	6318
product	O	6318
of	O	6318
the	O	6318
emerin	O	6318
gene	O	6318
and	O	6318
,	O	6318
therefore	O	6318
,	O	6318
cast	O	6318
some	O	6318
doubt	O	6318
upon	O	6318
the	O	6318
hypothesis	O	6318
that	O	6318
cardiac	B-Disease	6318
defects	I-Disease	6318
in	O	6318
edmd	B-Disease	6318
are	O	6318
caused	O	6318
by	O	6318
absence	O	6318
of	O	6318
emerin	O	6318
from	O	6318
intercalated	O	6318
discs	O	6318
.	O	6318
this	O	6320
distribution	O	6320
of	O	6320
emerin	O	6320
was	O	6320
similar	O	6320
to	O	6320
that	O	6320
of	O	6320
lamin	O	6320
a	O	6320
,	O	6320
a	O	6320
candidate	O	6320
gene	O	6320
for	O	6320
an	O	6320
autosomal	O	6320
form	O	6320
of	O	6320
edmd	B-Disease	6320
.	O	6320
in	O	6323
edmd	B-Disease	6323
,	O	6323
the	O	6323
additional	O	6323
absence	O	6323
of	O	6323
lamin	O	6323
b1	O	6323
from	O	6323
heart	O	6323
and	O	6323
skeletal	O	6323
muscle	O	6323
nuclei	O	6323
which	O	6323
already	O	6323
lack	O	6323
emerin	O	6323
may	O	6323
offer	O	6323
an	O	6323
alternative	O	6323
explanation	O	6323
of	O	6323
why	O	6323
these	O	6323
tissues	O	6323
are	O	6323
particularly	O	6323
affected	O	6323
.	O	6323
.	O	6323
genetic	O	6324
mapping	O	6324
of	O	6324
the	O	6324
copper	B-Disease	6324
toxicosis	I-Disease	6324
locus	O	6324
in	O	6324
bedlington	O	6324
terriers	O	6324
to	O	6324
dog	O	6324
chromosome	O	6324
10	O	6324
,	O	6324
in	O	6324
a	O	6324
region	O	6324
syntenic	O	6324
to	O	6324
human	O	6324
chromosome	O	6324
region	O	6324
2p13	O	6324
-	O	6324
p16	O	6324
.	O	6324
abnormal	O	6325
hepatic	B-Disease	6325
copper	I-Disease	6325
accumulation	I-Disease	6325
is	O	6325
recognized	O	6325
as	O	6325
an	O	6325
inherited	B-Disease	6325
disorder	I-Disease	6325
in	O	6325
man	O	6325
,	O	6325
mouse	O	6325
,	O	6325
rat	O	6325
and	O	6325
dog	O	6325
.	O	6325
the	O	6326
major	O	6326
cause	O	6326
of	O	6326
hepatic	B-Disease	6326
copper	I-Disease	6326
accumulation	I-Disease	6326
in	O	6326
man	O	6326
is	O	6326
a	O	6326
dysfunctional	O	6326
atp7b	O	6326
gene	O	6326
,	O	6326
causing	O	6326
wilson	B-Disease	6326
disease	I-Disease	6326
(	O	6326
wd	B-Disease	6326
)	O	6326
.	O	6326
the	O	6328
atp7b	O	6328
gene	O	6328
has	O	6328
been	O	6328
excluded	O	6328
in	O	6328
the	O	6328
much	O	6328
rarer	O	6328
human	O	6328
copper	B-Disease	6328
overload	I-Disease	6328
disease	O	6328
non	B-Disease	6328
-	I-Disease	6328
indian	I-Disease	6328
childhood	I-Disease	6328
cirrhosis	I-Disease	6328
,	O	6328
indicating	O	6328
genetic	O	6328
heterogeneity	O	6328
.	O	6328
by	O	6329
investigating	O	6329
the	O	6329
common	O	6329
autosomal	O	6329
recessive	O	6329
copper	B-Disease	6329
toxicosis	I-Disease	6329
(	O	6329
ct	B-Disease	6329
)	O	6329
in	O	6329
bedlington	O	6329
terriers	O	6329
,	O	6329
we	O	6329
have	O	6329
identified	O	6329
a	O	6329
new	O	6329
locus	O	6329
involved	O	6329
in	O	6329
progressive	O	6329
liver	B-Disease	6329
disease	I-Disease	6329
.	O	6329
we	O	6330
examined	O	6330
whether	O	6330
the	O	6330
wd	B-Disease	6330
gene	O	6330
atp7b	O	6330
was	O	6330
also	O	6330
causative	O	6330
for	O	6330
ct	B-Disease	6330
by	O	6330
investigating	O	6330
the	O	6330
chromosomal	O	6330
co	O	6330
-	O	6330
localization	O	6330
of	O	6330
atp7b	O	6330
and	O	6330
c04107	O	6330
,	O	6330
using	O	6330
fluorescence	O	6330
in	O	6330
situ	O	6330
hybridization	O	6330
(	O	6330
fish	O	6330
)	O	6330
.	O	6330
c04107	O	6331
is	O	6331
an	O	6331
anonymous	O	6331
microsatellite	O	6331
marker	O	6331
closely	O	6331
linked	O	6331
to	O	6331
ct	B-Disease	6331
.	O	6331
however	O	6332
,	O	6332
bac	O	6332
clones	O	6332
containing	O	6332
atp7b	O	6332
and	O	6332
c04107	O	6332
mapped	O	6332
to	O	6332
the	O	6332
canine	O	6332
chromosome	O	6332
regions	O	6332
cfa22q11	O	6332
and	O	6332
cfa10q26	O	6332
,	O	6332
respectively	O	6332
,	O	6332
demonstrating	O	6332
that	O	6332
wd	B-Disease	6332
cannot	O	6332
be	O	6332
homologous	O	6332
to	O	6332
ct	B-Disease	6332
.	O	6332
the	O	6333
copper	O	6333
transport	O	6333
genes	O	6333
ctr1	O	6333
and	O	6333
ctr2	O	6333
were	O	6333
also	O	6333
excluded	O	6333
as	O	6333
candidate	O	6333
genes	O	6333
for	O	6333
ct	B-Disease	6333
since	O	6333
they	O	6333
both	O	6333
mapped	O	6333
to	O	6333
canine	O	6333
chromosome	O	6333
region	O	6333
cfa11q22	O	6333
.	O	6333
molecular	O	6337
analysis	O	6337
of	O	6337
the	O	6337
apc	B-Disease	6337
gene	O	6337
in	O	6337
205	O	6337
families	O	6337
:	O	6337
extended	O	6337
genotype	O	6337
-	O	6337
phenotype	O	6337
correlations	O	6337
in	O	6337
fap	B-Disease	6337
and	O	6337
evidence	O	6337
for	O	6337
the	O	6337
role	O	6337
of	O	6337
apc	B-Disease	6337
amino	O	6337
acid	O	6337
changes	O	6337
in	O	6337
colorectal	B-Disease	6337
cancer	I-Disease	6337
predisposition	O	6337
.	O	6337
background	O	6338
/	O	6338
aims	O	6338
the	O	6338
development	O	6338
of	O	6338
colorectal	B-Disease	6338
cancer	I-Disease	6338
and	O	6338
a	O	6338
variable	O	6338
range	O	6338
of	O	6338
extracolonic	O	6338
manifestations	O	6338
in	O	6338
familial	B-Disease	6338
adenomatous	I-Disease	6338
polyposis	I-Disease	6338
(	O	6338
fap	B-Disease	6338
)	O	6338
is	O	6338
the	O	6338
result	O	6338
of	O	6338
the	O	6338
dominant	O	6338
inheritance	O	6338
of	O	6338
adenomatous	B-Disease	6338
polyposis	I-Disease	6338
coli	I-Disease	6338
(	O	6338
apc	B-Disease	6338
)	O	6338
gene	O	6338
mutations	O	6338
.	O	6338
in	O	6339
this	O	6339
study	O	6339
,	O	6339
direct	O	6339
mutation	O	6339
analysis	O	6339
of	O	6339
the	O	6339
apc	B-Disease	6339
gene	O	6339
was	O	6339
performed	O	6339
to	O	6339
determine	O	6339
genotype	O	6339
-	O	6339
phenotype	O	6339
correlations	O	6339
for	O	6339
nine	O	6339
extracolonic	O	6339
manifestations	O	6339
and	O	6339
to	O	6339
investigate	O	6339
the	O	6339
incidence	O	6339
of	O	6339
apc	B-Disease	6339
mutations	O	6339
in	O	6339
non	O	6339
-	O	6339
fap	O	6339
colorectal	B-Disease	6339
cancer	I-Disease	6339
.	O	6339
methods	O	6340
the	O	6340
apc	B-Disease	6340
gene	O	6340
was	O	6340
analysed	O	6340
in	O	6340
190	O	6340
unrelated	O	6340
fap	B-Disease	6340
and	O	6340
15	O	6340
non	O	6340
-	O	6340
fap	O	6340
colorectal	B-Disease	6340
cancer	I-Disease	6340
patients	O	6340
using	O	6340
denaturing	O	6340
gradient	O	6340
gel	O	6340
electrophoresis	O	6340
,	O	6340
the	O	6340
protein	O	6340
truncation	O	6340
test	O	6340
,	O	6340
and	O	6340
direct	O	6340
sequencing	O	6340
.	O	6340
results	O	6341
chain	O	6341
terminating	O	6341
signals	O	6341
were	O	6341
only	O	6341
identified	O	6341
in	O	6341
patients	O	6341
belonging	O	6341
to	O	6341
the	O	6341
fap	B-Disease	6341
group	O	6341
(	O	6341
105	O	6341
patients	O	6341
)	O	6341
.	O	6341
amino	O	6342
acid	O	6342
changes	O	6342
were	O	6342
identified	O	6342
in	O	6342
four	O	6342
patients	O	6342
,	O	6342
three	O	6342
of	O	6342
whom	O	6342
belonged	O	6342
to	O	6342
the	O	6342
non	O	6342
-	O	6342
fap	O	6342
group	O	6342
of	O	6342
colorectal	B-Disease	6342
cancer	I-Disease	6342
patients	O	6342
.	O	6342
genotype	O	6343
-	O	6343
phenotype	O	6343
correlations	O	6343
identified	O	6343
significant	O	6343
differences	O	6343
in	O	6343
the	O	6343
nature	O	6343
of	O	6343
certain	O	6343
extracolonic	O	6343
manifestations	O	6343
in	O	6343
fap	B-Disease	6343
patients	O	6343
belonging	O	6343
to	O	6343
three	O	6343
mutation	O	6343
subgroups	O	6343
.	O	6343
this	O	6345
study	O	6345
also	O	6345
provided	O	6345
evidence	O	6345
for	O	6345
the	O	6345
pathological	O	6345
nature	O	6345
of	O	6345
amino	O	6345
acid	O	6345
changes	O	6345
in	O	6345
apc	O	6345
associated	O	6345
with	O	6345
both	O	6345
fap	B-Disease	6345
and	O	6345
non	O	6345
-	O	6345
fap	O	6345
colorectal	B-Disease	6345
cancer	I-Disease	6345
patients	O	6345
.	O	6345
.	O	6345
inherited	B-Disease	6346
colorectal	I-Disease	6346
polyposis	I-Disease	6346
and	O	6346
cancer	B-Disease	6346
risk	O	6346
of	O	6346
the	O	6346
apc	O	6346
i1307k	O	6346
polymorphism	O	6346
.	O	6346
germ	O	6347
-	O	6347
line	O	6347
and	O	6347
somatic	O	6347
truncating	O	6347
mutations	O	6347
of	O	6347
the	O	6347
apc	B-Disease	6347
gene	O	6347
are	O	6347
thought	O	6347
to	O	6347
initiate	O	6347
colorectal	B-Disease	6347
tumor	I-Disease	6347
formation	O	6347
in	O	6347
familial	B-Disease	6347
adenomatous	I-Disease	6347
polyposis	I-Disease	6347
syndrome	I-Disease	6347
and	O	6347
sporadic	O	6347
colorectal	O	6347
carcinogenesis	O	6347
,	O	6347
respectively	O	6347
.	O	6347
recently	O	6348
,	O	6348
an	O	6348
isoleucine	O	6348
-	O	6348
-	O	6348
>	O	6348
lysine	O	6348
polymorphism	O	6348
at	O	6348
codon	O	6348
1307	O	6348
(	O	6348
i1307k	O	6348
)	O	6348
of	O	6348
the	O	6348
apc	B-Disease	6348
gene	O	6348
has	O	6348
been	O	6348
identified	O	6348
in	O	6348
6	O	6348
%	O	6348
-	O	6348
7	O	6348
%	O	6348
of	O	6348
the	O	6348
ashkenazi	O	6348
jewish	O	6348
population	O	6348
.	O	6348
to	O	6349
assess	O	6349
the	O	6349
risk	O	6349
of	O	6349
this	O	6349
common	O	6349
apc	B-Disease	6349
allelic	O	6349
variant	O	6349
in	O	6349
colorectal	O	6349
carcinogenesis	O	6349
,	O	6349
we	O	6349
have	O	6349
analyzed	O	6349
a	O	6349
large	O	6349
cohort	O	6349
of	O	6349
unselected	O	6349
ashkenazi	O	6349
jewish	O	6349
subjects	O	6349
with	O	6349
adenomatous	B-Disease	6349
polyps	I-Disease	6349
and	O	6349
.	O	6349
or	O	6349
colorectal	B-Disease	6349
cancer	I-Disease	6349
,	I-Disease	6349
for	O	6349
the	O	6349
apc	O	6349
i1307k	O	6349
polymorphism	O	6349
.	O	6349
7	O	6353
for	O	6353
colorectal	B-Disease	6353
neoplasia	I-Disease	6353
(	O	6353
both	O	6353
p	O	6353
=	O	6353
.	O	6353
01	O	6353
)	O	6353
.	O	6353
furthermore	O	6354
,	O	6354
compared	O	6354
with	O	6354
noncarriers	O	6354
,	O	6354
apc	O	6354
i1307k	O	6354
carriers	O	6354
had	O	6354
increased	O	6354
numbers	O	6354
of	O	6354
adenomas	B-Disease	6354
and	O	6354
colorectal	B-Disease	6354
cancers	I-Disease	6354
per	O	6354
patient	O	6354
(	O	6354
p	O	6354
=	O	6354
.	O	6354
03	O	6354
)	O	6354
,	O	6354
as	O	6354
well	O	6354
as	O	6354
a	O	6354
younger	O	6354
age	O	6354
at	O	6354
diagnosis	O	6354
.	O	6354
we	O	6355
conclude	O	6355
that	O	6355
the	O	6355
apc	O	6355
i1307k	O	6355
variant	O	6355
leads	O	6355
to	O	6355
increased	O	6355
adenoma	B-Disease	6355
formation	O	6355
and	O	6355
directly	O	6355
contributes	O	6355
to	O	6355
3	O	6355
%	O	6355
-	O	6355
4	O	6355
%	O	6355
of	O	6355
all	O	6355
ashkenazi	O	6355
jewish	O	6355
colorectal	B-Disease	6355
cancer	I-Disease	6355
.	O	6355
the	O	6356
estimated	O	6356
relative	O	6356
risk	O	6356
for	O	6356
carriers	O	6356
may	O	6356
justify	O	6356
specific	O	6356
clinical	O	6356
screening	O	6356
for	O	6356
the	O	6356
360	O	6356
,	O	6356
000	O	6356
americans	O	6356
expected	O	6356
to	O	6356
harbor	O	6356
this	O	6356
allele	O	6356
,	O	6356
and	O	6356
genetic	O	6356
testing	O	6356
in	O	6356
the	O	6356
setting	O	6356
of	O	6356
long	O	6356
-	O	6356
term	O	6356
-	O	6356
outcome	O	6356
studies	O	6356
may	O	6356
impact	O	6356
significantly	O	6356
on	O	6356
colorectal	B-Disease	6356
cancer	I-Disease	6356
prevention	O	6356
in	O	6356
this	O	6356
population	O	6356
.	O	6356
localization	O	6357
of	O	6357
human	O	6357
brca1	O	6357
and	O	6357
its	O	6357
loss	O	6357
in	O	6357
high	O	6357
-	O	6357
grade	O	6357
,	O	6357
non	B-Disease	6357
-	I-Disease	6357
inherited	I-Disease	6357
breast	I-Disease	6357
carcinomas	I-Disease	6357
.	O	6357
although	O	6358
the	O	6358
link	O	6358
between	O	6358
the	O	6358
brca1	O	6358
tumour	B-Disease	6358
-	O	6358
suppressor	O	6358
gene	O	6358
and	O	6358
hereditary	B-Disease	6358
breast	I-Disease	6358
and	I-Disease	6358
ovarian	I-Disease	6358
cancer	I-Disease	6358
is	O	6358
established	O	6358
,	O	6358
the	O	6358
role	O	6358
,	O	6358
if	O	6358
any	O	6358
,	O	6358
of	O	6358
brca1	O	6358
in	O	6358
non	B-Disease	6358
-	I-Disease	6358
familial	I-Disease	6358
cancers	I-Disease	6358
is	O	6358
unclear	O	6358
.	O	6358
brca1	O	6359
mutations	O	6359
are	O	6359
rare	O	6359
in	O	6359
sporadic	B-Disease	6359
cancers	I-Disease	6359
,	O	6359
but	O	6359
loss	O	6359
of	O	6359
brca1	O	6359
resulting	O	6359
from	O	6359
reduced	O	6359
expression	O	6359
or	O	6359
incorrect	O	6359
subcellular	O	6359
localization	O	6359
is	O	6359
postulated	O	6359
to	O	6359
be	O	6359
important	O	6359
in	O	6359
non	B-Disease	6359
-	I-Disease	6359
familial	I-Disease	6359
breast	I-Disease	6359
and	I-Disease	6359
ovarian	I-Disease	6359
cancers	I-Disease	6359
.	O	6359
these	O	6362
reagents	O	6362
detect	O	6362
a	O	6362
220	O	6362
-	O	6362
kd	O	6362
protein	O	6362
localized	O	6362
in	O	6362
discrete	O	6362
nuclear	O	6362
foci	O	6362
in	O	6362
all	O	6362
epithelial	O	6362
cell	O	6362
lines	O	6362
,	O	6362
including	O	6362
those	O	6362
derived	O	6362
from	O	6362
breast	B-Disease	6362
malignancies	I-Disease	6362
.	O	6362
immunohistochemical	O	6363
staining	O	6363
of	O	6363
human	O	6363
breast	O	6363
specimens	O	6363
also	O	6363
revealed	O	6363
brca1	O	6363
nuclear	O	6363
foci	O	6363
in	O	6363
benign	O	6363
breast	O	6363
,	O	6363
invasive	B-Disease	6363
lobular	I-Disease	6363
cancers	I-Disease	6363
and	O	6363
low	B-Disease	6363
-	I-Disease	6363
grade	I-Disease	6363
ductal	I-Disease	6363
carcinomas	I-Disease	6363
.	O	6363
conversely	O	6364
,	O	6364
brca1	O	6364
expression	O	6364
was	O	6364
reduced	O	6364
or	O	6364
undetectable	O	6364
in	O	6364
the	O	6364
majority	O	6364
of	O	6364
high	O	6364
-	O	6364
grade	O	6364
,	O	6364
ductal	B-Disease	6364
carcinomas	I-Disease	6364
,	O	6364
suggesting	O	6364
that	O	6364
absence	O	6364
of	O	6364
brca1	O	6364
may	O	6364
contribute	O	6364
to	O	6364
the	O	6364
pathogenesis	O	6364
of	O	6364
a	O	6364
significant	O	6364
percentage	O	6364
of	O	6364
sporadic	B-Disease	6364
breast	I-Disease	6364
cancers	I-Disease	6364
.	O	6364
germline	O	6366
mutations	O	6366
in	O	6366
brca1	O	6366
are	O	6366
responsible	O	6366
for	O	6366
most	O	6366
cases	O	6366
of	O	6366
inherited	B-Disease	6366
breast	I-Disease	6366
and	I-Disease	6366
ovarian	I-Disease	6366
cancer	I-Disease	6366
.	O	6366
as	O	6371
a	O	6371
regulated	O	6371
secretory	O	6371
protein	O	6371
,	O	6371
brca1	O	6371
appears	O	6371
to	O	6371
function	O	6371
by	O	6371
a	O	6371
mechanism	O	6371
not	O	6371
previously	O	6371
described	O	6371
for	O	6371
tumour	B-Disease	6371
suppressor	O	6371
gene	O	6371
products	O	6371
.	O	6371
.	O	6371
ovarian	B-Disease	6372
cancer	I-Disease	6372
risk	O	6372
in	O	6372
brca1	O	6372
carriers	O	6372
is	O	6372
modified	O	6372
by	O	6372
the	O	6372
hras1	O	6372
variable	O	6372
number	O	6372
of	O	6372
tandem	O	6372
repeat	O	6372
(	O	6372
vntr	O	6372
)	O	6372
locus	O	6372
.	O	6372
women	O	6373
who	O	6373
carry	O	6373
a	O	6373
mutation	O	6373
in	O	6373
the	O	6373
brca1	O	6373
gene	O	6373
(	O	6373
on	O	6373
chromosome	O	6373
17q21	O	6373
)	O	6373
,	O	6373
have	O	6373
an	O	6373
80	O	6373
%	O	6373
risk	O	6373
of	O	6373
breast	B-Disease	6373
cancer	I-Disease	6373
and	O	6373
a	O	6373
40	O	6373
%	O	6373
risk	O	6373
of	O	6373
ovarian	B-Disease	6373
cancer	I-Disease	6373
by	O	6373
the	O	6373
age	O	6373
of	O	6373
70	O	6373
(	O	6373
ref	O	6373
.	O	6373
1	O	6373
)	O	6373
.	O	6373
the	O	6375
hras1	O	6375
variable	O	6375
number	O	6375
of	O	6375
tandem	O	6375
repeats	O	6375
(	O	6375
vntr	O	6375
)	O	6375
polymorphism	O	6375
,	O	6375
located	O	6375
1	O	6375
kilobase	O	6375
(	O	6375
kb	O	6375
)	O	6375
downstream	O	6375
of	O	6375
the	O	6375
hras1	O	6375
proto	O	6375
-	O	6375
oncogene	O	6375
(	O	6375
chromosome	O	6375
11p15	O	6375
.	O	6375
5	O	6375
)	O	6375
is	O	6375
one	O	6375
possible	O	6375
genetic	O	6375
modifier	O	6375
of	O	6375
cancer	B-Disease	6375
penetrance	O	6375
.	O	6375
individuals	O	6376
who	O	6376
have	O	6376
rare	O	6376
alleles	O	6376
of	O	6376
the	O	6376
vntr	O	6376
have	O	6376
an	O	6376
increased	O	6376
risk	O	6376
of	O	6376
certain	O	6376
types	O	6376
of	O	6376
cancers	B-Disease	6376
,	O	6376
including	O	6376
breast	B-Disease	6376
cancer	I-Disease	6376
(	O	6376
2	O	6376
-	O	6376
4	O	6376
)	O	6376
.	O	6376
to	O	6377
investigate	O	6377
whether	O	6377
the	O	6377
presence	O	6377
of	O	6377
rare	O	6377
hras1	O	6377
alleles	O	6377
increases	O	6377
susceptibility	O	6377
to	O	6377
hereditary	B-Disease	6377
breast	I-Disease	6377
and	I-Disease	6377
ovarian	I-Disease	6377
cancer	I-Disease	6377
,	O	6377
we	O	6377
have	O	6377
typed	O	6377
a	O	6377
panel	O	6377
of	O	6377
307	O	6377
female	O	6377
brca1	O	6377
carriers	O	6377
at	O	6377
this	O	6377
locus	O	6377
using	O	6377
a	O	6377
pcr	O	6377
-	O	6377
based	O	6377
technique	O	6377
.	O	6377
the	O	6378
risk	O	6378
for	O	6378
ovarian	B-Disease	6378
cancer	I-Disease	6378
was	O	6378
2	O	6378
.	O	6378
the	O	6380
magnitude	O	6380
of	O	6380
the	O	6380
relative	O	6380
risk	O	6380
associated	O	6380
with	O	6380
a	O	6380
rare	O	6380
hras1	O	6380
allele	O	6380
was	O	6380
not	O	6380
altered	O	6380
by	O	6380
adjusting	O	6380
for	O	6380
the	O	6380
other	O	6380
known	O	6380
risk	O	6380
factors	O	6380
for	O	6380
hereditary	B-Disease	6380
ovarian	I-Disease	6380
cancer	I-Disease	6380
(	O	6380
5	O	6380
)	O	6380
.	O	6380
susceptibility	O	6381
to	O	6381
breast	B-Disease	6381
cancer	I-Disease	6381
did	O	6381
not	O	6381
appear	O	6381
to	O	6381
be	O	6381
affected	O	6381
by	O	6381
the	O	6381
presence	O	6381
of	O	6381
rare	O	6381
hras1	O	6381
alleles	O	6381
.	O	6381
this	O	6382
study	O	6382
is	O	6382
the	O	6382
first	O	6382
to	O	6382
show	O	6382
the	O	6382
effect	O	6382
of	O	6382
a	O	6382
modifying	O	6382
gene	O	6382
on	O	6382
the	O	6382
penetrance	O	6382
of	O	6382
an	O	6382
inherited	B-Disease	6382
cancer	I-Disease	6382
syndrome	I-Disease	6382
a	O	6383
novel	O	6383
homeodomain	O	6383
-	O	6383
encoding	O	6383
gene	O	6383
is	O	6383
associated	O	6383
with	O	6383
a	O	6383
large	O	6383
cpg	O	6383
island	O	6383
interrupted	O	6383
by	O	6383
the	O	6383
myotonic	B-Disease	6383
dystrophy	I-Disease	6383
unstable	O	6383
(	O	6383
ctg	O	6383
)	O	6383
n	O	6383
repeat	O	6383
.	O	6383
myotonic	B-Disease	6384
dystrophy	I-Disease	6384
(	O	6384
dm	B-Disease	6384
)	O	6384
is	O	6384
associated	O	6384
with	O	6384
a	O	6384
(	O	6384
ctg	O	6384
)	O	6384
n	O	6384
trinucleotide	O	6384
repeat	O	6384
expansion	O	6384
in	O	6384
the	O	6384
3	O	6384
-	O	6384
untranslated	O	6384
region	O	6384
of	O	6384
a	O	6384
protein	O	6384
kinase	O	6384
-	O	6384
encoding	O	6384
gene	O	6384
,	O	6384
dmpk	O	6384
,	O	6384
which	O	6384
maps	O	6384
to	O	6384
chromosome	O	6384
19q13	O	6384
.	O	6384
the	O	6387
dm	B-Disease	6387
region	O	6387
of	O	6387
chromosome	O	6387
19	O	6387
is	O	6387
gene	O	6387
rich	O	6387
,	O	6387
and	O	6387
it	O	6387
is	O	6387
possible	O	6387
that	O	6387
the	O	6387
repeat	O	6387
expansion	O	6387
may	O	6387
lead	O	6387
to	O	6387
dysfunction	O	6387
of	O	6387
a	O	6387
number	O	6387
of	O	6387
transcription	O	6387
units	O	6387
in	O	6387
the	O	6387
vicinity	O	6387
,	O	6387
perhaps	O	6387
as	O	6387
a	O	6387
consequence	O	6387
of	O	6387
chromatin	O	6387
disruption	O	6387
.	O	6387
rt	O	6393
-	O	6393
pcr	O	6393
analysis	O	6393
shows	O	6393
that	O	6393
this	O	6393
gene	O	6393
,	O	6393
which	O	6393
we	O	6393
have	O	6393
called	O	6393
dm	B-Disease	6393
locus	O	6393
-	O	6393
associated	O	6393
homeodomain	O	6393
protein	O	6393
(	O	6393
dmahp	O	6393
)	O	6393
,	O	6393
is	O	6393
expressed	O	6393
in	O	6393
a	O	6393
number	O	6393
of	O	6393
human	O	6393
tissues	O	6393
,	O	6393
including	O	6393
skeletal	O	6393
muscle	O	6393
,	O	6393
heart	O	6393
and	O	6393
brain	O	6393
.	O	6393
germline	O	6394
mutations	O	6394
in	O	6394
the	O	6394
rb1	O	6394
gene	O	6394
in	O	6394
patients	O	6394
with	O	6394
hereditary	B-Disease	6394
retinoblastoma	I-Disease	6394
.	O	6394
we	O	6395
have	O	6395
analyzed	O	6395
the	O	6395
27	O	6395
exons	O	6395
and	O	6395
the	O	6395
promoter	O	6395
region	O	6395
of	O	6395
the	O	6395
rb1	O	6395
gene	O	6395
in	O	6395
familial	B-Disease	6395
or	I-Disease	6395
sporadic	I-Disease	6395
bilateral	I-Disease	6395
retinoblastoma	I-Disease	6395
by	O	6395
using	O	6395
single	O	6395
-	O	6395
strand	O	6395
conformation	O	6395
polymorphism	O	6395
analysis	O	6395
.	O	6395
type	B-Disease	6400
ii	I-Disease	6400
human	I-Disease	6400
complement	I-Disease	6400
c2	I-Disease	6400
deficiency	I-Disease	6400
.	O	6400
type	B-Disease	6402
ii	I-Disease	6402
complement	I-Disease	6402
protein	I-Disease	6402
c2	I-Disease	6402
deficiency	I-Disease	6402
is	O	6402
characterized	O	6402
by	O	6402
a	O	6402
selective	O	6402
block	O	6402
in	O	6402
c2	O	6402
secretion	O	6402
.	O	6402
the	O	6403
type	O	6403
ii	O	6403
c2	O	6403
null	O	6403
allele	O	6403
(	O	6403
c2q0	O	6403
)	O	6403
is	O	6403
linked	O	6403
to	O	6403
two	O	6403
major	O	6403
histocompatibility	O	6403
haplotypes	O	6403
(	O	6403
mhc	O	6403
)	O	6403
that	O	6403
differ	O	6403
from	O	6403
the	O	6403
mhc	O	6403
of	O	6403
the	O	6403
more	O	6403
common	O	6403
type	B-Disease	6403
i	I-Disease	6403
c2	I-Disease	6403
deficiency	I-Disease	6403
.	O	6403
to	O	6404
determine	O	6404
the	O	6404
molecular	O	6404
basis	O	6404
of	O	6404
type	B-Disease	6404
ii	I-Disease	6404
deficiency	I-Disease	6404
the	O	6404
two	O	6404
type	O	6404
ii	O	6404
c2q0	O	6404
genes	O	6404
were	O	6404
isolated	O	6404
and	O	6404
transfected	O	6404
separately	O	6404
into	O	6404
l	O	6404
-	O	6404
cells	O	6404
.	O	6404
subsequent	O	6405
molecular	O	6405
biology	O	6405
,	O	6405
biosynthetic	O	6405
,	O	6405
and	O	6405
immunofluorescence	O	6405
studies	O	6405
demonstrated	O	6405
that	O	6405
c2	O	6405
secretion	O	6405
is	O	6405
impaired	O	6405
in	O	6405
type	B-Disease	6405
ii	I-Disease	6405
c2	I-Disease	6405
deficiency	I-Disease	6405
because	O	6405
of	O	6405
different	O	6405
missense	O	6405
mutations	O	6405
at	O	6405
highly	O	6405
conserved	O	6405
residues	O	6405
in	O	6405
each	O	6405
of	O	6405
the	O	6405
c2q0	O	6405
alleles	O	6405
.	O	6405
defective	O	6410
dimerization	O	6410
of	O	6410
von	B-Disease	6410
willebrand	I-Disease	6410
factor	O	6410
subunits	O	6410
due	O	6410
to	O	6410
a	O	6410
cys	O	6410
-	O	6410
>	O	6410
arg	O	6410
mutation	O	6410
in	O	6410
type	B-Disease	6410
iid	I-Disease	6410
von	I-Disease	6410
willebrand	I-Disease	6410
disease	I-Disease	6410
.	O	6410
the	O	6411
same	O	6411
heterozygous	O	6411
t	O	6411
-	O	6411
>	O	6411
c	O	6411
transition	O	6411
at	O	6411
nt	O	6411
8567	O	6411
of	O	6411
the	O	6411
von	B-Disease	6411
willebrand	I-Disease	6411
factor	O	6411
(	O	6411
vwf	O	6411
)	O	6411
transcript	O	6411
was	O	6411
found	O	6411
in	O	6411
two	O	6411
unrelated	O	6411
patients	O	6411
with	O	6411
type	B-Disease	6411
iid	I-Disease	6411
von	I-Disease	6411
willebrand	I-Disease	6411
disease	I-Disease	6411
,	O	6411
with	O	6411
no	O	6411
other	O	6411
apparent	O	6411
abnormality	O	6411
.	O	6411
we	O	6417
conclude	O	6417
that	O	6417
cys2010	O	6417
is	O	6417
essential	O	6417
for	O	6417
normal	O	6417
dimerization	O	6417
of	O	6417
vwf	O	6417
subunits	O	6417
through	O	6417
disulfide	O	6417
bonding	O	6417
of	O	6417
carboxyl	O	6417
-	O	6417
terminal	O	6417
domains	O	6417
and	O	6417
that	O	6417
a	O	6417
heterozygous	O	6417
mutation	O	6417
in	O	6417
the	O	6417
corresponding	O	6417
codon	O	6417
is	O	6417
responsible	O	6417
for	O	6417
defective	O	6417
multimer	O	6417
formation	O	6417
in	O	6417
type	B-Disease	6417
iid	I-Disease	6417
von	I-Disease	6417
willebrand	I-Disease	6417
disease	I-Disease	6417
.	O	6417
.	O	6417
wiskott	B-Disease	6418
-	I-Disease	6418
aldrich	I-Disease	6418
syndrome	I-Disease	6418
protein	O	6418
,	O	6418
a	O	6418
novel	O	6418
effector	O	6418
for	O	6418
the	O	6418
gtpase	O	6418
cdc42hs	O	6418
,	O	6418
is	O	6418
implicated	O	6418
in	O	6418
actin	O	6418
polymerization	O	6418
.	O	6418
we	O	6420
have	O	6420
identified	O	6420
wasp	O	6420
,	O	6420
the	O	6420
protein	O	6420
that	O	6420
is	O	6420
defective	O	6420
in	O	6420
wiskott	B-Disease	6420
-	I-Disease	6420
aldrich	I-Disease	6420
syndrome	I-Disease	6420
(	O	6420
was	B-Disease	6420
)	O	6420
,	O	6420
as	O	6420
a	O	6420
novel	O	6420
effector	O	6420
for	O	6420
cdc42hs	O	6420
,	O	6420
but	O	6420
not	O	6420
for	O	6420
the	O	6420
other	O	6420
rho	O	6420
family	O	6420
members	O	6420
,	O	6420
rac	O	6420
and	O	6420
rho	O	6420
.	O	6420
thus	O	6424
,	O	6424
wasp	O	6424
provides	O	6424
a	O	6424
novel	O	6424
link	O	6424
between	O	6424
cdc42hs	O	6424
and	O	6424
the	O	6424
actin	O	6424
cytoskeleton	O	6424
,	O	6424
which	O	6424
suggests	O	6424
a	O	6424
molecular	O	6424
mechanism	O	6424
for	O	6424
many	O	6424
of	O	6424
the	O	6424
cellular	O	6424
abnormalities	O	6424
in	O	6424
was	B-Disease	6424
.	O	6424
x	B-Disease	6426
-	I-Disease	6426
linked	I-Disease	6426
adrenoleukodystrophy	I-Disease	6426
is	O	6426
a	O	6426
frequent	O	6426
cause	O	6426
of	O	6426
idiopathic	O	6426
addison	B-Disease	6426
'	I-Disease	6426
s	I-Disease	6426
disease	I-Disease	6426
in	O	6426
young	O	6426
adult	O	6426
male	O	6426
patients	O	6426
.	O	6426
x	B-Disease	6427
-	I-Disease	6427
linked	I-Disease	6427
adrenoleukodystrophy	I-Disease	6427
(	O	6427
ald	B-Disease	6427
)	O	6427
is	O	6427
a	O	6427
genetic	B-Disease	6427
disease	I-Disease	6427
associated	O	6427
with	O	6427
demyelination	B-Disease	6427
of	I-Disease	6427
the	I-Disease	6427
central	I-Disease	6427
nervous	I-Disease	6427
system	I-Disease	6427
,	O	6427
adrenal	B-Disease	6427
insufficiency	I-Disease	6427
,	O	6427
and	O	6427
accumulation	O	6427
of	O	6427
very	O	6427
long	O	6427
chain	O	6427
fatty	O	6427
acids	O	6427
in	O	6427
tissue	O	6427
and	O	6427
body	O	6427
fluids	O	6427
.	O	6427
ald	B-Disease	6428
is	O	6428
due	O	6428
to	O	6428
mutation	O	6428
of	O	6428
a	O	6428
gene	O	6428
located	O	6428
in	O	6428
xq28	O	6428
that	O	6428
encodes	O	6428
a	O	6428
peroxisomal	O	6428
transporter	O	6428
protein	O	6428
of	O	6428
unknown	O	6428
function	O	6428
.	O	6428
the	O	6429
most	O	6429
common	O	6429
phenotype	O	6429
of	O	6429
ald	B-Disease	6429
is	O	6429
the	O	6429
cerebral	O	6429
form	O	6429
(	O	6429
45	O	6429
%	O	6429
)	O	6429
that	O	6429
develops	O	6429
in	O	6429
boys	O	6429
between	O	6429
5	O	6429
-	O	6429
12	O	6429
yr	O	6429
.	O	6429
adrenomyeloneuropathy	B-Disease	6430
(	O	6430
amn	B-Disease	6430
)	O	6430
involves	O	6430
the	O	6430
spinal	O	6430
cord	O	6430
and	O	6430
peripheral	O	6430
nerves	O	6430
in	O	6430
young	O	6430
adults	O	6430
(	O	6430
35	O	6430
%	O	6430
)	O	6430
.	O	6430
adrenal	B-Disease	6431
insufficiency	I-Disease	6431
(	O	6431
addisons	B-Disease	6431
disease	I-Disease	6431
)	O	6431
is	O	6431
frequently	O	6431
associated	O	6431
with	O	6431
amn	B-Disease	6431
or	O	6431
cerebral	B-Disease	6431
ald	I-Disease	6431
and	O	6431
may	O	6431
remain	O	6431
the	O	6431
only	O	6431
clinical	O	6431
expression	O	6431
of	O	6431
ald	B-Disease	6431
(	O	6431
8	O	6431
%	O	6431
of	O	6431
cases	O	6431
)	O	6431
.	O	6431
the	O	6432
prevalence	O	6432
of	O	6432
ald	B-Disease	6432
among	O	6432
adults	O	6432
with	O	6432
addisons	B-Disease	6432
disease	I-Disease	6432
remains	O	6432
unknown	O	6432
.	O	6432
to	O	6433
evaluate	O	6433
this	O	6433
prevalence	O	6433
,	O	6433
we	O	6433
performed	O	6433
biochemical	O	6433
analysis	O	6433
of	O	6433
very	O	6433
long	O	6433
chain	O	6433
fatty	O	6433
acids	O	6433
in	O	6433
14	O	6433
male	O	6433
patients	O	6433
(	O	6433
age	O	6433
ranging	O	6433
from	O	6433
12	O	6433
-	O	6433
45	O	6433
yr	O	6433
at	O	6433
diagnosis	O	6433
)	O	6433
previously	O	6433
diagnosed	O	6433
as	O	6433
having	O	6433
primary	O	6433
idiopathic	O	6433
adrenocortical	B-Disease	6433
insufficiency	I-Disease	6433
.	O	6433
by	O	6436
electrophysiological	O	6436
tests	O	6436
and	O	6436
magnetic	O	6436
resonance	O	6436
imaging	O	6436
it	O	6436
was	O	6436
determined	O	6436
that	O	6436
two	O	6436
patients	O	6436
had	O	6436
cerebral	B-Disease	6436
ald	I-Disease	6436
,	O	6436
one	O	6436
had	O	6436
adrenomyeloneuropathy	B-Disease	6436
with	O	6436
cerebral	O	6436
involvement	O	6436
,	O	6436
and	O	6436
two	O	6436
had	O	6436
preclinical	O	6436
amn	B-Disease	6436
.	O	6436
our	O	6437
data	O	6437
support	O	6437
the	O	6437
hypothesis	O	6437
that	O	6437
ald	B-Disease	6437
is	O	6437
a	O	6437
frequent	O	6437
cause	O	6437
of	O	6437
idiopathic	O	6437
addisons	B-Disease	6437
disease	I-Disease	6437
in	O	6437
children	O	6437
and	O	6437
adults	O	6437
.	O	6437
.	O	6437
tumor	B-Disease	6438
suppression	O	6438
and	O	6438
apoptosis	O	6438
of	O	6438
human	O	6438
prostate	B-Disease	6438
carcinoma	I-Disease	6438
mediated	O	6438
by	O	6438
a	O	6438
genetic	O	6438
locus	O	6438
within	O	6438
human	O	6438
chromosome	O	6438
10pter	O	6438
-	O	6438
q11	O	6438
.	O	6438
prostate	B-Disease	6439
cancer	I-Disease	6439
is	O	6439
the	O	6439
second	O	6439
leading	O	6439
cause	O	6439
of	O	6439
male	O	6439
cancer	B-Disease	6439
deaths	O	6439
in	O	6439
the	O	6439
united	O	6439
states	O	6439
.	O	6439
prostate	O	6441
secretory	O	6441
epithelial	O	6441
cells	O	6441
and	O	6441
androgen	O	6441
-	O	6441
dependent	O	6441
prostate	B-Disease	6441
carcinomas	I-Disease	6441
undergo	O	6441
apoptosis	O	6441
in	O	6441
response	O	6441
to	O	6441
androgen	O	6441
deprivation	O	6441
and	O	6441
,	O	6441
furthermore	O	6441
,	O	6441
most	O	6441
prostate	B-Disease	6441
carcinomas	I-Disease	6441
become	O	6441
androgen	O	6441
independent	O	6441
and	O	6441
refractory	O	6441
to	O	6441
further	O	6441
therapeutic	O	6441
manipulations	O	6441
during	O	6441
disease	O	6441
progression	O	6441
.	O	6441
we	O	6443
report	O	6443
the	O	6443
functional	O	6443
definition	O	6443
of	O	6443
a	O	6443
novel	O	6443
genetic	O	6443
locus	O	6443
within	O	6443
human	O	6443
chromosome	O	6443
10pter	O	6443
-	O	6443
q11	O	6443
that	O	6443
mediates	O	6443
both	O	6443
in	O	6443
vivo	O	6443
tumor	O	6443
suppression	O	6443
and	O	6443
in	O	6443
vitro	O	6443
apoptosis	O	6443
of	O	6443
prostatic	B-Disease	6443
adenocarcinoma	I-Disease	6443
cells	O	6443
.	O	6443
a	O	6444
defined	O	6444
fragment	O	6444
of	O	6444
human	O	6444
chromosome	O	6444
10	O	6444
was	O	6444
transferred	O	6444
via	O	6444
microcell	O	6444
fusion	O	6444
into	O	6444
a	O	6444
prostate	B-Disease	6444
adenocarcinoma	I-Disease	6444
cell	O	6444
line	O	6444
.	O	6444
these	O	6447
data	O	6447
functionally	O	6447
define	O	6447
a	O	6447
novel	O	6447
genetic	O	6447
locus	O	6447
,	O	6447
designated	O	6447
pac1	O	6447
,	O	6447
for	O	6447
prostate	O	6447
adenocarcinoma	O	6447
1	O	6447
,	O	6447
involved	O	6447
in	O	6447
tumor	O	6447
suppression	O	6447
of	O	6447
human	O	6447
prostate	B-Disease	6447
carcinoma	I-Disease	6447
and	O	6447
furthermore	O	6447
strongly	O	6447
suggest	O	6447
that	O	6447
the	O	6447
cell	O	6447
death	O	6447
pathway	O	6447
can	O	6447
be	O	6447
functionally	O	6447
restored	O	6447
in	O	6447
prostatic	B-Disease	6447
adenocarcinoma	I-Disease	6447
.	O	6447
.	O	6447
low	O	6448
incidence	O	6448
of	O	6448
brca2	O	6448
mutations	O	6448
in	O	6448
breast	B-Disease	6448
carcinoma	I-Disease	6448
and	O	6448
other	O	6448
cancers	B-Disease	6448
.	O	6448
inherited	O	6449
mutant	O	6449
alleles	O	6449
of	O	6449
familial	O	6449
tumour	B-Disease	6449
suppressor	O	6449
genes	O	6449
predispose	O	6449
individuals	O	6449
to	O	6449
particular	O	6449
types	O	6449
of	O	6449
cancer	B-Disease	6449
.	O	6449
in	O	6450
addition	O	6450
to	O	6450
an	O	6450
involvement	O	6450
in	O	6450
inherited	O	6450
susceptibility	O	6450
to	O	6450
cancer	B-Disease	6450
,	O	6450
these	O	6450
tumour	B-Disease	6450
suppressor	O	6450
genes	O	6450
are	O	6450
targets	O	6450
for	O	6450
somatic	O	6450
mutations	O	6450
in	O	6450
sporadic	B-Disease	6450
cancers	I-Disease	6450
of	O	6450
the	O	6450
same	O	6450
type	O	6450
found	O	6450
in	O	6450
the	O	6450
familial	O	6450
forms	O	6450
.	O	6450
an	O	6451
exception	O	6451
is	O	6451
brca1	O	6451
,	O	6451
which	O	6451
contributes	O	6451
to	O	6451
a	O	6451
significant	O	6451
fraction	O	6451
of	O	6451
familial	B-Disease	6451
breast	I-Disease	6451
and	I-Disease	6451
ovarian	I-Disease	6451
cancer	I-Disease	6451
,	O	6451
but	O	6451
undergoes	O	6451
mutation	O	6451
at	O	6451
very	O	6451
low	O	6451
rates	O	6451
in	O	6451
sporadic	B-Disease	6451
breast	I-Disease	6451
and	I-Disease	6451
ovarian	I-Disease	6451
cancers	I-Disease	6451
.	O	6451
this	O	6452
finding	O	6452
suggests	O	6452
that	O	6452
other	O	6452
genes	O	6452
may	O	6452
be	O	6452
the	O	6452
principal	O	6452
targets	O	6452
for	O	6452
somatic	O	6452
mutation	O	6452
in	O	6452
breast	B-Disease	6452
carcinoma	I-Disease	6452
.	O	6452
a	O	6453
second	O	6453
,	O	6453
recently	O	6453
identified	O	6453
familial	B-Disease	6453
breast	I-Disease	6453
cancer	I-Disease	6453
gene	O	6453
,	O	6453
brca2	O	6453
(	O	6453
refs	O	6453
5	O	6453
-	O	6453
8	O	6453
)	O	6453
,	O	6453
accounts	O	6453
for	O	6453
a	O	6453
proportion	O	6453
of	O	6453
breast	B-Disease	6453
cancer	I-Disease	6453
roughly	O	6453
equal	O	6453
to	O	6453
brca1	O	6453
.	O	6453
like	O	6454
brca1	O	6454
,	O	6454
brca2	O	6454
behaves	O	6454
as	O	6454
a	O	6454
dominantly	O	6454
inherited	O	6454
tumour	B-Disease	6454
suppressor	O	6454
gene	O	6454
.	O	6454
individuals	O	6455
who	O	6455
inherit	O	6455
one	O	6455
mutant	O	6455
allele	O	6455
are	O	6455
at	O	6455
increased	O	6455
risk	O	6455
for	O	6455
breast	B-Disease	6455
cancer	I-Disease	6455
,	O	6455
and	O	6455
the	O	6455
tumours	B-Disease	6455
they	O	6455
develop	O	6455
lose	O	6455
the	O	6455
wild	O	6455
-	O	6455
type	O	6455
allele	O	6455
by	O	6455
heterozygous	O	6455
deletion	O	6455
.	O	6455
here	O	6457
we	O	6457
investigate	O	6457
the	O	6457
rate	O	6457
of	O	6457
brca2	O	6457
mutation	O	6457
in	O	6457
sporadic	B-Disease	6457
breast	I-Disease	6457
cancers	I-Disease	6457
and	O	6457
in	O	6457
a	O	6457
set	O	6457
of	O	6457
cell	O	6457
lines	O	6457
that	O	6457
represent	O	6457
twelve	O	6457
other	O	6457
tumour	B-Disease	6457
types	O	6457
.	O	6457
surprisingly	O	6458
,	O	6458
mutations	O	6458
in	O	6458
brca2	O	6458
are	O	6458
infrequent	O	6458
in	O	6458
cancers	B-Disease	6458
including	O	6458
breast	B-Disease	6458
carcinoma	I-Disease	6458
.	O	6458
however	O	6459
,	O	6459
a	O	6459
probable	O	6459
germline	O	6459
mutation	O	6459
in	O	6459
a	O	6459
pancreatic	B-Disease	6459
tumour	I-Disease	6459
cell	O	6459
line	O	6459
suggests	O	6459
a	O	6459
role	O	6459
for	O	6459
brca2	O	6459
in	O	6459
susceptibility	O	6459
to	O	6459
pancreatic	B-Disease	6459
cancer	I-Disease	6459
.	O	6459
.	O	6459
founding	O	6460
brca1	O	6460
mutations	O	6460
in	O	6460
hereditary	B-Disease	6460
breast	I-Disease	6460
and	I-Disease	6460
ovarian	I-Disease	6460
cancer	I-Disease	6460
in	O	6460
southern	O	6460
sweden	O	6460
.	O	6460
nine	O	6461
different	O	6461
germ	O	6461
-	O	6461
line	O	6461
mutations	O	6461
in	O	6461
the	O	6461
brca1	O	6461
breast	B-Disease	6461
and	I-Disease	6461
ovarian	I-Disease	6461
cancer	I-Disease	6461
susceptibility	O	6461
gene	O	6461
were	O	6461
identified	O	6461
in	O	6461
15	O	6461
of	O	6461
47	O	6461
kindreds	O	6461
from	O	6461
southern	O	6461
sweden	O	6461
,	O	6461
by	O	6461
use	O	6461
of	O	6461
sscp	O	6461
and	O	6461
heteroduplex	O	6461
analysis	O	6461
of	O	6461
all	O	6461
exons	O	6461
and	O	6461
flanking	O	6461
intron	O	6461
region	O	6461
and	O	6461
by	O	6461
a	O	6461
protein	O	6461
-	O	6461
truncation	O	6461
test	O	6461
for	O	6461
exon	O	6461
11	O	6461
,	O	6461
followed	O	6461
by	O	6461
direct	O	6461
sequencing	O	6461
.	O	6461
eleven	O	6466
of	O	6466
the	O	6466
15	O	6466
kindreds	O	6466
manifesting	O	6466
brca1	O	6466
mutations	O	6466
were	O	6466
breast	B-Disease	6466
-	I-Disease	6466
ovarian	I-Disease	6466
cancer	I-Disease	6466
families	O	6466
,	O	6466
several	O	6466
of	O	6466
them	O	6466
with	O	6466
a	O	6466
predominant	O	6466
ovarian	B-Disease	6466
cancer	I-Disease	6466
phenotype	O	6466
.	O	6466
the	O	6467
set	O	6467
of	O	6467
32	O	6467
families	O	6467
in	O	6467
which	O	6467
no	O	6467
brca1	O	6467
alterations	O	6467
were	O	6467
detected	O	6467
included	O	6467
1	O	6467
breast	B-Disease	6467
-	I-Disease	6467
ovarian	I-Disease	6467
cancer	I-Disease	6467
kindred	O	6467
manifesting	O	6467
clear	O	6467
linkage	O	6467
to	O	6467
the	O	6467
brca1	O	6467
region	O	6467
and	O	6467
loss	O	6467
of	O	6467
the	O	6467
wild	O	6467
-	O	6467
type	O	6467
chromosome	O	6467
in	O	6467
associated	O	6467
tumors	B-Disease	6467
.	O	6467
other	O	6468
tumor	B-Disease	6468
types	O	6468
found	O	6468
in	O	6468
brca1	O	6468
mutation	O	6468
/	O	6468
haplotype	O	6468
carriers	O	6468
included	O	6468
prostatic	B-Disease	6468
,	I-Disease	6468
pancreas	I-Disease	6468
,	I-Disease	6468
skin	I-Disease	6468
,	I-Disease	6468
and	I-Disease	6468
lung	I-Disease	6468
cancer	I-Disease	6468
,	O	6468
a	O	6468
malignant	B-Disease	6468
melanoma	I-Disease	6468
,	O	6468
an	O	6468
oligodendroglioma	B-Disease	6468
,	O	6468
and	O	6468
a	O	6468
carcinosarcoma	B-Disease	6468
.	O	6468
in	O	6469
all	O	6469
,	O	6469
12	O	6469
of	O	6469
16	O	6469
kindreds	O	6469
manifesting	O	6469
brca1	O	6469
mutation	O	6469
or	O	6469
linkage	O	6469
contained	O	6469
ovarian	B-Disease	6469
cancer	I-Disease	6469
,	O	6469
as	O	6469
compared	O	6469
with	O	6469
only	O	6469
6	O	6469
of	O	6469
the	O	6469
remaining	O	6469
31	O	6469
families	O	6469
(	O	6469
p	O	6469
<	O	6469
.	O	6469
001	O	6469
)	O	6469
.	O	6469
the	O	6470
present	O	6470
study	O	6470
confirms	O	6470
the	O	6470
involvement	O	6470
of	O	6470
brca1	O	6470
in	O	6470
disease	O	6470
predisposition	O	6470
for	O	6470
a	O	6470
subset	O	6470
of	O	6470
hereditary	B-Disease	6470
breast	I-Disease	6470
cancer	I-Disease	6470
families	O	6470
often	O	6470
characterized	O	6470
by	O	6470
ovarian	B-Disease	6470
cancers	I-Disease	6470
.	O	6470
ukcccr	O	6472
familial	O	6472
ovarian	B-Disease	6472
cancer	I-Disease	6472
study	O	6472
group	O	6472
.	O	6472
germ	O	6473
-	O	6473
line	O	6473
mutations	O	6473
of	O	6473
the	O	6473
brca1	O	6473
gene	O	6473
are	O	6473
responsible	O	6473
for	O	6473
a	O	6473
substantial	O	6473
proportion	O	6473
of	O	6473
families	O	6473
with	O	6473
multiple	O	6473
cases	O	6473
of	O	6473
early	O	6473
-	O	6473
onset	O	6473
breast	B-Disease	6473
and	I-Disease	6473
/	I-Disease	6473
or	I-Disease	6473
ovarian	I-Disease	6473
cancer	I-Disease	6473
.	O	6473
we	O	6475
have	O	6475
developed	O	6475
a	O	6475
multiplex	O	6475
heteroduplex	O	6475
analysis	O	6475
that	O	6475
is	O	6475
designed	O	6475
to	O	6475
analyze	O	6475
one	O	6475
-	O	6475
quarter	O	6475
of	O	6475
the	O	6475
coding	O	6475
sequence	O	6475
in	O	6475
a	O	6475
single	O	6475
-	O	6475
step	O	6475
screening	O	6475
procedure	O	6475
and	O	6475
that	O	6475
will	O	6475
detect	O	6475
approximately	O	6475
50	O	6475
%	O	6475
of	O	6475
all	O	6475
brca1	O	6475
mutations	O	6475
so	O	6475
far	O	6475
reported	O	6475
in	O	6475
breast	B-Disease	6475
/	I-Disease	6475
ovarian	I-Disease	6475
cancer	I-Disease	6475
families	O	6475
.	O	6475
we	O	6476
have	O	6476
used	O	6476
this	O	6476
technique	O	6476
to	O	6476
analyze	O	6476
brca1	O	6476
in	O	6476
162	O	6476
families	O	6476
with	O	6476
a	O	6476
history	O	6476
of	O	6476
breast	B-Disease	6476
and	I-Disease	6476
/	I-Disease	6476
or	I-Disease	6476
ovarian	I-Disease	6476
cancer	I-Disease	6476
and	O	6476
identified	O	6476
12	O	6476
distinct	O	6476
mutations	O	6476
in	O	6476
35	O	6476
families	O	6476
.	O	6476
.	O	6476
a	O	6477
previously	O	6477
undescribed	O	6477
mutation	O	6477
within	O	6477
the	O	6477
tetramerisation	O	6477
domain	O	6477
of	O	6477
tp53	O	6477
in	O	6477
a	O	6477
family	O	6477
with	O	6477
li	B-Disease	6477
-	I-Disease	6477
fraumeni	I-Disease	6477
syndrome	I-Disease	6477
.	O	6477
we	O	6478
report	O	6478
details	O	6478
of	O	6478
a	O	6478
family	O	6478
with	O	6478
classic	O	6478
li	B-Disease	6478
-	I-Disease	6478
fraumeni	I-Disease	6478
syndrome	I-Disease	6478
in	O	6478
which	O	6478
there	O	6478
is	O	6478
a	O	6478
mutation	O	6478
in	O	6478
codon	O	6478
344	O	6478
of	O	6478
the	O	6478
tumour	B-Disease	6478
suppressor	O	6478
gene	O	6478
tp53	O	6478
.	O	6478
this	O	6480
is	O	6480
the	O	6480
first	O	6480
report	O	6480
of	O	6480
a	O	6480
mutation	O	6480
at	O	6480
this	O	6480
residue	O	6480
in	O	6480
either	O	6480
sporadic	B-Disease	6480
tumours	I-Disease	6480
or	O	6480
in	O	6480
the	O	6480
germline	O	6480
and	O	6480
the	O	6480
first	O	6480
report	O	6480
of	O	6480
a	O	6480
germline	O	6480
mutation	O	6480
within	O	6480
the	O	6480
tetramerisation	O	6480
domain	O	6480
.	O	6480
the	O	6481
family	O	6481
does	O	6481
not	O	6481
appear	O	6481
to	O	6481
be	O	6481
remarkable	O	6481
in	O	6481
the	O	6481
spectrum	O	6481
of	O	6481
tumours	B-Disease	6481
,	O	6481
and	O	6481
there	O	6481
is	O	6481
loss	O	6481
of	O	6481
the	O	6481
wild	O	6481
-	O	6481
type	O	6481
allele	O	6481
in	O	6481
a	O	6481
leiomyosarcoma	B-Disease	6481
from	O	6481
the	O	6481
proband	O	6481
.	O	6481
a	O	6482
cell	O	6482
line	O	6482
has	O	6482
been	O	6482
established	O	6482
from	O	6482
the	O	6482
tumour	B-Disease	6482
of	O	6482
the	O	6482
proband	O	6482
and	O	6482
cytogenetic	O	6482
and	O	6482
molecular	O	6482
studies	O	6482
carried	O	6482
out	O	6482
,	O	6482
providing	O	6482
an	O	6482
extensive	O	6482
analysis	O	6482
in	O	6482
this	O	6482
family	O	6482
.	O	6482
.	O	6482
the	O	6483
spectrum	O	6483
of	O	6483
rb1	O	6483
germ	O	6483
-	O	6483
line	O	6483
mutations	O	6483
in	O	6483
hereditary	B-Disease	6483
retinoblastoma	I-Disease	6483
.	O	6483
we	O	6484
have	O	6484
searched	O	6484
for	O	6484
germ	O	6484
-	O	6484
line	O	6484
rb1	O	6484
mutations	O	6484
in	O	6484
119	O	6484
patients	O	6484
with	O	6484
hereditary	B-Disease	6484
retinoblastoma	I-Disease	6484
.	O	6484
no	O	6495
correlation	O	6495
between	O	6495
the	O	6495
location	O	6495
of	O	6495
frameshift	O	6495
or	O	6495
nonsense	O	6495
mutations	O	6495
and	O	6495
phenotypic	O	6495
features	O	6495
,	O	6495
including	O	6495
age	O	6495
at	O	6495
diagnosis	O	6495
,	O	6495
the	O	6495
number	O	6495
of	O	6495
tumor	B-Disease	6495
foci	O	6495
,	O	6495
and	O	6495
manifestation	O	6495
of	O	6495
nonocular	B-Disease	6495
tumors	I-Disease	6495
was	O	6495
observed	O	6495
.	O	6495
.	O	6495
phenotypic	O	6496
characterization	O	6496
of	O	6496
individuals	O	6496
with	O	6496
30	O	6496
-	O	6496
40	O	6496
cag	O	6496
repeats	O	6496
in	O	6496
the	O	6496
huntington	B-Disease	6496
disease	I-Disease	6496
(	O	6496
hd	B-Disease	6496
)	O	6496
gene	O	6496
reveals	O	6496
hd	B-Disease	6496
cases	O	6496
with	O	6496
36	O	6496
repeats	O	6496
and	O	6496
apparently	O	6496
normal	O	6496
elderly	O	6496
individuals	O	6496
with	O	6496
36	O	6496
-	O	6496
39	O	6496
repeats	O	6496
.	O	6496
abnormal	O	6497
cag	O	6497
expansions	O	6497
in	O	6497
the	O	6497
it	O	6497
-	O	6497
15	O	6497
gene	O	6497
are	O	6497
associated	O	6497
with	O	6497
huntington	B-Disease	6497
disease	I-Disease	6497
(	O	6497
hd	B-Disease	6497
)	O	6497
.	O	6497
in	O	6498
the	O	6498
diagnostic	O	6498
setting	O	6498
it	O	6498
is	O	6498
necessary	O	6498
to	O	6498
define	O	6498
the	O	6498
limits	O	6498
of	O	6498
the	O	6498
cag	O	6498
size	O	6498
ranges	O	6498
on	O	6498
normal	O	6498
and	O	6498
hd	B-Disease	6498
-	O	6498
associated	O	6498
chromosomes	O	6498
.	O	6498
seven	O	6505
hd	B-Disease	6505
patients	O	6505
had	O	6505
36	O	6505
repeats	O	6505
,	O	6505
which	O	6505
confirms	O	6505
that	O	6505
this	O	6505
allele	O	6505
is	O	6505
associated	O	6505
with	O	6505
disease	O	6505
.	O	6505
individuals	O	6506
without	O	6506
apparent	O	6506
symptoms	O	6506
or	O	6506
signs	O	6506
of	O	6506
hd	B-Disease	6506
were	O	6506
found	O	6506
at	O	6506
36	O	6506
repeats	O	6506
(	O	6506
aged	O	6506
74	O	6506
,	O	6506
78	O	6506
,	O	6506
79	O	6506
,	O	6506
and	O	6506
87	O	6506
years	O	6506
)	O	6506
,	O	6506
37	O	6506
repeats	O	6506
(	O	6506
aged	O	6506
69	O	6506
years	O	6506
)	O	6506
,	O	6506
38	O	6506
repeats	O	6506
(	O	6506
aged	O	6506
69	O	6506
and	O	6506
90	O	6506
years	O	6506
)	O	6506
,	O	6506
and	O	6506
39	O	6506
repeats	O	6506
(	O	6506
aged	O	6506
67	O	6506
,	O	6506
90	O	6506
,	O	6506
and	O	6506
95	O	6506
years	O	6506
)	O	6506
.	O	6506
the	O	6507
detailed	O	6507
case	O	6507
histories	O	6507
of	O	6507
an	O	6507
exceptional	O	6507
case	O	6507
from	O	6507
this	O	6507
series	O	6507
will	O	6507
be	O	6507
presented	O	6507
a	O	6507
95	O	6507
-	O	6507
year	O	6507
-	O	6507
old	O	6507
man	O	6507
with	O	6507
39	O	6507
repeats	O	6507
who	O	6507
did	O	6507
not	O	6507
have	O	6507
classical	O	6507
features	O	6507
of	O	6507
hd	B-Disease	6507
.	O	6507
the	O	6508
apparently	O	6508
healthy	O	6508
survival	O	6508
into	O	6508
old	O	6508
age	O	6508
of	O	6508
some	O	6508
individuals	O	6508
with	O	6508
36	O	6508
-	O	6508
39	O	6508
repeats	O	6508
suggests	O	6508
that	O	6508
the	O	6508
hd	B-Disease	6508
mutation	O	6508
may	O	6508
not	O	6508
always	O	6508
be	O	6508
fully	O	6508
penetrant	O	6508
.	O	6508
.	O	6508
identification	O	6509
and	O	6509
expression	O	6509
of	O	6509
eight	O	6509
novel	O	6509
mutations	O	6509
among	O	6509
non	O	6509
-	O	6509
jewish	O	6509
patients	O	6509
with	O	6509
canavan	B-Disease	6509
disease	I-Disease	6509
.	O	6509
canavan	B-Disease	6510
disease	I-Disease	6510
is	O	6510
inherited	O	6510
as	O	6510
an	O	6510
autosomal	O	6510
recessive	O	6510
trait	O	6510
that	O	6510
is	O	6510
caused	O	6510
by	O	6510
the	O	6510
deficiency	B-Disease	6510
of	I-Disease	6510
aspartoacylase	I-Disease	6510
(	O	6510
aspa	O	6510
)	O	6510
.	O	6510
the	O	6511
majority	O	6511
of	O	6511
patients	O	6511
with	O	6511
canavan	B-Disease	6511
disease	I-Disease	6511
are	O	6511
from	O	6511
an	O	6511
ashkenazi	O	6511
jewish	O	6511
background	O	6511
.	O	6511
the	O	6513
current	O	6513
study	O	6513
was	O	6513
aimed	O	6513
at	O	6513
finding	O	6513
the	O	6513
molecular	O	6513
basis	O	6513
of	O	6513
canavan	B-Disease	6513
disease	I-Disease	6513
in	O	6513
25	O	6513
independent	O	6513
patients	O	6513
of	O	6513
non	O	6513
-	O	6513
jewish	O	6513
background	O	6513
.	O	6513
the	O	6517
homozygous	O	6517
32	O	6517
deltat	O	6517
deletion	O	6517
was	O	6517
identified	O	6517
in	O	6517
the	O	6517
only	O	6517
known	O	6517
patient	O	6517
of	O	6517
african	O	6517
-	O	6517
american	O	6517
origin	O	6517
with	O	6517
canavan	B-Disease	6517
disease	I-Disease	6517
.	O	6517
in	O	6521
vitro	O	6521
expression	O	6521
of	O	6521
mutant	O	6521
cdna	O	6521
clones	O	6521
demonstrated	O	6521
that	O	6521
all	O	6521
of	O	6521
these	O	6521
mutations	O	6521
led	O	6521
to	O	6521
a	O	6521
deficiency	B-Disease	6521
of	I-Disease	6521
aspa	I-Disease	6521
and	O	6521
should	O	6521
therefore	O	6521
result	O	6521
in	O	6521
canavan	B-Disease	6521
disease	I-Disease	6521
.	O	6521
.	O	6521
identification	O	6522
and	O	6522
chromosomal	O	6522
localization	O	6522
of	O	6522
atm	O	6522
,	O	6522
the	O	6522
mouse	O	6522
homolog	O	6522
of	O	6522
the	O	6522
ataxia	B-Disease	6522
-	I-Disease	6522
telangiectasia	I-Disease	6522
gene	O	6522
.	O	6522
atm	O	6523
,	O	6523
the	O	6523
mouse	O	6523
homolog	O	6523
of	O	6523
the	O	6523
human	O	6523
atm	O	6523
gene	O	6523
defective	O	6523
in	O	6523
ataxia	B-Disease	6523
-	I-Disease	6523
telangiectasia	I-Disease	6523
(	O	6523
a	B-Disease	6523
-	I-Disease	6523
t	I-Disease	6523
)	O	6523
,	O	6523
has	O	6523
been	O	6523
identified	O	6523
.	O	6523
the	O	6527
mouse	O	6527
homolog	O	6527
of	O	6527
the	O	6527
wiskott	B-Disease	6527
-	I-Disease	6527
aldrich	I-Disease	6527
syndrome	I-Disease	6527
protein	O	6527
(	O	6527
wasp	O	6527
)	O	6527
gene	O	6527
is	O	6527
highly	O	6527
conserved	O	6527
and	O	6527
maps	O	6527
near	O	6527
the	O	6527
scurfy	O	6527
(	O	6527
sf	O	6527
)	O	6527
mutation	O	6527
on	O	6527
the	O	6527
x	O	6527
chromosome	O	6527
.	O	6527
the	O	6528
mouse	O	6528
wasp	O	6528
gene	O	6528
,	O	6528
the	O	6528
homolog	O	6528
of	O	6528
the	O	6528
gene	O	6528
mutated	O	6528
in	O	6528
wiskott	B-Disease	6528
-	I-Disease	6528
aldrich	I-Disease	6528
syndrome	I-Disease	6528
,	O	6528
has	O	6528
been	O	6528
isolated	O	6528
and	O	6528
sequenced	O	6528
.	O	6528
the	O	6528
predicted	O	6528
amino	O	6528
acid	O	6528
sequence	O	6528
is	O	6528
86	O	6528
%	O	6528
identical	O	6528
to	O	6528
the	O	6528
human	O	6528
wasp	O	6528
sequence	O	6528
.	O	6528
this	O	6534
localization	O	6534
makes	O	6534
wasp	O	6534
a	O	6534
candidate	O	6534
for	O	6534
involvement	O	6534
in	O	6534
scurfy	O	6534
,	O	6534
a	O	6534
t	O	6534
cell	O	6534
-	O	6534
mediated	O	6534
fatal	B-Disease	6534
lymphoreticular	I-Disease	6534
disease	I-Disease	6534
of	O	6534
mice	O	6534
that	O	6534
has	O	6534
previously	O	6534
been	O	6534
proposed	O	6534
as	O	6534
a	O	6534
mouse	O	6534
homolog	O	6534
of	O	6534
wiskott	B-Disease	6534
-	I-Disease	6534
aldrich	I-Disease	6534
syndrome	I-Disease	6534
.	O	6534
colchicine	O	6536
in	O	6536
breast	O	6536
milk	O	6536
of	O	6536
patients	O	6536
with	O	6536
familial	B-Disease	6536
mediterranean	I-Disease	6536
fever	I-Disease	6536
.	O	6536
to	O	6538
clarify	O	6538
whether	O	6538
colchicine	O	6538
is	O	6538
excreted	O	6538
in	O	6538
breast	O	6538
milk	O	6538
,	O	6538
and	O	6538
to	O	6538
compare	O	6538
its	O	6538
concentrations	O	6538
in	O	6538
the	O	6538
serum	O	6538
and	O	6538
breast	O	6538
milk	O	6538
of	O	6538
lactating	O	6538
women	O	6538
who	O	6538
have	O	6538
familial	B-Disease	6538
mediterranean	I-Disease	6538
fever	I-Disease	6538
(	O	6538
fmf	B-Disease	6538
)	O	6538
.	O	6538
the	O	6541
study	O	6541
evaluated	O	6541
4	O	6541
patients	O	6541
with	O	6541
fmf	B-Disease	6541
who	O	6541
had	O	6541
been	O	6541
taking	O	6541
colchicine	O	6541
on	O	6541
a	O	6541
long	O	6541
-	O	6541
term	O	6541
basis	O	6541
.	O	6541
furthermore	O	6550
,	O	6550
based	O	6550
on	O	6550
our	O	6550
clinical	O	6550
experience	O	6550
,	O	6550
nursing	O	6550
appears	O	6550
to	O	6550
be	O	6550
safe	O	6550
for	O	6550
lactating	O	6550
women	O	6550
with	O	6550
fmf	B-Disease	6550
who	O	6550
continue	O	6550
to	O	6550
take	O	6550
colchicine	O	6550
.	O	6550
abnormal	O	6551
myotonic	B-Disease	6551
dystrophy	I-Disease	6551
protein	O	6551
kinase	O	6551
levels	O	6551
produce	O	6551
only	O	6551
mild	O	6551
myopathy	B-Disease	6551
in	O	6551
mice	O	6551
.	O	6551
myotonic	B-Disease	6552
dystrophy	I-Disease	6552
(	O	6552
dm	B-Disease	6552
)	O	6552
is	O	6552
commonly	O	6552
associated	O	6552
with	O	6552
ctg	O	6552
repeat	O	6552
expansions	O	6552
within	O	6552
the	O	6552
gene	O	6552
for	O	6552
dm	O	6552
-	O	6552
protein	O	6552
kinase	O	6552
(	O	6552
dmpk	O	6552
)	O	6552
.	O	6552
nullizygous	O	6554
(	O	6554
-	O	6554
/	O	6554
-	O	6554
)	O	6554
mice	O	6554
showed	O	6554
only	O	6554
inconsistent	O	6554
and	O	6554
minor	O	6554
size	O	6554
changes	O	6554
in	O	6554
head	O	6554
and	O	6554
neck	O	6554
muscle	O	6554
fibres	O	6554
at	O	6554
older	O	6554
age	O	6554
,	O	6554
animals	O	6554
with	O	6554
the	O	6554
highest	O	6554
dmpk	O	6554
transgene	O	6554
expression	O	6554
showed	O	6554
hypertrophic	B-Disease	6554
cardiomyopathy	I-Disease	6554
and	O	6554
enhanced	O	6554
neonatal	O	6554
mortality	O	6554
.	O	6554
however	O	6555
,	O	6555
both	O	6555
models	O	6555
lack	O	6555
other	O	6555
frequent	O	6555
dm	B-Disease	6555
symptoms	O	6555
including	O	6555
the	O	6555
fibre	O	6555
-	O	6555
type	O	6555
dependent	O	6555
atrophy	B-Disease	6555
,	O	6555
myotonia	B-Disease	6555
,	O	6555
cataract	B-Disease	6555
and	O	6555
male	B-Disease	6555
-	I-Disease	6555
infertility	I-Disease	6555
.	O	6555
mice	O	6557
lacking	O	6557
the	O	6557
myotonic	B-Disease	6557
dystrophy	I-Disease	6557
protein	O	6557
kinase	O	6557
develop	O	6557
a	O	6557
late	O	6557
onset	O	6557
progressive	O	6557
myopathy	B-Disease	6557
.	O	6557
myotonic	B-Disease	6558
dystrophy	I-Disease	6558
(	O	6558
dm	B-Disease	6558
)	O	6558
is	O	6558
an	O	6558
autosomal	B-Disease	6558
dominant	I-Disease	6558
disorder	I-Disease	6558
resulting	O	6558
from	O	6558
the	O	6558
expansion	O	6558
of	O	6558
a	O	6558
ctg	O	6558
repeat	O	6558
in	O	6558
the	O	6558
3	O	6558
untranslated	O	6558
region	O	6558
of	O	6558
a	O	6558
putative	O	6558
protein	O	6558
kinase	O	6558
(	O	6558
dmpk	O	6558
)	O	6558
.	O	6558
to	O	6559
elucidate	O	6559
the	O	6559
role	O	6559
of	O	6559
dmpk	O	6559
in	O	6559
dm	B-Disease	6559
pathogenesis	O	6559
we	O	6559
have	O	6559
developed	O	6559
dmpk	B-Disease	6559
deficient	I-Disease	6559
(	O	6559
dmpk	O	6559
-	O	6559
/	O	6559
-	O	6559
)	O	6559
mice	O	6559
.	O	6559
dmpk	O	6560
-	O	6560
/	O	6560
-	O	6560
mice	O	6560
develop	O	6560
a	O	6560
late	O	6560
-	O	6560
onset	O	6560
,	O	6560
progressive	B-Disease	6560
skeletal	I-Disease	6560
myopathy	I-Disease	6560
that	O	6560
shares	O	6560
some	O	6560
pathological	O	6560
features	O	6560
with	O	6560
dm	B-Disease	6560
.	O	6560
muscles	O	6561
from	O	6561
mature	O	6561
mice	O	6561
show	O	6561
variation	O	6561
in	O	6561
fibre	O	6561
size	O	6561
,	O	6561
increased	O	6561
fibre	B-Disease	6561
degeneration	I-Disease	6561
and	O	6561
fibrosis	B-Disease	6561
.	O	6561
our	O	6563
results	O	6563
indicate	O	6563
that	O	6563
dmpk	O	6563
may	O	6563
be	O	6563
necessary	O	6563
for	O	6563
the	O	6563
maintenance	O	6563
of	O	6563
skeletal	O	6563
muscle	O	6563
structure	O	6563
and	O	6563
function	O	6563
and	O	6563
suggest	O	6563
that	O	6563
a	O	6563
decrease	O	6563
in	O	6563
dmpk	O	6563
levels	O	6563
may	O	6563
contribute	O	6563
to	O	6563
dm	B-Disease	6563
pathology	O	6563
.	O	6563
.	O	6563
the	O	6564
tumor	B-Disease	6564
suppressor	O	6564
gene	O	6564
brca1	O	6564
is	O	6564
required	O	6564
for	O	6564
embryonic	O	6564
cellular	O	6564
proliferation	O	6564
in	O	6564
the	O	6564
mouse	O	6564
.	O	6564
mutations	O	6565
of	O	6565
the	O	6565
brca1	O	6565
gone	O	6565
in	O	6565
humans	O	6565
are	O	6565
associated	O	6565
with	O	6565
predisposition	O	6565
to	O	6565
breast	B-Disease	6565
and	I-Disease	6565
ovarian	I-Disease	6565
cancers	I-Disease	6565
.	O	6565
we	O	6566
show	O	6566
here	O	6566
that	O	6566
brca1	O	6566
+	O	6566
/	O	6566
-	O	6566
mice	O	6566
are	O	6566
normal	O	6566
and	O	6566
fertile	O	6566
and	O	6566
lack	O	6566
tumors	B-Disease	6566
by	O	6566
age	O	6566
eleven	O	6566
months	O	6566
.	O	6566
increased	O	6575
coronary	B-Disease	6575
heart	I-Disease	6575
disease	I-Disease	6575
in	O	6575
japanese	O	6575
-	O	6575
american	O	6575
men	O	6575
with	O	6575
mutation	O	6575
in	O	6575
the	O	6575
cholesteryl	O	6575
ester	O	6575
transfer	O	6575
protein	O	6575
gene	O	6575
despite	O	6575
increased	O	6575
hdl	O	6575
levels	O	6575
.	O	6575
plasma	O	6576
high	O	6576
density	O	6576
lipoprotein	O	6576
(	O	6576
hdl	O	6576
)	O	6576
levels	O	6576
are	O	6576
strongly	O	6576
genetically	O	6576
determined	O	6576
and	O	6576
show	O	6576
a	O	6576
general	O	6576
inverse	O	6576
relationship	O	6576
with	O	6576
coronary	B-Disease	6576
heart	I-Disease	6576
disease	I-Disease	6576
(	O	6576
chd	B-Disease	6576
)	O	6576
.	O	6576
however	O	6579
,	O	6579
the	O	6579
overall	O	6579
prevalence	O	6579
of	O	6579
definite	O	6579
chd	B-Disease	6579
was	O	6579
21	O	6579
%	O	6579
in	O	6579
men	O	6579
with	O	6579
mutations	O	6579
and	O	6579
16	O	6579
%	O	6579
in	O	6579
men	O	6579
without	O	6579
mutations	O	6579
.	O	6579
the	O	6580
relative	O	6580
risk	O	6580
(	O	6580
rr	O	6580
)	O	6580
of	O	6580
chd	B-Disease	6580
was	O	6580
1	O	6580
.	O	6580
43	O	6581
in	O	6581
men	O	6581
with	O	6581
mutations	O	6581
(	O	6581
p	O	6581
<	O	6581
.	O	6581
05	O	6581
)	O	6581
;	O	6581
after	O	6581
adjustment	O	6581
for	O	6581
chd	B-Disease	6581
risk	O	6581
factors	O	6581
,	O	6581
the	O	6581
rr	O	6581
was	O	6581
1	O	6581
.	O	6581
increased	O	6585
chd	B-Disease	6585
in	O	6585
men	O	6585
with	O	6585
mutations	O	6585
was	O	6585
primarily	O	6585
observed	O	6585
for	O	6585
hdl	O	6585
chol	O	6585
41	O	6585
-	O	6585
60	O	6585
mg	O	6585
/	O	6585
dl	O	6585
;	O	6585
for	O	6585
hdl	O	6585
chol	O	6585
>	O	6585
60	O	6585
mg	O	6585
/	O	6585
dl	O	6585
men	O	6585
with	O	6585
and	O	6585
without	O	6585
mutations	O	6585
had	O	6585
low	O	6585
chd	B-Disease	6585
prevalence	O	6585
.	O	6585
thus	O	6586
,	O	6586
genetic	O	6586
cetp	B-Disease	6586
deficiency	I-Disease	6586
appears	O	6586
to	O	6586
be	O	6586
an	O	6586
independent	O	6586
risk	O	6586
factor	O	6586
for	O	6586
chd	B-Disease	6586
,	O	6586
primarily	O	6586
due	O	6586
to	O	6586
increased	O	6586
chd	B-Disease	6586
prevalence	O	6586
in	O	6586
men	O	6586
with	O	6586
the	O	6586
d442g	O	6586
mutation	O	6586
and	O	6586
hdl	O	6586
cholesterol	O	6586
between	O	6586
41	O	6586
and	O	6586
60	O	6586
mg	O	6586
/	O	6586
dl	O	6586
.	O	6586
the	O	6589
rb1	O	6589
gene	O	6589
has	O	6589
been	O	6589
implicated	O	6589
with	O	6589
retinoblastoma	B-Disease	6589
and	O	6589
is	O	6589
located	O	6589
on	O	6589
human	O	6589
chromosome	O	6589
(	O	6589
chr	O	6589
)	O	6589
13q14	O	6589
.	O	6589
wiskott	B-Disease	6593
-	I-Disease	6593
aldrich	I-Disease	6593
syndrome	I-Disease	6593
:	O	6593
no	O	6593
strict	O	6593
genotype	O	6593
-	O	6593
phenotype	O	6593
correlations	O	6593
but	O	6593
clustering	O	6593
of	O	6593
missense	O	6593
mutations	O	6593
in	O	6593
the	O	6593
amino	O	6593
-	O	6593
terminal	O	6593
part	O	6593
of	O	6593
the	O	6593
wasp	O	6593
gene	O	6593
product	O	6593
.	O	6593
the	O	6594
wiskott	B-Disease	6594
-	I-Disease	6594
aldrich	I-Disease	6594
syndrome	I-Disease	6594
protein	O	6594
(	O	6594
wasp	O	6594
)	O	6594
gene	O	6594
was	O	6594
found	O	6594
to	O	6594
be	O	6594
mutated	O	6594
in	O	6594
patients	O	6594
presenting	O	6594
with	O	6594
was	B-Disease	6594
and	O	6594
in	O	6594
patients	O	6594
showing	O	6594
x	B-Disease	6594
-	I-Disease	6594
linked	I-Disease	6594
thrombocytopenia	I-Disease	6594
.	O	6594
no	O	6598
genotype	O	6598
-	O	6598
phenotype	O	6598
correlation	O	6598
emerged	O	6598
after	O	6598
a	O	6598
comparison	O	6598
of	O	6598
the	O	6598
identified	O	6598
mutations	O	6598
with	O	6598
the	O	6598
resulting	O	6598
clinical	O	6598
picture	O	6598
for	O	6598
a	O	6598
classical	O	6598
was	B-Disease	6598
phenotype	O	6598
.	O	6598
influence	O	6601
of	O	6601
pax6	O	6601
gene	O	6601
dosage	O	6601
on	O	6601
development	O	6601
:	O	6601
overexpression	O	6601
causes	O	6601
severe	O	6601
eye	B-Disease	6601
abnormalities	I-Disease	6601
.	O	6601
aniridia	B-Disease	6602
in	O	6602
man	O	6602
and	O	6602
small	O	6602
eye	O	6602
in	O	6602
mice	O	6602
are	O	6602
semidominant	B-Disease	6602
developmental	I-Disease	6602
disorders	I-Disease	6602
caused	O	6602
by	O	6602
mutations	O	6602
within	O	6602
the	O	6602
paired	O	6602
box	O	6602
gene	O	6602
pax6	O	6602
.	O	6602
whereas	O	6603
heterozygotes	O	6603
suffer	O	6603
from	O	6603
iris	B-Disease	6603
hypoplasia	I-Disease	6603
,	O	6603
homozygous	O	6603
mice	O	6603
lack	O	6603
eyes	O	6603
and	O	6603
nasal	O	6603
cavities	O	6603
and	O	6603
exhibit	O	6603
brain	B-Disease	6603
abnormalities	I-Disease	6603
.	O	6603
strikingly	O	6606
,	O	6606
mice	O	6606
carrying	O	6606
multiple	O	6606
copies	O	6606
on	O	6606
a	O	6606
wild	O	6606
-	O	6606
type	O	6606
background	O	6606
show	O	6606
specific	O	6606
developmental	B-Disease	6606
abnormalities	I-Disease	6606
of	I-Disease	6606
the	I-Disease	6606
eye	I-Disease	6606
,	O	6606
but	O	6606
not	O	6606
of	O	6606
other	O	6606
tissues	O	6606
expressing	O	6606
the	O	6606
gene	O	6606
.	O	6606
we	O	6608
provide	O	6608
evidence	O	6608
that	O	6608
not	O	6608
only	O	6608
reduced	O	6608
,	O	6608
but	O	6608
also	O	6608
increased	O	6608
levels	O	6608
of	O	6608
transcriptional	O	6608
regulators	O	6608
can	O	6608
cause	O	6608
developmental	B-Disease	6608
defects	I-Disease	6608
.	O	6608
.	O	6608
this	O	6611
question	O	6611
is	O	6611
of	O	6611
particular	O	6611
interest	O	6611
for	O	6611
the	O	6611
human	O	6611
enzyme	O	6611
galactose	O	6611
-	O	6611
l	O	6611
-	O	6611
phosphate	O	6611
uridylyl	O	6611
-	O	6611
transferase	O	6611
(	O	6611
galt	O	6611
)	O	6611
,	O	6611
impairment	O	6611
of	O	6611
which	O	6611
results	O	6611
in	O	6611
the	O	6611
inherited	B-Disease	6611
metabolic	I-Disease	6611
disorder	I-Disease	6611
galactosemia	B-Disease	6611
,	O	6611
because	O	6611
many	O	6611
if	O	6611
not	O	6611
most	O	6611
patients	O	6611
studied	O	6611
to	O	6611
date	O	6611
are	O	6611
compound	O	6611
heterozygotes	O	6611
rather	O	6611
than	O	6611
true	O	6611
molecular	O	6611
homozygotes	O	6611
.	O	6611
these	O	6616
results	O	6616
are	O	6616
significant	O	6616
not	O	6616
only	O	6616
in	O	6616
terms	O	6616
of	O	6616
their	O	6616
implications	O	6616
for	O	6616
furthering	O	6616
our	O	6616
understanding	O	6616
of	O	6616
galactosemia	B-Disease	6616
and	O	6616
galt	O	6616
holoenzyme	O	6616
structure	O	6616
-	O	6616
function	O	6616
relationships	O	6616
but	O	6616
also	O	6616
because	O	6616
the	O	6616
system	O	6616
described	O	6616
may	O	6616
serve	O	6616
as	O	6616
a	O	6616
model	O	6616
for	O	6616
similar	O	6616
studies	O	6616
of	O	6616
other	O	6616
complexes	O	6616
composed	O	6616
of	O	6616
multiple	O	6616
subunits	O	6616
.	O	6616
.	O	6616
apoptosis	O	6618
has	O	6618
recently	O	6618
been	O	6618
recognized	O	6618
as	O	6618
a	O	6618
mode	O	6618
of	O	6618
cell	O	6618
death	O	6618
in	O	6618
huntington	B-Disease	6618
disease	I-Disease	6618
(	O	6618
hd	B-Disease	6618
)	O	6618
.	O	6618
here	O	6620
we	O	6620
show	O	6620
that	O	6620
apoptotic	O	6620
extracts	O	6620
and	O	6620
apopain	O	6620
itself	O	6620
specifically	O	6620
cleave	O	6620
the	O	6620
hd	B-Disease	6620
gene	O	6620
product	O	6620
,	O	6620
huntingtin	O	6620
.	O	6620
our	O	6622
results	O	6622
show	O	6622
that	O	6622
huntingtin	O	6622
is	O	6622
cleaved	O	6622
by	O	6622
cysteine	O	6622
proteases	O	6622
and	O	6622
suggest	O	6622
that	O	6622
hd	B-Disease	6622
might	O	6622
be	O	6622
a	O	6622
disorder	B-Disease	6622
of	I-Disease	6622
inappropriate	I-Disease	6622
apoptosis	I-Disease	6622
.	O	6622
.	O	6622
to	O	6624
begin	O	6624
to	O	6624
address	O	6624
the	O	6624
hypothesis	O	6624
that	O	6624
abnormal	O	6624
regulation	O	6624
of	O	6624
the	O	6624
breast	B-Disease	6624
/	I-Disease	6624
ovarian	I-Disease	6624
cancer	I-Disease	6624
susceptibility	O	6624
gene	O	6624
brca1	O	6624
is	O	6624
a	O	6624
critical	O	6624
step	O	6624
in	O	6624
sporadic	O	6624
breast	O	6624
/	O	6624
ovarian	O	6624
tumorigenesis	O	6624
,	O	6624
we	O	6624
have	O	6624
determined	O	6624
the	O	6624
detailed	O	6624
structure	O	6624
of	O	6624
the	O	6624
brca1	O	6624
genomic	O	6624
region	O	6624
.	O	6624
deletion	O	6629
of	O	6629
small	O	6629
nuclear	O	6629
ribonucleoprotein	O	6629
polypeptide	O	6629
n	O	6629
(	O	6629
snrpn	O	6629
)	O	6629
in	O	6629
prader	B-Disease	6629
-	I-Disease	6629
willi	I-Disease	6629
syndrome	I-Disease	6629
detected	O	6629
by	O	6629
fluorescence	O	6629
in	O	6629
situ	O	6629
hybridization	O	6629
:	O	6629
two	O	6629
sibs	O	6629
with	O	6629
the	O	6629
typical	O	6629
phenotype	O	6629
without	O	6629
a	O	6629
cytogenetic	O	6629
deletion	O	6629
in	O	6629
chromosome	O	6629
15q	O	6629
.	O	6629
the	O	6630
small	O	6630
nuclear	O	6630
ribonucleoprotein	O	6630
polypeptide	O	6630
n	O	6630
(	O	6630
snrpn	O	6630
)	O	6630
gene	O	6630
is	O	6630
regarded	O	6630
as	O	6630
one	O	6630
of	O	6630
the	O	6630
candidates	O	6630
for	O	6630
prader	B-Disease	6630
-	I-Disease	6630
willi	I-Disease	6630
syndrome	I-Disease	6630
(	O	6630
pws	B-Disease	6630
)	O	6630
.	O	6630
we	O	6631
describe	O	6631
two	O	6631
sibs	O	6631
with	O	6631
typical	O	6631
pws	B-Disease	6631
presenting	O	6631
deletion	O	6631
of	O	6631
snrpn	O	6631
detected	O	6631
by	O	6631
fluorescence	O	6631
in	O	6631
situ	O	6631
hybridization	O	6631
(	O	6631
fish	O	6631
)	O	6631
.	O	6631
this	O	6633
implies	O	6633
a	O	6633
smaller	O	6633
deletion	O	6633
limited	O	6633
to	O	6633
the	O	6633
pws	B-Disease	6633
critical	O	6633
region	O	6633
.	O	6633
fish	O	6634
with	O	6634
a	O	6634
snrpn	O	6634
probe	O	6634
will	O	6634
permit	O	6634
analysis	O	6634
of	O	6634
pws	B-Disease	6634
patients	O	6634
with	O	6634
limited	O	6634
deletions	O	6634
not	O	6634
detectable	O	6634
with	O	6634
other	O	6634
probes	O	6634
.	O	6634
.	O	6634
expression	O	6635
of	O	6635
the	O	6635
von	B-Disease	6635
hippel	I-Disease	6635
-	I-Disease	6635
lindau	I-Disease	6635
disease	I-Disease	6635
tumour	I-Disease	6635
suppressor	O	6635
gene	O	6635
during	O	6635
human	O	6635
embryogenesis	O	6635
.	O	6635
the	O	6636
von	B-Disease	6636
hippel	I-Disease	6636
-	I-Disease	6636
lindau	I-Disease	6636
(	I-Disease	6636
vhl	I-Disease	6636
)	I-Disease	6636
disease	I-Disease	6636
product	O	6636
is	O	6636
thought	O	6636
to	O	6636
down	O	6636
-	O	6636
regulate	O	6636
transcription	O	6636
by	O	6636
antagonizing	O	6636
elongin	O	6636
-	O	6636
enhanced	O	6636
transcriptional	O	6636
elongation	O	6636
.	O	6636
germline	O	6637
vhl	B-Disease	6637
gene	O	6637
mutations	O	6637
predispose	O	6637
to	O	6637
the	O	6637
development	O	6637
of	O	6637
retinal	B-Disease	6637
,	I-Disease	6637
cerebellar	I-Disease	6637
and	I-Disease	6637
spinal	I-Disease	6637
haemangioblastomas	I-Disease	6637
,	O	6637
renal	B-Disease	6637
cell	I-Disease	6637
carcinoma	I-Disease	6637
and	O	6637
phaeochromocytoma	B-Disease	6637
.	O	6637
in	O	6638
addition	O	6638
,	O	6638
somatic	O	6638
inactivation	O	6638
of	O	6638
the	O	6638
vhl	B-Disease	6638
gene	O	6638
is	O	6638
frequent	O	6638
in	O	6638
sporadic	B-Disease	6638
renal	I-Disease	6638
cell	I-Disease	6638
carcinoma	I-Disease	6638
and	O	6638
haemangioblastoma	B-Disease	6638
.	O	6638
regulation	O	6639
of	O	6639
transcript	O	6639
elongation	O	6639
is	O	6639
an	O	6639
important	O	6639
control	O	6639
mechanism	O	6639
for	O	6639
gene	O	6639
expression	O	6639
and	O	6639
the	O	6639
vhl	B-Disease	6639
gene	O	6639
might	O	6639
modify	O	6639
the	O	6639
expression	O	6639
of	O	6639
proto	O	6639
-	O	6639
oncogenes	O	6639
and	O	6639
growth	O	6639
suppressor	O	6639
genes	O	6639
during	O	6639
embryogenesis	O	6639
.	O	6639
we	O	6640
therefore	O	6640
investigated	O	6640
the	O	6640
expression	O	6640
of	O	6640
vhl	B-Disease	6640
mrna	O	6640
during	O	6640
human	O	6640
embryogenesis	O	6640
by	O	6640
in	O	6640
situ	O	6640
hybridization	O	6640
studies	O	6640
at	O	6640
4	O	6640
,	O	6640
6	O	6640
and	O	6640
10	O	6640
weeks	O	6640
post	O	6640
conception	O	6640
.	O	6640
although	O	6641
vhl	B-Disease	6641
mrna	O	6641
was	O	6641
expressed	O	6641
in	O	6641
all	O	6641
three	O	6641
germ	O	6641
layers	O	6641
,	O	6641
strong	O	6641
expression	O	6641
was	O	6641
noted	O	6641
in	O	6641
the	O	6641
central	O	6641
nervous	O	6641
system	O	6641
,	O	6641
kidneys	O	6641
,	O	6641
testis	O	6641
and	O	6641
lung	O	6641
.	O	6641
within	O	6642
the	O	6642
kidney	O	6642
,	O	6642
vhl	B-Disease	6642
mrna	O	6642
was	O	6642
differentially	O	6642
expressed	O	6642
within	O	6642
renal	O	6642
tubules	O	6642
suggesting	O	6642
that	O	6642
the	O	6642
vhl	B-Disease	6642
gene	O	6642
product	O	6642
may	O	6642
have	O	6642
a	O	6642
specific	O	6642
role	O	6642
in	O	6642
kidney	O	6642
development	O	6642
.	O	6642
two	O	6643
alternatively	O	6643
spliced	O	6643
vhl	B-Disease	6643
mrnas	O	6643
characterized	O	6643
by	O	6643
inclusion	O	6643
(	O	6643
isoform	O	6643
i	O	6643
)	O	6643
or	O	6643
exclusion	O	6643
(	O	6643
isoform	O	6643
ii	O	6643
)	O	6643
of	O	6643
exon	O	6643
2	O	6643
are	O	6643
transcribed	O	6643
in	O	6643
adult	O	6643
tissues	O	6643
.	O	6643
to	O	6644
investigate	O	6644
if	O	6644
the	O	6644
two	O	6644
isoforms	O	6644
are	O	6644
differentially	O	6644
expressed	O	6644
during	O	6644
embryogenesis	O	6644
,	O	6644
vhl	B-Disease	6644
mrna	O	6644
was	O	6644
reverse	O	6644
transcribed	O	6644
from	O	6644
13	O	6644
fetal	O	6644
tissues	O	6644
(	O	6644
8	O	6644
-	O	6644
10	O	6644
weeks	O	6644
gestation	O	6644
)	O	6644
.	O	6644
the	O	6645
quantitative	O	6645
distribution	O	6645
of	O	6645
vhl	B-Disease	6645
mrna	O	6645
within	O	6645
fetal	O	6645
tissues	O	6645
reflected	O	6645
that	O	6645
seen	O	6645
by	O	6645
in	O	6645
situ	O	6645
hybridization	O	6645
and	O	6645
the	O	6645
ratio	O	6645
of	O	6645
the	O	6645
two	O	6645
vhl	B-Disease	6645
isoforms	O	6645
was	O	6645
similar	O	6645
between	O	6645
tissues	O	6645
.	O	6645
although	O	6646
the	O	6646
genes	O	6646
regulated	O	6646
by	O	6646
the	O	6646
vhl	B-Disease	6646
gene	O	6646
product	O	6646
have	O	6646
not	O	6646
yet	O	6646
been	O	6646
identified	O	6646
,	O	6646
our	O	6646
findings	O	6646
are	O	6646
compatible	O	6646
with	O	6646
the	O	6646
hypothesis	O	6646
that	O	6646
vhl	B-Disease	6646
-	O	6646
mediated	O	6646
control	O	6646
of	O	6646
transcriptional	O	6646
elongation	O	6646
may	O	6646
have	O	6646
a	O	6646
role	O	6646
in	O	6646
normal	O	6646
human	O	6646
development	O	6646
.	O	6646
.	O	6646
genetic	O	6647
heterogeneity	O	6647
in	O	6647
hereditary	B-Disease	6647
breast	I-Disease	6647
cancer	I-Disease	6647
:	O	6647
role	O	6647
of	O	6647
brca1	O	6647
and	O	6647
brca2	O	6647
.	O	6647
the	O	6648
common	O	6648
hereditary	O	6648
forms	O	6648
of	O	6648
breast	B-Disease	6648
cancer	I-Disease	6648
have	O	6648
been	O	6648
largely	O	6648
attributed	O	6648
to	O	6648
the	O	6648
inheritance	O	6648
of	O	6648
mutations	O	6648
in	O	6648
the	O	6648
brca1	O	6648
or	O	6648
brca2	O	6648
genes	O	6648
.	O	6648
however	O	6649
,	O	6649
it	O	6649
is	O	6649
not	O	6649
yet	O	6649
clear	O	6649
what	O	6649
proportion	O	6649
of	O	6649
hereditary	B-Disease	6649
breast	I-Disease	6649
cancer	I-Disease	6649
is	O	6649
explained	O	6649
by	O	6649
brca1	O	6649
and	O	6649
brca2	O	6649
or	O	6649
by	O	6649
some	O	6649
other	O	6649
unidentified	O	6649
susceptibility	O	6649
gene	O	6649
(	O	6649
s	O	6649
)	O	6649
.	O	6649
we	O	6650
describe	O	6650
the	O	6650
proportion	O	6650
of	O	6650
hereditary	B-Disease	6650
breast	I-Disease	6650
cancer	I-Disease	6650
explained	O	6650
by	O	6650
brca1	O	6650
or	O	6650
brca2	O	6650
in	O	6650
a	O	6650
sample	O	6650
of	O	6650
north	O	6650
american	O	6650
hereditary	B-Disease	6650
breast	I-Disease	6650
cancers	I-Disease	6650
and	O	6650
assess	O	6650
the	O	6650
evidence	O	6650
for	O	6650
additional	O	6650
susceptibility	O	6650
genes	O	6650
that	O	6650
may	O	6650
confer	O	6650
hereditary	B-Disease	6650
breast	I-Disease	6650
or	I-Disease	6650
ovarian	I-Disease	6650
cancer	I-Disease	6650
risk	O	6650
.	O	6650
twenty	O	6651
-	O	6651
three	O	6651
families	O	6651
were	O	6651
identified	O	6651
through	O	6651
two	O	6651
high	O	6651
-	O	6651
risk	O	6651
breast	B-Disease	6651
cancer	I-Disease	6651
research	O	6651
programs	O	6651
.	O	6651
genetic	O	6652
analysis	O	6652
was	O	6652
undertaken	O	6652
to	O	6652
establish	O	6652
linkage	O	6652
between	O	6652
the	O	6652
breast	B-Disease	6652
or	I-Disease	6652
ovarian	I-Disease	6652
cancer	I-Disease	6652
cases	O	6652
and	O	6652
markers	O	6652
on	O	6652
chromosomes	O	6652
17q	O	6652
(	O	6652
brca1	O	6652
)	O	6652
and	O	6652
13q	O	6652
(	O	6652
brca2	O	6652
)	O	6652
.	O	6652
the	O	6654
pattern	O	6654
of	O	6654
hereditary	B-Disease	6654
cancer	I-Disease	6654
in	O	6654
14	O	6654
(	O	6654
61	O	6654
%	O	6654
)	O	6654
of	O	6654
the	O	6654
23	O	6654
families	O	6654
studied	O	6654
was	O	6654
attributed	O	6654
to	O	6654
brca1	O	6654
by	O	6654
a	O	6654
combination	O	6654
of	O	6654
linkage	O	6654
and	O	6654
mutation	O	6654
analyses	O	6654
.	O	6654
brca1	O	6659
and	O	6659
brca2	O	6659
probably	O	6659
explain	O	6659
the	O	6659
majority	O	6659
of	O	6659
hereditary	B-Disease	6659
breast	I-Disease	6659
cancer	I-Disease	6659
that	O	6659
exists	O	6659
in	O	6659
the	O	6659
north	O	6659
american	O	6659
population	O	6659
.	O	6659
however	O	6660
,	O	6660
one	O	6660
or	O	6660
more	O	6660
additional	O	6660
genes	O	6660
may	O	6660
yet	O	6660
be	O	6660
found	O	6660
that	O	6660
explain	O	6660
some	O	6660
proportion	O	6660
of	O	6660
hereditary	B-Disease	6660
breast	I-Disease	6660
cancer	I-Disease	6660
.	O	6660
.	O	6660
an	O	6661
intronic	O	6661
mutation	O	6661
in	O	6661
a	O	6661
lariat	O	6661
branchpoint	O	6661
sequence	O	6661
is	O	6661
a	O	6661
direct	O	6661
cause	O	6661
of	O	6661
an	O	6661
inherited	B-Disease	6661
human	I-Disease	6661
disorder	I-Disease	6661
(	O	6661
fish	B-Disease	6661
-	I-Disease	6661
eye	I-Disease	6661
disease	I-Disease	6661
)	O	6661
.	O	6661
three	O	6665
sisters	O	6665
were	O	6665
shown	O	6665
to	O	6665
suffer	O	6665
from	O	6665
fish	B-Disease	6665
-	I-Disease	6665
eye	I-Disease	6665
disease	I-Disease	6665
(	O	6665
fed	B-Disease	6665
)	O	6665
,	O	6665
a	O	6665
disorder	O	6665
which	O	6665
is	O	6665
caused	O	6665
by	O	6665
mutations	O	6665
in	O	6665
the	O	6665
gene	O	6665
coding	O	6665
for	O	6665
lecithin	O	6665
cholesterol	O	6665
acyltransferase	O	6665
(	O	6665
lcat	O	6665
)	O	6665
.	O	6665
sequencing	O	6666
of	O	6666
the	O	6666
lcat	O	6666
gene	O	6666
of	O	6666
all	O	6666
three	O	6666
probands	O	6666
revealed	O	6666
compound	O	6666
heterozygosity	O	6666
for	O	6666
a	O	6666
missense	O	6666
mutation	O	6666
in	O	6666
exon	O	6666
4	O	6666
which	O	6666
is	O	6666
reported	O	6666
to	O	6666
underlie	O	6666
the	O	6666
fed	B-Disease	6666
phenotype	O	6666
,	O	6666
and	O	6666
a	O	6666
point	O	6666
mutation	O	6666
located	O	6666
in	O	6666
intron	O	6666
4	O	6666
(	O	6666
ivs4	O	6666
t	O	6666
-	O	6666
22c	O	6666
)	O	6666
.	O	6666
in	O	6668
conclusion	O	6668
,	O	6668
we	O	6668
demonstrated	O	6668
that	O	6668
a	O	6668
point	O	6668
mutation	O	6668
in	O	6668
a	O	6668
lariat	O	6668
branchpoint	O	6668
consensus	O	6668
sequence	O	6668
causes	O	6668
a	O	6668
null	O	6668
allele	O	6668
in	O	6668
a	O	6668
patient	O	6668
with	O	6668
fed	B-Disease	6668
.	O	6668
mutations	O	6671
associated	O	6671
with	O	6671
variant	O	6671
phenotypes	O	6671
in	O	6671
ataxia	B-Disease	6671
-	I-Disease	6671
telangiectasia	I-Disease	6671
.	O	6671
we	O	6672
have	O	6672
identified	O	6672
14	O	6672
families	O	6672
with	O	6672
ataxia	B-Disease	6672
-	I-Disease	6672
telangiectasia	I-Disease	6672
(	O	6672
a	B-Disease	6672
-	I-Disease	6672
t	I-Disease	6672
)	O	6672
in	O	6672
which	O	6672
mutation	O	6672
of	O	6672
the	O	6672
atm	O	6672
gene	O	6672
is	O	6672
associated	O	6672
with	O	6672
a	O	6672
less	O	6672
severe	O	6672
clinical	O	6672
and	O	6672
cellular	O	6672
phenotype	O	6672
(	O	6672
approximately	O	6672
10	O	6672
%	O	6672
-	O	6672
15	O	6672
%	O	6672
of	O	6672
a	B-Disease	6672
-	I-Disease	6672
t	I-Disease	6672
families	O	6672
identified	O	6672
in	O	6672
the	O	6672
united	O	6672
kingdom	O	6672
)	O	6672
.	O	6672
the	O	6674
second	O	6674
a	B-Disease	6674
-	I-Disease	6674
t	I-Disease	6674
allele	O	6674
has	O	6674
a	O	6674
different	O	6674
mutation	O	6674
in	O	6674
each	O	6674
patient	O	6674
.	O	6674
the	O	6676
level	O	6676
of	O	6676
the	O	6676
137	O	6676
-	O	6676
bp	O	6676
pcr	O	6676
product	O	6676
containing	O	6676
the	O	6676
insertion	O	6676
was	O	6676
lowest	O	6676
in	O	6676
two	O	6676
patients	O	6676
who	O	6676
showed	O	6676
a	O	6676
later	O	6676
onset	O	6676
of	O	6676
cerebellar	B-Disease	6676
ataxia	I-Disease	6676
.	O	6676
mutations	O	6678
detected	O	6678
in	O	6678
two	O	6678
of	O	6678
four	O	6678
of	O	6678
these	O	6678
are	O	6678
missense	O	6678
mutations	O	6678
,	O	6678
normally	O	6678
rare	O	6678
in	O	6678
a	B-Disease	6678
-	I-Disease	6678
t	I-Disease	6678
patients	O	6678
.	O	6678
the	O	6679
demonstration	O	6679
of	O	6679
mutations	O	6679
giving	O	6679
rise	O	6679
to	O	6679
a	O	6679
slightly	O	6679
milder	O	6679
phenotype	O	6679
in	O	6679
a	B-Disease	6679
-	I-Disease	6679
t	I-Disease	6679
raises	O	6679
the	O	6679
interesting	O	6679
question	O	6679
of	O	6679
what	O	6679
range	O	6679
of	O	6679
phenotypes	O	6679
might	O	6679
occur	O	6679
in	O	6679
individuals	O	6679
in	O	6679
whom	O	6679
both	O	6679
mutations	O	6679
are	O	6679
milder	O	6679
.	O	6679
mutation	O	6681
of	O	6681
the	O	6681
vhl	O	6681
gene	O	6681
is	O	6681
associated	O	6681
exclusively	O	6681
with	O	6681
the	O	6681
development	O	6681
of	O	6681
non	B-Disease	6681
-	I-Disease	6681
papillary	I-Disease	6681
renal	I-Disease	6681
cell	I-Disease	6681
carcinomas	I-Disease	6681
.	O	6681
to	O	6682
define	O	6682
the	O	6682
possible	O	6682
role	O	6682
of	O	6682
the	O	6682
vhl	B-Disease	6682
gene	O	6682
in	O	6682
the	O	6682
development	O	6682
of	O	6682
sporadic	B-Disease	6682
renal	I-Disease	6682
cell	I-Disease	6682
carcinomas	I-Disease	6682
,	O	6682
91	O	6682
different	O	6682
parenchymal	B-Disease	6682
tumours	I-Disease	6682
of	I-Disease	6682
the	I-Disease	6682
kidney	I-Disease	6682
have	O	6682
been	O	6682
investigated	O	6682
for	O	6682
mutation	O	6682
of	O	6682
the	O	6682
vhl	B-Disease	6682
gene	O	6682
by	O	6682
single	O	6682
strand	O	6682
conformation	O	6682
polymorphism	O	6682
(	O	6682
sscp	O	6682
)	O	6682
and	O	6682
/	O	6682
or	O	6682
heteroduplex	O	6682
(	O	6682
hd	O	6682
)	O	6682
techniques	O	6682
.	O	6682
chromosome	O	6683
3p	O	6683
deletion	O	6683
was	O	6683
detected	O	6683
in	O	6683
98	O	6683
per	O	6683
cent	O	6683
of	O	6683
non	B-Disease	6683
-	I-Disease	6683
papillary	I-Disease	6683
renal	I-Disease	6683
cell	I-Disease	6683
carcinomas	I-Disease	6683
and	O	6683
in	O	6683
25	O	6683
per	O	6683
cent	O	6683
of	O	6683
chromophobe	O	6683
renal	B-Disease	6683
cell	I-Disease	6683
carcinomas	I-Disease	6683
.	O	6683
in	O	6684
22	O	6684
of	O	6684
the	O	6684
43	O	6684
non	B-Disease	6684
-	I-Disease	6684
papillary	I-Disease	6684
renal	I-Disease	6684
cell	I-Disease	6684
carcinomas	I-Disease	6684
,	O	6684
abnormally	O	6684
migrating	O	6684
dna	O	6684
bands	O	6684
were	O	6684
detected	O	6684
by	O	6684
sscp	O	6684
and	O	6684
/	O	6684
or	O	6684
hd	O	6684
analysis	O	6684
.	O	6684
no	O	6685
mobility	O	6685
shift	O	6685
was	O	6685
seen	O	6685
in	O	6685
any	O	6685
of	O	6685
the	O	6685
23	O	6685
chromophobe	O	6685
renal	B-Disease	6685
cell	I-Disease	6685
carcinomas	I-Disease	6685
.	O	6685
in	O	6686
addition	O	6686
,	O	6686
15	O	6686
papillary	B-Disease	6686
renal	I-Disease	6686
cell	I-Disease	6686
tumours	I-Disease	6686
and	O	6686
ten	O	6686
renal	B-Disease	6686
oncocytomas	I-Disease	6686
,	O	6686
which	O	6686
are	O	6686
characterized	O	6686
by	O	6686
genetic	O	6686
changes	O	6686
other	O	6686
than	O	6686
loss	O	6686
of	O	6686
chromosome	O	6686
3p	O	6686
sequences	O	6686
,	O	6686
were	O	6686
analysed	O	6686
for	O	6686
mutation	O	6686
of	O	6686
the	O	6686
vhl	B-Disease	6686
gene	O	6686
.	O	6686
none	O	6687
of	O	6687
these	O	6687
tumours	B-Disease	6687
showed	O	6687
abnormal	O	6687
migration	O	6687
patterns	O	6687
.	O	6687
the	O	6688
results	O	6688
indicate	O	6688
that	O	6688
mutation	O	6688
of	O	6688
the	O	6688
vhl	B-Disease	6688
gene	O	6688
is	O	6688
associated	O	6688
exclusively	O	6688
with	O	6688
the	O	6688
development	O	6688
of	O	6688
non	B-Disease	6688
-	I-Disease	6688
papillary	I-Disease	6688
renal	I-Disease	6688
cell	I-Disease	6688
carcinoma	I-Disease	6688
.	O	6688
.	O	6688
the	O	6689
emery	B-Disease	6689
-	I-Disease	6689
dreifuss	I-Disease	6689
muscular	I-Disease	6689
dystrophy	I-Disease	6689
protein	O	6689
,	O	6689
emerin	O	6689
,	O	6689
is	O	6689
a	O	6689
nuclear	O	6689
membrane	O	6689
protein	O	6689
.	O	6689
a	O	6694
muscle	O	6694
biopsy	O	6694
from	O	6694
an	O	6694
emery	B-Disease	6694
-	I-Disease	6694
dreifuss	I-Disease	6694
muscular	I-Disease	6694
dystrophy	I-Disease	6694
(	O	6694
emdm	B-Disease	6694
)	O	6694
patient	O	6694
showed	O	6694
complete	O	6694
absence	O	6694
of	O	6694
emerin	O	6694
by	O	6694
both	O	6694
western	O	6694
blotting	O	6694
and	O	6694
immunohistochemistry	O	6694
,	O	6694
suggesting	O	6694
a	O	6694
simple	O	6694
diagnostic	O	6694
antibody	O	6694
test	O	6694
for	O	6694
edmd	B-Disease	6694
families	O	6694
.	O	6694
mutation	O	6697
of	O	6697
msh3	O	6697
in	O	6697
endometrial	B-Disease	6697
cancer	I-Disease	6697
and	O	6697
evidence	O	6697
for	O	6697
its	O	6697
functional	O	6697
role	O	6697
in	O	6697
heteroduplex	O	6697
repair	O	6697
.	O	6697
many	O	6698
human	O	6698
tumours	B-Disease	6698
have	O	6698
length	O	6698
alterations	O	6698
in	O	6698
repetitive	O	6698
sequence	O	6698
elements	O	6698
.	O	6698
although	O	6699
this	O	6699
microsatellite	B-Disease	6699
instability	I-Disease	6699
has	O	6699
been	O	6699
attributed	O	6699
to	O	6699
mutations	O	6699
in	O	6699
four	O	6699
dna	O	6699
mismatch	O	6699
repair	O	6699
genes	O	6699
in	O	6699
hereditary	B-Disease	6699
nonpolyposis	I-Disease	6699
colorectal	I-Disease	6699
cancer	I-Disease	6699
(	O	6699
hnpcc	B-Disease	6699
)	O	6699
kindreds	O	6699
,	O	6699
many	O	6699
sporadic	B-Disease	6699
tumours	I-Disease	6699
exhibit	O	6699
instability	O	6699
but	O	6699
no	O	6699
detectable	O	6699
mutations	O	6699
in	O	6699
these	O	6699
genes	O	6699
.	O	6699
thus	O	6702
,	O	6702
we	O	6702
screened	O	6702
16	O	6702
endometrial	B-Disease	6702
carcinomas	I-Disease	6702
with	O	6702
microsatellite	O	6702
instability	O	6702
for	O	6702
alterations	O	6702
in	O	6702
fen1	O	6702
(	O	6702
the	O	6702
human	O	6702
homolog	O	6702
of	O	6702
rth	O	6702
)	O	6702
and	O	6702
in	O	6702
msh3	O	6702
(	O	6702
refs	O	6702
12	O	6702
-	O	6702
14	O	6702
)	O	6702
.	O	6702
although	O	6703
we	O	6703
found	O	6703
no	O	6703
fen1	O	6703
mutations	O	6703
,	O	6703
a	O	6703
frameshift	O	6703
mutation	O	6703
in	O	6703
msh3	O	6703
was	O	6703
observed	O	6703
in	O	6703
an	O	6703
endometrial	B-Disease	6703
carcinoma	I-Disease	6703
and	O	6703
in	O	6703
an	O	6703
endometrial	B-Disease	6703
carcinoma	I-Disease	6703
cell	O	6703
line	O	6703
.	O	6703
together	O	6708
the	O	6708
data	O	6708
suggest	O	6708
that	O	6708
the	O	6708
msh3	O	6708
gene	O	6708
encodes	O	6708
a	O	6708
product	O	6708
that	O	6708
functions	O	6708
in	O	6708
repair	O	6708
of	O	6708
some	O	6708
but	O	6708
not	O	6708
all	O	6708
pre	O	6708
-	O	6708
mutational	O	6708
intermediates	O	6708
,	O	6708
its	O	6708
mutation	O	6708
in	O	6708
tumours	B-Disease	6708
can	O	6708
result	O	6708
in	O	6708
genomic	O	6708
instability	O	6708
and	O	6708
,	O	6708
as	O	6708
in	O	6708
yeast	O	6708
,	O	6708
msh3	O	6708
and	O	6708
msh6	O	6708
are	O	6708
partially	O	6708
redundant	O	6708
for	O	6708
mismatch	O	6708
repair	O	6708
.	O	6708
.	O	6708
comparative	O	6709
genome	O	6709
mapping	O	6709
of	O	6709
the	O	6709
ataxia	B-Disease	6709
-	I-Disease	6709
telangiectasia	I-Disease	6709
region	O	6709
in	O	6709
mouse	O	6709
,	O	6709
rat	O	6709
,	O	6709
and	O	6709
syrian	O	6709
hamster	O	6709
.	O	6709
chromosomal	O	6710
locations	O	6710
of	O	6710
the	O	6710
atm	O	6710
(	O	6710
ataxia	B-Disease	6710
-	I-Disease	6710
telangiectasia	I-Disease	6710
(	O	6710
at	B-Disease	6710
)	O	6710
-	O	6710
mutated	O	6710
)	O	6710
and	O	6710
acat1	O	6710
(	O	6710
mitochondrial	O	6710
acetoacetyl	O	6710
-	O	6710
coa	O	6710
thiolase	O	6710
)	O	6710
genes	O	6710
in	O	6710
mouse	O	6710
,	O	6710
rat	O	6710
,	O	6710
and	O	6710
syrian	O	6710
hamster	O	6710
were	O	6710
determined	O	6710
by	O	6710
direct	O	6710
r	O	6710
-	O	6710
banding	O	6710
fish	O	6710
.	O	6710
fine	O	6714
genetic	O	6714
linkage	O	6714
mapping	O	6714
of	O	6714
the	O	6714
mouse	O	6714
at	B-Disease	6714
region	O	6714
was	O	6714
performed	O	6714
using	O	6714
the	O	6714
interspecific	O	6714
backcross	O	6714
mice	O	6714
.	O	6714
an	O	6721
animal	O	6721
model	O	6721
for	O	6721
norrie	B-Disease	6721
disease	I-Disease	6721
(	O	6721
nd	B-Disease	6721
)	O	6721
:	O	6721
gene	O	6721
targeting	O	6721
of	O	6721
the	O	6721
mouse	O	6721
nd	B-Disease	6721
gene	O	6721
.	O	6721
in	O	6722
order	O	6722
to	O	6722
elucidate	O	6722
the	O	6722
cellular	O	6722
and	O	6722
molecular	O	6722
processes	O	6722
which	O	6722
are	O	6722
involved	O	6722
in	O	6722
norrie	B-Disease	6722
disease	I-Disease	6722
(	O	6722
nd	B-Disease	6722
)	O	6722
,	O	6722
we	O	6722
have	O	6722
used	O	6722
gene	O	6722
targeting	O	6722
technology	O	6722
to	O	6722
generate	O	6722
nd	B-Disease	6722
mutant	O	6722
mice	O	6722
.	O	6722
the	O	6723
murine	O	6723
homologue	O	6723
of	O	6723
the	O	6723
nd	B-Disease	6723
gene	O	6723
was	O	6723
cloned	O	6723
and	O	6723
shown	O	6723
to	O	6723
encode	O	6723
a	O	6723
polypeptide	O	6723
that	O	6723
shares	O	6723
94	O	6723
%	O	6723
of	O	6723
the	O	6723
amino	O	6723
acid	O	6723
sequence	O	6723
with	O	6723
its	O	6723
human	O	6723
counterpart	O	6723
.	O	6723
hemizygous	O	6725
mice	O	6725
carrying	O	6725
a	O	6725
replacement	O	6725
mutation	O	6725
in	O	6725
exon	O	6725
2	O	6725
of	O	6725
the	O	6725
nd	B-Disease	6725
gene	O	6725
developed	O	6725
retrolental	O	6725
structures	O	6725
in	O	6725
the	O	6725
vitreous	O	6725
body	O	6725
and	O	6725
showed	O	6725
an	O	6725
overall	O	6725
disorganization	O	6725
of	O	6725
the	O	6725
retinal	O	6725
ganglion	O	6725
cell	O	6725
layer	O	6725
.	O	6725
these	O	6728
ocular	O	6728
findings	O	6728
are	O	6728
consistent	O	6728
with	O	6728
observations	O	6728
in	O	6728
nd	B-Disease	6728
patients	O	6728
and	O	6728
the	O	6728
generated	O	6728
mouse	O	6728
line	O	6728
provides	O	6728
a	O	6728
faithful	O	6728
model	O	6728
for	O	6728
study	O	6728
of	O	6728
early	O	6728
pathogenic	O	6728
events	O	6728
in	O	6728
this	O	6728
severe	O	6728
x	B-Disease	6728
-	I-Disease	6728
linked	I-Disease	6728
recessive	I-Disease	6728
neurological	I-Disease	6728
disorder	I-Disease	6728
.	O	6728
.	O	6728
the	O	6729
hybrid	O	6729
pax3	O	6729
-	O	6729
fkhr	O	6729
fusion	O	6729
protein	O	6729
of	O	6729
alveolar	B-Disease	6729
rhabdomyosarcoma	I-Disease	6729
transforms	O	6729
fibroblasts	O	6729
in	O	6729
culture	O	6729
.	O	6729
pediatric	B-Disease	6730
alveolar	I-Disease	6730
rhabdomyosarcoma	I-Disease	6730
is	O	6730
characterized	O	6730
by	O	6730
a	O	6730
chromosomal	O	6730
translocation	O	6730
that	O	6730
fuses	O	6730
parts	O	6730
of	O	6730
the	O	6730
pax3	O	6730
and	O	6730
fkhr	O	6730
genes	O	6730
.	O	6730
somatic	O	6737
-	O	6737
cell	O	6737
selection	O	6737
is	O	6737
a	O	6737
major	O	6737
determinant	O	6737
of	O	6737
the	O	6737
blood	O	6737
-	O	6737
cell	O	6737
phenotype	O	6737
in	O	6737
heterozygotes	O	6737
for	O	6737
glucose	O	6737
-	O	6737
6	O	6737
-	O	6737
phosphate	O	6737
dehydrogenase	O	6737
mutations	O	6737
causing	O	6737
severe	O	6737
enzyme	B-Disease	6737
deficiency	I-Disease	6737
.	O	6737
in	O	6739
most	O	6739
people	O	6739
with	O	6739
red	O	6739
-	O	6739
blood	O	6739
-	O	6739
cell	O	6739
glucose	B-Disease	6739
-	I-Disease	6739
6	I-Disease	6739
-	I-Disease	6739
phosphate	I-Disease	6739
dehydrogenase	I-Disease	6739
(	I-Disease	6739
g6pd	I-Disease	6739
)	I-Disease	6739
deficiency	I-Disease	6739
,	O	6739
the	O	6739
enzyme	O	6739
-	O	6739
deficient	O	6739
phenotype	O	6739
is	O	6739
only	O	6739
moderately	O	6739
expressed	O	6739
in	O	6739
nucleated	O	6739
cells	O	6739
.	O	6739
however	O	6740
,	O	6740
in	O	6740
a	O	6740
small	O	6740
subset	O	6740
of	O	6740
hemizygous	O	6740
males	O	6740
who	O	6740
suffer	O	6740
from	O	6740
chronic	B-Disease	6740
nonspherocytic	I-Disease	6740
hemolytic	I-Disease	6740
anemia	I-Disease	6740
,	O	6740
the	O	6740
underlying	O	6740
mutations	O	6740
(	O	6740
designated	O	6740
class	O	6740
i	O	6740
)	O	6740
cause	O	6740
more	O	6740
-	O	6740
severe	O	6740
g6pd	B-Disease	6740
deficiency	I-Disease	6740
,	O	6740
and	O	6740
this	O	6740
might	O	6740
provide	O	6740
an	O	6740
opportunity	O	6740
for	O	6740
selection	O	6740
in	O	6740
heterozygous	O	6740
females	O	6740
during	O	6740
development	O	6740
.	O	6740
thus	O	6744
,	O	6744
it	O	6744
appears	O	6744
that	O	6744
severe	O	6744
g6pd	B-Disease	6744
deficiency	I-Disease	6744
affects	O	6744
adversely	O	6744
the	O	6744
proliferation	O	6744
or	O	6744
the	O	6744
survival	O	6744
of	O	6744
nucleated	O	6744
blood	O	6744
cells	O	6744
and	O	6744
that	O	6744
this	O	6744
phenotypic	O	6744
characteristic	O	6744
is	O	6744
critical	O	6744
during	O	6744
hematopoiesis	O	6744
.	O	6744
.	O	6744
analysis	O	6745
of	O	6745
meiotic	O	6745
segregation	O	6745
,	O	6745
using	O	6745
single	O	6745
-	O	6745
sperm	O	6745
typing	O	6745
:	O	6745
meiotic	O	6745
drive	O	6745
at	O	6745
the	O	6745
myotonic	B-Disease	6745
dystrophy	I-Disease	6745
locus	O	6745
.	O	6745
meiotic	O	6746
drive	O	6746
at	O	6746
the	O	6746
myotonic	B-Disease	6746
dystrophy	I-Disease	6746
(	O	6746
dm	B-Disease	6746
)	O	6746
locus	O	6746
has	O	6746
recently	O	6746
been	O	6746
suggested	O	6746
as	O	6746
being	O	6746
responsible	O	6746
for	O	6746
maintaining	O	6746
the	O	6746
frequency	O	6746
,	O	6746
in	O	6746
the	O	6746
human	O	6746
population	O	6746
,	O	6746
of	O	6746
dm	B-Disease	6746
chromosomes	O	6746
capable	O	6746
of	O	6746
expansion	O	6746
to	O	6746
the	O	6746
disease	O	6746
state	O	6746
.	O	6746
in	O	6747
order	O	6747
to	O	6747
test	O	6747
this	O	6747
hypothesis	O	6747
,	O	6747
we	O	6747
have	O	6747
studied	O	6747
samples	O	6747
of	O	6747
single	O	6747
sperm	O	6747
from	O	6747
three	O	6747
individuals	O	6747
heterozygous	O	6747
at	O	6747
the	O	6747
dm	B-Disease	6747
locus	O	6747
,	O	6747
each	O	6747
with	O	6747
one	O	6747
allele	O	6747
larger	O	6747
and	O	6747
one	O	6747
allele	O	6747
smaller	O	6747
than	O	6747
19	O	6747
ctg	O	6747
repeats	O	6747
.	O	6747
to	O	6748
guard	O	6748
against	O	6748
the	O	6748
possible	O	6748
problem	O	6748
of	O	6748
differential	O	6748
pcr	O	6748
amplification	O	6748
rates	O	6748
based	O	6748
on	O	6748
the	O	6748
lengths	O	6748
of	O	6748
the	O	6748
alleles	O	6748
,	O	6748
the	O	6748
sperm	O	6748
were	O	6748
also	O	6748
typed	O	6748
at	O	6748
another	O	6748
closely	O	6748
linked	O	6748
marker	O	6748
whose	O	6748
allele	O	6748
size	O	6748
was	O	6748
unrelated	O	6748
to	O	6748
the	O	6748
allele	O	6748
size	O	6748
at	O	6748
the	O	6748
dm	B-Disease	6748
locus	O	6748
.	O	6748
this	O	6753
suggests	O	6753
that	O	6753
any	O	6753
greater	O	6753
amount	O	6753
of	O	6753
segregation	O	6753
distortion	O	6753
at	O	6753
the	O	6753
myotonic	B-Disease	6753
dystrophy	I-Disease	6753
locus	O	6753
must	O	6753
result	O	6753
from	O	6753
events	O	6753
following	O	6753
sperm	O	6753
ejaculation	O	6753
.	O	6753
lpp	O	6754
,	O	6754
the	O	6754
preferred	O	6754
fusion	O	6754
partner	O	6754
gene	O	6754
of	O	6754
hmgic	O	6754
in	O	6754
lipomas	B-Disease	6754
,	O	6754
is	O	6754
a	O	6754
novel	O	6754
member	O	6754
of	O	6754
the	O	6754
lim	O	6754
protein	O	6754
gene	O	6754
family	O	6754
.	O	6754
a	O	6755
major	O	6755
cytogenetic	O	6755
subgroup	O	6755
of	O	6755
lipomas	B-Disease	6755
is	O	6755
characterized	O	6755
by	O	6755
recurrent	O	6755
chromosome	O	6755
aberrations	O	6755
,	O	6755
mainly	O	6755
translocations	O	6755
,	O	6755
that	O	6755
involve	O	6755
chromosome	O	6755
segment	O	6755
12q13	O	6755
-	O	6755
q15	O	6755
.	O	6755
here	O	6758
,	O	6758
we	O	6758
report	O	6758
the	O	6758
identification	O	6758
and	O	6758
characterization	O	6758
of	O	6758
the	O	6758
chromosome	O	6758
3	O	6758
-	O	6758
derived	O	6758
translocation	O	6758
partner	O	6758
gene	O	6758
,	O	6758
which	O	6758
we	O	6758
have	O	6758
designated	O	6758
lpp	O	6758
(	O	6758
lipoma	B-Disease	6758
preferred	O	6758
partner	O	6758
gene	O	6758
)	O	6758
.	O	6758
using	O	6759
3	O	6759
-	O	6759
race	O	6759
analysis	O	6759
of	O	6759
hmgic	O	6759
fusion	O	6759
transcripts	O	6759
in	O	6759
lipoma	B-Disease	6759
cell	O	6759
line	O	6759
li	O	6759
-	O	6759
501	O	6759
/	O	6759
sv40	O	6759
,	O	6759
ectopic	O	6759
genetic	O	6759
sequences	O	6759
were	O	6759
obtained	O	6759
,	O	6759
which	O	6759
by	O	6759
cash	O	6759
(	O	6759
chromosome	O	6759
assignment	O	6759
using	O	6759
somatic	O	6759
cell	O	6759
hybrids	O	6759
)	O	6759
and	O	6759
fish	O	6759
(	O	6759
fluorescence	O	6759
in	O	6759
situ	O	6759
hybridization	O	6759
)	O	6759
analysis	O	6759
were	O	6759
found	O	6759
to	O	6759
originate	O	6759
from	O	6759
chromosome	O	6759
segment	O	6759
3q27	O	6759
-	O	6759
q28	O	6759
.	O	6759
using	O	6765
reverse	O	6765
transcriptase	O	6765
combined	O	6765
with	O	6765
polymerase	O	6765
chain	O	6765
reactions	O	6765
in	O	6765
the	O	6765
analysis	O	6765
of	O	6765
a	O	6765
number	O	6765
of	O	6765
lipoma	B-Disease	6765
cell	O	6765
lines	O	6765
and	O	6765
primary	B-Disease	6765
lipomas	I-Disease	6765
,	O	6765
it	O	6765
appeared	O	6765
that	O	6765
lpp	O	6765
is	O	6765
frequently	O	6765
rearranged	O	6765
also	O	6765
in	O	6765
cases	O	6765
without	O	6765
a	O	6765
cytogenetically	O	6765
detectable	O	6765
involvement	O	6765
of	O	6765
3q27	O	6765
-	O	6765
q28	O	6765
.	O	6765
absence	O	6767
of	O	6767
disease	O	6767
phenotype	O	6767
and	O	6767
intergenerational	O	6767
stability	O	6767
of	O	6767
the	O	6767
cag	O	6767
repeat	O	6767
in	O	6767
transgenic	O	6767
mice	O	6767
expressing	O	6767
the	O	6767
human	O	6767
huntington	B-Disease	6767
disease	I-Disease	6767
transcript	O	6767
.	O	6767
the	O	6768
mutation	O	6768
underlying	O	6768
huntington	B-Disease	6768
disease	I-Disease	6768
(	O	6768
hd	B-Disease	6768
)	O	6768
is	O	6768
cag	O	6768
expansion	O	6768
in	O	6768
the	O	6768
first	O	6768
exon	O	6768
of	O	6768
the	O	6768
hd	B-Disease	6768
gene	O	6768
.	O	6768
in	O	6769
order	O	6769
to	O	6769
investigate	O	6769
the	O	6769
role	O	6769
of	O	6769
cag	O	6769
expansion	O	6769
in	O	6769
the	O	6769
pathogenesis	O	6769
of	O	6769
hd	B-Disease	6769
,	O	6769
we	O	6769
have	O	6769
produced	O	6769
transgenic	O	6769
mice	O	6769
containing	O	6769
the	O	6769
full	O	6769
length	O	6769
human	O	6769
hd	B-Disease	6769
cdna	O	6769
with	O	6769
44	O	6769
cag	O	6769
repeats	O	6769
.	O	6769
by	O	6770
1	O	6770
year	O	6770
,	O	6770
these	O	6770
mice	O	6770
have	O	6770
no	O	6770
behavioral	B-Disease	6770
abnormalities	I-Disease	6770
and	O	6770
morphometric	O	6770
analysis	O	6770
at	O	6770
6	O	6770
(	O	6770
one	O	6770
animal	O	6770
)	O	6770
and	O	6770
9	O	6770
(	O	6770
two	O	6770
animals	O	6770
)	O	6770
months	O	6770
age	O	6770
revealed	O	6770
no	O	6770
changes	O	6770
.	O	6770
despite	O	6771
high	O	6771
levels	O	6771
of	O	6771
mrna	O	6771
expression	O	6771
,	O	6771
there	O	6771
was	O	6771
no	O	6771
evidence	O	6771
of	O	6771
the	O	6771
hd	B-Disease	6771
gene	O	6771
product	O	6771
in	O	6771
any	O	6771
of	O	6771
these	O	6771
transgenic	O	6771
mice	O	6771
.	O	6771
in	O	6772
vitro	O	6772
transfection	O	6772
studies	O	6772
indicated	O	6772
that	O	6772
the	O	6772
inclusion	O	6772
of	O	6772
120	O	6772
bp	O	6772
of	O	6772
the	O	6772
5	O	6772
utr	O	6772
in	O	6772
the	O	6772
cdna	O	6772
construct	O	6772
and	O	6772
the	O	6772
presence	O	6772
of	O	6772
a	O	6772
frameshift	O	6772
mutation	O	6772
at	O	6772
nucleotide	O	6772
2349	O	6772
prevented	O	6772
expression	O	6772
of	O	6772
the	O	6772
hd	B-Disease	6772
cdna	O	6772
.	O	6772
these	O	6773
findings	O	6773
suggest	O	6773
that	O	6773
the	O	6773
pathogenesis	O	6773
of	O	6773
hd	B-Disease	6773
is	O	6773
not	O	6773
mediated	O	6773
through	O	6773
dna	O	6773
-	O	6773
protein	O	6773
interaction	O	6773
and	O	6773
that	O	6773
presence	O	6773
of	O	6773
the	O	6773
rna	O	6773
transcript	O	6773
with	O	6773
an	O	6773
expanded	O	6773
cag	O	6773
repeat	O	6773
is	O	6773
insufficient	O	6773
to	O	6773
cause	O	6773
the	O	6773
disease	O	6773
.	O	6773
rather	O	6774
,	O	6774
translation	O	6774
of	O	6774
the	O	6774
cag	O	6774
is	O	6774
crucial	O	6774
for	O	6774
the	O	6774
pathogenesis	O	6774
of	O	6774
hd	B-Disease	6774
.	O	6774
fish	O	6777
studies	O	6777
in	O	6777
a	O	6777
patient	O	6777
with	O	6777
sporadic	B-Disease	6777
aniridia	I-Disease	6777
and	O	6777
t	O	6777
(	O	6777
7	O	6777
;	O	6777
11	O	6777
)	O	6777
(	O	6777
q31	O	6777
.	O	6777
2	O	6777
;	O	6777
p13	O	6777
)	O	6777
.	O	6777
a	O	6778
2	O	6778
year	O	6778
old	O	6778
female	O	6778
presenting	O	6778
with	O	6778
bilateral	B-Disease	6778
sporadic	I-Disease	6778
aniridia	I-Disease	6778
was	O	6778
found	O	6778
to	O	6778
have	O	6778
an	O	6778
apparently	O	6778
balanced	O	6778
reciprocal	O	6778
translocation	O	6778
with	O	6778
a	O	6778
chromosome	O	6778
11	O	6778
breakpoint	O	6778
within	O	6778
band	O	6778
p13	O	6778
.	O	6778
fluorescence	O	6779
in	O	6779
situ	O	6779
hybridisation	O	6779
(	O	6779
fish	O	6779
)	O	6779
studies	O	6779
with	O	6779
distal	O	6779
11p13	O	6779
specific	O	6779
cosmids	O	6779
showed	O	6779
that	O	6779
the	O	6779
chromosome	O	6779
11	O	6779
breakpoint	O	6779
lay	O	6779
between	O	6779
the	O	6779
aniridia	B-Disease	6779
(	O	6779
pax6	O	6779
)	O	6779
locus	O	6779
and	O	6779
a	O	6779
region	O	6779
approximately	O	6779
100	O	6779
kb	O	6779
distal	O	6779
to	O	6779
pax6	O	6779
defined	O	6779
by	O	6779
the	O	6779
cosmid	O	6779
fo2121	O	6779
.	O	6779
although	O	6780
this	O	6780
patient	O	6780
did	O	6780
not	O	6780
have	O	6780
a	O	6780
detectable	O	6780
deletion	O	6780
within	O	6780
pax6	O	6780
,	O	6780
her	O	6780
aniridia	B-Disease	6780
may	O	6780
have	O	6780
resulted	O	6780
from	O	6780
a	O	6780
disruption	O	6780
of	O	6780
the	O	6780
distal	O	6780
chromatin	O	6780
domain	O	6780
containing	O	6780
either	O	6780
enhancers	O	6780
or	O	6780
regulators	O	6780
for	O	6780
pax6	O	6780
.	O	6780
this	O	6781
case	O	6781
may	O	6781
therefore	O	6781
be	O	6781
another	O	6781
example	O	6781
of	O	6781
aniridia	B-Disease	6781
caused	O	6781
by	O	6781
a	O	6781
position	O	6781
effect	O	6781
as	O	6781
recently	O	6781
described	O	6781
in	O	6781
two	O	6781
familial	B-Disease	6781
aniridia	I-Disease	6781
patients	O	6781
in	O	6781
which	O	6781
the	O	6781
phenotype	O	6781
cosegregated	O	6781
with	O	6781
chromosome	B-Disease	6781
abnormalities	I-Disease	6781
with	O	6781
11p13	O	6781
breakpoints	O	6781
.	O	6781
.	O	6781
muscle	O	6782
expression	O	6782
of	O	6782
glucose	B-Disease	6782
-	I-Disease	6782
6	I-Disease	6782
-	I-Disease	6782
phosphate	I-Disease	6782
dehydrogenase	I-Disease	6782
deficiency	I-Disease	6782
in	O	6782
different	O	6782
variants	O	6782
.	O	6782
muscle	O	6783
expression	O	6783
of	O	6783
g6pd	B-Disease	6783
deficiency	I-Disease	6783
has	O	6783
been	O	6783
investigated	O	6783
in	O	6783
mediterranean	O	6783
,	O	6783
seattle	O	6783
-	O	6783
like	O	6783
and	O	6783
a	O	6783
-	O	6783
variants	O	6783
.	O	6783
gene	O	6792
therapy	O	6792
for	O	6792
phenylketonuria	B-Disease	6792
.	O	6792
classical	O	6793
phenylketonuria	B-Disease	6793
(	O	6793
pku	B-Disease	6793
)	O	6793
is	O	6793
an	O	6793
autosomal	B-Disease	6793
recessive	I-Disease	6793
disorder	I-Disease	6793
caused	O	6793
by	O	6793
a	O	6793
deficiency	B-Disease	6793
of	I-Disease	6793
hepatic	I-Disease	6793
phenylalanine	I-Disease	6793
hydroxylase	I-Disease	6793
(	O	6793
pah	O	6793
)	O	6793
.	O	6793
limitations	O	6794
of	O	6794
the	O	6794
current	O	6794
dietary	O	6794
treatment	O	6794
for	O	6794
pku	B-Disease	6794
have	O	6794
led	O	6794
to	O	6794
the	O	6794
development	O	6794
of	O	6794
potential	O	6794
treatments	O	6794
based	O	6794
on	O	6794
somatic	O	6794
gene	O	6794
transfer	O	6794
.	O	6794
vectors	O	6796
derived	O	6796
from	O	6796
a	O	6796
recombinant	O	6796
retrovirus	O	6796
or	O	6796
a	O	6796
dna	O	6796
/	O	6796
protein	O	6796
complex	O	6796
can	O	6796
efficiently	O	6796
transduce	O	6796
the	O	6796
pah	O	6796
cdna	O	6796
into	O	6796
pah	B-Disease	6796
-	I-Disease	6796
deficient	I-Disease	6796
hepatocytes	O	6796
in	O	6796
vitro	O	6796
,	O	6796
but	O	6796
the	O	6796
application	O	6796
of	O	6796
these	O	6796
vector	O	6796
systems	O	6796
is	O	6796
presently	O	6796
limited	O	6796
by	O	6796
their	O	6796
low	O	6796
transduction	O	6796
efficiency	O	6796
in	O	6796
vivo	O	6796
.	O	6796
in	O	6797
contrast	O	6797
,	O	6797
a	O	6797
vector	O	6797
derived	O	6797
from	O	6797
a	O	6797
recombinant	O	6797
adenovirus	O	6797
can	O	6797
restore	O	6797
10	O	6797
%	O	6797
-	O	6797
80	O	6797
%	O	6797
of	O	6797
normal	O	6797
hepatic	O	6797
pah	O	6797
activity	O	6797
into	O	6797
pah	B-Disease	6797
-	I-Disease	6797
deficient	I-Disease	6797
mice	O	6797
,	O	6797
which	O	6797
completely	O	6797
normalizes	O	6797
serum	O	6797
phenylalanine	O	6797
levels	O	6797
.	O	6797
however	O	6799
,	O	6799
these	O	6799
findings	O	6799
suggest	O	6799
that	O	6799
pku	B-Disease	6799
can	O	6799
be	O	6799
completely	O	6799
corrected	O	6799
by	O	6799
somatic	O	6799
gene	O	6799
therapy	O	6799
,	O	6799
and	O	6799
provide	O	6799
some	O	6799
direction	O	6799
for	O	6799
the	O	6799
future	O	6799
development	O	6799
of	O	6799
adenoviral	O	6799
vectors	O	6799
.	O	6799
.	O	6799
the	O	6801
human	O	6801
neuronal	O	6801
nicotinic	O	6801
acetylcholine	O	6801
receptor	O	6801
alpha	O	6801
4	O	6801
subunit	O	6801
gene	O	6801
(	O	6801
chrna4	O	6801
)	O	6801
is	O	6801
located	O	6801
in	O	6801
the	O	6801
candidate	O	6801
region	O	6801
for	O	6801
three	O	6801
different	O	6801
phenotypes	O	6801
benign	B-Disease	6801
familial	I-Disease	6801
neonatal	I-Disease	6801
convulsions	I-Disease	6801
,	O	6801
autosomal	B-Disease	6801
dominant	I-Disease	6801
nocturnal	I-Disease	6801
frontal	I-Disease	6801
lobe	I-Disease	6801
epilepsy	I-Disease	6801
,	O	6801
and	O	6801
low	O	6801
-	O	6801
voltage	O	6801
eeg	O	6801
.	O	6801
recently	O	6802
,	O	6802
a	O	6802
missense	O	6802
mutation	O	6802
in	O	6802
transmembrane	O	6802
domain	O	6802
2	O	6802
of	O	6802
chrna4	O	6802
was	O	6802
found	O	6802
to	O	6802
be	O	6802
associated	O	6802
with	O	6802
autosomal	B-Disease	6802
dominant	I-Disease	6802
nocturnal	I-Disease	6802
frontal	I-Disease	6802
lobe	I-Disease	6802
epilepsy	I-Disease	6802
in	O	6802
one	O	6802
extended	O	6802
pedigree	O	6802
.	O	6802
the	O	6805
sequence	O	6805
analysis	O	6805
provides	O	6805
the	O	6805
basis	O	6805
for	O	6805
a	O	6805
comprehensive	O	6805
mutation	O	6805
screening	O	6805
of	O	6805
chrna4	O	6805
in	O	6805
the	O	6805
above	O	6805
-	O	6805
mentioned	O	6805
phenotypes	O	6805
and	O	6805
possibly	O	6805
in	O	6805
other	O	6805
types	O	6805
of	O	6805
idiopathic	B-Disease	6805
epilepsies	I-Disease	6805
.	O	6805
.	O	6805
brca1	O	6807
and	O	6807
brca2	O	6807
are	O	6807
the	O	6807
two	O	6807
major	O	6807
identified	O	6807
causes	O	6807
of	O	6807
inherited	B-Disease	6807
breast	I-Disease	6807
cancer	I-Disease	6807
,	O	6807
with	O	6807
mutations	O	6807
in	O	6807
either	O	6807
gene	O	6807
conferring	O	6807
up	O	6807
to	O	6807
80	O	6807
-	O	6807
90	O	6807
%	O	6807
lifetime	O	6807
risk	O	6807
of	O	6807
breast	B-Disease	6807
cancer	I-Disease	6807
in	O	6807
carrier	O	6807
females	O	6807
.	O	6807
mutations	O	6808
in	O	6808
brca1	O	6808
account	O	6808
for	O	6808
approximately	O	6808
45	O	6808
%	O	6808
of	O	6808
familial	B-Disease	6808
breast	I-Disease	6808
cancer	I-Disease	6808
and	O	6808
90	O	6808
%	O	6808
of	O	6808
inherited	B-Disease	6808
breast	I-Disease	6808
/	I-Disease	6808
ovarian	I-Disease	6808
cancer	I-Disease	6808
,	O	6808
whereas	O	6808
mutations	O	6808
in	O	6808
brca2	O	6808
account	O	6808
for	O	6808
a	O	6808
comparable	O	6808
percentage	O	6808
of	O	6808
inherited	B-Disease	6808
breast	I-Disease	6808
cancer	I-Disease	6808
cases	O	6808
.	O	6808
the	O	6812
6174delt	O	6812
mutation	O	6812
in	O	6812
brca2	O	6812
was	O	6812
recently	O	6812
identified	O	6812
as	O	6812
a	O	6812
frequent	O	6812
mutation	O	6812
in	O	6812
8	O	6812
out	O	6812
of	O	6812
107	O	6812
ashkenazi	O	6812
jewish	O	6812
women	O	6812
diagnosed	O	6812
with	O	6812
breast	B-Disease	6812
cancer	I-Disease	6812
by	O	6812
age	O	6812
50	O	6812
(	O	6812
ref	O	6812
.	O	6812
8	O	6812
)	O	6812
,	O	6812
as	O	6812
well	O	6812
as	O	6812
in	O	6812
three	O	6812
ashkenazi	O	6812
male	B-Disease	6812
breast	I-Disease	6812
cancer	I-Disease	6812
patients	O	6812
.	O	6812
we	O	6813
have	O	6813
conducted	O	6813
a	O	6813
large	O	6813
-	O	6813
scale	O	6813
population	O	6813
study	O	6813
to	O	6813
investigate	O	6813
the	O	6813
prevalence	O	6813
of	O	6813
specific	O	6813
brca1	O	6813
and	O	6813
brca2	O	6813
mutations	O	6813
in	O	6813
ashkenazi	O	6813
jewish	O	6813
individuals	O	6813
who	O	6813
were	O	6813
unselected	O	6813
for	O	6813
breast	B-Disease	6813
cancer	I-Disease	6813
.	O	6813
this	O	6819
expanded	O	6819
population	O	6819
-	O	6819
based	O	6819
study	O	6819
confirms	O	6819
that	O	6819
the	O	6819
brca1	O	6819
185delag	O	6819
mutation	O	6819
and	O	6819
the	O	6819
brca2	O	6819
6174delt	O	6819
mutation	O	6819
constitute	O	6819
the	O	6819
two	O	6819
most	O	6819
frequent	O	6819
mutation	O	6819
alleles	O	6819
predisposing	O	6819
to	O	6819
hereditary	B-Disease	6819
breast	I-Disease	6819
cancer	I-Disease	6819
among	O	6819
the	O	6819
ashkenazim	O	6819
,	O	6819
and	O	6819
suggests	O	6819
a	O	6819
relatively	O	6819
lower	O	6819
penetrance	O	6819
for	O	6819
the	O	6819
6174delt	O	6819
mutation	O	6819
in	O	6819
brca2	O	6819
the	O	6821
gene	O	6821
mutated	O	6821
in	O	6821
ataxia	B-Disease	6821
-	I-Disease	6821
telangiectasia	I-Disease	6821
(	O	6821
at	B-Disease	6821
)	O	6821
patients	O	6821
,	O	6821
denoted	O	6821
atm	O	6821
,	O	6821
encodes	O	6821
a	O	6821
putative	O	6821
protein	O	6821
or	O	6821
lipid	O	6821
kinase	O	6821
.	O	6821
consistent	O	6823
with	O	6823
cellular	O	6823
defects	O	6823
of	O	6823
at	B-Disease	6823
patients	O	6823
,	O	6823
the	O	6823
atm	O	6823
-	O	6823
/	O	6823
-	O	6823
cells	O	6823
are	O	6823
hypersensitive	O	6823
to	O	6823
gamma	O	6823
-	O	6823
irradiation	O	6823
and	O	6823
defective	O	6823
in	O	6823
cell	O	6823
-	O	6823
cycle	O	6823
arrest	O	6823
following	O	6823
radiation	O	6823
,	O	6823
correlating	O	6823
with	O	6823
a	O	6823
defective	O	6823
up	O	6823
-	O	6823
regulation	O	6823
of	O	6823
p53	O	6823
.	O	6823
atm	O	6828
+	O	6828
/	O	6828
-	O	6828
fibroblasts	O	6828
and	O	6828
thymocytes	O	6828
showed	O	6828
intermediately	O	6828
defective	O	6828
responses	O	6828
to	O	6828
irradiation	O	6828
but	O	6828
no	O	6828
growth	O	6828
defect	O	6828
,	O	6828
suggesting	O	6828
that	O	6828
the	O	6828
increased	O	6828
cancer	B-Disease	6828
risk	O	6828
of	O	6828
at	B-Disease	6828
heterozygotes	O	6828
could	O	6828
be	O	6828
attributable	O	6828
to	O	6828
poor	O	6828
checkpoint	O	6828
function	O	6828
.	O	6828
.	O	6828
targeted	O	6829
disruption	O	6829
of	O	6829
atm	O	6829
leads	O	6829
to	O	6829
growth	B-Disease	6829
retardation	I-Disease	6829
,	O	6829
chromosomal	B-Disease	6829
fragmentation	I-Disease	6829
during	I-Disease	6829
meiosis	I-Disease	6829
,	O	6829
immune	B-Disease	6829
defects	I-Disease	6829
,	O	6829
and	O	6829
thymic	B-Disease	6829
lymphoma	I-Disease	6829
.	O	6829
atm	O	6830
,	O	6830
the	O	6830
gene	O	6830
mutated	O	6830
in	O	6830
the	O	6830
inherited	B-Disease	6830
human	I-Disease	6830
disease	I-Disease	6830
ataxia	B-Disease	6830
-	I-Disease	6830
telangiectasia	I-Disease	6830
,	O	6830
is	O	6830
a	O	6830
member	O	6830
of	O	6830
a	O	6830
family	O	6830
of	O	6830
kinases	O	6830
involved	O	6830
in	O	6830
dna	O	6830
metabolism	O	6830
and	O	6830
cell	O	6830
-	O	6830
cycle	O	6830
checkpoint	O	6830
control	O	6830
.	O	6830
initial	O	6832
evaluation	O	6832
of	O	6832
the	O	6832
atm	O	6832
knockout	O	6832
animals	O	6832
indicates	O	6832
that	O	6832
inactivation	O	6832
of	O	6832
the	O	6832
mouse	O	6832
atm	O	6832
gene	O	6832
recreates	O	6832
much	O	6832
of	O	6832
the	O	6832
phenotype	O	6832
of	O	6832
ataxia	B-Disease	6832
-	I-Disease	6832
telangiectasia	I-Disease	6832
.	O	6832
the	O	6834
infertility	B-Disease	6834
of	O	6834
atm	O	6834
-	O	6834
/	O	6834
-	O	6834
mice	O	6834
results	O	6834
from	O	6834
meiotic	O	6834
failure	O	6834
.	O	6834
immune	B-Disease	6836
defects	I-Disease	6836
also	O	6836
are	O	6836
evident	O	6836
in	O	6836
atm	O	6836
-	O	6836
/	O	6836
-	O	6836
mice	O	6836
,	O	6836
including	O	6836
reduced	O	6836
numbers	O	6836
of	O	6836
b220	O	6836
+	O	6836
cd43	O	6836
-	O	6836
pre	O	6836
-	O	6836
b	O	6836
cells	O	6836
,	O	6836
thymocytes	O	6836
,	O	6836
and	O	6836
peripheral	O	6836
t	O	6836
cells	O	6836
,	O	6836
as	O	6836
well	O	6836
as	O	6836
functional	O	6836
impairment	O	6836
of	O	6836
t	O	6836
-	O	6836
cell	O	6836
-	O	6836
dependent	O	6836
immune	O	6836
responses	O	6836
.	O	6836
the	O	6837
cerebella	O	6837
of	O	6837
atm	O	6837
-	O	6837
/	O	6837
-	O	6837
mice	O	6837
appear	O	6837
normal	O	6837
by	O	6837
histologic	O	6837
examination	O	6837
at	O	6837
3	O	6837
to	O	6837
4	O	6837
months	O	6837
and	O	6837
the	O	6837
mice	O	6837
have	O	6837
no	O	6837
gross	O	6837
behavioral	B-Disease	6837
abnormalities	I-Disease	6837
.	O	6837
the	O	6838
majority	O	6838
of	O	6838
mutant	O	6838
mice	O	6838
rapidly	O	6838
develop	O	6838
thymic	B-Disease	6838
lymphomas	I-Disease	6838
and	O	6838
die	O	6838
before	O	6838
4	O	6838
months	O	6838
of	O	6838
age	O	6838
.	O	6838
these	O	6839
findings	O	6839
indicate	O	6839
that	O	6839
the	O	6839
atm	O	6839
gene	O	6839
product	O	6839
plays	O	6839
an	O	6839
essential	O	6839
role	O	6839
in	O	6839
a	O	6839
diverse	O	6839
group	O	6839
of	O	6839
cellular	O	6839
processes	O	6839
,	O	6839
including	O	6839
meiosis	O	6839
,	O	6839
the	O	6839
normal	O	6839
growth	O	6839
of	O	6839
somatic	O	6839
tissues	O	6839
,	O	6839
immune	O	6839
development	O	6839
,	O	6839
and	O	6839
tumor	B-Disease	6839
suppression	O	6839
.	O	6839
.	O	6839
this	O	6849
agrees	O	6849
well	O	6849
with	O	6849
the	O	6849
fact	O	6849
that	O	6849
cardiac	O	6849
and	O	6849
muscle	O	6849
symptoms	O	6849
are	O	6849
characteristic	O	6849
for	O	6849
patients	O	6849
with	O	6849
vlcad	B-Disease	6849
deficiency	I-Disease	6849
.	O	6849
northern	O	6850
blot	O	6850
analysis	O	6850
and	O	6850
sequencing	O	6850
of	O	6850
cloned	O	6850
pcr	O	6850
amplified	O	6850
vlcad	O	6850
cdna	O	6850
from	O	6850
four	O	6850
unrelated	O	6850
patients	O	6850
with	O	6850
vlcad	B-Disease	6850
deficiency	I-Disease	6850
showed	O	6850
that	O	6850
vlcad	O	6850
mrna	O	6850
was	O	6850
undetectable	O	6850
in	O	6850
one	O	6850
patient	O	6850
and	O	6850
that	O	6850
the	O	6850
other	O	6850
three	O	6850
have	O	6850
mutations	O	6850
in	O	6850
both	O	6850
vlcad	O	6850
alleles	O	6850
.	O	6850
molecular	O	6852
bases	O	6852
of	O	6852
combined	B-Disease	6852
subtotal	I-Disease	6852
deficiencies	I-Disease	6852
of	I-Disease	6852
c6	I-Disease	6852
and	I-Disease	6852
c7	I-Disease	6852
:	O	6852
their	O	6852
effects	O	6852
in	O	6852
combination	O	6852
with	O	6852
other	O	6852
c6	B-Disease	6852
and	I-Disease	6852
c7	I-Disease	6852
deficiencies	I-Disease	6852
.	O	6852
combined	B-Disease	6853
subtotal	I-Disease	6853
deficiency	I-Disease	6853
of	I-Disease	6853
c6	I-Disease	6853
and	I-Disease	6853
c7	I-Disease	6853
,	O	6853
in	O	6853
which	O	6853
both	O	6853
proteins	O	6853
are	O	6853
expressed	O	6853
at	O	6853
very	O	6853
low	O	6853
levels	O	6853
,	O	6853
has	O	6853
been	O	6853
observed	O	6853
in	O	6853
homozygous	O	6853
form	O	6853
in	O	6853
two	O	6853
families	O	6853
.	O	6853
the	O	6858
haplotype	O	6858
has	O	6858
been	O	6858
found	O	6858
in	O	6858
combination	O	6858
with	O	6858
a	O	6858
number	O	6858
of	O	6858
other	O	6858
haplotypes	O	6858
containing	O	6858
defective	O	6858
genes	O	6858
that	O	6858
lead	O	6858
either	O	6858
to	O	6858
c6	B-Disease	6858
or	I-Disease	6858
c7	I-Disease	6858
deficiency	I-Disease	6858
,	O	6858
but	O	6858
with	O	6858
different	O	6858
consequences	O	6858
.	O	6858
where	O	6859
it	O	6859
is	O	6859
combined	O	6859
with	O	6859
a	O	6859
c6	B-Disease	6859
-	I-Disease	6859
deficient	I-Disease	6859
gene	O	6859
,	O	6859
the	O	6859
serum	O	6859
c7	O	6859
levels	O	6859
can	O	6859
be	O	6859
surprisingly	O	6859
high	O	6859
,	O	6859
possibly	O	6859
because	O	6859
there	O	6859
is	O	6859
no	O	6859
c6	O	6859
generating	O	6859
c56	O	6859
to	O	6859
consume	O	6859
the	O	6859
c7	O	6859
.	O	6859
genetic	O	6862
bases	O	6862
of	O	6862
human	O	6862
complement	B-Disease	6862
c7	I-Disease	6862
deficiency	I-Disease	6862
.	O	6862
complement	B-Disease	6863
c7	I-Disease	6863
deficiency	I-Disease	6863
(	O	6863
c7d	B-Disease	6863
)	O	6863
is	O	6863
associated	O	6863
frequently	O	6863
with	O	6863
recurrent	O	6863
bacterial	B-Disease	6863
infections	I-Disease	6863
,	O	6863
especially	O	6863
meningitis	B-Disease	6863
caused	O	6863
by	O	6863
neisseria	B-Disease	6863
meningitidis	I-Disease	6863
.	O	6863
we	O	6864
report	O	6864
in	O	6864
this	O	6864
work	O	6864
the	O	6864
molecular	O	6864
bases	O	6864
of	O	6864
c7d	B-Disease	6864
in	O	6864
two	O	6864
unrelated	O	6864
japanese	O	6864
males	O	6864
.	O	6864
moreover	O	6870
,	O	6870
we	O	6870
detected	O	6870
a	O	6870
novel	O	6870
polymorphism	O	6870
in	O	6870
intron	O	6870
11	O	6870
that	O	6870
presumably	O	6870
is	O	6870
linked	O	6870
to	O	6870
the	O	6870
mutation	O	6870
responsible	O	6870
for	O	6870
c7d	B-Disease	6870
in	O	6870
case	O	6870
1	O	6870
.	O	6870
our	O	6871
results	O	6871
indicate	O	6871
that	O	6871
the	O	6871
pathogenesis	O	6871
of	O	6871
c7d	B-Disease	6871
is	O	6871
heterogeneous	O	6871
like	O	6871
most	O	6871
of	O	6871
the	O	6871
other	O	6871
deficiencies	B-Disease	6871
of	I-Disease	6871
complement	I-Disease	6871
components	I-Disease	6871
.	O	6871
.	O	6871
hprt	B-Disease	6872
-	I-Disease	6872
aprt	I-Disease	6872
-	I-Disease	6872
deficient	I-Disease	6872
mice	O	6872
are	O	6872
not	O	6872
a	O	6872
model	O	6872
for	O	6872
lesch	B-Disease	6872
-	I-Disease	6872
nyhan	I-Disease	6872
syndrome	I-Disease	6872
.	O	6872
complete	B-Disease	6873
hypoxanthine	I-Disease	6873
-	I-Disease	6873
guanine	I-Disease	6873
phosphoribosyl	I-Disease	6873
-	I-Disease	6873
transferase	I-Disease	6873
(	I-Disease	6873
hprt	I-Disease	6873
)	I-Disease	6873
deficiency	I-Disease	6873
in	O	6873
humans	O	6873
results	O	6873
in	O	6873
the	O	6873
lesch	B-Disease	6873
-	I-Disease	6873
nyhan	I-Disease	6873
syndrome	I-Disease	6873
which	O	6873
is	O	6873
characterized	O	6873
,	O	6873
among	O	6873
other	O	6873
features	O	6873
,	O	6873
by	O	6873
compulsive	O	6873
self	O	6873
-	O	6873
injurious	O	6873
behavior	O	6873
.	O	6873
hprt	B-Disease	6874
-	I-Disease	6874
deficient	I-Disease	6874
mice	O	6874
generated	O	6874
using	O	6874
mouse	O	6874
embryonic	O	6874
stem	O	6874
cells	O	6874
exhibit	O	6874
none	O	6874
of	O	6874
the	O	6874
behavioral	O	6874
symptoms	O	6874
associated	O	6874
with	O	6874
the	O	6874
lesch	B-Disease	6874
-	I-Disease	6874
nyhan	I-Disease	6874
syndrome	I-Disease	6874
.	O	6874
administration	O	6875
of	O	6875
drugs	O	6875
that	O	6875
inhibit	O	6875
adenine	O	6875
phosphoribosyltransferase	O	6875
(	O	6875
aprt	O	6875
)	O	6875
in	O	6875
hprt	B-Disease	6875
-	I-Disease	6875
deficient	I-Disease	6875
mice	O	6875
has	O	6875
produced	O	6875
the	O	6875
suggestion	O	6875
that	O	6875
deficiency	B-Disease	6875
of	I-Disease	6875
aprt	I-Disease	6875
in	O	6875
combination	O	6875
with	O	6875
hprt	B-Disease	6875
-	I-Disease	6875
deficiency	I-Disease	6875
in	O	6875
mice	O	6875
may	O	6875
lead	O	6875
to	O	6875
self	O	6875
-	O	6875
mutilation	O	6875
behavior	O	6875
[	O	6875
c	O	6875
.	O	6875
l	O	6875
.	O	6875
wu	O	6875
and	O	6875
d	O	6875
.	O	6875
w	O	6875
.	O	6875
melton	O	6875
(	O	6875
1993	O	6875
)	O	6875
nature	O	6875
genet	O	6875
.	O	6875
3	O	6875
,	O	6875
235	O	6875
-	O	6875
240	O	6875
]	O	6875
.	O	6875
to	O	6876
test	O	6876
this	O	6876
proposition	O	6876
,	O	6876
we	O	6876
bred	O	6876
hprt	B-Disease	6876
-	I-Disease	6876
aprt	I-Disease	6876
-	I-Disease	6876
deficient	I-Disease	6876
mice	O	6876
.	O	6876
although	O	6877
the	O	6877
doubly	O	6877
-	O	6877
deficient	O	6877
mice	O	6877
excrete	O	6877
adenine	O	6877
and	O	6877
its	O	6877
highly	O	6877
insoluble	O	6877
derivative	O	6877
,	O	6877
2	O	6877
,	O	6877
8	O	6877
-	O	6877
dihydroxyadenine	O	6877
,	O	6877
which	O	6877
are	O	6877
also	O	6877
associated	O	6877
with	O	6877
human	O	6877
aprt	B-Disease	6877
deficiency	I-Disease	6877
,	O	6877
additional	O	6877
abnormalities	O	6877
or	O	6877
any	O	6877
self	O	6877
-	O	6877
injurious	O	6877
behavior	O	6877
were	O	6877
not	O	6877
detected	O	6877
.	O	6877
thus	O	6878
,	O	6878
aprt	B-Disease	6878
-	I-Disease	6878
hprt	I-Disease	6878
-	I-Disease	6878
deficient	I-Disease	6878
mice	O	6878
,	O	6878
which	O	6878
are	O	6878
devoid	O	6878
of	O	6878
any	O	6878
purine	O	6878
salvage	O	6878
pathways	O	6878
,	O	6878
show	O	6878
no	O	6878
novel	O	6878
phenotype	O	6878
and	O	6878
are	O	6878
not	O	6878
a	O	6878
model	O	6878
for	O	6878
the	O	6878
behavioral	B-Disease	6878
abnormalities	I-Disease	6878
associated	O	6878
with	O	6878
the	O	6878
lesch	B-Disease	6878
-	I-Disease	6878
nyhan	I-Disease	6878
syndrome	I-Disease	6878
as	O	6878
previously	O	6878
suggested	O	6878
somatic	O	6879
alterations	O	6879
of	O	6879
the	O	6879
dpc4	O	6879
gene	O	6879
in	O	6879
human	O	6879
colorectal	B-Disease	6879
cancers	I-Disease	6879
in	O	6879
vivo	O	6879
.	O	6879
background	O	6880
&	O	6880
aims	O	6880
the	O	6880
chromosome	O	6880
region	O	6880
18q21	O	6880
has	O	6880
been	O	6880
shown	O	6880
to	O	6880
be	O	6880
frequently	O	6880
deleted	O	6880
in	O	6880
colorectal	B-Disease	6880
cancers	I-Disease	6880
,	O	6880
and	O	6880
such	O	6880
frequent	O	6880
allelic	O	6880
loss	O	6880
is	O	6880
a	O	6880
hallmark	O	6880
of	O	6880
the	O	6880
presence	O	6880
of	O	6880
a	O	6880
tumor	O	6880
-	O	6880
suppressor	O	6880
gene	O	6880
.	O	6880
the	O	6881
dpc4	O	6881
gene	O	6881
,	O	6881
which	O	6881
is	O	6881
located	O	6881
at	O	6881
18q21	O	6881
,	O	6881
has	O	6881
been	O	6881
identified	O	6881
as	O	6881
a	O	6881
tumor	O	6881
-	O	6881
suppressor	O	6881
gene	O	6881
from	O	6881
examination	O	6881
of	O	6881
pancreatic	B-Disease	6881
cancers	I-Disease	6881
.	O	6881
the	O	6882
aim	O	6882
of	O	6882
the	O	6882
present	O	6882
study	O	6882
was	O	6882
to	O	6882
determine	O	6882
if	O	6882
it	O	6882
might	O	6882
also	O	6882
be	O	6882
altered	O	6882
in	O	6882
colorectal	B-Disease	6882
cancers	I-Disease	6882
.	O	6882
methods	O	6883
mutation	O	6883
analyses	O	6883
of	O	6883
the	O	6883
dpc4	O	6883
gene	O	6883
were	O	6883
performed	O	6883
on	O	6883
complementary	O	6883
dna	O	6883
samples	O	6883
from	O	6883
31	O	6883
primary	O	6883
colorectal	B-Disease	6883
cancer	I-Disease	6883
specimens	O	6883
using	O	6883
a	O	6883
combination	O	6883
of	O	6883
polymerase	O	6883
chain	O	6883
reaction	O	6883
,	O	6883
single	O	6883
-	O	6883
strand	O	6883
conformation	O	6883
polymorphism	O	6883
,	O	6883
and	O	6883
dna	O	6883
sequencing	O	6883
.	O	6883
results	O	6884
four	O	6884
missense	O	6884
mutations	O	6884
producing	O	6884
amino	O	6884
acid	O	6884
substitutions	O	6884
and	O	6884
a	O	6884
somatic	O	6884
12	O	6884
-	O	6884
base	O	6884
pair	O	6884
deletion	O	6884
in	O	6884
the	O	6884
coding	O	6884
region	O	6884
of	O	6884
the	O	6884
dpc4	O	6884
gene	O	6884
were	O	6884
detected	O	6884
in	O	6884
the	O	6884
31	O	6884
cancers	B-Disease	6884
(	O	6884
16	O	6884
%	O	6884
;	O	6884
5	O	6884
of	O	6884
31	O	6884
)	O	6884
.	O	6884
conclusions	O	6885
the	O	6885
dpc4	O	6885
gene	O	6885
may	O	6885
play	O	6885
a	O	6885
role	O	6885
as	O	6885
a	O	6885
tumor	O	6885
-	O	6885
suppressor	O	6885
gene	O	6885
in	O	6885
a	O	6885
fraction	O	6885
of	O	6885
colorectal	B-Disease	6885
cancers	I-Disease	6885
;	O	6885
however	O	6885
,	O	6885
while	O	6885
allelic	O	6885
loss	O	6885
at	O	6885
18q21	O	6885
is	O	6885
very	O	6885
often	O	6885
seen	O	6885
in	O	6885
colorectal	B-Disease	6885
cancers	I-Disease	6885
,	O	6885
only	O	6885
a	O	6885
minority	O	6885
show	O	6885
dpc4	O	6885
mutations	O	6885
,	O	6885
suggesting	O	6885
that	O	6885
there	O	6885
might	O	6885
be	O	6885
another	O	6885
tumor	O	6885
-	O	6885
suppressor	O	6885
gene	O	6885
in	O	6885
this	O	6885
chromosome	O	6885
region	O	6885
.	O	6885
.	O	6885
pleiotropic	O	6886
defects	O	6886
in	O	6886
ataxia	B-Disease	6886
-	I-Disease	6886
telangiectasia	I-Disease	6886
protein	O	6886
-	O	6886
deficient	O	6886
mice	O	6886
.	O	6886
we	O	6887
have	O	6887
generated	O	6887
a	O	6887
mouse	O	6887
model	O	6887
for	O	6887
ataxia	B-Disease	6887
-	I-Disease	6887
telangiectasia	I-Disease	6887
by	O	6887
using	O	6887
gene	O	6887
targeting	O	6887
to	O	6887
generate	O	6887
mice	O	6887
that	O	6887
do	O	6887
not	O	6887
express	O	6887
the	O	6887
atm	O	6887
protein	O	6887
.	O	6887
atm	O	6888
-	O	6888
deficient	O	6888
mice	O	6888
are	O	6888
retarded	O	6888
in	O	6888
growth	O	6888
,	O	6888
do	O	6888
not	O	6888
produce	O	6888
mature	O	6888
sperm	O	6888
,	O	6888
and	O	6888
exhibit	O	6888
severe	O	6888
defects	O	6888
in	O	6888
t	O	6888
cell	O	6888
maturation	O	6888
while	O	6888
going	O	6888
on	O	6888
to	O	6888
develop	O	6888
thymomas	B-Disease	6888
.	O	6888
atm	O	6891
-	O	6891
deficient	O	6891
mice	O	6891
then	O	6891
exhibit	O	6891
many	O	6891
of	O	6891
the	O	6891
same	O	6891
symptoms	O	6891
found	O	6891
in	O	6891
ataxia	B-Disease	6891
-	I-Disease	6891
telangiectasia	I-Disease	6891
patients	O	6891
and	O	6891
in	O	6891
cells	O	6891
derived	O	6891
from	O	6891
them	O	6891
.	O	6891
the	O	6893
dcc	O	6893
protein	O	6893
and	O	6893
prognosis	O	6893
in	O	6893
colorectal	B-Disease	6893
cancer	I-Disease	6893
.	O	6893
background	O	6894
allelic	O	6894
loss	O	6894
of	O	6894
chromosome	O	6894
18q	O	6894
predicts	O	6894
a	O	6894
poor	O	6894
outcome	O	6894
in	O	6894
patients	O	6894
with	O	6894
stage	B-Disease	6894
ii	I-Disease	6894
colorectal	I-Disease	6894
cancer	I-Disease	6894
.	O	6894
although	O	6895
the	O	6895
specific	O	6895
gene	O	6895
inactivated	O	6895
by	O	6895
this	O	6895
allelic	O	6895
loss	O	6895
has	O	6895
not	O	6895
been	O	6895
elucidated	O	6895
,	O	6895
the	O	6895
dcc	O	6895
(	O	6895
deleted	O	6895
in	O	6895
colorectal	B-Disease	6895
cancer	I-Disease	6895
)	O	6895
gene	O	6895
is	O	6895
a	O	6895
candidate	O	6895
.	O	6895
we	O	6896
investigated	O	6896
whether	O	6896
the	O	6896
expression	O	6896
of	O	6896
the	O	6896
dcc	O	6896
protein	O	6896
in	O	6896
tumor	B-Disease	6896
cells	O	6896
is	O	6896
a	O	6896
prognostic	O	6896
marker	O	6896
in	O	6896
colorectal	B-Disease	6896
carcinoma	I-Disease	6896
.	O	6896
methods	O	6897
the	O	6897
expression	O	6897
of	O	6897
dcc	O	6897
was	O	6897
evaluated	O	6897
immunohistochemically	O	6897
in	O	6897
132	O	6897
paraffin	O	6897
-	O	6897
embedded	O	6897
samples	O	6897
from	O	6897
patients	O	6897
with	O	6897
curatively	O	6897
resected	O	6897
stage	B-Disease	6897
ii	I-Disease	6897
and	I-Disease	6897
iii	I-Disease	6897
colorectal	I-Disease	6897
carcinomas	I-Disease	6897
.	O	6897
the	O	6898
cox	O	6898
proportional	O	6898
-	O	6898
hazards	O	6898
model	O	6898
was	O	6898
used	O	6898
to	O	6898
adjust	O	6898
for	O	6898
covariates	O	6898
including	O	6898
age	O	6898
,	O	6898
sex	O	6898
,	O	6898
tumor	B-Disease	6898
site	O	6898
,	O	6898
degree	O	6898
of	O	6898
tumor	B-Disease	6898
differentiation	O	6898
,	O	6898
and	O	6898
use	O	6898
of	O	6898
adjuvant	O	6898
therapy	O	6898
.	O	6898
results	O	6899
the	O	6899
expression	O	6899
of	O	6899
dcc	O	6899
was	O	6899
a	O	6899
strong	O	6899
positive	O	6899
predictive	O	6899
factor	O	6899
for	O	6899
survival	O	6899
in	O	6899
both	O	6899
stage	B-Disease	6899
ii	I-Disease	6899
and	I-Disease	6899
stage	I-Disease	6899
iii	I-Disease	6899
colorectal	I-Disease	6899
carcinomas	I-Disease	6899
.	O	6899
in	O	6900
patients	O	6900
with	O	6900
stage	O	6900
ii	O	6900
disease	O	6900
whose	O	6900
tumors	B-Disease	6900
expressed	O	6900
dcc	O	6900
,	O	6900
the	O	6900
five	O	6900
-	O	6900
year	O	6900
survival	O	6900
rate	O	6900
was	O	6900
94	O	6900
.	O	6900
3	O	6901
percent	O	6901
,	O	6901
whereas	O	6901
in	O	6901
patients	O	6901
with	O	6901
dcc	B-Disease	6901
-	I-Disease	6901
negative	I-Disease	6901
tumors	I-Disease	6901
,	O	6901
the	O	6901
survival	O	6901
rate	O	6901
was	O	6901
61	O	6901
.	O	6901
in	O	6903
patients	O	6903
with	O	6903
stage	B-Disease	6903
iii	I-Disease	6903
disease	I-Disease	6903
,	O	6903
the	O	6903
respective	O	6903
survival	O	6903
rates	O	6903
were	O	6903
59	O	6903
.	O	6903
conclusions	O	6906
dcc	O	6906
is	O	6906
a	O	6906
prognostic	O	6906
marker	O	6906
in	O	6906
patients	O	6906
with	O	6906
stage	B-Disease	6906
ii	I-Disease	6906
or	I-Disease	6906
stage	I-Disease	6906
iii	I-Disease	6906
colorectal	I-Disease	6906
cancer	I-Disease	6906
.	O	6906
in	O	6907
stage	B-Disease	6907
ii	I-Disease	6907
colorectal	I-Disease	6907
carcinomas	I-Disease	6907
,	O	6907
the	O	6907
absence	O	6907
of	O	6907
dcc	O	6907
identifies	O	6907
a	O	6907
subgroup	O	6907
of	O	6907
patients	O	6907
with	O	6907
lesions	O	6907
that	O	6907
behave	O	6907
like	O	6907
stage	B-Disease	6907
iii	I-Disease	6907
cancers	I-Disease	6907
.	O	6907
association	O	6909
of	O	6909
anxiety	B-Disease	6909
-	I-Disease	6909
related	I-Disease	6909
traits	I-Disease	6909
with	O	6909
a	O	6909
polymorphism	O	6909
in	O	6909
the	O	6909
serotonin	O	6909
transporter	O	6909
gene	O	6909
regulatory	O	6909
region	O	6909
.	O	6909
transporter	O	6910
-	O	6910
facilitated	O	6910
uptake	O	6910
of	O	6910
serotonin	O	6910
(	O	6910
5	O	6910
-	O	6910
hydroxytryptamine	O	6910
or	O	6910
5	O	6910
-	O	6910
ht	O	6910
)	O	6910
has	O	6910
been	O	6910
implicated	O	6910
in	O	6910
anxiety	B-Disease	6910
in	O	6910
humans	O	6910
and	O	6910
animal	O	6910
models	O	6910
and	O	6910
is	O	6910
the	O	6910
site	O	6910
of	O	6910
action	O	6910
of	O	6910
widely	O	6910
used	O	6910
uptake	O	6910
-	O	6910
inhibiting	O	6910
antidepressant	O	6910
and	O	6910
antianxiety	O	6910
drugs	O	6910
.	O	6910
association	O	6913
studies	O	6913
in	O	6913
two	O	6913
independent	O	6913
samples	O	6913
totaling	O	6913
505	O	6913
individuals	O	6913
revealed	O	6913
that	O	6913
the	O	6913
5	O	6913
-	O	6913
htt	O	6913
polymorphism	O	6913
accounts	O	6913
for	O	6913
3	O	6913
to	O	6913
4	O	6913
percent	O	6913
of	O	6913
total	O	6913
variation	O	6913
and	O	6913
7	O	6913
to	O	6913
9	O	6913
percent	O	6913
of	O	6913
inherited	O	6913
variance	O	6913
in	O	6913
anxiety	B-Disease	6913
-	I-Disease	6913
related	I-Disease	6913
personality	I-Disease	6913
traits	I-Disease	6913
in	O	6913
individuals	O	6913
as	O	6913
well	O	6913
as	O	6913
sibships	O	6913
.	O	6913
.	O	6913
phenotypic	O	6914
and	O	6914
genotypic	O	6914
overlap	O	6914
between	O	6914
atelosteogenesis	B-Disease	6914
type	I-Disease	6914
2	I-Disease	6914
and	O	6914
diastrophic	B-Disease	6914
dysplasia	I-Disease	6914
.	O	6914
mutations	O	6915
in	O	6915
the	O	6915
diastrophic	B-Disease	6915
dysplasia	I-Disease	6915
sulfate	O	6915
transporter	O	6915
gene	O	6915
dtdst	O	6915
have	O	6915
been	O	6915
associated	O	6915
with	O	6915
a	O	6915
family	O	6915
of	O	6915
chondrodysplasias	B-Disease	6915
that	O	6915
comprises	O	6915
,	O	6915
in	O	6915
order	O	6915
of	O	6915
increasing	O	6915
severity	O	6915
,	O	6915
diastrophic	B-Disease	6915
dysplasia	I-Disease	6915
(	O	6915
dtd	B-Disease	6915
)	O	6915
,	O	6915
atelosteogenesis	B-Disease	6915
type	I-Disease	6915
2	I-Disease	6915
(	O	6915
ao2	B-Disease	6915
)	O	6915
,	O	6915
and	O	6915
achondrogenesis	B-Disease	6915
type	I-Disease	6915
1b	I-Disease	6915
(	O	6915
acg1b	B-Disease	6915
)	O	6915
.	O	6915
to	O	6916
learn	O	6916
more	O	6916
about	O	6916
the	O	6916
molecular	O	6916
basis	O	6916
of	O	6916
dtdst	B-Disease	6916
chondrodysplasias	I-Disease	6916
and	O	6916
about	O	6916
genotype	O	6916
-	O	6916
phenotype	O	6916
correlations	O	6916
,	O	6916
we	O	6916
studied	O	6916
fibroblast	O	6916
cultures	O	6916
of	O	6916
three	O	6916
new	O	6916
patients	O	6916
one	O	6916
with	O	6916
ao	B-Disease	6916
-	I-Disease	6916
2	I-Disease	6916
,	O	6916
one	O	6916
with	O	6916
dtd	B-Disease	6916
,	O	6916
and	O	6916
one	O	6916
with	O	6916
an	O	6916
intermediate	O	6916
phenotype	O	6916
(	O	6916
ao2	B-Disease	6916
/	O	6916
dtd	B-Disease	6916
)	O	6916
.	O	6916
in	O	6919
two	O	6919
patients	O	6919
(	O	6919
dtd	B-Disease	6919
and	O	6919
ao2	B-Disease	6919
/	O	6919
dtd	B-Disease	6919
)	O	6919
,	O	6919
no	O	6919
other	O	6919
structural	O	6919
mutation	O	6919
was	O	6919
found	O	6919
,	O	6919
but	O	6919
polymerase	O	6919
chain	O	6919
reaction	O	6919
amplification	O	6919
and	O	6919
single	O	6919
-	O	6919
strand	O	6919
conformation	O	6919
polymorphism	O	6919
analysis	O	6919
of	O	6919
fibroblast	O	6919
cdna	O	6919
showed	O	6919
reduced	O	6919
mrna	O	6919
levels	O	6919
of	O	6919
the	O	6919
wild	O	6919
-	O	6919
type	O	6919
dtdst	O	6919
allele	O	6919
these	O	6919
two	O	6919
patients	O	6919
may	O	6919
be	O	6919
compound	O	6919
heterozygotes	O	6919
for	O	6919
the	O	6919
finnish	O	6919
mutation	O	6919
(	O	6919
as	O	6919
yet	O	6919
uncharacterized	O	6919
at	O	6919
the	O	6919
dna	O	6919
level	O	6919
)	O	6919
,	O	6919
which	O	6919
causes	O	6919
reduced	O	6919
expression	O	6919
of	O	6919
dtdst	O	6919
.	O	6919
the	O	6920
third	O	6920
patient	O	6920
(	O	6920
with	O	6920
ao2	B-Disease	6920
)	O	6920
had	O	6920
the	O	6920
r279w	O	6920
mutation	O	6920
compounded	O	6920
with	O	6920
a	O	6920
novel	O	6920
mutation	O	6920
,	O	6920
the	O	6920
deletion	O	6920
of	O	6920
cytosine	O	6920
418	O	6920
(	O	6920
delta	O	6920
c418	O	6920
)	O	6920
,	O	6920
predicting	O	6920
a	O	6920
frameshift	O	6920
with	O	6920
premature	O	6920
termination	O	6920
.	O	6920
the	O	6922
presence	O	6922
of	O	6922
the	O	6922
dtdst	O	6922
r279w	O	6922
mutation	O	6922
in	O	6922
a	O	6922
total	O	6922
of	O	6922
11	O	6922
patients	O	6922
with	O	6922
ao2	B-Disease	6922
or	O	6922
dtd	B-Disease	6922
emphasizes	O	6922
the	O	6922
overlap	O	6922
between	O	6922
these	O	6922
conditions	O	6922
.	O	6922
this	O	6923
mutation	O	6923
has	O	6923
not	O	6923
been	O	6923
found	O	6923
so	O	6923
far	O	6923
in	O	6923
8	O	6923
analyzed	O	6923
acg1b	B-Disease	6923
patients	O	6923
,	O	6923
suggesting	O	6923
that	O	6923
it	O	6923
allows	O	6923
some	O	6923
residual	O	6923
activity	O	6923
of	O	6923
the	O	6923
sulfate	O	6923
transporter	O	6923
.	O	6923
.	O	6923
identification	O	6924
of	O	6924
wasp	O	6924
mutations	O	6924
,	O	6924
mutation	O	6924
hotspots	O	6924
and	O	6924
genotype	O	6924
-	O	6924
phenotype	O	6924
disparities	O	6924
in	O	6924
24	O	6924
patients	O	6924
with	O	6924
the	O	6924
wiskott	B-Disease	6924
-	I-Disease	6924
aldrich	I-Disease	6924
syndrome	I-Disease	6924
.	O	6924
the	O	6925
wiskott	B-Disease	6925
-	I-Disease	6925
aldrich	I-Disease	6925
syndrome	I-Disease	6925
(	O	6925
was	B-Disease	6925
)	O	6925
,	O	6925
an	O	6925
x	B-Disease	6925
-	I-Disease	6925
linked	I-Disease	6925
immunodeficiency	I-Disease	6925
disease	I-Disease	6925
caused	O	6925
by	O	6925
mutation	O	6925
in	O	6925
the	O	6925
recently	O	6925
isolated	O	6925
gene	O	6925
encoding	O	6925
was	B-Disease	6925
protein	O	6925
(	O	6925
wasp	O	6925
)	O	6925
,	O	6925
is	O	6925
known	O	6925
to	O	6925
be	O	6925
associated	O	6925
with	O	6925
extensive	O	6925
clinical	O	6925
heterogeneity	O	6925
.	O	6925
cumulative	O	6926
mutation	O	6926
data	O	6926
have	O	6926
revealed	O	6926
that	O	6926
wasp	O	6926
genotypes	O	6926
are	O	6926
also	O	6926
highly	O	6926
variable	O	6926
among	O	6926
was	B-Disease	6926
patients	O	6926
,	O	6926
but	O	6926
the	O	6926
relationship	O	6926
of	O	6926
phenotype	O	6926
with	O	6926
genotype	O	6926
in	O	6926
this	O	6926
disease	O	6926
remains	O	6926
unclear	O	6926
.	O	6926
to	O	6927
address	O	6927
this	O	6927
issue	O	6927
we	O	6927
characterized	O	6927
wasp	O	6927
mutations	O	6927
in	O	6927
24	O	6927
unrelated	O	6927
was	B-Disease	6927
patients	O	6927
,	O	6927
including	O	6927
18	O	6927
boys	O	6927
with	O	6927
severe	O	6927
classical	O	6927
was	B-Disease	6927
and	O	6927
6	O	6927
boys	O	6927
expressing	O	6927
mild	O	6927
forms	O	6927
of	O	6927
the	O	6927
disease	O	6927
,	O	6927
and	O	6927
then	O	6927
examined	O	6927
the	O	6927
degree	O	6927
of	O	6927
correlation	O	6927
of	O	6927
these	O	6927
as	O	6927
well	O	6927
as	O	6927
all	O	6927
previously	O	6927
published	O	6927
wasp	O	6927
mutations	O	6927
with	O	6927
disease	O	6927
severity	O	6927
.	O	6927
similarly	O	6930
,	O	6930
while	O	6930
the	O	6930
cumulative	O	6930
data	O	6930
revealed	O	6930
a	O	6930
predominance	O	6930
of	O	6930
missense	O	6930
mutations	O	6930
among	O	6930
the	O	6930
wasp	O	6930
gene	O	6930
lesions	O	6930
observed	O	6930
in	O	6930
boys	O	6930
with	O	6930
isolated	B-Disease	6930
thrombocytopenia	I-Disease	6930
,	O	6930
missense	O	6930
mutations	O	6930
were	O	6930
not	O	6930
exclusively	O	6930
associated	O	6930
with	O	6930
milder	O	6930
was	B-Disease	6930
phenotypes	O	6930
,	O	6930
but	O	6930
also	O	6930
comprised	O	6930
a	O	6930
substantial	O	6930
portion	O	6930
(	O	6930
38	O	6930
%	O	6930
)	O	6930
of	O	6930
the	O	6930
wasp	O	6930
gene	O	6930
defects	O	6930
found	O	6930
in	O	6930
patients	O	6930
with	O	6930
severe	O	6930
disease	O	6930
.	O	6930
these	O	6931
findings	O	6931
,	O	6931
as	O	6931
well	O	6931
as	O	6931
the	O	6931
detection	O	6931
of	O	6931
identical	O	6931
wasp	O	6931
mutations	O	6931
in	O	6931
patients	O	6931
with	O	6931
disparate	O	6931
phenotypes	O	6931
,	O	6931
reveal	O	6931
a	O	6931
lack	O	6931
of	O	6931
phenotype	O	6931
concordance	O	6931
with	O	6931
genotype	O	6931
in	O	6931
was	B-Disease	6931
and	O	6931
thus	O	6931
imply	O	6931
that	O	6931
phenotypic	O	6931
outcome	O	6931
in	O	6931
this	O	6931
disease	O	6931
cannot	O	6931
be	O	6931
reliably	O	6931
predicted	O	6931
solely	O	6931
on	O	6931
the	O	6931
basis	O	6931
of	O	6931
wasp	O	6931
genotypes	O	6931
.	O	6931
.	O	6931
germline	O	6932
mutations	O	6932
in	O	6932
the	O	6932
3	O	6932
'	O	6932
part	O	6932
of	O	6932
apc	B-Disease	6932
exon	O	6932
15	O	6932
do	O	6932
not	O	6932
result	O	6932
in	O	6932
truncated	O	6932
proteins	O	6932
and	O	6932
are	O	6932
associated	O	6932
with	O	6932
attenuated	O	6932
adenomatous	B-Disease	6932
polyposis	I-Disease	6932
coli	I-Disease	6932
.	O	6932
familial	B-Disease	6933
adenomatous	I-Disease	6933
polyposis	I-Disease	6933
(	O	6933
fap	B-Disease	6933
)	O	6933
is	O	6933
an	O	6933
inherited	O	6933
predisposition	O	6933
to	O	6933
colorectal	B-Disease	6933
cancer	I-Disease	6933
characterized	O	6933
by	O	6933
the	O	6933
development	O	6933
of	O	6933
numerous	O	6933
adenomatous	B-Disease	6933
polyps	I-Disease	6933
predominantly	O	6933
in	O	6933
the	O	6933
colorectal	O	6933
region	O	6933
.	O	6933
germline	O	6934
mutations	O	6934
in	O	6934
the	O	6934
adenomatous	B-Disease	6934
polyposis	I-Disease	6934
coli	I-Disease	6934
(	O	6934
apc	B-Disease	6934
)	O	6934
gene	O	6934
are	O	6934
responsible	O	6934
for	O	6934
most	O	6934
cases	O	6934
of	O	6934
fap	B-Disease	6934
.	O	6934
mutations	O	6935
at	O	6935
the	O	6935
5	O	6935
end	O	6935
of	O	6935
apc	B-Disease	6935
are	O	6935
known	O	6935
to	O	6935
be	O	6935
associated	O	6935
with	O	6935
a	O	6935
relatively	O	6935
mild	O	6935
form	O	6935
of	O	6935
the	O	6935
disease	O	6935
,	O	6935
called	O	6935
attenuated	B-Disease	6935
adenomatous	I-Disease	6935
polyposis	I-Disease	6935
coli	I-Disease	6935
(	O	6935
aapc	B-Disease	6935
)	O	6935
.	O	6935
we	O	6936
identified	O	6936
a	O	6936
frameshift	O	6936
mutation	O	6936
in	O	6936
the	O	6936
3	O	6936
part	O	6936
of	O	6936
exon	O	6936
15	O	6936
,	O	6936
resulting	O	6936
in	O	6936
a	O	6936
stop	O	6936
codon	O	6936
at	O	6936
1862	O	6936
,	O	6936
in	O	6936
a	O	6936
large	O	6936
dutch	O	6936
kindred	O	6936
with	O	6936
aapc	B-Disease	6936
.	O	6936
western	O	6937
blot	O	6937
analysis	O	6937
of	O	6937
lymphoblastoid	O	6937
cell	O	6937
lines	O	6937
derived	O	6937
from	O	6937
affected	O	6937
family	O	6937
members	O	6937
from	O	6937
this	O	6937
kindred	O	6937
,	O	6937
as	O	6937
well	O	6937
as	O	6937
from	O	6937
a	O	6937
previously	O	6937
reported	O	6937
swiss	O	6937
family	O	6937
carrying	O	6937
a	O	6937
frameshift	O	6937
mutation	O	6937
at	O	6937
codon	O	6937
1987	O	6937
and	O	6937
displaying	O	6937
a	O	6937
similar	O	6937
attenuated	O	6937
phenotype	O	6937
,	O	6937
showed	O	6937
only	O	6937
the	O	6937
wild	O	6937
-	O	6937
type	O	6937
apc	B-Disease	6937
protein	O	6937
.	O	6937
our	O	6938
study	O	6938
indicates	O	6938
that	O	6938
chain	O	6938
-	O	6938
terminating	O	6938
mutations	O	6938
located	O	6938
in	O	6938
the	O	6938
3	O	6938
part	O	6938
of	O	6938
apc	B-Disease	6938
do	O	6938
not	O	6938
result	O	6938
in	O	6938
detectable	O	6938
truncated	O	6938
polypeptides	O	6938
and	O	6938
we	O	6938
hypothesize	O	6938
that	O	6938
this	O	6938
is	O	6938
likely	O	6938
to	O	6938
be	O	6938
the	O	6938
basis	O	6938
for	O	6938
the	O	6938
observed	O	6938
aapc	B-Disease	6938
phenotype	O	6938
.	O	6938
.	O	6938
over	O	6940
100	O	6940
distinct	O	6940
disease	O	6940
-	O	6940
associated	O	6940
mutations	O	6940
have	O	6940
been	O	6940
identified	O	6940
in	O	6940
the	O	6940
breast	B-Disease	6940
-	I-Disease	6940
ovarian	I-Disease	6940
cancer	I-Disease	6940
susceptibility	O	6940
gene	O	6940
brca1	O	6940
.	O	6940
loss	O	6941
of	O	6941
the	O	6941
wild	O	6941
-	O	6941
type	O	6941
allele	O	6941
in	O	6941
>	O	6941
90	O	6941
%	O	6941
of	O	6941
tumors	B-Disease	6941
from	O	6941
patients	O	6941
with	O	6941
inherited	O	6941
brca1	O	6941
mutations	O	6941
indicates	O	6941
tumor	B-Disease	6941
suppressive	O	6941
function	O	6941
.	O	6941
the	O	6942
low	O	6942
incidence	O	6942
of	O	6942
somatic	O	6942
mutations	O	6942
suggests	O	6942
that	O	6942
brca1	O	6942
inactivation	O	6942
in	O	6942
sporadic	O	6942
tumors	B-Disease	6942
occurs	O	6942
by	O	6942
alternative	O	6942
mechanisms	O	6942
,	O	6942
such	O	6942
as	O	6942
interstitial	O	6942
chromosomal	O	6942
deletion	O	6942
or	O	6942
reduced	O	6942
transcription	O	6942
.	O	6942
the	O	6952
hereditary	B-Disease	6952
breast	I-Disease	6952
and	I-Disease	6952
ovarian	I-Disease	6952
cancer	I-Disease	6952
gene	O	6952
,	O	6952
brca1	O	6952
,	O	6952
encodes	O	6952
a	O	6952
large	O	6952
polypeptide	O	6952
that	O	6952
contains	O	6952
the	O	6952
cysteine	O	6952
-	O	6952
rich	O	6952
ring	O	6952
motif	O	6952
,	O	6952
a	O	6952
zinc	O	6952
-	O	6952
binding	O	6952
domain	O	6952
found	O	6952
in	O	6952
a	O	6952
variety	O	6952
of	O	6952
regulatory	O	6952
proteins	O	6952
.	O	6952
the	O	6955
bard1	O	6955
/	O	6955
brca1	O	6955
interaction	O	6955
is	O	6955
disrupted	O	6955
by	O	6955
brca1	O	6955
missense	O	6955
mutations	O	6955
that	O	6955
segregate	O	6955
with	O	6955
breast	B-Disease	6955
cancer	I-Disease	6955
susceptibility	O	6955
,	O	6955
indicating	O	6955
that	O	6955
bard1	O	6955
may	O	6955
be	O	6955
involved	O	6955
in	O	6955
mediating	O	6955
tumour	B-Disease	6955
suppression	O	6955
by	O	6955
brca1	O	6955
.	O	6955
.	O	6955
45	O	6959
-	O	6959
kilobases	O	6959
(	O	6959
kb	O	6959
)	O	6959
exon	O	6959
11	O	6959
of	O	6959
the	O	6959
hereditary	B-Disease	6959
breast	I-Disease	6959
and	I-Disease	6959
ovarian	I-Disease	6959
cancer	I-Disease	6959
gene	O	6959
brca1	O	6959
.	O	6959
autosomal	O	6964
dominant	O	6964
primary	O	6964
hyperparathyroidism	B-Disease	6964
and	I-Disease	6964
jaw	I-Disease	6964
tumor	I-Disease	6964
syndrome	I-Disease	6964
associated	O	6964
with	O	6964
renal	B-Disease	6964
hamartomas	I-Disease	6964
and	O	6964
cystic	B-Disease	6964
kidney	I-Disease	6964
disease	I-Disease	6964
:	O	6964
linkage	O	6964
to	O	6964
1q21	O	6964
-	O	6964
q32	O	6964
and	O	6964
loss	O	6964
of	O	6964
the	O	6964
wild	O	6964
type	O	6964
allele	O	6964
in	O	6964
renal	B-Disease	6964
hamartomas	I-Disease	6964
.	O	6964
hereditary	B-Disease	6965
hyperparathyroidism	I-Disease	6965
-	I-Disease	6965
jaw	I-Disease	6965
tumor	I-Disease	6965
syndrome	I-Disease	6965
(	O	6965
hpt	B-Disease	6965
-	I-Disease	6965
jt	I-Disease	6965
)	O	6965
is	O	6965
an	O	6965
autosomal	B-Disease	6965
dominant	I-Disease	6965
disease	I-Disease	6965
(	O	6965
omim	O	6965
145001	O	6965
)	O	6965
that	O	6965
has	O	6965
recently	O	6965
been	O	6965
mapped	O	6965
to	O	6965
chromosomal	O	6965
region	O	6965
1q21	O	6965
-	O	6965
q32	O	6965
(	O	6965
hrpt2	O	6965
)	O	6965
.	O	6965
here	O	6966
we	O	6966
report	O	6966
two	O	6966
families	O	6966
with	O	6966
hpt	B-Disease	6966
-	I-Disease	6966
jt	I-Disease	6966
syndrome	I-Disease	6966
in	O	6966
which	O	6966
adult	B-Disease	6966
renal	I-Disease	6966
hamartomas	I-Disease	6966
or	O	6966
cystic	B-Disease	6966
kidney	I-Disease	6966
disease	I-Disease	6966
were	O	6966
prominent	O	6966
associated	O	6966
features	O	6966
,	O	6966
possibly	O	6966
representing	O	6966
a	O	6966
new	O	6966
phenotypic	O	6966
variant	O	6966
of	O	6966
the	O	6966
hpt	B-Disease	6966
-	I-Disease	6966
jt	I-Disease	6966
syndrome	I-Disease	6966
.	O	6966
in	O	6967
the	O	6967
first	O	6967
family	O	6967
,	O	6967
renal	B-Disease	6967
lesions	I-Disease	6967
were	O	6967
present	O	6967
in	O	6967
five	O	6967
out	O	6967
of	O	6967
six	O	6967
affected	O	6967
individuals	O	6967
,	O	6967
whereas	O	6967
hpt	B-Disease	6967
and	O	6967
jt	B-Disease	6967
were	O	6967
seen	O	6967
in	O	6967
four	O	6967
and	O	6967
two	O	6967
cases	O	6967
,	O	6967
respectively	O	6967
.	O	6967
in	O	6968
the	O	6968
second	O	6968
family	O	6968
,	O	6968
jt	B-Disease	6968
was	O	6968
found	O	6968
in	O	6968
three	O	6968
of	O	6968
the	O	6968
five	O	6968
affected	O	6968
individuals	O	6968
and	O	6968
two	O	6968
affected	O	6968
members	O	6968
also	O	6968
exhibited	O	6968
polycystic	B-Disease	6968
kidney	I-Disease	6968
disease	I-Disease	6968
.	O	6968
a	O	6970
sex	O	6970
-	O	6970
dependent	O	6970
penetrance	O	6970
of	O	6970
primary	B-Disease	6970
hpt	I-Disease	6970
,	O	6970
resulting	O	6970
in	O	6970
predominantly	O	6970
male	O	6970
-	O	6970
affected	O	6970
cases	O	6970
was	O	6970
evident	O	6970
in	O	6970
the	O	6970
two	O	6970
families	O	6970
.	O	6970
twenty	O	6971
microsatellite	O	6971
markers	O	6971
in	O	6971
the	O	6971
hrpt2	O	6971
region	O	6971
were	O	6971
typed	O	6971
,	O	6971
in	O	6971
addition	O	6971
to	O	6971
markers	O	6971
in	O	6971
the	O	6971
multiple	B-Disease	6971
endocrine	I-Disease	6971
neoplasia	I-Disease	6971
(	I-Disease	6971
men	I-Disease	6971
)	I-Disease	6971
types	I-Disease	6971
1	I-Disease	6971
and	I-Disease	6971
2	I-Disease	6971
regions	O	6971
at	O	6971
11q13	O	6971
and	O	6971
10q11	O	6971
.	O	6971
the	O	6972
disease	O	6972
in	O	6972
these	O	6972
two	O	6972
kindreds	O	6972
was	O	6972
linked	O	6972
to	O	6972
five	O	6972
markers	O	6972
in	O	6972
the	O	6972
1q21	O	6972
-	O	6972
q32	O	6972
region	O	6972
(	O	6972
logarithm	O	6972
-	O	6972
of	O	6972
-	O	6972
odds	O	6972
scores	O	6972
3	O	6972
.	O	6972
2	O	6972
-	O	6972
4	O	6972
2	O	6972
-	O	6972
4	O	6972
.	O	6972
2	O	6972
)	O	6972
,	O	6972
whereas	O	6972
linkage	O	6972
to	O	6972
the	O	6972
men1	B-Disease	6972
and	O	6972
men2	B-Disease	6972
regions	O	6972
was	O	6972
excluded	O	6972
.	O	6972
loss	O	6974
of	O	6974
heterozygosity	O	6974
was	O	6974
studied	O	6974
in	O	6974
seven	O	6974
renal	B-Disease	6974
hamartomas	I-Disease	6974
from	O	6974
two	O	6974
affected	O	6974
individuals	O	6974
in	O	6974
the	O	6974
first	O	6974
family	O	6974
,	O	6974
as	O	6974
well	O	6974
as	O	6974
in	O	6974
a	O	6974
jaw	B-Disease	6974
tumor	I-Disease	6974
and	O	6974
a	O	6974
parathyroid	B-Disease	6974
tumor	I-Disease	6974
from	O	6974
the	O	6974
second	O	6974
family	O	6974
.	O	6974
all	O	6975
renal	B-Disease	6975
hamartomas	I-Disease	6975
showed	O	6975
loss	O	6975
of	O	6975
heterozygosity	O	6975
at	O	6975
the	O	6975
1q21	O	6975
-	O	6975
q32	O	6975
region	O	6975
.	O	6975
the	O	6976
losses	O	6976
invariably	O	6976
involved	O	6976
the	O	6976
wild	O	6976
type	O	6976
allele	O	6976
derived	O	6976
from	O	6976
the	O	6976
unaffected	O	6976
parent	O	6976
,	O	6976
suggesting	O	6976
the	O	6976
inactivation	O	6976
of	O	6976
a	O	6976
tumor	B-Disease	6976
suppressor	O	6976
gene	O	6976
in	O	6976
this	O	6976
region	O	6976
in	O	6980
a	O	6980
study	O	6980
of	O	6980
g6pd	B-Disease	6980
deficient	I-Disease	6980
patients	O	6980
who	O	6980
presented	O	6980
with	O	6980
clinical	O	6980
favism	B-Disease	6980
in	O	6980
spain	O	6980
,	O	6980
we	O	6980
have	O	6980
found	O	6980
a	O	6980
new	O	6980
polymorphic	O	6980
variant	O	6980
that	O	6980
we	O	6980
have	O	6980
called	O	6980
g6pd	O	6980
malaga	O	6980
,	O	6980
whose	O	6980
only	O	6980
abnormality	O	6980
is	O	6980
a	O	6980
542	O	6980
a	O	6980
-	O	6980
-	O	6980
>	O	6980
t	O	6980
(	O	6980
181	O	6980
asp	O	6980
-	O	6980
-	O	6980
>	O	6980
val	O	6980
)	O	6980
mutation	O	6980
.	O	6980
g6pd	O	6982
malaga	O	6982
is	O	6982
associated	O	6982
with	O	6982
enzyme	B-Disease	6982
deficiency	I-Disease	6982
(	O	6982
class	O	6982
iii	O	6982
)	O	6982
,	O	6982
and	O	6982
the	O	6982
enzymic	O	6982
properties	O	6982
of	O	6982
g6pd	O	6982
malaga	O	6982
and	O	6982
g6pd	O	6982
santamaria	O	6982
are	O	6982
quite	O	6982
similar	O	6982
,	O	6982
indicating	O	6982
that	O	6982
in	O	6982
this	O	6982
case	O	6982
the	O	6982
effects	O	6982
of	O	6982
the	O	6982
two	O	6982
mutations	O	6982
are	O	6982
additive	O	6982
rather	O	6982
than	O	6982
synergistic	O	6982
.	O	6982
brca1	O	6986
mutations	O	6986
cause	O	6986
increased	O	6986
risk	O	6986
for	O	6986
breast	B-Disease	6986
and	I-Disease	6986
ovarian	I-Disease	6986
cancer	I-Disease	6986
,	O	6986
frequently	O	6986
of	O	6986
early	O	6986
onset	O	6986
.	O	6986
many	O	6987
different	O	6987
mutations	O	6987
occur	O	6987
in	O	6987
brca1	O	6987
,	O	6987
including	O	6987
several	O	6987
examples	O	6987
of	O	6987
recurrent	O	6987
mutations	O	6987
,	O	6987
each	O	6987
of	O	6987
which	O	6987
accounts	O	6987
for	O	6987
a	O	6987
significant	O	6987
number	O	6987
of	O	6987
families	O	6987
with	O	6987
heritable	O	6987
cancer	B-Disease	6987
predisposition	O	6987
.	O	6987
these	O	6988
common	O	6988
mutations	O	6988
have	O	6988
an	O	6988
etiological	O	6988
role	O	6988
in	O	6988
many	O	6988
breast	B-Disease	6988
and	I-Disease	6988
ovarian	I-Disease	6988
cancer	I-Disease	6988
cases	O	6988
and	O	6988
provide	O	6988
the	O	6988
opportunity	O	6988
to	O	6988
examine	O	6988
genotype	O	6988
-	O	6988
phenotype	O	6988
correlations	O	6988
and	O	6988
genotype	O	6988
-	O	6988
environment	O	6988
interactions	O	6988
in	O	6988
individuals	O	6988
with	O	6988
the	O	6988
identical	O	6988
brca1	O	6988
lesion	O	6988
.	O	6988
we	O	6989
report	O	6989
a	O	6989
novel	O	6989
missense	O	6989
change	O	6989
in	O	6989
brca1	O	6989
,	O	6989
2640	O	6989
c	O	6989
-	O	6989
-	O	6989
>	O	6989
t	O	6989
(	O	6989
r841w	O	6989
)	O	6989
,	O	6989
found	O	6989
in	O	6989
3	O	6989
cases	O	6989
from	O	6989
a	O	6989
subject	O	6989
group	O	6989
of	O	6989
305	O	6989
breast	B-Disease	6989
and	I-Disease	6989
79	I-Disease	6989
ovarian	I-Disease	6989
cancer	I-Disease	6989
cases	O	6989
from	O	6989
orange	O	6989
county	O	6989
,	O	6989
ca	O	6989
.	O	6989
in	O	6991
all	O	6991
three	O	6991
cases	O	6991
,	O	6991
there	O	6991
is	O	6991
a	O	6991
strong	O	6991
family	O	6991
history	O	6991
of	O	6991
breast	B-Disease	6991
,	I-Disease	6991
ovarian	I-Disease	6991
,	I-Disease	6991
or	I-Disease	6991
other	I-Disease	6991
cancers	I-Disease	6991
possibly	O	6991
related	O	6991
to	O	6991
a	O	6991
brca1	O	6991
defect	O	6991
and	O	6991
family	O	6991
members	O	6991
showed	O	6991
a	O	6991
high	O	6991
concordance	O	6991
of	O	6991
cancer	B-Disease	6991
incidence	O	6991
with	O	6991
the	O	6991
presence	O	6991
of	O	6991
r841w	O	6991
.	O	6991
the	O	6992
age	O	6992
of	O	6992
cancer	B-Disease	6992
onset	O	6992
was	O	6992
not	O	6992
always	O	6992
distinct	O	6992
from	O	6992
typical	O	6992
sporadic	O	6992
cases	O	6992
.	O	6992
testing	O	6993
of	O	6993
a	O	6993
sample	O	6993
of	O	6993
413	O	6993
unrelated	O	6993
individuals	O	6993
to	O	6993
examine	O	6993
the	O	6993
hypothesis	O	6993
that	O	6993
r841w	O	6993
might	O	6993
be	O	6993
a	O	6993
rare	O	6993
polymorphism	O	6993
detected	O	6993
one	O	6993
additional	O	6993
instance	O	6993
in	O	6993
a	O	6993
woman	O	6993
with	O	6993
breast	B-Disease	6993
cancer	I-Disease	6993
diagnosed	O	6993
at	O	6993
age	O	6993
77	O	6993
years	O	6993
,	O	6993
and	O	6993
cancer	B-Disease	6993
in	O	6993
one	O	6993
parent	O	6993
.	O	6993
r841w	O	6994
is	O	6994
likely	O	6994
to	O	6994
be	O	6994
an	O	6994
etiologically	O	6994
significant	O	6994
lesion	O	6994
with	O	6994
involvement	O	6994
in	O	6994
close	O	6994
to	O	6994
1	O	6994
%	O	6994
(	O	6994
95	O	6994
%	O	6994
confidence	O	6994
interval	O	6994
of	O	6994
0	O	6994
-	O	6994
1	O	6994
.	O	6994
7	O	6994
%	O	6994
)	O	6994
of	O	6994
all	O	6994
breast	B-Disease	6994
and	I-Disease	6994
ovarian	I-Disease	6994
cancers	I-Disease	6994
in	O	6994
this	O	6994
population	O	6994
.	O	6994
ataxia	B-Disease	6995
-	I-Disease	6995
telangiectasia	I-Disease	6995
:	O	6995
founder	O	6995
effect	O	6995
among	O	6995
north	O	6995
african	O	6995
jews	O	6995
.	O	6995
the	O	6996
atm	O	6996
gene	O	6996
is	O	6996
responsible	O	6996
for	O	6996
the	O	6996
autosomal	B-Disease	6996
recessive	I-Disease	6996
disorder	I-Disease	6996
ataxia	B-Disease	6996
-	I-Disease	6996
telangiectasia	I-Disease	6996
(	O	6996
a	B-Disease	6996
-	I-Disease	6996
t	I-Disease	6996
)	O	6996
,	O	6996
characterized	O	6996
by	O	6996
cerebellar	B-Disease	6996
degeneration	I-Disease	6996
,	O	6996
immunodeficiency	B-Disease	6996
and	O	6996
cancer	B-Disease	6996
predisposition	I-Disease	6996
.	O	6996
a	B-Disease	6997
-	I-Disease	6997
t	I-Disease	6997
carriers	O	6997
were	O	6997
reported	O	6997
to	O	6997
be	O	6997
moderately	O	6997
cancer	B-Disease	6997
-	I-Disease	6997
prone	I-Disease	6997
.	O	6997
a	O	6998
wide	O	6998
variety	O	6998
of	O	6998
a	B-Disease	6998
-	I-Disease	6998
t	I-Disease	6998
mutations	O	6998
,	O	6998
most	O	6998
of	O	6998
which	O	6998
are	O	6998
unique	O	6998
to	O	6998
single	O	6998
families	O	6998
,	O	6998
were	O	6998
identified	O	6998
in	O	6998
various	O	6998
ethnic	O	6998
groups	O	6998
,	O	6998
precluding	O	6998
carrier	O	6998
screening	O	6998
with	O	6998
mutation	O	6998
-	O	6998
specific	O	6998
assays	O	6998
.	O	6998
however	O	6999
,	O	6999
a	O	6999
single	O	6999
mutation	O	6999
was	O	6999
observed	O	6999
in	O	6999
32	O	6999
/	O	6999
33	O	6999
defective	O	6999
atm	O	6999
alleles	O	6999
in	O	6999
jewish	O	6999
a	B-Disease	6999
-	I-Disease	6999
t	I-Disease	6999
families	O	6999
of	O	6999
north	O	6999
african	O	6999
origin	O	6999
,	O	6999
coming	O	6999
from	O	6999
various	O	6999
regions	O	6999
of	O	6999
morocco	O	6999
and	O	6999
tunisia	O	6999
.	O	6999
this	O	7003
founder	O	7003
effect	O	7003
provides	O	7003
a	O	7003
unique	O	7003
opportunity	O	7003
for	O	7003
population	O	7003
-	O	7003
based	O	7003
screening	O	7003
for	O	7003
a	B-Disease	7003
-	I-Disease	7003
t	I-Disease	7003
carriers	O	7003
in	O	7003
a	O	7003
large	O	7003
jewish	O	7003
community	O	7003
.	O	7003
.	O	7003
mutation	O	7004
analysis	O	7004
of	O	7004
brca1	O	7004
and	O	7004
brca2	O	7004
in	O	7004
a	O	7004
male	B-Disease	7004
breast	I-Disease	7004
cancer	I-Disease	7004
population	O	7004
.	O	7004
a	O	7005
population	O	7005
-	O	7005
based	O	7005
series	O	7005
of	O	7005
54	O	7005
male	B-Disease	7005
breast	I-Disease	7005
cancer	I-Disease	7005
cases	O	7005
from	O	7005
southern	O	7005
california	O	7005
were	O	7005
analyzed	O	7005
for	O	7005
germ	O	7005
-	O	7005
line	O	7005
mutations	O	7005
in	O	7005
the	O	7005
inherited	B-Disease	7005
breast	I-Disease	7005
/	I-Disease	7005
ovarian	I-Disease	7005
cancer	I-Disease	7005
genes	O	7005
,	O	7005
brca1	O	7005
and	O	7005
brca2	O	7005
.	O	7005
nine	O	7006
(	O	7006
17	O	7006
%	O	7006
)	O	7006
of	O	7006
the	O	7006
patients	O	7006
had	O	7006
a	O	7006
family	O	7006
history	O	7006
of	O	7006
breast	B-Disease	7006
and	I-Disease	7006
/	I-Disease	7006
or	I-Disease	7006
ovarian	I-Disease	7006
cancer	I-Disease	7006
in	O	7006
at	O	7006
least	O	7006
one	O	7006
first	O	7006
-	O	7006
degree	O	7006
relative	O	7006
.	O	7006
a	O	7007
further	O	7007
seven	O	7007
(	O	7007
13	O	7007
%	O	7007
)	O	7007
of	O	7007
the	O	7007
patients	O	7007
reported	O	7007
breast	B-Disease	7007
/	I-Disease	7007
ovarian	I-Disease	7007
cancer	I-Disease	7007
in	O	7007
at	O	7007
least	O	7007
one	O	7007
second	O	7007
-	O	7007
degree	O	7007
relative	O	7007
and	O	7007
in	O	7007
no	O	7007
first	O	7007
-	O	7007
degree	O	7007
relatives	O	7007
.	O	7007
two	O	7009
male	B-Disease	7009
breast	I-Disease	7009
cancer	I-Disease	7009
patients	O	7009
(	O	7009
4	O	7009
%	O	7009
of	O	7009
the	O	7009
total	O	7009
)	O	7009
were	O	7009
found	O	7009
to	O	7009
carry	O	7009
novel	O	7009
truncating	O	7009
mutations	O	7009
in	O	7009
the	O	7009
brca2	O	7009
gene	O	7009
.	O	7009
only	O	7010
one	O	7010
of	O	7010
the	O	7010
two	O	7010
male	B-Disease	7010
breast	I-Disease	7010
cancer	I-Disease	7010
patients	O	7010
carrying	O	7010
a	O	7010
brca2	O	7010
mutation	O	7010
had	O	7010
a	O	7010
family	O	7010
history	O	7010
of	O	7010
cancer	B-Disease	7010
,	O	7010
with	O	7010
one	O	7010
case	O	7010
of	O	7010
ovarian	B-Disease	7010
cancer	I-Disease	7010
in	O	7010
a	O	7010
first	O	7010
-	O	7010
degree	O	7010
relative	O	7010
.	O	7010
the	O	7011
remaining	O	7011
eight	O	7011
cases	O	7011
(	O	7011
89	O	7011
%	O	7011
)	O	7011
of	O	7011
male	B-Disease	7011
breast	I-Disease	7011
cancer	I-Disease	7011
with	O	7011
a	O	7011
family	O	7011
history	O	7011
of	O	7011
breast	B-Disease	7011
/	I-Disease	7011
ovarian	I-Disease	7011
cancer	I-Disease	7011
in	O	7011
first	O	7011
-	O	7011
degree	O	7011
relatives	O	7011
remain	O	7011
unaccounted	O	7011
for	O	7011
by	O	7011
mutations	O	7011
in	O	7011
either	O	7011
the	O	7011
brca1	O	7011
gene	O	7011
or	O	7011
the	O	7011
brca2	O	7011
gene	O	7011
.	O	7011
.	O	7011
molecular	O	7012
basis	O	7012
for	O	7012
duarte	B-Disease	7012
and	I-Disease	7012
los	I-Disease	7012
angeles	I-Disease	7012
variant	I-Disease	7012
galactosemia	I-Disease	7012
.	O	7012
human	O	7013
orythrocytes	O	7013
that	O	7013
are	O	7013
homozygous	O	7013
for	O	7013
the	O	7013
duarte	B-Disease	7013
enzyme	I-Disease	7013
variant	I-Disease	7013
of	I-Disease	7013
galactosemia	I-Disease	7013
(	O	7013
d	O	7013
/	O	7013
d	O	7013
)	O	7013
have	O	7013
a	O	7013
characteristic	O	7013
isoform	O	7013
on	O	7013
isoelectric	O	7013
focusing	O	7013
and	O	7013
50	O	7013
%	O	7013
reduction	O	7013
in	O	7013
galactose	O	7013
-	O	7013
1	O	7013
-	O	7013
phosphate	O	7013
uridyltransferase	O	7013
(	O	7013
galt	O	7013
)	O	7013
enzyme	O	7013
activity	O	7013
.	O	7013
we	O	7023
conclude	O	7023
that	O	7023
the	O	7023
codon	O	7023
change	O	7023
n314d	O	7023
in	O	7023
cis	O	7023
with	O	7023
the	O	7023
base	O	7023
-	O	7023
pair	O	7023
transition	O	7023
1721c	O	7023
-	O	7023
-	O	7023
>	O	7023
t	O	7023
produces	O	7023
the	O	7023
la	B-Disease	7023
variant	I-Disease	7023
of	I-Disease	7023
galactosemia	I-Disease	7023
and	O	7023
that	O	7023
this	O	7023
nucleotide	O	7023
change	O	7023
increases	O	7023
galt	O	7023
activity	O	7023
by	O	7023
increasing	O	7023
galt	O	7023
protein	O	7023
abundance	O	7023
without	O	7023
increasing	O	7023
transcription	O	7023
or	O	7023
decreasing	O	7023
thermal	O	7023
lability	O	7023
.	O	7023
the	O	7025
tsg101	O	7025
tumor	B-Disease	7025
susceptibility	O	7025
gene	O	7025
is	O	7025
located	O	7025
in	O	7025
chromosome	O	7025
11	O	7025
band	O	7025
p15	O	7025
and	O	7025
is	O	7025
mutated	O	7025
in	O	7025
human	O	7025
breast	B-Disease	7025
cancer	I-Disease	7025
.	O	7025
recent	O	7026
work	O	7026
has	O	7026
identified	O	7026
a	O	7026
mouse	O	7026
gene	O	7026
(	O	7026
tsg101	O	7026
)	O	7026
whose	O	7026
inactivation	O	7026
in	O	7026
fibroblasts	O	7026
results	O	7026
in	O	7026
cellular	O	7026
transformation	O	7026
and	O	7026
the	O	7026
ability	O	7026
to	O	7026
produce	O	7026
metastatic	B-Disease	7026
tumors	I-Disease	7026
in	O	7026
nude	O	7026
mice	O	7026
.	O	7026
2	O	7029
,	O	7029
a	O	7029
region	O	7029
proposed	O	7029
to	O	7029
contain	O	7029
tumor	B-Disease	7029
suppressor	O	7029
gene	O	7029
(	O	7029
s	O	7029
)	O	7029
,	O	7029
is	O	7029
mutated	O	7029
at	O	7029
high	O	7029
frequency	O	7029
in	O	7029
human	O	7029
breast	B-Disease	7029
cancer	I-Disease	7029
.	O	7029
in	O	7030
7	O	7030
of	O	7030
15	O	7030
uncultured	O	7030
primary	O	7030
human	O	7030
breast	B-Disease	7030
carcinomas	I-Disease	7030
,	O	7030
intragenic	O	7030
deletions	O	7030
were	O	7030
shown	O	7030
in	O	7030
tsg101	O	7030
genomic	O	7030
dna	O	7030
and	O	7030
transcripts	O	7030
by	O	7030
gel	O	7030
and	O	7030
sequence	O	7030
analysis	O	7030
,	O	7030
and	O	7030
mutations	O	7030
affecting	O	7030
two	O	7030
tsg101	O	7030
alleles	O	7030
were	O	7030
identified	O	7030
in	O	7030
four	O	7030
of	O	7030
these	O	7030
cancers	B-Disease	7030
.	O	7030
no	O	7031
tsg101	O	7031
defects	O	7031
were	O	7031
found	O	7031
in	O	7031
matched	O	7031
normal	O	7031
breast	O	7031
tissue	O	7031
from	O	7031
the	O	7031
breast	B-Disease	7031
cancer	I-Disease	7031
patients	O	7031
.	O	7031
these	O	7032
findings	O	7032
strongly	O	7032
implicate	O	7032
tsg101	O	7032
mutations	O	7032
in	O	7032
human	O	7032
breast	B-Disease	7032
cancer	I-Disease	7032
myotonic	B-Disease	7034
dystrophy	I-Disease	7034
(	O	7034
dm	B-Disease	7034
)	O	7034
is	O	7034
associated	O	7034
with	O	7034
the	O	7034
expansion	O	7034
of	O	7034
a	O	7034
(	O	7034
ctg	O	7034
)	O	7034
n	O	7034
trinucleotide	O	7034
repeat	O	7034
in	O	7034
the	O	7034
3	O	7034
untranslated	O	7034
region	O	7034
(	O	7034
utr	O	7034
)	O	7034
of	O	7034
the	O	7034
dm	B-Disease	7034
protein	O	7034
kinase	O	7034
gene	O	7034
(	O	7034
dmpk	O	7034
)	O	7034
.	O	7034
moreover	O	7038
,	O	7038
mitotic	O	7038
instability	O	7038
analysis	O	7038
of	O	7038
different	O	7038
human	O	7038
dm	B-Disease	7038
tissues	O	7038
shows	O	7038
length	O	7038
mosaicism	O	7038
between	O	7038
different	O	7038
cell	O	7038
lineages	O	7038
.	O	7038
missense	O	7042
mutations	O	7042
in	O	7042
the	O	7042
fas	O	7042
gene	O	7042
resulting	O	7042
in	O	7042
autoimmune	B-Disease	7042
lymphoproliferative	I-Disease	7042
syndrome	I-Disease	7042
:	O	7042
a	O	7042
molecular	O	7042
and	O	7042
immunological	O	7042
analysis	O	7042
.	O	7042
the	O	7044
fas	O	7044
/	O	7044
apo	O	7044
-	O	7044
1	O	7044
receptor	O	7044
plays	O	7044
a	O	7044
crucial	O	7044
role	O	7044
in	O	7044
the	O	7044
regulation	O	7044
of	O	7044
apoptosis	O	7044
,	O	7044
as	O	7044
demonstrated	O	7044
by	O	7044
lymphoproliferation	O	7044
in	O	7044
mrl	O	7044
-	O	7044
lpr	O	7044
/	O	7044
lpr	O	7044
mice	O	7044
and	O	7044
by	O	7044
the	O	7044
recently	O	7044
described	O	7044
autoimmune	B-Disease	7044
lymphoproliferative	I-Disease	7044
syndrome	I-Disease	7044
(	O	7044
alps	B-Disease	7044
)	O	7044
in	O	7044
humans	O	7044
,	O	7044
both	O	7044
of	O	7044
which	O	7044
are	O	7044
due	O	7044
to	O	7044
mutations	O	7044
in	O	7044
the	O	7044
fas	O	7044
gene	O	7044
.	O	7044
we	O	7045
describe	O	7045
a	O	7045
novel	O	7045
family	O	7045
with	O	7045
alps	B-Disease	7045
in	O	7045
which	O	7045
three	O	7045
affected	O	7045
siblings	O	7045
carry	O	7045
two	O	7045
distinct	O	7045
missense	O	7045
mutations	O	7045
on	O	7045
both	O	7045
the	O	7045
fas	O	7045
gene	O	7045
alleles	O	7045
and	O	7045
show	O	7045
lack	O	7045
of	O	7045
fas	O	7045
-	O	7045
induced	O	7045
apoptosis	O	7045
.	O	7045
the	O	7046
children	O	7046
share	O	7046
common	O	7046
clinical	O	7046
features	O	7046
including	O	7046
splenomegaly	B-Disease	7046
and	O	7046
lymphadenopathy	B-Disease	7046
,	O	7046
but	O	7046
only	O	7046
one	O	7046
developed	O	7046
severe	O	7046
autoimmune	B-Disease	7046
manifestations	I-Disease	7046
.	O	7046
the	O	7048
ataxia	B-Disease	7048
-	I-Disease	7048
telangiectasia	I-Disease	7048
gene	O	7048
product	O	7048
,	O	7048
a	O	7048
constitutively	O	7048
expressed	O	7048
nuclear	O	7048
protein	O	7048
that	O	7048
is	O	7048
not	O	7048
up	O	7048
-	O	7048
regulated	O	7048
following	O	7048
genome	O	7048
damage	O	7048
.	O	7048
the	O	7049
product	O	7049
of	O	7049
the	O	7049
ataxia	B-Disease	7049
-	I-Disease	7049
telangiectasia	I-Disease	7049
gene	O	7049
(	O	7049
atm	O	7049
)	O	7049
was	O	7049
identified	O	7049
by	O	7049
using	O	7049
an	O	7049
antiserum	O	7049
developed	O	7049
to	O	7049
a	O	7049
peptide	O	7049
corresponding	O	7049
to	O	7049
the	O	7049
deduced	O	7049
amino	O	7049
acid	O	7049
sequence	O	7049
.	O	7049
truncated	O	7052
atm	O	7052
protein	O	7052
was	O	7052
not	O	7052
detected	O	7052
in	O	7052
lymphoblasts	O	7052
from	O	7052
ataxia	B-Disease	7052
-	I-Disease	7052
telangiectasia	I-Disease	7052
patients	O	7052
homozygous	O	7052
for	O	7052
mutations	O	7052
leading	O	7052
to	O	7052
premature	O	7052
protein	O	7052
termination	O	7052
.	O	7052
mutations	O	7058
in	O	7058
the	O	7058
col3a1	O	7058
gene	O	7058
have	O	7058
been	O	7058
implicated	O	7058
as	O	7058
a	O	7058
cause	O	7058
of	O	7058
type	B-Disease	7058
iv	I-Disease	7058
ehlers	I-Disease	7058
-	I-Disease	7058
danlos	I-Disease	7058
syndrome	I-Disease	7058
,	O	7058
a	O	7058
disease	O	7058
leading	O	7058
to	O	7058
aortic	B-Disease	7058
rupture	I-Disease	7058
in	O	7058
early	O	7058
adult	O	7058
life	O	7058
.	O	7058
the	O	7062
major	O	7062
cause	O	7062
of	O	7062
death	O	7062
of	O	7062
mutant	O	7062
mice	O	7062
was	O	7062
rupture	O	7062
of	O	7062
the	O	7062
major	O	7062
blood	O	7062
vessels	O	7062
,	O	7062
similar	O	7062
to	O	7062
patients	O	7062
with	O	7062
type	B-Disease	7062
iv	I-Disease	7062
ehlers	I-Disease	7062
-	I-Disease	7062
danlos	I-Disease	7062
syndrome	I-Disease	7062
.	O	7062
nonsense	O	7064
mutation	O	7064
in	O	7064
exon	O	7064
3	O	7064
of	O	7064
the	O	7064
proteolipid	O	7064
protein	O	7064
gene	O	7064
(	O	7064
plp	O	7064
)	O	7064
in	O	7064
a	O	7064
family	O	7064
with	O	7064
an	O	7064
unusual	O	7064
form	O	7064
of	O	7064
pelizaeus	B-Disease	7064
-	I-Disease	7064
merzbacher	I-Disease	7064
disease	I-Disease	7064
.	O	7064
we	O	7065
report	O	7065
a	O	7065
g	O	7065
-	O	7065
-	O	7065
>	O	7065
a	O	7065
transition	O	7065
at	O	7065
nucleotide	O	7065
431	O	7065
of	O	7065
the	O	7065
proteolipid	O	7065
protein	O	7065
gene	O	7065
(	O	7065
plp	O	7065
)	O	7065
results	O	7065
in	O	7065
a	O	7065
nonsense	O	7065
codon	O	7065
in	O	7065
a	O	7065
family	O	7065
with	O	7065
an	O	7065
unusual	O	7065
form	O	7065
of	O	7065
pelizaeus	B-Disease	7065
-	I-Disease	7065
merzbacher	I-Disease	7065
disease	I-Disease	7065
(	O	7065
pmd	B-Disease	7065
)	O	7065
.	O	7065
the	O	7067
clinical	O	7067
picture	O	7067
resembles	O	7067
somewhat	O	7067
that	O	7067
of	O	7067
x	B-Disease	7067
-	I-Disease	7067
linked	I-Disease	7067
spastic	I-Disease	7067
paraplegia	I-Disease	7067
(	O	7067
spg	B-Disease	7067
)	O	7067
.	O	7067
it	O	7068
differs	O	7068
from	O	7068
this	O	7068
and	O	7068
both	O	7068
the	O	7068
classical	O	7068
and	O	7068
connatal	O	7068
forms	O	7068
of	O	7068
pmd	B-Disease	7068
in	O	7068
that	O	7068
it	O	7068
is	O	7068
relatively	O	7068
mild	O	7068
in	O	7068
form	O	7068
,	O	7068
onset	O	7068
is	O	7068
delayed	O	7068
beyond	O	7068
age	O	7068
2	O	7068
years	O	7068
,	O	7068
nystagmus	B-Disease	7068
is	O	7068
absent	O	7068
,	O	7068
tremors	B-Disease	7068
are	O	7068
prominent	O	7068
,	O	7068
mental	B-Disease	7068
retardation	I-Disease	7068
is	O	7068
not	O	7068
severe	O	7068
,	O	7068
some	O	7068
patients	O	7068
show	O	7068
dementia	B-Disease	7068
or	O	7068
personality	B-Disease	7068
disorders	I-Disease	7068
,	O	7068
the	O	7068
disease	O	7068
is	O	7068
progressive	O	7068
rather	O	7068
than	O	7068
static	O	7068
in	O	7068
some	O	7068
,	O	7068
and	O	7068
several	O	7068
females	O	7068
show	O	7068
signs	O	7068
of	O	7068
disease	O	7068
.	O	7068
the	O	7069
nonsense	O	7069
mutation	O	7069
,	O	7069
which	O	7069
is	O	7069
in	O	7069
exon	O	7069
3b	O	7069
,	O	7069
should	O	7069
block	O	7069
the	O	7069
synthesis	O	7069
of	O	7069
normal	O	7069
plp	O	7069
but	O	7069
spare	O	7069
dm20	O	7069
,	O	7069
the	O	7069
isoform	O	7069
whose	O	7069
persistence	O	7069
has	O	7069
been	O	7069
associated	O	7069
with	O	7069
mild	O	7069
forms	O	7069
of	O	7069
plp	B-Disease	7069
-	I-Disease	7069
associated	I-Disease	7069
disease	I-Disease	7069
in	O	7069
both	O	7069
humans	O	7069
and	O	7069
mice	O	7069
.	O	7069
.	O	7069
common	O	7070
brca1	O	7070
variants	O	7070
and	O	7070
susceptibility	O	7070
to	O	7070
breast	B-Disease	7070
and	I-Disease	7070
ovarian	I-Disease	7070
cancer	I-Disease	7070
in	O	7070
the	O	7070
general	O	7070
population	O	7070
.	O	7070
most	O	7071
multiple	O	7071
case	O	7071
families	O	7071
of	O	7071
young	O	7071
onset	O	7071
breast	B-Disease	7071
cancer	I-Disease	7071
and	O	7071
ovarian	B-Disease	7071
cancer	I-Disease	7071
are	O	7071
thought	O	7071
to	O	7071
be	O	7071
due	O	7071
to	O	7071
highly	O	7071
penetrant	O	7071
mutations	O	7071
in	O	7071
the	O	7071
predisposing	O	7071
genes	O	7071
brca1	O	7071
and	O	7071
brca2	O	7071
.	O	7071
however	O	7072
,	O	7072
these	O	7072
mutations	O	7072
are	O	7072
uncommon	O	7072
in	O	7072
the	O	7072
population	O	7072
and	O	7072
they	O	7072
probably	O	7072
account	O	7072
for	O	7072
only	O	7072
a	O	7072
few	O	7072
percent	O	7072
of	O	7072
all	O	7072
breast	B-Disease	7072
cancer	I-Disease	7072
incidence	O	7072
.	O	7072
a	O	7073
much	O	7073
larger	O	7073
fraction	O	7073
of	O	7073
breast	B-Disease	7073
cancer	I-Disease	7073
might	O	7073
,	O	7073
in	O	7073
principle	O	7073
,	O	7073
be	O	7073
due	O	7073
to	O	7073
common	O	7073
variants	O	7073
which	O	7073
confer	O	7073
more	O	7073
modest	O	7073
individual	O	7073
risks	O	7073
.	O	7073
we	O	7075
have	O	7075
examined	O	7075
the	O	7075
frequency	O	7075
of	O	7075
four	O	7075
of	O	7075
these	O	7075
polymorphisms	O	7075
gln356arg	O	7075
,	O	7075
pro871leu	O	7075
,	O	7075
glu1038gly	O	7075
and	O	7075
ser1613gly	O	7075
in	O	7075
large	O	7075
series	O	7075
of	O	7075
breast	B-Disease	7075
and	I-Disease	7075
ovarian	I-Disease	7075
cancer	I-Disease	7075
cases	O	7075
and	O	7075
matched	O	7075
controls	O	7075
.	O	7075
thus	O	7081
the	O	7081
most	O	7081
common	O	7081
polymorphisms	O	7081
of	O	7081
the	O	7081
brca1	O	7081
gene	O	7081
do	O	7081
not	O	7081
make	O	7081
a	O	7081
significant	O	7081
contribution	O	7081
to	O	7081
breast	B-Disease	7081
or	I-Disease	7081
ovarian	I-Disease	7081
cancer	I-Disease	7081
risk	O	7081
.	O	7081
however	O	7082
,	O	7082
our	O	7082
data	O	7082
suggest	O	7082
that	O	7082
the	O	7082
arg356	O	7082
allele	O	7082
may	O	7082
have	O	7082
a	O	7082
different	O	7082
genotype	O	7082
distribution	O	7082
in	O	7082
breast	B-Disease	7082
cancer	I-Disease	7082
patients	O	7082
from	O	7082
that	O	7082
in	O	7082
controls	O	7082
(	O	7082
arg356	O	7082
homozygotes	O	7082
are	O	7082
more	O	7082
frequent	O	7082
in	O	7082
the	O	7082
control	O	7082
groups	O	7082
,	O	7082
p	O	7082
=	O	7082
0	O	7082
.	O	7082
01	O	7082
)	O	7082
,	O	7082
indicating	O	7082
that	O	7082
it	O	7082
may	O	7082
be	O	7082
protective	O	7082
against	O	7082
breast	B-Disease	7082
cancer	I-Disease	7082
.	O	7082
kniest	B-Disease	7084
dysplasia	I-Disease	7084
:	O	7084
dr	O	7084
.	O	7084
w	O	7084
.	O	7084
kniest	B-Disease	7086
dysplasia	I-Disease	7086
is	O	7086
a	O	7086
severe	O	7086
chondrodysplasia	B-Disease	7086
caused	O	7086
by	O	7086
the	O	7086
defective	B-Disease	7086
formation	I-Disease	7086
of	I-Disease	7086
type	I-Disease	7086
ii	I-Disease	7086
collagen	I-Disease	7086
.	O	7086
we	O	7087
report	O	7087
about	O	7087
dr	O	7087
.	O	7087
kniest	O	7087
,	O	7087
who	O	7087
first	O	7087
described	O	7087
the	O	7087
condition	O	7087
in	O	7087
1952	O	7087
,	O	7087
and	O	7087
his	O	7087
patient	O	7087
,	O	7087
who	O	7087
,	O	7087
at	O	7087
the	O	7087
age	O	7087
of	O	7087
50	O	7087
years	O	7087
is	O	7087
severely	B-Disease	7087
handicapped	I-Disease	7087
with	O	7087
short	B-Disease	7087
stature	I-Disease	7087
,	O	7087
restricted	B-Disease	7087
joint	I-Disease	7087
mobility	I-Disease	7087
,	O	7087
and	O	7087
blindness	B-Disease	7087
but	O	7087
is	O	7087
mentally	O	7087
alert	O	7087
and	O	7087
leads	O	7087
an	O	7087
active	O	7087
life	O	7087
.	O	7087
this	O	7089
is	O	7089
in	O	7089
accordance	O	7089
with	O	7089
molecular	O	7089
findings	O	7089
in	O	7089
other	O	7089
patients	O	7089
with	O	7089
kniest	B-Disease	7089
dysplasia	I-Disease	7089
and	O	7089
confirms	O	7089
,	O	7089
in	O	7089
the	O	7089
original	O	7089
patient	O	7089
,	O	7089
that	O	7089
the	O	7089
disorder	O	7089
is	O	7089
caused	O	7089
by	O	7089
small	O	7089
inframe	O	7089
deletions	O	7089
often	O	7089
due	O	7089
to	O	7089
exon	O	7089
skipping	O	7089
as	O	7089
a	O	7089
result	O	7089
of	O	7089
col2a1	O	7089
splice	O	7089
site	O	7089
mutations	O	7089
.	O	7089
.	O	7089
cloning	O	7090
of	O	7090
the	O	7090
homogentisate	O	7090
1	O	7090
,	O	7090
2	O	7090
-	O	7090
dioxygenase	O	7090
gene	O	7090
,	O	7090
the	O	7090
key	O	7090
enzyme	O	7090
of	O	7090
alkaptonuria	B-Disease	7090
in	O	7090
mouse	O	7090
.	O	7090
this	O	7105
corresponds	O	7105
well	O	7105
to	O	7105
the	O	7105
previous	O	7105
assignment	O	7105
of	O	7105
the	O	7105
locus	O	7105
for	O	7105
the	O	7105
human	O	7105
alkaptonuria	B-Disease	7105
gene	O	7105
(	O	7105
aku	O	7105
)	O	7105
to	O	7105
the	O	7105
same	O	7105
chromosomal	O	7105
region	O	7105
by	O	7105
multipoint	O	7105
linkage	O	7105
analysis	O	7105
.	O	7105
we	O	7106
therefore	O	7106
conclude	O	7106
that	O	7106
the	O	7106
hgo	O	7106
cdna	O	7106
encodes	O	7106
the	O	7106
gene	O	7106
responsible	O	7106
for	O	7106
alkaptonuria	B-Disease	7106
.	O	7106
pten	O	7107
,	O	7107
a	O	7107
putative	O	7107
protein	O	7107
tyrosine	O	7107
phosphatase	O	7107
gene	O	7107
mutated	O	7107
in	O	7107
human	O	7107
brain	B-Disease	7107
,	I-Disease	7107
breast	I-Disease	7107
,	I-Disease	7107
and	I-Disease	7107
prostate	I-Disease	7107
cancer	I-Disease	7107
.	O	7107
mapping	O	7108
of	O	7108
homozygous	O	7108
deletions	O	7108
on	O	7108
human	O	7108
chromosome	O	7108
10q23	O	7108
has	O	7108
led	O	7108
to	O	7108
the	O	7108
isolation	O	7108
of	O	7108
a	O	7108
candidate	O	7108
tumor	B-Disease	7108
suppressor	O	7108
gene	O	7108
,	O	7108
pten	O	7108
,	O	7108
that	O	7108
appears	O	7108
to	O	7108
be	O	7108
mutated	O	7108
at	O	7108
considerable	O	7108
frequency	O	7108
in	O	7108
human	O	7108
cancers	B-Disease	7108
.	O	7108
in	O	7109
preliminary	O	7109
screens	O	7109
,	O	7109
mutations	O	7109
of	O	7109
pten	O	7109
were	O	7109
detected	O	7109
in	O	7109
31	O	7109
%	O	7109
(	O	7109
13	O	7109
/	O	7109
42	O	7109
)	O	7109
of	O	7109
glioblastoma	B-Disease	7109
cell	O	7109
lines	O	7109
and	O	7109
xenografts	O	7109
,	O	7109
100	O	7109
%	O	7109
(	O	7109
4	O	7109
/	O	7109
4	O	7109
)	O	7109
of	O	7109
prostate	B-Disease	7109
cancer	I-Disease	7109
cell	O	7109
lines	O	7109
,	O	7109
6	O	7109
%	O	7109
(	O	7109
4	O	7109
/	O	7109
65	O	7109
)	O	7109
of	O	7109
breast	B-Disease	7109
cancer	I-Disease	7109
cell	O	7109
lines	O	7109
and	O	7109
xenografts	O	7109
,	O	7109
and	O	7109
17	O	7109
%	O	7109
(	O	7109
3	O	7109
/	O	7109
18	O	7109
)	O	7109
of	O	7109
primary	B-Disease	7109
glioblastomas	I-Disease	7109
.	O	7109
these	O	7111
homologies	O	7111
suggest	O	7111
that	O	7111
pten	O	7111
may	O	7111
suppress	O	7111
tumor	B-Disease	7111
cell	O	7111
growth	O	7111
by	O	7111
antagonizing	O	7111
protein	O	7111
tyrosine	O	7111
kinases	O	7111
and	O	7111
may	O	7111
regulate	O	7111
tumor	B-Disease	7111
cell	O	7111
invasion	O	7111
and	O	7111
metastasis	B-Disease	7111
through	O	7111
interactions	O	7111
at	O	7111
focal	O	7111
adhesions	O	7111
.	O	7111
.	O	7111
heterogeneity	O	7112
in	O	7112
schwartz	B-Disease	7112
-	I-Disease	7112
jampel	I-Disease	7112
chondrodystrophic	I-Disease	7112
myotonia	I-Disease	7112
.	O	7112
the	O	7113
schwartz	B-Disease	7113
-	I-Disease	7113
jampel	I-Disease	7113
syndrome	I-Disease	7113
(	O	7113
sjs	B-Disease	7113
;	O	7113
chondrodystrophic	B-Disease	7113
myotonia	I-Disease	7113
;	O	7113
mck	O	7113
255	O	7113
,	O	7113
800	O	7113
)	O	7113
is	O	7113
a	O	7113
recessively	B-Disease	7113
inherited	I-Disease	7113
condition	I-Disease	7113
defined	O	7113
by	O	7113
myotonia	B-Disease	7113
,	O	7113
short	B-Disease	7113
stature	I-Disease	7113
,	O	7113
and	O	7113
bone	B-Disease	7113
dysplasia	I-Disease	7113
.	O	7113
genetic	O	7114
linkage	O	7114
between	O	7114
sjs	B-Disease	7114
and	O	7114
chromosomal	O	7114
region	O	7114
1q36	O	7114
-	O	7114
34	O	7114
has	O	7114
been	O	7114
observed	O	7114
in	O	7114
several	O	7114
families	O	7114
,	O	7114
but	O	7114
the	O	7114
gene	O	7114
has	O	7114
not	O	7114
yet	O	7114
been	O	7114
identified	O	7114
.	O	7114
in	O	7116
addition	O	7116
,	O	7116
we	O	7116
tested	O	7116
genetic	O	7116
linkage	O	7116
to	O	7116
the	O	7116
sjs	B-Disease	7116
locus	O	7116
on	O	7116
chromosome	O	7116
1	O	7116
in	O	7116
one	O	7116
family	O	7116
with	O	7116
two	O	7116
affected	O	7116
sibs	O	7116
.	O	7116
we	O	7117
found	O	7117
that	O	7117
a	O	7117
group	O	7117
of	O	7117
patients	O	7117
have	O	7117
mild	O	7117
skeletal	O	7117
changes	O	7117
which	O	7117
may	O	7117
be	O	7117
secondary	O	7117
consequences	O	7117
of	O	7117
myotonia	B-Disease	7117
,	O	7117
while	O	7117
another	O	7117
group	O	7117
of	O	7117
patients	O	7117
appear	O	7117
to	O	7117
have	O	7117
primary	O	7117
bone	B-Disease	7117
dysplasia	I-Disease	7117
with	O	7117
myotonia	B-Disease	7117
.	O	7117
we	O	7119
tentatively	O	7119
isolate	O	7119
three	O	7119
different	O	7119
types	O	7119
of	O	7119
sjs	B-Disease	7119
type	I-Disease	7119
1a	I-Disease	7119
,	O	7119
usually	O	7119
recognized	O	7119
in	O	7119
childhood	O	7119
,	O	7119
with	O	7119
moderate	O	7119
bone	B-Disease	7119
dysplasia	I-Disease	7119
,	O	7119
corresponding	O	7119
to	O	7119
the	O	7119
original	O	7119
descriptions	O	7119
of	O	7119
schwartz	O	7119
,	O	7119
jampel	O	7119
and	O	7119
aberfeld	O	7119
;	O	7119
type	O	7119
1b	O	7119
,	O	7119
similar	O	7119
to	O	7119
type	O	7119
1a	O	7119
but	O	7119
recognizable	O	7119
at	O	7119
birth	O	7119
,	O	7119
with	O	7119
more	O	7119
pronounced	O	7119
bone	B-Disease	7119
dysplasia	I-Disease	7119
resembling	O	7119
kniest	B-Disease	7119
dysplasia	I-Disease	7119
;	O	7119
and	O	7119
type	O	7119
2	O	7119
,	O	7119
manifest	O	7119
at	O	7119
birth	O	7119
,	O	7119
with	O	7119
increased	O	7119
mortality	O	7119
and	O	7119
bone	B-Disease	7119
dysplasia	I-Disease	7119
resembling	O	7119
pyle	B-Disease	7119
disease	I-Disease	7119
.	O	7119
genetic	O	7120
analysis	O	7120
of	O	7120
the	O	7120
family	O	7120
with	O	7120
two	O	7120
sibs	O	7120
affected	O	7120
by	O	7120
sjs	B-Disease	7120
type	I-Disease	7120
2	I-Disease	7120
showed	O	7120
evidence	O	7120
against	O	7120
linkage	O	7120
to	O	7120
chromosome	O	7120
1p36	O	7120
-	O	7120
34	O	7120
.	O	7120
conclusions	O	7121
sjs	B-Disease	7121
is	O	7121
clinically	O	7121
and	O	7121
radiologically	O	7121
heterogeneous	O	7121
.	O	7121
the	O	7122
causes	O	7122
of	O	7122
heterogeneity	O	7122
are	O	7122
not	O	7122
known	O	7122
yet	O	7122
but	O	7122
are	O	7122
likely	O	7122
to	O	7122
include	O	7122
both	O	7122
different	O	7122
mutations	O	7122
at	O	7122
the	O	7122
sjs	B-Disease	7122
locus	O	7122
on	O	7122
chromosome	O	7122
1	O	7122
and	O	7122
the	O	7122
presence	O	7122
of	O	7122
a	O	7122
second	O	7122
sjs	B-Disease	7122
locus	O	7122
.	O	7122
mutations	O	7125
in	O	7125
the	O	7125
wt1	O	7125
gene	O	7125
were	O	7125
anticipated	O	7125
to	O	7125
explain	O	7125
the	O	7125
genetic	O	7125
basis	O	7125
of	O	7125
the	O	7125
childhood	O	7125
kidney	B-Disease	7125
cancer	I-Disease	7125
,	O	7125
wilms	B-Disease	7125
tumour	I-Disease	7125
(	O	7125
wt	B-Disease	7125
)	O	7125
.	O	7125
while	O	7127
only	O	7127
5	O	7127
%	O	7127
of	O	7127
sporadic	B-Disease	7127
wilms	I-Disease	7127
tumours	I-Disease	7127
have	O	7127
intragenic	O	7127
wt1	O	7127
mutations	O	7127
,	O	7127
>	O	7127
90	O	7127
%	O	7127
of	O	7127
patients	O	7127
with	O	7127
the	O	7127
denys	B-Disease	7127
-	I-Disease	7127
drash	I-Disease	7127
syndrome	I-Disease	7127
(	O	7127
renal	B-Disease	7127
nephropathy	I-Disease	7127
,	O	7127
gonadal	B-Disease	7127
anomaly	I-Disease	7127
,	O	7127
predisposition	B-Disease	7127
to	I-Disease	7127
wt	I-Disease	7127
)	O	7127
carry	O	7127
constitutional	O	7127
intragenic	O	7127
wt1	O	7127
mutations	O	7127
.	O	7127
wt1	O	7128
mutations	O	7128
have	O	7128
also	O	7128
been	O	7128
reported	O	7128
in	O	7128
juvenile	B-Disease	7128
granulosa	I-Disease	7128
cell	I-Disease	7128
tumour	I-Disease	7128
,	O	7128
non	B-Disease	7128
-	I-Disease	7128
asbestos	I-Disease	7128
related	I-Disease	7128
mesothelioma	I-Disease	7128
,	O	7128
desmoplastic	B-Disease	7128
small	I-Disease	7128
round	I-Disease	7128
cell	I-Disease	7128
tumour	I-Disease	7128
and	O	7128
,	O	7128
most	O	7128
recently	O	7128
,	O	7128
acute	B-Disease	7128
myeloid	I-Disease	7128
leukemia	I-Disease	7128
.	O	7128
.	O	7128
a	O	7129
mutation	O	7129
in	O	7129
autosomal	B-Disease	7129
dominant	I-Disease	7129
myotonia	I-Disease	7129
congenita	I-Disease	7129
affects	O	7129
pore	O	7129
properties	O	7129
of	O	7129
the	O	7129
muscle	O	7129
chloride	O	7129
channel	O	7129
.	O	7129
autosomal	B-Disease	7130
dominant	I-Disease	7130
myotonia	I-Disease	7130
congenita	I-Disease	7130
is	O	7130
an	O	7130
inherited	B-Disease	7130
disorder	I-Disease	7130
of	I-Disease	7130
skeletal	I-Disease	7130
muscle	I-Disease	7130
caused	O	7130
by	O	7130
mutations	O	7130
in	O	7130
a	O	7130
voltage	O	7130
-	O	7130
gated	O	7130
cl	O	7130
-	O	7130
channel	O	7130
gene	O	7130
(	O	7130
clcn1	O	7130
,	O	7130
7q35	O	7130
)	O	7130
.	O	7130
the	O	7138
incidence	O	7138
of	O	7138
pax6	O	7138
mutation	O	7138
in	O	7138
patients	O	7138
with	O	7138
simple	O	7138
aniridia	B-Disease	7138
:	O	7138
an	O	7138
evaluation	O	7138
of	O	7138
mutation	O	7138
detection	O	7138
in	O	7138
12	O	7138
cases	O	7138
.	O	7138
twelve	O	7139
aniridia	B-Disease	7139
patients	O	7139
,	O	7139
five	O	7139
with	O	7139
a	O	7139
family	O	7139
history	O	7139
and	O	7139
seven	O	7139
presumed	O	7139
to	O	7139
be	O	7139
sporadic	O	7139
,	O	7139
were	O	7139
exhaustively	O	7139
screened	O	7139
in	O	7139
order	O	7139
to	O	7139
test	O	7139
what	O	7139
proportion	O	7139
of	O	7139
people	O	7139
with	O	7139
aniridia	B-Disease	7139
,	O	7139
uncomplicated	O	7139
by	O	7139
associated	O	7139
anomalies	O	7139
,	O	7139
carry	O	7139
mutations	O	7139
in	O	7139
the	O	7139
human	O	7139
pax6	O	7139
gene	O	7139
.	O	7139
insulin	O	7148
gene	O	7148
region	O	7148
contributes	O	7148
to	O	7148
genetic	O	7148
susceptibility	O	7148
to	O	7148
,	O	7148
but	O	7148
may	O	7148
not	O	7148
to	O	7148
low	O	7148
incidence	O	7148
of	O	7148
,	O	7148
insulin	B-Disease	7148
-	I-Disease	7148
dependent	I-Disease	7148
diabetes	I-Disease	7148
mellitus	I-Disease	7148
in	O	7148
japanese	O	7148
.	O	7148
in	O	7149
the	O	7149
caucasian	O	7149
population	O	7149
,	O	7149
it	O	7149
has	O	7149
been	O	7149
demonstrated	O	7149
that	O	7149
the	O	7149
insulin	O	7149
gene	O	7149
(	O	7149
ins	O	7149
)	O	7149
region	O	7149
contains	O	7149
the	O	7149
insulin	B-Disease	7149
-	I-Disease	7149
dependent	I-Disease	7149
diabetes	I-Disease	7149
mellitus	I-Disease	7149
locus	O	7149
(	O	7149
iddm2	O	7149
)	O	7149
.	O	7149
in	O	7150
the	O	7150
japanese	O	7150
population	O	7150
,	O	7150
however	O	7150
,	O	7150
there	O	7150
has	O	7150
been	O	7150
no	O	7150
report	O	7150
demonstrating	O	7150
the	O	7150
contribution	O	7150
of	O	7150
iddm2	O	7150
to	O	7150
the	O	7150
pathogenesis	O	7150
of	O	7150
iddm	B-Disease	7150
.	O	7150
we	O	7151
conducted	O	7151
an	O	7151
association	O	7151
study	O	7151
of	O	7151
iddm	B-Disease	7151
in	O	7151
a	O	7151
large	O	7151
number	O	7151
of	O	7151
japanese	O	7151
subjects	O	7151
with	O	7151
multiple	O	7151
polymorphisms	O	7151
in	O	7151
ins	O	7151
region	O	7151
.	O	7151
we	O	7152
found	O	7152
a	O	7152
significant	O	7152
association	O	7152
of	O	7152
the	O	7152
ins	O	7152
region	O	7152
with	O	7152
iddm	B-Disease	7152
.	O	7152
alleles	O	7153
positively	O	7153
associated	O	7153
with	O	7153
iddm	B-Disease	7153
in	O	7153
ins	O	7153
region	O	7153
were	O	7153
the	O	7153
same	O	7153
as	O	7153
those	O	7153
positively	O	7153
-	O	7153
associated	O	7153
with	O	7153
iddm	B-Disease	7153
in	O	7153
caucasian	O	7153
population	O	7153
,	O	7153
although	O	7153
positively	O	7153
-	O	7153
associated	O	7153
alleles	O	7153
are	O	7153
very	O	7153
common	O	7153
(	O	7153
allele	O	7153
frequencies	O	7153
>	O	7153
0	O	7153
.	O	7153
9	O	7153
)	O	7153
in	O	7153
the	O	7153
japanese	O	7153
general	O	7153
population	O	7153
.	O	7153
these	O	7154
data	O	7154
suggest	O	7154
that	O	7154
iddm2	O	7154
is	O	7154
involved	O	7154
in	O	7154
the	O	7154
genetic	O	7154
susceptibility	O	7154
to	O	7154
iddm	B-Disease	7154
in	O	7154
japanese	O	7154
.	O	7154
the	O	7155
high	O	7155
frequencies	O	7155
of	O	7155
disease	O	7155
-	O	7155
associated	O	7155
alleles	O	7155
in	O	7155
the	O	7155
general	O	7155
population	O	7155
suggest	O	7155
that	O	7155
iddm2	O	7155
locus	O	7155
is	O	7155
not	O	7155
responsible	O	7155
for	O	7155
the	O	7155
low	O	7155
incidence	O	7155
of	O	7155
iddm	B-Disease	7155
in	O	7155
japanese	O	7155
.	O	7155
deficiency	B-Disease	7159
of	I-Disease	7159
terminal	I-Disease	7159
complement	I-Disease	7159
components	I-Disease	7159
is	O	7159
generally	O	7159
associated	O	7159
with	O	7159
recurrent	O	7159
neisseria	B-Disease	7159
infections	I-Disease	7159
.	O	7159
we	O	7160
studied	O	7160
a	O	7160
previously	O	7160
described	O	7160
swiss	O	7160
family	O	7160
with	O	7160
inherited	B-Disease	7160
c9	I-Disease	7160
deficiency	I-Disease	7160
.	O	7160
to	O	7161
identify	O	7161
the	O	7161
genetic	O	7161
basis	O	7161
of	O	7161
c9	B-Disease	7161
deficiency	I-Disease	7161
,	O	7161
we	O	7161
developed	O	7161
an	O	7161
approach	O	7161
using	O	7161
exon	O	7161
-	O	7161
specific	O	7161
pcr	O	7161
and	O	7161
direct	O	7161
dna	O	7161
sequencing	O	7161
.	O	7161
as	O	7162
a	O	7162
cause	O	7162
of	O	7162
c9	B-Disease	7162
deficiency	I-Disease	7162
,	O	7162
we	O	7162
found	O	7162
two	O	7162
different	O	7162
point	O	7162
mutations	O	7162
,	O	7162
both	O	7162
generating	O	7162
tga	O	7162
stop	O	7162
codons	O	7162
in	O	7162
the	O	7162
coding	O	7162
sequence	O	7162
.	O	7162
in	O	7164
family	O	7164
studies	O	7164
of	O	7164
three	O	7164
first	O	7164
-	O	7164
degree	O	7164
relatives	O	7164
with	O	7164
heterozygous	O	7164
c9	B-Disease	7164
deficiency	I-Disease	7164
,	O	7164
we	O	7164
demonstrated	O	7164
that	O	7164
the	O	7164
two	O	7164
mutations	O	7164
are	O	7164
segregating	O	7164
independently	O	7164
.	O	7164
brca1	O	7169
mutations	O	7169
in	O	7169
women	O	7169
attending	O	7169
clinics	O	7169
that	O	7169
evaluate	O	7169
the	O	7169
risk	O	7169
of	O	7169
breast	B-Disease	7169
cancer	I-Disease	7169
.	O	7169
background	O	7170
to	O	7170
define	O	7170
the	O	7170
incidence	O	7170
of	O	7170
brca1	O	7170
mutations	O	7170
among	O	7170
patients	O	7170
seen	O	7170
in	O	7170
clinics	O	7170
that	O	7170
evaluate	O	7170
the	O	7170
risk	O	7170
of	O	7170
breast	B-Disease	7170
cancer	I-Disease	7170
,	O	7170
we	O	7170
analyzed	O	7170
dna	O	7170
samples	O	7170
from	O	7170
women	O	7170
seen	O	7170
in	O	7170
this	O	7170
setting	O	7170
and	O	7170
constructed	O	7170
probability	O	7170
tables	O	7170
to	O	7170
provide	O	7170
estimates	O	7170
of	O	7170
the	O	7170
likelihood	O	7170
of	O	7170
finding	O	7170
a	O	7170
brca1	O	7170
mutation	O	7170
in	O	7170
individual	O	7170
families	O	7170
.	O	7170
methods	O	7171
clinical	O	7171
information	O	7171
,	O	7171
family	O	7171
histories	O	7171
,	O	7171
and	O	7171
blood	O	7171
for	O	7171
dna	O	7171
analysis	O	7171
were	O	7171
obtained	O	7171
from	O	7171
263	O	7171
women	O	7171
with	O	7171
breast	B-Disease	7171
cancer	I-Disease	7171
.	O	7171
results	O	7173
brca1	O	7173
mutations	O	7173
were	O	7173
identified	O	7173
in	O	7173
16	O	7173
percent	O	7173
of	O	7173
women	O	7173
with	O	7173
a	O	7173
family	O	7173
history	O	7173
of	O	7173
breast	B-Disease	7173
cancer	I-Disease	7173
.	O	7173
only	O	7174
7	O	7174
percent	O	7174
of	O	7174
women	O	7174
from	O	7174
families	O	7174
with	O	7174
a	O	7174
history	O	7174
of	O	7174
breast	B-Disease	7174
cancer	I-Disease	7174
but	O	7174
not	O	7174
ovarian	B-Disease	7174
cancer	I-Disease	7174
had	O	7174
brca1	O	7174
mutations	O	7174
.	O	7174
the	O	7175
rates	O	7175
were	O	7175
higher	O	7175
among	O	7175
women	O	7175
from	O	7175
families	O	7175
with	O	7175
a	O	7175
history	O	7175
of	O	7175
both	O	7175
breast	B-Disease	7175
and	I-Disease	7175
ovarian	I-Disease	7175
cancer	I-Disease	7175
.	O	7175
among	O	7176
family	O	7176
members	O	7176
,	O	7176
an	O	7176
average	O	7176
age	O	7176
of	O	7176
less	O	7176
than	O	7176
55	O	7176
years	O	7176
at	O	7176
the	O	7176
diagnosis	O	7176
of	O	7176
breast	B-Disease	7176
cancer	I-Disease	7176
,	O	7176
the	O	7176
presence	O	7176
of	O	7176
ovarian	B-Disease	7176
cancer	I-Disease	7176
,	O	7176
the	O	7176
presence	O	7176
of	O	7176
breast	B-Disease	7176
and	I-Disease	7176
ovarian	I-Disease	7176
cancer	I-Disease	7176
in	O	7176
the	O	7176
same	O	7176
woman	O	7176
,	O	7176
and	O	7176
ashkenazi	O	7176
jewish	O	7176
ancestry	O	7176
were	O	7176
all	O	7176
associated	O	7176
with	O	7176
an	O	7176
increased	O	7176
risk	O	7176
of	O	7176
detecting	O	7176
a	O	7176
brca1	O	7176
mutation	O	7176
.	O	7176
no	O	7177
association	O	7177
was	O	7177
found	O	7177
between	O	7177
the	O	7177
presence	O	7177
of	O	7177
bilateral	O	7177
breast	B-Disease	7177
cancer	I-Disease	7177
or	O	7177
the	O	7177
number	O	7177
of	O	7177
breast	B-Disease	7177
cancers	I-Disease	7177
in	O	7177
a	O	7177
family	O	7177
and	O	7177
the	O	7177
detection	O	7177
of	O	7177
a	O	7177
brca1	O	7177
mutation	O	7177
,	O	7177
or	O	7177
between	O	7177
the	O	7177
position	O	7177
of	O	7177
the	O	7177
mutation	O	7177
in	O	7177
the	O	7177
brca1	O	7177
gene	O	7177
and	O	7177
the	O	7177
presence	O	7177
of	O	7177
ovarian	B-Disease	7177
cancer	I-Disease	7177
in	O	7177
a	O	7177
family	O	7177
.	O	7177
conclusions	O	7178
among	O	7178
women	O	7178
with	O	7178
breast	B-Disease	7178
cancer	I-Disease	7178
and	O	7178
a	O	7178
family	O	7178
history	O	7178
of	O	7178
the	O	7178
disease	O	7178
,	O	7178
the	O	7178
percentage	O	7178
with	O	7178
brca1	O	7178
coding	O	7178
-	O	7178
region	O	7178
mutations	O	7178
is	O	7178
less	O	7178
than	O	7178
the	O	7178
45	O	7178
percent	O	7178
predicted	O	7178
by	O	7178
genetic	O	7178
-	O	7178
linkage	O	7178
analysis	O	7178
.	O	7178
mutations	O	7180
in	O	7180
the	O	7180
arginine	O	7180
-	O	7180
rich	O	7180
protein	O	7180
gene	O	7180
(	O	7180
arp	O	7180
)	O	7180
in	O	7180
pancreatic	B-Disease	7180
cancer	I-Disease	7180
.	O	7180
at	O	7183
the	O	7183
cytogenetic	O	7183
level	O	7183
this	O	7183
region	O	7183
is	O	7183
frequently	O	7183
deleted	O	7183
in	O	7183
a	O	7183
variety	O	7183
of	O	7183
different	O	7183
solid	B-Disease	7183
tumors	I-Disease	7183
,	O	7183
although	O	7183
not	O	7183
in	O	7183
pancreatic	B-Disease	7183
cancer	I-Disease	7183
.	O	7183
we	O	7184
have	O	7184
reported	O	7184
the	O	7184
presence	O	7184
of	O	7184
a	O	7184
specific	O	7184
mutation	O	7184
(	O	7184
atg50	O	7184
-	O	7184
-	O	7184
>	O	7184
agg	O	7184
)	O	7184
or	O	7184
deletion	O	7184
of	O	7184
codon	O	7184
50	O	7184
of	O	7184
the	O	7184
arp	O	7184
gene	O	7184
in	O	7184
different	O	7184
tumor	B-Disease	7184
types	I-Disease	7184
(	O	7184
shridhar	O	7184
et	O	7184
al	O	7184
.	O	7184
,	O	7184
1996	O	7184
,	O	7184
1996a	O	7184
)	O	7184
.	O	7184
in	O	7185
the	O	7185
present	O	7185
study	O	7185
,	O	7185
we	O	7185
have	O	7185
observed	O	7185
mutations	O	7185
involving	O	7185
codon	O	7185
50	O	7185
in	O	7185
11	O	7185
of	O	7185
37	O	7185
pancreatic	B-Disease	7185
tumors	I-Disease	7185
.	O	7185
the	O	7186
frequency	O	7186
of	O	7186
codon	O	7186
50	O	7186
mutation	O	7186
is	O	7186
roughly	O	7186
the	O	7186
same	O	7186
in	O	7186
pancreatic	B-Disease	7186
tumors	I-Disease	7186
as	O	7186
in	O	7186
the	O	7186
other	O	7186
types	O	7186
of	O	7186
tumors	B-Disease	7186
previously	O	7186
examined	O	7186
.	O	7186
in	O	7187
addition	O	7187
,	O	7187
we	O	7187
have	O	7187
detected	O	7187
mutations	O	7187
at	O	7187
codon	O	7187
51	O	7187
in	O	7187
multiple	O	7187
pcr	O	7187
subclones	O	7187
in	O	7187
two	O	7187
other	O	7187
pancreatic	B-Disease	7187
tumors	I-Disease	7187
.	O	7187
mutations	O	7188
in	O	7188
the	O	7188
arp	O	7188
gene	O	7188
are	O	7188
thus	O	7188
commonly	O	7188
observed	O	7188
in	O	7188
pancreatic	B-Disease	7188
cancer	I-Disease	7188
,	O	7188
as	O	7188
well	O	7188
as	O	7188
many	O	7188
other	O	7188
cancers	B-Disease	7188
.	O	7188
difficulties	O	7189
in	O	7189
the	O	7189
ascertainment	O	7189
of	O	7189
c9	B-Disease	7189
deficiency	I-Disease	7189
:	O	7189
lessons	O	7189
to	O	7189
be	O	7189
drawn	O	7189
from	O	7189
a	O	7189
compound	O	7189
heterozygote	O	7189
c9	B-Disease	7189
-	I-Disease	7189
deficient	I-Disease	7189
subject	O	7189
.	O	7189
the	O	7193
patient	O	7193
was	O	7193
shown	O	7193
to	O	7193
be	O	7193
heterozygous	O	7193
for	O	7193
dna	O	7193
markers	O	7193
in	O	7193
the	O	7193
c6	O	7193
,	O	7193
c7	O	7193
and	O	7193
c9	O	7193
region	O	7193
of	O	7193
chromosome	O	7193
5	O	7193
and	O	7193
therefore	O	7193
appears	O	7193
to	O	7193
be	O	7193
a	O	7193
compound	O	7193
heterozygote	O	7193
for	O	7193
two	O	7193
uncharacterized	O	7193
c9	B-Disease	7193
deficiency	I-Disease	7193
genes	O	7193
.	O	7193
we	O	7196
hypothesize	O	7196
that	O	7196
the	O	7196
patient	O	7196
is	O	7196
heterozygous	O	7196
for	O	7196
a	O	7196
complete	B-Disease	7196
deficiency	I-Disease	7196
of	I-Disease	7196
c9	I-Disease	7196
and	O	7196
for	O	7196
a	O	7196
gene	O	7196
directing	O	7196
hyposynthesis	O	7196
of	O	7196
a	O	7196
defective	O	7196
c9	O	7196
.	O	7196
we	O	7197
also	O	7197
suggest	O	7197
that	O	7197
c9	B-Disease	7197
deficiency	I-Disease	7197
may	O	7197
be	O	7197
more	O	7197
common	O	7197
among	O	7197
caucasians	O	7197
than	O	7197
has	O	7197
been	O	7197
reported	O	7197
.	O	7197
.	O	7197
screening	O	7198
for	O	7198
esr	O	7198
mutations	O	7198
in	O	7198
breast	B-Disease	7198
and	I-Disease	7198
ovarian	I-Disease	7198
cancer	I-Disease	7198
patients	O	7198
.	O	7198
in	O	7199
the	O	7199
present	O	7199
study	O	7199
,	O	7199
leukocyte	O	7199
dna	O	7199
from	O	7199
143	O	7199
patients	O	7199
with	O	7199
familial	O	7199
clustering	O	7199
of	O	7199
breast	B-Disease	7199
and	I-Disease	7199
/	I-Disease	7199
or	I-Disease	7199
ovarian	I-Disease	7199
cancer	I-Disease	7199
and	O	7199
tumour	B-Disease	7199
dna	O	7199
from	O	7199
96	O	7199
breast	B-Disease	7199
carcinomas	I-Disease	7199
were	O	7199
screened	O	7199
for	O	7199
base	O	7199
mutations	O	7199
in	O	7199
the	O	7199
estrogen	O	7199
receptor	O	7199
gene	O	7199
(	O	7199
esr	O	7199
)	O	7199
.	O	7199
three	O	7200
patients	O	7200
with	O	7200
a	O	7200
family	O	7200
history	O	7200
of	O	7200
cancer	B-Disease	7200
were	O	7200
carrying	O	7200
a	O	7200
gly160cys	O	7200
germline	O	7200
substitution	O	7200
.	O	7200
however	O	7202
,	O	7202
in	O	7202
the	O	7202
229	O	7202
female	O	7202
controls	O	7202
in	O	7202
whom	O	7202
family	O	7202
history	O	7202
of	O	7202
cancer	B-Disease	7202
was	O	7202
known	O	7202
,	O	7202
one	O	7202
of	O	7202
two	O	7202
who	O	7202
had	O	7202
a	O	7202
sister	O	7202
with	O	7202
breast	B-Disease	7202
cancer	I-Disease	7202
was	O	7202
carrying	O	7202
the	O	7202
variant	O	7202
allele	O	7202
.	O	7202
somatic	O	7204
mutations	O	7204
were	O	7204
not	O	7204
detected	O	7204
in	O	7204
any	O	7204
of	O	7204
the	O	7204
tumours	B-Disease	7204
studied	O	7204
,	O	7204
and	O	7204
the	O	7204
present	O	7204
data	O	7204
do	O	7204
not	O	7204
provide	O	7204
support	O	7204
for	O	7204
somatic	O	7204
esr	O	7204
base	O	7204
mutations	O	7204
as	O	7204
an	O	7204
important	O	7204
mechanism	O	7204
for	O	7204
hormonal	O	7204
therapy	O	7204
resistance	O	7204
in	O	7204
estrogen	B-Disease	7204
receptor	I-Disease	7204
-	I-Disease	7204
positive	I-Disease	7204
breast	I-Disease	7204
carcinomas	I-Disease	7204
.	O	7204
.	O	7204
molecular	O	7205
bases	O	7205
of	O	7205
c7	B-Disease	7205
deficiency	I-Disease	7205
:	O	7205
three	O	7205
different	O	7205
defects	O	7205
.	O	7205
the	O	7206
molecular	O	7206
basis	O	7206
of	O	7206
c7	B-Disease	7206
deficiency	I-Disease	7206
has	O	7206
been	O	7206
investigated	O	7206
in	O	7206
two	O	7206
irish	O	7206
families	O	7206
and	O	7206
a	O	7206
number	O	7206
of	O	7206
israeli	O	7206
families	O	7206
of	O	7206
moroccan	O	7206
sephardic	O	7206
jewish	O	7206
origin	O	7206
.	O	7206
the	O	7210
israeli	O	7210
c7	B-Disease	7210
-	I-Disease	7210
deficient	I-Disease	7210
cases	O	7210
all	O	7210
share	O	7210
a	O	7210
c7	O	7210
haplotype	O	7210
and	O	7210
are	O	7210
homozygous	O	7210
for	O	7210
a	O	7210
mis	O	7210
-	O	7210
sense	O	7210
mutation	O	7210
in	O	7210
exon	O	7210
9	O	7210
.	O	7210
molecular	O	7212
heterogeneity	O	7212
of	O	7212
classical	B-Disease	7212
and	I-Disease	7212
duarte	I-Disease	7212
galactosemia	I-Disease	7212
:	O	7212
mutation	O	7212
analysis	O	7212
by	O	7212
denaturing	O	7212
gradient	O	7212
gel	O	7212
electrophoresis	O	7212
.	O	7212
classical	B-Disease	7213
galactosemia	I-Disease	7213
is	O	7213
caused	O	7213
by	O	7213
one	O	7213
common	O	7213
missense	O	7213
mutation	O	7213
(	O	7213
q188r	O	7213
)	O	7213
and	O	7213
by	O	7213
several	O	7213
rare	O	7213
mutations	O	7213
in	O	7213
the	O	7213
galactose	O	7213
-	O	7213
1	O	7213
-	O	7213
phosphate	O	7213
uridyltransferase	O	7213
(	O	7213
galt	O	7213
)	O	7213
gene	O	7213
.	O	7213
to	O	7216
study	O	7216
the	O	7216
molecular	O	7216
genetics	O	7216
of	O	7216
classical	B-Disease	7216
and	I-Disease	7216
duarte	I-Disease	7216
galactosemia	I-Disease	7216
,	O	7216
we	O	7216
analyzed	O	7216
the	O	7216
galt	O	7216
mutations	O	7216
in	O	7216
30	O	7216
families	O	7216
with	O	7216
classical	B-Disease	7216
galactosemia	I-Disease	7216
,	O	7216
in	O	7216
10	O	7216
families	O	7216
with	O	7216
the	O	7216
d	O	7216
-	O	7216
2	O	7216
variant	O	7216
and	O	7216
in	O	7216
3	O	7216
individuals	O	7216
carrying	O	7216
the	O	7216
d	O	7216
-	O	7216
1	O	7216
allele	O	7216
by	O	7216
denaturing	O	7216
gradient	O	7216
gel	O	7216
electrophoresis	O	7216
(	O	7216
dgge	O	7216
)	O	7216
.	O	7216
dgge	O	7217
detected	O	7217
59	O	7217
of	O	7217
the	O	7217
60	O	7217
classical	O	7217
galactosemia	B-Disease	7217
alleles	O	7217
.	O	7217
eight	O	7219
novel	O	7219
candidate	O	7219
galactosemia	B-Disease	7219
mutations	O	7219
were	O	7219
found	O	7219
.	O	7219
we	O	7221
conclude	O	7221
that	O	7221
the	O	7221
mutations	O	7221
causing	O	7221
galactosemia	B-Disease	7221
are	O	7221
highly	O	7221
heterogeneous	O	7221
and	O	7221
that	O	7221
k285n	O	7221
is	O	7221
a	O	7221
second	O	7221
common	O	7221
galactosemia	B-Disease	7221
mutation	O	7221
in	O	7221
our	O	7221
population	O	7221
.	O	7221
.	O	7221
isolation	O	7222
of	O	7222
full	O	7222
-	O	7222
length	O	7222
atm	O	7222
cdna	O	7222
and	O	7222
correction	O	7222
of	O	7222
the	O	7222
ataxia	B-Disease	7222
-	I-Disease	7222
telangiectasia	I-Disease	7222
cellular	O	7222
phenotype	O	7222
.	O	7222
a	O	7223
gene	O	7223
mutated	O	7223
in	O	7223
the	O	7223
human	O	7223
genetic	B-Disease	7223
disorder	I-Disease	7223
ataxia	B-Disease	7223
-	I-Disease	7223
telangiectasia	I-Disease	7223
(	O	7223
a	B-Disease	7223
-	I-Disease	7223
t	I-Disease	7223
)	O	7223
,	O	7223
atm	O	7223
,	O	7223
was	O	7223
recently	O	7223
identified	O	7223
by	O	7223
positional	O	7223
cloning	O	7223
.	O	7223
we	O	7225
describe	O	7225
herein	O	7225
,	O	7225
to	O	7225
our	O	7225
knowledge	O	7225
,	O	7225
for	O	7225
the	O	7225
first	O	7225
time	O	7225
,	O	7225
the	O	7225
cloning	O	7225
of	O	7225
a	O	7225
full	O	7225
-	O	7225
length	O	7225
cdna	O	7225
for	O	7225
atm	O	7225
and	O	7225
correction	O	7225
of	O	7225
multiple	O	7225
aspects	O	7225
of	O	7225
the	O	7225
radio	O	7225
-	O	7225
sensitive	O	7225
phenotype	O	7225
of	O	7225
a	B-Disease	7225
-	I-Disease	7225
t	I-Disease	7225
cells	O	7225
by	O	7225
transfection	O	7225
with	O	7225
this	O	7225
cdna	O	7225
.	O	7225
overexpression	O	7226
of	O	7226
atm	O	7226
cdna	O	7226
in	O	7226
a	B-Disease	7226
-	I-Disease	7226
t	I-Disease	7226
cells	O	7226
enhanced	O	7226
the	O	7226
survival	O	7226
of	O	7226
these	O	7226
cells	O	7226
in	O	7226
response	O	7226
to	O	7226
radiation	O	7226
exposure	O	7226
,	O	7226
decreased	O	7226
radiation	O	7226
-	O	7226
induced	O	7226
chromosome	O	7226
aberrations	O	7226
,	O	7226
reduced	O	7226
radio	O	7226
-	O	7226
resistant	O	7226
dna	O	7226
synthesis	O	7226
,	O	7226
and	O	7226
partially	O	7226
corrected	O	7226
defective	O	7226
cell	O	7226
cycle	O	7226
checkpoints	O	7226
and	O	7226
induction	O	7226
of	O	7226
stress	O	7226
-	O	7226
activated	O	7226
protein	O	7226
kinase	O	7226
.	O	7226
this	O	7227
correction	O	7227
of	O	7227
the	O	7227
defects	O	7227
in	O	7227
a	B-Disease	7227
-	I-Disease	7227
t	I-Disease	7227
cells	O	7227
provides	O	7227
further	O	7227
evidence	O	7227
of	O	7227
the	O	7227
multiplicity	O	7227
of	O	7227
effector	O	7227
functions	O	7227
of	O	7227
the	O	7227
atm	O	7227
protein	O	7227
and	O	7227
suggests	O	7227
possible	O	7227
approaches	O	7227
to	O	7227
gene	O	7227
therapy	O	7227
.	O	7227
.	O	7227
fusion	O	7228
genes	O	7228
resulting	O	7228
from	O	7228
alternative	O	7228
chromosomal	O	7228
translocations	O	7228
are	O	7228
overexpressed	O	7228
by	O	7228
gene	O	7228
-	O	7228
specific	O	7228
mechanisms	O	7228
in	O	7228
alveolar	B-Disease	7228
rhabdomyosarcoma	I-Disease	7228
.	O	7228
chromosomal	O	7229
translocations	O	7229
identified	O	7229
in	O	7229
hematopoietic	B-Disease	7229
and	I-Disease	7229
solid	I-Disease	7229
tumors	I-Disease	7229
result	O	7229
in	O	7229
deregulated	O	7229
expression	O	7229
of	O	7229
protooncogenes	O	7229
or	O	7229
creation	O	7229
of	O	7229
chimeric	O	7229
proteins	O	7229
with	O	7229
tumorigenic	O	7229
potential	O	7229
.	O	7229
in	O	7230
the	O	7230
pediatric	O	7230
solid	B-Disease	7230
tumor	I-Disease	7230
alveolar	B-Disease	7230
rhabdomyosarcoma	I-Disease	7230
,	O	7230
a	O	7230
consistent	O	7230
t	O	7230
(	O	7230
2	O	7230
;	O	7230
13	O	7230
)	O	7230
(	O	7230
q35	O	7230
;	O	7230
q14	O	7230
)	O	7230
or	O	7230
variant	O	7230
t	O	7230
(	O	7230
1	O	7230
;	O	7230
13	O	7230
)	O	7230
(	O	7230
p36	O	7230
;	O	7230
q14	O	7230
)	O	7230
translocation	O	7230
generates	O	7230
pax3	O	7230
-	O	7230
fkhr	O	7230
or	O	7230
pax7	O	7230
-	O	7230
fkhr	O	7230
fusion	O	7230
proteins	O	7230
,	O	7230
respectively	O	7230
.	O	7230
thus	O	7235
,	O	7235
gene	O	7235
-	O	7235
specific	O	7235
mechanisms	O	7235
were	O	7235
selected	O	7235
to	O	7235
overexpress	O	7235
pax3	O	7235
-	O	7235
fkhr	O	7235
and	O	7235
pax7	O	7235
-	O	7235
fkhr	O	7235
in	O	7235
alveolar	B-Disease	7235
rhabdomyosarcoma	I-Disease	7235
,	O	7235
presumably	O	7235
due	O	7235
to	O	7235
differences	O	7235
in	O	7235
regulation	O	7235
between	O	7235
the	O	7235
wild	O	7235
-	O	7235
type	O	7235
loci	O	7235
.	O	7235
atm	O	7237
and	O	7237
p53	O	7237
cooperate	O	7237
in	O	7237
apoptosis	O	7237
and	O	7237
suppression	O	7237
of	O	7237
tumorigenesis	O	7237
,	O	7237
but	O	7237
not	O	7237
in	O	7237
resistance	O	7237
to	O	7237
acute	B-Disease	7237
radiation	I-Disease	7237
toxicity	I-Disease	7237
.	O	7237
mutations	O	7238
in	O	7238
atm	O	7238
and	O	7238
p53	O	7238
cause	O	7238
the	O	7238
human	O	7238
cancer	B-Disease	7238
-	I-Disease	7238
associated	I-Disease	7238
diseases	I-Disease	7238
ataxia	B-Disease	7238
-	I-Disease	7238
telangiectasia	I-Disease	7238
and	O	7238
li	B-Disease	7238
-	I-Disease	7238
fraumeni	I-Disease	7238
syndrome	I-Disease	7238
,	O	7238
respectively	O	7238
.	O	7238
atm	O	7240
-	O	7240
null	O	7240
mice	O	7240
,	O	7240
as	O	7240
well	O	7240
as	O	7240
those	O	7240
null	O	7240
for	O	7240
p53	O	7240
,	O	7240
develop	O	7240
mainly	O	7240
t	B-Disease	7240
-	I-Disease	7240
cell	I-Disease	7240
lymphomas	I-Disease	7240
,	O	7240
supporting	O	7240
the	O	7240
view	O	7240
that	O	7240
these	O	7240
genes	O	7240
have	O	7240
similar	O	7240
roles	O	7240
in	O	7240
thymocyte	O	7240
development	O	7240
.	O	7240
mice	O	7242
doubly	O	7242
null	O	7242
for	O	7242
atm	O	7242
and	O	7242
p53	O	7242
exhibited	O	7242
a	O	7242
dramatic	O	7242
acceleration	O	7242
of	O	7242
tumour	B-Disease	7242
formation	O	7242
relative	O	7242
to	O	7242
singly	O	7242
null	O	7242
mice	O	7242
,	O	7242
indicating	O	7242
that	O	7242
both	O	7242
genes	O	7242
collaborate	O	7242
in	O	7242
a	O	7242
significant	O	7242
manner	O	7242
to	O	7242
prevent	O	7242
tumorigenesis	O	7242
.	O	7242
finally	O	7245
-	O	7245
and	O	7245
in	O	7245
contrast	O	7245
to	O	7245
prior	O	7245
predictions	O	7245
-	O	7245
atm	O	7245
and	O	7245
p53	O	7245
do	O	7245
not	O	7245
appear	O	7245
to	O	7245
interact	O	7245
in	O	7245
acute	B-Disease	7245
radiation	I-Disease	7245
toxicity	I-Disease	7245
,	O	7245
suggesting	O	7245
a	O	7245
separate	O	7245
atm	O	7245
effector	O	7245
pathway	O	7245
for	O	7245
this	O	7245
dna	O	7245
damage	O	7245
response	O	7245
and	O	7245
having	O	7245
implications	O	7245
for	O	7245
the	O	7245
prognosis	O	7245
and	O	7245
treatment	O	7245
of	O	7245
human	O	7245
tumours	B-Disease	7245
.	O	7245
.	O	7245
trinucleotide	O	7246
repeat	O	7246
expansion	O	7246
at	O	7246
the	O	7246
myotonic	B-Disease	7246
dystrophy	I-Disease	7246
locus	O	7246
reduces	O	7246
expression	O	7246
of	O	7246
dmahp	O	7246
.	O	7246
myotonic	B-Disease	7247
dystrophy	I-Disease	7247
,	O	7247
or	O	7247
dystrophia	B-Disease	7247
myotonica	I-Disease	7247
(	O	7247
dm	B-Disease	7247
)	O	7247
,	O	7247
is	O	7247
an	O	7247
autosomal	B-Disease	7247
dominant	I-Disease	7247
multisystem	I-Disease	7247
disorder	I-Disease	7247
caused	O	7247
by	O	7247
the	O	7247
expansion	O	7247
of	O	7247
a	O	7247
ctg	O	7247
trinucleotide	O	7247
repeat	O	7247
in	O	7247
the	O	7247
3	O	7247
untranslated	O	7247
region	O	7247
of	O	7247
the	O	7247
dmpk	O	7247
protein	O	7247
kinase	O	7247
gene	O	7247
on	O	7247
chromosome	O	7247
19q13	O	7247
.	O	7247
although	O	7249
the	O	7249
dm	B-Disease	7249
mutation	O	7249
was	O	7249
identified	O	7249
more	O	7249
than	O	7249
five	O	7249
years	O	7249
ago	O	7249
,	O	7249
the	O	7249
pathogenic	O	7249
mechanisms	O	7249
underlying	O	7249
this	O	7249
most	O	7249
prevalent	O	7249
form	O	7249
of	O	7249
hereditary	O	7249
adult	O	7249
neuromuscular	B-Disease	7249
disease	I-Disease	7249
remain	O	7249
elusive	O	7249
.	O	7249
analysis	O	7252
of	O	7252
dmahp	O	7252
expression	O	7252
in	O	7252
the	O	7252
cells	O	7252
of	O	7252
dm	B-Disease	7252
patients	O	7252
with	O	7252
loss	O	7252
of	O	7252
the	O	7252
hypersensitive	O	7252
site	O	7252
revealed	O	7252
a	O	7252
two	O	7252
-	O	7252
to	O	7252
fourfold	O	7252
reduction	O	7252
in	O	7252
steady	O	7252
-	O	7252
state	O	7252
dmahp	O	7252
transcript	O	7252
levels	O	7252
relative	O	7252
to	O	7252
wild	O	7252
-	O	7252
type	O	7252
controls	O	7252
.	O	7252
together	O	7254
,	O	7254
these	O	7254
results	O	7254
demonstrate	O	7254
that	O	7254
ctg	O	7254
-	O	7254
repeat	O	7254
expansions	O	7254
can	O	7254
suppress	O	7254
local	O	7254
gene	O	7254
expression	O	7254
and	O	7254
implicate	O	7254
dmahp	O	7254
in	O	7254
dm	B-Disease	7254
pathogenesis	O	7254
.	O	7254
constitutively	O	7255
methylated	O	7255
cpg	O	7255
dinucleotides	O	7255
as	O	7255
mutation	O	7255
hot	O	7255
spots	O	7255
in	O	7255
the	O	7255
retinoblastoma	B-Disease	7255
gene	O	7255
(	O	7255
rb1	O	7255
)	O	7255
.	O	7255
a	O	7256
wide	O	7256
spectrum	O	7256
of	O	7256
mutations	O	7256
,	O	7256
ranging	O	7256
from	O	7256
point	O	7256
mutations	O	7256
to	O	7256
large	O	7256
deletions	O	7256
,	O	7256
have	O	7256
been	O	7256
described	O	7256
in	O	7256
the	O	7256
retinoblastoma	B-Disease	7256
gene	O	7256
(	O	7256
rb1	O	7256
)	O	7256
.	O	7256
the	O	7265
von	B-Disease	7265
hippel	I-Disease	7265
-	I-Disease	7265
lindau	I-Disease	7265
tumor	I-Disease	7265
suppressor	O	7265
gene	O	7265
product	O	7265
interacts	O	7265
with	O	7265
sp1	O	7265
to	O	7265
repress	O	7265
vascular	O	7265
endothelial	O	7265
growth	O	7265
factor	O	7265
promoter	O	7265
activity	O	7265
.	O	7265
the	O	7266
von	B-Disease	7266
hippel	I-Disease	7266
-	I-Disease	7266
lindau	I-Disease	7266
tumor	I-Disease	7266
suppressor	O	7266
gene	O	7266
(	O	7266
vhl	O	7266
)	O	7266
has	O	7266
a	O	7266
critical	O	7266
role	O	7266
in	O	7266
the	O	7266
pathogenesis	O	7266
of	O	7266
clear	B-Disease	7266
-	I-Disease	7266
cell	I-Disease	7266
renal	I-Disease	7266
cell	I-Disease	7266
carcinoma	I-Disease	7266
(	O	7266
rcc	B-Disease	7266
)	O	7266
,	O	7266
as	O	7266
vhl	O	7266
mutations	O	7266
have	O	7266
been	O	7266
found	O	7266
in	O	7266
both	O	7266
von	B-Disease	7266
hippel	I-Disease	7266
-	I-Disease	7266
lindau	I-Disease	7266
disease	I-Disease	7266
-	I-Disease	7266
associated	I-Disease	7266
and	I-Disease	7266
sporadic	I-Disease	7266
rccs	I-Disease	7266
.	O	7266
recent	O	7267
studies	O	7267
suggest	O	7267
that	O	7267
vascular	O	7267
endothelial	O	7267
growth	O	7267
factor	O	7267
(	O	7267
vegf	O	7267
)	O	7267
mrna	O	7267
is	O	7267
upregulated	O	7267
in	O	7267
rcc	B-Disease	7267
-	I-Disease	7267
and	I-Disease	7267
von	I-Disease	7267
hippel	I-Disease	7267
-	I-Disease	7267
lindau	I-Disease	7267
disease	I-Disease	7267
-	I-Disease	7267
associated	I-Disease	7267
tumors	I-Disease	7267
.	O	7267
vegf	O	7269
promoter	O	7269
-	O	7269
luciferase	O	7269
constructs	O	7269
were	O	7269
transiently	O	7269
cotransfected	O	7269
with	O	7269
a	O	7269
wild	O	7269
-	O	7269
type	O	7269
vhl	O	7269
(	O	7269
wt	O	7269
-	O	7269
vhl	O	7269
)	O	7269
vector	O	7269
in	O	7269
several	O	7269
cell	O	7269
lines	O	7269
,	O	7269
including	O	7269
293	O	7269
embryonic	O	7269
kidney	O	7269
and	O	7269
rcc	B-Disease	7269
cell	O	7269
lines	O	7269
.	O	7269
furthermore	O	7275
,	O	7275
endogenous	O	7275
vegf	O	7275
mrna	O	7275
levels	O	7275
were	O	7275
suppressed	O	7275
in	O	7275
permanent	O	7275
rcc	B-Disease	7275
cell	O	7275
lines	O	7275
expressing	O	7275
wt	O	7275
-	O	7275
vhl	O	7275
,	O	7275
and	O	7275
nuclear	O	7275
run	O	7275
-	O	7275
on	O	7275
studies	O	7275
indicated	O	7275
that	O	7275
vhl	O	7275
regulation	O	7275
of	O	7275
vegf	O	7275
occurs	O	7275
at	O	7275
least	O	7275
partly	O	7275
at	O	7275
the	O	7275
transcriptional	O	7275
level	O	7275
.	O	7275
these	O	7276
observations	O	7276
support	O	7276
a	O	7276
new	O	7276
mechanism	O	7276
for	O	7276
vhl	O	7276
-	O	7276
mediated	O	7276
transcriptional	O	7276
repression	O	7276
via	O	7276
a	O	7276
direct	O	7276
inhibitory	O	7276
action	O	7276
on	O	7276
sp1	O	7276
and	O	7276
suggest	O	7276
that	O	7276
loss	O	7276
of	O	7276
sp1	O	7276
inhibition	O	7276
may	O	7276
be	O	7276
important	O	7276
in	O	7276
the	O	7276
pathogenesis	O	7276
of	O	7276
von	B-Disease	7276
hippel	I-Disease	7276
-	I-Disease	7276
lindau	I-Disease	7276
disease	I-Disease	7276
and	O	7276
rcc	B-Disease	7276
.	O	7276
.	O	7276
adult	B-Disease	7277
onset	I-Disease	7277
globoid	I-Disease	7277
cell	I-Disease	7277
leukodystrophy	I-Disease	7277
(	O	7277
krabbe	B-Disease	7277
disease	I-Disease	7277
)	O	7277
:	O	7277
analysis	O	7277
of	O	7277
galactosylceramidase	O	7277
cdna	O	7277
from	O	7277
four	O	7277
japanese	O	7277
patients	O	7277
.	O	7277
we	O	7278
examined	O	7278
galactosylceramidase	O	7278
(	O	7278
galc	O	7278
)	O	7278
cdna	O	7278
in	O	7278
four	O	7278
japanese	O	7278
patients	O	7278
with	O	7278
adult	B-Disease	7278
onset	I-Disease	7278
globoid	I-Disease	7278
cell	I-Disease	7278
leukodystrophy	I-Disease	7278
(	O	7278
krabbe	B-Disease	7278
disease	I-Disease	7278
;	O	7278
ao	B-Disease	7278
-	I-Disease	7278
gld	I-Disease	7278
)	O	7278
by	O	7278
polymerase	O	7278
chain	O	7278
reaction	O	7278
/	O	7278
single	O	7278
-	O	7278
strand	O	7278
conformation	O	7278
polymorphism	O	7278
(	O	7278
pcr	O	7278
-	O	7278
sscp	O	7278
)	O	7278
analysis	O	7278
,	O	7278
subsequent	O	7278
sequence	O	7278
determination	O	7278
,	O	7278
and	O	7278
restriction	O	7278
enzyme	O	7278
digestion	O	7278
of	O	7278
pcr	O	7278
products	O	7278
,	O	7278
initial	O	7278
symptoms	O	7278
were	O	7278
the	O	7278
onset	O	7278
of	O	7278
slowly	O	7278
progressive	O	7278
spastic	B-Disease	7278
paraplegia	I-Disease	7278
from	O	7278
the	O	7278
middle	O	7278
of	O	7278
the	O	7278
second	O	7278
decade	O	7278
,	O	7278
and	O	7278
all	O	7278
patients	O	7278
had	O	7278
diminished	B-Disease	7278
galc	I-Disease	7278
activity	I-Disease	7278
in	O	7278
their	O	7278
leukocytes	O	7278
.	O	7278
three	O	7283
mutations	O	7283
,	O	7283
viz	O	7283
.	O	7283
,	O	7283
g270d	O	7283
,	O	7283
l618s	O	7283
,	O	7283
and	O	7283
exon	O	7283
-	O	7283
6	O	7283
skipping	O	7283
(	O	7283
535	O	7283
-	O	7283
573del	O	7283
)	O	7283
,	O	7283
produced	O	7283
diminished	B-Disease	7283
galc	I-Disease	7283
activity	I-Disease	7283
as	O	7283
expected	O	7283
.	O	7283
ao	B-Disease	7286
-	I-Disease	7286
gld	I-Disease	7286
mutations	O	7286
,	O	7286
including	O	7286
those	O	7286
found	O	7286
here	O	7286
,	O	7286
are	O	7286
located	O	7286
in	O	7286
the	O	7286
n	O	7286
-	O	7286
terminus	O	7286
(	O	7286
i66m	O	7286
,	O	7286
g270d	O	7286
,	O	7286
535	O	7286
-	O	7286
573del	O	7286
)	O	7286
or	O	7286
c	O	7286
-	O	7286
terminus	O	7286
(	O	7286
l618s	O	7286
)	O	7286
of	O	7286
the	O	7286
galc	O	7286
enzyme	O	7286
,	O	7286
whereas	O	7286
the	O	7286
reported	O	7286
mutations	O	7286
in	O	7286
the	O	7286
infantile	O	7286
form	O	7286
(	O	7286
if	B-Disease	7286
-	I-Disease	7286
gld	I-Disease	7286
)	O	7286
are	O	7286
in	O	7286
the	O	7286
central	O	7286
domain	O	7286
.	O	7286
this	O	7287
difference	O	7287
in	O	7287
mutation	O	7287
sites	O	7287
may	O	7287
affect	O	7287
the	O	7287
clinical	O	7287
features	O	7287
of	O	7287
gld	B-Disease	7287
.	O	7287
